Citrus Sinensis ID: 044494
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 144 | 2.2.26 [Sep-21-2011] | |||||||
| Q8VZG8 | 1045 | Probable LRR receptor-lik | yes | no | 0.993 | 0.136 | 0.657 | 1e-51 | |
| Q9LP24 | 1120 | Probable leucine-rich rep | no | no | 0.993 | 0.127 | 0.657 | 5e-50 | |
| Q9LHP4 | 1141 | Receptor-like protein kin | no | no | 0.930 | 0.117 | 0.532 | 6e-37 | |
| Q9LVP0 | 1102 | Probable leucine-rich rep | no | no | 0.923 | 0.120 | 0.551 | 9e-37 | |
| Q9SHI2 | 1101 | Leucine-rich repeat recep | no | no | 0.937 | 0.122 | 0.551 | 1e-36 | |
| C0LGV1 | 1135 | LRR receptor-like serine/ | no | no | 0.930 | 0.118 | 0.514 | 4e-36 | |
| C0LGX3 | 993 | LRR receptor-like serine/ | no | no | 0.916 | 0.132 | 0.546 | 5e-36 | |
| Q9M0G7 | 1013 | Leucine-rich repeat recep | no | no | 0.937 | 0.133 | 0.510 | 1e-35 | |
| Q9FRS6 | 1029 | Leucine-rich repeat recep | no | no | 0.937 | 0.131 | 0.485 | 3e-34 | |
| Q9FIZ3 | 1252 | LRR receptor-like serine/ | no | no | 0.930 | 0.107 | 0.489 | 5e-34 |
| >sp|Q8VZG8|Y4885_ARATH Probable LRR receptor-like serine/threonine-protein kinase At4g08850 OS=Arabidopsis thaliana GN=At4g08850 PE=1 SV=3 | Back alignment and function desciption |
|---|
Score = 201 bits (512), Expect = 1e-51, Method: Composition-based stats.
Identities = 94/143 (65%), Positives = 115/143 (80%)
Query: 2 HRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHR 61
HR+ FL+YEYME GSL VL D+EA LDW KR+N+VKG+AHALSY+HHD +P IVHR
Sbjct: 845 HRRNTFLVYEYMERGSLRKVLENDDEAKKLDWGKRINVVKGVAHALSYMHHDRSPAIVHR 904
Query: 62 DISSNNILLNLELEAFVADFGVARLLNFDSSNRTLLAGTYGYIAPELAYTMVVTEKSDVY 121
DISS NILL + EA ++DFG A+LL DSSN + +AGTYGY+APELAY M VTEK DVY
Sbjct: 905 DISSGNILLGEDYEAKISDFGTAKLLKPDSSNWSAVAGTYGYVAPELAYAMKVTEKCDVY 964
Query: 122 SFGVVALEVLMGKHPGELLSSSS 144
SFGV+ LEV+ G+HPG+L+S+ S
Sbjct: 965 SFGVLTLEVIKGEHPGDLVSTLS 987
|
Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q9LP24|Y1571_ARATH Probable leucine-rich repeat receptor-like protein kinase At1g35710 OS=Arabidopsis thaliana GN=At1g35710 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 196 bits (497), Expect = 5e-50, Method: Composition-based stats.
Identities = 94/143 (65%), Positives = 114/143 (79%)
Query: 2 HRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHR 61
HR+ FLIYEYME GSL +L DEEA L W KR+N+VKG+AHALSY+HHD PIVHR
Sbjct: 921 HRRHTFLIYEYMEKGSLNKLLANDEEAKRLTWTKRINVVKGVAHALSYMHHDRITPIVHR 980
Query: 62 DISSNNILLNLELEAFVADFGVARLLNFDSSNRTLLAGTYGYIAPELAYTMVVTEKSDVY 121
DISS NILL+ + A ++DFG A+LL DSSN + +AGTYGY+APE AYTM VTEK DVY
Sbjct: 981 DISSGNILLDNDYTAKISDFGTAKLLKTDSSNWSAVAGTYGYVAPEFAYTMKVTEKCDVY 1040
Query: 122 SFGVVALEVLMGKHPGELLSSSS 144
SFGV+ LE+++GKHPG+L+SS S
Sbjct: 1041 SFGVLILELIIGKHPGDLVSSLS 1063
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LHP4|RCH2_ARATH Receptor-like protein kinase 2 OS=Arabidopsis thaliana GN=RCH2 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 152 bits (384), Expect = 6e-37, Method: Composition-based stats.
Identities = 73/137 (53%), Positives = 94/137 (68%), Gaps = 3/137 (2%)
Query: 2 HRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHR 61
+R L+Y+YM GSL +L + LDW R I+ G A L+YLHHDC PPIVHR
Sbjct: 860 NRNTRLLMYDYMPNGSLGSLLH-ERRGSSLDWDLRYRILLGAAQGLAYLHHDCLPPIVHR 918
Query: 62 DISSNNILLNLELEAFVADFGVARLLNFDSSNR--TLLAGTYGYIAPELAYTMVVTEKSD 119
DI +NNIL+ L+ E ++ADFG+A+L++ R +AG+YGYIAPE Y+M +TEKSD
Sbjct: 919 DIKANNILIGLDFEPYIADFGLAKLVDEGDIGRCSNTVAGSYGYIAPEYGYSMKITEKSD 978
Query: 120 VYSFGVVALEVLMGKHP 136
VYS+GVV LEVL GK P
Sbjct: 979 VYSYGVVVLEVLTGKQP 995
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LVP0|Y5639_ARATH Probable leucine-rich repeat receptor-like protein kinase At5g63930 OS=Arabidopsis thaliana GN=At5g63930 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 151 bits (382), Expect = 9e-37, Method: Composition-based stats.
Identities = 75/136 (55%), Positives = 96/136 (70%), Gaps = 3/136 (2%)
Query: 2 HRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHR 61
H+ L+YEYM GSL +L + + LDW+KR I G A L+YLHHDC P I HR
Sbjct: 874 HQGSNLLLYEYMPKGSLGEILH--DPSCNLDWSKRFKIALGAAQGLAYLHHDCKPRIFHR 931
Query: 62 DISSNNILLNLELEAFVADFGVARLLNF-DSSNRTLLAGTYGYIAPELAYTMVVTEKSDV 120
DI SNNILL+ + EA V DFG+A++++ S + + +AG+YGYIAPE AYTM VTEKSD+
Sbjct: 932 DIKSNNILLDDKFEAHVGDFGLAKVIDMPHSKSMSAIAGSYGYIAPEYAYTMKVTEKSDI 991
Query: 121 YSFGVVALEVLMGKHP 136
YS+GVV LE+L GK P
Sbjct: 992 YSYGVVLLELLTGKAP 1007
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SHI2|Y1723_ARATH Leucine-rich repeat receptor-like serine/threonine-protein kinase At1g17230 OS=Arabidopsis thaliana GN=At1g17230 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 151 bits (381), Expect = 1e-36, Method: Composition-based stats.
Identities = 75/136 (55%), Positives = 92/136 (67%), Gaps = 1/136 (0%)
Query: 2 HRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHR 61
H+ L+YEYM GSL L+ E+ LDW R I G A L YLHHDC P IVHR
Sbjct: 866 HQNSNLLLYEYMSKGSLGEQLQRGEKNCLLDWNARYRIALGAAEGLCYLHHDCRPQIVHR 925
Query: 62 DISSNNILLNLELEAFVADFGVARLLNFD-SSNRTLLAGTYGYIAPELAYTMVVTEKSDV 120
DI SNNILL+ +A V DFG+A+L++ S + + +AG+YGYIAPE AYTM VTEK D+
Sbjct: 926 DIKSNNILLDERFQAHVGDFGLAKLIDLSYSKSMSAVAGSYGYIAPEYAYTMKVTEKCDI 985
Query: 121 YSFGVVALEVLMGKHP 136
YSFGVV LE++ GK P
Sbjct: 986 YSFGVVLLELITGKPP 1001
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGV1|RCH1_ARATH LRR receptor-like serine/threonine-protein kinase RCH1 OS=Arabidopsis thaliana GN=RCH1 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 149 bits (377), Expect = 4e-36, Method: Composition-based stats.
Identities = 71/138 (51%), Positives = 93/138 (67%), Gaps = 4/138 (2%)
Query: 2 HRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHR 61
++ L+Y+YM GSL +L L W R I+ G A L+YLHHDC PPIVHR
Sbjct: 860 NKNTRLLMYDYMSNGSLGSLLHERSGVCSLGWEVRYKIILGAAQGLAYLHHDCVPPIVHR 919
Query: 62 DISSNNILLNLELEAFVADFGVARLL---NFDSSNRTLLAGTYGYIAPELAYTMVVTEKS 118
DI +NNIL+ + E ++ DFG+A+L+ +F S+ T +AG+YGYIAPE Y+M +TEKS
Sbjct: 920 DIKANNILIGPDFEPYIGDFGLAKLVDDGDFARSSNT-IAGSYGYIAPEYGYSMKITEKS 978
Query: 119 DVYSFGVVALEVLMGKHP 136
DVYS+GVV LEVL GK P
Sbjct: 979 DVYSYGVVVLEVLTGKQP 996
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGX3|HSL2_ARATH LRR receptor-like serine/threonine-protein kinase HSL2 OS=Arabidopsis thaliana GN=HSL2 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 149 bits (376), Expect = 5e-36, Method: Composition-based stats.
Identities = 77/141 (54%), Positives = 98/141 (69%), Gaps = 9/141 (6%)
Query: 7 FLIYEYMEMGSLFCVLRTDEE--AVG-LDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDI 63
FL+YE+ME GSL VL +++E AV LDW R +I G A LSYLHHD PPIVHRD+
Sbjct: 759 FLVYEFMENGSLGDVLHSEKEHRAVSPLDWTTRFSIAVGAAQGLSYLHHDSVPPIVHRDV 818
Query: 64 SSNNILLNLELEAFVADFGVARLLNFDSSN------RTLLAGTYGYIAPELAYTMVVTEK 117
SNNILL+ E++ VADFG+A+ L + ++ + +AG+YGYIAPE YT V EK
Sbjct: 819 KSNNILLDHEMKPRVADFGLAKPLKREDNDGVSDVSMSCVAGSYGYIAPEYGYTSKVNEK 878
Query: 118 SDVYSFGVVALEVLMGKHPGE 138
SDVYSFGVV LE++ GK P +
Sbjct: 879 SDVYSFGVVLLELITGKRPND 899
|
Receptor-like serine/threonine-kinase acting on substrates that controls floral organ abscission. Regulated by the 'INFLORESCENCE DEFICIENT IN ABSCISSION' (IDA) family of ligands. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9M0G7|PXL2_ARATH Leucine-rich repeat receptor-like protein kinase PXL2 OS=Arabidopsis thaliana GN=PXL2 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 148 bits (373), Expect = 1e-35, Method: Composition-based stats.
Identities = 70/137 (51%), Positives = 94/137 (68%), Gaps = 2/137 (1%)
Query: 4 KCMFLIYEYMEMGSLFCVLRTDEEAVGL--DWAKRVNIVKGMAHALSYLHHDCTPPIVHR 61
K M ++YE+M G+L + A L DW R NI G+AH L+YLHHDC PP++HR
Sbjct: 771 KNMMIVYEFMLNGNLGDAIHGKNAAGRLLVDWVSRYNIALGVAHGLAYLHHDCHPPVIHR 830
Query: 62 DISSNNILLNLELEAFVADFGVARLLNFDSSNRTLLAGTYGYIAPELAYTMVVTEKSDVY 121
DI SNNILL+ L+A +ADFG+AR++ +++AG+YGYIAPE YT+ V EK D+Y
Sbjct: 831 DIKSNNILLDANLDARIADFGLARMMARKKETVSMVAGSYGYIAPEYGYTLKVDEKIDIY 890
Query: 122 SFGVVALEVLMGKHPGE 138
S+GVV LE+L G+ P E
Sbjct: 891 SYGVVLLELLTGRRPLE 907
|
Involved in the regulation of procambium maintenance and polarity during vascular-tissue development. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9FRS6|PXL1_ARATH Leucine-rich repeat receptor-like protein kinase PXL1 OS=Arabidopsis thaliana GN=PXL1 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 143 bits (361), Expect = 3e-34, Method: Compositional matrix adjust.
Identities = 66/136 (48%), Positives = 95/136 (69%), Gaps = 1/136 (0%)
Query: 2 HRKCMFLIYEYMEMGSLFCVLRTDEEAVGL-DWAKRVNIVKGMAHALSYLHHDCTPPIVH 60
+ + + ++YEYM G+L L + +E L DW R N+ G+ L+YLH+DC PPI+H
Sbjct: 793 NEREVMMVYEYMPNGNLGTALHSKDEKFLLRDWLSRYNVAVGVVQGLNYLHNDCYPPIIH 852
Query: 61 RDISSNNILLNLELEAFVADFGVARLLNFDSSNRTLLAGTYGYIAPELAYTMVVTEKSDV 120
RDI SNNILL+ LEA +ADFG+A+++ + +++AG+YGYIAPE YT+ + EKSD+
Sbjct: 853 RDIKSNNILLDSNLEARIADFGLAKMMLHKNETVSMVAGSYGYIAPEYGYTLKIDEKSDI 912
Query: 121 YSFGVVALEVLMGKHP 136
YS GVV LE++ GK P
Sbjct: 913 YSLGVVLLELVTGKMP 928
|
Involved in the regulation of procambium maintenance and polarity during vascular-tissue development. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9FIZ3|GSO2_ARATH LRR receptor-like serine/threonine-protein kinase GSO2 OS=Arabidopsis thaliana GN=GSO2 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 142 bits (359), Expect = 5e-34, Method: Composition-based stats.
Identities = 69/141 (48%), Positives = 97/141 (68%), Gaps = 7/141 (4%)
Query: 7 FLIYEYMEMGSLFCVLRTDEEAVG---LDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDI 63
LIYEYM GS++ L +E L W R+ I G+A + YLH+DC PPIVHRDI
Sbjct: 1021 LLIYEYMANGSVWDWLHANENTKKKEVLGWETRLKIALGLAQGVEYLHYDCVPPIVHRDI 1080
Query: 64 SSNNILLNLELEAFVADFGVARLL--NFDSS--NRTLLAGTYGYIAPELAYTMVVTEKSD 119
S+N+LL+ +EA + DFG+A++L N+D++ + T+ AG+YGYIAPE AY++ TEKSD
Sbjct: 1081 KSSNVLLDSNIEAHLGDFGLAKILTGNYDTNTESNTMFAGSYGYIAPEYAYSLKATEKSD 1140
Query: 120 VYSFGVVALEVLMGKHPGELL 140
VYS G+V +E++ GK P E +
Sbjct: 1141 VYSMGIVLMEIVTGKMPTEAM 1161
|
Together with GSO1, receptor-like serine/threonine-kinase required during the development of the epidermal surface in embryos and cotyledons. Involved in the nuclear division phase of megagametogenesis. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 144 | ||||||
| 255563466 | 427 | conserved hypothetical protein [Ricinus | 0.993 | 0.334 | 0.804 | 7e-64 | |
| 224098415 | 667 | predicted protein [Populus trichocarpa] | 1.0 | 0.215 | 0.784 | 5e-62 | |
| 224108669 | 811 | predicted protein [Populus trichocarpa] | 1.0 | 0.177 | 0.777 | 8e-62 | |
| 224110024 | 827 | predicted protein [Populus trichocarpa] | 1.0 | 0.174 | 0.763 | 5e-61 | |
| 225452751 | 878 | PREDICTED: probable leucine-rich repeat | 1.0 | 0.164 | 0.763 | 2e-60 | |
| 224093626 | 1039 | predicted protein [Populus trichocarpa] | 1.0 | 0.138 | 0.763 | 4e-60 | |
| 359488981 | 757 | PREDICTED: probable LRR receptor-like se | 1.0 | 0.190 | 0.75 | 8e-60 | |
| 296082878 | 1699 | unnamed protein product [Vitis vinifera] | 1.0 | 0.084 | 0.75 | 9e-60 | |
| 224065667 | 362 | predicted protein [Populus trichocarpa] | 1.0 | 0.397 | 0.756 | 2e-59 | |
| 224110020 | 1048 | predicted protein [Populus trichocarpa] | 1.0 | 0.137 | 0.756 | 2e-59 |
| >gi|255563466|ref|XP_002522735.1| conserved hypothetical protein [Ricinus communis] gi|223537973|gb|EEF39586.1| conserved hypothetical protein [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 248 bits (632), Expect = 7e-64, Method: Compositional matrix adjust.
Identities = 115/143 (80%), Positives = 132/143 (92%)
Query: 1 LHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVH 60
LH++ M L+YEY++ G+LFCVLR D EAV LDW+KRVNIVKG+AHALSY+HHDC+PPIVH
Sbjct: 260 LHKRFMILVYEYLQRGNLFCVLRNDVEAVELDWSKRVNIVKGIAHALSYMHHDCSPPIVH 319
Query: 61 RDISSNNILLNLELEAFVADFGVARLLNFDSSNRTLLAGTYGYIAPELAYTMVVTEKSDV 120
RDISSNNILLN E+E F++DFG ARLLN DSSN TLLAGTYGYIAPELAYTM+VTEKSDV
Sbjct: 320 RDISSNNILLNSEMEGFMSDFGTARLLNPDSSNNTLLAGTYGYIAPELAYTMIVTEKSDV 379
Query: 121 YSFGVVALEVLMGKHPGELLSSS 143
YSFGVVALE+LMG+HPG+LLSSS
Sbjct: 380 YSFGVVALELLMGRHPGDLLSSS 402
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224098415|ref|XP_002334562.1| predicted protein [Populus trichocarpa] gi|222873082|gb|EEF10213.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 241 bits (616), Expect = 5e-62, Method: Compositional matrix adjust.
Identities = 113/144 (78%), Positives = 128/144 (88%)
Query: 1 LHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVH 60
LH++CMFL+YEYME GSLFC LR D EAV L W KR +I+K +AHALSYLHHDC PPIVH
Sbjct: 470 LHQRCMFLVYEYMEKGSLFCALRNDVEAVELKWMKRAHIIKDIAHALSYLHHDCNPPIVH 529
Query: 61 RDISSNNILLNLELEAFVADFGVARLLNFDSSNRTLLAGTYGYIAPELAYTMVVTEKSDV 120
RDISS+N+LLN E ++FVADFGVARLL+ DSSN T+LAGTYGYIAPELAYTMVVTEK DV
Sbjct: 530 RDISSSNVLLNSESKSFVADFGVARLLDPDSSNHTVLAGTYGYIAPELAYTMVVTEKCDV 589
Query: 121 YSFGVVALEVLMGKHPGELLSSSS 144
YSFGVVALE LMGKHPG++LSSS+
Sbjct: 590 YSFGVVALETLMGKHPGDILSSSA 613
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224108669|ref|XP_002333361.1| predicted protein [Populus trichocarpa] gi|222836312|gb|EEE74733.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 241 bits (615), Expect = 8e-62, Method: Composition-based stats.
Identities = 112/144 (77%), Positives = 128/144 (88%)
Query: 1 LHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVH 60
LH++CMFL+YEYME GSLFC LR D EAV L W KR +I+K +AHALSYLHH+C PPIVH
Sbjct: 582 LHQRCMFLVYEYMEKGSLFCALRNDVEAVELKWMKRAHIIKDIAHALSYLHHECNPPIVH 641
Query: 61 RDISSNNILLNLELEAFVADFGVARLLNFDSSNRTLLAGTYGYIAPELAYTMVVTEKSDV 120
RDISS+N+LLN E ++FVADFGVARLL+ DSSN T+LAGTYGYIAPELAYTMVVTEK DV
Sbjct: 642 RDISSSNVLLNSESKSFVADFGVARLLDPDSSNHTVLAGTYGYIAPELAYTMVVTEKCDV 701
Query: 121 YSFGVVALEVLMGKHPGELLSSSS 144
YSFGVVALE LMGKHPG++LSSS+
Sbjct: 702 YSFGVVALETLMGKHPGDILSSSA 725
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224110024|ref|XP_002333161.1| predicted protein [Populus trichocarpa] gi|222835014|gb|EEE73463.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 238 bits (607), Expect = 5e-61, Method: Composition-based stats.
Identities = 110/144 (76%), Positives = 126/144 (87%)
Query: 1 LHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVH 60
LH++CMFL+YEYME GSLFC LR D AV L W KR +I+K +AHALSYLHHDC PPIVH
Sbjct: 598 LHQRCMFLVYEYMEKGSLFCALRNDVGAVELKWMKRAHIIKDIAHALSYLHHDCNPPIVH 657
Query: 61 RDISSNNILLNLELEAFVADFGVARLLNFDSSNRTLLAGTYGYIAPELAYTMVVTEKSDV 120
RDISS+N+LLN E ++FVADFGVARLL+ DSSN T+LAGTYGYIAPELAYTM VTEK DV
Sbjct: 658 RDISSSNVLLNSEFKSFVADFGVARLLDPDSSNHTVLAGTYGYIAPELAYTMAVTEKCDV 717
Query: 121 YSFGVVALEVLMGKHPGELLSSSS 144
YSFGVVALE LMG+HPG++LSSS+
Sbjct: 718 YSFGVVALETLMGRHPGDILSSSA 741
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|225452751|ref|XP_002277606.1| PREDICTED: probable leucine-rich repeat receptor-like protein kinase At1g35710-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 236 bits (602), Expect = 2e-60, Method: Composition-based stats.
Identities = 110/144 (76%), Positives = 129/144 (89%)
Query: 1 LHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVH 60
LH KCMFL+Y+YME GSL+C+LR + E V LDW KRVN+VKG+A+ALSY+HHD T PI+H
Sbjct: 655 LHNKCMFLVYKYMEKGSLYCMLRDEVEVVQLDWIKRVNVVKGIANALSYMHHDSTLPIIH 714
Query: 61 RDISSNNILLNLELEAFVADFGVARLLNFDSSNRTLLAGTYGYIAPELAYTMVVTEKSDV 120
RDISSNNILL+ +LEAFVADFG ARLL+ DSSN+TLLAGTYGYIAPELAYTMVVTEK DV
Sbjct: 715 RDISSNNILLDSKLEAFVADFGTARLLDPDSSNQTLLAGTYGYIAPELAYTMVVTEKCDV 774
Query: 121 YSFGVVALEVLMGKHPGELLSSSS 144
YSFG+VALE +MGKHPG+L++S S
Sbjct: 775 YSFGMVALETIMGKHPGDLVTSLS 798
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224093626|ref|XP_002334827.1| predicted protein [Populus trichocarpa] gi|222875006|gb|EEF12137.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 235 bits (600), Expect = 4e-60, Method: Composition-based stats.
Identities = 110/144 (76%), Positives = 127/144 (88%)
Query: 1 LHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVH 60
LH++CMFL+YEYME GSLFC LR D AV L W KR +I+K +AHALSYLHH+C PPIVH
Sbjct: 810 LHQRCMFLVYEYMEKGSLFCALRNDVGAVELKWMKRAHIIKDIAHALSYLHHECNPPIVH 869
Query: 61 RDISSNNILLNLELEAFVADFGVARLLNFDSSNRTLLAGTYGYIAPELAYTMVVTEKSDV 120
RDISS+N+LLN E ++FVADFGVARLL+ DSSN T+LAGTYGYIAPELAYTMVVTEK DV
Sbjct: 870 RDISSSNVLLNSESKSFVADFGVARLLDPDSSNNTVLAGTYGYIAPELAYTMVVTEKCDV 929
Query: 121 YSFGVVALEVLMGKHPGELLSSSS 144
YSFGVVALE LMG+HPG++LSSS+
Sbjct: 930 YSFGVVALETLMGRHPGDILSSSA 953
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359488981|ref|XP_002275364.2| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At4g08850-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 234 bits (597), Expect = 8e-60, Method: Compositional matrix adjust.
Identities = 108/144 (75%), Positives = 128/144 (88%)
Query: 1 LHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVH 60
LH++CMFL+Y+YME GSL+C+LR + EAV LDW KRVN+VK +A+ALSY+HHDC PI+H
Sbjct: 534 LHKRCMFLVYKYMEKGSLYCMLRDEVEAVELDWIKRVNVVKSIANALSYMHHDCDLPIIH 593
Query: 61 RDISSNNILLNLELEAFVADFGVARLLNFDSSNRTLLAGTYGYIAPELAYTMVVTEKSDV 120
RDISSNNILL+ +LEAFV+DFG ARLL+ DSSNRTLLAGTYGYIAPELAYTMVVTEK DV
Sbjct: 594 RDISSNNILLDSKLEAFVSDFGTARLLDNDSSNRTLLAGTYGYIAPELAYTMVVTEKCDV 653
Query: 121 YSFGVVALEVLMGKHPGELLSSSS 144
YSFG+VALE +MG HPGE ++S S
Sbjct: 654 YSFGMVALETMMGMHPGEFITSLS 677
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|296082878|emb|CBI22179.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 234 bits (597), Expect = 9e-60, Method: Compositional matrix adjust.
Identities = 108/144 (75%), Positives = 128/144 (88%)
Query: 1 LHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVH 60
LH++CMFL+Y+YME GSL+C+LR + EAV LDW KRVN+VK +A+ALSY+HHDC PI+H
Sbjct: 833 LHKRCMFLVYKYMEKGSLYCMLRDEVEAVELDWIKRVNVVKSIANALSYMHHDCDLPIIH 892
Query: 61 RDISSNNILLNLELEAFVADFGVARLLNFDSSNRTLLAGTYGYIAPELAYTMVVTEKSDV 120
RDISSNNILL+ +LEAFV+DFG ARLL+ DSSNRTLLAGTYGYIAPELAYTMVVTEK DV
Sbjct: 893 RDISSNNILLDSKLEAFVSDFGTARLLDNDSSNRTLLAGTYGYIAPELAYTMVVTEKCDV 952
Query: 121 YSFGVVALEVLMGKHPGELLSSSS 144
YSFG+VALE +MG HPGE ++S S
Sbjct: 953 YSFGMVALETMMGMHPGEFITSLS 976
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224065667|ref|XP_002301911.1| predicted protein [Populus trichocarpa] gi|222843637|gb|EEE81184.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 233 bits (595), Expect = 2e-59, Method: Compositional matrix adjust.
Identities = 109/144 (75%), Positives = 126/144 (87%)
Query: 1 LHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVH 60
LH++CMFL+YEYME GSLFC LR D AV L W KR +I+K +AHALSYLHHDC PPIVH
Sbjct: 133 LHQRCMFLVYEYMEKGSLFCALRNDVGAVELKWMKRAHIIKDIAHALSYLHHDCNPPIVH 192
Query: 61 RDISSNNILLNLELEAFVADFGVARLLNFDSSNRTLLAGTYGYIAPELAYTMVVTEKSDV 120
RDISS+N+LLN ++FVADFGVARLL+ DSSN T+LAGTYGYIAPELAYTM+VTEK DV
Sbjct: 193 RDISSSNVLLNSVSKSFVADFGVARLLDPDSSNHTVLAGTYGYIAPELAYTMLVTEKCDV 252
Query: 121 YSFGVVALEVLMGKHPGELLSSSS 144
YSFGVVALE LMG+HPG++LSSS+
Sbjct: 253 YSFGVVALETLMGRHPGDILSSSA 276
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224110020|ref|XP_002333160.1| predicted protein [Populus trichocarpa] gi|222835013|gb|EEE73462.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 233 bits (593), Expect = 2e-59, Method: Composition-based stats.
Identities = 109/144 (75%), Positives = 127/144 (88%)
Query: 1 LHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVH 60
LH++CMFL+YEYME GSLFC LR D AV L W KR +I++ +AHALSYLHH+C PPIVH
Sbjct: 819 LHQRCMFLVYEYMEKGSLFCALRNDVGAVELKWMKRAHIIEDIAHALSYLHHECNPPIVH 878
Query: 61 RDISSNNILLNLELEAFVADFGVARLLNFDSSNRTLLAGTYGYIAPELAYTMVVTEKSDV 120
RDISS+N+LLN E ++FVADFGVARLL+ DSSN T+LAGTYGYIAPELAYTMVVTEK DV
Sbjct: 879 RDISSSNVLLNSESKSFVADFGVARLLDPDSSNHTVLAGTYGYIAPELAYTMVVTEKCDV 938
Query: 121 YSFGVVALEVLMGKHPGELLSSSS 144
YSFGVVALE LMG+HPG++LSSS+
Sbjct: 939 YSFGVVALETLMGRHPGDILSSSA 962
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 144 | ||||||
| TAIR|locus:2138268 | 1045 | AT4G08850 [Arabidopsis thalian | 0.993 | 0.136 | 0.601 | 2e-41 | |
| TAIR|locus:2011339 | 1120 | AT1G35710 [Arabidopsis thalian | 0.993 | 0.127 | 0.608 | 2.3e-41 | |
| TAIR|locus:2020417 | 1101 | AT1G17230 [Arabidopsis thalian | 0.937 | 0.122 | 0.5 | 2.5e-28 | |
| TAIR|locus:2160791 | 1102 | AT5G63930 [Arabidopsis thalian | 0.923 | 0.120 | 0.492 | 2.5e-28 | |
| TAIR|locus:2085949 | 1141 | AT3G24240 [Arabidopsis thalian | 0.930 | 0.117 | 0.481 | 7.2e-28 | |
| TAIR|locus:2154344 | 1135 | AT5G48940 [Arabidopsis thalian | 0.930 | 0.118 | 0.471 | 1.2e-27 | |
| TAIR|locus:2139885 | 1013 | AT4G28650 [Arabidopsis thalian | 0.930 | 0.132 | 0.449 | 3.3e-27 | |
| TAIR|locus:2161825 | 1090 | AT5G56040 [Arabidopsis thalian | 0.937 | 0.123 | 0.468 | 3.7e-27 | |
| TAIR|locus:2206179 | 592 | FEI1 "FEI 1" [Arabidopsis thal | 0.888 | 0.216 | 0.5 | 5.3e-27 | |
| TAIR|locus:2169975 | 993 | HSL2 "HAESA-like 2" [Arabidops | 0.916 | 0.132 | 0.496 | 6.7e-27 |
| TAIR|locus:2138268 AT4G08850 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 450 (163.5 bits), Expect = 2.0e-41, P = 2.0e-41
Identities = 86/143 (60%), Positives = 106/143 (74%)
Query: 2 HRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHR 61
HR+ FL+YEYME GSL VL D+EA LDW KR+N+VKG+AHALSY+HHD +P IVHR
Sbjct: 845 HRRNTFLVYEYMERGSLRKVLENDDEAKKLDWGKRINVVKGVAHALSYMHHDRSPAIVHR 904
Query: 62 DXXXXXXXXXXXXXAFVADFGVARLLNFDSSNRTLLAGTYGYIAPELAYTMVVTEKSDVY 121
D A ++DFG A+LL DSSN + +AGTYGY+APELAY M VTEK DVY
Sbjct: 905 DISSGNILLGEDYEAKISDFGTAKLLKPDSSNWSAVAGTYGYVAPELAYAMKVTEKCDVY 964
Query: 122 SFGVVALEVLMGKHPGELLSSSS 144
SFGV+ LEV+ G+HPG+L+S+ S
Sbjct: 965 SFGVLTLEVIKGEHPGDLVSTLS 987
|
|
| TAIR|locus:2011339 AT1G35710 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 450 (163.5 bits), Expect = 2.3e-41, P = 2.3e-41
Identities = 87/143 (60%), Positives = 105/143 (73%)
Query: 2 HRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHR 61
HR+ FLIYEYME GSL +L DEEA L W KR+N+VKG+AHALSY+HHD PIVHR
Sbjct: 921 HRRHTFLIYEYMEKGSLNKLLANDEEAKRLTWTKRINVVKGVAHALSYMHHDRITPIVHR 980
Query: 62 DXXXXXXXXXXXXXAFVADFGVARLLNFDSSNRTLLAGTYGYIAPELAYTMVVTEKSDVY 121
D A ++DFG A+LL DSSN + +AGTYGY+APE AYTM VTEK DVY
Sbjct: 981 DISSGNILLDNDYTAKISDFGTAKLLKTDSSNWSAVAGTYGYVAPEFAYTMKVTEKCDVY 1040
Query: 122 SFGVVALEVLMGKHPGELLSSSS 144
SFGV+ LE+++GKHPG+L+SS S
Sbjct: 1041 SFGVLILELIIGKHPGDLVSSLS 1063
|
|
| TAIR|locus:2020417 AT1G17230 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 328 (120.5 bits), Expect = 2.5e-28, P = 2.5e-28
Identities = 68/136 (50%), Positives = 83/136 (61%)
Query: 2 HRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHR 61
H+ L+YEYM GSL L+ E+ LDW R I G A L YLHHDC P IVHR
Sbjct: 866 HQNSNLLLYEYMSKGSLGEQLQRGEKNCLLDWNARYRIALGAAEGLCYLHHDCRPQIVHR 925
Query: 62 DXXXXXXXXXXXXXAFVADFGVARLLNFD-SSNRTLLAGTYGYIAPELAYTMVVTEKSDV 120
D A V DFG+A+L++ S + + +AG+YGYIAPE AYTM VTEK D+
Sbjct: 926 DIKSNNILLDERFQAHVGDFGLAKLIDLSYSKSMSAVAGSYGYIAPEYAYTMKVTEKCDI 985
Query: 121 YSFGVVALEVLMGKHP 136
YSFGVV LE++ GK P
Sbjct: 986 YSFGVVLLELITGKPP 1001
|
|
| TAIR|locus:2160791 AT5G63930 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 328 (120.5 bits), Expect = 2.5e-28, P = 2.5e-28
Identities = 67/136 (49%), Positives = 86/136 (63%)
Query: 2 HRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHR 61
H+ L+YEYM GSL +L + + LDW+KR I G A L+YLHHDC P I HR
Sbjct: 874 HQGSNLLLYEYMPKGSLGEILH--DPSCNLDWSKRFKIALGAAQGLAYLHHDCKPRIFHR 931
Query: 62 DXXXXXXXXXXXXXAFVADFGVARLLNFD-SSNRTLLAGTYGYIAPELAYTMVVTEKSDV 120
D A V DFG+A++++ S + + +AG+YGYIAPE AYTM VTEKSD+
Sbjct: 932 DIKSNNILLDDKFEAHVGDFGLAKVIDMPHSKSMSAIAGSYGYIAPEYAYTMKVTEKSDI 991
Query: 121 YSFGVVALEVLMGKHP 136
YS+GVV LE+L GK P
Sbjct: 992 YSYGVVLLELLTGKAP 1007
|
|
| TAIR|locus:2085949 AT3G24240 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 324 (119.1 bits), Expect = 7.2e-28, P = 7.2e-28
Identities = 66/137 (48%), Positives = 84/137 (61%)
Query: 2 HRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHR 61
+R L+Y+YM GSL +L + LDW R I+ G A L+YLHHDC PPIVHR
Sbjct: 860 NRNTRLLMYDYMPNGSLGSLLH-ERRGSSLDWDLRYRILLGAAQGLAYLHHDCLPPIVHR 918
Query: 62 DXXXXXXXXXXXXXAFVADFGVARLLNFDSSNR--TLLAGTYGYIAPELAYTMVVTEKSD 119
D ++ADFG+A+L++ R +AG+YGYIAPE Y+M +TEKSD
Sbjct: 919 DIKANNILIGLDFEPYIADFGLAKLVDEGDIGRCSNTVAGSYGYIAPEYGYSMKITEKSD 978
Query: 120 VYSFGVVALEVLMGKHP 136
VYS+GVV LEVL GK P
Sbjct: 979 VYSYGVVVLEVLTGKQP 995
|
|
| TAIR|locus:2154344 AT5G48940 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 322 (118.4 bits), Expect = 1.2e-27, P = 1.2e-27
Identities = 65/138 (47%), Positives = 84/138 (60%)
Query: 2 HRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHR 61
++ L+Y+YM GSL +L L W R I+ G A L+YLHHDC PPIVHR
Sbjct: 860 NKNTRLLMYDYMSNGSLGSLLHERSGVCSLGWEVRYKIILGAAQGLAYLHHDCVPPIVHR 919
Query: 62 DXXXXXXXXXXXXXAFVADFGVARLLN---FDSSNRTLLAGTYGYIAPELAYTMVVTEKS 118
D ++ DFG+A+L++ F S+ T+ AG+YGYIAPE Y+M +TEKS
Sbjct: 920 DIKANNILIGPDFEPYIGDFGLAKLVDDGDFARSSNTI-AGSYGYIAPEYGYSMKITEKS 978
Query: 119 DVYSFGVVALEVLMGKHP 136
DVYS+GVV LEVL GK P
Sbjct: 979 DVYSYGVVVLEVLTGKQP 996
|
|
| TAIR|locus:2139885 AT4G28650 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 317 (116.6 bits), Expect = 3.3e-27, P = 3.3e-27
Identities = 62/138 (44%), Positives = 86/138 (62%)
Query: 4 KCMFLIYEYMEMGSLFCVLRTDEEAVG---LDWAKRVNIVKGMAHALSYLHHDCTPPIVH 60
K M ++YE+M G+L + + A G +DW R NI G+AH L+YLHHDC PP++H
Sbjct: 771 KNMMIVYEFMLNGNLGDAIH-GKNAAGRLLVDWVSRYNIALGVAHGLAYLHHDCHPPVIH 829
Query: 61 RDXXXXXXXXXXXXXAFVADFGVARLLNFDSSNRTLLAGTYGYIAPELAYTMVVTEKSDV 120
RD A +ADFG+AR++ +++AG+YGYIAPE YT+ V EK D+
Sbjct: 830 RDIKSNNILLDANLDARIADFGLARMMARKKETVSMVAGSYGYIAPEYGYTLKVDEKIDI 889
Query: 121 YSFGVVALEVLMGKHPGE 138
YS+GVV LE+L G+ P E
Sbjct: 890 YSYGVVLLELLTGRRPLE 907
|
|
| TAIR|locus:2161825 AT5G56040 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 317 (116.6 bits), Expect = 3.7e-27, P = 3.7e-27
Identities = 68/145 (46%), Positives = 91/145 (62%)
Query: 2 HRKCMFLIYEYMEMGSLFCVLR-TDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVH 60
+R L Y+Y+ GSL +L + + G DW R ++V G+AHAL+YLHHDC PPI+H
Sbjct: 821 NRNLKLLFYDYLPNGSLSSLLHGAGKGSGGADWEARYDVVLGVAHALAYLHHDCLPPILH 880
Query: 61 RDXXXXXXXXXXXXXAFVADFGVARLLNF------DSS---NRTLLAGTYGYIAPELAYT 111
D +++ADFG+A++++ DSS NR LAG+YGY+APE A
Sbjct: 881 GDVKAMNVLLGSRFESYLADFGLAKIVSGEGVTDGDSSKLSNRPPLAGSYGYMAPEHASM 940
Query: 112 MVVTEKSDVYSFGVVALEVLMGKHP 136
+TEKSDVYS+GVV LEVL GKHP
Sbjct: 941 QHITEKSDVYSYGVVLLEVLTGKHP 965
|
|
| TAIR|locus:2206179 FEI1 "FEI 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 310 (114.2 bits), Expect = 5.3e-27, P = 5.3e-27
Identities = 65/130 (50%), Positives = 83/130 (63%)
Query: 8 LIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDXXXXX 67
L+Y+Y+ GSL L E LDW RVNI+ G A LSYLHHDC+P I+HRD
Sbjct: 377 LLYDYLPGGSLDEALHV-ERGEQLDWDSRVNIIIGAAKGLSYLHHDCSPRIIHRDIKSSN 435
Query: 68 XXXXXXXXAFVADFGVARLLNFDSSN-RTLLAGTYGYIAPELAYTMVVTEKSDVYSFGVV 126
A V+DFG+A+LL + S+ T++AGT+GY+APE + TEK+DVYSFGV+
Sbjct: 436 ILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAPEYMQSGRATEKTDVYSFGVL 495
Query: 127 ALEVLMGKHP 136
LEVL GK P
Sbjct: 496 VLEVLSGKRP 505
|
|
| TAIR|locus:2169975 HSL2 "HAESA-like 2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 314 (115.6 bits), Expect = 6.7e-27, P = 6.7e-27
Identities = 70/141 (49%), Positives = 87/141 (61%)
Query: 7 FLIYEYMEMGSLFCVLRTDEE--AVG-LDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDX 63
FL+YE+ME GSL VL +++E AV LDW R +I G A LSYLHHD PPIVHRD
Sbjct: 759 FLVYEFMENGSLGDVLHSEKEHRAVSPLDWTTRFSIAVGAAQGLSYLHHDSVPPIVHRDV 818
Query: 64 XXXXXXXXXXXXAFVADFGVARLLNFDSSN------RTLLAGTYGYIAPELAYTMVVTEK 117
VADFG+A+ L + ++ + +AG+YGYIAPE YT V EK
Sbjct: 819 KSNNILLDHEMKPRVADFGLAKPLKREDNDGVSDVSMSCVAGSYGYIAPEYGYTSKVNEK 878
Query: 118 SDVYSFGVVALEVLMGKHPGE 138
SDVYSFGVV LE++ GK P +
Sbjct: 879 SDVYSFGVVLLELITGKRPND 899
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
No confident hit for EC number transfering in SWISSPROT detected by BLAST
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
No EC number assignment, probably not an enzyme!
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 144 | |||
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 1e-29 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 1e-28 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 6e-27 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 2e-22 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 3e-21 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 3e-21 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 6e-21 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 2e-20 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 4e-20 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 7e-20 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 8e-20 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 2e-19 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 4e-19 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 6e-19 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 7e-19 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 5e-18 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 1e-17 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 2e-17 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 5e-17 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 7e-17 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 9e-17 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 3e-16 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 5e-16 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 5e-16 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 1e-15 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 2e-15 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 3e-15 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 4e-15 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 5e-15 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 5e-15 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 9e-15 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 1e-14 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 1e-14 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 1e-14 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 2e-14 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 3e-14 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 3e-14 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 3e-14 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 4e-14 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 4e-14 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 4e-14 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 2e-13 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 2e-13 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 2e-13 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 3e-13 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 3e-13 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 4e-13 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 1e-12 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 1e-12 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 2e-12 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 3e-12 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 3e-12 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 3e-12 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 4e-12 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 4e-12 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 5e-12 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 5e-12 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 5e-12 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 5e-12 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 8e-12 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 9e-12 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 1e-11 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 1e-11 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 2e-11 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 2e-11 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 3e-11 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 3e-11 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 3e-11 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 4e-11 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 4e-11 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 4e-11 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 5e-11 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 6e-11 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 6e-11 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 7e-11 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 8e-11 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 1e-10 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 1e-10 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 2e-10 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 2e-10 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 2e-10 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 2e-10 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 3e-10 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 3e-10 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 3e-10 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 3e-10 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 3e-10 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 4e-10 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 4e-10 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 5e-10 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 5e-10 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 5e-10 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 5e-10 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 6e-10 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 7e-10 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 7e-10 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 7e-10 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 8e-10 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 8e-10 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 9e-10 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 1e-09 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 1e-09 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 1e-09 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 1e-09 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 1e-09 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 2e-09 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 2e-09 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 2e-09 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 2e-09 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 2e-09 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 3e-09 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 3e-09 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 3e-09 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 3e-09 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 4e-09 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 6e-09 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 7e-09 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 7e-09 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 7e-09 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 8e-09 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 1e-08 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 1e-08 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 1e-08 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 1e-08 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 1e-08 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 1e-08 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 1e-08 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 2e-08 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 2e-08 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 2e-08 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 2e-08 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 2e-08 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 2e-08 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 3e-08 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 3e-08 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 3e-08 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 3e-08 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 3e-08 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 3e-08 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 3e-08 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 4e-08 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 4e-08 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 4e-08 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 4e-08 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 4e-08 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 4e-08 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 5e-08 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 6e-08 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 6e-08 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 6e-08 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 6e-08 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 8e-08 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 8e-08 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 9e-08 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 9e-08 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 9e-08 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 9e-08 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 9e-08 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 1e-07 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 1e-07 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 1e-07 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 1e-07 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 1e-07 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 1e-07 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 1e-07 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 1e-07 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 2e-07 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 2e-07 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 2e-07 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 2e-07 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 2e-07 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 3e-07 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 3e-07 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 3e-07 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 3e-07 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 4e-07 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 4e-07 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 5e-07 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 5e-07 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 5e-07 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 6e-07 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 6e-07 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 6e-07 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 7e-07 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 7e-07 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 8e-07 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 8e-07 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 8e-07 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 8e-07 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 9e-07 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 9e-07 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 1e-06 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 1e-06 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 1e-06 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 1e-06 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 1e-06 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 1e-06 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 1e-06 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 1e-06 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 2e-06 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 2e-06 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 2e-06 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 2e-06 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 2e-06 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 3e-06 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 3e-06 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 3e-06 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 3e-06 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 3e-06 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 3e-06 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 3e-06 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 4e-06 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 4e-06 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 4e-06 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 5e-06 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 5e-06 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 5e-06 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 5e-06 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 6e-06 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 6e-06 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 7e-06 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 8e-06 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 8e-06 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 8e-06 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 9e-06 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 1e-05 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 1e-05 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 1e-05 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 1e-05 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 1e-05 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 1e-05 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 1e-05 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 1e-05 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 2e-05 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 2e-05 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 2e-05 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 2e-05 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 2e-05 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 2e-05 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 2e-05 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 2e-05 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 2e-05 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 3e-05 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 3e-05 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 3e-05 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 3e-05 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 4e-05 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 4e-05 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 5e-05 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 5e-05 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 6e-05 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 6e-05 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 6e-05 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 7e-05 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 7e-05 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 8e-05 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 8e-05 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 8e-05 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 8e-05 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 9e-05 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 1e-04 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 1e-04 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 1e-04 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 1e-04 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 1e-04 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 1e-04 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 1e-04 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 2e-04 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 2e-04 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 2e-04 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 2e-04 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 3e-04 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 4e-04 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 6e-04 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 6e-04 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 8e-04 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 9e-04 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 0.001 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 0.001 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 0.001 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 0.002 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 0.002 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 0.002 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 0.003 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 0.003 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 0.003 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 0.004 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 106 bits (267), Expect = 1e-29
Identities = 46/129 (35%), Positives = 70/129 (54%), Gaps = 7/129 (5%)
Query: 3 RKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRD 62
++L+ EY E GSL +L+ E L + + I+ + L YLH + I+HRD
Sbjct: 63 ENHLYLVMEYCEGGSLKDLLK--ENEGKLSEDEILRILLQILEGLEYLHSN---GIIHRD 117
Query: 63 ISSNNILL-NLELEAFVADFGVARLLNFDSSNRTLLAGTYGYIAPE-LAYTMVVTEKSDV 120
+ NILL + + +ADFG+++LL D S + GT Y+APE L +EKSD+
Sbjct: 118 LKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLLGKGYYSEKSDI 177
Query: 121 YSFGVVALE 129
+S GV+ E
Sbjct: 178 WSLGVILYE 186
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 1e-28
Identities = 49/132 (37%), Positives = 66/132 (50%), Gaps = 7/132 (5%)
Query: 6 MFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISS 65
++L+ EY E G LF L L + I + L YLH + I+HRD+
Sbjct: 73 LYLVMEYCEGGDLFDYLSRG---GPLSEDEAKKIALQILRGLEYLHSN---GIIHRDLKP 126
Query: 66 NNILLNLELEAFVADFGVARLLNFDSSNRTLLAGTYGYIAPE-LAYTMVVTEKSDVYSFG 124
NILL+ +ADFG+A+ L SS+ T GT Y+APE L K DV+S G
Sbjct: 127 ENILLDENGVVKIADFGLAKKLLKSSSSLTTFVGTPWYMAPEVLLGGNGYGPKVDVWSLG 186
Query: 125 VVALEVLMGKHP 136
V+ E+L GK P
Sbjct: 187 VILYELLTGKPP 198
|
Length = 260 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 6e-27
Identities = 47/135 (34%), Positives = 70/135 (51%), Gaps = 7/135 (5%)
Query: 2 HRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHR 61
++L+ EY E G LF +L+ + D A+ ++ + AL YLH IVHR
Sbjct: 68 DEDKLYLVMEYCEGGDLFDLLK-KRGRLSEDEARF--YLRQILSALEYLHSKG---IVHR 121
Query: 62 DISSNNILLNLELEAFVADFGVARLLNFDSSNRTLLAGTYGYIAPELAYTMVVTEKSDVY 121
D+ NILL+ + +ADFG+AR L+ T GT Y+APE+ + D++
Sbjct: 122 DLKPENILLDEDGHVKLADFGLARQLD-PGEKLTTFVGTPEYMAPEVLLGKGYGKAVDIW 180
Query: 122 SFGVVALEVLMGKHP 136
S GV+ E+L GK P
Sbjct: 181 SLGVILYELLTGKPP 195
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 88.4 bits (220), Expect = 2e-22
Identities = 40/135 (29%), Positives = 66/135 (48%), Gaps = 16/135 (11%)
Query: 7 FLIYEYMEMGSL-----FCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHR 61
+++ E+ GSL E + + K + L YLH + I+HR
Sbjct: 73 WIVMEFCSGGSLKDLLKSTNQTLTESQIAY-------VCKELLKGLEYLH---SNGIIHR 122
Query: 62 DISSNNILLNLELEAFVADFGVARLLNFDSSNRTLLAGTYGYIAPELAYTMVVTEKSDVY 121
DI + NILL + E + DFG++ L+ D+ R + GT ++APE+ K+D++
Sbjct: 123 DIKAANILLTSDGEVKLIDFGLSAQLS-DTKARNTMVGTPYWMAPEVINGKPYDYKADIW 181
Query: 122 SFGVVALEVLMGKHP 136
S G+ A+E+ GK P
Sbjct: 182 SLGITAIELAEGKPP 196
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 85.7 bits (213), Expect = 3e-21
Identities = 43/140 (30%), Positives = 68/140 (48%), Gaps = 17/140 (12%)
Query: 4 KCMFLIY-EYMEMGSLFCVLRTD---EEAVGLDWAKRVNIVKGMAHALSYLH-HDCTPPI 58
K I+ EY+ GSL +L+ E V + ++ I++G L+YLH + I
Sbjct: 73 KNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQ--ILEG----LAYLHSNG----I 122
Query: 59 VHRDISSNNILLNLELEAFVADFGVARLL--NFDSSNRTLLAGTYGYIAPELAYTMVVTE 116
VHRDI NIL++ + +ADFG A+ L + GT ++APE+
Sbjct: 123 VHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRGEEYGR 182
Query: 117 KSDVYSFGVVALEVLMGKHP 136
+D++S G +E+ GK P
Sbjct: 183 AADIWSLGCTVIEMATGKPP 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 85.6 bits (213), Expect = 3e-21
Identities = 38/132 (28%), Positives = 61/132 (46%), Gaps = 15/132 (11%)
Query: 1 LHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLH-HDCTPPIV 59
+ ++++ EYM G L LR E + L + + +A + YL + V
Sbjct: 71 TQGEPLYIVTEYMPGGDLLDFLRKHGEKLTLKD--LLQMALQIAKGMEYLESKNF----V 124
Query: 60 HRDISSNNILLNLELEAFVADFGVARLLNFDSSNRTLLAGTYGYI-----APELAYTMVV 114
HRD+++ N L+ L ++DFG++R + D R G + APE
Sbjct: 125 HRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYR---KRGGGKLPIKWMAPESLKDGKF 181
Query: 115 TEKSDVYSFGVV 126
T KSDV+SFGV+
Sbjct: 182 TSKSDVWSFGVL 193
|
Length = 258 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 85.0 bits (211), Expect = 6e-21
Identities = 41/138 (29%), Positives = 68/138 (49%), Gaps = 21/138 (15%)
Query: 7 FLIYEYMEMGSLFCVLRTD----EEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRD 62
++ EYM+ GSL +L+ E + I + + L YLH I+HRD
Sbjct: 75 SIVLEYMDGGSLADLLKKVGKIPEPVLAY-------IARQILKGLDYLHTKRH--IIHRD 125
Query: 63 ISSNNILLNLELEAFVADFGVARLLNFDSSNRTLLAGTYGYIAPEL----AYTMVVTEKS 118
I +N+L+N + E +ADFG++++L GT Y++PE +Y+ +
Sbjct: 126 IKPSNLLINSKGEVKIADFGISKVLENTLDQCNTFVGTVTYMSPERIQGESYSY----AA 181
Query: 119 DVYSFGVVALEVLMGKHP 136
D++S G+ LE +GK P
Sbjct: 182 DIWSLGLTLLECALGKFP 199
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 85.6 bits (210), Expect = 2e-20
Identities = 49/153 (32%), Positives = 77/153 (50%), Gaps = 13/153 (8%)
Query: 2 HRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHR 61
++L+ EY++ GSL +L+ L ++ + I+ + AL YLH I+HR
Sbjct: 69 DEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKG---IIHR 125
Query: 62 DISSNNILLNLELEAFV-ADFGVARLLNFDSSNRTLLA------GTYGYIAPELAYTMV- 113
DI NILL+ + DFG+A+LL S ++ A GT GY+APE+ +
Sbjct: 126 DIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSL 185
Query: 114 --VTEKSDVYSFGVVALEVLMGKHPGELLSSSS 144
+ SD++S G+ E+L G P E +SS
Sbjct: 186 AYASSSSDIWSLGITLYELLTGLPPFEGEKNSS 218
|
Length = 384 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 82.6 bits (205), Expect = 4e-20
Identities = 38/133 (28%), Positives = 64/133 (48%), Gaps = 6/133 (4%)
Query: 6 MFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISS 65
+ ++ EYM G L LR + L + ++ +A + YL +HRD+++
Sbjct: 76 LMIVMEYMPGGDLLDYLRKNRPKE-LSLSDLLSFALQIARGMEYLESK---NFIHRDLAA 131
Query: 66 NNILLNLELEAFVADFGVARLLNFDSSNRTLLA-GTYGYIAPELAYTMVVTEKSDVYSFG 124
N L+ L ++DFG++R L D + ++APE T KSDV+SFG
Sbjct: 132 RNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKLPIRWMAPESLKEGKFTSKSDVWSFG 191
Query: 125 VVALEVL-MGKHP 136
V+ E+ +G+ P
Sbjct: 192 VLLWEIFTLGEEP 204
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 82.2 bits (204), Expect = 7e-20
Identities = 40/133 (30%), Positives = 66/133 (49%), Gaps = 7/133 (5%)
Query: 6 MFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISS 65
++++ EYME G L LR + L + ++ +A + YL +HRD+++
Sbjct: 76 LYIVMEYMEGGDLLSYLRKNRPK--LSLSDLLSFALQIARGMEYLESK---NFIHRDLAA 130
Query: 66 NNILLNLELEAFVADFGVARLLNFDSSNRTLLA-GTYGYIAPELAYTMVVTEKSDVYSFG 124
N L+ L ++DFG++R L D R ++APE T KSDV+SFG
Sbjct: 131 RNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKLPIRWMAPESLKEGKFTSKSDVWSFG 190
Query: 125 VVALEVL-MGKHP 136
V+ E+ +G+ P
Sbjct: 191 VLLWEIFTLGEQP 203
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 82.3 bits (204), Expect = 8e-20
Identities = 44/134 (32%), Positives = 70/134 (52%), Gaps = 13/134 (9%)
Query: 6 MFLIYEYMEMGSLFCVLRT---DEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRD 62
+++I EY GS +L+ DE + I++ + L YLH + +HRD
Sbjct: 74 LWIIMEYCGGGSCLDLLKPGKLDETYIAF-------ILREVLLGLEYLHEEGK---IHRD 123
Query: 63 ISSNNILLNLELEAFVADFGVARLLNFDSSNRTLLAGTYGYIAPELAYTMVVTEKSDVYS 122
I + NILL+ E + +ADFGV+ L S R GT ++APE+ EK+D++S
Sbjct: 124 IKAANILLSEEGDVKLADFGVSGQLTSTMSKRNTFVGTPFWMAPEVIKQSGYDEKADIWS 183
Query: 123 FGVVALEVLMGKHP 136
G+ A+E+ G+ P
Sbjct: 184 LGITAIELAKGEPP 197
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 81.1 bits (201), Expect = 2e-19
Identities = 42/141 (29%), Positives = 72/141 (51%), Gaps = 15/141 (10%)
Query: 1 LHRKCMFLIYEYMEMGSL-----FCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCT 55
L ++++ EYM+ GSL +R +E + + + + L YLH +
Sbjct: 85 LVGDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAY-------VCREVLQGLEYLH---S 134
Query: 56 PPIVHRDISSNNILLNLELEAFVADFGVARLLNFDSSNRTLLAGTYGYIAPELAYTMVVT 115
++HRDI S+NILL+ + +ADFG A L + S R + GT ++APE+
Sbjct: 135 QNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNSVVGTPYWMAPEVIKRKDYG 194
Query: 116 EKSDVYSFGVVALEVLMGKHP 136
K D++S G++ +E+ G+ P
Sbjct: 195 PKVDIWSLGIMCIEMAEGEPP 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 80.2 bits (198), Expect = 4e-19
Identities = 45/140 (32%), Positives = 74/140 (52%), Gaps = 24/140 (17%)
Query: 6 MFLIYEYMEMGSLFCVLRT---DEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRD 62
+++I EY E GS+ +++ E+ + + I++ + AL Y+H ++HRD
Sbjct: 77 LWIIMEYAEGGSVRTLMKAGPIAEKYISV-------IIREVLVALKYIHKV---GVIHRD 126
Query: 63 ISSNNILLNLELEAFVADFGVARLLNFDSSNRTLLAGTYGYIAPELAYTMVVTE------ 116
I + NIL+ + DFGVA LLN +SS R+ GT ++APE V+TE
Sbjct: 127 IKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTFVGTPYWMAPE-----VITEGKYYDT 181
Query: 117 KSDVYSFGVVALEVLMGKHP 136
K+D++S G+ E+ G P
Sbjct: 182 KADIWSLGITIYEMATGNPP 201
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 81.4 bits (201), Expect = 6e-19
Identities = 48/135 (35%), Positives = 74/135 (54%), Gaps = 11/135 (8%)
Query: 4 KCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDI 63
K +LI+EY+E +L VLR L W +R I G+A AL +LH C+P +V ++
Sbjct: 756 KGAYLIHEYIEGKNLSEVLR------NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNL 809
Query: 64 SSNNILLNLELEAFVADFGVARLLNFDSSNRTLLAGTYGYIAPELAYTMVVTEKSDVYSF 123
S I+++ + E + + LL D+ A Y+APE T +TEKSD+Y F
Sbjct: 810 SPEKIIIDGKDEPHLR-LSLPGLLCTDTKCFISSA----YVAPETRETKDITEKSDIYGF 864
Query: 124 GVVALEVLMGKHPGE 138
G++ +E+L GK P +
Sbjct: 865 GLILIELLTGKSPAD 879
|
Length = 968 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 79.5 bits (197), Expect = 7e-19
Identities = 43/141 (30%), Positives = 66/141 (46%), Gaps = 14/141 (9%)
Query: 6 MFLIYEYMEMGSLFCVLRT------DEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIV 59
++L+ EYME G L LR E L ++ +A + YL V
Sbjct: 71 LYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLAS---KKFV 127
Query: 60 HRDISSNNILLNLELEAFVADFGVARLLNFDSSNRTLLAGTYGYI---APELAYTMVVTE 116
HRD+++ N L+ +L ++DFG++R + +D G I APE + T
Sbjct: 128 HRDLAARNCLVGEDLVVKISDFGLSRDV-YDDDYYRKKTGGKLPIRWMAPESLKDGIFTS 186
Query: 117 KSDVYSFGVVALEVL-MGKHP 136
KSDV+SFGV+ E+ +G P
Sbjct: 187 KSDVWSFGVLLWEIFTLGATP 207
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 77.4 bits (191), Expect = 5e-18
Identities = 47/132 (35%), Positives = 71/132 (53%), Gaps = 9/132 (6%)
Query: 3 RKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRD 62
+ + +I EYME GSL LR ++ + V +++G+A + YL VHRD
Sbjct: 77 SRPVMIITEYMENGSLDKFLRENDGK--FTVGQLVGMLRGIASGMKYLSEMNY---VHRD 131
Query: 63 ISSNNILLNLELEAFVADFGVARLLNFDSSNRTLLAGTYG--YIAPE-LAYTMVVTEKSD 119
+++ NIL+N L V+DFG++R L + T G + APE +AY T SD
Sbjct: 132 LAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTAPEAIAYR-KFTSASD 190
Query: 120 VYSFGVVALEVL 131
V+SFG+V EV+
Sbjct: 191 VWSFGIVMWEVM 202
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 76.4 bits (188), Expect = 1e-17
Identities = 50/139 (35%), Positives = 74/139 (53%), Gaps = 20/139 (14%)
Query: 6 MFLIYEYMEMGSLFCVL------RTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIV 59
+ ++ EY E G L +L E+ V W + I+ G L++LH + I+
Sbjct: 74 LNIVMEYAENGDLHKLLKMQRGRPLPEDQV---WRFFIQILLG----LAHLH---SKKIL 123
Query: 60 HRDISSNNILLNLELEAFVADFGVARLLNFDSSN--RTLLAGTYGYIAPELAYTMVVTEK 117
HRDI S N+ L+ + D GVA+LL+ D++N T++ GT Y++PEL EK
Sbjct: 124 HRDIKSLNLFLDAYDNVKIGDLGVAKLLS-DNTNFANTIV-GTPYYLSPELCEDKPYNEK 181
Query: 118 SDVYSFGVVALEVLMGKHP 136
SDV++ GVV E GKHP
Sbjct: 182 SDVWALGVVLYECCTGKHP 200
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 75.9 bits (187), Expect = 2e-17
Identities = 45/144 (31%), Positives = 72/144 (50%), Gaps = 16/144 (11%)
Query: 3 RKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRD 62
++L+ Y+ GSL ++++ GLD A ++K + L YLH + +HRD
Sbjct: 71 GDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQ---IHRD 127
Query: 63 ISSNNILLNLELEAFVADFGVARLL--NFDSSN--RTLLAGTYGYIAPEL-----AYTMV 113
I + NILL + +ADFGV+ L D + R GT ++APE+ Y
Sbjct: 128 IKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQVHGY--- 184
Query: 114 VTEKSDVYSFGVVALEVLMGKHPG 137
K+D++SFG+ A+E+ G P
Sbjct: 185 -DFKADIWSFGITAIELATGAAPY 207
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 74.7 bits (184), Expect = 5e-17
Identities = 42/132 (31%), Positives = 69/132 (52%), Gaps = 10/132 (7%)
Query: 5 CMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDIS 64
CM EYM+ GSL +L+ + + ++ + + L+YLH I+HRD+
Sbjct: 77 CM----EYMDGGSLDKILKEVQGRIPERILGKIAV--AVLKGLTYLHEKHK--IIHRDVK 128
Query: 65 SNNILLNLELEAFVADFGVARLLNFDSSNRTLLAGTYGYIAPELAYTMVVTEKSDVYSFG 124
+NIL+N + + DFGV+ L +S +T GT Y+APE + KSD++S G
Sbjct: 129 PSNILVNSRGQIKLCDFGVSGQL-VNSLAKT-FVGTSSYMAPERIQGNDYSVKSDIWSLG 186
Query: 125 VVALEVLMGKHP 136
+ +E+ G+ P
Sbjct: 187 LSLIELATGRFP 198
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 74.0 bits (182), Expect = 7e-17
Identities = 47/127 (37%), Positives = 73/127 (57%), Gaps = 10/127 (7%)
Query: 7 FLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSN 66
++I E ME GSL LR+ E V L A +++ +A ++YL +HRD+++
Sbjct: 78 YIITELMEKGSLLAFLRSPEGQV-LPVASLIDMACQVAEGMAYLEEQ---NSIHRDLAAR 133
Query: 67 NILLNLELEAFVADFGVARLLNFD---SSNRTLLAGTYGYIAPELAYTMVVTEKSDVYSF 123
NIL+ +L VADFG+ARL+ D SS++ + Y + APE A + KSDV+SF
Sbjct: 134 NILVGEDLVCKVADFGLARLIKEDVYLSSDKKI---PYKWTAPEAASHGTFSTKSDVWSF 190
Query: 124 GVVALEV 130
G++ E+
Sbjct: 191 GILLYEM 197
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 73.9 bits (182), Expect = 9e-17
Identities = 36/99 (36%), Positives = 51/99 (51%), Gaps = 4/99 (4%)
Query: 46 ALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADFGVARLLNFDSSNRTLLAGTYGYIA 105
AL YLH + I+HRDI +NILL+ + + DF +A + + T +GT GY+A
Sbjct: 112 ALEYLH---SKGIIHRDIKPDNILLDEQGHVHITDFNIATKVT-PDTLTTSTSGTPGYMA 167
Query: 106 PELAYTMVVTEKSDVYSFGVVALEVLMGKHPGELLSSSS 144
PE+ + D +S GV A E L GK P S +
Sbjct: 168 PEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTI 206
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 72.8 bits (178), Expect = 3e-16
Identities = 39/131 (29%), Positives = 72/131 (54%), Gaps = 7/131 (5%)
Query: 6 MFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISS 65
+F++ EY+ GSL V+ +D A+ + + AL +LH + ++HRDI S
Sbjct: 91 LFVVMEYLAGGSLTDVV----TETCMDEAQIAAVCRECLQALEFLHAN---QVIHRDIKS 143
Query: 66 NNILLNLELEAFVADFGVARLLNFDSSNRTLLAGTYGYIAPELAYTMVVTEKSDVYSFGV 125
+N+LL ++ + DFG + + S R+ + GT ++APE+ K D++S G+
Sbjct: 144 DNVLLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGI 203
Query: 126 VALEVLMGKHP 136
+A+E++ G+ P
Sbjct: 204 MAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 71.8 bits (177), Expect = 5e-16
Identities = 44/150 (29%), Positives = 66/150 (44%), Gaps = 30/150 (20%)
Query: 1 LHRKCMFLIYEYMEMGSLFCVLRTD--------EEAVGLDWAKRVNIVKGMAHALSYLH- 51
+ + ++ EY + G L ++ EE + LDW V + AL YLH
Sbjct: 69 EEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQI-LDWF--VQLCL----ALKYLHS 121
Query: 52 -HDCTPPIVHRDISSNNILLNLELEAFVADFGVARLLNFDSSNRTLLAGTYGYIAPEL-- 108
I+HRDI NI L + DFG++++L+ + GT Y++PEL
Sbjct: 122 RK-----ILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKTVVGTPYYLSPELCQ 176
Query: 109 --AYTMVVTEKSDVYSFGVVALEVLMGKHP 136
Y KSD++S G V E+ KHP
Sbjct: 177 NKPYN----YKSDIWSLGCVLYELCTLKHP 202
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 71.9 bits (177), Expect = 5e-16
Identities = 43/132 (32%), Positives = 63/132 (47%), Gaps = 14/132 (10%)
Query: 9 IYEYMEMGSLFCVLRT----DEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDIS 64
I EY E GSL +++ E V V + L+YLH ++HRDI
Sbjct: 77 ILEYAENGSLRQIIKKFGPFPESLVA-------VYVYQVLQGLAYLH---EQGVIHRDIK 126
Query: 65 SNNILLNLELEAFVADFGVARLLNFDSSNRTLLAGTYGYIAPELAYTMVVTEKSDVYSFG 124
+ NIL + +ADFGVA LN S + + GT ++APE+ + SD++S G
Sbjct: 127 AANILTTKDGVVKLADFGVATKLNDVSKDDASVVGTPYWMAPEVIEMSGASTASDIWSLG 186
Query: 125 VVALEVLMGKHP 136
+E+L G P
Sbjct: 187 CTVIELLTGNPP 198
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 71.1 bits (174), Expect = 1e-15
Identities = 47/135 (34%), Positives = 74/135 (54%), Gaps = 11/135 (8%)
Query: 8 LIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNN 67
+I E+ME G+L LR ++ + + V +++G+A + YL VHRD+++ N
Sbjct: 82 IITEFMENGALDSFLRQNDGQFTV--IQLVGMLRGIAAGMKYLSE---MNYVHRDLAARN 136
Query: 68 ILLNLELEAFVADFGVARLLNFDSSNRTLLAGTYGYI-----APELAYTMVVTEKSDVYS 122
IL+N L V+DFG++R L D+S+ T + G I APE T SDV+S
Sbjct: 137 ILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWS 196
Query: 123 FGVVALEVL-MGKHP 136
+G+V EV+ G+ P
Sbjct: 197 YGIVMWEVMSYGERP 211
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 69.9 bits (172), Expect = 2e-15
Identities = 44/136 (32%), Positives = 65/136 (47%), Gaps = 16/136 (11%)
Query: 6 MFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLH-HDCTPPIVHRDIS 64
++L+ EY G LF L E + A+ + AL YLH I++RD+
Sbjct: 68 LYLVLEYAPGGELFSHLS-KEGRFSEERARF--YAAEIVLALEYLHSLG----IIYRDLK 120
Query: 65 SNNILLNLELEAFVADFGVARLLNFDSSNRTLLAGTYGYIAPEL----AYTMVVTEKSDV 120
NILL+ + + DFG+A+ L+ + S GT Y+APE+ Y V D
Sbjct: 121 PENILLDADGHIKLTDFGLAKELSSEGSRTNTFCGTPEYLAPEVLLGKGYGKAV----DW 176
Query: 121 YSFGVVALEVLMGKHP 136
+S GV+ E+L GK P
Sbjct: 177 WSLGVLLYEMLTGKPP 192
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 69.8 bits (171), Expect = 3e-15
Identities = 45/142 (31%), Positives = 70/142 (49%), Gaps = 20/142 (14%)
Query: 6 MFLIYEYMEMGSLFCVLRTDEEAVG----LDWAKRVNIVKGMAHALSYL--HHDCTPPIV 59
+ LI + M +G L +R ++ +G L+W V I KGM SYL +V
Sbjct: 83 VQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWC--VQIAKGM----SYLEEKR-----LV 131
Query: 60 HRDISSNNILLNLELEAFVADFGVARLLNFDSSNRTLLAGTY--GYIAPELAYTMVVTEK 117
HRD+++ N+L+ + DFG+A+LL+ D G ++A E + T K
Sbjct: 132 HRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESILHRIYTHK 191
Query: 118 SDVYSFGVVALEVL-MGKHPGE 138
SDV+S+GV E++ G P E
Sbjct: 192 SDVWSYGVTVWELMTFGAKPYE 213
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 69.8 bits (171), Expect = 4e-15
Identities = 47/142 (33%), Positives = 68/142 (47%), Gaps = 30/142 (21%)
Query: 8 LIYEYMEMGSLFCVL--------RTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIV 59
+ EY E GSL + R E+ +G I + + LSYLH + I+
Sbjct: 78 IAMEYCEGGSLDSIYKKVKKRGGRIGEKVLG-------KIAESVLKGLSYLH---SRKII 127
Query: 60 HRDISSNNILLNLELEAFVADFGVA-RLLNFDSSNRTLLAGTYGYIAPE----LAYTMVV 114
HRDI +NILL + + + DFGV+ L+N + T GT Y+APE Y++
Sbjct: 128 HRDIKPSNILLTRKGQVKLCDFGVSGELVNSLAGTFT---GTSFYMAPERIQGKPYSI-- 182
Query: 115 TEKSDVYSFGVVALEVLMGKHP 136
SDV+S G+ LEV + P
Sbjct: 183 --TSDVWSLGLTLLEVAQNRFP 202
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 5e-15
Identities = 43/131 (32%), Positives = 68/131 (51%), Gaps = 7/131 (5%)
Query: 6 MFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISS 65
+++I EY+ GS +L E LD + I++ + L YLH + +HRDI +
Sbjct: 77 LWIIMEYLGGGSALDLL----EPGPLDETQIATILREILKGLDYLHSE---KKIHRDIKA 129
Query: 66 NNILLNLELEAFVADFGVARLLNFDSSNRTLLAGTYGYIAPELAYTMVVTEKSDVYSFGV 125
N+LL+ E +ADFGVA L R GT ++APE+ K+D++S G+
Sbjct: 130 ANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGI 189
Query: 126 VALEVLMGKHP 136
A+E+ G+ P
Sbjct: 190 TAIELAKGEPP 200
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 69.4 bits (170), Expect = 5e-15
Identities = 46/140 (32%), Positives = 67/140 (47%), Gaps = 27/140 (19%)
Query: 5 CMFLIYEYMEMGSLFCVLRT----DEEAVGLDWAKRVNIVKGMAHALSYL---HHDCTPP 57
CM E+M+ GSL + + E +G I + L+YL H
Sbjct: 81 CM----EFMDCGSLDRIYKKGGPIPVEILG-------KIAVAVVEGLTYLYNVHR----- 124
Query: 58 IVHRDISSNNILLNLELEAFVADFGVA-RLLNFDSSNRTLLAGTYGYIAPELAYTMVVTE 116
I+HRDI +NIL+N + + DFGV+ L+N S GT Y++PE T
Sbjct: 125 IMHRDIKPSNILVNSRGQIKLCDFGVSGELIN---SIADTFVGTSTYMSPERIQGGKYTV 181
Query: 117 KSDVYSFGVVALEVLMGKHP 136
KSDV+S G+ +E+ +GK P
Sbjct: 182 KSDVWSLGISIIELALGKFP 201
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 9e-15
Identities = 50/138 (36%), Positives = 72/138 (52%), Gaps = 11/138 (7%)
Query: 4 KCMFLIYEYMEMGSLFCVLR-TDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRD 62
K +I EYME G+L LR D E + V +++G+A + YL VHRD
Sbjct: 79 KPAMIITEYMENGALDKYLRDHDGEFSSY---QLVGMLRGIAAGMKYLSD---MNYVHRD 132
Query: 63 ISSNNILLNLELEAFVADFGVARLLNFDSSNRTLLAG---TYGYIAPELAYTMVVTEKSD 119
+++ NIL+N LE V+DFG++R+L D +G + APE T SD
Sbjct: 133 LAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASD 192
Query: 120 VYSFGVVALEVL-MGKHP 136
V+SFG+V EV+ G+ P
Sbjct: 193 VWSFGIVMWEVMSFGERP 210
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 69.0 bits (168), Expect = 1e-14
Identities = 38/131 (29%), Positives = 71/131 (54%), Gaps = 7/131 (5%)
Query: 6 MFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISS 65
++++ EY+ GSL V+ +D + + + AL +LH + ++HRDI S
Sbjct: 91 LWVVMEYLAGGSLTDVV----TETCMDEGQIAAVCRECLQALDFLHSN---QVIHRDIKS 143
Query: 66 NNILLNLELEAFVADFGVARLLNFDSSNRTLLAGTYGYIAPELAYTMVVTEKSDVYSFGV 125
+NILL ++ + DFG + + S R+ + GT ++APE+ K D++S G+
Sbjct: 144 DNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGI 203
Query: 126 VALEVLMGKHP 136
+A+E++ G+ P
Sbjct: 204 MAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 68.6 bits (167), Expect = 1e-14
Identities = 38/131 (29%), Positives = 71/131 (54%), Gaps = 7/131 (5%)
Query: 6 MFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISS 65
++++ EY+ GSL V+ +D + + + AL +LH + ++HRDI S
Sbjct: 92 LWVVMEYLAGGSLTDVV----TETCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKS 144
Query: 66 NNILLNLELEAFVADFGVARLLNFDSSNRTLLAGTYGYIAPELAYTMVVTEKSDVYSFGV 125
+NILL ++ + DFG + + S R+ + GT ++APE+ K D++S G+
Sbjct: 145 DNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGI 204
Query: 126 VALEVLMGKHP 136
+A+E++ G+ P
Sbjct: 205 MAIEMIEGEPP 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 68.2 bits (166), Expect = 1e-14
Identities = 42/131 (32%), Positives = 69/131 (52%), Gaps = 7/131 (5%)
Query: 6 MFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISS 65
+++I EY+ GS +LR A D + ++K + L YLH + +HRDI +
Sbjct: 77 LWIIMEYLGGGSALDLLR----AGPFDEFQIATMLKEILKGLDYLHSE---KKIHRDIKA 129
Query: 66 NNILLNLELEAFVADFGVARLLNFDSSNRTLLAGTYGYIAPELAYTMVVTEKSDVYSFGV 125
N+LL+ + + +ADFGVA L R GT ++APE+ K+D++S G+
Sbjct: 130 ANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGI 189
Query: 126 VALEVLMGKHP 136
A+E+ G+ P
Sbjct: 190 TAIELAKGEPP 200
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 68.0 bits (166), Expect = 2e-14
Identities = 38/131 (29%), Positives = 71/131 (54%), Gaps = 7/131 (5%)
Query: 6 MFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISS 65
++++ EY+ GSL V+ +D + + + AL +LH + ++HRDI S
Sbjct: 91 LWVVMEYLAGGSLTDVV----TETCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKS 143
Query: 66 NNILLNLELEAFVADFGVARLLNFDSSNRTLLAGTYGYIAPELAYTMVVTEKSDVYSFGV 125
+NILL ++ + DFG + + S R+ + GT ++APE+ K D++S G+
Sbjct: 144 DNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGI 203
Query: 126 VALEVLMGKHP 136
+A+E++ G+ P
Sbjct: 204 MAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 67.2 bits (164), Expect = 3e-14
Identities = 36/105 (34%), Positives = 59/105 (56%), Gaps = 9/105 (8%)
Query: 38 NIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADFGVARLLNFDS------ 91
N V+ + L+YLH I+HRDI NIL++ + ++DFG+++ L +S
Sbjct: 110 NFVRQILKGLNYLH---NRGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTN 166
Query: 92 SNRTLLAGTYGYIAPELAYTMVVTEKSDVYSFGVVALEVLMGKHP 136
R L G+ ++APE+ T K+D++S G + +E+L GKHP
Sbjct: 167 GARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHP 211
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 67.9 bits (166), Expect = 3e-14
Identities = 47/136 (34%), Positives = 72/136 (52%), Gaps = 19/136 (13%)
Query: 8 LIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNN 67
++ E+M+ GSL DE+ + D A++ I+ G+A YLH IVHRDI +N
Sbjct: 149 VLLEFMDGGSLEGTHIADEQFLA-DVARQ--ILSGIA----YLHRR---HIVHRDIKPSN 198
Query: 68 ILLNLELEAFVADFGVARLLN--FDSSNRTLLAGTYGYIAPE-----LAYTMVVTEKSDV 120
+L+N +ADFGV+R+L D N ++ GT Y++PE L + D+
Sbjct: 199 LLINSAKNVKIADFGVSRILAQTMDPCNSSV--GTIAYMSPERINTDLNHGAYDGYAGDI 256
Query: 121 YSFGVVALEVLMGKHP 136
+S GV LE +G+ P
Sbjct: 257 WSLGVSILEFYLGRFP 272
|
Length = 353 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 66.9 bits (164), Expect = 3e-14
Identities = 39/103 (37%), Positives = 57/103 (55%), Gaps = 13/103 (12%)
Query: 39 IVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADFGVARLLNFDSSNRTLLA 98
I+ L YLH + +HRDI + NILLN E +A +ADFGV+ L + R +
Sbjct: 104 ILYQTLKGLEYLHSN---KKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNTVI 160
Query: 99 GTYGYIAPELAYTMVVTE-----KSDVYSFGVVALEVLMGKHP 136
GT ++APE V+ E K+D++S G+ A+E+ GK P
Sbjct: 161 GTPFWMAPE-----VIQEIGYNNKADIWSLGITAIEMAEGKPP 198
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 66.9 bits (164), Expect = 4e-14
Identities = 41/141 (29%), Positives = 66/141 (46%), Gaps = 17/141 (12%)
Query: 6 MFLIYEYMEMGSLFCVL--------RTDEEAVGLDWAKRVNIVKGMAHALSYLHH--DCT 55
++++ EY E G L ++ +EE + W I+ + AL H+ D
Sbjct: 76 LYIVMEYCEGGDLAQLIQKCKKERKYIEEEFI---W----RILTQLLLALYECHNRSDPG 128
Query: 56 PPIVHRDISSNNILLNLELEAFVADFGVARLLNFDSSNRTLLAGTYGYIAPELAYTMVVT 115
++HRD+ NI L+ + DFG+A++L DSS GT Y++PE M
Sbjct: 129 NTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKTYVGTPYYMSPEQLNHMSYD 188
Query: 116 EKSDVYSFGVVALEVLMGKHP 136
EKSD++S G + E+ P
Sbjct: 189 EKSDIWSLGCLIYELCALSPP 209
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 67.4 bits (164), Expect = 4e-14
Identities = 37/134 (27%), Positives = 74/134 (55%), Gaps = 13/134 (9%)
Query: 6 MFLIYEYMEMGSLFCVL---RTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRD 62
++++ E+++ G+L ++ R +EE + + + + AL YLH + ++HRD
Sbjct: 93 LWVLMEFLQGGALTDIVSQTRLNEEQIA-------TVCESVLQALCYLH---SQGVIHRD 142
Query: 63 ISSNNILLNLELEAFVADFGVARLLNFDSSNRTLLAGTYGYIAPELAYTMVVTEKSDVYS 122
I S++ILL L+ ++DFG ++ D R L GT ++APE+ + D++S
Sbjct: 143 IKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRTPYGTEVDIWS 202
Query: 123 FGVVALEVLMGKHP 136
G++ +E++ G+ P
Sbjct: 203 LGIMVIEMVDGEPP 216
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 66.7 bits (163), Expect = 4e-14
Identities = 38/127 (29%), Positives = 69/127 (54%), Gaps = 11/127 (8%)
Query: 6 MFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISS 65
++++ EYM GSL LR+ AV + A+++ + + YL VHRD+++
Sbjct: 75 LYIVTEYMAKGSLVDYLRSRGRAV-ITLAQQLGFALDVCEGMEYLE---EKNFVHRDLAA 130
Query: 66 NNILLNLELEAFVADFGVARLLNFDSSNRTLLAGTY--GYIAPELAYTMVVTEKSDVYSF 123
N+L++ +L A V+DFG+A+ +++ +G + APE + KSDV+SF
Sbjct: 131 RNVLVSEDLVAKVSDFGLAK-----EASQGQDSGKLPVKWTAPEALREKKFSTKSDVWSF 185
Query: 124 GVVALEV 130
G++ E+
Sbjct: 186 GILLWEI 192
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 65.1 bits (158), Expect = 2e-13
Identities = 40/131 (30%), Positives = 68/131 (51%), Gaps = 7/131 (5%)
Query: 6 MFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISS 65
+++I EY+ GS +L+ L+ I++ + L YLH + +HRDI +
Sbjct: 77 LWIIMEYLGGGSALDLLKPGP----LEETYIATILREILKGLDYLHSERK---IHRDIKA 129
Query: 66 NNILLNLELEAFVADFGVARLLNFDSSNRTLLAGTYGYIAPELAYTMVVTEKSDVYSFGV 125
N+LL+ + + +ADFGVA L R GT ++APE+ K+D++S G+
Sbjct: 130 ANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGI 189
Query: 126 VALEVLMGKHP 136
A+E+ G+ P
Sbjct: 190 TAIELAKGEPP 200
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 64.9 bits (158), Expect = 2e-13
Identities = 46/137 (33%), Positives = 71/137 (51%), Gaps = 9/137 (6%)
Query: 4 KCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDI 63
K + ++ EYME GSL LR + + + V +++G+A + YL VHRD+
Sbjct: 78 KPVMIVTEYMENGSLDAFLRKHDGQFTV--IQLVGMLRGIASGMKYL---SDMGYVHRDL 132
Query: 64 SSNNILLNLELEAFVADFGVARLLNFDSSNRTLLAG---TYGYIAPELAYTMVVTEKSDV 120
++ NIL+N L V+DFG++R+L D G + APE T SDV
Sbjct: 133 AARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDV 192
Query: 121 YSFGVVALEVL-MGKHP 136
+S+G+V EV+ G+ P
Sbjct: 193 WSYGIVMWEVMSYGERP 209
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 64.8 bits (158), Expect = 2e-13
Identities = 36/134 (26%), Positives = 73/134 (54%), Gaps = 13/134 (9%)
Query: 6 MFLIYEYMEMGSLFCVL---RTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRD 62
++++ E++E G+L ++ R +EE + + + ALS+LH ++HRD
Sbjct: 91 LWVVMEFLEGGALTDIVTHTRMNEEQIA-------TVCLAVLKALSFLH---AQGVIHRD 140
Query: 63 ISSNNILLNLELEAFVADFGVARLLNFDSSNRTLLAGTYGYIAPELAYTMVVTEKSDVYS 122
I S++ILL + ++DFG ++ + R L GT ++APE+ + + D++S
Sbjct: 141 IKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPEVISRLPYGTEVDIWS 200
Query: 123 FGVVALEVLMGKHP 136
G++ +E++ G+ P
Sbjct: 201 LGIMVIEMVDGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 64.5 bits (157), Expect = 3e-13
Identities = 42/129 (32%), Positives = 71/129 (55%), Gaps = 9/129 (6%)
Query: 6 MFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISS 65
+++I EYME GSL L+T E + L K +++ +A ++++ +HRD+ +
Sbjct: 75 IYIITEYMENGSLVDFLKTPE-GIKLTINKLIDMAAQIAEGMAFIERK---NYIHRDLRA 130
Query: 66 NNILLNLELEAFVADFGVARLLNFDSSNRTLLAGT---YGYIAPELAYTMVVTEKSDVYS 122
NIL++ L +ADFG+ARL+ + + T G + APE T KSDV+S
Sbjct: 131 ANILVSETLCCKIADFGLARLI--EDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWS 188
Query: 123 FGVVALEVL 131
FG++ E++
Sbjct: 189 FGILLTEIV 197
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 64.5 bits (157), Expect = 3e-13
Identities = 43/140 (30%), Positives = 65/140 (46%), Gaps = 16/140 (11%)
Query: 5 CMFLIYEYMEMGSLFCVLRTD------EEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPI 58
++++ +Y E G L+ + E+ + LDW V I + H HD I
Sbjct: 73 NLYIVMDYCEGGDLYKKINAQRGVLFPEDQI-LDWF--VQICLALKHV-----HD--RKI 122
Query: 59 VHRDISSNNILLNLELEAFVADFGVARLLNFDSSNRTLLAGTYGYIAPELAYTMVVTEKS 118
+HRDI S NI L + + DFG+AR+LN GT Y++PE+ KS
Sbjct: 123 LHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELARTCIGTPYYLSPEICENRPYNNKS 182
Query: 119 DVYSFGVVALEVLMGKHPGE 138
D+++ G V E+ KH E
Sbjct: 183 DIWALGCVLYEMCTLKHAFE 202
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 64.1 bits (157), Expect = 4e-13
Identities = 41/137 (29%), Positives = 64/137 (46%), Gaps = 22/137 (16%)
Query: 7 FLIYEYME---MGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDI 63
++++EYM+ G +L + E K +K + L YLH + I+HRDI
Sbjct: 76 YMVFEYMDHDLTG----LLDSPEVKFTESQIKC--YMKQLLEGLQYLHSN---GILHRDI 126
Query: 64 SSNNILLNLELEAFVADFGVARLLNFDSSNR-TLLAGTYGYIAPEL-----AYTMVVTEK 117
+NIL+N + +ADFG+AR +S T T Y PEL Y +
Sbjct: 127 KGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVITLWYRPPELLLGATRY----GPE 182
Query: 118 SDVYSFGVVALEVLMGK 134
D++S G + E+ +GK
Sbjct: 183 VDMWSVGCILAELFLGK 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 62.7 bits (153), Expect = 1e-12
Identities = 49/159 (30%), Positives = 70/159 (44%), Gaps = 45/159 (28%)
Query: 1 LHRKCMFLIYEYMEMGSLFCVLR----TDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTP 56
+HR+ +++ EY G+L +L DE + + + L+YLH +
Sbjct: 69 VHREKVYIFMEYCSGGTLEELLEHGRILDEHVIRV-------YTLQLLEGLAYLH---SH 118
Query: 57 PIVHRDISSNNILLN----LELEAFVADFGVARLLNFDSSNRTL-------LAGTYGYIA 105
IVHRDI NI L+ ++L DFG A L +N T LAGT Y+A
Sbjct: 119 GIVHRDIKPANIFLDHNGVIKL----GDFGCAVKL---KNNTTTMGEEVQSLAGTPAYMA 171
Query: 106 PELAYTMVVTEKS--------DVYSFGVVALEVLMGKHP 136
PE V+T D++S G V LE+ GK P
Sbjct: 172 PE-----VITGGKGKGHGRAADIWSLGCVVLEMATGKRP 205
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 1e-12
Identities = 48/139 (34%), Positives = 67/139 (48%), Gaps = 15/139 (10%)
Query: 12 YMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHA----LSY-------LHHDCTPPIVH 60
+ E G LF V+ E G D KR+N +G+ + LS+ L H I+H
Sbjct: 68 FQENGRLFIVM---EYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILH 124
Query: 61 RDISSNNILLNLE-LEAFVADFGVARLLNFDSSNRTLLAGTYGYIAPELAYTMVVTEKSD 119
RDI S NI L+ + A + DFG+AR LN GT Y++PE+ K+D
Sbjct: 125 RDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYTCVGTPYYLSPEICQNRPYNNKTD 184
Query: 120 VYSFGVVALEVLMGKHPGE 138
++S G V E+ KHP E
Sbjct: 185 IWSLGCVLYELCTLKHPFE 203
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 62.0 bits (151), Expect = 2e-12
Identities = 44/127 (34%), Positives = 67/127 (52%), Gaps = 9/127 (7%)
Query: 7 FLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSN 66
+++ EYM GSL L++ E L + V++ +A ++YL +HRD+++
Sbjct: 77 YIVTEYMSKGSLLDFLKSGE-GKKLRLPQLVDMAAQIAEGMAYLESR---NYIHRDLAAR 132
Query: 67 NILLNLELEAFVADFGVARLLNFDSSNRTLLAGTYGYI---APELAYTMVVTEKSDVYSF 123
NIL+ L +ADFG+ARL+ D T G I APE A T KSDV+SF
Sbjct: 133 NILVGENLVCKIADFGLARLIEDDEY--TAREGAKFPIKWTAPEAANYGRFTIKSDVWSF 190
Query: 124 GVVALEV 130
G++ E+
Sbjct: 191 GILLTEI 197
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.0 bits (151), Expect = 3e-12
Identities = 36/135 (26%), Positives = 65/135 (48%), Gaps = 9/135 (6%)
Query: 2 HRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLH-HDCTPPIVH 60
H+ ++L++E+M+ L+ +++ GL + + + + L++ H H I+H
Sbjct: 69 HKGDLYLVFEFMDT-DLYKLIKD--RQRGLPESLIKSYLYQLLQGLAFCHSHG----ILH 121
Query: 61 RDISSNNILLNLELEAFVADFGVARLLNFDSSNRTLLAGTYGYIAPELAYTM-VVTEKSD 119
RD+ N+L+N E +ADFG+AR T T Y APEL + D
Sbjct: 122 RDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYVVTRWYRAPELLLGDKGYSTPVD 181
Query: 120 VYSFGVVALEVLMGK 134
++S G + E+L +
Sbjct: 182 IWSVGCIFAELLSRR 196
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 3e-12
Identities = 45/136 (33%), Positives = 71/136 (52%), Gaps = 6/136 (4%)
Query: 3 RKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRD 62
+ ++++ EYM GSL L+ D E L V++ +A ++Y+ +HRD
Sbjct: 72 EEPIYIVTEYMSKGSLLDFLK-DGEGRALKLPNLVDMAAQVAAGMAYIER---MNYIHRD 127
Query: 63 ISSNNILLNLELEAFVADFGVARLL-NFDSSNRTLLAGTYGYIAPELAYTMVVTEKSDVY 121
+ S NIL+ L +ADFG+ARL+ + + + R + APE A T KSDV+
Sbjct: 128 LRSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVW 187
Query: 122 SFGVVALE-VLMGKHP 136
SFG++ E V G+ P
Sbjct: 188 SFGILLTELVTKGRVP 203
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 61.5 bits (150), Expect = 3e-12
Identities = 43/147 (29%), Positives = 70/147 (47%), Gaps = 22/147 (14%)
Query: 2 HRKCMFLIYEYMEMGSLFCVLRT----DEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPP 57
+K ++L+ EY+ G L +L DE D A+ + + AL YLH +
Sbjct: 64 GKKNLYLVMEYLPGGDLASLLENVGSLDE-----DVAR--IYIAEIVLALEYLHSN---G 113
Query: 58 IVHRDISSNNILLNLELEAFVADFGVARL--------LNFDSSNRTLLAGTYGYIAPELA 109
I+HRD+ +NIL++ + DFG++++ LN D + GT YIAPE+
Sbjct: 114 IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVI 173
Query: 110 YTMVVTEKSDVYSFGVVALEVLMGKHP 136
++ D +S G + E L+G P
Sbjct: 174 LGQGHSKTVDWWSLGCILYEFLVGIPP 200
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 4e-12
Identities = 37/134 (27%), Positives = 72/134 (53%), Gaps = 13/134 (9%)
Query: 6 MFLIYEYMEMGSLFCVL---RTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRD 62
++++ E++E G+L ++ R +EE + + + ALS LH ++HRD
Sbjct: 92 LWVVMEFLEGGALTDIVTHTRMNEEQIA-------AVCLAVLKALSVLH---AQGVIHRD 141
Query: 63 ISSNNILLNLELEAFVADFGVARLLNFDSSNRTLLAGTYGYIAPELAYTMVVTEKSDVYS 122
I S++ILL + ++DFG ++ + R L GT ++APEL + + D++S
Sbjct: 142 IKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELISRLPYGPEVDIWS 201
Query: 123 FGVVALEVLMGKHP 136
G++ +E++ G+ P
Sbjct: 202 LGIMVIEMVDGEPP 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 4e-12
Identities = 37/134 (27%), Positives = 73/134 (54%), Gaps = 13/134 (9%)
Query: 6 MFLIYEYMEMGSLFCVL---RTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRD 62
++++ E++E G+L ++ R +EE + + + ALSYLH ++HRD
Sbjct: 94 LWVVMEFLEGGALTDIVTHTRMNEEQIA-------TVCLSVLRALSYLH---NQGVIHRD 143
Query: 63 ISSNNILLNLELEAFVADFGVARLLNFDSSNRTLLAGTYGYIAPELAYTMVVTEKSDVYS 122
I S++ILL + ++DFG ++ + R L GT ++APE+ + + D++S
Sbjct: 144 IKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKSLVGTPYWMAPEVISRLPYGTEVDIWS 203
Query: 123 FGVVALEVLMGKHP 136
G++ +E++ G+ P
Sbjct: 204 LGIMVIEMIDGEPP 217
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 61.1 bits (149), Expect = 5e-12
Identities = 35/103 (33%), Positives = 52/103 (50%), Gaps = 8/103 (7%)
Query: 39 IVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADFGVARLLNFDSSNRTLLA 98
I++ L+YLH + ++HRDI NILL E + DFGV+ L+ R
Sbjct: 118 ILRETLRGLAYLHEN---KVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRNTFI 174
Query: 99 GTYGYIAPEL-----AYTMVVTEKSDVYSFGVVALEVLMGKHP 136
GT ++APE+ +SDV+S G+ A+E+ GK P
Sbjct: 175 GTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPP 217
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 61.0 bits (148), Expect = 5e-12
Identities = 35/99 (35%), Positives = 53/99 (53%), Gaps = 3/99 (3%)
Query: 38 NIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADFGVARLLNFDSSNRTLL 97
NI M AL YLH + IVHRD++ NNI+L + + + DFG+A+ S T +
Sbjct: 117 NIFVQMVLALRYLHKE--KRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQ-PESKLTSV 173
Query: 98 AGTYGYIAPELAYTMVVTEKSDVYSFGVVALEVLMGKHP 136
GT Y PE+ EK+DV++FG + ++ + P
Sbjct: 174 VGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPP 212
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 61.3 bits (149), Expect = 5e-12
Identities = 47/140 (33%), Positives = 75/140 (53%), Gaps = 27/140 (19%)
Query: 5 CMFLIYEYMEMGSLFCVL----RTDEEAVGLDWAKRVNI--VKGMAHALSYLH--HDCTP 56
CM E+M+ GSL VL R E +G +++I ++G L+YL H
Sbjct: 77 CM----EHMDGGSLDQVLKKAGRIPENILG-----KISIAVLRG----LTYLREKHK--- 120
Query: 57 PIVHRDISSNNILLNLELEAFVADFGVARLLNFDSSNRTLLAGTYGYIAPELAYTMVVTE 116
I+HRD+ +NIL+N E + DFGV+ L DS + + GT Y++PE T
Sbjct: 121 -IMHRDVKPSNILVNSRGEIKLCDFGVSGQL-IDSMANSFV-GTRSYMSPERLQGTHYTV 177
Query: 117 KSDVYSFGVVALEVLMGKHP 136
+SD++S G+ +E+ +G++P
Sbjct: 178 QSDIWSLGLSLVEMAIGRYP 197
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 60.9 bits (148), Expect = 5e-12
Identities = 45/147 (30%), Positives = 74/147 (50%), Gaps = 15/147 (10%)
Query: 3 RKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRV--NIVKGMAHALSYLHHDCTPPIVH 60
++ +F++ EYM G L LR + +G +W + ++ + M YL + +H
Sbjct: 71 QRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAME----YLESNG---FIH 123
Query: 61 RDISSNNILLNLELEAFVADFGVARLL---NFDSSNRTLLAGTYGYIAPELAYTMVVTEK 117
RD+++ N L+ + V+DFG+AR + + SS T + PE+ + K
Sbjct: 124 RDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQGTKFPVKWA--PPEVFDYSRFSSK 181
Query: 118 SDVYSFGVVALEVL-MGKHPGELLSSS 143
SDV+SFGV+ EV GK P E S+S
Sbjct: 182 SDVWSFGVLMWEVFSEGKMPYERFSNS 208
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 60.7 bits (148), Expect = 8e-12
Identities = 40/152 (26%), Positives = 66/152 (43%), Gaps = 26/152 (17%)
Query: 5 CMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDIS 64
++ + EY G L +R LD + AL YLH + I+HRD+
Sbjct: 76 NLYFVLEYAPNGELLQYIRK---YGSLDEKCTRFYAAEILLALEYLH---SKGIIHRDLK 129
Query: 65 SNNILLNLELEAFVADFGVARLLNFDSSNRTLLA--------------------GTYGYI 104
NILL+ ++ + DFG A++L+ +SS + GT Y+
Sbjct: 130 PENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYV 189
Query: 105 APELAYTMVVTEKSDVYSFGVVALEVLMGKHP 136
+PEL + SD+++ G + ++L GK P
Sbjct: 190 SPELLNEKPAGKSSDLWALGCIIYQMLTGKPP 221
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 60.1 bits (146), Expect = 9e-12
Identities = 39/135 (28%), Positives = 68/135 (50%), Gaps = 10/135 (7%)
Query: 6 MFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYL--HHDCTPPIVHRDI 63
++++ E M+ GSL L+ L + +++ +A ++YL + +HRD+
Sbjct: 76 IYIVTELMKYGSLLEYLQGGAGRA-LKLPQLIDMAAQVASGMAYLEAQN-----YIHRDL 129
Query: 64 SSNNILLNLELEAFVADFGVARLLNFDSSN-RTLLAGTYGYIAPELAYTMVVTEKSDVYS 122
++ N+L+ VADFG+AR++ D R + APE A + KSDV+S
Sbjct: 130 AARNVLVGENNICKVADFGLARVIKEDIYEAREGAKFPIKWTAPEAALYNRFSIKSDVWS 189
Query: 123 FGVVALE-VLMGKHP 136
FG++ E V G+ P
Sbjct: 190 FGILLTEIVTYGRMP 204
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 1e-11
Identities = 39/136 (28%), Positives = 74/136 (54%), Gaps = 6/136 (4%)
Query: 3 RKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRD 62
++ +++I E+M GSL L++DE K ++ +A ++++ +HRD
Sbjct: 72 KEPIYIITEFMAKGSLLDFLKSDE-GSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRD 127
Query: 63 ISSNNILLNLELEAFVADFGVARLL-NFDSSNRTLLAGTYGYIAPELAYTMVVTEKSDVY 121
+ + NIL++ L +ADFG+AR++ + + + R + APE T KSDV+
Sbjct: 128 LRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVW 187
Query: 122 SFGVVALEVL-MGKHP 136
SFG++ +E++ G+ P
Sbjct: 188 SFGILLMEIVTYGRIP 203
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 1e-11
Identities = 43/140 (30%), Positives = 75/140 (53%), Gaps = 6/140 (4%)
Query: 6 MFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISS 65
+++I EYM GSL L++DE + K ++ +A ++Y+ +HRD+ +
Sbjct: 76 IYIITEYMAKGSLLDFLKSDEGG-KVLLPKLIDFSAQIAEGMAYIERK---NYIHRDLRA 131
Query: 66 NNILLNLELEAFVADFGVARLLNFDS-SNRTLLAGTYGYIAPELAYTMVVTEKSDVYSFG 124
N+L++ L +ADFG+AR++ + + R + APE T KSDV+SFG
Sbjct: 132 ANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFG 191
Query: 125 VVALEVLM-GKHPGELLSSS 143
++ E++ GK P +S+S
Sbjct: 192 ILLYEIVTYGKIPYPGMSNS 211
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 59.8 bits (145), Expect = 2e-11
Identities = 32/107 (29%), Positives = 54/107 (50%), Gaps = 16/107 (14%)
Query: 39 IVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADFGVARLLNFDSSNRTLLA 98
+ + M AL++LH ++HRD+ + NILL L+ + +ADFGV+ R
Sbjct: 108 VCRQMLEALNFLHSH---KVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDTFI 164
Query: 99 GTYGYIAPELAYTMVVTE---------KSDVYSFGVVALEVLMGKHP 136
GT ++APE+ V E K+D++S G+ +E+ + P
Sbjct: 165 GTPYWMAPEV----VACETFKDNPYDYKADIWSLGITLIELAQMEPP 207
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 2e-11
Identities = 42/143 (29%), Positives = 68/143 (47%), Gaps = 15/143 (10%)
Query: 2 HRKCMFLIYEYMEMGSLF-CVLRTDEEAVGLDWAKRV--NIVKGMAHALSYLHHDCTPPI 58
H ++L+ E+ GS+ V T A+ DW + I++G+AH + H +
Sbjct: 90 HDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHL--HAHK-----V 142
Query: 59 VHRDISSNNILLNLELEAFVADFGVARLLNFDSSNRTLLAGTYGYIAPELAYT-----MV 113
+HRDI N+LL E + DFGV+ L+ R GT ++APE+
Sbjct: 143 IHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDAT 202
Query: 114 VTEKSDVYSFGVVALEVLMGKHP 136
+SD++S G+ A+E+ G P
Sbjct: 203 YDYRSDIWSLGITAIEMAEGAPP 225
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 59.3 bits (144), Expect = 3e-11
Identities = 43/141 (30%), Positives = 63/141 (44%), Gaps = 24/141 (17%)
Query: 2 HRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKR-----VNIVKGMAHALSYLHHDCTP 56
+ + LI EY+ GSL L+ + + L KR I KGM YL +
Sbjct: 79 GGRSLRLIMEYLPSGSLRDYLQRHRDQINL---KRLLLFSSQICKGMD----YLG---SQ 128
Query: 57 PIVHRDISSNNILLNLELEAFVADFGVARLLNFDS------SNRTLLAGTYGYIAPELAY 110
+HRD+++ NIL+ E ++DFG+A++L D Y APE
Sbjct: 129 RYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWY---APECLR 185
Query: 111 TMVVTEKSDVYSFGVVALEVL 131
T + SDV+SFGV E+
Sbjct: 186 TSKFSSASDVWSFGVTLYELF 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 3e-11
Identities = 42/126 (33%), Positives = 67/126 (53%), Gaps = 5/126 (3%)
Query: 6 MFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISS 65
++++ EYM GSL L+ E L + V++ +A ++Y+ VHRD+ +
Sbjct: 75 IYIVTEYMSKGSLLDFLK-GEMGKYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRA 130
Query: 66 NNILLNLELEAFVADFGVARLL-NFDSSNRTLLAGTYGYIAPELAYTMVVTEKSDVYSFG 124
NIL+ L VADFG+ARL+ + + + R + APE A T KSDV+SFG
Sbjct: 131 ANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFG 190
Query: 125 VVALEV 130
++ E+
Sbjct: 191 ILLTEL 196
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 59.0 bits (143), Expect = 3e-11
Identities = 38/108 (35%), Positives = 59/108 (54%), Gaps = 19/108 (17%)
Query: 37 VNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADFGVARLLNFDSSNRTL 96
V+IVK AL YLH + ++HRD+ +N+L+N + + DFG++ L DS +T+
Sbjct: 110 VSIVK----ALEYLHSKLS--VIHRDVKPSNVLINRNGQVKLCDFGISGYL-VDSVAKTI 162
Query: 97 LAGTYGYIAPEL--------AYTMVVTEKSDVYSFGVVALEVLMGKHP 136
AG Y+APE Y + KSDV+S G+ +E+ G+ P
Sbjct: 163 DAGCKPYMAPERINPELNQKGYDV----KSDVWSLGITMIELATGRFP 206
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 58.4 bits (141), Expect = 4e-11
Identities = 41/136 (30%), Positives = 62/136 (45%), Gaps = 14/136 (10%)
Query: 6 MFLIYEYMEMGSLFCVLRTDE-----EAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVH 60
++++ EY + G L ++ E L W V + G+ H H+ ++H
Sbjct: 73 LYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWF--VQMCLGVQHI-----HE--KRVLH 123
Query: 61 RDISSNNILLNLELEAFVADFGVARLLNFDSSNRTLLAGTYGYIAPELAYTMVVTEKSDV 120
RDI S NI L + + DFG ARLL + GT Y+ PE+ M KSD+
Sbjct: 124 RDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTYVGTPYYVPPEIWENMPYNNKSDI 183
Query: 121 YSFGVVALEVLMGKHP 136
+S G + E+ KHP
Sbjct: 184 WSLGCILYELCTLKHP 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 58.7 bits (143), Expect = 4e-11
Identities = 50/156 (32%), Positives = 72/156 (46%), Gaps = 41/156 (26%)
Query: 2 HRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAH----------ALSYLH 51
H+ + L++E+ME TD E V K +IV A L YLH
Sbjct: 73 HKSNINLVFEFME---------TDLEKV----IKDKSIVLTPADIKSYMLMTLRGLEYLH 119
Query: 52 HDCTPPIVHRDISSNNILLNLELEAFVADFGVARLLNFDSSNR--TLLAGTYGYIAPEL- 108
+ I+HRD+ NN+L+ + +ADFG+AR +F S NR T T Y APEL
Sbjct: 120 SNW---ILHRDLKPNNLLIASDGVLKLADFGLAR--SFGSPNRKMTHQVVTRWYRAPELL 174
Query: 109 ----AYTMVVTEKSDVYSFGVVALEVLMGKH--PGE 138
Y + V D++S G + E+L+ PG+
Sbjct: 175 FGARHYGVGV----DMWSVGCIFAELLLRVPFLPGD 206
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 58.4 bits (141), Expect = 4e-11
Identities = 38/140 (27%), Positives = 73/140 (52%), Gaps = 7/140 (5%)
Query: 6 MFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISS 65
++++ EYM G L LR E ++ + + K + ++YL + +HRD+++
Sbjct: 74 IYIVTEYMSNGCLLNYLR--EHGKRFQPSQLLEMCKDVCEGMAYLE---SKQFIHRDLAA 128
Query: 66 NNILLNLELEAFVADFGVARLLNFDSSNRTLLAG-TYGYIAPELAYTMVVTEKSDVYSFG 124
N L++ + V+DFG++R + D ++ + + PE+ + KSDV++FG
Sbjct: 129 RNCLVDDQGCVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFG 188
Query: 125 VVALEVL-MGKHPGELLSSS 143
V+ EV +GK P E ++S
Sbjct: 189 VLMWEVYSLGKMPYERFNNS 208
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 58.1 bits (141), Expect = 5e-11
Identities = 32/97 (32%), Positives = 49/97 (50%), Gaps = 14/97 (14%)
Query: 47 LSYLHHDCTPPIVHRDISSNNILLNLELEAFVADFGVARLLNFDSSNRTLLAGTYGYIAP 106
L+YLH +HRDI NILL + + +ADFGV+ L + R GT ++AP
Sbjct: 114 LAYLHET---GKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRKSFIGTPYWMAP 170
Query: 107 ELA-------YTMVVTEKSDVYSFGVVALEVLMGKHP 136
E+A Y K D+++ G+ A+E+ + P
Sbjct: 171 EVAAVERKGGY----DGKCDIWALGITAIELAELQPP 203
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 6e-11
Identities = 45/136 (33%), Positives = 74/136 (54%), Gaps = 19/136 (13%)
Query: 5 CMFLIYEYMEMGSLFCVL----RTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVH 60
CM E+M+ GSL VL R EE +G + +++G+A+ L H I+H
Sbjct: 81 CM----EHMDGGSLDQVLKEAKRIPEEILG---KVSIAVLRGLAY-LREKHQ-----IMH 127
Query: 61 RDISSNNILLNLELEAFVADFGVARLLNFDSSNRTLLAGTYGYIAPELAYTMVVTEKSDV 120
RD+ +NIL+N E + DFGV+ L DS + + GT Y++PE + +SD+
Sbjct: 128 RDVKPSNILVNSRGEIKLCDFGVSGQL-IDSMANSFV-GTRSYMSPERLQGTHYSVQSDI 185
Query: 121 YSFGVVALEVLMGKHP 136
+S G+ +E+ +G++P
Sbjct: 186 WSMGLSLVELAIGRYP 201
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 57.9 bits (140), Expect = 6e-11
Identities = 28/94 (29%), Positives = 58/94 (61%), Gaps = 7/94 (7%)
Query: 47 LSYLHHDCTPPIVHRDISSNNILLNLELEAFVADFGVARLLN--FDSSNRTLLAGTYGYI 104
L+YLH + I+HRD+ ++N+L++ + ++DFG+++ + +D+ + G+ ++
Sbjct: 121 LAYLH---SKGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWM 177
Query: 105 APEL--AYTMVVTEKSDVYSFGVVALEVLMGKHP 136
APE+ +Y+ + K D++S G V LE+ G+ P
Sbjct: 178 APEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRP 211
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 57.9 bits (140), Expect = 7e-11
Identities = 42/138 (30%), Positives = 66/138 (47%), Gaps = 18/138 (13%)
Query: 1 LHRKCMFLIYEYMEMGSLF------CVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDC 54
L K + ++ EY G+L C DE+ I+ L LHH
Sbjct: 69 LEDKALMIVMEYAPGGTLAEYIQKRCNSLLDED----------TILHFFVQILLALHHVH 118
Query: 55 TPPIVHRDISSNNILLNLELEAF-VADFGVARLLNFDSSNRTLLAGTYGYIAPELAYTMV 113
T I+HRD+ + NILL+ + DFG++++L+ S T++ GT YI+PEL
Sbjct: 119 TKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYTVV-GTPCYISPELCEGKP 177
Query: 114 VTEKSDVYSFGVVALEVL 131
+KSD+++ G V E+
Sbjct: 178 YNQKSDIWALGCVLYELA 195
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 8e-11
Identities = 37/131 (28%), Positives = 63/131 (48%), Gaps = 6/131 (4%)
Query: 6 MFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISS 65
+F + EY+ G L +++ + D + + L +LH + IV+RD+
Sbjct: 71 LFFVMEYLNGGDLMFHIQSCHK---FDLPRATFYAAEIICGLQFLH---SKGIVYRDLKL 124
Query: 66 NNILLNLELEAFVADFGVARLLNFDSSNRTLLAGTYGYIAPELAYTMVVTEKSDVYSFGV 125
+NILL+ + +ADFG+ + + GT YIAPE+ D +SFGV
Sbjct: 125 DNILLDTDGHIKIADFGMCKENMLGDAKTCTFCGTPDYIAPEILLGQKYNTSVDWWSFGV 184
Query: 126 VALEVLMGKHP 136
+ E+L+G+ P
Sbjct: 185 LLYEMLIGQSP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 57.5 bits (139), Expect = 1e-10
Identities = 41/135 (30%), Positives = 64/135 (47%), Gaps = 14/135 (10%)
Query: 6 MFLIYEYMEMGSLF----CVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHR 61
+F + EY+ G L R DE A+ I+ G L +LH I++R
Sbjct: 71 LFFVMEYLNGGDLMFHIQSSGRFDEARARFYAAE---IICG----LQFLH---KKGIIYR 120
Query: 62 DISSNNILLNLELEAFVADFGVARLLNFDSSNRTLLAGTYGYIAPELAYTMVVTEKSDVY 121
D+ +N+LL+ + +ADFG+ + + GT YIAPE+ E D +
Sbjct: 121 DLKLDNVLLDKDGHIKIADFGMCKENMNGEGKASTFCGTPDYIAPEILKGQKYNESVDWW 180
Query: 122 SFGVVALEVLMGKHP 136
SFGV+ E+L+G+ P
Sbjct: 181 SFGVLLYEMLIGQSP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 57.2 bits (138), Expect = 1e-10
Identities = 39/142 (27%), Positives = 65/142 (45%), Gaps = 18/142 (12%)
Query: 5 CMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDIS 64
+++ EYM+ GSL + G+ I + L +L + I+HRD+
Sbjct: 73 AVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHN--IIHRDVK 130
Query: 65 SNNILLNLELEAFVADFGVARLLNFDSSNRTLLAGTYGYIAPE----------LAYTMVV 114
N+L+N + + DFGV+ N +S G Y+APE YT+
Sbjct: 131 PTNVLVNGNGQVKLCDFGVSG--NLVASLAKTNIGCQSYMAPERIKSGGPNQNPTYTV-- 186
Query: 115 TEKSDVYSFGVVALEVLMGKHP 136
+SDV+S G+ LE+ +G++P
Sbjct: 187 --QSDVWSLGLSILEMALGRYP 206
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 56.8 bits (137), Expect = 2e-10
Identities = 40/127 (31%), Positives = 63/127 (49%), Gaps = 14/127 (11%)
Query: 11 EYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILL 70
E+M+ GSL + E +G V +VKG+ + S I+HRD+ +N+L+
Sbjct: 79 EFMDGGSLDVYRKIPEHVLG---RIAVAVVKGLTYLWSL-------KILHRDVKPSNMLV 128
Query: 71 NLELEAFVADFGVAR-LLNFDSSNRTLLAGTYGYIAPELAYTMVVTEKSDVYSFGVVALE 129
N + + DFGV+ L+N S GT Y+APE SDV+S G+ +E
Sbjct: 129 NTRGQVKLCDFGVSTQLVN---SIAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFME 185
Query: 130 VLMGKHP 136
+ +G+ P
Sbjct: 186 LALGRFP 192
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 2e-10
Identities = 44/140 (31%), Positives = 69/140 (49%), Gaps = 24/140 (17%)
Query: 8 LIYEYMEMGSLFCVLRTDEEAVG----LDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDI 63
L+ + +GSL +R +++ L+W V I KGM YL +VHR++
Sbjct: 85 LVTQLSPLGSLLDHVRQHRDSLDPQRLLNWC--VQIAKGM----YYLEEHR---MVHRNL 135
Query: 64 SSNNILLNLELEAFVADFGVARLLNFD------SSNRTLLAGTYGYIAPELAYTMVVTEK 117
++ NILL + +ADFGVA LL D S ++T + ++A E T +
Sbjct: 136 AARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIK----WMALESILFGRYTHQ 191
Query: 118 SDVYSFGVVALEVL-MGKHP 136
SDV+S+GV E++ G P
Sbjct: 192 SDVWSYGVTVWEMMSYGAEP 211
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 56.6 bits (137), Expect = 2e-10
Identities = 43/143 (30%), Positives = 61/143 (42%), Gaps = 30/143 (20%)
Query: 7 FLIYEYMEMGSLFCVLRT----DEEAVGLD---------WAKRVNIVKGMAHALSYLHHD 53
++ E M G L LR+ E GL A I GMA+ L+
Sbjct: 85 LVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMA--AEIADGMAY-LAAKK-- 139
Query: 54 CTPPIVHRDISSNNILLNLELEAFVADFGVARLLNFDSSNRTLLAGTYG-----YIAPEL 108
VHRD+++ N ++ +L + DFG+ R + R G G ++APE
Sbjct: 140 ----FVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRK---GGKGLLPVRWMAPES 192
Query: 109 AYTMVVTEKSDVYSFGVVALEVL 131
V T KSDV+SFGVV E+
Sbjct: 193 LKDGVFTTKSDVWSFGVVLWEMA 215
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 56.3 bits (136), Expect = 2e-10
Identities = 30/89 (33%), Positives = 49/89 (55%), Gaps = 3/89 (3%)
Query: 43 MAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADFGVARLLNFDSSNRTLLAGTYG 102
+ A+SY+H I+HRDI + NI L + DFG++++L + S + GT
Sbjct: 110 IVSAVSYIHKA---GILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAETVVGTPY 166
Query: 103 YIAPELAYTMVVTEKSDVYSFGVVALEVL 131
Y++PEL + KSD+++ G V E+L
Sbjct: 167 YMSPELCQGVKYNFKSDIWALGCVLYELL 195
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 56.3 bits (136), Expect = 3e-10
Identities = 44/135 (32%), Positives = 69/135 (51%), Gaps = 17/135 (12%)
Query: 6 MFLIYEYMEMGSLFCVLRTD---EEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRD 62
++++ EY+ G LF LR + GL +A + AL YLH + IV+RD
Sbjct: 76 LYMLMEYVPGGELFSYLRNSGRFSNSTGLFYASEI------VCALEYLH---SKEIVYRD 126
Query: 63 ISSNNILLNLELEAFVADFGVARLLNFDSSNRT-LLAGTYGYIAPELAYTMVVTEKSDVY 121
+ NILL+ E + DFG A+ L +RT L GT Y+APE+ + + D +
Sbjct: 127 LKPENILLDKEGHIKLTDFGFAKKL----RDRTWTLCGTPEYLAPEVIQSKGHNKAVDWW 182
Query: 122 SFGVVALEVLMGKHP 136
+ G++ E+L+G P
Sbjct: 183 ALGILIYEMLVGYPP 197
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 56.5 bits (136), Expect = 3e-10
Identities = 30/90 (33%), Positives = 52/90 (57%), Gaps = 3/90 (3%)
Query: 47 LSYLHHDCTPPIVHRDISSNNILLNLELEAFVADFGVARLLNFDSSNRTLLAGTYGYIAP 106
L +LH + I++RD+ +N++L+ + +ADFG+ + F + + GT YIAP
Sbjct: 109 LQFLH---SKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRASTFCGTPDYIAP 165
Query: 107 ELAYTMVVTEKSDVYSFGVVALEVLMGKHP 136
E+ + T D +SFGV+ E+L+G+ P
Sbjct: 166 EILQGLKYTFSVDWWSFGVLLYEMLIGQSP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 56.3 bits (135), Expect = 3e-10
Identities = 39/137 (28%), Positives = 66/137 (48%), Gaps = 11/137 (8%)
Query: 6 MFLIYEYMEMGSLFCVLR-TDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDIS 64
++L+ E+ GS+ +++ T + +W I + + LS+LH ++HRDI
Sbjct: 84 LWLVMEFCGAGSVTDLIKNTKGNTLKEEWI--AYICREILRGLSHLHQH---KVIHRDIK 138
Query: 65 SNNILLNLELEAFVADFGVARLLNFDSSNRTLLAGTYGYIAPELAYT-----MVVTEKSD 119
N+LL E + DFGV+ L+ R GT ++APE+ KSD
Sbjct: 139 GQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSD 198
Query: 120 VYSFGVVALEVLMGKHP 136
++S G+ A+E+ G P
Sbjct: 199 LWSLGITAIEMAEGAPP 215
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 56.1 bits (136), Expect = 3e-10
Identities = 40/139 (28%), Positives = 66/139 (47%), Gaps = 17/139 (12%)
Query: 3 RKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRD 62
+K ++++ EY G L+ +LR + D + + A YLH+ I++RD
Sbjct: 65 KKYIYMLMEYCLGGELWTILR---DRGLFDEYTARFYIACVVLAFEYLHNR---GIIYRD 118
Query: 63 ISSNNILLNLELEAFVADFGVARLLNFDSSNRTL-LAGTYGYIAPEL----AYTMVVTEK 117
+ N+LL+ + DFG A+ L S +T GT Y+APE+ Y V
Sbjct: 119 LKPENLLLDSNGYVKLVDFGFAKKLK--SGQKTWTFCGTPEYVAPEIILNKGYDFSV--- 173
Query: 118 SDVYSFGVVALEVLMGKHP 136
D +S G++ E+L G+ P
Sbjct: 174 -DYWSLGILLYELLTGRPP 191
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 3e-10
Identities = 41/133 (30%), Positives = 71/133 (53%), Gaps = 6/133 (4%)
Query: 6 MFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISS 65
++++ E+M GSL L+ + + L + V++ +A ++Y+ +HRD+ +
Sbjct: 75 IYIVTEFMGKGSLLDFLK-EGDGKYLKLPQLVDMAAQIADGMAYIER---MNYIHRDLRA 130
Query: 66 NNILLNLELEAFVADFGVARLL-NFDSSNRTLLAGTYGYIAPELAYTMVVTEKSDVYSFG 124
NIL+ L +ADFG+ARL+ + + + R + APE A T KSDV+SFG
Sbjct: 131 ANILVGDNLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFG 190
Query: 125 VVALE-VLMGKHP 136
++ E V G+ P
Sbjct: 191 ILLTELVTKGRVP 203
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 55.7 bits (134), Expect = 4e-10
Identities = 40/132 (30%), Positives = 70/132 (53%), Gaps = 8/132 (6%)
Query: 6 MFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISS 65
++++ E M G+L LRT A+ + + + +A + YL + +VHRD+++
Sbjct: 73 LYIVMELMSKGNLVNFLRTRGRAL-VSVIQLLQFSLDVAEGMEYLE---SKKLVHRDLAA 128
Query: 66 NNILLNLELEAFVADFGVARLLNFDSSNRTLLAGTYGYIAPELAYTMVVTEKSDVYSFGV 125
NIL++ + A V+DFG+AR + + + L + APE + KSDV+S+GV
Sbjct: 129 RNILVSEDGVAKVSDFGLAR-VGSMGVDNSKLP--VKWTAPEALKHKKFSSKSDVWSYGV 185
Query: 126 VALEVL-MGKHP 136
+ EV G+ P
Sbjct: 186 LLWEVFSYGRAP 197
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 55.6 bits (134), Expect = 4e-10
Identities = 45/143 (31%), Positives = 73/143 (51%), Gaps = 16/143 (11%)
Query: 7 FLIYEYMEMGSLFCVLR-TDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISS 65
++I E+M G+L LR + + ++ + + ++ A+ YL +HRD+++
Sbjct: 78 YIITEFMTYGNLLDYLRECNRQE--VNAVVLLYMATQISSAMEYLEKK---NFIHRDLAA 132
Query: 66 NNILLNLELEAFVADFGVARLLNFDSSNRTLLAGT---YGYIAPE-LAYTMVVTEKSDVY 121
N L+ VADFG++RL+ D+ T AG + APE LAY KSDV+
Sbjct: 133 RNCLVGENHLVKVADFGLSRLMTGDTY--TAHAGAKFPIKWTAPESLAYNKFSI-KSDVW 189
Query: 122 SFGVVALEVL---MGKHPGELLS 141
+FGV+ E+ M +PG LS
Sbjct: 190 AFGVLLWEIATYGMSPYPGIDLS 212
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 55.8 bits (135), Expect = 5e-10
Identities = 38/132 (28%), Positives = 60/132 (45%), Gaps = 11/132 (8%)
Query: 6 MFLIYEYME--MGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDI 63
+FL+ EY E + SL D ++ ++ + L YLH + I+HRD+
Sbjct: 83 IFLVMEYCEQDLASLL-----DNMPTPFSESQVKCLMLQLLRGLQYLHENF---IIHRDL 134
Query: 64 SSNNILLNLELEAFVADFGVARLLNFDSSNRTLLAGTYGYIAPELAYTMVV-TEKSDVYS 122
+N+LL + +ADFG+AR + T T Y APEL T D+++
Sbjct: 135 KVSNLLLTDKGCLKIADFGLARTYGLPAKPMTPKVVTLWYRAPELLLGCTTYTTAIDMWA 194
Query: 123 FGVVALEVLMGK 134
G + E+L K
Sbjct: 195 VGCILAELLAHK 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 5e-10
Identities = 41/126 (32%), Positives = 58/126 (46%), Gaps = 15/126 (11%)
Query: 16 GSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELE 75
G L C R DE + I+ G L +LH++ I+HRD+ NNILL E
Sbjct: 117 GLLICGQRLDEAMISY-------ILYGALLGLQHLHNN---RIIHRDVKGNNILLTTEGG 166
Query: 76 AFVADFGVARLLNFDSSNRTLLAGTYGYIAPEL-----AYTMVVTEKSDVYSFGVVALEV 130
+ DFGV+ L R GT ++APE+ Y + DV+S G+ A+E+
Sbjct: 167 VKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIEL 226
Query: 131 LMGKHP 136
G P
Sbjct: 227 GDGDPP 232
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 55.2 bits (133), Expect = 5e-10
Identities = 39/133 (29%), Positives = 61/133 (45%), Gaps = 14/133 (10%)
Query: 6 MFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISS 65
++L+ EY+ G +++T + DWAK + + + LH I+HRDI
Sbjct: 72 LYLVMEYLNGGDCASLIKT-LGGLPEDWAK--QYIAEVVLGVEDLHQR---GIIHRDIKP 125
Query: 66 NNILLNLELEAFVADFGVAR--LLNFDSSNRTLLAGTYGYIAPELAYTMVVTEKSDVYSF 123
N+L++ + DFG++R L N GT Y+APE + + SD +S
Sbjct: 126 ENLLIDQTGHLKLTDFGLSRNGLENKK------FVGTPDYLAPETILGVGDDKMSDWWSL 179
Query: 124 GVVALEVLMGKHP 136
G V E L G P
Sbjct: 180 GCVIFEFLFGYPP 192
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 5e-10
Identities = 45/136 (33%), Positives = 73/136 (53%), Gaps = 19/136 (13%)
Query: 5 CMFLIYEYMEMGSLFCVL----RTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVH 60
CM E+M+ GSL VL R E+ +G + ++KG L+YL I+H
Sbjct: 81 CM----EHMDGGSLDQVLKKAGRIPEQILG---KVSIAVIKG----LTYLRE--KHKIMH 127
Query: 61 RDISSNNILLNLELEAFVADFGVARLLNFDSSNRTLLAGTYGYIAPELAYTMVVTEKSDV 120
RD+ +NIL+N E + DFGV+ L DS + + GT Y++PE + +SD+
Sbjct: 128 RDVKPSNILVNSRGEIKLCDFGVSGQL-IDSMANSFV-GTRSYMSPERLQGTHYSVQSDI 185
Query: 121 YSFGVVALEVLMGKHP 136
+S G+ +E+ +G++P
Sbjct: 186 WSMGLSLVEMAIGRYP 201
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 55.7 bits (135), Expect = 6e-10
Identities = 47/148 (31%), Positives = 70/148 (47%), Gaps = 42/148 (28%)
Query: 7 FLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAH---------ALSYLHHDCTPP 57
+L++EYME TD AV R NI++ + AL Y+H +
Sbjct: 85 YLVFEYME---------TDLHAV-----IRANILEDVHKRYIMYQLLKALKYIH---SGN 127
Query: 58 IVHRDISSNNILLNLELEAFVADFGVARLLNFDSSNRTLLAGTYGYIA------PEL--- 108
++HRD+ +NILLN + +ADFG+AR L+ N T Y+A PE+
Sbjct: 128 VIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTD-YVATRWYRAPEILLG 186
Query: 109 --AYTMVVTEKSDVYSFGVVALEVLMGK 134
YT V D++S G + E+L+GK
Sbjct: 187 STRYTKGV----DMWSVGCILGEMLLGK 210
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 7e-10
Identities = 39/135 (28%), Positives = 63/135 (46%), Gaps = 14/135 (10%)
Query: 6 MFLIYEYMEMGSLFCVLRTDE-----EAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVH 60
++++ + E G L+ L+ + E ++W ++ A AL YLH I+H
Sbjct: 75 LYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQI------AMALQYLHEK---HILH 125
Query: 61 RDISSNNILLNLELEAFVADFGVARLLNFDSSNRTLLAGTYGYIAPELAYTMVVTEKSDV 120
RD+ + N+ L V D G+AR+L + L GT Y++PEL KSDV
Sbjct: 126 RDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMASTLIGTPYYMSPELFSNKPYNYKSDV 185
Query: 121 YSFGVVALEVLMGKH 135
++ G E+ KH
Sbjct: 186 WALGCCVYEMATLKH 200
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 7e-10
Identities = 42/136 (30%), Positives = 66/136 (48%), Gaps = 16/136 (11%)
Query: 8 LIYEYMEMGSLFCVLRTDEEAVG----LDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDI 63
LI + M G L +R ++ +G L+W V I KGM +YL +VHRD+
Sbjct: 85 LITQLMPFGCLLDYVREHKDNIGSQYLLNWC--VQIAKGM----NYLEER---RLVHRDL 135
Query: 64 SSNNILLNLELEAFVADFGVARLLNFDSSNRTLLAGTY--GYIAPELAYTMVVTEKSDVY 121
++ N+L+ + DFG+A+LL D G ++A E + T +SDV+
Sbjct: 136 AARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVW 195
Query: 122 SFGVVALEVL-MGKHP 136
S+GV E++ G P
Sbjct: 196 SYGVTVWELMTFGSKP 211
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 55.2 bits (133), Expect = 7e-10
Identities = 43/136 (31%), Positives = 70/136 (51%), Gaps = 16/136 (11%)
Query: 6 MFLIYEYMEMGSLFCVLRTD----EEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHR 61
++LI +++ G LF L + EE V A+ +A AL +LH + I++R
Sbjct: 73 LYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAE-------LALALDHLH---SLGIIYR 122
Query: 62 DISSNNILLNLELEAFVADFGVARLLNFDSSNRTL-LAGTYGYIAPELAYTMVVTEKSDV 120
D+ NILL+ E + DFG+++ + D + GT Y+APE+ T+ +D
Sbjct: 123 DLKPENILLDEEGHIKLTDFGLSKE-SIDHEKKAYSFCGTVEYMAPEVVNRRGHTQSADW 181
Query: 121 YSFGVVALEVLMGKHP 136
+SFGV+ E+L G P
Sbjct: 182 WSFGVLMFEMLTGSLP 197
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 55.2 bits (133), Expect = 8e-10
Identities = 45/143 (31%), Positives = 65/143 (45%), Gaps = 22/143 (15%)
Query: 6 MFLIYEYMEMGSLFCVLRT-----DEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVH 60
++L+ EY G L +L DE+ A+ V + + H + Y VH
Sbjct: 76 LYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSV-HQMGY---------VH 125
Query: 61 RDISSNNILLNLELEAFVADFGVARLLNFDSS-NRTLLAGTYGYIAPELAYTMVVTEKS- 118
RDI N+L++ +ADFG A L + N L GT YIAPE+ TM K
Sbjct: 126 RDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLPVGTPDYIAPEVLTTMNGDGKGT 185
Query: 119 -----DVYSFGVVALEVLMGKHP 136
D +S GV+A E++ G+ P
Sbjct: 186 YGVECDWWSLGVIAYEMIYGRSP 208
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 54.7 bits (132), Expect = 8e-10
Identities = 42/134 (31%), Positives = 62/134 (46%), Gaps = 19/134 (14%)
Query: 6 MFLIYEYMEMGSLFCVLRTDEEAVGLD---WAKRVNIVKGMAHALSYLHHDCTPPIVHRD 62
+ L+ E +G L L+ E D A +V + GMA YL + VHRD
Sbjct: 70 LMLVMELAPLGPLLKYLKKRREIPVSDLKELAHQVAM--GMA----YLE---SKHFVHRD 120
Query: 63 ISSNNILLNLELEAFVADFGVARLLNFDSSNRTLLAGTYG-----YIAPELAYTMVVTEK 117
+++ N+LL +A ++DFG++R L S A T G + APE + K
Sbjct: 121 LAARNVLLVNRHQAKISDFGMSRALGAGSDYYR--ATTAGRWPLKWYAPECINYGKFSSK 178
Query: 118 SDVYSFGVVALEVL 131
SDV+S+GV E
Sbjct: 179 SDVWSYGVTLWEAF 192
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 9e-10
Identities = 43/138 (31%), Positives = 69/138 (50%), Gaps = 16/138 (11%)
Query: 8 LIYEYMEMGSLFCVLRTDEEAVG----LDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDI 63
L+ + M G L +R +++ +G L+W V I KGM SYL +VHRD+
Sbjct: 85 LVTQLMPYGCLLDYVRENKDRIGSQDLLNWC--VQIAKGM----SYLEE---VRLVHRDL 135
Query: 64 SSNNILLNLELEAFVADFGVARLLNFDSSNRTLLAGTY--GYIAPELAYTMVVTEKSDVY 121
++ N+L+ + DFG+ARLL+ D + G ++A E T +SDV+
Sbjct: 136 AARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVW 195
Query: 122 SFGVVALEVL-MGKHPGE 138
S+GV E++ G P +
Sbjct: 196 SYGVTVWELMTFGAKPYD 213
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 55.2 bits (133), Expect = 1e-09
Identities = 43/144 (29%), Positives = 66/144 (45%), Gaps = 26/144 (18%)
Query: 6 MFLIYEYMEMGSLFCVLRTD-----EEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVH 60
+F ++EY+ +L VL D E L + ++ +A A H+ IVH
Sbjct: 54 LFAVFEYVPGRTLREVLAADGALPAGETGRL----MLQVLDALACA-----HNQG--IVH 102
Query: 61 RDISSNNILL---NLELEAFVADFGVARLL-NFDSSNRTLLA------GTYGYIAPELAY 110
RD+ NI++ + A V DFG+ LL ++ L GT Y APE
Sbjct: 103 RDLKPQNIMVSQTGVRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLR 162
Query: 111 TMVVTEKSDVYSFGVVALEVLMGK 134
VT SD+Y++G++ LE L G+
Sbjct: 163 GEPVTPNSDLYAWGLIFLECLTGQ 186
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 1e-09
Identities = 46/152 (30%), Positives = 72/152 (47%), Gaps = 21/152 (13%)
Query: 1 LHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRV-----NIVKGMAHALSYLHHDCT 55
R + L++E+ME G L LR G + + ++ +GMA YL
Sbjct: 69 TERSPICLVFEFMEHGCLSDYLRAQR---GKFSQETLLGMCLDVCEGMA----YLESSN- 120
Query: 56 PPIVHRDISSNNILLNLELEAFVADFGVARLL---NFDSSNRTLLAGTYGYIAPELAYTM 112
++HRD+++ N L+ V+DFG+ R + + SS T + +PE+
Sbjct: 121 --VIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVKWS--SPEVFSFS 176
Query: 113 VVTEKSDVYSFGVVALEVLM-GKHPGELLSSS 143
+ KSDV+SFGV+ EV GK P E S+S
Sbjct: 177 KYSSKSDVWSFGVLMWEVFSEGKTPYENRSNS 208
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 54.4 bits (132), Expect = 1e-09
Identities = 39/139 (28%), Positives = 63/139 (45%), Gaps = 15/139 (10%)
Query: 1 LHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVH 60
+ ++L++EY +M L L + + K I+ + L+Y H I+H
Sbjct: 68 HTERKLYLVFEYCDM-DLKKYLDKRPGPLSPNLIKS--IMYQLLRGLAYCHSHR---ILH 121
Query: 61 RDISSNNILLNLELEAFVADFGVARLLNFDSSNRTLLAGTYGYIAPEL-----AYTMVVT 115
RD+ NIL+N + +ADFG+AR T T Y APE+ Y+ V
Sbjct: 122 RDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHEVVTLWYRAPEILLGSKHYSTAV- 180
Query: 116 EKSDVYSFGVVALEVLMGK 134
D++S G + E++ GK
Sbjct: 181 ---DIWSVGCIFAEMITGK 196
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 54.5 bits (132), Expect = 1e-09
Identities = 34/103 (33%), Positives = 51/103 (49%), Gaps = 17/103 (16%)
Query: 46 ALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADFGVARLLNFDSSNRTLLAG---TYG 102
L YLH + ++HRD+ +NIL+N + + DFG+AR ++ D + L T
Sbjct: 115 GLKYLH---SANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVVTRW 171
Query: 103 YIAPEL-----AYTMVVTEKSDVYSFGVVALEVLMGKH--PGE 138
Y APEL YT + D++S G + E+L K PG
Sbjct: 172 YRAPELLLSSSRYTKAI----DIWSVGCIFAELLTRKPLFPGR 210
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 54.3 bits (131), Expect = 1e-09
Identities = 36/98 (36%), Positives = 51/98 (52%), Gaps = 14/98 (14%)
Query: 46 ALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADFGVARLLNFDSSNRTLLAGTYGYIA 105
AL+YL + I+HRD+ +NILL+ + DFG++ L DS +T AG Y+A
Sbjct: 119 ALNYLKEELK--IIHRDVKPSNILLDRNGNIKLCDFGISGQL-VDSIAKTRDAGCRPYMA 175
Query: 106 PEL-------AYTMVVTEKSDVYSFGVVALEVLMGKHP 136
PE Y + +SDV+S G+ EV GK P
Sbjct: 176 PERIDPSARDGYDV----RSDVWSLGITLYEVATGKFP 209
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 53.7 bits (130), Expect = 2e-09
Identities = 39/141 (27%), Positives = 69/141 (48%), Gaps = 25/141 (17%)
Query: 4 KCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLH-HDCTPPIVHRD 62
K LI +Y++ G LF +L+ + + L A+ I++ + AL+ LH H+ I+H D
Sbjct: 82 KGHVLIMDYIKDGDLFDLLKKEGK---LSEAEVKKIIRQLVEALNDLHKHN----IIHND 134
Query: 63 ISSNNILLN-LELEAFVADFGVARLLNFDSSNRTLLAGTYGYIAPE------LAYTMVVT 115
I N+L + + ++ D+G+ +++ S GT Y +PE +
Sbjct: 135 IKLENVLYDRAKDRIYLCDYGLCKIIGTPS----CYDGTLDYFSPEKIKGHNYDVSF--- 187
Query: 116 EKSDVYSFGVVALEVLMGKHP 136
D ++ GV+ E+L GKHP
Sbjct: 188 ---DWWAVGVLTYELLTGKHP 205
|
Length = 267 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 54.0 bits (130), Expect = 2e-09
Identities = 42/145 (28%), Positives = 70/145 (48%), Gaps = 28/145 (19%)
Query: 5 CMFLIYEYMEMGSL--FCVLRTDEEAVG-----------LDWAKRVNIVKGMAHALSYL- 50
CM ++EY+ G L F V + VG LD + ++I +A + YL
Sbjct: 84 CM--LFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLS 141
Query: 51 -HHDCTPPIVHRDISSNNILLNLELEAFVADFGVARLL----NFDSSNRTLLAGTYGYIA 105
HH VHRD+++ N L+ L ++DFG++R + + +++LL ++
Sbjct: 142 SHH-----FVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKSLLP--VRWMP 194
Query: 106 PELAYTMVVTEKSDVYSFGVVALEV 130
PE T +SD++SFGVV E+
Sbjct: 195 PEAILYGKFTTESDIWSFGVVLWEI 219
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 53.5 bits (129), Expect = 2e-09
Identities = 37/131 (28%), Positives = 59/131 (45%), Gaps = 13/131 (9%)
Query: 6 MFLIYEYMEMGSLFCVLRTDEEA---VGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRD 62
+ ++ E +GSL LR D + V I GM YL + +HRD
Sbjct: 70 LMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMR----YLE---SKRFIHRD 122
Query: 63 ISSNNILLNLELEAFVADFGVARLLNFDSSNRTL---LAGTYGYIAPELAYTMVVTEKSD 119
+++ NILL + + + DFG+ R L + + + L + + APE T + SD
Sbjct: 123 LAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESLRTRTFSHASD 182
Query: 120 VYSFGVVALEV 130
V+ FGV E+
Sbjct: 183 VWMFGVTLWEM 193
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 53.7 bits (129), Expect = 2e-09
Identities = 39/138 (28%), Positives = 69/138 (50%), Gaps = 7/138 (5%)
Query: 3 RKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRD 62
+K ++++ E+ME G L LR + + D +++ + + + YL + +HRD
Sbjct: 71 QKPLYIVTEFMENGCLLNYLRQRQGKLSKDML--LSMCQDVCEGMEYLERN---SFIHRD 125
Query: 63 ISSNNILLNLELEAFVADFGVARLLNFDSSNRTLLAG-TYGYIAPELAYTMVVTEKSDVY 121
+++ N L++ V+DFG+ R + D + A + PE+ + KSDV+
Sbjct: 126 LAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKFPVKWSPPEVFNFSKYSSKSDVW 185
Query: 122 SFGVVALEVLM-GKHPGE 138
SFGV+ EV GK P E
Sbjct: 186 SFGVLMWEVFTEGKMPFE 203
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 53.4 bits (128), Expect = 2e-09
Identities = 37/125 (29%), Positives = 64/125 (51%), Gaps = 7/125 (5%)
Query: 6 MFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISS 65
++++ EYM GSL LR+ +V L + + A+ YL + VHRD+++
Sbjct: 75 LYIVTEYMAKGSLVDYLRSRGRSV-LGGDCLLKFSLDVCEAMEYLEAN---NFVHRDLAA 130
Query: 66 NNILLNLELEAFVADFGVARLLNFDSSNRTLLAGTYGYIAPELAYTMVVTEKSDVYSFGV 125
N+L++ + A V+DFG+ + SS + + APE + KSDV+SFG+
Sbjct: 131 RNVLVSEDNVAKVSDFGLTKEA---SSTQDTGKLPVKWTAPEALREKKFSTKSDVWSFGI 187
Query: 126 VALEV 130
+ E+
Sbjct: 188 LLWEI 192
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 53.7 bits (129), Expect = 3e-09
Identities = 31/101 (30%), Positives = 48/101 (47%), Gaps = 4/101 (3%)
Query: 31 LDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADFGVARLLNFD 90
L + + I K + L YLH I+HRD+ + NI +N + + D G A+
Sbjct: 154 LPIDQALIIEKQILEGLRYLHAQ---RIIHRDVKTENIFINDVDQVCIGDLGAAQ-FPVV 209
Query: 91 SSNRTLLAGTYGYIAPELAYTMVVTEKSDVYSFGVVALEVL 131
+ LAGT APE+ K+D++S G+V E+L
Sbjct: 210 APAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEML 250
|
Length = 357 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 53.4 bits (128), Expect = 3e-09
Identities = 34/102 (33%), Positives = 52/102 (50%), Gaps = 9/102 (8%)
Query: 41 KGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADFGVARLLNFDSSNRT----- 95
K + ++YLH++C +VHRDI NN++L + DFG AR L + + T
Sbjct: 109 KQILDGVAYLHNNC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNML 165
Query: 96 -LLAGTYGYIAPELAYTMVVTEKSDVYSFGVVALEVLMGKHP 136
+ GT ++APE+ KSD++S G E+ GK P
Sbjct: 166 KSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPP 207
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 3e-09
Identities = 35/101 (34%), Positives = 49/101 (48%), Gaps = 10/101 (9%)
Query: 39 IVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADFGVARLLNFDSSNRTLLA 98
I G L+YLH ++HRDI + NILL + +ADFG A SS
Sbjct: 126 ITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASK----SSPANSFV 178
Query: 99 GTYGYIAPELAYTMVVTE---KSDVYSFGVVALEVLMGKHP 136
GT ++APE+ M + K DV+S G+ +E+ K P
Sbjct: 179 GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPP 219
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 3e-09
Identities = 31/97 (31%), Positives = 52/97 (53%), Gaps = 8/97 (8%)
Query: 39 IVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADFGVARLLNFDSSNRTLLA 98
I + M AL YLH + I+HRD+ + N+LL L+ + +ADFGV+ R
Sbjct: 115 ICRQMLEALQYLH---SMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDSFI 171
Query: 99 GTYGYIAPELAYTMVVTE-----KSDVYSFGVVALEV 130
GT ++APE+ + + K+D++S G+ +E+
Sbjct: 172 GTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEM 208
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 53.2 bits (128), Expect = 4e-09
Identities = 30/94 (31%), Positives = 50/94 (53%), Gaps = 3/94 (3%)
Query: 43 MAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADFGVARLLNFDSSNRTLLAGTYG 102
+A L +LH + I++RD+ +N++L+ E +ADFG+ + F GT
Sbjct: 110 IAIGLFFLH---SKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTTRTFCGTPD 166
Query: 103 YIAPELAYTMVVTEKSDVYSFGVVALEVLMGKHP 136
YIAPE+ + D ++FGV+ E+L G+ P
Sbjct: 167 YIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPP 200
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 52.6 bits (126), Expect = 6e-09
Identities = 32/93 (34%), Positives = 50/93 (53%), Gaps = 3/93 (3%)
Query: 46 ALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADFGVARLLNFDSSNRTLLAGTYGYIA 105
AL +LH I++RD+ +N+LL+ E +ADFG+ + F+ + GT YIA
Sbjct: 108 ALMFLH---DKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTSTFCGTPDYIA 164
Query: 106 PELAYTMVVTEKSDVYSFGVVALEVLMGKHPGE 138
PE+ M+ D ++ GV+ E+L G P E
Sbjct: 165 PEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFE 197
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 7e-09
Identities = 42/138 (30%), Positives = 70/138 (50%), Gaps = 13/138 (9%)
Query: 6 MFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMA-HALSYLHHDCTPPIVHRDIS 64
++L+ +Y G L +L E+ + D A+ +A H++ LH+ VHRDI
Sbjct: 76 LYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHY------VHRDIK 129
Query: 65 SNNILLNLELEAFVADFGVARLLNFDSSNRTLLA-GTYGYIAPELAYTM-----VVTEKS 118
+N+LL++ +ADFG +N D + ++ +A GT YI+PE+ M +
Sbjct: 130 PDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVAVGTPDYISPEILQAMEDGMGKYGPEC 189
Query: 119 DVYSFGVVALEVLMGKHP 136
D +S GV E+L G+ P
Sbjct: 190 DWWSLGVCMYEMLYGETP 207
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 52.3 bits (126), Expect = 7e-09
Identities = 42/143 (29%), Positives = 69/143 (48%), Gaps = 12/143 (8%)
Query: 1 LHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLH-HDCTPPIV 59
+ ++L++EY+E +L +L + GL + + + A++Y H H+ I+
Sbjct: 70 RRKGRLYLVFEYVER-TLLELL--EASPGGLPPDAVRSYIWQLLQAIAYCHSHN----II 122
Query: 60 HRDISSNNILLNLELEAFVADFGVARLLNFDSSNR-TLLAGTYGYIAPELAYTMVVTEKS 118
HRDI NIL++ + DFG AR L ++ T T Y APEL K
Sbjct: 123 HRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVATRWYRAPELLVGDTNYGKP 182
Query: 119 -DVYSFGVVALEVLMGK--HPGE 138
DV++ G + E+L G+ PG+
Sbjct: 183 VDVWAIGCIMAELLDGEPLFPGD 205
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 52.5 bits (126), Expect = 7e-09
Identities = 40/137 (29%), Positives = 66/137 (48%), Gaps = 14/137 (10%)
Query: 6 MFLIYEYMEMGSLFCVL---RTDEEAVGLDWAKRVNIVKGMAHALSYLH-HDCTPPIVHR 61
+F + EY+ G L + R +E +A V + AL +LH H +++R
Sbjct: 71 LFFVMEYVNGGDLMFQIQRSRKFDEPRSRFYAAEVTL------ALMFLHRHG----VIYR 120
Query: 62 DISSNNILLNLELEAFVADFGVARLLNFDSSNRTLLAGTYGYIAPELAYTMVVTEKSDVY 121
D+ +NILL+ E +ADFG+ + + T GT YIAPE+ + D +
Sbjct: 121 DLKLDNILLDAEGHCKLADFGMCKEGILNGVTTTTFCGTPDYIAPEILQELEYGPSVDWW 180
Query: 122 SFGVVALEVLMGKHPGE 138
+ GV+ E++ G+ P E
Sbjct: 181 ALGVLMYEMMAGQPPFE 197
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 52.1 bits (125), Expect = 8e-09
Identities = 35/101 (34%), Positives = 49/101 (48%), Gaps = 10/101 (9%)
Query: 39 IVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADFGVARLLNFDSSNRTLLA 98
I G L+YLH +HRDI + NILL +ADFG A L++ +S
Sbjct: 120 ICHGALQGLAYLHSHER---IHRDIKAGNILLTEPGTVKLADFGSASLVSPANS----FV 172
Query: 99 GTYGYIAPELAYTM---VVTEKSDVYSFGVVALEVLMGKHP 136
GT ++APE+ M K DV+S G+ +E+ K P
Sbjct: 173 GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPP 213
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 51.9 bits (125), Expect = 1e-08
Identities = 29/105 (27%), Positives = 53/105 (50%), Gaps = 12/105 (11%)
Query: 6 MFLIYEYMEMGSLFCVLRTDEEAV---GLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRD 62
+ L++E+++ L T GL ++++ + + +LH IVHRD
Sbjct: 81 LTLVFEHVD-----QDLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHR---IVHRD 132
Query: 63 ISSNNILLNLELEAFVADFGVARLLNFDSSNRTLLAGTYGYIAPE 107
+ NIL+ + + +ADFG+AR+ +F+ + T + T Y APE
Sbjct: 133 LKPQNILVTSDGQVKIADFGLARIYSFEMA-LTSVVVTLWYRAPE 176
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 1e-08
Identities = 43/152 (28%), Positives = 73/152 (48%), Gaps = 29/152 (19%)
Query: 6 MFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKG--------------MAHALSYLH 51
+++I EY G+L LR G++++ + V +A + YL
Sbjct: 96 LYVIVEYASKGNLREYLRA-RRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYL- 153
Query: 52 HDCTPPIVHRDISSNNILLNLELEAFVADFGVAR-LLNFDSSNRTLLAGTYG-----YIA 105
+ +HRD+++ N+L+ +ADFG+AR + N D +T T G ++A
Sbjct: 154 --ASQKCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKT----TNGRLPVKWMA 207
Query: 106 PELAYTMVVTEKSDVYSFGVVALEVL-MGKHP 136
PE + V T +SDV+SFGV+ E+ +G P
Sbjct: 208 PEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP 239
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 51.7 bits (124), Expect = 1e-08
Identities = 44/135 (32%), Positives = 63/135 (46%), Gaps = 16/135 (11%)
Query: 3 RKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRV----NIVKGMAHALSYLHHDCTPPI 58
R+ + L+ EY+ GSL L+ E LD K + I KGM YL +
Sbjct: 79 RRNLRLVMEYLPYGSLRDYLQKHRER--LDHRKLLLYASQICKGM----EYLG---SKRY 129
Query: 59 VHRDISSNNILLNLELEAFVADFGVARLLNFDSSNRTLLAGTYGYI---APELAYTMVVT 115
VHRD+++ NIL+ E + DFG+ ++L D + I APE +
Sbjct: 130 VHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYAPESLTESKFS 189
Query: 116 EKSDVYSFGVVALEV 130
SDV+SFGVV E+
Sbjct: 190 VASDVWSFGVVLYEL 204
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 1e-08
Identities = 39/128 (30%), Positives = 62/128 (48%), Gaps = 8/128 (6%)
Query: 8 LIYEYMEMGSLFCVL---RTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDIS 64
+I +M+ G L L R + L V + +A + YL + +HRD++
Sbjct: 83 VILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYL---SSKSFIHRDLA 139
Query: 65 SNNILLNLELEAFVADFGVA-RLLNFDSSNRTLLAGT-YGYIAPELAYTMVVTEKSDVYS 122
+ N +LN + VADFG++ ++ N D + +A +IA E V T KSDV+S
Sbjct: 140 ARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWS 199
Query: 123 FGVVALEV 130
FGV E+
Sbjct: 200 FGVTMWEI 207
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 51.6 bits (124), Expect = 1e-08
Identities = 37/105 (35%), Positives = 54/105 (51%), Gaps = 13/105 (12%)
Query: 37 VNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADFGVA-RLLNFDSSNRT 95
V IVK AL YL ++HRD+ +NILL+ + DFG++ RL+ DS +T
Sbjct: 121 VAIVK----ALHYLKE--KHGVIHRDVKPSNILLDASGNVKLCDFGISGRLV--DSKAKT 172
Query: 96 LLAGTYGYIAPELAYTMVVTEK----SDVYSFGVVALEVLMGKHP 136
AG Y+APE K +DV+S G+ +E+ G+ P
Sbjct: 173 RSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFP 217
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 51.3 bits (123), Expect = 1e-08
Identities = 31/95 (32%), Positives = 47/95 (49%), Gaps = 6/95 (6%)
Query: 45 HALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADFGVARLLNFDSSNRTLLA---GTY 101
+ YLH + IVHRDI NIL + + DFG ++ L S+ T + GT
Sbjct: 115 EGVEYLH---SNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTP 171
Query: 102 GYIAPELAYTMVVTEKSDVYSFGVVALEVLMGKHP 136
+++PE+ K+DV+S G +E+L K P
Sbjct: 172 YWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPP 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 1e-08
Identities = 31/96 (32%), Positives = 52/96 (54%), Gaps = 3/96 (3%)
Query: 43 MAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADFGVARLLNFDSSNRTLLAGTYG 102
+A L +LH + I++RD+ +N++L+ E +ADFG+ + +D GT
Sbjct: 110 IAIGLFFLH---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVTTKTFCGTPD 166
Query: 103 YIAPELAYTMVVTEKSDVYSFGVVALEVLMGKHPGE 138
YIAPE+ + D ++FGV+ E+L G+ P E
Sbjct: 167 YIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFE 202
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 51.5 bits (124), Expect = 2e-08
Identities = 40/138 (28%), Positives = 66/138 (47%), Gaps = 10/138 (7%)
Query: 5 CMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDIS 64
L+ EYM L VLR +E + K ++ + ++Y+H + I+HRD+
Sbjct: 73 GFVLVMEYM-PSDLSEVLRDEERPLPEAQVKS--YMRMLLKGVAYMHAN---GIMHRDLK 126
Query: 65 SNNILLNLELEAFVADFGVARLLNFDSSNR-TLLAGTYGYIAPELAY-TMVVTEKSDVYS 122
N+L++ + +ADFG+ARL + + + T Y APEL Y D+++
Sbjct: 127 PANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLYGARKYDPGVDLWA 186
Query: 123 FGVVALEVLMGK--HPGE 138
G + E+L G PGE
Sbjct: 187 VGCIFAELLNGSPLFPGE 204
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 51.4 bits (123), Expect = 2e-08
Identities = 32/90 (35%), Positives = 49/90 (54%), Gaps = 4/90 (4%)
Query: 50 LHHDCTPPIVHRDISSNNILLNLELEAFVADFGVARLLN---FDSSNRTLLAGTYGYIAP 106
+HH + ++HRDI S NILL + DFG +++ D RT GT Y+AP
Sbjct: 156 VHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTF-CGTPYYVAP 214
Query: 107 ELAYTMVVTEKSDVYSFGVVALEVLMGKHP 136
E+ ++K+D++S GV+ E+L K P
Sbjct: 215 EIWRRKPYSKKADMFSLGVLLYELLTLKRP 244
|
Length = 496 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 51.2 bits (123), Expect = 2e-08
Identities = 30/96 (31%), Positives = 50/96 (52%), Gaps = 9/96 (9%)
Query: 46 ALSYLH-HDCTPPIVHRDISSNNILLNLELEAFVADFGVAR--LLNFDSSNRTLLAGTYG 102
L +LH I++RD+ +N+LL+ E +ADFG+ + +L +++ GT
Sbjct: 108 GLQFLHERG----IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTST--FCGTPD 161
Query: 103 YIAPELAYTMVVTEKSDVYSFGVVALEVLMGKHPGE 138
YIAPE+ D ++ GV+ E+L G+ P E
Sbjct: 162 YIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFE 197
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 50.9 bits (122), Expect = 2e-08
Identities = 41/137 (29%), Positives = 66/137 (48%), Gaps = 11/137 (8%)
Query: 6 MFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISS 65
++L+ +Y G L +L E+ + D A+ + M A+ +H VHRDI
Sbjct: 76 LYLVMDYYVGGDLLTLLSKFEDRLPEDMARFY--LAEMVLAIDSVHQ---LGYVHRDIKP 130
Query: 66 NNILLNLELEAFVADFGVARLLNFDSSNRTLLA-GTYGYIAPELAYTM-----VVTEKSD 119
+N+LL+ +ADFG L D + ++ +A GT YI+PE+ M + D
Sbjct: 131 DNVLLDKNGHIRLADFGSCLRLLADGTVQSNVAVGTPDYISPEILQAMEDGKGRYGPECD 190
Query: 120 VYSFGVVALEVLMGKHP 136
+S GV E+L G+ P
Sbjct: 191 WWSLGVCMYEMLYGETP 207
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 50.8 bits (122), Expect = 2e-08
Identities = 39/135 (28%), Positives = 62/135 (45%), Gaps = 19/135 (14%)
Query: 6 MFLIYEYMEMGSLFCVLRT-DEEAVGLDWAKRVNIVKGMAHALSYLH-HDCTPPIVHRDI 63
+ L++EY + VL ++ G+ I+ A+++ H H+C +HRD+
Sbjct: 75 LHLVFEYCD----HTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHNC----IHRDV 126
Query: 64 SSNNILLNLELEAFVADFGVARLLNFDSSNRTLLAGTYGYIAPEL-----AYTMVVTEKS 118
NIL+ + + + DFG AR+L + T T Y APEL Y V
Sbjct: 127 KPENILITKQGQIKLCDFGFARILTGPGDDYTDYVATRWYRAPELLVGDTQYGPPV---- 182
Query: 119 DVYSFGVVALEVLMG 133
DV++ G V E+L G
Sbjct: 183 DVWAIGCVFAELLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 2e-08
Identities = 31/97 (31%), Positives = 50/97 (51%), Gaps = 8/97 (8%)
Query: 39 IVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADFGVARLLNFDSSNRTLLA 98
+ K AL+YLH + I+HRD+ + NIL L+ + +ADFGV+ R
Sbjct: 108 VCKQTLEALNYLHEN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFI 164
Query: 99 GTYGYIAPELAYTMVVTE-----KSDVYSFGVVALEV 130
GT ++APE+ + K+DV+S G+ +E+
Sbjct: 165 GTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEM 201
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 50.6 bits (121), Expect = 3e-08
Identities = 44/142 (30%), Positives = 64/142 (45%), Gaps = 25/142 (17%)
Query: 6 MFLIYEYMEMGSLFCVL----RTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHR 61
+ LI +Y+ G LF L E V RV I + + AL +LH I++R
Sbjct: 80 LHLILDYVNGGELFTHLYQREHFTESEV------RVYIAE-IVLALDHLHQ---LGIIYR 129
Query: 62 DISSNNILLNLELEAFVADFGVARLLNFDSSNRTL-LAGTYGYIAPEL------AYTMVV 114
DI NILL+ E + DFG+++ + R GT Y+APE+ + V
Sbjct: 130 DIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAV 189
Query: 115 TEKSDVYSFGVVALEVLMGKHP 136
D +S GV+ E+L G P
Sbjct: 190 ----DWWSLGVLTFELLTGASP 207
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 50.6 bits (122), Expect = 3e-08
Identities = 45/141 (31%), Positives = 67/141 (47%), Gaps = 25/141 (17%)
Query: 4 KCMFLIYEYMEMGSLFCVLRTD---EEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVH 60
++L+ EY+ G LF LR E V +A +V + AL YLH IV+
Sbjct: 74 SNLYLVMEYVPGGELFSHLRKSGRFPEPVARFYAAQVVL------ALEYLHSL---DIVY 124
Query: 61 RDISSNNILLNLELEAFVADFGVARLLNFDSSNRT-LLAGTYGYIAPEL----AYTMVVT 115
RD+ N+LL+ + + DFG A+ + RT L GT Y+APE+ Y V
Sbjct: 125 RDLKPENLLLDSDGYIKITDFGFAKRV----KGRTYTLCGTPEYLAPEIILSKGYGKAV- 179
Query: 116 EKSDVYSFGVVALEVLMGKHP 136
D ++ G++ E+L G P
Sbjct: 180 ---DWWALGILIYEMLAGYPP 197
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 50.9 bits (122), Expect = 3e-08
Identities = 33/94 (35%), Positives = 47/94 (50%), Gaps = 13/94 (13%)
Query: 47 LSYLHHDCTPPIVHRDISSNNILLNLELEAFVADFGVARLLNFDSS-NRTLLAGTYGYIA 105
L YLH + I+HRDI N+L+N + DFG+AR+ D S + T T Y A
Sbjct: 116 LKYLH---SAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQYYRA 172
Query: 106 PELA-----YTMVVTEKSDVYSFGVVALEVLMGK 134
PE+ YT V D++S G + E+L +
Sbjct: 173 PEILMGSRHYTSAV----DIWSVGCIFAELLGRR 202
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 3e-08
Identities = 43/152 (28%), Positives = 74/152 (48%), Gaps = 29/152 (19%)
Query: 6 MFLIYEYMEMGSLFCVLRTDEEAVGLDWA--------------KRVNIVKGMAHALSYLH 51
++++ EY G+L LR G+D++ V+ +A + YL
Sbjct: 93 LYVLVEYASKGNLREYLRA-RRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYL- 150
Query: 52 HDCTPPIVHRDISSNNILLNLELEAFVADFGVAR-LLNFDSSNRTLLAGTYG-----YIA 105
+ +HRD+++ N+L+ + +ADFG+AR + N D +T T G ++A
Sbjct: 151 --ASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKT----TNGRLPVKWMA 204
Query: 106 PELAYTMVVTEKSDVYSFGVVALEVL-MGKHP 136
PE + V T +SDV+SFGV+ E+ +G P
Sbjct: 205 PEALFDRVYTHQSDVWSFGVLLWEIFTLGGSP 236
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 3e-08
Identities = 28/94 (29%), Positives = 49/94 (52%), Gaps = 3/94 (3%)
Query: 43 MAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADFGVARLLNFDSSNRTLLAGTYG 102
++ L +LH I++RD+ +N++L+ E +ADFG+ + D GT
Sbjct: 110 ISVGLFFLHRR---GIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVTTRTFCGTPD 166
Query: 103 YIAPELAYTMVVTEKSDVYSFGVVALEVLMGKHP 136
YIAPE+ + D +++GV+ E+L G+ P
Sbjct: 167 YIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPP 200
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 3e-08
Identities = 44/155 (28%), Positives = 74/155 (47%), Gaps = 22/155 (14%)
Query: 6 MFLIYEYMEMGSLFCVLRT-----------DEEAVG-LDWAKRVNIVKGMAHALSYLHHD 53
+ +++EYM G L LR+ ++ A G L + + I +A + YL
Sbjct: 82 LLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYL--- 138
Query: 54 CTPPIVHRDISSNNILLNLELEAFVADFGVARLL----NFDSSNRTLLAGTYGYIAPELA 109
+ VHRD+++ N L+ L + DFG++R + + RT+L ++ PE
Sbjct: 139 ASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLP--IRWMPPESI 196
Query: 110 YTMVVTEKSDVYSFGVVALEVLM-GKHPGELLSSS 143
T +SD++SFGVV E+ GK P LS++
Sbjct: 197 LYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNT 231
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 50.2 bits (120), Expect = 3e-08
Identities = 31/95 (32%), Positives = 46/95 (48%), Gaps = 8/95 (8%)
Query: 47 LSYLHHDCTPPIVHRDISSNNILLNLELEAF-VADFGVARLLNFDSSNRTL----LAGTY 101
LSYLH + I+HRD+ N+L++ + +ADFG A L + L GT
Sbjct: 116 LSYLHEN---QIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTI 172
Query: 102 GYIAPELAYTMVVTEKSDVYSFGVVALEVLMGKHP 136
++APE+ DV+S G V +E+ K P
Sbjct: 173 AFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPP 207
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 4e-08
Identities = 32/96 (33%), Positives = 46/96 (47%), Gaps = 8/96 (8%)
Query: 46 ALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADFGVARLLNFDSSNRTLLAGTYGYIA 105
L +LH + T +HRD+ NNILL E + DFGV+ L R GT ++A
Sbjct: 136 GLQHLHVNKT---IHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMA 192
Query: 106 PEL-----AYTMVVTEKSDVYSFGVVALEVLMGKHP 136
PE+ + DV+S G+ A+E+ G P
Sbjct: 193 PEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPP 228
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 50.3 bits (120), Expect = 4e-08
Identities = 42/138 (30%), Positives = 65/138 (47%), Gaps = 19/138 (13%)
Query: 6 MFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNI-VKGMAHALSYLH-HDCTPPIVHRDI 63
++L+ +YM G LF L+ + G R + + AL +LH +D IV+RD+
Sbjct: 71 LYLVTDYMSGGELFWHLQKE----GRFSEDRAKFYIAELVLALEHLHKYD----IVYRDL 122
Query: 64 SSNNILLNLELEAFVADFGVARLLNFDSSNRTLLAGTYGYIAPEL-----AYTMVVTEKS 118
NILL+ + DFG+++ D+ GT Y+APE+ YT V
Sbjct: 123 KPENILLDATGHIALCDFGLSKANLTDNKTTNTFCGTTEYLAPEVLLDEKGYTKHV---- 178
Query: 119 DVYSFGVVALEVLMGKHP 136
D +S GV+ E+ G P
Sbjct: 179 DFWSLGVLVFEMCCGWSP 196
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 50.2 bits (120), Expect = 4e-08
Identities = 47/155 (30%), Positives = 72/155 (46%), Gaps = 15/155 (9%)
Query: 2 HRKCMFLIYEY-------MEMGSLFCVLRTDEEAVG-LDWAKRVNIVKGMAHALSYLHHD 53
HR + LI+ Y M M C L T + G L + + I + + AL+YLH
Sbjct: 145 HRAIINLIHAYRWKSTVCMVMPKYKCDLFTYVDRSGPLPLEQAITIQRRLLEALAYLHGR 204
Query: 54 CTPPIVHRDISSNNILLNLELEAFVADFGVARLLNF--DSSNRTLLAGTYGYIAPELAYT 111
I+HRD+ + NI L+ A + DFG A L+ D+ +GT +PEL
Sbjct: 205 ---GIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQCYGWSGTLETNSPELLAL 261
Query: 112 MVVTEKSDVYSFGVVALEVLMGKHP--GELLSSSS 144
K+D++S G+V E+ + G+ + SSS
Sbjct: 262 DPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSS 296
|
Length = 392 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 50.2 bits (120), Expect = 4e-08
Identities = 45/147 (30%), Positives = 67/147 (45%), Gaps = 39/147 (26%)
Query: 7 FLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVN--------IVKGMAHALSYLHHDCTPPI 58
+L++EYM D + +GL + V+ +K + L+Y H
Sbjct: 92 YLVFEYM-----------DHDLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKK---NF 137
Query: 59 VHRDISSNNILLNLELEAFVADFGVARLLNFDSS----NRTLLAGTYGYIAPEL-----A 109
+HRDI +NILLN + + +ADFG+ARL N + S N+ + T Y PEL
Sbjct: 138 LHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTNKVI---TLWYRPPELLLGEER 194
Query: 110 YTMVVTEKSDVYSFGVVALEVLMGKHP 136
Y + DV+S G + E L K P
Sbjct: 195 YGPAI----DVWSCGCILGE-LFTKKP 216
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 50.1 bits (119), Expect = 4e-08
Identities = 39/130 (30%), Positives = 62/130 (47%), Gaps = 15/130 (11%)
Query: 8 LIYEYMEMGSLFCVLRTDEEAVG----LDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDI 63
L+ + M G L + ++ +G L+W V I KGM YL +VHRD+
Sbjct: 85 LVTQLMPHGCLLDYVHEHKDNIGSQLLLNWC--VQIAKGMM----YLEER---RLVHRDL 135
Query: 64 SSNNILLNLELEAFVADFGVARLLNFDSSNRTLLAGTY--GYIAPELAYTMVVTEKSDVY 121
++ N+L+ + DFG+ARLL D G ++A E + T +SDV+
Sbjct: 136 AARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVW 195
Query: 122 SFGVVALEVL 131
S+GV E++
Sbjct: 196 SYGVTIWELM 205
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 50.1 bits (120), Expect = 4e-08
Identities = 33/95 (34%), Positives = 51/95 (53%), Gaps = 9/95 (9%)
Query: 46 ALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADFGVARLLNFDS---SNRTLLAGTYG 102
AL+YL + VHRDI++ N+L++ + DFG++R L +S +++ L
Sbjct: 119 ALAYLE---SKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKLP--IK 173
Query: 103 YIAPELAYTMVVTEKSDVYSFGVVALEVLM-GKHP 136
++APE T SDV+ FGV E+LM G P
Sbjct: 174 WMAPESINFRRFTSASDVWMFGVCMWEILMLGVKP 208
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 5e-08
Identities = 38/131 (29%), Positives = 62/131 (47%), Gaps = 6/131 (4%)
Query: 6 MFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISS 65
++ + +Y+ G LF L+ E L+ R + +A AL YLH + IV+RD+
Sbjct: 71 LYFVLDYINGGELFYHLQ--RERCFLEPRARFYAAE-IASALGYLH---SLNIVYRDLKP 124
Query: 66 NNILLNLELEAFVADFGVARLLNFDSSNRTLLAGTYGYIAPELAYTMVVTEKSDVYSFGV 125
NILL+ + + DFG+ + + + GT Y+APE+ + D + G
Sbjct: 125 ENILLDSQGHIVLTDFGLCKENIEHNGTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGA 184
Query: 126 VALEVLMGKHP 136
V E+L G P
Sbjct: 185 VLYEMLYGLPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 49.7 bits (119), Expect = 6e-08
Identities = 26/76 (34%), Positives = 44/76 (57%), Gaps = 2/76 (2%)
Query: 58 IVHRDISSNNILLNLELEAFVADFGVARLLNFDSSNRTLLAG--TYGYIAPELAYTMVVT 115
+HRD+++ N+L+ + +ADFG+AR ++ R G ++APE + V T
Sbjct: 153 CIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYT 212
Query: 116 EKSDVYSFGVVALEVL 131
+SDV+SFGV+ E+
Sbjct: 213 HQSDVWSFGVLLWEIF 228
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 50.1 bits (119), Expect = 6e-08
Identities = 42/141 (29%), Positives = 66/141 (46%), Gaps = 19/141 (13%)
Query: 6 MFLIYEYMEMGSLFCVLRTDEEAVGLDWAK----RVNIVKGMAHALSYLHHDCTPPIVHR 61
++L+ +Y G L +L E+ + D A+ + I H L Y VHR
Sbjct: 76 LYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHY---------VHR 126
Query: 62 DISSNNILLNLELEAFVADFGVARLLNFDSSNRTLLA-GTYGYIAPELAYTMV-----VT 115
DI +NIL+++ +ADFG L D + ++ +A GT YI+PE+ M
Sbjct: 127 DIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEDGKGKYG 186
Query: 116 EKSDVYSFGVVALEVLMGKHP 136
+ D +S GV E+L G+ P
Sbjct: 187 PECDWWSLGVCMYEMLYGETP 207
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 49.7 bits (118), Expect = 6e-08
Identities = 34/101 (33%), Positives = 52/101 (51%), Gaps = 10/101 (9%)
Query: 39 IVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADFGVARLLNFDSSNRTLLA 98
I G L+YLH + ++HRDI + NILL + +ADFG A + + +S
Sbjct: 130 ITHGALQGLAYLH---SHNMIHRDIKAGNILLTEPGQVKLADFGSASIASPANS----FV 182
Query: 99 GTYGYIAPELAYTMVVTE---KSDVYSFGVVALEVLMGKHP 136
GT ++APE+ M + K DV+S G+ +E+ K P
Sbjct: 183 GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPP 223
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 49.3 bits (118), Expect = 6e-08
Identities = 42/137 (30%), Positives = 67/137 (48%), Gaps = 18/137 (13%)
Query: 5 CMFLIYEYMEMGSLFCVLRT----DEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVH 60
+FL E + GSL +L+ E + L + ++ I+ G L YLH VH
Sbjct: 78 YIFL--ELVPGGSLAKLLKKYGSFPEPVIRL-YTRQ--ILLG----LEYLHDR---NTVH 125
Query: 61 RDISSNNILLNLELEAFVADFGVARLLNFDSSNRTLLAGTYGYIAPE-LAYTMVVTEKSD 119
RDI NIL++ +ADFG+A+ + S ++ G+ ++APE +A +D
Sbjct: 126 RDIKGANILVDTNGVVKLADFGMAKQVVEFSFAKS-FKGSPYWMAPEVIAQQGGYGLAAD 184
Query: 120 VYSFGVVALEVLMGKHP 136
++S G LE+ GK P
Sbjct: 185 IWSLGCTVLEMATGKPP 201
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 49.4 bits (118), Expect = 8e-08
Identities = 47/147 (31%), Positives = 71/147 (48%), Gaps = 33/147 (22%)
Query: 7 FLIY-EYMEMGSLFCVLRT------DEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIV 59
F I+ E + GSL +LR+ D E + + K+ I++G L YLH + IV
Sbjct: 80 FKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQ--ILEG----LKYLHDN---QIV 130
Query: 60 HRDISSNNILLNLELEAF-VADFGVA-RLLNFDSSNRTLLAGTYGYIAPELAYTMVVTEK 117
HRDI +N+L+N ++DFG + RL + T GT Y+APE V +K
Sbjct: 131 HRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTET-FTGTLQYMAPE------VIDK 183
Query: 118 --------SDVYSFGVVALEVLMGKHP 136
+D++S G +E+ GK P
Sbjct: 184 GPRGYGAPADIWSLGCTIVEMATGKPP 210
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 49.5 bits (118), Expect = 8e-08
Identities = 36/119 (30%), Positives = 63/119 (52%), Gaps = 14/119 (11%)
Query: 25 DEEAVGLDWAKRVNIVKGMAHALSYL-HHDCTPPIVHRDISSNNILLNLELEAFVADFGV 83
+E+ + LD ++ +A +S+L +C +HRD+++ NILL + DFG+
Sbjct: 205 EEDELALDTEDLLSFSYQVAKGMSFLASKNC----IHRDLAARNILLTHGRITKICDFGL 260
Query: 84 ARLLNFDSS-----NRTLLAGTYGYIAPELAYTMVVTEKSDVYSFGVVALEVL-MGKHP 136
AR + DS+ N L ++APE + V T +SDV+S+G++ E+ +G P
Sbjct: 261 ARDIRNDSNYVVKGNARL---PVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSP 316
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 9e-08
Identities = 37/135 (27%), Positives = 70/135 (51%), Gaps = 17/135 (12%)
Query: 6 MFLIYEYMEMGSLFCVLRTDEE---AVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRD 62
++L+ E++ G F LR ++ VG +A ++ ++ +L+ IV+RD
Sbjct: 106 LYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSLN---------IVYRD 156
Query: 63 ISSNNILLNLELEAFVADFGVARLLNFDSSNRTL-LAGTYGYIAPELAYTMVVTEKSDVY 121
+ N+LL+ + + DFG A++++ RT L GT YIAPE+ + + +D +
Sbjct: 157 LKPENLLLDKDGFIKMTDFGFAKVVD----TRTYTLCGTPEYIAPEILLNVGHGKAADWW 212
Query: 122 SFGVVALEVLMGKHP 136
+ G+ E+L+G P
Sbjct: 213 TLGIFIYEILVGCPP 227
|
Length = 340 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 9e-08
Identities = 41/153 (26%), Positives = 74/153 (48%), Gaps = 31/153 (20%)
Query: 6 MFLIYEYMEMGSL---------------FCVLRTDEEAVGLDWAKRVNIVKGMAHALSYL 50
+++I EY G+L F + + EE L + V+ +A + YL
Sbjct: 93 LYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQ--LSFKDLVSCAYQVARGMEYL 150
Query: 51 HHDCTPPIVHRDISSNNILLNLELEAFVADFGVAR-LLNFDSSNRTLLAGTYG-----YI 104
+ +HRD+++ N+L+ + +ADFG+AR + + D +T + G ++
Sbjct: 151 E---SRRCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKT----SNGRLPVKWM 203
Query: 105 APELAYTMVVTEKSDVYSFGVVALEVL-MGKHP 136
APE + V T +SDV+SFG++ E+ +G P
Sbjct: 204 APEALFDRVYTHQSDVWSFGILMWEIFTLGGSP 236
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 9e-08
Identities = 38/131 (29%), Positives = 62/131 (47%), Gaps = 16/131 (12%)
Query: 7 FLIYEYM--EMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDIS 64
+L+ +M ++G L + E+ + +V M L Y+H I+HRD+
Sbjct: 96 YLVMPFMGTDLGKLMKHEKLSEDRIQF-------LVYQMLKGLKYIH---AAGIIHRDLK 145
Query: 65 SNNILLNLELEAFVADFGVARLLNFDSSNRTLLAGTYGYIAPELAYT-MVVTEKSDVYSF 123
N+ +N + E + DFG+AR + S T T Y APE+ M T+ D++S
Sbjct: 146 PGNLAVNEDCELKILDFGLARQTD---SEMTGYVVTRWYRAPEVILNWMHYTQTVDIWSV 202
Query: 124 GVVALEVLMGK 134
G + E+L GK
Sbjct: 203 GCIMAEMLTGK 213
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 49.1 bits (117), Expect = 9e-08
Identities = 37/134 (27%), Positives = 59/134 (44%), Gaps = 12/134 (8%)
Query: 8 LIYEYMEMGSL-FCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSN 66
L+ M G L + + DEE G + + L +LH I++RD+
Sbjct: 70 LVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQR---RIIYRDLKPE 126
Query: 67 NILLNLELEAFVADFGVARLLNFDSSNRTLLAGTYGYIAPEL----AYTMVVTEKSDVYS 122
N+LL+ + ++D G+A L S AGT G++APEL Y V D ++
Sbjct: 127 NVLLDNDGNVRISDLGLAVELKDGQSKTKGYAGTPGFMAPELLQGEEYDFSV----DYFA 182
Query: 123 FGVVALEVLMGKHP 136
GV E++ + P
Sbjct: 183 LGVTLYEMIAARGP 196
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 48.9 bits (116), Expect = 9e-08
Identities = 42/139 (30%), Positives = 67/139 (48%), Gaps = 15/139 (10%)
Query: 4 KCMFLIYEYMEMGSLFCVLRTD---EEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVH 60
K + + EYM GS+ L+ E+V + ++ I++GM SYLH + IVH
Sbjct: 79 KTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQ--ILEGM----SYLHSNM---IVH 129
Query: 61 RDISSNNILLNLELEAFVADFGVARLLN---FDSSNRTLLAGTYGYIAPELAYTMVVTEK 117
RDI NIL + + DFG ++ L + + GT +++PE+ K
Sbjct: 130 RDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRK 189
Query: 118 SDVYSFGVVALEVLMGKHP 136
+DV+S G +E+L K P
Sbjct: 190 ADVWSLGCTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 1e-07
Identities = 32/94 (34%), Positives = 45/94 (47%), Gaps = 3/94 (3%)
Query: 43 MAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADFGVARLLNFDSSNRTLLAGTYG 102
+A AL YLH + IV+RD+ NILL+ + + DFG+ + S T GT
Sbjct: 105 IASALGYLH---SINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTTTFCGTPE 161
Query: 103 YIAPELAYTMVVTEKSDVYSFGVVALEVLMGKHP 136
Y+APE+ D + G V E+L G P
Sbjct: 162 YLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 49.0 bits (117), Expect = 1e-07
Identities = 44/149 (29%), Positives = 71/149 (47%), Gaps = 21/149 (14%)
Query: 6 MFLIYEYMEMGSLFCVLRTDEEAVG-----LDWAKRVNIVKGMAHALSYLHHDCTPPIVH 60
+ +I EY G L LR E+ L ++ +V KGMA S +C +H
Sbjct: 114 ILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQV--AKGMAFLAS---KNC----IH 164
Query: 61 RDISSNNILLNLELEAFVADFGVARLLNFDSSNRTLLAGTY---GYIAPELAYTMVVTEK 117
RD+++ N+LL + DFG+AR + D SN + ++APE + V T +
Sbjct: 165 RDLAARNVLLTHGKIVKICDFGLARDIMND-SNYVVKGNARLPVKWMAPESIFNCVYTFE 223
Query: 118 SDVYSFGVVALEVL---MGKHPGELLSSS 143
SDV+S+G++ E+ +PG + S
Sbjct: 224 SDVWSYGILLWEIFSLGSNPYPGMPVDSK 252
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 49.3 bits (117), Expect = 1e-07
Identities = 29/98 (29%), Positives = 51/98 (52%), Gaps = 3/98 (3%)
Query: 46 ALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADFGVARLLNFDSSNRTLLAGTYGYIA 105
AL+YLH I++RD+ +N+LL+ E + D+G+ + + GT YIA
Sbjct: 108 ALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIA 164
Query: 106 PELAYTMVVTEKSDVYSFGVVALEVLMGKHPGELLSSS 143
PE+ D ++ GV+ E++ G+ P +++ SS
Sbjct: 165 PEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSS 202
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 48.9 bits (117), Expect = 1e-07
Identities = 34/97 (35%), Positives = 52/97 (53%), Gaps = 15/97 (15%)
Query: 46 ALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADFGVARL-LNFDSSNRTLLAGTYGYI 104
L YLH + IV+RD+ +N+LL+ E +ADFG+ + + F T GT ++
Sbjct: 113 GLQYLHEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDRTST-FCGTPEFL 168
Query: 105 APELAYTMVVTEKS-----DVYSFGVVALEVLMGKHP 136
APE V+TE S D + GV+ E+L+G+ P
Sbjct: 169 APE-----VLTETSYTRAVDWWGLGVLIYEMLVGESP 200
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 49.0 bits (117), Expect = 1e-07
Identities = 34/101 (33%), Positives = 48/101 (47%), Gaps = 16/101 (15%)
Query: 43 MAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADFGVARLLNFDSSNRTL---LAG 99
+ AL Y+H T + HRD+ NIL N + + + DFG+AR+ D+
Sbjct: 112 LLRALKYIH---TANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVA 168
Query: 100 TYGYIAPELA------YTMVVTEKSDVYSFGVVALEVLMGK 134
T Y APEL YT + D++S G + EVL GK
Sbjct: 169 TRWYRAPELCGSFFSKYTPAI----DIWSIGCIFAEVLTGK 205
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 48.8 bits (116), Expect = 1e-07
Identities = 42/163 (25%), Positives = 75/163 (46%), Gaps = 43/163 (26%)
Query: 6 MFLIYEYMEMGSLFCVLRT-----------------------DEEAVGLD------WAKR 36
+ LI EY + GSL LR DE A+ + W
Sbjct: 78 LLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAW--- 134
Query: 37 VNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADFGVARLLNFDSS--NR 94
I +GM + L+ + +VHRD+++ N+L+ + ++DFG++R + + S R
Sbjct: 135 -QISRGMQY-LAEMK------LVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSYVKR 186
Query: 95 TLLAGTYGYIAPELAYTMVVTEKSDVYSFGVVALEVL-MGKHP 136
+ ++A E + + T +SDV+SFGV+ E++ +G +P
Sbjct: 187 SKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNP 229
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 48.8 bits (117), Expect = 1e-07
Identities = 31/97 (31%), Positives = 50/97 (51%), Gaps = 7/97 (7%)
Query: 39 IVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADFGVARLLNFDSSNRTLLA 98
+V + L Y+H + I+HRD+ +NI +N + E + DFG+AR + + T
Sbjct: 123 LVYQILRGLKYIH---SAGIIHRDLKPSNIAVNEDCELKILDFGLARHTDDE---MTGYV 176
Query: 99 GTYGYIAPELAYT-MVVTEKSDVYSFGVVALEVLMGK 134
T Y APE+ M + D++S G + E+L GK
Sbjct: 177 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGK 213
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 48.6 bits (116), Expect = 1e-07
Identities = 36/141 (25%), Positives = 63/141 (44%), Gaps = 20/141 (14%)
Query: 6 MFLIYEYMEMGSLFCVLRTD--------EEAVGLDWAKRVNIVKGMAHALSYLHHDCTPP 57
+ ++ EY G L + E+ + W + +++G L LH
Sbjct: 74 LCIVMEYAPFGDLSKAISKRKKKRKLIPEQEI---WRIFIQLLRG----LQALHEQ---K 123
Query: 58 IVHRDISSNNILLNLELEAFVADFGVARLLNFDSSNRTLLAGTYGYIAPELAYTMVVTEK 117
I+HRD+ S NILL + D G++++L + + + GT Y+APE+ + K
Sbjct: 124 ILHRDLKSANILLVANDLVKIGDLGISKVLKKNMAKTQI--GTPHYMAPEVWKGRPYSYK 181
Query: 118 SDVYSFGVVALEVLMGKHPGE 138
SD++S G + E+ P E
Sbjct: 182 SDIWSLGCLLYEMATFAPPFE 202
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 48.5 bits (116), Expect = 2e-07
Identities = 31/98 (31%), Positives = 50/98 (51%), Gaps = 10/98 (10%)
Query: 47 LSYLHHDCTPPIVHRDISSNNILLNLELEAFVADFGVARLLNFDSSNR----TLLAGTYG 102
L Y+H ++HRD+ +N+L+N + E + DFG+AR L+ + T T
Sbjct: 120 LKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATRW 176
Query: 103 YIAPELAYTMV-VTEKSDVYSFGVVALEVLMGKH--PG 137
Y APEL ++ T D++S G + E+L + PG
Sbjct: 177 YRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPG 214
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 2e-07
Identities = 31/85 (36%), Positives = 47/85 (55%), Gaps = 11/85 (12%)
Query: 59 VHRDISSNNILLNLELEAFVADFGVARLLNFD------SSNRTLLAGTYGYIAPELAYTM 112
+HRD+++ NILL+ + DFG+AR + D S R L ++APE +
Sbjct: 196 IHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLK----WMAPESIFDK 251
Query: 113 VVTEKSDVYSFGVVALEVL-MGKHP 136
V T +SDV+SFGV+ E+ +G P
Sbjct: 252 VYTTQSDVWSFGVLLWEIFSLGASP 276
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 2e-07
Identities = 43/156 (27%), Positives = 75/156 (48%), Gaps = 23/156 (14%)
Query: 6 MFLIYEYMEMGSLFCVLRTD------------EEAVG-LDWAKRVNIVKGMAHALSYLHH 52
+ +++EYM+ G L LR +A G L ++ ++I +A + YL
Sbjct: 82 LIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYL-- 139
Query: 53 DCTPPIVHRDISSNNILLNLELEAFVADFGVARLLNFDSSNRTLLAG----TYGYIAPEL 108
+ VHRD+++ N L+ L + DFG++R + S++ + G ++ PE
Sbjct: 140 -ASQHFVHRDLATRNCLVGANLLVKIGDFGMSR--DVYSTDYYRVGGHTMLPIRWMPPES 196
Query: 109 AYTMVVTEKSDVYSFGVVALEVLM-GKHPGELLSSS 143
T +SDV+SFGV+ E+ GK P LS++
Sbjct: 197 IMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNT 232
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 48.2 bits (115), Expect = 2e-07
Identities = 45/149 (30%), Positives = 69/149 (46%), Gaps = 27/149 (18%)
Query: 7 FLIYEYMEMGSLFCVLRT-DEEAVGLDWAKR----------VNIVKGMAHALSYL--HHD 53
+++EYME G L LR+ +A L + I +A + YL H
Sbjct: 84 IMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQH- 142
Query: 54 CTPPIVHRDISSNNILLNLELEAFVADFGVARLL----NFDSSNRTLLAGTYGYIAPE-L 108
VHRD+++ N L+ +L + DFG++R + + T+L ++ PE +
Sbjct: 143 ----FVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGGHTMLP--IRWMPPESI 196
Query: 109 AYTMVVTEKSDVYSFGVVALEVL-MGKHP 136
Y TE SDV+SFGVV E+ GK P
Sbjct: 197 MYRKFTTE-SDVWSFGVVLWEIFTYGKQP 224
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 48.0 bits (115), Expect = 2e-07
Identities = 33/131 (25%), Positives = 61/131 (46%), Gaps = 11/131 (8%)
Query: 7 FLIYEYMEMGSLFCVLRT--DEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDIS 64
+++ EY+E L++ + ++ ++ + +++LH + I+HRD+
Sbjct: 82 YMVMEYVEHD-----LKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNW---ILHRDLK 133
Query: 65 SNNILLNLELEAFVADFGVARLLNFDSSNRTLLAGTYGYIAPELAY-TMVVTEKSDVYSF 123
++N+LLN + DFG+AR T L T Y APEL + D++S
Sbjct: 134 TSNLLLNNRGILKICDFGLAREYGSPLKPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSV 193
Query: 124 GVVALEVLMGK 134
G + E+L K
Sbjct: 194 GCIFAELLTKK 204
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 47.8 bits (114), Expect = 3e-07
Identities = 32/102 (31%), Positives = 44/102 (43%), Gaps = 25/102 (24%)
Query: 58 IVHRDISSNNILLNLELEAFVADFGVARLLNFDSSNRTLLAGTYG--------------Y 103
+HRD+S NI +N + +ADFG+AR + + TL Y
Sbjct: 140 FMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWY 199
Query: 104 IAPEL-----AYTMVVTEKSDVYSFGVVALEVLMGK--HPGE 138
APEL Y V D++S G + E+L GK PGE
Sbjct: 200 RAPELLMGAEKYHFAV----DMWSVGCIFAELLTGKPLFPGE 237
|
Length = 335 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 3e-07
Identities = 32/101 (31%), Positives = 56/101 (55%), Gaps = 14/101 (13%)
Query: 43 MAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADFGVAR-LLNFDSSNRTLLAGTY 101
+A + YL + +HRD+++ N+L+ + +ADFG+AR + + D +T T
Sbjct: 149 VARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKT----TN 201
Query: 102 G-----YIAPELAYTMVVTEKSDVYSFGVVALEVL-MGKHP 136
G ++APE + + T +SDV+SFGV+ E+ +G P
Sbjct: 202 GRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSP 242
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 48.0 bits (114), Expect = 3e-07
Identities = 31/92 (33%), Positives = 48/92 (52%), Gaps = 5/92 (5%)
Query: 46 ALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADFGVARLLNFDSSNRT-LLAGTYGYI 104
AL LH +++RD+ NILL+ + + DFG+ +L N ++T GT Y+
Sbjct: 105 ALENLH---KFNVIYRDLKPENILLDYQGHIALCDFGLCKL-NMKDDDKTNTFCGTPEYL 160
Query: 105 APELAYTMVVTEKSDVYSFGVVALEVLMGKHP 136
APEL T+ D ++ GV+ E+L G P
Sbjct: 161 APELLLGHGYTKAVDWWTLGVLLYEMLTGLPP 192
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 47.9 bits (114), Expect = 3e-07
Identities = 30/84 (35%), Positives = 49/84 (58%), Gaps = 9/84 (10%)
Query: 59 VHRDISSNNILLNLELEAFVADFGVARLLNFDSS-----NRTLLAGTYGYIAPELAYTMV 113
+HRD+++ N+LL A + DFG+AR + DS+ N L ++APE + V
Sbjct: 234 IHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNARL---PVKWMAPESIFDCV 290
Query: 114 VTEKSDVYSFGVVALEVL-MGKHP 136
T +SDV+S+G++ E+ +GK P
Sbjct: 291 YTVQSDVWSYGILLWEIFSLGKSP 314
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 47.4 bits (112), Expect = 4e-07
Identities = 43/153 (28%), Positives = 75/153 (49%), Gaps = 20/153 (13%)
Query: 6 MFLIYEYMEMGSLFCVLRTD-EEAV---------GLDWAKRVNIVKGMAHALSYLHHDCT 55
+ +++EYM+ G L LR +AV L ++ ++I + +A + YL +
Sbjct: 82 LIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYL---AS 138
Query: 56 PPIVHRDISSNNILLNLELEAFVADFGVARLLNFDSSNRTLLAG----TYGYIAPELAYT 111
VHRD+++ N L+ L + DFG++R + S++ + G ++ PE
Sbjct: 139 QHFVHRDLATRNCLVGENLLVKIGDFGMSR--DVYSTDYYRVGGHTMLPIRWMPPESIMY 196
Query: 112 MVVTEKSDVYSFGVVALEVLM-GKHPGELLSSS 143
T +SDV+S GVV E+ GK P LS++
Sbjct: 197 RKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNN 229
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 47.2 bits (112), Expect = 4e-07
Identities = 39/129 (30%), Positives = 61/129 (47%), Gaps = 12/129 (9%)
Query: 8 LIYEYMEMGSLFCVLRTDEEAVGLDWAKR--VNIVKGMAHALSYLHHDCTPPIVHRDISS 65
LI E++ GSL L ++ + L + V I KGM + S + VHRD+++
Sbjct: 85 LIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQY-------VHRDLAA 137
Query: 66 NNILLNLELEAFVADFGVARLLNFDSSNRTL---LAGTYGYIAPELAYTMVVTEKSDVYS 122
N+L+ E + + DFG+ + + D T+ L + APE SDV+S
Sbjct: 138 RNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWS 197
Query: 123 FGVVALEVL 131
FGV E+L
Sbjct: 198 FGVTLYELL 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 47.1 bits (112), Expect = 5e-07
Identities = 32/95 (33%), Positives = 49/95 (51%), Gaps = 9/95 (9%)
Query: 47 LSYLHHDCTPPIVHRDISSNNILLNLELEAFVADFGVARLLNFDSSNRTLLAGTYGYIAP 106
L Y+H + +VHRD+ +NIL+N + + DFG+AR+ T T Y AP
Sbjct: 121 LKYVH---SAGVVHRDLKPSNILINENCDLKICDFGLARI---QDPQMTGYVSTRYYRAP 174
Query: 107 ELAYT-MVVTEKSDVYSFGVVALEVLMGK--HPGE 138
E+ T + D++S G + E+L GK PG+
Sbjct: 175 EIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGK 209
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 47.1 bits (112), Expect = 5e-07
Identities = 39/137 (28%), Positives = 62/137 (45%), Gaps = 21/137 (15%)
Query: 6 MFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHA-----LSYLHHDCTPPIVH 60
++ + E++ G LF LR + N V HA YLH I++
Sbjct: 93 VYFLLEFVVGGELFTHLRKA--------GRFPNDVAKFYHAELVLAFEYLH-SKD--IIY 141
Query: 61 RDISSNNILLNLELEAFVADFGVARLLNFDSSNRTL-LAGTYGYIAPELAYTMVVTEKSD 119
RD+ N+LL+ + V DFG A+ + +RT L GT Y+APE+ + + D
Sbjct: 142 RDLKPENLLLDNKGHVKVTDFGFAKKV----PDRTFTLCGTPEYLAPEVIQSKGHGKAVD 197
Query: 120 VYSFGVVALEVLMGKHP 136
++ GV+ E + G P
Sbjct: 198 WWTMGVLLYEFIAGYPP 214
|
Length = 329 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 47.4 bits (112), Expect = 5e-07
Identities = 34/123 (27%), Positives = 59/123 (47%), Gaps = 24/123 (19%)
Query: 37 VNIVKGMAHALSYLHHDCTPP----IVHRDISSNNILLNLELE----------------- 75
V+I + + HAL+Y H+ P ++HRD+ NI L+ +
Sbjct: 121 VDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPI 180
Query: 76 AFVADFGVARLLNFDSSNRTLLAGTYGYIAPELAY--TMVVTEKSDVYSFGVVALEVLMG 133
A + DFG+++ + +S + + GT Y +PEL T +KSD+++ G + E+ G
Sbjct: 181 AKIGDFGLSKNIGIESMAHSCV-GTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSG 239
Query: 134 KHP 136
K P
Sbjct: 240 KTP 242
|
Length = 1021 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 47.0 bits (111), Expect = 6e-07
Identities = 31/102 (30%), Positives = 51/102 (50%), Gaps = 12/102 (11%)
Query: 39 IVKGMAHALSYLH-HDCTPPIVHRDISSNNILLNLELEAFVADFGVARLLNFDSSNRTLL 97
+ G L+YLH H+ ++HRD+ + NILL+ + DFG A ++ +
Sbjct: 120 VTHGALQGLAYLHSHN----MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANX----F 171
Query: 98 AGTYGYIAPELAYTMVVTE---KSDVYSFGVVALEVLMGKHP 136
GT ++APE+ M + K DV+S G+ +E+ K P
Sbjct: 172 VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPP 213
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 46.7 bits (111), Expect = 6e-07
Identities = 37/135 (27%), Positives = 63/135 (46%), Gaps = 9/135 (6%)
Query: 8 LIYEYMEMGSLFCVL---RTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDIS 64
+I +M+ G L L R L + + +A + YL +HRD++
Sbjct: 84 VILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYL---SNRNFIHRDLA 140
Query: 65 SNNILLNLELEAFVADFGVAR-LLNFDSSNRTLLAGT-YGYIAPELAYTMVVTEKSDVYS 122
+ N +L ++ VADFG+++ + + D + +A +IA E V T KSDV++
Sbjct: 141 ARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWA 200
Query: 123 FGVVALEVL-MGKHP 136
FGV E+ G+ P
Sbjct: 201 FGVTMWEIATRGQTP 215
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 47.0 bits (111), Expect = 6e-07
Identities = 40/152 (26%), Positives = 67/152 (44%), Gaps = 24/152 (15%)
Query: 1 LHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVH 60
+ +K F +Y +M + D + L R I+K + A+ Y+H ++H
Sbjct: 241 ITQKYDFDLYSFMYDEAF------DWKDRPLLKQTR-AIMKQLLCAVEYIH---DKKLIH 290
Query: 61 RDISSNNILLNLELEAFVADFGVARLLNFDSSNRTLLAGTYGYIA---PELAYTMVVTEK 117
RDI NI LN + + + DFG A + F+ G G +A PE+ E
Sbjct: 291 RDIKLENIFLNCDGKIVLGDFGTA--MPFEKEREAFDYGWVGTVATNSPEILAGDGYCEI 348
Query: 118 SDVYSFGVVALEVLM---------GKHPGELL 140
+D++S G++ L++L G PG+ L
Sbjct: 349 TDIWSCGLILLDMLSHDFCPIGDGGGKPGKQL 380
|
Length = 501 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 46.5 bits (110), Expect = 7e-07
Identities = 28/78 (35%), Positives = 39/78 (50%), Gaps = 1/78 (1%)
Query: 58 IVHRDISSNNILLNLELEAFVADFGVARLLNFDSSNRTLLAGTYGYIAPELAYTMVVTEK 117
I+HRD+ + NI L L + DFGV+RLL T GT Y++PE K
Sbjct: 127 ILHRDLKAKNIFLKNNLLK-IGDFGVSRLLMGSCDLATTFTGTPYYMSPEALKHQGYDSK 185
Query: 118 SDVYSFGVVALEVLMGKH 135
SD++S G + E+ H
Sbjct: 186 SDIWSLGCILYEMCCLAH 203
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 46.6 bits (110), Expect = 7e-07
Identities = 31/93 (33%), Positives = 48/93 (51%), Gaps = 14/93 (15%)
Query: 45 HALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADFGVARLLNFDSSNRTLLAGTYGYI 104
L+YLH + +HRDI NILL + +ADFGVA + + R GT ++
Sbjct: 117 QGLAYLH---SKGKMHRDIKGANILLTDNGDVKLADFGVAAKITATIAKRKSFIGTPYWM 173
Query: 105 APELAYTMVVTEKS-------DVYSFGVVALEV 130
APE+A EK+ D+++ G+ A+E+
Sbjct: 174 APEVA----AVEKNGGYNQLCDIWAVGITAIEL 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 46.5 bits (110), Expect = 8e-07
Identities = 30/99 (30%), Positives = 47/99 (47%), Gaps = 4/99 (4%)
Query: 37 VNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADFGVARLLNFDSSNRTL 96
+ I + + A+ YLH + I+HRDI + NI +N + + DFG A ++N+
Sbjct: 185 LAIERSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANKYY 241
Query: 97 -LAGTYGYIAPELAYTMVVTEKSDVYSFGVVALEVLMGK 134
AGT APEL D++S G+V E+
Sbjct: 242 GWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCH 280
|
Length = 391 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 46.4 bits (110), Expect = 8e-07
Identities = 30/85 (35%), Positives = 46/85 (54%), Gaps = 11/85 (12%)
Query: 59 VHRDISSNNILLNLELEAFVADFGVARLLNFD------SSNRTLLAGTYGYIAPELAYTM 112
+HRD+++ NILL+ + DFG+AR + D R L ++APE +
Sbjct: 195 IHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLK----WMAPESIFDK 250
Query: 113 VVTEKSDVYSFGVVALEVL-MGKHP 136
V T +SDV+SFGV+ E+ +G P
Sbjct: 251 VYTTQSDVWSFGVLLWEIFSLGASP 275
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 46.3 bits (110), Expect = 8e-07
Identities = 32/129 (24%), Positives = 58/129 (44%), Gaps = 11/129 (8%)
Query: 6 MFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISS 65
++++ E + GSL LR + L K + + A + YL +HRD+++
Sbjct: 67 IYIVMELVPGGSLLTFLRK--KKNRLTVKKLLQMSLDAAAGMEYLESKNC---IHRDLAA 121
Query: 66 NNILLNLELEAFVADFGVARLLNFDSSNRTLLAGT----YGYIAPELAYTMVVTEKSDVY 121
N L+ ++DFG++R + T+ G + APE T +SDV+
Sbjct: 122 RNCLVGENNVLKISDFGMSR--EEEGGIYTVSDGLKQIPIKWTAPEALNYGRYTSESDVW 179
Query: 122 SFGVVALEV 130
S+G++ E
Sbjct: 180 SYGILLWET 188
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 46.6 bits (110), Expect = 8e-07
Identities = 36/129 (27%), Positives = 59/129 (45%), Gaps = 6/129 (4%)
Query: 8 LIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNN 67
+ EY+ G LF L + E D + + AL YLH + IV+RD+ N
Sbjct: 72 FVMEYVNGGELFFHL-SRERVFSEDRTRFYG--AEIVSALDYLH---SGKIVYRDLKLEN 125
Query: 68 ILLNLELEAFVADFGVARLLNFDSSNRTLLAGTYGYIAPELAYTMVVTEKSDVYSFGVVA 127
++L+ + + DFG+ + D++ GT Y+APE+ D + GVV
Sbjct: 126 LMLDKDGHIKITDFGLCKEGITDAATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVM 185
Query: 128 LEVLMGKHP 136
E++ G+ P
Sbjct: 186 YEMMCGRLP 194
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 46.3 bits (110), Expect = 9e-07
Identities = 36/136 (26%), Positives = 62/136 (45%), Gaps = 20/136 (14%)
Query: 7 FLIYEYMEMGSLFCVLRTDEEAVG------LDWAKRVNIVKGMAHALSYLHHDCTPPIVH 60
++I EY ++G L LR + L ++V + +A + +L VH
Sbjct: 84 YMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLS---NARFVH 140
Query: 61 RDISSNNILLNLELEAFVADFGVARLLNFDSSN------RTLLAGTYGYIAPELAYTMVV 114
RD+++ N L++ + E V+ +++ D N R L ++APE
Sbjct: 141 RDLAARNCLVSSQREVKVSLLSLSK----DVYNSEYYKLRNALI-PLRWLAPEAVQEDDF 195
Query: 115 TEKSDVYSFGVVALEV 130
+ KSDV+SFGV+ EV
Sbjct: 196 STKSDVWSFGVLMWEV 211
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 46.7 bits (111), Expect = 9e-07
Identities = 27/97 (27%), Positives = 46/97 (47%), Gaps = 18/97 (18%)
Query: 58 IVHRDISSNNILLNLELEAFVADFGVARLLNFD---------------SSNRTL---LAG 99
++HRD+ +NILL L E + D+G A + S+ T+ + G
Sbjct: 134 VLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVG 193
Query: 100 TYGYIAPELAYTMVVTEKSDVYSFGVVALEVLMGKHP 136
T Y+APE + +E +D+Y+ GV+ ++L P
Sbjct: 194 TPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFP 230
|
Length = 932 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 46.1 bits (109), Expect = 1e-06
Identities = 33/93 (35%), Positives = 48/93 (51%), Gaps = 5/93 (5%)
Query: 46 ALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADFGVARLLNFDSSNRTL-LAGTYGYI 104
AL +LH IV+RDI NILL+ E + DFG+++ + RT GT Y+
Sbjct: 117 ALEHLH---KLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFCGTIEYM 173
Query: 105 APELAYTMVVTEKS-DVYSFGVVALEVLMGKHP 136
APE+ K+ D +S G++ E+L G P
Sbjct: 174 APEIIRGKGGHGKAVDWWSLGILIFELLTGASP 206
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 46.2 bits (110), Expect = 1e-06
Identities = 41/155 (26%), Positives = 58/155 (37%), Gaps = 39/155 (25%)
Query: 1 LHRKCMFLIYEYMEMGSLFCVLRTDE-EAVGLDWAKR-----------VNIVKGMAHALS 48
+ +I EYME G L L+ E GL + I GM + L
Sbjct: 89 TVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRY-LE 147
Query: 49 YLHHDCTPPIVHRDISSNNILLNLELEAFVADFGVARLLNFDSSNRTLLAGTYGYI---- 104
L+ VHRD+++ N L+ +ADFG +R L + Y +
Sbjct: 148 SLN------FVHRDLATRNCLVGKNYTIKIADFG---------MSRNLYSSDYYRVQGRA 192
Query: 105 -------APELAYTMVVTEKSDVYSFGVVALEVLM 132
A E T KSDV++FGV E+L
Sbjct: 193 PLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILT 227
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 46.1 bits (109), Expect = 1e-06
Identities = 43/154 (27%), Positives = 68/154 (44%), Gaps = 28/154 (18%)
Query: 2 HRKCMFLIYEYMEMGSLFCVLR------TD-------EEAVGLDWAKRVNIVKGMAHALS 48
HR ++L EY G+L LR TD A L + ++ +A +
Sbjct: 79 HRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMD 138
Query: 49 YLHHDCTPPIVHRDISSNNILLNLELEAFVADFGVARLLNFDSSNRTLLAGTYG-----Y 103
YL +HRD+++ NIL+ A +ADFG++R + T G +
Sbjct: 139 YLSQK---QFIHRDLAARNILVGENYVAKIADFGLSR------GQEVYVKKTMGRLPVRW 189
Query: 104 IAPELAYTMVVTEKSDVYSFGVVALEVL-MGKHP 136
+A E V T SDV+S+GV+ E++ +G P
Sbjct: 190 MAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTP 223
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 45.7 bits (108), Expect = 1e-06
Identities = 28/76 (36%), Positives = 44/76 (57%), Gaps = 7/76 (9%)
Query: 59 VHRDISSNNILLNLELEAFVADFGVARLLNFDSSNRTLLAGTYG-----YIAPELAYTMV 113
VHRD+++ N+LL + A ++DFG+++ L D + A T+G + APE
Sbjct: 117 VHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYK--AKTHGKWPVKWYAPECMNYYK 174
Query: 114 VTEKSDVYSFGVVALE 129
+ KSDV+SFGV+ E
Sbjct: 175 FSSKSDVWSFGVLMWE 190
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 1e-06
Identities = 30/85 (35%), Positives = 46/85 (54%), Gaps = 11/85 (12%)
Query: 59 VHRDISSNNILLNLELEAFVADFGVARLLNFD------SSNRTLLAGTYGYIAPELAYTM 112
+HRD+++ NILL+ + DFG+AR + D R L ++APE +
Sbjct: 201 IHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLK----WMAPETIFDR 256
Query: 113 VVTEKSDVYSFGVVALEVL-MGKHP 136
V T +SDV+SFGV+ E+ +G P
Sbjct: 257 VYTIQSDVWSFGVLLWEIFSLGASP 281
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 1e-06
Identities = 35/141 (24%), Positives = 67/141 (47%), Gaps = 12/141 (8%)
Query: 6 MFLIYEYMEMGSLFCVL---RTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRD 62
+FL+ EY+ G L + R E +A + I AL++LH I++RD
Sbjct: 71 LFLVIEYVNGGDLMFHMQRQRKLPEEHARFYAAEICI------ALNFLHER---GIIYRD 121
Query: 63 ISSNNILLNLELEAFVADFGVARLLNFDSSNRTLLAGTYGYIAPELAYTMVVTEKSDVYS 122
+ +N+LL+ + + D+G+ + + GT YIAPE+ D ++
Sbjct: 122 LKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWA 181
Query: 123 FGVVALEVLMGKHPGELLSSS 143
GV+ E++ G+ P ++++ +
Sbjct: 182 LGVLMFEMMAGRSPFDIITDN 202
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 1e-06
Identities = 30/92 (32%), Positives = 52/92 (56%), Gaps = 9/92 (9%)
Query: 59 VHRDISSNNILLNLELEAFVADFGVARLL----NFDSSNRTLLAGTYGYIAPELAYTMVV 114
VHRD+++ N+LL + DFG+AR + N+ S T L ++APE + +
Sbjct: 259 VHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLP--VKWMAPESIFDNLY 316
Query: 115 TEKSDVYSFGVVALEVL-MG--KHPGELLSSS 143
T SDV+S+G++ E+ +G +PG ++ S+
Sbjct: 317 TTLSDVWSYGILLWEIFSLGGTPYPGMIVDST 348
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 45.7 bits (108), Expect = 1e-06
Identities = 27/84 (32%), Positives = 45/84 (53%), Gaps = 8/84 (9%)
Query: 59 VHRDISSNNILLNLELEAFVADFGVARLLNFDSSNRTLLAGTYG-----YIAPELAYTMV 113
VHRD+++ N+LL + A ++DFG+++ L D S A + G + APE
Sbjct: 117 VHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYK--ARSAGKWPLKWYAPECINFRK 174
Query: 114 VTEKSDVYSFGVVALEVL-MGKHP 136
+ +SDV+S+G+ E G+ P
Sbjct: 175 FSSRSDVWSYGITMWEAFSYGQKP 198
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 45.6 bits (108), Expect = 2e-06
Identities = 30/98 (30%), Positives = 46/98 (46%), Gaps = 8/98 (8%)
Query: 39 IVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADFGVARLLNFDSSNRTLLA 98
I+ G+ H LH IV+RD+ N+LL+ ++D G+A L A
Sbjct: 104 IICGLEH----LHQR---RIVYRDLKPENVLLDDHGNVRISDLGLAVELK-GGKKIKGRA 155
Query: 99 GTYGYIAPELAYTMVVTEKSDVYSFGVVALEVLMGKHP 136
GT GY+APE+ V D ++ G E++ G+ P
Sbjct: 156 GTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSP 193
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 45.3 bits (107), Expect = 2e-06
Identities = 37/130 (28%), Positives = 63/130 (48%), Gaps = 12/130 (9%)
Query: 8 LIYEYMEMGSLFCVLRTDEEAV---GLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDIS 64
L++E+++ LRT + V GL ++++ L +LH +C IVHRD+
Sbjct: 84 LVFEHVDQD-----LRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLK 135
Query: 65 SNNILLNLELEAFVADFGVARLLNFDSSNRTLLAGTYGYIAPELAYTMVVTEKSDVYSFG 124
NIL+ + +ADFG+AR+ + + T + T Y APE+ D++S G
Sbjct: 136 PENILVTSGGQVKLADFGLARIYSCQMA-LTPVVVTLWYRAPEVLLQSTYATPVDMWSVG 194
Query: 125 VVALEVLMGK 134
+ E+ K
Sbjct: 195 CIFAEMFRRK 204
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 2e-06
Identities = 41/135 (30%), Positives = 61/135 (45%), Gaps = 11/135 (8%)
Query: 6 MFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKG-MAHALSYLHHDCTPPIVHRDIS 64
+ LI +Y+ G LF L E + V I G + AL +LH I++RDI
Sbjct: 80 LHLILDYINGGELFTHLSQRERFK----EQEVQIYSGEIVLALEHLH---KLGIIYRDIK 132
Query: 65 SNNILLNLELEAFVADFGVARLLNFDSSNRTL-LAGTYGYIAPELAYTMVVTEKS--DVY 121
NILL+ + DFG+++ + D R GT Y+AP++ D +
Sbjct: 133 LENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWW 192
Query: 122 SFGVVALEVLMGKHP 136
S GV+ E+L G P
Sbjct: 193 SMGVLMYELLTGASP 207
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 45.3 bits (107), Expect = 2e-06
Identities = 45/155 (29%), Positives = 67/155 (43%), Gaps = 41/155 (26%)
Query: 5 CMFLIYEYMEMGSLFCVLRT----DEEAVGLD------------WAKRVNIVKGMAHALS 48
CM I EYME G L L + D+E G D ++ +++ +A +
Sbjct: 95 CM--ITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMK 152
Query: 49 YLHHDCTPPIVHRDISSNNILLNLELEAFVADFGVARLLNFDSSNRTLLAGTY------- 101
YL + VHRD+++ N L+ L +ADFG++ R L AG Y
Sbjct: 153 YL---SSLNFVHRDLATRNCLVGENLTIKIADFGMS---------RNLYAGDYYRIQGRA 200
Query: 102 ----GYIAPELAYTMVVTEKSDVYSFGVVALEVLM 132
++A E T SDV++FGV E+LM
Sbjct: 201 VLPIRWMAWECILMGKFTTASDVWAFGVTLWEILM 235
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 2e-06
Identities = 29/97 (29%), Positives = 49/97 (50%), Gaps = 7/97 (7%)
Query: 39 IVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADFGVARLLNFDSSNRTLLA 98
++ + L Y+H + I+HRD+ +N+ +N + E + DFG+AR + T
Sbjct: 123 LIYQLLRGLKYIH---SAGIIHRDLKPSNVAVNEDCELRILDFGLARQAD---DEMTGYV 176
Query: 99 GTYGYIAPELAYT-MVVTEKSDVYSFGVVALEVLMGK 134
T Y APE+ M + D++S G + E+L GK
Sbjct: 177 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGK 213
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 45.1 bits (106), Expect = 3e-06
Identities = 43/154 (27%), Positives = 68/154 (44%), Gaps = 28/154 (18%)
Query: 2 HRKCMFLIYEYMEMGSLFCVLR------TDE-------EAVGLDWAKRVNIVKGMAHALS 48
HR ++L EY G+L LR TD A L + ++ +A +
Sbjct: 67 HRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMD 126
Query: 49 YLHHDCTPPIVHRDISSNNILLNLELEAFVADFGVARLLNFDSSNRTLLAGTYG-----Y 103
YL +HRD+++ NIL+ A +ADFG++R + T G +
Sbjct: 127 YLSQK---QFIHRDLAARNILVGENYVAKIADFGLSR------GQEVYVKKTMGRLPVRW 177
Query: 104 IAPELAYTMVVTEKSDVYSFGVVALEVL-MGKHP 136
+A E V T SDV+S+GV+ E++ +G P
Sbjct: 178 MAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTP 211
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 44.9 bits (106), Expect = 3e-06
Identities = 39/135 (28%), Positives = 63/135 (46%), Gaps = 9/135 (6%)
Query: 8 LIYEYMEMGSLFCVL---RTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDIS 64
+I +M+ G L L R EE L V + +A + YL + +HRD++
Sbjct: 84 VILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLS---SKNFIHRDLA 140
Query: 65 SNNILLNLELEAFVADFGVARLLNFDSSNRTLLAGTY--GYIAPELAYTMVVTEKSDVYS 122
+ N +LN + VADFG+++ + R A ++A E V T SDV++
Sbjct: 141 ARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWA 200
Query: 123 FGVVALEVL-MGKHP 136
FGV E++ G+ P
Sbjct: 201 FGVTMWEIMTRGQTP 215
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 44.8 bits (106), Expect = 3e-06
Identities = 29/77 (37%), Positives = 43/77 (55%), Gaps = 4/77 (5%)
Query: 59 VHRDISSNNILLNLELEAFVADFGVARLL---NFDS-SNRTLLAGTYGYIAPELAYTMVV 114
VHRD+++ N +L+ VADFG+AR + + S N T ++A E T
Sbjct: 120 VHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALESLQTQKF 179
Query: 115 TEKSDVYSFGVVALEVL 131
T KSDV+SFGV+ E++
Sbjct: 180 TTKSDVWSFGVLLWELM 196
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 44.9 bits (106), Expect = 3e-06
Identities = 30/97 (30%), Positives = 50/97 (51%), Gaps = 7/97 (7%)
Query: 39 IVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADFGVARLLNFDSSNRTLLA 98
+V M L Y+H + I+HRD+ N+ +N + E + DFG+AR + + + +
Sbjct: 122 LVYQMLCGLKYIH---SAGIIHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVV-- 176
Query: 99 GTYGYIAPELAYT-MVVTEKSDVYSFGVVALEVLMGK 134
T Y APE+ M + D++S G + E+L GK
Sbjct: 177 -TRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGK 212
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 3e-06
Identities = 38/152 (25%), Positives = 69/152 (45%), Gaps = 24/152 (15%)
Query: 2 HRKCMFLIYEYMEMGSLFCVLR------TD-----EEAVGLDWAKRVNIVKGMAHALSYL 50
+R +++ EY G+L LR TD E + +++ + + +
Sbjct: 74 NRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQ-QLLQFASDVATGM 132
Query: 51 HHDCTPPIVHRDISSNNILLNLELEAFVADFGVARLLNFDSSNRTLLAGTYG-----YIA 105
+ +HRD+++ N+L+ L + +ADFG++R + T G ++A
Sbjct: 133 QYLSEKQFIHRDLAARNVLVGENLASKIADFGLSR------GEEVYVKKTMGRLPVRWMA 186
Query: 106 PELAYTMVVTEKSDVYSFGVVALEVL-MGKHP 136
E V T KSDV+SFGV+ E++ +G P
Sbjct: 187 IESLNYSVYTTKSDVWSFGVLLWEIVSLGGTP 218
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 3e-06
Identities = 38/139 (27%), Positives = 63/139 (45%), Gaps = 14/139 (10%)
Query: 2 HRKCMFLIYEYMEMGSLFCVLRTD----EEAVGLDWAKRVNIVKGMAHALSYLHHDCTPP 57
H + F++ EY G LF L + E+ A+ V+ AL YLH +
Sbjct: 67 HDRLCFVM-EYANGGELFFHLSRERVFSEDRARFYGAEIVS-------ALDYLHSE--KN 116
Query: 58 IVHRDISSNNILLNLELEAFVADFGVARLLNFDSSNRTLLAGTYGYIAPELAYTMVVTEK 117
+V+RD+ N++L+ + + DFG+ + D + GT Y+APE+
Sbjct: 117 VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRA 176
Query: 118 SDVYSFGVVALEVLMGKHP 136
D + GVV E++ G+ P
Sbjct: 177 VDWWGLGVVMYEMMCGRLP 195
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 44.7 bits (106), Expect = 3e-06
Identities = 32/95 (33%), Positives = 48/95 (50%), Gaps = 13/95 (13%)
Query: 47 LSYLHHDCTPPIVHRDISSNNILLNLELEAFVADFGVARLLNFDSSNRTLLAGTYGYIAP 106
L Y+H + ++HRD+ +N+LLN + + DFG+AR + T T Y AP
Sbjct: 121 LKYIH---SANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDFMTEYVVTRWYRAP 177
Query: 107 EL-----AYTMVVTEKSDVYSFGVVALEVLMGKHP 136
EL YT + DV+S G + E L+G+ P
Sbjct: 178 ELLLNCSEYTTAI----DVWSVGCIFAE-LLGRKP 207
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 4e-06
Identities = 41/139 (29%), Positives = 68/139 (48%), Gaps = 9/139 (6%)
Query: 3 RKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRD 62
R ++L++EY+E L + +E G+ K + + + A+ + H + IVHRD
Sbjct: 72 RGKLYLVFEYVEKNMLELL---EEMPNGVPPEKVRSYIYQLIKAIHWCHKN---DIVHRD 125
Query: 63 ISSNNILLNLELEAFVADFGVARLLNFDS-SNRTLLAGTYGYIAPELAYTMVVTEKSDVY 121
I N+L++ + DFG AR L+ S +N T T Y +PEL + D++
Sbjct: 126 IKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELLLGAPYGKAVDMW 185
Query: 122 SFGVVALEVLMGK--HPGE 138
S G + E+ G+ PGE
Sbjct: 186 SVGCILGELSDGQPLFPGE 204
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 44.6 bits (106), Expect = 4e-06
Identities = 31/114 (27%), Positives = 55/114 (48%), Gaps = 12/114 (10%)
Query: 3 RKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRD 62
R ++++ YM+ L +L + +V L ++ + + ++YLH + I+HRD
Sbjct: 87 RGSVYMVTPYMD-HDLSGLL--ENPSVKLTESQIKCYMLQLLEGINYLHEN---HILHRD 140
Query: 63 ISSNNILLNLELEAFVADFGVARLLNFDSSNRTLLAGTYGYIAPELAYT-MVVT 115
I + NIL++ + +ADFG+AR + N G YT +VVT
Sbjct: 141 IKAANILIDNQGILKIADFGLARPYDGPPPN-----PKGGGGGGTRKYTNLVVT 189
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 4e-06
Identities = 28/91 (30%), Positives = 45/91 (49%), Gaps = 3/91 (3%)
Query: 46 ALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADFGVARLLNFDSSNRTLLAGTYGYIA 105
AL YLH + +V+RDI N++L+ + + DFG+ + D + GT Y+A
Sbjct: 107 ALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLA 163
Query: 106 PELAYTMVVTEKSDVYSFGVVALEVLMGKHP 136
PE+ D + GVV E++ G+ P
Sbjct: 164 PEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 194
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 44.4 bits (105), Expect = 5e-06
Identities = 36/142 (25%), Positives = 66/142 (46%), Gaps = 20/142 (14%)
Query: 4 KCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAK--RVNIVKGMA--HALSYLHHDCTPPIV 59
K ++++ EYM G L ++ + + WA+ +V + H++ + +
Sbjct: 116 KYLYMVMEYMPGGDLVNLMSNYD--IPEKWARFYTAEVVLALDAIHSMGF---------I 164
Query: 60 HRDISSNNILLNLELEAFVADFGVARLLNFDSSNRTLLA-GTYGYIAPELAYTMVVT--- 115
HRD+ +N+LL+ +ADFG ++ + R A GT YI+PE+ +
Sbjct: 165 HRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDTAVGTPDYISPEVLKSQGGDGYY 224
Query: 116 -EKSDVYSFGVVALEVLMGKHP 136
+ D +S GV E+L+G P
Sbjct: 225 GRECDWWSVGVFLYEMLVGDTP 246
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 44.1 bits (104), Expect = 5e-06
Identities = 46/147 (31%), Positives = 62/147 (42%), Gaps = 36/147 (24%)
Query: 6 MFLIYEYMEMGSLFC----VLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHR 61
+FL+ ++ E G L+ L EE V WA M AL LH + IV R
Sbjct: 60 VFLVLQHAEGGKLWSHISKFLNIPEECVK-RWAAE------MVVALDALHRE---GIVCR 109
Query: 62 DISSNNILLNLELEAFVADFGVARLLNF-------DSSNRTLLAGTYGYIAPELAYTMVV 114
D++ NNILL+ D G +L F DS + + Y APE+
Sbjct: 110 DLNPNNILLD--------DRGHIQLTYFSRWSEVEDSCDGEAVENMY--CAPEVGGISEE 159
Query: 115 TEKSDVYSFGVVALEVLMGK-----HP 136
TE D +S G + E+L GK HP
Sbjct: 160 TEACDWWSLGAILFELLTGKTLVECHP 186
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 5e-06
Identities = 30/108 (27%), Positives = 54/108 (50%), Gaps = 4/108 (3%)
Query: 29 VGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADFGVARLLN 88
GL+ + ++ + + +LH + IV+RD+ N+LL+ + ++D G+A L
Sbjct: 90 RGLEMERVIHYSAQITCGILHLH---SMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELK 146
Query: 89 FDSSNRTLLAGTYGYIAPELAYTMVVTEKSDVYSFGVVALEVLMGKHP 136
D T AGT GY+APE+ + D ++ G E++ G+ P
Sbjct: 147 -DGKTITQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTP 193
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 5e-06
Identities = 36/134 (26%), Positives = 59/134 (44%), Gaps = 12/134 (8%)
Query: 6 MFLIYEYMEMGSLFCVLRTDE---EAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRD 62
++ + +Y+ G LF L+ + E +A V A A+ YLH + I++RD
Sbjct: 71 LYFVLDYVNGGELFFHLQRERCFLEPRARFYAAEV------ASAIGYLH---SLNIIYRD 121
Query: 63 ISSNNILLNLELEAFVADFGVARLLNFDSSNRTLLAGTYGYIAPELAYTMVVTEKSDVYS 122
+ NILL+ + + DFG+ + + GT Y+APE+ D +
Sbjct: 122 LKPENILLDSQGHVVLTDFGLCKEGVEPEETTSTFCGTPEYLAPEVLRKEPYDRTVDWWC 181
Query: 123 FGVVALEVLMGKHP 136
G V E+L G P
Sbjct: 182 LGAVLYEMLYGLPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 44.3 bits (104), Expect = 6e-06
Identities = 28/90 (31%), Positives = 45/90 (50%), Gaps = 7/90 (7%)
Query: 46 ALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADFGVARLLNFDSSNRTLLAGTYGYIA 105
L Y+H + I+HRD+ +N+ +N + E + DFG+AR T T Y A
Sbjct: 132 GLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEMTGYVATRWYRA 185
Query: 106 PELAYT-MVVTEKSDVYSFGVVALEVLMGK 134
PE+ M + D++S G + E+L G+
Sbjct: 186 PEIMLNWMHYNQTVDIWSVGCIMAELLTGR 215
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 43.8 bits (103), Expect = 6e-06
Identities = 38/145 (26%), Positives = 69/145 (47%), Gaps = 25/145 (17%)
Query: 5 CMFLIYEYMEMGSL--FCVLRTDEEAVG------------LDWAKRVNIVKGMAHALSYL 50
CM ++EY+ G L F ++R+ VG LD ++I +A + YL
Sbjct: 83 CM--LFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYL 140
Query: 51 HHDCTPPIVHRDISSNNILLNLELEAFVADFGVARLL----NFDSSNRTLLAGTYGYIAP 106
+ VH+D+++ NIL+ +L ++D G++R + + ++LL ++ P
Sbjct: 141 ---SSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLLP--IRWMPP 195
Query: 107 ELAYTMVVTEKSDVYSFGVVALEVL 131
E + SD++SFGVV E+
Sbjct: 196 EAIMYGKFSSDSDIWSFGVVLWEIF 220
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 43.9 bits (103), Expect = 7e-06
Identities = 38/136 (27%), Positives = 64/136 (47%), Gaps = 12/136 (8%)
Query: 6 MFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISS 65
++++ EYM G L ++ + V WA+ + AL +H + +HRD+
Sbjct: 118 LYMVMEYMPGGDLVNLMSNYD--VPEKWARFYT--AEVVLALDAIH---SMGFIHRDVKP 170
Query: 66 NNILLNLELEAFVADFGVARLLNFDSSNRTLLA-GTYGYIAPELAYTM----VVTEKSDV 120
+N+LL+ +ADFG +N + R A GT YI+PE+ + + D
Sbjct: 171 DNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDW 230
Query: 121 YSFGVVALEVLMGKHP 136
+S GV E+L+G P
Sbjct: 231 WSVGVFLYEMLVGDTP 246
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 43.7 bits (103), Expect = 8e-06
Identities = 40/142 (28%), Positives = 64/142 (45%), Gaps = 15/142 (10%)
Query: 7 FLIYEYMEMGSLFCVLR----TDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRD 62
++I E ME G L LR L + ++I +A YL +HRD
Sbjct: 75 YIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQ---MHFIHRD 131
Query: 63 ISSNNILLNLELEAF-----VADFGVARLLNFDSSNRTLLAGTYG--YIAPELAYTMVVT 115
+++ N L++ + + DFG+AR + R G ++APE T
Sbjct: 132 LAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFT 191
Query: 116 EKSDVYSFGVVALEVL-MGKHP 136
+SDV+SFGV+ E+L +G+ P
Sbjct: 192 TQSDVWSFGVLMWEILTLGQQP 213
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 43.8 bits (104), Expect = 8e-06
Identities = 27/93 (29%), Positives = 48/93 (51%), Gaps = 7/93 (7%)
Query: 46 ALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADFGVARLLNFDSSNRTLLA---GTYG 102
L Y+H + ++HRD+ +N+LLN + + DFG+AR+ + + + L T
Sbjct: 118 GLKYIH---SANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVATRW 174
Query: 103 YIAPELAYTMVVTEKS-DVYSFGVVALEVLMGK 134
Y APE+ K+ D++S G + E+L +
Sbjct: 175 YRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNR 207
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 8e-06
Identities = 29/94 (30%), Positives = 46/94 (48%), Gaps = 6/94 (6%)
Query: 46 ALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADFGVARLLN---FDSSNRTLLAGTYG 102
+SYLH + IVHRDI NIL + + DFG ++ L + + GT
Sbjct: 118 GVSYLHSNM---IVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPY 174
Query: 103 YIAPELAYTMVVTEKSDVYSFGVVALEVLMGKHP 136
+++PE+ K+D++S G +E+L K P
Sbjct: 175 WMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 43.2 bits (102), Expect = 9e-06
Identities = 39/135 (28%), Positives = 60/135 (44%), Gaps = 16/135 (11%)
Query: 7 FLIYEYMEMGSLFCVLR----TDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRD 62
F++ E M G L LR E L + + +A YL +HRD
Sbjct: 85 FILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLE---ENHFIHRD 141
Query: 63 ISSNNILLNLELE---AFVADFGVARLLN----FDSSNRTLLAGTYGYIAPELAYTMVVT 115
I++ N LL + A +ADFG+AR + + R +L ++ PE + T
Sbjct: 142 IAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAMLP--IKWMPPEAFLDGIFT 199
Query: 116 EKSDVYSFGVVALEV 130
K+DV+SFGV+ E+
Sbjct: 200 SKTDVWSFGVLLWEI 214
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 43.2 bits (102), Expect = 1e-05
Identities = 37/132 (28%), Positives = 64/132 (48%), Gaps = 8/132 (6%)
Query: 6 MFLIYEYMEMGSLFCVLRTDEEAVGL-DWAKRVNIVKGMAHALSYLHHDCTPPIVHRDIS 64
++LI EY+ G LF L + E + + D A + ++ AL +LH I++RD+
Sbjct: 75 LYLILEYLSGGELFMHL--EREGIFMEDTACFY--LSEISLALEHLHQQ---GIIYRDLK 127
Query: 65 SNNILLNLELEAFVADFGVARLLNFDSSNRTLLAGTYGYIAPELAYTMVVTEKSDVYSFG 124
NILL+ + + DFG+ + + + GT Y+APE+ + D +S G
Sbjct: 128 PENILLDAQGHVKLTDFGLCKESIHEGTVTHTFCGTIEYMAPEILMRSGHGKAVDWWSLG 187
Query: 125 VVALEVLMGKHP 136
+ ++L G P
Sbjct: 188 ALMYDMLTGAPP 199
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 43.0 bits (101), Expect = 1e-05
Identities = 26/80 (32%), Positives = 42/80 (52%), Gaps = 3/80 (3%)
Query: 58 IVHRDISSNNILLNLELEAFVADFGVARLLNFDSSNRTLLAGTYGYIAPELAYTMVVTEK 117
+V+RD+ NILL+ ++D G+A +F GT+GY+APE+ V +
Sbjct: 118 VVYRDLKPANILLDEHGHVRISDLGLA--CDFSKKKPHASVGTHGYMAPEVLQKGVAYDS 175
Query: 118 S-DVYSFGVVALEVLMGKHP 136
S D +S G + ++L G P
Sbjct: 176 SADWFSLGCMLFKLLRGHSP 195
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 1e-05
Identities = 37/144 (25%), Positives = 70/144 (48%), Gaps = 24/144 (16%)
Query: 6 MFLIYEYMEMGSL--FCVLRTDEEAVG-----------LDWAKRVNIVKGMAHALSYL-- 50
+ +I+ Y L F V+R+ VG L+ A V+IV +A + +L
Sbjct: 83 LSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSS 142
Query: 51 HHDCTPPIVHRDISSNNILLNLELEAFVADFGVARLLNFDSSNRTLLAGTY---GYIAPE 107
HH +VH+D+++ N+L+ +L ++D G+ R + + + L+ + +++PE
Sbjct: 143 HH-----VVHKDLATRNVLVFDKLNVKISDLGLFREV-YAADYYKLMGNSLLPIRWMSPE 196
Query: 108 LAYTMVVTEKSDVYSFGVVALEVL 131
+ SD++S+GVV EV
Sbjct: 197 AIMYGKFSIDSDIWSYGVVLWEVF 220
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 43.2 bits (102), Expect = 1e-05
Identities = 38/137 (27%), Positives = 62/137 (45%), Gaps = 17/137 (12%)
Query: 3 RKCMFLIYEYMEMGSLFCVLRTDEEAV-GLDWAKRVNIVKGMAHALSYLHHDCTPPIVHR 61
+K ++L++E+++ VL E+ GLD ++ + + + + H I+HR
Sbjct: 72 KKRLYLVFEFVD----HTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSH---NIIHR 124
Query: 62 DISSNNILLNLELEAFVADFGVARLLNFDSSNRTLLAGTYGYIAPEL-----AYTMVVTE 116
DI NIL++ + DFG AR L T T Y APEL Y V
Sbjct: 125 DIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTDYVATRWYRAPELLVGDTKYGRAV-- 182
Query: 117 KSDVYSFGVVALEVLMG 133
D+++ G + E+L G
Sbjct: 183 --DIWAVGCLVTEMLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 43.3 bits (102), Expect = 1e-05
Identities = 38/119 (31%), Positives = 57/119 (47%), Gaps = 15/119 (12%)
Query: 31 LDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADFGVARLLNFD 90
L A+ + + + A+ Y+H + I+HRDI + N+L+N + + DFG A
Sbjct: 257 LGLAQVTAVARQLLSAIDYIHGE---GIIHRDIKTENVLVNGPEDICLGDFGAACFARGS 313
Query: 91 SSNRTL--LAGTYGYIAPE-LA---YTMVVTEKSDVYSFGVVALEVLMGKHPGELLSSS 143
S +AGT APE LA YT V D++S G+V E + H L S+S
Sbjct: 314 WSTPFHYGIAGTVDTNAPEVLAGDPYTPSV----DIWSAGLVIFEAAV--HTASLFSAS 366
|
Length = 461 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 42.9 bits (101), Expect = 1e-05
Identities = 39/150 (26%), Positives = 67/150 (44%), Gaps = 28/150 (18%)
Query: 4 KCMFLIYEYMEMGSLFCVLRT-------------------DEEAVGLDWAKRVNIVKGMA 44
K M L++EYM G L LR + L +++ I K +A
Sbjct: 81 KPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVA 140
Query: 45 HALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADFGVARLLNFDSSNRTLLAGT---- 100
++YL VHRD+++ N L+ + +ADFG++R N S++ +
Sbjct: 141 AGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGLSR--NIYSADYYKASENDAIP 195
Query: 101 YGYIAPELAYTMVVTEKSDVYSFGVVALEV 130
++ PE + T +SDV+++GVV E+
Sbjct: 196 IRWMPPESIFYNRYTTESDVWAYGVVLWEI 225
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 1e-05
Identities = 26/86 (30%), Positives = 45/86 (52%), Gaps = 4/86 (4%)
Query: 46 ALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADFGVARLLNFDSSNRTLLAGTYGYIA 105
L +LH + +VHRD+ NIL+ + +ADFG+AR+ +F + +++ T Y A
Sbjct: 122 GLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVV-TLWYRA 177
Query: 106 PELAYTMVVTEKSDVYSFGVVALEVL 131
PE+ D++S G + E+
Sbjct: 178 PEVLLQSSYATPVDLWSVGCIFAEMF 203
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 1e-05
Identities = 36/133 (27%), Positives = 61/133 (45%), Gaps = 12/133 (9%)
Query: 7 FLIYEYMEMGSLFCVLRT---DEEAVGL----DWAKRVNIVKGMAHALSYLHHDCTPPIV 59
+I E M G L LR+ + E + K + + +A ++YL+ + V
Sbjct: 85 LVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNAN---KFV 141
Query: 60 HRDISSNNILLNLELEAFVADFGVARLLNFDSSNRTLLAGTYG--YIAPELAYTMVVTEK 117
HRD+++ N ++ + + DFG+ R + R G +++PE V T
Sbjct: 142 HRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTY 201
Query: 118 SDVYSFGVVALEV 130
SDV+SFGVV E+
Sbjct: 202 SDVWSFGVVLWEI 214
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 42.9 bits (101), Expect = 2e-05
Identities = 29/102 (28%), Positives = 52/102 (50%), Gaps = 11/102 (10%)
Query: 46 ALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADFGVARLLNFDSSNRTLLAGTYGYIA 105
AL++LH I++RD+ +N+LL+ E + D+G+ + + GT YIA
Sbjct: 108 ALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTSTFCGTPNYIA 164
Query: 106 PEL----AYTMVVTEKSDVYSFGVVALEVLMGKHPGELLSSS 143
PE+ Y V D ++ GV+ E++ G+ P +++ S
Sbjct: 165 PEILRGEDYGFSV----DWWALGVLMFEMMAGRSPFDIVGMS 202
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 2e-05
Identities = 42/149 (28%), Positives = 65/149 (43%), Gaps = 16/149 (10%)
Query: 5 CMFLIYEYMEMGSLFCVLRTDE------EAVGLDWAKRVNIVKGMAHALSYLHHDCTPPI 58
CM I EYME G L L E A + N++ S + + +
Sbjct: 93 CM--ITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNF 150
Query: 59 VHRDISSNNILLNLELEAFVADFGVARLLNFDSSNRTLLAGTYGYIAPELAYTMVV---- 114
VHRD+++ N L+ +ADFG++R N S + + G +A+ ++
Sbjct: 151 VHRDLATRNCLVGNHYTIKIADFGMSR--NLYSGDYYRIQGRAVLPIRWMAWESILLGKF 208
Query: 115 TEKSDVYSFGVVALEV--LMGKHPGELLS 141
T SDV++FGV E+ L + P LLS
Sbjct: 209 TTASDVWAFGVTLWEMFTLCKEQPYSLLS 237
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 2e-05
Identities = 39/138 (28%), Positives = 65/138 (47%), Gaps = 12/138 (8%)
Query: 4 KCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDI 63
K ++++ EYM G L ++ + V WAK + AL +H + ++HRD+
Sbjct: 116 KYLYMVMEYMPGGDLVNLMSNYD--VPEKWAKFYT--AEVVLALDAIH---SMGLIHRDV 168
Query: 64 SSNNILLNLELEAFVADFGVARLLNFDSSNRTLLA-GTYGYIAPELAYTM----VVTEKS 118
+N+LL+ +ADFG ++ R A GT YI+PE+ + +
Sbjct: 169 KPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGREC 228
Query: 119 DVYSFGVVALEVLMGKHP 136
D +S GV E+L+G P
Sbjct: 229 DWWSVGVFLFEMLVGDTP 246
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 2e-05
Identities = 23/89 (25%), Positives = 42/89 (47%)
Query: 48 SYLHHDCTPPIVHRDISSNNILLNLELEAFVADFGVARLLNFDSSNRTLLAGTYGYIAPE 107
S + H + ++HRDI N+ + + D G+ R + ++ L GT Y++PE
Sbjct: 117 SAVEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPE 176
Query: 108 LAYTMVVTEKSDVYSFGVVALEVLMGKHP 136
+ KSD++S G + E+ + P
Sbjct: 177 RIHENGYNFKSDIWSLGCLLYEMAALQSP 205
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 2e-05
Identities = 25/80 (31%), Positives = 41/80 (51%), Gaps = 3/80 (3%)
Query: 58 IVHRDISSNNILLNLELEAFVADFGVARLLNFDSSNRTLLAGTYGYIAPELAYTMVVTEK 117
+V+RD+ NILL+ ++D G+A +F GT+GY+APE+ +
Sbjct: 118 VVYRDLKPANILLDEHGHVRISDLGLA--CDFSKKKPHASVGTHGYMAPEVLQKGTAYDS 175
Query: 118 S-DVYSFGVVALEVLMGKHP 136
S D +S G + ++L G P
Sbjct: 176 SADWFSLGCMLFKLLRGHSP 195
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 42.5 bits (100), Expect = 2e-05
Identities = 32/130 (24%), Positives = 61/130 (46%), Gaps = 5/130 (3%)
Query: 6 MFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISS 65
+ L++EYM+ L + T LD + + +++ H + ++HRD+
Sbjct: 73 LMLVFEYMD-KDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHEN---RVLHRDLKP 128
Query: 66 NNILLNLELEAFVADFGVARLLNFDSSNRTLLAGTYGYIAPE-LAYTMVVTEKSDVYSFG 124
N+L+N E +ADFG+AR + + T Y AP+ L + + D++S G
Sbjct: 129 QNLLINKRGELKLADFGLARAFGIPVNTFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVG 188
Query: 125 VVALEVLMGK 134
+ E++ G+
Sbjct: 189 CIMAEMITGR 198
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 42.5 bits (100), Expect = 2e-05
Identities = 27/91 (29%), Positives = 45/91 (49%), Gaps = 3/91 (3%)
Query: 46 ALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADFGVARLLNFDSSNRTLLAGTYGYIA 105
AL YLH + +V+RD+ N++L+ + + DFG+ + D + GT Y+A
Sbjct: 107 ALGYLH---SCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLA 163
Query: 106 PELAYTMVVTEKSDVYSFGVVALEVLMGKHP 136
PE+ D + GVV E++ G+ P
Sbjct: 164 PEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 194
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 2e-05
Identities = 28/83 (33%), Positives = 46/83 (55%), Gaps = 7/83 (8%)
Query: 59 VHRDISSNNILLNLELEAFVADFGVARLL----NFDSSNRTLLAGTYGYIAPELAYTMVV 114
VHRD+++ N+L+ + DFG+AR + N+ S T L ++APE + +
Sbjct: 261 VHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLP--LKWMAPESIFNNLY 318
Query: 115 TEKSDVYSFGVVALEVL-MGKHP 136
T SDV+SFG++ E+ +G P
Sbjct: 319 TTLSDVWSFGILLWEIFTLGGTP 341
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 2e-05
Identities = 30/92 (32%), Positives = 44/92 (47%), Gaps = 12/92 (13%)
Query: 45 HALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADFGVARLLNFDSSNRTLLAGTYGYI 104
L YLH +HRDI NILL +ADFGV+ + + R GT ++
Sbjct: 117 QGLYYLHSKGK---MHRDIKGANILLTDNGHVKLADFGVSAQITATIAKRKSFIGTPYWM 173
Query: 105 APELAYTMVVTEKS------DVYSFGVVALEV 130
APE+A V K D+++ G+ A+E+
Sbjct: 174 APEVA---AVERKGGYNQLCDIWAVGITAIEL 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 42.1 bits (100), Expect = 3e-05
Identities = 33/146 (22%), Positives = 66/146 (45%), Gaps = 33/146 (22%)
Query: 3 RKCMFLIYEYMEMGSLFCVLRT------DEEAVGLDWAKRVNIVKGMAHALSYLHHDCTP 56
++ ++EYME G+L+ +++ E + +I+ + L+++H
Sbjct: 70 NDELYFVFEYME-GNLYQLMKDRKGKPFSESVIR-------SIIYQILQGLAHIHKH--- 118
Query: 57 PIVHRDISSNNILLNLELEAFVADFGVARLLNFDSSNR---TLLAGTYGYIAPEL----- 108
HRD+ N+L++ +ADFG+AR + +R T T Y APE+
Sbjct: 119 GFFHRDLKPENLLVSGPEVVKIADFGLAR----EIRSRPPYTDYVSTRWYRAPEILLRST 174
Query: 109 AYTMVVTEKSDVYSFGVVALEVLMGK 134
+Y+ V D+++ G + E+ +
Sbjct: 175 SYSSPV----DIWALGCIMAELYTLR 196
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 41.8 bits (98), Expect = 3e-05
Identities = 34/138 (24%), Positives = 59/138 (42%), Gaps = 22/138 (15%)
Query: 8 LIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAH----ALSYLHHDCTPPIVHRDI 63
L+ E+ +G L LR++ V K V ++ MA L +LH +H D+
Sbjct: 72 LVLEFCPLGDLKNYLRSNRGMVAQMAQKDV--LQRMACEVASGLLWLHQA---DFIHSDL 126
Query: 64 SSNNILLNLELEAFVADFGVA----RLLNFDSSNRTLLAGTYGYIAPELA-------YTM 112
+ N L +L + D+G+A + + + A ++APEL
Sbjct: 127 ALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDC--HAVPLRWLAPELVEIRGQDLLPK 184
Query: 113 VVTEKSDVYSFGVVALEV 130
T+KS+++S GV E+
Sbjct: 185 DQTKKSNIWSLGVTMWEL 202
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 3e-05
Identities = 29/107 (27%), Positives = 51/107 (47%), Gaps = 4/107 (3%)
Query: 30 GLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADFGVARLLNF 89
G + + V + L LH + IV+RD+ NILL+ ++D G+A +
Sbjct: 98 GFEEGRAVFYAAEICCGLEDLHQE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPE 154
Query: 90 DSSNRTLLAGTYGYIAPELAYTMVVTEKSDVYSFGVVALEVLMGKHP 136
+ + + GT GY+APE+ T D ++ G + E++ G+ P
Sbjct: 155 GQTIKGRV-GTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 42.1 bits (99), Expect = 3e-05
Identities = 30/94 (31%), Positives = 45/94 (47%), Gaps = 3/94 (3%)
Query: 43 MAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADFGVARLLNFDSSNRTLLAGTYG 102
+A AL YLH + I++RD+ NILL+ + + DFG+ + S + GT
Sbjct: 105 IASALGYLH---SLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTSTFCGTPE 161
Query: 103 YIAPELAYTMVVTEKSDVYSFGVVALEVLMGKHP 136
Y+APE+ D + G V E+L G P
Sbjct: 162 YLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 4e-05
Identities = 28/95 (29%), Positives = 45/95 (47%), Gaps = 6/95 (6%)
Query: 45 HALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADFGVARLLN---FDSSNRTLLAGTY 101
+SYLH + IVHRDI NIL + + DFG ++ + + + GT
Sbjct: 117 QGVSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTP 173
Query: 102 GYIAPELAYTMVVTEKSDVYSFGVVALEVLMGKHP 136
+++PE+ K+DV+S +E+L K P
Sbjct: 174 YWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 4e-05
Identities = 40/146 (27%), Positives = 69/146 (47%), Gaps = 20/146 (13%)
Query: 6 MFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISS 65
++++ E ++ G LRT E L + + +V+ A + YL +HRD+++
Sbjct: 68 IYIVMELVQGGDFLTFLRT--EGPRLKVKELIQMVENAAAGMEYLESKHC---IHRDLAA 122
Query: 66 NNILLNLELEAFVADFGVARLLNFDSSNRTLLAGTYG-------YIAPE-LAYTMVVTEK 117
N L+ + ++DFG++R + A T G + APE L Y +E
Sbjct: 123 RNCLVTEKNVLKISDFGMSR-----EEEDGVYASTGGMKQIPVKWTAPEALNYGRYSSE- 176
Query: 118 SDVYSFGVVALEVL-MGKHPGELLSS 142
SDV+SFG++ E +G P LS+
Sbjct: 177 SDVWSFGILLWEAFSLGAVPYANLSN 202
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 41.6 bits (97), Expect = 5e-05
Identities = 33/128 (25%), Positives = 62/128 (48%), Gaps = 10/128 (7%)
Query: 6 MFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISS 65
++L+ E M+ +L V+ + LD + ++ M + +LH + I+HRD+
Sbjct: 101 VYLVMELMD-ANLCQVIHME-----LDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKP 151
Query: 66 NNILLNLELEAFVADFGVARLLNFDSSNRTLLAGTYGYIAPELAYTMVVTEKSDVYSFGV 125
+NI++ + + DFG+AR + + Y Y APE+ M E D++S G
Sbjct: 152 SNIVVKSDCTLKILDFGLARTACTNFMMTPYVVTRY-YRAPEVILGMGYKENVDIWSVGC 210
Query: 126 VALEVLMG 133
+ E++ G
Sbjct: 211 IMGELVKG 218
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 41.2 bits (96), Expect = 5e-05
Identities = 24/89 (26%), Positives = 42/89 (47%)
Query: 48 SYLHHDCTPPIVHRDISSNNILLNLELEAFVADFGVARLLNFDSSNRTLLAGTYGYIAPE 107
S L H + ++HRDI N+ + + D G+ R + ++ L GT Y++PE
Sbjct: 117 SALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPE 176
Query: 108 LAYTMVVTEKSDVYSFGVVALEVLMGKHP 136
+ KSD++S G + E+ + P
Sbjct: 177 RIHENGYNFKSDIWSLGCLLYEMAALQSP 205
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 41.1 bits (96), Expect = 6e-05
Identities = 35/133 (26%), Positives = 65/133 (48%), Gaps = 7/133 (5%)
Query: 6 MFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISS 65
M ++ EYM G+L LR E L + + ++ G+A + YL VH+ +++
Sbjct: 81 MMIVTEYMSNGALDSFLRKHEGQ--LVAGQLMGMLPGLASGMKYLSE---MGYVHKGLAA 135
Query: 66 NNILLNLELEAFVADFGVARLLNFDSSNRTLLAGTYG-YIAPELAYTMVVTEKSDVYSFG 124
+ +L+N +L ++ F + ++ T+ + + APE + SDV+SFG
Sbjct: 136 HKVLVNSDLVCKISGFRRLQEDKSEAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFG 195
Query: 125 VVALEVL-MGKHP 136
+V EV+ G+ P
Sbjct: 196 IVMWEVMSYGERP 208
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 40.9 bits (96), Expect = 6e-05
Identities = 24/87 (27%), Positives = 42/87 (48%), Gaps = 3/87 (3%)
Query: 43 MAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADFGVARLLNFDSSNRTLLAGTYG 102
+ AL ++H + I+HRDI N+ + + D G+ R + ++ L GT
Sbjct: 115 LCSALEHMH---SKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPY 171
Query: 103 YIAPELAYTMVVTEKSDVYSFGVVALE 129
Y++PE + KSD++S G + E
Sbjct: 172 YMSPERIHENGYNFKSDIWSLGCLLYE 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 41.0 bits (96), Expect = 6e-05
Identities = 37/146 (25%), Positives = 62/146 (42%), Gaps = 33/146 (22%)
Query: 5 CMFLIYEYMEMGSL---FCVLR-----TDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTP 56
CM I EYME G L + V + ++ + + +A + YL +
Sbjct: 95 CM--ITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLS---SL 149
Query: 57 PIVHRDISSNNILLNLELEAFVADFGVARLLNFDSSNRTLLAGTYGYIAPE-------LA 109
VHRD+++ N L+ +ADFG++ R L +G Y I ++
Sbjct: 150 NFVHRDLATRNCLVGKNYTIKIADFGMS---------RNLYSGDYYRIQGRAVLPIRWMS 200
Query: 110 YTMVV----TEKSDVYSFGVVALEVL 131
+ ++ T SDV++FGV E+L
Sbjct: 201 WESILLGKFTTASDVWAFGVTLWEIL 226
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 40.7 bits (95), Expect = 7e-05
Identities = 28/91 (30%), Positives = 44/91 (48%), Gaps = 4/91 (4%)
Query: 46 ALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADFGVARLLNFDSSNRTLLAGTYGYIA 105
L LH + V+RD+ NILL+ ++D G+A + S R + GT GY+A
Sbjct: 114 GLEDLHRE---NTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGESIRGRV-GTVGYMA 169
Query: 106 PELAYTMVVTEKSDVYSFGVVALEVLMGKHP 136
PE+ T D + G + E++ G+ P
Sbjct: 170 PEVLNNQRYTLSPDYWGLGCLIYEMIEGQSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 40.7 bits (96), Expect = 7e-05
Identities = 38/133 (28%), Positives = 64/133 (48%), Gaps = 17/133 (12%)
Query: 4 KCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRV-NIVKGMAHALSYLHHDCTPPIVHRD 62
+ L++E M+M +L+ +++ + + KRV + + + +L ++H + I HRD
Sbjct: 73 GRLALVFELMDM-NLYELIKGRKRPLP---EKRVKSYMYQLLKSLDHMHRN---GIFHRD 125
Query: 63 ISSNNILLN---LELEAFVADFGVARLLNFDSSNRTLLAGTYGYIAPELAYTM-VVTEKS 118
I NIL+ L+L ADFG R + + T T Y APE T K
Sbjct: 126 IKPENILIKDDILKL----ADFGSCRGI-YSKPPYTEYISTRWYRAPECLLTDGYYGPKM 180
Query: 119 DVYSFGVVALEVL 131
D+++ G V E+L
Sbjct: 181 DIWAVGCVFFEIL 193
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 40.8 bits (95), Expect = 8e-05
Identities = 31/97 (31%), Positives = 47/97 (48%), Gaps = 13/97 (13%)
Query: 46 ALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADFGVARL------LNFDSSNRTLLAG 99
AL +H ++HRD+ S NI L + DFG ++ L+ SS G
Sbjct: 181 ALDEVHSRK---MMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASS----FCG 233
Query: 100 TYGYIAPELAYTMVVTEKSDVYSFGVVALEVLMGKHP 136
T Y+APEL ++K+D++S GV+ E+L P
Sbjct: 234 TPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRP 270
|
Length = 478 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 40.7 bits (95), Expect = 8e-05
Identities = 27/91 (29%), Positives = 48/91 (52%), Gaps = 8/91 (8%)
Query: 47 LSYLHHDCTPPIVHRDISSNNILLNLELEAFVADFGVARLLNFDSSNRTLLAGTYGYIAP 106
L+Y+H I+HRD+ N+L++ E +ADFG+AR + S + T Y P
Sbjct: 116 LAYIHGQ---HILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVVTLWYRPP 172
Query: 107 ELAYTMVVTEKS---DVYSFGVVALEVLMGK 134
++ + T+ S D++ G + +E+L G+
Sbjct: 173 DV--LLGATDYSSALDIWGAGCIFIEMLQGQ 201
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 40.5 bits (95), Expect = 8e-05
Identities = 33/140 (23%), Positives = 59/140 (42%), Gaps = 12/140 (8%)
Query: 8 LIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLH-HDCTPPIVHRDISSN 66
LI EY G L VL +++ L + ++++ L L+ + P +++++S
Sbjct: 99 LILEYCTRGYLREVLDKEKD---LSFKTKLDMAIDCCKGLYNLYKYTNKP---YKNLTSV 152
Query: 67 NILLNLELEAFVADFGVARLLNFDSSNRTLLAGTYGYIAPELAYTMV--VTEKSDVYSFG 124
+ L+ E + L SS Y + ++ + T K D+YS G
Sbjct: 153 SFLVT---ENYKLKIICHGLEKILSSPPFKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLG 209
Query: 125 VVALEVLMGKHPGELLSSSS 144
VV E+ GK P E L++
Sbjct: 210 VVLWEIFTGKIPFENLTTKE 229
|
Length = 283 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 40.8 bits (95), Expect = 8e-05
Identities = 28/104 (26%), Positives = 49/104 (47%), Gaps = 4/104 (3%)
Query: 31 LDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADFGVARLLNFD 90
LD + ++ M + +LH + I+HRD+ +NI++ + + DFG+AR
Sbjct: 123 LDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS 179
Query: 91 SSNRTLLAGTYGYIAPELAYTMVVTEKSDVYSFGVVALEVLMGK 134
+ Y Y APE+ M E D++S G + E++ G
Sbjct: 180 FMMTPYVVTRY-YRAPEVILGMGYKENVDIWSVGCIMGEMIKGG 222
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 40.7 bits (95), Expect = 9e-05
Identities = 40/139 (28%), Positives = 66/139 (47%), Gaps = 26/139 (18%)
Query: 4 KCMFLIYEYMEMGSLFCVLRTDEEAVG--LDWAKRVNIVKGMAHALSYLHHDCTPPIVHR 61
K + LI EY+ +GSL L + + L +A++ I +GMA YLH + +HR
Sbjct: 81 KGLQLIMEYVPLGSLRDYLPKHKLNLAQLLLFAQQ--ICEGMA----YLH---SQHYIHR 131
Query: 62 DISSNNILLNLELEAFVADFGVARLL---------NFDSSNRTLLAGTYGYIAPELAYTM 112
D+++ N+LL+ + + DFG+A+ + D + + A E
Sbjct: 132 DLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVF------WYAVECLKEN 185
Query: 113 VVTEKSDVYSFGVVALEVL 131
+ SDV+SFGV E+L
Sbjct: 186 KFSYASDVWSFGVTLYELL 204
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 40.5 bits (95), Expect = 1e-04
Identities = 39/144 (27%), Positives = 70/144 (48%), Gaps = 23/144 (15%)
Query: 7 FLIYEYMEMGSLFCVLRTDEEAVG-----LDWAKRVNIVKGMAHALSYLHHDCTPPIVHR 61
F++Y YM G+L L+ L + V++ +A +SYLH ++H+
Sbjct: 85 FVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLH---KRGVIHK 141
Query: 62 DISSNNILLNLELEAFVADFGVARLLNF--------DSSNRTLLAGTYGYIAPELAYTMV 113
DI++ N +++ EL+ + D ++R L F D+ NR + ++A E
Sbjct: 142 DIAARNCVIDEELQVKITDNALSRDL-FPMDYHCLGDNENRPV-----KWMALESLVNKE 195
Query: 114 VTEKSDVYSFGVVALE-VLMGKHP 136
+ SDV+SFGV+ E + +G+ P
Sbjct: 196 YSSASDVWSFGVLLWELMTLGQTP 219
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 40.4 bits (94), Expect = 1e-04
Identities = 25/79 (31%), Positives = 41/79 (51%), Gaps = 1/79 (1%)
Query: 58 IVHRDISSNNILLNLELEAFVADFGVARLLNFDSSNRTLLAGTYGYIAPELAYTMVVTEK 117
IV+RD+ NILL+ ++D G+A + + R + GT GY+APE+ T
Sbjct: 123 IVYRDLKPENILLDDRGHIRISDLGLAVQIPEGETVRGRV-GTVGYMAPEVINNEKYTFS 181
Query: 118 SDVYSFGVVALEVLMGKHP 136
D + G + E++ G+ P
Sbjct: 182 PDWWGLGCLIYEMIQGQSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 40.5 bits (95), Expect = 1e-04
Identities = 28/92 (30%), Positives = 45/92 (48%), Gaps = 4/92 (4%)
Query: 43 MAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADFGVARLLNFDSSNRTLLAGTYG 102
M + +LH + I+HRD+ +NI++ + + DFG+AR S T T
Sbjct: 127 MLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG-TSFMMTPYVVTRY 182
Query: 103 YIAPELAYTMVVTEKSDVYSFGVVALEVLMGK 134
Y APE+ M E D++S G + E++ G
Sbjct: 183 YRAPEVILGMGYKENVDIWSVGCIMGEMIRGT 214
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 40.5 bits (95), Expect = 1e-04
Identities = 30/98 (30%), Positives = 49/98 (50%), Gaps = 16/98 (16%)
Query: 46 ALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADFGVARLLNFD----SSNRTLLAGTY 101
L Y+H + ++HRD+ N+L+N + E + DFG+AR + + + T T
Sbjct: 117 GLKYIH---SANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVATR 173
Query: 102 GYIAPEL-----AYTMVVTEKSDVYSFGVVALEVLMGK 134
Y APE+ +YT + DV+S G + E+L K
Sbjct: 174 WYRAPEIMLSFQSYTKAI----DVWSVGCILAELLGRK 207
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 40.2 bits (94), Expect = 1e-04
Identities = 31/106 (29%), Positives = 49/106 (46%), Gaps = 18/106 (16%)
Query: 46 ALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADFGVAR--LLNF---------DSSNR 94
AL YLH IVHRD+ +N+L+ + DFG+++ L++ + R
Sbjct: 113 ALEYLH---NYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTR 169
Query: 95 TLL----AGTYGYIAPELAYTMVVTEKSDVYSFGVVALEVLMGKHP 136
L GT YIAPE+ + D ++ G++ E L+G P
Sbjct: 170 EFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVP 215
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 40.3 bits (95), Expect = 1e-04
Identities = 40/150 (26%), Positives = 69/150 (46%), Gaps = 38/150 (25%)
Query: 4 KCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMA--------HALSYLHHDCT 55
K ++L+++Y E L+ +++ +A KRV+I M + + YLH +
Sbjct: 77 KSVYLLFDYAEH-DLWQIIKFHRQA------KRVSIPPSMVKSLLWQILNGVHYLHSNW- 128
Query: 56 PPIVHRDISSNNILLNLELEAF----VADFGVARLLNFDSSNRTLLAG-----TYGYIAP 106
++HRD+ NIL+ E + D G+ARL F++ + L T Y AP
Sbjct: 129 --VLHRDLKPANILVMGEGPERGVVKIGDLGLARL--FNAPLKPLADLDPVVVTIWYRAP 184
Query: 107 ELA-----YTMVVTEKSDVYSFGVVALEVL 131
EL YT + D+++ G + E+L
Sbjct: 185 ELLLGARHYTKAI----DIWAIGCIFAELL 210
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 40.5 bits (94), Expect = 1e-04
Identities = 35/129 (27%), Positives = 63/129 (48%), Gaps = 10/129 (7%)
Query: 6 MFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISS 65
++L+ E M+ +L V++ + LD + ++ M + +LH + I+HRD+
Sbjct: 97 VYLVMELMD-ANLCQVIQME-----LDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKP 147
Query: 66 NNILLNLELEAFVADFGVARLLNFDSSNRTLLAGTYGYIAPELAYTMVVTEKSDVYSFGV 125
+NI++ + + DFG+AR S T T Y APE+ M E D++S G
Sbjct: 148 SNIVVKSDCTLKILDFGLARTAG-TSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGC 206
Query: 126 VALEVLMGK 134
+ E++ K
Sbjct: 207 IMGEMVRHK 215
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 40.0 bits (93), Expect = 2e-04
Identities = 44/173 (25%), Positives = 71/173 (41%), Gaps = 49/173 (28%)
Query: 3 RKCMFLIYEYMEMGSLFCVLRT----DEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPI 58
++ ++LI E++ G + +L EEA A+ V + + H L +
Sbjct: 73 KRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAI-HQLGF--------- 122
Query: 59 VHRDISSNNILLNLELEAFVADFGVARLL-----------------------NFDS---- 91
+HRDI +N+LL+ + ++DFG+ L N +S
Sbjct: 123 IHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKA 182
Query: 92 ----SNRTLLA----GTYGYIAPELAYTMVVTEKSDVYSFGVVALEVLMGKHP 136
NR LA GT YIAPE+ + D +S GV+ E+L+G P
Sbjct: 183 ETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPP 235
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 39.8 bits (93), Expect = 2e-04
Identities = 38/147 (25%), Positives = 71/147 (48%), Gaps = 25/147 (17%)
Query: 4 KCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKG----MAHALSYLHHDCTPPIV 59
K ++L++EY+++ L+ ++ D+AK ++K + ++Y H + ++
Sbjct: 74 KRLYLVFEYLDLD-----LKKHMDSSP-DFAKNPRLIKTYLYQILRGIAYCH---SHRVL 124
Query: 60 HRDISSNNILLNLELEAF-VADFGVARLLNFDSSNRTLLAGTYGYIAPEL-----AYTMV 113
HRD+ N+L++ A +ADFG+AR T T Y APE+ Y+
Sbjct: 125 HRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVVTLWYRAPEILLGSRHYSTP 184
Query: 114 VTEKSDVYSFGVVALEVLMGK--HPGE 138
V D++S G + E++ K PG+
Sbjct: 185 V----DIWSVGCIFAEMVNQKPLFPGD 207
|
Length = 294 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 39.6 bits (92), Expect = 2e-04
Identities = 30/105 (28%), Positives = 54/105 (51%), Gaps = 10/105 (9%)
Query: 43 MAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADFGVARLLN----FDSSNRTLLA 98
+A ++YL+ VHRD+++ N ++ + + DFG+ R + + + LL
Sbjct: 128 IADGMAYLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLP 184
Query: 99 GTYGYIAPELAYTMVVTEKSDVYSFGVVALEV-LMGKHPGELLSS 142
++APE V T SD++SFGVV E+ + + P + LS+
Sbjct: 185 --VRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSN 227
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 39.4 bits (92), Expect = 2e-04
Identities = 29/97 (29%), Positives = 51/97 (52%), Gaps = 16/97 (16%)
Query: 47 LSYLHHDCTPPIVHRDISSNNILLNLE-LEAFVADFGVARLLNFDSSNRTLLA---GTYG 102
L Y+H + ++HRD+ N+ +N E L + DFG+AR+++ S++ L+ T
Sbjct: 127 LKYIH---SANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKW 183
Query: 103 YIAPELA-----YTMVVTEKSDVYSFGVVALEVLMGK 134
Y +P L YT + D+++ G + E+L GK
Sbjct: 184 YRSPRLLLSPNNYTKAI----DMWAAGCIFAEMLTGK 216
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 39.3 bits (91), Expect = 3e-04
Identities = 43/170 (25%), Positives = 68/170 (40%), Gaps = 49/170 (28%)
Query: 6 MFLIYEYMEMGSLFCVLRTD----EEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHR 61
++LI E++ G + +L EE A+ V + + H L + +HR
Sbjct: 76 LYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSI-HQLGF---------IHR 125
Query: 62 DISSNNILLNLELEAFVADFGVARLL-----------------------NFDSS------ 92
DI +N+LL+ + ++DFG+ L N +S
Sbjct: 126 DIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETW 185
Query: 93 --NRTLLA----GTYGYIAPELAYTMVVTEKSDVYSFGVVALEVLMGKHP 136
NR LA GT YIAPE+ + D +S GV+ E+L+G P
Sbjct: 186 KRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPP 235
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 38.7 bits (90), Expect = 4e-04
Identities = 25/85 (29%), Positives = 44/85 (51%), Gaps = 14/85 (16%)
Query: 6 MFLIYEYMEMGSLFCVLRT----DEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHR 61
++L+ EY+ G + +L DEE V + +A AL YLH I+HR
Sbjct: 79 VYLVMEYLIGGDVKSLLHIYGYFDEEMA-------VKYISEVALALDYLHRH---GIIHR 128
Query: 62 DISSNNILLNLELEAFVADFGVARL 86
D+ +N+L++ E + DFG++++
Sbjct: 129 DLKPDNMLISNEGHIKLTDFGLSKV 153
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 38.2 bits (89), Expect = 6e-04
Identities = 29/101 (28%), Positives = 48/101 (47%), Gaps = 14/101 (13%)
Query: 45 HALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADFGVARLLNFDSSNRTLLAGTYGYI 104
L++ H + ++HRD+ N+L+N E +ADFG+AR T T Y
Sbjct: 111 QGLAFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYR 167
Query: 105 APELA-----YTMVVTEKSDVYSFGVVALEVLMGK--HPGE 138
APE+ Y+ V D++S G + E++ + PG+
Sbjct: 168 APEILLGCKYYSTAV----DIWSLGCIFAEMVTRRALFPGD 204
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 38.0 bits (88), Expect = 6e-04
Identities = 41/146 (28%), Positives = 70/146 (47%), Gaps = 24/146 (16%)
Query: 8 LIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNN 67
++ E++E G L LR ++ V + W ++ + + +A ALSYL +VH ++ + N
Sbjct: 93 MVEEFVEHGPLDVCLRKEKGRVPVAW--KITVAQQLASALSYLEDK---NLVHGNVCAKN 147
Query: 68 ILL-NLELE----AFV--ADFGVARLLNFDSSNRTLLAGTYGYIAPE-LAYTMVVTEKSD 119
ILL L L F+ +D GV+ F + +R +IAPE + ++ +D
Sbjct: 148 ILLARLGLAEGTSPFIKLSDPGVS----FTALSREERVERIPWIAPECVPGGNSLSTAAD 203
Query: 120 VYSFGVVALEV-------LMGKHPGE 138
+SFG LE+ L + P E
Sbjct: 204 KWSFGTTLLEICFDGEVPLKERTPSE 229
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 37.7 bits (88), Expect = 8e-04
Identities = 31/140 (22%), Positives = 64/140 (45%), Gaps = 22/140 (15%)
Query: 4 KCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKG----MAHALSYLHHDCTPPIV 59
++L++E++++ L+ ++ L ++K + ++Y H + ++
Sbjct: 71 NKLYLVFEFLDLD-----LKKYMDSSPLT-GLDPPLIKSYLYQLLQGIAYCH---SHRVL 121
Query: 60 HRDISSNNILLNLELEAFVADFGVARLLNFDSSNRTLLAGTYGYIAPEL-----AYTMVV 114
HRD+ N+L++ E +ADFG+AR T T Y APE+ Y+ V
Sbjct: 122 HRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGSRQYSTPV 181
Query: 115 TEKSDVYSFGVVALEVLMGK 134
D++S G + E++ +
Sbjct: 182 ----DIWSIGCIFAEMVNRR 197
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 37.9 bits (88), Expect = 9e-04
Identities = 26/79 (32%), Positives = 41/79 (51%), Gaps = 1/79 (1%)
Query: 58 IVHRDISSNNILLNLELEAFVADFGVARLLNFDSSNRTLLAGTYGYIAPELAYTMVVTEK 117
IV+RD+ NILL+ ++D G+A + + R + GT GY+APE+ T
Sbjct: 123 IVYRDLKPENILLDDYGHIRISDLGLAVEIPEGETIRGRV-GTVGYMAPEVVKNERYTFS 181
Query: 118 SDVYSFGVVALEVLMGKHP 136
D + G + E++ GK P
Sbjct: 182 PDWWGLGCLIYEMIEGKSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 37.3 bits (86), Expect = 0.001
Identities = 34/143 (23%), Positives = 66/143 (46%), Gaps = 15/143 (10%)
Query: 2 HRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLH-HDCTPPIVH 60
R+ ++++ E + G LR ++ L + V A ++YL +C +H
Sbjct: 63 QRQPIYIVMELVPGGDFLSFLRKKKDE--LKTKQLVKFALDAAAGMAYLESKNC----IH 116
Query: 61 RDISSNNILLNLELEAFVADFGVARLLN---FDSSNRTLLAGTYGYIAPELAYTMVVTEK 117
RD+++ N L+ ++DFG++R + + SS L + APE + +
Sbjct: 117 RDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSG--LKQIPIKWTAPEALNYGRYSSE 174
Query: 118 SDVYSFGVVALEVL---MGKHPG 137
SDV+S+G++ E + +PG
Sbjct: 175 SDVWSYGILLWETFSLGVCPYPG 197
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 37.3 bits (86), Expect = 0.001
Identities = 28/91 (30%), Positives = 46/91 (50%), Gaps = 8/91 (8%)
Query: 47 LSYLHHDCTPPIVHRDISSNNILLNLELEAFVADFGVARLLNFDSSNRTLLAGTYGYIAP 106
LSY H I+HRD+ N+L+N + E +ADFG+AR + + + T Y P
Sbjct: 116 LSYCHKR---KILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVVTLWYRPP 172
Query: 107 ELAYTMVVTEKS---DVYSFGVVALEVLMGK 134
++ + TE S D++ G + E+ G+
Sbjct: 173 DV--LLGSTEYSTPIDMWGVGCILYEMATGR 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 37.3 bits (86), Expect = 0.001
Identities = 33/125 (26%), Positives = 49/125 (39%), Gaps = 47/125 (37%)
Query: 59 VHRDISSNNILLNLELEAFVADFGVARLLNF-------------------------DSSN 93
+HRDI +NIL++L+ + DFG+ + D SN
Sbjct: 123 IHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSN 182
Query: 94 -------RTL---------------LAGTYGYIAPELAYTMVVTEKSDVYSFGVVALEVL 131
+TL L GT YIAPE+ T+ D +S GV+ E+L
Sbjct: 183 CRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVILFEML 242
Query: 132 MGKHP 136
+G+ P
Sbjct: 243 VGQPP 247
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 37.0 bits (86), Expect = 0.002
Identities = 36/134 (26%), Positives = 50/134 (37%), Gaps = 55/134 (41%)
Query: 45 HALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADFGV------------ARLL----- 87
H L Y +HRDI +N+LL+ + ++DFG+ R+L
Sbjct: 118 HKLGY---------IHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALP 168
Query: 88 ---------NFDSS--------NRTLLA----GTYGYIAPEL----AYTMVVTEKSDVYS 122
S NR LA GT YIAPE+ Y D +S
Sbjct: 169 SNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKEC----DWWS 224
Query: 123 FGVVALEVLMGKHP 136
GV+ E+L+G P
Sbjct: 225 LGVIMYEMLVGYPP 238
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 36.7 bits (85), Expect = 0.002
Identities = 17/66 (25%), Positives = 36/66 (54%), Gaps = 5/66 (7%)
Query: 8 LIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNN 67
++ EY++ GSL L+ ++ + + W ++ + K +A AL +L + H ++ + N
Sbjct: 76 MVQEYVKFGSLDTYLKKNKNLINISW--KLEVAKQLAWALHFLEDK---GLTHGNVCAKN 130
Query: 68 ILLNLE 73
+LL E
Sbjct: 131 VLLIRE 136
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 36.2 bits (84), Expect = 0.002
Identities = 15/39 (38%), Positives = 24/39 (61%), Gaps = 3/39 (7%)
Query: 47 LSYLHHDCTPPIVHRDISSNNILLNLELEAFVADFGVAR 85
L+Y H ++HRD+ N+L++ E +ADFG+AR
Sbjct: 116 LAYCHQR---RVLHRDLKPQNLLISERGELKLADFGLAR 151
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 36.2 bits (83), Expect = 0.003
Identities = 28/94 (29%), Positives = 48/94 (51%), Gaps = 8/94 (8%)
Query: 43 MAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADFGVARLLNFDSSNRTLLAGTYG 102
+ LSY+H I+HRD+ N+L++ E +ADFG+AR + S + T
Sbjct: 112 LLRGLSYIHQRY---ILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHTYSNEVVTLW 168
Query: 103 YIAPELAYTMVVTEKS---DVYSFGVVALEVLMG 133
Y P++ + TE S D++ G + +E++ G
Sbjct: 169 YRPPDV--LLGSTEYSTCLDMWGVGCIFVEMIQG 200
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 36.2 bits (84), Expect = 0.003
Identities = 32/140 (22%), Positives = 64/140 (45%), Gaps = 13/140 (9%)
Query: 6 MFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISS 65
++++ M GS +L+T GL I+K + +AL Y+H +HR + +
Sbjct: 74 LYVVSPLMAYGSCEDLLKT-HFPEGLPELAIAFILKDVLNALDYIHSK---GFIHRSVKA 129
Query: 66 NNILLNLELEAFVADFGVAR-LLNFDSSNRTLLAGTYG------YIAPELAYTMV--VTE 116
++ILL+ + + ++ + ++ R + +++PE+ + E
Sbjct: 130 SHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPEVLQQNLQGYNE 189
Query: 117 KSDVYSFGVVALEVLMGKHP 136
KSD+YS G+ A E+ G P
Sbjct: 190 KSDIYSVGITACELANGHVP 209
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 36.5 bits (84), Expect = 0.003
Identities = 39/148 (26%), Positives = 74/148 (50%), Gaps = 29/148 (19%)
Query: 6 MFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISS 65
+++I +M GS +L+T G+ A NI+ G L+YLH + +HR+I +
Sbjct: 74 LWVISPFMAYGSANSLLKTYFPE-GMSEALIGNILFGALRGLNYLHQN---GYIHRNIKA 129
Query: 66 NNILLNLE----------LEAFVADFGVARLL-NFDSSNRTLLAGTYGYIAPEL------ 108
++IL++ + L + V + A+++ +F + ++L +++PEL
Sbjct: 130 SHILISGDGLVSLSGLSHLYSLVRNGQKAKVVYDFPQFSTSVLP----WLSPELLRQDLY 185
Query: 109 AYTMVVTEKSDVYSFGVVALEVLMGKHP 136
Y + KSD+YS G+ A E+ G+ P
Sbjct: 186 GYNV----KSDIYSVGITACELATGRVP 209
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 35.9 bits (83), Expect = 0.004
Identities = 30/121 (24%), Positives = 46/121 (38%), Gaps = 43/121 (35%)
Query: 59 VHRDISSNNILLNLELEAFVADFGV------------------ARLLNFDSSNR------ 94
+HRDI +NIL++ + + DFG+ R + + S
Sbjct: 123 IHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDR 182
Query: 95 ----TL---------------LAGTYGYIAPELAYTMVVTEKSDVYSFGVVALEVLMGKH 135
L L GT YIAPE+ T+ D +S GV+ E+L+G+
Sbjct: 183 CRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQP 242
Query: 136 P 136
P
Sbjct: 243 P 243
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 144 | |||
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 99.98 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 99.98 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 99.98 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 99.98 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 99.98 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 99.98 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 99.98 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 99.98 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 99.98 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 99.98 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 99.98 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 99.98 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 99.98 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 99.98 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 99.98 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 99.97 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 99.97 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 99.97 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 99.97 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 99.97 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 99.97 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 99.97 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 99.97 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 99.97 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 99.97 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.97 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 99.97 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 99.97 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 99.97 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 99.97 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 99.97 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 99.97 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 99.97 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 99.97 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 99.97 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 99.97 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 99.97 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 99.97 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 99.97 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 99.97 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 99.97 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 99.97 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 99.97 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 99.97 | |
| PTZ00284 | 467 | protein kinase; Provisional | 99.97 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 99.97 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 99.97 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 99.97 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 99.97 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 99.97 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 99.97 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 99.97 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 99.96 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 99.96 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 99.96 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 99.96 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 99.96 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 99.96 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 99.96 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 99.96 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 99.96 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 99.96 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 99.96 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 99.96 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 99.96 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 99.96 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 99.96 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 99.96 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.96 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 99.96 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 99.96 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 99.96 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 99.96 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 99.96 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 99.96 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 99.96 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 99.96 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 99.96 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 99.96 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 99.96 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 99.96 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 99.96 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.96 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 99.96 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 99.96 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 99.96 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 99.96 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 99.96 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 99.96 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 99.96 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 99.96 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 99.96 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 99.96 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.96 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 99.96 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 99.96 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 99.96 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 99.96 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 99.96 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 99.96 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 99.96 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 99.96 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 99.96 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 99.96 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 99.96 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 99.96 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 99.96 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 99.96 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 99.96 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 99.96 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 99.96 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.96 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 99.96 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 99.96 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 99.96 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 99.96 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 99.96 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 99.96 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 99.96 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 99.96 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 99.96 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 99.96 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 99.96 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 99.96 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 99.96 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 99.96 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 99.96 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 99.96 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 99.96 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 99.96 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 99.96 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 99.96 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 99.95 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 99.95 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 99.95 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 99.95 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 99.95 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 99.95 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 99.95 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 99.95 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 99.95 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 99.95 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 99.95 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 99.95 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 99.95 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 99.95 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 99.95 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 99.95 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 99.95 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 99.95 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 99.95 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 99.95 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 99.95 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 99.95 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 99.95 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 99.95 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 99.95 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 99.95 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 99.95 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 99.95 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 99.95 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 99.95 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 99.95 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 99.95 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 99.95 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 99.95 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 99.95 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 99.95 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 99.95 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 99.95 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 99.95 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 99.95 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 99.95 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 99.95 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 99.95 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 99.95 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 99.95 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 99.95 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 99.95 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 99.95 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 99.95 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 99.95 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 99.95 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 99.95 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 99.95 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 99.95 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 99.95 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 99.95 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 99.95 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 99.95 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 99.95 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 99.95 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 99.95 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 99.95 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 99.95 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 99.95 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 99.95 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 99.95 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 99.95 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 99.95 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 99.95 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 99.95 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 99.95 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 99.95 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 99.95 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 99.95 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 99.95 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 99.95 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 99.95 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 99.95 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 99.95 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 99.95 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 99.95 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 99.95 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 99.95 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 99.95 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 99.95 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 99.95 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 99.95 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 99.95 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 99.95 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 99.95 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 99.95 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 99.95 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 99.95 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 99.95 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 99.95 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 99.95 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 99.95 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 99.95 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 99.95 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 99.95 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 99.95 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 99.95 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 99.95 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 99.94 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 99.94 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 99.94 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 99.94 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 99.94 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 99.94 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 99.94 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 99.94 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 99.94 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 99.94 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 99.94 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 99.94 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 99.94 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 99.94 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 99.94 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 99.94 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 99.94 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 99.94 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 99.94 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 99.94 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 99.94 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 99.94 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 99.94 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 99.94 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 99.94 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 99.94 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.94 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 99.94 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 99.94 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.94 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 99.94 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 99.94 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 99.94 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.94 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 99.94 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 99.94 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 99.94 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 99.93 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 99.93 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 99.93 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 99.93 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 99.93 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 99.93 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 99.93 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 99.93 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.93 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 99.93 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 99.93 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 99.93 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 99.93 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 99.93 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.93 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 99.93 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 99.93 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 99.93 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 99.93 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 99.93 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 99.93 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 99.93 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 99.93 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 99.92 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 99.92 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 99.92 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 99.92 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 99.92 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.92 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 99.92 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.92 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.91 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 99.91 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.91 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 99.91 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 99.91 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.91 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 99.9 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.9 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 99.9 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.9 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.9 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 99.9 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.9 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.89 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.89 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.86 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.86 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.86 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.84 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.84 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.82 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.81 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.81 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.8 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 99.8 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.8 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.79 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.77 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.72 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.72 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.69 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.68 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.67 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.67 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.67 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.66 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.65 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.65 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.63 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.6 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.55 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.54 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.43 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.43 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.42 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.4 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.38 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.34 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.34 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.28 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.19 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 99.15 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.14 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.14 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.07 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 99.01 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.01 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.0 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.99 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.97 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 98.93 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 98.91 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.8 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 98.77 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 98.75 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.74 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 98.64 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.5 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.47 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.46 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.45 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 98.41 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 98.38 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.05 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 97.96 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 97.74 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 97.55 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 97.51 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 97.25 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 97.13 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 96.63 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 96.32 | |
| PF07387 | 308 | Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099 | 96.31 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 96.19 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 96.16 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 96.06 | |
| COG0510 | 269 | ycfN Thiamine kinase and related kinases [Coenzyme | 96.04 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 95.98 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 95.82 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 95.79 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 95.73 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 95.71 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 95.57 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 95.51 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 95.5 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 95.47 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 95.45 | |
| PRK10271 | 188 | thiK thiamine kinase; Provisional | 95.4 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 94.94 | |
| PLN02236 | 344 | choline kinase | 94.64 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 94.61 | |
| smart00587 | 196 | CHK ZnF_C4 abd HLH domain containing kinases domai | 94.2 | |
| COG2334 | 331 | Putative homoserine kinase type II (protein kinase | 94.06 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 93.8 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 93.73 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 93.67 | |
| PRK06148 | 1013 | hypothetical protein; Provisional | 93.65 | |
| PHA03111 | 444 | Ser/Thr kinase; Provisional | 92.94 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 92.83 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 92.26 | |
| PRK06149 | 972 | hypothetical protein; Provisional | 92.16 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 92.13 | |
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 92.02 | |
| COG4499 | 434 | Predicted membrane protein [Function unknown] | 91.78 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 89.17 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 88.98 | |
| PF02958 | 294 | EcKinase: Ecdysteroid kinase; InterPro: IPR004119 | 88.32 |
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-39 Score=219.14 Aligned_cols=133 Identities=27% Similarity=0.429 Sum_probs=124.0
Q ss_pred CceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeeec
Q 044494 3 RKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADFG 82 (144)
Q Consensus 3 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~~ 82 (144)
.+++|+|+||+.||.|..+|++++. +++..+..+++.|+.||.||| ++||+|||+||+||+++.+|+++++|||
T Consensus 97 ~~kLylVld~~~GGeLf~hL~~eg~---F~E~~arfYlaEi~lAL~~LH---~~gIiyRDlKPENILLd~~GHi~LtDFg 170 (357)
T KOG0598|consen 97 EEKLYLVLDYLNGGELFYHLQREGR---FSEDRARFYLAEIVLALGYLH---SKGIIYRDLKPENILLDEQGHIKLTDFG 170 (357)
T ss_pred CCeEEEEEeccCCccHHHHHHhcCC---cchhHHHHHHHHHHHHHHHHH---hCCeeeccCCHHHeeecCCCcEEEeccc
Confidence 5789999999999999999997665 999999999999999999999 9999999999999999999999999999
Q ss_pred ceeecccCCCCcccccccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCC
Q 044494 83 VARLLNFDSSNRTLLAGTYGYIAPELAYTMVVTEKSDVYSFGVVALEVLMGKHPGELLS 141 (144)
Q Consensus 83 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~d~~slg~~l~~~~~g~~p~~~~~ 141 (144)
+++..........+.+||+.|||||++...+++..+|.||+|+++|+|++|.+||...+
T Consensus 171 L~k~~~~~~~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~ 229 (357)
T KOG0598|consen 171 LCKEDLKDGDATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAED 229 (357)
T ss_pred cchhcccCCCccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCcc
Confidence 99976655566777899999999999999999999999999999999999999998755
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-39 Score=221.63 Aligned_cols=131 Identities=33% Similarity=0.497 Sum_probs=119.0
Q ss_pred CceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCC------CCe
Q 044494 3 RKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLE------LEA 76 (144)
Q Consensus 3 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~------~~~ 76 (144)
++++|+|||||.||+|.+++++.+. +++.++..++.|++.|+++|| +++|+|||+||+||+++.. ..+
T Consensus 81 ~~~i~lVMEyC~gGDLs~yi~~~~~---l~e~t~r~Fm~QLA~alq~L~---~~~IiHRDLKPQNiLLs~~~~~~~~~~L 154 (429)
T KOG0595|consen 81 DDFIYLVMEYCNGGDLSDYIRRRGR---LPEATARHFMQQLASALQFLH---ENNIIHRDLKPQNILLSTTARNDTSPVL 154 (429)
T ss_pred CCeEEEEEEeCCCCCHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHH---HCCeeeccCCcceEEeccCCCCCCCceE
Confidence 5689999999999999999997654 999999999999999999999 9999999999999999875 457
Q ss_pred EEeeecceeecccCCCCcccccccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCC
Q 044494 77 FVADFGVARLLNFDSSNRTLLAGTYGYIAPELAYTMVVTEKSDVYSFGVVALEVLMGKHPGELL 140 (144)
Q Consensus 77 ~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~d~~slg~~l~~~~~g~~p~~~~ 140 (144)
||+|||+++.... .....+.+|+|.|||||++...+|+.|+|+||+|+++|+|++|..||+..
T Consensus 155 KIADFGfAR~L~~-~~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~ 217 (429)
T KOG0595|consen 155 KIADFGFARFLQP-GSMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAE 217 (429)
T ss_pred EecccchhhhCCc-hhHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCcccc
Confidence 9999999997763 34456688999999999999999999999999999999999999999843
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-38 Score=209.09 Aligned_cols=132 Identities=27% Similarity=0.425 Sum_probs=122.4
Q ss_pred CCceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeee
Q 044494 2 HRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADF 81 (144)
Q Consensus 2 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~ 81 (144)
+.+++|+||||.+||.|+.++++.++ +++..+.+++.+++.|++||| +.++++||+||+||+++.+|.+|+.||
T Consensus 115 d~~~lymvmeyv~GGElFS~Lrk~~r---F~e~~arFYAAeivlAleylH---~~~iiYRDLKPENiLlD~~G~iKitDF 188 (355)
T KOG0616|consen 115 DNSNLYMVMEYVPGGELFSYLRKSGR---FSEPHARFYAAEIVLALEYLH---SLDIIYRDLKPENLLLDQNGHIKITDF 188 (355)
T ss_pred cCCeEEEEEeccCCccHHHHHHhcCC---CCchhHHHHHHHHHHHHHHHH---hcCeeeccCChHHeeeccCCcEEEEec
Confidence 57889999999999999999997665 999999999999999999999 899999999999999999999999999
Q ss_pred cceeecccCCCCcccccccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCC
Q 044494 82 GVARLLNFDSSNRTLLAGTYGYIAPELAYTMVVTEKSDVYSFGVVALEVLMGKHPGELLSS 142 (144)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~d~~slg~~l~~~~~g~~p~~~~~~ 142 (144)
|++++.. ....+.+|||.|+|||+++..++...+|.||||+++|||+.|.+||-..++
T Consensus 189 GFAK~v~---~rT~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~ 246 (355)
T KOG0616|consen 189 GFAKRVS---GRTWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNP 246 (355)
T ss_pred cceEEec---CcEEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCCh
Confidence 9999765 236678899999999999999999999999999999999999999976543
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=214.23 Aligned_cols=134 Identities=26% Similarity=0.475 Sum_probs=120.8
Q ss_pred CCceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeee
Q 044494 2 HRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADF 81 (144)
Q Consensus 2 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~ 81 (144)
++..+|+|+||+++|+|.+++++-+. +++.....++.+|+.||+||| +.||+||||||+||+++.+++++|.||
T Consensus 145 D~~sLYFvLe~A~nGdll~~i~K~Gs---fde~caR~YAAeIldAleylH---~~GIIHRDlKPENILLd~dmhikITDF 218 (604)
T KOG0592|consen 145 DEESLYFVLEYAPNGDLLDLIKKYGS---FDETCARFYAAEILDALEYLH---SNGIIHRDLKPENILLDKDGHIKITDF 218 (604)
T ss_pred cccceEEEEEecCCCcHHHHHHHhCc---chHHHHHHHHHHHHHHHHHHH---hcCceeccCChhheeEcCCCcEEEeec
Confidence 46789999999999999999998665 999999999999999999999 999999999999999999999999999
Q ss_pred cceeecccCCCC-----------c--ccccccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCC
Q 044494 82 GVARLLNFDSSN-----------R--TLLAGTYGYIAPELAYTMVVTEKSDVYSFGVVALEVLMGKHPGELLS 141 (144)
Q Consensus 82 ~~~~~~~~~~~~-----------~--~~~~~~~~~~~pe~~~~~~~~~~~d~~slg~~l~~~~~g~~p~~~~~ 141 (144)
|.++.+...... . ..++||..|.+||++.....++.+|+|+|||++|+|+.|++||.+.+
T Consensus 219 GsAK~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~N 291 (604)
T KOG0592|consen 219 GSAKILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAAN 291 (604)
T ss_pred cccccCChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCcccc
Confidence 999877532211 1 34789999999999999999999999999999999999999998754
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=215.62 Aligned_cols=133 Identities=29% Similarity=0.523 Sum_probs=124.8
Q ss_pred CCceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeee
Q 044494 2 HRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADF 81 (144)
Q Consensus 2 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~ 81 (144)
+.+++|+|.|+|..++|..+++++.. ++|.++..++.||+.|+.||| +++|+|||+|..|++++.+..+||+||
T Consensus 89 Ds~nVYivLELC~~~sL~el~Krrk~---ltEpEary~l~QIv~GlkYLH---~~~IiHRDLKLGNlfL~~~~~VKIgDF 162 (592)
T KOG0575|consen 89 DSNNVYIVLELCHRGSLMELLKRRKP---LTEPEARYFLRQIVEGLKYLH---SLGIIHRDLKLGNLFLNENMNVKIGDF 162 (592)
T ss_pred cCCceEEEEEecCCccHHHHHHhcCC---CCcHHHHHHHHHHHHHHHHHH---hcCceecccchhheeecCcCcEEeccc
Confidence 46789999999999999999985444 999999999999999999999 999999999999999999999999999
Q ss_pred cceeecccCCCCcccccccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCC
Q 044494 82 GVARLLNFDSSNRTLLAGTYGYIAPELAYTMVVTEKSDVYSFGVVALEVLMGKHPGELL 140 (144)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~d~~slg~~l~~~~~g~~p~~~~ 140 (144)
|+|.....+...+.+.+|||.|+|||++...+.+..+|+||+||++|.++.|++||+..
T Consensus 163 GLAt~le~~~Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk 221 (592)
T KOG0575|consen 163 GLATQLEYDGERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETK 221 (592)
T ss_pred ceeeeecCcccccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccc
Confidence 99999887767788899999999999999999999999999999999999999999864
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=203.84 Aligned_cols=135 Identities=23% Similarity=0.273 Sum_probs=120.7
Q ss_pred EEEEEeeccCCCHHHHhhc-ccccCCCCHHHHHHHHHHHHHHHHHHhcCC-CCCeEecCCCCCcEEEcCCCCeEEeeecc
Q 044494 6 MFLIYEYMEMGSLFCVLRT-DEEAVGLDWAKRVNIVKGMAHALSYLHHDC-TPPIVHRDISSNNILLNLELEAFVADFGV 83 (144)
Q Consensus 6 ~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~-~~~~~h~~i~~~ni~~~~~~~~~l~d~~~ 83 (144)
+++|||+|..|+|..+++. ....+.+++..+|.++.|+|.||..+|... +.-+.||||||.||+++.+|.+|++|||+
T Consensus 95 lnivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL 174 (375)
T KOG0591|consen 95 LNIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGL 174 (375)
T ss_pred hHHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchh
Confidence 7899999999999999975 233345999999999999999999999421 12399999999999999999999999999
Q ss_pred eeecccCCCCcccccccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCC
Q 044494 84 ARLLNFDSSNRTLLAGTYGYIAPELAYTMVVTEKSDVYSFGVVALEVLMGKHPGELL 140 (144)
Q Consensus 84 ~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~d~~slg~~l~~~~~g~~p~~~~ 140 (144)
++...+.........|||.||+||.+...+|+.++|+||+||++|||++-++||.+.
T Consensus 175 ~r~l~s~~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~ 231 (375)
T KOG0591|consen 175 GRFLSSKTTFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGD 231 (375)
T ss_pred HhHhcchhHHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccc
Confidence 998877666677789999999999999999999999999999999999999999874
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-37 Score=207.63 Aligned_cols=131 Identities=31% Similarity=0.452 Sum_probs=118.9
Q ss_pred Cc-eEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeee
Q 044494 3 RK-CMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADF 81 (144)
Q Consensus 3 ~~-~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~ 81 (144)
+. .++++||||.+|+|.+.+...+. +++.....++.++++||.|||. +++|+||||||+|+++...|.|||+||
T Consensus 149 ~~~~isI~mEYMDgGSLd~~~k~~g~---i~E~~L~~ia~~VL~GL~YLh~--~~~IIHRDIKPsNlLvNskGeVKicDF 223 (364)
T KOG0581|consen 149 NGEEISICMEYMDGGSLDDILKRVGR---IPEPVLGKIARAVLRGLSYLHE--ERKIIHRDIKPSNLLVNSKGEVKICDF 223 (364)
T ss_pred CCceEEeehhhcCCCCHHHHHhhcCC---CCHHHHHHHHHHHHHHHHHHhh--ccCeeeccCCHHHeeeccCCCEEeccc
Confidence 44 48999999999999999987544 9999999999999999999994 389999999999999999999999999
Q ss_pred cceeecccCCCCcccccccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCC
Q 044494 82 GVARLLNFDSSNRTLLAGTYGYIAPELAYTMVVTEKSDVYSFGVVALEVLMGKHPGELL 140 (144)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~d~~slg~~l~~~~~g~~p~~~~ 140 (144)
|.+...... ...+..||..|||||.+.+..|+.++||||||+.++|+..|++||...
T Consensus 224 GVS~~lvnS--~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~ 280 (364)
T KOG0581|consen 224 GVSGILVNS--IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPP 280 (364)
T ss_pred cccHHhhhh--hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCc
Confidence 999876532 456788999999999999999999999999999999999999999764
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=206.43 Aligned_cols=132 Identities=26% Similarity=0.413 Sum_probs=119.0
Q ss_pred ceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCC-CCeEEeeec
Q 044494 4 KCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLE-LEAFVADFG 82 (144)
Q Consensus 4 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~-~~~~l~d~~ 82 (144)
.++|+||||+.||+|.+++...+. +.+..+..+..|++.|++||| ++|++||||||+|++++.+ +.+|++|||
T Consensus 93 ~~~~ivmEy~~gGdL~~~i~~~g~---l~E~~ar~~F~Qlisav~y~H---~~gi~HRDLK~ENilld~~~~~~Kl~DFG 166 (370)
T KOG0583|consen 93 TKIYIVMEYCSGGDLFDYIVNKGR---LKEDEARKYFRQLISAVAYCH---SRGIVHRDLKPENILLDGNEGNLKLSDFG 166 (370)
T ss_pred CeEEEEEEecCCccHHHHHHHcCC---CChHHHHHHHHHHHHHHHHHH---hCCEeeCCCCHHHEEecCCCCCEEEeccc
Confidence 458999999999999999987444 889999999999999999999 9999999999999999999 999999999
Q ss_pred ceeecccCCCCcccccccccccCccccccCC-CC-CcchhHHHHHHHHHHHhCCCCCCCCC
Q 044494 83 VARLLNFDSSNRTLLAGTYGYIAPELAYTMV-VT-EKSDVYSFGVVALEVLMGKHPGELLS 141 (144)
Q Consensus 83 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~-~~-~~~d~~slg~~l~~~~~g~~p~~~~~ 141 (144)
++...........+.+|++.|+|||++.+.. |+ .++|+||+|+++|.|++|..||+..+
T Consensus 167 ~s~~~~~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~ 227 (370)
T KOG0583|consen 167 LSAISPGEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSN 227 (370)
T ss_pred cccccCCCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCcc
Confidence 9987643344566788999999999999987 75 78999999999999999999998743
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=208.74 Aligned_cols=132 Identities=32% Similarity=0.461 Sum_probs=115.6
Q ss_pred CceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCC---CCeEEe
Q 044494 3 RKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLE---LEAFVA 79 (144)
Q Consensus 3 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~---~~~~l~ 79 (144)
....|+||||+.||.|.+.+-.... +.+...+.+++|++.|++||| ++||+||||||+||+++.+ -.+|+.
T Consensus 248 ~ds~YmVlE~v~GGeLfd~vv~nk~---l~ed~~K~~f~Qll~avkYLH---~~GI~HRDiKPeNILl~~~~e~~llKIt 321 (475)
T KOG0615|consen 248 PDSSYMVLEYVEGGELFDKVVANKY---LREDLGKLLFKQLLTAVKYLH---SQGIIHRDIKPENILLSNDAEDCLLKIT 321 (475)
T ss_pred CCceEEEEEEecCccHHHHHHhccc---cccchhHHHHHHHHHHHHHHH---HcCcccccCCcceEEeccCCcceEEEec
Confidence 3566999999999999999875443 888888999999999999999 9999999999999999877 568999
Q ss_pred eecceeecccCCCCcccccccccccCccccccCCCC---CcchhHHHHHHHHHHHhCCCCCCCCC
Q 044494 80 DFGVARLLNFDSSNRTLLAGTYGYIAPELAYTMVVT---EKSDVYSFGVVALEVLMGKHPGELLS 141 (144)
Q Consensus 80 d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~---~~~d~~slg~~l~~~~~g~~p~~~~~ 141 (144)
|||+++..+ ......+.+|||.|.|||++...... .+.|+||+||++|.+++|.+||....
T Consensus 322 DFGlAK~~g-~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~ 385 (475)
T KOG0615|consen 322 DFGLAKVSG-EGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEY 385 (475)
T ss_pred ccchhhccc-cceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCccccc
Confidence 999999876 45556778999999999999977643 37799999999999999999997643
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=202.60 Aligned_cols=134 Identities=40% Similarity=0.599 Sum_probs=118.1
Q ss_pred eEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCC-eEecCCCCCcEEEcCCC-CeEEeeec
Q 044494 5 CMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPP-IVHRDISSNNILLNLEL-EAFVADFG 82 (144)
Q Consensus 5 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~-~~h~~i~~~ni~~~~~~-~~~l~d~~ 82 (144)
.+++||||+++|+|.+++... ....++...++.++.|++.|++||| +++ ++|||+||+|++++.+. .+||+|||
T Consensus 114 ~~~iVtEy~~~GsL~~~l~~~-~~~~l~~~~~l~~aldiArGm~YLH---~~~~iIHrDLK~~NiLv~~~~~~~KI~DFG 189 (362)
T KOG0192|consen 114 SLCIVTEYMPGGSLSVLLHKK-RKRKLPLKVRLRIALDIARGMEYLH---SEGPIIHRDLKSDNILVDLKGKTLKIADFG 189 (362)
T ss_pred ceEEEEEeCCCCcHHHHHhhc-ccCCCCHHHHHHHHHHHHHHHHHHh---cCCCeeecccChhhEEEcCCCCEEEECCCc
Confidence 589999999999999999863 2344999999999999999999999 888 99999999999999997 99999999
Q ss_pred ceeecccCCCCcccccccccccCccccc--cCCCCCcchhHHHHHHHHHHHhCCCCCCCCCC
Q 044494 83 VARLLNFDSSNRTLLAGTYGYIAPELAY--TMVVTEKSDVYSFGVVALEVLMGKHPGELLSS 142 (144)
Q Consensus 83 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~--~~~~~~~~d~~slg~~l~~~~~g~~p~~~~~~ 142 (144)
+++.............||+.|||||++. ...++.|+|+||||+++||++||..||+.+++
T Consensus 190 lsr~~~~~~~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~ 251 (362)
T KOG0192|consen 190 LSREKVISKTSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAP 251 (362)
T ss_pred cceeeccccccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCH
Confidence 9987553222333367999999999999 56899999999999999999999999998764
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-35 Score=206.93 Aligned_cols=130 Identities=31% Similarity=0.511 Sum_probs=121.0
Q ss_pred CceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeeec
Q 044494 3 RKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADFG 82 (144)
Q Consensus 3 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~~ 82 (144)
.+.+|+||||++||+|.+.+.... +++.++..+.+.++.||++|| .+||+|||||.+||++..+|.+|++|||
T Consensus 342 ~deLWVVMEym~ggsLTDvVt~~~----~~E~qIA~Icre~l~aL~fLH---~~gIiHrDIKSDnILL~~~g~vKltDFG 414 (550)
T KOG0578|consen 342 GDELWVVMEYMEGGSLTDVVTKTR----MTEGQIAAICREILQGLKFLH---ARGIIHRDIKSDNILLTMDGSVKLTDFG 414 (550)
T ss_pred cceeEEEEeecCCCchhhhhhccc----ccHHHHHHHHHHHHHHHHHHH---hcceeeeccccceeEeccCCcEEEeeee
Confidence 467999999999999999887532 899999999999999999999 9999999999999999999999999999
Q ss_pred ceeecccCCCCcccccccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCC
Q 044494 83 VARLLNFDSSNRTLLAGTYGYIAPELAYTMVVTEKSDVYSFGVVALEVLMGKHPGEL 139 (144)
Q Consensus 83 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~d~~slg~~l~~~~~g~~p~~~ 139 (144)
++..+........+..|||.|||||++....|+++.||||||+.++||+.|++||-.
T Consensus 415 Fcaqi~~~~~KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYln 471 (550)
T KOG0578|consen 415 FCAQISEEQSKRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLN 471 (550)
T ss_pred eeeccccccCccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccC
Confidence 999887766677778999999999999999999999999999999999999999964
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-35 Score=211.49 Aligned_cols=133 Identities=25% Similarity=0.391 Sum_probs=118.9
Q ss_pred CceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeeec
Q 044494 3 RKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADFG 82 (144)
Q Consensus 3 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~~ 82 (144)
++++|+||||+.||++..+.+. . .+++..+..+++.++.||+||| ++||++||+|.+||+++.+|.+||+|||
T Consensus 441 ~~~l~fvmey~~Ggdm~~~~~~-~---~F~e~rarfyaAev~l~L~fLH---~~~IIYRDlKLdNiLLD~eGh~kiADFG 513 (694)
T KOG0694|consen 441 KEHLFFVMEYVAGGDLMHHIHT-D---VFSEPRARFYAAEVVLGLQFLH---ENGIIYRDLKLDNLLLDTEGHVKIADFG 513 (694)
T ss_pred CCeEEEEEEecCCCcEEEEEec-c---cccHHHHHHHHHHHHHHHHHHH---hcCceeeecchhheEEcccCcEEecccc
Confidence 4689999999999994433332 2 2999999999999999999999 9999999999999999999999999999
Q ss_pred ceeecccCCCCcccccccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCC
Q 044494 83 VARLLNFDSSNRTLLAGTYGYIAPELAYTMVVTEKSDVYSFGVVALEVLMGKHPGELLSS 142 (144)
Q Consensus 83 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~d~~slg~~l~~~~~g~~p~~~~~~ 142 (144)
+++.--.......+.+|||.|+|||++....|+..+|.||||+++|||+.|++||.+.+.
T Consensus 514 lcKe~m~~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddE 573 (694)
T KOG0694|consen 514 LCKEGMGQGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDE 573 (694)
T ss_pred cccccCCCCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCH
Confidence 998654345567789999999999999999999999999999999999999999998664
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=203.91 Aligned_cols=135 Identities=24% Similarity=0.377 Sum_probs=117.0
Q ss_pred CCceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeee
Q 044494 2 HRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADF 81 (144)
Q Consensus 2 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~ 81 (144)
+..++||||||++||++..+|.+... +++..+.+++.+++.|+..+| +.|++||||||+|++++..|++||+||
T Consensus 212 D~~~LYLiMEylPGGD~mTLL~~~~~---L~e~~arfYiaE~vlAI~~iH---~~gyIHRDIKPdNlLiD~~GHiKLSDF 285 (550)
T KOG0605|consen 212 DKEYLYLIMEYLPGGDMMTLLMRKDT---LTEDWARFYIAETVLAIESIH---QLGYIHRDIKPDNLLIDAKGHIKLSDF 285 (550)
T ss_pred CCCeeEEEEEecCCccHHHHHHhcCc---CchHHHHHHHHHHHHHHHHHH---HcCcccccCChhheeecCCCCEeeccc
Confidence 35789999999999999999986554 999999999999999999999 999999999999999999999999999
Q ss_pred cceeecccC------------------------CC----Cc-------------------ccccccccccCccccccCCC
Q 044494 82 GVARLLNFD------------------------SS----NR-------------------TLLAGTYGYIAPELAYTMVV 114 (144)
Q Consensus 82 ~~~~~~~~~------------------------~~----~~-------------------~~~~~~~~~~~pe~~~~~~~ 114 (144)
|++...... .. .. ....|||-|+|||++.+.+|
T Consensus 286 GLs~gl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY 365 (550)
T KOG0605|consen 286 GLSTGLDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGY 365 (550)
T ss_pred cccchhhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCC
Confidence 998543210 00 00 01358999999999999999
Q ss_pred CCcchhHHHHHHHHHHHhCCCCCCCCCC
Q 044494 115 TEKSDVYSFGVVALEVLMGKHPGELLSS 142 (144)
Q Consensus 115 ~~~~d~~slg~~l~~~~~g~~p~~~~~~ 142 (144)
+..+|.||||||+|||+.|.+||..-++
T Consensus 366 ~~~cDwWSLG~ImyEmLvGyPPF~s~tp 393 (550)
T KOG0605|consen 366 GKECDWWSLGCIMYEMLVGYPPFCSETP 393 (550)
T ss_pred CccccHHHHHHHHHHHHhCCCCCCCCCH
Confidence 9999999999999999999999987553
|
|
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=197.50 Aligned_cols=133 Identities=26% Similarity=0.374 Sum_probs=114.9
Q ss_pred CceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeeec
Q 044494 3 RKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADFG 82 (144)
Q Consensus 3 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~~ 82 (144)
+..+|+||||+++|+|.+++.+... +++..+..++.|++.||+||| ++|++||||||+||+++.++.++|+|||
T Consensus 73 ~~~~~lv~E~~~gg~L~~~l~~~~~---l~~~~~~~~~~qi~~aL~~lH---~~givHrDlKp~NILi~~~~~vkL~DFG 146 (363)
T cd05628 73 KLNLYLIMEFLPGGDMMTLLMKKDT---LTEEETQFYIAETVLAIDSIH---QLGFIHRDIKPDNLLLDSKGHVKLSDFG 146 (363)
T ss_pred CCeEEEEEcCCCCCcHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHH---hCCeEecCCCHHHeEECCCCCEEEeecc
Confidence 4678999999999999999976443 899999999999999999999 8999999999999999999999999999
Q ss_pred ceeecccCCC-----------------------------------CcccccccccccCccccccCCCCCcchhHHHHHHH
Q 044494 83 VARLLNFDSS-----------------------------------NRTLLAGTYGYIAPELAYTMVVTEKSDVYSFGVVA 127 (144)
Q Consensus 83 ~~~~~~~~~~-----------------------------------~~~~~~~~~~~~~pe~~~~~~~~~~~d~~slg~~l 127 (144)
++........ ......|++.|+|||++.+..++.++|+||+|+++
T Consensus 147 la~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil 226 (363)
T cd05628 147 LCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIM 226 (363)
T ss_pred CcccccccccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHH
Confidence 9875321100 01234689999999999988899999999999999
Q ss_pred HHHHhCCCCCCCCC
Q 044494 128 LEVLMGKHPGELLS 141 (144)
Q Consensus 128 ~~~~~g~~p~~~~~ 141 (144)
|+|++|..||...+
T Consensus 227 ~ell~G~~Pf~~~~ 240 (363)
T cd05628 227 YEMLIGYPPFCSET 240 (363)
T ss_pred HHHHhCCCCCCCCC
Confidence 99999999997643
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-33 Score=193.79 Aligned_cols=133 Identities=26% Similarity=0.421 Sum_probs=116.5
Q ss_pred CceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeeec
Q 044494 3 RKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADFG 82 (144)
Q Consensus 3 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~~ 82 (144)
++.+|+||||+++|+|.+++..... +++..+..++.|++.||.||| +++++||||||+||+++.++.++++|||
T Consensus 73 ~~~~~lv~E~~~~g~L~~~~~~~~~---~~~~~~~~~~~qi~~al~~lH---~~~ivH~dlkp~Nill~~~~~~kL~Dfg 146 (324)
T cd05587 73 MDRLYFVMEYVNGGDLMYHIQQVGK---FKEPHAVFYAAEIAIGLFFLH---SKGIIYRDLKLDNVMLDAEGHIKIADFG 146 (324)
T ss_pred CCEEEEEEcCCCCCcHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHeEEcCCCCEEEeecC
Confidence 5678999999999999998875443 889999999999999999999 8999999999999999999999999999
Q ss_pred ceeecccCCCCcccccccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCC
Q 044494 83 VARLLNFDSSNRTLLAGTYGYIAPELAYTMVVTEKSDVYSFGVVALEVLMGKHPGELLS 141 (144)
Q Consensus 83 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~d~~slg~~l~~~~~g~~p~~~~~ 141 (144)
++..............|++.|+|||++.+..++.++|+||+|+++|+|++|+.||...+
T Consensus 147 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~ 205 (324)
T cd05587 147 MCKENIFGGKTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGED 205 (324)
T ss_pred cceecCCCCCceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCC
Confidence 98754322333344568999999999998888999999999999999999999997654
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-33 Score=194.52 Aligned_cols=133 Identities=27% Similarity=0.423 Sum_probs=116.9
Q ss_pred CceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeeec
Q 044494 3 RKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADFG 82 (144)
Q Consensus 3 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~~ 82 (144)
++.+|+||||+++|+|.+++..... +++..+..++.|++.|+.+|| +++++||||||+||+++.++.++++|||
T Consensus 73 ~~~~~lv~E~~~~g~L~~~~~~~~~---~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~Nill~~~~~~kL~DfG 146 (323)
T cd05616 73 MDRLYFVMEYVNGGDLMYQIQQVGR---FKEPHAVFYAAEIAIGLFFLH---SKGIIYRDLKLDNVMLDSEGHIKIADFG 146 (323)
T ss_pred CCEEEEEEcCCCCCCHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHH---HCCEEecCCCHHHeEECCCCcEEEccCC
Confidence 4678999999999999998875443 889999999999999999999 8999999999999999999999999999
Q ss_pred ceeecccCCCCcccccccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCC
Q 044494 83 VARLLNFDSSNRTLLAGTYGYIAPELAYTMVVTEKSDVYSFGVVALEVLMGKHPGELLS 141 (144)
Q Consensus 83 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~d~~slg~~l~~~~~g~~p~~~~~ 141 (144)
++..............|++.|+|||++....++.++|+||+|+++|+|++|..||...+
T Consensus 147 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~ 205 (323)
T cd05616 147 MCKENMWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGED 205 (323)
T ss_pred CceecCCCCCccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCC
Confidence 98754333333344568999999999999989999999999999999999999998754
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=202.91 Aligned_cols=132 Identities=30% Similarity=0.442 Sum_probs=121.5
Q ss_pred CCceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeee
Q 044494 2 HRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADF 81 (144)
Q Consensus 2 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~ 81 (144)
.++++|+|.||++||.|++++.+.++ +++.++..++.||+.|+.|+| ..+++|||+||+|++++.++.+||+||
T Consensus 83 ~~~~lylvlEyv~gGELFdylv~kG~---l~e~eaa~ff~QIi~gv~yCH---~~~icHRDLKpENlLLd~~~nIKIADF 156 (786)
T KOG0588|consen 83 NKQHLYLVLEYVPGGELFDYLVRKGP---LPEREAAHFFRQILDGVSYCH---AFNICHRDLKPENLLLDVKNNIKIADF 156 (786)
T ss_pred cCceEEEEEEecCCchhHHHHHhhCC---CCCHHHHHHHHHHHHHHHHHh---hhcceeccCCchhhhhhcccCEeeecc
Confidence 46789999999999999999987766 899999999999999999999 889999999999999999999999999
Q ss_pred cceeecccCCCCcccccccccccCccccccCCCC-CcchhHHHHHHHHHHHhCCCCCCCC
Q 044494 82 GVARLLNFDSSNRTLLAGTYGYIAPELAYTMVVT-EKSDVYSFGVVALEVLMGKHPGELL 140 (144)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~-~~~d~~slg~~l~~~~~g~~p~~~~ 140 (144)
|.|.... +.+..++.+|+|.|.+||++.+.+|+ .++|+||+|+|++.+++|..||++.
T Consensus 157 GMAsLe~-~gklLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDd 215 (786)
T KOG0588|consen 157 GMASLEV-PGKLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDD 215 (786)
T ss_pred ceeeccc-CCccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCc
Confidence 9998654 56778889999999999999999985 6899999999999999999999853
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=195.05 Aligned_cols=134 Identities=25% Similarity=0.355 Sum_probs=116.7
Q ss_pred CCceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeee
Q 044494 2 HRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADF 81 (144)
Q Consensus 2 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~ 81 (144)
.++++|+||||+++++|.+++..... +++..+..++.|++.||+||| +.|++||||||+||+++.++.++++||
T Consensus 66 ~~~~~~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~qi~~~L~~lH---~~~ivHrDlkp~NIll~~~~~~kl~Df 139 (323)
T cd05571 66 THDRLCFVMEYANGGELFFHLSRERV---FSEDRARFYGAEIVSALGYLH---SCDVVYRDLKLENLMLDKDGHIKITDF 139 (323)
T ss_pred cCCEEEEEEeCCCCCcHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHH---hCCeEeCCCCHHHEEECCCCCEEEeeC
Confidence 35678999999999999998875443 899999999999999999999 899999999999999999999999999
Q ss_pred cceeecccCCCCcccccccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCC
Q 044494 82 GVARLLNFDSSNRTLLAGTYGYIAPELAYTMVVTEKSDVYSFGVVALEVLMGKHPGELLS 141 (144)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~d~~slg~~l~~~~~g~~p~~~~~ 141 (144)
|++..............|++.|+|||.+....++.++|+||+|+++++|++|..||...+
T Consensus 140 G~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~ 199 (323)
T cd05571 140 GLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD 199 (323)
T ss_pred CCCcccccCCCcccceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCC
Confidence 998754322233344568999999999998889999999999999999999999997543
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-34 Score=194.12 Aligned_cols=130 Identities=32% Similarity=0.441 Sum_probs=113.3
Q ss_pred eEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcC-CCCeEEeeecc
Q 044494 5 CMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNL-ELEAFVADFGV 83 (144)
Q Consensus 5 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~-~~~~~l~d~~~ 83 (144)
.++++|||+++|+|.+++.+.+. .++++.+..+..|+++|++||| ++|++|+||||.||+++. ++.+||+|||.
T Consensus 90 ~~~i~mEy~~~GsL~~~~~~~g~--~l~E~~v~~ytr~iL~GL~ylH---s~g~vH~DiK~~NiLl~~~~~~~KlaDFG~ 164 (313)
T KOG0198|consen 90 EYNIFMEYAPGGSLSDLIKRYGG--KLPEPLVRRYTRQILEGLAYLH---SKGIVHCDIKPANILLDPSNGDVKLADFGL 164 (313)
T ss_pred eeEeeeeccCCCcHHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHH---hCCEeccCcccceEEEeCCCCeEEeccCcc
Confidence 68999999999999999987543 4999999999999999999999 999999999999999999 79999999998
Q ss_pred eeeccc---CCCCcccccccccccCccccccC-CCCCcchhHHHHHHHHHHHhCCCCCCC
Q 044494 84 ARLLNF---DSSNRTLLAGTYGYIAPELAYTM-VVTEKSDVYSFGVVALEVLMGKHPGEL 139 (144)
Q Consensus 84 ~~~~~~---~~~~~~~~~~~~~~~~pe~~~~~-~~~~~~d~~slg~~l~~~~~g~~p~~~ 139 (144)
+..... .........|++.|||||++... ..++++|+||+||++.||+||..||..
T Consensus 165 a~~~~~~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~ 224 (313)
T KOG0198|consen 165 AKKLESKGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSE 224 (313)
T ss_pred ccccccccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchh
Confidence 886652 11223347799999999999853 334589999999999999999999986
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=198.95 Aligned_cols=135 Identities=32% Similarity=0.479 Sum_probs=116.8
Q ss_pred ceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeeecc
Q 044494 4 KCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADFGV 83 (144)
Q Consensus 4 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~~~ 83 (144)
+.+||||||++.|+|.++|+.. ....+...+.+.++.|||+|++||+ ++++||||+...||+++.+..+||+|||+
T Consensus 274 ~piyIVtE~m~~GsLl~yLr~~-~~~~l~~~~Ll~~a~qIaeGM~YLe---s~~~IHRDLAARNiLV~~~~~vKIsDFGL 349 (468)
T KOG0197|consen 274 EPIYIVTEYMPKGSLLDYLRTR-EGGLLNLPQLLDFAAQIAEGMAYLE---SKNYIHRDLAARNILVDEDLVVKISDFGL 349 (468)
T ss_pred CceEEEEEecccCcHHHHhhhc-CCCccchHHHHHHHHHHHHHHHHHH---hCCccchhhhhhheeeccCceEEEccccc
Confidence 4689999999999999999972 2334899999999999999999999 99999999999999999999999999999
Q ss_pred eeecccCCC-CcccccccccccCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCC
Q 044494 84 ARLLNFDSS-NRTLLAGTYGYIAPELAYTMVVTEKSDVYSFGVVALEVLM-GKHPGELLSS 142 (144)
Q Consensus 84 ~~~~~~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~d~~slg~~l~~~~~-g~~p~~~~~~ 142 (144)
++......- ......-...|.|||.+....++.++|+||||++++|++| |+.||.+++.
T Consensus 350 Ar~~~d~~Y~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn 410 (468)
T KOG0197|consen 350 ARLIGDDEYTASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSN 410 (468)
T ss_pred ccccCCCceeecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCH
Confidence 995432211 1222334568999999999999999999999999999998 9999999875
|
|
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-33 Score=193.24 Aligned_cols=133 Identities=29% Similarity=0.468 Sum_probs=117.1
Q ss_pred CceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeeec
Q 044494 3 RKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADFG 82 (144)
Q Consensus 3 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~~ 82 (144)
.+.+|+||||+++|+|.+++.+... +++..+..++.|++.|+.+|| +.+++||||||+||+++.++.++++|||
T Consensus 68 ~~~~~iv~Ey~~~g~L~~~i~~~~~---l~~~~~~~~~~ql~~~L~~lH---~~~ivH~dlkp~NIli~~~~~~kL~DfG 141 (320)
T cd05590 68 PDRLFFVMEFVNGGDLMFHIQKSRR---FDEARARFYAAEITSALMFLH---DKGIIYRDLKLDNVLLDHEGHCKLADFG 141 (320)
T ss_pred CCEEEEEEcCCCCchHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCCHHHeEECCCCcEEEeeCC
Confidence 5678999999999999998876443 899999999999999999999 8999999999999999999999999999
Q ss_pred ceeecccCCCCcccccccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCC
Q 044494 83 VARLLNFDSSNRTLLAGTYGYIAPELAYTMVVTEKSDVYSFGVVALEVLMGKHPGELLS 141 (144)
Q Consensus 83 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~d~~slg~~l~~~~~g~~p~~~~~ 141 (144)
++..............|++.|+|||.+....++.++|+||+|+++|+|++|..||...+
T Consensus 142 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~ 200 (320)
T cd05590 142 MCKEGIFNGKTTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAEN 200 (320)
T ss_pred CCeecCcCCCcccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCC
Confidence 98754333333444668999999999998888999999999999999999999997654
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-33 Score=192.07 Aligned_cols=133 Identities=28% Similarity=0.457 Sum_probs=116.7
Q ss_pred CceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeeec
Q 044494 3 RKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADFG 82 (144)
Q Consensus 3 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~~ 82 (144)
++.+|+||||+++|+|.+++..... +++..+..++.|++.|+.||| +.+++||||||+||+++.++.++++|||
T Consensus 68 ~~~~~lv~e~~~gg~L~~~~~~~~~---~~~~~~~~~~~qi~~al~~LH---~~~ivH~dlkp~Nill~~~~~~kL~Dfg 141 (316)
T cd05592 68 KEHLFFVMEYLNGGDLMFHIQSSGR---FDEARARFYAAEIICGLQFLH---KKGIIYRDLKLDNVLLDKDGHIKIADFG 141 (316)
T ss_pred CCEEEEEEcCCCCCcHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHH---HCCEEeCCCCHHHeEECCCCCEEEccCc
Confidence 4678999999999999998875443 899999999999999999999 8999999999999999999999999999
Q ss_pred ceeecccCCCCcccccccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCC
Q 044494 83 VARLLNFDSSNRTLLAGTYGYIAPELAYTMVVTEKSDVYSFGVVALEVLMGKHPGELLS 141 (144)
Q Consensus 83 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~d~~slg~~l~~~~~g~~p~~~~~ 141 (144)
++..............|++.|+|||.+.+..++.++|+||+|+++++|++|..||...+
T Consensus 142 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~ 200 (316)
T cd05592 142 MCKENMNGEGKASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGED 200 (316)
T ss_pred CCeECCCCCCccccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCC
Confidence 98764333333344568999999999998889999999999999999999999997654
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-33 Score=192.12 Aligned_cols=133 Identities=26% Similarity=0.366 Sum_probs=115.9
Q ss_pred CceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeeec
Q 044494 3 RKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADFG 82 (144)
Q Consensus 3 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~~ 82 (144)
++++|+||||+++++|..++..... +++..+..++.|++.|+.+|| ++|++||||||+||+++.++.++++|||
T Consensus 67 ~~~~~lv~E~~~~~~L~~~l~~~~~---~~~~~~~~~~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~Dfg 140 (323)
T cd05595 67 HDRLCFVMEYANGGELFFHLSRERV---FTEERARFYGAEIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFG 140 (323)
T ss_pred CCEEEEEEeCCCCCcHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHEEEcCCCCEEecccH
Confidence 5678999999999999988875443 899999999999999999999 8999999999999999999999999999
Q ss_pred ceeecccCCCCcccccccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCC
Q 044494 83 VARLLNFDSSNRTLLAGTYGYIAPELAYTMVVTEKSDVYSFGVVALEVLMGKHPGELLS 141 (144)
Q Consensus 83 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~d~~slg~~l~~~~~g~~p~~~~~ 141 (144)
++..............+++.|+|||.+.+..++.++|+||+|+++|+|++|..||...+
T Consensus 141 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~ 199 (323)
T cd05595 141 LCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD 199 (323)
T ss_pred HhccccCCCCccccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCC
Confidence 88753322222334568999999999998889999999999999999999999997643
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-33 Score=191.98 Aligned_cols=134 Identities=26% Similarity=0.467 Sum_probs=116.6
Q ss_pred CCceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeee
Q 044494 2 HRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADF 81 (144)
Q Consensus 2 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~ 81 (144)
.++.+|+||||+++++|.+++..... +++..+..++.|++.|+++|| ++|++||||||+||+++.++.++++||
T Consensus 67 ~~~~~~lv~E~~~~g~L~~~i~~~~~---~~~~~~~~~~~qi~~~l~~lH---~~~ivHrDlkp~Nil~~~~~~~kl~Df 140 (316)
T cd05620 67 TKEHLFFVMEFLNGGDLMFHIQDKGR---FDLYRATFYAAEIVCGLQFLH---SKGIIYRDLKLDNVMLDRDGHIKIADF 140 (316)
T ss_pred eCCEEEEEECCCCCCcHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHeEECCCCCEEeCcc
Confidence 35678999999999999998876433 889999999999999999999 899999999999999999999999999
Q ss_pred cceeecccCCCCcccccccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCC
Q 044494 82 GVARLLNFDSSNRTLLAGTYGYIAPELAYTMVVTEKSDVYSFGVVALEVLMGKHPGELLS 141 (144)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~d~~slg~~l~~~~~g~~p~~~~~ 141 (144)
|++..............|++.|+|||.+.+..++.++|+||+|+++++|++|..||...+
T Consensus 141 g~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~ 200 (316)
T cd05620 141 GMCKENVFGDNRASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDD 200 (316)
T ss_pred CCCeecccCCCceeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCC
Confidence 998753322223344568999999999998889999999999999999999999997654
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-33 Score=192.86 Aligned_cols=134 Identities=27% Similarity=0.444 Sum_probs=117.0
Q ss_pred CCceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeee
Q 044494 2 HRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADF 81 (144)
Q Consensus 2 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~ 81 (144)
.++.+|+||||+++++|..++..... +++..+..++.|++.|+.+|| +.|++||||||+||+++.++.++++||
T Consensus 67 ~~~~~~lv~E~~~~~~L~~~l~~~~~---~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDikp~Nill~~~~~~kL~Df 140 (321)
T cd05591 67 TKDRLFFVMEYVNGGDLMFQIQRSRK---FDEPRSRFYAAEVTLALMFLH---RHGVIYRDLKLDNILLDAEGHCKLADF 140 (321)
T ss_pred cCCeEEEEEeCCCCCcHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHeEECCCCCEEEeec
Confidence 35678999999999999988875443 889999999999999999999 899999999999999999999999999
Q ss_pred cceeecccCCCCcccccccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCC
Q 044494 82 GVARLLNFDSSNRTLLAGTYGYIAPELAYTMVVTEKSDVYSFGVVALEVLMGKHPGELLS 141 (144)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~d~~slg~~l~~~~~g~~p~~~~~ 141 (144)
|++..............+++.|+|||.+....++.++|+||+|+++|+|++|..||...+
T Consensus 141 g~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~ 200 (321)
T cd05591 141 GMCKEGILNGVTTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADN 200 (321)
T ss_pred ccceecccCCccccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCC
Confidence 998754333333344568999999999998889999999999999999999999998654
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-33 Score=191.99 Aligned_cols=133 Identities=25% Similarity=0.403 Sum_probs=116.7
Q ss_pred CceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeeec
Q 044494 3 RKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADFG 82 (144)
Q Consensus 3 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~~ 82 (144)
++.+|+||||+++|+|.+++..... +++..+..++.|++.|+.+|| ++|++||||||+||+++.++.++++|||
T Consensus 73 ~~~~~lv~Ey~~~g~L~~~i~~~~~---l~~~~~~~i~~qi~~al~~lH---~~~ivHrDikp~Nill~~~~~ikL~Dfg 146 (323)
T cd05615 73 VDRLYFVMEYVNGGDLMYHIQQVGK---FKEPQAVFYAAEISVGLFFLH---RRGIIYRDLKLDNVMLDSEGHIKIADFG 146 (323)
T ss_pred CCEEEEEEcCCCCCcHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHeEECCCCCEEEeccc
Confidence 4678999999999999998875443 899999999999999999999 8999999999999999999999999999
Q ss_pred ceeecccCCCCcccccccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCC
Q 044494 83 VARLLNFDSSNRTLLAGTYGYIAPELAYTMVVTEKSDVYSFGVVALEVLMGKHPGELLS 141 (144)
Q Consensus 83 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~d~~slg~~l~~~~~g~~p~~~~~ 141 (144)
++..............|++.|+|||++.+..++.++|+||+|+++++|++|..||...+
T Consensus 147 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~ 205 (323)
T cd05615 147 MCKEHMVDGVTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGED 205 (323)
T ss_pred cccccCCCCccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCC
Confidence 98754332333344568999999999998888999999999999999999999998754
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-33 Score=192.25 Aligned_cols=132 Identities=24% Similarity=0.410 Sum_probs=115.7
Q ss_pred CceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeeec
Q 044494 3 RKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADFG 82 (144)
Q Consensus 3 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~~ 82 (144)
++.+|+||||+++++|..++..... +++..+..++.|++.|+++|| +++++||||||+||+++.++.++|+|||
T Consensus 68 ~~~~~lv~e~~~~~~L~~~~~~~~~---l~~~~~~~~~~qi~~al~~lH---~~~ivHrDlkp~Nili~~~~~~kl~Dfg 141 (327)
T cd05617 68 TSRLFLVIEYVNGGDLMFHMQRQRK---LPEEHARFYAAEICIALNFLH---ERGIIYRDLKLDNVLLDADGHIKLTDYG 141 (327)
T ss_pred CCEEEEEEeCCCCCcHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHEEEeCCCCEEEeccc
Confidence 5678999999999999988875443 899999999999999999999 8999999999999999999999999999
Q ss_pred ceeecccCCCCcccccccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCC
Q 044494 83 VARLLNFDSSNRTLLAGTYGYIAPELAYTMVVTEKSDVYSFGVVALEVLMGKHPGELL 140 (144)
Q Consensus 83 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~d~~slg~~l~~~~~g~~p~~~~ 140 (144)
++..............|++.|+|||.+.+..++.++|+||+|+++|+|++|..||...
T Consensus 142 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~ 199 (327)
T cd05617 142 MCKEGLGPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDII 199 (327)
T ss_pred cceeccCCCCceecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCcc
Confidence 8875332223334466899999999999888999999999999999999999999643
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-33 Score=192.21 Aligned_cols=134 Identities=25% Similarity=0.377 Sum_probs=116.1
Q ss_pred CCceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeee
Q 044494 2 HRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADF 81 (144)
Q Consensus 2 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~ 81 (144)
.++.+|+||||+++|+|..++..... +++..+..++.|++.|++||| +++++||||||+||+++.++.++++||
T Consensus 66 ~~~~~~lv~Ey~~~g~L~~~l~~~~~---l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDikp~NIll~~~~~~kL~Df 139 (328)
T cd05593 66 TKDRLCFVMEYVNGGELFFHLSRERV---FSEDRTRFYGAEIVSALDYLH---SGKIVYRDLKLENLMLDKDGHIKITDF 139 (328)
T ss_pred cCCEEEEEEeCCCCCCHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHH---hCCeEecccCHHHeEECCCCcEEEecC
Confidence 35678999999999999988875433 899999999999999999999 899999999999999999999999999
Q ss_pred cceeecccCCCCcccccccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCC
Q 044494 82 GVARLLNFDSSNRTLLAGTYGYIAPELAYTMVVTEKSDVYSFGVVALEVLMGKHPGELLS 141 (144)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~d~~slg~~l~~~~~g~~p~~~~~ 141 (144)
|++..............+++.|+|||.+....++.++|+||+|+++|+|++|..||...+
T Consensus 140 G~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~ 199 (328)
T cd05593 140 GLCKEGITDAATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD 199 (328)
T ss_pred cCCccCCCcccccccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCC
Confidence 998753322222334568999999999998888999999999999999999999997643
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-32 Score=190.79 Aligned_cols=133 Identities=27% Similarity=0.414 Sum_probs=116.4
Q ss_pred CCceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeee
Q 044494 2 HRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADF 81 (144)
Q Consensus 2 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~ 81 (144)
.++.+|+||||+++|+|.+++.+... +++..+..++.|++.|+.||| +++++||||||+||+++.++.++++||
T Consensus 64 ~~~~~~lv~e~~~~g~L~~~l~~~~~---~~~~~~~~~~~qi~~~l~~lH---~~~i~HrDlkp~Nili~~~~~~kl~Df 137 (312)
T cd05585 64 SPEKLYLVLAFINGGELFHHLQREGR---FDLSRARFYTAELLCALENLH---KFNVIYRDLKPENILLDYQGHIALCDF 137 (312)
T ss_pred cCCeEEEEEcCCCCCcHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHH---hCCeEeCCCCHHHeEECCCCcEEEEEC
Confidence 35678999999999999999876443 899999999999999999999 899999999999999999999999999
Q ss_pred cceeecccCCCCcccccccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCC
Q 044494 82 GVARLLNFDSSNRTLLAGTYGYIAPELAYTMVVTEKSDVYSFGVVALEVLMGKHPGELL 140 (144)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~d~~slg~~l~~~~~g~~p~~~~ 140 (144)
|++..............|++.|+|||.+.+..++.++|+||+|+++++|++|..||...
T Consensus 138 g~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~ 196 (312)
T cd05585 138 GLCKLNMKDDDKTNTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDE 196 (312)
T ss_pred cccccCccCCCccccccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCC
Confidence 99875432222334456899999999999988999999999999999999999999754
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-33 Score=192.33 Aligned_cols=133 Identities=27% Similarity=0.427 Sum_probs=123.8
Q ss_pred ceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeeecc
Q 044494 4 KCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADFGV 83 (144)
Q Consensus 4 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~~~ 83 (144)
.++|+||||+.||+|...+++-++ +.++.++.++..|+-||-+|| ++||+.||+|.+|++++.+|++||.|||.
T Consensus 423 DRLyFVMEyvnGGDLMyhiQQ~Gk---FKEp~AvFYAaEiaigLFFLh---~kgIiYRDLKLDNvmLd~eGHiKi~DFGm 496 (683)
T KOG0696|consen 423 DRLYFVMEYVNGGDLMYHIQQVGK---FKEPVAVFYAAEIAIGLFFLH---SKGIIYRDLKLDNVMLDSEGHIKIADFGM 496 (683)
T ss_pred hheeeEEEEecCchhhhHHHHhcc---cCCchhhhhhHHHHHHhhhhh---cCCeeeeeccccceEeccCCceEeeeccc
Confidence 468999999999999999987665 888999999999999999999 99999999999999999999999999999
Q ss_pred eeecccCCCCcccccccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCC
Q 044494 84 ARLLNFDSSNRTLLAGTYGYIAPELAYTMVVTEKSDVYSFGVVALEVLMGKHPGELLSS 142 (144)
Q Consensus 84 ~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~d~~slg~~l~~~~~g~~p~~~~~~ 142 (144)
++.--.......+.+|||.|+|||++.+++|+..+|.||+|+++|||+.|+.||++-|.
T Consensus 497 cKEni~~~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE 555 (683)
T KOG0696|consen 497 CKENIFDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDE 555 (683)
T ss_pred ccccccCCcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCH
Confidence 98765566677889999999999999999999999999999999999999999998765
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-33 Score=198.22 Aligned_cols=129 Identities=33% Similarity=0.481 Sum_probs=120.5
Q ss_pred CceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeeec
Q 044494 3 RKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADFG 82 (144)
Q Consensus 3 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~~ 82 (144)
.+.+|+|+||+.| +|..++...+. ++++.+..++.+++.|+.||| +.++.|||+||+||++...+.+|++|||
T Consensus 73 ~~~~~vVte~a~g-~L~~il~~d~~---lpEe~v~~~a~~LVsaL~yLh---s~rilhrd~kPqniLl~~~~~~KlcdFg 145 (808)
T KOG0597|consen 73 SAHLWVVTEYAVG-DLFTILEQDGK---LPEEQVRAIAYDLVSALYYLH---SNRILHRDMKPQNILLEKGGTLKLCDFG 145 (808)
T ss_pred cceEEEEehhhhh-hHHHHHHhccC---CCHHHHHHHHHHHHHHHHHHH---hcCcccccCCcceeeecCCCceeechhh
Confidence 4678999999987 99999986554 999999999999999999999 8999999999999999999999999999
Q ss_pred ceeecccCCCCcccccccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCC
Q 044494 83 VARLLNFDSSNRTLLAGTYGYIAPELAYTMVVTEKSDVYSFGVVALEVLMGKHPGE 138 (144)
Q Consensus 83 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~d~~slg~~l~~~~~g~~p~~ 138 (144)
+++.+..+........|||.|||||......|+..+|+||+||++||+++|++||-
T Consensus 146 ~Ar~m~~~t~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~ 201 (808)
T KOG0597|consen 146 LARAMSTNTSVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFY 201 (808)
T ss_pred hhhhcccCceeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCch
Confidence 99988877767777899999999999999999999999999999999999999994
|
|
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-33 Score=191.80 Aligned_cols=133 Identities=26% Similarity=0.408 Sum_probs=116.1
Q ss_pred CceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeeec
Q 044494 3 RKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADFG 82 (144)
Q Consensus 3 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~~ 82 (144)
++.+|+||||+++|+|..++.+... +++..+..++.|++.||+||| ++|++||||||+||+++.++.++++|||
T Consensus 68 ~~~~~lv~e~~~~g~L~~~l~~~~~---~~~~~~~~~~~qi~~~l~~lH---~~givH~dikp~NIll~~~~~~kl~Dfg 141 (323)
T cd05575 68 ADKLYFVLDYVNGGELFFHLQRERS---FPEPRARFYAAEIASALGYLH---SLNIIYRDLKPENILLDSQGHVVLTDFG 141 (323)
T ss_pred CCEEEEEEcCCCCCCHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCCHHHeEECCCCcEEEeccC
Confidence 5678999999999999998876443 889999999999999999999 8999999999999999999999999999
Q ss_pred ceeecccCCCCcccccccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCC
Q 044494 83 VARLLNFDSSNRTLLAGTYGYIAPELAYTMVVTEKSDVYSFGVVALEVLMGKHPGELLS 141 (144)
Q Consensus 83 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~d~~slg~~l~~~~~g~~p~~~~~ 141 (144)
++..............+++.|+|||.+.+..++.++|+||+|+++|+|++|..||...+
T Consensus 142 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~ 200 (323)
T cd05575 142 LCKEGIEHSKTTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRD 200 (323)
T ss_pred CCcccccCCCccccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCC
Confidence 88753322233334568999999999998889999999999999999999999997643
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-32 Score=189.25 Aligned_cols=133 Identities=28% Similarity=0.478 Sum_probs=116.0
Q ss_pred CceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeeec
Q 044494 3 RKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADFG 82 (144)
Q Consensus 3 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~~ 82 (144)
++.+|+||||+++|+|.+++..... +++..+..++.|++.|+.+|| +.+++||||||+||+++.++.++++|||
T Consensus 68 ~~~~~lv~ey~~~g~L~~~l~~~~~---~~~~~~~~~~~qi~~al~~LH---~~~ivHrdikp~Nil~~~~~~~kl~Dfg 141 (316)
T cd05619 68 KENLFFVMEYLNGGDLMFHIQSCHK---FDLPRATFYAAEIICGLQFLH---SKGIVYRDLKLDNILLDTDGHIKIADFG 141 (316)
T ss_pred CCEEEEEEeCCCCCcHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHH---hCCeEeCCCCHHHEEECCCCCEEEccCC
Confidence 5678999999999999999875433 889999999999999999999 8999999999999999999999999999
Q ss_pred ceeecccCCCCcccccccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCC
Q 044494 83 VARLLNFDSSNRTLLAGTYGYIAPELAYTMVVTEKSDVYSFGVVALEVLMGKHPGELLS 141 (144)
Q Consensus 83 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~d~~slg~~l~~~~~g~~p~~~~~ 141 (144)
++..............+++.|+|||.+.+..++.++|+||+|+++|+|++|..||...+
T Consensus 142 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~ 200 (316)
T cd05619 142 MCKENMLGDAKTCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHD 200 (316)
T ss_pred cceECCCCCCceeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCC
Confidence 98754322223344568999999999998889999999999999999999999997654
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-33 Score=184.35 Aligned_cols=134 Identities=26% Similarity=0.346 Sum_probs=116.6
Q ss_pred CceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeeec
Q 044494 3 RKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADFG 82 (144)
Q Consensus 3 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~~ 82 (144)
+++++||+|||.. ++.+-+.+ ...+++...+..++.|++.|+.|+| +.+++||||||+||+++.++.+|+||||
T Consensus 73 krklhLVFE~~dh-TvL~eLe~--~p~G~~~~~vk~~l~Q~l~ai~~cH---k~n~IHRDIKPENILit~~gvvKLCDFG 146 (396)
T KOG0593|consen 73 KRKLHLVFEYCDH-TVLHELER--YPNGVPSELVKKYLYQLLKAIHFCH---KNNCIHRDIKPENILITQNGVVKLCDFG 146 (396)
T ss_pred cceeEEEeeecch-HHHHHHHh--ccCCCCHHHHHHHHHHHHHHhhhhh---hcCeecccCChhheEEecCCcEEeccch
Confidence 4688999999976 55555653 2234999999999999999999999 9999999999999999999999999999
Q ss_pred ceeecccCCCCcccccccccccCcccccc-CCCCCcchhHHHHHHHHHHHhCCCCCCCCCC
Q 044494 83 VARLLNFDSSNRTLLAGTYGYIAPELAYT-MVVTEKSDVYSFGVVALEVLMGKHPGELLSS 142 (144)
Q Consensus 83 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~-~~~~~~~d~~slg~~l~~~~~g~~p~~~~~~ 142 (144)
+++....+...-.....|.+|.|||.+.+ .+|+...|+||+||++.||++|.+-|.+.++
T Consensus 147 FAR~L~~pgd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SD 207 (396)
T KOG0593|consen 147 FARTLSAPGDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSD 207 (396)
T ss_pred hhHhhcCCcchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcch
Confidence 99977655555555678999999999998 6789999999999999999999999987664
|
|
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-33 Score=193.01 Aligned_cols=133 Identities=25% Similarity=0.363 Sum_probs=115.5
Q ss_pred CceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCC-CCeEecCCCCCcEEEcCCCCeEEeee
Q 044494 3 RKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCT-PPIVHRDISSNNILLNLELEAFVADF 81 (144)
Q Consensus 3 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~-~~~~h~~i~~~ni~~~~~~~~~l~d~ 81 (144)
++.+|+||||+++|+|..++..... +++..+..++.|++.|+.||| + .+++||||||+||+++.++.++|+||
T Consensus 67 ~~~~~lv~E~~~~~~L~~~l~~~~~---l~~~~~~~~~~qi~~aL~~lH---~~~~ivHrDikp~NIll~~~~~~kL~Df 140 (325)
T cd05594 67 HDRLCFVMEYANGGELFFHLSRERV---FSEDRARFYGAEIVSALDYLH---SEKNVVYRDLKLENLMLDKDGHIKITDF 140 (325)
T ss_pred CCEEEEEEeCCCCCcHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHH---hcCCEEecCCCCCeEEECCCCCEEEecC
Confidence 5678999999999999988875433 899999999999999999999 6 79999999999999999999999999
Q ss_pred cceeecccCCCCcccccccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCC
Q 044494 82 GVARLLNFDSSNRTLLAGTYGYIAPELAYTMVVTEKSDVYSFGVVALEVLMGKHPGELLS 141 (144)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~d~~slg~~l~~~~~g~~p~~~~~ 141 (144)
|++..............+++.|+|||++.+..++.++|+||+|+++|+|++|..||...+
T Consensus 141 g~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~ 200 (325)
T cd05594 141 GLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD 200 (325)
T ss_pred CCCeecCCCCcccccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCC
Confidence 998754322223334568999999999998888999999999999999999999997643
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-32 Score=190.86 Aligned_cols=131 Identities=24% Similarity=0.398 Sum_probs=115.0
Q ss_pred CceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeeec
Q 044494 3 RKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADFG 82 (144)
Q Consensus 3 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~~ 82 (144)
++.+|+||||+++|+|.+++.+.+. +++..+..++.|++.|+.+|| ++|++||||||+||+++.++.++|+|||
T Consensus 68 ~~~~~lv~e~~~~g~L~~~~~~~~~---l~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nili~~~~~~kL~Dfg 141 (329)
T cd05588 68 ESRLFFVIEFVSGGDLMFHMQRQRK---LPEEHARFYSAEISLALNFLH---ERGIIYRDLKLDNVLLDAEGHIKLTDYG 141 (329)
T ss_pred CCEEEEEEeCCCCCCHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHeEECCCCCEEECcCc
Confidence 5678999999999999988875443 899999999999999999999 8999999999999999999999999999
Q ss_pred ceeecccCCCCcccccccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCC
Q 044494 83 VARLLNFDSSNRTLLAGTYGYIAPELAYTMVVTEKSDVYSFGVVALEVLMGKHPGEL 139 (144)
Q Consensus 83 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~d~~slg~~l~~~~~g~~p~~~ 139 (144)
++..............|++.|+|||.+.+..++.++|+||+|+++|++++|..||+.
T Consensus 142 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~ 198 (329)
T cd05588 142 MCKEGIRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDI 198 (329)
T ss_pred cccccccCCCccccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCccc
Confidence 886432222233445689999999999998899999999999999999999999964
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=191.31 Aligned_cols=133 Identities=26% Similarity=0.395 Sum_probs=116.0
Q ss_pred CceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeeec
Q 044494 3 RKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADFG 82 (144)
Q Consensus 3 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~~ 82 (144)
++.+|+||||+++++|.+++..... +.+..+..++.|++.||.+|| +.|++||||||+||+++.++.++++|||
T Consensus 68 ~~~~~lv~e~~~~~~L~~~~~~~~~---~~~~~~~~~~~qi~~~L~~lH---~~giiHrDlkp~Nili~~~~~~kl~DfG 141 (325)
T cd05602 68 ADKLYFVLDYINGGELFYHLQRERC---FLEPRARFYAAEIASALGYLH---SLNIVYRDLKPENILLDSQGHIVLTDFG 141 (325)
T ss_pred CCeEEEEEeCCCCCcHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHeEECCCCCEEEccCC
Confidence 5678999999999999998875433 788889999999999999999 8999999999999999999999999999
Q ss_pred ceeecccCCCCcccccccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCC
Q 044494 83 VARLLNFDSSNRTLLAGTYGYIAPELAYTMVVTEKSDVYSFGVVALEVLMGKHPGELLS 141 (144)
Q Consensus 83 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~d~~slg~~l~~~~~g~~p~~~~~ 141 (144)
++..............|++.|+|||++.+..++.++|+||+|+++|+|++|..||...+
T Consensus 142 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~ 200 (325)
T cd05602 142 LCKENIEHNGTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRN 200 (325)
T ss_pred CCcccccCCCCcccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCC
Confidence 98754322333344568999999999999889999999999999999999999997643
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=191.06 Aligned_cols=134 Identities=25% Similarity=0.377 Sum_probs=115.6
Q ss_pred CCceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeee
Q 044494 2 HRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADF 81 (144)
Q Consensus 2 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~ 81 (144)
.++.+|+||||+++++|...+..... +++..+..++.|++.||.+|| +.+++||||||+||+++.++.++++||
T Consensus 67 ~~~~~~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~qi~~~L~~lH---~~~ivH~Dlkp~NIll~~~~~~kl~Df 140 (321)
T cd05603 67 TAEKLYFVLDYVNGGELFFHLQRERC---FLEPRARFYAAEVASAIGYLH---SLNIIYRDLKPENILLDSQGHVVLTDF 140 (321)
T ss_pred cCCEEEEEEcCCCCCCHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHH---HCCeEeccCCHHHeEECCCCCEEEccC
Confidence 35678999999999999988865433 888999999999999999999 899999999999999999999999999
Q ss_pred cceeecccCCCCcccccccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCC
Q 044494 82 GVARLLNFDSSNRTLLAGTYGYIAPELAYTMVVTEKSDVYSFGVVALEVLMGKHPGELLS 141 (144)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~d~~slg~~l~~~~~g~~p~~~~~ 141 (144)
|++..............+++.|+|||.+....++.++|+||+|+++|+|++|..||...+
T Consensus 141 g~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~ 200 (321)
T cd05603 141 GLCKEGVEPEETTSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRD 200 (321)
T ss_pred CCCccCCCCCCccccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCC
Confidence 988753322222334568899999999998888999999999999999999999997653
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-32 Score=190.72 Aligned_cols=131 Identities=25% Similarity=0.411 Sum_probs=115.1
Q ss_pred CceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeeec
Q 044494 3 RKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADFG 82 (144)
Q Consensus 3 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~~ 82 (144)
++.+|+||||+++++|..++.+... +++..+..++.|++.|+.||| +++++||||||+||+++.++.++|+|||
T Consensus 68 ~~~~~lv~E~~~~~~L~~~~~~~~~---l~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dikp~Nili~~~~~~kL~DfG 141 (329)
T cd05618 68 ESRLFFVIEYVNGGDLMFHMQRQRK---LPEEHARFYSAEISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYG 141 (329)
T ss_pred CCEEEEEEeCCCCCCHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHHHEEECCCCCEEEeeCC
Confidence 5678999999999999988875433 899999999999999999999 8999999999999999999999999999
Q ss_pred ceeecccCCCCcccccccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCC
Q 044494 83 VARLLNFDSSNRTLLAGTYGYIAPELAYTMVVTEKSDVYSFGVVALEVLMGKHPGEL 139 (144)
Q Consensus 83 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~d~~slg~~l~~~~~g~~p~~~ 139 (144)
++..............|++.|+|||.+.+..++.++|+||+|+++|+|++|..||..
T Consensus 142 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~ 198 (329)
T cd05618 142 MCKEGLRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDI 198 (329)
T ss_pred ccccccCCCCccccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCcc
Confidence 987543222333446689999999999988889999999999999999999999963
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-32 Score=189.77 Aligned_cols=134 Identities=25% Similarity=0.377 Sum_probs=116.4
Q ss_pred CCceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeee
Q 044494 2 HRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADF 81 (144)
Q Consensus 2 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~ 81 (144)
.++.+|+||||+++++|.+++.+... +.+..+..++.|++.||.+|| +.+++||||||+||+++.++.++|+||
T Consensus 71 ~~~~~~lv~e~~~~~~L~~~~~~~~~---~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~Df 144 (323)
T cd05584 71 TGGKLYLILEYLSGGELFMHLEREGI---FMEDTACFYLSEISLALEHLH---QQGIIYRDLKPENILLDAQGHVKLTDF 144 (323)
T ss_pred cCCeEEEEEeCCCCchHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCCEEEeeC
Confidence 35678999999999999999876443 788889999999999999999 899999999999999999999999999
Q ss_pred cceeecccCCCCcccccccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCC
Q 044494 82 GVARLLNFDSSNRTLLAGTYGYIAPELAYTMVVTEKSDVYSFGVVALEVLMGKHPGELLS 141 (144)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~d~~slg~~l~~~~~g~~p~~~~~ 141 (144)
|++..............+++.|+|||.+.+..++.++|+||+|+++|+|++|..||...+
T Consensus 145 g~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~ 204 (323)
T cd05584 145 GLCKESIHEGTVTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAEN 204 (323)
T ss_pred cCCeecccCCCcccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCC
Confidence 998754333333334568999999999998888899999999999999999999997643
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-32 Score=186.86 Aligned_cols=131 Identities=30% Similarity=0.453 Sum_probs=115.6
Q ss_pred CCceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeee
Q 044494 2 HRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADF 81 (144)
Q Consensus 2 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~ 81 (144)
+++.+|+||||+++++|.+++..... +++..+..++.|++.|+++|| ++|++|+||||+||+++.++.++++||
T Consensus 72 ~~~~~~lv~e~~~~~~L~~~~~~~~~---~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~NIli~~~~~~kl~Df 145 (291)
T cd05612 72 DQRFLYMLMEYVPGGELFSYLRNSGR---FSNSTGLFYASEIVCALEYLH---SKEIVYRDLKPENILLDKEGHIKLTDF 145 (291)
T ss_pred cCCeEEEEEeCCCCCCHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHeEECCCCCEEEEec
Confidence 45678999999999999999876443 889999999999999999999 899999999999999999999999999
Q ss_pred cceeecccCCCCcccccccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCC
Q 044494 82 GVARLLNFDSSNRTLLAGTYGYIAPELAYTMVVTEKSDVYSFGVVALEVLMGKHPGELLS 141 (144)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~d~~slg~~l~~~~~g~~p~~~~~ 141 (144)
|++..... ......+++.|+|||.+.+..++.++|+||+|+++|+|++|..||...+
T Consensus 146 g~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~ 202 (291)
T cd05612 146 GFAKKLRD---RTWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDN 202 (291)
T ss_pred CcchhccC---CcccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 99875432 1223468899999999998888999999999999999999999997654
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-32 Score=192.19 Aligned_cols=134 Identities=28% Similarity=0.392 Sum_probs=118.4
Q ss_pred CceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeeec
Q 044494 3 RKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADFG 82 (144)
Q Consensus 3 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~~ 82 (144)
...+|||+|||+. +|..++.. ....+++.+++.+.+||+.||+|+| .+|++|||||.+||+++.+|.+||+|||
T Consensus 190 ~~siYlVFeYMdh-DL~GLl~~--p~vkft~~qIKc~mkQLl~Gl~~cH---~~gvlHRDIK~SNiLidn~G~LKiaDFG 263 (560)
T KOG0600|consen 190 SGSIYLVFEYMDH-DLSGLLSS--PGVKFTEPQIKCYMKQLLEGLEYCH---SRGVLHRDIKGSNILIDNNGVLKIADFG 263 (560)
T ss_pred CceEEEEEecccc-hhhhhhcC--CCcccChHHHHHHHHHHHHHHHHHh---hcCeeeccccccceEEcCCCCEEecccc
Confidence 3679999999975 89888874 3345999999999999999999999 9999999999999999999999999999
Q ss_pred ceeecccCCCC-cccccccccccCccccccC-CCCCcchhHHHHHHHHHHHhCCCCCCCCCC
Q 044494 83 VARLLNFDSSN-RTLLAGTYGYIAPELAYTM-VVTEKSDVYSFGVVALEVLMGKHPGELLSS 142 (144)
Q Consensus 83 ~~~~~~~~~~~-~~~~~~~~~~~~pe~~~~~-~~~~~~d~~slg~~l~~~~~g~~p~~~~~~ 142 (144)
+++.+...... ....+.|.+|.|||.+.+. .|++..|+||+|||+.||+.|++.|++.++
T Consensus 264 LAr~y~~~~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tE 325 (560)
T KOG0600|consen 264 LARFYTPSGSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTE 325 (560)
T ss_pred ceeeccCCCCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccH
Confidence 99977654443 4557789999999999976 689999999999999999999999988653
|
|
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-33 Score=194.98 Aligned_cols=136 Identities=26% Similarity=0.410 Sum_probs=124.3
Q ss_pred CCce-EEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEee
Q 044494 2 HRKC-MFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVAD 80 (144)
Q Consensus 2 ~~~~-~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d 80 (144)
+++. +++||+|++||++.+.+.+++ ...++++.++.|+.|++.|++||| +..++|||+|+.||+++.++.|++.|
T Consensus 74 ~~~~~l~Ivm~Y~eGg~l~~~i~~~k-~~~f~E~~i~~~~~Q~~~av~ylH---~~~iLHRDlK~~Nifltk~~~VkLgD 149 (426)
T KOG0589|consen 74 EDGQLLCIVMEYCEGGDLAQLIKEQK-GVLFPEERILKWFVQILLAVNYLH---ENRVLHRDLKCANIFLTKDKKVKLGD 149 (426)
T ss_pred cCCceEEEEEeecCCCCHHHHHHHHh-hccccHHHHHHHHHHHHHHHHHHH---hhhhhcccchhhhhhccccCceeecc
Confidence 4555 899999999999999998754 455999999999999999999999 89999999999999999999999999
Q ss_pred ecceeecccCCCCcccccccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCC
Q 044494 81 FGVARLLNFDSSNRTLLAGTYGYIAPELAYTMVVTEKSDVYSFGVVALEVLMGKHPGELLS 141 (144)
Q Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~d~~slg~~l~~~~~g~~p~~~~~ 141 (144)
||+++..+.......+..||+.|++||++.+.+|..|+|+|||||++|||++-+.+|+..+
T Consensus 150 fGlaK~l~~~~~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~ 210 (426)
T KOG0589|consen 150 FGLAKILNPEDSLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASN 210 (426)
T ss_pred hhhhhhcCCchhhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccc
Confidence 9999988866645666889999999999999999999999999999999999999998755
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=4e-33 Score=198.79 Aligned_cols=133 Identities=35% Similarity=0.576 Sum_probs=121.7
Q ss_pred ceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeeecc
Q 044494 4 KCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADFGV 83 (144)
Q Consensus 4 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~~~ 83 (144)
-.+++|||||+.|-|...|+.++. +.....+.|..+|+.|++||| ...|+|||+|.-||+++.+..|||+|||-
T Consensus 185 PcyCIiMEfCa~GqL~~VLka~~~---itp~llv~Wsk~IA~GM~YLH---~hKIIHRDLKSPNiLIs~~d~VKIsDFGT 258 (904)
T KOG4721|consen 185 PCYCIIMEFCAQGQLYEVLKAGRP---ITPSLLVDWSKGIAGGMNYLH---LHKIIHRDLKSPNILISYDDVVKISDFGT 258 (904)
T ss_pred ceeEEeeeccccccHHHHHhccCc---cCHHHHHHHHHHhhhhhHHHH---HhhHhhhccCCCceEeeccceEEeccccc
Confidence 367899999999999999987655 888899999999999999999 88999999999999999999999999998
Q ss_pred eeecccCCCCcccccccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCC
Q 044494 84 ARLLNFDSSNRTLLAGTYGYIAPELAYTMVVTEKSDVYSFGVVALEVLMGKHPGELLSSS 143 (144)
Q Consensus 84 ~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~d~~slg~~l~~~~~g~~p~~~~~~~ 143 (144)
++.+.. ...+..+.||..|||||++.+++.+.|+||||||+++|||+||..||++.+++
T Consensus 259 S~e~~~-~STkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdss 317 (904)
T KOG4721|consen 259 SKELSD-KSTKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSS 317 (904)
T ss_pred hHhhhh-hhhhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchh
Confidence 887653 35567788999999999999999999999999999999999999999998764
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.8e-32 Score=189.04 Aligned_cols=137 Identities=29% Similarity=0.447 Sum_probs=117.9
Q ss_pred CCceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeee
Q 044494 2 HRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADF 81 (144)
Q Consensus 2 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~ 81 (144)
.++.+|+||+||.+|++.+.++..-+ .++++..+.-+++++++||.||| ++|.+|||||+.||+++.+|.|+++||
T Consensus 95 v~~~LWvVmpfMa~GS~ldIik~~~~-~Gl~E~~Ia~iLre~LkaL~YLH---~~G~IHRdvKAgnILi~~dG~VkLadF 170 (516)
T KOG0582|consen 95 VDSELWVVMPFMAGGSLLDIIKTYYP-DGLEEASIATILREVLKALDYLH---QNGHIHRDVKAGNILIDSDGTVKLADF 170 (516)
T ss_pred ecceeEEeehhhcCCcHHHHHHHHcc-ccccHHHHHHHHHHHHHHHHHHH---hcCceecccccccEEEcCCCcEEEcCc
Confidence 46789999999999999999986332 34999999999999999999999 999999999999999999999999999
Q ss_pred cceeecccCCCCc----ccccccccccCccccccC--CCCCcchhHHHHHHHHHHHhCCCCCCCCCC
Q 044494 82 GVARLLNFDSSNR----TLLAGTYGYIAPELAYTM--VVTEKSDVYSFGVVALEVLMGKHPGELLSS 142 (144)
Q Consensus 82 ~~~~~~~~~~~~~----~~~~~~~~~~~pe~~~~~--~~~~~~d~~slg~~l~~~~~g~~p~~~~~~ 142 (144)
|............ .+..|++.|||||++... +|+.|+||||||++..|+.+|..||...++
T Consensus 171 gvsa~l~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pP 237 (516)
T KOG0582|consen 171 GVSASLFDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPP 237 (516)
T ss_pred eeeeeecccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCCh
Confidence 8876554333222 445799999999995543 688999999999999999999999987664
|
|
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.4e-32 Score=191.13 Aligned_cols=133 Identities=27% Similarity=0.417 Sum_probs=116.4
Q ss_pred CceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeeec
Q 044494 3 RKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADFG 82 (144)
Q Consensus 3 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~~ 82 (144)
++.+|+||||+++|+|..++..... +++..+..++.|++.|+.||| +.|++||||||+||+++.++.++++|||
T Consensus 68 ~~~~~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~qi~~al~~lH---~~givH~Dlkp~NIll~~~~~~kL~DfG 141 (325)
T cd05604 68 TEKLYFVLDFVNGGELFFHLQRERS---FPEPRARFYAAEIASALGYLH---SINIVYRDLKPENILLDSQGHVVLTDFG 141 (325)
T ss_pred CCEEEEEEcCCCCCCHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHeEECCCCCEEEeecC
Confidence 5678999999999999988875443 899999999999999999999 8999999999999999999999999999
Q ss_pred ceeecccCCCCcccccccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCC
Q 044494 83 VARLLNFDSSNRTLLAGTYGYIAPELAYTMVVTEKSDVYSFGVVALEVLMGKHPGELLS 141 (144)
Q Consensus 83 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~d~~slg~~l~~~~~g~~p~~~~~ 141 (144)
++..............+++.|+|||.+.+..++.++|+||+|+++|+|++|..||...+
T Consensus 142 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~ 200 (325)
T cd05604 142 LCKEGIAQSDTTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRD 200 (325)
T ss_pred CcccCCCCCCCcccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCC
Confidence 98754322333344568999999999999889999999999999999999999997643
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.7e-32 Score=194.30 Aligned_cols=133 Identities=24% Similarity=0.386 Sum_probs=113.2
Q ss_pred CceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeeec
Q 044494 3 RKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADFG 82 (144)
Q Consensus 3 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~~ 82 (144)
++.+|+||||+++|+|.+++.+... +++..+..++.|++.|+++|| +++++||||||+||+++.++.++|+|||
T Consensus 73 ~~~~~lv~E~~~gg~L~~~l~~~~~---~~e~~~~~~~~qi~~al~~lH---~~~ivHrDlKp~NILl~~~g~~kL~DFG 146 (382)
T cd05625 73 KDNLYFVMDYIPGGDMMSLLIRMGI---FPEDLARFYIAELTCAVESVH---KMGFIHRDIKPDNILIDRDGHIKLTDFG 146 (382)
T ss_pred CCEEEEEEeCCCCCcHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEEeECC
Confidence 5678999999999999999875433 889999999999999999999 8999999999999999999999999999
Q ss_pred ceeecccCC-----------------------------------------------CCcccccccccccCccccccCCCC
Q 044494 83 VARLLNFDS-----------------------------------------------SNRTLLAGTYGYIAPELAYTMVVT 115 (144)
Q Consensus 83 ~~~~~~~~~-----------------------------------------------~~~~~~~~~~~~~~pe~~~~~~~~ 115 (144)
++....... .......|++.|+|||++.+..++
T Consensus 147 la~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~ 226 (382)
T cd05625 147 LCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYT 226 (382)
T ss_pred CCccccccccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCC
Confidence 875321000 001124588999999999998999
Q ss_pred CcchhHHHHHHHHHHHhCCCCCCCCC
Q 044494 116 EKSDVYSFGVVALEVLMGKHPGELLS 141 (144)
Q Consensus 116 ~~~d~~slg~~l~~~~~g~~p~~~~~ 141 (144)
.++|+||+||++|||++|..||...+
T Consensus 227 ~~~DiwSlGvil~elltG~~Pf~~~~ 252 (382)
T cd05625 227 QLCDWWSVGVILYEMLVGQPPFLAQT 252 (382)
T ss_pred CeeeEEechHHHHHHHhCCCCCCCCC
Confidence 99999999999999999999997644
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=99.98 E-value=2e-32 Score=191.39 Aligned_cols=130 Identities=25% Similarity=0.420 Sum_probs=115.7
Q ss_pred CceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeeec
Q 044494 3 RKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADFG 82 (144)
Q Consensus 3 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~~ 82 (144)
++.+|+||||+++|+|.+++.+... +++..+..++.|++.++.||| +.+++||||||+||+++.++.++++|||
T Consensus 103 ~~~~~lv~Ey~~~g~L~~~i~~~~~---~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDLkp~NILl~~~~~ikL~DFG 176 (340)
T PTZ00426 103 ESYLYLVLEFVIGGEFFTFLRRNKR---FPNDVGCFYAAQIVLIFEYLQ---SLNIVYRDLKPENLLLDKDGFIKMTDFG 176 (340)
T ss_pred CCEEEEEEeCCCCCcHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHH---HCCeEccCCCHHHEEECCCCCEEEecCC
Confidence 4678999999999999999976443 899999999999999999999 8999999999999999999999999999
Q ss_pred ceeecccCCCCcccccccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCC
Q 044494 83 VARLLNFDSSNRTLLAGTYGYIAPELAYTMVVTEKSDVYSFGVVALEVLMGKHPGELLS 141 (144)
Q Consensus 83 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~d~~slg~~l~~~~~g~~p~~~~~ 141 (144)
++..... ......|++.|+|||++.+..++.++|+||+|+++|+|++|..||...+
T Consensus 177 ~a~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~ 232 (340)
T PTZ00426 177 FAKVVDT---RTYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANE 232 (340)
T ss_pred CCeecCC---CcceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCC
Confidence 9876532 2234568999999999998888999999999999999999999998654
|
|
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.9e-32 Score=188.30 Aligned_cols=133 Identities=27% Similarity=0.359 Sum_probs=115.8
Q ss_pred CCceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeee
Q 044494 2 HRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADF 81 (144)
Q Consensus 2 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~ 81 (144)
.++.+|+||||+++++|...+... .+++..+..++.|++.|+++|| +.+++||||||+||+++.++.++++||
T Consensus 73 ~~~~~~lv~E~~~~~~L~~~~~~~----~l~~~~~~~~~~qi~~al~~lH---~~~ivHrdlkp~Nill~~~~~~kL~Df 145 (324)
T cd05589 73 TEDHVCFVMEYAAGGDLMMHIHTD----VFSEPRAVFYAACVVLGLQYLH---ENKIVYRDLKLDNLLLDTEGFVKIADF 145 (324)
T ss_pred cCCEEEEEEcCCCCCcHHHHhhcC----CCCHHHHHHHHHHHHHHHHHHH---hCCeEecCCCHHHeEECCCCcEEeCcc
Confidence 356789999999999999887642 3899999999999999999999 899999999999999999999999999
Q ss_pred cceeecccCCCCcccccccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCC
Q 044494 82 GVARLLNFDSSNRTLLAGTYGYIAPELAYTMVVTEKSDVYSFGVVALEVLMGKHPGELLS 141 (144)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~d~~slg~~l~~~~~g~~p~~~~~ 141 (144)
|++..............+++.|+|||.+.+..++.++|+||+|+++|+|++|..||...+
T Consensus 146 g~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~ 205 (324)
T cd05589 146 GLCKEGMGFGDRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDD 205 (324)
T ss_pred cCCccCCCCCCcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCC
Confidence 988754322333344668999999999998888999999999999999999999997643
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=2e-32 Score=206.01 Aligned_cols=131 Identities=29% Similarity=0.425 Sum_probs=117.7
Q ss_pred CCceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeee
Q 044494 2 HRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADF 81 (144)
Q Consensus 2 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~ 81 (144)
+++++|+||||++||+|..++.+.. .+++..+.+++..++.||..+| +.|+|||||||+|++++..|+++++||
T Consensus 146 D~~~LYlVMdY~pGGDlltLlSk~~---~~pE~~ArFY~aEiVlAldslH---~mgyVHRDiKPDNvLld~~GHikLADF 219 (1317)
T KOG0612|consen 146 DERYLYLVMDYMPGGDLLTLLSKFD---RLPEDWARFYTAEIVLALDSLH---SMGYVHRDIKPDNVLLDKSGHIKLADF 219 (1317)
T ss_pred CccceEEEEecccCchHHHHHhhcC---CChHHHHHHHHHHHHHHHHHHH---hccceeccCCcceeEecccCcEeeccc
Confidence 5789999999999999999998654 3999999999999999999999 899999999999999999999999999
Q ss_pred cceeecccCCC-CcccccccccccCcccccc-----CCCCCcchhHHHHHHHHHHHhCCCCCC
Q 044494 82 GVARLLNFDSS-NRTLLAGTYGYIAPELAYT-----MVVTEKSDVYSFGVVALEVLMGKHPGE 138 (144)
Q Consensus 82 ~~~~~~~~~~~-~~~~~~~~~~~~~pe~~~~-----~~~~~~~d~~slg~~l~~~~~g~~p~~ 138 (144)
|.+..+...+. .....+|||-|.+||+++. ..|++..|.||+|+++|||+-|..||=
T Consensus 220 GsClkm~~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFY 282 (1317)
T KOG0612|consen 220 GSCLKMDADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFY 282 (1317)
T ss_pred hhHHhcCCCCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcch
Confidence 99988875444 3455789999999999884 347789999999999999999999983
|
|
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.1e-32 Score=193.99 Aligned_cols=133 Identities=26% Similarity=0.387 Sum_probs=114.7
Q ss_pred CceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeeec
Q 044494 3 RKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADFG 82 (144)
Q Consensus 3 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~~ 82 (144)
++.+|+||||+++|+|.+++.+... +++..+..++.|++.++++|| +.|++||||||+||+++.++.++++|||
T Consensus 73 ~~~~~lv~E~~~gg~L~~~l~~~~~---l~~~~~~~~~~qi~~~L~~lH---~~givHrDLkp~NIli~~~~~vkL~DfG 146 (360)
T cd05627 73 KRNLYLIMEFLPGGDMMTLLMKKDT---LSEEATQFYIAETVLAIDAIH---QLGFIHRDIKPDNLLLDAKGHVKLSDFG 146 (360)
T ss_pred CCEEEEEEeCCCCccHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHH---HCCeEccCCCHHHEEECCCCCEEEeecc
Confidence 5678999999999999999876443 899999999999999999999 8999999999999999999999999999
Q ss_pred ceeecccCC-----------------------------------CCcccccccccccCccccccCCCCCcchhHHHHHHH
Q 044494 83 VARLLNFDS-----------------------------------SNRTLLAGTYGYIAPELAYTMVVTEKSDVYSFGVVA 127 (144)
Q Consensus 83 ~~~~~~~~~-----------------------------------~~~~~~~~~~~~~~pe~~~~~~~~~~~d~~slg~~l 127 (144)
++....... .......|++.|+|||++.+..++.++|+||+||++
T Consensus 147 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil 226 (360)
T cd05627 147 LCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIM 226 (360)
T ss_pred CCcccccccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceecccccee
Confidence 886432110 001124689999999999999999999999999999
Q ss_pred HHHHhCCCCCCCCC
Q 044494 128 LEVLMGKHPGELLS 141 (144)
Q Consensus 128 ~~~~~g~~p~~~~~ 141 (144)
|+|++|..||...+
T Consensus 227 yel~tG~~Pf~~~~ 240 (360)
T cd05627 227 YEMLIGYPPFCSET 240 (360)
T ss_pred eecccCCCCCCCCC
Confidence 99999999997654
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.2e-31 Score=182.95 Aligned_cols=136 Identities=26% Similarity=0.344 Sum_probs=117.0
Q ss_pred CceEEEEEeeccCCCHHHHhhc-ccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeee
Q 044494 3 RKCMFLIYEYMEMGSLFCVLRT-DEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADF 81 (144)
Q Consensus 3 ~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~ 81 (144)
++.+|+||||+++|+|..++.. ......+++..++.++.|++.|+.||| +.+++|+||||+||+++.++.++++||
T Consensus 65 ~~~~~lv~e~~~~g~L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~~l~df 141 (280)
T cd05608 65 KTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLH---QRRIIYRDLKPENVLLDNDGNVRISDL 141 (280)
T ss_pred CCeEEEEEeCCCCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEeeC
Confidence 4678999999999999887743 223345899999999999999999999 899999999999999999999999999
Q ss_pred cceeecccCCCCcccccccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCC
Q 044494 82 GVARLLNFDSSNRTLLAGTYGYIAPELAYTMVVTEKSDVYSFGVVALEVLMGKHPGELLS 141 (144)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~d~~slg~~l~~~~~g~~p~~~~~ 141 (144)
|.+..............+++.|+|||.+.+..++.++|+||+|+++|++++|..||...+
T Consensus 142 g~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~ 201 (280)
T cd05608 142 GLAVELKDGQSKTKGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARG 201 (280)
T ss_pred ccceecCCCCccccccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCC
Confidence 998765543333334568899999999999889999999999999999999999997643
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.6e-32 Score=186.94 Aligned_cols=133 Identities=26% Similarity=0.411 Sum_probs=116.1
Q ss_pred CceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeeec
Q 044494 3 RKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADFG 82 (144)
Q Consensus 3 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~~ 82 (144)
.+.+|+||||+++++|..++.+... +++..+..++.|++.++.+|| +.+++|+||||+||+++.++.++++|||
T Consensus 68 ~~~~~lv~e~~~~~~L~~~~~~~~~---l~~~~~~~~~~qi~~~l~~LH---~~~ivH~dlkp~Nill~~~~~~kl~Dfg 141 (318)
T cd05570 68 KDRLFFVMEYVNGGDLMFHIQRSGR---FDEPRARFYAAEIVLGLQFLH---ERGIIYRDLKLDNVLLDSEGHIKIADFG 141 (318)
T ss_pred CCEEEEEEcCCCCCCHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHH---hCCeEccCCCHHHeEECCCCcEEecccC
Confidence 5678999999999999988875433 899999999999999999999 8999999999999999999999999999
Q ss_pred ceeecccCCCCcccccccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCC
Q 044494 83 VARLLNFDSSNRTLLAGTYGYIAPELAYTMVVTEKSDVYSFGVVALEVLMGKHPGELLS 141 (144)
Q Consensus 83 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~d~~slg~~l~~~~~g~~p~~~~~ 141 (144)
++..............+++.|+|||.+.+..++.++|+||+|++++++++|..||...+
T Consensus 142 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~ 200 (318)
T cd05570 142 MCKEGILGGVTTSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDD 200 (318)
T ss_pred CCeecCcCCCcccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCC
Confidence 88753322223334568899999999999889999999999999999999999997644
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.98 E-value=9.4e-32 Score=181.81 Aligned_cols=135 Identities=23% Similarity=0.324 Sum_probs=119.1
Q ss_pred ceEEEEEeeccCCCHHHHhhccccc-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeeec
Q 044494 4 KCMFLIYEYMEMGSLFCVLRTDEEA-VGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADFG 82 (144)
Q Consensus 4 ~~~~lv~e~~~~~~L~~~l~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~~ 82 (144)
.++++|+||+.. +|..++...... .+++...++.+..|++.|+.||| +++|+|||+||+|++++..|.+|++|||
T Consensus 90 ~~l~lvfe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H---~~~IlHRDLKPQNlLi~~~G~lKlaDFG 165 (323)
T KOG0594|consen 90 GKLYLVFEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLH---SHGILHRDLKPQNLLISSSGVLKLADFG 165 (323)
T ss_pred ceEEEEEEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHH---hCCeecccCCcceEEECCCCcEeeeccc
Confidence 378999999975 999999864321 45788899999999999999999 9999999999999999999999999999
Q ss_pred ceeecccCCCCcccccccccccCccccccC-CCCCcchhHHHHHHHHHHHhCCCCCCCCCC
Q 044494 83 VARLLNFDSSNRTLLAGTYGYIAPELAYTM-VVTEKSDVYSFGVVALEVLMGKHPGELLSS 142 (144)
Q Consensus 83 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~-~~~~~~d~~slg~~l~~~~~g~~p~~~~~~ 142 (144)
+++....+........+|..|.|||++.+. .|+...|+||+|||+.||++++.-|.+.++
T Consensus 166 lAra~~ip~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se 226 (323)
T KOG0594|consen 166 LARAFSIPMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSE 226 (323)
T ss_pred hHHHhcCCcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcH
Confidence 999777566656667789999999999877 689999999999999999999999987654
|
|
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.1e-32 Score=191.82 Aligned_cols=134 Identities=25% Similarity=0.376 Sum_probs=115.1
Q ss_pred CCceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeee
Q 044494 2 HRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADF 81 (144)
Q Consensus 2 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~ 81 (144)
.++.+|+||||+++|+|.+++..... +++..+..++.|++.||+||| +.+++||||||+||+++.++.++++||
T Consensus 72 ~~~~~~lv~E~~~~g~L~~~l~~~~~---l~~~~~~~~~~qi~~aL~~lH---~~~ivH~Dlkp~NIl~~~~~~~kl~Df 145 (364)
T cd05599 72 DENYLYLIMEYLPGGDMMTLLMKKDT---FTEEETRFYIAETILAIDSIH---KLGYIHRDIKPDNLLLDAKGHIKLSDF 145 (364)
T ss_pred cCCeEEEEECCCCCcHHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHH---HCCeEeccCCHHHeEECCCCCEEEeec
Confidence 35678999999999999999876443 899999999999999999999 899999999999999999999999999
Q ss_pred cceeecccCCC--------------------------------------CcccccccccccCccccccCCCCCcchhHHH
Q 044494 82 GVARLLNFDSS--------------------------------------NRTLLAGTYGYIAPELAYTMVVTEKSDVYSF 123 (144)
Q Consensus 82 ~~~~~~~~~~~--------------------------------------~~~~~~~~~~~~~pe~~~~~~~~~~~d~~sl 123 (144)
|++........ ......|++.|+|||++....++.++|+||+
T Consensus 146 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSl 225 (364)
T cd05599 146 GLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSL 225 (364)
T ss_pred ccceeccccccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecc
Confidence 99875431110 0012358999999999998889999999999
Q ss_pred HHHHHHHHhCCCCCCCCC
Q 044494 124 GVVALEVLMGKHPGELLS 141 (144)
Q Consensus 124 g~~l~~~~~g~~p~~~~~ 141 (144)
||++|+|++|..||...+
T Consensus 226 G~il~el~~G~~Pf~~~~ 243 (364)
T cd05599 226 GVIMYEMLVGYPPFCSDN 243 (364)
T ss_pred hhHHHHhhcCCCCCCCCC
Confidence 999999999999997643
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.98 E-value=5e-32 Score=187.09 Aligned_cols=132 Identities=24% Similarity=0.406 Sum_probs=121.6
Q ss_pred CceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeeec
Q 044494 3 RKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADFG 82 (144)
Q Consensus 3 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~~ 82 (144)
..++.+||||..+|.|++|+.+.+. +++.++..+.+||+.|+.|+| ..+++|||+|.+||++++++.+||+|||
T Consensus 125 kdKIvivMEYaS~GeLYDYiSer~~---LsErEaRhfFRQIvSAVhYCH---knrVvHRDLKLENILLD~N~NiKIADFG 198 (668)
T KOG0611|consen 125 KDKIVIVMEYASGGELYDYISERGS---LSEREARHFFRQIVSAVHYCH---KNRVVHRDLKLENILLDQNNNIKIADFG 198 (668)
T ss_pred CceEEEEEEecCCccHHHHHHHhcc---ccHHHHHHHHHHHHHHHHHHh---hccceecccchhheeecCCCCeeeeccc
Confidence 4578999999999999999987666 999999999999999999999 8899999999999999999999999999
Q ss_pred ceeecccCCCCcccccccccccCccccccCCC-CCcchhHHHHHHHHHHHhCCCCCCCCC
Q 044494 83 VARLLNFDSSNRTLLAGTYGYIAPELAYTMVV-TEKSDVYSFGVVALEVLMGKHPGELLS 141 (144)
Q Consensus 83 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~-~~~~d~~slg~~l~~~~~g~~p~~~~~ 141 (144)
++..+. ..+...+++|+|.|.+||++++.+| .+..|-||||+++|.++.|..||++.|
T Consensus 199 LSNly~-~~kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~D 257 (668)
T KOG0611|consen 199 LSNLYA-DKKFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRD 257 (668)
T ss_pred hhhhhc-cccHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCch
Confidence 998765 3445677899999999999999998 478999999999999999999999876
|
|
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.7e-32 Score=191.93 Aligned_cols=133 Identities=26% Similarity=0.361 Sum_probs=114.0
Q ss_pred CCceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeee
Q 044494 2 HRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADF 81 (144)
Q Consensus 2 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~ 81 (144)
.++.+|+||||+++|+|.+++... .+++..+..++.|++.|+++|| +++++||||||+||+++.++.++|+||
T Consensus 114 ~~~~~~lv~Ey~~gg~L~~~l~~~----~~~~~~~~~~~~qil~aL~~LH---~~~IvHrDLKp~NILl~~~~~~kL~DF 186 (370)
T cd05621 114 DDKYLYMVMEYMPGGDLVNLMSNY----DVPEKWAKFYTAEVVLALDAIH---SMGLIHRDVKPDNMLLDKHGHLKLADF 186 (370)
T ss_pred cCCEEEEEEcCCCCCcHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHEEECCCCCEEEEec
Confidence 356789999999999999988643 2788999999999999999999 899999999999999999999999999
Q ss_pred cceeecccCCC-CcccccccccccCccccccCC----CCCcchhHHHHHHHHHHHhCCCCCCCCC
Q 044494 82 GVARLLNFDSS-NRTLLAGTYGYIAPELAYTMV----VTEKSDVYSFGVVALEVLMGKHPGELLS 141 (144)
Q Consensus 82 ~~~~~~~~~~~-~~~~~~~~~~~~~pe~~~~~~----~~~~~d~~slg~~l~~~~~g~~p~~~~~ 141 (144)
|++........ ......|++.|+|||++.... ++.++|+||+|+++|+|++|..||...+
T Consensus 187 G~a~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~ 251 (370)
T cd05621 187 GTCMKMDETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADS 251 (370)
T ss_pred ccceecccCCceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCC
Confidence 99986542221 223456899999999987643 6789999999999999999999997644
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.2e-32 Score=189.03 Aligned_cols=131 Identities=26% Similarity=0.360 Sum_probs=115.8
Q ss_pred CCceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeee
Q 044494 2 HRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADF 81 (144)
Q Consensus 2 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~ 81 (144)
+++.+|+||||+++++|.+++..... +++..+..++.|++.||+||| +.+++|+||||+||+++.++.++++||
T Consensus 89 ~~~~~~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~qi~~aL~~LH---~~~ivH~dlkp~NIll~~~~~~kl~Df 162 (329)
T PTZ00263 89 DENRVYFLLEFVVGGELFTHLRKAGR---FPNDVAKFYHAELVLAFEYLH---SKDIIYRDLKPENLLLDNKGHVKVTDF 162 (329)
T ss_pred cCCEEEEEEcCCCCChHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHEEECCCCCEEEeec
Confidence 35788999999999999999876443 888999999999999999999 899999999999999999999999999
Q ss_pred cceeecccCCCCcccccccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCC
Q 044494 82 GVARLLNFDSSNRTLLAGTYGYIAPELAYTMVVTEKSDVYSFGVVALEVLMGKHPGELLS 141 (144)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~d~~slg~~l~~~~~g~~p~~~~~ 141 (144)
|++...... .....+++.|+|||.+....++.++|+||+|+++|+|++|..||...+
T Consensus 163 g~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~ 219 (329)
T PTZ00263 163 GFAKKVPDR---TFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDT 219 (329)
T ss_pred cCceEcCCC---cceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCC
Confidence 999865421 223568999999999999888999999999999999999999997643
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.9e-31 Score=182.34 Aligned_cols=135 Identities=24% Similarity=0.314 Sum_probs=115.8
Q ss_pred CCceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeee
Q 044494 2 HRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADF 81 (144)
Q Consensus 2 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~ 81 (144)
.++.+++||||+++|+|.+++.... ...+++..+..++.|++.|+.+|| +.+++||||||+||+++.++.++++||
T Consensus 71 ~~~~~~lv~e~~~~g~L~~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH---~~~iiH~dikp~Nill~~~~~~kl~Df 146 (285)
T cd05631 71 TKDALCLVLTIMNGGDLKFHIYNMG-NPGFDEQRAIFYAAELCCGLEDLQ---RERIVYRDLKPENILLDDRGHIRISDL 146 (285)
T ss_pred cCCeEEEEEEecCCCcHHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHH---hCCEEeCCCCHHHEEECCCCCEEEeeC
Confidence 3567899999999999988875422 234899999999999999999999 899999999999999999999999999
Q ss_pred cceeecccCCCCcccccccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCC
Q 044494 82 GVARLLNFDSSNRTLLAGTYGYIAPELAYTMVVTEKSDVYSFGVVALEVLMGKHPGELLS 141 (144)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~d~~slg~~l~~~~~g~~p~~~~~ 141 (144)
|++...... .......+++.|+|||.+.+..++.++|+||+|+++|+|++|..||...+
T Consensus 147 g~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~ 205 (285)
T cd05631 147 GLAVQIPEG-ETVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRK 205 (285)
T ss_pred CCcEEcCCC-CeecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCC
Confidence 998765321 12233568899999999999899999999999999999999999997644
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.1e-32 Score=189.27 Aligned_cols=130 Identities=23% Similarity=0.304 Sum_probs=115.6
Q ss_pred CceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeeec
Q 044494 3 RKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADFG 82 (144)
Q Consensus 3 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~~ 82 (144)
++.+|+||||+++++|.+++..... +++..+..++.|++.++.+|| +.+++||||||+||+++.++.++|+|||
T Consensus 73 ~~~~~lv~e~~~g~~L~~~l~~~~~---l~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kL~Dfg 146 (333)
T cd05600 73 DEYLYLAMEYVPGGDFRTLLNNLGV---LSEDHARFYMAEMFEAVDALH---ELGYIHRDLKPENFLIDASGHIKLTDFG 146 (333)
T ss_pred CCEEEEEEeCCCCCCHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEECCCCCEEEEeCc
Confidence 5678999999999999999975443 889999999999999999999 8999999999999999999999999999
Q ss_pred ceeecccCCCCcccccccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCC
Q 044494 83 VARLLNFDSSNRTLLAGTYGYIAPELAYTMVVTEKSDVYSFGVVALEVLMGKHPGELLS 141 (144)
Q Consensus 83 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~d~~slg~~l~~~~~g~~p~~~~~ 141 (144)
++..... ......+++.|+|||.+.+..++.++|+||+|+++|+|++|..||...+
T Consensus 147 ~a~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~ 202 (333)
T cd05600 147 LSKGIVT---YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGST 202 (333)
T ss_pred CCccccc---ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCC
Confidence 9875432 2334568999999999998889999999999999999999999997643
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.8e-32 Score=191.63 Aligned_cols=134 Identities=25% Similarity=0.416 Sum_probs=113.7
Q ss_pred CCceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeee
Q 044494 2 HRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADF 81 (144)
Q Consensus 2 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~ 81 (144)
+++++|+||||+++|+|.+++.+... +++..+..++.|++.|+++|| ..+++||||||+||+++.++.++++||
T Consensus 72 ~~~~~~lv~E~~~gg~L~~~l~~~~~---~~e~~~~~~~~qi~~aL~~LH---~~givHrDlKp~Nili~~~~~~kL~DF 145 (381)
T cd05626 72 DKDNLYFVMDYIPGGDMMSLLIRMEV---FPEVLARFYIAELTLAIESVH---KMGFIHRDIKPDNILIDLDGHIKLTDF 145 (381)
T ss_pred cCCEEEEEEecCCCCcHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHH---hCCeeecCCcHHHEEECCCCCEEEeeC
Confidence 35678999999999999999876443 889999999999999999999 899999999999999999999999999
Q ss_pred cceeecccCC-----------------------------------------------CCcccccccccccCccccccCCC
Q 044494 82 GVARLLNFDS-----------------------------------------------SNRTLLAGTYGYIAPELAYTMVV 114 (144)
Q Consensus 82 ~~~~~~~~~~-----------------------------------------------~~~~~~~~~~~~~~pe~~~~~~~ 114 (144)
|++....... .......|++.|+|||.+.+..+
T Consensus 146 Gl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~ 225 (381)
T cd05626 146 GLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGY 225 (381)
T ss_pred cCCcccccccccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCC
Confidence 9875321000 00112468999999999998889
Q ss_pred CCcchhHHHHHHHHHHHhCCCCCCCCC
Q 044494 115 TEKSDVYSFGVVALEVLMGKHPGELLS 141 (144)
Q Consensus 115 ~~~~d~~slg~~l~~~~~g~~p~~~~~ 141 (144)
+.++|+||+||++|||++|..||...+
T Consensus 226 ~~~~DiwSlG~il~elltG~~Pf~~~~ 252 (381)
T cd05626 226 TQLCDWWSVGVILFEMLVGQPPFLAPT 252 (381)
T ss_pred CCccceeehhhHHHHHHhCCCCCcCCC
Confidence 999999999999999999999997644
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.3e-32 Score=193.31 Aligned_cols=134 Identities=24% Similarity=0.387 Sum_probs=113.8
Q ss_pred CCceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeee
Q 044494 2 HRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADF 81 (144)
Q Consensus 2 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~ 81 (144)
+++.+|+||||+++|+|.+++.+... +++..+..++.|++.||++|| +.+++||||||+||+++.++.++|+||
T Consensus 72 ~~~~~~lv~E~~~~g~L~~~i~~~~~---~~~~~~~~~~~qi~~al~~lH---~~~ivHrDlkp~Nill~~~~~ikL~DF 145 (376)
T cd05598 72 DKDNLYFVMDYIPGGDMMSLLIRLGI---FEEDLARFYIAELTCAIESVH---KMGFIHRDIKPDNILIDRDGHIKLTDF 145 (376)
T ss_pred cCCEEEEEEeCCCCCcHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCCHHHEEECCCCCEEEEeC
Confidence 35788999999999999999976433 888999999999999999999 899999999999999999999999999
Q ss_pred cceeecccC-------------------------------------------CCCcccccccccccCccccccCCCCCcc
Q 044494 82 GVARLLNFD-------------------------------------------SSNRTLLAGTYGYIAPELAYTMVVTEKS 118 (144)
Q Consensus 82 ~~~~~~~~~-------------------------------------------~~~~~~~~~~~~~~~pe~~~~~~~~~~~ 118 (144)
|++...... ........|++.|+|||++.+..++.++
T Consensus 146 G~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~ 225 (376)
T cd05598 146 GLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLC 225 (376)
T ss_pred CCCccccccccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcce
Confidence 987422100 0001124689999999999998899999
Q ss_pred hhHHHHHHHHHHHhCCCCCCCCC
Q 044494 119 DVYSFGVVALEVLMGKHPGELLS 141 (144)
Q Consensus 119 d~~slg~~l~~~~~g~~p~~~~~ 141 (144)
|+||+||++|+|++|..||...+
T Consensus 226 DiwSlGvilyell~G~~Pf~~~~ 248 (376)
T cd05598 226 DWWSVGVILYEMLVGQPPFLADT 248 (376)
T ss_pred eeeeccceeeehhhCCCCCCCCC
Confidence 99999999999999999997654
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.2e-32 Score=187.93 Aligned_cols=132 Identities=28% Similarity=0.389 Sum_probs=113.4
Q ss_pred CceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeeec
Q 044494 3 RKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADFG 82 (144)
Q Consensus 3 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~~ 82 (144)
++.+++||||+++|+|.+++.+... +++..+..++.|++.||.+|| +++++||||||+||+++.++.++|+|||
T Consensus 77 ~~~~~lv~e~~~~g~L~~~l~~~~~---~~~~~~~~~~~qi~~~l~~lH---~~~ivHrDlkp~Nili~~~~~~kl~DfG 150 (332)
T cd05614 77 EAKLHLILDYVSGGEMFTHLYQRDN---FSEDEVRFYSGEIILALEHLH---KLGIVYRDIKLENILLDSEGHVVLTDFG 150 (332)
T ss_pred CCEEEEEEeCCCCCcHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHH---HCCcEecCCCHHHeEECCCCCEEEeeCc
Confidence 5678999999999999999875443 899999999999999999999 8999999999999999999999999999
Q ss_pred ceeecccCCC-CcccccccccccCccccccC-CCCCcchhHHHHHHHHHHHhCCCCCCCC
Q 044494 83 VARLLNFDSS-NRTLLAGTYGYIAPELAYTM-VVTEKSDVYSFGVVALEVLMGKHPGELL 140 (144)
Q Consensus 83 ~~~~~~~~~~-~~~~~~~~~~~~~pe~~~~~-~~~~~~d~~slg~~l~~~~~g~~p~~~~ 140 (144)
++........ ......|++.|+|||.+.+. .++.++|+||+|+++|+|++|..||...
T Consensus 151 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~ 210 (332)
T cd05614 151 LSKEFLSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLE 210 (332)
T ss_pred CCccccccCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCC
Confidence 9876432222 22235689999999998865 3678899999999999999999999753
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.9e-32 Score=192.22 Aligned_cols=134 Identities=24% Similarity=0.341 Sum_probs=113.4
Q ss_pred CCceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeee
Q 044494 2 HRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADF 81 (144)
Q Consensus 2 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~ 81 (144)
+++.+|+||||+++|+|.+++..... +++..+..++.|++.||+||| +.|++||||||+||+++.++.++++||
T Consensus 72 ~~~~~~lv~E~~~gg~L~~~l~~~~~---~~~~~~~~~~~ql~~aL~~LH---~~givHrDlkp~NIll~~~~~~kl~Df 145 (377)
T cd05629 72 DAQYLYLIMEFLPGGDLMTMLIKYDT---FSEDVTRFYMAECVLAIEAVH---KLGFIHRDIKPDNILIDRGGHIKLSDF 145 (377)
T ss_pred cCCeeEEEEeCCCCCcHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHEEECCCCCEEEeec
Confidence 35678999999999999999875433 889999999999999999999 899999999999999999999999999
Q ss_pred cceeecccCCC-----------------------------------------------CcccccccccccCccccccCCC
Q 044494 82 GVARLLNFDSS-----------------------------------------------NRTLLAGTYGYIAPELAYTMVV 114 (144)
Q Consensus 82 ~~~~~~~~~~~-----------------------------------------------~~~~~~~~~~~~~pe~~~~~~~ 114 (144)
|+++....... ......|++.|+|||++.+..+
T Consensus 146 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~ 225 (377)
T cd05629 146 GLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGY 225 (377)
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCC
Confidence 98863211000 0002358899999999998889
Q ss_pred CCcchhHHHHHHHHHHHhCCCCCCCCC
Q 044494 115 TEKSDVYSFGVVALEVLMGKHPGELLS 141 (144)
Q Consensus 115 ~~~~d~~slg~~l~~~~~g~~p~~~~~ 141 (144)
+.++|+||+||++|||++|..||...+
T Consensus 226 ~~~~DiwSlGvil~elltG~~Pf~~~~ 252 (377)
T cd05629 226 GQECDWWSLGAIMFECLIGWPPFCSEN 252 (377)
T ss_pred CCceeeEecchhhhhhhcCCCCCCCCC
Confidence 999999999999999999999997643
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.6e-33 Score=192.85 Aligned_cols=136 Identities=32% Similarity=0.487 Sum_probs=123.2
Q ss_pred CCCceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEee
Q 044494 1 LHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVAD 80 (144)
Q Consensus 1 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d 80 (144)
+++..++++|||+.||++.+.++.... +.+..+.-++++++.|+.|+| .++.+|||||+.||++..+|.++++|
T Consensus 81 l~g~~LwiiMey~~gGsv~~lL~~~~~---~~E~~i~~ilre~l~~l~ylH---~~~kiHrDIKaanil~s~~g~vkl~D 154 (467)
T KOG0201|consen 81 LKGTKLWIIMEYCGGGSVLDLLKSGNI---LDEFEIAVILREVLKGLDYLH---SEKKIHRDIKAANILLSESGDVKLAD 154 (467)
T ss_pred eecccHHHHHHHhcCcchhhhhccCCC---CccceeeeehHHHHHHhhhhh---hcceecccccccceeEeccCcEEEEe
Confidence 356788999999999999999986543 578888888999999999999 99999999999999999999999999
Q ss_pred ecceeecccCCCCcccccccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCC
Q 044494 81 FGVARLLNFDSSNRTLLAGTYGYIAPELAYTMVVTEKSDVYSFGVVALEVLMGKHPGELLSS 142 (144)
Q Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~d~~slg~~l~~~~~g~~p~~~~~~ 142 (144)
||++...+.......+..|||.|||||++++..|+.|+||||||++.+||.+|.+|+....+
T Consensus 155 fgVa~ql~~~~~rr~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hP 216 (467)
T KOG0201|consen 155 FGVAGQLTNTVKRRKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHP 216 (467)
T ss_pred cceeeeeechhhccccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCc
Confidence 99998877666666788999999999999999999999999999999999999999987654
|
|
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-31 Score=189.66 Aligned_cols=133 Identities=26% Similarity=0.361 Sum_probs=113.7
Q ss_pred CCceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeee
Q 044494 2 HRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADF 81 (144)
Q Consensus 2 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~ 81 (144)
.++.+|+||||+++|+|.+++... .+++..+..++.|++.|+++|| +++++||||||+||+++.++.++|+||
T Consensus 114 ~~~~~~lv~Ey~~gg~L~~~~~~~----~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDLkp~NIll~~~~~ikL~Df 186 (371)
T cd05622 114 DDRYLYMVMEYMPGGDLVNLMSNY----DVPEKWARFYTAEVVLALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADF 186 (371)
T ss_pred cCCEEEEEEcCCCCCcHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHH---HCCEEeCCCCHHHEEECCCCCEEEEeC
Confidence 356789999999999999988643 2788889999999999999999 899999999999999999999999999
Q ss_pred cceeecccCCC-CcccccccccccCccccccCC----CCCcchhHHHHHHHHHHHhCCCCCCCCC
Q 044494 82 GVARLLNFDSS-NRTLLAGTYGYIAPELAYTMV----VTEKSDVYSFGVVALEVLMGKHPGELLS 141 (144)
Q Consensus 82 ~~~~~~~~~~~-~~~~~~~~~~~~~pe~~~~~~----~~~~~d~~slg~~l~~~~~g~~p~~~~~ 141 (144)
|++........ ......|++.|+|||++.... ++.++|+||+|+++|+|++|..||...+
T Consensus 187 G~a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~ 251 (371)
T cd05622 187 GTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADS 251 (371)
T ss_pred CceeEcCcCCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCC
Confidence 99986543221 223456899999999987643 6789999999999999999999997643
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-32 Score=190.97 Aligned_cols=133 Identities=28% Similarity=0.407 Sum_probs=114.7
Q ss_pred CceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeeec
Q 044494 3 RKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADFG 82 (144)
Q Consensus 3 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~~ 82 (144)
++.+|+||||+++|+|.+++.+... +++..+..++.|++.|+.||| +++++||||||+||+++.++.++++|||
T Consensus 68 ~~~~~lv~e~~~~g~L~~~l~~~~~---~~~~~~~~~~~qil~al~~LH---~~~ivHrDlkp~Nili~~~~~~kl~Dfg 141 (330)
T cd05586 68 DSDLYLVTDYMSGGELFWHLQKEGR---FSEDRAKFYIAELVLALEHLH---KYDIVYRDLKPENILLDATGHIALCDFG 141 (330)
T ss_pred CCeEEEEEcCCCCChHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHH---HCCeEeccCCHHHeEECCCCCEEEecCC
Confidence 5678999999999999998875443 899999999999999999999 8999999999999999999999999999
Q ss_pred ceeecccCCCCcccccccccccCccccccC-CCCCcchhHHHHHHHHHHHhCCCCCCCCC
Q 044494 83 VARLLNFDSSNRTLLAGTYGYIAPELAYTM-VVTEKSDVYSFGVVALEVLMGKHPGELLS 141 (144)
Q Consensus 83 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~-~~~~~~d~~slg~~l~~~~~g~~p~~~~~ 141 (144)
++..............|++.|+|||.+... .++.++|+||+|+++|+|++|..||...+
T Consensus 142 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~ 201 (330)
T cd05586 142 LSKANLTDNKTTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAED 201 (330)
T ss_pred cCcCCCCCCCCccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCC
Confidence 987543333334446689999999998754 47889999999999999999999997643
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.5e-32 Score=189.99 Aligned_cols=134 Identities=28% Similarity=0.390 Sum_probs=117.3
Q ss_pred CCceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeee
Q 044494 2 HRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADF 81 (144)
Q Consensus 2 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~ 81 (144)
+++++|+||||+++++|.+++.+.. .+++..+..++.|++.||.+|| +.|++||||||+||+++.++.++++||
T Consensus 72 ~~~~~~lv~e~~~~~~L~~~l~~~~---~l~~~~~~~i~~qi~~aL~~LH---~~giiH~Dlkp~NIll~~~~~~kL~Df 145 (350)
T cd05573 72 DEEHLYLVMEYMPGGDLMNLLIRKD---VFPEETARFYIAELVLALDSVH---KLGFIHRDIKPDNILIDADGHIKLADF 145 (350)
T ss_pred cCCeEEEEEcCCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHeEECCCCCEEeecC
Confidence 4577899999999999999997653 3899999999999999999999 899999999999999999999999999
Q ss_pred cceeecccCC-----------------------------CCcccccccccccCccccccCCCCCcchhHHHHHHHHHHHh
Q 044494 82 GVARLLNFDS-----------------------------SNRTLLAGTYGYIAPELAYTMVVTEKSDVYSFGVVALEVLM 132 (144)
Q Consensus 82 ~~~~~~~~~~-----------------------------~~~~~~~~~~~~~~pe~~~~~~~~~~~d~~slg~~l~~~~~ 132 (144)
|++....... .......+++.|+|||.+....++.++|+||+|+++|+|++
T Consensus 146 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~ 225 (350)
T cd05573 146 GLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLY 225 (350)
T ss_pred CCCccCcccCcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhcc
Confidence 9987654322 12233568999999999999999999999999999999999
Q ss_pred CCCCCCCCC
Q 044494 133 GKHPGELLS 141 (144)
Q Consensus 133 g~~p~~~~~ 141 (144)
|..||...+
T Consensus 226 g~~Pf~~~~ 234 (350)
T cd05573 226 GFPPFYSDT 234 (350)
T ss_pred CCCCCCCCC
Confidence 999997654
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.8e-32 Score=187.50 Aligned_cols=132 Identities=26% Similarity=0.327 Sum_probs=119.0
Q ss_pred ceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeeecc
Q 044494 4 KCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADFGV 83 (144)
Q Consensus 4 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~~~ 83 (144)
..+++|+..|+||+|.-++-..+ .+++++..+.+++.+|+.||+.|| +.+|+.||+||+||++|.+|+++|+|+|+
T Consensus 258 d~LClVLtlMNGGDLkfHiyn~g-~~gF~e~ra~FYAAEi~cGLehlH---~~~iVYRDLKPeNILLDd~GhvRISDLGL 333 (591)
T KOG0986|consen 258 DALCLVLTLMNGGDLKFHIYNHG-NPGFDEQRARFYAAEIICGLEHLH---RRRIVYRDLKPENILLDDHGHVRISDLGL 333 (591)
T ss_pred CceEEEEEeecCCceeEEeeccC-CCCCchHHHHHHHHHHHhhHHHHH---hcceeeccCChhheeeccCCCeEeeccce
Confidence 46899999999999998886543 367999999999999999999999 99999999999999999999999999999
Q ss_pred eeecccCCCCcccccccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCC
Q 044494 84 ARLLNFDSSNRTLLAGTYGYIAPELAYTMVVTEKSDVYSFGVVALEVLMGKHPGELL 140 (144)
Q Consensus 84 ~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~d~~slg~~l~~~~~g~~p~~~~ 140 (144)
+..+.. .+....+.||.+|||||++++..|+...|.||+||++|||+.|+.||...
T Consensus 334 Avei~~-g~~~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~ 389 (591)
T KOG0986|consen 334 AVEIPE-GKPIRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQR 389 (591)
T ss_pred EEecCC-CCccccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhh
Confidence 998763 33344458999999999999999999999999999999999999999754
|
|
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.2e-31 Score=181.27 Aligned_cols=136 Identities=25% Similarity=0.330 Sum_probs=116.7
Q ss_pred CceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeeec
Q 044494 3 RKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADFG 82 (144)
Q Consensus 3 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~~ 82 (144)
++..|+|||||+||+|..+++++. ...+++..+.+++..++.||+||| ..||+.||+||+||++..+|++-++||.
T Consensus 149 ~~~~cl~meyCpGGdL~~LrqkQp-~~~fse~~aRFYaAEvl~ALEYLH---mlGivYRDLKPENILvredGHIMLsDFD 224 (459)
T KOG0610|consen 149 DKYSCLVMEYCPGGDLHSLRQKQP-GKRFSESAARFYAAEVLLALEYLH---MLGIVYRDLKPENILVREDGHIMLSDFD 224 (459)
T ss_pred cceeEEEEecCCCccHHHHHhhCC-CCccchhhHHHHHHHHHHHHHHHH---hhceeeccCCcceeEEecCCcEEeeecc
Confidence 467899999999999999888754 455999999999999999999999 9999999999999999999999999998
Q ss_pred ceeeccc---------------------------------CCC-----------------------CcccccccccccCc
Q 044494 83 VARLLNF---------------------------------DSS-----------------------NRTLLAGTYGYIAP 106 (144)
Q Consensus 83 ~~~~~~~---------------------------------~~~-----------------------~~~~~~~~~~~~~p 106 (144)
++..... ..+ .....+||-.|+||
T Consensus 225 LS~~~~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAP 304 (459)
T KOG0610|consen 225 LSLRCPVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAP 304 (459)
T ss_pred ccccCCCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccc
Confidence 7643310 000 01124678899999
Q ss_pred cccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCC
Q 044494 107 ELAYTMVVTEKSDVYSFGVVALEVLMGKHPGELLSS 142 (144)
Q Consensus 107 e~~~~~~~~~~~d~~slg~~l~~~~~g~~p~~~~~~ 142 (144)
|++.+.+.+..+|.|+||+++|||+-|..||.+.+.
T Consensus 305 EvI~G~GHgsAVDWWtfGIflYEmLyG~TPFKG~~~ 340 (459)
T KOG0610|consen 305 EVIRGEGHGSAVDWWTFGIFLYEMLYGTTPFKGSNN 340 (459)
T ss_pred eeeecCCCCchhhHHHHHHHHHHHHhCCCCcCCCCc
Confidence 999999999999999999999999999999998764
|
|
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-31 Score=188.41 Aligned_cols=133 Identities=26% Similarity=0.368 Sum_probs=113.4
Q ss_pred CCceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeee
Q 044494 2 HRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADF 81 (144)
Q Consensus 2 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~ 81 (144)
+++.+|+||||+++|+|.+++... .+++..+..++.|++.||+||| +.+++||||||+||+++.++.++|+||
T Consensus 114 ~~~~~~lv~Ey~~gg~L~~~l~~~----~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDLkp~NILl~~~~~~kL~Df 186 (370)
T cd05596 114 DDKYLYMVMEYMPGGDLVNLMSNY----DIPEKWARFYTAEVVLALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADF 186 (370)
T ss_pred cCCEEEEEEcCCCCCcHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHEEEcCCCCEEEEec
Confidence 356789999999999999988643 2788889999999999999999 899999999999999999999999999
Q ss_pred cceeecccCCC-CcccccccccccCccccccC----CCCCcchhHHHHHHHHHHHhCCCCCCCCC
Q 044494 82 GVARLLNFDSS-NRTLLAGTYGYIAPELAYTM----VVTEKSDVYSFGVVALEVLMGKHPGELLS 141 (144)
Q Consensus 82 ~~~~~~~~~~~-~~~~~~~~~~~~~pe~~~~~----~~~~~~d~~slg~~l~~~~~g~~p~~~~~ 141 (144)
|++........ ......|++.|+|||.+... .++.++|+||+|+++|+|++|..||...+
T Consensus 187 G~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~ 251 (370)
T cd05596 187 GTCMKMDANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADS 251 (370)
T ss_pred cceeeccCCCcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCC
Confidence 99986543221 22345689999999998754 36789999999999999999999997644
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-31 Score=180.68 Aligned_cols=133 Identities=27% Similarity=0.294 Sum_probs=119.5
Q ss_pred CceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeeec
Q 044494 3 RKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADFG 82 (144)
Q Consensus 3 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~~ 82 (144)
-+.+|+||||++. +|...+..-. ..+...+++.+..|++.|++||| ...|+|||+|++|++++..|.+|++|||
T Consensus 149 ~d~iy~VMe~~Eh-DLksl~d~m~--q~F~~~evK~L~~QlL~glk~lH---~~wilHRDLK~SNLLm~~~G~lKiaDFG 222 (419)
T KOG0663|consen 149 MDKIYIVMEYVEH-DLKSLMETMK--QPFLPGEVKTLMLQLLRGLKHLH---DNWILHRDLKTSNLLLSHKGILKIADFG 222 (419)
T ss_pred cceeeeeHHHHHh-hHHHHHHhcc--CCCchHHHHHHHHHHHHHHHHHh---hceeEecccchhheeeccCCcEEecccc
Confidence 3568999999986 9999887522 34899999999999999999999 8899999999999999999999999999
Q ss_pred ceeecccCCCCcccccccccccCccccccC-CCCCcchhHHHHHHHHHHHhCCCCCCCCC
Q 044494 83 VARLLNFDSSNRTLLAGTYGYIAPELAYTM-VVTEKSDVYSFGVVALEVLMGKHPGELLS 141 (144)
Q Consensus 83 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~-~~~~~~d~~slg~~l~~~~~g~~p~~~~~ 141 (144)
+++.++.+.+.......|.+|.|||.+.+. .|+...|+||+|||+.|++++.+-|.+.+
T Consensus 223 LAR~ygsp~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~s 282 (419)
T KOG0663|consen 223 LAREYGSPLKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKS 282 (419)
T ss_pred hhhhhcCCcccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCc
Confidence 999999887777778899999999999876 58899999999999999999999888755
|
|
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.2e-32 Score=179.69 Aligned_cols=127 Identities=31% Similarity=0.503 Sum_probs=114.3
Q ss_pred ceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeeecc
Q 044494 4 KCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADFGV 83 (144)
Q Consensus 4 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~~~ 83 (144)
..+++|+|.++.|.|+|++..... +++.+...+.+|+.++++||| .++|+|||+||+||+++.+..++++|||+
T Consensus 96 sF~FlVFdl~prGELFDyLts~Vt---lSEK~tR~iMrqlfegVeylH---a~~IVHRDLKpENILlddn~~i~isDFGF 169 (411)
T KOG0599|consen 96 AFVFLVFDLMPRGELFDYLTSKVT---LSEKETRRIMRQLFEGVEYLH---ARNIVHRDLKPENILLDDNMNIKISDFGF 169 (411)
T ss_pred chhhhhhhhcccchHHHHhhhhee---ecHHHHHHHHHHHHHHHHHHH---HhhhhhcccChhheeeccccceEEeccce
Confidence 456899999999999999986544 999999999999999999999 99999999999999999999999999999
Q ss_pred eeecccCCCCcccccccccccCccccccC------CCCCcchhHHHHHHHHHHHhCCCCC
Q 044494 84 ARLLNFDSSNRTLLAGTYGYIAPELAYTM------VVTEKSDVYSFGVVALEVLMGKHPG 137 (144)
Q Consensus 84 ~~~~~~~~~~~~~~~~~~~~~~pe~~~~~------~~~~~~d~~slg~~l~~~~~g~~p~ 137 (144)
++...+ .......+|||+|+|||.+.+. +|+...|+||+|+|+|.++.|.+||
T Consensus 170 a~~l~~-GekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPF 228 (411)
T KOG0599|consen 170 ACQLEP-GEKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPF 228 (411)
T ss_pred eeccCC-chhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCch
Confidence 998764 4445557899999999999865 4667899999999999999999998
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.9e-32 Score=192.06 Aligned_cols=134 Identities=25% Similarity=0.383 Sum_probs=124.3
Q ss_pred CCceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeee
Q 044494 2 HRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADF 81 (144)
Q Consensus 2 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~ 81 (144)
+++++|++||-|-||.++..++.++. ++..+..++...+++|+.||| ++||+.||+||+|++++.+|.+|+.||
T Consensus 491 d~kyvYmLmEaClGGElWTiLrdRg~---Fdd~tarF~~acv~EAfeYLH---~k~iIYRDLKPENllLd~~Gy~KLVDF 564 (732)
T KOG0614|consen 491 DSKYVYMLMEACLGGELWTILRDRGS---FDDYTARFYVACVLEAFEYLH---RKGIIYRDLKPENLLLDNRGYLKLVDF 564 (732)
T ss_pred cchhhhhhHHhhcCchhhhhhhhcCC---cccchhhhhHHHHHHHHHHHH---hcCceeccCChhheeeccCCceEEeeh
Confidence 46788999999999999999998776 888999999999999999999 999999999999999999999999999
Q ss_pred cceeecccCCCCcccccccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCC
Q 044494 82 GVARLLNFDSSNRTLLAGTYGYIAPELAYTMVVTEKSDVYSFGVVALEVLMGKHPGELLSS 142 (144)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~d~~slg~~l~~~~~g~~p~~~~~~ 142 (144)
|+++.... .....+++|||.|.|||++.+.+.+..+|.||||+++||+++|.+||.+.++
T Consensus 565 GFAKki~~-g~KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dp 624 (732)
T KOG0614|consen 565 GFAKKIGS-GRKTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDP 624 (732)
T ss_pred hhHHHhcc-CCceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCch
Confidence 99998874 3445668999999999999999999999999999999999999999998775
|
|
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-31 Score=185.92 Aligned_cols=134 Identities=28% Similarity=0.413 Sum_probs=114.0
Q ss_pred CCceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeee
Q 044494 2 HRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADF 81 (144)
Q Consensus 2 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~ 81 (144)
.++..|+||||+++|+|.+++.+... .+++..+..++.|++.+|++|| +++++||||||+||+++.++.++++||
T Consensus 72 ~~~~~~lv~Ey~~gg~L~~~l~~~~~--~l~~~~~~~~~~qi~~~L~~lH---~~~iiHrDlkp~Nill~~~~~~kl~Df 146 (331)
T cd05624 72 DENYLYLVMDYYVGGDLLTLLSKFED--RLPEDMARFYIAEMVLAIHSIH---QLHYVHRDIKPDNVLLDMNGHIRLADF 146 (331)
T ss_pred cCCEEEEEEeCCCCCcHHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCchHHEEEcCCCCEEEEec
Confidence 35678999999999999999975322 3889999999999999999999 899999999999999999999999999
Q ss_pred cceeecccCCCC-cccccccccccCcccccc-----CCCCCcchhHHHHHHHHHHHhCCCCCCCC
Q 044494 82 GVARLLNFDSSN-RTLLAGTYGYIAPELAYT-----MVVTEKSDVYSFGVVALEVLMGKHPGELL 140 (144)
Q Consensus 82 ~~~~~~~~~~~~-~~~~~~~~~~~~pe~~~~-----~~~~~~~d~~slg~~l~~~~~g~~p~~~~ 140 (144)
|++......... .....|++.|+|||++.. ..++.++|+||+|+++|+|++|..||...
T Consensus 147 G~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~ 211 (331)
T cd05624 147 GSCLKMNQDGTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAE 211 (331)
T ss_pred cceeeccCCCceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCC
Confidence 998765432221 223568999999999875 45678899999999999999999999754
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.9e-32 Score=187.44 Aligned_cols=133 Identities=29% Similarity=0.396 Sum_probs=116.6
Q ss_pred CceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeeec
Q 044494 3 RKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADFG 82 (144)
Q Consensus 3 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~~ 82 (144)
++.+|+||||+++++|.+++.+... +++..+..++.|++.||.||| +.+++|+||||+||+++.++.++|+|||
T Consensus 70 ~~~~~lv~e~~~~~~L~~~l~~~~~---l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kL~Dfg 143 (318)
T cd05582 70 EGKLYLILDFLRGGDLFTRLSKEVM---FTEEDVKFYLAELALALDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFG 143 (318)
T ss_pred CCEEEEEEcCCCCCcHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHeEECCCCcEEEeecc
Confidence 5678999999999999998875433 899999999999999999999 8999999999999999999999999999
Q ss_pred ceeecccCCCCcccccccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCC
Q 044494 83 VARLLNFDSSNRTLLAGTYGYIAPELAYTMVVTEKSDVYSFGVVALEVLMGKHPGELLS 141 (144)
Q Consensus 83 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~d~~slg~~l~~~~~g~~p~~~~~ 141 (144)
++..............+++.|++||.+....++.++|+||+|+++|+|++|..||...+
T Consensus 144 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~ 202 (318)
T cd05582 144 LSKESIDHEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKD 202 (318)
T ss_pred CCcccCCCCCceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCC
Confidence 98765433233344568999999999998888999999999999999999999997643
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=8e-31 Score=190.46 Aligned_cols=136 Identities=27% Similarity=0.318 Sum_probs=116.6
Q ss_pred CceEEEEEeeccCCCHHHHhhcc-cccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeee
Q 044494 3 RKCMFLIYEYMEMGSLFCVLRTD-EEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADF 81 (144)
Q Consensus 3 ~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~ 81 (144)
++++|+||||+++|+|.+++... .....+++..+..++.|++.+|.+|| +++++||||||+||+++.++.++++||
T Consensus 137 ~~~~~lv~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH---~~~ivHrDlkp~NIll~~~~~~kL~DF 213 (478)
T PTZ00267 137 DDKLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVH---SRKMMHRDLKSANIFLMPTGIIKLGDF 213 (478)
T ss_pred CCEEEEEEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---hCCEEECCcCHHhEEECCCCcEEEEeC
Confidence 56889999999999999987642 22334889999999999999999999 899999999999999999999999999
Q ss_pred cceeecccCCC--CcccccccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCC
Q 044494 82 GVARLLNFDSS--NRTLLAGTYGYIAPELAYTMVVTEKSDVYSFGVVALEVLMGKHPGELLS 141 (144)
Q Consensus 82 ~~~~~~~~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~d~~slg~~l~~~~~g~~p~~~~~ 141 (144)
|++........ ......|++.|+|||++....++.++|+||+|+++++|++|..||...+
T Consensus 214 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~ 275 (478)
T PTZ00267 214 GFSKQYSDSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPS 275 (478)
T ss_pred cCceecCCccccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCC
Confidence 99986543211 1334568999999999998889999999999999999999999997643
|
|
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.1e-31 Score=184.82 Aligned_cols=134 Identities=29% Similarity=0.399 Sum_probs=113.1
Q ss_pred CceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeeec
Q 044494 3 RKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADFG 82 (144)
Q Consensus 3 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~~ 82 (144)
.+.+|+||||+++|+|.+++.+... .+++..+..++.|++.++.+|| +.+++||||||+||+++.++.++++|||
T Consensus 73 ~~~~~lv~ey~~~g~L~~~l~~~~~--~l~~~~~~~~~~qi~~al~~lH---~~~iiHrDlkp~Nili~~~~~~kL~DfG 147 (332)
T cd05623 73 ENNLYLVMDYYVGGDLLTLLSKFED--RLPEDMARFYLAEMVIAIDSVH---QLHYVHRDIKPDNILMDMNGHIRLADFG 147 (332)
T ss_pred CCEEEEEEeccCCCcHHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHEEECCCCCEEEeecc
Confidence 4678999999999999999975322 3889999999999999999999 8999999999999999999999999999
Q ss_pred ceeecccCCC-CcccccccccccCccccc-----cCCCCCcchhHHHHHHHHHHHhCCCCCCCCC
Q 044494 83 VARLLNFDSS-NRTLLAGTYGYIAPELAY-----TMVVTEKSDVYSFGVVALEVLMGKHPGELLS 141 (144)
Q Consensus 83 ~~~~~~~~~~-~~~~~~~~~~~~~pe~~~-----~~~~~~~~d~~slg~~l~~~~~g~~p~~~~~ 141 (144)
++........ ......|++.|+|||++. ...++.++|+||+|+++|+|++|..||...+
T Consensus 148 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~ 212 (332)
T cd05623 148 SCLKLMEDGTVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAES 212 (332)
T ss_pred hheecccCCcceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCC
Confidence 9875432221 223356899999999986 2356789999999999999999999997643
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.7e-31 Score=184.13 Aligned_cols=137 Identities=46% Similarity=0.744 Sum_probs=117.0
Q ss_pred Cc-eEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeee
Q 044494 3 RK-CMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADF 81 (144)
Q Consensus 3 ~~-~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~ 81 (144)
++ ..+||+||+++|+|.+++...... .++|.....|+.+++.||.|||..+...++|||||++||++|.+...||+||
T Consensus 143 ~~~~~~LVYEym~nGsL~d~L~~~~~~-~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsDF 221 (361)
T KOG1187|consen 143 GGEHRLLVYEYMPNGSLEDHLHGKKGE-PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSDF 221 (361)
T ss_pred CCceEEEEEEccCCCCHHHHhCCCCCC-CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccCc
Confidence 44 489999999999999999865433 5899999999999999999999765567999999999999999999999999
Q ss_pred cceeecccCCCCcccc-cccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCC
Q 044494 82 GVARLLNFDSSNRTLL-AGTYGYIAPELAYTMVVTEKSDVYSFGVVALEVLMGKHPGELL 140 (144)
Q Consensus 82 ~~~~~~~~~~~~~~~~-~~~~~~~~pe~~~~~~~~~~~d~~slg~~l~~~~~g~~p~~~~ 140 (144)
|+++............ .|+.+|++||+......+.|+|+||+|+++.|+++|+.|.+..
T Consensus 222 GLa~~~~~~~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~ 281 (361)
T KOG1187|consen 222 GLAKLGPEGDTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQS 281 (361)
T ss_pred cCcccCCccccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCC
Confidence 9996543211112222 7999999999999988899999999999999999999888754
|
|
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.9e-31 Score=183.08 Aligned_cols=133 Identities=29% Similarity=0.370 Sum_probs=112.8
Q ss_pred CceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeeec
Q 044494 3 RKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADFG 82 (144)
Q Consensus 3 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~~ 82 (144)
++++|+||||+++|+|.+++.+.. ..+++..+..++.|++.++++|| +++++||||||+||+++.++.++++|||
T Consensus 73 ~~~~~lv~e~~~g~~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nill~~~~~~kl~Dfg 147 (331)
T cd05597 73 ENNLYLVMDYYVGGDLLTLLSKFE--DRLPEDMARFYLAEMVLAIDSVH---QLGYVHRDIKPDNVLLDKNGHIRLADFG 147 (331)
T ss_pred CCeEEEEEecCCCCcHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---hCCeEECCCCHHHEEECCCCCEEEEECC
Confidence 567899999999999999997522 23899999999999999999999 8999999999999999999999999999
Q ss_pred ceeecccCCC-CcccccccccccCcccccc-----CCCCCcchhHHHHHHHHHHHhCCCCCCCC
Q 044494 83 VARLLNFDSS-NRTLLAGTYGYIAPELAYT-----MVVTEKSDVYSFGVVALEVLMGKHPGELL 140 (144)
Q Consensus 83 ~~~~~~~~~~-~~~~~~~~~~~~~pe~~~~-----~~~~~~~d~~slg~~l~~~~~g~~p~~~~ 140 (144)
++........ ......+++.|+|||++.. ..++.++|+||+|+++|+|++|..||...
T Consensus 148 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~ 211 (331)
T cd05597 148 SCLRLLADGTVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAE 211 (331)
T ss_pred ceeecCCCCCccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCC
Confidence 9876543222 1223458999999999873 34677899999999999999999999764
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-30 Score=181.61 Aligned_cols=136 Identities=28% Similarity=0.423 Sum_probs=112.3
Q ss_pred CceEEEEEeeccCCCHHHHhhcccc-------------------------------------------------------
Q 044494 3 RKCMFLIYEYMEMGSLFCVLRTDEE------------------------------------------------------- 27 (144)
Q Consensus 3 ~~~~~lv~e~~~~~~L~~~l~~~~~------------------------------------------------------- 27 (144)
++.+++||||+++|+|.+++.....
T Consensus 84 ~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (338)
T cd05102 84 NGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQET 163 (338)
T ss_pred CCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhc
Confidence 3468999999999999999865221
Q ss_pred ----cCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeeecceeecccCCC--Ccccccccc
Q 044494 28 ----AVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADFGVARLLNFDSS--NRTLLAGTY 101 (144)
Q Consensus 28 ----~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~~~ 101 (144)
...+++.++..++.|++.|+.||| +++++||||||.||+++.++.++++|||+++....... ......+++
T Consensus 164 ~~~~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~ 240 (338)
T cd05102 164 DDLWKSPLTMEDLICYSFQVARGMEFLA---SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPL 240 (338)
T ss_pred cccccCCCCHHHHHHHHHHHHHHHHHHH---HCCEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCc
Confidence 123777888999999999999999 89999999999999999999999999999975432211 122234567
Q ss_pred cccCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCC
Q 044494 102 GYIAPELAYTMVVTEKSDVYSFGVVALEVLM-GKHPGELLS 141 (144)
Q Consensus 102 ~~~~pe~~~~~~~~~~~d~~slg~~l~~~~~-g~~p~~~~~ 141 (144)
.|+|||.+....++.++|+||+|+++|||++ |..||...+
T Consensus 241 ~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~ 281 (338)
T cd05102 241 KWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQ 281 (338)
T ss_pred cccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCC
Confidence 8999999988889999999999999999997 999998643
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.4e-31 Score=189.68 Aligned_cols=134 Identities=22% Similarity=0.323 Sum_probs=117.2
Q ss_pred CCCceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCC--CCeEE
Q 044494 1 LHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLE--LEAFV 78 (144)
Q Consensus 1 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~--~~~~l 78 (144)
.+++++|+|+|.+. -+|+++++. +...+++...+..++.|++.+|..|| +.+|+|+|+||+|||+... ..+||
T Consensus 258 ~fr~HlciVfELL~-~NLYellK~-n~f~Glsl~~ir~~~~Qil~~L~~L~---~l~IIHcDLKPENILL~~~~r~~vKV 332 (586)
T KOG0667|consen 258 YFRNHLCIVFELLS-TNLYELLKN-NKFRGLSLPLVRKFAQQILTALLFLH---ELGIIHCDLKPENILLKDPKRSRIKV 332 (586)
T ss_pred ccccceeeeehhhh-hhHHHHHHh-cCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCChhheeeccCCcCceeE
Confidence 47899999999995 599999986 34456999999999999999999999 9999999999999999754 46999
Q ss_pred eeecceeecccCCCCcccccccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCC
Q 044494 79 ADFGVARLLNFDSSNRTLLAGTYGYIAPELAYTMVVTEKSDVYSFGVVALEVLMGKHPGELLSS 142 (144)
Q Consensus 79 ~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~d~~slg~~l~~~~~g~~p~~~~~~ 142 (144)
+|||.++... ....+...+..|.|||++.+.+|+.+.||||||||++||++|.+-|.+-+.
T Consensus 333 IDFGSSc~~~---q~vytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne 393 (586)
T KOG0667|consen 333 IDFGSSCFES---QRVYTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNE 393 (586)
T ss_pred EecccccccC---CcceeeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCH
Confidence 9999998643 223366788999999999999999999999999999999999988877653
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-30 Score=169.85 Aligned_cols=135 Identities=27% Similarity=0.344 Sum_probs=119.5
Q ss_pred CCceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeee
Q 044494 2 HRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADF 81 (144)
Q Consensus 2 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~ 81 (144)
|.+++-+|+||++. +|+..++... ..++...+..++.++++|+.||| ++.++|||+||.|++++.+|.+|++||
T Consensus 72 ~~~~l~lVfEfm~t-dLe~vIkd~~--i~l~pa~iK~y~~m~LkGl~y~H---~~~IlHRDlKPnNLLis~~g~lKiADF 145 (318)
T KOG0659|consen 72 HKSNLSLVFEFMPT-DLEVVIKDKN--IILSPADIKSYMLMTLKGLAYCH---SKWILHRDLKPNNLLISSDGQLKIADF 145 (318)
T ss_pred CCCceEEEEEeccc-cHHHHhcccc--cccCHHHHHHHHHHHHHHHHHHH---hhhhhcccCCccceEEcCCCcEEeecc
Confidence 56788999999975 9999888543 34999999999999999999999 999999999999999999999999999
Q ss_pred cceeecccCCCCcccccccccccCccccccC-CCCCcchhHHHHHHHHHHHhCCCCCCCCCC
Q 044494 82 GVARLLNFDSSNRTLLAGTYGYIAPELAYTM-VVTEKSDVYSFGVVALEVLMGKHPGELLSS 142 (144)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~-~~~~~~d~~slg~~l~~~~~g~~p~~~~~~ 142 (144)
|+++.+.++.........|.+|.|||.+-+. .|+...|+||.||++.|++-|.+-|.+.++
T Consensus 146 GLAr~f~~p~~~~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sD 207 (318)
T KOG0659|consen 146 GLARFFGSPNRIQTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSD 207 (318)
T ss_pred cchhccCCCCcccccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCch
Confidence 9999988776666666789999999988765 588899999999999999999888777553
|
|
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.7e-30 Score=178.03 Aligned_cols=132 Identities=23% Similarity=0.330 Sum_probs=110.8
Q ss_pred CceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeeec
Q 044494 3 RKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADFG 82 (144)
Q Consensus 3 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~~ 82 (144)
++..++||||+. ++|.+++.... ..+++..+..++.|++.|+++|| +.+++|+||||+||+++.++.++++|||
T Consensus 75 ~~~~~lv~e~~~-~~l~~~~~~~~--~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dlkp~Nill~~~~~~kl~Dfg 148 (303)
T cd07869 75 KETLTLVFEYVH-TDLCQYMDKHP--GGLHPENVKLFLFQLLRGLSYIH---QRYILHRDLKPQNLLISDTGELKLADFG 148 (303)
T ss_pred CCeEEEEEECCC-cCHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEECCCC
Confidence 567899999996 58888776532 23888999999999999999999 8999999999999999999999999999
Q ss_pred ceeecccCCCCcccccccccccCccccccC-CCCCcchhHHHHHHHHHHHhCCCCCCCC
Q 044494 83 VARLLNFDSSNRTLLAGTYGYIAPELAYTM-VVTEKSDVYSFGVVALEVLMGKHPGELL 140 (144)
Q Consensus 83 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~-~~~~~~d~~slg~~l~~~~~g~~p~~~~ 140 (144)
.+..............+++.|+|||++.+. .++.++|+||+|+++++|++|..||...
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~ 207 (303)
T cd07869 149 LARAKSVPSHTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGM 207 (303)
T ss_pred cceeccCCCccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 987544333333345678899999988654 4678899999999999999999999764
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.3e-31 Score=175.87 Aligned_cols=132 Identities=28% Similarity=0.422 Sum_probs=117.3
Q ss_pred CceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcC---CCCeEEe
Q 044494 3 RKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNL---ELEAFVA 79 (144)
Q Consensus 3 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~---~~~~~l~ 79 (144)
.+++.+|||.++||.|+..++.++. ..+.+.++.++.+||+.|+.||| +.+|.|||+||+|++... +..+|++
T Consensus 131 rkcLLiVmE~meGGeLfsriq~~g~-~afTErea~eI~~qI~~Av~~lH---~~nIAHRDlKpENLLyt~t~~na~lKLt 206 (400)
T KOG0604|consen 131 RKCLLIVMECMEGGELFSRIQDRGD-QAFTEREASEIMKQIGLAVRYLH---SMNIAHRDLKPENLLYTTTSPNAPLKLT 206 (400)
T ss_pred ceeeEeeeecccchHHHHHHHHccc-ccchHHHHHHHHHHHHHHHHHHH---hcchhhccCChhheeeecCCCCcceEec
Confidence 4678899999999999999987543 45999999999999999999999 999999999999999964 5678999
Q ss_pred eecceeecccCCCCcccccccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCC
Q 044494 80 DFGVARLLNFDSSNRTLLAGTYGYIAPELAYTMVVTEKSDVYSFGVVALEVLMGKHPGEL 139 (144)
Q Consensus 80 d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~d~~slg~~l~~~~~g~~p~~~ 139 (144)
|||+++.... .....+.+.||.|.|||++-.++|+...|+||+|+++|-|+.|.+||=.
T Consensus 207 DfGFAK~t~~-~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS 265 (400)
T KOG0604|consen 207 DFGFAKETQE-PGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYS 265 (400)
T ss_pred ccccccccCC-CccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccc
Confidence 9999987653 3445667889999999999999999999999999999999999999943
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.6e-31 Score=182.84 Aligned_cols=131 Identities=21% Similarity=0.326 Sum_probs=115.3
Q ss_pred eEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeeecce
Q 044494 5 CMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADFGVA 84 (144)
Q Consensus 5 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~~~~ 84 (144)
.+|+|||||.. +|+++++.+ .+.+++..+..|+.|+++||+++| .+|+.|||+||+||++.....+||+|||+|
T Consensus 84 ~L~fVfE~Md~-NLYqLmK~R--~r~fse~~irnim~QilqGL~hiH---k~GfFHRDlKPENiLi~~~~~iKiaDFGLA 157 (538)
T KOG0661|consen 84 ILYFVFEFMDC-NLYQLMKDR--NRLFSESDIRNIMYQILQGLAHIH---KHGFFHRDLKPENILISGNDVIKIADFGLA 157 (538)
T ss_pred eEeeeHHhhhh-hHHHHHhhc--CCcCCHHHHHHHHHHHHHHHHHHH---hcCcccccCChhheEecccceeEecccccc
Confidence 89999999975 999999865 456999999999999999999999 999999999999999999889999999999
Q ss_pred eecccCCCCcccccccccccCccccccC-CCCCcchhHHHHHHHHHHHhCCCCCCCCCC
Q 044494 85 RLLNFDSSNRTLLAGTYGYIAPELAYTM-VVTEKSDVYSFGVVALEVLMGKHPGELLSS 142 (144)
Q Consensus 85 ~~~~~~~~~~~~~~~~~~~~~pe~~~~~-~~~~~~d~~slg~~l~~~~~g~~p~~~~~~ 142 (144)
+...+...-.. ...|.+|.|||++... .|+.+.|+||+||+++|+.+-++-|.+-++
T Consensus 158 Rev~SkpPYTe-YVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE 215 (538)
T KOG0661|consen 158 REVRSKPPYTE-YVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASE 215 (538)
T ss_pred cccccCCCcch-hhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcH
Confidence 98765443333 5678999999998866 578999999999999999999888877553
|
|
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.5e-30 Score=178.94 Aligned_cols=130 Identities=28% Similarity=0.368 Sum_probs=113.6
Q ss_pred CceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCC-CeEecCCCCCcEEEcCCCCeEEeee
Q 044494 3 RKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTP-PIVHRDISSNNILLNLELEAFVADF 81 (144)
Q Consensus 3 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~-~~~h~~i~~~ni~~~~~~~~~l~d~ 81 (144)
++.+++||||+++++|.+++..... +++..+..++.|++.++.||| ++ +++|+||||+||+++.++.++++||
T Consensus 75 ~~~~~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~~i~~~l~~lH---~~~~ivH~dlkp~Nil~~~~~~~kl~Df 148 (331)
T cd06649 75 DGEISICMEHMDGGSLDQVLKEAKR---IPEEILGKVSIAVLRGLAYLR---EKHQIMHRDVKPSNILVNSRGEIKLCDF 148 (331)
T ss_pred CCEEEEEeecCCCCcHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHh---hcCCEEcCCCChhhEEEcCCCcEEEccC
Confidence 5678999999999999999876433 899999999999999999999 64 6999999999999999999999999
Q ss_pred cceeecccCCCCcccccccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCC
Q 044494 82 GVARLLNFDSSNRTLLAGTYGYIAPELAYTMVVTEKSDVYSFGVVALEVLMGKHPGELL 140 (144)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~d~~slg~~l~~~~~g~~p~~~~ 140 (144)
|++..... .......+++.|+|||.+.+..++.++|+||+|+++|++++|..||...
T Consensus 149 g~~~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~ 205 (331)
T cd06649 149 GVSGQLID--SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPP 205 (331)
T ss_pred cccccccc--cccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCC
Confidence 99875432 1223356889999999999888999999999999999999999999654
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.4e-30 Score=176.07 Aligned_cols=133 Identities=29% Similarity=0.330 Sum_probs=112.0
Q ss_pred CceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeeec
Q 044494 3 RKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADFG 82 (144)
Q Consensus 3 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~~ 82 (144)
++.+|+||||++++.+..+.... ..+++..+..++.|++.|+.+|| +.+++|+||||+||+++.++.++++|||
T Consensus 72 ~~~~~lv~e~~~~~~l~~~~~~~---~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~dlkp~Nill~~~~~~kl~Dfg 145 (287)
T cd07848 72 RGKLYLVFEYVEKNMLELLEEMP---NGVPPEKVRSYIYQLIKAIHWCH---KNDIVHRDIKPENLLISHNDVLKLCDFG 145 (287)
T ss_pred CCEEEEEEecCCCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCcEEEeecc
Confidence 56789999999987665544322 23899999999999999999999 8999999999999999999999999999
Q ss_pred ceeecccCCC-CcccccccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCC
Q 044494 83 VARLLNFDSS-NRTLLAGTYGYIAPELAYTMVVTEKSDVYSFGVVALEVLMGKHPGELLS 141 (144)
Q Consensus 83 ~~~~~~~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~d~~slg~~l~~~~~g~~p~~~~~ 141 (144)
++........ ......+++.|+|||++.+..++.++|+||+|+++|+|++|..||...+
T Consensus 146 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~ 205 (287)
T cd07848 146 FARNLSEGSNANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGES 205 (287)
T ss_pred CcccccccccccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCC
Confidence 9876542221 2223468889999999988888999999999999999999999998654
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.4e-30 Score=176.42 Aligned_cols=133 Identities=23% Similarity=0.340 Sum_probs=112.1
Q ss_pred CceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeeec
Q 044494 3 RKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADFG 82 (144)
Q Consensus 3 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~~ 82 (144)
++..++||||+.+ +|.+++..... .+++..+..++.|++.|+.+|| ++|++||||||+||+++.++.++++|||
T Consensus 75 ~~~~~lv~e~~~~-~l~~~l~~~~~--~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~dlkp~Nil~~~~~~~kl~DfG 148 (288)
T cd07871 75 ERCLTLVFEYLDS-DLKQYLDNCGN--LMSMHNVKIFMFQLLRGLSYCH---KRKILHRDLKPQNLLINEKGELKLADFG 148 (288)
T ss_pred CCeEEEEEeCCCc-CHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEECCCCCEEECcCc
Confidence 4578999999975 89988865332 3788899999999999999999 8999999999999999999999999999
Q ss_pred ceeecccCCCCcccccccccccCcccccc-CCCCCcchhHHHHHHHHHHHhCCCCCCCCC
Q 044494 83 VARLLNFDSSNRTLLAGTYGYIAPELAYT-MVVTEKSDVYSFGVVALEVLMGKHPGELLS 141 (144)
Q Consensus 83 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~-~~~~~~~d~~slg~~l~~~~~g~~p~~~~~ 141 (144)
++..............+++.|+|||.+.+ ..++.++|+||+|+++++|++|..||...+
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~ 208 (288)
T cd07871 149 LARAKSVPTKTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGST 208 (288)
T ss_pred ceeeccCCCccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 98765433333344567889999998865 457889999999999999999999997643
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.4e-30 Score=187.72 Aligned_cols=134 Identities=25% Similarity=0.335 Sum_probs=115.2
Q ss_pred eEEEEEeeccCCCHHHHhhcc-cccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeeecc
Q 044494 5 CMFLIYEYMEMGSLFCVLRTD-EEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADFGV 83 (144)
Q Consensus 5 ~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~~~ 83 (144)
.+++||||+++|+|.+++... .....+++..+..++.|++.+|.||| +.+++||||||+||+++.++.++|+|||+
T Consensus 113 ~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH---~~~IiHrDLKP~NILl~~~~~vkL~DFGl 189 (496)
T PTZ00283 113 MIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVH---SKHMIHRDIKSANILLCSNGLVKLGDFGF 189 (496)
T ss_pred EEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEeCCCCEEEEeccc
Confidence 368999999999999988642 23345899999999999999999999 89999999999999999999999999999
Q ss_pred eeecccCC--CCcccccccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCC
Q 044494 84 ARLLNFDS--SNRTLLAGTYGYIAPELAYTMVVTEKSDVYSFGVVALEVLMGKHPGELLS 141 (144)
Q Consensus 84 ~~~~~~~~--~~~~~~~~~~~~~~pe~~~~~~~~~~~d~~slg~~l~~~~~g~~p~~~~~ 141 (144)
++...... .......|++.|+|||.+....++.++|+||+|+++|+|++|..||...+
T Consensus 190 s~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~ 249 (496)
T PTZ00283 190 SKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGEN 249 (496)
T ss_pred CeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCC
Confidence 87654221 12234568999999999999889999999999999999999999997643
|
|
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=99.97 E-value=7e-30 Score=174.02 Aligned_cols=133 Identities=25% Similarity=0.344 Sum_probs=114.4
Q ss_pred CceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeeec
Q 044494 3 RKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADFG 82 (144)
Q Consensus 3 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~~ 82 (144)
+..+|+||||+++++|.+++.... ...+++..+..++.|++.|+++|| +.+++|+||||+||+++.++.++++|||
T Consensus 65 ~~~~~lv~e~~~g~~L~~~~~~~~-~~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dikp~Nili~~~~~~~l~Dfg 140 (277)
T cd05607 65 KTHLCLVMSLMNGGDLKYHIYNVG-ERGLEMERVIHYSAQITCGILHLH---SMDIVYRDMKPENVLLDDQGNCRLSDLG 140 (277)
T ss_pred CCeEEEEEecCCCCCHHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHH---HCCEEEccCChHhEEEcCCCCEEEeece
Confidence 567899999999999998876432 233888999999999999999999 8999999999999999999999999999
Q ss_pred ceeecccCCCCcccccccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCC
Q 044494 83 VARLLNFDSSNRTLLAGTYGYIAPELAYTMVVTEKSDVYSFGVVALEVLMGKHPGELL 140 (144)
Q Consensus 83 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~d~~slg~~l~~~~~g~~p~~~~ 140 (144)
.+...... .......+++.|+|||++....++.++|+||+|+++|++++|..||...
T Consensus 141 ~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~ 197 (277)
T cd05607 141 LAVELKDG-KTITQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDH 197 (277)
T ss_pred eeeecCCC-ceeeccCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCC
Confidence 98765422 1223346888999999998888999999999999999999999999754
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.5e-31 Score=184.34 Aligned_cols=133 Identities=30% Similarity=0.410 Sum_probs=113.5
Q ss_pred CceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeeec
Q 044494 3 RKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADFG 82 (144)
Q Consensus 3 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~~ 82 (144)
++.+|+||||+++++|.+++.+.. ..+++..+..++.|++.+|++|| +.+++||||||+||+++.++.++|+|||
T Consensus 73 ~~~~~lv~e~~~~~~L~~~l~~~~--~~l~~~~~~~~~~qi~~aL~~lH---~~~i~H~Dlkp~NIll~~~~~~kL~Dfg 147 (330)
T cd05601 73 KDNLYLVMEYQPGGDLLSLLNRYE--DQFDEDMAQFYLAELVLAIHSVH---QMGYVHRDIKPENVLIDRTGHIKLADFG 147 (330)
T ss_pred CCeEEEEECCCCCCCHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---HCCeEcccCchHheEECCCCCEEeccCC
Confidence 567899999999999999997642 23899999999999999999999 8999999999999999999999999999
Q ss_pred ceeecccCCC-CcccccccccccCccccc------cCCCCCcchhHHHHHHHHHHHhCCCCCCCC
Q 044494 83 VARLLNFDSS-NRTLLAGTYGYIAPELAY------TMVVTEKSDVYSFGVVALEVLMGKHPGELL 140 (144)
Q Consensus 83 ~~~~~~~~~~-~~~~~~~~~~~~~pe~~~------~~~~~~~~d~~slg~~l~~~~~g~~p~~~~ 140 (144)
++........ ......+++.|+|||++. ...++.++|+||+|+++|+|++|..||...
T Consensus 148 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~ 212 (330)
T cd05601 148 SAARLTANKMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEG 212 (330)
T ss_pred CCeECCCCCceeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCC
Confidence 9976543222 122346889999999987 345678899999999999999999999754
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.1e-31 Score=177.42 Aligned_cols=134 Identities=25% Similarity=0.349 Sum_probs=122.1
Q ss_pred CceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeeec
Q 044494 3 RKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADFG 82 (144)
Q Consensus 3 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~~ 82 (144)
+.++++||||.+||.|+-++.+..- ++++....+-..|+.||.||| +++++.||+|.+|++++.+|++||.|||
T Consensus 240 ~drlCFVMeyanGGeLf~HLsrer~---FsE~RtRFYGaEIvsAL~YLH---s~~ivYRDlKLENLlLDkDGHIKitDFG 313 (516)
T KOG0690|consen 240 QDRLCFVMEYANGGELFFHLSRERV---FSEDRTRFYGAEIVSALGYLH---SRNIVYRDLKLENLLLDKDGHIKITDFG 313 (516)
T ss_pred CceEEEEEEEccCceEeeehhhhhc---ccchhhhhhhHHHHHHhhhhh---hCCeeeeechhhhheeccCCceEeeecc
Confidence 4678999999999999998876433 899999999999999999999 8999999999999999999999999999
Q ss_pred ceeecccCCCCcccccccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCC
Q 044494 83 VARLLNFDSSNRTLLAGTYGYIAPELAYTMVVTEKSDVYSFGVVALEVLMGKHPGELLSS 142 (144)
Q Consensus 83 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~d~~slg~~l~~~~~g~~p~~~~~~ 142 (144)
+++.-........+.+|+|.|+|||++....|+...|.|.+|+++|||+.|+.||-..+.
T Consensus 314 LCKE~I~~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh 373 (516)
T KOG0690|consen 314 LCKEEIKYGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDH 373 (516)
T ss_pred cchhcccccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccch
Confidence 998765556667788999999999999999999999999999999999999999976553
|
|
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.2e-30 Score=175.83 Aligned_cols=133 Identities=26% Similarity=0.341 Sum_probs=114.0
Q ss_pred CceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeeec
Q 044494 3 RKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADFG 82 (144)
Q Consensus 3 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~~ 82 (144)
+..+++||||+. ++|.+++.... ...+++..++.++.|++.|+.+|| +.+++|+||||+||+++.++.++++|||
T Consensus 81 ~~~~~lv~e~~~-~~l~~~~~~~~-~~~~~~~~~~~i~~qi~~aL~~lH---~~~iiH~dlkp~Nil~~~~~~~kl~Dfg 155 (290)
T cd07862 81 ETKLTLVFEHVD-QDLTTYLDKVP-EPGVPTETIKDMMFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFG 155 (290)
T ss_pred CCcEEEEEccCC-CCHHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHHHEEEcCCCCEEEcccc
Confidence 356899999996 58999887532 234899999999999999999999 8999999999999999999999999999
Q ss_pred ceeecccCCCCcccccccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCC
Q 044494 83 VARLLNFDSSNRTLLAGTYGYIAPELAYTMVVTEKSDVYSFGVVALEVLMGKHPGELLS 141 (144)
Q Consensus 83 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~d~~slg~~l~~~~~g~~p~~~~~ 141 (144)
.+...... .......+++.|+|||.+....++.++|+||+|+++|+|++|..||.+.+
T Consensus 156 ~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~ 213 (290)
T cd07862 156 LARIYSFQ-MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSS 213 (290)
T ss_pred ceEeccCC-cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCC
Confidence 99765432 22334568899999999988888999999999999999999999998654
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.3e-30 Score=178.67 Aligned_cols=130 Identities=31% Similarity=0.432 Sum_probs=110.0
Q ss_pred eEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeeecce
Q 044494 5 CMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADFGVA 84 (144)
Q Consensus 5 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~~~~ 84 (144)
.+|+||||+. ++|.+++..... +++..+..++.|++.||.||| +++++|+||||+||+++.++.++|+|||++
T Consensus 78 ~~~lv~e~~~-~~L~~~l~~~~~---~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIll~~~~~~kL~Dfg~~ 150 (338)
T cd07859 78 DIYVVFELME-SDLHQVIKANDD---LTPEHHQFFLYQLLRALKYIH---TANVFHRDLKPKNILANADCKLKICDFGLA 150 (338)
T ss_pred eEEEEEecCC-CCHHHHHHhccc---CCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCcEEEccCccc
Confidence 5899999995 689888875433 899999999999999999999 899999999999999999999999999998
Q ss_pred eecccCCC---CcccccccccccCcccccc--CCCCCcchhHHHHHHHHHHHhCCCCCCCCC
Q 044494 85 RLLNFDSS---NRTLLAGTYGYIAPELAYT--MVVTEKSDVYSFGVVALEVLMGKHPGELLS 141 (144)
Q Consensus 85 ~~~~~~~~---~~~~~~~~~~~~~pe~~~~--~~~~~~~d~~slg~~l~~~~~g~~p~~~~~ 141 (144)
........ ......+++.|+|||++.. ..++.++|+||+|+++|+|++|+.||...+
T Consensus 151 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~ 212 (338)
T cd07859 151 RVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKN 212 (338)
T ss_pred cccccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCC
Confidence 75432111 1123468899999999875 567889999999999999999999997643
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-30 Score=181.96 Aligned_cols=130 Identities=25% Similarity=0.368 Sum_probs=108.4
Q ss_pred CceEEEEEeeccCCCHHHHhhcccccCC-CCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeee
Q 044494 3 RKCMFLIYEYMEMGSLFCVLRTDEEAVG-LDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADF 81 (144)
Q Consensus 3 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~-~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~ 81 (144)
.+++|||+|||..|.+... ..... +.+.++..++++++.||+||| .+||+||||||+|++++.+|.+||+||
T Consensus 182 s~~~YlVley~s~G~v~w~----p~d~~els~~~Ar~ylrDvv~GLEYLH---~QgiiHRDIKPsNLLl~~~g~VKIsDF 254 (576)
T KOG0585|consen 182 SDKLYLVLEYCSKGEVKWC----PPDKPELSEQQARKYLRDVVLGLEYLH---YQGIIHRDIKPSNLLLSSDGTVKISDF 254 (576)
T ss_pred cCceEEEEEeccCCccccC----CCCcccccHHHHHHHHHHHHHHHHHHH---hcCeeccccchhheEEcCCCcEEeecc
Confidence 5789999999998887542 22223 899999999999999999999 999999999999999999999999999
Q ss_pred cceeecccC-----CCCcccccccccccCccccccCC----CCCcchhHHHHHHHHHHHhCCCCCCC
Q 044494 82 GVARLLNFD-----SSNRTLLAGTYGYIAPELAYTMV----VTEKSDVYSFGVVALEVLMGKHPGEL 139 (144)
Q Consensus 82 ~~~~~~~~~-----~~~~~~~~~~~~~~~pe~~~~~~----~~~~~d~~slg~~l~~~~~g~~p~~~ 139 (144)
|.+...... ........|||.|+|||...... -+.+.|+||+|+++|.++.|+.||.+
T Consensus 255 GVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~ 321 (576)
T KOG0585|consen 255 GVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFD 321 (576)
T ss_pred ceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCccc
Confidence 999865211 11123367999999999987632 24679999999999999999999975
|
|
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.9e-30 Score=185.55 Aligned_cols=129 Identities=21% Similarity=0.278 Sum_probs=110.1
Q ss_pred CceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCC-CCeEecCCCCCcEEEcCCC-------
Q 044494 3 RKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCT-PPIVHRDISSNNILLNLEL------- 74 (144)
Q Consensus 3 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~-~~~~h~~i~~~ni~~~~~~------- 74 (144)
+..+++|||++ +++|.+++.+... +++..+..++.|++.||.||| + .|++||||||+||+++.++
T Consensus 204 ~~~~~iv~~~~-g~~l~~~l~~~~~---l~~~~~~~i~~qi~~aL~yLH---~~~gIiHrDlKP~NILl~~~~~~~~~~~ 276 (467)
T PTZ00284 204 TGHMCIVMPKY-GPCLLDWIMKHGP---FSHRHLAQIIFQTGVALDYFH---TELHLMHTDLKPENILMETSDTVVDPVT 276 (467)
T ss_pred CceEEEEEecc-CCCHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHH---hcCCeecCCCCHHHEEEecCCccccccc
Confidence 35688999988 6789988875433 899999999999999999999 6 5999999999999998765
Q ss_pred ---------CeEEeeecceeecccCCCCcccccccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCC
Q 044494 75 ---------EAFVADFGVARLLNFDSSNRTLLAGTYGYIAPELAYTMVVTEKSDVYSFGVVALEVLMGKHPGELLS 141 (144)
Q Consensus 75 ---------~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~d~~slg~~l~~~~~g~~p~~~~~ 141 (144)
.++|+|||.+.... .......+++.|+|||++.+..++.++|+||+||++|||++|+.||+..+
T Consensus 277 ~~~~~~~~~~vkl~DfG~~~~~~---~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~ 349 (467)
T PTZ00284 277 NRALPPDPCRVRICDLGGCCDER---HSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHD 349 (467)
T ss_pred ccccCCCCceEEECCCCccccCc---cccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 48999999875422 22334578999999999999999999999999999999999999998654
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.1e-30 Score=174.90 Aligned_cols=129 Identities=23% Similarity=0.302 Sum_probs=111.5
Q ss_pred ceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCC-CCeEecCCCCCcEEEcCCCCeEEeeec
Q 044494 4 KCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCT-PPIVHRDISSNNILLNLELEAFVADFG 82 (144)
Q Consensus 4 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~-~~~~h~~i~~~ni~~~~~~~~~l~d~~ 82 (144)
.++++||||+++|+|.+++.... .+++.....++.+++.++.+|| . .+++||||||+|++++.++.++++|||
T Consensus 95 ~~~~lv~Ey~~~g~L~~~l~~~~---~~~~~~~~~i~~~i~~~l~~lH---~~~~~~Hrdlkp~nill~~~~~~kl~dfg 168 (283)
T PHA02988 95 PRLSLILEYCTRGYLREVLDKEK---DLSFKTKLDMAIDCCKGLYNLY---KYTNKPYKNLTSVSFLVTENYKLKIICHG 168 (283)
T ss_pred CceEEEEEeCCCCcHHHHHhhCC---CCChhHHHHHHHHHHHHHHHHH---hcCCCCCCcCChhhEEECCCCcEEEcccc
Confidence 46899999999999999997643 3888999999999999999999 5 488999999999999999999999999
Q ss_pred ceeecccCCCCcccccccccccCcccccc--CCCCCcchhHHHHHHHHHHHhCCCCCCCCC
Q 044494 83 VARLLNFDSSNRTLLAGTYGYIAPELAYT--MVVTEKSDVYSFGVVALEVLMGKHPGELLS 141 (144)
Q Consensus 83 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~--~~~~~~~d~~slg~~l~~~~~g~~p~~~~~ 141 (144)
++....... ....+++.|+|||.+.. ..++.++|+||+|+++||+++|..||+..+
T Consensus 169 ~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~ 226 (283)
T PHA02988 169 LEKILSSPP---FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLT 226 (283)
T ss_pred hHhhhcccc---ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCC
Confidence 987543211 22457889999999976 578899999999999999999999998764
|
|
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-29 Score=173.49 Aligned_cols=134 Identities=26% Similarity=0.323 Sum_probs=115.0
Q ss_pred CceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeeec
Q 044494 3 RKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADFG 82 (144)
Q Consensus 3 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~~ 82 (144)
++.+++||||+++++|.+++.... ...+++..+..++.|++.|+.+|| +.+++|+||+|+||+++.++.++++|||
T Consensus 72 ~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~~l~Dfg 147 (285)
T cd05605 72 KDALCLVLTLMNGGDLKFHIYNMG-NPGFDEERAVFYAAEITCGLEDLH---RERIVYRDLKPENILLDDYGHIRISDLG 147 (285)
T ss_pred CCeEEEEEeccCCCcHHHHHHhcC-cCCCCHHHHHHHHHHHHHHHHHHH---HCCcEecCCCHHHEEECCCCCEEEeeCC
Confidence 467899999999999998876432 234899999999999999999999 8899999999999999999999999999
Q ss_pred ceeecccCCCCcccccccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCC
Q 044494 83 VARLLNFDSSNRTLLAGTYGYIAPELAYTMVVTEKSDVYSFGVVALEVLMGKHPGELLS 141 (144)
Q Consensus 83 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~d~~slg~~l~~~~~g~~p~~~~~ 141 (144)
++...... .......+++.|++||.+....++.++|+||+|+++|++++|..||.+.+
T Consensus 148 ~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~ 205 (285)
T cd05605 148 LAVEIPEG-ETIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRK 205 (285)
T ss_pred CceecCCC-CccccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCc
Confidence 98765322 12233467899999999988888999999999999999999999998643
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-29 Score=172.87 Aligned_cols=131 Identities=23% Similarity=0.313 Sum_probs=112.9
Q ss_pred CceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeeec
Q 044494 3 RKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADFG 82 (144)
Q Consensus 3 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~~ 82 (144)
++..++||||+++++|.+++..... +++..+..++.|++.|+.+|| +.+++|+||||+||+++.++.++++|||
T Consensus 69 ~~~~~lv~e~~~~~~L~~~i~~~~~---l~~~~~~~i~~qi~~al~~lH---~~~ivH~dikp~Nil~~~~~~~~l~dfg 142 (279)
T cd05633 69 PDKLCFILDLMNGGDLHYHLSQHGV---FSEKEMRFYATEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLG 142 (279)
T ss_pred CCeEEEEEecCCCCCHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHH---HCCcCCCCCCHHHEEECCCCCEEEccCC
Confidence 4678999999999999998875443 899999999999999999999 8999999999999999999999999999
Q ss_pred ceeecccCCCCcccccccccccCcccccc-CCCCCcchhHHHHHHHHHHHhCCCCCCCCC
Q 044494 83 VARLLNFDSSNRTLLAGTYGYIAPELAYT-MVVTEKSDVYSFGVVALEVLMGKHPGELLS 141 (144)
Q Consensus 83 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~-~~~~~~~d~~slg~~l~~~~~g~~p~~~~~ 141 (144)
++...... ......+++.|+|||.... ..++.++|+||+|++++++++|..||...+
T Consensus 143 ~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~ 200 (279)
T cd05633 143 LACDFSKK--KPHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHK 200 (279)
T ss_pred cceecccc--CccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCC
Confidence 98754321 2233468899999998864 557889999999999999999999997643
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.2e-31 Score=179.75 Aligned_cols=133 Identities=29% Similarity=0.367 Sum_probs=112.2
Q ss_pred eEEEEEeeccCCCHHHHhhc-ccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCC-CCeEEeeec
Q 044494 5 CMFLIYEYMEMGSLFCVLRT-DEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLE-LEAFVADFG 82 (144)
Q Consensus 5 ~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~-~~~~l~d~~ 82 (144)
+..+||||++. +|.+.++. ......++.-.+..+..||.+|+.||| ..|++||||||+|++++.+ |.+||+|||
T Consensus 96 ~lnlVleymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh---~~~IcHRDIKPqNlLvD~~tg~LKicDFG 171 (364)
T KOG0658|consen 96 YLNLVLEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLH---SHGICHRDIKPQNLLVDPDTGVLKICDFG 171 (364)
T ss_pred HHHHHHHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHH---hcCcccCCCChheEEEcCCCCeEEeccCC
Confidence 34589999987 99998874 122334777778889999999999999 8999999999999999987 889999999
Q ss_pred ceeecccCCCCcccccccccccCccccccC-CCCCcchhHHHHHHHHHHHhCCCCCCCCCC
Q 044494 83 VARLLNFDSSNRTLLAGTYGYIAPELAYTM-VVTEKSDVYSFGVVALEVLMGKHPGELLSS 142 (144)
Q Consensus 83 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~-~~~~~~d~~slg~~l~~~~~g~~p~~~~~~ 142 (144)
.|+.......+ ....++..|.|||.+.+. .|+.+.|+||.||++.||+.|++-|.+.++
T Consensus 172 SAK~L~~~epn-iSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~ 231 (364)
T KOG0658|consen 172 SAKVLVKGEPN-ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSS 231 (364)
T ss_pred cceeeccCCCc-eeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCH
Confidence 99987643333 446689999999988765 689999999999999999999999998654
|
|
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.8e-29 Score=170.30 Aligned_cols=129 Identities=29% Similarity=0.476 Sum_probs=114.0
Q ss_pred CceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCC-CeEEeee
Q 044494 3 RKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLEL-EAFVADF 81 (144)
Q Consensus 3 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~-~~~l~d~ 81 (144)
++..|+||||+++++|.+++.... .+++..+..++.|++.++.+|| +.+++|+||+|.||+++.++ .++++||
T Consensus 81 ~~~~~iv~e~~~~~~L~~~l~~~~---~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~~~l~df 154 (267)
T PHA03390 81 LKGHVLIMDYIKDGDLFDLLKKEG---KLSEAEVKKIIRQLVEALNDLH---KHNIIHNDIKLENVLYDRAKDRIYLCDY 154 (267)
T ss_pred CCeeEEEEEcCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEEeCCCCeEEEecC
Confidence 567899999999999999997644 4899999999999999999999 88999999999999999988 9999999
Q ss_pred cceeecccCCCCcccccccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCC
Q 044494 82 GVARLLNFDSSNRTLLAGTYGYIAPELAYTMVVTEKSDVYSFGVVALEVLMGKHPGELLS 141 (144)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~d~~slg~~l~~~~~g~~p~~~~~ 141 (144)
|.+..... .....++..|+|||.+....++.++|+||+|++++++++|..||...+
T Consensus 155 g~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~ 210 (267)
T PHA03390 155 GLCKIIGT----PSCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDE 210 (267)
T ss_pred ccceecCC----CccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCC
Confidence 98876442 123457889999999998888999999999999999999999997543
|
|
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-29 Score=178.39 Aligned_cols=132 Identities=27% Similarity=0.410 Sum_probs=119.0
Q ss_pred CceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCC----CCeEE
Q 044494 3 RKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLE----LEAFV 78 (144)
Q Consensus 3 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~----~~~~l 78 (144)
...+++|||++.||.|++.+.+. .+++..+..++.|++.+++||| +.|++|||+||+|+++... +.+++
T Consensus 108 ~~~~~lvmEL~~GGeLfd~i~~~----~~sE~da~~~~~~il~av~~lH---~~gvvHrDlKpEN~L~~~~~~~~~~ik~ 180 (382)
T KOG0032|consen 108 PDSVYLVMELCEGGELFDRIVKK----HYSERDAAGIIRQILEAVKYLH---SLGVVHRDLKPENLLLASKDEGSGRIKL 180 (382)
T ss_pred CCeEEEEEEecCCchHHHHHHHc----cCCHHHHHHHHHHHHHHHHHHH---hCCceeccCCHHHeeeccccCCCCcEEE
Confidence 35789999999999999999865 2999999999999999999999 8999999999999999654 47999
Q ss_pred eeecceeecccCCCCcccccccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCC
Q 044494 79 ADFGVARLLNFDSSNRTLLAGTYGYIAPELAYTMVVTEKSDVYSFGVVALEVLMGKHPGELLSS 142 (144)
Q Consensus 79 ~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~d~~slg~~l~~~~~g~~p~~~~~~ 142 (144)
+|||++..... ........|++.|+|||++....++...|+||+|+++|.|++|..||...+.
T Consensus 181 ~DFGla~~~~~-~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~ 243 (382)
T KOG0032|consen 181 IDFGLAKFIKP-GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETE 243 (382)
T ss_pred eeCCCceEccC-CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCCh
Confidence 99999998775 4456668899999999999999999999999999999999999999987653
|
|
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.9e-29 Score=168.64 Aligned_cols=136 Identities=32% Similarity=0.438 Sum_probs=117.8
Q ss_pred CCceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeee
Q 044494 2 HRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADF 81 (144)
Q Consensus 2 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~ 81 (144)
.++..|+||||+++++|.+++.... ...+++..++.++.+++.++.+|| +.+++|+|++|+||+++.++.++++||
T Consensus 70 ~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~i~~~l~~al~~lH---~~~i~h~dl~~~nili~~~~~~~l~df 145 (256)
T cd08529 70 DKGKLNIVMEYAENGDLHKLLKMQR-GRPLPEDQVWRFFIQILLGLAHLH---SKKILHRDIKSLNLFLDAYDNVKIGDL 145 (256)
T ss_pred cCCEEEEEEEeCCCCcHHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCcceEEEeCCCCEEEccc
Confidence 4567899999999999999987532 234889999999999999999999 899999999999999999999999999
Q ss_pred cceeecccCCCCcccccccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCC
Q 044494 82 GVARLLNFDSSNRTLLAGTYGYIAPELAYTMVVTEKSDVYSFGVVALEVLMGKHPGELLS 141 (144)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~d~~slg~~l~~~~~g~~p~~~~~ 141 (144)
|++..............+++.|+|||......++.++|+||+|++++++++|..||...+
T Consensus 146 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 205 (256)
T cd08529 146 GVAKLLSDNTNFANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANN 205 (256)
T ss_pred ccceeccCccchhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCC
Confidence 998866543333344567889999999998888899999999999999999999997654
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-29 Score=172.11 Aligned_cols=134 Identities=25% Similarity=0.333 Sum_probs=115.2
Q ss_pred CCceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeee
Q 044494 2 HRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADF 81 (144)
Q Consensus 2 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~ 81 (144)
.++.+++||||+++++|.+++.... ...+++..+..++.|++.|+.+|| +.+++|+||||+||+++.++.++++||
T Consensus 71 ~~~~~~lv~e~~~g~~L~~~l~~~~-~~~l~~~~~~~~~~qi~~~l~~lH---~~~iiH~dikp~Nil~~~~~~~~l~Df 146 (285)
T cd05630 71 TKDALCLVLTLMNGGDLKFHIYHMG-EAGFEEGRAVFYAAEICCGLEDLH---QERIVYRDLKPENILLDDHGHIRISDL 146 (285)
T ss_pred cCCEEEEEEEecCCCcHHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHH---hCCEEeCCCCHHHEEECCCCCEEEeec
Confidence 3567899999999999999885422 234899999999999999999999 899999999999999999999999999
Q ss_pred cceeecccCCCCcccccccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCC
Q 044494 82 GVARLLNFDSSNRTLLAGTYGYIAPELAYTMVVTEKSDVYSFGVVALEVLMGKHPGELL 140 (144)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~d~~slg~~l~~~~~g~~p~~~~ 140 (144)
|++....... ......++..|+|||.+....++.++|+||+|+++++|++|..||...
T Consensus 147 g~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~ 204 (285)
T cd05630 147 GLAVHVPEGQ-TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQR 204 (285)
T ss_pred cceeecCCCc-cccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCC
Confidence 9987644222 222346889999999999888999999999999999999999999864
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2e-29 Score=175.92 Aligned_cols=130 Identities=28% Similarity=0.364 Sum_probs=112.9
Q ss_pred CceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCC-CeEecCCCCCcEEEcCCCCeEEeee
Q 044494 3 RKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTP-PIVHRDISSNNILLNLELEAFVADF 81 (144)
Q Consensus 3 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~-~~~h~~i~~~ni~~~~~~~~~l~d~ 81 (144)
++.+++||||+++++|.+++..... +++..+..++.+++.++.||| +. +++|+||||+||+++.++.++++||
T Consensus 75 ~~~~~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~~l~~~l~~lH---~~~~ivH~dlkp~Nili~~~~~~kL~Df 148 (333)
T cd06650 75 DGEISICMEHMDGGSLDQVLKKAGR---IPEQILGKVSIAVIKGLTYLR---EKHKIMHRDVKPSNILVNSRGEIKLCDF 148 (333)
T ss_pred CCEEEEEEecCCCCcHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHH---hcCCEEecCCChhhEEEcCCCCEEEeeC
Confidence 5678999999999999999976443 888999999999999999999 54 7999999999999999999999999
Q ss_pred cceeecccCCCCcccccccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCC
Q 044494 82 GVARLLNFDSSNRTLLAGTYGYIAPELAYTMVVTEKSDVYSFGVVALEVLMGKHPGELL 140 (144)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~d~~slg~~l~~~~~g~~p~~~~ 140 (144)
|++..... .......++..|+|||.+.+..++.++|+||+|+++|++++|..||...
T Consensus 149 g~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~ 205 (333)
T cd06650 149 GVSGQLID--SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPP 205 (333)
T ss_pred Ccchhhhh--hccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCc
Confidence 99875432 1223346888999999999888899999999999999999999999754
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.7e-29 Score=169.83 Aligned_cols=135 Identities=24% Similarity=0.418 Sum_probs=112.8
Q ss_pred CCceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCC---CeEE
Q 044494 2 HRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLEL---EAFV 78 (144)
Q Consensus 2 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~---~~~l 78 (144)
++.++|||||.++||+|...++++.- +++.++..+.++++.||.+|| .+||.|||+||+||+..... -+||
T Consensus 147 dd~~FYLVfEKm~GGplLshI~~~~~---F~E~EAs~vvkdia~aLdFlH---~kgIAHRDlKPENiLC~~pn~vsPvKi 220 (463)
T KOG0607|consen 147 DDTRFYLVFEKMRGGPLLSHIQKRKH---FNEREASRVVKDIASALDFLH---TKGIAHRDLKPENILCESPNKVSPVKI 220 (463)
T ss_pred ccceEEEEEecccCchHHHHHHHhhh---ccHHHHHHHHHHHHHHHHHHh---hcCcccccCCccceeecCCCCcCceee
Confidence 46789999999999999999986543 999999999999999999999 99999999999999997654 3799
Q ss_pred eeecceeecccCCC-------CcccccccccccCccccc-----cCCCCCcchhHHHHHHHHHHHhCCCCCCCCCC
Q 044494 79 ADFGVARLLNFDSS-------NRTLLAGTYGYIAPELAY-----TMVVTEKSDVYSFGVVALEVLMGKHPGELLSS 142 (144)
Q Consensus 79 ~d~~~~~~~~~~~~-------~~~~~~~~~~~~~pe~~~-----~~~~~~~~d~~slg~~l~~~~~g~~p~~~~~~ 142 (144)
+||.+...+..... ..-+..|+..|||||+.. ...|+.+.|.||||+++|-|++|+.||.+.=+
T Consensus 221 CDfDLgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg 296 (463)
T KOG0607|consen 221 CDFDLGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCG 296 (463)
T ss_pred eccccccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccC
Confidence 99987765432211 123457888999999765 23578899999999999999999999988643
|
|
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.5e-29 Score=170.67 Aligned_cols=130 Identities=24% Similarity=0.305 Sum_probs=112.8
Q ss_pred CceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeeec
Q 044494 3 RKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADFG 82 (144)
Q Consensus 3 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~~ 82 (144)
++.+++||||+.+++|.+++.... .+++..+..++.|++.++.+|| +.+++|+||+|+||+++.++.++++|||
T Consensus 69 ~~~~~~v~e~~~g~~L~~~l~~~~---~l~~~~~~~~~~ql~~~l~~lH---~~~i~H~di~p~nili~~~~~~kl~dfg 142 (278)
T cd05606 69 PDKLSFILDLMNGGDLHYHLSQHG---VFSEAEMRFYAAEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLG 142 (278)
T ss_pred CCEEEEEEecCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH---HCCEEcCCCCHHHEEECCCCCEEEccCc
Confidence 467899999999999999886543 3899999999999999999999 8999999999999999999999999999
Q ss_pred ceeecccCCCCcccccccccccCccccccC-CCCCcchhHHHHHHHHHHHhCCCCCCCC
Q 044494 83 VARLLNFDSSNRTLLAGTYGYIAPELAYTM-VVTEKSDVYSFGVVALEVLMGKHPGELL 140 (144)
Q Consensus 83 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~-~~~~~~d~~slg~~l~~~~~g~~p~~~~ 140 (144)
++...... ......++..|++||.+... .++.++|+||+|++++++++|..||...
T Consensus 143 ~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~ 199 (278)
T cd05606 143 LACDFSKK--KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQH 199 (278)
T ss_pred CccccCcc--CCcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCC
Confidence 98754322 22345688999999998744 5788999999999999999999999765
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.4e-30 Score=173.56 Aligned_cols=132 Identities=28% Similarity=0.434 Sum_probs=113.3
Q ss_pred ceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeeecc
Q 044494 4 KCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADFGV 83 (144)
Q Consensus 4 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~~~ 83 (144)
+.+|+|+|+|+ .+|...++.+.. ++...+..++.|++.|++|+| +.+++|||+||.|++++.+...|++|||+
T Consensus 99 ~DvYiV~elMe-tDL~~iik~~~~---L~d~H~q~f~YQiLrgLKyiH---SAnViHRDLKPsNll~n~~c~lKI~DFGL 171 (359)
T KOG0660|consen 99 NDVYLVFELME-TDLHQIIKSQQD---LTDDHAQYFLYQILRGLKYIH---SANVIHRDLKPSNLLLNADCDLKICDFGL 171 (359)
T ss_pred ceeEEehhHHh-hHHHHHHHcCcc---ccHHHHHHHHHHHHHhcchhh---cccccccccchhheeeccCCCEEeccccc
Confidence 56899999994 589888886554 999999999999999999999 89999999999999999999999999999
Q ss_pred eeecccC--CCCcccccccccccCccccc-cCCCCCcchhHHHHHHHHHHHhCCCCCCCCCC
Q 044494 84 ARLLNFD--SSNRTLLAGTYGYIAPELAY-TMVVTEKSDVYSFGVVALEVLMGKHPGELLSS 142 (144)
Q Consensus 84 ~~~~~~~--~~~~~~~~~~~~~~~pe~~~-~~~~~~~~d~~slg~~l~~~~~g~~p~~~~~~ 142 (144)
++..... .........|.+|.|||++. ...|+...|+||+|||+.||++|+.-|.+.+.
T Consensus 172 AR~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~ 233 (359)
T KOG0660|consen 172 ARYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDY 233 (359)
T ss_pred eeeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCch
Confidence 9977532 11122356789999999876 44688999999999999999999999988653
|
|
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.4e-29 Score=164.98 Aligned_cols=132 Identities=29% Similarity=0.423 Sum_probs=115.9
Q ss_pred CceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcC---CCCeEEe
Q 044494 3 RKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNL---ELEAFVA 79 (144)
Q Consensus 3 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~---~~~~~l~ 79 (144)
....|+|+|++.|++|..-+-++. .+++..+...++||++++.|+| .++|+|||+||+|+++.. ..-+|++
T Consensus 82 ~~~~ylvFe~m~G~dl~~eIV~R~---~ySEa~aSH~~rQiLeal~yCH---~n~IvHRDvkP~nllLASK~~~A~vKL~ 155 (355)
T KOG0033|consen 82 ESFHYLVFDLVTGGELFEDIVARE---FYSEADASHCIQQILEALAYCH---SNGIVHRDLKPENLLLASKAKGAAVKLA 155 (355)
T ss_pred cceeEEEEecccchHHHHHHHHHH---HHHHHHHHHHHHHHHHHHHHHH---hcCceeccCChhheeeeeccCCCceeec
Confidence 356799999999999987665432 3788889999999999999999 999999999999999954 3568999
Q ss_pred eecceeecccCCCCcccccccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCC
Q 044494 80 DFGVARLLNFDSSNRTLLAGTYGYIAPELAYTMVVTEKSDVYSFGVVALEVLMGKHPGELLS 141 (144)
Q Consensus 80 d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~d~~slg~~l~~~~~g~~p~~~~~ 141 (144)
|||++.... .......+.|+|.||+||+++..+++..+|+|+.|+++|-++.|..||-+-+
T Consensus 156 ~FGvAi~l~-~g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~ 216 (355)
T KOG0033|consen 156 DFGLAIEVN-DGEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDED 216 (355)
T ss_pred ccceEEEeC-CccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCcc
Confidence 999999887 4555666889999999999999999999999999999999999999997744
|
|
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.3e-29 Score=175.96 Aligned_cols=128 Identities=31% Similarity=0.458 Sum_probs=106.0
Q ss_pred CCceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeee
Q 044494 2 HRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADF 81 (144)
Q Consensus 2 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~ 81 (144)
+++.+|+||||+.+++|.+.. ...+..+..++.|++.||.||| +.+++||||||+||+++.++.++|+||
T Consensus 143 ~~~~~~lv~e~~~~~~L~~~~-------~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~~~~kL~Df 212 (353)
T PLN00034 143 HNGEIQVLLEFMDGGSLEGTH-------IADEQFLADVARQILSGIAYLH---RRHIVHRDIKPSNLLINSAKNVKIADF 212 (353)
T ss_pred cCCeEEEEEecCCCCcccccc-------cCCHHHHHHHHHHHHHHHHHHH---HCCEeecCCCHHHEEEcCCCCEEEccc
Confidence 356789999999999986432 2567778889999999999999 899999999999999999999999999
Q ss_pred cceeecccCCCCcccccccccccCccccccC-----CCCCcchhHHHHHHHHHHHhCCCCCCC
Q 044494 82 GVARLLNFDSSNRTLLAGTYGYIAPELAYTM-----VVTEKSDVYSFGVVALEVLMGKHPGEL 139 (144)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~-----~~~~~~d~~slg~~l~~~~~g~~p~~~ 139 (144)
|++..............++..|++||.+... ..+.++|+||||+++|+|++|..||..
T Consensus 213 G~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~ 275 (353)
T PLN00034 213 GVSRILAQTMDPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGV 275 (353)
T ss_pred ccceecccccccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCC
Confidence 9987654322223345689999999987532 234589999999999999999999974
|
|
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.3e-29 Score=169.01 Aligned_cols=132 Identities=27% Similarity=0.363 Sum_probs=113.1
Q ss_pred CceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeeec
Q 044494 3 RKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADFG 82 (144)
Q Consensus 3 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~~ 82 (144)
++.+|+||||+++++|.+++..... +++.++..++.|++.++++|| +.|++|+||+|+||+++.++.++++|||
T Consensus 78 ~~~~~lv~e~~~~~~L~~~~~~~~~---~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~nili~~~~~~~l~dfg 151 (267)
T cd06645 78 RDKLWICMEFCGGGSLQDIYHVTGP---LSESQIAYVSRETLQGLYYLH---SKGKMHRDIKGANILLTDNGHVKLADFG 151 (267)
T ss_pred CCEEEEEEeccCCCcHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEECcce
Confidence 5678999999999999998875443 899999999999999999999 8899999999999999999999999999
Q ss_pred ceeecccCCCCcccccccccccCccccc---cCCCCCcchhHHHHHHHHHHHhCCCCCCCC
Q 044494 83 VARLLNFDSSNRTLLAGTYGYIAPELAY---TMVVTEKSDVYSFGVVALEVLMGKHPGELL 140 (144)
Q Consensus 83 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~---~~~~~~~~d~~slg~~l~~~~~g~~p~~~~ 140 (144)
.+..............+++.|+|||.+. ...++.++|+||+|++++++++|..||...
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~ 212 (267)
T cd06645 152 VSAQITATIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDL 212 (267)
T ss_pred eeeEccCcccccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccc
Confidence 9876543333334456888999999874 345778999999999999999999998543
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.9e-29 Score=166.24 Aligned_cols=135 Identities=29% Similarity=0.403 Sum_probs=116.0
Q ss_pred CceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeeec
Q 044494 3 RKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADFG 82 (144)
Q Consensus 3 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~~ 82 (144)
++.+|++|||+++++|.+++.... ...+++.++..++.+++.++.+|| +.+++|+||+|+||+++.++.++++|||
T Consensus 72 ~~~~~lv~e~~~~~~l~~~l~~~~-~~~l~~~~~~~~~~~l~~~l~~lH---~~~i~H~di~p~nil~~~~~~~~l~df~ 147 (257)
T cd08223 72 DGLLYIVMGFCEGGDLYHKLKEQK-GKLLPENQVVEWFVQIAMALQYLH---EKHILHRDLKTQNVFLTRTNIIKVGDLG 147 (257)
T ss_pred CCEEEEEecccCCCcHHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCchhEEEecCCcEEEeccc
Confidence 346799999999999999887532 234899999999999999999999 8999999999999999999999999999
Q ss_pred ceeecccCCCCcccccccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCC
Q 044494 83 VARLLNFDSSNRTLLAGTYGYIAPELAYTMVVTEKSDVYSFGVVALEVLMGKHPGELLS 141 (144)
Q Consensus 83 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~d~~slg~~l~~~~~g~~p~~~~~ 141 (144)
++..............+++.|+|||......++.++|+||+|++++++++|..||...+
T Consensus 148 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~ 206 (257)
T cd08223 148 IARVLENQCDMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKD 206 (257)
T ss_pred ceEEecccCCccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCC
Confidence 98866433333344567889999999998888899999999999999999999997543
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.8e-29 Score=169.78 Aligned_cols=135 Identities=23% Similarity=0.292 Sum_probs=115.7
Q ss_pred CCceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeee
Q 044494 2 HRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADF 81 (144)
Q Consensus 2 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~ 81 (144)
.++..++||||+++++|.+++.... ...+++..+..++.|++.++.+|| +.+++|+||+|.|++++.++.++++||
T Consensus 71 ~~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~ql~~~l~~lH---~~~iiH~dikp~Nili~~~~~~kl~Df 146 (285)
T cd05632 71 TKDALCLVLTIMNGGDLKFHIYNMG-NPGFEEERALFYAAEILCGLEDLH---RENTVYRDLKPENILLDDYGHIRISDL 146 (285)
T ss_pred cCCEEEEEEEeccCccHHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecCCCHHHEEECCCCCEEEecC
Confidence 3567899999999999998886432 234899999999999999999999 899999999999999999999999999
Q ss_pred cceeecccCCCCcccccccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCC
Q 044494 82 GVARLLNFDSSNRTLLAGTYGYIAPELAYTMVVTEKSDVYSFGVVALEVLMGKHPGELLS 141 (144)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~d~~slg~~l~~~~~g~~p~~~~~ 141 (144)
|++....... ......++..|+|||.+.+..++.++|+||+|++++++++|..||...+
T Consensus 147 g~~~~~~~~~-~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~ 205 (285)
T cd05632 147 GLAVKIPEGE-SIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRK 205 (285)
T ss_pred CcceecCCCC-cccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCC
Confidence 9887643221 2233568899999999988888999999999999999999999997643
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.8e-29 Score=171.61 Aligned_cols=133 Identities=26% Similarity=0.442 Sum_probs=114.8
Q ss_pred CCceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeee
Q 044494 2 HRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADF 81 (144)
Q Consensus 2 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~ 81 (144)
.++..|+||||+++++|.+++... .+++..+..++.|++.++.+|| +.+++|+||+|.||+++.++.++++||
T Consensus 90 ~~~~~~lv~e~~~~~~L~~~~~~~----~l~~~~~~~~~~qi~~~l~~LH---~~~ivH~dlkp~Nill~~~~~~kL~df 162 (292)
T cd06658 90 VGDELWVVMEFLEGGALTDIVTHT----RMNEEQIATVCLSVLRALSYLH---NQGVIHRDIKSDSILLTSDGRIKLSDF 162 (292)
T ss_pred cCCeEEEEEeCCCCCcHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHH---HCCEeecCCCHHHEEEcCCCCEEEccC
Confidence 356789999999999999987542 2788999999999999999999 899999999999999999999999999
Q ss_pred cceeecccCCCCcccccccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCC
Q 044494 82 GVARLLNFDSSNRTLLAGTYGYIAPELAYTMVVTEKSDVYSFGVVALEVLMGKHPGELLS 141 (144)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~d~~slg~~l~~~~~g~~p~~~~~ 141 (144)
|++..............++..|+|||......++.++|+||+|++++++++|..||...+
T Consensus 163 g~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~ 222 (292)
T cd06658 163 GFCAQVSKEVPKRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEP 222 (292)
T ss_pred cchhhcccccccCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 988755433333344567889999999988888899999999999999999999997643
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.3e-29 Score=167.65 Aligned_cols=134 Identities=25% Similarity=0.389 Sum_probs=111.5
Q ss_pred CceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeeec
Q 044494 3 RKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADFG 82 (144)
Q Consensus 3 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~~ 82 (144)
....++||||+++++|.+++.... ..+++..++.++.|++.++.+|| .++++|+||||+||+++.++.++++|||
T Consensus 66 ~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~nil~~~~~~~kl~dfg 140 (257)
T cd05115 66 AEALMLVMEMASGGPLNKFLSGKK--DEITVSNVVELMHQVSMGMKYLE---GKNFVHRDLAARNVLLVNQHYAKISDFG 140 (257)
T ss_pred CCCeEEEEEeCCCCCHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHH---hcCeeecccchheEEEcCCCcEEeccCC
Confidence 356789999999999999987422 24899999999999999999999 8899999999999999999999999999
Q ss_pred ceeecccCCCCc---ccccccccccCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCC
Q 044494 83 VARLLNFDSSNR---TLLAGTYGYIAPELAYTMVVTEKSDVYSFGVVALEVLM-GKHPGELLS 141 (144)
Q Consensus 83 ~~~~~~~~~~~~---~~~~~~~~~~~pe~~~~~~~~~~~d~~slg~~l~~~~~-g~~p~~~~~ 141 (144)
++.......... ....++..|+|||.+....++.++|+||||+++|++++ |..||...+
T Consensus 141 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~ 203 (257)
T cd05115 141 LSKALGADDSYYKARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMK 203 (257)
T ss_pred ccccccCCccceeccCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCC
Confidence 887543222111 11123467999999988888899999999999999996 999997654
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.9e-29 Score=182.86 Aligned_cols=132 Identities=36% Similarity=0.438 Sum_probs=116.7
Q ss_pred ceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCC----CeEEe
Q 044494 4 KCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLEL----EAFVA 79 (144)
Q Consensus 4 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~----~~~l~ 79 (144)
....+|||||+||+|...+++-+...++++.+.+.++.+++.|+++|| +.||+||||||.||++.... .-|++
T Consensus 90 ~~~vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~Lr---En~IvHRDlKP~NIvl~~Gedgq~IyKLt 166 (732)
T KOG4250|consen 90 RLPVLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLR---ENGIVHRDLKPGNIVLQIGEDGQSIYKLT 166 (732)
T ss_pred ccceEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHH---HcCceeccCCCCcEEEeecCCCceEEeee
Confidence 345789999999999999998788889999999999999999999999 89999999999999986543 24799
Q ss_pred eecceeecccCCCCcccccccccccCcccccc-CCCCCcchhHHHHHHHHHHHhCCCCCCC
Q 044494 80 DFGVARLLNFDSSNRTLLAGTYGYIAPELAYT-MVVTEKSDVYSFGVVALEVLMGKHPGEL 139 (144)
Q Consensus 80 d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~-~~~~~~~d~~slg~~l~~~~~g~~p~~~ 139 (144)
|||.++.... ........||+.|++||..-. ..|+..+|.||+|+++|++.||..||..
T Consensus 167 DfG~Arel~d-~s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p 226 (732)
T KOG4250|consen 167 DFGAARELDD-NSLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIP 226 (732)
T ss_pred cccccccCCC-CCeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCc
Confidence 9999998763 335666889999999999984 7788889999999999999999999964
|
|
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.4e-29 Score=180.35 Aligned_cols=132 Identities=22% Similarity=0.291 Sum_probs=108.1
Q ss_pred eEEEEEeeccCCCHHHHhhc-ccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCC-CeEEeeec
Q 044494 5 CMFLIYEYMEMGSLFCVLRT-DEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLEL-EAFVADFG 82 (144)
Q Consensus 5 ~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~-~~~l~d~~ 82 (144)
.+++||||+++ ++.+++.. ......+++..+..++.|++.||.||| +.+++||||||+||+++.++ .++|+|||
T Consensus 141 ~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH---~~~IiHrDLKp~NILl~~~~~~vkL~DFG 216 (440)
T PTZ00036 141 FLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIH---SKFICHRDLKPQNLLIDPNTHTLKLCDFG 216 (440)
T ss_pred EEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCcCHHHEEEcCCCCceeeeccc
Confidence 46799999975 77776653 122344899999999999999999999 89999999999999999765 69999999
Q ss_pred ceeecccCCCCcccccccccccCccccccC-CCCCcchhHHHHHHHHHHHhCCCCCCCCC
Q 044494 83 VARLLNFDSSNRTLLAGTYGYIAPELAYTM-VVTEKSDVYSFGVVALEVLMGKHPGELLS 141 (144)
Q Consensus 83 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~-~~~~~~d~~slg~~l~~~~~g~~p~~~~~ 141 (144)
+++...... ......+++.|+|||++.+. .++.++|+||+||++|+|++|..||.+.+
T Consensus 217 la~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~ 275 (440)
T PTZ00036 217 SAKNLLAGQ-RSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQS 275 (440)
T ss_pred cchhccCCC-CcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 998654322 22235678999999988654 68899999999999999999999997653
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.2e-29 Score=170.83 Aligned_cols=131 Identities=24% Similarity=0.402 Sum_probs=120.5
Q ss_pred CceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeeec
Q 044494 3 RKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADFG 82 (144)
Q Consensus 3 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~~ 82 (144)
..++++|.||.+||+|.-.++++.+ ++++.+..+...|+.|+.||| ++||+.||+|.+|++++..|.+|+.|+|
T Consensus 323 esrlffvieyv~ggdlmfhmqrqrk---lpeeharfys~ei~lal~flh---~rgiiyrdlkldnvlldaeghikltdyg 396 (593)
T KOG0695|consen 323 ESRLFFVIEYVNGGDLMFHMQRQRK---LPEEHARFYSAEICLALNFLH---ERGIIYRDLKLDNVLLDAEGHIKLTDYG 396 (593)
T ss_pred cceEEEEEEEecCcceeeehhhhhc---CcHHHhhhhhHHHHHHHHHHh---hcCeeeeeccccceEEccCCceeecccc
Confidence 4578999999999999887776554 999999999999999999999 9999999999999999999999999999
Q ss_pred ceeecccCCCCcccccccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCC
Q 044494 83 VARLLNFDSSNRTLLAGTYGYIAPELAYTMVVTEKSDVYSFGVVALEVLMGKHPGEL 139 (144)
Q Consensus 83 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~d~~slg~~l~~~~~g~~p~~~ 139 (144)
.++.--.+.....+.+|||.|.|||++.+..|....|.|++|++++||+.|+.||+-
T Consensus 397 mcke~l~~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdi 453 (593)
T KOG0695|consen 397 MCKEGLGPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDI 453 (593)
T ss_pred hhhcCCCCCcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcce
Confidence 998765556667788999999999999999999999999999999999999999963
|
|
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.2e-29 Score=176.02 Aligned_cols=128 Identities=26% Similarity=0.349 Sum_probs=109.9
Q ss_pred ceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeeecc
Q 044494 4 KCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADFGV 83 (144)
Q Consensus 4 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~~~ 83 (144)
..+|+||||+.+ +|.+.+.. .+++..+..++.|++.||.+|| ++|++||||||+||+++.++.++++|||+
T Consensus 102 ~~~~lv~e~~~~-~l~~~~~~-----~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~DfG~ 172 (364)
T cd07875 102 QDVYIVMELMDA-NLCQVIQM-----ELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGL 172 (364)
T ss_pred CeEEEEEeCCCC-CHHHHHHh-----cCCHHHHHHHHHHHHHHHHHHh---hCCeecCCCCHHHEEECCCCcEEEEeCCC
Confidence 457999999975 77776653 2788889999999999999999 89999999999999999999999999999
Q ss_pred eeecccCCCCcccccccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCC
Q 044494 84 ARLLNFDSSNRTLLAGTYGYIAPELAYTMVVTEKSDVYSFGVVALEVLMGKHPGELLS 141 (144)
Q Consensus 84 ~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~d~~slg~~l~~~~~g~~p~~~~~ 141 (144)
++...... ......+++.|+|||++.+..++.++|+||+|+++|+|++|..||...+
T Consensus 173 a~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~ 229 (364)
T cd07875 173 ARTAGTSF-MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTD 229 (364)
T ss_pred ccccCCCC-cccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCC
Confidence 97654221 2233568899999999999889999999999999999999999997643
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.6e-29 Score=177.04 Aligned_cols=109 Identities=29% Similarity=0.445 Sum_probs=92.0
Q ss_pred CCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeeecceeecccCCC--CcccccccccccCcc
Q 044494 30 GLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADFGVARLLNFDSS--NRTLLAGTYGYIAPE 107 (144)
Q Consensus 30 ~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~~~~~~~pe 107 (144)
.+++..+..++.|++.|+.||| +++++||||||+||+++.++.++|+|||++........ ......++..|+|||
T Consensus 208 ~l~~~~~~~i~~qi~~aL~yLH---~~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE 284 (374)
T cd05106 208 PLDLDDLLRFSSQVAQGMDFLA---SKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNARLPVKWMAPE 284 (374)
T ss_pred CcCHHHHHHHHHHHHHHHHHHH---HCCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeeccCCCCccceeCHH
Confidence 3778889999999999999999 89999999999999999999999999999876532211 111223456799999
Q ss_pred ccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCC
Q 044494 108 LAYTMVVTEKSDVYSFGVVALEVLM-GKHPGELLS 141 (144)
Q Consensus 108 ~~~~~~~~~~~d~~slg~~l~~~~~-g~~p~~~~~ 141 (144)
++....++.++|+||+|+++|+|++ |..||....
T Consensus 285 ~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~ 319 (374)
T cd05106 285 SIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGIL 319 (374)
T ss_pred HhcCCCCCccccHHHHHHHHHHHHhCCCCCCcccc
Confidence 9988889999999999999999997 999997644
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.6e-29 Score=163.51 Aligned_cols=134 Identities=34% Similarity=0.486 Sum_probs=120.7
Q ss_pred CCceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeee
Q 044494 2 HRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADF 81 (144)
Q Consensus 2 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~ 81 (144)
++.++||++||...|+++..|+.+. ...+++...+.++.|++.|+.|+| .++++||||||+|++++.++..+++||
T Consensus 93 d~~riyLilEya~~gel~k~L~~~~-~~~f~e~~~a~Yi~q~A~Al~y~h---~k~VIhRdiKpenlLlg~~~~lkiAdf 168 (281)
T KOG0580|consen 93 DSKRIYLILEYAPRGELYKDLQEGR-MKRFDEQRAATYIKQLANALLYCH---LKRVIHRDIKPENLLLGSAGELKIADF 168 (281)
T ss_pred ccceeEEEEEecCCchHHHHHHhcc-cccccccchhHHHHHHHHHHHHhc---cCCcccCCCCHHHhccCCCCCeeccCC
Confidence 5778999999999999999998533 344889999999999999999999 999999999999999999999999999
Q ss_pred cceeecccCCCCcccccccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCC
Q 044494 82 GVARLLNFDSSNRTLLAGTYGYIAPELAYTMVVTEKSDVYSFGVVALEVLMGKHPGELLS 141 (144)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~d~~slg~~l~~~~~g~~p~~~~~ 141 (144)
|.+.... .....+.+||..|++||...+...+...|+|++|++.||++.|..||+..+
T Consensus 169 GwsV~~p--~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~ 226 (281)
T KOG0580|consen 169 GWSVHAP--SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQS 226 (281)
T ss_pred CceeecC--CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhh
Confidence 9887543 344566889999999999999999999999999999999999999998765
|
|
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.9e-29 Score=171.82 Aligned_cols=132 Identities=29% Similarity=0.495 Sum_probs=114.2
Q ss_pred CceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeeec
Q 044494 3 RKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADFG 82 (144)
Q Consensus 3 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~~ 82 (144)
+++.|+||||+++++|.+++... .+++.++..++.|++.++.+|| +.+++|+||+|+||+++.++.++++|||
T Consensus 89 ~~~~~lv~e~~~~~~L~~~~~~~----~~~~~~~~~i~~ql~~aL~~LH---~~gi~H~dLkp~Nill~~~~~~kl~dfg 161 (296)
T cd06654 89 GDELWVVMEYLAGGSLTDVVTET----CMDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFG 161 (296)
T ss_pred CCEEEEeecccCCCCHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEcCCCCEEECccc
Confidence 56789999999999999988642 2788899999999999999999 8999999999999999999999999999
Q ss_pred ceeecccCCCCcccccccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCC
Q 044494 83 VARLLNFDSSNRTLLAGTYGYIAPELAYTMVVTEKSDVYSFGVVALEVLMGKHPGELLS 141 (144)
Q Consensus 83 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~d~~slg~~l~~~~~g~~p~~~~~ 141 (144)
.+..............+++.|+|||.+....++.++|+||+|++++++++|..||...+
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~ 220 (296)
T cd06654 162 FCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNEN 220 (296)
T ss_pred cchhccccccccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCC
Confidence 88765433222333467889999999988888899999999999999999999997543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.6e-29 Score=169.19 Aligned_cols=134 Identities=28% Similarity=0.420 Sum_probs=113.2
Q ss_pred ceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeeecc
Q 044494 4 KCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADFGV 83 (144)
Q Consensus 4 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~~~ 83 (144)
..+|++|||+.+++|.+++.... ...+++..+..++.|++.++.||| +++++|+|++|+||+++.++.++++|||+
T Consensus 82 ~~~~iv~e~~~~~~L~~~l~~~~-~~~l~~~~~~~~~~qi~~~l~~LH---~~~ivh~dl~~~nili~~~~~~~l~Dfg~ 157 (272)
T cd06637 82 DQLWLVMEFCGAGSVTDLIKNTK-GNTLKEEWIAYICREILRGLSHLH---QHKVIHRDIKGQNVLLTENAEVKLVDFGV 157 (272)
T ss_pred cEEEEEEEcCCCCcHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCCHHHEEECCCCCEEEccCCC
Confidence 46899999999999999987532 234889999999999999999999 88999999999999999999999999999
Q ss_pred eeecccCCCCcccccccccccCcccccc-----CCCCCcchhHHHHHHHHHHHhCCCCCCCCC
Q 044494 84 ARLLNFDSSNRTLLAGTYGYIAPELAYT-----MVVTEKSDVYSFGVVALEVLMGKHPGELLS 141 (144)
Q Consensus 84 ~~~~~~~~~~~~~~~~~~~~~~pe~~~~-----~~~~~~~d~~slg~~l~~~~~g~~p~~~~~ 141 (144)
+..............+++.|+|||.+.. ..++.++|+||+|++++++++|..||...+
T Consensus 158 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~ 220 (272)
T cd06637 158 SAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMH 220 (272)
T ss_pred ceecccccccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccC
Confidence 8765433333344568889999999863 356778999999999999999999997543
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.6e-29 Score=186.26 Aligned_cols=135 Identities=26% Similarity=0.357 Sum_probs=111.8
Q ss_pred ceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeeecc
Q 044494 4 KCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADFGV 83 (144)
Q Consensus 4 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~~~ 83 (144)
-.++|+||||.||.|-+++.++.. ..|++.+++.|++|+|+|+..||.. .--++|||||.+|++++.++..||||||.
T Consensus 115 ~EvllLmEyC~gg~Lvd~mn~Rlq-~~lte~eVLkIf~dv~~AVa~mH~~-~pPiIHRDLKiENvLls~~g~~KLCDFGS 192 (738)
T KOG1989|consen 115 WEVLLLMEYCKGGSLVDFMNTRLQ-TRLTEDEVLKIFYDVCEAVAAMHYL-KPPIIHRDLKIENVLLSADGNYKLCDFGS 192 (738)
T ss_pred eEEEeehhhccCCcHHHHHHHHHh-ccCChHHHHHHHHHHHHHHHHHhcC-CCccchhhhhhhheEEcCCCCEEeCcccc
Confidence 357899999999999999986433 2399999999999999999999944 44599999999999999999999999999
Q ss_pred eeecccCCCC-cc--------cccccccccCccccc---cCCCCCcchhHHHHHHHHHHHhCCCCCCCC
Q 044494 84 ARLLNFDSSN-RT--------LLAGTYGYIAPELAY---TMVVTEKSDVYSFGVVALEVLMGKHPGELL 140 (144)
Q Consensus 84 ~~~~~~~~~~-~~--------~~~~~~~~~~pe~~~---~~~~~~~~d~~slg~~l~~~~~g~~p~~~~ 140 (144)
+.-....... .. ...-|+.|++||.+. +...+.|+|||||||++|.++-...||+.-
T Consensus 193 att~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~s 261 (738)
T KOG1989|consen 193 ATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEES 261 (738)
T ss_pred cccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcC
Confidence 8754322211 11 133588999999876 456789999999999999999999999874
|
|
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.6e-29 Score=167.10 Aligned_cols=133 Identities=28% Similarity=0.432 Sum_probs=112.1
Q ss_pred CceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeeec
Q 044494 3 RKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADFG 82 (144)
Q Consensus 3 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~~ 82 (144)
++..++||||+++++|.+++.... .+++..+..++.|++.++++|| +++++|+||||.||+++.++.++++|||
T Consensus 67 ~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~al~~lH---~~~i~H~dlkp~nill~~~~~~kl~Dfg 140 (257)
T cd05116 67 AESWMLVMELAELGPLNKFLQKNK---HVTEKNITELVHQVSMGMKYLE---ETNFVHRDLAARNVLLVTQHYAKISDFG 140 (257)
T ss_pred CCCcEEEEecCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH---HCCEeecccchhhEEEcCCCeEEECCCc
Confidence 456789999999999999987543 3899999999999999999999 8999999999999999999999999999
Q ss_pred ceeecccCCCC---cccccccccccCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCC
Q 044494 83 VARLLNFDSSN---RTLLAGTYGYIAPELAYTMVVTEKSDVYSFGVVALEVLM-GKHPGELLS 141 (144)
Q Consensus 83 ~~~~~~~~~~~---~~~~~~~~~~~~pe~~~~~~~~~~~d~~slg~~l~~~~~-g~~p~~~~~ 141 (144)
.+......... .....++..|+|||.+....++.++|+||+|+++||+++ |..||...+
T Consensus 141 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~ 203 (257)
T cd05116 141 LSKALGADENYYKAKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMK 203 (257)
T ss_pred cccccCCCCCeeeecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCC
Confidence 98765432211 111223468999999988888889999999999999998 999998653
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.8e-29 Score=179.93 Aligned_cols=135 Identities=25% Similarity=0.400 Sum_probs=114.7
Q ss_pred CCceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeee
Q 044494 2 HRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADF 81 (144)
Q Consensus 2 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~ 81 (144)
++.++|+||+|++||++..+|-+-+- +.+..+.+++..+.+|+++.| ..|++||||||+||+++.+|++||.||
T Consensus 700 DkdnLYFVMdYIPGGDmMSLLIrmgI---FeE~LARFYIAEltcAiesVH---kmGFIHRDiKPDNILIDrdGHIKLTDF 773 (1034)
T KOG0608|consen 700 DKDNLYFVMDYIPGGDMMSLLIRMGI---FEEDLARFYIAELTCAIESVH---KMGFIHRDIKPDNILIDRDGHIKLTDF 773 (1034)
T ss_pred cCCceEEEEeccCCccHHHHHHHhcc---CHHHHHHHHHHHHHHHHHHHH---hccceecccCccceEEccCCceeeeec
Confidence 46789999999999999998875443 788888999999999999999 889999999999999999999999999
Q ss_pred cceeecc--cCC---------CCc-------------------------------ccccccccccCccccccCCCCCcch
Q 044494 82 GVARLLN--FDS---------SNR-------------------------------TLLAGTYGYIAPELAYTMVVTEKSD 119 (144)
Q Consensus 82 ~~~~~~~--~~~---------~~~-------------------------------~~~~~~~~~~~pe~~~~~~~~~~~d 119 (144)
|++..+. .+. ... ....||+.|+|||++...+++..+|
T Consensus 774 GLCTGfRWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cd 853 (1034)
T KOG0608|consen 774 GLCTGFRWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCD 853 (1034)
T ss_pred cccccceeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccch
Confidence 9997441 000 000 0135799999999999999999999
Q ss_pred hHHHHHHHHHHHhCCCCCCCCCC
Q 044494 120 VYSFGVVALEVLMGKHPGELLSS 142 (144)
Q Consensus 120 ~~slg~~l~~~~~g~~p~~~~~~ 142 (144)
.||.|+|++||+.|+.||-..++
T Consensus 854 wws~gvil~em~~g~~pf~~~tp 876 (1034)
T KOG0608|consen 854 WWSVGVILYEMLVGQPPFLADTP 876 (1034)
T ss_pred hhHhhHHHHHHhhCCCCccCCCC
Confidence 99999999999999999966443
|
|
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=6e-29 Score=176.84 Aligned_cols=132 Identities=25% Similarity=0.338 Sum_probs=113.2
Q ss_pred CceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeeec
Q 044494 3 RKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADFG 82 (144)
Q Consensus 3 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~~ 82 (144)
++.+++|||++. ++|.+++.... .+++..+..++.|++.||.+|| +++++||||||+||+++.++.++|+|||
T Consensus 158 ~~~~~lv~e~~~-~~l~~~l~~~~---~l~~~~~~~i~~ql~~aL~~LH---~~givHrDlkp~Nill~~~~~~~l~DfG 230 (392)
T PHA03207 158 KSTVCMVMPKYK-CDLFTYVDRSG---PLPLEQAITIQRRLLEALAYLH---GRGIIHRDVKTENIFLDEPENAVLGDFG 230 (392)
T ss_pred CCEEEEEehhcC-CCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEEcCCCCEEEccCc
Confidence 467899999996 58888885433 3899999999999999999999 8999999999999999999999999999
Q ss_pred ceeecccCCC--CcccccccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCC
Q 044494 83 VARLLNFDSS--NRTLLAGTYGYIAPELAYTMVVTEKSDVYSFGVVALEVLMGKHPGELLS 141 (144)
Q Consensus 83 ~~~~~~~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~d~~slg~~l~~~~~g~~p~~~~~ 141 (144)
++........ ......+++.|+|||.+....++.++|+||+|+++|+|++|..||.+.+
T Consensus 231 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~ 291 (392)
T PHA03207 231 AACKLDAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQ 291 (392)
T ss_pred cccccCcccccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCC
Confidence 9876543222 1223568999999999998889999999999999999999999997654
|
|
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.3e-29 Score=174.86 Aligned_cols=128 Identities=27% Similarity=0.354 Sum_probs=109.0
Q ss_pred ceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeeecc
Q 044494 4 KCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADFGV 83 (144)
Q Consensus 4 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~~~ 83 (144)
..+|+||||+.+ ++.+.+.. .+++..+..++.|++.||.+|| +.|++||||||+||+++.++.++|+|||+
T Consensus 99 ~~~~lv~e~~~~-~l~~~~~~-----~~~~~~~~~~~~qi~~~L~~LH---~~~ivHrDlkp~NIl~~~~~~~kl~Dfg~ 169 (359)
T cd07876 99 QDVYLVMELMDA-NLCQVIHM-----ELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGL 169 (359)
T ss_pred ceeEEEEeCCCc-CHHHHHhc-----cCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEECCCCCEEEecCCC
Confidence 357999999975 67666542 2788889999999999999999 89999999999999999999999999999
Q ss_pred eeecccCCCCcccccccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCC
Q 044494 84 ARLLNFDSSNRTLLAGTYGYIAPELAYTMVVTEKSDVYSFGVVALEVLMGKHPGELLS 141 (144)
Q Consensus 84 ~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~d~~slg~~l~~~~~g~~p~~~~~ 141 (144)
+...... .......+++.|+|||.+.+..++.++|+||+|+++|+|++|..||...+
T Consensus 170 a~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~ 226 (359)
T cd07876 170 ARTACTN-FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTD 226 (359)
T ss_pred ccccccC-ccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCC
Confidence 8754322 22233567889999999999889999999999999999999999998654
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.4e-28 Score=166.08 Aligned_cols=134 Identities=28% Similarity=0.365 Sum_probs=114.3
Q ss_pred CCceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeee
Q 044494 2 HRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADF 81 (144)
Q Consensus 2 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~ 81 (144)
.++.+++|+||+++++|.+.+..... +++..+..++.|++.++.+|| +.+++|+||+|+||+++.++.++++||
T Consensus 75 ~~~~~~~v~e~~~~~~l~~~~~~~~~---~~~~~~~~~~~~l~~~l~~lH---~~~i~H~dl~p~nilv~~~~~~~l~df 148 (263)
T cd06625 75 DDETLSIFMEYMPGGSVKDQLKAYGA---LTETVTRKYTRQILEGVEYLH---SNMIVHRDIKGANILRDSAGNVKLGDF 148 (263)
T ss_pred cCCeEEEEEEECCCCcHHHHHHHhCC---CCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEeec
Confidence 35678999999999999998875433 888999999999999999999 899999999999999999999999999
Q ss_pred cceeecccCCCCc---ccccccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCC
Q 044494 82 GVARLLNFDSSNR---TLLAGTYGYIAPELAYTMVVTEKSDVYSFGVVALEVLMGKHPGELLS 141 (144)
Q Consensus 82 ~~~~~~~~~~~~~---~~~~~~~~~~~pe~~~~~~~~~~~d~~slg~~l~~~~~g~~p~~~~~ 141 (144)
|.+.......... ....++..|+|||...+..++.++|+||+|+++|++++|..||...+
T Consensus 149 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~ 211 (263)
T cd06625 149 GASKRLQTICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFE 211 (263)
T ss_pred ccceeccccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccc
Confidence 9987653221111 22456788999999998888999999999999999999999997643
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.8e-29 Score=176.44 Aligned_cols=129 Identities=27% Similarity=0.356 Sum_probs=109.6
Q ss_pred CceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeeec
Q 044494 3 RKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADFG 82 (144)
Q Consensus 3 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~~ 82 (144)
++..++|+|++. ++|.+++..... +++..++.++.|++.||.||| +.+++||||||+||+++.++.++|+|||
T Consensus 155 ~~~~~lv~e~~~-~~L~~~l~~~~~---l~~~~~~~i~~qi~~aL~ylH---~~~IvHrDiKP~NIll~~~~~vkL~DFG 227 (391)
T PHA03212 155 NKFTCLILPRYK-TDLYCYLAAKRN---IAICDILAIERSVLRAIQYLH---ENRIIHRDIKAENIFINHPGDVCLGDFG 227 (391)
T ss_pred CCeeEEEEecCC-CCHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHH---hCCcccCCCChHhEEEcCCCCEEEEeCC
Confidence 456799999995 688888865433 889999999999999999999 8999999999999999999999999999
Q ss_pred ceeecccC-CCCcccccccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCC
Q 044494 83 VARLLNFD-SSNRTLLAGTYGYIAPELAYTMVVTEKSDVYSFGVVALEVLMGKHPGE 138 (144)
Q Consensus 83 ~~~~~~~~-~~~~~~~~~~~~~~~pe~~~~~~~~~~~d~~slg~~l~~~~~g~~p~~ 138 (144)
++...... ........|++.|+|||++....++.++|+||+|+++|++++|..||-
T Consensus 228 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~ 284 (391)
T PHA03212 228 AACFPVDINANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLF 284 (391)
T ss_pred cccccccccccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcC
Confidence 98643211 112233568999999999998889999999999999999999997764
|
|
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.4e-29 Score=188.00 Aligned_cols=136 Identities=24% Similarity=0.396 Sum_probs=112.5
Q ss_pred CceEEEEEeeccCCCHHHHhhcccc--------cCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCC
Q 044494 3 RKCMFLIYEYMEMGSLFCVLRTDEE--------AVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLEL 74 (144)
Q Consensus 3 ~~~~~lv~e~~~~~~L~~~l~~~~~--------~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~ 74 (144)
++..|+||||++|++|.+++..... ....+...++.++.|++.|+++|| ++|++||||||+||+++.++
T Consensus 74 ~~~lyLVMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLH---s~GIIHRDLKPeNILLd~dg 150 (932)
T PRK13184 74 GDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVH---SKGVLHRDLKPDNILLGLFG 150 (932)
T ss_pred CCEEEEEEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHH---HCCccccCCchheEEEcCCC
Confidence 5678999999999999998864211 122556778889999999999999 89999999999999999999
Q ss_pred CeEEeeecceeecccCC------------------CCcccccccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCC
Q 044494 75 EAFVADFGVARLLNFDS------------------SNRTLLAGTYGYIAPELAYTMVVTEKSDVYSFGVVALEVLMGKHP 136 (144)
Q Consensus 75 ~~~l~d~~~~~~~~~~~------------------~~~~~~~~~~~~~~pe~~~~~~~~~~~d~~slg~~l~~~~~g~~p 136 (144)
.++++|||++....... .......|++.|+|||.+.+..++.++|+||+|+++++|++|..|
T Consensus 151 ~vKLiDFGLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~P 230 (932)
T PRK13184 151 EVVILDWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFP 230 (932)
T ss_pred CEEEEecCcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCC
Confidence 99999999997652110 001124589999999999988899999999999999999999999
Q ss_pred CCCCC
Q 044494 137 GELLS 141 (144)
Q Consensus 137 ~~~~~ 141 (144)
|...+
T Consensus 231 F~~~~ 235 (932)
T PRK13184 231 YRRKK 235 (932)
T ss_pred CCCcc
Confidence 97643
|
|
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.2e-28 Score=168.09 Aligned_cols=135 Identities=28% Similarity=0.395 Sum_probs=113.0
Q ss_pred CCceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeee
Q 044494 2 HRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADF 81 (144)
Q Consensus 2 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~ 81 (144)
.++..|+|+||+++++|..++.+.. ..+++..+..++.|++.++.+|| +.+++|+||+|+||+++.++.++++||
T Consensus 73 ~~~~~~~v~e~~~~~~l~~~~~~~~--~~l~~~~~~~~~~qi~~~L~~LH---~~~i~H~dlkp~nili~~~~~~kl~df 147 (282)
T cd06643 73 YENNLWILIEFCAGGAVDAVMLELE--RPLTEPQIRVVCKQTLEALNYLH---ENKIIHRDLKAGNILFTLDGDIKLADF 147 (282)
T ss_pred eCCEEEEEEEecCCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCcccEEEccCCCEEEccc
Confidence 3567899999999999988776422 24899999999999999999999 899999999999999999999999999
Q ss_pred cceeecccCCCCcccccccccccCccccc-----cCCCCCcchhHHHHHHHHHHHhCCCCCCCCC
Q 044494 82 GVARLLNFDSSNRTLLAGTYGYIAPELAY-----TMVVTEKSDVYSFGVVALEVLMGKHPGELLS 141 (144)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~-----~~~~~~~~d~~slg~~l~~~~~g~~p~~~~~ 141 (144)
|++..............+++.|++||.+. ...++.++|+||+|++++++++|..||...+
T Consensus 148 g~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~ 212 (282)
T cd06643 148 GVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELN 212 (282)
T ss_pred cccccccccccccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccC
Confidence 99876543333334456788999999874 3446778999999999999999999997654
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.3e-28 Score=168.74 Aligned_cols=131 Identities=28% Similarity=0.395 Sum_probs=115.0
Q ss_pred CCceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeee
Q 044494 2 HRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADF 81 (144)
Q Consensus 2 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~ 81 (144)
+++.+|+||||+++++|.+++..... +++..+..++.|++.++.+|| +.+++|+||+|.||+++.++.++++||
T Consensus 72 ~~~~~~~v~e~~~~~~L~~~~~~~~~---l~~~~~~~~~~qil~~l~~lH---~~~i~H~dl~p~nili~~~~~~kl~df 145 (290)
T cd05580 72 DDSNLYLVMEYVPGGELFSHLRKSGR---FPEPVARFYAAQVVLALEYLH---SLDIVYRDLKPENLLLDSDGYIKITDF 145 (290)
T ss_pred cCCeEEEEEecCCCCCHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHEEECCCCCEEEeeC
Confidence 35678999999999999999876543 899999999999999999999 899999999999999999999999999
Q ss_pred cceeecccCCCCcccccccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCC
Q 044494 82 GVARLLNFDSSNRTLLAGTYGYIAPELAYTMVVTEKSDVYSFGVVALEVLMGKHPGELLS 141 (144)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~d~~slg~~l~~~~~g~~p~~~~~ 141 (144)
|++...... .....+++.|++||.+.....+.++|+||+|+++++|++|..||...+
T Consensus 146 g~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 202 (290)
T cd05580 146 GFAKRVKGR---TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDN 202 (290)
T ss_pred CCccccCCC---CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCC
Confidence 998765432 233457889999999988888889999999999999999999997643
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.3e-29 Score=170.90 Aligned_cols=136 Identities=28% Similarity=0.387 Sum_probs=111.0
Q ss_pred CceEEEEEeeccCCCHHHHhhccc----------------ccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCC
Q 044494 3 RKCMFLIYEYMEMGSLFCVLRTDE----------------EAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSN 66 (144)
Q Consensus 3 ~~~~~lv~e~~~~~~L~~~l~~~~----------------~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ 66 (144)
++..++||||+++++|.+++.... ....+++..+..++.|++.|+.+|| +.+++|+||||+
T Consensus 91 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH---~~~ivH~dlkp~ 167 (304)
T cd05096 91 EDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLS---SLNFVHRDLATR 167 (304)
T ss_pred CCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHH---HCCccccCcchh
Confidence 466899999999999999886421 1123677888999999999999999 889999999999
Q ss_pred cEEEcCCCCeEEeeecceeecccCCC--CcccccccccccCccccccCCCCCcchhHHHHHHHHHHHh--CCCCCCCCC
Q 044494 67 NILLNLELEAFVADFGVARLLNFDSS--NRTLLAGTYGYIAPELAYTMVVTEKSDVYSFGVVALEVLM--GKHPGELLS 141 (144)
Q Consensus 67 ni~~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~d~~slg~~l~~~~~--g~~p~~~~~ 141 (144)
||+++.++.++++|||++........ ......++..|+|||.+....++.++|+||+|+++++|++ +..||...+
T Consensus 168 Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~ 246 (304)
T cd05096 168 NCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQPYGELT 246 (304)
T ss_pred heEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCCCCCcCC
Confidence 99999999999999999876532211 1222345678999999988889999999999999999986 567887643
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=99.96 E-value=8e-29 Score=167.84 Aligned_cols=135 Identities=26% Similarity=0.361 Sum_probs=111.9
Q ss_pred CCceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeee
Q 044494 2 HRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADF 81 (144)
Q Consensus 2 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~ 81 (144)
.++..++||||+++|+|.+++.... ..+++..++.++.|++.|+++|| +++++|+||||+||+++.++.++++||
T Consensus 77 ~~~~~~lv~e~~~~~~L~~~l~~~~--~~l~~~~~~~~~~~i~~al~~lH---~~~iiH~dikp~nili~~~~~~~l~df 151 (266)
T cd05064 77 RGNTMMIVTEYMSNGALDSFLRKHE--GQLVAGQLMGMLPGLASGMKYLS---EMGYVHKGLAAHKVLVNSDLVCKISGF 151 (266)
T ss_pred cCCCcEEEEEeCCCCcHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHH---HCCEeeccccHhhEEEcCCCcEEECCC
Confidence 3567899999999999999987532 23889999999999999999999 899999999999999999999999999
Q ss_pred cceeecccCCCC-cccccccccccCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCC
Q 044494 82 GVARLLNFDSSN-RTLLAGTYGYIAPELAYTMVVTEKSDVYSFGVVALEVLM-GKHPGELLS 141 (144)
Q Consensus 82 ~~~~~~~~~~~~-~~~~~~~~~~~~pe~~~~~~~~~~~d~~slg~~l~~~~~-g~~p~~~~~ 141 (144)
|........... .....++..|+|||.+.+..++.++|+||+|++++++++ |..||...+
T Consensus 152 g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~ 213 (266)
T cd05064 152 RRLQEDKSEAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMS 213 (266)
T ss_pred cccccccccchhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCC
Confidence 977643211111 111234568999999998889999999999999999875 999997654
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-28 Score=168.70 Aligned_cols=131 Identities=26% Similarity=0.319 Sum_probs=111.5
Q ss_pred ceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeeecc
Q 044494 4 KCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADFGV 83 (144)
Q Consensus 4 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~~~ 83 (144)
..+++||||+.+ +|.+++.... ...+++..+..++.|++.|+++|| +.|++|+||||+||+++.++.++++|||+
T Consensus 80 ~~~~lv~e~~~~-~l~~~~~~~~-~~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dikp~Nili~~~~~~kl~dfg~ 154 (288)
T cd07863 80 TKVTLVFEHVDQ-DLRTYLDKVP-PPGLPAETIKDLMRQFLRGLDFLH---ANCIVHRDLKPENILVTSGGQVKLADFGL 154 (288)
T ss_pred ceEEEEEccccc-CHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEECccCc
Confidence 457999999975 8888886532 234899999999999999999999 89999999999999999999999999999
Q ss_pred eeecccCCCCcccccccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCC
Q 044494 84 ARLLNFDSSNRTLLAGTYGYIAPELAYTMVVTEKSDVYSFGVVALEVLMGKHPGELL 140 (144)
Q Consensus 84 ~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~d~~slg~~l~~~~~g~~p~~~~ 140 (144)
+...... .......++..|+|||.+.+..++.++|+||+|+++++|++|..||...
T Consensus 155 ~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~ 210 (288)
T cd07863 155 ARIYSCQ-MALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGN 210 (288)
T ss_pred cccccCc-ccCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCC
Confidence 8765422 2223345788999999998888899999999999999999999998654
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1e-28 Score=167.16 Aligned_cols=132 Identities=29% Similarity=0.385 Sum_probs=112.1
Q ss_pred CceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeeec
Q 044494 3 RKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADFG 82 (144)
Q Consensus 3 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~~ 82 (144)
++.+|+||||+++++|.++++.... +++..+..++.|++.++++|| +.+++|+|++|.|++++.++.++++|||
T Consensus 78 ~~~~~iv~e~~~~~~L~~~~~~~~~---~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~nill~~~~~~~l~dfg 151 (267)
T cd06646 78 REKLWICMEYCGGGSLQDIYHVTGP---LSELQIAYVCRETLQGLAYLH---SKGKMHRDIKGANILLTDNGDVKLADFG 151 (267)
T ss_pred CCEEEEEEeCCCCCcHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEECCCCCEEECcCc
Confidence 4678999999999999998875433 889999999999999999999 8899999999999999999999999999
Q ss_pred ceeecccCCCCcccccccccccCccccc---cCCCCCcchhHHHHHHHHHHHhCCCCCCCC
Q 044494 83 VARLLNFDSSNRTLLAGTYGYIAPELAY---TMVVTEKSDVYSFGVVALEVLMGKHPGELL 140 (144)
Q Consensus 83 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~---~~~~~~~~d~~slg~~l~~~~~g~~p~~~~ 140 (144)
.+..............+++.|+|||.+. ...++.++|+||+|+++++|++|..||...
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~ 212 (267)
T cd06646 152 VAAKITATIAKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDL 212 (267)
T ss_pred cceeecccccccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCcccc
Confidence 9986543333333456788999999875 334677899999999999999999998654
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.2e-28 Score=166.24 Aligned_cols=135 Identities=29% Similarity=0.401 Sum_probs=115.2
Q ss_pred CCceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeee
Q 044494 2 HRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADF 81 (144)
Q Consensus 2 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~ 81 (144)
.++.+|++|||+.+++|.+++.... ..+++..+..++.|++.++.+|| +.+++|+|++|+||+++.++.++++||
T Consensus 71 ~~~~~~l~~e~~~~~~l~~~~~~~~--~~l~~~~~~~~~~ql~~~l~~lh---~~~i~h~dl~p~ni~i~~~~~~~l~d~ 145 (262)
T cd06613 71 RRDKLWIVMEYCGGGSLQDIYQVTR--GPLSELQIAYVCRETLKGLAYLH---ETGKIHRDIKGANILLTEDGDVKLADF 145 (262)
T ss_pred eCCEEEEEEeCCCCCcHHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHH---hCCceecCCChhhEEECCCCCEEECcc
Confidence 3567899999999999999887541 23899999999999999999999 899999999999999999999999999
Q ss_pred cceeecccCCCCcccccccccccCccccccC---CCCCcchhHHHHHHHHHHHhCCCCCCCCC
Q 044494 82 GVARLLNFDSSNRTLLAGTYGYIAPELAYTM---VVTEKSDVYSFGVVALEVLMGKHPGELLS 141 (144)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~---~~~~~~d~~slg~~l~~~~~g~~p~~~~~ 141 (144)
|.+..............++..|++||..... .++.++|+||+|+++++|++|..||...+
T Consensus 146 g~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~ 208 (262)
T cd06613 146 GVSAQLTATIAKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLH 208 (262)
T ss_pred ccchhhhhhhhccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCC
Confidence 9887654322223345577889999998876 77889999999999999999999997654
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.5e-28 Score=170.16 Aligned_cols=135 Identities=24% Similarity=0.388 Sum_probs=109.0
Q ss_pred CceEEEEEeeccCCCHHHHhhccc------ccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEE----cC
Q 044494 3 RKCMFLIYEYMEMGSLFCVLRTDE------EAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILL----NL 72 (144)
Q Consensus 3 ~~~~~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~----~~ 72 (144)
+..+|++|||+. ++|.+++.... ....+++..+..++.|++.|++||| +++++||||||+||++ +.
T Consensus 72 ~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH---~~~ivHrDlkp~Nil~~~~~~~ 147 (317)
T cd07868 72 DRKVWLLFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLH---ANWVLHRDLKPANILVMGEGPE 147 (317)
T ss_pred CcEEEEEEeccC-CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHH---hCCEEcCCCCHHHEEEecCCCC
Confidence 356899999986 58888775321 1234889999999999999999999 8999999999999999 45
Q ss_pred CCCeEEeeecceeecccCCC---CcccccccccccCccccccC-CCCCcchhHHHHHHHHHHHhCCCCCCCCC
Q 044494 73 ELEAFVADFGVARLLNFDSS---NRTLLAGTYGYIAPELAYTM-VVTEKSDVYSFGVVALEVLMGKHPGELLS 141 (144)
Q Consensus 73 ~~~~~l~d~~~~~~~~~~~~---~~~~~~~~~~~~~pe~~~~~-~~~~~~d~~slg~~l~~~~~g~~p~~~~~ 141 (144)
.+.++++|||++........ ......+++.|+|||++.+. .++.++|+||+|+++++|++|..||....
T Consensus 148 ~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~ 220 (317)
T cd07868 148 RGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ 220 (317)
T ss_pred cCcEEEeecCceeccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCc
Confidence 57899999999986543221 12335678999999998764 57889999999999999999999997543
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.6e-28 Score=167.39 Aligned_cols=136 Identities=26% Similarity=0.405 Sum_probs=113.4
Q ss_pred CceEEEEEeeccCCCHHHHhhcccc-------------cCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEE
Q 044494 3 RKCMFLIYEYMEMGSLFCVLRTDEE-------------AVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNIL 69 (144)
Q Consensus 3 ~~~~~lv~e~~~~~~L~~~l~~~~~-------------~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~ 69 (144)
.+..+++|||+++++|.+++..... ...+++..+..++.|++.++.+|| +.+++|+||||+||+
T Consensus 80 ~~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH---~~~i~H~dlkp~Nil 156 (283)
T cd05048 80 EQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLS---SHHFVHRDLAARNCL 156 (283)
T ss_pred CCceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccccccceEE
Confidence 4568999999999999999875321 134788899999999999999999 899999999999999
Q ss_pred EcCCCCeEEeeecceeecccCCC--CcccccccccccCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCC
Q 044494 70 LNLELEAFVADFGVARLLNFDSS--NRTLLAGTYGYIAPELAYTMVVTEKSDVYSFGVVALEVLM-GKHPGELLS 141 (144)
Q Consensus 70 ~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~d~~slg~~l~~~~~-g~~p~~~~~ 141 (144)
++.++.++++|||++........ ......+++.|+|||.+....++.++|+||+|++++||++ |..||.+.+
T Consensus 157 ~~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~ 231 (283)
T cd05048 157 VGEGLTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFS 231 (283)
T ss_pred EcCCCcEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCC
Confidence 99999999999999875432211 1222345678999999988888999999999999999998 999997644
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-28 Score=164.66 Aligned_cols=129 Identities=27% Similarity=0.245 Sum_probs=111.1
Q ss_pred CCceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeee
Q 044494 2 HRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADF 81 (144)
Q Consensus 2 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~ 81 (144)
+.+..++||||+++++|.+++.+... +++..+..++.|++.++.+|| +++++|+||||+||+++.++.++++||
T Consensus 56 ~~~~~~lv~e~~~~~~L~~~l~~~~~---l~~~~~~~~~~ql~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~l~df 129 (237)
T cd05576 56 SEDSVFLVLQHAEGGKLWSHISKFLN---IPEECVKRWAAEMVVALDALH---REGIVCRDLNPNNILLDDRGHIQLTYF 129 (237)
T ss_pred cCCeEEEEEecCCCCCHHHHHHHhcC---CCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHEEEcCCCCEEEecc
Confidence 35678999999999999999875433 899999999999999999999 899999999999999999999999999
Q ss_pred cceeecccCCCCcccccccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCC
Q 044494 82 GVARLLNFDSSNRTLLAGTYGYIAPELAYTMVVTEKSDVYSFGVVALEVLMGKHPGEL 139 (144)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~d~~slg~~l~~~~~g~~p~~~ 139 (144)
|.+...... .....++..|++||......++.++|+||+|++++++++|..|+..
T Consensus 130 ~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~ 184 (237)
T cd05576 130 SRWSEVEDS---CDGEAVENMYCAPEVGGISEETEACDWWSLGAILFELLTGKTLVEC 184 (237)
T ss_pred cchhccccc---cccCCcCccccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhc
Confidence 987654421 1223456779999999888888999999999999999999988764
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.6e-28 Score=167.44 Aligned_cols=133 Identities=29% Similarity=0.386 Sum_probs=112.6
Q ss_pred ceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeeecc
Q 044494 4 KCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADFGV 83 (144)
Q Consensus 4 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~~~ 83 (144)
...++++||+++|+|.+++.... ..+++..+..++.|++.|+.||| +++++|+||||+||+++.++.++++|||.
T Consensus 81 ~~~~~i~e~~~~gsL~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~lH---~~~iiH~dlkp~nili~~~~~~kl~Dfg~ 155 (279)
T cd05111 81 ASLQLVTQLSPLGSLLDHVRQHR--DSLDPQRLLNWCVQIAKGMYYLE---EHRMVHRNLAARNILLKSDSIVQIADFGV 155 (279)
T ss_pred CccEEEEEeCCCCcHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHH---HCCEeccccCcceEEEcCCCcEEEcCCcc
Confidence 45689999999999999997533 23899999999999999999999 89999999999999999999999999999
Q ss_pred eeecccCCC--CcccccccccccCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCC
Q 044494 84 ARLLNFDSS--NRTLLAGTYGYIAPELAYTMVVTEKSDVYSFGVVALEVLM-GKHPGELLS 141 (144)
Q Consensus 84 ~~~~~~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~d~~slg~~l~~~~~-g~~p~~~~~ 141 (144)
++....... ......++..|++||...+..++.++|+||+|+++||+++ |..||....
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~ 216 (279)
T cd05111 156 ADLLYPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMR 216 (279)
T ss_pred ceeccCCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCC
Confidence 976532211 1122345678999999988889999999999999999998 999997654
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-28 Score=170.32 Aligned_cols=133 Identities=21% Similarity=0.305 Sum_probs=111.3
Q ss_pred CceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeeec
Q 044494 3 RKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADFG 82 (144)
Q Consensus 3 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~~ 82 (144)
++..++||||+.+ +|.+++..... .+++..+..++.|++.|+.+|| +.+++||||||+||+++.++.++++|||
T Consensus 76 ~~~~~lv~e~~~~-~l~~~~~~~~~--~~~~~~~~~~~~qi~~aL~~lH---~~~ivH~dlkp~Nill~~~~~~kl~Dfg 149 (309)
T cd07872 76 DKSLTLVFEYLDK-DLKQYMDDCGN--IMSMHNVKIFLYQILRGLAYCH---RRKVLHRDLKPQNLLINERGELKLADFG 149 (309)
T ss_pred CCeEEEEEeCCCC-CHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEECccc
Confidence 5678999999975 88887765332 3788899999999999999999 8999999999999999999999999999
Q ss_pred ceeecccCCCCcccccccccccCcccccc-CCCCCcchhHHHHHHHHHHHhCCCCCCCCC
Q 044494 83 VARLLNFDSSNRTLLAGTYGYIAPELAYT-MVVTEKSDVYSFGVVALEVLMGKHPGELLS 141 (144)
Q Consensus 83 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~-~~~~~~~d~~slg~~l~~~~~g~~p~~~~~ 141 (144)
.+..............+++.|+|||.+.+ ..++.++|+||+|+++++|++|..||...+
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~ 209 (309)
T cd07872 150 LARAKSVPTKTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGST 209 (309)
T ss_pred cceecCCCccccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 98765433333334557889999998865 457889999999999999999999997644
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.7e-29 Score=167.04 Aligned_cols=135 Identities=27% Similarity=0.397 Sum_probs=116.2
Q ss_pred CceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeeec
Q 044494 3 RKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADFG 82 (144)
Q Consensus 3 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~~ 82 (144)
++.+|++|||+++++|.+++.... ...+++..+..++.|++.++.+|| +.+++|+||+|+||+++.++.++++|||
T Consensus 70 ~~~~~lv~e~~~~~~l~~~~~~~~-~~~~~~~~~~~~~~~i~~al~~lH---~~~i~H~dl~p~nili~~~~~~~l~dfg 145 (255)
T cd08219 70 DGHLYIVMEYCDGGDLMQKIKLQR-GKLFPEDTILQWFVQMCLGVQHIH---EKRVLHRDIKSKNIFLTQNGKVKLGDFG 145 (255)
T ss_pred CCEEEEEEeeCCCCcHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHh---hCCcccCCCCcceEEECCCCcEEEcccC
Confidence 567899999999999999886422 234789999999999999999999 8999999999999999999999999999
Q ss_pred ceeecccCCCCcccccccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCC
Q 044494 83 VARLLNFDSSNRTLLAGTYGYIAPELAYTMVVTEKSDVYSFGVVALEVLMGKHPGELLS 141 (144)
Q Consensus 83 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~d~~slg~~l~~~~~g~~p~~~~~ 141 (144)
.+..............+++.|+|||.+.+..++.++|+||+|+++++|++|..||...+
T Consensus 146 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~ 204 (255)
T cd08219 146 SARLLTSPGAYACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANS 204 (255)
T ss_pred cceeecccccccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCC
Confidence 98766533333334567888999999988888999999999999999999999997643
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.6e-28 Score=168.33 Aligned_cols=136 Identities=29% Similarity=0.432 Sum_probs=113.8
Q ss_pred CceEEEEEeeccCCCHHHHhhcccc-------------cCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEE
Q 044494 3 RKCMFLIYEYMEMGSLFCVLRTDEE-------------AVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNIL 69 (144)
Q Consensus 3 ~~~~~lv~e~~~~~~L~~~l~~~~~-------------~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~ 69 (144)
++..++||||+++++|.+++..... ...+++..++.++.|++.++++|| +++++|+||||.||+
T Consensus 79 ~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH---~~~i~H~dlkp~Nil 155 (291)
T cd05094 79 GDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLA---SQHFVHRDLATRNCL 155 (291)
T ss_pred CCceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccCcceEE
Confidence 4678999999999999999865321 224788999999999999999999 899999999999999
Q ss_pred EcCCCCeEEeeecceeecccCCC--CcccccccccccCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCC
Q 044494 70 LNLELEAFVADFGVARLLNFDSS--NRTLLAGTYGYIAPELAYTMVVTEKSDVYSFGVVALEVLM-GKHPGELLS 141 (144)
Q Consensus 70 ~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~d~~slg~~l~~~~~-g~~p~~~~~ 141 (144)
++.++.++++|||++........ ......++..|+|||.+....++.++|+||+|+++++|++ |..||...+
T Consensus 156 ~~~~~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~ 230 (291)
T cd05094 156 VGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLS 230 (291)
T ss_pred EccCCcEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC
Confidence 99999999999999875432211 1122345678999999988888999999999999999998 999986644
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.3e-28 Score=169.34 Aligned_cols=132 Identities=30% Similarity=0.501 Sum_probs=114.9
Q ss_pred CceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeeec
Q 044494 3 RKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADFG 82 (144)
Q Consensus 3 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~~ 82 (144)
.+.+|+|+||+++++|.+++... .+++..+..++.+++.++.+|| +.+++|+||+|+||+++.++.++++|||
T Consensus 88 ~~~~~lv~e~~~~~~L~~~~~~~----~l~~~~~~~i~~~l~~al~~LH---~~~i~H~dL~p~Nili~~~~~~kl~dfg 160 (296)
T cd06655 88 GDELFVVMEYLAGGSLTDVVTET----CMDEAQIAAVCRECLQALEFLH---ANQVIHRDIKSDNVLLGMDGSVKLTDFG 160 (296)
T ss_pred CceEEEEEEecCCCcHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEccCc
Confidence 56789999999999999988642 2889999999999999999999 8999999999999999999999999999
Q ss_pred ceeecccCCCCcccccccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCC
Q 044494 83 VARLLNFDSSNRTLLAGTYGYIAPELAYTMVVTEKSDVYSFGVVALEVLMGKHPGELLS 141 (144)
Q Consensus 83 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~d~~slg~~l~~~~~g~~p~~~~~ 141 (144)
++..............++..|++||.+....++.++|+||+|+++|++++|..||...+
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~ 219 (296)
T cd06655 161 FCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNEN 219 (296)
T ss_pred cchhcccccccCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 88765433322333457889999999988888899999999999999999999997654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.6e-28 Score=165.14 Aligned_cols=136 Identities=32% Similarity=0.469 Sum_probs=116.5
Q ss_pred CceEEEEEeeccCCCHHHHhhcccc------cCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCe
Q 044494 3 RKCMFLIYEYMEMGSLFCVLRTDEE------AVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEA 76 (144)
Q Consensus 3 ~~~~~lv~e~~~~~~L~~~l~~~~~------~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~ 76 (144)
++.+++||||+++++|.+++..... ...+++..++.++.|++.++.+|| +++++|+||+|+||+++.++.+
T Consensus 68 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH---~~~i~H~di~p~nili~~~~~~ 144 (262)
T cd00192 68 EEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLA---SKKFVHRDLAARNCLVGEDLVV 144 (262)
T ss_pred CCceEEEEEeccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHH---cCCcccCccCcceEEECCCCcE
Confidence 4678999999999999999986421 244899999999999999999999 8999999999999999999999
Q ss_pred EEeeecceeecccCC--CCcccccccccccCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCC
Q 044494 77 FVADFGVARLLNFDS--SNRTLLAGTYGYIAPELAYTMVVTEKSDVYSFGVVALEVLM-GKHPGELLS 141 (144)
Q Consensus 77 ~l~d~~~~~~~~~~~--~~~~~~~~~~~~~~pe~~~~~~~~~~~d~~slg~~l~~~~~-g~~p~~~~~ 141 (144)
+++|||.+....... .......++..|+|||......++.++|+||+|++++++++ |..||...+
T Consensus 145 ~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~ 212 (262)
T cd00192 145 KISDFGLSRDVYDDDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLS 212 (262)
T ss_pred EEcccccccccccccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCC
Confidence 999999998765332 12233456778999999988888999999999999999999 699998754
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.6e-28 Score=167.23 Aligned_cols=132 Identities=31% Similarity=0.502 Sum_probs=114.7
Q ss_pred CceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeeec
Q 044494 3 RKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADFG 82 (144)
Q Consensus 3 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~~ 82 (144)
++..|+||||+++++|.+++... .+++..+..++.+++.++.+|| +.+++|+|++|+||+++.++.++++|||
T Consensus 74 ~~~~~lv~e~~~~~~L~~~i~~~----~l~~~~~~~~~~~l~~~l~~lh---~~~ivH~dl~p~Nil~~~~~~~~l~dfg 146 (277)
T cd06640 74 GTKLWIIMEYLGGGSALDLLRAG----PFDEFQIATMLKEILKGLDYLH---SEKKIHRDIKAANVLLSEQGDVKLADFG 146 (277)
T ss_pred CCEEEEEEecCCCCcHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHH---hCCccCcCCChhhEEEcCCCCEEEcccc
Confidence 56789999999999999988742 2788999999999999999999 8999999999999999999999999999
Q ss_pred ceeecccCCCCcccccccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCC
Q 044494 83 VARLLNFDSSNRTLLAGTYGYIAPELAYTMVVTEKSDVYSFGVVALEVLMGKHPGELLS 141 (144)
Q Consensus 83 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~d~~slg~~l~~~~~g~~p~~~~~ 141 (144)
.+..............++..|+|||.+.+...+.++|+||+|+++++|++|..||+..+
T Consensus 147 ~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~ 205 (277)
T cd06640 147 VAGQLTDTQIKRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMH 205 (277)
T ss_pred cceeccCCccccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcC
Confidence 98765533323333457778999999988888999999999999999999999997654
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.6e-28 Score=166.16 Aligned_cols=132 Identities=27% Similarity=0.347 Sum_probs=112.5
Q ss_pred ceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeeecc
Q 044494 4 KCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADFGV 83 (144)
Q Consensus 4 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~~~ 83 (144)
..++++|||+++++|.+++..... +++..+..++.|++.++.+|| +++++|+||+|+||+++.++.++++|||.
T Consensus 79 ~~~~~v~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~~l~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~~l~Dfg~ 152 (265)
T cd06652 79 RTLSIFMEHMPGGSIKDQLKSYGA---LTENVTRKYTRQILEGVSYLH---SNMIVHRDIKGANILRDSVGNVKLGDFGA 152 (265)
T ss_pred ceEEEEEEecCCCcHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEecCCCCEEECcCcc
Confidence 468899999999999999875433 788889999999999999999 89999999999999999999999999998
Q ss_pred eeecccCC---CCcccccccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCC
Q 044494 84 ARLLNFDS---SNRTLLAGTYGYIAPELAYTMVVTEKSDVYSFGVVALEVLMGKHPGELLS 141 (144)
Q Consensus 84 ~~~~~~~~---~~~~~~~~~~~~~~pe~~~~~~~~~~~d~~slg~~l~~~~~g~~p~~~~~ 141 (144)
+....... .......++..|+|||...+..++.++|+||+|+++|++++|..||...+
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~ 213 (265)
T cd06652 153 SKRLQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFE 213 (265)
T ss_pred ccccccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccc
Confidence 87543211 11223457788999999988888899999999999999999999997643
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.96 E-value=7e-29 Score=167.06 Aligned_cols=132 Identities=36% Similarity=0.508 Sum_probs=115.7
Q ss_pred CceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeeec
Q 044494 3 RKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADFG 82 (144)
Q Consensus 3 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~~ 82 (144)
++..++||||+++++|.+++..... +++..++.++.|++.+|.+|| +.+++|+||+|+||+++.++.++++|||
T Consensus 70 ~~~~~~v~~~~~~~~L~~~l~~~~~---~~~~~~~~~~~qi~~~L~~Lh---~~~i~H~dikp~NIl~~~~~~~~l~Dfg 143 (260)
T PF00069_consen 70 DNYLYIVMEYCPGGSLQDYLQKNKP---LSEEEILKIAYQILEALAYLH---SKGIVHRDIKPENILLDENGEVKLIDFG 143 (260)
T ss_dssp SSEEEEEEEEETTEBHHHHHHHHSS---BBHHHHHHHHHHHHHHHHHHH---HTTEEESSBSGGGEEESTTSEEEESSGT
T ss_pred ccccccccccccccccccccccccc---ccccccccccccccccccccc---cccccccccccccccccccccccccccc
Confidence 5678999999999999999983333 899999999999999999999 8899999999999999999999999999
Q ss_pred ceeecccCCCCcccccccccccCccccc-cCCCCCcchhHHHHHHHHHHHhCCCCCCCC
Q 044494 83 VARLLNFDSSNRTLLAGTYGYIAPELAY-TMVVTEKSDVYSFGVVALEVLMGKHPGELL 140 (144)
Q Consensus 83 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~-~~~~~~~~d~~slg~~l~~~~~g~~p~~~~ 140 (144)
.+..............+++.|+|||... ....+.++|+||+|+++++|++|..||...
T Consensus 144 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~ 202 (260)
T PF00069_consen 144 SSVKLSENNENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEES 202 (260)
T ss_dssp TTEESTSTTSEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTS
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 9876432333344566888999999998 777889999999999999999999999875
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.2e-28 Score=169.41 Aligned_cols=133 Identities=29% Similarity=0.484 Sum_probs=115.4
Q ss_pred CCceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeee
Q 044494 2 HRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADF 81 (144)
Q Consensus 2 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~ 81 (144)
.++..|+||||+++++|.+++.+. .+++..+..++.|++.++.+|| +.+++|+|++|+||+++.++.++++||
T Consensus 87 ~~~~~~lv~e~~~~~~L~~~~~~~----~~~~~~~~~~~~~l~~~L~~LH---~~~i~H~dL~p~Nili~~~~~~~l~Df 159 (297)
T cd06656 87 VGDELWVVMEYLAGGSLTDVVTET----CMDEGQIAAVCRECLQALDFLH---SNQVIHRDIKSDNILLGMDGSVKLTDF 159 (297)
T ss_pred cCCEEEEeecccCCCCHHHHHHhC----CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEECcC
Confidence 356789999999999999988642 2788899999999999999999 899999999999999999999999999
Q ss_pred cceeecccCCCCcccccccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCC
Q 044494 82 GVARLLNFDSSNRTLLAGTYGYIAPELAYTMVVTEKSDVYSFGVVALEVLMGKHPGELLS 141 (144)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~d~~slg~~l~~~~~g~~p~~~~~ 141 (144)
|++..............+++.|++||...+..++.++|+||+|++++++++|..||...+
T Consensus 160 g~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~ 219 (297)
T cd06656 160 GFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNEN 219 (297)
T ss_pred ccceEccCCccCcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 998765433333334567889999999998888899999999999999999999997643
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.6e-28 Score=166.07 Aligned_cols=135 Identities=20% Similarity=0.256 Sum_probs=115.6
Q ss_pred CceEEEEEeeccCCCHHHHhhcc-cccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeee
Q 044494 3 RKCMFLIYEYMEMGSLFCVLRTD-EEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADF 81 (144)
Q Consensus 3 ~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~ 81 (144)
++..+++|||+++++|.+++... .....+++..++.++.|++.++.+|| +.+++|+||+|+||+++.++.++++||
T Consensus 74 ~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dl~p~nili~~~~~~~l~df 150 (267)
T cd08229 74 DNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMH---SRRVMHRDIKPANVFITATGVVKLGDL 150 (267)
T ss_pred CCeEEEEEEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCCEEECcc
Confidence 56789999999999999988642 22334899999999999999999999 899999999999999999999999999
Q ss_pred cceeecccCCCCcccccccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCC
Q 044494 82 GVARLLNFDSSNRTLLAGTYGYIAPELAYTMVVTEKSDVYSFGVVALEVLMGKHPGELL 140 (144)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~d~~slg~~l~~~~~g~~p~~~~ 140 (144)
|.+..............++..|++||......++.++|+||+|++++++++|..||...
T Consensus 151 g~~~~~~~~~~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~ 209 (267)
T cd08229 151 GLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGD 209 (267)
T ss_pred hhhhccccCCcccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccc
Confidence 98876543333333456788999999998888889999999999999999999999653
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.7e-28 Score=167.16 Aligned_cols=133 Identities=28% Similarity=0.421 Sum_probs=111.7
Q ss_pred CceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeeec
Q 044494 3 RKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADFG 82 (144)
Q Consensus 3 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~~ 82 (144)
++.+|+||||+++++|..++.+.. ..+++..+..++.|++.++.+|| +.+++|+|++|+||+++.++.++++|||
T Consensus 81 ~~~~~lv~e~~~~~~l~~~~~~~~--~~l~~~~~~~~~~ql~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~kl~dfg 155 (292)
T cd06644 81 DGKLWIMIEFCPGGAVDAIMLELD--RGLTEPQIQVICRQMLEALQYLH---SMKIIHRDLKAGNVLLTLDGDIKLADFG 155 (292)
T ss_pred CCeEEEEEecCCCCcHHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHh---cCCeeecCCCcceEEEcCCCCEEEccCc
Confidence 467899999999999988776432 23899999999999999999999 8999999999999999999999999999
Q ss_pred ceeecccCCCCcccccccccccCccccc-----cCCCCCcchhHHHHHHHHHHHhCCCCCCCC
Q 044494 83 VARLLNFDSSNRTLLAGTYGYIAPELAY-----TMVVTEKSDVYSFGVVALEVLMGKHPGELL 140 (144)
Q Consensus 83 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~-----~~~~~~~~d~~slg~~l~~~~~g~~p~~~~ 140 (144)
.+..............+++.|++||.+. ...++.++|+||+|+++|+|++|..||...
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~ 218 (292)
T cd06644 156 VSAKNVKTLQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHEL 218 (292)
T ss_pred cceeccccccccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccc
Confidence 8875443333334456788999999884 344677899999999999999999999654
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.8e-28 Score=167.26 Aligned_cols=135 Identities=21% Similarity=0.262 Sum_probs=113.0
Q ss_pred CCceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeee
Q 044494 2 HRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADF 81 (144)
Q Consensus 2 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~ 81 (144)
.++.+|+||||+. ++|.+++........+++..+..++.|++.||.+|| +.+++|+|++|+||+++.++.++++||
T Consensus 70 ~~~~~~~v~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~dl~p~nil~~~~~~~~l~df 145 (285)
T cd07861 70 QESRLYLIFEFLS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCH---SRRVLHRDLKPQNLLIDNKGVIKLADF 145 (285)
T ss_pred eCCeEEEEEecCC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHH---hCCeeecCCCHHHEEEcCCCcEEECcc
Confidence 3567899999997 589888865443345899999999999999999999 899999999999999999999999999
Q ss_pred cceeecccCCCCcccccccccccCccccccC-CCCCcchhHHHHHHHHHHHhCCCCCCCC
Q 044494 82 GVARLLNFDSSNRTLLAGTYGYIAPELAYTM-VVTEKSDVYSFGVVALEVLMGKHPGELL 140 (144)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~-~~~~~~d~~slg~~l~~~~~g~~p~~~~ 140 (144)
|++..............+++.|+|||.+... .++.++|+||+|++++++++|..||...
T Consensus 146 g~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~ 205 (285)
T cd07861 146 GLARAFGIPVRVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGD 205 (285)
T ss_pred cceeecCCCcccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCC
Confidence 9987654333333334567889999987654 4678899999999999999999999754
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.8e-28 Score=164.79 Aligned_cols=135 Identities=21% Similarity=0.270 Sum_probs=115.5
Q ss_pred CCceEEEEEeeccCCCHHHHhhcc-cccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEee
Q 044494 2 HRKCMFLIYEYMEMGSLFCVLRTD-EEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVAD 80 (144)
Q Consensus 2 ~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d 80 (144)
.++..++||||+++++|.+++... .....+++..+..++.+++.++.+|| +.|++|+|++|+||+++.++.++++|
T Consensus 73 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~dl~p~nil~~~~~~~~l~d 149 (267)
T cd08224 73 ENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMH---SKRIMHRDIKPANVFITATGVVKLGD 149 (267)
T ss_pred cCCeEEEEEecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHH---hCCEecCCcChhhEEECCCCcEEEec
Confidence 356789999999999999988642 22344899999999999999999999 89999999999999999999999999
Q ss_pred ecceeecccCCCCcccccccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCC
Q 044494 81 FGVARLLNFDSSNRTLLAGTYGYIAPELAYTMVVTEKSDVYSFGVVALEVLMGKHPGEL 139 (144)
Q Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~d~~slg~~l~~~~~g~~p~~~ 139 (144)
||.+..............+++.|+|||.+.+..++.++|+||+|++++++++|..||..
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~ 208 (267)
T cd08224 150 LGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYG 208 (267)
T ss_pred cceeeeccCCCcccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCccc
Confidence 99887654333333345678889999999888888999999999999999999999854
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.9e-28 Score=167.84 Aligned_cols=135 Identities=30% Similarity=0.352 Sum_probs=112.4
Q ss_pred ceEEEEEeeccCCCHHHHhhcc-cccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeeec
Q 044494 4 KCMFLIYEYMEMGSLFCVLRTD-EEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADFG 82 (144)
Q Consensus 4 ~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~~ 82 (144)
+.+|+||||+++++|.++++.. .....+++..+..++.|++.++++|| +.+++|+||+|+||+++.++.++++|||
T Consensus 97 ~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dlkp~nili~~~~~~kl~dfg 173 (291)
T cd06639 97 GQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLH---NNRIIHRDVKGNNILLTTEGGVKLVDFG 173 (291)
T ss_pred CeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHEEEcCCCCEEEeecc
Confidence 4689999999999999988642 12234899999999999999999999 8999999999999999999999999999
Q ss_pred ceeecccCCCCcccccccccccCccccccCC-----CCCcchhHHHHHHHHHHHhCCCCCCCCC
Q 044494 83 VARLLNFDSSNRTLLAGTYGYIAPELAYTMV-----VTEKSDVYSFGVVALEVLMGKHPGELLS 141 (144)
Q Consensus 83 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~-----~~~~~d~~slg~~l~~~~~g~~p~~~~~ 141 (144)
.+..............++..|++||.+.... ++.++|+||+|++++++++|..||...+
T Consensus 174 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~ 237 (291)
T cd06639 174 VSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMH 237 (291)
T ss_pred cchhcccccccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCc
Confidence 8876543222233345788899999876432 5789999999999999999999997654
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.1e-28 Score=167.50 Aligned_cols=137 Identities=28% Similarity=0.426 Sum_probs=113.9
Q ss_pred CCceEEEEEeeccCCCHHHHhhccc----------ccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEc
Q 044494 2 HRKCMFLIYEYMEMGSLFCVLRTDE----------EAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLN 71 (144)
Q Consensus 2 ~~~~~~lv~e~~~~~~L~~~l~~~~----------~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~ 71 (144)
.++.+++||||+++++|.+++.... ....+++..+..++.|++.++++|| +.|++||||||+||+++
T Consensus 78 ~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH---~~~i~H~dlkp~Nili~ 154 (288)
T cd05093 78 EGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLA---SQHFVHRDLATRNCLVG 154 (288)
T ss_pred cCCccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccCcceEEEc
Confidence 3567899999999999999986432 1234899999999999999999999 89999999999999999
Q ss_pred CCCCeEEeeecceeecccCCC--CcccccccccccCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCC
Q 044494 72 LELEAFVADFGVARLLNFDSS--NRTLLAGTYGYIAPELAYTMVVTEKSDVYSFGVVALEVLM-GKHPGELLS 141 (144)
Q Consensus 72 ~~~~~~l~d~~~~~~~~~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~d~~slg~~l~~~~~-g~~p~~~~~ 141 (144)
.++.++++|||.+........ ......++..|+|||.+....++.++|+||+|+++++|++ |..||...+
T Consensus 155 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~ 227 (288)
T cd05093 155 ENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLS 227 (288)
T ss_pred cCCcEEeccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC
Confidence 999999999999875432211 1122334678999999988888999999999999999998 999997643
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=7e-29 Score=178.14 Aligned_cols=131 Identities=28% Similarity=0.369 Sum_probs=113.4
Q ss_pred CCceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEE-cCCCCeEEee
Q 044494 2 HRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILL-NLELEAFVAD 80 (144)
Q Consensus 2 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~-~~~~~~~l~d 80 (144)
.+.+.|+|||.+.|+-+.+.+..... ....+..|+++|+.++.+|| ++|++|||+||.||++ ...+.++++|
T Consensus 387 ~~~~~~~v~e~l~g~ell~ri~~~~~----~~~e~~~w~~~lv~Av~~LH---~~gvvhRDLkp~NIL~~~~~g~lrlty 459 (612)
T KOG0603|consen 387 DGKEIYLVMELLDGGELLRRIRSKPE----FCSEASQWAAELVSAVDYLH---EQGVVHRDLKPGNILLDGSAGHLRLTY 459 (612)
T ss_pred CCceeeeeehhccccHHHHHHHhcch----hHHHHHHHHHHHHHHHHHHH---hcCeeecCCChhheeecCCCCcEEEEE
Confidence 35678999999999999887765432 22667789999999999999 9999999999999999 5889999999
Q ss_pred ecceeecccCCCCcccccccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCC
Q 044494 81 FGVARLLNFDSSNRTLLAGTYGYIAPELAYTMVVTEKSDVYSFGVVALEVLMGKHPGELLSS 142 (144)
Q Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~d~~slg~~l~~~~~g~~p~~~~~~ 142 (144)
||.+...+.. ..+...|..|.|||++....++..+|+||||+++|+|++|+.||+..++
T Consensus 460 FG~a~~~~~~---~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~ 518 (612)
T KOG0603|consen 460 FGFWSELERS---CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPA 518 (612)
T ss_pred echhhhCchh---hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCc
Confidence 9999865532 4445678899999999999999999999999999999999999988765
|
|
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.9e-28 Score=166.73 Aligned_cols=133 Identities=31% Similarity=0.485 Sum_probs=114.3
Q ss_pred CCceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeee
Q 044494 2 HRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADF 81 (144)
Q Consensus 2 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~ 81 (144)
.++..|+||||+++++|.+++... .+++..+..++.|++.++.+|| +++++|+|++|+||+++.++.++++||
T Consensus 73 ~~~~~~lv~e~~~~~~L~~~~~~~----~~~~~~~~~~~~~i~~~l~~lH---~~~ivH~dl~p~ni~i~~~~~~~l~df 145 (277)
T cd06642 73 KGTKLWIIMEYLGGGSALDLLKPG----PLEETYIATILREILKGLDYLH---SERKIHRDIKAANVLLSEQGDVKLADF 145 (277)
T ss_pred cCCceEEEEEccCCCcHHHHhhcC----CCCHHHHHHHHHHHHHHHHHHh---cCCeeccCCChheEEEeCCCCEEEccc
Confidence 356789999999999999988642 2788999999999999999999 899999999999999999999999999
Q ss_pred cceeecccCCCCcccccccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCC
Q 044494 82 GVARLLNFDSSNRTLLAGTYGYIAPELAYTMVVTEKSDVYSFGVVALEVLMGKHPGELLS 141 (144)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~d~~slg~~l~~~~~g~~p~~~~~ 141 (144)
|++..............++..|++||.+....++.++|+||+|++++++++|..||+...
T Consensus 146 g~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~ 205 (277)
T cd06642 146 GVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLH 205 (277)
T ss_pred cccccccCcchhhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccc
Confidence 998765432222233457788999999998888999999999999999999999997543
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.5e-28 Score=173.89 Aligned_cols=109 Identities=29% Similarity=0.443 Sum_probs=92.3
Q ss_pred CCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeeecceeecccCCC--CcccccccccccCcc
Q 044494 30 GLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADFGVARLLNFDSS--NRTLLAGTYGYIAPE 107 (144)
Q Consensus 30 ~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~~~~~~~pe 107 (144)
.+++..+..++.|++.|+.||| +.+++|+||||+||+++.++.++++|||++........ ......++..|+|||
T Consensus 210 ~l~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE 286 (375)
T cd05104 210 ALDTEDLLSFSYQVAKGMSFLA---SKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKGNARLPVKWMAPE 286 (375)
T ss_pred CCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCchhhEEEECCCcEEEecCccceeccCcccccccCCCCCCcceeChh
Confidence 3678889999999999999999 89999999999999999999999999999876543221 112233456799999
Q ss_pred ccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCC
Q 044494 108 LAYTMVVTEKSDVYSFGVVALEVLM-GKHPGELLS 141 (144)
Q Consensus 108 ~~~~~~~~~~~d~~slg~~l~~~~~-g~~p~~~~~ 141 (144)
.+....++.++|+||+|++++++++ |..||...+
T Consensus 287 ~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~ 321 (375)
T cd05104 287 SIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMP 321 (375)
T ss_pred HhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCC
Confidence 9998889999999999999999998 899997654
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.9e-28 Score=166.52 Aligned_cols=132 Identities=34% Similarity=0.472 Sum_probs=116.5
Q ss_pred CceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeeec
Q 044494 3 RKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADFG 82 (144)
Q Consensus 3 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~~ 82 (144)
+..+|+|+||+++++|.+++... .+++..+..++.|++.++.+|| +.+++|+|++|+|++++.++.++++|||
T Consensus 71 ~~~~~~v~e~~~~~~L~~~~~~~----~~~~~~~~~~~~ql~~~l~~lh---~~~i~h~dl~p~ni~i~~~~~~~l~d~g 143 (274)
T cd06609 71 GSKLWIIMEYCGGGSCLDLLKPG----KLDETYIAFILREVLLGLEYLH---EEGKIHRDIKAANILLSEEGDVKLADFG 143 (274)
T ss_pred CCeEEEEEEeeCCCcHHHHHhhc----CCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEECCCCCEEEcccc
Confidence 46789999999999999998754 3899999999999999999999 8999999999999999999999999999
Q ss_pred ceeecccCCCCcccccccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCC
Q 044494 83 VARLLNFDSSNRTLLAGTYGYIAPELAYTMVVTEKSDVYSFGVVALEVLMGKHPGELLS 141 (144)
Q Consensus 83 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~d~~slg~~l~~~~~g~~p~~~~~ 141 (144)
++..............+++.|++||.+.+..++.++|+||+|+++|++++|..||+..+
T Consensus 144 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~ 202 (274)
T cd06609 144 VSGQLTSTMSKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLH 202 (274)
T ss_pred cceeecccccccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCc
Confidence 99876543333334567788999999998889999999999999999999999997643
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.4e-28 Score=169.14 Aligned_cols=132 Identities=27% Similarity=0.475 Sum_probs=114.1
Q ss_pred CceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeeec
Q 044494 3 RKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADFG 82 (144)
Q Consensus 3 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~~ 82 (144)
++..|+|+||+++++|.+++... .+++..++.++.|++.++.+|| +.+++|+||+|+||+++.++.++++|||
T Consensus 90 ~~~~~iv~e~~~~~~L~~~~~~~----~~~~~~~~~~~~qi~~~L~~LH---~~~ivH~dl~p~Nill~~~~~~kL~dfg 162 (297)
T cd06659 90 GEELWVLMEFLQGGALTDIVSQT----RLNEEQIATVCESVLQALCYLH---SQGVIHRDIKSDSILLTLDGRVKLSDFG 162 (297)
T ss_pred CCeEEEEEecCCCCCHHHHHhhc----CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHeEEccCCcEEEeech
Confidence 56789999999999999877542 3889999999999999999999 8999999999999999999999999999
Q ss_pred ceeecccCCCCcccccccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCC
Q 044494 83 VARLLNFDSSNRTLLAGTYGYIAPELAYTMVVTEKSDVYSFGVVALEVLMGKHPGELLS 141 (144)
Q Consensus 83 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~d~~slg~~l~~~~~g~~p~~~~~ 141 (144)
++..............++..|+|||.+....++.++|+||+|++++++++|..||...+
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~ 221 (297)
T cd06659 163 FCAQISKDVPKRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDS 221 (297)
T ss_pred hHhhcccccccccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 88754433223334567889999999988888999999999999999999999996543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.7e-28 Score=166.04 Aligned_cols=136 Identities=30% Similarity=0.431 Sum_probs=113.5
Q ss_pred CceEEEEEeeccCCCHHHHhhccc-----------ccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEc
Q 044494 3 RKCMFLIYEYMEMGSLFCVLRTDE-----------EAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLN 71 (144)
Q Consensus 3 ~~~~~lv~e~~~~~~L~~~l~~~~-----------~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~ 71 (144)
++..++||||+++++|.+++.... ....+++..+..++.|++.++.+|| +.+++|+||+|+||+++
T Consensus 80 ~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH---~~~i~h~dlkp~nili~ 156 (280)
T cd05049 80 GDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLA---SQHFVHRDLATRNCLVG 156 (280)
T ss_pred CCCeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHh---hCCeeccccccceEEEc
Confidence 467899999999999999997532 1234788899999999999999999 89999999999999999
Q ss_pred CCCCeEEeeecceeecccCC--CCcccccccccccCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCC
Q 044494 72 LELEAFVADFGVARLLNFDS--SNRTLLAGTYGYIAPELAYTMVVTEKSDVYSFGVVALEVLM-GKHPGELLS 141 (144)
Q Consensus 72 ~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~~~~~pe~~~~~~~~~~~d~~slg~~l~~~~~-g~~p~~~~~ 141 (144)
.++.++++|||++....... .......+++.|+|||.+....++.++|+||+|+++++|++ |..||...+
T Consensus 157 ~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~ 229 (280)
T cd05049 157 YDLVVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLS 229 (280)
T ss_pred CCCeEEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCC
Confidence 99999999999887543211 11122335678999999998889999999999999999998 999997644
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.2e-28 Score=164.92 Aligned_cols=129 Identities=26% Similarity=0.377 Sum_probs=113.1
Q ss_pred CceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeeec
Q 044494 3 RKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADFG 82 (144)
Q Consensus 3 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~~ 82 (144)
++.+|+|+||+++++|.++++.... +++..+..++.|++.|+.+|| +.+++|+|++|+||+++.++.++++|||
T Consensus 69 ~~~~~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~i~~qi~~aL~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg 142 (260)
T cd05611 69 KDYLYLVMEYLNGGDCASLIKTLGG---LPEDWAKQYIAEVVLGVEDLH---QRGIIHRDIKPENLLIDQTGHLKLTDFG 142 (260)
T ss_pred CCeEEEEEeccCCCCHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCcEEEeecc
Confidence 4678999999999999999875433 889999999999999999999 8999999999999999999999999999
Q ss_pred ceeecccCCCCcccccccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCC
Q 044494 83 VARLLNFDSSNRTLLAGTYGYIAPELAYTMVVTEKSDVYSFGVVALEVLMGKHPGELLS 141 (144)
Q Consensus 83 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~d~~slg~~l~~~~~g~~p~~~~~ 141 (144)
++..... .....+++.|++||...+..++.++|+||+|++++++++|..||...+
T Consensus 143 ~~~~~~~----~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~ 197 (260)
T cd05611 143 LSRNGLE----NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAET 197 (260)
T ss_pred cceeccc----cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCC
Confidence 8875332 233457788999999988878899999999999999999999997643
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1e-28 Score=173.56 Aligned_cols=128 Identities=27% Similarity=0.336 Sum_probs=109.5
Q ss_pred ceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeeecc
Q 044494 4 KCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADFGV 83 (144)
Q Consensus 4 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~~~ 83 (144)
..+|+||||+.+ ++.+.+.. .+++..+..++.|++.||.+|| +.|++||||||+||+++.++.++++|||+
T Consensus 95 ~~~~lv~e~~~~-~l~~~~~~-----~l~~~~~~~~~~qi~~aL~~LH---~~givHrDikp~Nill~~~~~~kl~Dfg~ 165 (355)
T cd07874 95 QDVYLVMELMDA-NLCQVIQM-----ELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGL 165 (355)
T ss_pred ceeEEEhhhhcc-cHHHHHhh-----cCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCChHHEEECCCCCEEEeeCcc
Confidence 357999999975 67766643 2788889999999999999999 89999999999999999999999999999
Q ss_pred eeecccCCCCcccccccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCC
Q 044494 84 ARLLNFDSSNRTLLAGTYGYIAPELAYTMVVTEKSDVYSFGVVALEVLMGKHPGELLS 141 (144)
Q Consensus 84 ~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~d~~slg~~l~~~~~g~~p~~~~~ 141 (144)
++..... .......+++.|+|||.+.+..++.++|+||+|+++++|++|..||.+.+
T Consensus 166 ~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~ 222 (355)
T cd07874 166 ARTAGTS-FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRD 222 (355)
T ss_pred cccCCCc-cccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 9765422 22233568899999999998889999999999999999999999997643
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.8e-28 Score=166.35 Aligned_cols=135 Identities=29% Similarity=0.426 Sum_probs=110.9
Q ss_pred CceEEEEEeeccCCCHHHHhhccc-------------ccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEE
Q 044494 3 RKCMFLIYEYMEMGSLFCVLRTDE-------------EAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNIL 69 (144)
Q Consensus 3 ~~~~~lv~e~~~~~~L~~~l~~~~-------------~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~ 69 (144)
++.+|+||||+++++|.+++.... ....+++..+..++.|++.|+++|| +.+++|+||||+|++
T Consensus 68 ~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH---~~~i~H~dikp~nil 144 (270)
T cd05047 68 RGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNIL 144 (270)
T ss_pred CCCceEEEEeCCCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccccceEE
Confidence 456899999999999999986532 1234789999999999999999999 899999999999999
Q ss_pred EcCCCCeEEeeecceeecccCCCCcccccccccccCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCC
Q 044494 70 LNLELEAFVADFGVARLLNFDSSNRTLLAGTYGYIAPELAYTMVVTEKSDVYSFGVVALEVLM-GKHPGELLS 141 (144)
Q Consensus 70 ~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~d~~slg~~l~~~~~-g~~p~~~~~ 141 (144)
++.++.++++|||++....... .......+..|+|||......++.++|+||+|++++++++ |..||...+
T Consensus 145 i~~~~~~kl~dfgl~~~~~~~~-~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~ 216 (270)
T cd05047 145 VGENYVAKIADFGLSRGQEVYV-KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT 216 (270)
T ss_pred EcCCCeEEECCCCCccccchhh-hccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccC
Confidence 9999999999999886332111 1111223557999999988888999999999999999997 999997643
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.9e-28 Score=167.10 Aligned_cols=135 Identities=27% Similarity=0.422 Sum_probs=112.6
Q ss_pred CceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeeec
Q 044494 3 RKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADFG 82 (144)
Q Consensus 3 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~~ 82 (144)
++.+|++|||+++|+|.+++.... ...+++..++.++.|++.++.+|| +.+++|+|++|+||+++.++.++++|||
T Consensus 91 ~~~~~iv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~qi~~al~~LH---~~~ivH~dl~~~nili~~~~~~~l~dfg 166 (282)
T cd06636 91 DDQLWLVMEFCGAGSVTDLVKNTK-GNALKEDWIAYICREILRGLAHLH---AHKVIHRDIKGQNVLLTENAEVKLVDFG 166 (282)
T ss_pred CCEEEEEEEeCCCCcHHHHHHHcc-CCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEeeCc
Confidence 457899999999999999887532 223788889999999999999999 8999999999999999999999999999
Q ss_pred ceeecccCCCCcccccccccccCccccc-----cCCCCCcchhHHHHHHHHHHHhCCCCCCCCC
Q 044494 83 VARLLNFDSSNRTLLAGTYGYIAPELAY-----TMVVTEKSDVYSFGVVALEVLMGKHPGELLS 141 (144)
Q Consensus 83 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~-----~~~~~~~~d~~slg~~l~~~~~g~~p~~~~~ 141 (144)
.+..............+++.|+|||.+. ...++.++|+||+|++++++++|..||....
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~ 230 (282)
T cd06636 167 VSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMH 230 (282)
T ss_pred chhhhhccccCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccC
Confidence 8875543222334456888999999876 3356778999999999999999999996543
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-28 Score=170.14 Aligned_cols=136 Identities=29% Similarity=0.437 Sum_probs=112.1
Q ss_pred CCceEEEEEeeccCCCHHHHhhccc-------------ccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcE
Q 044494 2 HRKCMFLIYEYMEMGSLFCVLRTDE-------------EAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNI 68 (144)
Q Consensus 2 ~~~~~~lv~e~~~~~~L~~~l~~~~-------------~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni 68 (144)
+++.+|+||||+++++|.+++.+.. ....+++.+++.++.|++.|+++|| +.|++|+||||+|+
T Consensus 79 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH---~~gi~H~dlkp~Ni 155 (303)
T cd05088 79 HRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNI 155 (303)
T ss_pred CCCCceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHH---hCCccccccchheE
Confidence 3567899999999999999987532 1234789999999999999999999 89999999999999
Q ss_pred EEcCCCCeEEeeecceeecccCCCCcccccccccccCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCC
Q 044494 69 LLNLELEAFVADFGVARLLNFDSSNRTLLAGTYGYIAPELAYTMVVTEKSDVYSFGVVALEVLM-GKHPGELLS 141 (144)
Q Consensus 69 ~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~d~~slg~~l~~~~~-g~~p~~~~~ 141 (144)
+++.++.++++|||++...... ........+..|++||......++.++|+||+|++++++++ |..||...+
T Consensus 156 li~~~~~~kl~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~ 228 (303)
T cd05088 156 LVGENYVAKIADFGLSRGQEVY-VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT 228 (303)
T ss_pred EecCCCcEEeCccccCcccchh-hhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCC
Confidence 9999999999999988643211 11111223567999999988888899999999999999998 999997543
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1e-28 Score=174.93 Aligned_cols=135 Identities=27% Similarity=0.407 Sum_probs=119.6
Q ss_pred CceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEc-CCCCeEEeee
Q 044494 3 RKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLN-LELEAFVADF 81 (144)
Q Consensus 3 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~-~~~~~~l~d~ 81 (144)
+.++|||.|.=.+|+|++|+.++.. ++.+..+..+.+||+.|+.|+| +.+++|||+||+|+++. .-|-+|+.||
T Consensus 89 QTKlyLiLELGD~GDl~DyImKHe~--Gl~E~La~kYF~QI~~AI~YCH---qLHVVHRDLKPENVVFFEKlGlVKLTDF 163 (864)
T KOG4717|consen 89 QTKLYLILELGDGGDLFDYIMKHEE--GLNEDLAKKYFAQIVHAISYCH---QLHVVHRDLKPENVVFFEKLGLVKLTDF 163 (864)
T ss_pred cceEEEEEEecCCchHHHHHHhhhc--cccHHHHHHHHHHHHHHHHHHh---hhhhhcccCCcceeEEeeecCceEeeec
Confidence 4578999999999999999987554 4999999999999999999999 77899999999998775 5688999999
Q ss_pred cceeecccCCCCcccccccccccCccccccCCCC-CcchhHHHHHHHHHHHhCCCCCCCCCCC
Q 044494 82 GVARLLNFDSSNRTLLAGTYGYIAPELAYTMVVT-EKSDVYSFGVVALEVLMGKHPGELLSSS 143 (144)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~-~~~d~~slg~~l~~~~~g~~p~~~~~~~ 143 (144)
|++..+. +.+...+.+|+..|-|||++.+..|+ +..||||||+|+|.++.|+.||+.-+++
T Consensus 164 GFSNkf~-PG~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDS 225 (864)
T KOG4717|consen 164 GFSNKFQ-PGKKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDS 225 (864)
T ss_pred cccccCC-CcchhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccch
Confidence 9998876 45667778999999999999999886 6899999999999999999999875543
|
|
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.1e-28 Score=166.59 Aligned_cols=137 Identities=26% Similarity=0.353 Sum_probs=111.8
Q ss_pred CCceEEEEEeeccCCCHHHHhhcccc-------cCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCC
Q 044494 2 HRKCMFLIYEYMEMGSLFCVLRTDEE-------AVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLEL 74 (144)
Q Consensus 2 ~~~~~~lv~e~~~~~~L~~~l~~~~~-------~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~ 74 (144)
.++..++||||+++++|.++++.... ...++...+..++.|++.++.+|| +.+++|+|+||+||+++.++
T Consensus 80 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~~vH~dlkp~Nil~~~~~ 156 (277)
T cd05062 80 QGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDF 156 (277)
T ss_pred CCCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCcchheEEEcCCC
Confidence 35678999999999999999865321 123577888899999999999999 88999999999999999999
Q ss_pred CeEEeeecceeecccCCCC--cccccccccccCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCC
Q 044494 75 EAFVADFGVARLLNFDSSN--RTLLAGTYGYIAPELAYTMVVTEKSDVYSFGVVALEVLM-GKHPGELLS 141 (144)
Q Consensus 75 ~~~l~d~~~~~~~~~~~~~--~~~~~~~~~~~~pe~~~~~~~~~~~d~~slg~~l~~~~~-g~~p~~~~~ 141 (144)
.++++|||++......... .....+++.|+|||.+....++.++|+||+|++++++++ |..||...+
T Consensus 157 ~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~ 226 (277)
T cd05062 157 TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMS 226 (277)
T ss_pred CEEECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCC
Confidence 9999999988754321111 111234678999999988888999999999999999998 788987654
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=3e-28 Score=164.15 Aligned_cols=133 Identities=27% Similarity=0.400 Sum_probs=112.7
Q ss_pred CceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeeec
Q 044494 3 RKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADFG 82 (144)
Q Consensus 3 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~~ 82 (144)
.+..++||||+++++|.+++.... .+++..+..++.|++.++++|| ..+++|+||+|+|++++.++.++++|||
T Consensus 67 ~~~~~~v~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lh---~~~i~H~di~p~nili~~~~~~kl~df~ 140 (257)
T cd05060 67 GEPLMLVMELAPLGPLLKYLKKRR---EIPVSDLKELAHQVAMGMAYLE---SKHFVHRDLAARNVLLVNRHQAKISDFG 140 (257)
T ss_pred CCceEEEEEeCCCCcHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHh---hcCeeccCcccceEEEcCCCcEEecccc
Confidence 456799999999999999997644 3899999999999999999999 8899999999999999999999999999
Q ss_pred ceeecccCCCCc---ccccccccccCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCC
Q 044494 83 VARLLNFDSSNR---TLLAGTYGYIAPELAYTMVVTEKSDVYSFGVVALEVLM-GKHPGELLS 141 (144)
Q Consensus 83 ~~~~~~~~~~~~---~~~~~~~~~~~pe~~~~~~~~~~~d~~slg~~l~~~~~-g~~p~~~~~ 141 (144)
.++......... ....++..|++||......++.++|+||+|++++++++ |..||+..+
T Consensus 141 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~ 203 (257)
T cd05060 141 MSRALGAGSDYYRATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMK 203 (257)
T ss_pred ccceeecCCcccccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCC
Confidence 988654322211 11123457999999988889999999999999999998 999997654
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.6e-28 Score=167.70 Aligned_cols=135 Identities=29% Similarity=0.438 Sum_probs=110.6
Q ss_pred CceEEEEEeeccCCCHHHHhhccc-------------ccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEE
Q 044494 3 RKCMFLIYEYMEMGSLFCVLRTDE-------------EAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNIL 69 (144)
Q Consensus 3 ~~~~~lv~e~~~~~~L~~~l~~~~-------------~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~ 69 (144)
+..+|+++||+++++|.+++++.. ....+++..+..++.|++.|+++|| +.|++|+||||+||+
T Consensus 75 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH---~~~ivH~dlkp~Nil 151 (297)
T cd05089 75 RGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLS---EKQFIHRDLAARNVL 151 (297)
T ss_pred CCcceEEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCcCCcceEE
Confidence 456899999999999999986532 1124788999999999999999999 899999999999999
Q ss_pred EcCCCCeEEeeecceeecccCCCCcccccccccccCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCC
Q 044494 70 LNLELEAFVADFGVARLLNFDSSNRTLLAGTYGYIAPELAYTMVVTEKSDVYSFGVVALEVLM-GKHPGELLS 141 (144)
Q Consensus 70 ~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~d~~slg~~l~~~~~-g~~p~~~~~ 141 (144)
++.++.++++|||++....... .......+..|++||......++.++|+||+|+++++|++ |..||...+
T Consensus 152 l~~~~~~kl~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~ 223 (297)
T cd05089 152 VGENLASKIADFGLSRGEEVYV-KKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMT 223 (297)
T ss_pred ECCCCeEEECCcCCCcccccee-ccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCC
Confidence 9999999999999886432111 1111223456999999988888999999999999999997 999997643
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.7e-28 Score=163.93 Aligned_cols=135 Identities=31% Similarity=0.467 Sum_probs=116.5
Q ss_pred CCceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeee
Q 044494 2 HRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADF 81 (144)
Q Consensus 2 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~ 81 (144)
.++.+|+++||+.+++|.+++.... ..+++..+..++.|++.++.+|| +.+++|+|++|.||+++.++.++++||
T Consensus 69 ~~~~~~l~~e~~~~~~L~~~l~~~~--~~l~~~~~~~~~~~l~~~l~~lh---~~~i~H~dl~~~ni~~~~~~~~~l~df 143 (256)
T cd06612 69 KNTDLWIVMEYCGAGSVSDIMKITN--KTLTEEEIAAILYQTLKGLEYLH---SNKKIHRDIKAGNILLNEEGQAKLADF 143 (256)
T ss_pred cCCcEEEEEecCCCCcHHHHHHhCc--cCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCcceEEECCCCcEEEccc
Confidence 3567899999999999999986432 34899999999999999999999 889999999999999999999999999
Q ss_pred cceeecccCCCCcccccccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCC
Q 044494 82 GVARLLNFDSSNRTLLAGTYGYIAPELAYTMVVTEKSDVYSFGVVALEVLMGKHPGELLS 141 (144)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~d~~slg~~l~~~~~g~~p~~~~~ 141 (144)
|.+..............++..|++||.+.+..++.++|+||+|++++++++|..||+..+
T Consensus 144 g~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~ 203 (256)
T cd06612 144 GVSGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIH 203 (256)
T ss_pred ccchhcccCccccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcc
Confidence 998865533323334557889999999988888999999999999999999999997654
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.8e-28 Score=163.52 Aligned_cols=131 Identities=27% Similarity=0.409 Sum_probs=111.5
Q ss_pred CceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeeec
Q 044494 3 RKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADFG 82 (144)
Q Consensus 3 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~~ 82 (144)
++..+++|||+++++|.++++.... ..+++..+..++.|++.++++|| +++++|+||+|+||+++.++.++++|||
T Consensus 72 ~~~~~lv~e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~nil~~~~~~~kl~dfg 147 (256)
T cd05082 72 KGGLYIVTEYMAKGSLVDYLRSRGR-SVLGGDCLLKFSLDVCEAMEYLE---ANNFVHRDLAARNVLVSEDNVAKVSDFG 147 (256)
T ss_pred CCceEEEEECCCCCcHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHH---hCCEeccccchheEEEcCCCcEEecCCc
Confidence 4568999999999999999875332 33788999999999999999999 8999999999999999999999999999
Q ss_pred ceeecccCCCCcccccccccccCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCC
Q 044494 83 VARLLNFDSSNRTLLAGTYGYIAPELAYTMVVTEKSDVYSFGVVALEVLM-GKHPGELL 140 (144)
Q Consensus 83 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~d~~slg~~l~~~~~-g~~p~~~~ 140 (144)
++....... .....+..|+|||......++.++|+||+|+++|++++ |..||...
T Consensus 148 ~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~ 203 (256)
T cd05082 148 LTKEASSTQ---DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRI 203 (256)
T ss_pred cceeccccC---CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCC
Confidence 887543221 22334567999999988888899999999999999997 99998653
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.2e-28 Score=164.17 Aligned_cols=135 Identities=34% Similarity=0.500 Sum_probs=114.2
Q ss_pred CceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeeec
Q 044494 3 RKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADFG 82 (144)
Q Consensus 3 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~~ 82 (144)
.+..++||||+++++|.+++.... ...+++..+..++.|++.++.+|| +.+++|+||+|+||+++.++.++++|||
T Consensus 74 ~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~al~~lH---~~~i~h~dl~~~nilv~~~~~~kl~d~g 149 (261)
T cd05148 74 GEPVYIITELMEKGSLLAFLRSPE-GQVLPVASLIDMACQVAEGMAYLE---EQNSIHRDLAARNILVGEDLVCKVADFG 149 (261)
T ss_pred CCCeEEEEeecccCCHHHHHhcCC-CCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccccCcceEEEcCCceEEEcccc
Confidence 456799999999999999997633 234889999999999999999999 8999999999999999999999999999
Q ss_pred ceeecccCCCCcccccccccccCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCC
Q 044494 83 VARLLNFDSSNRTLLAGTYGYIAPELAYTMVVTEKSDVYSFGVVALEVLM-GKHPGELLS 141 (144)
Q Consensus 83 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~d~~slg~~l~~~~~-g~~p~~~~~ 141 (144)
.+..............++..|++||......++.++|+||+|++++++++ |..||...+
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~ 209 (261)
T cd05148 150 LARLIKEDVYLSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMN 209 (261)
T ss_pred chhhcCCccccccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCC
Confidence 98765432222223345667999999988888899999999999999998 899997654
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.1e-28 Score=165.87 Aligned_cols=133 Identities=27% Similarity=0.421 Sum_probs=111.7
Q ss_pred ceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeeecc
Q 044494 4 KCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADFGV 83 (144)
Q Consensus 4 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~~~ 83 (144)
...++++||+++|+|.++++... ..+++..+..++.|++.|+.+|| +++++|+||||+||+++.++.++++|||+
T Consensus 81 ~~~~l~~~~~~~g~l~~~l~~~~--~~~~~~~~~~~~~qi~~~L~~lH---~~~iiH~dlkp~Nil~~~~~~~kL~dfG~ 155 (279)
T cd05109 81 STVQLVTQLMPYGCLLDYVRENK--DRIGSQDLLNWCVQIAKGMSYLE---EVRLVHRDLAARNVLVKSPNHVKITDFGL 155 (279)
T ss_pred CCcEEEEEcCCCCCHHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHH---HCCeeccccccceEEEcCCCcEEECCCCc
Confidence 34679999999999999987532 23899999999999999999999 89999999999999999999999999999
Q ss_pred eeecccCCCC--cccccccccccCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCC
Q 044494 84 ARLLNFDSSN--RTLLAGTYGYIAPELAYTMVVTEKSDVYSFGVVALEVLM-GKHPGELLS 141 (144)
Q Consensus 84 ~~~~~~~~~~--~~~~~~~~~~~~pe~~~~~~~~~~~d~~slg~~l~~~~~-g~~p~~~~~ 141 (144)
++........ .....+++.|++||...+..++.++|+||+|+++||+++ |..||+..+
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~ 216 (279)
T cd05109 156 ARLLDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIP 216 (279)
T ss_pred eeecccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCC
Confidence 9865432221 111234567999999988888999999999999999998 999997643
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.4e-28 Score=169.27 Aligned_cols=133 Identities=26% Similarity=0.429 Sum_probs=112.1
Q ss_pred ceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeeecc
Q 044494 4 KCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADFGV 83 (144)
Q Consensus 4 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~~~ 83 (144)
...++++||+++|+|.+++..... .+++..+..++.|++.||+||| +++++|+||||+||+++.++.++++|||+
T Consensus 81 ~~~~~v~e~~~~g~l~~~l~~~~~--~~~~~~~~~~~~qi~~~L~~LH---~~~iiH~dlkp~Nill~~~~~~kl~DfG~ 155 (316)
T cd05108 81 STVQLITQLMPFGCLLDYVREHKD--NIGSQYLLNWCVQIAKGMNYLE---ERRLVHRDLAARNVLVKTPQHVKITDFGL 155 (316)
T ss_pred CCceeeeecCCCCCHHHHHHhccc--cCCHHHHHHHHHHHHHHHHHHH---hcCeeccccchhheEecCCCcEEEccccc
Confidence 456799999999999999875332 3788899999999999999999 89999999999999999999999999999
Q ss_pred eeecccCCCC--cccccccccccCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCC
Q 044494 84 ARLLNFDSSN--RTLLAGTYGYIAPELAYTMVVTEKSDVYSFGVVALEVLM-GKHPGELLS 141 (144)
Q Consensus 84 ~~~~~~~~~~--~~~~~~~~~~~~pe~~~~~~~~~~~d~~slg~~l~~~~~-g~~p~~~~~ 141 (144)
++........ ......+..|++||.+....++.++|+||+|+++|++++ |..||++.+
T Consensus 156 a~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~ 216 (316)
T cd05108 156 AKLLGADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIP 216 (316)
T ss_pred cccccCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCC
Confidence 9865432221 112234567999999998889999999999999999998 999998754
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.7e-28 Score=169.25 Aligned_cols=108 Identities=29% Similarity=0.432 Sum_probs=92.7
Q ss_pred CCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeeecceeecccCCC--CcccccccccccCcc
Q 044494 30 GLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADFGVARLLNFDSS--NRTLLAGTYGYIAPE 107 (144)
Q Consensus 30 ~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~~~~~~~pe 107 (144)
.+++..+..++.|++.++.+|| +.+++||||||.||+++.++.++|+|||++........ ......++..|+|||
T Consensus 169 ~l~~~~~~~~~~qi~~aL~~lH---~~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE 245 (337)
T cd05054 169 PLTLEDLISYSFQVARGMEFLA---SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPE 245 (337)
T ss_pred CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCccccCcH
Confidence 4788999999999999999999 89999999999999999999999999999986532221 122234566899999
Q ss_pred ccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCC
Q 044494 108 LAYTMVVTEKSDVYSFGVVALEVLM-GKHPGELL 140 (144)
Q Consensus 108 ~~~~~~~~~~~d~~slg~~l~~~~~-g~~p~~~~ 140 (144)
.+....++.++|+||+|++++++++ |..||...
T Consensus 246 ~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~ 279 (337)
T cd05054 246 SIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGV 279 (337)
T ss_pred HhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCC
Confidence 9999999999999999999999998 99999653
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.6e-28 Score=163.76 Aligned_cols=135 Identities=27% Similarity=0.384 Sum_probs=112.5
Q ss_pred CceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeeec
Q 044494 3 RKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADFG 82 (144)
Q Consensus 3 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~~ 82 (144)
++.++++|||+++++|.+++.... ...+++..+..++.|++.++.+|| +.+++|+||+|+||+++.++.++++|||
T Consensus 74 ~~~~~lv~e~~~~~~L~~~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lH---~~~i~H~dlkp~nil~~~~~~~kl~df~ 149 (263)
T cd05052 74 EPPFYIITEFMTYGNLLDYLRECN-RQEVNAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFG 149 (263)
T ss_pred CCCcEEEEEeCCCCcHHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHH---hCCEeecccCcceEEEcCCCcEEeCCCc
Confidence 567899999999999999987533 234888999999999999999999 8999999999999999999999999999
Q ss_pred ceeecccCCCC-cccccccccccCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCC
Q 044494 83 VARLLNFDSSN-RTLLAGTYGYIAPELAYTMVVTEKSDVYSFGVVALEVLM-GKHPGELLS 141 (144)
Q Consensus 83 ~~~~~~~~~~~-~~~~~~~~~~~~pe~~~~~~~~~~~d~~slg~~l~~~~~-g~~p~~~~~ 141 (144)
.+......... ......+..|++||.+.+..++.++|+||+|+++++|++ |..||...+
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~ 210 (263)
T cd05052 150 LSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID 210 (263)
T ss_pred cccccccceeeccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCC
Confidence 98765432211 111223567999999988888999999999999999998 999987643
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.4e-28 Score=166.05 Aligned_cols=136 Identities=27% Similarity=0.350 Sum_probs=113.1
Q ss_pred CceEEEEEeeccCCCHHHHhhcc-cccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeee
Q 044494 3 RKCMFLIYEYMEMGSLFCVLRTD-EEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADF 81 (144)
Q Consensus 3 ~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~ 81 (144)
++.+++||||+++++|.+++... .....+++..+..++.|++.++.+|| +.+++|+|++|+||+++.++.++++||
T Consensus 92 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~nili~~~~~~kl~df 168 (286)
T cd06638 92 GDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLH---VNKTIHRDVKGNNILLTTEGGVKLVDF 168 (286)
T ss_pred CCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHH---hCCccccCCCHHhEEECCCCCEEEccC
Confidence 35689999999999999987532 12234888999999999999999999 899999999999999999999999999
Q ss_pred cceeecccCCCCcccccccccccCcccccc-----CCCCCcchhHHHHHHHHHHHhCCCCCCCCC
Q 044494 82 GVARLLNFDSSNRTLLAGTYGYIAPELAYT-----MVVTEKSDVYSFGVVALEVLMGKHPGELLS 141 (144)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~-----~~~~~~~d~~slg~~l~~~~~g~~p~~~~~ 141 (144)
|.+..............+++.|+|||.+.. ..++.++|+||+|++++++++|..||...+
T Consensus 169 g~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~ 233 (286)
T cd06638 169 GVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLH 233 (286)
T ss_pred CceeecccCCCccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCc
Confidence 998765433323334568889999998753 346789999999999999999999987643
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.2e-30 Score=198.64 Aligned_cols=136 Identities=33% Similarity=0.453 Sum_probs=117.0
Q ss_pred CCCceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEee
Q 044494 1 LHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVAD 80 (144)
Q Consensus 1 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d 80 (144)
||++.+++.||||.+|+|.+.++.... .++....-+..|++.|+.||| ..||+||||||.||+++.+|.+|+.|
T Consensus 1304 vHRekv~IFMEyC~~GsLa~ll~~gri---~dE~vt~vyt~qll~gla~LH---~~gIVHRDIK~aNI~Ld~~g~iK~~D 1377 (1509)
T KOG4645|consen 1304 VHREKVYIFMEYCEGGSLASLLEHGRI---EDEMVTRVYTKQLLEGLAYLH---EHGIVHRDIKPANILLDFNGLIKYGD 1377 (1509)
T ss_pred ecHHHHHHHHHHhccCcHHHHHHhcch---hhhhHHHHHHHHHHHHHHHHH---hcCceecCCCccceeeecCCcEEeec
Confidence 688999999999999999999875433 666666677899999999999 99999999999999999999999999
Q ss_pred ecceeecccCC----CCcccccccccccCccccccCC---CCCcchhHHHHHHHHHHHhCCCCCCCCCC
Q 044494 81 FGVARLLNFDS----SNRTLLAGTYGYIAPELAYTMV---VTEKSDVYSFGVVALEVLMGKHPGELLSS 142 (144)
Q Consensus 81 ~~~~~~~~~~~----~~~~~~~~~~~~~~pe~~~~~~---~~~~~d~~slg~~l~~~~~g~~p~~~~~~ 142 (144)
||.+.....+. .......||+.|||||++-+.. ...+.||||+||++.||+||+.||..+|+
T Consensus 1378 FGsa~ki~~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dn 1446 (1509)
T KOG4645|consen 1378 FGSAVKIKNNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDN 1446 (1509)
T ss_pred ccceeEecCchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccc
Confidence 99998776442 2234467999999999987653 45679999999999999999999998775
|
|
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.1e-28 Score=165.58 Aligned_cols=130 Identities=28% Similarity=0.366 Sum_probs=110.6
Q ss_pred ceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeeecc
Q 044494 4 KCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADFGV 83 (144)
Q Consensus 4 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~~~ 83 (144)
+.+++||||+++++|.+++... .+++..+..++.|++.++.+|| +.+++|+||||+||+++.++.++++|||+
T Consensus 81 ~~~~lv~e~~~~~~l~~~~~~~----~l~~~~~~~i~~~l~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~~l~dfg~ 153 (283)
T cd05080 81 KGLQLIMEYVPLGSLRDYLPKH----KLNLAQLLLFAQQICEGMAYLH---SQHYIHRDLAARNVLLDNDRLVKIGDFGL 153 (283)
T ss_pred ceEEEEecCCCCCCHHHHHHHc----CCCHHHHHHHHHHHHHHHHHHH---HCCeeccccChheEEEcCCCcEEEeeccc
Confidence 4589999999999999998753 2899999999999999999999 89999999999999999999999999999
Q ss_pred eeecccCCCC---cccccccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCC
Q 044494 84 ARLLNFDSSN---RTLLAGTYGYIAPELAYTMVVTEKSDVYSFGVVALEVLMGKHPGELL 140 (144)
Q Consensus 84 ~~~~~~~~~~---~~~~~~~~~~~~pe~~~~~~~~~~~d~~slg~~l~~~~~g~~p~~~~ 140 (144)
+......... .....++..|++||......++.++|+||+|+++++|++|..||...
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~ 213 (283)
T cd05080 154 AKAVPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSP 213 (283)
T ss_pred ccccCCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCC
Confidence 8765432211 11123455789999998888899999999999999999999998654
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.8e-28 Score=162.50 Aligned_cols=135 Identities=26% Similarity=0.373 Sum_probs=116.8
Q ss_pred CCceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeee
Q 044494 2 HRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADF 81 (144)
Q Consensus 2 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~ 81 (144)
.++.++++|||+++++|.+++.+.. ...+++..+..++.|++.++.+|| +.+++|+|++|+||+++.++.++++||
T Consensus 70 ~~~~~~~~~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~dl~p~ni~~~~~~~~kl~d~ 145 (256)
T cd08221 70 DDNTLLIEMEYANGGTLYDKIVRQK-GQLFEEEMVLWYLFQIVSAVSYIH---KAGILHRDIKTLNIFLTKAGLIKLGDF 145 (256)
T ss_pred cCCeEEEEEEecCCCcHHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHH---hCCccccCCChHhEEEeCCCCEEECcC
Confidence 3567899999999999999987542 234899999999999999999999 889999999999999999999999999
Q ss_pred cceeecccCCCCcccccccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCC
Q 044494 82 GVARLLNFDSSNRTLLAGTYGYIAPELAYTMVVTEKSDVYSFGVVALEVLMGKHPGELL 140 (144)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~d~~slg~~l~~~~~g~~p~~~~ 140 (144)
|.+..............+++.|++||...+..++.++|+||+|+++++|++|..||+..
T Consensus 146 ~~~~~~~~~~~~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~ 204 (256)
T cd08221 146 GISKILGSEYSMAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDAT 204 (256)
T ss_pred cceEEcccccccccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCC
Confidence 99886654332334456888999999998888888999999999999999999999764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.5e-28 Score=167.67 Aligned_cols=134 Identities=24% Similarity=0.389 Sum_probs=108.2
Q ss_pred CceEEEEEeeccCCCHHHHhhcc------cccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEE----cC
Q 044494 3 RKCMFLIYEYMEMGSLFCVLRTD------EEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILL----NL 72 (144)
Q Consensus 3 ~~~~~lv~e~~~~~~L~~~l~~~------~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~----~~ 72 (144)
+..+++|+||+.+ +|.+++... .....+++..+..++.|++.||.+|| +.+++|+||||+||++ +.
T Consensus 72 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH---~~~ivH~Dlkp~Nil~~~~~~~ 147 (317)
T cd07867 72 DRKVWLLFDYAEH-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLH---ANWVLHRDLKPANILVMGEGPE 147 (317)
T ss_pred CCeEEEEEeeeCC-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHH---hCCEEcCCCCHHHEEEccCCCC
Confidence 4578999999864 888776431 12234888999999999999999999 8999999999999999 45
Q ss_pred CCCeEEeeecceeecccCCC---CcccccccccccCccccccC-CCCCcchhHHHHHHHHHHHhCCCCCCCC
Q 044494 73 ELEAFVADFGVARLLNFDSS---NRTLLAGTYGYIAPELAYTM-VVTEKSDVYSFGVVALEVLMGKHPGELL 140 (144)
Q Consensus 73 ~~~~~l~d~~~~~~~~~~~~---~~~~~~~~~~~~~pe~~~~~-~~~~~~d~~slg~~l~~~~~g~~p~~~~ 140 (144)
.+.++|+|||+++....... ......+++.|+|||.+.+. .++.++|+||+|+++++|++|..||...
T Consensus 148 ~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~ 219 (317)
T cd07867 148 RGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 219 (317)
T ss_pred CCcEEEeeccceeccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccc
Confidence 67899999999986543221 12234678899999998764 4788999999999999999999999754
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.6e-28 Score=165.79 Aligned_cols=133 Identities=26% Similarity=0.337 Sum_probs=112.1
Q ss_pred CceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeeec
Q 044494 3 RKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADFG 82 (144)
Q Consensus 3 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~~ 82 (144)
.+.+++||||++++.|..+..... .+++..+..++.|++.++.+|| +.+++|+||+|+||+++.++.++++|||
T Consensus 72 ~~~~~~v~e~~~~~~l~~~~~~~~---~~~~~~~~~~~~ql~~~l~~LH---~~~i~H~dl~p~nil~~~~~~~~l~dfg 145 (286)
T cd07847 72 KRKLHLVFEYCDHTVLNELEKNPR---GVPEHLIKKIIWQTLQAVNFCH---KHNCIHRDVKPENILITKQGQIKLCDFG 145 (286)
T ss_pred CCEEEEEEeccCccHHHHHHhCCC---CCCHHHHHHHHHHHHHHHHHHH---HCCceecCCChhhEEEcCCCcEEECccc
Confidence 457899999999888877665433 3899999999999999999999 8999999999999999999999999999
Q ss_pred ceeecccCCCCcccccccccccCcccccc-CCCCCcchhHHHHHHHHHHHhCCCCCCCCC
Q 044494 83 VARLLNFDSSNRTLLAGTYGYIAPELAYT-MVVTEKSDVYSFGVVALEVLMGKHPGELLS 141 (144)
Q Consensus 83 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~-~~~~~~~d~~slg~~l~~~~~g~~p~~~~~ 141 (144)
++..............++..|++||.+.+ ..++.++|+||+|++++++++|..||.+.+
T Consensus 146 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~ 205 (286)
T cd07847 146 FARILTGPGDDYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKS 205 (286)
T ss_pred cceecCCCcccccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCC
Confidence 99876543323333456788999999875 456789999999999999999999997644
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.6e-29 Score=159.28 Aligned_cols=136 Identities=29% Similarity=0.397 Sum_probs=112.5
Q ss_pred CCceEEEEEeeccCCCHHHHhhc-ccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEee
Q 044494 2 HRKCMFLIYEYMEMGSLFCVLRT-DEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVAD 80 (144)
Q Consensus 2 ~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d 80 (144)
....+++.||.|. .||..+-++ -......++.-+-.++..+..|+.+||. ...++|||+||+||+++.+|++|+||
T Consensus 116 regdvwIcME~M~-tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~--kL~vIHRDvKPsNiLIn~~GqVKiCD 192 (282)
T KOG0984|consen 116 REGDVWICMELMD-TSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHS--KLSVIHRDVKPSNILINYDGQVKICD 192 (282)
T ss_pred ccccEEEeHHHhh-hhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHH--HhhhhhccCCcceEEEccCCcEEEcc
Confidence 3567899999996 588776544 1223448999999999999999999995 56899999999999999999999999
Q ss_pred ecceeecccCCCCcccccccccccCcccccc----CCCCCcchhHHHHHHHHHHHhCCCCCCCCC
Q 044494 81 FGVARLLNFDSSNRTLLAGTYGYIAPELAYT----MVVTEKSDVYSFGVVALEVLMGKHPGELLS 141 (144)
Q Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~----~~~~~~~d~~slg~~l~~~~~g~~p~~~~~ 141 (144)
||.+..... .-+.....|...|+|||.+.. ..|+.++|+||||+++.||.+++.||+.+.
T Consensus 193 FGIsG~L~d-SiAkt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~ 256 (282)
T KOG0984|consen 193 FGISGYLVD-SIAKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWG 256 (282)
T ss_pred cccceeehh-hhHHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccC
Confidence 999876552 223333568899999998773 368899999999999999999999998763
|
|
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.3e-28 Score=162.57 Aligned_cols=135 Identities=28% Similarity=0.452 Sum_probs=113.4
Q ss_pred CceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeeec
Q 044494 3 RKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADFG 82 (144)
Q Consensus 3 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~~ 82 (144)
++..|++|||+++++|.+++.... ...+++..+..++.|++.++.+|| +.+++|+||+|+||+++.++.++++|||
T Consensus 73 ~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~l~dfg 148 (261)
T cd05068 73 EEPIYIVTELMKYGSLLEYLQGGA-GRALKLPQLIDMAAQVASGMAYLE---AQNYIHRDLAARNVLVGENNICKVADFG 148 (261)
T ss_pred CCCeeeeeecccCCcHHHHHhccC-CCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCCcceEEEcCCCCEEECCcc
Confidence 567899999999999999987533 234899999999999999999999 8899999999999999999999999999
Q ss_pred ceeecccCCCC-cccccccccccCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCC
Q 044494 83 VARLLNFDSSN-RTLLAGTYGYIAPELAYTMVVTEKSDVYSFGVVALEVLM-GKHPGELLS 141 (144)
Q Consensus 83 ~~~~~~~~~~~-~~~~~~~~~~~~pe~~~~~~~~~~~d~~slg~~l~~~~~-g~~p~~~~~ 141 (144)
++......... ......+..|++||......++.++|+||+|++++++++ |..||...+
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~ 209 (261)
T cd05068 149 LARVIKEDIYEAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMT 209 (261)
T ss_pred eEEEccCCcccccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCC
Confidence 99876522111 111223457999999988888999999999999999999 999997654
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.4e-28 Score=171.89 Aligned_cols=130 Identities=28% Similarity=0.354 Sum_probs=109.5
Q ss_pred eEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeeecce
Q 044494 5 CMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADFGVA 84 (144)
Q Consensus 5 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~~~~ 84 (144)
.+|+||||+. ++|.+.+.... .+++..+..++.|++.||.||| +.+++||||||+||+++.++.++++|||++
T Consensus 78 ~~~lv~e~~~-~~l~~~~~~~~---~l~~~~~~~~~~qi~~aL~~LH---~~~ivH~dlkp~Nili~~~~~~kL~Dfg~a 150 (372)
T cd07853 78 EIYVVTELMQ-SDLHKIIVSPQ---PLSSDHVKVFLYQILRGLKYLH---SAGILHRDIKPGNLLVNSNCVLKICDFGLA 150 (372)
T ss_pred eEEEEeeccc-cCHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChHHEEECCCCCEEeccccce
Confidence 6899999996 57888776433 3899999999999999999999 899999999999999999999999999999
Q ss_pred eecccCCC-CcccccccccccCccccccC-CCCCcchhHHHHHHHHHHHhCCCCCCCCC
Q 044494 85 RLLNFDSS-NRTLLAGTYGYIAPELAYTM-VVTEKSDVYSFGVVALEVLMGKHPGELLS 141 (144)
Q Consensus 85 ~~~~~~~~-~~~~~~~~~~~~~pe~~~~~-~~~~~~d~~slg~~l~~~~~g~~p~~~~~ 141 (144)
........ ......+++.|+|||.+.+. .++.++|+||+|+++++|++|..||...+
T Consensus 151 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~ 209 (372)
T cd07853 151 RVEEPDESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQS 209 (372)
T ss_pred eecccCccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCC
Confidence 86542221 12234578899999998764 46889999999999999999999997654
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.9e-28 Score=164.90 Aligned_cols=134 Identities=31% Similarity=0.488 Sum_probs=114.4
Q ss_pred CCceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeee
Q 044494 2 HRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADF 81 (144)
Q Consensus 2 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~ 81 (144)
+.+..++||||+++++|.+++..... +++..+..++.|++.++.+|| +.+++|+||+|+||+++.++.++++||
T Consensus 77 ~~~~~~lv~e~~~~~~L~~~l~~~~~---l~~~~~~~~~~~l~~~l~~lH---~~~ivH~di~p~nil~~~~~~~~l~df 150 (267)
T cd06628 77 DADHLNIFLEYVPGGSVAALLNNYGA---FEETLVRNFVRQILKGLNYLH---NRGIIHRDIKGANILVDNKGGIKISDF 150 (267)
T ss_pred eCCccEEEEEecCCCCHHHHHHhccC---ccHHHHHHHHHHHHHHHHHHH---hcCcccccCCHHHEEEcCCCCEEeccc
Confidence 35678999999999999999976433 788899999999999999999 889999999999999999999999999
Q ss_pred cceeecccCCC------CcccccccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCC
Q 044494 82 GVARLLNFDSS------NRTLLAGTYGYIAPELAYTMVVTEKSDVYSFGVVALEVLMGKHPGELLS 141 (144)
Q Consensus 82 ~~~~~~~~~~~------~~~~~~~~~~~~~pe~~~~~~~~~~~d~~slg~~l~~~~~g~~p~~~~~ 141 (144)
|.+........ ......++..|++||.+....++.++|+||+|++++++++|..||+..+
T Consensus 151 g~~~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~ 216 (267)
T cd06628 151 GISKKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCT 216 (267)
T ss_pred CCCcccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCcc
Confidence 98876642111 1122357788999999988888889999999999999999999997643
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.4e-28 Score=162.84 Aligned_cols=135 Identities=24% Similarity=0.383 Sum_probs=111.3
Q ss_pred CCceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeee
Q 044494 2 HRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADF 81 (144)
Q Consensus 2 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~ 81 (144)
.++..|+||||+++++|.+++.... ..+++..++.++.|++.++.||| +.+++|+|++|.||+++.++.++++||
T Consensus 64 ~~~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~dl~p~nil~~~~~~~kl~df 138 (252)
T cd05084 64 QKQPIYIVMELVQGGDFLTFLRTEG--PRLKVKELIQMVENAAAGMEYLE---SKHCIHRDLAARNCLVTEKNVLKISDF 138 (252)
T ss_pred CCCCeEEEEeeccCCcHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHH---hCCccccccchheEEEcCCCcEEECcc
Confidence 3567899999999999999987532 23789999999999999999999 899999999999999999999999999
Q ss_pred cceeecccCCCC--cccccccccccCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCC
Q 044494 82 GVARLLNFDSSN--RTLLAGTYGYIAPELAYTMVVTEKSDVYSFGVVALEVLM-GKHPGELLS 141 (144)
Q Consensus 82 ~~~~~~~~~~~~--~~~~~~~~~~~~pe~~~~~~~~~~~d~~slg~~l~~~~~-g~~p~~~~~ 141 (144)
|++......... ......+..|+|||.+....++.++|+||+|++++++++ |..||...+
T Consensus 139 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~ 201 (252)
T cd05084 139 GMSREEEDGVYASTGGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLS 201 (252)
T ss_pred ccCcccccccccccCCCCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccC
Confidence 998754321111 111123456999999988888999999999999999997 999997654
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.5e-28 Score=164.05 Aligned_cols=133 Identities=29% Similarity=0.377 Sum_probs=113.4
Q ss_pred CceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeeec
Q 044494 3 RKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADFG 82 (144)
Q Consensus 3 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~~ 82 (144)
++.+++++||+++++|.+++..... +++...+.++.|++.++++|| +.+++|+|++|+||+++.++.++++|||
T Consensus 78 ~~~~~l~~e~~~~~~L~~~l~~~~~---l~~~~~~~~~~qi~~~l~~LH---~~~i~H~~l~p~nil~~~~~~~~l~dfg 151 (266)
T cd06651 78 EKTLTIFMEYMPGGSVKDQLKAYGA---LTESVTRKYTRQILEGMSYLH---SNMIVHRDIKGANILRDSAGNVKLGDFG 151 (266)
T ss_pred CCEEEEEEeCCCCCcHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEECCCCCEEEccCC
Confidence 3578899999999999999875433 788999999999999999999 8999999999999999999999999999
Q ss_pred ceeecccCC---CCcccccccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCC
Q 044494 83 VARLLNFDS---SNRTLLAGTYGYIAPELAYTMVVTEKSDVYSFGVVALEVLMGKHPGELLS 141 (144)
Q Consensus 83 ~~~~~~~~~---~~~~~~~~~~~~~~pe~~~~~~~~~~~d~~slg~~l~~~~~g~~p~~~~~ 141 (144)
++....... .......++..|+|||.+.+..++.++|+||+|++++++++|..||...+
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~ 213 (266)
T cd06651 152 ASKRLQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYE 213 (266)
T ss_pred CccccccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccc
Confidence 987543211 11122447788999999998888999999999999999999999997653
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.1e-28 Score=167.13 Aligned_cols=131 Identities=30% Similarity=0.364 Sum_probs=113.0
Q ss_pred CCceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCC-CCeEecCCCCCcEEEcCCCCeEEee
Q 044494 2 HRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCT-PPIVHRDISSNNILLNLELEAFVAD 80 (144)
Q Consensus 2 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~-~~~~h~~i~~~ni~~~~~~~~~l~d 80 (144)
.++.+++||||+++++|.+++++... +++..+..++.|++.++.||| + .+++|+|++|.||+++.++.++++|
T Consensus 70 ~~~~~~lv~ey~~~~~L~~~l~~~~~---~~~~~~~~~~~~i~~~l~~lH---~~~~i~H~dl~p~nil~~~~~~~~l~d 143 (308)
T cd06615 70 SDGEISICMEHMDGGSLDQVLKKAGR---IPENILGKISIAVLRGLTYLR---EKHKIMHRDVKPSNILVNSRGEIKLCD 143 (308)
T ss_pred eCCEEEEEeeccCCCcHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHH---hhCCEEECCCChHHEEEecCCcEEEcc
Confidence 35788999999999999999976433 889999999999999999999 6 5899999999999999999999999
Q ss_pred ecceeecccCCCCcccccccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCC
Q 044494 81 FGVARLLNFDSSNRTLLAGTYGYIAPELAYTMVVTEKSDVYSFGVVALEVLMGKHPGELL 140 (144)
Q Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~d~~slg~~l~~~~~g~~p~~~~ 140 (144)
||++..... .......+++.|++||...+..++.++|+||+|++++++++|..||...
T Consensus 144 fg~~~~~~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~ 201 (308)
T cd06615 144 FGVSGQLID--SMANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPP 201 (308)
T ss_pred CCCcccccc--cccccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCc
Confidence 998865432 1223356788999999998888889999999999999999999998643
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.6e-29 Score=179.83 Aligned_cols=136 Identities=27% Similarity=0.383 Sum_probs=117.6
Q ss_pred CCceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeee
Q 044494 2 HRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADF 81 (144)
Q Consensus 2 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~ 81 (144)
++..+|+|||+|+||+|.++|++... .++..+...++.+.+.||+||| +++++||||..+|++++.++.+|++||
T Consensus 232 ~~~Pl~ivmEl~~gGsL~~~L~k~~~--~v~~~ek~~~~~~AA~Gl~YLh---~k~~IHRDIAARNcL~~~~~~vKISDF 306 (474)
T KOG0194|consen 232 LEEPLMLVMELCNGGSLDDYLKKNKK--SLPTLEKLRFCYDAARGLEYLH---SKNCIHRDIAARNCLYSKKGVVKISDF 306 (474)
T ss_pred CCCccEEEEEecCCCcHHHHHHhCCC--CCCHHHHHHHHHHHHhHHHHHH---HCCCcchhHhHHHheecCCCeEEeCcc
Confidence 56778999999999999999997543 3899999999999999999999 999999999999999999999999999
Q ss_pred cceeecccCCCCcccccccccccCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCC
Q 044494 82 GVARLLNFDSSNRTLLAGTYGYIAPELAYTMVVTEKSDVYSFGVVALEVLM-GKHPGELLSS 142 (144)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~d~~slg~~l~~~~~-g~~p~~~~~~ 142 (144)
|+++.-...............|+|||.++...++.++|+||+|+++||+++ |..||.++..
T Consensus 307 GLs~~~~~~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~ 368 (474)
T KOG0194|consen 307 GLSRAGSQYVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKN 368 (474)
T ss_pred ccccCCcceeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCH
Confidence 998754322222222345678999999999999999999999999999998 8999998763
|
|
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.4e-28 Score=166.50 Aligned_cols=129 Identities=23% Similarity=0.311 Sum_probs=106.5
Q ss_pred EEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeeeccee
Q 044494 6 MFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADFGVAR 85 (144)
Q Consensus 6 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~~~~~ 85 (144)
.++++|++. .++.+.+..... .++..+..++.|++.|+.+|| +.+++||||||+||+++.++.++++|||+++
T Consensus 102 ~~~~~~~~~-~~~~~~~~~~~~---~~~~~~~~i~~qi~~~l~~lH---~~~iiHrDiKp~Nill~~~~~~~l~DFGla~ 174 (294)
T PHA02882 102 RFILLEKLV-ENTKEIFKRIKC---KNKKLIKNIMKDMLTTLEYIH---EHGISHGDIKPENIMVDGNNRGYIIDYGIAS 174 (294)
T ss_pred EEEEEehhc-cCHHHHHHhhcc---CCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCcEEEEEcCCce
Confidence 367788774 366666654222 577888999999999999999 8999999999999999999999999999997
Q ss_pred ecccCC-------CCcccccccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCC
Q 044494 86 LLNFDS-------SNRTLLAGTYGYIAPELAYTMVVTEKSDVYSFGVVALEVLMGKHPGELLS 141 (144)
Q Consensus 86 ~~~~~~-------~~~~~~~~~~~~~~pe~~~~~~~~~~~d~~slg~~l~~~~~g~~p~~~~~ 141 (144)
...... .......+++.|+|||...+..++.++|+||+|++++++++|..||+..+
T Consensus 175 ~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~ 237 (294)
T PHA02882 175 HFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFG 237 (294)
T ss_pred eeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccc
Confidence 653211 11223468999999999999999999999999999999999999998764
|
|
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.3e-28 Score=165.74 Aligned_cols=135 Identities=27% Similarity=0.438 Sum_probs=113.6
Q ss_pred CCceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeee
Q 044494 2 HRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADF 81 (144)
Q Consensus 2 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~ 81 (144)
.+..+|+||||+++++|.+++.+.. ..+++..+..++.|++.++.+|| +.+++|+|++|+|++++.++.++++||
T Consensus 73 ~~~~~~lv~e~~~~~~L~~~~~~~~--~~l~~~~~~~~~~ql~~~l~~lh---~~~i~h~dl~p~nili~~~~~~~l~d~ 147 (280)
T cd06611 73 YENKLWILIEFCDGGALDSIMLELE--RGLTEPQIRYVCRQMLEALNFLH---SHKVIHRDLKAGNILLTLDGDVKLADF 147 (280)
T ss_pred cCCeEEEEeeccCCCcHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChhhEEECCCCCEEEccC
Confidence 3567899999999999999887533 23899999999999999999999 899999999999999999999999999
Q ss_pred cceeecccCCCCcccccccccccCccccc-----cCCCCCcchhHHHHHHHHHHHhCCCCCCCCC
Q 044494 82 GVARLLNFDSSNRTLLAGTYGYIAPELAY-----TMVVTEKSDVYSFGVVALEVLMGKHPGELLS 141 (144)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~-----~~~~~~~~d~~slg~~l~~~~~g~~p~~~~~ 141 (144)
|.+..............+++.|++||.+. ...++.++|+||+|+++|+|++|..||...+
T Consensus 148 g~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~ 212 (280)
T cd06611 148 GVSAKNKSTLQKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELN 212 (280)
T ss_pred ccchhhcccccccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCC
Confidence 98765543333333455788899999875 3346678999999999999999999997654
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.1e-28 Score=164.42 Aligned_cols=137 Identities=25% Similarity=0.331 Sum_probs=108.8
Q ss_pred CCceEEEEEeeccCCCHHHHhhcccc--cCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEe
Q 044494 2 HRKCMFLIYEYMEMGSLFCVLRTDEE--AVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVA 79 (144)
Q Consensus 2 ~~~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~ 79 (144)
+...+|+||||+++|+|.+++..... ....++..+..++.|++.|++||| +++++|+||||+||+++.++.++++
T Consensus 66 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nill~~~~~~kl~ 142 (269)
T cd05042 66 ESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLH---QADFIHSDLALRNCQLTADLSVKIG 142 (269)
T ss_pred CCCceEEEEEeCCCCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHH---hcCEecccccHhheEecCCCcEEEe
Confidence 35678999999999999999875322 223567788899999999999999 8999999999999999999999999
Q ss_pred eecceeecccCCC--CcccccccccccCcccccc-------CCCCCcchhHHHHHHHHHHHh-CCCCCCCCC
Q 044494 80 DFGVARLLNFDSS--NRTLLAGTYGYIAPELAYT-------MVVTEKSDVYSFGVVALEVLM-GKHPGELLS 141 (144)
Q Consensus 80 d~~~~~~~~~~~~--~~~~~~~~~~~~~pe~~~~-------~~~~~~~d~~slg~~l~~~~~-g~~p~~~~~ 141 (144)
|||++........ ......+++.|+|||+... ..++.++|+||+|++++++++ |..||....
T Consensus 143 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~ 214 (269)
T cd05042 143 DYGLALEQYPEDYYITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLS 214 (269)
T ss_pred ccccccccccchheeccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCC
Confidence 9998865432111 1122334567999998643 345778999999999999998 888987653
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.1e-30 Score=170.93 Aligned_cols=134 Identities=31% Similarity=0.468 Sum_probs=121.3
Q ss_pred CCceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeee
Q 044494 2 HRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADF 81 (144)
Q Consensus 2 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~ 81 (144)
.+..+|+|||||-.|+..+.++.++ +.+.+.++..++++.++||+||| ...-+|||||.-||++..+|..|++||
T Consensus 99 K~sDLWIVMEYCGAGSiSDI~R~R~--K~L~E~EIs~iL~~TLKGL~YLH---~~~KIHRDIKAGNILLNT~G~AKLADF 173 (502)
T KOG0574|consen 99 KHSDLWIVMEYCGAGSISDIMRARR--KPLSEQEISAVLRDTLKGLQYLH---DLKKIHRDIKAGNILLNTDGIAKLADF 173 (502)
T ss_pred cCCceEeehhhcCCCcHHHHHHHhc--CCccHHHHHHHHHHHHhHHHHHH---HHHHHHhhcccccEEEcccchhhhhhc
Confidence 4667899999999999999988544 45999999999999999999999 667899999999999999999999999
Q ss_pred cceeecccCCCCcccccccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCC
Q 044494 82 GVARLLNFDSSNRTLLAGTYGYIAPELAYTMVVTEKSDVYSFGVVALEVLMGKHPGELL 140 (144)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~d~~slg~~l~~~~~g~~p~~~~ 140 (144)
|.+...+.-.....+..|||.|||||++..-+|..++|+||||++..||..|++||...
T Consensus 174 GVAGQLTDTMAKRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDI 232 (502)
T KOG0574|consen 174 GVAGQLTDTMAKRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDI 232 (502)
T ss_pred cccchhhhhHHhhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccc
Confidence 99987765455567788999999999999999999999999999999999999999874
|
|
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.2e-28 Score=163.68 Aligned_cols=135 Identities=31% Similarity=0.473 Sum_probs=112.8
Q ss_pred CceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeeec
Q 044494 3 RKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADFG 82 (144)
Q Consensus 3 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~~ 82 (144)
.+..+++|||+++++|.+++.... ...++......++.|++.++++|| +.+++|+||+|+||+++.++.++++|||
T Consensus 73 ~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~~l~~~l~~LH---~~~i~H~dl~p~nili~~~~~~~l~dfg 148 (261)
T cd05072 73 EEPIYIITEYMAKGSLLDFLKSDE-GGKVLLPKLIDFSAQIAEGMAYIE---RKNYIHRDLRAANVLVSESLMCKIADFG 148 (261)
T ss_pred CCCcEEEEecCCCCcHHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccccchhhEEecCCCcEEECCCc
Confidence 466899999999999999987532 234788889999999999999999 8899999999999999999999999999
Q ss_pred ceeecccCCC-CcccccccccccCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCC
Q 044494 83 VARLLNFDSS-NRTLLAGTYGYIAPELAYTMVVTEKSDVYSFGVVALEVLM-GKHPGELLS 141 (144)
Q Consensus 83 ~~~~~~~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~d~~slg~~l~~~~~-g~~p~~~~~ 141 (144)
++........ ......++..|+|||......++.++|+||+|+++|++++ |..||...+
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~ 209 (261)
T cd05072 149 LARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMS 209 (261)
T ss_pred cceecCCCceeccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCC
Confidence 9986542211 1122334567999999988888899999999999999998 999997543
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=99.96 E-value=6e-28 Score=162.85 Aligned_cols=134 Identities=30% Similarity=0.453 Sum_probs=117.6
Q ss_pred CCceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCC-CCeEecCCCCCcEEEcCCCCeEEee
Q 044494 2 HRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCT-PPIVHRDISSNNILLNLELEAFVAD 80 (144)
Q Consensus 2 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~-~~~~h~~i~~~ni~~~~~~~~~l~d 80 (144)
+.+.+++||||+++++|.+++.... .+++..++.++.|++.++.+|| + .+++|+|++|+||+++.++.++++|
T Consensus 70 ~~~~~~lv~e~~~~~~L~~~l~~~~---~l~~~~~~~~~~~l~~~l~~lh---~~~~~~H~~l~~~ni~~~~~~~~~l~d 143 (264)
T cd06623 70 KEGEISIVLEYMDGGSLADLLKKVG---KIPEPVLAYIARQILKGLDYLH---TKRHIIHRDIKPSNLLINSKGEVKIAD 143 (264)
T ss_pred cCCeEEEEEEecCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHh---ccCCCccCCCCHHHEEECCCCCEEEcc
Confidence 4567899999999999999997643 3899999999999999999999 8 9999999999999999999999999
Q ss_pred ecceeecccCCCCcccccccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCC
Q 044494 81 FGVARLLNFDSSNRTLLAGTYGYIAPELAYTMVVTEKSDVYSFGVVALEVLMGKHPGELLS 141 (144)
Q Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~d~~slg~~l~~~~~g~~p~~~~~ 141 (144)
||.+..............++..|++||......++.++|+||+|++++++++|..||...+
T Consensus 144 f~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~ 204 (264)
T cd06623 144 FGISKVLENTLDQCNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPG 204 (264)
T ss_pred CccceecccCCCcccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccc
Confidence 9998876543333334567888999999998888899999999999999999999997764
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.1e-28 Score=165.08 Aligned_cols=136 Identities=25% Similarity=0.403 Sum_probs=112.3
Q ss_pred CceEEEEEeeccCCCHHHHhhcccc--------------cCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcE
Q 044494 3 RKCMFLIYEYMEMGSLFCVLRTDEE--------------AVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNI 68 (144)
Q Consensus 3 ~~~~~lv~e~~~~~~L~~~l~~~~~--------------~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni 68 (144)
++..|+||||+++++|.+++..... ...+++..+..++.|++.++.+|| +++++|+||||+||
T Consensus 79 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH---~~~i~H~dlkp~ni 155 (283)
T cd05090 79 EQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLS---SHFFVHKDLAARNI 155 (283)
T ss_pred CCceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHH---hcCeehhccccceE
Confidence 4678999999999999998853211 123788889999999999999999 89999999999999
Q ss_pred EEcCCCCeEEeeecceeecccCC--CCcccccccccccCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCC
Q 044494 69 LLNLELEAFVADFGVARLLNFDS--SNRTLLAGTYGYIAPELAYTMVVTEKSDVYSFGVVALEVLM-GKHPGELLS 141 (144)
Q Consensus 69 ~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~~~~~pe~~~~~~~~~~~d~~slg~~l~~~~~-g~~p~~~~~ 141 (144)
+++.++.++++|||++....... .......++..|++||.+.+..++.++|+||+|+++++|++ |..||...+
T Consensus 156 li~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~ 231 (283)
T cd05090 156 LIGEQLHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFS 231 (283)
T ss_pred EEcCCCcEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCC
Confidence 99999999999999997653221 11223345667999999988888999999999999999998 999997643
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.1e-28 Score=162.89 Aligned_cols=135 Identities=32% Similarity=0.503 Sum_probs=113.6
Q ss_pred CceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeeec
Q 044494 3 RKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADFG 82 (144)
Q Consensus 3 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~~ 82 (144)
++..+++|||+++++|.+++.... ...+++.....++.|++.++++|| +.+++|+||+|+|++++.++.++++|||
T Consensus 72 ~~~~~~v~e~~~~~~L~~~~~~~~-~~~~~~~~~~~i~~~i~~al~~LH---~~~i~H~dl~p~ni~i~~~~~~~l~dfg 147 (260)
T cd05067 72 QEPIYIITEYMENGSLVDFLKTPE-GIKLTINKLIDMAAQIAEGMAFIE---RKNYIHRDLRAANILVSETLCCKIADFG 147 (260)
T ss_pred cCCcEEEEEcCCCCCHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHh---cCCeecccccHHhEEEcCCCCEEEccCc
Confidence 456799999999999999886533 234888999999999999999999 8999999999999999999999999999
Q ss_pred ceeecccCC-CCcccccccccccCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCC
Q 044494 83 VARLLNFDS-SNRTLLAGTYGYIAPELAYTMVVTEKSDVYSFGVVALEVLM-GKHPGELLS 141 (144)
Q Consensus 83 ~~~~~~~~~-~~~~~~~~~~~~~~pe~~~~~~~~~~~d~~slg~~l~~~~~-g~~p~~~~~ 141 (144)
.+....... .......++..|++||.+....++.++|+||+|++++++++ |..||...+
T Consensus 148 ~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~ 208 (260)
T cd05067 148 LARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMT 208 (260)
T ss_pred ceeecCCCCcccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCC
Confidence 987654221 11222345678999999988888899999999999999998 999997654
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.9e-28 Score=164.70 Aligned_cols=136 Identities=29% Similarity=0.434 Sum_probs=112.7
Q ss_pred CceEEEEEeeccCCCHHHHhhcccc------------cCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEE
Q 044494 3 RKCMFLIYEYMEMGSLFCVLRTDEE------------AVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILL 70 (144)
Q Consensus 3 ~~~~~lv~e~~~~~~L~~~l~~~~~------------~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~ 70 (144)
....+++|||+++++|.+++..... ...+++..+..++.|++.|+++|| +.+++|+||+|+||++
T Consensus 79 ~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH---~~~i~H~dlkp~nil~ 155 (280)
T cd05092 79 GRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLA---SLHFVHRDLATRNCLV 155 (280)
T ss_pred CCceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHH---HCCeecccccHhhEEE
Confidence 4668999999999999999875321 124788999999999999999999 8999999999999999
Q ss_pred cCCCCeEEeeecceeecccCCC--CcccccccccccCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCC
Q 044494 71 NLELEAFVADFGVARLLNFDSS--NRTLLAGTYGYIAPELAYTMVVTEKSDVYSFGVVALEVLM-GKHPGELLS 141 (144)
Q Consensus 71 ~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~d~~slg~~l~~~~~-g~~p~~~~~ 141 (144)
+.++.++++|||++........ ......+++.|++||...+..++.++|+||||++++++++ |..||...+
T Consensus 156 ~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~ 229 (280)
T cd05092 156 GQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLS 229 (280)
T ss_pred cCCCCEEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCC
Confidence 9999999999999875432111 1122234678999999998889999999999999999998 999996543
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.6e-28 Score=163.58 Aligned_cols=133 Identities=27% Similarity=0.411 Sum_probs=115.5
Q ss_pred CCceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeee
Q 044494 2 HRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADF 81 (144)
Q Consensus 2 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~ 81 (144)
.++.+|+++||+++++|.+++.+... +++..+..++.|++.++++|| +.+++|+|++|+||+++.++.++++||
T Consensus 64 ~~~~~~lv~e~~~~~~L~~~l~~~~~---l~~~~~~~~~~~i~~~l~~lH---~~~~~h~dl~~~nilv~~~~~~~l~df 137 (262)
T cd05572 64 DKKYIYMLMEYCLGGELWTILRDRGL---FDEYTARFYIACVVLAFEYLH---NRGIIYRDLKPENLLLDSNGYVKLVDF 137 (262)
T ss_pred cCCccEEEEecCCCCcHHHHHhhcCC---CCHHHHHHHHHHHHHHHHHHh---hCCcccCCCCHHHEEEcCCCCEEEeeC
Confidence 35678999999999999999976433 889999999999999999999 899999999999999999999999999
Q ss_pred cceeecccCCCCcccccccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCC
Q 044494 82 GVARLLNFDSSNRTLLAGTYGYIAPELAYTMVVTEKSDVYSFGVVALEVLMGKHPGELLS 141 (144)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~d~~slg~~l~~~~~g~~p~~~~~ 141 (144)
|.+....... ......+++.|++||.+....++.++|+||+|+++|++++|..||...+
T Consensus 138 ~~~~~~~~~~-~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 196 (262)
T cd05572 138 GFAKKLKSGQ-KTWTFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDD 196 (262)
T ss_pred CcccccCccc-ccccccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCC
Confidence 9987654322 2233457889999999888888899999999999999999999997655
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=7e-28 Score=166.76 Aligned_cols=136 Identities=26% Similarity=0.363 Sum_probs=114.2
Q ss_pred CCceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeee
Q 044494 2 HRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADF 81 (144)
Q Consensus 2 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~ 81 (144)
+++..|+||||+.+++|.+++.+.. ...+++..+..++.|++.++.+|| +.+++|+||||+||+++.++.++++||
T Consensus 72 ~~~~~~lv~e~~~~~~L~~~~~~~~-~~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~~l~df 147 (316)
T cd05574 72 TETYLCLVMDYCPGGELFRLLQRQP-GKCLSEEVARFYAAEVLLALEYLH---LLGIVYRDLKPENILLHESGHIMLSDF 147 (316)
T ss_pred cCCEEEEEEEecCCCCHHHHHHhCC-CCccCHHHHHHHHHHHHHHHHHHH---HCCeeccCCChHHeEEcCCCCEEEeec
Confidence 3567899999999999999987532 234899999999999999999999 899999999999999999999999999
Q ss_pred cceeecccCCC-----------------------------CcccccccccccCccccccCCCCCcchhHHHHHHHHHHHh
Q 044494 82 GVARLLNFDSS-----------------------------NRTLLAGTYGYIAPELAYTMVVTEKSDVYSFGVVALEVLM 132 (144)
Q Consensus 82 ~~~~~~~~~~~-----------------------------~~~~~~~~~~~~~pe~~~~~~~~~~~d~~slg~~l~~~~~ 132 (144)
|++........ ......++..|++||...+..++.++|+||+|+++|++++
T Consensus 148 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~ 227 (316)
T cd05574 148 DLSKQSDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLY 227 (316)
T ss_pred chhhcccccccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhh
Confidence 98765431110 0112356788999999998888999999999999999999
Q ss_pred CCCCCCCCC
Q 044494 133 GKHPGELLS 141 (144)
Q Consensus 133 g~~p~~~~~ 141 (144)
|..||...+
T Consensus 228 g~~pf~~~~ 236 (316)
T cd05574 228 GTTPFKGSN 236 (316)
T ss_pred CCCCCCCCc
Confidence 999997654
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.9e-28 Score=164.82 Aligned_cols=134 Identities=26% Similarity=0.326 Sum_probs=114.6
Q ss_pred CceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeeec
Q 044494 3 RKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADFG 82 (144)
Q Consensus 3 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~~ 82 (144)
++.+|+||||+++++|.+++..... ..+++..+..++.|++.++.+|| +.+++|+||+|+||+++.++.++++|||
T Consensus 65 ~~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~ql~~~l~~lH---~~~i~H~di~p~Nil~~~~~~~~l~dfg 140 (277)
T cd05577 65 KDDLCLVMTLMNGGDLKYHIYNVGE-PGFPEARAIFYAAQIICGLEHLH---QRRIVYRDLKPENVLLDDHGNVRISDLG 140 (277)
T ss_pred CCeEEEEEecCCCCcHHHHHHHcCc-CCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEECCCCCEEEccCc
Confidence 4678999999999999998875432 34899999999999999999999 8999999999999999999999999999
Q ss_pred ceeecccCCCCcccccccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCC
Q 044494 83 VARLLNFDSSNRTLLAGTYGYIAPELAYTMVVTEKSDVYSFGVVALEVLMGKHPGELLS 141 (144)
Q Consensus 83 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~d~~slg~~l~~~~~g~~p~~~~~ 141 (144)
.+..... ........++..|++||...+..++.++|+||+|++++++++|..||...+
T Consensus 141 ~~~~~~~-~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 198 (277)
T cd05577 141 LAVELKG-GKKIKGRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRK 198 (277)
T ss_pred chhhhcc-CCccccccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCc
Confidence 8875432 122233456778999999988888899999999999999999999997654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.8e-29 Score=187.39 Aligned_cols=138 Identities=29% Similarity=0.420 Sum_probs=117.0
Q ss_pred CCceEEEEEeeccCCCHHHHhhccc----ccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeE
Q 044494 2 HRKCMFLIYEYMEMGSLFCVLRTDE----EAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAF 77 (144)
Q Consensus 2 ~~~~~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~ 77 (144)
.....++++|||++|+|..+|++.. ....+.....+.++.|+++|++||+ +++++||||..+|++++....+|
T Consensus 766 ~~~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe---~~~fvHRDLAaRNCLL~~~r~VK 842 (1025)
T KOG1095|consen 766 DSGPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLE---SKHFVHRDLAARNCLLDERRVVK 842 (1025)
T ss_pred CCCCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHH---hCCCcCcchhhhheeecccCcEE
Confidence 3566799999999999999998641 1344888999999999999999999 99999999999999999999999
Q ss_pred EeeecceeecccCCC-Cccc-ccccccccCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCC
Q 044494 78 VADFGVARLLNFDSS-NRTL-LAGTYGYIAPELAYTMVVTEKSDVYSFGVVALEVLM-GKHPGELLSS 142 (144)
Q Consensus 78 l~d~~~~~~~~~~~~-~~~~-~~~~~~~~~pe~~~~~~~~~~~d~~slg~~l~~~~~-g~~p~~~~~~ 142 (144)
|+|||+++++..... .... -.....|||||.+....++.|+|+||||+++||++| |..||...++
T Consensus 843 IaDFGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n 910 (1025)
T KOG1095|consen 843 IADFGLARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSN 910 (1025)
T ss_pred EcccchhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcch
Confidence 999999995532211 1111 234568999999999999999999999999999998 9999988764
|
|
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.1e-28 Score=164.20 Aligned_cols=126 Identities=29% Similarity=0.389 Sum_probs=109.6
Q ss_pred CceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeeec
Q 044494 3 RKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADFG 82 (144)
Q Consensus 3 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~~ 82 (144)
++..++||||+++++|..+. .+++..+..++.|++.++.+|| +.+++|+||+|+||+++.++.++++|||
T Consensus 71 ~~~~~lv~e~~~~~~l~~~~-------~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nill~~~~~~~l~dfg 140 (279)
T cd06619 71 ENRISICTEFMDGGSLDVYR-------KIPEHVLGRIAVAVVKGLTYLW---SLKILHRDVKPSNMLVNTRGQVKLCDFG 140 (279)
T ss_pred CCEEEEEEecCCCCChHHhh-------cCCHHHHHHHHHHHHHHHHHHH---HCCEeeCCCCHHHEEECCCCCEEEeeCC
Confidence 46788999999999986542 2788888999999999999999 8999999999999999999999999999
Q ss_pred ceeecccCCCCcccccccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCC
Q 044494 83 VARLLNFDSSNRTLLAGTYGYIAPELAYTMVVTEKSDVYSFGVVALEVLMGKHPGELL 140 (144)
Q Consensus 83 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~d~~slg~~l~~~~~g~~p~~~~ 140 (144)
++..... .......++..|+|||.+....++.++|+||+|++++++++|..||...
T Consensus 141 ~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~ 196 (279)
T cd06619 141 VSTQLVN--SIAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQI 196 (279)
T ss_pred cceeccc--ccccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhh
Confidence 9876542 2233356888999999999888899999999999999999999999653
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4e-28 Score=157.87 Aligned_cols=133 Identities=27% Similarity=0.339 Sum_probs=111.8
Q ss_pred ceEEEEEeeccCCCHHHHhhcc-cccCCCCHHHHHHHHHHHHHHHHHHhcCCCCC--eEecCCCCCcEEEcCCCCeEEee
Q 044494 4 KCMFLIYEYMEMGSLFCVLRTD-EEAVGLDWAKRVNIVKGMAHALSYLHHDCTPP--IVHRDISSNNILLNLELEAFVAD 80 (144)
Q Consensus 4 ~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~--~~h~~i~~~ni~~~~~~~~~l~d 80 (144)
...|++++|+..|+|.+.+... .+...+++.+++.+..++|+|+++|| +.. +.||||||.||+++..+.+++.|
T Consensus 96 ~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH---~~~~~yAH~DiKP~NILls~~~~~vl~D 172 (302)
T KOG2345|consen 96 HEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALH---EKEPPYAHRDIKPANILLSDSGLPVLMD 172 (302)
T ss_pred eeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHh---ccCCcccccCCCcceeEecCCCceEEEe
Confidence 4589999999999999998752 23335999999999999999999999 666 99999999999999999999999
Q ss_pred ecceeecccCCCC---------cccccccccccCccccccCC---CCCcchhHHHHHHHHHHHhCCCCCCC
Q 044494 81 FGVARLLNFDSSN---------RTLLAGTYGYIAPELAYTMV---VTEKSDVYSFGVVALEVLMGKHPGEL 139 (144)
Q Consensus 81 ~~~~~~~~~~~~~---------~~~~~~~~~~~~pe~~~~~~---~~~~~d~~slg~~l~~~~~g~~p~~~ 139 (144)
||.++...-.... .....+|..|.|||.+..+. .+.+.|+|||||++|.|+-|..||+.
T Consensus 173 ~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~ 243 (302)
T KOG2345|consen 173 LGSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFER 243 (302)
T ss_pred ccCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchH
Confidence 9998765422111 11245789999999998654 46799999999999999999999975
|
|
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.7e-28 Score=163.85 Aligned_cols=135 Identities=19% Similarity=0.246 Sum_probs=114.5
Q ss_pred CceEEEEEeeccCCCHHHHhhcc-cccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeee
Q 044494 3 RKCMFLIYEYMEMGSLFCVLRTD-EEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADF 81 (144)
Q Consensus 3 ~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~ 81 (144)
.+..++++||+++++|.+++... .....+++..+..++.|++.|+.+|| +.+++|+||+|+||+++.++.++++||
T Consensus 74 ~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dl~~~nil~~~~~~~~l~d~ 150 (267)
T cd08228 74 DNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMH---SRRVMHRDIKPANVFITATGVVKLGDL 150 (267)
T ss_pred CCeEEEEEEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHh---hCCeeCCCCCHHHEEEcCCCCEEECcc
Confidence 46789999999999999888542 12234788999999999999999999 899999999999999999999999999
Q ss_pred cceeecccCCCCcccccccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCC
Q 044494 82 GVARLLNFDSSNRTLLAGTYGYIAPELAYTMVVTEKSDVYSFGVVALEVLMGKHPGELL 140 (144)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~d~~slg~~l~~~~~g~~p~~~~ 140 (144)
|.+..............+++.|+|||.+....++.++|+||+|++++++++|..||...
T Consensus 151 g~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~ 209 (267)
T cd08228 151 GLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGD 209 (267)
T ss_pred ccceeccchhHHHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccc
Confidence 98886553332233356788999999998888889999999999999999999998643
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=6e-28 Score=162.64 Aligned_cols=134 Identities=31% Similarity=0.444 Sum_probs=111.5
Q ss_pred CceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeeec
Q 044494 3 RKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADFG 82 (144)
Q Consensus 3 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~~ 82 (144)
++..|+||||+++++|.+++..... .+++..+..++.|++.++.+|| +.+++|+|++|+||+++.++.++++|||
T Consensus 71 ~~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dl~p~ni~i~~~~~~kl~dfg 145 (256)
T cd05059 71 QRPIFIVTEYMANGCLLNYLRERKG--KLGTEWLLDMCSDVCEAMEYLE---SNGFIHRDLAARNCLVGEDNVVKVSDFG 145 (256)
T ss_pred CCceEEEEecCCCCCHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHH---HCCcccccccHhhEEECCCCcEEECCcc
Confidence 4568999999999999999875332 4899999999999999999999 8999999999999999999999999999
Q ss_pred ceeecccCCCCc-ccccccccccCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCC
Q 044494 83 VARLLNFDSSNR-TLLAGTYGYIAPELAYTMVVTEKSDVYSFGVVALEVLM-GKHPGELLS 141 (144)
Q Consensus 83 ~~~~~~~~~~~~-~~~~~~~~~~~pe~~~~~~~~~~~d~~slg~~l~~~~~-g~~p~~~~~ 141 (144)
.++......... ....++..|+|||...+..++.++|+||+|+++|++++ |..||...+
T Consensus 146 ~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~ 206 (256)
T cd05059 146 LARYVLDDQYTSSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFS 206 (256)
T ss_pred cceecccccccccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCC
Confidence 887543221111 11123347999999988888999999999999999998 899997654
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.9e-28 Score=162.28 Aligned_cols=134 Identities=29% Similarity=0.426 Sum_probs=111.9
Q ss_pred CceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeeec
Q 044494 3 RKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADFG 82 (144)
Q Consensus 3 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~~ 82 (144)
++..++||||+++|+|.++++.... .+++..+..++.|++.++++|| +.+++|+|++|+|++++.++.++++|||
T Consensus 71 ~~~~~iv~e~~~~~~L~~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~ni~i~~~~~~kl~d~g 145 (256)
T cd05114 71 QKPLYIVTEFMENGCLLNYLRQRQG--KLSKDMLLSMCQDVCEGMEYLE---RNSFIHRDLAARNCLVSSTGVVKVSDFG 145 (256)
T ss_pred CCCEEEEEEcCCCCcHHHHHHhCcc--CCCHHHHHHHHHHHHHHHHHHH---HCCccccccCcceEEEcCCCeEEECCCC
Confidence 4568999999999999999875332 3889999999999999999999 8899999999999999999999999999
Q ss_pred ceeecccCCC-CcccccccccccCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCC
Q 044494 83 VARLLNFDSS-NRTLLAGTYGYIAPELAYTMVVTEKSDVYSFGVVALEVLM-GKHPGELLS 141 (144)
Q Consensus 83 ~~~~~~~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~d~~slg~~l~~~~~-g~~p~~~~~ 141 (144)
.+........ ......++..|+|||.+.+..++.++|+||+|++++++++ |+.||...+
T Consensus 146 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~ 206 (256)
T cd05114 146 MTRYVLDDEYTSSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKS 206 (256)
T ss_pred CccccCCCceeccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCC
Confidence 8875432111 1112234557999999988888999999999999999999 999997654
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.3e-28 Score=166.04 Aligned_cols=134 Identities=22% Similarity=0.310 Sum_probs=111.5
Q ss_pred CCceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeee
Q 044494 2 HRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADF 81 (144)
Q Consensus 2 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~ 81 (144)
..+.+++||||+. ++|.+++.... ..+++..+..++.|++.|+.+|| +.+++|+||+|+||+++.++.++++||
T Consensus 75 ~~~~~~lv~e~~~-~~l~~~l~~~~--~~~~~~~~~~~~~qi~~aL~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~df 148 (301)
T cd07873 75 TEKSLTLVFEYLD-KDLKQYLDDCG--NSINMHNVKLFLFQLLRGLNYCH---RRKVLHRDLKPQNLLINERGELKLADF 148 (301)
T ss_pred cCCeEEEEEeccc-cCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCCHHHEEECCCCcEEECcC
Confidence 3567899999997 58988886532 23889999999999999999999 899999999999999999999999999
Q ss_pred cceeecccCCCCcccccccccccCccccccC-CCCCcchhHHHHHHHHHHHhCCCCCCCCC
Q 044494 82 GVARLLNFDSSNRTLLAGTYGYIAPELAYTM-VVTEKSDVYSFGVVALEVLMGKHPGELLS 141 (144)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~-~~~~~~d~~slg~~l~~~~~g~~p~~~~~ 141 (144)
|++..............+++.|++||.+.+. .++.++|+||+|+++++|++|..||...+
T Consensus 149 g~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~ 209 (301)
T cd07873 149 GLARAKSIPTKTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGST 209 (301)
T ss_pred cchhccCCCCCcccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 9987654333333334568899999988654 46788999999999999999999997643
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=8e-28 Score=162.77 Aligned_cols=135 Identities=34% Similarity=0.475 Sum_probs=113.5
Q ss_pred CCceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeee
Q 044494 2 HRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADF 81 (144)
Q Consensus 2 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~ 81 (144)
.++..++||||+++++|.+++..... .+++..+..++.|++.++.+|| +.+++|+||+|+||+++.++.++++||
T Consensus 76 ~~~~~~iv~e~~~~~~L~~~~~~~~~--~~~~~~~~~~~~~l~~~l~~Lh---~~~i~H~di~p~nili~~~~~~~l~df 150 (266)
T cd05033 76 KSRPVMIITEYMENGSLDKFLRENDG--KFTVGQLVGMLRGIASGMKYLS---EMNYVHRDLAARNILVNSNLVCKVSDF 150 (266)
T ss_pred cCCceEEEEEcCCCCCHHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCcceEEEcCCCCEEECcc
Confidence 35678999999999999999875332 4899999999999999999999 899999999999999999999999999
Q ss_pred cceeecccCCCC--cccccccccccCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCC
Q 044494 82 GVARLLNFDSSN--RTLLAGTYGYIAPELAYTMVVTEKSDVYSFGVVALEVLM-GKHPGELLS 141 (144)
Q Consensus 82 ~~~~~~~~~~~~--~~~~~~~~~~~~pe~~~~~~~~~~~d~~slg~~l~~~~~-g~~p~~~~~ 141 (144)
|++......... .....++..|++||...+..++.++|+||+|++++++++ |..||...+
T Consensus 151 g~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~ 213 (266)
T cd05033 151 GLSRRLEDSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMS 213 (266)
T ss_pred chhhcccccccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCC
Confidence 999866421111 111234567999999998888999999999999999998 999997654
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=8.9e-28 Score=168.06 Aligned_cols=126 Identities=26% Similarity=0.372 Sum_probs=108.2
Q ss_pred ceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeeecc
Q 044494 4 KCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADFGV 83 (144)
Q Consensus 4 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~~~ 83 (144)
...|+++|++ +++|.+++... .+++..+..++.|++.||.||| +.+++||||||+||+++.++.++++|||+
T Consensus 93 ~~~~~~~~~~-~~~l~~~~~~~----~l~~~~~~~i~~qi~~aL~~LH---~~~ivHrdikp~Nil~~~~~~~kl~Dfg~ 164 (343)
T cd07878 93 NEVYLVTNLM-GADLNNIVKCQ----KLSDEHVQFLIYQLLRGLKYIH---SAGIIHRDLKPSNVAVNEDCELRILDFGL 164 (343)
T ss_pred CcEEEEeecC-CCCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHH---HCCeecccCChhhEEECCCCCEEEcCCcc
Confidence 3578999988 67998877532 3899999999999999999999 89999999999999999999999999999
Q ss_pred eeecccCCCCcccccccccccCcccccc-CCCCCcchhHHHHHHHHHHHhCCCCCCCC
Q 044494 84 ARLLNFDSSNRTLLAGTYGYIAPELAYT-MVVTEKSDVYSFGVVALEVLMGKHPGELL 140 (144)
Q Consensus 84 ~~~~~~~~~~~~~~~~~~~~~~pe~~~~-~~~~~~~d~~slg~~l~~~~~g~~p~~~~ 140 (144)
+..... ......+++.|+|||++.+ ..++.++|+||+|+++++|++|..||...
T Consensus 165 ~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~ 219 (343)
T cd07878 165 ARQADD---EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGN 219 (343)
T ss_pred ceecCC---CcCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCC
Confidence 986542 2233468899999999876 45788999999999999999999999754
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=8.9e-28 Score=161.69 Aligned_cols=133 Identities=28% Similarity=0.425 Sum_probs=113.7
Q ss_pred ceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeeecc
Q 044494 4 KCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADFGV 83 (144)
Q Consensus 4 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~~~ 83 (144)
+.+++||||+++++|.+++..... ..+++..++.++.|++.++.+|| +.+++|+||+|+||+++.++.++++|||+
T Consensus 68 ~~~~~v~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~di~p~nil~~~~~~~kl~dfg~ 143 (257)
T cd05040 68 HPLMMVTELAPLGSLLDRLRKDAL-GHFLISTLCDYAVQIANGMRYLE---SKRFIHRDLAARNILLASDDKVKIGDFGL 143 (257)
T ss_pred CeEEEEEEecCCCcHHHHHHhccc-ccCcHHHHHHHHHHHHHHHHHHH---hCCccccccCcccEEEecCCEEEeccccc
Confidence 568999999999999999876432 34899999999999999999999 89999999999999999999999999999
Q ss_pred eeecccCCC---CcccccccccccCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCC
Q 044494 84 ARLLNFDSS---NRTLLAGTYGYIAPELAYTMVVTEKSDVYSFGVVALEVLM-GKHPGELL 140 (144)
Q Consensus 84 ~~~~~~~~~---~~~~~~~~~~~~~pe~~~~~~~~~~~d~~slg~~l~~~~~-g~~p~~~~ 140 (144)
+........ ......++..|++||.+....++.++|+||+|+++++|++ |..||+..
T Consensus 144 ~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~ 204 (257)
T cd05040 144 MRALPQNEDHYVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGL 204 (257)
T ss_pred cccccccccceecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCC
Confidence 886543211 1122346678999999988888999999999999999998 99999654
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=8.6e-28 Score=163.40 Aligned_cols=132 Identities=31% Similarity=0.474 Sum_probs=114.1
Q ss_pred CceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeeec
Q 044494 3 RKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADFG 82 (144)
Q Consensus 3 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~~ 82 (144)
+...|+||||+++++|.++++.. .+++..++.++.|++.++.+|| +.+++|+|++|+||+++.++.++++|||
T Consensus 74 ~~~~~lv~e~~~~~~L~~~~~~~----~l~~~~~~~i~~~i~~~l~~lh---~~~i~H~dl~p~ni~i~~~~~~~l~dfg 146 (277)
T cd06917 74 GPRLWIIMEYAEGGSVRTLMKAG----PIAEKYISVIIREVLVALKYIH---KVGVIHRDIKAANILVTNTGNVKLCDFG 146 (277)
T ss_pred CCEEEEEEecCCCCcHHHHHHcc----CCCHHHHHHHHHHHHHHHHHHH---hCCcccCCcCHHHEEEcCCCCEEEccCC
Confidence 46789999999999999988653 3889999999999999999999 8999999999999999999999999999
Q ss_pred ceeecccCCCCcccccccccccCccccccC-CCCCcchhHHHHHHHHHHHhCCCCCCCCC
Q 044494 83 VARLLNFDSSNRTLLAGTYGYIAPELAYTM-VVTEKSDVYSFGVVALEVLMGKHPGELLS 141 (144)
Q Consensus 83 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~-~~~~~~d~~slg~~l~~~~~g~~p~~~~~ 141 (144)
.+..............++..|++||.+... .++.++|+||+|+++|+|++|..||...+
T Consensus 147 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~ 206 (277)
T cd06917 147 VAALLNQNSSKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVD 206 (277)
T ss_pred ceeecCCCccccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCC
Confidence 998765444333445688899999988653 46789999999999999999999997654
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.7e-28 Score=166.38 Aligned_cols=136 Identities=28% Similarity=0.424 Sum_probs=111.8
Q ss_pred CceEEEEEeeccCCCHHHHhhcccc-------------cCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEE
Q 044494 3 RKCMFLIYEYMEMGSLFCVLRTDEE-------------AVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNIL 69 (144)
Q Consensus 3 ~~~~~lv~e~~~~~~L~~~l~~~~~-------------~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~ 69 (144)
++..|+||||+++++|.+++..... ...+++.++..++.|++.++++|| +.|++|+||||+||+
T Consensus 96 ~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH---~~gi~H~dlkp~Nil 172 (307)
T cd05098 96 DGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNVL 172 (307)
T ss_pred CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHH---HCCcccccccHHheE
Confidence 4678999999999999999975321 124788899999999999999999 899999999999999
Q ss_pred EcCCCCeEEeeecceeecccCCCCc--ccccccccccCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCC
Q 044494 70 LNLELEAFVADFGVARLLNFDSSNR--TLLAGTYGYIAPELAYTMVVTEKSDVYSFGVVALEVLM-GKHPGELLS 141 (144)
Q Consensus 70 ~~~~~~~~l~d~~~~~~~~~~~~~~--~~~~~~~~~~~pe~~~~~~~~~~~d~~slg~~l~~~~~-g~~p~~~~~ 141 (144)
++.++.++++|||.+.......... ....+++.|+|||.+.+..++.++|+||+|+++|+|++ |..||...+
T Consensus 173 l~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~ 247 (307)
T cd05098 173 VTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP 247 (307)
T ss_pred EcCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCC
Confidence 9999999999999987543211111 11223467999999988888999999999999999998 888987543
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=9.3e-28 Score=165.53 Aligned_cols=133 Identities=26% Similarity=0.350 Sum_probs=111.7
Q ss_pred CceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeeec
Q 044494 3 RKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADFG 82 (144)
Q Consensus 3 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~~ 82 (144)
++.+++||||+++++|.+++.... .+++..+..++.|++.++++|| +.+++|+|++|.||+++.++.++++|||
T Consensus 73 ~~~~~lv~e~~~g~~L~~~l~~~~---~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~NIll~~~~~~~l~dfg 146 (305)
T cd05609 73 KRHLCMVMEYVEGGDCATLLKNIG---ALPVDMARMYFAETVLALEYLH---NYGIVHRDLKPDNLLITSMGHIKLTDFG 146 (305)
T ss_pred CCEEEEEEecCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCchHHEEECCCCCEEEeeCC
Confidence 567899999999999999997543 3899999999999999999999 8999999999999999999999999999
Q ss_pred ceeecccC---------------CCCcccccccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCC
Q 044494 83 VARLLNFD---------------SSNRTLLAGTYGYIAPELAYTMVVTEKSDVYSFGVVALEVLMGKHPGELLS 141 (144)
Q Consensus 83 ~~~~~~~~---------------~~~~~~~~~~~~~~~pe~~~~~~~~~~~d~~slg~~l~~~~~g~~p~~~~~ 141 (144)
.++..... ........++..|++||.+....++.++|+||+|++++++++|..||.+.+
T Consensus 147 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~ 220 (305)
T cd05609 147 LSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDT 220 (305)
T ss_pred CccccCcCccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 87632100 001112346778999999988888999999999999999999999997543
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.1e-27 Score=165.85 Aligned_cols=136 Identities=27% Similarity=0.416 Sum_probs=111.9
Q ss_pred CceEEEEEeeccCCCHHHHhhccc-------------ccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEE
Q 044494 3 RKCMFLIYEYMEMGSLFCVLRTDE-------------EAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNIL 69 (144)
Q Consensus 3 ~~~~~lv~e~~~~~~L~~~l~~~~-------------~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~ 69 (144)
++.+|++|||+++|+|.+++.... ....+++.++..++.|++.++.+|| +.|++|+||||+||+
T Consensus 90 ~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH---~~gi~H~dlkp~Nil 166 (314)
T cd05099 90 EGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLE---SRRCIHRDLAARNVL 166 (314)
T ss_pred CCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHH---HCCeeeccccceeEE
Confidence 467899999999999999996532 1234888899999999999999999 899999999999999
Q ss_pred EcCCCCeEEeeecceeecccCCCCc--ccccccccccCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCC
Q 044494 70 LNLELEAFVADFGVARLLNFDSSNR--TLLAGTYGYIAPELAYTMVVTEKSDVYSFGVVALEVLM-GKHPGELLS 141 (144)
Q Consensus 70 ~~~~~~~~l~d~~~~~~~~~~~~~~--~~~~~~~~~~~pe~~~~~~~~~~~d~~slg~~l~~~~~-g~~p~~~~~ 141 (144)
++.++.++++|||.++......... ....++..|++||.+....++.++|+||+|+++|++++ |..||...+
T Consensus 167 l~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~ 241 (314)
T cd05099 167 VTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIP 241 (314)
T ss_pred EcCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCC
Confidence 9999999999999997543211111 11223457999999988888999999999999999998 888987654
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=1e-27 Score=162.16 Aligned_cols=131 Identities=27% Similarity=0.346 Sum_probs=112.4
Q ss_pred ceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeeecc
Q 044494 4 KCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADFGV 83 (144)
Q Consensus 4 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~~~ 83 (144)
+.+++++||+++++|.+++..... +++..+..++.|++.++.+|| +.+++|+|++|+||+++.++.++++|||+
T Consensus 79 ~~~~~v~e~~~~~~L~~~~~~~~~---l~~~~~~~~~~~i~~al~~LH---~~~i~H~dl~p~ni~i~~~~~~~l~dfg~ 152 (264)
T cd06653 79 KKLSIFVEYMPGGSIKDQLKAYGA---LTENVTRRYTRQILQGVSYLH---SNMIVHRDIKGANILRDSAGNVKLGDFGA 152 (264)
T ss_pred CEEEEEEEeCCCCcHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEcCCCCEEECcccc
Confidence 568899999999999998875433 788899999999999999999 89999999999999999999999999999
Q ss_pred eeecccCC---CCcccccccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCC
Q 044494 84 ARLLNFDS---SNRTLLAGTYGYIAPELAYTMVVTEKSDVYSFGVVALEVLMGKHPGELL 140 (144)
Q Consensus 84 ~~~~~~~~---~~~~~~~~~~~~~~pe~~~~~~~~~~~d~~slg~~l~~~~~g~~p~~~~ 140 (144)
+....... .......++..|++||.+.+..++.++|+||+|++++++++|..||...
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~ 212 (264)
T cd06653 153 SKRIQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEY 212 (264)
T ss_pred ccccccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCcc
Confidence 87653211 1112345788899999998888889999999999999999999999764
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.2e-27 Score=161.85 Aligned_cols=135 Identities=32% Similarity=0.451 Sum_probs=112.8
Q ss_pred CceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeeec
Q 044494 3 RKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADFG 82 (144)
Q Consensus 3 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~~ 82 (144)
....|+||||+++++|.+++.+.. ...+++..+..++.|++.++.+|| +.+++|+||+|.||+++.++.++++|||
T Consensus 72 ~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~aL~~lH---~~~i~H~dl~p~Nill~~~~~~~L~dfg 147 (262)
T cd05071 72 EEPIYIVTEYMSKGSLLDFLKGEM-GKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFG 147 (262)
T ss_pred CCCcEEEEEcCCCCcHHHHHhhcc-ccCCCHHHHHHHHHHHHHHHHHHH---HCCccccccCcccEEEcCCCcEEeccCC
Confidence 355789999999999999997532 234788999999999999999999 8999999999999999999999999999
Q ss_pred ceeecccCCCC-cccccccccccCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCC
Q 044494 83 VARLLNFDSSN-RTLLAGTYGYIAPELAYTMVVTEKSDVYSFGVVALEVLM-GKHPGELLS 141 (144)
Q Consensus 83 ~~~~~~~~~~~-~~~~~~~~~~~~pe~~~~~~~~~~~d~~slg~~l~~~~~-g~~p~~~~~ 141 (144)
.+......... .....++..|++||......++.++|+||+|++++++++ |..||...+
T Consensus 148 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~ 208 (262)
T cd05071 148 LARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMV 208 (262)
T ss_pred ceeeccccccccccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCC
Confidence 98765432211 122335667999999988888999999999999999999 888997654
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=1e-27 Score=163.92 Aligned_cols=131 Identities=25% Similarity=0.444 Sum_probs=113.6
Q ss_pred CceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeeec
Q 044494 3 RKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADFG 82 (144)
Q Consensus 3 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~~ 82 (144)
.+..++++||+++++|.+++.. . .+++..+..++.|++.++++|| +.+++|+||+|+||+++.++.++++|||
T Consensus 88 ~~~~~~v~e~~~~~~L~~~~~~-~---~~~~~~~~~~~~ql~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~l~d~g 160 (285)
T cd06648 88 GDELWVVMEFLEGGALTDIVTH-T---RMNEEQIATVCLAVLKALSFLH---AQGVIHRDIKSDSILLTSDGRVKLSDFG 160 (285)
T ss_pred CCeEEEEEeccCCCCHHHHHHh-C---CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCChhhEEEcCCCcEEEcccc
Confidence 4678999999999999998875 2 2889999999999999999999 8999999999999999999999999999
Q ss_pred ceeecccCCCCcccccccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCC
Q 044494 83 VARLLNFDSSNRTLLAGTYGYIAPELAYTMVVTEKSDVYSFGVVALEVLMGKHPGELL 140 (144)
Q Consensus 83 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~d~~slg~~l~~~~~g~~p~~~~ 140 (144)
.+..............+++.|++||......++.++|+||+|++++++++|..||...
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~ 218 (285)
T cd06648 161 FCAQVSKEVPRRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNE 218 (285)
T ss_pred cchhhccCCcccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCC
Confidence 8765443332333455788999999998888889999999999999999999998653
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=99.95 E-value=7.7e-28 Score=162.70 Aligned_cols=134 Identities=28% Similarity=0.384 Sum_probs=114.1
Q ss_pred CCceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeee
Q 044494 2 HRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADF 81 (144)
Q Consensus 2 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~ 81 (144)
.++.+++++||+++++|.+++.+... +++..+..++.|++.++++|| +.+++|+||+|+||+++.++.++++||
T Consensus 73 ~~~~~~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~~l~df 146 (265)
T cd06631 73 DDNTISIFMEFVPGGSISSILNRFGP---LPEPVFCKYTKQILDGVAYLH---NNCVVHRDIKGNNVMLMPNGIIKLIDF 146 (265)
T ss_pred cCCeEEEEEecCCCCcHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHH---hCCcccCCcCHHhEEECCCCeEEeccc
Confidence 35678999999999999999976433 789999999999999999999 889999999999999999999999999
Q ss_pred cceeecccC------CCCcccccccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCC
Q 044494 82 GVARLLNFD------SSNRTLLAGTYGYIAPELAYTMVVTEKSDVYSFGVVALEVLMGKHPGELLS 141 (144)
Q Consensus 82 ~~~~~~~~~------~~~~~~~~~~~~~~~pe~~~~~~~~~~~d~~slg~~l~~~~~g~~p~~~~~ 141 (144)
|.+...... ........++..|+|||...+..++.++|+||+|++++++++|..||...+
T Consensus 147 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~ 212 (265)
T cd06631 147 GCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMD 212 (265)
T ss_pred hhhHhhhhccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCC
Confidence 988754211 111123457888999999998888899999999999999999999997644
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.9e-28 Score=163.80 Aligned_cols=136 Identities=28% Similarity=0.368 Sum_probs=112.5
Q ss_pred CceEEEEEeeccCCCHHHHhhcccc-------cCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCC
Q 044494 3 RKCMFLIYEYMEMGSLFCVLRTDEE-------AVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELE 75 (144)
Q Consensus 3 ~~~~~lv~e~~~~~~L~~~l~~~~~-------~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~ 75 (144)
....|+||||+++++|.+++..... ...+++..+..++.|++.++.+|| +.+++|+||+|+||+++.++.
T Consensus 81 ~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~di~p~nill~~~~~ 157 (277)
T cd05032 81 GQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLA---AKKFVHRDLAARNCMVAEDLT 157 (277)
T ss_pred CCCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHH---hCCccccccChheEEEcCCCC
Confidence 4578999999999999999865321 123678889999999999999999 899999999999999999999
Q ss_pred eEEeeecceeecccCCC--CcccccccccccCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCC
Q 044494 76 AFVADFGVARLLNFDSS--NRTLLAGTYGYIAPELAYTMVVTEKSDVYSFGVVALEVLM-GKHPGELLS 141 (144)
Q Consensus 76 ~~l~d~~~~~~~~~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~d~~slg~~l~~~~~-g~~p~~~~~ 141 (144)
++++|||.++....... ......++..|+|||.+....++.++|+||+|++++++++ |..||...+
T Consensus 158 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~ 226 (277)
T cd05032 158 VKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLS 226 (277)
T ss_pred EEECCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCC
Confidence 99999998875432211 1122345678999999988888999999999999999998 999997654
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=99.95 E-value=1e-27 Score=166.88 Aligned_cols=135 Identities=21% Similarity=0.337 Sum_probs=109.4
Q ss_pred CceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeeec
Q 044494 3 RKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADFG 82 (144)
Q Consensus 3 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~~ 82 (144)
++..|+||||+++++|.+++.... ...+++..++.++.|++.||.||| +.+++|+||||+||+++.++.+++.||+
T Consensus 71 ~~~~~lv~e~~~~~~l~~~~~~~~-~~~l~~~~~~~i~~qi~~~L~~LH---~~~iiH~dlkp~Nil~~~~~~~~l~~~~ 146 (327)
T cd08227 71 DNELWVVTSFMAYGSAKDLICTHF-MDGMSELAIAYILQGVLKALDYIH---HMGYVHRSVKASHILISVDGKVYLSGLR 146 (327)
T ss_pred CCEEEEEEeccCCCcHHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCChhhEEEecCCcEEEcccc
Confidence 567899999999999999986532 224889999999999999999999 8999999999999999999999999987
Q ss_pred ceeecccCCCC-------cccccccccccCcccccc--CCCCCcchhHHHHHHHHHHHhCCCCCCCCC
Q 044494 83 VARLLNFDSSN-------RTLLAGTYGYIAPELAYT--MVVTEKSDVYSFGVVALEVLMGKHPGELLS 141 (144)
Q Consensus 83 ~~~~~~~~~~~-------~~~~~~~~~~~~pe~~~~--~~~~~~~d~~slg~~l~~~~~g~~p~~~~~ 141 (144)
........... .....++..|+|||.+.. ..++.++|+||+|++++++++|..||...+
T Consensus 147 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~ 214 (327)
T cd08227 147 SNLSMINHGQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMP 214 (327)
T ss_pred hhhccccccccccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcc
Confidence 54432211110 112235667999999876 357889999999999999999999997643
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.8e-27 Score=162.62 Aligned_cols=135 Identities=27% Similarity=0.368 Sum_probs=111.2
Q ss_pred CCceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeee
Q 044494 2 HRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADF 81 (144)
Q Consensus 2 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~ 81 (144)
.++.+|+||||+++++|.+++........+++..+..++.+++.++.+||. +.+++|+||+|+||+++.++.++++||
T Consensus 70 ~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~--~~~i~H~dl~p~nil~~~~~~~~l~df 147 (286)
T cd06622 70 IEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKE--EHNIIHRDVKPTNVLVNGNGQVKLCDF 147 (286)
T ss_pred cCCeEEEEEeecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHh--cCCEeeCCCCHHHEEECCCCCEEEeec
Confidence 357889999999999999888754223348999999999999999999992 248999999999999999999999999
Q ss_pred cceeecccCCCCcccccccccccCccccccCC------CCCcchhHHHHHHHHHHHhCCCCCCCC
Q 044494 82 GVARLLNFDSSNRTLLAGTYGYIAPELAYTMV------VTEKSDVYSFGVVALEVLMGKHPGELL 140 (144)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~------~~~~~d~~slg~~l~~~~~g~~p~~~~ 140 (144)
|.+...... ......+++.|++||.+.... ++.++|+||+|++++++++|..||...
T Consensus 148 g~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~ 210 (286)
T cd06622 148 GVSGNLVAS--LAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPE 210 (286)
T ss_pred CCcccccCC--ccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCc
Confidence 988754321 222345778899999886543 467899999999999999999999653
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.2e-27 Score=164.20 Aligned_cols=132 Identities=29% Similarity=0.492 Sum_probs=114.4
Q ss_pred CceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeeec
Q 044494 3 RKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADFG 82 (144)
Q Consensus 3 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~~ 82 (144)
.+..|+|+||+++++|.+++.+. .+++..+..++.|++.++.+|| +++++|+|++|+||+++.++.++++|||
T Consensus 88 ~~~~~lv~e~~~~~~L~~~~~~~----~l~~~~~~~i~~~l~~al~~LH---~~gi~H~dL~p~Nili~~~~~~kL~dfg 160 (293)
T cd06647 88 GDELWVVMEYLAGGSLTDVVTET----CMDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFG 160 (293)
T ss_pred CCcEEEEEecCCCCcHHHHHhhc----CCCHHHHHHHHHHHHHHHHHHH---hCCEeeccCCHHHEEEcCCCCEEEccCc
Confidence 46789999999999999988753 2788889999999999999999 8999999999999999999999999999
Q ss_pred ceeecccCCCCcccccccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCC
Q 044494 83 VARLLNFDSSNRTLLAGTYGYIAPELAYTMVVTEKSDVYSFGVVALEVLMGKHPGELLS 141 (144)
Q Consensus 83 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~d~~slg~~l~~~~~g~~p~~~~~ 141 (144)
++..............+++.|++||.+....++.++|+||+|++++++++|..||...+
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~ 219 (293)
T cd06647 161 FCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNEN 219 (293)
T ss_pred ceecccccccccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 88765433333334467888999999988888899999999999999999999997643
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=7.1e-28 Score=183.60 Aligned_cols=137 Identities=26% Similarity=0.398 Sum_probs=109.8
Q ss_pred CceEEEEEeeccCCCHHHHhhccc-ccCCCCHHHHHHHHHHHHHHHHHHhcCC----CCCeEecCCCCCcEEEcCC----
Q 044494 3 RKCMFLIYEYMEMGSLFCVLRTDE-EAVGLDWAKRVNIVKGMAHALSYLHHDC----TPPIVHRDISSNNILLNLE---- 73 (144)
Q Consensus 3 ~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~~~l~~~l~~lh~~~----~~~~~h~~i~~~ni~~~~~---- 73 (144)
+..+|+||||+++++|.+++.... ....+++..++.++.||+.||.|||... ..+|+|+||||+||+++..
T Consensus 86 ~~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~l 165 (1021)
T PTZ00266 86 NQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHI 165 (1021)
T ss_pred CCEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcccc
Confidence 356899999999999999987521 2234899999999999999999999321 1459999999999999642
Q ss_pred -------------CCeEEeeecceeecccCCCCcccccccccccCcccccc--CCCCCcchhHHHHHHHHHHHhCCCCCC
Q 044494 74 -------------LEAFVADFGVARLLNFDSSNRTLLAGTYGYIAPELAYT--MVVTEKSDVYSFGVVALEVLMGKHPGE 138 (144)
Q Consensus 74 -------------~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~--~~~~~~~d~~slg~~l~~~~~g~~p~~ 138 (144)
+.++|+|||++....... ......+++.|+|||++.. ..++.++|+|||||++|+|++|..||.
T Consensus 166 g~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s-~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~ 244 (1021)
T PTZ00266 166 GKITAQANNLNGRPIAKIGDFGLSKNIGIES-MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFH 244 (1021)
T ss_pred ccccccccccCCCCceEEccCCccccccccc-cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCC
Confidence 348999999997654322 2234568999999999864 347889999999999999999999997
Q ss_pred CC
Q 044494 139 LL 140 (144)
Q Consensus 139 ~~ 140 (144)
..
T Consensus 245 ~~ 246 (1021)
T PTZ00266 245 KA 246 (1021)
T ss_pred cC
Confidence 54
|
|
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.6e-27 Score=164.24 Aligned_cols=136 Identities=29% Similarity=0.409 Sum_probs=112.0
Q ss_pred CceEEEEEeeccCCCHHHHhhcccc-------------cCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEE
Q 044494 3 RKCMFLIYEYMEMGSLFCVLRTDEE-------------AVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNIL 69 (144)
Q Consensus 3 ~~~~~lv~e~~~~~~L~~~l~~~~~-------------~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~ 69 (144)
+...|+||||+++++|.+++..... ...++..++..++.|++.|+.+|| +.|++|+||||+||+
T Consensus 93 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH---~~givH~dlkp~Nil 169 (304)
T cd05101 93 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLA---SQKCIHRDLAARNVL 169 (304)
T ss_pred CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHH---HCCeeecccccceEE
Confidence 4567999999999999999875321 124778889999999999999999 899999999999999
Q ss_pred EcCCCCeEEeeecceeecccCCCC--cccccccccccCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCC
Q 044494 70 LNLELEAFVADFGVARLLNFDSSN--RTLLAGTYGYIAPELAYTMVVTEKSDVYSFGVVALEVLM-GKHPGELLS 141 (144)
Q Consensus 70 ~~~~~~~~l~d~~~~~~~~~~~~~--~~~~~~~~~~~~pe~~~~~~~~~~~d~~slg~~l~~~~~-g~~p~~~~~ 141 (144)
++.++.++++|||++......... .....+++.|+|||.+....++.++|+||+|++++++++ |..||...+
T Consensus 170 i~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~ 244 (304)
T cd05101 170 VTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP 244 (304)
T ss_pred EcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCC
Confidence 999999999999998865432211 112234567999999988888999999999999999998 788886543
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=8.3e-28 Score=162.91 Aligned_cols=135 Identities=30% Similarity=0.415 Sum_probs=112.9
Q ss_pred CceEEEEEeeccCCCHHHHhhccc-ccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeee
Q 044494 3 RKCMFLIYEYMEMGSLFCVLRTDE-EAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADF 81 (144)
Q Consensus 3 ~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~ 81 (144)
.+.+|+||||+++++|.+++.... ....+++..+..++.|++.++.+|| +.+++|+|++|+||+++.++.++++||
T Consensus 81 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH---~~~i~H~~l~p~ni~~~~~~~~~l~d~ 157 (275)
T cd06608 81 DDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLH---ENKVIHRDIKGQNILLTKNAEVKLVDF 157 (275)
T ss_pred ceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHh---cCCcccCCCCHHHEEEccCCeEEECCC
Confidence 456899999999999999886522 2234899999999999999999999 899999999999999999999999999
Q ss_pred cceeecccCCCCcccccccccccCccccccC-----CCCCcchhHHHHHHHHHHHhCCCCCCCC
Q 044494 82 GVARLLNFDSSNRTLLAGTYGYIAPELAYTM-----VVTEKSDVYSFGVVALEVLMGKHPGELL 140 (144)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~-----~~~~~~d~~slg~~l~~~~~g~~p~~~~ 140 (144)
|.+..............++..|+|||.+... .++.++|+||+|++++++++|..||...
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~ 221 (275)
T cd06608 158 GVSAQLDSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDM 221 (275)
T ss_pred ccceecccchhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCcccc
Confidence 9987654333333445678899999987542 3567899999999999999999999754
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.3e-27 Score=164.72 Aligned_cols=135 Identities=27% Similarity=0.405 Sum_probs=113.0
Q ss_pred CceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeeec
Q 044494 3 RKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADFG 82 (144)
Q Consensus 3 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~~ 82 (144)
++.+|+||||+++++|.++++... ...+++.++..++.+++.++.+|| +++++|+||+|+||+++.++.++++|||
T Consensus 111 ~~~~~lv~e~~~~~~L~~~i~~~~-~~~l~~~~~~~i~~~i~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~~l~dfg 186 (302)
T cd05055 111 GGPILVITEYCCYGDLLNFLRRKR-ESFLTLEDLLSFSYQVAKGMAFLA---SKNCIHRDLAARNVLLTHGKIVKICDFG 186 (302)
T ss_pred CCceEEEEEcCCCCcHHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHH---HCCeehhhhccceEEEcCCCeEEECCCc
Confidence 456899999999999999987532 233899999999999999999999 8999999999999999999999999999
Q ss_pred ceeecccCCC--CcccccccccccCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCC
Q 044494 83 VARLLNFDSS--NRTLLAGTYGYIAPELAYTMVVTEKSDVYSFGVVALEVLM-GKHPGELLS 141 (144)
Q Consensus 83 ~~~~~~~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~d~~slg~~l~~~~~-g~~p~~~~~ 141 (144)
.+........ ......++..|+|||.+....++.++|+||+|++++++++ |..||...+
T Consensus 187 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~ 248 (302)
T cd05055 187 LARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMP 248 (302)
T ss_pred ccccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCC
Confidence 9875432211 1122345678999999988888999999999999999998 999987543
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.7e-27 Score=159.76 Aligned_cols=134 Identities=23% Similarity=0.366 Sum_probs=111.6
Q ss_pred CceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeeec
Q 044494 3 RKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADFG 82 (144)
Q Consensus 3 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~~ 82 (144)
.+..++||||+++++|.+++..... .+++..+..++.+++.++.++| +.+++|+|++|+||+++.++.++++|||
T Consensus 64 ~~~~~lv~e~~~~~~L~~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lH---~~~~~H~dl~p~nili~~~~~~~l~d~g 138 (250)
T cd05085 64 RQPIYIVMELVPGGDFLSFLRKKKD--ELKTKQLVKFALDAAAGMAYLE---SKNCIHRDLAARNCLVGENNVLKISDFG 138 (250)
T ss_pred CCccEEEEECCCCCcHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHH---hCCeeecccChheEEEcCCCeEEECCCc
Confidence 4568999999999999998865332 3789999999999999999999 8999999999999999999999999999
Q ss_pred ceeecccCCCC-cccccccccccCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCC
Q 044494 83 VARLLNFDSSN-RTLLAGTYGYIAPELAYTMVVTEKSDVYSFGVVALEVLM-GKHPGELLS 141 (144)
Q Consensus 83 ~~~~~~~~~~~-~~~~~~~~~~~~pe~~~~~~~~~~~d~~slg~~l~~~~~-g~~p~~~~~ 141 (144)
++......... ......+..|++||......++.++|+||+|++++++++ |..||....
T Consensus 139 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~ 199 (250)
T cd05085 139 MSRQEDDGIYSSSGLKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMT 199 (250)
T ss_pred cceeccccccccCCCCCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCC
Confidence 88754322111 112234567999999988888899999999999999998 999997643
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.1e-27 Score=161.42 Aligned_cols=134 Identities=27% Similarity=0.441 Sum_probs=112.0
Q ss_pred CceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeeec
Q 044494 3 RKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADFG 82 (144)
Q Consensus 3 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~~ 82 (144)
+..+++||||+++++|.+++..... .+++..++.++.|++.++.+|| +.+++|+||+|.||+++.++.++++|||
T Consensus 71 ~~~~~lv~e~~~~~~l~~~i~~~~~--~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~nili~~~~~~kl~d~g 145 (256)
T cd05113 71 QRPIYIVTEYMSNGCLLNYLREHGK--RFQPSQLLEMCKDVCEGMAYLE---SKQFIHRDLAARNCLVDDQGCVKVSDFG 145 (256)
T ss_pred CCCcEEEEEcCCCCcHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHH---hCCeeccccCcceEEEcCCCCEEECCCc
Confidence 4567999999999999999875332 4899999999999999999999 8999999999999999999999999999
Q ss_pred ceeecccCCCC-cccccccccccCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCC
Q 044494 83 VARLLNFDSSN-RTLLAGTYGYIAPELAYTMVVTEKSDVYSFGVVALEVLM-GKHPGELLS 141 (144)
Q Consensus 83 ~~~~~~~~~~~-~~~~~~~~~~~~pe~~~~~~~~~~~d~~slg~~l~~~~~-g~~p~~~~~ 141 (144)
.++........ .....++..|++||......++.++|+||+|++++++++ |..||...+
T Consensus 146 ~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~ 206 (256)
T cd05113 146 LSRYVLDDEYTSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFN 206 (256)
T ss_pred cceecCCCceeecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCC
Confidence 88754322111 111234567999999988888899999999999999998 999997654
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.1e-28 Score=175.10 Aligned_cols=131 Identities=31% Similarity=0.514 Sum_probs=113.4
Q ss_pred ceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeeecc
Q 044494 4 KCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADFGV 83 (144)
Q Consensus 4 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~~~ 83 (144)
..+.+|+-+|+|-+|+.+++..+ ..+...+...|++|++.|+.||| .++|+|+|+|..||++..++.|+|.|||+
T Consensus 460 p~~AIiTqwCeGsSLY~hlHv~e--tkfdm~~~idIAqQiaqGM~YLH---AK~IIHrDLKSnNIFl~~~~kVkIgDFGL 534 (678)
T KOG0193|consen 460 PPLAIITQWCEGSSLYTHLHVQE--TKFDMNTTIDIAQQIAQGMDYLH---AKNIIHRDLKSNNIFLHEDLKVKIGDFGL 534 (678)
T ss_pred CceeeeehhccCchhhhhccchh--hhhhHHHHHHHHHHHHHhhhhhh---hhhhhhhhccccceEEccCCcEEEecccc
Confidence 34478999999999999998644 34889999999999999999999 99999999999999999999999999999
Q ss_pred eeecccC--CCCcccccccccccCccccccC---CCCCcchhHHHHHHHHHHHhCCCCCCC
Q 044494 84 ARLLNFD--SSNRTLLAGTYGYIAPELAYTM---VVTEKSDVYSFGVVALEVLMGKHPGEL 139 (144)
Q Consensus 84 ~~~~~~~--~~~~~~~~~~~~~~~pe~~~~~---~~~~~~d~~slg~~l~~~~~g~~p~~~ 139 (144)
+..-... ........+...|||||++..+ +++..+|+||+|+++|||++|..||..
T Consensus 535 atvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi 595 (678)
T KOG0193|consen 535 ATVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSI 595 (678)
T ss_pred eeeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCC
Confidence 9865433 2233446788899999998843 588999999999999999999999984
|
|
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.4e-27 Score=170.15 Aligned_cols=108 Identities=28% Similarity=0.434 Sum_probs=91.9
Q ss_pred CCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeeecceeecccCCC--CcccccccccccCcc
Q 044494 30 GLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADFGVARLLNFDSS--NRTLLAGTYGYIAPE 107 (144)
Q Consensus 30 ~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~~~~~~~pe 107 (144)
.+++..+..++.|++.|++||| ..+++|+||||+||+++.++.++++|||++........ ......+++.|+|||
T Consensus 233 ~l~~~~~~~~~~qi~~aL~~LH---~~~ivH~dikp~Nill~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE 309 (400)
T cd05105 233 GLTTLDLLSFTYQVARGMEFLA---SKNCVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPE 309 (400)
T ss_pred CCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChHhEEEeCCCEEEEEeCCcceeccccccccccCCcCCCcceEChh
Confidence 3777888999999999999999 89999999999999999999999999999876532211 122234567899999
Q ss_pred ccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCC
Q 044494 108 LAYTMVVTEKSDVYSFGVVALEVLM-GKHPGELL 140 (144)
Q Consensus 108 ~~~~~~~~~~~d~~slg~~l~~~~~-g~~p~~~~ 140 (144)
.+....++.++|+||+|++++++++ |..||...
T Consensus 310 ~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~ 343 (400)
T cd05105 310 SIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGM 343 (400)
T ss_pred hhcCCCCCchhhHHHHHHHHHHHHHCCCCCCccc
Confidence 9988888999999999999999997 99998764
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=9.3e-28 Score=162.14 Aligned_cols=137 Identities=31% Similarity=0.485 Sum_probs=116.2
Q ss_pred CCceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeee
Q 044494 2 HRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADF 81 (144)
Q Consensus 2 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~ 81 (144)
.++..|+|+|++++++|.++++.......+++..+..++.|++.++.+|| +.+++|+|++|+||+++.++.++++||
T Consensus 70 ~~~~~~iv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh---~~~i~h~~l~p~ni~~~~~~~~~l~df 146 (267)
T cd06610 70 VGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLH---SNGQIHRDIKAGNILLGEDGSVKIADF 146 (267)
T ss_pred eCCEEEEEEeccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHhEEEcCCCCEEEccc
Confidence 35678999999999999999976433345899999999999999999999 899999999999999999999999999
Q ss_pred cceeecccCCCC----cccccccccccCccccccC-CCCCcchhHHHHHHHHHHHhCCCCCCCCC
Q 044494 82 GVARLLNFDSSN----RTLLAGTYGYIAPELAYTM-VVTEKSDVYSFGVVALEVLMGKHPGELLS 141 (144)
Q Consensus 82 ~~~~~~~~~~~~----~~~~~~~~~~~~pe~~~~~-~~~~~~d~~slg~~l~~~~~g~~p~~~~~ 141 (144)
|++......... .....++..|++||.+... .++.++|+||+|+++++|++|..||...+
T Consensus 147 ~~~~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~ 211 (267)
T cd06610 147 GVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYP 211 (267)
T ss_pred chHHHhccCccccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccC
Confidence 988765432221 1234578889999998776 67889999999999999999999997654
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.1e-27 Score=161.33 Aligned_cols=134 Identities=31% Similarity=0.417 Sum_probs=116.9
Q ss_pred CCceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeee
Q 044494 2 HRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADF 81 (144)
Q Consensus 2 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~ 81 (144)
.++..|+|+||+.+++|.+++.... .+++..+..++.|+++++.+|| +.+++|+|++|+||+++.++.++++||
T Consensus 71 ~~~~~~lv~e~~~~~~L~~~l~~~~---~l~~~~~~~~~~~i~~~l~~lh---~~~i~h~dl~~~nil~~~~~~~~l~d~ 144 (258)
T cd05578 71 DEENMYLVVDLLLGGDLRYHLSQKV---KFSEEQVKFWICEIVLALEYLH---SKGIIHRDIKPDNILLDEQGHVHITDF 144 (258)
T ss_pred CCCeEEEEEeCCCCCCHHHHHHhcC---CcCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHeEEcCCCCEEEeec
Confidence 3567899999999999999987642 3899999999999999999999 889999999999999999999999999
Q ss_pred cceeecccCCCCcccccccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCC
Q 044494 82 GVARLLNFDSSNRTLLAGTYGYIAPELAYTMVVTEKSDVYSFGVVALEVLMGKHPGELLSS 142 (144)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~d~~slg~~l~~~~~g~~p~~~~~~ 142 (144)
|.+....... ......++..|++||.+....++.++|+||+|++++++++|..||...+.
T Consensus 145 ~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~ 204 (258)
T cd05578 145 NIATKVTPDT-LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSR 204 (258)
T ss_pred ccccccCCCc-cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCc
Confidence 9887654322 22335577889999999988889999999999999999999999987653
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.5e-27 Score=161.78 Aligned_cols=136 Identities=27% Similarity=0.355 Sum_probs=108.5
Q ss_pred CceEEEEEeeccCCCHHHHhhccc--ccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEee
Q 044494 3 RKCMFLIYEYMEMGSLFCVLRTDE--EAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVAD 80 (144)
Q Consensus 3 ~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d 80 (144)
...+++||||+++|+|.+++.... .....++..+..++.|++.++.+|| +.+++|+|+||+|++++.++.++++|
T Consensus 67 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~i~H~dlkp~nil~~~~~~~kL~d 143 (269)
T cd05087 67 VTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLH---KNNFIHSDLALRNCLLTADLTVKIGD 143 (269)
T ss_pred CCCcEEEEECCCCCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHH---HCCEeccccCcceEEEcCCCcEEECC
Confidence 456789999999999999987532 2223567777889999999999999 89999999999999999999999999
Q ss_pred ecceeecccCCC--CcccccccccccCccccccC-------CCCCcchhHHHHHHHHHHHh-CCCCCCCCC
Q 044494 81 FGVARLLNFDSS--NRTLLAGTYGYIAPELAYTM-------VVTEKSDVYSFGVVALEVLM-GKHPGELLS 141 (144)
Q Consensus 81 ~~~~~~~~~~~~--~~~~~~~~~~~~~pe~~~~~-------~~~~~~d~~slg~~l~~~~~-g~~p~~~~~ 141 (144)
||.+........ ......++..|+|||++... .++.++|+||+|++++++++ |..||...+
T Consensus 144 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~ 214 (269)
T cd05087 144 YGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLS 214 (269)
T ss_pred ccccccccCcceeecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCC
Confidence 998865432211 11223466789999988643 34678999999999999996 999997643
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.2e-27 Score=162.17 Aligned_cols=134 Identities=28% Similarity=0.397 Sum_probs=111.0
Q ss_pred eEEEEEeeccCCCHHHHhhcc---cccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeee
Q 044494 5 CMFLIYEYMEMGSLFCVLRTD---EEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADF 81 (144)
Q Consensus 5 ~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~ 81 (144)
..+++|||+++|+|.+++... .....+++..+..++.|++.|+.+|| +.+++|+|+||+||+++.++.++++||
T Consensus 80 ~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Df 156 (272)
T cd05075 80 SPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLS---SKSFIHRDLAARNCMLNENMNVCVADF 156 (272)
T ss_pred CcEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHH---HCCeeccccchhheEEcCCCCEEECCC
Confidence 468999999999999887431 12234889999999999999999999 899999999999999999999999999
Q ss_pred cceeecccCCC--CcccccccccccCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCC
Q 044494 82 GVARLLNFDSS--NRTLLAGTYGYIAPELAYTMVVTEKSDVYSFGVVALEVLM-GKHPGELLS 141 (144)
Q Consensus 82 ~~~~~~~~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~d~~slg~~l~~~~~-g~~p~~~~~ 141 (144)
|++........ .......++.|++||......++.++|+||+|++++++++ |..||...+
T Consensus 157 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~ 219 (272)
T cd05075 157 GLSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVE 219 (272)
T ss_pred CcccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCC
Confidence 99886542221 1122345668999999998888999999999999999998 889997643
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.95 E-value=7.7e-28 Score=164.87 Aligned_cols=136 Identities=27% Similarity=0.409 Sum_probs=112.5
Q ss_pred CceEEEEEeeccCCCHHHHhhcc-------------cccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEE
Q 044494 3 RKCMFLIYEYMEMGSLFCVLRTD-------------EEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNIL 69 (144)
Q Consensus 3 ~~~~~lv~e~~~~~~L~~~l~~~-------------~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~ 69 (144)
++.++++|||+++++|.++++.. .....+++..+..++.|++.++++|| +.+++|+||+|.||+
T Consensus 88 ~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH---~~~ivH~dlkp~Nil 164 (293)
T cd05053 88 EGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLA---SKKCIHRDLAARNVL 164 (293)
T ss_pred CCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHH---HCCccccccceeeEE
Confidence 45789999999999999998642 12345889999999999999999999 899999999999999
Q ss_pred EcCCCCeEEeeecceeecccCCC--CcccccccccccCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCC
Q 044494 70 LNLELEAFVADFGVARLLNFDSS--NRTLLAGTYGYIAPELAYTMVVTEKSDVYSFGVVALEVLM-GKHPGELLS 141 (144)
Q Consensus 70 ~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~d~~slg~~l~~~~~-g~~p~~~~~ 141 (144)
++.++.++++|||++........ ......++..|+|||......++.++|+||+|+++|++++ |..||...+
T Consensus 165 ~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~ 239 (293)
T cd05053 165 VTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIP 239 (293)
T ss_pred EcCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCC
Confidence 99999999999999876542211 1111224567999999988888999999999999999997 999987643
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.5e-27 Score=163.78 Aligned_cols=131 Identities=26% Similarity=0.432 Sum_probs=113.4
Q ss_pred CceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeeec
Q 044494 3 RKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADFG 82 (144)
Q Consensus 3 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~~ 82 (144)
++..++||||+++++|.+++... .+++..+..++.|++.++++|| +.|++|+|++|+||+++.++.++++|||
T Consensus 89 ~~~~~lv~e~~~~~~L~~~~~~~----~~~~~~~~~~~~ql~~~l~~lH---~~givH~dl~p~Nilv~~~~~~~l~dfg 161 (292)
T cd06657 89 GDELWVVMEFLEGGALTDIVTHT----RMNEEQIAAVCLAVLKALSVLH---AQGVIHRDIKSDSILLTHDGRVKLSDFG 161 (292)
T ss_pred CCEEEEEEecCCCCcHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEEcccc
Confidence 56789999999999999877542 2788999999999999999999 8899999999999999999999999999
Q ss_pred ceeecccCCCCcccccccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCC
Q 044494 83 VARLLNFDSSNRTLLAGTYGYIAPELAYTMVVTEKSDVYSFGVVALEVLMGKHPGELL 140 (144)
Q Consensus 83 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~d~~slg~~l~~~~~g~~p~~~~ 140 (144)
.+..............+++.|++||......++.++|+||+|++++++++|..||...
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~ 219 (292)
T cd06657 162 FCAQVSKEVPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNE 219 (292)
T ss_pred cceecccccccccccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 8876543333333456788999999998888889999999999999999999999754
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.6e-27 Score=160.82 Aligned_cols=135 Identities=32% Similarity=0.475 Sum_probs=112.4
Q ss_pred CceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeeec
Q 044494 3 RKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADFG 82 (144)
Q Consensus 3 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~~ 82 (144)
.+..|++|||+++++|.+++.... ...+++.++..++.+++.++.+|| +.+++|+||+|.||+++.++.++++|||
T Consensus 72 ~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~al~~lH---~~~i~H~di~p~Nili~~~~~~~l~dfg 147 (260)
T cd05070 72 EEPIYIVTEYMSKGSLLDFLKDGE-GRALKLPNLVDMAAQVAAGMAYIE---RMNYIHRDLRSANILVGDGLVCKIADFG 147 (260)
T ss_pred CCCcEEEEEecCCCcHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCccceEEEeCCceEEeCCce
Confidence 456789999999999999987532 234889999999999999999999 8899999999999999999999999999
Q ss_pred ceeecccCCC-CcccccccccccCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCC
Q 044494 83 VARLLNFDSS-NRTLLAGTYGYIAPELAYTMVVTEKSDVYSFGVVALEVLM-GKHPGELLS 141 (144)
Q Consensus 83 ~~~~~~~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~d~~slg~~l~~~~~-g~~p~~~~~ 141 (144)
.+........ ......++..|+|||......++.++|+||+|++++++++ |..||...+
T Consensus 148 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~ 208 (260)
T cd05070 148 LARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMN 208 (260)
T ss_pred eeeeccCcccccccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCC
Confidence 9976542211 1112234567999999988888899999999999999999 899997654
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.5e-27 Score=161.52 Aligned_cols=135 Identities=34% Similarity=0.483 Sum_probs=112.5
Q ss_pred CCceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeee
Q 044494 2 HRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADF 81 (144)
Q Consensus 2 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~ 81 (144)
+++.+|+||||+++++|.+++.+... .++..++..++.|++.++.+|| +.+++|+|++|+|++++.++.++++||
T Consensus 76 ~~~~~~lv~e~~~~~~L~~~~~~~~~--~~~~~~~~~i~~~i~~~l~~lH---~~~i~h~dlkp~nili~~~~~~~l~df 150 (267)
T cd05066 76 KSKPVMIVTEYMENGSLDAFLRKHDG--QFTVIQLVGMLRGIASGMKYLS---DMGYVHRDLAARNILVNSNLVCKVSDF 150 (267)
T ss_pred cCCccEEEEEcCCCCCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHH---HCCEeehhhchhcEEECCCCeEEeCCC
Confidence 35678999999999999999875332 3788999999999999999999 899999999999999999999999999
Q ss_pred cceeecccCCCCcc---cccccccccCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCC
Q 044494 82 GVARLLNFDSSNRT---LLAGTYGYIAPELAYTMVVTEKSDVYSFGVVALEVLM-GKHPGELLS 141 (144)
Q Consensus 82 ~~~~~~~~~~~~~~---~~~~~~~~~~pe~~~~~~~~~~~d~~slg~~l~~~~~-g~~p~~~~~ 141 (144)
|.+........... ....+..|++||.+.+..++.++|+||+|++++++++ |..||...+
T Consensus 151 g~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~ 214 (267)
T cd05066 151 GLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMS 214 (267)
T ss_pred CcccccccccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCC
Confidence 98876543221111 1122457999999998888999999999999999886 999997654
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.8e-27 Score=160.56 Aligned_cols=133 Identities=29% Similarity=0.392 Sum_probs=108.6
Q ss_pred CceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeeec
Q 044494 3 RKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADFG 82 (144)
Q Consensus 3 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~~ 82 (144)
++..++||||+.+++|.+++.+... ..++..+..++.|++.|+.+|| +.+++|+||+|+||+++.++.++++|||
T Consensus 69 ~~~~~lv~e~~~~~~L~~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlk~~nili~~~~~~kl~dfg 143 (262)
T cd05058 69 EGSPLVVLPYMKHGDLRNFIRSETH--NPTVKDLIGFGLQVAKGMEYLA---SKKFVHRDLAARNCMLDESFTVKVADFG 143 (262)
T ss_pred CCCcEEEEecCCCCCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHH---hCCccccccCcceEEEcCCCcEEECCcc
Confidence 4567899999999999999875322 2577778889999999999999 8899999999999999999999999999
Q ss_pred ceeecccCC----CCcccccccccccCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCC
Q 044494 83 VARLLNFDS----SNRTLLAGTYGYIAPELAYTMVVTEKSDVYSFGVVALEVLM-GKHPGELL 140 (144)
Q Consensus 83 ~~~~~~~~~----~~~~~~~~~~~~~~pe~~~~~~~~~~~d~~slg~~l~~~~~-g~~p~~~~ 140 (144)
+++...... .......++..|+|||......++.++|+||+|++++++++ |..||...
T Consensus 144 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~ 206 (262)
T cd05058 144 LARDIYDKEYYSVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDV 206 (262)
T ss_pred ccccccCCcceeecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCC
Confidence 987543211 11122345668999999988888999999999999999999 56677643
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.9e-27 Score=162.76 Aligned_cols=133 Identities=23% Similarity=0.325 Sum_probs=110.3
Q ss_pred CceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeeec
Q 044494 3 RKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADFG 82 (144)
Q Consensus 3 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~~ 82 (144)
++..++||||+.+ +|.+++.+... .+++..+..++.|++.|+.+|| +.+++|+||+|+||+++.++.++++|||
T Consensus 75 ~~~~~lv~e~~~~-~L~~~~~~~~~--~~~~~~~~~~~~ql~~al~~lH---~~~i~H~dl~p~nil~~~~~~~kl~dfg 148 (291)
T cd07844 75 KKTLTLVFEYLDT-DLKQYMDDCGG--GLSMHNVRLFLFQLLRGLAYCH---QRRVLHRDLKPQNLLISERGELKLADFG 148 (291)
T ss_pred CCeEEEEEecCCC-CHHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHH---hCCeecccCCHHHEEEcCCCCEEECccc
Confidence 5678999999975 89988875332 4889999999999999999999 8999999999999999999999999999
Q ss_pred ceeecccCCCCcccccccccccCcccccc-CCCCCcchhHHHHHHHHHHHhCCCCCCCCC
Q 044494 83 VARLLNFDSSNRTLLAGTYGYIAPELAYT-MVVTEKSDVYSFGVVALEVLMGKHPGELLS 141 (144)
Q Consensus 83 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~-~~~~~~~d~~slg~~l~~~~~g~~p~~~~~ 141 (144)
++..............++..|+|||...+ ..++.++|+||+|+++++|++|..||...+
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~ 208 (291)
T cd07844 149 LARAKSVPSKTYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGST 208 (291)
T ss_pred cccccCCCCccccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCc
Confidence 88754322222222345778999998875 457888999999999999999999996543
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.1e-27 Score=160.84 Aligned_cols=134 Identities=36% Similarity=0.469 Sum_probs=111.1
Q ss_pred CceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeeec
Q 044494 3 RKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADFG 82 (144)
Q Consensus 3 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~~ 82 (144)
.+..|+||||+++++|.+++.... ..+++..+..++.|++.|+++|| +.+++|+|++|+||+++.++.++++|||
T Consensus 78 ~~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~l~~al~~lH---~~~i~H~dlkp~Nili~~~~~~kl~dfg 152 (268)
T cd05063 78 FKPAMIITEYMENGALDKYLRDHD--GEFSSYQLVGMLRGIAAGMKYLS---DMNYVHRDLAARNILVNSNLECKVSDFG 152 (268)
T ss_pred CCCcEEEEEcCCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHH---HCCeeccccchhhEEEcCCCcEEECCCc
Confidence 456899999999999999987532 23889999999999999999999 8899999999999999999999999999
Q ss_pred ceeecccCCCCcc---cccccccccCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCC
Q 044494 83 VARLLNFDSSNRT---LLAGTYGYIAPELAYTMVVTEKSDVYSFGVVALEVLM-GKHPGELLS 141 (144)
Q Consensus 83 ~~~~~~~~~~~~~---~~~~~~~~~~pe~~~~~~~~~~~d~~slg~~l~~~~~-g~~p~~~~~ 141 (144)
++........... ....++.|++||.+....++.++|+||+|+++|++++ |..||...+
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~ 215 (268)
T cd05063 153 LSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMS 215 (268)
T ss_pred cceecccccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCC
Confidence 9876542221111 1122356999999988888899999999999999997 999996543
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.4e-27 Score=163.24 Aligned_cols=134 Identities=30% Similarity=0.476 Sum_probs=115.5
Q ss_pred CceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeeec
Q 044494 3 RKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADFG 82 (144)
Q Consensus 3 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~~ 82 (144)
.+..|+|+||+++++|.+++.... ..+++..+..++.+++.++.+|| +.|++|+|++|+||+++.++.++++||+
T Consensus 87 ~~~~~lv~e~~~~~~L~~~l~~~~--~~l~~~~~~~i~~~i~~~L~~lH---~~gi~H~dl~p~ni~i~~~~~~~l~d~~ 161 (286)
T cd06614 87 GDELWVVMEYMDGGSLTDIITQNF--VRMNEPQIAYVCREVLQGLEYLH---SQNVIHRDIKSDNILLSKDGSVKLADFG 161 (286)
T ss_pred CCEEEEEEeccCCCcHHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCChhhEEEcCCCCEEECccc
Confidence 467899999999999999998643 24899999999999999999999 8999999999999999999999999999
Q ss_pred ceeecccCCCCcccccccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCC
Q 044494 83 VARLLNFDSSNRTLLAGTYGYIAPELAYTMVVTEKSDVYSFGVVALEVLMGKHPGELLS 141 (144)
Q Consensus 83 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~d~~slg~~l~~~~~g~~p~~~~~ 141 (144)
.+..............+++.|++||.+....++.++|+||+|++++++++|..||...+
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~ 220 (286)
T cd06614 162 FAAQLTKEKSKRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREP 220 (286)
T ss_pred hhhhhccchhhhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCC
Confidence 87654433222333457788999999988888899999999999999999999997654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.2e-27 Score=159.93 Aligned_cols=132 Identities=29% Similarity=0.442 Sum_probs=113.8
Q ss_pred CceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeeec
Q 044494 3 RKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADFG 82 (144)
Q Consensus 3 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~~ 82 (144)
++..|+++||+++++|.+++.+.. .+++..+..++.|++.++.+|| +.+++|+||+|+||+++.++.++++|||
T Consensus 65 ~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~~L~~lH---~~~i~H~di~~~nil~~~~~~~~l~dfg 138 (265)
T cd05579 65 KKNLYLVMEYLPGGDLASLLENVG---SLDEDVARIYIAEIVLALEYLH---SNGIIHRDLKPDNILIDSNGHLKLTDFG 138 (265)
T ss_pred CcEEEEEEecCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHH---HcCeecCCCCHHHeEEcCCCCEEEEecc
Confidence 567899999999999999987644 3899999999999999999999 8999999999999999999999999999
Q ss_pred ceeecccCCC--------CcccccccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCC
Q 044494 83 VARLLNFDSS--------NRTLLAGTYGYIAPELAYTMVVTEKSDVYSFGVVALEVLMGKHPGELL 140 (144)
Q Consensus 83 ~~~~~~~~~~--------~~~~~~~~~~~~~pe~~~~~~~~~~~d~~slg~~l~~~~~g~~p~~~~ 140 (144)
++........ ......++..|++||.......+.++|+||+|++++++++|..||...
T Consensus 139 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~ 204 (265)
T cd05579 139 LSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGE 204 (265)
T ss_pred cchhcccCcccccccccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCC
Confidence 8875432211 222345677899999998888888999999999999999999999754
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.5e-27 Score=159.73 Aligned_cols=138 Identities=28% Similarity=0.390 Sum_probs=116.8
Q ss_pred CceEEEEEeeccCCCHHHHhhcc-cccCCCCHHHHHHHHHHHHHHHHHHhcCC--CCCeEecCCCCCcEEEcCCCCeEEe
Q 044494 3 RKCMFLIYEYMEMGSLFCVLRTD-EEAVGLDWAKRVNIVKGMAHALSYLHHDC--TPPIVHRDISSNNILLNLELEAFVA 79 (144)
Q Consensus 3 ~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--~~~~~h~~i~~~ni~~~~~~~~~l~ 79 (144)
+...+++|||+++++|.+++... .....+++..++.++.+++.++.+||..+ +.+++|+||+|+||+++.++.++++
T Consensus 73 ~~~~~~~~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~ 152 (265)
T cd08217 73 NQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLG 152 (265)
T ss_pred CCEEEEEehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEe
Confidence 45679999999999999998652 22334899999999999999999999443 5689999999999999999999999
Q ss_pred eecceeecccCCCCcccccccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCC
Q 044494 80 DFGVARLLNFDSSNRTLLAGTYGYIAPELAYTMVVTEKSDVYSFGVVALEVLMGKHPGELL 140 (144)
Q Consensus 80 d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~d~~slg~~l~~~~~g~~p~~~~ 140 (144)
|||.+..............+++.|++||.+....++.++|+||+|++++++++|..||...
T Consensus 153 d~g~~~~~~~~~~~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~ 213 (265)
T cd08217 153 DFGLAKILGHDSSFAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTAR 213 (265)
T ss_pred cccccccccCCcccccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCc
Confidence 9999987654333233456788999999998888888999999999999999999999765
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.2e-27 Score=159.97 Aligned_cols=135 Identities=28% Similarity=0.370 Sum_probs=110.9
Q ss_pred CceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcC-CCCeEEeee
Q 044494 3 RKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNL-ELEAFVADF 81 (144)
Q Consensus 3 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~-~~~~~l~d~ 81 (144)
++.+++|+||+++++|.+++.........++..+..++.|++.++.+|| +.+++|+|++|+||+++. .+.++++||
T Consensus 77 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~i~h~dl~p~nil~~~~~~~~~l~df 153 (268)
T cd06624 77 NGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLH---DNQIVHRDIKGDNVLVNTYSGVVKISDF 153 (268)
T ss_pred CCEEEEEEecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHH---HCCEeecCCCHHHEEEcCCCCeEEEecc
Confidence 4678999999999999999875322211378888999999999999999 899999999999999976 678999999
Q ss_pred cceeecccCCCCcccccccccccCccccccCC--CCCcchhHHHHHHHHHHHhCCCCCCCC
Q 044494 82 GVARLLNFDSSNRTLLAGTYGYIAPELAYTMV--VTEKSDVYSFGVVALEVLMGKHPGELL 140 (144)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~--~~~~~d~~slg~~l~~~~~g~~p~~~~ 140 (144)
|.+..............+++.|++||.+.... ++.++|+||+|++++++++|..||...
T Consensus 154 g~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~ 214 (268)
T cd06624 154 GTSKRLAGINPCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIEL 214 (268)
T ss_pred hhheecccCCCccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccc
Confidence 98876543233233345788999999986543 678999999999999999999999754
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.8e-27 Score=160.34 Aligned_cols=134 Identities=25% Similarity=0.370 Sum_probs=111.4
Q ss_pred eEEEEEeeccCCCHHHHhhcc---cccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeee
Q 044494 5 CMFLIYEYMEMGSLFCVLRTD---EEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADF 81 (144)
Q Consensus 5 ~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~ 81 (144)
..++++||+++++|..++... .....+++..+..++.|++.|+.+|| +.+++|+|+||+||+++.++.++++||
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~df 157 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLS---NRNFIHRDLAARNCMLREDMTVCVADF 157 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHH---hCCeeccccchheEEECCCCeEEECCc
Confidence 478999999999999988542 12235899999999999999999999 899999999999999999999999999
Q ss_pred cceeecccCCCC--cccccccccccCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCC
Q 044494 82 GVARLLNFDSSN--RTLLAGTYGYIAPELAYTMVVTEKSDVYSFGVVALEVLM-GKHPGELLS 141 (144)
Q Consensus 82 ~~~~~~~~~~~~--~~~~~~~~~~~~pe~~~~~~~~~~~d~~slg~~l~~~~~-g~~p~~~~~ 141 (144)
|+++........ ......+..|++||.+....++.++|+||+|++++|+++ |..||...+
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~ 220 (273)
T cd05035 158 GLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVE 220 (273)
T ss_pred cceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCC
Confidence 998865432211 111234567999999988888999999999999999999 999997644
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.6e-27 Score=161.36 Aligned_cols=133 Identities=29% Similarity=0.445 Sum_probs=112.1
Q ss_pred ceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeeecc
Q 044494 4 KCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADFGV 83 (144)
Q Consensus 4 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~~~ 83 (144)
...++||||+++|+|.+++..... .+++..+..++.|++.|+.+|| +.+++|+||+|+||+++.++.++++|||.
T Consensus 81 ~~~~~v~e~~~~g~L~~~l~~~~~--~~~~~~~~~~~~qi~~~l~~LH---~~~i~H~di~p~nil~~~~~~~kL~dfg~ 155 (279)
T cd05057 81 SQVQLITQLMPLGCLLDYVRNHKD--NIGSQYLLNWCVQIAKGMSYLE---EKRLVHRDLAARNVLVKTPQHVKITDFGL 155 (279)
T ss_pred CceEEEEecCCCCcHHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHH---hCCEEecccCcceEEEcCCCeEEECCCcc
Confidence 467899999999999999875332 2899999999999999999999 89999999999999999999999999999
Q ss_pred eeecccCCCCc--ccccccccccCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCC
Q 044494 84 ARLLNFDSSNR--TLLAGTYGYIAPELAYTMVVTEKSDVYSFGVVALEVLM-GKHPGELLS 141 (144)
Q Consensus 84 ~~~~~~~~~~~--~~~~~~~~~~~pe~~~~~~~~~~~d~~slg~~l~~~~~-g~~p~~~~~ 141 (144)
+.......... ....++..|++||......++.++|+||+|++++++++ |..||+..+
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~ 216 (279)
T cd05057 156 AKLLDVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIP 216 (279)
T ss_pred cccccCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCC
Confidence 87654322111 11223467999999988888899999999999999998 999998754
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.8e-27 Score=162.46 Aligned_cols=133 Identities=28% Similarity=0.304 Sum_probs=111.7
Q ss_pred CceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeeec
Q 044494 3 RKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADFG 82 (144)
Q Consensus 3 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~~ 82 (144)
++.+++||||+ +++|.+++.... ..+++..+..++.|++++|.+|| +.+++|+||+|+||+++.++.++++|||
T Consensus 74 ~~~~~lv~e~~-~~~L~~~i~~~~--~~~~~~~~~~~~~qi~~al~~lH---~~~i~H~dl~p~nill~~~~~~~l~dfg 147 (298)
T cd07841 74 KSNINLVFEFM-ETDLEKVIKDKS--IVLTPADIKSYMLMTLRGLEYLH---SNWILHRDLKPNNLLIASDGVLKLADFG 147 (298)
T ss_pred CCEEEEEEccc-CCCHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHH---hCCeeecCCChhhEEEcCCCCEEEccce
Confidence 46789999999 889999987543 24899999999999999999999 8999999999999999999999999999
Q ss_pred ceeecccCCCCcccccccccccCcccccc-CCCCCcchhHHHHHHHHHHHhCCCCCCCCC
Q 044494 83 VARLLNFDSSNRTLLAGTYGYIAPELAYT-MVVTEKSDVYSFGVVALEVLMGKHPGELLS 141 (144)
Q Consensus 83 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~-~~~~~~~d~~slg~~l~~~~~g~~p~~~~~ 141 (144)
++..............+++.|+|||.+.. ..++.++|+||+|++++++++|..||...+
T Consensus 148 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~ 207 (298)
T cd07841 148 LARSFGSPNRKMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDS 207 (298)
T ss_pred eeeeccCCCccccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCc
Confidence 99876543333333456778999998854 356788999999999999999988776543
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.3e-27 Score=159.72 Aligned_cols=129 Identities=26% Similarity=0.366 Sum_probs=109.5
Q ss_pred ceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCC-------Ce
Q 044494 4 KCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLEL-------EA 76 (144)
Q Consensus 4 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~-------~~ 76 (144)
...++||||+++++|.+++..... .++...+..++.|++.++++|| +++++|+||||+||+++.++ .+
T Consensus 73 ~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dlkp~Nill~~~~~~~~~~~~~ 147 (259)
T cd05037 73 DENIMVEEYVKFGPLDVFLHREKN--NVSLHWKLDVAKQLASALHYLE---DKKLVHGNVCGKNILVARYGLNEGYVPFI 147 (259)
T ss_pred CCcEEEEEcCCCCcHHHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHh---hCCeecccCccceEEEecCccccCCceeE
Confidence 456899999999999999976432 4889999999999999999999 89999999999999999887 78
Q ss_pred EEeeecceeecccCCCCcccccccccccCccccccC--CCCCcchhHHHHHHHHHHHh-CCCCCCCCC
Q 044494 77 FVADFGVARLLNFDSSNRTLLAGTYGYIAPELAYTM--VVTEKSDVYSFGVVALEVLM-GKHPGELLS 141 (144)
Q Consensus 77 ~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~--~~~~~~d~~slg~~l~~~~~-g~~p~~~~~ 141 (144)
+++|||++..... .....+...|++||.+... .++.++|+||+|++++++++ |..||...+
T Consensus 148 kl~Dfg~a~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~ 211 (259)
T cd05037 148 KLSDPGIPITVLS----REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLS 211 (259)
T ss_pred EeCCCCccccccc----ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCC
Confidence 9999998876432 2234456789999998876 67889999999999999999 678887653
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.7e-27 Score=159.75 Aligned_cols=135 Identities=30% Similarity=0.456 Sum_probs=112.4
Q ss_pred CceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeeec
Q 044494 3 RKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADFG 82 (144)
Q Consensus 3 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~~ 82 (144)
.+..+++|||+.+++|.+++.... ...+++..+..++.|++.++.+|| +.+++|+||+|+|++++.++.++++|||
T Consensus 72 ~~~~~~v~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~al~~lH---~~~i~H~dl~~~Nill~~~~~~~l~dfg 147 (260)
T cd05069 72 EEPIYIVTEFMGKGSLLDFLKEGD-GKYLKLPQLVDMAAQIADGMAYIE---RMNYIHRDLRAANILVGDNLVCKIADFG 147 (260)
T ss_pred CCCcEEEEEcCCCCCHHHHHhhCC-CCCCCHHHHHHHHHHHHHHHHHHH---hCCEeecccCcceEEEcCCCeEEECCCc
Confidence 345789999999999999997532 234788999999999999999999 8899999999999999999999999999
Q ss_pred ceeecccCCC-CcccccccccccCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCC
Q 044494 83 VARLLNFDSS-NRTLLAGTYGYIAPELAYTMVVTEKSDVYSFGVVALEVLM-GKHPGELLS 141 (144)
Q Consensus 83 ~~~~~~~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~d~~slg~~l~~~~~-g~~p~~~~~ 141 (144)
.+........ ......++..|++||.......+.++|+||+|+++|++++ |..||....
T Consensus 148 ~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~ 208 (260)
T cd05069 148 LARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMV 208 (260)
T ss_pred cceEccCCcccccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCC
Confidence 9876532211 1122335567999999988888899999999999999999 999997643
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.8e-27 Score=158.75 Aligned_cols=135 Identities=25% Similarity=0.368 Sum_probs=111.9
Q ss_pred CCceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeee
Q 044494 2 HRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADF 81 (144)
Q Consensus 2 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~ 81 (144)
..++.++||||+++++|.+++..... .++...+..++.+++.++.+|| +++++|+||+|+||+++.++.++++||
T Consensus 63 ~~~~~~~v~e~~~~~~l~~~l~~~~~--~~~~~~~~~~~~~~~~~l~~lH---~~~i~h~di~p~nili~~~~~~~l~d~ 137 (251)
T cd05041 63 QKQPIYIVMELVPGGSLLTFLRKKKN--RLTVKKLLQMSLDAAAGMEYLE---SKNCIHRDLAARNCLVGENNVLKISDF 137 (251)
T ss_pred cCCCeEEEEEcCCCCcHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHH---hCCEehhhcCcceEEEcCCCcEEEeec
Confidence 35678999999999999999865322 3788999999999999999999 899999999999999999999999999
Q ss_pred cceeecccCCC--CcccccccccccCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCC
Q 044494 82 GVARLLNFDSS--NRTLLAGTYGYIAPELAYTMVVTEKSDVYSFGVVALEVLM-GKHPGELLS 141 (144)
Q Consensus 82 ~~~~~~~~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~d~~slg~~l~~~~~-g~~p~~~~~ 141 (144)
|.+........ .......+..|+|||.+.+..++.++|+||+|++++++++ |..||...+
T Consensus 138 g~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~ 200 (251)
T cd05041 138 GMSREEEGGIYTVSDGLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMS 200 (251)
T ss_pred cccccccCCcceeccccCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCC
Confidence 98875432111 1111223456999999988888999999999999999998 889997654
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.7e-28 Score=174.45 Aligned_cols=131 Identities=27% Similarity=0.436 Sum_probs=118.2
Q ss_pred CceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeeec
Q 044494 3 RKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADFG 82 (144)
Q Consensus 3 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~~ 82 (144)
...+|+||||..+|.+++++.+.+. ..+..+..+..|++.+++||| +++++|||+|++|++++.+..++|+|||
T Consensus 127 ~~~lylV~eya~~ge~~~yl~~~gr---~~e~~ar~~F~q~vsaveYcH---~k~ivHrdLk~eNilL~~~mnikIaDfg 200 (596)
T KOG0586|consen 127 EATLYLVMEYASGGELFDYLVKHGR---MKEKEARAKFRQIVSAVEYCH---SKNIVHRDLKAENILLDENMNIKIADFG 200 (596)
T ss_pred cceeEEEEEeccCchhHHHHHhccc---chhhhhhhhhHHHHHHHHHHh---hcceeccccchhhcccccccceeeeccc
Confidence 4678999999999999999987665 555777888999999999999 9999999999999999999999999999
Q ss_pred ceeecccCCCCcccccccccccCccccccCCC-CCcchhHHHHHHHHHHHhCCCCCCCC
Q 044494 83 VARLLNFDSSNRTLLAGTYGYIAPELAYTMVV-TEKSDVYSFGVVALEVLMGKHPGELL 140 (144)
Q Consensus 83 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~-~~~~d~~slg~~l~~~~~g~~p~~~~ 140 (144)
++..+. ......+.+|++.|.|||++.+..+ .++.|+|++|+++|.++.|..||++.
T Consensus 201 fS~~~~-~~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~ 258 (596)
T KOG0586|consen 201 FSTFFD-YGLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQ 258 (596)
T ss_pred cceeec-ccccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCc
Confidence 999876 4455677889999999999999887 57899999999999999999999963
|
|
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.6e-27 Score=161.44 Aligned_cols=131 Identities=28% Similarity=0.404 Sum_probs=110.7
Q ss_pred CceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeeec
Q 044494 3 RKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADFG 82 (144)
Q Consensus 3 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~~ 82 (144)
++.+|+||||+++++|.+++..... +++..+..++.|++.++.+|| +.+++|+||+|+||+++.++.++++|||
T Consensus 77 ~~~~~lv~e~~~~~~L~~~l~~~~~---l~~~~~~~~~~qi~~al~~lH---~~~i~H~dl~p~nil~~~~~~~kl~dfg 150 (290)
T cd05613 77 DTKLHLILDYINGGELFTHLSQRER---FKEQEVQIYSGEIVLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFG 150 (290)
T ss_pred CCeEEEEEecCCCCcHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHeEECCCCCEEEeeCc
Confidence 4578999999999999999876433 788999999999999999999 8999999999999999999999999999
Q ss_pred ceeecccCCC-CcccccccccccCccccccC--CCCCcchhHHHHHHHHHHHhCCCCCCC
Q 044494 83 VARLLNFDSS-NRTLLAGTYGYIAPELAYTM--VVTEKSDVYSFGVVALEVLMGKHPGEL 139 (144)
Q Consensus 83 ~~~~~~~~~~-~~~~~~~~~~~~~pe~~~~~--~~~~~~d~~slg~~l~~~~~g~~p~~~ 139 (144)
++........ ......++..|++||..... .++.++|+||+|++++++++|..||..
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~ 210 (290)
T cd05613 151 LSKEFHEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTV 210 (290)
T ss_pred cceecccccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCc
Confidence 8876542211 12234578899999998753 356789999999999999999999964
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.5e-27 Score=162.15 Aligned_cols=136 Identities=25% Similarity=0.350 Sum_probs=110.5
Q ss_pred CceEEEEEeeccCCCHHHHhhcccc-------cCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCC
Q 044494 3 RKCMFLIYEYMEMGSLFCVLRTDEE-------AVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELE 75 (144)
Q Consensus 3 ~~~~~lv~e~~~~~~L~~~l~~~~~-------~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~ 75 (144)
++..|+||||+++|+|.++++.... ........+..++.|++.++.+|| +++++|+||||+||+++.++.
T Consensus 81 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~i~H~dikp~nili~~~~~ 157 (288)
T cd05061 81 GQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLN---AKKFVHRDLAARNCMVAHDFT 157 (288)
T ss_pred CCCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCCcCCCCChheEEEcCCCc
Confidence 4568999999999999999975221 223566778889999999999999 899999999999999999999
Q ss_pred eEEeeecceeecccCCCC--cccccccccccCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCC
Q 044494 76 AFVADFGVARLLNFDSSN--RTLLAGTYGYIAPELAYTMVVTEKSDVYSFGVVALEVLM-GKHPGELLS 141 (144)
Q Consensus 76 ~~l~d~~~~~~~~~~~~~--~~~~~~~~~~~~pe~~~~~~~~~~~d~~slg~~l~~~~~-g~~p~~~~~ 141 (144)
++++|||+++........ .....++..|++||.+....++.++|+||+|++++++++ |..||...+
T Consensus 158 ~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~ 226 (288)
T cd05061 158 VKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLS 226 (288)
T ss_pred EEECcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCC
Confidence 999999988754321111 111234567999999988888999999999999999998 788997644
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.9e-27 Score=156.95 Aligned_cols=134 Identities=30% Similarity=0.442 Sum_probs=116.5
Q ss_pred CCceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeee
Q 044494 2 HRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADF 81 (144)
Q Consensus 2 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~ 81 (144)
.++.+++||||+++++|.+++.... .+++..+..++.|++.++.+|| +.+++|+||+|.||+++.++.++++||
T Consensus 64 ~~~~~~~v~e~~~~~~L~~~l~~~~---~l~~~~~~~~~~qi~~~l~~lh---~~~~~H~~l~p~ni~~~~~~~~~l~d~ 137 (250)
T cd05123 64 TEEKLYLVLEYAPGGELFSHLSKEG---RFSEERARFYAAEIVLALEYLH---SLGIIYRDLKPENILLDADGHIKLTDF 137 (250)
T ss_pred cCCeeEEEEecCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCcceEEEcCCCcEEEeec
Confidence 3567899999999999999997643 3899999999999999999999 899999999999999999999999999
Q ss_pred cceeecccCCCCcccccccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCC
Q 044494 82 GVARLLNFDSSNRTLLAGTYGYIAPELAYTMVVTEKSDVYSFGVVALEVLMGKHPGELLS 141 (144)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~d~~slg~~l~~~~~g~~p~~~~~ 141 (144)
|.+..............++..|++||.......+.++|+||+|++++++++|..||...+
T Consensus 138 ~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~ 197 (250)
T cd05123 138 GLAKELSSEGSRTNTFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAED 197 (250)
T ss_pred CcceecccCCCcccCCcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCC
Confidence 998875533223344567888999999988888889999999999999999999997544
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=99.95 E-value=3e-27 Score=158.95 Aligned_cols=132 Identities=27% Similarity=0.346 Sum_probs=113.9
Q ss_pred CceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeeec
Q 044494 3 RKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADFG 82 (144)
Q Consensus 3 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~~ 82 (144)
++.+|+++||+++++|.+++.+.. .+++..+..++.|++.++.+|| +.+++|+||+|+||+++.++.++++|||
T Consensus 74 ~~~~~lv~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~~~ni~~~~~~~~kl~d~~ 147 (258)
T cd06632 74 EDNLYIFLELVPGGSLAKLLKKYG---SFPEPVIRLYTRQILLGLEYLH---DRNTVHRDIKGANILVDTNGVVKLADFG 147 (258)
T ss_pred CCeEEEEEEecCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEccCc
Confidence 467899999999999999987543 3789999999999999999999 8999999999999999999999999999
Q ss_pred ceeecccCCCCcccccccccccCccccccCC-CCCcchhHHHHHHHHHHHhCCCCCCCCC
Q 044494 83 VARLLNFDSSNRTLLAGTYGYIAPELAYTMV-VTEKSDVYSFGVVALEVLMGKHPGELLS 141 (144)
Q Consensus 83 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~-~~~~~d~~slg~~l~~~~~g~~p~~~~~ 141 (144)
.+....... ......++..|++||.+.... ++.++|+||+|++++++++|..||...+
T Consensus 148 ~~~~~~~~~-~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~ 206 (258)
T cd06632 148 MAKQVVEFS-FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLE 206 (258)
T ss_pred cceeccccc-cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCc
Confidence 887654322 233455788899999987766 8889999999999999999999997654
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.6e-27 Score=161.20 Aligned_cols=136 Identities=29% Similarity=0.375 Sum_probs=110.2
Q ss_pred CceEEEEEeeccCCCHHHHhhcccc----cCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCC---C
Q 044494 3 RKCMFLIYEYMEMGSLFCVLRTDEE----AVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLEL---E 75 (144)
Q Consensus 3 ~~~~~lv~e~~~~~~L~~~l~~~~~----~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~---~ 75 (144)
.+..++||||+++++|.+++..... ...+++..+..++.|++.++++|| +.+++|+||+|+||+++.++ .
T Consensus 81 ~~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivH~dlkp~nil~~~~~~~~~ 157 (277)
T cd05036 81 RLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLE---ENHFIHRDIAARNCLLTCKGPGRV 157 (277)
T ss_pred CCCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccchheEEEeccCCCcc
Confidence 4567899999999999999865321 124889999999999999999999 88999999999999998764 5
Q ss_pred eEEeeecceeecccCCCC--cccccccccccCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCC
Q 044494 76 AFVADFGVARLLNFDSSN--RTLLAGTYGYIAPELAYTMVVTEKSDVYSFGVVALEVLM-GKHPGELLS 141 (144)
Q Consensus 76 ~~l~d~~~~~~~~~~~~~--~~~~~~~~~~~~pe~~~~~~~~~~~d~~slg~~l~~~~~-g~~p~~~~~ 141 (144)
++++|||.++........ ......+..|++||.+....++.++|+||+|++++++++ |..||...+
T Consensus 158 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~ 226 (277)
T cd05036 158 AKIADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRT 226 (277)
T ss_pred eEeccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCC
Confidence 899999998765321111 111223467999999988889999999999999999997 999997643
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.2e-27 Score=162.49 Aligned_cols=136 Identities=27% Similarity=0.434 Sum_probs=112.0
Q ss_pred CceEEEEEeeccCCCHHHHhhccc---------------------ccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEec
Q 044494 3 RKCMFLIYEYMEMGSLFCVLRTDE---------------------EAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHR 61 (144)
Q Consensus 3 ~~~~~lv~e~~~~~~L~~~l~~~~---------------------~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~ 61 (144)
++..++++||+.+++|.+++.... ....+++.+++.++.|++.++.+|| +.+++|+
T Consensus 75 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH---~~~ivH~ 151 (290)
T cd05045 75 DGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLA---EMKLVHR 151 (290)
T ss_pred CCCcEEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHH---HCCeehh
Confidence 456789999999999999886421 1124788899999999999999999 8999999
Q ss_pred CCCCCcEEEcCCCCeEEeeecceeecccCCC--CcccccccccccCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCC
Q 044494 62 DISSNNILLNLELEAFVADFGVARLLNFDSS--NRTLLAGTYGYIAPELAYTMVVTEKSDVYSFGVVALEVLM-GKHPGE 138 (144)
Q Consensus 62 ~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~d~~slg~~l~~~~~-g~~p~~ 138 (144)
||+|+||+++.++.++++|||+++....... ......++..|++||......++.++|+||+|+++++|++ |..||.
T Consensus 152 dikp~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~ 231 (290)
T cd05045 152 DLAARNVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYP 231 (290)
T ss_pred hhhhheEEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCC
Confidence 9999999999999999999999875432211 1122334568999999888888999999999999999998 999997
Q ss_pred CCC
Q 044494 139 LLS 141 (144)
Q Consensus 139 ~~~ 141 (144)
..+
T Consensus 232 ~~~ 234 (290)
T cd05045 232 GIA 234 (290)
T ss_pred CCC
Confidence 654
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.8e-27 Score=158.53 Aligned_cols=131 Identities=30% Similarity=0.441 Sum_probs=110.4
Q ss_pred ceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeeecc
Q 044494 4 KCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADFGV 83 (144)
Q Consensus 4 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~~~ 83 (144)
+..++||||+++++|.+++.... ...+++..+..++.|++.++.+|| +.|++|+|++|+||+++.++.++++|||.
T Consensus 71 ~~~~~v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~qi~~al~~lH---~~~~~H~dl~p~nili~~~~~~kl~Dfg~ 146 (254)
T cd05083 71 NGLYIVMELMSKGNLVNFLRTRG-RALVSVIQLLQFSLDVAEGMEYLE---SKKLVHRDLAARNILVSEDGVAKVSDFGL 146 (254)
T ss_pred CCcEEEEECCCCCCHHHHHHhcC-cCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccccCcceEEEcCCCcEEECCCcc
Confidence 45789999999999999987533 234789999999999999999999 89999999999999999999999999998
Q ss_pred eeecccCCCCcccccccccccCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCC
Q 044494 84 ARLLNFDSSNRTLLAGTYGYIAPELAYTMVVTEKSDVYSFGVVALEVLM-GKHPGELLS 141 (144)
Q Consensus 84 ~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~d~~slg~~l~~~~~-g~~p~~~~~ 141 (144)
+...... ......+..|++||.+....++.++|+||+|++++++++ |..||...+
T Consensus 147 ~~~~~~~---~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~ 202 (254)
T cd05083 147 ARVGSMG---VDNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMS 202 (254)
T ss_pred ceecccc---CCCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCC
Confidence 8754321 112234567999999988888899999999999999998 999997643
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.2e-27 Score=161.75 Aligned_cols=133 Identities=24% Similarity=0.342 Sum_probs=109.0
Q ss_pred CceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeeec
Q 044494 3 RKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADFG 82 (144)
Q Consensus 3 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~~ 82 (144)
++..|+||||+. +++.+++.... ..+++..+..++.|++.|+.+|| +.+++|+||||+||+++.++.++++|||
T Consensus 75 ~~~~~lv~e~~~-~~l~~~~~~~~--~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~dlkp~Nil~~~~~~~~l~Dfg 148 (291)
T cd07870 75 KETLTFVFEYMH-TDLAQYMIQHP--GGLHPYNVRLFMFQLLRGLAYIH---GQHILHRDLKPQNLLISYLGELKLADFG 148 (291)
T ss_pred CCeEEEEEeccc-CCHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCChHHEEEcCCCcEEEeccc
Confidence 457899999996 67777665422 23778888899999999999999 8899999999999999999999999999
Q ss_pred ceeecccCCCCcccccccccccCccccccC-CCCCcchhHHHHHHHHHHHhCCCCCCCCC
Q 044494 83 VARLLNFDSSNRTLLAGTYGYIAPELAYTM-VVTEKSDVYSFGVVALEVLMGKHPGELLS 141 (144)
Q Consensus 83 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~-~~~~~~d~~slg~~l~~~~~g~~p~~~~~ 141 (144)
++..............+++.|+|||.+.+. .++.++|+||+|++++++++|..||+..+
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~ 208 (291)
T cd07870 149 LARAKSIPSQTYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVS 208 (291)
T ss_pred cccccCCCCCCCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCch
Confidence 887544333233334568899999998754 46788999999999999999999997643
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.5e-27 Score=161.65 Aligned_cols=131 Identities=22% Similarity=0.324 Sum_probs=108.9
Q ss_pred CCceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeee
Q 044494 2 HRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADF 81 (144)
Q Consensus 2 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~ 81 (144)
+.+.+++|+||+. ++|.+++.... ..+++..+..++.|+++|+.+|| +++++|+||+|+||+++.++.++++||
T Consensus 70 ~~~~~~lv~e~~~-~~l~~~~~~~~--~~~~~~~~~~~~~qi~~al~~LH---~~~i~H~dl~~~nil~~~~~~~~l~df 143 (284)
T cd07839 70 SDKKLTLVFEYCD-QDLKKYFDSCN--GDIDPEIVKSFMFQLLKGLAFCH---SHNVLHRDLKPQNLLINKNGELKLADF 143 (284)
T ss_pred cCCceEEEEecCC-CCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHEEEcCCCcEEECcc
Confidence 3567899999997 48888776422 23899999999999999999999 899999999999999999999999999
Q ss_pred cceeecccCCCCcccccccccccCccccccC-CCCCcchhHHHHHHHHHHHhCCCCCC
Q 044494 82 GVARLLNFDSSNRTLLAGTYGYIAPELAYTM-VVTEKSDVYSFGVVALEVLMGKHPGE 138 (144)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~-~~~~~~d~~slg~~l~~~~~g~~p~~ 138 (144)
|++..............+++.|+|||.+.+. .++.++|+||+|+++++|++|..|+.
T Consensus 144 g~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~ 201 (284)
T cd07839 144 GLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLF 201 (284)
T ss_pred chhhccCCCCCCcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCc
Confidence 9987654333333334567889999988764 46889999999999999999888853
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.3e-27 Score=166.13 Aligned_cols=130 Identities=26% Similarity=0.319 Sum_probs=108.1
Q ss_pred CceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeeec
Q 044494 3 RKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADFG 82 (144)
Q Consensus 3 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~~ 82 (144)
.+..++|+|++. ++|.+++.... ..+++..+..++.|++.||.||| +.+++||||||+||+++.++.++++|||
T Consensus 129 ~~~~~lv~e~~~-~~l~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~Nill~~~~~~kl~DfG 202 (357)
T PHA03209 129 GAITCMVLPHYS-SDLYTYLTKRS--RPLPIDQALIIEKQILEGLRYLH---AQRIIHRDVKTENIFINDVDQVCIGDLG 202 (357)
T ss_pred CCeeEEEEEccC-CcHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEEecCc
Confidence 456789999996 58888886432 24899999999999999999999 8999999999999999999999999999
Q ss_pred ceeecccCCCCcccccccccccCccccccCCCCCcchhHHHHHHHHHHHhCC-CCCCC
Q 044494 83 VARLLNFDSSNRTLLAGTYGYIAPELAYTMVVTEKSDVYSFGVVALEVLMGK-HPGEL 139 (144)
Q Consensus 83 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~d~~slg~~l~~~~~g~-~p~~~ 139 (144)
.+..... ........+++.|+|||.+.+..++.++|+||+|+++|+|+++. .+|+.
T Consensus 203 ~a~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f~~ 259 (357)
T PHA03209 203 AAQFPVV-APAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFED 259 (357)
T ss_pred ccccccc-CcccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccccC
Confidence 8864321 11223356889999999999888999999999999999999854 44443
|
|
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=99.95 E-value=4e-27 Score=164.26 Aligned_cols=137 Identities=28% Similarity=0.407 Sum_probs=112.2
Q ss_pred CCceEEEEEeeccCCCHHHHhhccc-------------ccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcE
Q 044494 2 HRKCMFLIYEYMEMGSLFCVLRTDE-------------EAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNI 68 (144)
Q Consensus 2 ~~~~~~lv~e~~~~~~L~~~l~~~~-------------~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni 68 (144)
+++.+|+++||+++|+|.+++.+.. ....++..++..++.|++.|+.+|| +.|++|+||+|+||
T Consensus 89 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH---~~givH~dlkp~Ni 165 (334)
T cd05100 89 QDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLA---SQKCIHRDLAARNV 165 (334)
T ss_pred cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHH---HCCeeccccccceE
Confidence 3567899999999999999987532 1234778888999999999999999 89999999999999
Q ss_pred EEcCCCCeEEeeecceeecccCCCC--cccccccccccCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCC
Q 044494 69 LLNLELEAFVADFGVARLLNFDSSN--RTLLAGTYGYIAPELAYTMVVTEKSDVYSFGVVALEVLM-GKHPGELLS 141 (144)
Q Consensus 69 ~~~~~~~~~l~d~~~~~~~~~~~~~--~~~~~~~~~~~~pe~~~~~~~~~~~d~~slg~~l~~~~~-g~~p~~~~~ 141 (144)
+++.++.++++|||+++........ .....++..|++||.+....++.++|+||+|+++++|++ |..||...+
T Consensus 166 ll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~ 241 (334)
T cd05100 166 LVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIP 241 (334)
T ss_pred EEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCC
Confidence 9999999999999998765422111 111223457999999998888999999999999999998 888987643
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.4e-27 Score=158.75 Aligned_cols=134 Identities=28% Similarity=0.413 Sum_probs=114.2
Q ss_pred CCceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeee
Q 044494 2 HRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADF 81 (144)
Q Consensus 2 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~ 81 (144)
.++..++|+||+++++|.+++.... ...+++..+..++.|++.++.+|| +.+++|+|++|+||+++.++.++++||
T Consensus 70 ~~~~~~lv~e~~~~~~l~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~~l~~~nil~~~~~~~~l~d~ 145 (256)
T cd08218 70 ENGNLYIVMDYCEGGDLYKKINAQR-GVLFPEDQILDWFVQICLALKHVH---DRKILHRDIKSQNIFLTKDGTIKLGDF 145 (256)
T ss_pred CCCeEEEEEecCCCCcHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEcCCCCEEEeec
Confidence 3567899999999999999887532 223789999999999999999999 899999999999999999999999999
Q ss_pred cceeecccCCCCcccccccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCC
Q 044494 82 GVARLLNFDSSNRTLLAGTYGYIAPELAYTMVVTEKSDVYSFGVVALEVLMGKHPGEL 139 (144)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~d~~slg~~l~~~~~g~~p~~~ 139 (144)
|.+..............+++.|+|||.......+.++|+||+|++++++++|..||..
T Consensus 146 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~ 203 (256)
T cd08218 146 GIARVLNSTVELARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEA 203 (256)
T ss_pred cceeecCcchhhhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccC
Confidence 9987654322222334577889999999888888899999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.2e-27 Score=159.56 Aligned_cols=134 Identities=29% Similarity=0.406 Sum_probs=111.6
Q ss_pred CceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeeec
Q 044494 3 RKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADFG 82 (144)
Q Consensus 3 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~~ 82 (144)
++..|+||||+++++|.+++.+... .+++..+..++.+++.++++|| +.+++|+||+|+||+++.++.++++|||
T Consensus 78 ~~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~l~~~l~~lH---~~~~~H~dl~p~nili~~~~~~~l~d~g 152 (270)
T cd05056 78 ENPVWIVMELAPLGELRSYLQVNKY--SLDLASLILYSYQLSTALAYLE---SKRFVHRDIAARNVLVSSPDCVKLGDFG 152 (270)
T ss_pred CCCcEEEEEcCCCCcHHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHH---hCCeeccccChheEEEecCCCeEEccCc
Confidence 4567899999999999999975332 3899999999999999999999 8999999999999999999999999999
Q ss_pred ceeecccCCCC-cccccccccccCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCC
Q 044494 83 VARLLNFDSSN-RTLLAGTYGYIAPELAYTMVVTEKSDVYSFGVVALEVLM-GKHPGELLS 141 (144)
Q Consensus 83 ~~~~~~~~~~~-~~~~~~~~~~~~pe~~~~~~~~~~~d~~slg~~l~~~~~-g~~p~~~~~ 141 (144)
++......... .....++..|+|||.+....++.++|+||+|++++++++ |..||...+
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~ 213 (270)
T cd05056 153 LSRYLEDESYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVK 213 (270)
T ss_pred eeeecccccceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCC
Confidence 88755322111 111223467999999988888899999999999999986 999997654
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.8e-28 Score=177.67 Aligned_cols=137 Identities=28% Similarity=0.366 Sum_probs=118.8
Q ss_pred CCceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcC-CCCeEEee
Q 044494 2 HRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNL-ELEAFVAD 80 (144)
Q Consensus 2 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~-~~~~~l~d 80 (144)
+++.+-+.||..+||+|.++++..=....-++.++..+.+||++|++||| .+.|+|||||-+|+++.. .|.+||+|
T Consensus 643 enGf~kIFMEqVPGGSLSsLLrskWGPlKDNEstm~fYtkQILeGLkYLH---en~IVHRDIKGDNVLvNTySGvlKISD 719 (1226)
T KOG4279|consen 643 ENGFFKIFMEQVPGGSLSSLLRSKWGPLKDNESTMNFYTKQILEGLKYLH---ENKIVHRDIKGDNVLVNTYSGVLKISD 719 (1226)
T ss_pred CCCeEEEEeecCCCCcHHHHHHhccCCCccchhHHHHHHHHHHHHhhhhh---hcceeeccccCCcEEEeeccceEEecc
Confidence 35677899999999999999986332233489999999999999999999 899999999999999974 68899999
Q ss_pred ecceeecccCCCCcccccccccccCccccccC--CCCCcchhHHHHHHHHHHHhCCCCCCCCC
Q 044494 81 FGVARLLNFDSSNRTLLAGTYGYIAPELAYTM--VVTEKSDVYSFGVVALEVLMGKHPGELLS 141 (144)
Q Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~--~~~~~~d~~slg~~l~~~~~g~~p~~~~~ 141 (144)
||-+++...-.....++.||..|||||++... +|+..+|||||||++.||.||++||-.+.
T Consensus 720 FGTsKRLAginP~TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~Elg 782 (1226)
T KOG4279|consen 720 FGTSKRLAGINPCTETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELG 782 (1226)
T ss_pred cccchhhccCCccccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecC
Confidence 99988776555667889999999999999865 58889999999999999999999996543
|
|
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.2e-27 Score=160.19 Aligned_cols=132 Identities=33% Similarity=0.506 Sum_probs=114.1
Q ss_pred CceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeeec
Q 044494 3 RKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADFG 82 (144)
Q Consensus 3 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~~ 82 (144)
+++.|+||||+.+++|.+++... .+++..+..++.+++.++.+|| +.+++|+|++|+||+++.++.++++|||
T Consensus 74 ~~~~~lv~e~~~~~~l~~~i~~~----~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~dl~p~Ni~i~~~~~~~l~dfg 146 (277)
T cd06641 74 DTKLWIIMEYLGGGSALDLLEPG----PLDETQIATILREILKGLDYLH---SEKKIHRDIKAANVLLSEHGEVKLADFG 146 (277)
T ss_pred CCeEEEEEEeCCCCcHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHc---cCCeecCCCCHHhEEECCCCCEEEeecc
Confidence 46789999999999999988642 3789999999999999999999 8999999999999999999999999999
Q ss_pred ceeecccCCCCcccccccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCC
Q 044494 83 VARLLNFDSSNRTLLAGTYGYIAPELAYTMVVTEKSDVYSFGVVALEVLMGKHPGELLS 141 (144)
Q Consensus 83 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~d~~slg~~l~~~~~g~~p~~~~~ 141 (144)
++..............++..|++||.+.....+.++|+||+|++++++++|..||...+
T Consensus 147 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~ 205 (277)
T cd06641 147 VAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELH 205 (277)
T ss_pred cceecccchhhhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccc
Confidence 88765433322333457788999999988888889999999999999999999997643
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.4e-27 Score=162.07 Aligned_cols=137 Identities=28% Similarity=0.380 Sum_probs=111.7
Q ss_pred CCceEEEEEeeccCCCHHHHhhcccc--------cCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCC
Q 044494 2 HRKCMFLIYEYMEMGSLFCVLRTDEE--------AVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLE 73 (144)
Q Consensus 2 ~~~~~~lv~e~~~~~~L~~~l~~~~~--------~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~ 73 (144)
+++..++||||+++++|.+++..... ...+++.++..++.|++.|+++|| +.+++|+||||+||+++.+
T Consensus 90 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH---~~~i~H~dlkp~Nili~~~ 166 (296)
T cd05095 90 TSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLS---SLNFVHRDLATRNCLVGKN 166 (296)
T ss_pred cCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHH---HCCeecccCChheEEEcCC
Confidence 35678999999999999999875321 123778889999999999999999 8899999999999999999
Q ss_pred CCeEEeeecceeecccCCC--CcccccccccccCccccccCCCCCcchhHHHHHHHHHHHh--CCCCCCCCC
Q 044494 74 LEAFVADFGVARLLNFDSS--NRTLLAGTYGYIAPELAYTMVVTEKSDVYSFGVVALEVLM--GKHPGELLS 141 (144)
Q Consensus 74 ~~~~l~d~~~~~~~~~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~d~~slg~~l~~~~~--g~~p~~~~~ 141 (144)
+.++++|||++........ .......++.|++||......++.++|+||+|+++||+++ |..||...+
T Consensus 167 ~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~ 238 (296)
T cd05095 167 YTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLS 238 (296)
T ss_pred CCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccC
Confidence 9999999999875432211 1122334567999998888888999999999999999998 778887543
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=4e-27 Score=158.95 Aligned_cols=134 Identities=30% Similarity=0.479 Sum_probs=112.1
Q ss_pred ceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeeecc
Q 044494 4 KCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADFGV 83 (144)
Q Consensus 4 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~~~ 83 (144)
+..+++|||+++++|.+++.+.. ....+..++..++.|++.++.+|| +.+++|+||+|+|++++.++.++++|||.
T Consensus 73 ~~~~~v~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~aL~~lH---~~~i~H~dl~p~ni~i~~~~~~~l~d~~~ 148 (260)
T cd05073 73 EPIYIITEFMAKGSLLDFLKSDE-GSKQPLPKLIDFSAQIAEGMAFIE---QRNYIHRDLRAANILVSASLVCKIADFGL 148 (260)
T ss_pred CCeEEEEEeCCCCcHHHHHHhCC-ccccCHHHHHHHHHHHHHHHHHHH---hCCccccccCcceEEEcCCCcEEECCCcc
Confidence 56799999999999999997532 234788889999999999999999 88999999999999999999999999998
Q ss_pred eeecccCCC-CcccccccccccCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCC
Q 044494 84 ARLLNFDSS-NRTLLAGTYGYIAPELAYTMVVTEKSDVYSFGVVALEVLM-GKHPGELLS 141 (144)
Q Consensus 84 ~~~~~~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~d~~slg~~l~~~~~-g~~p~~~~~ 141 (144)
+........ ......++..|++||.+....++.++|+||+|++++++++ |..||...+
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~ 208 (260)
T cd05073 149 ARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMS 208 (260)
T ss_pred eeeccCCCcccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCC
Confidence 876542211 1122334567999999988888889999999999999998 999998654
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.6e-27 Score=158.60 Aligned_cols=132 Identities=33% Similarity=0.445 Sum_probs=112.9
Q ss_pred CceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeeec
Q 044494 3 RKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADFG 82 (144)
Q Consensus 3 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~~ 82 (144)
.+.+++|+||+++++|.+++..... +++..+..++.+++.++.+|| +.+++|+|++|+||+++.++.++++|||
T Consensus 71 ~~~~~lv~e~~~~~~L~~~~~~~~~---~~~~~~~~i~~~i~~~l~~lh---~~~i~H~dl~~~nil~~~~~~~kl~d~g 144 (264)
T cd06626 71 REKVYIFMEYCSGGTLEELLEHGRI---LDEHVIRVYTLQLLEGLAYLH---SHGIVHRDIKPANIFLDHNGVIKLGDFG 144 (264)
T ss_pred CCEEEEEEecCCCCcHHHHHhhcCC---CChHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEcccc
Confidence 5678999999999999999876432 788889999999999999999 8999999999999999999999999999
Q ss_pred ceeecccCCCCc----ccccccccccCccccccCC---CCCcchhHHHHHHHHHHHhCCCCCCCC
Q 044494 83 VARLLNFDSSNR----TLLAGTYGYIAPELAYTMV---VTEKSDVYSFGVVALEVLMGKHPGELL 140 (144)
Q Consensus 83 ~~~~~~~~~~~~----~~~~~~~~~~~pe~~~~~~---~~~~~d~~slg~~l~~~~~g~~p~~~~ 140 (144)
++.......... ....+++.|++||.+.... .+.++|+||+|++++++++|..||...
T Consensus 145 ~~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~ 209 (264)
T cd06626 145 CAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSEL 209 (264)
T ss_pred cccccCCCCCcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCC
Confidence 988654322211 1245678999999988765 778999999999999999999999765
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.8e-27 Score=159.13 Aligned_cols=135 Identities=28% Similarity=0.387 Sum_probs=115.0
Q ss_pred CCceEEEEEeeccCCCHHHHhhcc-cccCCCCHHHHHHHHHHHHHHHHHHhcCCC-CCeEecCCCCCcEEEcCCCCeEEe
Q 044494 2 HRKCMFLIYEYMEMGSLFCVLRTD-EEAVGLDWAKRVNIVKGMAHALSYLHHDCT-PPIVHRDISSNNILLNLELEAFVA 79 (144)
Q Consensus 2 ~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~-~~~~h~~i~~~ni~~~~~~~~~l~ 79 (144)
+++..+++|||+++++|.+++... .....+++..++.++.|++.++.+|| + .+++|+||+|.||+++.++.++++
T Consensus 80 ~~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh---~~~~i~H~dl~~~nil~~~~~~~~l~ 156 (269)
T cd08528 80 ENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLH---KEKRIVHRDLTPNNIMLGEDDKVTIT 156 (269)
T ss_pred cCCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhc---cCCceeecCCCHHHEEECCCCcEEEe
Confidence 457889999999999999987531 12234899999999999999999999 5 679999999999999999999999
Q ss_pred eecceeecccCCCCcccccccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCC
Q 044494 80 DFGVARLLNFDSSNRTLLAGTYGYIAPELAYTMVVTEKSDVYSFGVVALEVLMGKHPGELL 140 (144)
Q Consensus 80 d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~d~~slg~~l~~~~~g~~p~~~~ 140 (144)
|||.+....... ......++..|++||......++.++|+||+|+++|++++|..||...
T Consensus 157 dfg~~~~~~~~~-~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~ 216 (269)
T cd08528 157 DFGLAKQKQPES-KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYST 216 (269)
T ss_pred cccceeeccccc-ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCccccc
Confidence 999998655332 334456788999999999888899999999999999999999999654
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.5e-27 Score=161.81 Aligned_cols=129 Identities=26% Similarity=0.397 Sum_probs=108.6
Q ss_pred ceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeeecc
Q 044494 4 KCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADFGV 83 (144)
Q Consensus 4 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~~~ 83 (144)
...++||||+++++|.+++.+... .+++..++.++.|++.++.+|| ++|++|+||||+||+++.++.++++|||+
T Consensus 81 ~~~~lv~e~~~g~~L~~~l~~~~~--~~~~~~~~~i~~~i~~aL~~lH---~~gi~H~dlkp~Nil~~~~~~~~l~dfg~ 155 (284)
T cd05079 81 NGIKLIMEFLPSGSLKEYLPRNKN--KINLKQQLKYAVQICKGMDYLG---SRQYVHRDLAARNVLVESEHQVKIGDFGL 155 (284)
T ss_pred CceEEEEEccCCCCHHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHH---HCCeeecccchheEEEcCCCCEEECCCcc
Confidence 568999999999999999865332 3899999999999999999999 89999999999999999999999999999
Q ss_pred eeecccCCC---CcccccccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCC
Q 044494 84 ARLLNFDSS---NRTLLAGTYGYIAPELAYTMVVTEKSDVYSFGVVALEVLMGKHPG 137 (144)
Q Consensus 84 ~~~~~~~~~---~~~~~~~~~~~~~pe~~~~~~~~~~~d~~slg~~l~~~~~g~~p~ 137 (144)
+........ ......++..|+|||...+..++.++|+||+|+++++++++..|.
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~ 212 (284)
T cd05079 156 TKAIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSE 212 (284)
T ss_pred ccccccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCC
Confidence 886543221 112344566799999988888889999999999999999976554
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=99.95 E-value=7.4e-28 Score=177.39 Aligned_cols=138 Identities=30% Similarity=0.434 Sum_probs=118.2
Q ss_pred CCceEEEEEeeccCCCHHHHhhcccc-----------cCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEE
Q 044494 2 HRKCMFLIYEYMEMGSLFCVLRTDEE-----------AVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILL 70 (144)
Q Consensus 2 ~~~~~~lv~e~~~~~~L~~~l~~~~~-----------~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~ 70 (144)
+++.+++|+|||..|+|.++|+...+ ...++..+.+.++.||+.|+.||- ++.++|||+...|+++
T Consensus 560 ~~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs---~~~FVHRDLATRNCLV 636 (774)
T KOG1026|consen 560 EGDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLS---SHHFVHRDLATRNCLV 636 (774)
T ss_pred cCCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHH---hCcccccchhhhhcee
Confidence 46778999999999999999975221 123888899999999999999999 8999999999999999
Q ss_pred cCCCCeEEeeecceeecccC--CCCcccccccccccCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCC
Q 044494 71 NLELEAFVADFGVARLLNFD--SSNRTLLAGTYGYIAPELAYTMVVTEKSDVYSFGVVALEVLM-GKHPGELLSS 142 (144)
Q Consensus 71 ~~~~~~~l~d~~~~~~~~~~--~~~~~~~~~~~~~~~pe~~~~~~~~~~~d~~slg~~l~~~~~-g~~p~~~~~~ 142 (144)
..+..|||+|||+++..-.. -+.........+|||||.+.+.+++.++|+||+|+++||+++ |..||.++++
T Consensus 637 ge~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn 711 (774)
T KOG1026|consen 637 GENLVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSN 711 (774)
T ss_pred ccceEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccch
Confidence 99999999999999976432 111223345679999999999999999999999999999998 9999998875
|
|
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.9e-27 Score=161.96 Aligned_cols=136 Identities=23% Similarity=0.312 Sum_probs=111.9
Q ss_pred CCceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeee
Q 044494 2 HRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADF 81 (144)
Q Consensus 2 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~ 81 (144)
.++..|++|||+++++|.+++..... ..+++..+..++.|++.|++||| +.+++|+||+|+||+++.++.++++||
T Consensus 70 ~~~~~~~~~e~~~~~~l~~~l~~~~~-~~~~~~~~~~~~~~l~~~L~~LH---~~~ivH~dlk~~Nili~~~~~~kl~d~ 145 (314)
T cd08216 70 VDSELYVVSPLMAYGSCEDLLKTHFP-EGLPELAIAFILKDVLNALDYIH---SKGFIHRSVKASHILLSGDGKVVLSGL 145 (314)
T ss_pred cCCeEEEEEeccCCCCHHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCcceEEEecCCceEEecC
Confidence 35678999999999999999875322 24889999999999999999999 899999999999999999999999999
Q ss_pred cceeecccCCCC-------cccccccccccCccccccC--CCCCcchhHHHHHHHHHHHhCCCCCCCCC
Q 044494 82 GVARLLNFDSSN-------RTLLAGTYGYIAPELAYTM--VVTEKSDVYSFGVVALEVLMGKHPGELLS 141 (144)
Q Consensus 82 ~~~~~~~~~~~~-------~~~~~~~~~~~~pe~~~~~--~~~~~~d~~slg~~l~~~~~g~~p~~~~~ 141 (144)
+.+......... .....++..|++||.+... .++.++|+||+|++++++++|..||...+
T Consensus 146 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~ 214 (314)
T cd08216 146 RYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMP 214 (314)
T ss_pred ccceeeccccccccccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Confidence 988654321111 1223456689999998763 57789999999999999999999997643
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.7e-27 Score=158.92 Aligned_cols=136 Identities=22% Similarity=0.316 Sum_probs=107.2
Q ss_pred CceEEEEEeeccCCCHHHHhhcccc-cCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeee
Q 044494 3 RKCMFLIYEYMEMGSLFCVLRTDEE-AVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADF 81 (144)
Q Consensus 3 ~~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~ 81 (144)
....|+||||+++|+|.+++++... ....+...+..++.|++.|++||| +.+++|+||||+||+++.++.++++||
T Consensus 67 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH---~~~i~H~dikp~nil~~~~~~~~l~Df 143 (268)
T cd05086 67 AIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMH---KHNFLHSDLALRNCFLTSDLTVKVGDY 143 (268)
T ss_pred CCccEEEEecCCCCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHH---HCCeeccCCccceEEEcCCccEEeccc
Confidence 4567999999999999999875322 233667778889999999999999 889999999999999999999999999
Q ss_pred cceeecccCC--CCcccccccccccCcccccc-------CCCCCcchhHHHHHHHHHHHh-CCCCCCCCC
Q 044494 82 GVARLLNFDS--SNRTLLAGTYGYIAPELAYT-------MVVTEKSDVYSFGVVALEVLM-GKHPGELLS 141 (144)
Q Consensus 82 ~~~~~~~~~~--~~~~~~~~~~~~~~pe~~~~-------~~~~~~~d~~slg~~l~~~~~-g~~p~~~~~ 141 (144)
|++....... .......++..|++||+... ..++.++|+||+|+++++|++ |..||...+
T Consensus 144 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~ 213 (268)
T cd05086 144 GIGPSRYKEDYIETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLS 213 (268)
T ss_pred ccccccCcchhhhcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCC
Confidence 9875422111 11223456788999998753 234678999999999999997 577886543
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.95 E-value=7.5e-28 Score=162.65 Aligned_cols=136 Identities=36% Similarity=0.509 Sum_probs=111.4
Q ss_pred CCceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeee
Q 044494 2 HRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADF 81 (144)
Q Consensus 2 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~ 81 (144)
+.+..++|+||+++|+|.+++... ....+++...+.++.|++.||.||| +.+++|++++++||+++.++.+|++||
T Consensus 72 ~~~~~~lv~e~~~~g~L~~~L~~~-~~~~~~~~~~~~i~~~i~~~l~~Lh---~~~iiH~~l~~~nill~~~~~~Kl~~f 147 (259)
T PF07714_consen 72 ENEPLFLVMEYCPGGSLDDYLKSK-NKEPLSEQQRLSIAIQIAEALSYLH---SNNIIHGNLSPSNILLDSNGQVKLSDF 147 (259)
T ss_dssp SSSSEEEEEE--TTEBHHHHHHHT-CTTTSBHHHHHHHHHHHHHHHHHHH---HTTEEEST-SGGGEEEETTTEEEEEST
T ss_pred cccccccccccccccccccccccc-ccccccccccccccccccccccccc---ccccccccccccccccccccccccccc
Confidence 345689999999999999999875 1233899999999999999999999 889999999999999999999999999
Q ss_pred cceeecccCCC--CcccccccccccCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCC
Q 044494 82 GVARLLNFDSS--NRTLLAGTYGYIAPELAYTMVVTEKSDVYSFGVVALEVLM-GKHPGELLS 141 (144)
Q Consensus 82 ~~~~~~~~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~d~~slg~~l~~~~~-g~~p~~~~~ 141 (144)
|+......... ..........|+|||.+....++.++|+||||++++|+++ |..||...+
T Consensus 148 ~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~ 210 (259)
T PF07714_consen 148 GLSRPISEKSKYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYD 210 (259)
T ss_dssp TTGEETTTSSSEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSC
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 99987632111 1223446678999999998889999999999999999999 789998764
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.6e-27 Score=161.68 Aligned_cols=136 Identities=29% Similarity=0.404 Sum_probs=112.8
Q ss_pred CceEEEEEeeccCCCHHHHhhccc--------ccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCC
Q 044494 3 RKCMFLIYEYMEMGSLFCVLRTDE--------EAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLEL 74 (144)
Q Consensus 3 ~~~~~lv~e~~~~~~L~~~l~~~~--------~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~ 74 (144)
+...+++|||+++++|.+++.+.. ....+++..++.++.|++.|+.+|| +.+++|+||||+||+++.++
T Consensus 91 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH---~~~i~H~dlkp~Nili~~~~ 167 (296)
T cd05051 91 DPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLE---SLNFVHRDLATRNCLVGKNY 167 (296)
T ss_pred CCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHH---HcCccccccchhceeecCCC
Confidence 467899999999999999987533 1124899999999999999999999 89999999999999999999
Q ss_pred CeEEeeecceeecccCC--CCcccccccccccCccccccCCCCCcchhHHHHHHHHHHHh--CCCCCCCCC
Q 044494 75 EAFVADFGVARLLNFDS--SNRTLLAGTYGYIAPELAYTMVVTEKSDVYSFGVVALEVLM--GKHPGELLS 141 (144)
Q Consensus 75 ~~~l~d~~~~~~~~~~~--~~~~~~~~~~~~~~pe~~~~~~~~~~~d~~slg~~l~~~~~--g~~p~~~~~ 141 (144)
.++++|||++....... .......+++.|+|||......++.++|+||+|+++|++++ +..||...+
T Consensus 168 ~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~ 238 (296)
T cd05051 168 TIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLT 238 (296)
T ss_pred ceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcC
Confidence 99999999987543221 11223345678999999988888999999999999999987 778887643
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.4e-27 Score=158.67 Aligned_cols=133 Identities=29% Similarity=0.410 Sum_probs=112.8
Q ss_pred CCceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCC-CeEEee
Q 044494 2 HRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLEL-EAFVAD 80 (144)
Q Consensus 2 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~-~~~l~d 80 (144)
+++.+++|+||+++++|.+++.+.. .+++..+..++.|++.|+.+|| ++|++|+||+|.||+++.++ .++++|
T Consensus 74 ~~~~~~~v~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~ql~~al~~LH---~~~i~H~~i~~~nil~~~~~~~~~l~d 147 (268)
T cd06630 74 EDSHFNLFVEWMAGGSVSHLLSKYG---AFKEAVIINYTEQLLRGLSYLH---ENQIIHRDVKGANLLIDSTGQRLRIAD 147 (268)
T ss_pred cCCeEEEEEeccCCCcHHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEEcc
Confidence 4577899999999999999987543 3889999999999999999999 89999999999999998776 589999
Q ss_pred ecceeecccCCCC----cccccccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCC
Q 044494 81 FGVARLLNFDSSN----RTLLAGTYGYIAPELAYTMVVTEKSDVYSFGVVALEVLMGKHPGELL 140 (144)
Q Consensus 81 ~~~~~~~~~~~~~----~~~~~~~~~~~~pe~~~~~~~~~~~d~~slg~~l~~~~~g~~p~~~~ 140 (144)
||.+......... .....++..|++||.+....++.++|+||+|++++++++|..||...
T Consensus 148 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~ 211 (268)
T cd06630 148 FGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAE 211 (268)
T ss_pred cccccccccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCC
Confidence 9998766532111 12245778999999998888889999999999999999999999754
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.6e-27 Score=158.59 Aligned_cols=129 Identities=26% Similarity=0.308 Sum_probs=106.6
Q ss_pred CceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCC-------
Q 044494 3 RKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELE------- 75 (144)
Q Consensus 3 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~------- 75 (144)
+...++||||+++++|..++.... ..+++..+..++.|++.|++||| +++++|+||||+||+++.++.
T Consensus 76 ~~~~~lv~e~~~~~~l~~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dlkp~Nill~~~~~~~~~~~~ 150 (262)
T cd05077 76 DVENIMVEEFVEFGPLDLFMHRKS--DVLTTPWKFKVAKQLASALSYLE---DKDLVHGNVCTKNILLAREGIDGECGPF 150 (262)
T ss_pred CCCCEEEEecccCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHhh---hCCeECCCCCcccEEEecCCccCCCCce
Confidence 456789999999999998886532 23899999999999999999999 899999999999999986654
Q ss_pred eEEeeecceeecccCCCCcccccccccccCccccc-cCCCCCcchhHHHHHHHHHHH-hCCCCCCCC
Q 044494 76 AFVADFGVARLLNFDSSNRTLLAGTYGYIAPELAY-TMVVTEKSDVYSFGVVALEVL-MGKHPGELL 140 (144)
Q Consensus 76 ~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~-~~~~~~~~d~~slg~~l~~~~-~g~~p~~~~ 140 (144)
++++|||++..... .....++..|+|||.+. ...++.++|+||+|+++|+++ .|..||...
T Consensus 151 ~~l~d~g~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~ 213 (262)
T cd05077 151 IKLSDPGIPITVLS----RQECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDK 213 (262)
T ss_pred eEeCCCCCCccccC----cccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCc
Confidence 78999998865432 22345678899999887 456788999999999999998 588888654
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.9e-27 Score=159.76 Aligned_cols=132 Identities=30% Similarity=0.394 Sum_probs=114.1
Q ss_pred CCceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCC-CCeEecCCCCCcEEEcCCCCeEEee
Q 044494 2 HRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCT-PPIVHRDISSNNILLNLELEAFVAD 80 (144)
Q Consensus 2 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~-~~~~h~~i~~~ni~~~~~~~~~l~d 80 (144)
.++.+++++||+.+++|.+++.... ..+++..+..++.|++.++.+|| + .+++|+||+|+||+++.++.++++|
T Consensus 70 ~~~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lH---~~~~i~H~dl~~~ni~~~~~~~~~l~d 144 (265)
T cd06605 70 NNGDISICMEYMDGGSLDKILKEVQ--GRIPERILGKIAVAVLKGLTYLH---EKHKIIHRDVKPSNILVNSRGQIKLCD 144 (265)
T ss_pred cCCEEEEEEEecCCCcHHHHHHHcc--CCCCHHHHHHHHHHHHHHHHHHc---CCCCeecCCCCHHHEEECCCCCEEEee
Confidence 3567899999999999999987542 34899999999999999999999 7 8999999999999999999999999
Q ss_pred ecceeecccCCCCcccccccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCC
Q 044494 81 FGVARLLNFDSSNRTLLAGTYGYIAPELAYTMVVTEKSDVYSFGVVALEVLMGKHPGELL 140 (144)
Q Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~d~~slg~~l~~~~~g~~p~~~~ 140 (144)
||.+....... .....++..|++||...+..++.++|+||+|++++++++|..||...
T Consensus 145 ~g~~~~~~~~~--~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~ 202 (265)
T cd06605 145 FGVSGQLVNSL--AKTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPE 202 (265)
T ss_pred cccchhhHHHH--hhcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCcc
Confidence 99886543211 11256778899999998888899999999999999999999999765
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.4e-27 Score=160.06 Aligned_cols=132 Identities=25% Similarity=0.323 Sum_probs=110.9
Q ss_pred CceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeeec
Q 044494 3 RKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADFG 82 (144)
Q Consensus 3 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~~ 82 (144)
++..|+|+||+++++|..+...... +++..+..++.|++.++.+|| +.+++|+|++|+||+++.++.++++|||
T Consensus 72 ~~~~~lv~e~~~~~~l~~~~~~~~~---~~~~~~~~~~~~i~~~l~~LH---~~~i~h~~l~p~ni~~~~~~~~~l~dfg 145 (286)
T cd07846 72 KKRLYLVFEFVDHTVLDDLEKYPNG---LDESRVRKYLFQILRGIEFCH---SHNIIHRDIKPENILVSQSGVVKLCDFG 145 (286)
T ss_pred CCeEEEEEecCCccHHHHHHhccCC---CCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEECCCCcEEEEeee
Confidence 5678999999999888876654332 899999999999999999999 8899999999999999999999999999
Q ss_pred ceeecccCCCCcccccccccccCccccccC-CCCCcchhHHHHHHHHHHHhCCCCCCCC
Q 044494 83 VARLLNFDSSNRTLLAGTYGYIAPELAYTM-VVTEKSDVYSFGVVALEVLMGKHPGELL 140 (144)
Q Consensus 83 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~-~~~~~~d~~slg~~l~~~~~g~~p~~~~ 140 (144)
++..............++..|++||...+. .++.++|+||+|++++++++|..||...
T Consensus 146 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~ 204 (286)
T cd07846 146 FARTLAAPGEVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGD 204 (286)
T ss_pred eeeeccCCccccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCC
Confidence 987654333333334577889999988753 4677899999999999999999998653
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.6e-27 Score=161.03 Aligned_cols=132 Identities=30% Similarity=0.417 Sum_probs=113.0
Q ss_pred CceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeeec
Q 044494 3 RKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADFG 82 (144)
Q Consensus 3 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~~ 82 (144)
.+.+++||||+++++|.+++.+... +++..+..++.+++.++.+||+ ..+++|+|++|+||+++.++.++++|||
T Consensus 75 ~~~~~lv~e~~~~~~L~~~~~~~~~---~~~~~~~~~~~~i~~~l~~LH~--~~~i~H~dl~p~nil~~~~~~~~l~d~g 149 (284)
T cd06620 75 ENNICMCMEFMDCGSLDRIYKKGGP---IPVEILGKIAVAVVEGLTYLYN--VHRIMHRDIKPSNILVNSRGQIKLCDFG 149 (284)
T ss_pred CCEEEEEEecCCCCCHHHHHHhccC---CCHHHHHHHHHHHHHHHHHHHH--hcCeeccCCCHHHEEECCCCcEEEccCC
Confidence 4678999999999999998875433 8899999999999999999993 2589999999999999999999999999
Q ss_pred ceeecccCCCCcccccccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCC
Q 044494 83 VARLLNFDSSNRTLLAGTYGYIAPELAYTMVVTEKSDVYSFGVVALEVLMGKHPGELLS 141 (144)
Q Consensus 83 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~d~~slg~~l~~~~~g~~p~~~~~ 141 (144)
++..... .......++..|++||.+....++.++|+||+|++++++++|..||...+
T Consensus 150 l~~~~~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~ 206 (284)
T cd06620 150 VSGELIN--SIADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSN 206 (284)
T ss_pred cccchhh--hccCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccc
Confidence 8865432 12233568889999999988888899999999999999999999998644
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.7e-27 Score=162.43 Aligned_cols=133 Identities=26% Similarity=0.375 Sum_probs=111.0
Q ss_pred ceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeeecc
Q 044494 4 KCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADFGV 83 (144)
Q Consensus 4 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~~~ 83 (144)
...++++||+++|+|.+++..... .+++..+..++.|++.|+.+|| +++++|+||||+||+++.++.++++|||+
T Consensus 81 ~~~~~v~e~~~~g~l~~~~~~~~~--~~~~~~~~~~~~qi~~~L~~LH---~~~ivH~dikp~Nill~~~~~~kL~Dfg~ 155 (303)
T cd05110 81 PTIQLVTQLMPHGCLLDYVHEHKD--NIGSQLLLNWCVQIAKGMMYLE---ERRLVHRDLAARNVLVKSPNHVKITDFGL 155 (303)
T ss_pred CCceeeehhcCCCCHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHh---hcCeeccccccceeeecCCCceEEccccc
Confidence 345789999999999999875332 3788899999999999999999 89999999999999999999999999999
Q ss_pred eeecccCCCC--cccccccccccCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCC
Q 044494 84 ARLLNFDSSN--RTLLAGTYGYIAPELAYTMVVTEKSDVYSFGVVALEVLM-GKHPGELLS 141 (144)
Q Consensus 84 ~~~~~~~~~~--~~~~~~~~~~~~pe~~~~~~~~~~~d~~slg~~l~~~~~-g~~p~~~~~ 141 (144)
+......... .....++..|++||.+.+..++.++|+||+|+++|++++ |..||...+
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~ 216 (303)
T cd05110 156 ARLLEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIP 216 (303)
T ss_pred cccccCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCC
Confidence 9865422211 122334668999999988888999999999999999997 899997653
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.4e-27 Score=158.81 Aligned_cols=136 Identities=29% Similarity=0.388 Sum_probs=111.8
Q ss_pred CCceEEEEEeeccCCCHHHHhhccc----ccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCC---
Q 044494 2 HRKCMFLIYEYMEMGSLFCVLRTDE----EAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLEL--- 74 (144)
Q Consensus 2 ~~~~~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~--- 74 (144)
.++..++||||+++++|.+++.... ....+++..+..++.|++.++++|| +.+++|+|++|+||+++.++
T Consensus 70 ~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~~ 146 (269)
T cd05044 70 LNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLE---QMHFIHRDLAARNCLVSEKGYDA 146 (269)
T ss_pred CCCCeEEEEeccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHH---hCCcccCCCChheEEEecCCCCC
Confidence 3567899999999999999986522 2234788999999999999999999 88999999999999999877
Q ss_pred --CeEEeeecceeecccCC--CCcccccccccccCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCC
Q 044494 75 --EAFVADFGVARLLNFDS--SNRTLLAGTYGYIAPELAYTMVVTEKSDVYSFGVVALEVLM-GKHPGELL 140 (144)
Q Consensus 75 --~~~l~d~~~~~~~~~~~--~~~~~~~~~~~~~~pe~~~~~~~~~~~d~~slg~~l~~~~~-g~~p~~~~ 140 (144)
.++++|||++....... .......++..|++||.+....++.++|+||||++++++++ |..||...
T Consensus 147 ~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~ 217 (269)
T cd05044 147 DRVVKIGDFGLARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPAL 217 (269)
T ss_pred CcceEECCcccccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCccc
Confidence 89999999987543211 11122345678999999998888999999999999999998 99998654
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=9e-27 Score=156.79 Aligned_cols=132 Identities=28% Similarity=0.452 Sum_probs=112.2
Q ss_pred CceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeeec
Q 044494 3 RKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADFG 82 (144)
Q Consensus 3 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~~ 82 (144)
....++||||+++++|.++++.... ..+++..+..++.|++.++.+|| ..+++|+||+|+||+++.++.++++|||
T Consensus 72 ~~~~~~v~e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lh---~~~i~H~di~p~Nili~~~~~~~l~d~g 147 (256)
T cd05039 72 GNPLYIVTEYMAKGSLVDYLRSRGR-AVITLAQQLGFALDVCEGMEYLE---EKNFVHRDLAARNVLVSEDLVAKVSDFG 147 (256)
T ss_pred CCCeEEEEEecCCCcHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHH---hCCccchhcccceEEEeCCCCEEEcccc
Confidence 5678999999999999999875432 24899999999999999999999 8999999999999999999999999999
Q ss_pred ceeecccCCCCcccccccccccCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCC
Q 044494 83 VARLLNFDSSNRTLLAGTYGYIAPELAYTMVVTEKSDVYSFGVVALEVLM-GKHPGELLS 141 (144)
Q Consensus 83 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~d~~slg~~l~~~~~-g~~p~~~~~ 141 (144)
.+........ ....+..|++||.+....++.++|+||+|++++++++ |..||...+
T Consensus 148 ~~~~~~~~~~---~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~ 204 (256)
T cd05039 148 LAKEASQGQD---SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP 204 (256)
T ss_pred cccccccccc---cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCC
Confidence 9876532211 2234557999999988888889999999999999997 999986543
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=7.2e-27 Score=160.39 Aligned_cols=137 Identities=28% Similarity=0.359 Sum_probs=111.6
Q ss_pred CCceEEEEEeeccCCCHHHHhhccc---------ccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcC
Q 044494 2 HRKCMFLIYEYMEMGSLFCVLRTDE---------EAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNL 72 (144)
Q Consensus 2 ~~~~~~lv~e~~~~~~L~~~l~~~~---------~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~ 72 (144)
.++..++||||+++++|.+++.... ....+++..++.++.|++.++.+|| +.+++|+||||+|++++.
T Consensus 88 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH---~~~i~H~dlkp~Nill~~ 164 (295)
T cd05097 88 SDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLA---SLNFVHRDLATRNCLVGN 164 (295)
T ss_pred CCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHH---hcCeeccccChhhEEEcC
Confidence 3567899999999999999886422 1123688889999999999999999 899999999999999999
Q ss_pred CCCeEEeeecceeecccCCC--CcccccccccccCccccccCCCCCcchhHHHHHHHHHHHh--CCCCCCCCC
Q 044494 73 ELEAFVADFGVARLLNFDSS--NRTLLAGTYGYIAPELAYTMVVTEKSDVYSFGVVALEVLM--GKHPGELLS 141 (144)
Q Consensus 73 ~~~~~l~d~~~~~~~~~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~d~~slg~~l~~~~~--g~~p~~~~~ 141 (144)
++.++++|||++........ ......++..|+|||......++.++|+||||++++++++ +..||...+
T Consensus 165 ~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~ 237 (295)
T cd05097 165 HYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLS 237 (295)
T ss_pred CCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccC
Confidence 99999999999875432211 1122344678999999988888999999999999999988 667887643
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=7.5e-27 Score=160.07 Aligned_cols=132 Identities=19% Similarity=0.258 Sum_probs=108.6
Q ss_pred eEEEEEeeccCCCHHHHhhcccc--cCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcC-CCCeEEeee
Q 044494 5 CMFLIYEYMEMGSLFCVLRTDEE--AVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNL-ELEAFVADF 81 (144)
Q Consensus 5 ~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~-~~~~~l~d~ 81 (144)
..|+||||+.+ +|.+++..... ...+++..++.++.|++.+|.+|| +++++|+||+|+||+++. ++.++++||
T Consensus 80 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH---~~~i~H~dl~~~nil~~~~~~~~kl~df 155 (295)
T cd07837 80 SLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCH---KHGVMHRDLKPQNLLVDKQKGLLKIADL 155 (295)
T ss_pred eEEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCChHHEEEecCCCeEEEeec
Confidence 37999999985 88888764322 245899999999999999999999 899999999999999998 889999999
Q ss_pred cceeecccCCCCcccccccccccCcccccc-CCCCCcchhHHHHHHHHHHHhCCCCCCCC
Q 044494 82 GVARLLNFDSSNRTLLAGTYGYIAPELAYT-MVVTEKSDVYSFGVVALEVLMGKHPGELL 140 (144)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~-~~~~~~~d~~slg~~l~~~~~g~~p~~~~ 140 (144)
|.+..............+++.|+|||.+.. ..++.++|+||+|+++++|++|..||...
T Consensus 156 g~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~ 215 (295)
T cd07837 156 GLGRAFSIPVKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGD 215 (295)
T ss_pred ccceecCCCccccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCC
Confidence 998765432222223346788999998765 45688999999999999999999999654
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.2e-27 Score=159.78 Aligned_cols=130 Identities=29% Similarity=0.401 Sum_probs=107.5
Q ss_pred ceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeeecc
Q 044494 4 KCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADFGV 83 (144)
Q Consensus 4 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~~~ 83 (144)
..+++||||+++++|.+++.... ..+++..+..++.|++.++.+|| +.|++|+||||+||+++.++.++++|||+
T Consensus 80 ~~~~lv~e~~~~~~L~~~l~~~~--~~l~~~~~~~~~~~l~~aL~~LH---~~~i~H~dlkp~nili~~~~~~~l~dfg~ 154 (284)
T cd05081 80 RNLRLVMEYLPYGSLRDYLQKHR--ERLDHRKLLLYASQICKGMEYLG---SKRYVHRDLATRNILVESENRVKIGDFGL 154 (284)
T ss_pred CceEEEEEecCCCCHHHHHHhcC--cCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCCHhhEEECCCCeEEECCCcc
Confidence 46889999999999999986532 23889999999999999999999 89999999999999999999999999999
Q ss_pred eeecccCCCC---cccccccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCC
Q 044494 84 ARLLNFDSSN---RTLLAGTYGYIAPELAYTMVVTEKSDVYSFGVVALEVLMGKHPGE 138 (144)
Q Consensus 84 ~~~~~~~~~~---~~~~~~~~~~~~pe~~~~~~~~~~~d~~slg~~l~~~~~g~~p~~ 138 (144)
+......... .....++..|++||...+..++.++|+||+|++++|+++|..|+.
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~ 212 (284)
T cd05081 155 TKVLPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSC 212 (284)
T ss_pred cccccCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCC
Confidence 8865422111 111123345899999988888999999999999999999876654
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.8e-27 Score=158.04 Aligned_cols=135 Identities=33% Similarity=0.507 Sum_probs=112.8
Q ss_pred CceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeeec
Q 044494 3 RKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADFG 82 (144)
Q Consensus 3 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~~ 82 (144)
+...++||||+++++|.+++.... ...+++..+..++.+++.++.+|| +.+++|+||+|+||+++.++.++++|||
T Consensus 73 ~~~~~~v~e~~~~~~L~~~i~~~~-~~~~~~~~~~~~~~~i~~al~~lh---~~~i~h~di~p~nili~~~~~~~l~d~g 148 (261)
T cd05034 73 EEPIYIVTEYMSKGSLLDFLKSGE-GKKLRLPQLVDMAAQIAEGMAYLE---SRNYIHRDLAARNILVGENLVCKIADFG 148 (261)
T ss_pred CCceEEEEeccCCCCHHHHHhccc-cCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCcchheEEEcCCCCEEECccc
Confidence 367899999999999999987532 234899999999999999999999 8899999999999999999999999999
Q ss_pred ceeecccCCC-CcccccccccccCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCC
Q 044494 83 VARLLNFDSS-NRTLLAGTYGYIAPELAYTMVVTEKSDVYSFGVVALEVLM-GKHPGELLS 141 (144)
Q Consensus 83 ~~~~~~~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~d~~slg~~l~~~~~-g~~p~~~~~ 141 (144)
.+........ .......+..|++||...+..++.++|+||+|++++++++ |..||...+
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~ 209 (261)
T cd05034 149 LARLIEDDEYTAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMT 209 (261)
T ss_pred cceeccchhhhhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCC
Confidence 8876542111 1112234567999999988888899999999999999998 999997644
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=9.8e-27 Score=155.54 Aligned_cols=132 Identities=31% Similarity=0.488 Sum_probs=115.6
Q ss_pred CceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeeec
Q 044494 3 RKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADFG 82 (144)
Q Consensus 3 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~~ 82 (144)
++..++++||+++++|.+++.... ..+++..+..++.+++.++.+|| ..+++|+|++|+||+++.++.++|+|||
T Consensus 69 ~~~~~l~~e~~~~~~L~~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lh---~~~i~h~dl~p~ni~i~~~~~~~l~d~~ 143 (253)
T cd05122 69 KDELWIVMEFCSGGSLKDLLKSTN--QTLTESQIAYVCKELLKGLEYLH---SNGIIHRDIKAANILLTSDGEVKLIDFG 143 (253)
T ss_pred CCeEEEEEecCCCCcHHHHHhhcC--CCCCHHHHHHHHHHHHHHHHHhh---cCCEecCCCCHHHEEEccCCeEEEeecc
Confidence 467899999999999999887642 34899999999999999999999 8999999999999999999999999999
Q ss_pred ceeecccCCCCcccccccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCC
Q 044494 83 VARLLNFDSSNRTLLAGTYGYIAPELAYTMVVTEKSDVYSFGVVALEVLMGKHPGELL 140 (144)
Q Consensus 83 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~d~~slg~~l~~~~~g~~p~~~~ 140 (144)
.+........ .....++..|++||.+.....+.++|+||+|++++++++|..||...
T Consensus 144 ~~~~~~~~~~-~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~ 200 (253)
T cd05122 144 LSAQLSDTKA-RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSEL 200 (253)
T ss_pred cccccccccc-ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCC
Confidence 8876653322 34456788999999998888889999999999999999999999765
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=99.95 E-value=7.7e-27 Score=158.20 Aligned_cols=135 Identities=34% Similarity=0.508 Sum_probs=110.7
Q ss_pred CCceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeee
Q 044494 2 HRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADF 81 (144)
Q Consensus 2 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~ 81 (144)
.++..++||||+++++|.+++..... .+++..+..++.|++.++++|| ++|++|+||+|+||+++.++.++++||
T Consensus 76 ~~~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~i~~~l~~al~~lH---~~g~~H~dl~p~nili~~~~~~kl~df 150 (269)
T cd05065 76 KSRPVMIITEFMENGALDSFLRQNDG--QFTVIQLVGMLRGIAAGMKYLS---EMNYVHRDLAARNILVNSNLVCKVSDF 150 (269)
T ss_pred CCCceEEEEecCCCCcHHHHHhhCCC--CCCHHHHHHHHHHHHHHHHHHH---HCCEeecccChheEEEcCCCcEEECCC
Confidence 35678999999999999999875332 3889999999999999999999 899999999999999999999999999
Q ss_pred cceeecccCCCCc--cccc---ccccccCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCC
Q 044494 82 GVARLLNFDSSNR--TLLA---GTYGYIAPELAYTMVVTEKSDVYSFGVVALEVLM-GKHPGELLS 141 (144)
Q Consensus 82 ~~~~~~~~~~~~~--~~~~---~~~~~~~pe~~~~~~~~~~~d~~slg~~l~~~~~-g~~p~~~~~ 141 (144)
|.+.......... .... .+..|++||.+....++.++|+||+|++++|+++ |..||...+
T Consensus 151 g~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~ 216 (269)
T cd05065 151 GLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMS 216 (269)
T ss_pred ccccccccCccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCC
Confidence 9886543211110 1111 1346999999988888999999999999999886 999997654
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.6e-27 Score=172.49 Aligned_cols=136 Identities=25% Similarity=0.380 Sum_probs=118.8
Q ss_pred CCCceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEee
Q 044494 1 LHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVAD 80 (144)
Q Consensus 1 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d 80 (144)
++.+++|++.|||.||-....+-.- .+.+.+.++.-+.+|+++||+||| ++.|+|||+|.-||+++.+|.++++|
T Consensus 99 y~enkLwiliEFC~GGAVDaimlEL--~r~LtE~QIqvvc~q~ldALn~LH---s~~iIHRDLKAGNiL~TldGdirLAD 173 (1187)
T KOG0579|consen 99 YFENKLWILIEFCGGGAVDAIMLEL--GRVLTEDQIQVVCYQVLDALNWLH---SQNIIHRDLKAGNILLTLDGDIRLAD 173 (1187)
T ss_pred hccCceEEEEeecCCchHhHHHHHh--ccccchHHHHHHHHHHHHHHHHHh---hcchhhhhccccceEEEecCcEeeec
Confidence 3678999999999999988877643 234999999999999999999999 99999999999999999999999999
Q ss_pred ecceeecccCCCCcccccccccccCcccccc-----CCCCCcchhHHHHHHHHHHHhCCCCCCCCC
Q 044494 81 FGVARLLNFDSSNRTLLAGTYGYIAPELAYT-----MVVTEKSDVYSFGVVALEVLMGKHPGELLS 141 (144)
Q Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~-----~~~~~~~d~~slg~~l~~~~~g~~p~~~~~ 141 (144)
||.+............+.|||.|||||+..+ .+|++++||||||+++.||..+.+|-..++
T Consensus 174 FGVSAKn~~t~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHheln 239 (1187)
T KOG0579|consen 174 FGVSAKNKSTRQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELN 239 (1187)
T ss_pred ccccccchhHHhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccc
Confidence 9998765544455667889999999998764 468899999999999999999999986654
|
|
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=9.4e-27 Score=158.94 Aligned_cols=132 Identities=28% Similarity=0.330 Sum_probs=111.0
Q ss_pred CceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeeec
Q 044494 3 RKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADFG 82 (144)
Q Consensus 3 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~~ 82 (144)
++..++||||++++.+..+..... .+++..+..++.|++.++.+|| ..+++|+|++|+||+++.++.++++|||
T Consensus 72 ~~~~~iv~e~~~~~~l~~~~~~~~---~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dl~~~ni~~~~~~~~kl~d~g 145 (288)
T cd07833 72 KGRLYLVFEYVERTLLELLEASPG---GLPPDAVRSYIWQLLQAIAYCH---SHNIIHRDIKPENILVSESGVLKLCDFG 145 (288)
T ss_pred CCEEEEEEecCCCCHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCCEEEEeee
Confidence 467899999999866665554332 2899999999999999999999 8899999999999999999999999999
Q ss_pred ceeecccCCC-CcccccccccccCccccccC-CCCCcchhHHHHHHHHHHHhCCCCCCCC
Q 044494 83 VARLLNFDSS-NRTLLAGTYGYIAPELAYTM-VVTEKSDVYSFGVVALEVLMGKHPGELL 140 (144)
Q Consensus 83 ~~~~~~~~~~-~~~~~~~~~~~~~pe~~~~~-~~~~~~d~~slg~~l~~~~~g~~p~~~~ 140 (144)
.+........ ......++..|+|||..... .++.++|+||+|++++++++|..||...
T Consensus 146 ~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~ 205 (288)
T cd07833 146 FARALRARPASPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGD 205 (288)
T ss_pred cccccCCCccccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 9876553322 22334567889999999887 7788999999999999999999998753
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=99.95 E-value=7.3e-27 Score=160.12 Aligned_cols=131 Identities=26% Similarity=0.295 Sum_probs=111.3
Q ss_pred ceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeeecc
Q 044494 4 KCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADFGV 83 (144)
Q Consensus 4 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~~~ 83 (144)
+.+|+||||+.+ +|.+++..... .+++..+..++.|++.||++|| +.+++|+||+|+||+++.++.++++|||+
T Consensus 79 ~~~~lv~e~~~~-~L~~~~~~~~~--~l~~~~~~~i~~qi~~aL~~LH---~~~i~H~dl~p~nili~~~~~~~l~d~g~ 152 (293)
T cd07843 79 DKIYMVMEYVEH-DLKSLMETMKQ--PFLQSEVKCLMLQLLSGVAHLH---DNWILHRDLKTSNLLLNNRGILKICDFGL 152 (293)
T ss_pred CcEEEEehhcCc-CHHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCCHHHEEECCCCcEEEeecCc
Confidence 689999999974 89888865332 4899999999999999999999 88999999999999999999999999999
Q ss_pred eeecccCCCCcccccccccccCccccccCC-CCCcchhHHHHHHHHHHHhCCCCCCCC
Q 044494 84 ARLLNFDSSNRTLLAGTYGYIAPELAYTMV-VTEKSDVYSFGVVALEVLMGKHPGELL 140 (144)
Q Consensus 84 ~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~-~~~~~d~~slg~~l~~~~~g~~p~~~~ 140 (144)
+..............+++.|++||.+.+.. ++.++|+||+|+++++|++|..||...
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~ 210 (293)
T cd07843 153 AREYGSPLKPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGK 210 (293)
T ss_pred eeeccCCccccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 887654333333345678899999887543 578899999999999999999999754
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.8e-27 Score=159.85 Aligned_cols=136 Identities=24% Similarity=0.317 Sum_probs=111.2
Q ss_pred CceEEEEEeeccCCCHHHHhhccc-------------ccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEE
Q 044494 3 RKCMFLIYEYMEMGSLFCVLRTDE-------------EAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNIL 69 (144)
Q Consensus 3 ~~~~~lv~e~~~~~~L~~~l~~~~-------------~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~ 69 (144)
....++++||+.+++|.+++.... ....+++..+..++.|++.|+.++| +.|++|+||||.||+
T Consensus 80 ~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH---~~gi~H~dlkp~Nil 156 (283)
T cd05091 80 EQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLS---SHHVVHKDLATRNVL 156 (283)
T ss_pred CCceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHH---HcCccccccchhheE
Confidence 456889999999999999885321 1123788889999999999999999 899999999999999
Q ss_pred EcCCCCeEEeeecceeecccCCC--CcccccccccccCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCC
Q 044494 70 LNLELEAFVADFGVARLLNFDSS--NRTLLAGTYGYIAPELAYTMVVTEKSDVYSFGVVALEVLM-GKHPGELLS 141 (144)
Q Consensus 70 ~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~d~~slg~~l~~~~~-g~~p~~~~~ 141 (144)
++.++.++++|||+++....... ......+++.|+|||.+....++.++|+||+|++++||++ |..||...+
T Consensus 157 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~ 231 (283)
T cd05091 157 VFDKLNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYS 231 (283)
T ss_pred ecCCCceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCC
Confidence 99999999999998875432211 1122345678999999988888999999999999999998 888987643
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=99.95 E-value=7.7e-27 Score=159.17 Aligned_cols=135 Identities=23% Similarity=0.339 Sum_probs=112.4
Q ss_pred CceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeeec
Q 044494 3 RKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADFG 82 (144)
Q Consensus 3 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~~ 82 (144)
.+..++||||+++ +|.+++........+++..+..++.|++.++.+|| +.+++|+|++|+||+++.++.++++|||
T Consensus 70 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~h~dl~p~ni~~~~~~~~~l~d~g 145 (284)
T cd07836 70 ENKLMLVFEYMDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCH---ENRVLHRDLKPQNLLINKRGELKLADFG 145 (284)
T ss_pred CCcEEEEEecCCc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHHHEEECCCCcEEEeecc
Confidence 4678999999985 88888865443345899999999999999999999 8899999999999999999999999999
Q ss_pred ceeecccCCCCcccccccccccCccccccC-CCCCcchhHHHHHHHHHHHhCCCCCCCCC
Q 044494 83 VARLLNFDSSNRTLLAGTYGYIAPELAYTM-VVTEKSDVYSFGVVALEVLMGKHPGELLS 141 (144)
Q Consensus 83 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~-~~~~~~d~~slg~~l~~~~~g~~p~~~~~ 141 (144)
.+..............+++.|++||.+... .++.++|+||+|++++++++|..||...+
T Consensus 146 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~ 205 (284)
T cd07836 146 LARAFGIPVNTFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTN 205 (284)
T ss_pred hhhhhcCCccccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 887554332223334567889999988654 46788999999999999999999997643
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=7.9e-27 Score=168.48 Aligned_cols=129 Identities=26% Similarity=0.309 Sum_probs=108.6
Q ss_pred CceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeeec
Q 044494 3 RKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADFG 82 (144)
Q Consensus 3 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~~ 82 (144)
++..++|||++. ++|.+++.... ..+++..++.++.|++.+|.||| ++|++||||||+||+++.++.++|+|||
T Consensus 232 ~~~~~lv~e~~~-~~L~~~l~~~~--~~l~~~~~~~i~~qi~~aL~yLH---~~gIvHrDLKP~NILl~~~~~vkL~DFG 305 (461)
T PHA03211 232 GGLTCLVLPKYR-SDLYTYLGARL--RPLGLAQVTAVARQLLSAIDYIH---GEGIIHRDIKTENVLVNGPEDICLGDFG 305 (461)
T ss_pred CCEEEEEEEccC-CCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHH---HCCEEECcCCHHHEEECCCCCEEEcccC
Confidence 457899999995 68888876432 24899999999999999999999 8999999999999999999999999999
Q ss_pred ceeecccCCC--CcccccccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCC
Q 044494 83 VARLLNFDSS--NRTLLAGTYGYIAPELAYTMVVTEKSDVYSFGVVALEVLMGKHPG 137 (144)
Q Consensus 83 ~~~~~~~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~d~~slg~~l~~~~~g~~p~ 137 (144)
+++....... ......|++.|++||++.+..++.++|+||||+++|||++|..|+
T Consensus 306 la~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~l 362 (461)
T PHA03211 306 AACFARGSWSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASL 362 (461)
T ss_pred CceecccccccccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCc
Confidence 9876532211 122346899999999999988999999999999999999877554
|
|
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.1e-26 Score=155.77 Aligned_cols=133 Identities=32% Similarity=0.431 Sum_probs=116.2
Q ss_pred CceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeeec
Q 044494 3 RKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADFG 82 (144)
Q Consensus 3 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~~ 82 (144)
.+..+++|||+++++|.+++.... .+++..+..++.|++.++.+|| +.|++|+|++|+||+++.++.++++|||
T Consensus 71 ~~~~~~v~e~~~~~~L~~~~~~~~---~l~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~ni~i~~~~~~~l~d~~ 144 (254)
T cd06627 71 SDSLYIILEYAENGSLRQIIKKFG---PFPESLVAVYVYQVLQGLAYLH---EQGVIHRDIKAANILTTKDGVVKLADFG 144 (254)
T ss_pred CCEEEEEEecCCCCcHHHHHHhcc---CCCHHHHHHHHHHHHHHHHHHh---hCCcccCCCCHHHEEECCCCCEEEeccc
Confidence 467899999999999999987643 3899999999999999999999 8999999999999999999999999999
Q ss_pred ceeecccCCCCcccccccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCC
Q 044494 83 VARLLNFDSSNRTLLAGTYGYIAPELAYTMVVTEKSDVYSFGVVALEVLMGKHPGELLS 141 (144)
Q Consensus 83 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~d~~slg~~l~~~~~g~~p~~~~~ 141 (144)
.+..............++..|++||.......+.++|+|++|++++++++|..||...+
T Consensus 145 ~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~ 203 (254)
T cd06627 145 VATKLNDVSKDDASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLN 203 (254)
T ss_pred cceecCCCcccccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCcc
Confidence 99876543333334567889999999988878889999999999999999999997543
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=99.95 E-value=8.2e-27 Score=157.33 Aligned_cols=129 Identities=22% Similarity=0.382 Sum_probs=106.6
Q ss_pred CceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCC-------
Q 044494 3 RKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELE------- 75 (144)
Q Consensus 3 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~------- 75 (144)
+...++||||+++|+|.++++.... .+++..+..++.|++.++.+|| +.+++|+||||+||+++.++.
T Consensus 71 ~~~~~lv~e~~~~g~L~~~l~~~~~--~~~~~~~~~~~~qi~~~l~~lH---~~~iiH~dlkp~nili~~~~~~~~~~~~ 145 (258)
T cd05078 71 GDESIMVQEYVKFGSLDTYLKKNKN--LINISWKLEVAKQLAWALHFLE---DKGLTHGNVCAKNVLLIREEDRKTGNPP 145 (258)
T ss_pred CCCcEEEEecCCCCcHHHHHhcCCC--CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCccceEEEecccccccCCCc
Confidence 3567899999999999999975432 4888999999999999999999 899999999999999987765
Q ss_pred -eEEeeecceeecccCCCCcccccccccccCccccccC-CCCCcchhHHHHHHHHHHHhC-CCCCCCC
Q 044494 76 -AFVADFGVARLLNFDSSNRTLLAGTYGYIAPELAYTM-VVTEKSDVYSFGVVALEVLMG-KHPGELL 140 (144)
Q Consensus 76 -~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~-~~~~~~d~~slg~~l~~~~~g-~~p~~~~ 140 (144)
++++|||.+..... .....++..|++||.+... .++.++|+||+|+++|++++| ..||...
T Consensus 146 ~~~l~d~g~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~ 209 (258)
T cd05078 146 FIKLSDPGISITVLP----KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSAL 209 (258)
T ss_pred eEEecccccccccCC----chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhc
Confidence 58899998765432 2234577889999998864 468899999999999999998 4666554
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=8.3e-27 Score=163.79 Aligned_cols=128 Identities=27% Similarity=0.372 Sum_probs=109.7
Q ss_pred ceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeeecc
Q 044494 4 KCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADFGV 83 (144)
Q Consensus 4 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~~~ 83 (144)
...|+||||+. ++|.+.+... +++..+..++.|++.|+.+|| +.|++|+||||+||+++.++.++++|||.
T Consensus 94 ~~~~lv~e~~~-~~l~~~~~~~-----l~~~~~~~~~~ql~~aL~~LH---~~gi~H~dlkp~Nil~~~~~~~kL~Dfg~ 164 (353)
T cd07850 94 QDVYLVMELMD-ANLCQVIQMD-----LDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGL 164 (353)
T ss_pred CcEEEEEeccC-CCHHHHHhhc-----CCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEECCCCCEEEccCcc
Confidence 35799999996 4888877532 788899999999999999999 89999999999999999999999999999
Q ss_pred eeecccCCCCcccccccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCC
Q 044494 84 ARLLNFDSSNRTLLAGTYGYIAPELAYTMVVTEKSDVYSFGVVALEVLMGKHPGELLS 141 (144)
Q Consensus 84 ~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~d~~slg~~l~~~~~g~~p~~~~~ 141 (144)
+....... ......+++.|+|||.+.+..++.++|+||+|+++++|++|..||...+
T Consensus 165 ~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~ 221 (353)
T cd07850 165 ARTAGTSF-MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTD 221 (353)
T ss_pred ceeCCCCC-CCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCC
Confidence 98654322 1233457888999999998889999999999999999999999997543
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.2e-27 Score=170.23 Aligned_cols=131 Identities=29% Similarity=0.451 Sum_probs=114.2
Q ss_pred CCceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCC-CCeEEee
Q 044494 2 HRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLE-LEAFVAD 80 (144)
Q Consensus 2 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~-~~~~l~d 80 (144)
+++++.+|+|.+.+|+|..|+++.+. ++...++.|.+||++||.|||.- .-.|+|||||-+||++..+ |.|||+|
T Consensus 114 ~n~~in~iTEL~TSGtLr~Y~kk~~~---vn~kaik~W~RQILkGL~yLHs~-~PPIIHRDLKCDNIFinG~~G~VKIGD 189 (632)
T KOG0584|consen 114 DNKTINFITELFTSGTLREYRKKHRR---VNIKAIKSWCRQILKGLVYLHSQ-DPPIIHRDLKCDNIFVNGNLGEVKIGD 189 (632)
T ss_pred CCceeeeeeecccCCcHHHHHHHhcc---CCHHHHHHHHHHHHHHhhhhhcC-CCCccccccccceEEEcCCcCceeecc
Confidence 46778999999999999999987655 88889999999999999999932 4479999999999999865 8999999
Q ss_pred ecceeecccCCCCcccccccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCC
Q 044494 81 FGVARLLNFDSSNRTLLAGTYGYIAPELAYTMVVTEKSDVYSFGVVALEVLMGKHPGEL 139 (144)
Q Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~d~~slg~~l~~~~~g~~p~~~ 139 (144)
+|+|....... .....|||.|||||..- ..|....|+||||+++.||.|+.+||..
T Consensus 190 LGLAtl~r~s~--aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsE 245 (632)
T KOG0584|consen 190 LGLATLLRKSH--AKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSE 245 (632)
T ss_pred hhHHHHhhccc--cceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhh
Confidence 99998765322 22378999999999986 7788999999999999999999999953
|
|
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=99.95 E-value=7.5e-27 Score=159.07 Aligned_cols=136 Identities=26% Similarity=0.361 Sum_probs=113.1
Q ss_pred CceEEEEEeeccCCCHHHHhhccccc-----CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeE
Q 044494 3 RKCMFLIYEYMEMGSLFCVLRTDEEA-----VGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAF 77 (144)
Q Consensus 3 ~~~~~lv~e~~~~~~L~~~l~~~~~~-----~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~ 77 (144)
+...++++||+++++|.+++...... ..+++..++.++.|++.|+.+|| +.+++|+||+|+|++++.++.++
T Consensus 81 ~~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH---~~~i~H~di~p~nil~~~~~~~k 157 (280)
T cd05043 81 GEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLH---KRGVIHKDIAARNCVIDEELQVK 157 (280)
T ss_pred CCCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccCHhhEEEcCCCcEE
Confidence 35678999999999999998653221 45899999999999999999999 88999999999999999999999
Q ss_pred EeeecceeecccCCCC--cccccccccccCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCC
Q 044494 78 VADFGVARLLNFDSSN--RTLLAGTYGYIAPELAYTMVVTEKSDVYSFGVVALEVLM-GKHPGELLS 141 (144)
Q Consensus 78 l~d~~~~~~~~~~~~~--~~~~~~~~~~~~pe~~~~~~~~~~~d~~slg~~l~~~~~-g~~p~~~~~ 141 (144)
++|||+++........ .....++..|+|||.+....++.++|+||+|++++++++ |..||...+
T Consensus 158 l~d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~ 224 (280)
T cd05043 158 ITDNALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEID 224 (280)
T ss_pred ECCCCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCC
Confidence 9999998754322111 112334567999999988888999999999999999998 999997643
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.7e-26 Score=155.17 Aligned_cols=134 Identities=29% Similarity=0.402 Sum_probs=113.5
Q ss_pred CceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCC-CeEEeee
Q 044494 3 RKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLEL-EAFVADF 81 (144)
Q Consensus 3 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~-~~~l~d~ 81 (144)
++..++||||+++++|.+++.... ...+++..+..++.+++.++++|| +++++|+|++|.||+++.++ .++++||
T Consensus 71 ~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lh---~~~i~h~dl~~~nil~~~~~~~~~l~d~ 146 (256)
T cd08220 71 DKALMIVMEYAPGGTLAEYIQKRC-NSLLDEDTILHFFVQILLALHHVH---TKLILHRDLKTQNILLDKHKMVVKIGDF 146 (256)
T ss_pred CCEEEEEEecCCCCCHHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEEccC
Confidence 567899999999999999997532 233789999999999999999999 89999999999999998654 5799999
Q ss_pred cceeecccCCCCcccccccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCC
Q 044494 82 GVARLLNFDSSNRTLLAGTYGYIAPELAYTMVVTEKSDVYSFGVVALEVLMGKHPGELLS 141 (144)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~d~~slg~~l~~~~~g~~p~~~~~ 141 (144)
|.+....... ......++..|++||.+....++.++|+||+|++++++++|..||+..+
T Consensus 147 ~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~ 205 (256)
T cd08220 147 GISKILSSKS-KAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAAN 205 (256)
T ss_pred CCceecCCCc-cccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCc
Confidence 9998665322 2223457889999999998888899999999999999999999997654
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=1e-26 Score=159.04 Aligned_cols=133 Identities=31% Similarity=0.368 Sum_probs=112.6
Q ss_pred CceEEEEEeeccCCCHHHHhhcc-cccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeee
Q 044494 3 RKCMFLIYEYMEMGSLFCVLRTD-EEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADF 81 (144)
Q Consensus 3 ~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~ 81 (144)
++++|+||||+++++|.+++... .....+++..+..++.|++.++.+|| +.+++|+|++|+||+++.++.++++||
T Consensus 73 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH---~~~i~H~dl~~~nil~~~~~~~~l~df 149 (287)
T cd06621 73 SSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLH---SRKIIHRDIKPSNILLTRKGQVKLCDF 149 (287)
T ss_pred CCeEEEEEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEecCCeEEEeec
Confidence 34689999999999999887541 22334788999999999999999999 899999999999999999999999999
Q ss_pred cceeecccCCCCcccccccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCC
Q 044494 82 GVARLLNFDSSNRTLLAGTYGYIAPELAYTMVVTEKSDVYSFGVVALEVLMGKHPGELL 140 (144)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~d~~slg~~l~~~~~g~~p~~~~ 140 (144)
|++....... .....++..|++||.+....++.++|+||+|+++|++++|..||+..
T Consensus 150 g~~~~~~~~~--~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~ 206 (287)
T cd06621 150 GVSGELVNSL--AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPE 206 (287)
T ss_pred cccccccccc--cccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcc
Confidence 9987543221 22345677899999998888899999999999999999999999765
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.3e-26 Score=157.84 Aligned_cols=130 Identities=27% Similarity=0.322 Sum_probs=105.9
Q ss_pred CceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCC-------C
Q 044494 3 RKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLEL-------E 75 (144)
Q Consensus 3 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~-------~ 75 (144)
+...++||||+++++|..++.+.. ..+++.....++.|++.|++||| +++++|+||||+||+++..+ .
T Consensus 88 ~~~~~lv~ey~~~g~L~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~lH---~~~iiH~dlkp~Nill~~~~~~~~~~~~ 162 (274)
T cd05076 88 GSENIMVEEFVEHGPLDVCLRKEK--GRVPVAWKITVAQQLASALSYLE---DKNLVHGNVCAKNILLARLGLAEGTSPF 162 (274)
T ss_pred CCceEEEEecCCCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHH---cCCccCCCCCcccEEEeccCcccCccce
Confidence 456799999999999999886532 23788999999999999999999 89999999999999997643 3
Q ss_pred eEEeeecceeecccCCCCcccccccccccCcccccc-CCCCCcchhHHHHHHHHHHH-hCCCCCCCCC
Q 044494 76 AFVADFGVARLLNFDSSNRTLLAGTYGYIAPELAYT-MVVTEKSDVYSFGVVALEVL-MGKHPGELLS 141 (144)
Q Consensus 76 ~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~-~~~~~~~d~~slg~~l~~~~-~g~~p~~~~~ 141 (144)
++++|||.+..... .....++..|++||.+.. ..++.++|+||+|+++|+++ +|..||...+
T Consensus 163 ~kl~d~g~~~~~~~----~~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~ 226 (274)
T cd05076 163 IKLSDPGVSFTALS----REERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERT 226 (274)
T ss_pred eeecCCcccccccc----ccccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccC
Confidence 78999998754321 122346778999998865 45788999999999999985 6999997654
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=99.95 E-value=2e-26 Score=161.35 Aligned_cols=107 Identities=29% Similarity=0.426 Sum_probs=89.9
Q ss_pred CCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeeecceeecccCCC--CcccccccccccCccc
Q 044494 31 LDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADFGVARLLNFDSS--NRTLLAGTYGYIAPEL 108 (144)
Q Consensus 31 ~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~~~~~~~pe~ 108 (144)
++......++.|++.|+.||| +++++|+||||.||+++.++.++++|||++........ ......++..|++||.
T Consensus 176 ~~~~~~~~~~~qi~~al~~lH---~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~ 252 (343)
T cd05103 176 LTLEDLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPET 252 (343)
T ss_pred CCHHHHHHHHHHHHHHHHHHH---hCCeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCCCCcceECcHH
Confidence 577788889999999999999 89999999999999999999999999999876432211 1122334567999999
Q ss_pred cccCCCCCcchhHHHHHHHHHHHh-CCCCCCCC
Q 044494 109 AYTMVVTEKSDVYSFGVVALEVLM-GKHPGELL 140 (144)
Q Consensus 109 ~~~~~~~~~~d~~slg~~l~~~~~-g~~p~~~~ 140 (144)
.....++.++|+||+|++++++++ |..||...
T Consensus 253 ~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~ 285 (343)
T cd05103 253 IFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGV 285 (343)
T ss_pred hcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCc
Confidence 988888999999999999999997 99999654
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.5e-26 Score=156.95 Aligned_cols=132 Identities=25% Similarity=0.411 Sum_probs=111.9
Q ss_pred CceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeeec
Q 044494 3 RKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADFG 82 (144)
Q Consensus 3 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~~ 82 (144)
.+.+++||||+++++|.+++++.. .+++..+..++.|++.++.+|| +.+++|+||+|+||+++.++.++++|||
T Consensus 80 ~~~~~lv~e~~~~~~L~~~l~~~~---~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~~~nil~~~~~~~~l~d~~ 153 (272)
T cd06629 80 EEYLSIFLEYVPGGSIGSCLRTYG---RFEEQLVRFFTEQVLEGLAYLH---SKGILHRDLKADNLLVDADGICKISDFG 153 (272)
T ss_pred CCceEEEEecCCCCcHHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHh---hCCeeecCCChhhEEEcCCCeEEEeecc
Confidence 467899999999999999987653 3888999999999999999999 8999999999999999999999999999
Q ss_pred ceeecccCC--CCcccccccccccCccccccCC--CCCcchhHHHHHHHHHHHhCCCCCCCC
Q 044494 83 VARLLNFDS--SNRTLLAGTYGYIAPELAYTMV--VTEKSDVYSFGVVALEVLMGKHPGELL 140 (144)
Q Consensus 83 ~~~~~~~~~--~~~~~~~~~~~~~~pe~~~~~~--~~~~~d~~slg~~l~~~~~g~~p~~~~ 140 (144)
.+....... .......++..|++||...... ++.++|+||+|++++++++|..||...
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~ 215 (272)
T cd06629 154 ISKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDE 215 (272)
T ss_pred ccccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCc
Confidence 887543211 1122345778899999987654 788999999999999999999999653
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.4e-27 Score=158.25 Aligned_cols=135 Identities=27% Similarity=0.360 Sum_probs=115.7
Q ss_pred CCceEEEEEeeccCCCHHHHhhc--ccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCC----CC
Q 044494 2 HRKCMFLIYEYMEMGSLFCVLRT--DEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLE----LE 75 (144)
Q Consensus 2 ~~~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~----~~ 75 (144)
+++++++++||.+. +|...++- ....+.++...+..++.||+.|+.||| +.=++|||+||.||++..+ |.
T Consensus 99 ~d~~v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH---~NWvlHRDLKPaNIlvmgdgperG~ 174 (438)
T KOG0666|consen 99 HDKKVWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLH---SNWVLHRDLKPANILVMGDGPERGR 174 (438)
T ss_pred cCceEEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHh---hhheeeccCCcceEEEeccCCccCe
Confidence 47899999999975 99998853 233356999999999999999999999 7789999999999999887 89
Q ss_pred eEEeeecceeecccCCCC---cccccccccccCccccccC-CCCCcchhHHHHHHHHHHHhCCCCCCCC
Q 044494 76 AFVADFGVARLLNFDSSN---RTLLAGTYGYIAPELAYTM-VVTEKSDVYSFGVVALEVLMGKHPGELL 140 (144)
Q Consensus 76 ~~l~d~~~~~~~~~~~~~---~~~~~~~~~~~~pe~~~~~-~~~~~~d~~slg~~l~~~~~g~~p~~~~ 140 (144)
|||+|+|+++.+..+-+. ......|.+|.|||.+.+. .|++..|+||+|||+.||++-++-|.+.
T Consensus 175 VKIaDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~ 243 (438)
T KOG0666|consen 175 VKIADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGR 243 (438)
T ss_pred eEeecccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccch
Confidence 999999999988754332 3456789999999999876 5889999999999999999998888663
|
|
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.3e-26 Score=160.05 Aligned_cols=132 Identities=29% Similarity=0.346 Sum_probs=109.9
Q ss_pred ceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeeecc
Q 044494 4 KCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADFGV 83 (144)
Q Consensus 4 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~~~ 83 (144)
+.+++||||+.+ +|.+++.... ..+++..+..++.|++.++.+|| +.+++|+||+|+||+++.++.++++|||.
T Consensus 81 ~~~~lv~e~~~~-~l~~~l~~~~--~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~kL~dfg~ 154 (309)
T cd07845 81 DSIFLVMEYCEQ-DLASLLDNMP--TPFSESQVKCLMLQLLRGLQYLH---ENFIIHRDLKVSNLLLTDKGCLKIADFGL 154 (309)
T ss_pred CeEEEEEecCCC-CHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEECccce
Confidence 468999999974 8888876532 34899999999999999999999 89999999999999999999999999999
Q ss_pred eeecccCCCCcccccccccccCcccccc-CCCCCcchhHHHHHHHHHHHhCCCCCCCCC
Q 044494 84 ARLLNFDSSNRTLLAGTYGYIAPELAYT-MVVTEKSDVYSFGVVALEVLMGKHPGELLS 141 (144)
Q Consensus 84 ~~~~~~~~~~~~~~~~~~~~~~pe~~~~-~~~~~~~d~~slg~~l~~~~~g~~p~~~~~ 141 (144)
+..............+++.|+|||.+.+ ..++.++|+||+|+++|++++|..||...+
T Consensus 155 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~ 213 (309)
T cd07845 155 ARTYGLPAKPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKS 213 (309)
T ss_pred eeecCCccCCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 9876533222222345778999998865 456889999999999999999999997544
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.2e-26 Score=158.71 Aligned_cols=135 Identities=30% Similarity=0.449 Sum_probs=110.9
Q ss_pred CceEEEEEeeccCCCHHHHhhccc-------------------ccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCC
Q 044494 3 RKCMFLIYEYMEMGSLFCVLRTDE-------------------EAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDI 63 (144)
Q Consensus 3 ~~~~~lv~e~~~~~~L~~~l~~~~-------------------~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i 63 (144)
+...++++||+++++|.+++.... ....+++..++.++.|++.++.+|| +.+++|+||
T Consensus 80 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH---~~~i~H~dl 156 (288)
T cd05050 80 GKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLS---ERKFVHRDL 156 (288)
T ss_pred CCccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHH---hCCeecccc
Confidence 456899999999999999986421 1234788889999999999999999 899999999
Q ss_pred CCCcEEEcCCCCeEEeeecceeecccCCC--CcccccccccccCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCC
Q 044494 64 SSNNILLNLELEAFVADFGVARLLNFDSS--NRTLLAGTYGYIAPELAYTMVVTEKSDVYSFGVVALEVLM-GKHPGELL 140 (144)
Q Consensus 64 ~~~ni~~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~d~~slg~~l~~~~~-g~~p~~~~ 140 (144)
+|.||+++.++.++++|||++........ .......+..|+|||...+..++.++|+||+|++++++++ |..||...
T Consensus 157 ~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~ 236 (288)
T cd05050 157 ATRNCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGM 236 (288)
T ss_pred cHhheEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Confidence 99999999999999999998875432211 1122234567999999988889999999999999999997 88888654
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.1e-26 Score=154.71 Aligned_cols=134 Identities=29% Similarity=0.442 Sum_probs=112.8
Q ss_pred CceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeeec
Q 044494 3 RKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADFG 82 (144)
Q Consensus 3 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~~ 82 (144)
++..+++|||+++++|.+++..... ..+++..+..++.|++.++.+|| +.+++|+||+|+||+++.++.++++|||
T Consensus 73 ~~~~~~i~e~~~~~~l~~~~~~~~~-~~~~~~~~~~~~~ql~~~l~~lh---~~~~~h~dl~~~nil~~~~~~~~l~dfg 148 (258)
T smart00219 73 EEPLMIVMEYMEGGDLLDYLRKNRP-KELSLSDLLSFALQIARGMEYLE---SKNFIHRDLAARNCLVGENLVVKISDFG 148 (258)
T ss_pred CCeeEEEEeccCCCCHHHHHHhhhh-ccCCHHHHHHHHHHHHHHHHHHh---cCCeeecccccceEEEccCCeEEEcccC
Confidence 4678999999999999999875332 22899999999999999999999 8999999999999999999999999999
Q ss_pred ceeecccCCCCcc-cccccccccCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCC
Q 044494 83 VARLLNFDSSNRT-LLAGTYGYIAPELAYTMVVTEKSDVYSFGVVALEVLM-GKHPGELL 140 (144)
Q Consensus 83 ~~~~~~~~~~~~~-~~~~~~~~~~pe~~~~~~~~~~~d~~slg~~l~~~~~-g~~p~~~~ 140 (144)
.+........... ...+++.|++||......++.++|+||+|++++++++ |..||...
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~ 208 (258)
T smart00219 149 LSRDLYDDDYYKKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGM 208 (258)
T ss_pred CceecccccccccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Confidence 9986653311111 1235678999999988888999999999999999998 88998754
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.4e-26 Score=158.34 Aligned_cols=131 Identities=29% Similarity=0.419 Sum_probs=110.9
Q ss_pred CceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeeec
Q 044494 3 RKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADFG 82 (144)
Q Consensus 3 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~~ 82 (144)
++.+++||||+++++|.+++.... .+++..+..++.|++.++.+|| +.+++|+|++|.||+++.++.++++|||
T Consensus 77 ~~~~~lv~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~ql~~~l~~lH---~~~~~H~dl~p~nil~~~~~~~~l~dfg 150 (288)
T cd05583 77 DTKLHLILDYVNGGELFTHLYQRE---HFTESEVRVYIAEIVLALDHLH---QLGIIYRDIKLENILLDSEGHVVLTDFG 150 (288)
T ss_pred CCEEEEEEecCCCCcHHHHHhhcC---CcCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHeEECCCCCEEEEECc
Confidence 467899999999999999887543 3889999999999999999999 8999999999999999999999999999
Q ss_pred ceeecccCCC-CcccccccccccCccccccCC--CCCcchhHHHHHHHHHHHhCCCCCCC
Q 044494 83 VARLLNFDSS-NRTLLAGTYGYIAPELAYTMV--VTEKSDVYSFGVVALEVLMGKHPGEL 139 (144)
Q Consensus 83 ~~~~~~~~~~-~~~~~~~~~~~~~pe~~~~~~--~~~~~d~~slg~~l~~~~~g~~p~~~ 139 (144)
++........ ......++..|++||...+.. .+.++|+||+|+++++|++|..||..
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~ 210 (288)
T cd05583 151 LSKEFLAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTV 210 (288)
T ss_pred cccccccccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCccc
Confidence 8876442221 122245788999999987654 67889999999999999999999964
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.3e-26 Score=157.46 Aligned_cols=134 Identities=30% Similarity=0.491 Sum_probs=115.2
Q ss_pred CCceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeee
Q 044494 2 HRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADF 81 (144)
Q Consensus 2 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~ 81 (144)
+++..++||||+++++|.+++.+.. .+++..+..++.|++.++.+|| +.+++|+|++|+||+++.++.++++||
T Consensus 73 ~~~~~~lv~e~~~~~~L~~~l~~~~---~l~~~~~~~i~~ql~~~l~~Lh---~~~~~H~dl~~~ni~i~~~~~~~l~df 146 (280)
T cd05581 73 DEENLYFVLEYAPNGELLQYIRKYG---SLDEKCTRFYAAEILLALEYLH---SKGIIHRDLKPENILLDKDMHIKITDF 146 (280)
T ss_pred CCceEEEEEcCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHeEECCCCCEEecCC
Confidence 4567899999999999999997644 3999999999999999999999 899999999999999999999999999
Q ss_pred cceeecccCCC--------------------CcccccccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCC
Q 044494 82 GVARLLNFDSS--------------------NRTLLAGTYGYIAPELAYTMVVTEKSDVYSFGVVALEVLMGKHPGELLS 141 (144)
Q Consensus 82 ~~~~~~~~~~~--------------------~~~~~~~~~~~~~pe~~~~~~~~~~~d~~slg~~l~~~~~g~~p~~~~~ 141 (144)
|.+........ ......++..|++||......++.++|+||+|++++++++|..||...+
T Consensus 147 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~ 226 (280)
T cd05581 147 GTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSN 226 (280)
T ss_pred ccccccCCccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCcc
Confidence 98876543221 1122346788999999888888889999999999999999999998654
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=99.94 E-value=1e-26 Score=158.49 Aligned_cols=133 Identities=27% Similarity=0.414 Sum_probs=109.2
Q ss_pred CceEEEEEeeccCCCHHHHhhcc-cccCCCCHHHHHHHHHHHHHHHHHHhcCCCC-CeEecCCCCCcEEEcCCCCeEEee
Q 044494 3 RKCMFLIYEYMEMGSLFCVLRTD-EEAVGLDWAKRVNIVKGMAHALSYLHHDCTP-PIVHRDISSNNILLNLELEAFVAD 80 (144)
Q Consensus 3 ~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~-~~~h~~i~~~ni~~~~~~~~~l~d 80 (144)
++.+|++|||++ ++|.+++... .....+++..++.++.|++.++.+|| ++ +++|+|++|+||+++.++.++++|
T Consensus 72 ~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~~i~h~dlkp~nil~~~~~~~kl~d 147 (283)
T cd06617 72 EGDVWICMEVMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLH---SKLSVIHRDVKPSNVLINRNGQVKLCD 147 (283)
T ss_pred CCcEEEEhhhhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHh---hcCCeecCCCCHHHEEECCCCCEEEee
Confidence 567899999997 5888877542 22345899999999999999999999 76 999999999999999999999999
Q ss_pred ecceeecccCCCCcccccccccccCcccccc----CCCCCcchhHHHHHHHHHHHhCCCCCCCC
Q 044494 81 FGVARLLNFDSSNRTLLAGTYGYIAPELAYT----MVVTEKSDVYSFGVVALEVLMGKHPGELL 140 (144)
Q Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~----~~~~~~~d~~slg~~l~~~~~g~~p~~~~ 140 (144)
||.+...... .......++..|++||.+.. ..++.++|+||+|+++++|++|+.||...
T Consensus 148 fg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~ 210 (283)
T cd06617 148 FGISGYLVDS-VAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSW 210 (283)
T ss_pred cccccccccc-cccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCcc
Confidence 9998764321 11222457788999998864 34578899999999999999999999754
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.1e-26 Score=164.06 Aligned_cols=109 Identities=28% Similarity=0.441 Sum_probs=91.4
Q ss_pred CCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeeecceeecccCCC--CcccccccccccCcc
Q 044494 30 GLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADFGVARLLNFDSS--NRTLLAGTYGYIAPE 107 (144)
Q Consensus 30 ~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~~~~~~~pe 107 (144)
.+++..+..++.|++.|+.||| +.+++|+||||+||+++.++.++++|||+++....... ......+++.|++||
T Consensus 235 ~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrdlkp~NiLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE 311 (401)
T cd05107 235 ALSYMDLVGFSYQVANGMEFLA---SKNCVHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPE 311 (401)
T ss_pred CCCHHHHHHHHHHHHHHHHHHh---cCCcCcccCCcceEEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChH
Confidence 3667778889999999999999 89999999999999999999999999999875432111 122234677899999
Q ss_pred ccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCC
Q 044494 108 LAYTMVVTEKSDVYSFGVVALEVLM-GKHPGELLS 141 (144)
Q Consensus 108 ~~~~~~~~~~~d~~slg~~l~~~~~-g~~p~~~~~ 141 (144)
.+....++.++|+||+|++++|+++ |..||...+
T Consensus 312 ~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~ 346 (401)
T cd05107 312 SIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELP 346 (401)
T ss_pred HhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCC
Confidence 9988888999999999999999998 889997643
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.5e-26 Score=157.10 Aligned_cols=135 Identities=26% Similarity=0.346 Sum_probs=112.0
Q ss_pred CceEEEEEeeccCCCHHHHhhccccc------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCe
Q 044494 3 RKCMFLIYEYMEMGSLFCVLRTDEEA------VGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEA 76 (144)
Q Consensus 3 ~~~~~lv~e~~~~~~L~~~l~~~~~~------~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~ 76 (144)
....|+||||+++++|.+++...... ..+++..+..++.|++.++++|| +.+++|+||||+|++++.++.+
T Consensus 80 ~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH---~~~i~H~dlkp~Nili~~~~~~ 156 (275)
T cd05046 80 AEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLS---NARFVHRDLAARNCLVSSQREV 156 (275)
T ss_pred CCcceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhh---hcCcccCcCccceEEEeCCCcE
Confidence 45689999999999999998754321 14899999999999999999999 8899999999999999999999
Q ss_pred EEeeecceeecccCC-CCcccccccccccCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCC
Q 044494 77 FVADFGVARLLNFDS-SNRTLLAGTYGYIAPELAYTMVVTEKSDVYSFGVVALEVLM-GKHPGELL 140 (144)
Q Consensus 77 ~l~d~~~~~~~~~~~-~~~~~~~~~~~~~~pe~~~~~~~~~~~d~~slg~~l~~~~~-g~~p~~~~ 140 (144)
+++|++++....... .......++..|++||.+.....+.++|+||+|++++++++ |..||...
T Consensus 157 ~l~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~ 222 (275)
T cd05046 157 KVSLLSLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGL 222 (275)
T ss_pred EEcccccccccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCcccc
Confidence 999999876433211 11223345677999999988888889999999999999998 88899654
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.6e-26 Score=155.19 Aligned_cols=135 Identities=26% Similarity=0.321 Sum_probs=115.9
Q ss_pred CCceEEEEEeeccCCCHHHHhhccc-ccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEee
Q 044494 2 HRKCMFLIYEYMEMGSLFCVLRTDE-EAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVAD 80 (144)
Q Consensus 2 ~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d 80 (144)
.+...|+|+||+++++|.+++.+.. ....+++..++.++.|++.|+.+|| +.|++|+|++|.||+++.++.++++|
T Consensus 70 ~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh---~~~i~h~~l~~~ni~~~~~~~~kl~d 146 (256)
T cd08530 70 DGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALH---EQKILHRDLKSANILLVANDLVKIGD 146 (256)
T ss_pred cCCEEEEEehhcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHh---hCCcccCCCCcceEEEecCCcEEEee
Confidence 3567899999999999999886522 2234889999999999999999999 89999999999999999999999999
Q ss_pred ecceeecccCCCCcccccccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCC
Q 044494 81 FGVARLLNFDSSNRTLLAGTYGYIAPELAYTMVVTEKSDVYSFGVVALEVLMGKHPGELLS 141 (144)
Q Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~d~~slg~~l~~~~~g~~p~~~~~ 141 (144)
||++...... ......+++.|++||......++.++|+||+|++++++++|..||+..+
T Consensus 147 ~g~~~~~~~~--~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~ 205 (256)
T cd08530 147 LGISKVLKKN--MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARS 205 (256)
T ss_pred ccchhhhccC--CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 9998765533 2233457889999999988888889999999999999999999997654
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.7e-26 Score=157.55 Aligned_cols=132 Identities=29% Similarity=0.379 Sum_probs=111.2
Q ss_pred CceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeeec
Q 044494 3 RKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADFG 82 (144)
Q Consensus 3 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~~ 82 (144)
++..++|+||+ +++|.+++.... ..+++..+..++.|++.++.+|| +.+++|+||+|+||+++.++.++++|||
T Consensus 71 ~~~~~~v~e~~-~~~L~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~ni~~~~~~~~~l~dfg 144 (286)
T cd07832 71 GSGFVLVMEYM-PSDLSEVLRDEE--RPLPEAQVKSYMRMLLKGVAYMH---ANGIMHRDLKPANLLISADGVLKIADFG 144 (286)
T ss_pred CCeeEEEeccc-CCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCcCHHHEEEcCCCcEEEeeee
Confidence 56789999999 999999887533 34899999999999999999999 8999999999999999999999999999
Q ss_pred ceeecccCCC-CcccccccccccCccccccCC-CCCcchhHHHHHHHHHHHhCCCCCCCC
Q 044494 83 VARLLNFDSS-NRTLLAGTYGYIAPELAYTMV-VTEKSDVYSFGVVALEVLMGKHPGELL 140 (144)
Q Consensus 83 ~~~~~~~~~~-~~~~~~~~~~~~~pe~~~~~~-~~~~~d~~slg~~l~~~~~g~~p~~~~ 140 (144)
.+........ ......++..|+|||.+.... ++.++|+||+|++++++++|..||...
T Consensus 145 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~ 204 (286)
T cd07832 145 LARLFSEEEPRLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGE 204 (286)
T ss_pred ecccccCCCCCccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCC
Confidence 8876543221 123345788999999886543 578999999999999999998888653
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.2e-26 Score=156.94 Aligned_cols=134 Identities=22% Similarity=0.324 Sum_probs=111.2
Q ss_pred CCceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeee
Q 044494 2 HRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADF 81 (144)
Q Consensus 2 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~ 81 (144)
.++..|++|||++ ++|.+++..... ..+++..+..++.|++.++++|| +.+++|+|++|+||+++.++.++++||
T Consensus 69 ~~~~~~iv~e~~~-~~l~~~~~~~~~-~~~~~~~~~~~~~~i~~~L~~lH---~~~~~H~dl~p~nil~~~~~~~~l~df 143 (283)
T cd07835 69 SENKLYLVFEFLD-LDLKKYMDSSPL-TGLDPPLIKSYLYQLLQGIAYCH---SHRVLHRDLKPQNLLIDREGALKLADF 143 (283)
T ss_pred cCCeEEEEEeccC-cCHHHHHhhCCC-CCCCHHHHHHHHHHHHHHHHHHH---HCCeeCCCCCHHHEEEcCCCcEEEeec
Confidence 3567899999995 689998875331 34899999999999999999999 889999999999999999999999999
Q ss_pred cceeecccCCCCcccccccccccCccccccC-CCCCcchhHHHHHHHHHHHhCCCCCCCC
Q 044494 82 GVARLLNFDSSNRTLLAGTYGYIAPELAYTM-VVTEKSDVYSFGVVALEVLMGKHPGELL 140 (144)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~-~~~~~~d~~slg~~l~~~~~g~~p~~~~ 140 (144)
|.+..............++..|+|||.+... .++.++|+||+|+++|++++|..||...
T Consensus 144 ~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~ 203 (283)
T cd07835 144 GLARAFGVPVRTYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGD 203 (283)
T ss_pred ccccccCCCccccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 9987654332222334567889999987654 4678899999999999999999999754
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=99.94 E-value=2e-26 Score=157.24 Aligned_cols=134 Identities=22% Similarity=0.331 Sum_probs=110.6
Q ss_pred CCceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeee
Q 044494 2 HRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADF 81 (144)
Q Consensus 2 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~ 81 (144)
.++..++||||+. ++|.+++.... ...+++..+..++.|++.|++||| +.+++|+|++|+||+++.++.++++||
T Consensus 70 ~~~~~~~v~e~~~-~~l~~~~~~~~-~~~l~~~~~~~~~~~i~~~l~~lh---~~~i~H~~l~p~nill~~~~~~~l~df 144 (284)
T cd07860 70 TENKLYLVFEFLH-QDLKKFMDASP-LSGIPLPLIKSYLFQLLQGLAFCH---SHRVLHRDLKPQNLLINTEGAIKLADF 144 (284)
T ss_pred cCCcEEEEeeccc-cCHHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEEeec
Confidence 3567899999996 58988886532 234899999999999999999999 889999999999999999999999999
Q ss_pred cceeecccCCCCcccccccccccCccccccCC-CCCcchhHHHHHHHHHHHhCCCCCCCC
Q 044494 82 GVARLLNFDSSNRTLLAGTYGYIAPELAYTMV-VTEKSDVYSFGVVALEVLMGKHPGELL 140 (144)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~-~~~~~d~~slg~~l~~~~~g~~p~~~~ 140 (144)
|++..............+++.|++||...+.. ++.++|+||+|++++++++|..||...
T Consensus 145 g~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~ 204 (284)
T cd07860 145 GLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGD 204 (284)
T ss_pred cchhhcccCccccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCC
Confidence 98875543322233344678899999887644 578899999999999999999999654
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.4e-26 Score=154.31 Aligned_cols=136 Identities=29% Similarity=0.411 Sum_probs=117.1
Q ss_pred CceEEEEEeeccCCCHHHHhhccc-ccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeee
Q 044494 3 RKCMFLIYEYMEMGSLFCVLRTDE-EAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADF 81 (144)
Q Consensus 3 ~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~ 81 (144)
....++|+||+++++|.+++.+.. ....+++..+..++.+++.++.+|| +.+++|+|++|+||+++.++.++++||
T Consensus 71 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh---~~~~~H~dl~~~nil~~~~~~~~l~d~ 147 (258)
T cd08215 71 KGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLH---SRKILHRDIKPQNIFLTSNGLVKLGDF 147 (258)
T ss_pred CCEEEEEEEecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHH---hCCEecccCChHHeEEcCCCcEEECCc
Confidence 467899999999999999987632 2345899999999999999999999 889999999999999999999999999
Q ss_pred cceeecccCCCCcccccccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCC
Q 044494 82 GVARLLNFDSSNRTLLAGTYGYIAPELAYTMVVTEKSDVYSFGVVALEVLMGKHPGELLS 141 (144)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~d~~slg~~l~~~~~g~~p~~~~~ 141 (144)
|.+..............+++.|++||......++.++|+||+|++++++++|..||+..+
T Consensus 148 ~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~ 207 (258)
T cd08215 148 GISKVLSSTVDLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGEN 207 (258)
T ss_pred cceeecccCcceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCc
Confidence 998866543323334567888999999988888899999999999999999999997653
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.4e-26 Score=159.95 Aligned_cols=136 Identities=24% Similarity=0.345 Sum_probs=110.4
Q ss_pred CceEEEEEeeccCCCHHHHhhccc--ccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcC----CCCe
Q 044494 3 RKCMFLIYEYMEMGSLFCVLRTDE--EAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNL----ELEA 76 (144)
Q Consensus 3 ~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~----~~~~ 76 (144)
++.+++||||+++ ++.+.+.... ....+++..++.++.|++.++.+|| +.+++|+||+|+||+++. ++.+
T Consensus 76 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~h~dlkp~Nil~~~~~~~~~~~ 151 (316)
T cd07842 76 DKSVYLLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLH---SNWVLHRDLKPANILVMGEGPERGVV 151 (316)
T ss_pred CceEEEEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHH---hCCEeeCCCCHHHEEEcCCCCccceE
Confidence 3679999999975 7777765321 2235899999999999999999999 899999999999999999 8999
Q ss_pred EEeeecceeecccCCC---CcccccccccccCccccccC-CCCCcchhHHHHHHHHHHHhCCCCCCCCCC
Q 044494 77 FVADFGVARLLNFDSS---NRTLLAGTYGYIAPELAYTM-VVTEKSDVYSFGVVALEVLMGKHPGELLSS 142 (144)
Q Consensus 77 ~l~d~~~~~~~~~~~~---~~~~~~~~~~~~~pe~~~~~-~~~~~~d~~slg~~l~~~~~g~~p~~~~~~ 142 (144)
+++|||++........ ......+++.|+|||.+.+. .++.++|+||+|++++++++|..||...+.
T Consensus 152 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~ 221 (316)
T cd07842 152 KIGDLGLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREA 221 (316)
T ss_pred EECCCccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcc
Confidence 9999998876543222 12234567889999987654 467889999999999999999999987654
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.5e-26 Score=154.12 Aligned_cols=132 Identities=30% Similarity=0.402 Sum_probs=116.5
Q ss_pred ceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeeecc
Q 044494 4 KCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADFGV 83 (144)
Q Consensus 4 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~~~ 83 (144)
+.+++++||+++++|.+++.... .+++..+..++.+++.++.+|| +.+++|+|++|+||+++.++.++++||+.
T Consensus 74 ~~~~lv~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~l~~~l~~lh---~~~~~h~dl~p~ni~i~~~~~~~l~d~~~ 147 (260)
T cd06606 74 NTLNIFLEYVSGGSLSSLLKKFG---KLPEPVIRKYTRQILEGLAYLH---SNGIVHRDIKGANILVDSDGVVKLADFGC 147 (260)
T ss_pred CeEEEEEEecCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEEcCCCCEEEccccc
Confidence 67899999999999999987644 4899999999999999999999 89999999999999999999999999999
Q ss_pred eeecccCCC--CcccccccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCC
Q 044494 84 ARLLNFDSS--NRTLLAGTYGYIAPELAYTMVVTEKSDVYSFGVVALEVLMGKHPGELLS 141 (144)
Q Consensus 84 ~~~~~~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~d~~slg~~l~~~~~g~~p~~~~~ 141 (144)
+........ ......++..|++||.......+.++|+||+|++++++++|..||...+
T Consensus 148 ~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~ 207 (260)
T cd06606 148 AKRLGDIETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELG 207 (260)
T ss_pred EEecccccccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 887654332 1334567889999999988888899999999999999999999997754
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.94 E-value=9.1e-27 Score=165.48 Aligned_cols=131 Identities=26% Similarity=0.332 Sum_probs=108.7
Q ss_pred CCceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeee
Q 044494 2 HRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADF 81 (144)
Q Consensus 2 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~ 81 (144)
-+..+|+||||= ..+|..+|++.... .+...+..+++|++.++++.| ..||+|-|+||.|+++-. |.+|++||
T Consensus 431 ~d~~lYmvmE~G-d~DL~kiL~k~~~~--~~~~~lk~ywkqML~aV~~IH---~~gIVHSDLKPANFLlVk-G~LKLIDF 503 (677)
T KOG0596|consen 431 TDGYLYMVMECG-DIDLNKILKKKKSI--DPDWFLKFYWKQMLLAVKTIH---QHGIVHSDLKPANFLLVK-GRLKLIDF 503 (677)
T ss_pred cCceEEEEeecc-cccHHHHHHhccCC--CchHHHHHHHHHHHHHHHHHH---HhceeecCCCcccEEEEe-eeEEeeee
Confidence 467899999975 46999999865443 333478899999999999999 899999999999997754 67999999
Q ss_pred cceeecccCCCC--cccccccccccCccccccCC-----------CCCcchhHHHHHHHHHHHhCCCCCCC
Q 044494 82 GVARLLNFDSSN--RTLLAGTYGYIAPELAYTMV-----------VTEKSDVYSFGVVALEVLMGKHPGEL 139 (144)
Q Consensus 82 ~~~~~~~~~~~~--~~~~~~~~~~~~pe~~~~~~-----------~~~~~d~~slg~~l~~~~~g~~p~~~ 139 (144)
|++..+..+... .....||+.||+||.+.... .++++|+||||||+|+|+-|+.||..
T Consensus 504 GIA~aI~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~ 574 (677)
T KOG0596|consen 504 GIANAIQPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQ 574 (677)
T ss_pred chhcccCccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHH
Confidence 999987755433 45678999999999887443 34689999999999999999999965
|
|
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.7e-26 Score=154.38 Aligned_cols=133 Identities=29% Similarity=0.435 Sum_probs=111.0
Q ss_pred CceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeeec
Q 044494 3 RKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADFG 82 (144)
Q Consensus 3 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~~ 82 (144)
....++|+||+++++|.+++..... .++++.+..++.+++.++.+|| +.+++|+|++|+||+++.++.++++|||
T Consensus 71 ~~~~~~v~e~~~~~~L~~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lH---~~~i~h~dl~p~ni~i~~~~~~~l~d~g 145 (256)
T cd05112 71 RSPICLVFEFMEHGCLSDYLRAQRG--KFSQETLLGMCLDVCEGMAYLE---SSNVIHRDLAARNCLVGENQVVKVSDFG 145 (256)
T ss_pred CCceEEEEEcCCCCcHHHHHHhCcc--CCCHHHHHHHHHHHHHHHHHHH---HCCccccccccceEEEcCCCeEEECCCc
Confidence 4568999999999999998875322 3788999999999999999999 8899999999999999999999999999
Q ss_pred ceeecccCCCC-cccccccccccCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCC
Q 044494 83 VARLLNFDSSN-RTLLAGTYGYIAPELAYTMVVTEKSDVYSFGVVALEVLM-GKHPGELL 140 (144)
Q Consensus 83 ~~~~~~~~~~~-~~~~~~~~~~~~pe~~~~~~~~~~~d~~slg~~l~~~~~-g~~p~~~~ 140 (144)
.+......... .....++..|++||...+..++.++|+||+|+++|++++ |..||+..
T Consensus 146 ~~~~~~~~~~~~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~ 205 (256)
T cd05112 146 MTRFVLDDQYTSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENR 205 (256)
T ss_pred ceeecccCcccccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcC
Confidence 88755322111 112234568999999988888899999999999999998 99999754
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.1e-26 Score=154.83 Aligned_cols=135 Identities=30% Similarity=0.391 Sum_probs=113.9
Q ss_pred CCceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCC-eEEee
Q 044494 2 HRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELE-AFVAD 80 (144)
Q Consensus 2 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~-~~l~d 80 (144)
.+..+++|+||+++++|.+++.+... ..+++..+..++.+++.++.+|| +.+++|+|++|+||+++.++. ++++|
T Consensus 70 ~~~~~~lv~e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh---~~~i~H~dl~~~nil~~~~~~~~~l~d 145 (257)
T cd08225 70 ENGRLFIVMEYCDGGDLMKRINRQRG-VLFSEDQILSWFVQISLGLKHIH---DRKILHRDIKSQNIFLSKNGMVAKLGD 145 (257)
T ss_pred cCCeEEEEEecCCCCcHHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHH---HCCcccccCCHHHEEEcCCCCeEEecc
Confidence 35678999999999999998875332 24789999999999999999999 889999999999999998864 59999
Q ss_pred ecceeecccCCCCcccccccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCC
Q 044494 81 FGVARLLNFDSSNRTLLAGTYGYIAPELAYTMVVTEKSDVYSFGVVALEVLMGKHPGELL 140 (144)
Q Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~d~~slg~~l~~~~~g~~p~~~~ 140 (144)
|+.+..............+++.|+|||......++.++|+||+|++++++++|..||...
T Consensus 146 ~~~~~~~~~~~~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~ 205 (257)
T cd08225 146 FGIARQLNDSMELAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGN 205 (257)
T ss_pred cccchhccCCcccccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCc
Confidence 998876553332233345788899999998888889999999999999999999999754
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.9e-28 Score=159.91 Aligned_cols=126 Identities=27% Similarity=0.345 Sum_probs=101.5
Q ss_pred EEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeeecceeec
Q 044494 8 LIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADFGVARLL 87 (144)
Q Consensus 8 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~~~~~~~ 87 (144)
+.||.|. ..+..++++- ...+++.-+-.+...+++||.||-. ..+++|||+||+||+++..|.+|++|||++.+.
T Consensus 168 IcMelMs-~C~ekLlkri--k~piPE~ilGk~tva~v~AL~YLKe--KH~viHRDvKPSNILlDe~GniKlCDFGIsGrl 242 (391)
T KOG0983|consen 168 ICMELMS-TCAEKLLKRI--KGPIPERILGKMTVAIVKALYYLKE--KHGVIHRDVKPSNILLDERGNIKLCDFGISGRL 242 (391)
T ss_pred HHHHHHH-HHHHHHHHHh--cCCchHHhhhhhHHHHHHHHHHHHH--hcceeecccCccceEEccCCCEEeeccccccee
Confidence 3444442 2444444431 1228888888888999999999985 458999999999999999999999999999876
Q ss_pred ccCCCCcccccccccccCccccccC---CCCCcchhHHHHHHHHHHHhCCCCCCC
Q 044494 88 NFDSSNRTLLAGTYGYIAPELAYTM---VVTEKSDVYSFGVVALEVLMGKHPGEL 139 (144)
Q Consensus 88 ~~~~~~~~~~~~~~~~~~pe~~~~~---~~~~~~d~~slg~~l~~~~~g~~p~~~ 139 (144)
. ..++.....|.+.||+||.+.-. .|+.++|+||||++++|+.||++||++
T Consensus 243 v-dSkAhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~ 296 (391)
T KOG0983|consen 243 V-DSKAHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKG 296 (391)
T ss_pred e-cccccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCC
Confidence 5 34555567799999999988744 577899999999999999999999987
|
|
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.8e-26 Score=156.61 Aligned_cols=133 Identities=22% Similarity=0.301 Sum_probs=107.8
Q ss_pred CceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcC-CCCeEEeee
Q 044494 3 RKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNL-ELEAFVADF 81 (144)
Q Consensus 3 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~-~~~~~l~d~ 81 (144)
++..|+||||++ ++|.+.+..... ...++..+..++.|++.|+++|| +++++|+||+|+||+++. ++.++++||
T Consensus 73 ~~~~~lv~e~~~-~~l~~~~~~~~~-~~~~~~~~~~~~~qi~~aL~~LH---~~~i~H~dl~p~nill~~~~~~~kl~df 147 (294)
T PLN00009 73 EKRLYLVFEYLD-LDLKKHMDSSPD-FAKNPRLIKTYLYQILRGIAYCH---SHRVLHRDLKPQNLLIDRRTNALKLADF 147 (294)
T ss_pred CCeEEEEEeccc-ccHHHHHHhCCC-CCcCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCCcceEEEECCCCEEEEccc
Confidence 567899999996 588887764332 23678888899999999999999 899999999999999985 456899999
Q ss_pred cceeecccCCCCcccccccccccCccccccC-CCCCcchhHHHHHHHHHHHhCCCCCCCC
Q 044494 82 GVARLLNFDSSNRTLLAGTYGYIAPELAYTM-VVTEKSDVYSFGVVALEVLMGKHPGELL 140 (144)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~-~~~~~~d~~slg~~l~~~~~g~~p~~~~ 140 (144)
|++..............+++.|++||.+.+. .++.++|+||+|++++++++|..||...
T Consensus 148 g~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~ 207 (294)
T PLN00009 148 GLARAFGIPVRTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGD 207 (294)
T ss_pred ccccccCCCccccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 9997654333223334567889999988654 4678999999999999999999999754
|
|
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.5e-26 Score=155.16 Aligned_cols=134 Identities=27% Similarity=0.378 Sum_probs=112.6
Q ss_pred CCceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeee
Q 044494 2 HRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADF 81 (144)
Q Consensus 2 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~ 81 (144)
.++.+++|+||+.+ ++.+.+.... ..+++..+..++.|++.++.+|| +.+++|+|++|+||+++.++.++++||
T Consensus 69 ~~~~~~~v~e~~~~-~l~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dl~p~nili~~~~~~~l~df 142 (283)
T cd05118 69 HKGDLYLVFEFMDT-DLYKLIKDRQ--RGLPESLIKSYLYQLLQGLAFCH---SHGILHRDLKPENLLINTEGVLKLADF 142 (283)
T ss_pred cCCCEEEEEeccCC-CHHHHHHhhc--ccCCHHHHHHHHHHHHHHHHHHH---HCCeeecCcCHHHEEECCCCcEEEeee
Confidence 34678999999975 8888877533 24899999999999999999999 899999999999999999999999999
Q ss_pred cceeecccCCCCcccccccccccCccccccC-CCCCcchhHHHHHHHHHHHhCCCCCCCCC
Q 044494 82 GVARLLNFDSSNRTLLAGTYGYIAPELAYTM-VVTEKSDVYSFGVVALEVLMGKHPGELLS 141 (144)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~-~~~~~~d~~slg~~l~~~~~g~~p~~~~~ 141 (144)
|.+..............++..|++||.+... .++.++|+||+|++++++++|+.||...+
T Consensus 143 ~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~ 203 (283)
T cd05118 143 GLARSFGSPVRPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKS 203 (283)
T ss_pred eeeEecCCCcccccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Confidence 9987765433223334577789999998776 67889999999999999999999996543
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.2e-26 Score=160.52 Aligned_cols=131 Identities=27% Similarity=0.399 Sum_probs=110.0
Q ss_pred ceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeeecc
Q 044494 4 KCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADFGV 83 (144)
Q Consensus 4 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~~~ 83 (144)
..+|+||||+. ++|.+++..... +++..+..++.|++.|+.+|| +.+++|+||+|+||+++.++.++++|||.
T Consensus 81 ~~~~lv~e~~~-~~l~~~~~~~~~---~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~Nil~~~~~~~kl~dfg~ 153 (334)
T cd07855 81 KDVYVVMDLME-SDLHHIIHSDQP---LTEEHIRYFLYQLLRGLKYIH---SANVIHRDLKPSNLLVNEDCELRIGDFGM 153 (334)
T ss_pred ceEEEEEehhh-hhHHHHhccCCC---CCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCcEEeccccc
Confidence 56899999996 589888865433 899999999999999999999 88999999999999999999999999999
Q ss_pred eeecccCCCC----cccccccccccCcccccc-CCCCCcchhHHHHHHHHHHHhCCCCCCCCC
Q 044494 84 ARLLNFDSSN----RTLLAGTYGYIAPELAYT-MVVTEKSDVYSFGVVALEVLMGKHPGELLS 141 (144)
Q Consensus 84 ~~~~~~~~~~----~~~~~~~~~~~~pe~~~~-~~~~~~~d~~slg~~l~~~~~g~~p~~~~~ 141 (144)
+......... .....++..|++||.+.. ..++.++|+||+|+++++|++|..||...+
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~ 216 (334)
T cd07855 154 ARGLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKN 216 (334)
T ss_pred ceeecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCC
Confidence 8765432211 122457888999998765 457889999999999999999999997643
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.7e-26 Score=159.66 Aligned_cols=131 Identities=28% Similarity=0.367 Sum_probs=112.2
Q ss_pred ceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeeecc
Q 044494 4 KCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADFGV 83 (144)
Q Consensus 4 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~~~ 83 (144)
+.+|++|||++ ++|.+++.+.. .+++..+..++.+++.++++|| +.|++|+||||.||+++.++.++++|||.
T Consensus 77 ~~~~lv~e~~~-~~l~~~l~~~~---~l~~~~~~~i~~~l~~~l~~LH---~~gi~H~dlkp~nili~~~~~~~L~dfg~ 149 (330)
T cd07834 77 NDVYIVTELME-TDLHKVIKSPQ---PLTDDHIQYFLYQILRGLKYLH---SANVIHRDLKPSNILVNSNCDLKICDFGL 149 (330)
T ss_pred cceEEEecchh-hhHHHHHhCCC---CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEcccCc
Confidence 36899999997 48888887543 4899999999999999999999 89999999999999999999999999999
Q ss_pred eeecccCC---CCcccccccccccCccccccC-CCCCcchhHHHHHHHHHHHhCCCCCCCCC
Q 044494 84 ARLLNFDS---SNRTLLAGTYGYIAPELAYTM-VVTEKSDVYSFGVVALEVLMGKHPGELLS 141 (144)
Q Consensus 84 ~~~~~~~~---~~~~~~~~~~~~~~pe~~~~~-~~~~~~d~~slg~~l~~~~~g~~p~~~~~ 141 (144)
+....... .......+++.|++||.+.+. .++.++|+||+|++++++++|..||...+
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~ 211 (330)
T cd07834 150 ARGVDPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRD 211 (330)
T ss_pred eEeecccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCC
Confidence 98765432 122334578889999999887 78889999999999999999999997543
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.8e-26 Score=160.26 Aligned_cols=130 Identities=28% Similarity=0.378 Sum_probs=109.7
Q ss_pred ceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeeecc
Q 044494 4 KCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADFGV 83 (144)
Q Consensus 4 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~~~ 83 (144)
..+|+|+||+. ++|.+++.... .+++..+..++.|++.++.+|| +.+++|+|++|+||+++.++.++++|||+
T Consensus 82 ~~~~lv~e~~~-~~L~~~~~~~~---~l~~~~~~~i~~qi~~aL~~LH---~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~ 154 (337)
T cd07858 82 NDVYIVYELMD-TDLHQIIRSSQ---TLSDDHCQYFLYQLLRGLKYIH---SANVLHRDLKPSNLLLNANCDLKICDFGL 154 (337)
T ss_pred CcEEEEEeCCC-CCHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEcCCCCEEECcCcc
Confidence 35799999996 68988887543 3899999999999999999999 89999999999999999999999999999
Q ss_pred eeecccCCCCcccccccccccCcccccc-CCCCCcchhHHHHHHHHHHHhCCCCCCCC
Q 044494 84 ARLLNFDSSNRTLLAGTYGYIAPELAYT-MVVTEKSDVYSFGVVALEVLMGKHPGELL 140 (144)
Q Consensus 84 ~~~~~~~~~~~~~~~~~~~~~~pe~~~~-~~~~~~~d~~slg~~l~~~~~g~~p~~~~ 140 (144)
+..............++..|+|||.+.. ..++.++|+||+|++++++++|..||...
T Consensus 155 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~ 212 (337)
T cd07858 155 ARTTSEKGDFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGK 212 (337)
T ss_pred ccccCCCcccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCC
Confidence 8765432222233457788999998764 45788999999999999999999999754
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.9e-26 Score=166.77 Aligned_cols=132 Identities=23% Similarity=0.316 Sum_probs=106.0
Q ss_pred CceEEEEEeeccCCCHHHHhhcccc--cCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEee
Q 044494 3 RKCMFLIYEYMEMGSLFCVLRTDEE--AVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVAD 80 (144)
Q Consensus 3 ~~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d 80 (144)
.+..|+|+|++. ++|.+++..... ........+..++.|++.||+||| +++++||||||+||+++.++.++|+|
T Consensus 235 ~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH---~~gIiHrDLKP~NILl~~~~~vkL~D 310 (501)
T PHA03210 235 EANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIH---DKKLIHRDIKLENIFLNCDGKIVLGD 310 (501)
T ss_pred CCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEEEe
Confidence 456789999985 577777653211 112345667789999999999999 89999999999999999999999999
Q ss_pred ecceeecccCCC-CcccccccccccCccccccCCCCCcchhHHHHHHHHHHHhCCC-CCC
Q 044494 81 FGVARLLNFDSS-NRTLLAGTYGYIAPELAYTMVVTEKSDVYSFGVVALEVLMGKH-PGE 138 (144)
Q Consensus 81 ~~~~~~~~~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~d~~slg~~l~~~~~g~~-p~~ 138 (144)
||++........ ......|++.|++||++.+..++.++|+||+|+++|||++|.. ||.
T Consensus 311 FGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~ 370 (501)
T PHA03210 311 FGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIG 370 (501)
T ss_pred CCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCcc
Confidence 999986643222 1223568999999999999889999999999999999999764 554
|
|
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.5e-26 Score=155.18 Aligned_cols=130 Identities=25% Similarity=0.259 Sum_probs=108.0
Q ss_pred ceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeeecc
Q 044494 4 KCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADFGV 83 (144)
Q Consensus 4 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~~~ 83 (144)
+.+++||||+. +++.+.+.... ..+++..+..++.|++.|+++|| +.+++|+||+|+||+++. +.++++|||.
T Consensus 73 ~~~~lv~e~~~-~~l~~~l~~~~--~~~~~~~~~~~~~qi~~~L~~LH---~~~i~H~dl~p~ni~l~~-~~~kl~dfg~ 145 (282)
T cd07831 73 GRLALVFELMD-MNLYELIKGRK--RPLPEKRVKSYMYQLLKSLDHMH---RNGIFHRDIKPENILIKD-DILKLADFGS 145 (282)
T ss_pred CcEEEEEecCC-ccHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHH---HCCceecccCHHHEEEcC-CCeEEEeccc
Confidence 67899999997 58888776532 23899999999999999999999 889999999999999999 9999999999
Q ss_pred eeecccCCCCcccccccccccCcccccc-CCCCCcchhHHHHHHHHHHHhCCCCCCCCC
Q 044494 84 ARLLNFDSSNRTLLAGTYGYIAPELAYT-MVVTEKSDVYSFGVVALEVLMGKHPGELLS 141 (144)
Q Consensus 84 ~~~~~~~~~~~~~~~~~~~~~~pe~~~~-~~~~~~~d~~slg~~l~~~~~g~~p~~~~~ 141 (144)
+........ .....+++.|+|||.... ..++.++|+||+|+++++|++|..||...+
T Consensus 146 ~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~ 203 (282)
T cd07831 146 CRGIYSKPP-YTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTN 203 (282)
T ss_pred ccccccCCC-cCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCC
Confidence 876543222 222457788999997654 446789999999999999999999997643
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.9e-28 Score=171.93 Aligned_cols=132 Identities=28% Similarity=0.389 Sum_probs=112.8
Q ss_pred CceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCC---CCeEEe
Q 044494 3 RKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLE---LEAFVA 79 (144)
Q Consensus 3 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~---~~~~l~ 79 (144)
.+++++|||.+.| +..+++-..++. .+++..-++++.||+.||+||| -++|+|.|+||+|+++... ..+|++
T Consensus 635 ~ervFVVMEKl~G-DMLEMILSsEkg-RL~er~TkFlvtQIL~ALr~LH---~knIvHCDLKPENVLLas~~~FPQvKlC 709 (888)
T KOG4236|consen 635 PERVFVVMEKLHG-DMLEMILSSEKG-RLPERITKFLVTQILVALRYLH---FKNIVHCDLKPENVLLASASPFPQVKLC 709 (888)
T ss_pred CceEEEEehhhcc-hHHHHHHHhhcc-cchHHHHHHHHHHHHHHHHHhh---hcceeeccCCchheeeccCCCCCceeec
Confidence 3678999999965 666665433322 2899999999999999999999 8999999999999999754 568999
Q ss_pred eecceeecccCCCCcccccccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCC
Q 044494 80 DFGVARLLNFDSSNRTLLAGTYGYIAPELAYTMVVTEKSDVYSFGVVALEVLMGKHPGELL 140 (144)
Q Consensus 80 d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~d~~slg~~l~~~~~g~~p~~~~ 140 (144)
|||+++.++.... .....|||.|+|||++..++|...-|+||.|+|+|..++|.+||+..
T Consensus 710 DFGfARiIgEksF-RrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEd 769 (888)
T KOG4236|consen 710 DFGFARIIGEKSF-RRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNED 769 (888)
T ss_pred cccceeecchhhh-hhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCc
Confidence 9999998875433 45578999999999999999999999999999999999999999753
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.7e-27 Score=160.95 Aligned_cols=132 Identities=21% Similarity=0.341 Sum_probs=113.6
Q ss_pred CceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcC----------
Q 044494 3 RKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNL---------- 72 (144)
Q Consensus 3 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~---------- 72 (144)
++++++|+|.+ |.|+++++...+ -..++...+..+..|+++++++|| +.+++|.|+||+||++..
T Consensus 163 rghiCivfell-G~S~~dFlk~N~-y~~fpi~~ir~m~~QL~~sv~fLh---~~kl~HTDLKPENILfvss~~~~~~~~k 237 (415)
T KOG0671|consen 163 RGHICIVFELL-GLSTFDFLKENN-YIPFPIDHIRHMGYQLLESVAFLH---DLKLTHTDLKPENILFVSSEYFKTYNPK 237 (415)
T ss_pred cCceEEEEecc-ChhHHHHhccCC-ccccchHHHHHHHHHHHHHHHHHH---hcceeecCCChheEEEeccceEEEeccC
Confidence 57889999988 679999998743 445899999999999999999999 899999999999999832
Q ss_pred ----------CCCeEEeeecceeecccCCCCcccccccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCC
Q 044494 73 ----------ELEAFVADFGVARLLNFDSSNRTLLAGTYGYIAPELAYTMVVTEKSDVYSFGVVALEVLMGKHPGELLSS 142 (144)
Q Consensus 73 ----------~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~d~~slg~~l~~~~~g~~p~~~~~~ 142 (144)
...++++|||.++.-. ..+.....|..|.|||++.+.+++.++|+||+|||+.|+.+|..-|+..++
T Consensus 238 ~~~~~~r~~ks~~I~vIDFGsAtf~~---e~hs~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHen 314 (415)
T KOG0671|consen 238 KKVCFIRPLKSTAIKVIDFGSATFDH---EHHSTIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHEN 314 (415)
T ss_pred CccceeccCCCcceEEEecCCcceec---cCcceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCCc
Confidence 2347899999997533 233556788999999999999999999999999999999999999988764
|
|
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=99.94 E-value=6.4e-26 Score=156.26 Aligned_cols=132 Identities=24% Similarity=0.346 Sum_probs=108.2
Q ss_pred ceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeeecc
Q 044494 4 KCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADFGV 83 (144)
Q Consensus 4 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~~~ 83 (144)
...++||||+. ++|.+.+.... ..+++.+++.++.|++.|+++|| +.+++|+||+|+||+++.++.++++|||+
T Consensus 92 ~~~~lv~e~~~-~~l~~~l~~~~--~~~~~~~~~~i~~qi~~al~~lH---~~~i~H~dl~p~nil~~~~~~~kl~dfg~ 165 (310)
T cd07865 92 GSFYLVFEFCE-HDLAGLLSNKN--VKFTLSEIKKVMKMLLNGLYYIH---RNKILHRDMKAANILITKDGILKLADFGL 165 (310)
T ss_pred ceEEEEEcCCC-cCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHEEECCCCcEEECcCCC
Confidence 45699999996 48888776532 24899999999999999999999 88999999999999999999999999999
Q ss_pred eeecccCCCC----cccccccccccCccccccC-CCCCcchhHHHHHHHHHHHhCCCCCCCCC
Q 044494 84 ARLLNFDSSN----RTLLAGTYGYIAPELAYTM-VVTEKSDVYSFGVVALEVLMGKHPGELLS 141 (144)
Q Consensus 84 ~~~~~~~~~~----~~~~~~~~~~~~pe~~~~~-~~~~~~d~~slg~~l~~~~~g~~p~~~~~ 141 (144)
+......... .....++..|+|||.+.+. .++.++|+||+|++++++++|..||...+
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~ 228 (310)
T cd07865 166 ARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNT 228 (310)
T ss_pred cccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCC
Confidence 8765422111 1223467789999988654 36788999999999999999999997543
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.8e-26 Score=156.25 Aligned_cols=133 Identities=27% Similarity=0.407 Sum_probs=111.4
Q ss_pred CceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeeec
Q 044494 3 RKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADFG 82 (144)
Q Consensus 3 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~~ 82 (144)
+...+++|||+++++|.+++..... .+++..+..++.|++.++.+|| +.+++|+|++|.||+++.++.++++|||
T Consensus 80 ~~~~~lv~e~~~~~~l~~~l~~~~~--~~~~~~~~~~~~~l~~aL~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg 154 (284)
T cd05038 80 GRSLRLIMEYLPSGSLRDYLQRHRD--QINLKRLLLFSSQICKGMDYLG---SQRYIHRDLAARNILVESEDLVKISDFG 154 (284)
T ss_pred CCceEEEEecCCCCCHHHHHHhCcc--ccCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHhEEEcCCCCEEEcccc
Confidence 4568999999999999999975432 3899999999999999999999 8999999999999999999999999999
Q ss_pred ceeecccCCCC---cccccccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCC
Q 044494 83 VARLLNFDSSN---RTLLAGTYGYIAPELAYTMVVTEKSDVYSFGVVALEVLMGKHPGELL 140 (144)
Q Consensus 83 ~~~~~~~~~~~---~~~~~~~~~~~~pe~~~~~~~~~~~d~~slg~~l~~~~~g~~p~~~~ 140 (144)
.+......... .....++..|++||......++.++|+||+|+++++|++|..|+...
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~ 215 (284)
T cd05038 155 LAKVLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSP 215 (284)
T ss_pred cccccccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccc
Confidence 98865422111 11123445689999998888889999999999999999999988653
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.1e-26 Score=170.25 Aligned_cols=135 Identities=27% Similarity=0.404 Sum_probs=121.7
Q ss_pred CCceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeee
Q 044494 2 HRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADF 81 (144)
Q Consensus 2 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~ 81 (144)
.+..+|||||||.+|+..|+++... ...+.|+.+..+++.++.|+..|| ...++|||||-.||+++.++.+|++||
T Consensus 92 ~~DqLWLVMEfC~gGSVTDLVKn~~-g~rl~E~~IaYI~re~lrgl~HLH---~nkviHRDikG~NiLLT~e~~VKLvDF 167 (953)
T KOG0587|consen 92 NGDQLWLVMEFCGGGSVTDLVKNTK-GNRLKEEWIAYILREILRGLAHLH---NNKVIHRDIKGQNVLLTENAEVKLVDF 167 (953)
T ss_pred CCCeEEEEeeccCCccHHHHHhhhc-ccchhhHHHHHHHHHHHHHHHHHh---hcceeeecccCceEEEeccCcEEEeee
Confidence 3578999999999999999998644 445999999999999999999999 888999999999999999999999999
Q ss_pred cceeecccCCCCcccccccccccCccccccCC-----CCCcchhHHHHHHHHHHHhCCCCCCCC
Q 044494 82 GVARLLNFDSSNRTLLAGTYGYIAPELAYTMV-----VTEKSDVYSFGVVALEVLMGKHPGELL 140 (144)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~-----~~~~~d~~slg~~l~~~~~g~~p~~~~ 140 (144)
|++...+.-.....+..|+|.|||||++.+.. |+..+|+||||++..||-.|.+|+-.+
T Consensus 168 GvSaQldsT~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~Dm 231 (953)
T KOG0587|consen 168 GVSAQLDSTVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDM 231 (953)
T ss_pred eeeeeeecccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCc
Confidence 99998887677778889999999999998664 567899999999999999999998765
|
|
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=7e-26 Score=158.13 Aligned_cols=129 Identities=26% Similarity=0.399 Sum_probs=107.4
Q ss_pred ceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeeecc
Q 044494 4 KCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADFGV 83 (144)
Q Consensus 4 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~~~ 83 (144)
..+|+|+||+.+ ++.+.+... .+++..+..++.|++.++.+|| +.+++|+||+|+||+++.++.++++|||+
T Consensus 81 ~~~~lv~e~~~~-~l~~~~~~~----~l~~~~~~~i~~ql~~aL~~LH---~~~ivH~dlkp~Nill~~~~~~kl~dfg~ 152 (336)
T cd07849 81 NDVYIVQELMET-DLYKLIKTQ----HLSNDHIQYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTNCDLKICDFGL 152 (336)
T ss_pred ceEEEEehhccc-CHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHEEECCCCCEEECcccc
Confidence 357999999964 888777542 3899999999999999999999 89999999999999999999999999999
Q ss_pred eeecccCCC---CcccccccccccCcccccc-CCCCCcchhHHHHHHHHHHHhCCCCCCCC
Q 044494 84 ARLLNFDSS---NRTLLAGTYGYIAPELAYT-MVVTEKSDVYSFGVVALEVLMGKHPGELL 140 (144)
Q Consensus 84 ~~~~~~~~~---~~~~~~~~~~~~~pe~~~~-~~~~~~~d~~slg~~l~~~~~g~~p~~~~ 140 (144)
+........ ......+++.|+|||.+.. ..++.++|+||+|+++++|++|..||...
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~ 213 (336)
T cd07849 153 ARIADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGK 213 (336)
T ss_pred eeeccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 876543221 1122457888999998654 45788999999999999999999999653
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.1e-25 Score=151.81 Aligned_cols=134 Identities=29% Similarity=0.361 Sum_probs=112.7
Q ss_pred CCceEEEEEeeccCCCHHHHhhcc-cccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEee
Q 044494 2 HRKCMFLIYEYMEMGSLFCVLRTD-EEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVAD 80 (144)
Q Consensus 2 ~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d 80 (144)
+++..++|+||+++++|.+++... .....+++..++.++.|++.++.+|| +.+++|+|++|+|++++. +.++++|
T Consensus 73 ~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~i~h~~l~~~nili~~-~~~~l~d 148 (260)
T cd08222 73 ERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMH---QRRILHRDLKAKNIFLKN-NLLKIGD 148 (260)
T ss_pred cCCceEEEEEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHH---HcCccccCCChhheEeec-CCEeecc
Confidence 356789999999999999988642 22345899999999999999999999 899999999999999975 5699999
Q ss_pred ecceeecccCCCCcccccccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCC
Q 044494 81 FGVARLLNFDSSNRTLLAGTYGYIAPELAYTMVVTEKSDVYSFGVVALEVLMGKHPGEL 139 (144)
Q Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~d~~slg~~l~~~~~g~~p~~~ 139 (144)
||.+..............+++.|++||......++.++|+||+|++++++++|..||+.
T Consensus 149 ~g~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~ 207 (260)
T cd08222 149 FGVSRLLMGSCDLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEG 207 (260)
T ss_pred cCceeecCCCcccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 99887654333333345678889999999888888899999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=99.94 E-value=9.9e-26 Score=157.40 Aligned_cols=129 Identities=34% Similarity=0.470 Sum_probs=108.0
Q ss_pred ceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeeecc
Q 044494 4 KCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADFGV 83 (144)
Q Consensus 4 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~~~ 83 (144)
..+|+||||+. ++|..++... .+++.....++.|++.++.+|| +.|++|+|++|+||+++.++.++++|||.
T Consensus 82 ~~~~lv~e~~~-~~L~~~~~~~----~~~~~~~~~i~~qi~~~L~~LH---~~~i~H~dl~p~nill~~~~~~kl~d~g~ 153 (337)
T cd07852 82 KDIYLVFEYME-TDLHAVIRAN----ILEDVHKRYIMYQLLKALKYIH---SGNVIHRDLKPSNILLNSDCRVKLADFGL 153 (337)
T ss_pred ceEEEEecccc-cCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCcEEEeeccc
Confidence 46899999997 5998888753 3788888899999999999999 89999999999999999999999999998
Q ss_pred eeecccCCC-----CcccccccccccCcccccc-CCCCCcchhHHHHHHHHHHHhCCCCCCCC
Q 044494 84 ARLLNFDSS-----NRTLLAGTYGYIAPELAYT-MVVTEKSDVYSFGVVALEVLMGKHPGELL 140 (144)
Q Consensus 84 ~~~~~~~~~-----~~~~~~~~~~~~~pe~~~~-~~~~~~~d~~slg~~l~~~~~g~~p~~~~ 140 (144)
+........ ......+++.|++||.+.. ..++.++|+||+|++++++++|+.||...
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~ 216 (337)
T cd07852 154 ARSLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGT 216 (337)
T ss_pred hhccccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCC
Confidence 876543221 2223457888999998765 45678899999999999999999999754
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.9e-26 Score=176.11 Aligned_cols=131 Identities=18% Similarity=0.163 Sum_probs=102.2
Q ss_pred CceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCC-------
Q 044494 3 RKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELE------- 75 (144)
Q Consensus 3 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~------- 75 (144)
.+.++.++|++ +++|.+++.... ..+++.+++.++.|++.||.||| ++||+||||||+||+++..+.
T Consensus 52 ~~~~~~~~e~~-~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~al~~lH---~~gIvHrDlKP~NiLl~~~~~~k~~d~~ 125 (793)
T PLN00181 52 DDSIVRALECE-DVSLRQWLDNPD--RSVDAFECFHVFRQIVEIVNAAH---SQGIVVHNVRPSCFVMSSFNHVSFIESA 125 (793)
T ss_pred cchhhhhhccC-CccHHHHHhccc--ccccHHHHHHHHHHHHHHHHHHH---hCCeeeccCCchhEEEcccCcEEEeecc
Confidence 45678889988 569999997432 34899999999999999999999 999999999999999965444
Q ss_pred ------------eEEeeecceeecccCC----------------CCcccccccccccCccccccCCCCCcchhHHHHHHH
Q 044494 76 ------------AFVADFGVARLLNFDS----------------SNRTLLAGTYGYIAPELAYTMVVTEKSDVYSFGVVA 127 (144)
Q Consensus 76 ------------~~l~d~~~~~~~~~~~----------------~~~~~~~~~~~~~~pe~~~~~~~~~~~d~~slg~~l 127 (144)
++++|||+++...... .......+++.|+|||.+.+..++.++|+||+||++
T Consensus 126 ~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~sDVwSlGviL 205 (793)
T PLN00181 126 SCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSPEEDNGSSSNCASDVYRLGVLL 205 (793)
T ss_pred ccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEChhhhccCCCCchhhhhhHHHHH
Confidence 4555555554321000 000113467889999999998899999999999999
Q ss_pred HHHHhCCCCCCC
Q 044494 128 LEVLMGKHPGEL 139 (144)
Q Consensus 128 ~~~~~g~~p~~~ 139 (144)
|||++|..|+..
T Consensus 206 ~ELl~~~~~~~~ 217 (793)
T PLN00181 206 FELFCPVSSREE 217 (793)
T ss_pred HHHhhCCCchhh
Confidence 999999988764
|
|
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.94 E-value=1e-25 Score=157.19 Aligned_cols=132 Identities=27% Similarity=0.283 Sum_probs=108.9
Q ss_pred CceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeeec
Q 044494 3 RKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADFG 82 (144)
Q Consensus 3 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~~ 82 (144)
++..++||||+. ++|.+++..... +++.....++.|++.++++|| +.+++|+||+|+||+++.++.++++|||
T Consensus 92 ~~~~~lv~e~~~-~~l~~~l~~~~~---~~~~~~~~~~~ql~~aL~~LH---~~~i~H~dl~~~nill~~~~~~kl~dfg 164 (335)
T PTZ00024 92 GDFINLVMDIMA-SDLKKVVDRKIR---LTESQVKCILLQILNGLNVLH---KWYFMHRDLSPANIFINSKGICKIADFG 164 (335)
T ss_pred CCcEEEEEeccc-cCHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHH---hCCeecccccHHHeEECCCCCEEECCcc
Confidence 467899999997 589888865333 899999999999999999999 8999999999999999999999999999
Q ss_pred ceeecccC--------------CCCcccccccccccCccccccC-CCCCcchhHHHHHHHHHHHhCCCCCCCCC
Q 044494 83 VARLLNFD--------------SSNRTLLAGTYGYIAPELAYTM-VVTEKSDVYSFGVVALEVLMGKHPGELLS 141 (144)
Q Consensus 83 ~~~~~~~~--------------~~~~~~~~~~~~~~~pe~~~~~-~~~~~~d~~slg~~l~~~~~g~~p~~~~~ 141 (144)
.+...... ........+++.|++||.+.+. .++.++|+||+|++++++++|..||...+
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~ 238 (335)
T PTZ00024 165 LARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGEN 238 (335)
T ss_pred ceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 88765411 1111223457789999988754 35789999999999999999999997543
|
|
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=99.94 E-value=8.4e-26 Score=157.53 Aligned_cols=130 Identities=28% Similarity=0.389 Sum_probs=108.5
Q ss_pred ceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeeecc
Q 044494 4 KCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADFGV 83 (144)
Q Consensus 4 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~~~ 83 (144)
+.+|+++||+. ++|.+.+.... .+++..+..++.|++.||++|| ..|++|+||||+||+++.++.++|+|||+
T Consensus 79 ~~~~~~~e~~~-~~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH---~~givH~dlkp~Nili~~~~~~kl~Dfg~ 151 (332)
T cd07857 79 NELYLYEELME-ADLHQIIRSGQ---PLTDAHFQSFIYQILCGLKYIH---SANVLHRDLKPGNLLVNADCELKICDFGL 151 (332)
T ss_pred CcEEEEEeccc-CCHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHeEEcCCCCEEeCcCCC
Confidence 35788999886 58988886543 3899999999999999999999 89999999999999999999999999999
Q ss_pred eeecccCCC----CcccccccccccCcccccc-CCCCCcchhHHHHHHHHHHHhCCCCCCCC
Q 044494 84 ARLLNFDSS----NRTLLAGTYGYIAPELAYT-MVVTEKSDVYSFGVVALEVLMGKHPGELL 140 (144)
Q Consensus 84 ~~~~~~~~~----~~~~~~~~~~~~~pe~~~~-~~~~~~~d~~slg~~l~~~~~g~~p~~~~ 140 (144)
+........ ......++..|++||...+ ..++.++|+||+|++++++++|..||...
T Consensus 152 a~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~ 213 (332)
T cd07857 152 ARGFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGK 213 (332)
T ss_pred ceecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCC
Confidence 976542211 1223457889999998765 45788999999999999999999999764
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1e-27 Score=172.03 Aligned_cols=130 Identities=29% Similarity=0.392 Sum_probs=112.6
Q ss_pred CceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeeec
Q 044494 3 RKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADFG 82 (144)
Q Consensus 3 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~~ 82 (144)
+.+.|||||||-| +..|.+.-..+ ++.+-++..+..+.+.||.||| +.+.+|||||.-||+++..|.||++|||
T Consensus 98 e~TaWLVMEYClG-SAsDlleVhkK--plqEvEIAAi~~gaL~gLaYLH---S~~~IHRDiKAGNILLse~g~VKLaDFG 171 (948)
T KOG0577|consen 98 EHTAWLVMEYCLG-SASDLLEVHKK--PLQEVEIAAITHGALQGLAYLH---SHNRIHRDIKAGNILLSEPGLVKLADFG 171 (948)
T ss_pred cchHHHHHHHHhc-cHHHHHHHHhc--cchHHHHHHHHHHHHHHHHHHH---HhhHHhhhccccceEecCCCeeeecccc
Confidence 3456899999974 88888865332 3889999999999999999999 9999999999999999999999999999
Q ss_pred ceeecccCCCCcccccccccccCcccccc---CCCCCcchhHHHHHHHHHHHhCCCCCCCCCC
Q 044494 83 VARLLNFDSSNRTLLAGTYGYIAPELAYT---MVVTEKSDVYSFGVVALEVLMGKHPGELLSS 142 (144)
Q Consensus 83 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~---~~~~~~~d~~slg~~l~~~~~g~~p~~~~~~ 142 (144)
.+....+ ...+.|||.|||||++.. ..|+.++|+||||++..|+...++|+-+++.
T Consensus 172 SAsi~~P----AnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNA 230 (948)
T KOG0577|consen 172 SASIMAP----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA 230 (948)
T ss_pred chhhcCc----hhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchH
Confidence 9876542 446789999999999874 4688999999999999999999999877653
|
|
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.6e-25 Score=152.38 Aligned_cols=132 Identities=27% Similarity=0.335 Sum_probs=111.9
Q ss_pred CceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeeec
Q 044494 3 RKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADFG 82 (144)
Q Consensus 3 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~~ 82 (144)
.+..++|+||+. ++|.+++.+.. ..+++..+..++.+++.++.+|| +.+++|+|++|+||+++.++.++++|||
T Consensus 70 ~~~~~~v~e~~~-~~l~~~i~~~~--~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~~l~~~ni~~~~~~~~~l~d~g 143 (282)
T cd07829 70 ERKLYLVFEYCD-MDLKKYLDKRP--GPLSPNLIKSIMYQLLRGLAYCH---SHRILHRDLKPQNILINRDGVLKLADFG 143 (282)
T ss_pred CCceEEEecCcC-cCHHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChheEEEcCCCCEEEecCC
Confidence 467899999997 58999987642 23899999999999999999999 8899999999999999999999999999
Q ss_pred ceeecccCCCCcccccccccccCccccccC-CCCCcchhHHHHHHHHHHHhCCCCCCCC
Q 044494 83 VARLLNFDSSNRTLLAGTYGYIAPELAYTM-VVTEKSDVYSFGVVALEVLMGKHPGELL 140 (144)
Q Consensus 83 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~-~~~~~~d~~slg~~l~~~~~g~~p~~~~ 140 (144)
.+...............+..|+|||.+... .++.++|+||+|++++++++|..||...
T Consensus 144 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~ 202 (282)
T cd07829 144 LARAFGIPLRTYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGD 202 (282)
T ss_pred cccccCCCccccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCc
Confidence 887654333233334456789999998766 6788999999999999999999999654
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.8e-25 Score=152.48 Aligned_cols=131 Identities=26% Similarity=0.383 Sum_probs=111.0
Q ss_pred eEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeeecce
Q 044494 5 CMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADFGVA 84 (144)
Q Consensus 5 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~~~~ 84 (144)
.++++|||+.+ +|.+++..... ..+++..++.++.|++.|+.+|| +.+++|+|++|+||+++.++.++++|||.+
T Consensus 80 ~~~l~~e~~~~-~l~~~l~~~~~-~~l~~~~~~~~~~~i~~al~~LH---~~~i~h~~l~~~nili~~~~~~~l~dfg~~ 154 (287)
T cd07838 80 KLTLVFEHVDQ-DLATYLSKCPK-PGLPPETIKDLMRQLLRGVDFLH---SHRIVHRDLKPQNILVTSDGQVKIADFGLA 154 (287)
T ss_pred eeEEEehhccc-CHHHHHHHccC-CCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCChhhEEEccCCCEEEeccCcc
Confidence 48999999975 89888865332 24899999999999999999999 889999999999999999999999999998
Q ss_pred eecccCCCCcccccccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCC
Q 044494 85 RLLNFDSSNRTLLAGTYGYIAPELAYTMVVTEKSDVYSFGVVALEVLMGKHPGELLS 141 (144)
Q Consensus 85 ~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~d~~slg~~l~~~~~g~~p~~~~~ 141 (144)
........ .....++..|++||.+.+..++.++|+||+|+++++|++|..||...+
T Consensus 155 ~~~~~~~~-~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~ 210 (287)
T cd07838 155 RIYSFEMA-LTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTS 210 (287)
T ss_pred eeccCCcc-cccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCC
Confidence 77643322 222346788999999988888999999999999999999999987643
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.1e-25 Score=156.73 Aligned_cols=135 Identities=25% Similarity=0.334 Sum_probs=107.9
Q ss_pred CceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeeec
Q 044494 3 RKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADFG 82 (144)
Q Consensus 3 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~~ 82 (144)
++..++|+||+.++++.+++.+... ..+++..+..++.|++.||++|| +.+++||||||+||+++.++.+++.||+
T Consensus 71 ~~~~~~v~e~~~~~~l~~~l~~~~~-~~~~~~~~~~~~~qi~~aL~~lH---~~~ivHrDlkp~Nill~~~~~~~~~~~~ 146 (328)
T cd08226 71 GSWLWVISPFMAYGSANSLLKTYFP-EGMSEALIGNILFGALRGLNYLH---QNGYIHRNIKASHILISGDGLVSLSGLS 146 (328)
T ss_pred CCceEEEEecccCCCHHHHHHhhcc-cCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEeCCCcEEEechH
Confidence 4568999999999999998875322 34889999999999999999999 8999999999999999999999999987
Q ss_pred ceeecccCCCC-------cccccccccccCccccccC--CCCCcchhHHHHHHHHHHHhCCCCCCCCC
Q 044494 83 VARLLNFDSSN-------RTLLAGTYGYIAPELAYTM--VVTEKSDVYSFGVVALEVLMGKHPGELLS 141 (144)
Q Consensus 83 ~~~~~~~~~~~-------~~~~~~~~~~~~pe~~~~~--~~~~~~d~~slg~~l~~~~~g~~p~~~~~ 141 (144)
.+......... .....++..|++||.+.+. .++.++|+||+|++++++++|..||...+
T Consensus 147 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~ 214 (328)
T cd08226 147 HLYSLVRNGQKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDML 214 (328)
T ss_pred HHhhhhccCccccccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcC
Confidence 54322111110 0112245579999998764 46789999999999999999999997653
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.2e-25 Score=151.26 Aligned_cols=133 Identities=27% Similarity=0.418 Sum_probs=108.7
Q ss_pred EEEEEeeccCCCHHHHhhcc---cccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeeec
Q 044494 6 MFLIYEYMEMGSLFCVLRTD---EEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADFG 82 (144)
Q Consensus 6 ~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~~ 82 (144)
.++++||+++|+|.+++... .....++...+..++.|++.++++|| +.+++|+||||+||+++.++.++++|||
T Consensus 82 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH---~~~i~H~dikp~nili~~~~~~kl~dfg 158 (273)
T cd05074 82 PMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLS---SKNFIHRDLAARNCMLNENMTVCVADFG 158 (273)
T ss_pred eEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCEeecccchhhEEEcCCCCEEECccc
Confidence 47899999999998877431 12224788899999999999999999 8999999999999999999999999999
Q ss_pred ceeecccCCC--CcccccccccccCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCC
Q 044494 83 VARLLNFDSS--NRTLLAGTYGYIAPELAYTMVVTEKSDVYSFGVVALEVLM-GKHPGELLS 141 (144)
Q Consensus 83 ~~~~~~~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~d~~slg~~l~~~~~-g~~p~~~~~ 141 (144)
.++....... ......+++.|++||......++.++|+||+|+++|++++ |..||...+
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~ 220 (273)
T cd05074 159 LSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVE 220 (273)
T ss_pred ccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCC
Confidence 8876542211 1122334567999999988888899999999999999998 889987654
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.7e-25 Score=150.83 Aligned_cols=132 Identities=21% Similarity=0.338 Sum_probs=110.6
Q ss_pred CceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeeec
Q 044494 3 RKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADFG 82 (144)
Q Consensus 3 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~~ 82 (144)
++..|+||||+ +++|.+++.... ...+++..+..++.|++.++.+|| +.+++|+|++|.||+++.++.++++|||
T Consensus 70 ~~~~~lv~e~~-~~~l~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~Lh---~~~i~H~dl~~~ni~i~~~~~~~l~d~~ 144 (283)
T cd07830 70 NDELYFVFEYM-EGNLYQLMKDRK-GKPFSESVIRSIIYQILQGLAHIH---KHGFFHRDLKPENLLVSGPEVVKIADFG 144 (283)
T ss_pred CCcEEEEEecC-CCCHHHHHHhcc-cccCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChhhEEEcCCCCEEEeecc
Confidence 56789999999 779999887543 234899999999999999999999 8899999999999999999999999999
Q ss_pred ceeecccCCCCcccccccccccCcccccc-CCCCCcchhHHHHHHHHHHHhCCCCCCCC
Q 044494 83 VARLLNFDSSNRTLLAGTYGYIAPELAYT-MVVTEKSDVYSFGVVALEVLMGKHPGELL 140 (144)
Q Consensus 83 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~-~~~~~~~d~~slg~~l~~~~~g~~p~~~~ 140 (144)
.+........ .....++..|+|||.+.. ..++.++|+||+|++++++++|..||...
T Consensus 145 ~~~~~~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~ 202 (283)
T cd07830 145 LAREIRSRPP-YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGS 202 (283)
T ss_pred cceeccCCCC-cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCC
Confidence 9876543221 223457788999998754 45688999999999999999999999654
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.1e-25 Score=153.92 Aligned_cols=128 Identities=31% Similarity=0.423 Sum_probs=107.1
Q ss_pred CceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeeec
Q 044494 3 RKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADFG 82 (144)
Q Consensus 3 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~~ 82 (144)
++..|+|+||+. |++.+.+.... ..+++..+..++.|++.++.+|| +.+++|+|++|+||+++.++.++++|||
T Consensus 87 ~~~~~lv~e~~~-g~l~~~~~~~~--~~l~~~~~~~~~~ql~~~L~~LH---~~~i~H~dl~p~nIl~~~~~~~kL~dfg 160 (307)
T cd06607 87 EHTAWLVMEYCL-GSASDILEVHK--KPLQEVEIAAICHGALQGLAYLH---SHERIHRDIKAGNILLTEPGTVKLADFG 160 (307)
T ss_pred CCeEEEEHHhhC-CCHHHHHHHcc--cCCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCcccEEECCCCCEEEeecC
Confidence 467899999997 57777665322 23899999999999999999999 8899999999999999999999999999
Q ss_pred ceeecccCCCCcccccccccccCccccc---cCCCCCcchhHHHHHHHHHHHhCCCCCCCC
Q 044494 83 VARLLNFDSSNRTLLAGTYGYIAPELAY---TMVVTEKSDVYSFGVVALEVLMGKHPGELL 140 (144)
Q Consensus 83 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~---~~~~~~~~d~~slg~~l~~~~~g~~p~~~~ 140 (144)
++..... .....+++.|+|||.+. ...++.++|+||+|+++|++++|..||...
T Consensus 161 ~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~ 217 (307)
T cd06607 161 SASLVSP----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM 217 (307)
T ss_pred cceecCC----CCCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCc
Confidence 8865432 22345778899999874 345778999999999999999999998754
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.93 E-value=2e-25 Score=156.39 Aligned_cols=127 Identities=25% Similarity=0.372 Sum_probs=106.7
Q ss_pred ceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeeecc
Q 044494 4 KCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADFGV 83 (144)
Q Consensus 4 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~~~ 83 (144)
+..|++++++ +++|.++++.. .+++..+..++.|++.|+.+|| +.+++|+||+|+||+++.++.++++|||+
T Consensus 95 ~~~~lv~~~~-~~~L~~~~~~~----~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIll~~~~~~kl~dfg~ 166 (345)
T cd07877 95 NDVYLVTHLM-GADLNNIVKCQ----KLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGL 166 (345)
T ss_pred ccEEEEehhc-ccCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCChHHEEEcCCCCEEEecccc
Confidence 3468888877 77998877642 2899999999999999999999 89999999999999999999999999999
Q ss_pred eeecccCCCCcccccccccccCcccccc-CCCCCcchhHHHHHHHHHHHhCCCCCCCCC
Q 044494 84 ARLLNFDSSNRTLLAGTYGYIAPELAYT-MVVTEKSDVYSFGVVALEVLMGKHPGELLS 141 (144)
Q Consensus 84 ~~~~~~~~~~~~~~~~~~~~~~pe~~~~-~~~~~~~d~~slg~~l~~~~~g~~p~~~~~ 141 (144)
+..... ......++..|+|||...+ ..++.++|+||+|++++++++|..||...+
T Consensus 167 ~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~ 222 (345)
T cd07877 167 ARHTDD---EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 222 (345)
T ss_pred cccccc---cccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 875432 2223457888999998866 457889999999999999999999996543
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=99.93 E-value=2e-25 Score=153.90 Aligned_cols=132 Identities=28% Similarity=0.346 Sum_probs=107.0
Q ss_pred ceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeeecc
Q 044494 4 KCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADFGV 83 (144)
Q Consensus 4 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~~~ 83 (144)
..+++|+||+.+ ++...+.... ..+++..+..++.|+++++.+|| +++++|+|++|+||+++.++.++++|||+
T Consensus 88 ~~~~lv~~~~~~-~l~~~~~~~~--~~~~~~~~~~i~~~l~~al~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~ 161 (311)
T cd07866 88 GSVYMVTPYMDH-DLSGLLENPS--VKLTESQIKCYMLQLLEGINYLH---ENHILHRDIKAANILIDNQGILKIADFGL 161 (311)
T ss_pred ceEEEEEecCCc-CHHHHHhccc--cCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEECcCcc
Confidence 457999999975 7777665422 24899999999999999999999 89999999999999999999999999998
Q ss_pred eeecccCCCCc-----------ccccccccccCccccccC-CCCCcchhHHHHHHHHHHHhCCCCCCCCC
Q 044494 84 ARLLNFDSSNR-----------TLLAGTYGYIAPELAYTM-VVTEKSDVYSFGVVALEVLMGKHPGELLS 141 (144)
Q Consensus 84 ~~~~~~~~~~~-----------~~~~~~~~~~~pe~~~~~-~~~~~~d~~slg~~l~~~~~g~~p~~~~~ 141 (144)
+.......... ....+++.|+|||.+.+. .++.++|+||+|+++++|++|..||.+.+
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~ 231 (311)
T cd07866 162 ARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKS 231 (311)
T ss_pred chhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCC
Confidence 87554221111 123457789999987654 46889999999999999999999997543
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.7e-25 Score=164.99 Aligned_cols=133 Identities=22% Similarity=0.301 Sum_probs=101.0
Q ss_pred CceEEEEEeeccCCCHHHHhhccccc-----------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCC
Q 044494 3 RKCMFLIYEYMEMGSLFCVLRTDEEA-----------------VGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISS 65 (144)
Q Consensus 3 ~~~~~lv~e~~~~~~L~~~l~~~~~~-----------------~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~ 65 (144)
+..+++|+||+.+++|.+++...... .......+..++.|++.+|.||| +++++||||||
T Consensus 207 ~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH---~~gIiHRDLKP 283 (566)
T PLN03225 207 EDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLH---STGIVHRDVKP 283 (566)
T ss_pred CCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHH---HCCEEeCcCCH
Confidence 45789999999999999988643210 01123346678999999999999 89999999999
Q ss_pred CcEEEcC-CCCeEEeeecceeecccC-CCCcccccccccccCccccccCC----------------------CCCcchhH
Q 044494 66 NNILLNL-ELEAFVADFGVARLLNFD-SSNRTLLAGTYGYIAPELAYTMV----------------------VTEKSDVY 121 (144)
Q Consensus 66 ~ni~~~~-~~~~~l~d~~~~~~~~~~-~~~~~~~~~~~~~~~pe~~~~~~----------------------~~~~~d~~ 121 (144)
+||+++. ++.++++|||+++..... ........+++.|+|||.+.... +..++|+|
T Consensus 284 ~NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DVw 363 (566)
T PLN03225 284 QNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIY 363 (566)
T ss_pred HHEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcccH
Confidence 9999986 578999999999754322 11223456889999999654322 23356999
Q ss_pred HHHHHHHHHHhCCCCCC
Q 044494 122 SFGVVALEVLMGKHPGE 138 (144)
Q Consensus 122 slg~~l~~~~~g~~p~~ 138 (144)
|+||++|||+++..|++
T Consensus 364 SlGviL~el~~~~~~~~ 380 (566)
T PLN03225 364 SAGLIFLQMAFPNLRSD 380 (566)
T ss_pred HHHHHHHHHHhCcCCCc
Confidence 99999999998776654
|
|
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=99.93 E-value=2e-25 Score=152.62 Aligned_cols=134 Identities=28% Similarity=0.328 Sum_probs=106.3
Q ss_pred CceEEEEEeeccCCCHHHHhhc--ccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEee
Q 044494 3 RKCMFLIYEYMEMGSLFCVLRT--DEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVAD 80 (144)
Q Consensus 3 ~~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d 80 (144)
.+..+++|||+.. ++.++... ......+++..+..++.+++.++++||+ ..+++|+||+|+||+++.++.++++|
T Consensus 75 ~~~~~~~~e~~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~--~~~i~H~dlkp~Nil~~~~~~~kl~d 151 (288)
T cd06616 75 EGDCWICMELMDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKE--ELKIIHRDVKPSNILLDRNGNIKLCD 151 (288)
T ss_pred CCcEEEEEecccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhh--cCCeeccCCCHHHEEEccCCcEEEee
Confidence 4567899999864 66554321 1122348999999999999999999993 24899999999999999999999999
Q ss_pred ecceeecccCCCCcccccccccccCccccccC---CCCCcchhHHHHHHHHHHHhCCCCCCCC
Q 044494 81 FGVARLLNFDSSNRTLLAGTYGYIAPELAYTM---VVTEKSDVYSFGVVALEVLMGKHPGELL 140 (144)
Q Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~---~~~~~~d~~slg~~l~~~~~g~~p~~~~ 140 (144)
||++....... ......+++.|++||.+... .++.++|+||+|++++++++|..||...
T Consensus 152 fg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~ 213 (288)
T cd06616 152 FGISGQLVDSI-AKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKW 213 (288)
T ss_pred cchhHHhccCC-ccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhc
Confidence 99987543221 22234578889999998766 5788999999999999999999999654
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=99.93 E-value=5.1e-25 Score=152.50 Aligned_cols=130 Identities=30% Similarity=0.415 Sum_probs=108.3
Q ss_pred CCceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeee
Q 044494 2 HRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADF 81 (144)
Q Consensus 2 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~ 81 (144)
+++..|+||||+. +++.+.+.... ..+++.++..++.|++.++.+|| +.|++|+|++|+||+++.++.++++||
T Consensus 92 ~~~~~~lv~e~~~-~~l~~~l~~~~--~~l~~~~~~~~~~qi~~al~~LH---~~gi~H~dl~p~nili~~~~~~kL~df 165 (313)
T cd06633 92 KEHTAWLVMEYCL-GSASDLLEVHK--KPLQEVEIAAITHGALQGLAYLH---SHNMIHRDIKAGNILLTEPGQVKLADF 165 (313)
T ss_pred eCCEEEEEEecCC-CCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCChhhEEECCCCCEEEeec
Confidence 3467899999996 57887776432 23889999999999999999999 889999999999999999999999999
Q ss_pred cceeecccCCCCcccccccccccCccccc---cCCCCCcchhHHHHHHHHHHHhCCCCCCCCC
Q 044494 82 GVARLLNFDSSNRTLLAGTYGYIAPELAY---TMVVTEKSDVYSFGVVALEVLMGKHPGELLS 141 (144)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~---~~~~~~~~d~~slg~~l~~~~~g~~p~~~~~ 141 (144)
|++.... ......++..|++||.+. ...++.++|+||+|++++++++|..||...+
T Consensus 166 g~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~ 224 (313)
T cd06633 166 GSASKSS----PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN 224 (313)
T ss_pred CCCcccC----CCCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 9876432 223356788899999974 3457788999999999999999999997654
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=99.93 E-value=5e-25 Score=152.78 Aligned_cols=130 Identities=29% Similarity=0.397 Sum_probs=107.7
Q ss_pred CCceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeee
Q 044494 2 HRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADF 81 (144)
Q Consensus 2 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~ 81 (144)
.++..|+||||+.+ ++.+.+.... ..+++..+..++.+++.++.+|| ..+++|+|++|+||+++.++.++++||
T Consensus 96 ~~~~~~lv~e~~~g-~l~~~~~~~~--~~l~~~~~~~i~~~i~~~l~~lH---~~~i~H~dL~p~Nil~~~~~~~kl~df 169 (317)
T cd06635 96 REHTAWLVMEYCLG-SASDLLEVHK--KPLQEVEIAAITHGALQGLAYLH---SHNMIHRDIKAGNILLTEPGQVKLADF 169 (317)
T ss_pred eCCeEEEEEeCCCC-CHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCcccEEECCCCCEEEecC
Confidence 34678999999975 7877765422 23889999999999999999999 889999999999999999999999999
Q ss_pred cceeecccCCCCcccccccccccCccccc---cCCCCCcchhHHHHHHHHHHHhCCCCCCCCC
Q 044494 82 GVARLLNFDSSNRTLLAGTYGYIAPELAY---TMVVTEKSDVYSFGVVALEVLMGKHPGELLS 141 (144)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~---~~~~~~~~d~~slg~~l~~~~~g~~p~~~~~ 141 (144)
|++..... .....+++.|++||.+. ...++.++|+||+|++++++++|..||...+
T Consensus 170 g~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~ 228 (317)
T cd06635 170 GSASIASP----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN 228 (317)
T ss_pred CCccccCC----cccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCcc
Confidence 98764332 22345788899999874 3457889999999999999999999986543
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=99.93 E-value=4.2e-25 Score=151.84 Aligned_cols=131 Identities=31% Similarity=0.398 Sum_probs=107.3
Q ss_pred ceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeeecc
Q 044494 4 KCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADFGV 83 (144)
Q Consensus 4 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~~~ 83 (144)
+.+++|+||+++ ++...+... ...+++..+..++.|++.|+.+|| +.+++|+|++|+||+++.++.++++|||.
T Consensus 89 ~~~~lv~e~~~~-~l~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH---~~~i~H~dl~p~nili~~~~~~kl~dfg~ 162 (302)
T cd07864 89 GAFYLVFEYMDH-DLMGLLESG--LVHFSEDHIKSFMKQLLEGLNYCH---KKNFLHRDIKCSNILLNNKGQIKLADFGL 162 (302)
T ss_pred CcEEEEEcccCc-cHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCcEEeCcccc
Confidence 478999999976 777776643 224899999999999999999999 88999999999999999999999999998
Q ss_pred eeecccCCC-CcccccccccccCccccccC-CCCCcchhHHHHHHHHHHHhCCCCCCCC
Q 044494 84 ARLLNFDSS-NRTLLAGTYGYIAPELAYTM-VVTEKSDVYSFGVVALEVLMGKHPGELL 140 (144)
Q Consensus 84 ~~~~~~~~~-~~~~~~~~~~~~~pe~~~~~-~~~~~~d~~slg~~l~~~~~g~~p~~~~ 140 (144)
+........ ......++..|++||.+... .++.++|+||+|++++++++|+.||...
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~ 221 (302)
T cd07864 163 ARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQAN 221 (302)
T ss_pred cccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCC
Confidence 876543221 11223456789999987643 4678999999999999999999999753
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.6e-25 Score=150.89 Aligned_cols=132 Identities=30% Similarity=0.416 Sum_probs=110.0
Q ss_pred ceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeeecc
Q 044494 4 KCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADFGV 83 (144)
Q Consensus 4 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~~~ 83 (144)
+..++|+||+++ +|.+++.... ..+++..++.++.|++.|+++|| ..+++|+|++|+||+++.++.++++|||.
T Consensus 73 ~~~~lv~e~~~~-~l~~~~~~~~--~~~~~~~~~~i~~~i~~al~~LH---~~~~~h~dl~p~nil~~~~~~~~l~d~g~ 146 (287)
T cd07840 73 GSIYMVFEYMDH-DLTGLLDSPE--VKFTESQIKCYMKQLLEGLQYLH---SNGILHRDIKGSNILINNDGVLKLADFGL 146 (287)
T ss_pred CcEEEEeccccc-cHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCcHHHeEEcCCCCEEEccccc
Confidence 678999999975 8888876532 34899999999999999999999 88999999999999999999999999999
Q ss_pred eeecccCCC-CcccccccccccCcccccc-CCCCCcchhHHHHHHHHHHHhCCCCCCCCC
Q 044494 84 ARLLNFDSS-NRTLLAGTYGYIAPELAYT-MVVTEKSDVYSFGVVALEVLMGKHPGELLS 141 (144)
Q Consensus 84 ~~~~~~~~~-~~~~~~~~~~~~~pe~~~~-~~~~~~~d~~slg~~l~~~~~g~~p~~~~~ 141 (144)
+........ ......++..|++||.+.+ ..++.++|+||+|++++++++|..||+..+
T Consensus 147 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~ 206 (287)
T cd07840 147 ARPYTKRNSADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGST 206 (287)
T ss_pred eeeccCCCcccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 986653321 1222446778999997764 356889999999999999999999997543
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.1e-26 Score=154.41 Aligned_cols=127 Identities=29% Similarity=0.371 Sum_probs=111.0
Q ss_pred eEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeeecce
Q 044494 5 CMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADFGVA 84 (144)
Q Consensus 5 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~~~~ 84 (144)
.+|+|||++. .+|...+.. .++..++..++.|.+.|+++|| +.|++|||+||+||++..+...|+.|||++
T Consensus 95 e~y~v~e~m~-~nl~~vi~~-----elDH~tis~i~yq~~~~ik~lh---s~~IihRdLkPsnivv~~~~~lKi~dfg~a 165 (369)
T KOG0665|consen 95 EVYLVMELMD-ANLCQVILM-----ELDHETISYILYQMLCGIKHLH---SAGIIHRDLKPSNIVVNSDCTLKILDFGLA 165 (369)
T ss_pred hHHHHHHhhh-hHHHHHHHH-----hcchHHHHHHHHHHHHHHHHHH---hcceeecccCcccceecchhheeeccchhh
Confidence 4689999995 599988872 2888999999999999999999 999999999999999999999999999999
Q ss_pred eecccCCCCcccccccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCC
Q 044494 85 RLLNFDSSNRTLLAGTYGYIAPELAYTMVVTEKSDVYSFGVVALEVLMGKHPGELLS 141 (144)
Q Consensus 85 ~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~d~~slg~~l~~~~~g~~p~~~~~ 141 (144)
+..+.. ........+..|.|||++.+.++...+||||+||++.||+.|..-|.+.+
T Consensus 166 r~e~~~-~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d 221 (369)
T KOG0665|consen 166 RTEDTD-FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKD 221 (369)
T ss_pred cccCcc-cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCch
Confidence 876543 22333567889999999999999999999999999999999998887654
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.1e-27 Score=157.58 Aligned_cols=137 Identities=28% Similarity=0.340 Sum_probs=110.1
Q ss_pred CCceEEEEEeeccCCCHHHHhhc--ccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEe
Q 044494 2 HRKCMFLIYEYMEMGSLFCVLRT--DEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVA 79 (144)
Q Consensus 2 ~~~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~ 79 (144)
..+-.|++||.|. .++..+-+. ......+++.-+-.+....+.||.||-. ...++|||+||+||+++..|.+|+|
T Consensus 134 ~EGdcWiCMELMd-~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~--~lkiIHRDvKPSNILldr~G~vKLC 210 (361)
T KOG1006|consen 134 SEGDCWICMELMD-ISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKE--ELKIIHRDVKPSNILLDRHGDVKLC 210 (361)
T ss_pred cCCceeeeHHHHh-hhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHH--HhhhhhccCChhheEEecCCCEeee
Confidence 3456799999995 577665432 1222348888888888888999999985 5689999999999999999999999
Q ss_pred eecceeecccCCCCcccccccccccCccccccC--CCCCcchhHHHHHHHHHHHhCCCCCCCCCC
Q 044494 80 DFGVARLLNFDSSNRTLLAGTYGYIAPELAYTM--VVTEKSDVYSFGVVALEVLMGKHPGELLSS 142 (144)
Q Consensus 80 d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~--~~~~~~d~~slg~~l~~~~~g~~p~~~~~~ 142 (144)
|||++..... ..+...-.|...|||||.+... +|+.++|+||||++++|..||.+||..|++
T Consensus 211 DFGIcGqLv~-SiAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~s 274 (361)
T KOG1006|consen 211 DFGICGQLVD-SIAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDS 274 (361)
T ss_pred cccchHhHHH-HHHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHH
Confidence 9999875542 2334445688999999988744 588899999999999999999999998864
|
|
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.8e-25 Score=152.82 Aligned_cols=129 Identities=28% Similarity=0.416 Sum_probs=107.4
Q ss_pred CceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeeec
Q 044494 3 RKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADFG 82 (144)
Q Consensus 3 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~~ 82 (144)
++..++||||+. +++.+.+.... ..+++..+..++.|++.++.+|| +.+++|+||+|+||+++.++.++++|||
T Consensus 87 ~~~~~lv~e~~~-~~l~~~~~~~~--~~l~~~~~~~~~~~l~~~l~~LH---~~~i~H~dl~p~nil~~~~~~~kl~dfg 160 (308)
T cd06634 87 EHTAWLVMEYCL-GSASDLLEVHK--KPLQEVEIAAVTHGALQGLAYLH---SHNMIHRDVKAGNILLSEPGLVKLGDFG 160 (308)
T ss_pred CCeeEEEEEccC-CCHHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHhEEECCCCcEEECCcc
Confidence 456899999997 58877765432 23789999999999999999999 8899999999999999999999999999
Q ss_pred ceeecccCCCCcccccccccccCccccc---cCCCCCcchhHHHHHHHHHHHhCCCCCCCCC
Q 044494 83 VARLLNFDSSNRTLLAGTYGYIAPELAY---TMVVTEKSDVYSFGVVALEVLMGKHPGELLS 141 (144)
Q Consensus 83 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~---~~~~~~~~d~~slg~~l~~~~~g~~p~~~~~ 141 (144)
++..... .....+++.|+|||.+. ....+.++|+||+|++++++++|..||...+
T Consensus 161 ~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~ 218 (308)
T cd06634 161 SASIMAP----ANXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN 218 (308)
T ss_pred cceeecC----cccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCcccc
Confidence 8875432 22345778899999875 3456788999999999999999999987643
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=99.93 E-value=6.3e-25 Score=150.83 Aligned_cols=130 Identities=26% Similarity=0.365 Sum_probs=106.4
Q ss_pred CceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCC-CCeEecCCCCCcEEEcCCCCeEEeee
Q 044494 3 RKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCT-PPIVHRDISSNNILLNLELEAFVADF 81 (144)
Q Consensus 3 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~-~~~~h~~i~~~ni~~~~~~~~~l~d~ 81 (144)
.+..|+||||+. +++.+.+..... .+++..+..++.|++.++.||| + .+++|+||+|+||+++.++.++++||
T Consensus 86 ~~~~~~v~e~~~-~~l~~l~~~~~~--~l~~~~~~~i~~~i~~~l~~lH---~~~~i~H~dl~p~nill~~~~~~kL~df 159 (296)
T cd06618 86 DSDVFICMELMS-TCLDKLLKRIQG--PIPEDILGKMTVAIVKALHYLK---EKHGVIHRDVKPSNILLDASGNVKLCDF 159 (296)
T ss_pred CCeEEEEeeccC-cCHHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---hhCCEecCCCcHHHEEEcCCCCEEECcc
Confidence 567899999985 477776654222 4889999999999999999999 6 58999999999999999999999999
Q ss_pred cceeecccCCCCcccccccccccCccccccCC----CCCcchhHHHHHHHHHHHhCCCCCCC
Q 044494 82 GVARLLNFDSSNRTLLAGTYGYIAPELAYTMV----VTEKSDVYSFGVVALEVLMGKHPGEL 139 (144)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~----~~~~~d~~slg~~l~~~~~g~~p~~~ 139 (144)
|.+........ .....++..|++||.+.... ++.++|+||+|++++++++|..||..
T Consensus 160 g~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~ 220 (296)
T cd06618 160 GISGRLVDSKA-KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKN 220 (296)
T ss_pred ccchhccCCCc-ccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCc
Confidence 98876542221 22234677899999987553 67889999999999999999999975
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.93 E-value=4.4e-25 Score=154.58 Aligned_cols=125 Identities=28% Similarity=0.380 Sum_probs=107.0
Q ss_pred eEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeeecce
Q 044494 5 CMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADFGVA 84 (144)
Q Consensus 5 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~~~~ 84 (144)
..++|+||+ +++|.+++... .+++..+..++.|++.++.+|| +.|++|+||+|+||+++.++.++++|||.+
T Consensus 94 ~~~lv~e~~-~~~L~~~~~~~----~l~~~~~~~~~~ql~~aL~~LH---~~gi~H~dlkp~Nill~~~~~~kL~dfg~~ 165 (343)
T cd07851 94 DVYLVTHLM-GADLNNIVKCQ----KLSDDHIQFLVYQILRGLKYIH---SAGIIHRDLKPSNIAVNEDCELKILDFGLA 165 (343)
T ss_pred cEEEEEecC-CCCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCCEEEcccccc
Confidence 489999998 67999888642 3899999999999999999999 899999999999999999999999999998
Q ss_pred eecccCCCCcccccccccccCcccccc-CCCCCcchhHHHHHHHHHHHhCCCCCCCC
Q 044494 85 RLLNFDSSNRTLLAGTYGYIAPELAYT-MVVTEKSDVYSFGVVALEVLMGKHPGELL 140 (144)
Q Consensus 85 ~~~~~~~~~~~~~~~~~~~~~pe~~~~-~~~~~~~d~~slg~~l~~~~~g~~p~~~~ 140 (144)
...... .....++..|++||.+.. ..++.++|+||+|++++++++|..||...
T Consensus 166 ~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~ 219 (343)
T cd07851 166 RHTDDE---MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGS 219 (343)
T ss_pred cccccc---ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCC
Confidence 765422 223456788999998765 35678999999999999999999999654
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.93 E-value=6.1e-25 Score=153.89 Aligned_cols=125 Identities=29% Similarity=0.394 Sum_probs=106.4
Q ss_pred eEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeeecce
Q 044494 5 CMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADFGVA 84 (144)
Q Consensus 5 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~~~~ 84 (144)
.+++||||+ +++|.+++... .+++..+..++.|++.|+.+|| +.|++|+||+|+||+++.++.++++|||.+
T Consensus 94 ~~~lv~e~~-~~~l~~~~~~~----~l~~~~~~~i~~qi~~al~~LH---~~gi~H~dlkp~Nill~~~~~~kl~dfg~~ 165 (343)
T cd07880 94 DFYLVMPFM-GTDLGKLMKHE----KLSEDRIQFLVYQMLKGLKYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLA 165 (343)
T ss_pred eEEEEEecC-CCCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEeecccc
Confidence 468999998 67898877642 3899999999999999999999 899999999999999999999999999998
Q ss_pred eecccCCCCcccccccccccCcccccc-CCCCCcchhHHHHHHHHHHHhCCCCCCCC
Q 044494 85 RLLNFDSSNRTLLAGTYGYIAPELAYT-MVVTEKSDVYSFGVVALEVLMGKHPGELL 140 (144)
Q Consensus 85 ~~~~~~~~~~~~~~~~~~~~~pe~~~~-~~~~~~~d~~slg~~l~~~~~g~~p~~~~ 140 (144)
...... .....+++.|++||.+.. ..++.++|+||+|++++++++|..||...
T Consensus 166 ~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~ 219 (343)
T cd07880 166 RQTDSE---MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGH 219 (343)
T ss_pred cccccC---ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 754321 223456788999998875 35778899999999999999999999754
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=99.93 E-value=4.7e-25 Score=154.38 Aligned_cols=129 Identities=26% Similarity=0.383 Sum_probs=104.6
Q ss_pred ceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcC-CCCeEEeeec
Q 044494 4 KCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNL-ELEAFVADFG 82 (144)
Q Consensus 4 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~-~~~~~l~d~~ 82 (144)
...|+||||+. ++|.+++... .+++..+..++.|++.|+++|| +.|++|+||||+||+++. ++.++++|||
T Consensus 89 ~~~~lv~e~~~-~~L~~~~~~~----~l~~~~~~~~~~qi~~aL~~LH---~~givH~dikp~Nili~~~~~~~kl~dfg 160 (342)
T cd07854 89 NSVYIVQEYME-TDLANVLEQG----PLSEEHARLFMYQLLRGLKYIH---SANVLHRDLKPANVFINTEDLVLKIGDFG 160 (342)
T ss_pred ceEEEEeeccc-ccHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEEcCCCceEEECCcc
Confidence 46799999997 5888877532 2889999999999999999999 899999999999999975 4568999999
Q ss_pred ceeecccCCCC---cccccccccccCcccccc-CCCCCcchhHHHHHHHHHHHhCCCCCCCC
Q 044494 83 VARLLNFDSSN---RTLLAGTYGYIAPELAYT-MVVTEKSDVYSFGVVALEVLMGKHPGELL 140 (144)
Q Consensus 83 ~~~~~~~~~~~---~~~~~~~~~~~~pe~~~~-~~~~~~~d~~slg~~l~~~~~g~~p~~~~ 140 (144)
.+......... .....++..|+|||.+.. ..++.++|+||+|++++++++|..||...
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~ 222 (342)
T cd07854 161 LARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGA 222 (342)
T ss_pred cceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 98765322111 122346778999998654 45678899999999999999999999754
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=6.9e-27 Score=171.45 Aligned_cols=135 Identities=36% Similarity=0.546 Sum_probs=116.6
Q ss_pred CceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeeec
Q 044494 3 RKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADFG 82 (144)
Q Consensus 3 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~~ 82 (144)
.+.+++|+|||++|+|..+|++... .+...+++.+++.|+.|++||- +.+++|||+...||+++.+-.+|++|||
T Consensus 702 s~PvMIiTEyMENGsLDsFLR~~DG--qftviQLVgMLrGIAsGMkYLs---dm~YVHRDLAARNILVNsnLvCKVsDFG 776 (996)
T KOG0196|consen 702 SKPVMIITEYMENGSLDSFLRQNDG--QFTVIQLVGMLRGIASGMKYLS---DMNYVHRDLAARNILVNSNLVCKVSDFG 776 (996)
T ss_pred CceeEEEhhhhhCCcHHHHHhhcCC--ceEeehHHHHHHHHHHHhHHHh---hcCchhhhhhhhheeeccceEEEecccc
Confidence 4567999999999999999987443 2888899999999999999999 8999999999999999999999999999
Q ss_pred ceeecccCCCCccc-ccc--cccccCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCC
Q 044494 83 VARLLNFDSSNRTL-LAG--TYGYIAPELAYTMVVTEKSDVYSFGVVALEVLM-GKHPGELLSS 142 (144)
Q Consensus 83 ~~~~~~~~~~~~~~-~~~--~~~~~~pe~~~~~~~~~~~d~~slg~~l~~~~~-g~~p~~~~~~ 142 (144)
+++..........+ ..| ..+|.|||.+...+++..+|+||+|+++||.++ |..||=.+++
T Consensus 777 LSRvledd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSN 840 (996)
T KOG0196|consen 777 LSRVLEDDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSN 840 (996)
T ss_pred ceeecccCCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccch
Confidence 99977544422222 222 358999999999999999999999999999998 9999977764
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.93 E-value=7.2e-25 Score=170.47 Aligned_cols=126 Identities=37% Similarity=0.628 Sum_probs=105.7
Q ss_pred CceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeeec
Q 044494 3 RKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADFG 82 (144)
Q Consensus 3 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~~ 82 (144)
++..|+||||+++|+|.++++. +++.....++.|++.|++|||+.++.+++|||+||+||+++.++..++. ++
T Consensus 755 ~~~~~lv~Ey~~~g~L~~~l~~------l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~ 827 (968)
T PLN00113 755 EKGAYLIHEYIEGKNLSEVLRN------LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LS 827 (968)
T ss_pred CCCCEEEEeCCCCCcHHHHHhc------CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ec
Confidence 4567999999999999999963 7888999999999999999996656799999999999999988877765 44
Q ss_pred ceeecccCCCCcccccccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCC
Q 044494 83 VARLLNFDSSNRTLLAGTYGYIAPELAYTMVVTEKSDVYSFGVVALEVLMGKHPGEL 139 (144)
Q Consensus 83 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~d~~slg~~l~~~~~g~~p~~~ 139 (144)
...... ......+++.|+|||+.....++.++|+||+|+++||+++|+.||+.
T Consensus 828 ~~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~ 880 (968)
T PLN00113 828 LPGLLC----TDTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADA 880 (968)
T ss_pred cccccc----cCCCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCc
Confidence 333211 11223578899999999988899999999999999999999999853
|
|
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.9e-25 Score=161.61 Aligned_cols=137 Identities=27% Similarity=0.385 Sum_probs=116.9
Q ss_pred CCceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeee
Q 044494 2 HRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADF 81 (144)
Q Consensus 2 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~ 81 (144)
+.-.+|+|+|||..|+|.+||++.+.. .++.--.+.++.||..+++||. .++++|||+...|+++..+..+|++||
T Consensus 334 ~EpPFYIiTEfM~yGNLLdYLRecnr~-ev~avvLlyMAtQIsSaMeYLE---kknFIHRDLAARNCLVgEnhiVKvADF 409 (1157)
T KOG4278|consen 334 HEPPFYIITEFMCYGNLLDYLRECNRS-EVPAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHIVKVADF 409 (1157)
T ss_pred cCCCeEEEEecccCccHHHHHHHhchh-hcchhHHHHHHHHHHHHHHHHH---HhhhhhhhhhhhhccccccceEEeecc
Confidence 345689999999999999999975542 3666677888999999999999 899999999999999999999999999
Q ss_pred cceeecccCCC-CcccccccccccCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCC
Q 044494 82 GVARLLNFDSS-NRTLLAGTYGYIAPELAYTMVVTEKSDVYSFGVVALEVLM-GKHPGELLSS 142 (144)
Q Consensus 82 ~~~~~~~~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~d~~slg~~l~~~~~-g~~p~~~~~~ 142 (144)
|+++.+....- ++........|.|||.+.+..++.|+|+|+||+++||+.| |-.||.+.+-
T Consensus 410 GLsRlMtgDTYTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidl 472 (1157)
T KOG4278|consen 410 GLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDL 472 (1157)
T ss_pred chhhhhcCCceecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccH
Confidence 99998763322 2223345678999999999999999999999999999988 9999988763
|
|
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.4e-25 Score=160.69 Aligned_cols=137 Identities=29% Similarity=0.399 Sum_probs=119.1
Q ss_pred CceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeeec
Q 044494 3 RKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADFG 82 (144)
Q Consensus 3 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~~ 82 (144)
.+.+|+|||.++-|.|..+++..... ++......+..|++.++.||| +..++||||...||+++...-+|++|||
T Consensus 462 e~P~WivmEL~~~GELr~yLq~nk~s--L~l~tL~ly~~Qi~talaYLe---SkrfVHRDIAaRNiLVsSp~CVKLaDFG 536 (974)
T KOG4257|consen 462 EQPMWIVMELAPLGELREYLQQNKDS--LPLRTLTLYCYQICTALAYLE---SKRFVHRDIAARNILVSSPQCVKLADFG 536 (974)
T ss_pred ccceeEEEecccchhHHHHHHhcccc--chHHHHHHHHHHHHHHHHHHH---hhchhhhhhhhhheeecCcceeeecccc
Confidence 46789999999999999999875543 889999999999999999999 9999999999999999999999999999
Q ss_pred ceeecccCCCCcc-cccccccccCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCC
Q 044494 83 VARLLNFDSSNRT-LLAGTYGYIAPELAYTMVVTEKSDVYSFGVVALEVLM-GKHPGELLSSSS 144 (144)
Q Consensus 83 ~~~~~~~~~~~~~-~~~~~~~~~~pe~~~~~~~~~~~d~~slg~~l~~~~~-g~~p~~~~~~~~ 144 (144)
+++......--+. .-.....||+||.++...++..+|+|-||+++||+++ |-.||++..+++
T Consensus 537 LSR~~ed~~yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsD 600 (974)
T KOG4257|consen 537 LSRYLEDDAYYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSD 600 (974)
T ss_pred hhhhccccchhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccc
Confidence 9997753322121 2334668999999999999999999999999999986 999999987653
|
|
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.1e-24 Score=151.75 Aligned_cols=127 Identities=27% Similarity=0.352 Sum_probs=106.6
Q ss_pred CceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeeec
Q 044494 3 RKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADFG 82 (144)
Q Consensus 3 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~~ 82 (144)
++..|+++||+ +++|.++++.. .+++..+..++.|+++++++|| +.+++|+|++|+|++++.++.++++|||
T Consensus 82 ~~~~~lv~e~~-~~~L~~~~~~~----~~~~~~~~~~~~ql~~aL~~LH---~~~iiH~dl~p~Nili~~~~~~~l~dfg 153 (328)
T cd07856 82 LEDIYFVTELL-GTDLHRLLTSR----PLEKQFIQYFLYQILRGLKYVH---SAGVVHRDLKPSNILINENCDLKICDFG 153 (328)
T ss_pred CCcEEEEeehh-ccCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEeECCCCCEEeCccc
Confidence 45689999998 56888877632 2788888899999999999999 8999999999999999999999999999
Q ss_pred ceeecccCCCCcccccccccccCcccccc-CCCCCcchhHHHHHHHHHHHhCCCCCCCC
Q 044494 83 VARLLNFDSSNRTLLAGTYGYIAPELAYT-MVVTEKSDVYSFGVVALEVLMGKHPGELL 140 (144)
Q Consensus 83 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~-~~~~~~~d~~slg~~l~~~~~g~~p~~~~ 140 (144)
.+..... ......++..|++||.+.. ..++.++|+||+|++++++++|..||...
T Consensus 154 ~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~ 209 (328)
T cd07856 154 LARIQDP---QMTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGK 209 (328)
T ss_pred cccccCC---CcCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 8875432 1223456778999998765 56788999999999999999999999654
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.5e-24 Score=151.87 Aligned_cols=126 Identities=29% Similarity=0.402 Sum_probs=104.7
Q ss_pred ceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeeecc
Q 044494 4 KCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADFGV 83 (144)
Q Consensus 4 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~~~ 83 (144)
..+|+|+||+.. +|..+.. ..+++..+..++.|++.|+.+|| +.+++|+||+|+||+++.++.++++|||+
T Consensus 93 ~~~~lv~e~~~~-~l~~~~~-----~~~~~~~~~~~~~qi~~aL~~LH---~~~i~H~dlkp~NIll~~~~~~kL~dfg~ 163 (342)
T cd07879 93 QDFYLVMPYMQT-DLQKIMG-----HPLSEDKVQYLVYQMLCGLKYIH---SAGIIHRDLKPGNLAVNEDCELKILDFGL 163 (342)
T ss_pred ceEEEEeccccc-CHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEeeCCC
Confidence 356899999964 7766543 13888999999999999999999 88999999999999999999999999999
Q ss_pred eeecccCCCCcccccccccccCcccccc-CCCCCcchhHHHHHHHHHHHhCCCCCCCCC
Q 044494 84 ARLLNFDSSNRTLLAGTYGYIAPELAYT-MVVTEKSDVYSFGVVALEVLMGKHPGELLS 141 (144)
Q Consensus 84 ~~~~~~~~~~~~~~~~~~~~~~pe~~~~-~~~~~~~d~~slg~~l~~~~~g~~p~~~~~ 141 (144)
+..... ......+++.|+|||.+.. ..++.++|+||+|++++++++|+.||...+
T Consensus 164 ~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~ 219 (342)
T cd07879 164 ARHADA---EMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKD 219 (342)
T ss_pred CcCCCC---CCCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 875432 1223456788999999865 457889999999999999999999997643
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.5e-24 Score=161.27 Aligned_cols=136 Identities=30% Similarity=0.465 Sum_probs=114.0
Q ss_pred CceEEEEEeeccCCCHHHHhhccc-----cc--------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEE
Q 044494 3 RKCMFLIYEYMEMGSLFCVLRTDE-----EA--------VGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNIL 69 (144)
Q Consensus 3 ~~~~~lv~e~~~~~~L~~~l~~~~-----~~--------~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~ 69 (144)
++.+++|+||+..|+|.++++... .. ..+.....+.++.|++.|++||. +..++|||+...||+
T Consensus 374 ~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~---~~~~vHRDLAaRNVL 450 (609)
T KOG0200|consen 374 DGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLA---SVPCVHRDLAARNVL 450 (609)
T ss_pred CCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHh---hCCccchhhhhhhEE
Confidence 467899999999999999998644 01 12888899999999999999999 899999999999999
Q ss_pred EcCCCCeEEeeecceeecccCCCCc-ccc--cccccccCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCC
Q 044494 70 LNLELEAFVADFGVARLLNFDSSNR-TLL--AGTYGYIAPELAYTMVVTEKSDVYSFGVVALEVLM-GKHPGELLS 141 (144)
Q Consensus 70 ~~~~~~~~l~d~~~~~~~~~~~~~~-~~~--~~~~~~~~pe~~~~~~~~~~~d~~slg~~l~~~~~-g~~p~~~~~ 141 (144)
+..+..+|++|||+++.......-. ... .....|||||.+....++.++|+||+|+++||+++ |..||.+.+
T Consensus 451 i~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~ 526 (609)
T KOG0200|consen 451 ITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIP 526 (609)
T ss_pred ecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCC
Confidence 9999999999999999654221111 111 13456999999999999999999999999999998 999998754
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.5e-24 Score=137.71 Aligned_cols=108 Identities=25% Similarity=0.187 Sum_probs=92.5
Q ss_pred CCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeeecceeecccCCCCcc
Q 044494 16 GSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADFGVARLLNFDSSNRT 95 (144)
Q Consensus 16 ~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~ 95 (144)
|+|.++++..+ ..+++..++.++.|++.|++||| +++ ||+||+++.++.+++ ||.+......
T Consensus 1 GsL~~~l~~~~--~~l~~~~~~~i~~qi~~~L~~lH---~~~------kp~Nil~~~~~~~~~--fG~~~~~~~~----- 62 (176)
T smart00750 1 VSLADILEVRG--RPLNEEEIWAVCLQCLRALRELH---RQA------KSGNILLTWDGLLKL--DGSVAFKTPE----- 62 (176)
T ss_pred CcHHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHH---hcC------CcccEeEcCccceee--ccceEeeccc-----
Confidence 68899887532 23999999999999999999999 666 999999999999998 9988764421
Q ss_pred cccccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCC
Q 044494 96 LLAGTYGYIAPELAYTMVVTEKSDVYSFGVVALEVLMGKHPGELLS 141 (144)
Q Consensus 96 ~~~~~~~~~~pe~~~~~~~~~~~d~~slg~~l~~~~~g~~p~~~~~ 141 (144)
...+++.|+|||++.+..++.++|+||+|+++|||++|..||....
T Consensus 63 ~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~ 108 (176)
T smart00750 63 QSRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEER 108 (176)
T ss_pred cCCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccc
Confidence 1257899999999999999999999999999999999999997643
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.92 E-value=8.9e-25 Score=166.17 Aligned_cols=124 Identities=29% Similarity=0.464 Sum_probs=101.8
Q ss_pred ceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeeecc
Q 044494 4 KCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADFGV 83 (144)
Q Consensus 4 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~~~ 83 (144)
-.+|+-||||+...+.+++++..-. -.....+.+.++|++|+.|+| ++|++|||+||.||+++.+..|||+|||+
T Consensus 669 ~~LYIQMEyCE~~ll~~iI~~N~~~--~~~d~~wrLFreIlEGLaYIH---~~giIHRDLKP~NIFLd~~~~VKIGDFGL 743 (1351)
T KOG1035|consen 669 LILYIQMEYCEKTLLRDIIRRNHFN--SQRDEAWRLFREILEGLAYIH---DQGIIHRDLKPRNIFLDSRNSVKIGDFGL 743 (1351)
T ss_pred eEEEEEHhhhhhhHHHHHHHhcccc--hhhHHHHHHHHHHHHHHHHHH---hCceeeccCCcceeEEcCCCCeeeccccc
Confidence 4679999999987777777654321 146778999999999999999 99999999999999999999999999999
Q ss_pred eeecc------------------cCCCCcccccccccccCccccccCC---CCCcchhHHHHHHHHHHHh
Q 044494 84 ARLLN------------------FDSSNRTLLAGTYGYIAPELAYTMV---VTEKSDVYSFGVVALEVLM 132 (144)
Q Consensus 84 ~~~~~------------------~~~~~~~~~~~~~~~~~pe~~~~~~---~~~~~d~~slg~~l~~~~~ 132 (144)
++... ..........||..|+|||.+.... |+.|.|+||||++++||+.
T Consensus 744 At~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~Yn~KiDmYSLGIVlFEM~y 813 (1351)
T KOG1035|consen 744 ATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNKYNSKIDMYSLGIVLFEMLY 813 (1351)
T ss_pred chhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccccccccchhhhHHHHHHHHHHhc
Confidence 98721 0011223467899999999988665 8899999999999999964
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.92 E-value=6.3e-24 Score=141.05 Aligned_cols=130 Identities=35% Similarity=0.512 Sum_probs=113.9
Q ss_pred CceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeeec
Q 044494 3 RKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADFG 82 (144)
Q Consensus 3 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~~ 82 (144)
+...++++||+.+++|.+++..... ++...++.++.+++.++.+|| +.+++|+|++|.||+++.++.++++||+
T Consensus 59 ~~~~~l~~e~~~~~~L~~~~~~~~~---~~~~~~~~~~~~l~~~l~~lh---~~~i~h~~i~~~ni~~~~~~~~~l~d~~ 132 (244)
T smart00220 59 EDKLYLVMEYCDGGDLFDLLKKRGR---LSEDEARFYARQILSALEYLH---SNGIIHRDLKPENILLDEDGHVKLADFG 132 (244)
T ss_pred CCEEEEEEeCCCCCCHHHHHHhccC---CCHHHHHHHHHHHHHHHHHHH---HcCeecCCcCHHHeEECCCCcEEEcccc
Confidence 3578999999999999999876443 788999999999999999999 8899999999999999999999999999
Q ss_pred ceeecccCCCCcccccccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCC
Q 044494 83 VARLLNFDSSNRTLLAGTYGYIAPELAYTMVVTEKSDVYSFGVVALEVLMGKHPGEL 139 (144)
Q Consensus 83 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~d~~slg~~l~~~~~g~~p~~~ 139 (144)
.+....... ......++..|++||.......+.++|+|++|++++++++|..||..
T Consensus 133 ~~~~~~~~~-~~~~~~~~~~~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~ 188 (244)
T smart00220 133 LARQLDPGG-LLTTFVGTPEYMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPG 188 (244)
T ss_pred ceeeecccc-ccccccCCcCCCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 998765332 23345577889999999888888899999999999999999999976
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.91 E-value=1e-24 Score=142.99 Aligned_cols=133 Identities=24% Similarity=0.368 Sum_probs=112.0
Q ss_pred CceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeeec
Q 044494 3 RKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADFG 82 (144)
Q Consensus 3 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~~ 82 (144)
+..+|+|+.+|+. +|...+... ...++..++..+..++.+|+.|+| +..++|||+|+.|++++.++.++++|||
T Consensus 96 r~t~ylVf~~ceh-DLaGlLsn~--~vr~sls~Ikk~Mk~Lm~GL~~iH---r~kilHRDmKaaNvLIt~dgilklADFG 169 (376)
T KOG0669|consen 96 RATFYLVFDFCEH-DLAGLLSNR--KVRFSLSEIKKVMKGLMNGLYYIH---RNKILHRDMKAANVLITKDGILKLADFG 169 (376)
T ss_pred cceeeeeHHHhhh-hHHHHhcCc--cccccHHHHHHHHHHHHHHHHHHH---HhhHHhhcccHhhEEEcCCceEEeeccc
Confidence 4568999999975 898888743 234899999999999999999999 9999999999999999999999999999
Q ss_pred ceeecccC-CCCc---ccccccccccCccccccC-CCCCcchhHHHHHHHHHHHhCCCCCCCCC
Q 044494 83 VARLLNFD-SSNR---TLLAGTYGYIAPELAYTM-VVTEKSDVYSFGVVALEVLMGKHPGELLS 141 (144)
Q Consensus 83 ~~~~~~~~-~~~~---~~~~~~~~~~~pe~~~~~-~~~~~~d~~slg~~l~~~~~g~~p~~~~~ 141 (144)
+++.+... .... ..+..|.+|++||.+.+. .|+++.|+|+.||++.||.++++-+++.+
T Consensus 170 lar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnt 233 (376)
T KOG0669|consen 170 LARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNT 233 (376)
T ss_pred cccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCCh
Confidence 99765422 1112 224568899999998866 57899999999999999999998887654
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=2e-25 Score=159.84 Aligned_cols=137 Identities=31% Similarity=0.387 Sum_probs=115.5
Q ss_pred CCceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeee
Q 044494 2 HRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADF 81 (144)
Q Consensus 2 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~ 81 (144)
-++.+++|+||+++|+|.+++.+..... +.-...+++..||+.|++||. +.+++|||+.+.|++++.+..+||+||
T Consensus 606 ~DePicmI~EYmEnGDLnqFl~aheapt-~~t~~~vsi~tqiasgmaYLe---s~nfVHrd~a~rNcLv~~e~~iKiadf 681 (807)
T KOG1094|consen 606 QDDPLCMITEYMENGDLNQFLSAHELPT-AETAPGVSICTQIASGMAYLE---SLNFVHRDLATRNCLVDGEFTIKIADF 681 (807)
T ss_pred cCCchHHHHHHHhcCcHHHHHHhccCcc-cccchhHHHHHHHHHHHHHHH---hhchhhccccccceeecCcccEEecCc
Confidence 3677899999999999999998754322 455567789999999999999 899999999999999999999999999
Q ss_pred cceeeccc--CCCCcccccccccccCccccccCCCCCcchhHHHHHHHHHHHh--CCCCCCCCCC
Q 044494 82 GVARLLNF--DSSNRTLLAGTYGYIAPELAYTMVVTEKSDVYSFGVVALEVLM--GKHPGELLSS 142 (144)
Q Consensus 82 ~~~~~~~~--~~~~~~~~~~~~~~~~pe~~~~~~~~~~~d~~slg~~l~~~~~--g~~p~~~~~~ 142 (144)
|.++..-. .-...........|||+|.+...+++.++|+|++|+++||+++ ...||..+.+
T Consensus 682 gmsR~lysg~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~ 746 (807)
T KOG1094|consen 682 GMSRNLYSGDYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTD 746 (807)
T ss_pred ccccccccCCceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhH
Confidence 99985432 2223344556789999999999999999999999999999864 7889987764
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.91 E-value=3.3e-25 Score=157.08 Aligned_cols=135 Identities=25% Similarity=0.285 Sum_probs=118.2
Q ss_pred CCceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCC-CCeEEee
Q 044494 2 HRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLE-LEAFVAD 80 (144)
Q Consensus 2 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~-~~~~l~d 80 (144)
|.+++|||+|-+.. +|.+.|++-+...++....+..++.|+..||+.|- ..|++|.||||.||++... ...||||
T Consensus 505 hknHLClVFE~Lsl-NLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK---~c~vlHaDIKPDNiLVNE~k~iLKLCD 580 (752)
T KOG0670|consen 505 HKNHLCLVFEPLSL-NLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLK---KCGVLHADIKPDNILVNESKNILKLCD 580 (752)
T ss_pred hcceeEEEehhhhc-hHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHH---hcCeeecccCccceEeccCcceeeecc
Confidence 68899999999964 99999998777788999999999999999999999 7899999999999999866 4568999
Q ss_pred ecceeecccCCCCcccccccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCC
Q 044494 81 FGVARLLNFDSSNRTLLAGTYGYIAPELAYTMVVTEKSDVYSFGVVALEVLMGKHPGELLSS 142 (144)
Q Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~d~~slg~~l~~~~~g~~p~~~~~~ 142 (144)
||.+..... ........+..|.|||++.+..|++..|+||+||++||+.||+.-|.+-++
T Consensus 581 fGSA~~~~e--neitPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TN 640 (752)
T KOG0670|consen 581 FGSASFASE--NEITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTN 640 (752)
T ss_pred Ccccccccc--ccccHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCc
Confidence 999976542 223335678899999999999999999999999999999999999887553
|
|
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=7.3e-25 Score=159.75 Aligned_cols=135 Identities=25% Similarity=0.388 Sum_probs=115.9
Q ss_pred ceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeeecc
Q 044494 4 KCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADFGV 83 (144)
Q Consensus 4 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~~~ 83 (144)
..+++|||.++.|+|.+.|++.. ...+-......++.||+.|+.||. .++++|||+...|+++.....|||+|||+
T Consensus 183 qp~mMV~ELaplGSLldrLrka~-~~~llv~~Lcdya~QiA~aM~YLe---skrlvHRDLAARNlllasprtVKI~DFGL 258 (1039)
T KOG0199|consen 183 QPAMMVFELAPLGSLLDRLRKAK-KAILLVSRLCDYAMQIAKAMQYLE---SKRLVHRDLAARNLLLASPRTVKICDFGL 258 (1039)
T ss_pred chhhHHhhhcccchHHHHHhhcc-ccceeHHHHHHHHHHHHHHHHHHh---hhhhhhhhhhhhhheecccceeeeecccc
Confidence 55688999999999999998732 234788889999999999999999 99999999999999999999999999999
Q ss_pred eeecccCCCC---cccccccccccCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCC
Q 044494 84 ARLLNFDSSN---RTLLAGTYGYIAPELAYTMVVTEKSDVYSFGVVALEVLM-GKHPGELLSS 142 (144)
Q Consensus 84 ~~~~~~~~~~---~~~~~~~~~~~~pe~~~~~~~~~~~d~~slg~~l~~~~~-g~~p~~~~~~ 142 (144)
.+..+..... .........|+|||.++...++.++|+|++|+++|||++ |..||.+..+
T Consensus 259 mRaLg~ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g 321 (1039)
T KOG0199|consen 259 MRALGENEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRG 321 (1039)
T ss_pred eeccCCCCcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCH
Confidence 9876532221 222445668999999999999999999999999999998 9999988654
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.3e-23 Score=147.15 Aligned_cols=131 Identities=32% Similarity=0.534 Sum_probs=109.3
Q ss_pred CceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCC------CCCeEecCCCCCcEEEcCCCCe
Q 044494 3 RKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDC------TPPIVHRDISSNNILLNLELEA 76 (144)
Q Consensus 3 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~------~~~~~h~~i~~~ni~~~~~~~~ 76 (144)
+..++||+||.+.|+|.++|...- +++....+++..++.||+|||.-. ...|+|||||++||++..++..
T Consensus 280 ~~eywLVt~fh~kGsL~dyL~~nt----isw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTc 355 (534)
T KOG3653|consen 280 RMEYWLVTEFHPKGSLCDYLKANT----ISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTC 355 (534)
T ss_pred ccceeEEeeeccCCcHHHHHHhcc----ccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcE
Confidence 346899999999999999998643 899999999999999999999632 3479999999999999999999
Q ss_pred EEeeecceeecccCCCC--cccccccccccCccccccCCC-C-----CcchhHHHHHHHHHHHhCCCCC
Q 044494 77 FVADFGVARLLNFDSSN--RTLLAGTYGYIAPELAYTMVV-T-----EKSDVYSFGVVALEVLMGKHPG 137 (144)
Q Consensus 77 ~l~d~~~~~~~~~~~~~--~~~~~~~~~~~~pe~~~~~~~-~-----~~~d~~slg~~l~~~~~g~~p~ 137 (144)
.|+|||++.++...... .-...||.+|||||++-+... . .+.|+||+|.++||++++...+
T Consensus 356 cIaDFGLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~ 424 (534)
T KOG3653|consen 356 CIADFGLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDA 424 (534)
T ss_pred EeeccceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccc
Confidence 99999999988643222 223789999999999876532 1 3589999999999999866544
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.6e-23 Score=151.00 Aligned_cols=134 Identities=20% Similarity=0.220 Sum_probs=102.9
Q ss_pred CceEEEEEeeccCCCHHHHhhcccc---------------------cCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEec
Q 044494 3 RKCMFLIYEYMEMGSLFCVLRTDEE---------------------AVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHR 61 (144)
Q Consensus 3 ~~~~~lv~e~~~~~~L~~~l~~~~~---------------------~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~ 61 (144)
.+..++|+||+++++|.++++.... ...+++..+..++.|++.++.+|| +.+++||
T Consensus 257 ~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~~~~~~~~~~~i~~ql~~aL~~lH---~~~ivHr 333 (507)
T PLN03224 257 KGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQDKRDINVIKGVMRQVLTGLRKLH---RIGIVHR 333 (507)
T ss_pred CCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcccccCCHHHHHHHHHHHHHHHHHHH---HCCeecC
Confidence 3567999999999999998864211 112456778889999999999999 8899999
Q ss_pred CCCCCcEEEcCCCCeEEeeecceeecccCCCCc-ccccccccccCccccccCCC----------------------CCcc
Q 044494 62 DISSNNILLNLELEAFVADFGVARLLNFDSSNR-TLLAGTYGYIAPELAYTMVV----------------------TEKS 118 (144)
Q Consensus 62 ~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~-~~~~~~~~~~~pe~~~~~~~----------------------~~~~ 118 (144)
||||.||+++.++.++++|||++.......... ....+++.|++||.+..... ..+.
T Consensus 334 DLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aPE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~ 413 (507)
T PLN03224 334 DIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPPEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLF 413 (507)
T ss_pred CCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeChhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCcc
Confidence 999999999999999999999987543221111 11234789999998764321 1246
Q ss_pred hhHHHHHHHHHHHhCCC-CCCC
Q 044494 119 DVYSFGVVALEVLMGKH-PGEL 139 (144)
Q Consensus 119 d~~slg~~l~~~~~g~~-p~~~ 139 (144)
|+||+|+++++|+++.. ||..
T Consensus 414 DvwSlGvil~em~~~~l~p~~~ 435 (507)
T PLN03224 414 DSYTAGVLLMQMCVPELRPVAN 435 (507)
T ss_pred chhhHHHHHHHHHhCCCCCccc
Confidence 99999999999999874 7753
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=1e-24 Score=161.13 Aligned_cols=133 Identities=26% Similarity=0.407 Sum_probs=116.1
Q ss_pred eEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeeecce
Q 044494 5 CMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADFGVA 84 (144)
Q Consensus 5 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~~~~ 84 (144)
.+.||++|++.|+|.++++.++.. +.....+.|..||++|++||| .+.++||||...|+++..-..+|+.|||++
T Consensus 771 ~~qlvtq~mP~G~LlDyvr~hr~~--igsq~lLnw~~QIAkgM~YLe---~qrlVHrdLaaRNVLVksP~hvkitdfgla 845 (1177)
T KOG1025|consen 771 TLQLVTQLMPLGCLLDYVREHRDN--IGSQDLLNWCYQIAKGMKYLE---EQRLVHRDLAARNVLVKSPNHVKITDFGLA 845 (1177)
T ss_pred hHHHHHHhcccchHHHHHHHhhcc--ccHHHHHHHHHHHHHHHHHHH---hcchhhhhhhhhheeecCCCeEEEEecchh
Confidence 357899999999999999875443 778888999999999999999 999999999999999999999999999999
Q ss_pred eecccCCCCc--ccccccccccCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCC
Q 044494 85 RLLNFDSSNR--TLLAGTYGYIAPELAYTMVVTEKSDVYSFGVVALEVLM-GKHPGELLSS 142 (144)
Q Consensus 85 ~~~~~~~~~~--~~~~~~~~~~~pe~~~~~~~~~~~d~~slg~~l~~~~~-g~~p~~~~~~ 142 (144)
+........- ..-...+.|+|-|.+....+++++|+||+|+++||++| |+.||++++.
T Consensus 846 ~ll~~d~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~ 906 (1177)
T KOG1025|consen 846 KLLAPDEKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPA 906 (1177)
T ss_pred hccCcccccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCH
Confidence 8765443332 22335678999999999999999999999999999998 9999999864
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.90 E-value=5.2e-23 Score=135.56 Aligned_cols=132 Identities=35% Similarity=0.490 Sum_probs=111.7
Q ss_pred CceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeeec
Q 044494 3 RKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADFG 82 (144)
Q Consensus 3 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~~ 82 (144)
+...++++|++++++|.+++...... +++..+..++.+++.++.+|| ..+++|+|++|.|++++.++.++++|||
T Consensus 69 ~~~~~~v~e~~~~~~L~~~~~~~~~~--~~~~~~~~~~~~l~~~l~~lh---~~~i~h~di~~~ni~v~~~~~~~l~d~g 143 (225)
T smart00221 69 PEPLYLVMEYCEGGDLFDYLRKKGGK--LSEEEARFYLRQILEALEYLH---SLGIVHRDLKPENILLGMDGLVKLADFG 143 (225)
T ss_pred CCceEEEEeccCCCCHHHHHHhcccC--CCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEeeCc
Confidence 35789999999999999998753321 788899999999999999999 8899999999999999999999999999
Q ss_pred ceeecccCC-CCcccccccccccCcccc-ccCCCCCcchhHHHHHHHHHHHhCCCCCCC
Q 044494 83 VARLLNFDS-SNRTLLAGTYGYIAPELA-YTMVVTEKSDVYSFGVVALEVLMGKHPGEL 139 (144)
Q Consensus 83 ~~~~~~~~~-~~~~~~~~~~~~~~pe~~-~~~~~~~~~d~~slg~~l~~~~~g~~p~~~ 139 (144)
.+....... .......+...|++||.. ....++.++|+|++|++++++++|..||..
T Consensus 144 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 144 LARFIHRDLAALLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred eeeEecCcccccccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 888765322 122334567789999998 566677899999999999999999999966
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=5.6e-24 Score=133.59 Aligned_cols=133 Identities=22% Similarity=0.296 Sum_probs=114.6
Q ss_pred CceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeeec
Q 044494 3 RKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADFG 82 (144)
Q Consensus 3 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~~ 82 (144)
++++-+|+|||.. +|..+....+. .++.+.+..+..|++.|+.++| +.++.|||+||+|+++..+|..|++|||
T Consensus 73 dkkltlvfe~cdq-dlkkyfdslng--~~d~~~~rsfmlqllrgl~fch---shnvlhrdlkpqnllin~ngelkladfg 146 (292)
T KOG0662|consen 73 DKKLTLVFEFCDQ-DLKKYFDSLNG--DLDPEIVRSFMLQLLRGLGFCH---SHNVLHRDLKPQNLLINRNGELKLADFG 146 (292)
T ss_pred CceeEEeHHHhhH-HHHHHHHhcCC--cCCHHHHHHHHHHHHhhhhhhh---hhhhhhccCCcceEEeccCCcEEecccc
Confidence 4677899999975 89888876433 2888999999999999999999 9999999999999999999999999999
Q ss_pred ceeecccCCCCcccccccccccCccccccCC-CCCcchhHHHHHHHHHHHh-CCCCCCCCC
Q 044494 83 VARLLNFDSSNRTLLAGTYGYIAPELAYTMV-VTEKSDVYSFGVVALEVLM-GKHPGELLS 141 (144)
Q Consensus 83 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~-~~~~~d~~slg~~l~~~~~-g~~p~~~~~ 141 (144)
+++.++.+.........+.+|.+|+++-+.+ |+...|+||.||++.|+.. |.+-|.+.+
T Consensus 147 larafgipvrcysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~d 207 (292)
T KOG0662|consen 147 LARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGND 207 (292)
T ss_pred hhhhcCCceEeeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCc
Confidence 9998886665555667889999999988764 7889999999999999975 777776644
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.1e-25 Score=149.14 Aligned_cols=129 Identities=29% Similarity=0.344 Sum_probs=106.0
Q ss_pred EEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeeeccee
Q 044494 6 MFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADFGVAR 85 (144)
Q Consensus 6 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~~~~~ 85 (144)
+|+++|.+.. +|...+-.. ..++.+.++-+++||+.|++||| +.+|.||||||-|+++..+-..|++|||+++
T Consensus 132 iYV~TELmQS-DLHKIIVSP---Q~Ls~DHvKVFlYQILRGLKYLH---sA~ILHRDIKPGNLLVNSNCvLKICDFGLAR 204 (449)
T KOG0664|consen 132 LYVLTELMQS-DLHKIIVSP---QALTPDHVKVFVYQILRGLKYLH---TANILHRDIKPGNLLVNSNCILKICDFGLAR 204 (449)
T ss_pred HHHHHHHHHh-hhhheeccC---CCCCcchhhhhHHHHHhhhHHHh---hcchhhccCCCccEEeccCceEEeccccccc
Confidence 4677777754 676655432 33888899999999999999999 8999999999999999999999999999999
Q ss_pred ecccCCCCc-ccccccccccCccccccC-CCCCcchhHHHHHHHHHHHhCCCCCCCCC
Q 044494 86 LLNFDSSNR-TLLAGTYGYIAPELAYTM-VVTEKSDVYSFGVVALEVLMGKHPGELLS 141 (144)
Q Consensus 86 ~~~~~~~~~-~~~~~~~~~~~pe~~~~~-~~~~~~d~~slg~~l~~~~~g~~p~~~~~ 141 (144)
..+...... .....|..|.+||++.+. .|+...|+||.|||+.|++-++.-|+.-+
T Consensus 205 vee~d~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~ 262 (449)
T KOG0664|consen 205 TWDQRDRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAG 262 (449)
T ss_pred ccchhhhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccC
Confidence 776443332 335578899999999876 58889999999999999998888776543
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.2e-24 Score=141.77 Aligned_cols=126 Identities=27% Similarity=0.472 Sum_probs=100.7
Q ss_pred ceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcC--CCCeEEeee
Q 044494 4 KCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNL--ELEAFVADF 81 (144)
Q Consensus 4 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~--~~~~~l~d~ 81 (144)
..+++++||++.|+|.+-+.. .++.+...+.+..|++.|+.||| +++++|||||.+||++-. ..++|++||
T Consensus 95 d~YvF~qE~aP~gdL~snv~~----~GigE~~~K~v~~ql~SAi~fMH---sknlVHRdlK~eNiLif~~df~rvKlcDF 167 (378)
T KOG1345|consen 95 DAYVFVQEFAPRGDLRSNVEA----AGIGEANTKKVFAQLLSAIEFMH---SKNLVHRDLKAENILIFDADFYRVKLCDF 167 (378)
T ss_pred ceEEEeeccCccchhhhhcCc----ccccHHHHHHHHHHHHHHHHHhh---ccchhhcccccceEEEecCCccEEEeeec
Confidence 357899999999999876654 34889999999999999999999 999999999999999953 357999999
Q ss_pred cceeecccCCCCcccccccccccCccccccCC-----CCCcchhHHHHHHHHHHHhCCCCCCC
Q 044494 82 GVARLLNFDSSNRTLLAGTYGYIAPELAYTMV-----VTEKSDVYSFGVVALEVLMGKHPGEL 139 (144)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~-----~~~~~d~~slg~~l~~~~~g~~p~~~ 139 (144)
|..+..+.-.. .......|.+||...... ..+..|+|+||++++.+++|..||+.
T Consensus 168 G~t~k~g~tV~---~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQk 227 (378)
T KOG1345|consen 168 GLTRKVGTTVK---YLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQK 227 (378)
T ss_pred ccccccCceeh---hhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchh
Confidence 99876553221 122345677887654322 34678999999999999999999984
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.7e-23 Score=144.00 Aligned_cols=124 Identities=30% Similarity=0.505 Sum_probs=103.2
Q ss_pred ceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCC-----CCCeEecCCCCCcEEEcCCCCeEE
Q 044494 4 KCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDC-----TPPIVHRDISSNNILLNLELEAFV 78 (144)
Q Consensus 4 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~-----~~~~~h~~i~~~ni~~~~~~~~~l 78 (144)
.++|||++|.+.|||+|+|.+ .. ++-...+.++..++.||.+||... .-.+.|||||+.||++..++...|
T Consensus 282 TQLwLvTdYHe~GSL~DyL~r-~t---v~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~I 357 (513)
T KOG2052|consen 282 TQLWLVTDYHEHGSLYDYLNR-NT---VTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCI 357 (513)
T ss_pred EEEEEeeecccCCcHHHHHhh-cc---CCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEE
Confidence 368999999999999999986 32 888999999999999999999410 236999999999999999999999
Q ss_pred eeecceeecccCCC----CcccccccccccCccccccCCCC------CcchhHHHHHHHHHHH
Q 044494 79 ADFGVARLLNFDSS----NRTLLAGTYGYIAPELAYTMVVT------EKSDVYSFGVVALEVL 131 (144)
Q Consensus 79 ~d~~~~~~~~~~~~----~~~~~~~~~~~~~pe~~~~~~~~------~~~d~~slg~~l~~~~ 131 (144)
+|+|++-+...... ....+.||.+|||||++...... ..+||||+|.++||+.
T Consensus 358 ADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEia 420 (513)
T KOG2052|consen 358 ADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIA 420 (513)
T ss_pred eeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHH
Confidence 99999987654322 23457899999999998855321 2589999999999975
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.1e-23 Score=142.99 Aligned_cols=137 Identities=23% Similarity=0.290 Sum_probs=117.0
Q ss_pred CceEEEEEeeccCCCHHHHhh-----cccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeE
Q 044494 3 RKCMFLIYEYMEMGSLFCVLR-----TDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAF 77 (144)
Q Consensus 3 ~~~~~lv~e~~~~~~L~~~l~-----~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~ 77 (144)
..+.++++++..-|+|..+++ +......+..-+.+.++.|++.|+.+|| ..+++|.||...|.+++..-++|
T Consensus 360 ~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh---~~~ViHkDiAaRNCvIdd~LqVk 436 (563)
T KOG1024|consen 360 YATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLH---NHGVIHKDIAARNCVIDDQLQVK 436 (563)
T ss_pred cCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHH---hcCcccchhhhhcceehhheeEE
Confidence 456789999999999999997 3333445777788999999999999999 99999999999999999999999
Q ss_pred EeeecceeecccCCC--CcccccccccccCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCC
Q 044494 78 VADFGVARLLNFDSS--NRTLLAGTYGYIAPELAYTMVVTEKSDVYSFGVVALEVLM-GKHPGELLSS 142 (144)
Q Consensus 78 l~d~~~~~~~~~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~d~~slg~~l~~~~~-g~~p~~~~~~ 142 (144)
++|-.++++..+..- ..........||++|.++...++..+|+||||+++||++| |+.||...|+
T Consensus 437 ltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDP 504 (563)
T KOG1024|consen 437 LTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDP 504 (563)
T ss_pred eccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCH
Confidence 999999987654322 1233445678999999999999999999999999999998 9999988775
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.6e-23 Score=145.70 Aligned_cols=135 Identities=32% Similarity=0.482 Sum_probs=112.0
Q ss_pred CCCceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCC---CCeE
Q 044494 1 LHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLE---LEAF 77 (144)
Q Consensus 1 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~---~~~~ 77 (144)
+++..++-|.|||+|-+|.-||+.... +++.++..++-|++.||.||-.. .-.|+|-|+||.||++... |.+|
T Consensus 538 lDtdsFCTVLEYceGNDLDFYLKQhkl---mSEKEARSIiMQiVnAL~YLNEi-kpPIIHYDLKPgNILLv~GtacGeIK 613 (775)
T KOG1151|consen 538 LDTDSFCTVLEYCEGNDLDFYLKQHKL---MSEKEARSIIMQIVNALKYLNEI-KPPIIHYDLKPGNILLVNGTACGEIK 613 (775)
T ss_pred eccccceeeeeecCCCchhHHHHhhhh---hhHHHHHHHHHHHHHHHHHHhcc-CCCeeeeccCCccEEEecCcccceeE
Confidence 356778999999999899888886554 89999999999999999999854 5679999999999999654 7899
Q ss_pred EeeecceeecccCCCC-------cccccccccccCccccccC----CCCCcchhHHHHHHHHHHHhCCCCCCC
Q 044494 78 VADFGVARLLNFDSSN-------RTLLAGTYGYIAPELAYTM----VVTEKSDVYSFGVVALEVLMGKHPGEL 139 (144)
Q Consensus 78 l~d~~~~~~~~~~~~~-------~~~~~~~~~~~~pe~~~~~----~~~~~~d~~slg~~l~~~~~g~~p~~~ 139 (144)
|.|||+++.+...... .....||.+|++||.+.-. ..+.++|+||+|+|+|.++-|+.||-.
T Consensus 614 ITDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGh 686 (775)
T KOG1151|consen 614 ITDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGH 686 (775)
T ss_pred eeecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCC
Confidence 9999999987643222 1224689999999988754 356789999999999999999999953
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.2e-23 Score=150.55 Aligned_cols=130 Identities=24% Similarity=0.326 Sum_probs=111.9
Q ss_pred CCceEEEEEeec-cCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEee
Q 044494 2 HRKCMFLIYEYM-EMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVAD 80 (144)
Q Consensus 2 ~~~~~~lv~e~~-~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d 80 (144)
+++++|++||-- +|-+|++++....+ +++.++..+.+|++.+++.|| ++||+|||||-+|++++.+|-++++|
T Consensus 640 ddd~yyl~te~hg~gIDLFd~IE~kp~---m~E~eAk~IFkQV~agi~hlh---~~~ivhrdikdenvivd~~g~~klid 713 (772)
T KOG1152|consen 640 DDDYYYLETEVHGEGIDLFDFIEFKPR---MDEPEAKLIFKQVVAGIKHLH---DQGIVHRDIKDENVIVDSNGFVKLID 713 (772)
T ss_pred cCCeeEEEecCCCCCcchhhhhhccCc---cchHHHHHHHHHHHhcccccc---ccCceecccccccEEEecCCeEEEee
Confidence 467889999955 34589999976544 899999999999999999999 99999999999999999999999999
Q ss_pred ecceeecccCCCCcccccccccccCccccccCCC-CCcchhHHHHHHHHHHHhCCCCCCC
Q 044494 81 FGVARLLNFDSSNRTLLAGTYGYIAPELAYTMVV-TEKSDVYSFGVVALEVLMGKHPGEL 139 (144)
Q Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~-~~~~d~~slg~~l~~~~~g~~p~~~ 139 (144)
||.+.... ........||..|.|||++.+.+| +...|||++|+++|.++-...||=+
T Consensus 714 fgsaa~~k--sgpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyyn 771 (772)
T KOG1152|consen 714 FGSAAYTK--SGPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYYN 771 (772)
T ss_pred ccchhhhc--CCCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCcC
Confidence 99887543 233456789999999999999987 4568999999999999888888843
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=1e-22 Score=150.42 Aligned_cols=135 Identities=29% Similarity=0.397 Sum_probs=108.0
Q ss_pred CCceEEEEEeeccCCCHHHHhhcccccCC-CCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcC---CC--C
Q 044494 2 HRKCMFLIYEYMEMGSLFCVLRTDEEAVG-LDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNL---EL--E 75 (144)
Q Consensus 2 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~-~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~---~~--~ 75 (144)
++...|++.|.|.- +|.+++........ ...-....++.|+++|+..|| +.+++|||+||+||+++. ++ +
T Consensus 574 d~qF~YIalELC~~-sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLH---sl~iVHRDLkPQNILI~~~~~~~~~r 649 (903)
T KOG1027|consen 574 DRQFLYIALELCAC-SLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLH---SLKIVHRDLKPQNILISVPSADGTLR 649 (903)
T ss_pred CCceEEEEehHhhh-hHHHHHhccccchhhcccccHHHHHHHHHHHHHHHH---hcccccccCCCceEEEEccCCCccee
Confidence 46678999999975 99999976311111 111345678899999999999 899999999999999986 33 5
Q ss_pred eEEeeecceeecccCCCC---cccccccccccCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCC
Q 044494 76 AFVADFGVARLLNFDSSN---RTLLAGTYGYIAPELAYTMVVTEKSDVYSFGVVALEVLM-GKHPGELL 140 (144)
Q Consensus 76 ~~l~d~~~~~~~~~~~~~---~~~~~~~~~~~~pe~~~~~~~~~~~d~~slg~~l~~~~~-g~~p~~~~ 140 (144)
++|+|||++++....... .....|+-+|.|||.+.........||+|+||++|+.++ |..||...
T Consensus 650 a~iSDfglsKkl~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~ 718 (903)
T KOG1027|consen 650 AKISDFGLSKKLAGGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDS 718 (903)
T ss_pred EEecccccccccCCCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCch
Confidence 679999999988754333 234568999999999998888889999999999999998 58999764
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.86 E-value=7.4e-22 Score=128.04 Aligned_cols=128 Identities=22% Similarity=0.325 Sum_probs=102.6
Q ss_pred ceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCC-CCeEEeeec
Q 044494 4 KCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLE-LEAFVADFG 82 (144)
Q Consensus 4 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~-~~~~l~d~~ 82 (144)
+..-||+||.++.+...+... +..-.+..++.+++.||.|+| ++||.|||+||.|++++.. -..+++|+|
T Consensus 108 ktpaLiFE~v~n~Dfk~ly~t------l~d~dIryY~~elLkALdyCH---S~GImHRDVKPhNvmIdh~~rkLrlIDWG 178 (338)
T KOG0668|consen 108 KTPSLIFEYVNNTDFKQLYPT------LTDYDIRYYIYELLKALDYCH---SMGIMHRDVKPHNVMIDHELRKLRLIDWG 178 (338)
T ss_pred cCchhHhhhhccccHHHHhhh------hchhhHHHHHHHHHHHHhHHH---hcCcccccCCcceeeechhhceeeeeecc
Confidence 455688899887666554432 777788999999999999999 9999999999999999976 457899999
Q ss_pred ceeecccCCCCcccccccccccCcccccc-CCCCCcchhHHHHHHHHHHHhCCCCC-CCCC
Q 044494 83 VARLLNFDSSNRTLLAGTYGYIAPELAYT-MVVTEKSDVYSFGVVALEVLMGKHPG-ELLS 141 (144)
Q Consensus 83 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~-~~~~~~~d~~slg~~l~~~~~g~~p~-~~~~ 141 (144)
++.... +.+.-..+..+..|--||.+.. +.|+.+-|+||+||.+..|+..+.|| .+.+
T Consensus 179 LAEFYH-p~~eYnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~d 238 (338)
T KOG0668|consen 179 LAEFYH-PGKEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHD 238 (338)
T ss_pred hHhhcC-CCceeeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCC
Confidence 998765 3444455667777888998774 45788999999999999999877776 4443
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=8.9e-21 Score=131.96 Aligned_cols=135 Identities=24% Similarity=0.333 Sum_probs=112.4
Q ss_pred CceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCC-----CCeE
Q 044494 3 RKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLE-----LEAF 77 (144)
Q Consensus 3 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~-----~~~~ 77 (144)
+..-|+||+.+ |.+|.++..... ...++..+...++.|++.+|+++| +.|++||||||.|+++... ..+.
T Consensus 93 ~~~~~iVM~l~-G~sL~dl~~~~~-~~~fs~~T~l~ia~q~l~~l~~lH---~~G~iHRDiKp~N~~~g~~~~~~~~~~~ 167 (322)
T KOG1164|consen 93 EDFNFIVMSLL-GPSLEDLRKRNP-PGRFSRKTVLRIAIQNLNALEDLH---SKGFIHRDIKPENFVVGQSSRSEVRTLY 167 (322)
T ss_pred CceeEEEEecc-CccHHHHHHhCC-CCCcCHhHHHHHHHHHHHHHHHHH---hcCcccCCcCHHHeeecCCCCcccceEE
Confidence 45678999977 889999876544 456999999999999999999999 9999999999999999865 3578
Q ss_pred Eeeecceeecc--cCC-C------C-cccccccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCC
Q 044494 78 VADFGVARLLN--FDS-S------N-RTLLAGTYGYIAPELAYTMVVTEKSDVYSFGVVALEVLMGKHPGELLSS 142 (144)
Q Consensus 78 l~d~~~~~~~~--~~~-~------~-~~~~~~~~~~~~pe~~~~~~~~~~~d~~slg~~l~~~~~g~~p~~~~~~ 142 (144)
++|||+++... ... . . .....||..|.++....+...+++.|+||++.++.++..|..||+....
T Consensus 168 llDfGlar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~ 242 (322)
T KOG1164|consen 168 LLDFGLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEM 242 (322)
T ss_pred EEecCCCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccc
Confidence 99999998322 111 0 1 1234589999999999999999999999999999999999999987653
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.84 E-value=4.5e-20 Score=119.84 Aligned_cols=122 Identities=37% Similarity=0.581 Sum_probs=103.2
Q ss_pred ceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcC-CCCeEEeeec
Q 044494 4 KCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNL-ELEAFVADFG 82 (144)
Q Consensus 4 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~-~~~~~l~d~~ 82 (144)
...++++|++.+++|.+++.... ..++......++.+++.++++|| +.+++|+|++|.||+++. ++.++++||+
T Consensus 64 ~~~~~~~e~~~~~~l~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh---~~~~~H~dl~~~ni~~~~~~~~~~l~d~~ 138 (215)
T cd00180 64 NHLYLVMEYCEGGSLKDLLKENE--GKLSEDEILRILLQILEGLEYLH---SNGIIHRDLKPENILLDSDNGKVKLADFG 138 (215)
T ss_pred CeEEEEEecCCCCcHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHhhEEEeCCCCcEEEecCC
Confidence 57899999999899999987542 23888999999999999999999 889999999999999999 8999999999
Q ss_pred ceeecccCCCCcccccccccccCccccccC-CCCCcchhHHHHHHHHHH
Q 044494 83 VARLLNFDSSNRTLLAGTYGYIAPELAYTM-VVTEKSDVYSFGVVALEV 130 (144)
Q Consensus 83 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~-~~~~~~d~~slg~~l~~~ 130 (144)
.+..............+...|++||..... ..+.+.|+|++|++++++
T Consensus 139 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l 187 (215)
T cd00180 139 LSKLLTSDKSLLKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL 187 (215)
T ss_pred ceEEccCCcchhhcccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH
Confidence 998665332223334577789999998876 677889999999998876
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.84 E-value=2.1e-20 Score=131.71 Aligned_cols=65 Identities=23% Similarity=0.445 Sum_probs=57.5
Q ss_pred CCceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEE
Q 044494 2 HRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILL 70 (144)
Q Consensus 2 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~ 70 (144)
+..++++|+|++ |.+|..++.+.. -++++...+++|++|++.||.|||. ..||+|.||||+||++
T Consensus 157 NG~HVCMVfEvL-GdnLLklI~~s~-YrGlpl~~VK~I~~qvL~GLdYLH~--ecgIIHTDlKPENvLl 221 (590)
T KOG1290|consen 157 NGQHVCMVFEVL-GDNLLKLIKYSN-YRGLPLSCVKEICRQVLTGLDYLHR--ECGIIHTDLKPENVLL 221 (590)
T ss_pred CCcEEEEEehhh-hhHHHHHHHHhC-CCCCcHHHHHHHHHHHHHHHHHHHH--hcCccccCCCcceeee
Confidence 567899999999 789999998633 3569999999999999999999996 4599999999999998
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.82 E-value=1.4e-20 Score=139.39 Aligned_cols=128 Identities=23% Similarity=0.408 Sum_probs=109.8
Q ss_pred EEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeeecceee
Q 044494 7 FLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADFGVARL 86 (144)
Q Consensus 7 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~~~~~~ 86 (144)
+-.|||+++ +|+.++..... +...++..+.+|++.|++|+| ..|+.|||+|++|+++..++.++++|||.+..
T Consensus 397 ~~~mE~~~~-Dlf~~~~~~~~---~~~~e~~c~fKqL~~Gv~y~h---~~GiahrdlK~enll~~~~g~lki~Dfg~~~v 469 (601)
T KOG0590|consen 397 LQSMEYCPY-DLFSLVMSNGK---LTPLEADCFFKQLLRGVKYLH---SMGLAHRDLKLENLLVTENGILKIIDFGAASV 469 (601)
T ss_pred hhhhhcccH-HHHHHHhcccc---cchhhhhHHHHHHHHHHHHHH---hcCceeccCccccEEEecCCceEEeecCccee
Confidence 344999998 99998876433 788888999999999999999 99999999999999999999999999999887
Q ss_pred cccCCC----CcccccccccccCccccccCCCCC-cchhHHHHHHHHHHHhCCCCCCCCC
Q 044494 87 LNFDSS----NRTLLAGTYGYIAPELAYTMVVTE-KSDVYSFGVVALEVLMGKHPGELLS 141 (144)
Q Consensus 87 ~~~~~~----~~~~~~~~~~~~~pe~~~~~~~~~-~~d~~slg~~l~~~~~g~~p~~~~~ 141 (144)
+..+.. ......|+..|+|||.+....|++ ..|+||.|+++..|.+|+.||....
T Consensus 470 f~~~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~ 529 (601)
T KOG0590|consen 470 FRYPWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAK 529 (601)
T ss_pred eccCcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCcccccc
Confidence 653322 234467899999999999998875 4899999999999999999997644
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.81 E-value=3.5e-20 Score=121.06 Aligned_cols=135 Identities=21% Similarity=0.302 Sum_probs=112.0
Q ss_pred CceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCC---CCeEEe
Q 044494 3 RKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLE---LEAFVA 79 (144)
Q Consensus 3 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~---~~~~l~ 79 (144)
+.+-.+||+.+ |.+|+++..-.... ++..+++.++-|++.-++|+| .++++||||||+|++...+ ..+.++
T Consensus 83 ~~ynvlVMdLL-GPsLEdLfnfC~R~--ftmkTvLMLaDQml~RiEyvH---~r~fiHRDIKPdNFLMGlgrh~~kl~LI 156 (341)
T KOG1163|consen 83 KDYNVLVMDLL-GPSLEDLFNFCSRR--FTMKTVLMLADQMLSRIEYVH---LRNFIHRDIKPDNFLMGLGRHCNKLYLI 156 (341)
T ss_pred cccceeeeecc-CccHHHHHHHHhhh--hhHHhHHHHHHHHHHHHHHHH---hhccccccCCccceeeccccccceEEEE
Confidence 45567999988 89999988754432 888899999999999999999 9999999999999998755 457799
Q ss_pred eecceeecccCCC-------CcccccccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCC
Q 044494 80 DFGVARLLNFDSS-------NRTLLAGTYGYIAPELAYTMVVTEKSDVYSFGVVALEVLMGKHPGELLSSS 143 (144)
Q Consensus 80 d~~~~~~~~~~~~-------~~~~~~~~~~~~~pe~~~~~~~~~~~d~~slg~~l~~~~~g~~p~~~~~~~ 143 (144)
|||+++++-.... ......||..|.+.....+...+.+.|+-|+|.++.++--|..||+++.++
T Consensus 157 DFGLaKky~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~ 227 (341)
T KOG1163|consen 157 DFGLAKKYRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAA 227 (341)
T ss_pred eccchhhhccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchh
Confidence 9999987642211 123467899999988888777888999999999999999999999998764
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.81 E-value=3.4e-20 Score=128.28 Aligned_cols=130 Identities=30% Similarity=0.399 Sum_probs=105.2
Q ss_pred CCceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCC-CCeEEee
Q 044494 2 HRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLE-LEAFVAD 80 (144)
Q Consensus 2 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~-~~~~l~d 80 (144)
++.++.+|+||++.....++... ++...+..++..++.||+++| .+||+||||||+|++.+.. +...|+|
T Consensus 106 nnd~v~ivlp~~~H~~f~~l~~~------l~~~~i~~Yl~~ll~Al~~~h---~~GIvHRDiKpsNFL~n~~t~rg~LvD 176 (418)
T KOG1167|consen 106 NNDQVAIVLPYFEHDRFRDLYRS------LSLAEIRWYLRNLLKALAHLH---KNGIVHRDIKPSNFLYNRRTQRGVLVD 176 (418)
T ss_pred cCCeeEEEecccCccCHHHHHhc------CCHHHHHHHHHHHHHHhhhhh---ccCccccCCCccccccccccCCceEEe
Confidence 35678999999999888887764 778889999999999999999 9999999999999999865 5678999
Q ss_pred ecceeecccC-------C----C--C-------------------------------cccccccccccCccccccC-CCC
Q 044494 81 FGVARLLNFD-------S----S--N-------------------------------RTLLAGTYGYIAPELAYTM-VVT 115 (144)
Q Consensus 81 ~~~~~~~~~~-------~----~--~-------------------------------~~~~~~~~~~~~pe~~~~~-~~~ 115 (144)
||++...... . . . .-.+.||++|.|||++... ..+
T Consensus 177 FgLA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~Qt 256 (418)
T KOG1167|consen 177 FGLAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQT 256 (418)
T ss_pred chhHHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcC
Confidence 9999732100 0 0 0 0013578999999987744 467
Q ss_pred CcchhHHHHHHHHHHHhCCCCCCCC
Q 044494 116 EKSDVYSFGVVALEVLMGKHPGELL 140 (144)
Q Consensus 116 ~~~d~~slg~~l~~~~~g~~p~~~~ 140 (144)
++.|+||.|+|+..++++..||-.-
T Consensus 257 taiDiws~GVI~Lslls~~~PFf~a 281 (418)
T KOG1167|consen 257 TAIDIWSAGVILLSLLSRRYPFFKA 281 (418)
T ss_pred CccceeeccceeehhhccccccccC
Confidence 8999999999999999999998543
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.80 E-value=3e-20 Score=135.07 Aligned_cols=131 Identities=28% Similarity=0.388 Sum_probs=113.8
Q ss_pred CCceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeee
Q 044494 2 HRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADF 81 (144)
Q Consensus 2 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~ 81 (144)
.+.+++++||||-+|+|.+.-+-.+. +++.++....+..+.+++||| ++|-+|||||-.||+++..+.+++.||
T Consensus 83 r~dklwicMEycgggslQdiy~~Tgp---lselqiayvcRetl~gl~ylh---s~gk~hRdiKGanilltd~gDvklaDf 156 (829)
T KOG0576|consen 83 RRDKLWICMEYCGGGSLQDIYHVTGP---LSELQIAYVCRETLQGLKYLH---SQGKIHRDIKGANILLTDEGDVKLADF 156 (829)
T ss_pred hhcCcEEEEEecCCCcccceeeeccc---chhHHHHHHHhhhhccchhhh---cCCcccccccccceeecccCceeeccc
Confidence 46788999999999999987765444 899999999999999999999 899999999999999999999999999
Q ss_pred cceeecccCCCCcccccccccccCccccc---cCCCCCcchhHHHHHHHHHHHhCCCCCC
Q 044494 82 GVARLLNFDSSNRTLLAGTYGYIAPELAY---TMVVTEKSDVYSFGVVALEVLMGKHPGE 138 (144)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~---~~~~~~~~d~~slg~~l~~~~~g~~p~~ 138 (144)
|.+..++.-......+.|++.||+||+.. ...|...+|+|++|++..|+-.-+.|-.
T Consensus 157 gvsaqitati~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplf 216 (829)
T KOG0576|consen 157 GVSAQITATIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLF 216 (829)
T ss_pred CchhhhhhhhhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCccc
Confidence 99988876666667788999999999865 3356778999999999998877666643
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=99.80 E-value=1.3e-19 Score=136.42 Aligned_cols=118 Identities=25% Similarity=0.341 Sum_probs=96.0
Q ss_pred CceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeeec
Q 044494 3 RKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADFG 82 (144)
Q Consensus 3 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~~ 82 (144)
...+|+||||+.+++|.+++..... +++..++.++.|++.||.||| ..+++||||||+||+++.++.++|+|||
T Consensus 76 ~~~~~lVmEy~~g~~L~~li~~~~~---l~~~~~~~i~~qil~aL~yLH---~~gIiHrDLKP~NILl~~~g~vkL~DFG 149 (669)
T cd05610 76 ANNVYLVMEYLIGGDVKSLLHIYGY---FDEEMAVKYISEVALALDYLH---RHGIIHRDLKPDNMLISNEGHIKLTDFG 149 (669)
T ss_pred CCEEEEEEeCCCCCCHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHH---hCCEEeCCccHHHEEEcCCCCEEEEeCC
Confidence 4578999999999999999875433 888999999999999999999 8899999999999999999999999999
Q ss_pred ceeecccCCCCcccccccccccCccccccCCC-CCcchhHHHHHH
Q 044494 83 VARLLNFDSSNRTLLAGTYGYIAPELAYTMVV-TEKSDVYSFGVV 126 (144)
Q Consensus 83 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~-~~~~d~~slg~~ 126 (144)
+++.............+++.|.+||....... ...+++|++|.-
T Consensus 150 ls~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~s~~~s~g~~ 194 (669)
T cd05610 150 LSKVTLNRELNMMDILTTPSMAKPKNDYSRTPGQVLSLISSLGFN 194 (669)
T ss_pred CCccccCCcccccccccCccccCccccccCCCCceeeeeeecCcC
Confidence 99865433333344568889999987655432 335677777743
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.80 E-value=2.5e-19 Score=121.64 Aligned_cols=133 Identities=21% Similarity=0.280 Sum_probs=112.2
Q ss_pred eEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCC-----CCeEEe
Q 044494 5 CMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLE-----LEAFVA 79 (144)
Q Consensus 5 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~-----~~~~l~ 79 (144)
+..||+|.+ |.+|+|+..-.+. .++..+++.++.|++.-++++| ++.++.|||||+|+++... ..+.++
T Consensus 98 ~NiLVidLL-GPSLEDLFD~CgR--~FSvKTV~miA~Qmi~rie~vH---~k~LIYRDIKPdNFLIGrp~~k~~n~Ihii 171 (449)
T KOG1165|consen 98 YNILVIDLL-GPSLEDLFDLCGR--RFSVKTVAMIAKQMITRIEYVH---EKDLIYRDIKPDNFLIGRPGTKDANVIHII 171 (449)
T ss_pred hhhhhhhhh-CcCHHHHHHHhcC--cccHHhHHHHHHHHHHHHHHHH---hcceeecccCccceeecCCCCCCCceEEEE
Confidence 446899987 8899998865433 3899999999999999999999 9999999999999999643 347899
Q ss_pred eecceeecccCCCC-------cccccccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCC
Q 044494 80 DFGVARLLNFDSSN-------RTLLAGTYGYIAPELAYTMVVTEKSDVYSFGVVALEVLMGKHPGELLSSS 143 (144)
Q Consensus 80 d~~~~~~~~~~~~~-------~~~~~~~~~~~~pe~~~~~~~~~~~d~~slg~~l~~~~~g~~p~~~~~~~ 143 (144)
|||+++.+..+... +....||..||+.-...+...+.+.|+-|+|.++.+.+-|+.||+++...
T Consensus 172 DFGmAK~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~ 242 (449)
T KOG1165|consen 172 DFGMAKEYRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAD 242 (449)
T ss_pred eccchhhhcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCc
Confidence 99999977533221 23467999999999999999999999999999999999999999998653
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.79 E-value=4.5e-18 Score=116.73 Aligned_cols=135 Identities=34% Similarity=0.486 Sum_probs=112.8
Q ss_pred ceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCC-CeEEeeec
Q 044494 4 KCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLEL-EAFVADFG 82 (144)
Q Consensus 4 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~-~~~l~d~~ 82 (144)
+..+++++++.++++.+++........+.......+..|++.+++++| +.+++|||+||+|++++..+ .++++|||
T Consensus 71 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H---~~~~~hrd~kp~nil~~~~~~~~~l~dfg 147 (384)
T COG0515 71 GSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLH---SKGIIHRDIKPENILLDRDGRVVKLIDFG 147 (384)
T ss_pred CEEEEEEecCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHeeecCCCCeEEEeccC
Confidence 346899999999999976664321124889999999999999999999 88999999999999999988 69999999
Q ss_pred ceeecccCCC------CcccccccccccCcccccc---CCCCCcchhHHHHHHHHHHHhCCCCCCCCC
Q 044494 83 VARLLNFDSS------NRTLLAGTYGYIAPELAYT---MVVTEKSDVYSFGVVALEVLMGKHPGELLS 141 (144)
Q Consensus 83 ~~~~~~~~~~------~~~~~~~~~~~~~pe~~~~---~~~~~~~d~~slg~~l~~~~~g~~p~~~~~ 141 (144)
.+........ ......++..|++||.... .......|+|++|++++++++|..||....
T Consensus 148 ~~~~~~~~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~ 215 (384)
T COG0515 148 LAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEK 215 (384)
T ss_pred cceecCCCCccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCC
Confidence 9885543321 2355678999999999987 467788999999999999999999977654
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.77 E-value=1.1e-19 Score=129.07 Aligned_cols=123 Identities=25% Similarity=0.408 Sum_probs=106.5
Q ss_pred ceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeeecc
Q 044494 4 KCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADFGV 83 (144)
Q Consensus 4 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~~~ 83 (144)
.++|+.|++|...+|.+++.........+....+.+..|+..+++| ++.+|+|+||.||+...+..++|.|||+
T Consensus 329 ~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y------k~~ihrdlkp~nif~~~d~q~kIgDFgl 402 (516)
T KOG1033|consen 329 VYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY------KGLIHRDLKPSNIFFSDDDQLKIGDFGL 402 (516)
T ss_pred cchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh------ccchhhhccccccccccchhhhhhhhhh
Confidence 4689999999999999999765555557788888999999999987 5899999999999999999999999999
Q ss_pred eeecccCC------CCcccccccccccCccccccCCCCCcchhHHHHHHHHHHHh
Q 044494 84 ARLLNFDS------SNRTLLAGTYGYIAPELAYTMVVTEKSDVYSFGVVALEVLM 132 (144)
Q Consensus 84 ~~~~~~~~------~~~~~~~~~~~~~~pe~~~~~~~~~~~d~~slg~~l~~~~~ 132 (144)
........ .......++..||+||.+.+..|+.++||||||++++|++.
T Consensus 403 ~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~ 457 (516)
T KOG1033|consen 403 VTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLI 457 (516)
T ss_pred eeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHH
Confidence 98765322 12334679999999999999999999999999999999987
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.72 E-value=1.5e-18 Score=125.49 Aligned_cols=125 Identities=32% Similarity=0.436 Sum_probs=106.7
Q ss_pred CceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeeec
Q 044494 3 RKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADFG 82 (144)
Q Consensus 3 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~~ 82 (144)
+.+.+++.++..+|.+...+..... +.+.....+...++-++..+| +.+++++|+|++||+++.+|++++.|||
T Consensus 69 ~~kl~l~ld~~rgg~lft~l~~~~~---f~~~~~~~~~aelaLald~lh---~l~iiyrd~k~enilld~~Ghi~~tdfg 142 (612)
T KOG0603|consen 69 DGKLYLILDFLRGGDLFTRLSKEVM---FDELDVAFYLAELALALDHLH---KLGIAYRDYKLENVLLLLEGHIKLTDFG 142 (612)
T ss_pred ccchhHhhhhcccchhhhccccCCc---hHHHHHHHHHHHHHHHHhhcc---hhHHHHhcccccceeecccCccccCCch
Confidence 4567889999999999877765443 777778888899999999999 9999999999999999999999999999
Q ss_pred ceeecccCCCCcccccccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCC
Q 044494 83 VARLLNFDSSNRTLLAGTYGYIAPELAYTMVVTEKSDVYSFGVVALEVLMGKHPGEL 139 (144)
Q Consensus 83 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~d~~slg~~l~~~~~g~~p~~~ 139 (144)
+.+..-... ..+|+..||+||+++ .....+|.||+|++.+++++|..||..
T Consensus 143 lske~v~~~----~~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~ 193 (612)
T KOG0603|consen 143 LSKEAVKEK----IACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG 193 (612)
T ss_pred hhhHhHhhh----hcccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch
Confidence 987643211 127899999999998 455678999999999999999999976
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.72 E-value=6.7e-18 Score=114.51 Aligned_cols=131 Identities=23% Similarity=0.317 Sum_probs=88.8
Q ss_pred eEEEEEeeccCCCHHHHhhc---ccc-cCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEee
Q 044494 5 CMFLIYEYMEMGSLFCVLRT---DEE-AVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVAD 80 (144)
Q Consensus 5 ~~~lv~e~~~~~~L~~~l~~---~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d 80 (144)
+.+++|+-+. ++|.+++.. ... ...+.......+..|+++.+.+|| ..|++|+||+|+|++++.+|.+.++|
T Consensus 113 n~~~l~P~~~-~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh---~~GlVHgdi~~~nfll~~~G~v~Lg~ 188 (288)
T PF14531_consen 113 NRFLLMPRAQ-GDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLH---SYGLVHGDIKPENFLLDQDGGVFLGD 188 (288)
T ss_dssp SEEEEEE--S-EEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHH---HTTEEEST-SGGGEEE-TTS-EEE--
T ss_pred hhhhccchhh-hcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHh---hcceEecccceeeEEEcCCCCEEEcC
Confidence 3478888885 588887642 111 111333344555689999999999 89999999999999999999999999
Q ss_pred ecceeecccCCCCcccccccccccCccccccC--------CCCCcchhHHHHHHHHHHHhCCCCCCCCCC
Q 044494 81 FGVARLLNFDSSNRTLLAGTYGYIAPELAYTM--------VVTEKSDVYSFGVVALEVLMGKHPGELLSS 142 (144)
Q Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~--------~~~~~~d~~slg~~l~~~~~g~~p~~~~~~ 142 (144)
|+.....+..... ...+..|.+||..... .++.+.|.|++|+++|.+.++..||...++
T Consensus 189 F~~~~r~g~~~~~---~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~lPf~~~~~ 255 (288)
T PF14531_consen 189 FSSLVRAGTRYRC---SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCGRLPFGLSSP 255 (288)
T ss_dssp GGGEEETTEEEEG---GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS-STCCCGG
T ss_pred hHHHeecCceeec---cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHccCCCCCCCc
Confidence 9988765532111 2344678899876542 467789999999999999999999987654
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.69 E-value=2.9e-16 Score=109.38 Aligned_cols=130 Identities=28% Similarity=0.371 Sum_probs=98.7
Q ss_pred CCceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCC----CeE
Q 044494 2 HRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLEL----EAF 77 (144)
Q Consensus 2 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~----~~~ 77 (144)
+++.+|+||..++. +|.+++-.+. .+.....-++.|+++++.+|| .+|+.|||+|++||++.-+. ...
T Consensus 314 ~~~tlylvMkrY~~-tLr~yl~~~~----~s~r~~~~~laQlLEav~hL~---~hgvAhRDlKSDNiL~ElddD~~P~LV 385 (598)
T KOG4158|consen 314 EPKTLYLVMKRYRQ-TLREYLWTRH----RSYRTGRVILAQLLEAVTHLH---KHGVAHRDLKSDNILLELDDDEIPQLV 385 (598)
T ss_pred CCceEEEehhcchh-hHHHHHhcCC----CchHHHHHHHHHHHHHHHHHH---HccchhhcccccceEEEecCCCCcEEE
Confidence 56789999999976 9999987543 566777778999999999999 99999999999999996442 356
Q ss_pred EeeecceeecccCCCC------cccccccccccCccccccCC------CCCcchhHHHHHHHHHHHhCCCCCCC
Q 044494 78 VADFGVARLLNFDSSN------RTLLAGTYGYIAPELAYTMV------VTEKSDVYSFGVVALEVLMGKHPGEL 139 (144)
Q Consensus 78 l~d~~~~~~~~~~~~~------~~~~~~~~~~~~pe~~~~~~------~~~~~d~~slg~~l~~~~~g~~p~~~ 139 (144)
++|||-+---....-. .....|.-.-||||+....+ .-.|+|.|+.|.+.||++....||=.
T Consensus 386 vaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~ 459 (598)
T KOG4158|consen 386 VADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYK 459 (598)
T ss_pred EcccceeeeccccccccccccccccCCCcceecchhhhhcCCCCceeeccchhhhhhhhhhHHHHhccCCcccc
Confidence 8899855322111111 11234666789999887543 12479999999999999999999854
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.68 E-value=1.8e-16 Score=121.08 Aligned_cols=126 Identities=21% Similarity=0.220 Sum_probs=106.5
Q ss_pred ceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcC-------CCCe
Q 044494 4 KCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNL-------ELEA 76 (144)
Q Consensus 4 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~-------~~~~ 76 (144)
+.-++|+||.+.|+|.+++. .....++.-...++.|++..++.|| ..+|+|+||||+|+++.. ...+
T Consensus 767 ~~S~lv~ey~~~Gtlld~~N---~~~~m~e~lv~~~~~qml~ive~lH---~~~IIHgDiKPDNfll~~~~~~~~~~~~l 840 (974)
T KOG1166|consen 767 NASVLVSEYSPYGTLLDLIN---TNKVMDEYLVMFFSCQMLRIVEHLH---AMGIIHGDIKPDNFLLRREICADSDSKGL 840 (974)
T ss_pred CcceeeeeccccccHHHhhc---cCCCCCchhhhHHHHHHHHHHHHHH---hcceecccCCcceeEeecccCCCCcccce
Confidence 44578999999999999998 3344888999999999999999999 899999999999999954 2458
Q ss_pred EEeeecceeecccC--CCCcccccccccccCccccccCCCCCcchhHHHHHHHHHHHhCCC
Q 044494 77 FVADFGVARLLNFD--SSNRTLLAGTYGYIAPELAYTMVVTEKSDVYSFGVVALEVLMGKH 135 (144)
Q Consensus 77 ~l~d~~~~~~~~~~--~~~~~~~~~~~~~~~pe~~~~~~~~~~~d~~slg~~l~~~~~g~~ 135 (144)
+|+|||.+.++..- .........+-.+-++|...+..|++..|.|.++.+++.|+.|++
T Consensus 841 ~lIDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y 901 (974)
T KOG1166|consen 841 YLIDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKY 901 (974)
T ss_pred EEEecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHH
Confidence 89999999877532 223344566778889999999999999999999999999999874
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.67 E-value=2.3e-16 Score=102.59 Aligned_cols=121 Identities=13% Similarity=0.077 Sum_probs=88.4
Q ss_pred eEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCC-CCCcEEEcCCCCeEEeeecc
Q 044494 5 CMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDI-SSNNILLNLELEAFVADFGV 83 (144)
Q Consensus 5 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i-~~~ni~~~~~~~~~l~d~~~ 83 (144)
..+++|||+.|.+|.+.... . ...+..+++.+++++| +.|++|+|+ ||.||+++.++.++|+|||+
T Consensus 72 ~~~lvmeyI~G~~L~~~~~~---------~-~~~~~~qi~~~L~~lH---~~GIvHrDL~kp~NILv~~~g~i~LIDFG~ 138 (218)
T PRK12274 72 GRHLDRSYLAGAAMYQRPPR---------G-DLAYFRAARRLLQQLH---RCGVAHNDLAKEANWLVQEDGSPAVIDFQL 138 (218)
T ss_pred CEEEEEeeecCccHHhhhhh---------h-hHHHHHHHHHHHHHHH---HCcCccCCCCCcceEEEcCCCCEEEEECCC
Confidence 45899999999888653321 1 1346788999999999 999999999 79999999999999999999
Q ss_pred eeecccCCCC-------------cccccccccccCccccccC-CCC-CcchhHHHHHHHHHHHhCCCCCC
Q 044494 84 ARLLNFDSSN-------------RTLLAGTYGYIAPELAYTM-VVT-EKSDVYSFGVVALEVLMGKHPGE 138 (144)
Q Consensus 84 ~~~~~~~~~~-------------~~~~~~~~~~~~pe~~~~~-~~~-~~~d~~slg~~l~~~~~g~~p~~ 138 (144)
+......... ......++.++.|+--.-. ..+ ...+.++.|.-+|.++|+..|.-
T Consensus 139 A~~~~~~~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~ 208 (218)
T PRK12274 139 AVRGNPRARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHW 208 (218)
T ss_pred ceecCCcchHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCcc
Confidence 9865433321 0112356677777644322 122 45678899999999999887653
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.67 E-value=2.3e-16 Score=102.18 Aligned_cols=75 Identities=17% Similarity=0.222 Sum_probs=62.9
Q ss_pred EEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHH-hcCCCCCeEecCCCCCcEEEcCCCCeEEeeecce
Q 044494 6 MFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYL-HHDCTPPIVHRDISSNNILLNLELEAFVADFGVA 84 (144)
Q Consensus 6 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~l-h~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~~~~ 84 (144)
.++||||++++++........ .++...+..++.|++.++.++ | +.|++|||+||.||+++ ++.++++|||++
T Consensus 92 ~~iVmE~i~g~~l~~~~~~~~---~~~~~~~~~i~~qi~~~L~~l~H---~~giiHrDlkP~NIli~-~~~v~LiDFG~a 164 (190)
T cd05147 92 HVLVMEFIGDDGWAAPRLKDA---PLSESKARELYLQVIQIMRILYQ---DCRLVHADLSEYNLLYH-DGKLYIIDVSQS 164 (190)
T ss_pred CEEEEEEeCCCCCcchhhhcC---CCCHHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEEE-CCcEEEEEcccc
Confidence 389999999877655432222 388899999999999999999 6 78999999999999998 478999999998
Q ss_pred eec
Q 044494 85 RLL 87 (144)
Q Consensus 85 ~~~ 87 (144)
...
T Consensus 165 ~~~ 167 (190)
T cd05147 165 VEH 167 (190)
T ss_pred ccC
Confidence 754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.67 E-value=3.4e-16 Score=109.98 Aligned_cols=96 Identities=23% Similarity=0.176 Sum_probs=73.2
Q ss_pred ceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCC-CCCcEEEcCCCCeEEeeec
Q 044494 4 KCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDI-SSNNILLNLELEAFVADFG 82 (144)
Q Consensus 4 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i-~~~ni~~~~~~~~~l~d~~ 82 (144)
+..|+||||++|++|.. ... .. ...++.+++.++.+|| +.|++|||| ||+||+++.++.++|+|||
T Consensus 91 ~~~~LVmE~~~G~~L~~-~~~------~~---~~~~~~~i~~aL~~lH---~~gIiHrDL~KP~NILv~~~~~ikLiDFG 157 (365)
T PRK09188 91 GKDGLVRGWTEGVPLHL-ARP------HG---DPAWFRSAHRALRDLH---RAGITHNDLAKPQNWLMGPDGEAAVIDFQ 157 (365)
T ss_pred CCcEEEEEccCCCCHHH-hCc------cc---hHHHHHHHHHHHHHHH---HCCCeeCCCCCcceEEEcCCCCEEEEECc
Confidence 45799999999999963 211 11 1356789999999999 899999999 9999999999999999999
Q ss_pred ceeecccCCCCc--------ccccccccccCccccccC
Q 044494 83 VARLLNFDSSNR--------TLLAGTYGYIAPELAYTM 112 (144)
Q Consensus 83 ~~~~~~~~~~~~--------~~~~~~~~~~~pe~~~~~ 112 (144)
+++......... ....+++.|.+||.+...
T Consensus 158 lA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~ 195 (365)
T PRK09188 158 LASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPR 195 (365)
T ss_pred cceecccCcchhhhhhhhhhhhhhccCccCCcccCChh
Confidence 998765322111 234567778899987643
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.66 E-value=8.2e-17 Score=106.29 Aligned_cols=101 Identities=14% Similarity=0.146 Sum_probs=74.7
Q ss_pred ceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeeecc
Q 044494 4 KCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADFGV 83 (144)
Q Consensus 4 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~~~ 83 (144)
+..+++|||++|.+|.+... +++. ...+++.++..+| +.|++|+|++|.|++++.++ ++++|||.
T Consensus 116 ~~~~lvmEyi~G~tL~~~~~-------~~~~----~~~~i~~~l~~lH---~~gi~H~Dikp~Nili~~~g-i~liDfg~ 180 (232)
T PRK10359 116 HTYIMLIEYIEGVELNDMPE-------ISED----VKAKIKASIESLH---QHGMVSGDPHKGNFIVSKNG-LRIIDLSG 180 (232)
T ss_pred CCeEEEEEEECCccHHHhhh-------ccHH----HHHHHHHHHHHHH---HcCCccCCCChHHEEEeCCC-EEEEECCC
Confidence 46789999999999977632 3332 3568999999999 99999999999999999988 99999997
Q ss_pred eeecccCCCCcccccccccccCccccccCCCCCcchhHHHHHHHHHHH
Q 044494 84 ARLLNFDSSNRTLLAGTYGYIAPELAYTMVVTEKSDVYSFGVVALEVL 131 (144)
Q Consensus 84 ~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~d~~slg~~l~~~~ 131 (144)
........ ... .++....+..++|+|++|+++....
T Consensus 181 ~~~~~e~~-a~d-----------~~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 181 KRCTAQRK-AKD-----------RIDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred cccccchh-hHH-----------HHHHHhHhcccccccceeEeehHHH
Confidence 76432111 111 1223334556899999999876543
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.65 E-value=6.8e-16 Score=100.07 Aligned_cols=76 Identities=20% Similarity=0.251 Sum_probs=63.2
Q ss_pred EEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCC-CCeEecCCCCCcEEEcCCCCeEEeeecce
Q 044494 6 MFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCT-PPIVHRDISSNNILLNLELEAFVADFGVA 84 (144)
Q Consensus 6 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~-~~~~h~~i~~~ni~~~~~~~~~l~d~~~~ 84 (144)
.|+||||++|+++........ .++......++.+++.++.++| . .|++|+|+||.||+++ ++.++++|||++
T Consensus 92 ~~lVmE~~~g~~~~~~~l~~~---~~~~~~~~~i~~~l~~~l~~lH---~~~givHrDlkP~NIll~-~~~~~liDFG~a 164 (190)
T cd05145 92 NVLVMEFIGDDGSPAPRLKDV---PLEEEEAEELYEQVVEQMRRLY---QEAGLVHGDLSEYNILYH-DGKPYIIDVSQA 164 (190)
T ss_pred CEEEEEEecCCCchhhhhhhc---cCCHHHHHHHHHHHHHHHHHHH---HhCCEecCCCChhhEEEE-CCCEEEEEcccc
Confidence 389999999875544322222 2678888999999999999999 7 8999999999999999 889999999999
Q ss_pred eecc
Q 044494 85 RLLN 88 (144)
Q Consensus 85 ~~~~ 88 (144)
....
T Consensus 165 ~~~~ 168 (190)
T cd05145 165 VELD 168 (190)
T ss_pred eecC
Confidence 7654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.65 E-value=5.9e-17 Score=123.64 Aligned_cols=128 Identities=26% Similarity=0.319 Sum_probs=98.2
Q ss_pred eEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeeecce
Q 044494 5 CMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADFGVA 84 (144)
Q Consensus 5 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~~~~ 84 (144)
.-|+|-+|... +|+|.+..+.- +..-+.+-++.|++.|++.+| ..|++|+|||.+||+++.=.++.+.||...
T Consensus 95 AAylvRqyvkh-nLyDRlSTRPF---L~~iEKkWiaFQLL~al~qcH---~~gVcHGDIKsENILiTSWNW~~LtDFAsF 167 (1431)
T KOG1240|consen 95 AAYLVRQYVKH-NLYDRLSTRPF---LVLIEKKWIAFQLLKALSQCH---KLGVCHGDIKSENILITSWNWLYLTDFASF 167 (1431)
T ss_pred HHHHHHHHHhh-hhhhhhccchH---HHHHHHHHHHHHHHHHHHHHH---HcCccccccccceEEEeeechhhhhccccc
Confidence 34677778864 99998875432 667777778899999999999 999999999999999999999999999877
Q ss_pred eecccCC--CCc-----ccccccccccCccccccCC-----------CCCcchhHHHHHHHHHHHh-CCCCCCC
Q 044494 85 RLLNFDS--SNR-----TLLAGTYGYIAPELAYTMV-----------VTEKSDVYSFGVVALEVLM-GKHPGEL 139 (144)
Q Consensus 85 ~~~~~~~--~~~-----~~~~~~~~~~~pe~~~~~~-----------~~~~~d~~slg~~l~~~~~-g~~p~~~ 139 (144)
+....+. ... .+...-..|+|||.+.... .+++=||||+||++.|+++ |++||+.
T Consensus 168 KPtYLPeDNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~L 241 (1431)
T KOG1240|consen 168 KPTYLPEDNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTL 241 (1431)
T ss_pred CCccCCCCCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccH
Confidence 6442211 111 1222334789999877421 4567899999999999986 8999964
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.63 E-value=9.2e-16 Score=102.40 Aligned_cols=130 Identities=23% Similarity=0.350 Sum_probs=102.7
Q ss_pred ceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEe--ee
Q 044494 4 KCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVA--DF 81 (144)
Q Consensus 4 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~--d~ 81 (144)
.++.++..|++.|+|+..++.+. ...++..+++.++.+++.|+.|||.. +.-+.--.+++.+++++.+...++. |-
T Consensus 260 pnlv~isq~mp~gslynvlhe~t-~vvvd~sqav~faldiargmaflhsl-ep~ipr~~lns~hvmidedltarismad~ 337 (448)
T KOG0195|consen 260 PNLVIISQYMPFGSLYNVLHEQT-SVVVDHSQAVRFALDIARGMAFLHSL-EPMIPRFYLNSKHVMIDEDLTARISMADT 337 (448)
T ss_pred CCceEeeeeccchHHHHHHhcCc-cEEEecchHHHHHHHHHhhHHHHhhc-chhhhhhhcccceEEecchhhhheecccc
Confidence 35688999999999999998743 34578888999999999999999955 4446666788999999988766553 42
Q ss_pred cceeecccCCCCcccccccccccCccccccCCCC---CcchhHHHHHHHHHHHhCCCCCCCCCC
Q 044494 82 GVARLLNFDSSNRTLLAGTYGYIAPELAYTMVVT---EKSDVYSFGVVALEVLMGKHPGELLSS 142 (144)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~---~~~d~~slg~~l~~~~~g~~p~~~~~~ 142 (144)
.++ .........|.|++||.++..+.+ ..+|+|||++++||+.|...||..+++
T Consensus 338 kfs-------fqe~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlsp 394 (448)
T KOG0195|consen 338 KFS-------FQEVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSP 394 (448)
T ss_pred eee-------eeccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCc
Confidence 221 112335578999999999877643 468999999999999999999998875
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.60 E-value=6.6e-16 Score=117.53 Aligned_cols=97 Identities=29% Similarity=0.403 Sum_probs=83.1
Q ss_pred HHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeeecceeecccC---------------CCCcccccccccccCc
Q 044494 42 GMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADFGVARLLNFD---------------SSNRTLLAGTYGYIAP 106 (144)
Q Consensus 42 ~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~---------------~~~~~~~~~~~~~~~p 106 (144)
+++.+++|+| .-|++|||+||+|.++..-|++|+.|||+.+..-.. .......+++|.|.||
T Consensus 151 dmvla~Eylh---~ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaP 227 (1205)
T KOG0606|consen 151 DMVLAVEYLH---SYGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATNLKEGHIEKDTHEFQDKQVCGTPEYIAP 227 (1205)
T ss_pred hhhHHhHhhc---cCCeecCCCCCCcceeeecccccccchhhhhhhhhhccchhhhcchHHHHHHhhhccccCCccccCh
Confidence 3467899999 899999999999999999999999999988754210 1112235799999999
Q ss_pred cccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCC
Q 044494 107 ELAYTMVVTEKSDVYSFGVVALEVLMGKHPGELLS 141 (144)
Q Consensus 107 e~~~~~~~~~~~d~~slg~~l~~~~~g~~p~~~~~ 141 (144)
|++..++|...+|.|++|+|+||.+-|..||.+..
T Consensus 228 eVilrqgygkpvdwwamGiIlyeFLVgcvpffGdt 262 (1205)
T KOG0606|consen 228 EVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDT 262 (1205)
T ss_pred hhhhhhccCCCccHHHHHHHHHHHheeeeeccCCC
Confidence 99999999999999999999999999999998763
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.55 E-value=3.4e-14 Score=102.31 Aligned_cols=135 Identities=30% Similarity=0.511 Sum_probs=108.2
Q ss_pred CCceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeee
Q 044494 2 HRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADF 81 (144)
Q Consensus 2 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~ 81 (144)
+...++.|.+||.-|+|.+.+.. ....+++.....++++++.|+.|+|.+ ....|+.+++.|.+++..-.+|+.||
T Consensus 18 ~~~~~~~i~~~c~rGsl~D~i~~--~~~~~d~~F~~s~~rdi~~Gl~ylh~s--~i~~hg~l~s~nClvd~~w~lklt~~ 93 (484)
T KOG1023|consen 18 DGPEMIVIWEYCSRGSLLDILSN--EDIKLDYFFILSFIRDISKGLAYLHNS--PIGYHGALKSSNCLVDSRWVLKLTDF 93 (484)
T ss_pred cCCceEEEEeeecCccHHhHHhc--cccCccHHHHHHHHHHHHHHHHHHhcC--cceeeeeeccccceeeeeEEEEechh
Confidence 45678899999999999999985 234488888999999999999999953 23399999999999999999999999
Q ss_pred cceeeccc--CCCCcccccccccccCccccccCC-------CCCcchhHHHHHHHHHHHhCCCCCCCC
Q 044494 82 GVARLLNF--DSSNRTLLAGTYGYIAPELAYTMV-------VTEKSDVYSFGVVALEVLMGKHPGELL 140 (144)
Q Consensus 82 ~~~~~~~~--~~~~~~~~~~~~~~~~pe~~~~~~-------~~~~~d~~slg~~l~~~~~g~~p~~~~ 140 (144)
|+...... .............|.+||.+.... .+.+.|+||+|++++|+++.+.||...
T Consensus 94 Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~~~~~ 161 (484)
T KOG1023|consen 94 GLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGPFDLR 161 (484)
T ss_pred hhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCccccc
Confidence 98876532 112222233455789999988641 356799999999999999999999763
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.54 E-value=1.9e-14 Score=96.18 Aligned_cols=77 Identities=18% Similarity=0.228 Sum_probs=63.8
Q ss_pred eEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCC-eEecCCCCCcEEEcCCCCeEEeeecc
Q 044494 5 CMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPP-IVHRDISSNNILLNLELEAFVADFGV 83 (144)
Q Consensus 5 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~-~~h~~i~~~ni~~~~~~~~~l~d~~~ 83 (144)
..++||||++|+++........ .........++.|++.++.+|| ..| ++|+|+||.||+++ ++.++++|||.
T Consensus 122 ~~~lV~E~~~g~~L~~~~~~~~---~~~~~~~~~i~~qi~~~l~~LH---~~g~iiH~Dikp~NIli~-~~~i~LiDFg~ 194 (237)
T smart00090 122 RNVLVMEFIGGDGLPAPRLKDV---EPEEEEEFELYDDILEEMRKLY---KEGELVHGDLSEYNILVH-DGKVVIIDVSQ 194 (237)
T ss_pred CceEEEEEecCCcccccccccC---CcchHHHHHHHHHHHHHHHHHH---hcCCEEeCCCChhhEEEE-CCCEEEEEChh
Confidence 4589999999988876543222 2556667889999999999999 889 99999999999999 88899999998
Q ss_pred eeecc
Q 044494 84 ARLLN 88 (144)
Q Consensus 84 ~~~~~ 88 (144)
+....
T Consensus 195 a~~~~ 199 (237)
T smart00090 195 SVELD 199 (237)
T ss_pred hhccC
Confidence 87544
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.43 E-value=6.4e-13 Score=87.28 Aligned_cols=73 Identities=21% Similarity=0.499 Sum_probs=63.4
Q ss_pred CceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeeec
Q 044494 3 RKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADFG 82 (144)
Q Consensus 3 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~~ 82 (144)
.+..+++|||++|++|.+.+.... . ....++.+++.++.++| +.+++|+|++|.||+++ ++.++++|||
T Consensus 71 ~~~~~lv~e~~~G~~L~~~~~~~~------~-~~~~i~~~i~~~l~~lH---~~~i~H~Dl~p~Nil~~-~~~~~liDf~ 139 (211)
T PRK14879 71 PENFIIVMEYIEGEPLKDLINSNG------M-EELELSREIGRLVGKLH---SAGIIHGDLTTSNMILS-GGKIYLIDFG 139 (211)
T ss_pred CCCCEEEEEEeCCcCHHHHHHhcc------H-HHHHHHHHHHHHHHHHH---hCCcccCCCCcccEEEE-CCCEEEEECC
Confidence 456789999999999999886421 1 67788999999999999 89999999999999999 7889999999
Q ss_pred ceee
Q 044494 83 VARL 86 (144)
Q Consensus 83 ~~~~ 86 (144)
.+..
T Consensus 140 ~a~~ 143 (211)
T PRK14879 140 LAEF 143 (211)
T ss_pred cccC
Confidence 8865
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.43 E-value=5.1e-13 Score=87.13 Aligned_cols=73 Identities=16% Similarity=0.243 Sum_probs=61.0
Q ss_pred ceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeeecc
Q 044494 4 KCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADFGV 83 (144)
Q Consensus 4 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~~~ 83 (144)
...++||||++|++|...... .....++.+++.++.++| ..+++|+|++|.||+++.++.++++|||.
T Consensus 104 ~~~~lv~e~~~g~~L~~~~~~---------~~~~~~~~~i~~~l~~lh---~~gi~H~Dl~p~Nill~~~~~~~liDfg~ 171 (198)
T cd05144 104 NRHAVVMEYIDGVELYRVRVL---------EDPEEVLDEILEEIVKAY---KHGIIHGDLSEFNILVDDDEKIYIIDWPQ 171 (198)
T ss_pred CCceEEEEEeCCcchhhcccc---------ccHHHHHHHHHHHHHHHH---HCCCCcCCCCcccEEEcCCCcEEEEECCc
Confidence 456899999999988764321 234567889999999999 89999999999999999999999999998
Q ss_pred eeecc
Q 044494 84 ARLLN 88 (144)
Q Consensus 84 ~~~~~ 88 (144)
+....
T Consensus 172 ~~~~~ 176 (198)
T cd05144 172 MVSTD 176 (198)
T ss_pred cccCC
Confidence 86543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.42 E-value=6e-13 Score=86.69 Aligned_cols=71 Identities=23% Similarity=0.480 Sum_probs=60.7
Q ss_pred CceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeeec
Q 044494 3 RKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADFG 82 (144)
Q Consensus 3 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~~ 82 (144)
.+..++||||++|++|.+.+..... .++.+++.++.++| +.+++|+|++|.|++++ ++.++++|||
T Consensus 69 ~~~~~lv~e~~~g~~l~~~~~~~~~----------~~~~~i~~~l~~lH---~~gi~H~Dl~~~Nil~~-~~~~~liDfg 134 (199)
T TIGR03724 69 PDNKTIVMEYIEGKPLKDVIEEGND----------ELLREIGRLVGKLH---KAGIVHGDLTTSNIIVR-DDKLYLIDFG 134 (199)
T ss_pred CCCCEEEEEEECCccHHHHHhhcHH----------HHHHHHHHHHHHHH---HCCeecCCCCcceEEEE-CCcEEEEECC
Confidence 3456899999999999987754211 67889999999999 89999999999999999 8899999999
Q ss_pred ceeec
Q 044494 83 VARLL 87 (144)
Q Consensus 83 ~~~~~ 87 (144)
.+...
T Consensus 135 ~a~~~ 139 (199)
T TIGR03724 135 LGKYS 139 (199)
T ss_pred CCcCC
Confidence 88653
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.40 E-value=1.5e-12 Score=87.23 Aligned_cols=71 Identities=21% Similarity=0.341 Sum_probs=59.2
Q ss_pred EEEEeeccC-CCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeeeccee
Q 044494 7 FLIYEYMEM-GSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADFGVAR 85 (144)
Q Consensus 7 ~lv~e~~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~~~~~ 85 (144)
++|||+++| .+|.+++... .+++. .+.+++.++.+|| +.|++|+|+||.||+++.++.++++|||.+.
T Consensus 122 ~lV~e~l~G~~~L~~~l~~~----~l~~~----~~~~i~~~l~~lH---~~GI~HrDlkp~NILv~~~~~v~LIDfg~~~ 190 (239)
T PRK01723 122 DILIERIEGARDLVALLQEA----PLSEE----QWQAIGQLIARFH---DAGVYHADLNAHNILLDPDGKFWLIDFDRGE 190 (239)
T ss_pred eEEEEecCCCCCHHHHHhcC----CCCHH----HHHHHHHHHHHHH---HCCCCCCCCCchhEEEcCCCCEEEEECCCcc
Confidence 599999997 6888887642 14443 3568999999999 9999999999999999998899999999887
Q ss_pred ecc
Q 044494 86 LLN 88 (144)
Q Consensus 86 ~~~ 88 (144)
...
T Consensus 191 ~~~ 193 (239)
T PRK01723 191 LRT 193 (239)
T ss_pred cCC
Confidence 543
|
|
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.38 E-value=1.2e-12 Score=96.96 Aligned_cols=70 Identities=23% Similarity=0.417 Sum_probs=60.9
Q ss_pred CceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeeec
Q 044494 3 RKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADFG 82 (144)
Q Consensus 3 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~~ 82 (144)
.+..++||||+++++|.+++. ....++.+++.++.+|| +.+++|||+||.||++ .++.++++|||
T Consensus 408 ~~~~~lv~E~~~g~~L~~~l~-----------~~~~~~~~i~~~L~~lH---~~giiHrDlkp~NILl-~~~~~~liDFG 472 (535)
T PRK09605 408 PEEKTIVMEYIGGKDLKDVLE-----------GNPELVRKVGEIVAKLH---KAGIVHGDLTTSNFIV-RDDRLYLIDFG 472 (535)
T ss_pred CCCCEEEEEecCCCcHHHHHH-----------HHHHHHHHHHHHHHHHH---hCCCccCCCChHHEEE-ECCcEEEEeCc
Confidence 345789999999999998775 23567889999999999 8999999999999999 57789999999
Q ss_pred ceeec
Q 044494 83 VARLL 87 (144)
Q Consensus 83 ~~~~~ 87 (144)
+++..
T Consensus 473 la~~~ 477 (535)
T PRK09605 473 LGKYS 477 (535)
T ss_pred ccccC
Confidence 99764
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.34 E-value=2.6e-13 Score=101.11 Aligned_cols=138 Identities=28% Similarity=0.388 Sum_probs=110.6
Q ss_pred CceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCC-CeEEeee
Q 044494 3 RKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLEL-EAFVADF 81 (144)
Q Consensus 3 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~-~~~l~d~ 81 (144)
.+..+++++|..|+++.+-+.. ......+...+..++.|+..++.|+|. ..++.|+|++|+|.+++..+ ..+..||
T Consensus 93 ~~~~~~~~~~s~g~~~f~~i~~-~~~~~~~~~~~~~~~~ql~s~l~~~H~--~~~~~h~~ikP~n~~l~~s~~~l~~~df 169 (601)
T KOG0590|consen 93 PRSYLLSLSYSDGGSLFSKISH-PDSTGTSSSSASRYLPQLNSGLSYLHP--ENGVTHRDIKPSNSLLDESGSALKIADF 169 (601)
T ss_pred CcccccccCccccccccccccc-CCccCCCCcchhhhhhhhccCccccCc--ccccccCCCCCccchhccCCCcccCCCc
Confidence 4566889999999999887731 122236666778899999999999994 46899999999999999999 8999999
Q ss_pred cceeeccc-CCC--Ccccccc-cccccCccccccCCC-CCcchhHHHHHHHHHHHhCCCCCCCCCCC
Q 044494 82 GVARLLNF-DSS--NRTLLAG-TYGYIAPELAYTMVV-TEKSDVYSFGVVALEVLMGKHPGELLSSS 143 (144)
Q Consensus 82 ~~~~~~~~-~~~--~~~~~~~-~~~~~~pe~~~~~~~-~~~~d~~slg~~l~~~~~g~~p~~~~~~~ 143 (144)
+++..... ... ......| ++.|.+||...+..+ .+..|+||+|+++..+++|..||+..+..
T Consensus 170 ~~At~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~ 236 (601)
T KOG0590|consen 170 GLATAYRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRK 236 (601)
T ss_pred hhhccccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccc
Confidence 99987664 211 2233567 999999999988543 56789999999999999999999886653
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.34 E-value=5.5e-12 Score=82.86 Aligned_cols=68 Identities=19% Similarity=0.160 Sum_probs=53.2
Q ss_pred EEEee--ccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHH-HHHhcCCCCCeEecCCCCCcEEEcCC----CCeEEee
Q 044494 8 LIYEY--MEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHAL-SYLHHDCTPPIVHRDISSNNILLNLE----LEAFVAD 80 (144)
Q Consensus 8 lv~e~--~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l-~~lh~~~~~~~~h~~i~~~ni~~~~~----~~~~l~d 80 (144)
+|+|| +.+++|.+++++. . +++. ..++.+++.++ +||| +.+++||||||+||+++.. ..++|+|
T Consensus 82 ~I~e~~G~~~~tL~~~l~~~-~---~~e~--~~~~~~~L~~l~~yLh---~~~IvhrDlKp~NILl~~~~~~~~~~~LiD 152 (210)
T PRK10345 82 VIADFDGKPSITLTEFAEQC-R---YEED--VAQLRQLLKKLKRYLL---DNRIVTMELKPQNILCQRISESEVIPVVCD 152 (210)
T ss_pred EEecCCCCcchhHHHHHHcc-c---ccHh--HHHHHHHHHHHHHHHH---HCCEeecCCCHHHEEEeccCCCCCcEEEEE
Confidence 78999 5579999999753 2 5555 34567777777 8999 8999999999999999743 3799999
Q ss_pred ecce
Q 044494 81 FGVA 84 (144)
Q Consensus 81 ~~~~ 84 (144)
++.+
T Consensus 153 g~G~ 156 (210)
T PRK10345 153 NIGE 156 (210)
T ss_pred CCCC
Confidence 5434
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.28 E-value=1.4e-11 Score=79.41 Aligned_cols=75 Identities=19% Similarity=0.276 Sum_probs=58.5
Q ss_pred eEEEEEeeccCCCHHHH-hhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCC-CCeEecCCCCCcEEEcCCCCeEEeeec
Q 044494 5 CMFLIYEYMEMGSLFCV-LRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCT-PPIVHRDISSNNILLNLELEAFVADFG 82 (144)
Q Consensus 5 ~~~lv~e~~~~~~L~~~-l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~-~~~~h~~i~~~ni~~~~~~~~~l~d~~ 82 (144)
..++||||++++.+... +.. .. .. ..+..++.+++.++..+| . .+++|+|++|.||+++ ++.++++|||
T Consensus 89 ~~~lv~e~~~g~~~~~~~l~~-~~---~~-~~~~~~~~~~~~~l~~lh---~~~~ivH~Dl~p~Nili~-~~~~~liDfg 159 (187)
T cd05119 89 RHVLVMEFIGGDGIPAPRLKD-VR---LL-EDPEELYDQILELMRKLY---REAGLVHGDLSEYNILVD-DGKVYIIDVP 159 (187)
T ss_pred CCEEEEEEeCCCCccChhhhh-hh---hc-ccHHHHHHHHHHHHHHHh---hccCcCcCCCChhhEEEE-CCcEEEEECc
Confidence 45899999998544321 111 10 11 556788999999999999 7 8999999999999999 8899999999
Q ss_pred ceeecc
Q 044494 83 VARLLN 88 (144)
Q Consensus 83 ~~~~~~ 88 (144)
.+....
T Consensus 160 ~a~~~~ 165 (187)
T cd05119 160 QAVEID 165 (187)
T ss_pred cccccc
Confidence 987543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.19 E-value=9.9e-11 Score=72.39 Aligned_cols=73 Identities=23% Similarity=0.256 Sum_probs=59.6
Q ss_pred ceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeeecc
Q 044494 4 KCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADFGV 83 (144)
Q Consensus 4 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~~~ 83 (144)
+..+++|||++++.+..+ +......+..+++.++..+|..+..+++|+|++|.|++++..+.++++||+.
T Consensus 66 ~~~~~v~e~~~g~~~~~~----------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~ 135 (155)
T cd05120 66 GWSYLLMEWIEGETLDEV----------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEY 135 (155)
T ss_pred CccEEEEEecCCeecccC----------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEeccc
Confidence 457999999988766543 4445566788999999999954335899999999999999988999999998
Q ss_pred eee
Q 044494 84 ARL 86 (144)
Q Consensus 84 ~~~ 86 (144)
+..
T Consensus 136 ~~~ 138 (155)
T cd05120 136 AGY 138 (155)
T ss_pred ccC
Confidence 753
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=99.15 E-value=6.1e-11 Score=90.00 Aligned_cols=81 Identities=19% Similarity=0.219 Sum_probs=60.8
Q ss_pred ecCCCCC-cEEEcCCCCeEEeeecceeecccCC--CCcccccccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCC
Q 044494 60 HRDISSN-NILLNLELEAFVADFGVARLLNFDS--SNRTLLAGTYGYIAPELAYTMVVTEKSDVYSFGVVALEVLMGKHP 136 (144)
Q Consensus 60 h~~i~~~-ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~~~~~pe~~~~~~~~~~~d~~slg~~l~~~~~g~~p 136 (144)
+++..|. |++++..+..++.+|+.+....... .......||+.|+|||++.+..++.++|+||+||++|||++|..|
T Consensus 500 ~~~~~p~~~~~~~p~~~~~~~~~~~~~~~~~g~~~~~~~~~vGT~~Y~APE~l~~~~~~~~~DiwSlG~il~ElltG~~p 579 (669)
T cd05610 500 TQKPRPHGNLYQTPKQVKIGTPYRTPKSVRRGAAPVEGERILGTPDYLAPELLLGKPHGPAVDWWALGVCLFEFLTGIPP 579 (669)
T ss_pred CCCCCCCCceeECCccccccccCCCchhhhcccccccCCceeeCccccCHHHcCCCCCCcHHHHHHHHHHHHHHHHCCCC
Confidence 3444444 5666666666777888776543221 123345789999999999998899999999999999999999999
Q ss_pred CCCC
Q 044494 137 GELL 140 (144)
Q Consensus 137 ~~~~ 140 (144)
|.+.
T Consensus 580 f~~~ 583 (669)
T cd05610 580 FNDE 583 (669)
T ss_pred CCCC
Confidence 9764
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.14 E-value=2.6e-10 Score=78.39 Aligned_cols=130 Identities=27% Similarity=0.382 Sum_probs=96.8
Q ss_pred ceEEEEEeeccCCCHHHHhhc-ccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeee-
Q 044494 4 KCMFLIYEYMEMGSLFCVLRT-DEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADF- 81 (144)
Q Consensus 4 ~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~- 81 (144)
.+..+++||+..|++.++|++ ......+....-..|..|++.||.|||.+ +--++|+++.-+.+++..++-+++..-
T Consensus 145 ~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~-~PpiihgnlTc~tifiq~ngLIkig~~a 223 (458)
T KOG1266|consen 145 PRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSC-DPPIIHGNLTCDTIFIQHNGLIKIGSVA 223 (458)
T ss_pred cceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhcc-CCccccCCcchhheeecCCceEEecccC
Confidence 456789999999999999986 33345578888889999999999999966 778999999999999998887776421
Q ss_pred -cceeec-cc-CCCCcccccccccccCccccccCCCCCcchhHHHHHHHHHHHhCC
Q 044494 82 -GVARLL-NF-DSSNRTLLAGTYGYIAPELAYTMVVTEKSDVYSFGVVALEVLMGK 134 (144)
Q Consensus 82 -~~~~~~-~~-~~~~~~~~~~~~~~~~pe~~~~~~~~~~~d~~slg~~l~~~~~g~ 134 (144)
...... .. .........+.+.|.+|+.-...+....+|||++|+...+|-.+.
T Consensus 224 p~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemailE 279 (458)
T KOG1266|consen 224 PDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAILE 279 (458)
T ss_pred ccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHHHhe
Confidence 111100 00 011122234567888998877777777899999999998886554
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.14 E-value=2.8e-10 Score=73.85 Aligned_cols=77 Identities=17% Similarity=0.189 Sum_probs=57.6
Q ss_pred ceEEEEEeeccCCCHHH-HhhcccccCCCCHHHHHHHHHHHHHHHHHH-hcCCCCCeEecCCCCCcEEEcCCCCeEEeee
Q 044494 4 KCMFLIYEYMEMGSLFC-VLRTDEEAVGLDWAKRVNIVKGMAHALSYL-HHDCTPPIVHRDISSNNILLNLELEAFVADF 81 (144)
Q Consensus 4 ~~~~lv~e~~~~~~L~~-~l~~~~~~~~~~~~~~~~~~~~l~~~l~~l-h~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~ 81 (144)
+.-++||||+.++.+.. .++. ..++......+..+++.++..+ | ..|++|+|+++.||++. ++.+.++||
T Consensus 97 ~~~~lvME~Ig~~~~~~~~Lkd----~~~~~~~~~~i~~~i~~~l~~l~H---~~glVHGDLs~~NIL~~-~~~v~iIDF 168 (197)
T cd05146 97 KKHVLVMSFIGDDQVPAPKLKD----AKLNDEEMKNAYYQVLSMMKQLYK---ECNLVHADLSEYNMLWH-DGKVWFIDV 168 (197)
T ss_pred cCCEEEEEEcCCCCccchhhhc----cccCHHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEE-CCcEEEEEC
Confidence 34578999997643322 1221 1245556677788999999988 7 78999999999999997 467999999
Q ss_pred cceeecc
Q 044494 82 GVARLLN 88 (144)
Q Consensus 82 ~~~~~~~ 88 (144)
+.+....
T Consensus 169 ~qav~~~ 175 (197)
T cd05146 169 SQSVEPT 175 (197)
T ss_pred CCceeCC
Confidence 9886543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.07 E-value=2.9e-09 Score=78.85 Aligned_cols=119 Identities=18% Similarity=0.178 Sum_probs=87.7
Q ss_pred CceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeeec
Q 044494 3 RKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADFG 82 (144)
Q Consensus 3 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~~ 82 (144)
.+.+|+|+|.+. .|..++++ +......--+.||+.||.+||+ +.+++|+++.-..++++..|.-++.+|.
T Consensus 81 ~~~~ylvTErV~--Pl~~~lk~------l~~~~v~~Gl~qIl~AL~FL~~--d~~lvHgNv~~~SVfVn~~GeWkLggle 150 (690)
T KOG1243|consen 81 EGTLYLVTERVR--PLETVLKE------LGKEEVCLGLFQILAALSFLND--DCNLVHGNVCKDSVFVNESGEWKLGGLE 150 (690)
T ss_pred cCceEEEeeccc--cHHHHHHH------hHHHHHHHHHHHHHHHHHHHhc--cCCeeeccEeeeeEEEcCCCcEEEeeeE
Confidence 467899999985 78888875 3345555568999999999985 6789999999999999999999999998
Q ss_pred ceeecccCCCCcccccccccccCccccccCCCCCcchhHHHHHHHHHHHhC
Q 044494 83 VARLLNFDSSNRTLLAGTYGYIAPELAYTMVVTEKSDVYSFGVVALEVLMG 133 (144)
Q Consensus 83 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~d~~slg~~l~~~~~g 133 (144)
++....-.............|..|+.+....+ ..|.|-||+++++++.|
T Consensus 151 ~v~~~~~~~~~~~~~~~~~s~~~P~~~~~s~~--s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 151 LVSKASGFNAPAKSLYLIESFDDPEEIDPSEW--SIDSWGLGCLIEELFNG 199 (690)
T ss_pred EEeccccCCcccccchhhhcccChhhcCcccc--chhhhhHHHHHHHHhCc
Confidence 88654321211111222234555655443332 36999999999999998
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.01 E-value=7.7e-09 Score=73.65 Aligned_cols=133 Identities=16% Similarity=0.262 Sum_probs=99.2
Q ss_pred EEEEEeeccCCC-HHHHh---hcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeee
Q 044494 6 MFLIYEYMEMGS-LFCVL---RTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADF 81 (144)
Q Consensus 6 ~~lv~e~~~~~~-L~~~l---~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~ 81 (144)
+-++|+.+++.. ...+. .++.+.+...++..+...+.++.+...|| ..|..-+|++++|++++.++.+.+.|-
T Consensus 85 iGflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH---~~Gh~vGDVn~~~~lVsd~~~V~LVds 161 (637)
T COG4248 85 IGFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLH---EHGHVVGDVNQNSFLVSDDSKVVLVDS 161 (637)
T ss_pred eEEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHH---hcCCcccccCccceeeecCceEEEEcc
Confidence 567788777642 22222 22445566889999999999999999999 889999999999999999999999874
Q ss_pred cceeecccCCCCcccccccccccCcccccc-----CCCCCcchhHHHHHHHHHHHhC-CCCCCCCCC
Q 044494 82 GVARLLNFDSSNRTLLAGTYGYIAPELAYT-----MVVTEKSDVYSFGVVALEVLMG-KHPGELLSS 142 (144)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~-----~~~~~~~d~~slg~~l~~~~~g-~~p~~~~~~ 142 (144)
.....- .+........+...|++||.-.- -.-+...|.|.||+++++++.| ..||.+...
T Consensus 162 Dsfqi~-~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~ 227 (637)
T COG4248 162 DSFQIN-ANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPL 227 (637)
T ss_pred cceeec-cCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccc
Confidence 433321 22333444668889999997552 2234678999999999999875 999988653
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.01 E-value=1.4e-09 Score=78.89 Aligned_cols=76 Identities=24% Similarity=0.323 Sum_probs=57.5
Q ss_pred eEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHH-HHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeeecc
Q 044494 5 CMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAH-ALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADFGV 83 (144)
Q Consensus 5 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~-~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~~~ 83 (144)
.-++||||++|++|.+....... .... ..++..++. .+..+| ..|++|+|++|.||+++.++.++++|||.
T Consensus 232 ~~vLvmE~i~G~~L~~~~~~~~~--~~~~---~~ia~~~~~~~l~ql~---~~g~~H~D~hPgNilv~~~g~i~liDfG~ 303 (437)
T TIGR01982 232 ERVLTMEWIDGIPLSDIAALDEA--GLDR---KALAENLARSFLNQVL---RDGFFHADLHPGNIFVLKDGKIIALDFGI 303 (437)
T ss_pred CceEEEEeECCcccccHHHHHhc--CCCH---HHHHHHHHHHHHHHHH---hCCceeCCCCcccEEECCCCcEEEEeCCC
Confidence 34799999999999887653211 1222 234444444 466778 88999999999999999999999999999
Q ss_pred eeecc
Q 044494 84 ARLLN 88 (144)
Q Consensus 84 ~~~~~ 88 (144)
+....
T Consensus 304 ~~~l~ 308 (437)
T TIGR01982 304 VGRLS 308 (437)
T ss_pred eeECC
Confidence 98765
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.00 E-value=3.2e-10 Score=87.33 Aligned_cols=134 Identities=25% Similarity=0.325 Sum_probs=103.9
Q ss_pred CceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeeec
Q 044494 3 RKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADFG 82 (144)
Q Consensus 3 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~~ 82 (144)
+...+|+++|+.+++|...++... ..+.+.....+..+..+.++|| ...+.|++.+|.|.+...++..++.+++
T Consensus 876 rsP~~L~~~~~~~~~~~Skl~~~~---~~saepaRs~i~~~vqs~e~L~---s~~r~h~~~~p~~~l~~~~gh~~l~~~~ 949 (1205)
T KOG0606|consen 876 RSPLPLVGHYLNGGDLPSKLHNSG---CLSAEPARSPILERVQSLESLH---SSLRKHRDLKPDSLLIAYDGHRPLTDFG 949 (1205)
T ss_pred CCCcchhhHHhccCCchhhhhcCC---CcccccccchhHHHHhhhhccc---cchhhcccccccchhhcccCCcccCccc
Confidence 346789999999999999887643 2444455566677888999999 6678999999999999999988888876
Q ss_pred ceeecccC---------------------------C----CCcccccccccccCccccccCCCCCcchhHHHHHHHHHHH
Q 044494 83 VARLLNFD---------------------------S----SNRTLLAGTYGYIAPELAYTMVVTEKSDVYSFGVVALEVL 131 (144)
Q Consensus 83 ~~~~~~~~---------------------------~----~~~~~~~~~~~~~~pe~~~~~~~~~~~d~~slg~~l~~~~ 131 (144)
.....+.- . .......+++.|.+||...+......+|.|+.|+++++.+
T Consensus 950 t~~~vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l 1029 (1205)
T KOG0606|consen 950 TLSKVGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVL 1029 (1205)
T ss_pred cccccccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhh
Confidence 32221100 0 0011245788999999999998888999999999999999
Q ss_pred hCCCCCCCCCC
Q 044494 132 MGKHPGELLSS 142 (144)
Q Consensus 132 ~g~~p~~~~~~ 142 (144)
+|..||+...+
T Consensus 1030 ~g~pp~na~tp 1040 (1205)
T KOG0606|consen 1030 TGIPPFNAETP 1040 (1205)
T ss_pred cCCCCCCCcch
Confidence 99999987654
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.99 E-value=2.9e-09 Score=72.46 Aligned_cols=78 Identities=26% Similarity=0.218 Sum_probs=62.7
Q ss_pred eEEEEEeeccCC-CHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcC-------CCCe
Q 044494 5 CMFLIYEYMEMG-SLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNL-------ELEA 76 (144)
Q Consensus 5 ~~~lv~e~~~~~-~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~-------~~~~ 76 (144)
.-++|||++++. +|.+++..... ...+......++.+++..+.-|| ..|++|+|+++.||+++. +..+
T Consensus 109 ~s~LVte~l~~~~sL~~~~~~~~~-~~~~~~~~~~ll~~la~~i~~LH---~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~ 184 (268)
T PRK15123 109 TSFIITEDLAPTISLEDYCADWAT-NPPDPRLKRMLIKRVATMVRDMH---AAGINHRDCYICHFLLHLPFPGREEDLKL 184 (268)
T ss_pred eeEEEEeeCCCCccHHHHHHhhcc-cCCCHHHHHHHHHHHHHHHHHHH---HCcCccCCCChhhEEEeccccCCCCCceE
Confidence 468999999886 78888753211 12456667788999999999999 999999999999999985 4578
Q ss_pred EEeeecceee
Q 044494 77 FVADFGVARL 86 (144)
Q Consensus 77 ~l~d~~~~~~ 86 (144)
.++||+.+..
T Consensus 185 ~LIDl~r~~~ 194 (268)
T PRK15123 185 SVIDLHRAQI 194 (268)
T ss_pred EEEECCcccc
Confidence 8999998853
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.97 E-value=3.7e-09 Score=69.43 Aligned_cols=77 Identities=26% Similarity=0.387 Sum_probs=64.2
Q ss_pred eEEEEEeeccCC-CHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCC---CeEEee
Q 044494 5 CMFLIYEYMEMG-SLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLEL---EAFVAD 80 (144)
Q Consensus 5 ~~~lv~e~~~~~-~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~---~~~l~d 80 (144)
.-++|+|++++. +|.+++..... .+......++.++...+.-|| ..|++|+|+++.||+++.++ .+.++|
T Consensus 91 ~s~lite~l~~~~~L~~~~~~~~~---~~~~~~~~ll~~l~~~i~~lH---~~gi~H~Dl~~~NILv~~~~~~~~~~lID 164 (206)
T PF06293_consen 91 RSYLITEALPGAQDLRDLLQQWEQ---LDPSQRRELLRALARLIAKLH---DAGIYHGDLNPSNILVDPDDGQYRFYLID 164 (206)
T ss_pred eEEEEEEeCCCcccHHHHHHhhcc---cchhhHHHHHHHHHHHHHHHH---HCcCCCCCCCcccEEEeCCCCceeEEEEc
Confidence 458999999874 78888875332 455666788999999999999 99999999999999999887 788999
Q ss_pred ecceeec
Q 044494 81 FGVARLL 87 (144)
Q Consensus 81 ~~~~~~~ 87 (144)
|+.+...
T Consensus 165 ld~~~~~ 171 (206)
T PF06293_consen 165 LDRMRFR 171 (206)
T ss_pred chhceeC
Confidence 9987653
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=98.93 E-value=3e-09 Score=67.48 Aligned_cols=67 Identities=25% Similarity=0.420 Sum_probs=51.8
Q ss_pred eEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCC-----eEecCCCCCcEEEcCCCCeEEe
Q 044494 5 CMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPP-----IVHRDISSNNILLNLELEAFVA 79 (144)
Q Consensus 5 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~-----~~h~~i~~~ni~~~~~~~~~l~ 79 (144)
..++||||++|.++.+. . .. ......+++.++..|| ..+ ++|+|++|.|++++ ++.++++
T Consensus 65 ~~~lv~e~i~G~~l~~~-----~---~~---~~~~~~~l~~~l~~LH---~~~~~~~~~~HgD~~~~Nil~~-~~~~~li 129 (170)
T cd05151 65 TGVLITEFIEGSELLTE-----D---FS---DPENLEKIAKLLKKLH---SSPLPDLVPCHNDLLPGNFLLD-DGRLWLI 129 (170)
T ss_pred CCeEEEEecCCCccccc-----c---cc---CHHHHHHHHHHHHHHh---CCCCCCceeecCCCCcCcEEEE-CCeEEEE
Confidence 35799999999877542 0 11 1234578899999999 555 59999999999999 6679999
Q ss_pred eecceee
Q 044494 80 DFGVARL 86 (144)
Q Consensus 80 d~~~~~~ 86 (144)
||+.+..
T Consensus 130 Df~~a~~ 136 (170)
T cd05151 130 DWEYAGM 136 (170)
T ss_pred ecccccC
Confidence 9998764
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.91 E-value=6.8e-09 Score=66.22 Aligned_cols=71 Identities=24% Similarity=0.430 Sum_probs=56.9
Q ss_pred CCceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeee
Q 044494 2 HRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADF 81 (144)
Q Consensus 2 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~ 81 (144)
+..+..++|||.+|..|.+.+.... ..+...+=.-+.-|| ..|++|+|+.++|++++.+. +.++||
T Consensus 70 D~~~~~I~me~I~G~~lkd~l~~~~----------~~~~r~vG~~vg~lH---~~givHGDLTtsNiIl~~~~-i~~IDf 135 (204)
T COG3642 70 DPDNGLIVMEYIEGELLKDALEEAR----------PDLLREVGRLVGKLH---KAGIVHGDLTTSNIILSGGR-IYFIDF 135 (204)
T ss_pred cCCCCEEEEEEeCChhHHHHHHhcc----------hHHHHHHHHHHHHHH---hcCeecCCCccceEEEeCCc-EEEEEC
Confidence 3456679999999999988887531 234455556677899 89999999999999998876 999999
Q ss_pred cceee
Q 044494 82 GVARL 86 (144)
Q Consensus 82 ~~~~~ 86 (144)
|++..
T Consensus 136 GLg~~ 140 (204)
T COG3642 136 GLGEF 140 (204)
T ss_pred Ccccc
Confidence 99874
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.80 E-value=2e-08 Score=64.93 Aligned_cols=75 Identities=24% Similarity=0.340 Sum_probs=48.0
Q ss_pred eEEEEEeecc--CCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHH-HHhcCCCCCeEecCCCCCcEEEcCCCCeEEeee
Q 044494 5 CMFLIYEYME--MGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALS-YLHHDCTPPIVHRDISSNNILLNLELEAFVADF 81 (144)
Q Consensus 5 ~~~lv~e~~~--~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~-~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~ 81 (144)
.-.+||||+. |..+..+... . ++......++.+++..+. .+| ..|++|+|+++.||+++.+ .+.++||
T Consensus 80 ~~~ivME~I~~~G~~~~~l~~~-~----~~~~~~~~~~~~il~~~~~~~~---~~givHGDLs~~NIlv~~~-~~~iIDf 150 (188)
T PF01163_consen 80 RNVIVMEYIGEDGVPLPRLKDV-D----LSPEEPKELLEEILEEIIKMLH---KAGIVHGDLSEYNILVDDG-KVYIIDF 150 (188)
T ss_dssp TTEEEEE--EETTEEGGCHHHC-G----GGGSTHHHHHHHHHHHHHHHHH---CTTEEESS-STTSEEEETT-CEEE--G
T ss_pred CCEEEEEecCCCccchhhHHhc-c----ccchhHHHHHHHHHHHHHHHHH---hcCceecCCChhhEEeecc-eEEEEec
Confidence 3479999998 5445433322 1 112334556667777444 467 8899999999999999988 8999999
Q ss_pred cceeecc
Q 044494 82 GVARLLN 88 (144)
Q Consensus 82 ~~~~~~~ 88 (144)
+.+....
T Consensus 151 ~qav~~~ 157 (188)
T PF01163_consen 151 GQAVDSS 157 (188)
T ss_dssp TTEEETT
T ss_pred CcceecC
Confidence 9887644
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.77 E-value=5.3e-08 Score=62.29 Aligned_cols=82 Identities=17% Similarity=0.287 Sum_probs=61.8
Q ss_pred CCceEEEEEeeccC-CCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCC---eE
Q 044494 2 HRKCMFLIYEYMEM-GSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELE---AF 77 (144)
Q Consensus 2 ~~~~~~lv~e~~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~---~~ 77 (144)
+.+.-.++|||+.| .++.+++...-... ...+....++..+-+.+.-|| +.+++|+|+..+||++..++. +.
T Consensus 81 D~~~~~i~ME~~~g~~~vk~~i~~~~~~~-~~d~~~~~~~~~iG~~igklH---~ndiiHGDLTTSNill~~~~~~~~~~ 156 (229)
T KOG3087|consen 81 DTYGGQIYMEFIDGASTVKDFILSTMEDE-SEDEGLAELARRIGELIGKLH---DNDIIHGDLTTSNILLRSDGNQITPI 156 (229)
T ss_pred ecCCCeEEEEeccchhHHHHHHHHHccCc-ccchhHHHHHHHHHHHHHHhh---hCCeecccccccceEEecCCCcCceE
Confidence 34556788999976 48888887633322 333333678888999999999 999999999999999976653 47
Q ss_pred Eeeecceeec
Q 044494 78 VADFGVARLL 87 (144)
Q Consensus 78 l~d~~~~~~~ 87 (144)
++|||++...
T Consensus 157 lIdfgls~~s 166 (229)
T KOG3087|consen 157 LIDFGLSSVS 166 (229)
T ss_pred EEeecchhcc
Confidence 8999988643
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.75 E-value=2.2e-08 Score=73.08 Aligned_cols=128 Identities=28% Similarity=0.308 Sum_probs=99.1
Q ss_pred CceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHH----HHHHHhcCCCCCeEecCCCCCcEEEcCC-CCeE
Q 044494 3 RKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAH----ALSYLHHDCTPPIVHRDISSNNILLNLE-LEAF 77 (144)
Q Consensus 3 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~----~l~~lh~~~~~~~~h~~i~~~ni~~~~~-~~~~ 77 (144)
+...|+-+|.+ +.+|.++...-. .-++...++..+.+... |+..+| ..+++|-+++|.|++...+ ...+
T Consensus 190 ~~~lfiqtE~~-~~sl~~~~~~~~--~~~p~~~l~~~~~~~~~~~~~al~~~h---s~~~~~~~~kp~~i~~~~~~~s~~ 263 (524)
T KOG0601|consen 190 SGILFIQTELC-GESLQSYCHTPC--NFLPDNLLWNSLRDWLSRDVTALSHLH---SNNIVHDDLKPANIFTTSDWTSCK 263 (524)
T ss_pred CCcceeeeccc-cchhHHhhhccc--ccCCchhhhhHHhhhhhcccccccccC---CCcccccccchhheecccccceee
Confidence 34567777877 468877776422 22677778888888888 999999 8999999999999999998 8889
Q ss_pred EeeecceeecccCCCCccc-----ccccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCC
Q 044494 78 VADFGVARLLNFDSSNRTL-----LAGTYGYIAPELAYTMVVTEKSDVYSFGVVALEVLMGKHPG 137 (144)
Q Consensus 78 l~d~~~~~~~~~~~~~~~~-----~~~~~~~~~pe~~~~~~~~~~~d~~slg~~l~~~~~g~~p~ 137 (144)
+.||++...+......... ..+...|++||..+.. ++...|++++|.+..+...+..+.
T Consensus 264 ~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l-~~~~~di~sl~ev~l~~~l~~~~~ 327 (524)
T KOG0601|consen 264 LTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGL-ATFASDIFSLGEVILEAILGSHLP 327 (524)
T ss_pred cCCcceeEEccCCccccceeeeecCCCCceEeChhhhccc-cchHhhhcchhhhhHhhHhhcccc
Confidence 9999999887654322222 2567789999999766 466789999999999988776543
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.74 E-value=4.1e-08 Score=64.60 Aligned_cols=67 Identities=22% Similarity=0.257 Sum_probs=51.8
Q ss_pred eEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeeecce
Q 044494 5 CMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADFGVA 84 (144)
Q Consensus 5 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~~~~ 84 (144)
..+++|||++|..|.+... +++. +...+.++++.+| ..|+.|+|.+|.|++++.++ ++++|++..
T Consensus 117 ~~~ll~EYIeG~~l~d~~~-------i~e~----~~~ki~~~ikqlH---~~G~~HGD~hpgNFlv~~~~-i~iID~~~k 181 (229)
T PF06176_consen 117 SYVLLMEYIEGVELNDIED-------IDED----LAEKIVEAIKQLH---KHGFYHGDPHPGNFLVSNNG-IRIIDTQGK 181 (229)
T ss_pred EEEEEEEEecCeecccchh-------cCHH----HHHHHHHHHHHHH---HcCCccCCCCcCcEEEECCc-EEEEECccc
Confidence 4568999999988866432 3322 3355777889999 89999999999999999655 999999755
Q ss_pred ee
Q 044494 85 RL 86 (144)
Q Consensus 85 ~~ 86 (144)
+.
T Consensus 182 ~~ 183 (229)
T PF06176_consen 182 RM 183 (229)
T ss_pred cc
Confidence 43
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=98.64 E-value=5.7e-08 Score=71.90 Aligned_cols=74 Identities=19% Similarity=0.179 Sum_probs=50.4
Q ss_pred eEEEEEeeccCCCHHHHh--hccc-ccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCC----CeE
Q 044494 5 CMFLIYEYMEMGSLFCVL--RTDE-EAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLEL----EAF 77 (144)
Q Consensus 5 ~~~lv~e~~~~~~L~~~l--~~~~-~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~----~~~ 77 (144)
.-++||||+.|+.+.+.- ...+ ....+.+..+..++ ..+. ..|+.|+|++|.||+++.++ .++
T Consensus 235 ~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~-------~Qif---~~GffHaDpHPGNIlv~~~g~~~~~i~ 304 (537)
T PRK04750 235 ETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFF-------TQVF---RDGFFHADMHPGNIFVSYDPPENPRYI 304 (537)
T ss_pred CceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHH-------HHHH---hCCeeeCCCChHHeEEecCCCCCCeEE
Confidence 346999999999998742 2211 10112222222222 2233 67999999999999999888 899
Q ss_pred Eeeecceeecc
Q 044494 78 VADFGVARLLN 88 (144)
Q Consensus 78 l~d~~~~~~~~ 88 (144)
++|||......
T Consensus 305 llDFGivg~l~ 315 (537)
T PRK04750 305 ALDFGIVGSLN 315 (537)
T ss_pred EEecceEEECC
Confidence 99999998764
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.50 E-value=9.5e-07 Score=57.96 Aligned_cols=77 Identities=19% Similarity=0.078 Sum_probs=62.3
Q ss_pred EEEEEeeccC-CCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCC--eEEeeec
Q 044494 6 MFLIYEYMEM-GSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELE--AFVADFG 82 (144)
Q Consensus 6 ~~lv~e~~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~--~~l~d~~ 82 (144)
-+||+|-+.| .+|.+++..... ...+......++.+++..+.-|| +.|+.|+|+.+.||+++.++. +.++||.
T Consensus 100 A~LVTe~L~g~~~L~~~l~~~~~-~~~~~~~k~~il~~va~~ia~LH---~~Gv~Hgdly~khIll~~~g~~~v~lIDlE 175 (216)
T PRK09902 100 ALLVTEDMAGFISIADWYAQHAV-SPYSDEVRQAMLKAVALAFKKMH---SVNRQHGCCYVRHIYVKTEGKAEAGFLDLE 175 (216)
T ss_pred EEEEEEeCCCCccHHHHHhcCCc-CCcchHHHHHHHHHHHHHHHHHH---HCCCcCCCCCHhheeecCCCCeeEEEEEhh
Confidence 5799998864 488888765322 23566667789999999999999 999999999999999986666 8899998
Q ss_pred ceee
Q 044494 83 VARL 86 (144)
Q Consensus 83 ~~~~ 86 (144)
.++.
T Consensus 176 k~r~ 179 (216)
T PRK09902 176 KSRR 179 (216)
T ss_pred ccch
Confidence 7764
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.47 E-value=5.2e-07 Score=61.03 Aligned_cols=74 Identities=24% Similarity=0.253 Sum_probs=55.6
Q ss_pred CCceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeee
Q 044494 2 HRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADF 81 (144)
Q Consensus 2 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~ 81 (144)
..++-.+|||++.|-.|...- ++...+..++..+++-+.... ..|++|+|+++-||+++.+|.+.++||
T Consensus 178 ~~nRHaVvMe~ieG~eL~~~r--------~~~en~~~il~~il~~~~~~~---~~GiVHGDlSefNIlV~~dg~~~vIDw 246 (304)
T COG0478 178 AWNRHAVVMEYIEGVELYRLR--------LDVENPDEILDKILEEVRKAY---RRGIVHGDLSEFNILVTEDGDIVVIDW 246 (304)
T ss_pred ccccceeeeehcccceeeccc--------CcccCHHHHHHHHHHHHHHHH---HcCccccCCchheEEEecCCCEEEEeC
Confidence 456678999999986664322 123334455666777777666 789999999999999999999999998
Q ss_pred cceee
Q 044494 82 GVARL 86 (144)
Q Consensus 82 ~~~~~ 86 (144)
--+..
T Consensus 247 PQ~v~ 251 (304)
T COG0478 247 PQAVP 251 (304)
T ss_pred ccccc
Confidence 76654
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.46 E-value=3.5e-06 Score=61.65 Aligned_cols=114 Identities=15% Similarity=0.284 Sum_probs=85.4
Q ss_pred CCCceEEEEEeeccC-CCHHHHhhc------------ccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCc
Q 044494 1 LHRKCMFLIYEYMEM-GSLFCVLRT------------DEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNN 67 (144)
Q Consensus 1 ~~~~~~~lv~e~~~~-~~L~~~l~~------------~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~n 67 (144)
+++..+++|++|+++ ++|.++--. -....+++++.+|.++.|+..+|+++| +.|+..+-+.+.+
T Consensus 347 F~D~SlvlvYDYyP~s~TL~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIH---ssGLAck~L~~~k 423 (655)
T KOG3741|consen 347 FGDLSLVLVYDYYPSSPTLYDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIH---SSGLACKTLDLKK 423 (655)
T ss_pred cCcceEEEEEecCCCCchHHHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHH---hcCceeecccHhH
Confidence 357788999999996 577765311 112446899999999999999999999 8899999999999
Q ss_pred EEEcCCCCeEEeeecceeecccCCCCcccccccccccCccccccCCCCCcchhHHHHHHHHHHHhCC
Q 044494 68 ILLNLELEAFVADFGVARLLNFDSSNRTLLAGTYGYIAPELAYTMVVTEKSDVYSFGVVALEVLMGK 134 (144)
Q Consensus 68 i~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~d~~slg~~l~~~~~g~ 134 (144)
|+++.+.++++...|......++. . +-+... .+.|.-.||.++..+.+|.
T Consensus 424 Ilv~G~~RIriS~C~i~Dvl~~d~------------~--~~le~~---Qq~D~~~lG~ll~aLAt~~ 473 (655)
T KOG3741|consen 424 ILVTGKMRIRISGCGIMDVLQEDP------------T--EPLESQ---QQNDLRDLGLLLLALATGT 473 (655)
T ss_pred eEeeCcceEEEecccceeeecCCC------------C--cchhHH---hhhhHHHHHHHHHHHhhcc
Confidence 999999999988766555433221 0 111111 2458889999999988874
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.45 E-value=3.3e-08 Score=73.61 Aligned_cols=97 Identities=27% Similarity=0.371 Sum_probs=73.6
Q ss_pred HHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeeecceeecccCCC--------Cc-ccccccccccCccccc
Q 044494 40 VKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADFGVARLLNFDSS--------NR-TLLAGTYGYIAPELAY 110 (144)
Q Consensus 40 ~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~--------~~-~~~~~~~~~~~pe~~~ 110 (144)
+.+.++|+.++|. +.+++|++|.|++|.+...+..|++.|+.+.....+.. .. ........|.+||++.
T Consensus 105 l~~v~dgl~flh~--sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~ 182 (700)
T KOG2137|consen 105 LGNVADGLAFLHR--SAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLL 182 (700)
T ss_pred hhcccchhhhhcc--CcceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhc
Confidence 3456689999995 56899999999999999999999999887765432110 00 1122345799999999
Q ss_pred cCCCCCcchhHHHHHHHHHHH-hCCCCCC
Q 044494 111 TMVVTEKSDVYSFGVVALEVL-MGKHPGE 138 (144)
Q Consensus 111 ~~~~~~~~d~~slg~~l~~~~-~g~~p~~ 138 (144)
....+.++|++|+|+++|.+. .|+.-++
T Consensus 183 ~~~~~~~sd~fSlG~li~~i~~~gk~i~~ 211 (700)
T KOG2137|consen 183 GTTNTPASDVFSLGVLIYTIYNGGKSIIA 211 (700)
T ss_pred cccccccccceeeeeEEEEEecCCcchhh
Confidence 988889999999999999877 4554443
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.41 E-value=8.1e-08 Score=70.20 Aligned_cols=123 Identities=26% Similarity=0.331 Sum_probs=89.0
Q ss_pred ceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCC-CCeEEeeec
Q 044494 4 KCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLE-LEAFVADFG 82 (144)
Q Consensus 4 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~-~~~~l~d~~ 82 (144)
++.|+=-||++++++.....-.. .+.+...+.+..|++.++.++| +..++|.|++|+||++..+ +..++.|++
T Consensus 339 r~~~ip~e~~~~~s~~l~~~~~~---~~d~~~~~~~~~q~~~~l~~i~---s~~~~~~d~~psni~i~~~~~~~~~~~~~ 412 (524)
T KOG0601|consen 339 RQGYIPLEFCEGGSSSLRSVTSQ---MLDEDPRLRLTAQILTALNVIH---SKLFVHLDVKPSNILISNDGFFSKLGDFG 412 (524)
T ss_pred ccccCchhhhcCcchhhhhHHHH---hcCcchhhhhHHHHHhcccccc---chhhhcccccccceeeccchhhhhccccc
Confidence 44567778999888876553222 2777888899999999999999 8999999999999999986 566788888
Q ss_pred ceeecccCCCCccccc-ccccc-cCccccccCCCCCcchhHHHHHHHHHHHhCCC
Q 044494 83 VARLLNFDSSNRTLLA-GTYGY-IAPELAYTMVVTEKSDVYSFGVVALEVLMGKH 135 (144)
Q Consensus 83 ~~~~~~~~~~~~~~~~-~~~~~-~~pe~~~~~~~~~~~d~~slg~~l~~~~~g~~ 135 (144)
........ ..... .+..| .++.......+..+.|++++|..+.+.+++..
T Consensus 413 ~~t~~~~~---~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ 464 (524)
T KOG0601|consen 413 CWTRLAFS---SGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSP 464 (524)
T ss_pred ccccccee---cccccccccccccchhhccccccccccccccccccccccccCcc
Confidence 77643211 11111 22233 34444555566778999999999999888764
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=98.38 E-value=2.3e-06 Score=56.37 Aligned_cols=78 Identities=26% Similarity=0.298 Sum_probs=55.1
Q ss_pred eEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcC-------------------------------
Q 044494 5 CMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHD------------------------------- 53 (144)
Q Consensus 5 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~------------------------------- 53 (144)
..++||||++|.++.+.+.. ..++......++.+++..+..||..
T Consensus 74 ~~~~v~e~i~G~~l~~~~~~----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 149 (223)
T cd05154 74 TPFYVMERVDGRVLRDRLLR----PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDAS 149 (223)
T ss_pred CceEEEEEeCCEecCCCCCC----CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhh
Confidence 56899999999877664421 1145555555666666666666631
Q ss_pred ----------------------CCCCeEecCCCCCcEEEcC--CCCeEEeeecceee
Q 044494 54 ----------------------CTPPIVHRDISSNNILLNL--ELEAFVADFGVARL 86 (144)
Q Consensus 54 ----------------------~~~~~~h~~i~~~ni~~~~--~~~~~l~d~~~~~~ 86 (144)
....++|+|+.+.|++++. ++.+.++||+.+..
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 150 RTDEPPAMERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred cccccHHHHHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 0356899999999999998 56678999987753
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.05 E-value=2.4e-05 Score=52.52 Aligned_cols=78 Identities=21% Similarity=0.315 Sum_probs=55.7
Q ss_pred eEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeeecce
Q 044494 5 CMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADFGVA 84 (144)
Q Consensus 5 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~~~~ 84 (144)
+..|||||+..... -...-+...+.......+..++++.+.-|.. ..+++|+|++.-||++. ++.+.++|++-+
T Consensus 140 ~nVLvMEfIg~~g~---pAP~LkDv~~e~~e~~~~~~~~v~~~~~l~~--~a~LVHgDLSEyNiL~~-~~~p~iID~~Qa 213 (268)
T COG1718 140 NNVLVMEFIGDDGL---PAPRLKDVPLELEEAEGLYEDVVEYMRRLYK--EAGLVHGDLSEYNILVH-DGEPYIIDVSQA 213 (268)
T ss_pred CCeEEEEeccCCCC---CCCCcccCCcCchhHHHHHHHHHHHHHHHHH--hcCcccccchhhheEEE-CCeEEEEECccc
Confidence 45789999954311 1111122223343567778889898988873 37999999999999999 888999999988
Q ss_pred eecc
Q 044494 85 RLLN 88 (144)
Q Consensus 85 ~~~~ 88 (144)
....
T Consensus 214 V~~~ 217 (268)
T COG1718 214 VTID 217 (268)
T ss_pred cccC
Confidence 7554
|
|
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=97.96 E-value=7.2e-05 Score=48.54 Aligned_cols=80 Identities=23% Similarity=0.299 Sum_probs=60.5
Q ss_pred EEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeeecceee
Q 044494 7 FLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADFGVARL 86 (144)
Q Consensus 7 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~~~~~~ 86 (144)
+.|+||...+++...-..-......++.....++.++++.+..+++.....+.-.|++++|+.++.+++++++|...+..
T Consensus 32 ~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~~~lcDv~~~nfgv~~~~~lk~iDld~v~~ 111 (188)
T PF12260_consen 32 FYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGFFYLCDVSPDNFGVNDDGRLKLIDLDDVFV 111 (188)
T ss_pred EEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCcEEEeecchHHeEEeCCCcEEEEechhcch
Confidence 46889998766643210001112268889999999999999999965445689999999999999999999999876543
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.74 E-value=0.00017 Score=53.66 Aligned_cols=78 Identities=19% Similarity=0.253 Sum_probs=54.3
Q ss_pred ceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeeecc
Q 044494 4 KCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADFGV 83 (144)
Q Consensus 4 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~~~ 83 (144)
+.-.++|||+.|..+.+...-.. .+.+...+...+.++ -++.+- ..|+.|.|..|-|++++.++.+.+.|||.
T Consensus 239 ~~~VLtmE~i~Gi~i~d~~~l~~--~g~d~k~ia~~~~~~--f~~q~~---~dgffHaDpHpGNi~v~~~g~i~~lDfGi 311 (517)
T COG0661 239 TRRVLTMEWIDGIKISDIAALKS--AGIDRKELAELLVRA--FLRQLL---RDGFFHADPHPGNILVRSDGRIVLLDFGI 311 (517)
T ss_pred CCcEEEEEeeCCEecccHHHHHh--cCCCHHHHHHHHHHH--HHHHHH---hcCccccCCCccceEEecCCcEEEEcCcc
Confidence 34578999999988888743211 224533333333222 122233 56999999999999999999999999999
Q ss_pred eeecc
Q 044494 84 ARLLN 88 (144)
Q Consensus 84 ~~~~~ 88 (144)
.....
T Consensus 312 ~g~l~ 316 (517)
T COG0661 312 VGRLD 316 (517)
T ss_pred eecCC
Confidence 87664
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=97.55 E-value=0.0013 Score=43.92 Aligned_cols=31 Identities=19% Similarity=0.260 Sum_probs=26.6
Q ss_pred CCCeEecCCCCCcEEEcCCCCeEEeeecceee
Q 044494 55 TPPIVHRDISSNNILLNLELEAFVADFGVARL 86 (144)
Q Consensus 55 ~~~~~h~~i~~~ni~~~~~~~~~l~d~~~~~~ 86 (144)
...++|+|+.|.|++++.++ +.++||+.+..
T Consensus 152 ~~~~~HgD~~~~Nii~~~~~-~~iIDwe~a~~ 182 (226)
T TIGR02172 152 TSTCLHGDFQIGNLITSGKG-TYWIDLGDFGY 182 (226)
T ss_pred CCceEecCCCCCcEEEcCCC-cEEEechhcCc
Confidence 34678999999999999888 99999987753
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.51 E-value=0.00051 Score=51.23 Aligned_cols=77 Identities=18% Similarity=0.191 Sum_probs=51.1
Q ss_pred eEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcC----CCCeEEee
Q 044494 5 CMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNL----ELEAFVAD 80 (144)
Q Consensus 5 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~----~~~~~l~d 80 (144)
+-.|+|||+.|..+.+.-.- ...+++...+..-+.+. . +++....|++|.|-.|-||+++. +..+.+.|
T Consensus 276 ~RVLtME~~~G~~i~Dl~~i--~~~gi~~~~i~~~l~~~---~--~~qIf~~GffHaDPHPGNilv~~~~~~~~~ivllD 348 (538)
T KOG1235|consen 276 KRVLTMEYVDGIKINDLDAI--DKRGISPHDILNKLVEA---Y--LEQIFKTGFFHADPHPGNILVRPNPEGDEEIVLLD 348 (538)
T ss_pred ceEEEEEecCCccCCCHHHH--HHcCCCHHHHHHHHHHH---H--HHHHHhcCCccCCCCCCcEEEecCCCCCccEEEEc
Confidence 45799999999887775321 11125555444333332 1 12111568999999999999994 56788999
Q ss_pred ecceeecc
Q 044494 81 FGVARLLN 88 (144)
Q Consensus 81 ~~~~~~~~ 88 (144)
+|+.....
T Consensus 349 hGl~~~is 356 (538)
T KOG1235|consen 349 HGLYAVIS 356 (538)
T ss_pred cccccccc
Confidence 99887654
|
|
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=97.25 E-value=0.00051 Score=48.38 Aligned_cols=73 Identities=16% Similarity=0.151 Sum_probs=52.2
Q ss_pred CCCceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEee
Q 044494 1 LHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVAD 80 (144)
Q Consensus 1 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d 80 (144)
|+.++-++|||++.|-.|...-+- .+.+++. ..+...+.-|. ..|++|+|.+--||++..++.++++|
T Consensus 178 iD~~RH~Vvmelv~g~Pl~~v~~v------~d~~~ly---~~lm~~Iv~la---~~GlIHgDFNEFNimv~dd~~i~vID 245 (465)
T KOG2268|consen 178 IDHNRHCVVMELVDGYPLRQVRHV------EDPPTLY---DDLMGLIVRLA---NHGLIHGDFNEFNIMVKDDDKIVVID 245 (465)
T ss_pred ccccceeeHHHhhcccceeeeeec------CChHHHH---HHHHHHHHHHH---HcCceecccchheeEEecCCCEEEee
Confidence 356677899999998777653321 2223332 23444455555 78999999999999999999999999
Q ss_pred eccee
Q 044494 81 FGVAR 85 (144)
Q Consensus 81 ~~~~~ 85 (144)
|--..
T Consensus 246 FPQmv 250 (465)
T KOG2268|consen 246 FPQMV 250 (465)
T ss_pred chHhh
Confidence 96544
|
|
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.13 E-value=0.0043 Score=44.49 Aligned_cols=75 Identities=19% Similarity=0.273 Sum_probs=55.8
Q ss_pred CceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeeec
Q 044494 3 RKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADFG 82 (144)
Q Consensus 3 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~~ 82 (144)
+.+.|++|++- |+++.- + ..-..++++.++.+.+..+.-+.. .-.+-||++.-.||+++ +|.+.++||.
T Consensus 298 ~~y~yl~~kdh-gt~is~-i------k~~~~~e~lsff~s~~sil~~lek--kf~fehrnlt~~niLId-~GnvtLIDfk 366 (488)
T COG5072 298 TLYLYLHFKDH-GTPISI-I------KADRSEEELSFFWSCISILDILEK--KFPFEHRNLTLDNILID-EGNVTLIDFK 366 (488)
T ss_pred ceEEEEEEecC-Cceeee-e------ecccHHHHHHHHHHHHHHHhhhhh--cCCcccccccccceeee-cCceEEEEee
Confidence 45667777765 555532 1 124567778888888777777774 34688999999999999 9999999999
Q ss_pred ceeecc
Q 044494 83 VARLLN 88 (144)
Q Consensus 83 ~~~~~~ 88 (144)
+++...
T Consensus 367 lsRl~~ 372 (488)
T COG5072 367 LSRLSY 372 (488)
T ss_pred eeeccc
Confidence 998543
|
|
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=96.63 E-value=0.00017 Score=59.56 Aligned_cols=132 Identities=14% Similarity=0.052 Sum_probs=90.8
Q ss_pred EEEEEeeccCCCHHHHhhccc-ccCCCCHHHHHHHHHHHHHHHHHHhcCC--CCCeEecCCCCCcEEEcCCCCeEEeeec
Q 044494 6 MFLIYEYMEMGSLFCVLRTDE-EAVGLDWAKRVNIVKGMAHALSYLHHDC--TPPIVHRDISSNNILLNLELEAFVADFG 82 (144)
Q Consensus 6 ~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~~~l~~~l~~lh~~~--~~~~~h~~i~~~ni~~~~~~~~~l~d~~ 82 (144)
-|..++|+.+|.+++.+-++- +...+...-+...-++.+....-.|... +.--+|+++++.|.++..+..+++.++|
T Consensus 1306 e~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~tnlg~T~v~~~Lkf~lpmIVtny~v~~gk~g 1385 (2724)
T KOG1826|consen 1306 EYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLTNLGNTNVSKSLKFTLPMIVTNYNVKLGKGG 1385 (2724)
T ss_pred HHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhcccCCccchhhhhhhhccceecCCcccccccc
Confidence 356778888999999886532 2233333333333333345555544211 2346899999999999999999999999
Q ss_pred ceeecccCCCCcccccccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCC
Q 044494 83 VARLLNFDSSNRTLLAGTYGYIAPELAYTMVVTEKSDVYSFGVVALEVLMGKHPG 137 (144)
Q Consensus 83 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~d~~slg~~l~~~~~g~~p~ 137 (144)
+.+.............+++-|+.+++.+.-.++.++|+|..++-+|+...|..+|
T Consensus 1386 LdKIknp~~sf~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly~rs~~n~~f 1440 (2724)
T KOG1826|consen 1386 LDKIKNPVLSFFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLYLRSDGNAYF 1440 (2724)
T ss_pred cccccCchHhhhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHHHHhcccHHH
Confidence 9884332233344566778888999888888887799999999988877666554
|
|
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=96.32 E-value=0.019 Score=39.91 Aligned_cols=33 Identities=27% Similarity=0.298 Sum_probs=28.6
Q ss_pred CCCeEecCCCCCcEEEcCC----CCeEEeeecceeec
Q 044494 55 TPPIVHRDISSNNILLNLE----LEAFVADFGVARLL 87 (144)
Q Consensus 55 ~~~~~h~~i~~~ni~~~~~----~~~~l~d~~~~~~~ 87 (144)
..+++|+|+.+.||+++.+ +.+.++||..+...
T Consensus 178 ~~~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~~~ 214 (302)
T cd05156 178 PVVFCHNDLQEGNILLLNPSSETKKLVLIDFEYASYN 214 (302)
T ss_pred CceEEecCCCcCeEEecCCCCCCCcEEEEeeCCCCCC
Confidence 5689999999999999975 78999999988643
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length | Back alignment and domain information |
|---|
Probab=96.31 E-value=0.0054 Score=41.15 Aligned_cols=38 Identities=18% Similarity=0.134 Sum_probs=31.2
Q ss_pred HHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeeec
Q 044494 44 AHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADFG 82 (144)
Q Consensus 44 ~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~~ 82 (144)
++.+...|.. ..+.+|+|.+|+||+.+..|.+|+.|=+
T Consensus 151 i~~L~~fH~~-~~~~lHGD~np~NiM~D~~G~lKlVDP~ 188 (308)
T PF07387_consen 151 IKDLMDFHSE-NQHCLHGDCNPDNIMCDKFGYLKLVDPV 188 (308)
T ss_pred HHHHHHhhcc-CCCeecCCCChhheeecCCCCEEecChh
Confidence 3556667754 5789999999999999999999998743
|
The function of this family is unknown. |
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=96.19 E-value=0.013 Score=39.01 Aligned_cols=32 Identities=25% Similarity=0.277 Sum_probs=27.5
Q ss_pred CCCeEecCCCCCcEEEcC-CCCeEEeeecceee
Q 044494 55 TPPIVHRDISSNNILLNL-ELEAFVADFGVARL 86 (144)
Q Consensus 55 ~~~~~h~~i~~~ni~~~~-~~~~~l~d~~~~~~ 86 (144)
..+++|+|+.+.||+++. ++.+.++||..+..
T Consensus 169 ~~~l~H~Dl~~~Nil~~~~~~~~~lIDwe~a~~ 201 (235)
T cd05157 169 PIVFCHNDLLSGNIIYNEEKNSVKFIDYEYAGY 201 (235)
T ss_pred CEEEEcCCCCcCcEEEeCCCCCEEEEEcccCCc
Confidence 357999999999999998 57799999987754
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=96.16 E-value=0.0096 Score=39.87 Aligned_cols=32 Identities=28% Similarity=0.430 Sum_probs=26.6
Q ss_pred CCCeEecCCCCCcEEEcCCCCeEEeeecceee
Q 044494 55 TPPIVHRDISSNNILLNLELEAFVADFGVARL 86 (144)
Q Consensus 55 ~~~~~h~~i~~~ni~~~~~~~~~l~d~~~~~~ 86 (144)
..+++|+|+.+.|++++.+....++||+.+..
T Consensus 163 ~~~l~HGD~~~~Nvlv~~~~i~giIDw~~a~~ 194 (235)
T cd05155 163 PPVWFHGDLAPGNLLVQDGRLSAVIDFGCLGV 194 (235)
T ss_pred CceEEeCCCCCCcEEEECCCEEEEEeCcccCc
Confidence 45699999999999998766567999997753
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=96.06 E-value=0.07 Score=42.46 Aligned_cols=31 Identities=23% Similarity=0.351 Sum_probs=24.6
Q ss_pred CCeEecCCCCCcEEEcCC-CC-eEEeeecceee
Q 044494 56 PPIVHRDISSNNILLNLE-LE-AFVADFGVARL 86 (144)
Q Consensus 56 ~~~~h~~i~~~ni~~~~~-~~-~~l~d~~~~~~ 86 (144)
..++|+|.++.|++++.+ +. ..|+||..+..
T Consensus 225 ~~LvHGD~~~~Nvl~~~~~~~v~aVLDWE~a~~ 257 (822)
T PLN02876 225 TGIVHGDFRIDNLVFHPTEDRVIGILDWELSTL 257 (822)
T ss_pred cceEecCcccccEEEcCCCCeEEEEEeeecccc
Confidence 359999999999999853 33 46899987764
|
|
| >COG0510 ycfN Thiamine kinase and related kinases [Coenzyme transport and metabolism] | Back alignment and domain information |
|---|
Probab=96.04 E-value=0.023 Score=39.08 Aligned_cols=47 Identities=28% Similarity=0.351 Sum_probs=35.5
Q ss_pred HHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeeecceee
Q 044494 39 IVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADFGVARL 86 (144)
Q Consensus 39 ~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~~~~~~ 86 (144)
.+..+-..+.-.+.. ..-++|+|+.|.|++.+..+.+.++||..+..
T Consensus 137 ~~~~l~~~l~~~~~~-~~v~cH~Dl~~~N~l~t~~~~l~LIDWEyAg~ 183 (269)
T COG0510 137 KLKELRRALEEVPKD-DLVPCHNDLNPGNLLLTDKGGLFLIDWEYAGL 183 (269)
T ss_pred HHHHHHHHhhhcCCC-ceeeecCCCCccceEEcCCCcEEEEecccCCC
Confidence 444455555555521 14699999999999999999999999988864
|
|
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.98 E-value=0.0062 Score=42.65 Aligned_cols=32 Identities=22% Similarity=0.243 Sum_probs=27.0
Q ss_pred CCCeEecCCCCCcEEEcCCCCeEEeeecceee
Q 044494 55 TPPIVHRDISSNNILLNLELEAFVADFGVARL 86 (144)
Q Consensus 55 ~~~~~h~~i~~~ni~~~~~~~~~l~d~~~~~~ 86 (144)
..+++|+|+.|.|++++.+....++||+.+..
T Consensus 186 p~~liHgD~~~~Nil~~~~~~~~iIDf~~~~~ 217 (319)
T PRK05231 186 PRGVIHADLFRDNVLFEGDRLSGFIDFYFACN 217 (319)
T ss_pred CcccCCCCCCCCcEEEECCceEEEEecccccC
Confidence 46899999999999999766568999987753
|
|
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=95.82 E-value=0.039 Score=38.40 Aligned_cols=30 Identities=33% Similarity=0.465 Sum_probs=25.7
Q ss_pred CCCeEecCCCCCcEEEcCCCCeEEeeeccee
Q 044494 55 TPPIVHRDISSNNILLNLELEAFVADFGVAR 85 (144)
Q Consensus 55 ~~~~~h~~i~~~ni~~~~~~~~~l~d~~~~~ 85 (144)
..+++|+|+.+.|++++. +.+.++||+.+.
T Consensus 186 ~~~liHgD~~~~Nil~~~-~~i~lIDfd~~~ 215 (313)
T TIGR02906 186 IRGFCHQDYAYHNILLKD-NEVYVIDFDYCT 215 (313)
T ss_pred cCceEcCCCCcccEEEeC-CcEEEEECcccc
Confidence 368999999999999987 668899998664
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=95.79 E-value=0.045 Score=44.66 Aligned_cols=120 Identities=16% Similarity=0.145 Sum_probs=73.3
Q ss_pred EEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCC---cEEEcCCCCeEEe--eecc
Q 044494 9 IYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSN---NILLNLELEAFVA--DFGV 83 (144)
Q Consensus 9 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~---ni~~~~~~~~~l~--d~~~ 83 (144)
..|++...++.+.++.... .+......+..++.+|+.++| +....|.-+... +.-.+.++.+... |++.
T Consensus 264 ~~~~~s~~~~~~~~q~v~~---i~~~~~r~~~~~~~~GL~~~h---~~~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~s 337 (1351)
T KOG1035|consen 264 LQEICSKVELRSLLQSVGS---IPLETLRILHQKLLEGLAYLH---SLSLEHVVLSASSSKESTVDGEGVVAISLSDFDS 337 (1351)
T ss_pred HHhhcCccchHHHHhhccc---cCHHHHHHHHHHHhhhHHHHH---HhccceeEEecccccccccCccceeecchhhhcc
Confidence 3456666677666664443 788888889999999999999 554444433333 2233334444544 6666
Q ss_pred eeecccCCCCcccccccccccCccccccCCCCC--cchhHHHHHHHHHHHhCCC
Q 044494 84 ARLLNFDSSNRTLLAGTYGYIAPELAYTMVVTE--KSDVYSFGVVALEVLMGKH 135 (144)
Q Consensus 84 ~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~--~~d~~slg~~l~~~~~g~~ 135 (144)
.......... ........+.+++.......+. ..|+|.+|.+...+..|..
T Consensus 338 s~~l~d~~~~-~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgll~~~~~~~~~ 390 (1351)
T KOG1035|consen 338 SKPLPDNEKS-FSDLLAEIRNADEDLKENTAKKSRLTDLWCLGLLLLQLSQGED 390 (1351)
T ss_pred cccCCCcccc-hhhcCccccccccccccccchhhhhhHHHHHHHHHhhhhhcCc
Confidence 6544322211 1122334556777666655443 4699999999988877654
|
|
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=95.73 E-value=0.023 Score=39.64 Aligned_cols=31 Identities=26% Similarity=0.334 Sum_probs=27.5
Q ss_pred CCCeEecCCCCCcEEEcCCCCeEEeeeccee
Q 044494 55 TPPIVHRDISSNNILLNLELEAFVADFGVAR 85 (144)
Q Consensus 55 ~~~~~h~~i~~~ni~~~~~~~~~l~d~~~~~ 85 (144)
..+++|+|+.+.|++++.++...++||+.+.
T Consensus 186 ~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~ 216 (307)
T TIGR00938 186 PRGVIHADLFPDNVLFDGDSVKGVIDFYFAC 216 (307)
T ss_pred CCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence 5789999999999999988767899998775
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=95.71 E-value=0.0022 Score=48.78 Aligned_cols=97 Identities=27% Similarity=0.254 Sum_probs=66.0
Q ss_pred CHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeeecceeecccCCCCcccccccccccCcccccc
Q 044494 32 DWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADFGVARLLNFDSSNRTLLAGTYGYIAPELAYT 111 (144)
Q Consensus 32 ~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~ 111 (144)
.+.+.......-.++++++| +..-+|+| ||+.+. ...+..+++.....+... ...+..+++.+++||+...
T Consensus 334 ~~~~~~~~~r~et~~l~~l~---~~~~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~-~~~t~~~~~~~~~pev~~~ 404 (829)
T KOG0576|consen 334 EQYQFAYPLRKETRPLAELH---SSYKVHRD----NILGSE-EEVKLLDFAVPPQLTRTM-KPRTAIGTPEPLAPEVIQE 404 (829)
T ss_pred hhhhhhhhhhhhcccccccc---cccccCcc----cccccc-cccccccccCCcccCccc-ccccCCCCCCCCCchhhcc
Confidence 33334444555566788888 44446776 555444 567888888877655332 3445678999999999999
Q ss_pred CCCCCcchhHHHHHHHHHHHhCCCCC
Q 044494 112 MVVTEKSDVYSFGVVALEVLMGKHPG 137 (144)
Q Consensus 112 ~~~~~~~d~~slg~~l~~~~~g~~p~ 137 (144)
..+....|.|+++.=..++--|..|-
T Consensus 405 ~~~~~~p~~~~~~~~~~~~ap~~pPr 430 (829)
T KOG0576|consen 405 NTIDGCPDSGSLAVSAIQMAPGLPPR 430 (829)
T ss_pred cccccCCCccCCCcchhhcCCCCCCC
Confidence 98888999999997545554455543
|
|
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=95.57 E-value=0.009 Score=39.40 Aligned_cols=32 Identities=28% Similarity=0.442 Sum_probs=22.1
Q ss_pred CCCeEecCCCCCcEEEc-CCCCeEEeeecceee
Q 044494 55 TPPIVHRDISSNNILLN-LELEAFVADFGVARL 86 (144)
Q Consensus 55 ~~~~~h~~i~~~ni~~~-~~~~~~l~d~~~~~~ 86 (144)
...++|+|+.|.||+++ .++.+.++||+.+..
T Consensus 165 ~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~~ 197 (239)
T PF01636_consen 165 PPVLIHGDLHPGNILVDPSDGRIGIIDFEDAGW 197 (239)
T ss_dssp CEEEE-SS-SGGGEEEESSTTEEEE--GTT-EE
T ss_pred CcEEEEeccccccceeeeccceeEEEecccceE
Confidence 56799999999999999 556667999987754
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=95.51 E-value=0.012 Score=38.80 Aligned_cols=31 Identities=32% Similarity=0.427 Sum_probs=22.2
Q ss_pred CCeEecCCCCCcEEE-cCCCCeEEeeecceee
Q 044494 56 PPIVHRDISSNNILL-NLELEAFVADFGVARL 86 (144)
Q Consensus 56 ~~~~h~~i~~~ni~~-~~~~~~~l~d~~~~~~ 86 (144)
..++|+|+.+.||++ ..++.++++||..+..
T Consensus 143 ~v~cHnDl~~~Nil~~~~~~~~~lIDfEya~~ 174 (211)
T PF01633_consen 143 LVFCHNDLNPGNILINNKDGEVKLIDFEYAGY 174 (211)
T ss_dssp EEEE-S--SGGGEEETSSSSCEEE--GTT-EE
T ss_pred ceEeeccCccccEEeccCCCeEEEecHHHHhh
Confidence 579999999999999 8889999999998864
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=95.50 E-value=0.011 Score=40.82 Aligned_cols=32 Identities=25% Similarity=0.302 Sum_probs=27.4
Q ss_pred CCCeEecCCCCCcEEEcCCCCeEEeeecceee
Q 044494 55 TPPIVHRDISSNNILLNLELEAFVADFGVARL 86 (144)
Q Consensus 55 ~~~~~h~~i~~~ni~~~~~~~~~l~d~~~~~~ 86 (144)
..+++|+|+.|.|++++.++.+.|+||+.+..
T Consensus 174 ~~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~~ 205 (296)
T cd05153 174 PRGVIHADLFRDNVLFDGDELSGVIDFYFACT 205 (296)
T ss_pred CCcCCccCcCcccEEEeCCceEEEeehhhhcC
Confidence 35799999999999999877778999987653
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=95.47 E-value=0.015 Score=39.43 Aligned_cols=30 Identities=17% Similarity=0.175 Sum_probs=26.1
Q ss_pred CCeEecCCCCCcEEEcCCCCeEEeeecceee
Q 044494 56 PPIVHRDISSNNILLNLELEAFVADFGVARL 86 (144)
Q Consensus 56 ~~~~h~~i~~~ni~~~~~~~~~l~d~~~~~~ 86 (144)
..++|+|+.|.|++++.++ +.++||..+..
T Consensus 146 ~~l~H~Dl~~~Nil~~~~~-~~lIDwE~a~~ 175 (256)
T TIGR02721 146 LAPLHMDVHAYNLVVTPQG-LKLIDWEYASD 175 (256)
T ss_pred CeeecCCCCcCcEEEeCCC-CEEEeccccCc
Confidence 4689999999999999877 78999987764
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=95.45 E-value=0.016 Score=38.98 Aligned_cols=32 Identities=19% Similarity=0.175 Sum_probs=27.3
Q ss_pred CCCeEecCCCCCcEEEcCCCCeEEeeecceee
Q 044494 55 TPPIVHRDISSNNILLNLELEAFVADFGVARL 86 (144)
Q Consensus 55 ~~~~~h~~i~~~ni~~~~~~~~~l~d~~~~~~ 86 (144)
...++|+|+.|.|++++.+..+.|+||+.+..
T Consensus 162 ~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~~ 193 (244)
T cd05150 162 DLVVTHGDACLPNIIVDPGKFSGFIDLGRLGV 193 (244)
T ss_pred ceEEECCCCCCccEEEeCCcEEEEEEcccccc
Confidence 35699999999999999977778999987753
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >PRK10271 thiK thiamine kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.40 E-value=0.018 Score=37.42 Aligned_cols=32 Identities=16% Similarity=0.090 Sum_probs=26.9
Q ss_pred CCCeEecCCCCCcEEEcCCCCeEEeeecceeec
Q 044494 55 TPPIVHRDISSNNILLNLELEAFVADFGVARLL 87 (144)
Q Consensus 55 ~~~~~h~~i~~~ni~~~~~~~~~l~d~~~~~~~ 87 (144)
....+|+|+.|.|++++.++ ++++|++.+...
T Consensus 76 ~~~p~H~D~~~~N~~~~~~~-~~lIDwe~a~~g 107 (188)
T PRK10271 76 RLAPLHMDVHAGNLVHSASG-LRLIDWEYAGDG 107 (188)
T ss_pred CeeeecCCCCCccEEEECCC-EEEEeCCcccCC
Confidence 34679999999999998777 889999988653
|
|
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=94.94 E-value=0.23 Score=32.69 Aligned_cols=63 Identities=22% Similarity=0.211 Sum_probs=39.6
Q ss_pred EEEEeeccC------CCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCC----Ce
Q 044494 7 FLIYEYMEM------GSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLEL----EA 76 (144)
Q Consensus 7 ~lv~e~~~~------~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~----~~ 76 (144)
-+|+|.+.+ .+|.++++... ++. .....+. +-.++|- +.+|+.+|++|.||++.... .+
T Consensus 93 Glv~e~I~d~dG~~s~TL~~~l~~~~----~~~-~~~~~L~---~f~~~l~---~~~Iv~~dl~~~NIv~~~~~~~~~~l 161 (199)
T PF10707_consen 93 GLVVELIRDADGNISPTLEDYLKEGG----LTE-ELRQALD---EFKRYLL---DHHIVIRDLNPHNIVVQRRDSGEFRL 161 (199)
T ss_pred EEEEEEEECCCCCcCccHHHHHHcCC----ccH-HHHHHHH---HHHHHHH---HcCCeecCCCcccEEEEecCCCceEE
Confidence 356665543 36777775432 454 3333333 3445555 77899999999999997543 35
Q ss_pred EEee
Q 044494 77 FVAD 80 (144)
Q Consensus 77 ~l~d 80 (144)
.++|
T Consensus 162 vlID 165 (199)
T PF10707_consen 162 VLID 165 (199)
T ss_pred EEEe
Confidence 5676
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=94.64 E-value=0.1 Score=37.27 Aligned_cols=33 Identities=18% Similarity=0.265 Sum_probs=27.5
Q ss_pred CCCeEecCCCCCcEEEcC-CCCeEEeeecceeec
Q 044494 55 TPPIVHRDISSNNILLNL-ELEAFVADFGVARLL 87 (144)
Q Consensus 55 ~~~~~h~~i~~~ni~~~~-~~~~~l~d~~~~~~~ 87 (144)
...++|+|+++.||+++. ++.+.++||..+...
T Consensus 199 ~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~~ 232 (344)
T PLN02236 199 EIGFCHNDLQYGNIMIDEETRAITIIDYEYASYN 232 (344)
T ss_pred CceEEeCCCCcCcEEEeCCCCcEEEEeehhcccc
Confidence 457999999999999986 467999999877643
|
|
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=94.61 E-value=0.024 Score=39.62 Aligned_cols=32 Identities=19% Similarity=0.334 Sum_probs=28.4
Q ss_pred CCCeEecCCCCCcEEEcCCCCeEEeeecceee
Q 044494 55 TPPIVHRDISSNNILLNLELEAFVADFGVARL 86 (144)
Q Consensus 55 ~~~~~h~~i~~~ni~~~~~~~~~l~d~~~~~~ 86 (144)
..+++|+|+.+.|++++.++.+.++||..+..
T Consensus 195 ~~~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~ 226 (309)
T TIGR02904 195 RTVLVHGKLSLSHFLYDETRGGYFINFEKASF 226 (309)
T ss_pred ceeeeCCCCcHHhEEEcCCCCEEEEEhhhccc
Confidence 45899999999999999998899999987753
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >smart00587 CHK ZnF_C4 abd HLH domain containing kinases domain | Back alignment and domain information |
|---|
Probab=94.20 E-value=0.052 Score=35.45 Aligned_cols=32 Identities=22% Similarity=0.393 Sum_probs=26.3
Q ss_pred CCCeEecCCCCCcEEEcCCC-----CeEEeeecceee
Q 044494 55 TPPIVHRDISSNNILLNLEL-----EAFVADFGVARL 86 (144)
Q Consensus 55 ~~~~~h~~i~~~ni~~~~~~-----~~~l~d~~~~~~ 86 (144)
...++|+|+.+.|+++..++ .+.++||..+..
T Consensus 119 ~~vl~HgD~~~~N~~~~~~~~~~~~~~~liDfq~~~~ 155 (196)
T smart00587 119 FNVLNHGDLWANNIMFKYDDEGKPEDVALIDFQLSHY 155 (196)
T ss_pred ceEEeeCCCCccceeeccCCCCCccceEEEecccCCc
Confidence 45799999999999998653 578999987764
|
subfamily of choline kinases |
| >COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only] | Back alignment and domain information |
|---|
Probab=94.06 E-value=0.17 Score=36.01 Aligned_cols=28 Identities=29% Similarity=0.509 Sum_probs=25.2
Q ss_pred eEecCCCCCcEEEcCCCC-eEEeeeccee
Q 044494 58 IVHRDISSNNILLNLELE-AFVADFGVAR 85 (144)
Q Consensus 58 ~~h~~i~~~ni~~~~~~~-~~l~d~~~~~ 85 (144)
++|+|+.|.|++++.+.. +.++||+-+.
T Consensus 199 iIH~D~~~~NVl~d~~~~~~g~iDFdDa~ 227 (331)
T COG2334 199 IIHGDLHPDNVLFDDDTDVSGFIDFDDAG 227 (331)
T ss_pred eeecCCCccceeEcCCCCeeeEEEccccc
Confidence 999999999999999885 8899998765
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=93.80 E-value=0.062 Score=37.10 Aligned_cols=32 Identities=22% Similarity=0.409 Sum_probs=26.0
Q ss_pred CCCeEecCCCCCcEEEcCCCC-eEEeeecceee
Q 044494 55 TPPIVHRDISSNNILLNLELE-AFVADFGVARL 86 (144)
Q Consensus 55 ~~~~~h~~i~~~ni~~~~~~~-~~l~d~~~~~~ 86 (144)
...++|+|+++.|++++.++. ..|+||+.+..
T Consensus 184 ~~~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i 216 (276)
T cd05152 184 HTVLVHGDLHPGHILIDEDARVTGLIDWTEAKV 216 (276)
T ss_pred CCeeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence 346999999999999997555 46999997764
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=93.73 E-value=0.21 Score=36.35 Aligned_cols=77 Identities=16% Similarity=0.187 Sum_probs=54.6
Q ss_pred eEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeeecce
Q 044494 5 CMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADFGVA 84 (144)
Q Consensus 5 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~~~~ 84 (144)
.-.|||+++- ++-+ -...-....++...+..+-.+++.-++-|.+ ..+++|.|++--|+++-. |.+.++|.+-+
T Consensus 238 ~hVLVM~FlG-rdgw--~aPkLKd~~ls~~ka~~~Y~~~v~~MR~lY~--~c~LVHADLSEfN~Lyhd-G~lyiIDVSQS 311 (520)
T KOG2270|consen 238 NHVLVMEFLG-RDGW--AAPKLKDASLSTSKARELYQQCVRIMRRLYQ--KCRLVHADLSEFNLLYHD-GKLYIIDVSQS 311 (520)
T ss_pred cceEeeeecc-CCCC--cCcccccccCChHHHHHHHHHHHHHHHHHHH--HhceeccchhhhhheEEC-CEEEEEEcccc
Confidence 4478999994 3322 2222223347777788888899999998886 448999999999997754 56888988766
Q ss_pred eec
Q 044494 85 RLL 87 (144)
Q Consensus 85 ~~~ 87 (144)
...
T Consensus 312 VE~ 314 (520)
T KOG2270|consen 312 VEH 314 (520)
T ss_pred ccC
Confidence 543
|
|
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=93.67 E-value=0.077 Score=37.60 Aligned_cols=31 Identities=29% Similarity=0.427 Sum_probs=26.3
Q ss_pred CeEecCCCCCcEEEcC-CCCeEEeeecceeec
Q 044494 57 PIVHRDISSNNILLNL-ELEAFVADFGVARLL 87 (144)
Q Consensus 57 ~~~h~~i~~~ni~~~~-~~~~~l~d~~~~~~~ 87 (144)
.++|+|+.+.||+++. ++.+.++||..+..-
T Consensus 183 v~CHnDl~~~NiL~~~~~~~l~lID~EYag~n 214 (330)
T PLN02421 183 VFAHNDLLSGNLMLNEDEGKLYFIDFEYGSYS 214 (330)
T ss_pred EEEECCCCcccEEEeCCCCcEEEEcccccCCC
Confidence 5899999999999975 578999999888643
|
|
| >PRK06148 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=93.65 E-value=0.27 Score=40.18 Aligned_cols=32 Identities=28% Similarity=0.409 Sum_probs=26.5
Q ss_pred CCCeEecCCCCCcEEEcCCC--Ce-EEeeecceee
Q 044494 55 TPPIVHRDISSNNILLNLEL--EA-FVADFGVARL 86 (144)
Q Consensus 55 ~~~~~h~~i~~~ni~~~~~~--~~-~l~d~~~~~~ 86 (144)
..+++|+|+++.||+++.++ .+ .|+|||-+..
T Consensus 202 p~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~~ 236 (1013)
T PRK06148 202 PAQVIHNDANDYNILVDADDGERISGLIDFGDAVH 236 (1013)
T ss_pred CcceECCCCCcccEEEcCCCCcceEEEEECccccc
Confidence 57899999999999999875 44 4999997753
|
|
| >PHA03111 Ser/Thr kinase; Provisional | Back alignment and domain information |
|---|
Probab=92.94 E-value=0.46 Score=34.14 Aligned_cols=39 Identities=21% Similarity=0.198 Sum_probs=25.6
Q ss_pred HHHHHHHHHHHH-HHHhcCCCCCeEecCCCCCcEEEcCCC
Q 044494 36 RVNIVKGMAHAL-SYLHHDCTPPIVHRDISSNNILLNLEL 74 (144)
Q Consensus 36 ~~~~~~~l~~~l-~~lh~~~~~~~~h~~i~~~ni~~~~~~ 74 (144)
+..+..|++-.. +.....+-..++|.|+||+||++-...
T Consensus 281 ikfifLQiaLLyikIYelp~c~nF~H~DLKPdNILiFds~ 320 (444)
T PHA03111 281 IKFIFLQIALLYIKIYELPCCDNFLHVDLKPDNILIFDSD 320 (444)
T ss_pred HHHHHHHHHHHHHhhhcCCCcceeeeccCCCCcEEEecCC
Confidence 344555665443 443434346799999999999996554
|
|
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=92.83 E-value=0.15 Score=36.09 Aligned_cols=33 Identities=27% Similarity=0.395 Sum_probs=28.9
Q ss_pred CCCeEecCCCCCcEEEcCCCCeEEeeecceeec
Q 044494 55 TPPIVHRDISSNNILLNLELEAFVADFGVARLL 87 (144)
Q Consensus 55 ~~~~~h~~i~~~ni~~~~~~~~~l~d~~~~~~~ 87 (144)
...++|+|..+.|++++.+..+.|+||+.+..-
T Consensus 197 ~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~lG 229 (321)
T COG3173 197 PPVLVHGDYRPGNLIIDPGRPTGVLDWELATLG 229 (321)
T ss_pred CceeeeCCcccCCEEEeCCCeeEEEeccccccC
Confidence 347999999999999999988999999988653
|
|
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=92.26 E-value=0.42 Score=34.98 Aligned_cols=30 Identities=27% Similarity=0.358 Sum_probs=25.7
Q ss_pred CCCeEecCCCCCcEEEcCCCCeEEeeeccee
Q 044494 55 TPPIVHRDISSNNILLNLELEAFVADFGVAR 85 (144)
Q Consensus 55 ~~~~~h~~i~~~ni~~~~~~~~~l~d~~~~~ 85 (144)
...++|+|+.+.||++..+ .++++|+..+.
T Consensus 222 ~~~l~HgDl~~gni~~~~~-~~~viD~E~a~ 251 (401)
T PRK09550 222 AEALLHGDLHTGSIFVTEE-ETKVIDPEFAF 251 (401)
T ss_pred CCceeeccCCcccEEeeCC-CcEEEeccccc
Confidence 5679999999999999776 58999988664
|
|
| >PRK06149 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=92.16 E-value=0.39 Score=39.18 Aligned_cols=31 Identities=29% Similarity=0.336 Sum_probs=25.4
Q ss_pred CCCeEecCCCCCcEEEcCCC--C---eEEeeeccee
Q 044494 55 TPPIVHRDISSNNILLNLEL--E---AFVADFGVAR 85 (144)
Q Consensus 55 ~~~~~h~~i~~~ni~~~~~~--~---~~l~d~~~~~ 85 (144)
..+++|+|+++.|++++.+. . ..++|||-+.
T Consensus 207 ~~g~IH~Dl~~~Nilv~~~~~~~~~v~giIDFgD~~ 242 (972)
T PRK06149 207 PLQAVHLDITDDNVVGSRDADGRWQPDGVIDFGDLV 242 (972)
T ss_pred cccccCCCCCcccEEEcCCCCCCcceeEEEEcccch
Confidence 67899999999999998653 2 3689998665
|
|
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=92.13 E-value=0.33 Score=31.57 Aligned_cols=67 Identities=19% Similarity=0.179 Sum_probs=43.6
Q ss_pred EEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCC-CcEEEcCCCCeEEeeeccee
Q 044494 7 FLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISS-NNILLNLELEAFVADFGVAR 85 (144)
Q Consensus 7 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~-~ni~~~~~~~~~l~d~~~~~ 85 (144)
++.|||+.|.+|.+.-.. .+..++ ..+++..--|. ..||-|+.++- ...++..+..+.++||..++
T Consensus 88 ~i~me~i~G~~L~~~~~~------~~rk~l----~~vlE~a~~LD---~~GI~H~El~~~~k~vlv~~~~~~iIDFd~At 154 (201)
T COG2112 88 FIRMEYIDGRPLGKLEIG------GDRKHL----LRVLEKAYKLD---RLGIEHGELSRPWKNVLVNDRDVYIIDFDSAT 154 (201)
T ss_pred hhhhhhhcCcchhhhhhc------ccHHHH----HHHHHHHHHHH---HhccchhhhcCCceeEEecCCcEEEEEccchh
Confidence 456999998888664432 122233 33444455555 77899998875 44455555589999999887
Q ss_pred e
Q 044494 86 L 86 (144)
Q Consensus 86 ~ 86 (144)
.
T Consensus 155 ~ 155 (201)
T COG2112 155 F 155 (201)
T ss_pred h
Confidence 3
|
|
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=92.02 E-value=0.48 Score=33.53 Aligned_cols=30 Identities=27% Similarity=0.349 Sum_probs=24.9
Q ss_pred CCCeEecCCCCCcEEEcCCCCeEEeeecceee
Q 044494 55 TPPIVHRDISSNNILLNLELEAFVADFGVARL 86 (144)
Q Consensus 55 ~~~~~h~~i~~~ni~~~~~~~~~l~d~~~~~~ 86 (144)
..+++|+|+.+.|++++ + .+.++||+-+..
T Consensus 195 ~~~liHgD~h~~NvL~~-d-~~~iIDFDd~~~ 224 (325)
T PRK11768 195 RLLRLHGDCHPGNILWR-D-GPHFVDLDDARM 224 (325)
T ss_pred CccceecCCCchhcccc-C-CcEEEeCCCCCC
Confidence 56799999999999995 3 578999987753
|
|
| >COG4499 Predicted membrane protein [Function unknown] | Back alignment and domain information |
|---|
Probab=91.78 E-value=2.5 Score=30.67 Aligned_cols=83 Identities=18% Similarity=0.154 Sum_probs=55.6
Q ss_pred CCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeeecceeecccCCCCcccccccccccCccccc
Q 044494 31 LDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADFGVARLLNFDSSNRTLLAGTYGYIAPELAY 110 (144)
Q Consensus 31 ~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~ 110 (144)
......++++.+....+..+- +.-.|.=+.|+||+++.+..+.+..+|+-....+ .-+.||.+
T Consensus 82 ~~k~~Klr~a~~~I~~l~e~~----~tr~~~~laPeNilf~~~l~p~~vH~Glk~~lpP------------ye~tee~f- 144 (434)
T COG4499 82 KEKTRKLRLALQNIATLSELN----NTRYTFFLAPENILFDGGLTPFFVHRGLKNSLPP------------YEMTEERF- 144 (434)
T ss_pred HHHHHHHHHHHHHHHHHHHhh----ccceeEEecchheEEcCCCceEEEecchhccCCC------------CCCCHHHH-
Confidence 455566777777777777664 4467788899999999999999998887654321 11222222
Q ss_pred cCCCCCcchhHHHHHHHHHHHhCCCCCCC
Q 044494 111 TMVVTEKSDVYSFGVVALEVLMGKHPGEL 139 (144)
Q Consensus 111 ~~~~~~~~d~~slg~~l~~~~~g~~p~~~ 139 (144)
.-.+-+++..++.|..+|+.
T Consensus 145 ---------~~~ykA~~~~~fn~k~~Fe~ 164 (434)
T COG4499 145 ---------LKEYKALAIYAFNGKFSFES 164 (434)
T ss_pred ---------HHHHHHHHHHHHcCCccHHH
Confidence 22555666677777777754
|
|
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=89.17 E-value=0.81 Score=33.54 Aligned_cols=30 Identities=17% Similarity=0.294 Sum_probs=25.1
Q ss_pred CCCeEecCCCCCcEEEcCCCCeEEeeeccee
Q 044494 55 TPPIVHRDISSNNILLNLELEAFVADFGVAR 85 (144)
Q Consensus 55 ~~~~~h~~i~~~ni~~~~~~~~~l~d~~~~~ 85 (144)
.+.++|+|+.|.||+++.+. ++++|...+.
T Consensus 226 ~~aLlHGDlHtGSI~v~~~~-~kvIDpEFAf 255 (409)
T PRK12396 226 AQALIHGDLHTGSVFVKNDS-TKVIDPEFAF 255 (409)
T ss_pred chhhccCcCCCCCEEecCCc-eEEEcccccc
Confidence 67899999999999999864 8899866553
|
|
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=88.98 E-value=1 Score=32.55 Aligned_cols=30 Identities=23% Similarity=0.262 Sum_probs=25.1
Q ss_pred CCCeEecCCCCCcEEEcCCCCeEEeeeccee
Q 044494 55 TPPIVHRDISSNNILLNLELEAFVADFGVAR 85 (144)
Q Consensus 55 ~~~~~h~~i~~~ni~~~~~~~~~l~d~~~~~ 85 (144)
...++|+|+.+.||+++.++ ++++|+..+.
T Consensus 191 ~~~llHGDl~~gNi~~~~~~-~~~iD~e~~~ 220 (370)
T TIGR01767 191 AETLLHGDLHSGSIFVSEHE-TKVIDPEFAF 220 (370)
T ss_pred cceeeeccCCcccEEEcCCC-CEEEcCcccc
Confidence 67899999999999997754 7799987554
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >PF02958 EcKinase: Ecdysteroid kinase; InterPro: IPR004119 This family includes proteins of unknown function | Back alignment and domain information |
|---|
Probab=88.32 E-value=0.31 Score=33.69 Aligned_cols=31 Identities=32% Similarity=0.534 Sum_probs=25.3
Q ss_pred CCeEecCCCCCcEEEcCCC-----CeEEeeecceee
Q 044494 56 PPIVHRDISSNNILLNLEL-----EAFVADFGVARL 86 (144)
Q Consensus 56 ~~~~h~~i~~~ni~~~~~~-----~~~l~d~~~~~~ 86 (144)
.-++|+|+.+.|+++..++ .+.++||..++.
T Consensus 215 ~vl~HGD~w~nNilf~~~~~g~~~~~~liDfQ~~~~ 250 (294)
T PF02958_consen 215 NVLCHGDFWTNNILFKYDDDGKPIDVVLIDFQLARY 250 (294)
T ss_pred eEEEcCccCHHhEeEccccccccccceeeccccccC
Confidence 4699999999999997653 578999987764
|
All known members of this group are proteins from drosophila and Caenorhabditis elegans. |
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 144 | ||||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 8e-21 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 4e-20 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 5e-16 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 3e-15 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 3e-14 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 8e-14 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 6e-13 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 1e-12 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 1e-12 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 3e-12 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 2e-11 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 2e-11 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 2e-11 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 2e-11 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 2e-11 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 3e-11 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 3e-11 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 3e-11 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 3e-11 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 3e-11 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 3e-11 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 3e-11 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 4e-11 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 4e-11 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 4e-11 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 4e-11 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 6e-11 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 6e-11 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 7e-11 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 7e-11 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 8e-11 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 9e-11 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 9e-11 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 9e-11 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 1e-10 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 1e-10 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 1e-10 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 1e-10 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 2e-10 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 2e-10 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 2e-10 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 4e-10 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 6e-10 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 7e-10 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 7e-10 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 7e-10 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 8e-10 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 1e-09 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 1e-09 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 2e-09 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 2e-09 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 2e-09 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 2e-09 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 2e-09 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 2e-09 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 3e-09 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 5e-09 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 5e-09 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 6e-09 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 1e-08 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 2e-08 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 2e-08 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 3e-08 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 3e-08 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 3e-08 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 3e-08 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 4e-08 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 4e-08 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 5e-08 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 5e-08 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 6e-08 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 6e-08 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 6e-08 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 6e-08 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 6e-08 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 7e-08 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 7e-08 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 7e-08 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 7e-08 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 9e-08 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 9e-08 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 1e-07 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 1e-07 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 1e-07 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 1e-07 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 1e-07 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 1e-07 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 1e-07 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 1e-07 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 1e-07 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 1e-07 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 1e-07 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 2e-07 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 2e-07 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 2e-07 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-07 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 2e-07 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 2e-07 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 2e-07 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-07 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 3e-07 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 4e-07 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 4e-07 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 4e-07 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 4e-07 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 4e-07 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 4e-07 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 4e-07 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 4e-07 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 4e-07 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 4e-07 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 4e-07 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 4e-07 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 5e-07 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 5e-07 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 5e-07 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 5e-07 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 6e-07 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 6e-07 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 7e-07 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 7e-07 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 7e-07 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 8e-07 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 8e-07 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 8e-07 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 1e-06 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 1e-06 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 1e-06 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 1e-06 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 1e-06 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 1e-06 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 1e-06 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 1e-06 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 1e-06 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 1e-06 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 1e-06 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 1e-06 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 1e-06 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 2e-06 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 2e-06 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 2e-06 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-06 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 2e-06 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 2e-06 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 2e-06 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 2e-06 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 2e-06 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 2e-06 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 2e-06 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 2e-06 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 2e-06 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 3e-06 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 3e-06 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 3e-06 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 3e-06 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 3e-06 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 3e-06 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 3e-06 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 3e-06 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 3e-06 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 3e-06 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 3e-06 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 3e-06 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 3e-06 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 4e-06 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 4e-06 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 4e-06 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 4e-06 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 4e-06 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-06 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 4e-06 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 4e-06 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 4e-06 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 4e-06 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-06 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-06 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-06 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 4e-06 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-06 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-06 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-06 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 4e-06 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 4e-06 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 4e-06 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 4e-06 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 4e-06 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 4e-06 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 4e-06 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 4e-06 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 4e-06 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 4e-06 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-06 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 4e-06 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 4e-06 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-06 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 5e-06 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 5e-06 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 5e-06 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-06 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-06 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 5e-06 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 6e-06 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 6e-06 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 6e-06 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 6e-06 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 6e-06 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 7e-06 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 8e-06 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 8e-06 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 8e-06 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 9e-06 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 1e-05 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 1e-05 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 1e-05 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 1e-05 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 1e-05 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 1e-05 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 1e-05 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 1e-05 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 1e-05 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 1e-05 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 1e-05 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 1e-05 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 1e-05 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 1e-05 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 1e-05 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 1e-05 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 1e-05 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 1e-05 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 2e-05 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 2e-05 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 2e-05 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 2e-05 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 2e-05 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 2e-05 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 2e-05 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 2e-05 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 2e-05 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-05 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 3e-05 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 3e-05 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 3e-05 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 3e-05 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 3e-05 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 3e-05 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 3e-05 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 3e-05 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 3e-05 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 3e-05 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 3e-05 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 3e-05 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 4e-05 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 4e-05 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 4e-05 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 4e-05 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 4e-05 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 4e-05 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 4e-05 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-05 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 4e-05 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 4e-05 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 4e-05 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 4e-05 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 4e-05 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 5e-05 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 5e-05 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 5e-05 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 5e-05 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 6e-05 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 6e-05 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 6e-05 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 6e-05 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 6e-05 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 7e-05 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 7e-05 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 7e-05 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 7e-05 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 7e-05 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 7e-05 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 7e-05 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 7e-05 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 7e-05 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 7e-05 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 8e-05 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 8e-05 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 8e-05 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 8e-05 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 8e-05 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 9e-05 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 9e-05 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 9e-05 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 9e-05 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 9e-05 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 1e-04 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 1e-04 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 1e-04 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 1e-04 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 1e-04 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 1e-04 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 1e-04 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 1e-04 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 1e-04 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 1e-04 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 1e-04 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 1e-04 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 1e-04 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 1e-04 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 1e-04 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 1e-04 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 1e-04 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 1e-04 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 1e-04 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 1e-04 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 1e-04 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 1e-04 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 1e-04 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-04 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 1e-04 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 1e-04 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 1e-04 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 1e-04 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 1e-04 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 1e-04 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 1e-04 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 1e-04 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 1e-04 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 1e-04 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-04 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 1e-04 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 1e-04 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-04 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-04 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 1e-04 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 1e-04 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 1e-04 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 1e-04 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 1e-04 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 1e-04 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 1e-04 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 2e-04 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 2e-04 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 2e-04 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-04 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 2e-04 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 2e-04 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 2e-04 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 2e-04 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 2e-04 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 2e-04 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 2e-04 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 2e-04 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 2e-04 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 2e-04 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 2e-04 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 2e-04 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 2e-04 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 2e-04 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 2e-04 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 2e-04 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 2e-04 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 2e-04 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 2e-04 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 2e-04 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 2e-04 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 2e-04 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 2e-04 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 2e-04 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 2e-04 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-04 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 2e-04 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 2e-04 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-04 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 2e-04 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 2e-04 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 2e-04 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 2e-04 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 2e-04 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 2e-04 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-04 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 3e-04 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 3e-04 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 3e-04 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 3e-04 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 3e-04 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 3e-04 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 3e-04 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 3e-04 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 4e-04 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 4e-04 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 4e-04 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 4e-04 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 4e-04 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 4e-04 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 4e-04 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 4e-04 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 4e-04 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 4e-04 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 4e-04 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 4e-04 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 4e-04 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 5e-04 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 5e-04 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 5e-04 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 6e-04 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 6e-04 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 6e-04 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 6e-04 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 6e-04 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 6e-04 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 6e-04 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 6e-04 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 6e-04 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 6e-04 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 6e-04 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 6e-04 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 6e-04 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 6e-04 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 6e-04 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 6e-04 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 6e-04 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 7e-04 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 7e-04 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 7e-04 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 7e-04 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 7e-04 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 7e-04 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 7e-04 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 7e-04 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 7e-04 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 7e-04 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 7e-04 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 7e-04 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 8e-04 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 9e-04 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 9e-04 |
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 176 bits (448), Expect = 1e-55
Identities = 57/131 (43%), Positives = 82/131 (62%), Gaps = 2/131 (1%)
Query: 8 LIYEYMEMGSL-FCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSN 66
L+Y YM GS+ C+ E LDW KR I G A L+YLH C P I+HRD+ +
Sbjct: 104 LVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAA 163
Query: 67 NILLNLELEAFVADFGVARLLNFDSSN-RTLLAGTYGYIAPELAYTMVVTEKSDVYSFGV 125
NILL+ E EA V DFG+A+L+++ ++ T + GT G+IAPE T +EK+DV+ +GV
Sbjct: 164 NILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGV 223
Query: 126 VALEVLMGKHP 136
+ LE++ G+
Sbjct: 224 MLLELITGQRA 234
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 154 bits (391), Expect = 2e-47
Identities = 56/136 (41%), Positives = 76/136 (55%), Gaps = 10/136 (7%)
Query: 6 MFLIYEYMEMGSLFCVL-RTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDIS 64
M LIY+YME G+L L +D + + W +R+ I G A L YLH T I+HRD+
Sbjct: 110 MILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLH---TRAIIHRDVK 166
Query: 65 SNNILLNLELEAFVADFGVARLLNFDSSNR----TLLAGTYGYIAPELAYTMVVTEKSDV 120
S NILL+ + DFG+++ ++ T++ GT GYI PE +TEKSDV
Sbjct: 167 SINILLDENFVPKITDFGISKK--GTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDV 224
Query: 121 YSFGVVALEVLMGKHP 136
YSFGVV EVL +
Sbjct: 225 YSFGVVLFEVLCARSA 240
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 145 bits (368), Expect = 5e-44
Identities = 51/131 (38%), Positives = 72/131 (54%), Gaps = 6/131 (4%)
Query: 8 LIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNN 67
L+Y YM GSL L + L W R I +G A+ +++LH + +HRDI S N
Sbjct: 107 LVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENH---HIHRDIKSAN 163
Query: 68 ILLNLELEAFVADFGVARLL--NFDSSNRTLLAGTYGYIAPELAYTMVVTEKSDVYSFGV 125
ILL+ A ++DFG+AR + + + GT Y+APE A +T KSD+YSFGV
Sbjct: 164 ILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPE-ALRGEITPKSDIYSFGV 222
Query: 126 VALEVLMGKHP 136
V LE++ G
Sbjct: 223 VLLEIITGLPA 233
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 5e-42
Identities = 45/147 (30%), Positives = 68/147 (46%), Gaps = 18/147 (12%)
Query: 6 MFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHD-------CTPPI 58
++LI + E GSL L+ + + W + +I + MA L+YLH D P I
Sbjct: 97 LWLITAFHEKGSLSDFLKANV----VSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAI 152
Query: 59 VHRDISSNNILLNLELEAFVADFGVARLLNFDSS--NRTLLAGTYGYIAPELA-----YT 111
HRDI S N+LL L A +ADFG+A S + GT Y+APE+ +
Sbjct: 153 SHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQ 212
Query: 112 MVVTEKSDVYSFGVVALEVLMGKHPGE 138
+ D+Y+ G+V E+ +
Sbjct: 213 RDAFLRIDMYAMGLVLWELASRCTAAD 239
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 4e-40
Identities = 46/132 (34%), Positives = 75/132 (56%), Gaps = 1/132 (0%)
Query: 5 CMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDIS 64
+ ++ EY+ GSL+ +L LD +R+++ +A ++YLH+ PPIVHR++
Sbjct: 108 NLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHN-RNPPIVHRNLK 166
Query: 65 SNNILLNLELEAFVADFGVARLLNFDSSNRTLLAGTYGYIAPELAYTMVVTEKSDVYSFG 124
S N+L++ + V DFG++RL + AGT ++APE+ EKSDVYSFG
Sbjct: 167 SPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFG 226
Query: 125 VVALEVLMGKHP 136
V+ E+ + P
Sbjct: 227 VILWELATLQQP 238
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 4e-40
Identities = 38/132 (28%), Positives = 64/132 (48%), Gaps = 4/132 (3%)
Query: 6 MFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISS 65
+ L+ EY E GSL+ VL E A ++ + ++YLH ++HRD+
Sbjct: 74 VCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKP 133
Query: 66 NNILLNLELEAF-VADFGVARLLNFDSSNRTLLAGTYGYIAPELAYTMVVTEKSDVYSFG 124
N+LL + DFG A + +N G+ ++APE+ +EK DV+S+G
Sbjct: 134 PNLLLVAGGTVLKICDFGTACDIQTHMTNNK---GSAAWMAPEVFEGSNYSEKCDVFSWG 190
Query: 125 VVALEVLMGKHP 136
++ EV+ + P
Sbjct: 191 IILWEVITRRKP 202
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 1e-37
Identities = 40/140 (28%), Positives = 67/140 (47%), Gaps = 13/140 (9%)
Query: 4 KCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDI 63
++ E++ G L+ L + W+ ++ ++ +A + Y+ + PPIVHRD+
Sbjct: 94 NPPRMVMEFVPCGDLYHRLLDKAHP--IKWSVKLRLMLDIALGIEYMQN-QNPPIVHRDL 150
Query: 64 SSNNILLNLELEAF-----VADFGVARLLNFDSSNRTLLAGTYGYIAPEL--AYTMVVTE 116
S NI L E VADFG+++ S G + ++APE A TE
Sbjct: 151 RSPNIFLQSLDENAPVCAKVADFGLSQQSVHSVSGLL---GNFQWMAPETIGAEEESYTE 207
Query: 117 KSDVYSFGVVALEVLMGKHP 136
K+D YSF ++ +L G+ P
Sbjct: 208 KADTYSFAMILYTILTGEGP 227
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 2e-36
Identities = 43/140 (30%), Positives = 72/140 (51%), Gaps = 14/140 (10%)
Query: 5 CMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDIS 64
+ L+ E+ G L VL + VN +A ++YLH + PI+HRD+
Sbjct: 80 NLCLVMEFARGGPLNRVLSGKR----IPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLK 135
Query: 65 SNNILLNLELEAF--------VADFGVARLLNFDSSNRTLLAGTYGYIAPELAYTMVVTE 116
S+NIL+ ++E + DFG+AR + + AG Y ++APE+ + ++
Sbjct: 136 SSNILILQKVENGDLSNKILKITDFGLAREW--HRTTKMSAAGAYAWMAPEVIRASMFSK 193
Query: 117 KSDVYSFGVVALEVLMGKHP 136
SDV+S+GV+ E+L G+ P
Sbjct: 194 GSDVWSYGVLLWELLTGEVP 213
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 1e-35
Identities = 30/134 (22%), Positives = 58/134 (43%), Gaps = 10/134 (7%)
Query: 6 MFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISS 65
LI +M GSL+ VL V +D ++ V MA +++LH P I ++S
Sbjct: 84 PTLITHWMPYGSLYNVLHEGTNFV-VDQSQAVKFALDMARGMAFLHT-LEPLIPRHALNS 141
Query: 66 NNILLNLELEAFVADFGVARLLNFDSSNRTLLAGTYGYIAPEL---AYTMVVTEKSDVYS 122
+++++ ++ A ++ V S ++APE +D++S
Sbjct: 142 RSVMIDEDMTARISMADVKF-----SFQSPGRMYAPAWVAPEALQKKPEDTNRRSADMWS 196
Query: 123 FGVVALEVLMGKHP 136
F V+ E++ + P
Sbjct: 197 FAVLLWELVTREVP 210
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 2e-34
Identities = 41/148 (27%), Positives = 64/148 (43%), Gaps = 19/148 (12%)
Query: 6 MFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLH-----HDCTPPIVH 60
++LI +Y E GSL+ L++ LD + + L +LH P I H
Sbjct: 110 LYLITDYHENGSLYDYLKSTT----LDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAH 165
Query: 61 RDISSNNILLNLELEAFVADFGVARLLNFDSSNRTLL----AGTYGYIAPE-LAYTMVV- 114
RD+ S NIL+ +AD G+A D++ + GT Y+ PE L ++
Sbjct: 166 RDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRN 225
Query: 115 ----TEKSDVYSFGVVALEVLMGKHPGE 138
+D+YSFG++ EV G
Sbjct: 226 HFQSYIMADMYSFGLILWEVARRCVSGG 253
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 4e-34
Identities = 42/148 (28%), Positives = 68/148 (45%), Gaps = 19/148 (12%)
Query: 6 MFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHD-----CTPPIVH 60
++LI Y EMGSL+ L+ LD + IV +A L++LH + P I H
Sbjct: 81 LWLITHYHEMGSLYDYLQLTT----LDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAH 136
Query: 61 RDISSNNILLNLELEAFVADFGVARLLNFDSS----NRTLLAGTYGYIAPEL------AY 110
RD+ S NIL+ + +AD G+A + + ++ GT Y+APE+
Sbjct: 137 RDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVD 196
Query: 111 TMVVTEKSDVYSFGVVALEVLMGKHPGE 138
++ D+++FG+V EV
Sbjct: 197 CFDSYKRVDIWAFGLVLWEVARRMVSNG 224
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 3e-33
Identities = 40/137 (29%), Positives = 71/137 (51%), Gaps = 10/137 (7%)
Query: 5 CMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDIS 64
+ ++ ++ E SL+ L E + K ++I + A + YLH I+HRD+
Sbjct: 93 QLAIVTQWCEGSSLYHHLHASETK--FEMKKLIDIARQTARGMDYLH---AKSIIHRDLK 147
Query: 65 SNNILLNLELEAFVADFGVARLLN--FDSSNRTLLAGTYGYIAPEL---AYTMVVTEKSD 119
SNNI L+ + + DFG+A + S L+G+ ++APE+ + + +SD
Sbjct: 148 SNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSD 207
Query: 120 VYSFGVVALEVLMGKHP 136
VY+FG+V E++ G+ P
Sbjct: 208 VYAFGIVLYELMTGQLP 224
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 6e-33
Identities = 37/148 (25%), Positives = 63/148 (42%), Gaps = 19/148 (12%)
Query: 6 MFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHD-----CTPPIVH 60
++L+ +Y E GSLF L + + + A L++LH + P I H
Sbjct: 115 LWLVSDYHEHGSLFDYLNRYT----VTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAH 170
Query: 61 RDISSNNILLNLELEAFVADFGVARLLNFDSSNRTLL----AGTYGYIAPEL------AY 110
RD+ S NIL+ +AD G+A + + + GT Y+APE+
Sbjct: 171 RDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMK 230
Query: 111 TMVVTEKSDVYSFGVVALEVLMGKHPGE 138
+++D+Y+ G+V E+ G
Sbjct: 231 HFESFKRADIYAMGLVFWEIARRCSIGG 258
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 116 bits (291), Expect = 2e-32
Identities = 37/150 (24%), Positives = 62/150 (41%), Gaps = 25/150 (16%)
Query: 6 MFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHD------CTPPIV 59
L+ EY GSL L DW + + L+YLH + P I
Sbjct: 87 YLLVMEYYPNGSLXKYLSLHT----SDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAIS 142
Query: 60 HRDISSNNILLNLELEAFVADFGVARLL--------NFDSSNRTLLAGTYGYIAPELAYT 111
HRD++S N+L+ + ++DFG++ L + + GT Y+APE+
Sbjct: 143 HRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEG 202
Query: 112 MV-------VTEKSDVYSFGVVALEVLMGK 134
V ++ D+Y+ G++ E+ M
Sbjct: 203 AVNLRDXESALKQVDMYALGLIYWEIFMRC 232
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 3e-32
Identities = 43/149 (28%), Positives = 77/149 (51%), Gaps = 19/149 (12%)
Query: 2 HRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHR 61
K + I EY++ G+L ++++ + W++RV+ K +A ++YLH + I+HR
Sbjct: 78 KDKRLNFITEYIKGGTLRGIIKSMDSQ--YPWSQRVSFAKDIASGMAYLH---SMNIIHR 132
Query: 62 DISSNNILLNLELEAFVADFGVARLLNFDSSN--------------RTLLAGTYGYIAPE 107
D++S+N L+ VADFG+ARL+ + + R + G ++APE
Sbjct: 133 DLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPE 192
Query: 108 LAYTMVVTEKSDVYSFGVVALEVLMGKHP 136
+ EK DV+SFG+V E++ +
Sbjct: 193 MINGRSYDEKVDVFSFGIVLCEIIGRVNA 221
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 5e-32
Identities = 30/146 (20%), Positives = 62/146 (42%), Gaps = 20/146 (13%)
Query: 5 CMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDIS 64
+ +I + +L+ V+R + LD K I + + + YLH I+H+D+
Sbjct: 103 HLAIITSLCKGRTLYSVVRDAKIV--LDVNKTRQIAQEIVKGMGYLH---AKGILHKDLK 157
Query: 65 SNNILLNLELEAFVADFGVARLLNFDSSNR-----TLLAGTYGYIAPEL---------AY 110
S N+ + + + DFG+ + + R + G ++APE+
Sbjct: 158 SKNVFYD-NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEED 216
Query: 111 TMVVTEKSDVYSFGVVALEVLMGKHP 136
+ ++ SDV++ G + E+ + P
Sbjct: 217 KLPFSKHSDVFALGTIWYELHAREWP 242
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 99.3 bits (248), Expect = 2e-26
Identities = 44/140 (31%), Positives = 70/140 (50%), Gaps = 16/140 (11%)
Query: 2 HRKCMFLIYEYMEMGSLFCVLRT----DEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPP 57
+KC+ L+ E M G+L L+ + + W + I+KG L +LH TPP
Sbjct: 100 GKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRS-WCR--QILKG----LQFLH-TRTPP 151
Query: 58 IVHRDISSNNILLNLEL-EAFVADFGVARLLNFDSSNRTLLAGTYGYIAPELAYTMVVTE 116
I+HRD+ +NI + + D G+A L +S + GT ++APE+ Y E
Sbjct: 152 IIHRDLKCDNIFITGPTGSVKIGDLGLATLKR--ASFAKAVIGTPEFMAPEM-YEEKYDE 208
Query: 117 KSDVYSFGVVALEVLMGKHP 136
DVY+FG+ LE+ ++P
Sbjct: 209 SVDVYAFGMCMLEMATSEYP 228
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 94.8 bits (236), Expect = 2e-24
Identities = 41/141 (29%), Positives = 64/141 (45%), Gaps = 14/141 (9%)
Query: 1 LHRKCMFLIYEYMEMGSLFCVLRTD-----EEAVGLDWAKRVNIVKGMAHALSYLHHDCT 55
++++ +Y E G LF + +E LDW + + AL ++H
Sbjct: 93 EENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQ------ICLALKHVH---D 143
Query: 56 PPIVHRDISSNNILLNLELEAFVADFGVARLLNFDSSNRTLLAGTYGYIAPELAYTMVVT 115
I+HRDI S NI L + + DFG+AR+LN GT Y++PE+
Sbjct: 144 RKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACIGTPYYLSPEICENKPYN 203
Query: 116 EKSDVYSFGVVALEVLMGKHP 136
KSD+++ G V E+ KH
Sbjct: 204 NKSDIWALGCVLYELCTLKHA 224
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 93.0 bits (231), Expect = 1e-23
Identities = 42/136 (30%), Positives = 69/136 (50%), Gaps = 19/136 (13%)
Query: 5 CMFLIYEYMEMGSLFCVLRT----DEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVH 60
CM E+M+ GSL VL+ E+ +G + + L+YL I+H
Sbjct: 109 CM----EHMDGGSLDQVLKKAGRIPEQILGK-------VSIAVIKGLTYLREKHK--IMH 155
Query: 61 RDISSNNILLNLELEAFVADFGVARLLNFDSSNRTLLAGTYGYIAPELAYTMVVTEKSDV 120
RD+ +NIL+N E + DFGV+ L DS + GT Y++PE + +SD+
Sbjct: 156 RDVKPSNILVNSRGEIKLCDFGVSGQLI-DSMANS-FVGTRSYMSPERLQGTHYSVQSDI 213
Query: 121 YSFGVVALEVLMGKHP 136
+S G+ +E+ +G++P
Sbjct: 214 WSMGLSLVEMAVGRYP 229
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 91.5 bits (228), Expect = 2e-23
Identities = 35/132 (26%), Positives = 57/132 (43%), Gaps = 7/132 (5%)
Query: 6 MFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISS 65
+++ + L +LR L + V IV+ + AL H HRD+
Sbjct: 109 LYVDMRLINGVDLAAMLRRQG---PLAPPRAVAIVRQIGSALDAAHAA---GATHRDVKP 162
Query: 66 NNILLNLELEAFVADFGVARLLNFDSSNRT-LLAGTYGYIAPELAYTMVVTEKSDVYSFG 124
NIL++ + A++ DFG+A + + GT Y+APE T ++D+Y+
Sbjct: 163 ENILVSADDFAYLVDFGIASATTDEKLTQLGNTVGTLYYMAPERFSESHATYRADIYALT 222
Query: 125 VVALEVLMGKHP 136
V E L G P
Sbjct: 223 CVLYECLTGSPP 234
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 90.4 bits (225), Expect = 6e-23
Identities = 40/131 (30%), Positives = 65/131 (49%), Gaps = 7/131 (5%)
Query: 7 FLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSN 66
+L+ EY+E +L + + L +N + + + H IVHRDI
Sbjct: 87 YLVMEYIEGPTLSEYIESHGP---LSVDTAINFTNQILDGIKHAHDM---RIVHRDIKPQ 140
Query: 67 NILLNLELEAFVADFGVARLLNFDSSNRT-LLAGTYGYIAPELAYTMVVTEKSDVYSFGV 125
NIL++ + DFG+A+ L+ S +T + GT Y +PE A E +D+YS G+
Sbjct: 141 NILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGI 200
Query: 126 VALEVLMGKHP 136
V E+L+G+ P
Sbjct: 201 VLYEMLVGEPP 211
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 90.4 bits (225), Expect = 7e-23
Identities = 39/133 (29%), Positives = 70/133 (52%), Gaps = 9/133 (6%)
Query: 7 FLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSN 66
+++ EY++ +L ++ T+ + + + ++ AL++ H + I+HRD+
Sbjct: 92 YIVMEYVDGVTLRDIVHTEGP---MTPKRAIEVIADACQALNFSHQN---GIIHRDVKPA 145
Query: 67 NILLNLELEAFVADFGVARLLNFDSSNRT---LLAGTYGYIAPELAYTMVVTEKSDVYSF 123
NI+++ V DFG+AR + ++ T + GT Y++PE A V +SDVYS
Sbjct: 146 NIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSL 205
Query: 124 GVVALEVLMGKHP 136
G V EVL G+ P
Sbjct: 206 GCVLYEVLTGEPP 218
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 89.6 bits (223), Expect = 8e-23
Identities = 43/143 (30%), Positives = 66/143 (46%), Gaps = 17/143 (11%)
Query: 4 KCMFLIYEYMEMGSLFCVLRT--------DEEAVGLDWAKRVNIVKGMAHALSYLH--HD 53
++++ EY E G L V+ DEE V L + + AL H D
Sbjct: 80 TTLYIVMEYCEGGDLASVITKGTKERQYLDEEFV-LRVMTQ------LTLALKECHRRSD 132
Query: 54 CTPPIVHRDISSNNILLNLELEAFVADFGVARLLNFDSSNRTLLAGTYGYIAPELAYTMV 113
++HRD+ N+ L+ + + DFG+AR+LN D+S GT Y++PE M
Sbjct: 133 GGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFVGTPYYMSPEQMNRMS 192
Query: 114 VTEKSDVYSFGVVALEVLMGKHP 136
EKSD++S G + E+ P
Sbjct: 193 YNEKSDIWSLGCLLYELCALMPP 215
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 88.5 bits (220), Expect = 3e-22
Identities = 29/143 (20%), Positives = 60/143 (41%), Gaps = 17/143 (11%)
Query: 1 LHRKCMFLIYEYMEMGSLFCVLRT------DEEAVGLDWAKRVNIVKGMAHALSYLHHDC 54
KC+F+ E+ + G+L + D+ + + + + + Y+H
Sbjct: 90 SKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLA-------LELFEQITKGVDYIHSKK 142
Query: 55 TPPIVHRDISSNNILLNLELEAFVADFGVARLLNFDSSNRTLLAGTYGYIAPELAYTMVV 114
+++RD+ +NI L + + DFG+ L D GT Y++PE +
Sbjct: 143 ---LINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTR-SKGTLRYMSPEQISSQDY 198
Query: 115 TEKSDVYSFGVVALEVLMGKHPG 137
++ D+Y+ G++ E+L
Sbjct: 199 GKEVDLYALGLILAELLHVCDTA 221
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 89.0 bits (221), Expect = 3e-22
Identities = 36/141 (25%), Positives = 59/141 (41%), Gaps = 23/141 (16%)
Query: 5 CMFLIYEYMEMGSLFCVLRT----DEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVH 60
M E M + R E +G + + AL YL ++H
Sbjct: 102 AM----ELMGTCAEKLKKRMQGPIPERILG-------KMTVAIVKALYYLKEKHG--VIH 148
Query: 61 RDISSNNILLNLELEAFVADFGVARLLNFDSSNRTLLAGTYGYIAPELAYTMVVTE---- 116
RD+ +NILL+ + + DFG++ L D + AG Y+APE T+
Sbjct: 149 RDVKPSNILLDERGQIKLCDFGISGRL-VDDKAKDRSAGCAAYMAPERIDPPDPTKPDYD 207
Query: 117 -KSDVYSFGVVALEVLMGKHP 136
++DV+S G+ +E+ G+ P
Sbjct: 208 IRADVWSLGISLVELATGQFP 228
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 87.8 bits (217), Expect = 1e-21
Identities = 18/135 (13%), Positives = 37/135 (27%), Gaps = 11/135 (8%)
Query: 7 FLIYEYM--EMGSLFCVLRTDEEAVG-LDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDI 63
L+ ++ LF L G + + + L +VH
Sbjct: 164 LLLMPAASVDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKG---LVHGHF 220
Query: 64 SSNNILLNLELEAFVADFGVARLLNFDSSNRTLLAGTYGYIAPEL--AYTMVVTEKSDVY 121
+ +N+ + + + D + + + Y E A T T + +
Sbjct: 221 TPDNLFIMPDGRLMLGDVSALWKVG---TRGPASSVPVTYAPREFLNASTATFTHALNAW 277
Query: 122 SFGVVALEVLMGKHP 136
G+ V P
Sbjct: 278 QLGLSIYRVWCLFLP 292
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 85.8 bits (213), Expect = 3e-21
Identities = 29/144 (20%), Positives = 57/144 (39%), Gaps = 18/144 (12%)
Query: 1 LHRKCMFLIYEYMEMGSLFCVLRT--------DEEAVGLDWAKRVNIVKGMAHALSYLHH 52
+ + ++ E + G L +++ E V + AL ++H
Sbjct: 102 IEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTV-------WKYFVQLCSALEHMHS 154
Query: 53 DCTPPIVHRDISSNNILLNLELEAFVADFGVARLLNFDSSNRTLLAGTYGYIAPELAYTM 112
++HRDI N+ + + D G+ R + ++ L GT Y++PE +
Sbjct: 155 RR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHEN 211
Query: 113 VVTEKSDVYSFGVVALEVLMGKHP 136
KSD++S G + E+ + P
Sbjct: 212 GYNFKSDIWSLGCLLYEMAALQSP 235
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 86.2 bits (214), Expect = 5e-21
Identities = 31/137 (22%), Positives = 60/137 (43%), Gaps = 14/137 (10%)
Query: 6 MFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISS 65
++++ E ++ G LRT+ + + + +V A + YL +HRD+++
Sbjct: 187 IYIVMELVQGGDFLTFLRTEGARLRVK--TLLQMVGDAAAGMEYLESK---CCIHRDLAA 241
Query: 66 NNILLNLELEAFVADFGVARLLNFDSSNRTLLAGTYGYI-----APELAYTMVVTEKSDV 120
N L+ + ++DFG++R +G + APE + +SDV
Sbjct: 242 RNCLVTEKNVLKISDFGMSREEADGVYAA---SGGLRQVPVKWTAPEALNYGRYSSESDV 298
Query: 121 YSFGVVALEVLM-GKHP 136
+SFG++ E G P
Sbjct: 299 WSFGILLWETFSLGASP 315
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 85.6 bits (212), Expect = 6e-21
Identities = 39/151 (25%), Positives = 64/151 (42%), Gaps = 30/151 (19%)
Query: 1 LHRKCMFLIYEYMEMGSLFCVLRT----DEEAVGLDWAKRVNIVKGMAHALSYLHHDCTP 56
+ + E +E GSL +++ E+ + L YLH
Sbjct: 120 REGPWVNIFMELLEGGSLGQLIKQMGCLPEDRAL-------YYLGQALEGLEYLHTRR-- 170
Query: 57 PIVHRDISSNNILLNLE-LEAFVADFGVARLLNFDSSNRTL-----LAGTYGYIAPELAY 110
I+H D+ ++N+LL+ + A + DFG A L D ++L + GT ++APE
Sbjct: 171 -ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPE--- 226
Query: 111 TMVVTE-----KSDVYSFGVVALEVLMGKHP 136
VV K D++S + L +L G HP
Sbjct: 227 --VVMGKPCDAKVDIWSSCCMMLHMLNGCHP 255
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 85.1 bits (211), Expect = 7e-21
Identities = 40/146 (27%), Positives = 59/146 (40%), Gaps = 30/146 (20%)
Query: 5 CMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVN------IVKGMAHALSYLHHDCTPPI 58
CM E M S + + + I AL++L + I
Sbjct: 99 CM----ELMS-TSFDKFYKYVYSVLD----DVIPEEILGKITLATVKALNHLKENLK--I 147
Query: 59 VHRDISSNNILLNLELEAFVADFGVARLLNFDSSNRTLLAGTYGYIAPE--------LAY 110
+HRDI +NILL+ + DFG++ L DS +T AG Y+APE Y
Sbjct: 148 IHRDIKPSNILLDRSGNIKLCDFGISGQL-VDSIAKTRDAGCRPYMAPERIDPSASRQGY 206
Query: 111 TMVVTEKSDVYSFGVVALEVLMGKHP 136
+SDV+S G+ E+ G+ P
Sbjct: 207 ----DVRSDVWSLGITLYELATGRFP 228
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 84.2 bits (208), Expect = 2e-20
Identities = 28/148 (18%), Positives = 59/148 (39%), Gaps = 15/148 (10%)
Query: 2 HRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHR 61
+ +++ + +L + + ++I +A A+ +LH ++HR
Sbjct: 132 PKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKG---LMHR 188
Query: 62 DISSNNILLNLELEAFVADFGVARLLNFDSS------------NRTLLAGTYGYIAPELA 109
D+ +NI ++ V DFG+ ++ D T GT Y++PE
Sbjct: 189 DLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQI 248
Query: 110 YTMVVTEKSDVYSFGVVALEVLMGKHPG 137
+ + K D++S G++ E+L
Sbjct: 249 HGNNYSHKVDIFSLGLILFELLYSFSTQ 276
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 83.6 bits (207), Expect = 2e-20
Identities = 28/143 (19%), Positives = 62/143 (43%), Gaps = 15/143 (10%)
Query: 2 HRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHR 61
+ +++ + +L + + + ++I +A A+ +LH + ++HR
Sbjct: 86 PKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLH---SKGLMHR 142
Query: 62 DISSNNILLNLELEAFVADFGVARLLNFDS------------SNRTLLAGTYGYIAPELA 109
D+ +NI ++ V DFG+ ++ D + T GT Y++PE
Sbjct: 143 DLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQI 202
Query: 110 YTMVVTEKSDVYSFGVVALEVLM 132
+ + K D++S G++ E+L
Sbjct: 203 HGNSYSHKVDIFSLGLILFELLY 225
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 83.1 bits (206), Expect = 3e-20
Identities = 34/140 (24%), Positives = 64/140 (45%), Gaps = 19/140 (13%)
Query: 5 CMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDIS 64
CM E M+ + ++ + I + AL +LH + ++HRD+
Sbjct: 84 CM----ELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLS--VIHRDVK 137
Query: 65 SNNILLNLELEAFVADFGVARLLNFDSSNRTLLAGTYGYIAPE--------LAYTMVVTE 116
+N+L+N + + DFG++ L D + + AG Y+APE Y++
Sbjct: 138 PSNVLINALGQVKMCDFGISGYLV-DDVAKDIDAGCKPYMAPERINPELNQKGYSV---- 192
Query: 117 KSDVYSFGVVALEVLMGKHP 136
KSD++S G+ +E+ + + P
Sbjct: 193 KSDIWSLGITMIELAILRFP 212
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 83.1 bits (206), Expect = 4e-20
Identities = 41/144 (28%), Positives = 64/144 (44%), Gaps = 28/144 (19%)
Query: 6 MFLIYEYMEMGSLFCVLRTDEEAVG----LDWAKRVNIVKGMAHALSYL--HHDCTPPIV 59
+ LI + M G L +R ++ +G L+W V I KGM YL +V
Sbjct: 91 VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWC--VQIAKGMN----YLEDRR-----LV 139
Query: 60 HRDISSNNILLNLELEAFVADFGVARLLNFDSSNRTLLAG------TYGYIAPELAYTMV 113
HRD+++ N+L+ + DFG+A+LL + G A E +
Sbjct: 140 HRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM----ALESILHRI 195
Query: 114 VTEKSDVYSFGVVALEVLM-GKHP 136
T +SDV+S+GV E++ G P
Sbjct: 196 YTHQSDVWSYGVTVWELMTFGSKP 219
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 82.8 bits (204), Expect = 1e-19
Identities = 42/136 (30%), Positives = 59/136 (43%), Gaps = 7/136 (5%)
Query: 4 KCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDI 63
L EY E G L L E GL ++ ++ AL YLH + I+HRD+
Sbjct: 91 DLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENR---IIHRDL 147
Query: 64 SSNNILLNLELEAF---VADFGVARLLNFDSSNRTLLAGTYGYIAPELAYTMVVTEKSDV 120
NI+L + + D G A+ L+ + GT Y+APEL T D
Sbjct: 148 KPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFV-GTLQYLAPELLEQKKYTVTVDY 206
Query: 121 YSFGVVALEVLMGKHP 136
+SFG +A E + G P
Sbjct: 207 WSFGTLAFECITGFRP 222
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 81.6 bits (201), Expect = 2e-19
Identities = 21/151 (13%), Positives = 44/151 (29%), Gaps = 18/151 (11%)
Query: 1 LHRKCMFLIYEYMEMGSLFCVLRTDEEAVG--LDWAKRVNIVKGMAHALSYLHHDCTPPI 58
L + L+ E G+L + + + ++ M + + +H I
Sbjct: 137 LFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVH---DCEI 193
Query: 59 VHRDISSNNILLNLELEAF-----------VADFGVARLLNFDSSNRTL--LAGTYGYIA 105
+H DI +N +L + D G + + T G+
Sbjct: 194 IHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQC 253
Query: 106 PELAYTMVVTEKSDVYSFGVVALEVLMGKHP 136
E+ + D + +L G +
Sbjct: 254 VEMLSNKPWNYQIDYFGVAATVYCMLFGTYM 284
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 80.4 bits (199), Expect = 3e-19
Identities = 43/139 (30%), Positives = 68/139 (48%), Gaps = 13/139 (9%)
Query: 1 LHRKCMFLIYEYMEMGSLFCVLRT---DEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPP 57
L +++I EY+ GS +L DE + I++ + L YLH +
Sbjct: 90 LKDTKLWIIMEYLGGGSALDLLEPGPLDETQIAT-------ILREILKGLDYLHSE---K 139
Query: 58 IVHRDISSNNILLNLELEAFVADFGVARLLNFDSSNRTLLAGTYGYIAPELAYTMVVTEK 117
+HRDI + N+LL+ E +ADFGVA L R GT ++APE+ K
Sbjct: 140 KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSK 199
Query: 118 SDVYSFGVVALEVLMGKHP 136
+D++S G+ A+E+ G+ P
Sbjct: 200 ADIWSLGITAIELARGEPP 218
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 80.0 bits (198), Expect = 4e-19
Identities = 37/145 (25%), Positives = 63/145 (43%), Gaps = 18/145 (12%)
Query: 1 LHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVH 60
+ + E + GSL +LR+ + + K + L YLH + IVH
Sbjct: 89 SENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQ---IVH 145
Query: 61 RDISSNNILLNLELEAFV--ADFGVARLLNFDSSNRTLLAGTYGYIAPELAYTMVV---- 114
RDI +N+L+N + +DFG ++ L + GT Y+APE ++
Sbjct: 146 RDIKGDNVLIN-TYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPE-----IIDKGP 199
Query: 115 ---TEKSDVYSFGVVALEVLMGKHP 136
+ +D++S G +E+ GK P
Sbjct: 200 RGYGKAADIWSLGCTIIEMATGKPP 224
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 81.4 bits (201), Expect = 4e-19
Identities = 39/147 (26%), Positives = 70/147 (47%), Gaps = 20/147 (13%)
Query: 3 RKCMFLIYEYMEMGSLF-CVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHR 61
R+ ++ E +L V + D +GL+ + +++ L++LH IVHR
Sbjct: 90 RQFQYIAIELCA-ATLQEYVEQKDFAHLGLE---PITLLQQTTSGLAHLHSLN---IVHR 142
Query: 62 DISSNNILL-----NLELEAFVADFGVARLLNFDSSNRTLL---AGTYGYIAPEL---AY 110
D+ +NIL+ + +++A ++DFG+ + L + + GT G+IAPE+
Sbjct: 143 DLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDC 202
Query: 111 TMVVTEKSDVYSFGVVALEVL-MGKHP 136
T D++S G V V+ G HP
Sbjct: 203 KENPTYTVDIFSAGCVFYYVISEGSHP 229
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 80.1 bits (198), Expect = 6e-19
Identities = 41/141 (29%), Positives = 65/141 (46%), Gaps = 22/141 (15%)
Query: 6 MFLIYEYMEMGSLFCVLRTDEEAVG----LDWAKRVNIVKGMAHALSYLHHDCTPPIVHR 61
+ LI + M G L +R ++ +G L+W V I KGM YL +VHR
Sbjct: 91 VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWC--VQIAKGMN----YLEDRR---LVHR 141
Query: 62 DISSNNILLNLELEAFVADFGVARLLNFDSSNRTLLAGTYGYI-----APELAYTMVVTE 116
D+++ N+L+ + DFG+A+LL + G + A E + T
Sbjct: 142 DLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYH---AEGGKVPIKWMALESILHRIYTH 198
Query: 117 KSDVYSFGVVALEVLM-GKHP 136
+SDV+S+GV E++ G P
Sbjct: 199 QSDVWSYGVTVWELMTFGSKP 219
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 80.1 bits (198), Expect = 6e-19
Identities = 46/143 (32%), Positives = 68/143 (47%), Gaps = 26/143 (18%)
Query: 6 MFLIYEYMEMGSLFCVLRTDEEAVG----LDWAKRVNIVKGMAHALSYL--HHDCTPPIV 59
+ L+ +Y+ +GSL +R A+G L+W V I KGM YL H +V
Sbjct: 89 LQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWG--VQIAKGMY----YLEEHG-----MV 137
Query: 60 HRDISSNNILLNLELEAFVADFGVARLLNFDSSNRTLLAGTYGYI-----APELAYTMVV 114
HR++++ N+LL + VADFGVA LL D + A E +
Sbjct: 138 HRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQL---LYSEAKTPIKWMALESIHFGKY 194
Query: 115 TEKSDVYSFGVVALEVLM-GKHP 136
T +SDV+S+GV E++ G P
Sbjct: 195 THQSDVWSYGVTVWELMTFGAEP 217
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 81.1 bits (200), Expect = 6e-19
Identities = 33/130 (25%), Positives = 56/130 (43%), Gaps = 14/130 (10%)
Query: 7 FLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSN 66
+++ EY+ SL + L A+ + + + ALSYLH +V+ D+
Sbjct: 160 YIVMEYVGGQSL-----KRSKGQKLPVAEAIAYLLEILPALSYLHSI---GLVYNDLKPE 211
Query: 67 NILLNLELEAFVADFGVARLLNFDSSNRTLLAGTYGYIAPELAYTMVVTEKSDVYSFGVV 126
NI+L E + + D G +N L GT G+ APE+ T T +D+Y+ G
Sbjct: 212 NIMLT-EEQLKLIDLGAVSRINSFGY----LYGTPGFQAPEIVRTGP-TVATDIYTVGRT 265
Query: 127 ALEVLMGKHP 136
+ +
Sbjct: 266 LAALTLDLPT 275
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 80.3 bits (198), Expect = 7e-19
Identities = 30/151 (19%), Positives = 68/151 (45%), Gaps = 25/151 (16%)
Query: 1 LHRKCMFLIYEYMEMGSLFCVLRT------DEEAVGLDWAKRVNIVKGMAHALSYLHHDC 54
+ ++++ +M GS ++ T +E A+ I++G+ AL Y+HH
Sbjct: 96 IADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAY-------ILQGVLKALDYIHHM- 147
Query: 55 TPPIVHRDISSNNILLNLELEAFVADFGVARLLNFDSSNRTLL-------AGTYGYIAPE 107
VHR + +++IL++++ + +++ + + ++ +++PE
Sbjct: 148 --GYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPE 205
Query: 108 LAYTMVV--TEKSDVYSFGVVALEVLMGKHP 136
+ + KSD+YS G+ A E+ G P
Sbjct: 206 VLQQNLQGYDAKSDIYSVGITACELANGHVP 236
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 78.9 bits (195), Expect = 1e-18
Identities = 43/144 (29%), Positives = 74/144 (51%), Gaps = 23/144 (15%)
Query: 1 LHRKCMFLIYEYMEMGSLFCVLRT---DEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPP 57
L ++++ EY+ GSL V+ DE + + + AL +LH +
Sbjct: 87 LVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAA-------VCRECLQALEFLHSN---Q 136
Query: 58 IVHRDISSNNILLNLELEAFVADFGVARLLNFDSSNRTLLAGTYGYIAPELAYTMVVTE- 116
++HRDI S+NILL ++ + DFG + + S R+ + GT ++APE VVT
Sbjct: 137 VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPE-----VVTRK 191
Query: 117 ----KSDVYSFGVVALEVLMGKHP 136
K D++S G++A+E++ G+ P
Sbjct: 192 AYGPKVDIWSLGIMAIEMIEGEPP 215
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 79.9 bits (197), Expect = 1e-18
Identities = 42/136 (30%), Positives = 69/136 (50%), Gaps = 12/136 (8%)
Query: 6 MFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLH-HDCTPPIVHRDIS 64
++++ EYM GSL L+ + L + V++ +A ++Y+ + VHRD+
Sbjct: 336 IYIVTEYMSKGSLLDFLKGETGKY-LRLPQLVDMAAQIASGMAYVERMNY----VHRDLR 390
Query: 65 SNNILLNLELEAFVADFGVARLLNFD---SSNRTLLAGTYGYIAPELAYTMVVTEKSDVY 121
+ NIL+ L VADFG+ARL+ + + + APE A T KSDV+
Sbjct: 391 AANILVGENLVCKVADFGLARLIEDNEYTARQGAKFP--IKWTAPEAALYGRFTIKSDVW 448
Query: 122 SFGVVALEVLM-GKHP 136
SFG++ E+ G+ P
Sbjct: 449 SFGILLTELTTKGRVP 464
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 79.3 bits (195), Expect = 2e-18
Identities = 23/141 (16%), Positives = 49/141 (34%), Gaps = 16/141 (11%)
Query: 7 FLIYEYME--MGSLFCVLRTDEEAVG-LDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDI 63
F +Y M+ + + VL + L R+ + + L+ LHH +VH +
Sbjct: 181 FFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG---LVHTYL 237
Query: 64 SSNNILLNLELEAFVADFGVARLLNFDSSNRTLLAGTYG---YIAPELAY-----TMVVT 115
+I+L+ F+ F +S + + + A + ++T
Sbjct: 238 RPVDIVLDQRGGVFLTGFEHLVRD--GASAVSPIGRGFAPPETTAERMLPFGQHHPTLMT 295
Query: 116 EKSDVYSFGVVALEVLMGKHP 136
D ++ G+ + P
Sbjct: 296 FAFDTWTLGLAIYWIWCADLP 316
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 79.4 bits (196), Expect = 2e-18
Identities = 35/136 (25%), Positives = 62/136 (45%), Gaps = 12/136 (8%)
Query: 6 MFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLH-HDCTPPIVHRDIS 64
++I E+M G+L LR + + + ++ A+ YL + +HR+++
Sbjct: 291 FYIITEFMTYGNLLDYLRECNRQE-VSAVVLLYMATQISSAMEYLEKKNF----IHRNLA 345
Query: 65 SNNILLNLELEAFVADFGVARLLNFD---SSNRTLLAGTYGYIAPELAYTMVVTEKSDVY 121
+ N L+ VADFG++RL+ D + + APE + KSDV+
Sbjct: 346 ARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFP--IKWTAPESLAYNKFSIKSDVW 403
Query: 122 SFGVVALEVLM-GKHP 136
+FGV+ E+ G P
Sbjct: 404 AFGVLLWEIATYGMSP 419
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 79.6 bits (196), Expect = 2e-18
Identities = 35/137 (25%), Positives = 62/137 (45%), Gaps = 13/137 (9%)
Query: 6 MFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYL--HHDCTPPIVHRDI 63
+ L+ E G L L E + + ++ ++ + YL + VHR++
Sbjct: 410 LMLVMEMAGGGPLHKFLVGKREE--IPVSNVAELLHQVSMGMKYLEEKN-----FVHRNL 462
Query: 64 SSNNILLNLELEAFVADFGVARLLNFDSSNRTLLAGTYGYI---APELAYTMVVTEKSDV 120
++ N+LL A ++DFG+++ L D S T + + APE + +SDV
Sbjct: 463 AARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDV 522
Query: 121 YSFGVVALEVLM-GKHP 136
+S+GV E L G+ P
Sbjct: 523 WSYGVTMWEALSYGQKP 539
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 78.1 bits (193), Expect = 2e-18
Identities = 36/139 (25%), Positives = 59/139 (42%), Gaps = 17/139 (12%)
Query: 6 MFLIYEYMEMGSLFCVLRTDEEAVG----LDWAKRVNIVKGMAHALSYLHHDCTPPIVHR 61
M ++ E +GSL LR + +A V + +GM YL +HR
Sbjct: 95 MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYA--VQVAEGMG----YLESKR---FIHR 145
Query: 62 DISSNNILLNLELEAFVADFGVARLLNFDSSNRTLLAGT---YGYIAPELAYTMVVTEKS 118
D+++ N+LL + DFG+ R L + + + + + APE T + S
Sbjct: 146 DLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHAS 205
Query: 119 DVYSFGVVALEVLM-GKHP 136
D + FGV E+ G+ P
Sbjct: 206 DTWMFGVTLWEMFTYGQEP 224
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 78.5 bits (194), Expect = 2e-18
Identities = 40/139 (28%), Positives = 68/139 (48%), Gaps = 16/139 (11%)
Query: 3 RKCMFLIYEYMEMGSLFCVLR-----TDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPP 57
+F++ E SL + + T+ EA R ++ + YLH +
Sbjct: 113 NDFVFVVLELCRRRSLLELHKRRKALTEPEA-------R-YYLRQIVLGCQYLHRNR--- 161
Query: 58 IVHRDISSNNILLNLELEAFVADFGVARLLNFDSSNRTLLAGTYGYIAPELAYTMVVTEK 117
++HRD+ N+ LN +LE + DFG+A + +D + +L GT YIAPE+ + +
Sbjct: 162 VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGHSFE 221
Query: 118 SDVYSFGVVALEVLMGKHP 136
DV+S G + +L+GK P
Sbjct: 222 VDVWSIGCIMYTLLVGKPP 240
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 77.7 bits (192), Expect = 3e-18
Identities = 36/140 (25%), Positives = 63/140 (45%), Gaps = 13/140 (9%)
Query: 3 RKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYL--HHDCTPPIVH 60
+ + L+ E G L L E + + ++ ++ + YL + VH
Sbjct: 81 AEALMLVMEMAGGGPLHKFLVGKREE--IPVSNVAELLHQVSMGMKYLEEKN-----FVH 133
Query: 61 RDISSNNILLNLELEAFVADFGVARLLNFDSSNRTLLAGTYGYI---APELAYTMVVTEK 117
RD+++ N+LL A ++DFG+++ L D S T + + APE + +
Sbjct: 134 RDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSR 193
Query: 118 SDVYSFGVVALEVLM-GKHP 136
SDV+S+GV E L G+ P
Sbjct: 194 SDVWSYGVTMWEALSYGQKP 213
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 77.8 bits (192), Expect = 4e-18
Identities = 43/141 (30%), Positives = 69/141 (48%), Gaps = 15/141 (10%)
Query: 1 LHRKCMFLIYEYMEMGSLFCVLRT-----DEEAVGLDWAKRVNIVKGMAHALSYLHHDCT 55
++++ EY GS+ ++R E+ + I++ L YLH
Sbjct: 94 FKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIAT-------ILQSTLKGLEYLHFM-- 144
Query: 56 PPIVHRDISSNNILLNLELEAFVADFGVARLLNFDSSNRTLLAGTYGYIAPELAYTMVVT 115
+HRDI + NILLN E A +ADFGVA L + R + GT ++APE+ +
Sbjct: 145 -RKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYN 203
Query: 116 EKSDVYSFGVVALEVLMGKHP 136
+D++S G+ A+E+ GK P
Sbjct: 204 CVADIWSLGITAIEMAEGKPP 224
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 78.3 bits (193), Expect = 4e-18
Identities = 42/135 (31%), Positives = 68/135 (50%), Gaps = 10/135 (7%)
Query: 6 MFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISS 65
++++ EYM GSL L+ + L + V++ +A ++Y+ VHRD+ +
Sbjct: 253 IYIVTEYMSKGSLLDFLKGETGKY-LRLPQLVDMAAQIASGMAYVERMN---YVHRDLRA 308
Query: 66 NNILLNLELEAFVADFGVARLLNFD---SSNRTLLAGTYGYIAPELAYTMVVTEKSDVYS 122
NIL+ L VADFG+ARL+ + + + APE A T KSDV+S
Sbjct: 309 ANILVGENLVCKVADFGLARLIEDNEYTARQGAKFP--IKWTAPEAALYGRFTIKSDVWS 366
Query: 123 FGVVALEVLM-GKHP 136
FG++ E+ G+ P
Sbjct: 367 FGILLTELTTKGRVP 381
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 77.8 bits (192), Expect = 4e-18
Identities = 37/139 (26%), Positives = 76/139 (54%), Gaps = 13/139 (9%)
Query: 1 LHRKCMFLIYEYMEMGSLFCVLRT---DEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPP 57
L + ++++ E+++ G+L ++ +EE + + + + AL+YLH
Sbjct: 112 LVGEELWVLMEFLQGGALTDIVSQVRLNEEQIAT-------VCEAVLQALAYLH---AQG 161
Query: 58 IVHRDISSNNILLNLELEAFVADFGVARLLNFDSSNRTLLAGTYGYIAPELAYTMVVTEK 117
++HRDI S++ILL L+ ++DFG ++ D R L GT ++APE+ + +
Sbjct: 162 VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRSLYATE 221
Query: 118 SDVYSFGVVALEVLMGKHP 136
D++S G++ +E++ G+ P
Sbjct: 222 VDIWSLGIMVIEMVDGEPP 240
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 77.2 bits (191), Expect = 4e-18
Identities = 40/139 (28%), Positives = 68/139 (48%), Gaps = 16/139 (11%)
Query: 3 RKCMFLIYEYMEMGSLFCVLR-----TDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPP 57
+F++ E SL + + T+ EA R ++ + YLH +
Sbjct: 87 NDFVFVVLELCRRRSLLELHKRRKALTEPEA-------R-YYLRQIVLGCQYLHRNR--- 135
Query: 58 IVHRDISSNNILLNLELEAFVADFGVARLLNFDSSNRTLLAGTYGYIAPELAYTMVVTEK 117
++HRD+ N+ LN +LE + DFG+A + +D + +L GT YIAPE+ + +
Sbjct: 136 VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGHSFE 195
Query: 118 SDVYSFGVVALEVLMGKHP 136
DV+S G + +L+GK P
Sbjct: 196 VDVWSIGCIMYTLLVGKPP 214
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 77.7 bits (191), Expect = 5e-18
Identities = 27/147 (18%), Positives = 50/147 (34%), Gaps = 27/147 (18%)
Query: 7 FLIYEYMEM------GSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVH 60
F +Y M+ L T + L R+ + + L+ LHH +VH
Sbjct: 176 FFLYPRMQSNLQTFGEVLLSHSSTHKS---LVHHARLQLTLQVIRLLASLHHYG---LVH 229
Query: 61 RDISSNNILLNLELEAFVADFGVARLLNFDSSNRTLLAGTYGYIAPEL-----------A 109
+ +I+L+ F+ F R + + + G+ PEL
Sbjct: 230 TYLRPVDIVLDQRGGVFLTGFEHLVRDG----ARVVSSVSRGFEPPELEARRATISYHRD 285
Query: 110 YTMVVTEKSDVYSFGVVALEVLMGKHP 136
++T D ++ G+V + P
Sbjct: 286 RRTLMTFSFDAWALGLVIYWIWCADLP 312
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 77.0 bits (190), Expect = 6e-18
Identities = 34/137 (24%), Positives = 51/137 (37%), Gaps = 14/137 (10%)
Query: 3 RKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRD 62
++L E SL L A+ ++ AL++LH +VH D
Sbjct: 129 GGILYLQTELCG-PSLQQHCE--AWGASLPEAQVWGYLRDTLLALAHLHSQ---GLVHLD 182
Query: 63 ISSNNILLNLELEAFVADFGVARLLNFDSSNRTLLAGTYGYIAPEL---AYTMVVTEKSD 119
+ NI L + DFG+ L + G Y+APEL +Y +D
Sbjct: 183 VKPANIFLGPRGRCKLGDFGLLVELGTAGAGEVQE-GDPRYMAPELLQGSY----GTAAD 237
Query: 120 VYSFGVVALEVLMGKHP 136
V+S G+ LEV
Sbjct: 238 VFSLGLTILEVACNMEL 254
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 77.4 bits (191), Expect = 6e-18
Identities = 43/142 (30%), Positives = 62/142 (43%), Gaps = 23/142 (16%)
Query: 6 MFLIYEYMEMGSLFCVLRTDEEAVG----LDWAKRVNIVKGMAHALSYLH-HDCTPPIVH 60
+ L+ EY+ G L L+ + L ++ I KGM YL C VH
Sbjct: 101 LRLVMEYLPSGCLRDFLQRHRARLDASRLLLYS--SQICKGME----YLGSRRC----VH 150
Query: 61 RDISSNNILLNLELEAFVADFGVARLLNFDSSNRTLLAGTYGYI-----APELAYTMVVT 115
RD+++ NIL+ E +ADFG+A+LL D G APE + +
Sbjct: 151 RDLAARNILVESEAHVKIADFGLAKLLPLDKDYYV--VREPGQSPIFWYAPESLSDNIFS 208
Query: 116 EKSDVYSFGVVALEVLM-GKHP 136
+SDV+SFGVV E+
Sbjct: 209 RQSDVWSFGVVLYELFTYCDKS 230
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 76.1 bits (188), Expect = 8e-18
Identities = 47/138 (34%), Positives = 70/138 (50%), Gaps = 16/138 (11%)
Query: 3 RKCMFLIYEYMEMGSLFCVLRT----DEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPI 58
++LI EY +G+++ L+ DE+ + +A+ALSY H +
Sbjct: 81 ATRVYLILEYAPLGTVYRELQKLSKFDEQR-----TAT--YITELANALSYCHSKR---V 130
Query: 59 VHRDISSNNILLNLELEAFVADFGVARLLNFDSSNRTLLAGTYGYIAPELAYTMVVTEKS 118
+HRDI N+LL E +ADFG + SS RT L GT Y+ PE+ + EK
Sbjct: 131 IHRDIKPENLLLGSAGELKIADFGWSVHA--PSSRRTDLCGTLDYLPPEMIEGRMHDEKV 188
Query: 119 DVYSFGVVALEVLMGKHP 136
D++S GV+ E L+GK P
Sbjct: 189 DLWSLGVLCYEFLVGKPP 206
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 76.6 bits (189), Expect = 9e-18
Identities = 32/144 (22%), Positives = 59/144 (40%), Gaps = 18/144 (12%)
Query: 7 FLIYEYMEMGSLFCVLRTDEEAVG-LDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISS 65
+L+ + + G+L+ + ++ L + + ++ G+ L +H HRD+
Sbjct: 106 WLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHA---KGYAHRDLKP 162
Query: 66 NNILLNLELEAFVADFGVARLLNFDSSNRTLLA---------GTYGYIAPEL----AYTM 112
NILL E + + D G T Y APEL ++
Sbjct: 163 TNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHC- 221
Query: 113 VVTEKSDVYSFGVVALEVLMGKHP 136
V+ E++DV+S G V ++ G+ P
Sbjct: 222 VIDERTDVWSLGCVLYAMMFGEGP 245
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 76.7 bits (189), Expect = 1e-17
Identities = 40/147 (27%), Positives = 62/147 (42%), Gaps = 30/147 (20%)
Query: 9 IYEYMEM--GSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLH-HDCTPPIVHRDISS 65
IY ME L L+ + +D +R + K M A+ +H H IVH D+
Sbjct: 84 IYMVMECGNIDLNSWLKKKK---SIDPWERKSYWKNMLEAVHTIHQHG----IVHSDLKP 136
Query: 66 NNILL---NLELEAFVADFGVARLLNFDSSN--RTLLAGTYGYIAPEL-----------A 109
N L+ L+L DFG+A + D+++ + GT Y+ PE
Sbjct: 137 ANFLIVDGMLKL----IDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGK 192
Query: 110 YTMVVTEKSDVYSFGVVALEVLMGKHP 136
++ KSDV+S G + + GK P
Sbjct: 193 SKSKISPKSDVWSLGCILYYMTYGKTP 219
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 76.2 bits (188), Expect = 1e-17
Identities = 40/137 (29%), Positives = 59/137 (43%), Gaps = 22/137 (16%)
Query: 6 MFLIYEYMEMGSLFCVLRTDEEAVG----LDWAKRVNIVKGMAHALSYLH-HDCTPPIVH 60
+ LI E++ GSL L ++ + L +A V I KGM YL VH
Sbjct: 100 IKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYA--VQICKGMD----YLGSRQY----VH 149
Query: 61 RDISSNNILLNLELEAFVADFGVARLLNFDSSNRTLLAGTYGYI-----APELAYTMVVT 115
RD+++ N+L+ E + + DFG+ + + D T APE
Sbjct: 150 RDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYT--VKDDRDSPVFWYAPECLMQSKFY 207
Query: 116 EKSDVYSFGVVALEVLM 132
SDV+SFGV E+L
Sbjct: 208 IASDVWSFGVTLHELLT 224
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 76.6 bits (189), Expect = 1e-17
Identities = 45/137 (32%), Positives = 68/137 (49%), Gaps = 13/137 (9%)
Query: 6 MFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYL--HHDCTPPIVHRDI 63
+ ++ EYME GSL LR + + V +++G+A + YL VHRD+
Sbjct: 121 VMIVTEYMENGSLDSFLRKHDAQ--FTVIQLVGMLRGIASGMKYLSDMG-----YVHRDL 173
Query: 64 SSNNILLNLELEAFVADFGVARLLNFDSSNRTLLAGTYGYI---APELAYTMVVTEKSDV 120
++ NIL+N L V+DFG+ R+L D G I +PE T SDV
Sbjct: 174 AARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDV 233
Query: 121 YSFGVVALEVLM-GKHP 136
+S+G+V EV+ G+ P
Sbjct: 234 WSYGIVLWEVMSYGERP 250
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 75.8 bits (187), Expect = 2e-17
Identities = 39/139 (28%), Positives = 66/139 (47%), Gaps = 18/139 (12%)
Query: 6 MFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYL--HHDCTPPIVHRDI 63
L+ E E+G L L+ + + + +V ++ + YL + VHRD+
Sbjct: 92 WMLVMEMAELGPLNKYLQQNRH---VKDKNIIELVHQVSMGMKYLEESN-----FVHRDL 143
Query: 64 SSNNILLNLELEAFVADFGVARLLNFDSSNRTLLAGTYGYI-----APELAYTMVVTEKS 118
++ N+LL + A ++DFG+++ L D + A T+G APE + KS
Sbjct: 144 AARNVLLVTQHYAKISDFGLSKALRADENYYK--AQTHGKWPVKWYAPECINYYKFSSKS 201
Query: 119 DVYSFGVVALEVLM-GKHP 136
DV+SFGV+ E G+ P
Sbjct: 202 DVWSFGVLMWEAFSYGQKP 220
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 75.8 bits (187), Expect = 2e-17
Identities = 36/150 (24%), Positives = 63/150 (42%), Gaps = 29/150 (19%)
Query: 4 KCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLH-HDCTPPIVHRD 62
+ ++++ E L L+ ++++ K K M A+ +H H IVH D
Sbjct: 101 QYIYMVMECGN-IDLNSWLK-KKKSIDPWERKS--YWKNMLEAVHTIHQHG----IVHSD 152
Query: 63 ISSNNILL---NLELEAFVADFGVARLLNFDSSN--RTLLAGTYGYIAPEL--------- 108
+ N L+ L+L DFG+A + D+++ + GT Y+ PE
Sbjct: 153 LKPANFLIVDGMLKL----IDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRE 208
Query: 109 --AYTMVVTEKSDVYSFGVVALEVLMGKHP 136
++ KSDV+S G + + GK P
Sbjct: 209 NGKSKSKISPKSDVWSLGCILYYMTYGKTP 238
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 75.4 bits (186), Expect = 2e-17
Identities = 41/134 (30%), Positives = 60/134 (44%), Gaps = 18/134 (13%)
Query: 6 MFLIYEYMEMGSLFCVLRTDEEAVG----LDWAKRVNIVKGMAHALSYLH-HDCTPPIVH 60
+ LI EY+ GSL L+ +E + L + I KGM YL +H
Sbjct: 88 LKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYT--SQICKGME----YLGTKRY----IH 137
Query: 61 RDISSNNILLNLELEAFVADFGVARLLNFDSSNRTLLAGTYGYI---APELAYTMVVTEK 117
RD+++ NIL+ E + DFG+ ++L D + I APE +
Sbjct: 138 RDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVA 197
Query: 118 SDVYSFGVVALEVL 131
SDV+SFGVV E+
Sbjct: 198 SDVWSFGVVLYELF 211
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 75.3 bits (186), Expect = 2e-17
Identities = 38/136 (27%), Positives = 64/136 (47%), Gaps = 17/136 (12%)
Query: 7 FLIYEYMEMGSLFCVLR------TDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVH 60
+L+ E G + L+ ++ EA + + + + YLH I+H
Sbjct: 87 YLVLEMCHNGEMNRYLKNRVKPFSENEAR--------HFMHQIITGMLYLHSHG---ILH 135
Query: 61 RDISSNNILLNLELEAFVADFGVARLLNFDSSNRTLLAGTYGYIAPELAYTMVVTEKSDV 120
RD++ +N+LL + +ADFG+A L L GT YI+PE+A +SDV
Sbjct: 136 RDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLCGTPNYISPEIATRSAHGLESDV 195
Query: 121 YSFGVVALEVLMGKHP 136
+S G + +L+G+ P
Sbjct: 196 WSLGCMFYTLLIGRPP 211
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 75.9 bits (187), Expect = 2e-17
Identities = 39/142 (27%), Positives = 66/142 (46%), Gaps = 21/142 (14%)
Query: 6 MFLIYEYMEMGSLFCVLRT------DEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIV 59
++L+ E+ GS+ +++ EE + I + + LS+LH ++
Sbjct: 102 LWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAY-------ICREILRGLSHLHQHK---VI 151
Query: 60 HRDISSNNILLNLELEAFVADFGVARLLNFDSSNRTLLAGTYGYIAPELAYTMVVTE--- 116
HRDI N+LL E + DFGV+ L+ R GT ++APE+ +
Sbjct: 152 HRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATY 211
Query: 117 --KSDVYSFGVVALEVLMGKHP 136
KSD++S G+ A+E+ G P
Sbjct: 212 DFKSDLWSLGITAIEMAEGAPP 233
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 76.0 bits (187), Expect = 2e-17
Identities = 39/147 (26%), Positives = 60/147 (40%), Gaps = 30/147 (20%)
Query: 9 IYEYMEM--GSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLH-HDCTPPIVHRDISS 65
IY ME L L+ + +D +R + K M A+ +H H IVH D+
Sbjct: 131 IYMVMECGNIDLNSWLKKKK---SIDPWERKSYWKNMLEAVHTIHQHG----IVHSDLKP 183
Query: 66 NNILL---NLELEAFVADFGVARLLNFDSSNRTL--LAGTYGYIAPEL-----------A 109
N L+ L+L DFG+A + D+++ G Y+ PE
Sbjct: 184 ANFLIVDGMLKL----IDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGK 239
Query: 110 YTMVVTEKSDVYSFGVVALEVLMGKHP 136
++ KSDV+S G + + GK P
Sbjct: 240 SKSKISPKSDVWSLGCILYYMTYGKTP 266
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 75.4 bits (186), Expect = 2e-17
Identities = 39/156 (25%), Positives = 66/156 (42%), Gaps = 30/156 (19%)
Query: 3 RKCMFLIYEYMEMGSLFCVLR-----TDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPP 57
+ +F+ EY E G+L+ ++ + + + + ALSY+H
Sbjct: 87 KSTLFIQMEYCENGTLYDLIHSENLNQQRDEY-------WRLFRQILEALSYIHSQG--- 136
Query: 58 IVHRDISSNNILLNLELEAFVADFGVARLLNFD--------------SSNRTLLAGTYGY 103
I+HRD+ NI ++ + DFG+A+ ++ S N T GT Y
Sbjct: 137 IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMY 196
Query: 104 IAPE-LAYTMVVTEKSDVYSFGVVALEVLMGKHPGE 138
+A E L T EK D+YS G++ E++ G
Sbjct: 197 VATEVLDGTGHYNEKIDMYSLGIIFFEMIYPFSTGM 232
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 75.2 bits (185), Expect = 3e-17
Identities = 33/145 (22%), Positives = 58/145 (40%), Gaps = 19/145 (13%)
Query: 3 RKCMFLIYEYMEMGSLFCVLR-----TDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPP 57
+++IYEYME S+ + I+K + ++ SY+H++
Sbjct: 115 YDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKN-- 172
Query: 58 IVHRDISSNNILLNLELEAFVADFGVARLLNFDSSNRTLLAGTYGYIAPELAYTMVVTE- 116
I HRD+ +NIL++ ++DFG + GTY ++ PE E
Sbjct: 173 ICHRDVKPSNILMDKNGRVKLSDFGESEY--MVDKKIKGSRGTYEFMPPE----FFSNES 226
Query: 117 -----KSDVYSFGVVALEVLMGKHP 136
K D++S G+ + P
Sbjct: 227 SYNGAKVDIWSLGICLYVMFYNVVP 251
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 75.1 bits (185), Expect = 4e-17
Identities = 41/134 (30%), Positives = 60/134 (44%), Gaps = 18/134 (13%)
Query: 6 MFLIYEYMEMGSLFCVLRTDEEAVG----LDWAKRVNIVKGMAHALSYLH-HDCTPPIVH 60
+ LI EY+ GSL L+ +E + L + I KGM YL +H
Sbjct: 119 LKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYT--SQICKGME----YLGTKRY----IH 168
Query: 61 RDISSNNILLNLELEAFVADFGVARLLNFDSSNRTLLAGTYGYI---APELAYTMVVTEK 117
RD+++ NIL+ E + DFG+ ++L D + I APE +
Sbjct: 169 RDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVA 228
Query: 118 SDVYSFGVVALEVL 131
SDV+SFGVV E+
Sbjct: 229 SDVWSFGVVLYELF 242
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 75.0 bits (185), Expect = 4e-17
Identities = 47/139 (33%), Positives = 69/139 (49%), Gaps = 17/139 (12%)
Query: 6 MFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYL--HHDCTPPIVHRDI 63
++ EYME GSL LRT + + V +++G+ + YL VHRD+
Sbjct: 125 AMIVTEYMENGSLDTFLRTHDGQ--FTIMQLVGMLRGVGAGMRYLSDLG-----YVHRDL 177
Query: 64 SSNNILLNLELEAFVADFGVARLLNFDSSNRTLLAGTYGYI-----APELAYTMVVTEKS 118
++ N+L++ L V+DFG++R+L D T G I APE + S
Sbjct: 178 AARNVLVDSNLVCKVSDFGLSRVLEDDPD--AAYTTTGGKIPIRWTAPEAIAFRTFSSAS 235
Query: 119 DVYSFGVVALEVLM-GKHP 136
DV+SFGVV EVL G+ P
Sbjct: 236 DVWSFGVVMWEVLAYGERP 254
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 75.5 bits (186), Expect = 4e-17
Identities = 41/136 (30%), Positives = 73/136 (53%), Gaps = 12/136 (8%)
Query: 6 MFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYL-HHDCTPPIVHRDIS 64
+++I E+M GSL L++DE + K ++ +A ++++ + +HRD+
Sbjct: 257 IYIITEFMAKGSLLDFLKSDEGSK-QPLPKLIDFSAQIAEGMAFIEQRNY----IHRDLR 311
Query: 65 SNNILLNLELEAFVADFGVARLLNFDSSNRTLLAGTYGYI---APELAYTMVVTEKSDVY 121
+ NIL++ L +ADFG+AR++ + T G I APE T KSDV+
Sbjct: 312 AANILVSASLVCKIADFGLARVIEDNE--YTAREGAKFPIKWTAPEAINFGSFTIKSDVW 369
Query: 122 SFGVVALEVLM-GKHP 136
SFG++ +E++ G+ P
Sbjct: 370 SFGILLMEIVTYGRIP 385
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 74.8 bits (184), Expect = 4e-17
Identities = 38/143 (26%), Positives = 63/143 (44%), Gaps = 16/143 (11%)
Query: 6 MFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISS 65
LI E+ GSL+ VL A GL ++ + +++ + +++L + IVHR+I
Sbjct: 84 KVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKP 140
Query: 66 NNILLNLELEAF----VADFGVARLLNFDSSNRTLLAGTYGYIAPELAYTMVV------- 114
NI+ + + + DFG AR L D +L GT Y+ P++ V+
Sbjct: 141 GNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLY-GTEEYLHPDMYERAVLRKDHQKK 199
Query: 115 -TEKSDVYSFGVVALEVLMGKHP 136
D++S GV G P
Sbjct: 200 YGATVDLWSIGVTFYHAATGSLP 222
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 75.3 bits (185), Expect = 5e-17
Identities = 38/143 (26%), Positives = 63/143 (44%), Gaps = 16/143 (11%)
Query: 6 MFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISS 65
LI E+ GSL+ VL A GL ++ + +++ + +++L + IVHR+I
Sbjct: 84 KVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKP 140
Query: 66 NNILLNLELEAF----VADFGVARLLNFDSSNRTLLAGTYGYIAPELAYTMVV------- 114
NI+ + + + DFG AR L D +L GT Y+ P++ V+
Sbjct: 141 GNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLY-GTEEYLHPDMYERAVLRKDHQKK 199
Query: 115 -TEKSDVYSFGVVALEVLMGKHP 136
D++S GV G P
Sbjct: 200 YGATVDLWSIGVTFYHAATGSLP 222
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 74.3 bits (183), Expect = 5e-17
Identities = 34/146 (23%), Positives = 69/146 (47%), Gaps = 20/146 (13%)
Query: 1 LHRKCMFLIYEYMEMGSLFCVLRT-----DEEAVGLDWAKRVNIVKGMAHALSYLHHDCT 55
H ++++ E+ G++ ++ E + + + + M AL++LH
Sbjct: 86 YHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQV-------VCRQMLEALNFLHSK-- 136
Query: 56 PPIVHRDISSNNILLNLELEAFVADFGVARLLNFDSSNRTLLAGTYGYIAPELAYTMVVT 115
I+HRD+ + N+L+ LE + +ADFGV+ R GT ++APE+ +
Sbjct: 137 -RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFIGTPYWMAPEVVMCETMK 195
Query: 116 E-----KSDVYSFGVVALEVLMGKHP 136
+ K+D++S G+ +E+ + P
Sbjct: 196 DTPYDYKADIWSLGITLIEMAQIEPP 221
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 73.9 bits (182), Expect = 1e-16
Identities = 48/137 (35%), Positives = 71/137 (51%), Gaps = 13/137 (9%)
Query: 6 MFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYL--HHDCTPPIVHRDI 63
M +I EYME G+L LR + + V +++G+A + YL + VHRD+
Sbjct: 121 MMIITEYMENGALDKFLREKDGE--FSVLQLVGMLRGIAAGMKYLANMN-----YVHRDL 173
Query: 64 SSNNILLNLELEAFVADFGVARLLNFDSSNRTLLAGTYGYI---APELAYTMVVTEKSDV 120
++ NIL+N L V+DFG++R+L D +G I APE T SDV
Sbjct: 174 AARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDV 233
Query: 121 YSFGVVALEVLM-GKHP 136
+SFG+V EV+ G+ P
Sbjct: 234 WSFGIVMWEVMTYGERP 250
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 73.0 bits (180), Expect = 1e-16
Identities = 40/140 (28%), Positives = 64/140 (45%), Gaps = 21/140 (15%)
Query: 6 MFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYL--HHDCTPPIVHRDI 63
+ L+ E+ME G L LRT + + + + ++YL ++HRD+
Sbjct: 78 ICLVTEFMEHGCLSDYLRTQRGLFAAE--TLLGMCLDVCEGMAYLEEAC-----VIHRDL 130
Query: 64 SSNNILLNLELEAFVADFGVARLLNFD---SSNRTLLAGTYGYI---APELAYTMVVTEK 117
++ N L+ V+DFG+ R + D SS T + +PE+ + K
Sbjct: 131 AARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFP-----VKWASPEVFSFSRYSSK 185
Query: 118 SDVYSFGVVALEVLM-GKHP 136
SDV+SFGV+ EV GK P
Sbjct: 186 SDVWSFGVLMWEVFSEGKIP 205
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 72.7 bits (179), Expect = 2e-16
Identities = 28/148 (18%), Positives = 60/148 (40%), Gaps = 33/148 (22%)
Query: 6 MFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYL--HHDCTPPIVHRDI 63
L+ E+++ GSL L+ ++ + + W ++ + K +A A+ +L + ++H ++
Sbjct: 87 NILVQEFVKFGSLDTYLKKNKNCINILW--KLEVAKQLAAAMHFLEENT-----LIHGNV 139
Query: 64 SSNNILLNLELEAF--------VADFGVARLLNFDSSNRTLLAGTYGYI-----APE-LA 109
+ NILL E + ++D G++ + PE +
Sbjct: 140 CAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKD---------ILQERIPWVPPECIE 190
Query: 110 YTMVVTEKSDVYSFGVVALEVLM-GKHP 136
+ +D +SFG E+ G P
Sbjct: 191 NPKNLNLATDKWSFGTTLWEICSGGDKP 218
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 73.7 bits (181), Expect = 2e-16
Identities = 38/138 (27%), Positives = 65/138 (47%), Gaps = 17/138 (12%)
Query: 6 MFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLH-HDCTPPIVHRDIS 64
+++I E +G L L+ + ++ L A + ++ AL+YL VHRDI+
Sbjct: 465 VWIIMELCTLGELRSFLQVRKFSLDL--ASLILYAYQLSTALAYLESKRF----VHRDIA 518
Query: 65 SNNILLNLELEAFVADFGVARLLNFDSSNRTLLAGTYGYI-----APELAYTMVVTEKSD 119
+ N+L++ + DFG++R + + + + G + APE T SD
Sbjct: 519 ARNVLVSSNDCVKLGDFGLSRYMEDSTYYKA----SKGKLPIKWMAPESINFRRFTSASD 574
Query: 120 VYSFGVVALEVLM-GKHP 136
V+ FGV E+LM G P
Sbjct: 575 VWMFGVCMWEILMHGVKP 592
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 72.7 bits (179), Expect = 2e-16
Identities = 39/152 (25%), Positives = 75/152 (49%), Gaps = 24/152 (15%)
Query: 1 LHRKCMFLIYEYMEMGSLFCVLRT-----DEEAVGLDWAKRVNIVKGMAHALSYLHHDCT 55
+ + ++L+ + + GS+ +++ + ++ LD + I++ + L YLH +
Sbjct: 83 VVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKN-- 140
Query: 56 PPIVHRDISSNNILLNLELEAFVADFGVARLLN-----FDSSNRTLLAGTYGYIAPELAY 110
+HRD+ + NILL + +ADFGV+ L + R GT ++APE
Sbjct: 141 -GQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPE--- 196
Query: 111 TMVVTE------KSDVYSFGVVALEVLMGKHP 136
V+ + K+D++SFG+ A+E+ G P
Sbjct: 197 --VMEQVRGYDFKADIWSFGITAIELATGAAP 226
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 73.2 bits (180), Expect = 2e-16
Identities = 38/133 (28%), Positives = 67/133 (50%), Gaps = 10/133 (7%)
Query: 6 MFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYL-HHDCTPPIVHRDIS 64
++++ EYM GSL LR+ +V L + + A+ YL ++ VHRD++
Sbjct: 262 LYIVTEYMAKGSLVDYLRSRGRSV-LGGDCLLKFSLDVCEAMEYLEGNNF----VHRDLA 316
Query: 65 SNNILLNLELEAFVADFGVARLLNFDSSNRTLLAGTYGYIAPELAYTMVVTEKSDVYSFG 124
+ N+L++ + A V+DFG+ + + L + APE + KSDV+SFG
Sbjct: 317 ARNVLVSEDNVAKVSDFGLTKEASSTQDTGKL---PVKWTAPEALREKKFSTKSDVWSFG 373
Query: 125 VVALEVLM-GKHP 136
++ E+ G+ P
Sbjct: 374 ILLWEIYSFGRVP 386
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 71.9 bits (177), Expect = 4e-16
Identities = 42/139 (30%), Positives = 71/139 (51%), Gaps = 18/139 (12%)
Query: 6 MFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYL-HHDCTPPIVHRDIS 64
+++I EYME GSL L+T L K +++ +A ++++ + +HRD+
Sbjct: 82 IYIITEYMENGSLVDFLKTPSGIK-LTINKLLDMAAQIAEGMAFIEERNY----IHRDLR 136
Query: 65 SNNILLNLELEAFVADFGVARLLNFD---SSNRTLLAGTYGYI---APELAYTMVVTEKS 118
+ NIL++ L +ADFG+ARL+ + + I APE T KS
Sbjct: 137 AANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFP-----IKWTAPEAINYGTFTIKS 191
Query: 119 DVYSFGVVALEVLM-GKHP 136
DV+SFG++ E++ G+ P
Sbjct: 192 DVWSFGILLTEIVTHGRIP 210
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 72.4 bits (178), Expect = 4e-16
Identities = 39/135 (28%), Positives = 59/135 (43%), Gaps = 20/135 (14%)
Query: 6 MFLIYEYMEMGSLFCVLRTDEEAVG--LDWAKRVNIVKGMAHALSYLH-HDCTPPIVHRD 62
+ L+ EY+ +GSL L + L +A I +GMA YLH +HRD
Sbjct: 110 LQLVMEYVPLGSLRDYLPRHSIGLAQLLLFA--QQICEGMA----YLHAQHY----IHRD 159
Query: 63 ISSNNILLNLELEAFVADFGVARLLNFDSSNRTLLAGTYGYI-----APELAYTMVVTEK 117
+++ N+LL+ + + DFG+A+ + G APE
Sbjct: 160 LAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYR--VREDGDSPVFWYAPECLKEYKFYYA 217
Query: 118 SDVYSFGVVALEVLM 132
SDV+SFGV E+L
Sbjct: 218 SDVWSFGVTLYELLT 232
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 72.5 bits (178), Expect = 4e-16
Identities = 37/163 (22%), Positives = 69/163 (42%), Gaps = 33/163 (20%)
Query: 3 RKCMFLIYEYMEMGSLFCVL----RTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPI 58
+ +++ E +L ++ +DE +++++ +A +++LH I
Sbjct: 81 DRFLYIALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLK---I 136
Query: 59 VHRDISSNNILL-------------NLELEAFVADFGVARLLNFDSSNRTL----LAGTY 101
+HRD+ NIL+ L ++DFG+ + L+ S+ +GT
Sbjct: 137 IHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTS 196
Query: 102 GYIAPEL-------AYTMVVTEKSDVYSFGVVALEVL-MGKHP 136
G+ APEL +T D++S G V +L GKHP
Sbjct: 197 GWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHP 239
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 71.1 bits (175), Expect = 6e-16
Identities = 39/140 (27%), Positives = 65/140 (46%), Gaps = 21/140 (15%)
Query: 6 MFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYL--HHDCTPPIVHRDI 63
+F+I EYM G L LR + + + K + A+ YL +HRD+
Sbjct: 94 IFIITEYMANGCLLNYLREMRHRFQTQ--QLLEMCKDVCEAMEYLESKQ-----FLHRDL 146
Query: 64 SSNNILLNLELEAFVADFGVARLLNFD---SSNRTLLAGTYGYI---APELAYTMVVTEK 117
++ N L+N + V+DFG++R + D SS + + PE+ + K
Sbjct: 147 AARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFP-----VRWSPPEVLMYSKFSSK 201
Query: 118 SDVYSFGVVALEVLM-GKHP 136
SD+++FGV+ E+ GK P
Sbjct: 202 SDIWAFGVLMWEIYSLGKMP 221
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 71.1 bits (175), Expect = 7e-16
Identities = 39/144 (27%), Positives = 62/144 (43%), Gaps = 29/144 (20%)
Query: 6 MFLIYEYMEMGSLFCVLRTDEEAVG----LDWAKRVNIVKGMAHALSYL--HHDCTPPIV 59
++I E G L L ++ ++ + ++ + I K MA YL + V
Sbjct: 87 TWIIMELYPYGELGHYLERNKNSLKVLTLVLYS--LQICKAMA----YLESIN-----CV 135
Query: 60 HRDISSNNILLNLELEAFVADFGVARLLNFD---SSNRTLLAGTYGYI---APELAYTMV 113
HRDI+ NIL+ + DFG++R + + ++ T L I +PE
Sbjct: 136 HRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLP-----IKWMSPESINFRR 190
Query: 114 VTEKSDVYSFGVVALEVLM-GKHP 136
T SDV+ F V E+L GK P
Sbjct: 191 FTTASDVWMFAVCMWEILSFGKQP 214
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 71.7 bits (176), Expect = 8e-16
Identities = 33/145 (22%), Positives = 56/145 (38%), Gaps = 16/145 (11%)
Query: 7 FLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSN 66
FL+ + G L L+ E L + I A+ ++H PPI+HRD+
Sbjct: 109 FLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHR-QKPPIIHRDLKVE 167
Query: 67 NILLNLELEAFVADFGVARLLNFDSSNRTLLA------------GTYGYIAPELAYTM-- 112
N+LL+ + + DFG A ++ T Y PE+
Sbjct: 168 NLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSN 227
Query: 113 -VVTEKSDVYSFGVVALEVLMGKHP 136
+ EK D+++ G + + +HP
Sbjct: 228 FPIGEKQDIWALGCILYLLCFRQHP 252
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 71.1 bits (175), Expect = 8e-16
Identities = 38/138 (27%), Positives = 62/138 (44%), Gaps = 16/138 (11%)
Query: 6 MFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYL-HHDCTPPIVHRDIS 64
++I E+M G+L LR + + + ++ A+ YL + +HRD++
Sbjct: 84 FYIITEFMTYGNLLDYLRECNRQE-VSAVVLLYMATQISSAMEYLEKKNF----IHRDLA 138
Query: 65 SNNILLNLELEAFVADFGVARLLNFDSSNRTLLAGTYGYI-----APELAYTMVVTEKSD 119
+ N L+ VADFG++RL+ D T A APE + KSD
Sbjct: 139 ARNCLVGENHLVKVADFGLSRLMTGD----TYTAHAGAKFPIKWTAPESLAYNKFSIKSD 194
Query: 120 VYSFGVVALEVLM-GKHP 136
V++FGV+ E+ G P
Sbjct: 195 VWAFGVLLWEIATYGMSP 212
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 70.8 bits (174), Expect = 9e-16
Identities = 24/157 (15%), Positives = 49/157 (31%), Gaps = 28/157 (17%)
Query: 1 LHRKCMFLIYEYMEMGSLFCVLRTDEEAVG-LDWAKRVNIVKGMAHALSYLHHDCTPPIV 59
M + EY GSL + + + A+ +++ + L Y+H +V
Sbjct: 81 AEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSM---SLV 137
Query: 60 HRDISSNNILLNLELEAFV-------------------ADFGVARLLNFDSSNRTLLAGT 100
H DI +NI ++ D G ++ G
Sbjct: 138 HMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSPQV----EEGD 193
Query: 101 YGYIAPE-LAYTMVVTEKSDVYSFGVVALEVLMGKHP 136
++A E L K+D+++ + + +
Sbjct: 194 SRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPL 230
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 71.2 bits (175), Expect = 1e-15
Identities = 44/143 (30%), Positives = 67/143 (46%), Gaps = 28/143 (19%)
Query: 6 MFLIYEYMEMGSLFCVLRT----DEEAVGLDWAKRVNIVKGMAHALSYLH-HDCTPPIVH 60
MF++ + + G L L+ EE V L + + AL YL I+H
Sbjct: 90 MFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICE-------LVMALDYLQNQR----IIH 138
Query: 61 RDISSNNILLNLELEAFVADFGVARLLNFDSSNRTLLAGTYGYIAPEL-------AYTMV 113
RD+ +NILL+ + DF +A +L ++ T +AGT Y+APE+ Y+
Sbjct: 139 RDMKPDNILLDEHGHVHITDFNIAAMLPRETQITT-MAGTKPYMAPEMFSSRKGAGYSFA 197
Query: 114 VTEKSDVYSFGVVALEVLMGKHP 136
V D +S GV A E+L G+ P
Sbjct: 198 V----DWWSLGVTAYELLRGRRP 216
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 70.9 bits (174), Expect = 1e-15
Identities = 39/141 (27%), Positives = 65/141 (46%), Gaps = 20/141 (14%)
Query: 6 MFLIYEYMEMGSLFCVLRTDEEAVG----LDWAKRVNIVKGMAHALSYLHHDCTPPIVHR 61
++ YM+ G L +R + + + + + KGM L+ VHR
Sbjct: 166 PLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFG--LQVAKGMKF-LASKK------FVHR 216
Query: 62 DISSNNILLNLELEAFVADFGVARLLNFDSSNRTLLAGTYGYI-----APELAYTMVVTE 116
D+++ N +L+ + VADFG+AR + +D ++ T + A E T T
Sbjct: 217 DLAARNCMLDEKFTVKVADFGLARDM-YDKEFDSVHNKTGAKLPVKWMALESLQTQKFTT 275
Query: 117 KSDVYSFGVVALEVLM-GKHP 136
KSDV+SFGV+ E++ G P
Sbjct: 276 KSDVWSFGVLLWELMTRGAPP 296
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 70.3 bits (173), Expect = 2e-15
Identities = 38/138 (27%), Positives = 65/138 (47%), Gaps = 17/138 (12%)
Query: 6 MFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYL-HHDCTPPIVHRDIS 64
+++I E +G L L+ + ++ L A + ++ AL+YL VHRDI+
Sbjct: 90 VWIIMELCTLGELRSFLQVRKYSLDL--ASLILYAYQLSTALAYLESKRF----VHRDIA 143
Query: 65 SNNILLNLELEAFVADFGVARLLNFDSSNRTLLAGTYGYI-----APELAYTMVVTEKSD 119
+ N+L++ + DFG++R + + + + G + APE T SD
Sbjct: 144 ARNVLVSSNDCVKLGDFGLSRYMEDSTYYKA----SKGKLPIKWMAPESINFRRFTSASD 199
Query: 120 VYSFGVVALEVLM-GKHP 136
V+ FGV E+LM G P
Sbjct: 200 VWMFGVCMWEILMHGVKP 217
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 69.9 bits (172), Expect = 2e-15
Identities = 37/137 (27%), Positives = 72/137 (52%), Gaps = 15/137 (10%)
Query: 6 MFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYL--HHDCTPPIVHRDI 63
++++ EY+ G L LR+ + L+ ++ + + + +++L H +HRD+
Sbjct: 78 IYIVTEYISNGCLLNYLRSHGKG--LEPSQLLEMCYDVCEGMAFLESHQ-----FIHRDL 130
Query: 64 SSNNILLNLELEAFVADFGVARLLNFDSSNRTLLAGTYGYI---APELAYTMVVTEKSDV 120
++ N L++ +L V+DFG+ R + D + GT + APE+ + + KSDV
Sbjct: 131 AARNCLVDRDLCVKVSDFGMTRYVLDDQYVSS--VGTKFPVKWSAPEVFHYFKYSSKSDV 188
Query: 121 YSFGVVALEVLM-GKHP 136
++FG++ EV GK P
Sbjct: 189 WAFGILMWEVFSLGKMP 205
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 69.9 bits (172), Expect = 2e-15
Identities = 42/138 (30%), Positives = 66/138 (47%), Gaps = 16/138 (11%)
Query: 3 RKCMFLIYEYMEMGSLFCVL----RTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPI 58
RK ++L+ E+ G L+ L R DE+ + ++ +A AL Y H +
Sbjct: 86 RKRIYLMLEFAPRGELYKELQKHGRFDEQR-----SAT--FMEELADALHYCHERK---V 135
Query: 59 VHRDISSNNILLNLELEAFVADFGVARLLNFDSSNRTLLAGTYGYIAPELAYTMVVTEKS 118
+HRDI N+L+ + E +ADFG + S R + GT Y+ PE+ EK
Sbjct: 136 IHRDIKPENLLMGYKGELKIADFGWSVHA--PSLRRRTMCGTLDYLPPEMIEGKTHDEKV 193
Query: 119 DVYSFGVVALEVLMGKHP 136
D++ GV+ E L+G P
Sbjct: 194 DLWCAGVLCYEFLVGMPP 211
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 68.8 bits (169), Expect = 5e-15
Identities = 38/140 (27%), Positives = 64/140 (45%), Gaps = 20/140 (14%)
Query: 7 FLIYEYMEMGSLFCVLRTDEEAVG----LDWAKRVNIVKGMAHALSYLHHDCTPPIVHRD 62
++ YM G L +R+ + + + + + +GM + L+ VHRD
Sbjct: 99 HVLLPYMCHGDLLQFIRSPQRNPTVKDLISFG--LQVARGMEY-LAEQK------FVHRD 149
Query: 63 ISSNNILLNLELEAFVADFGVARLLNFDSSNRTLLAGTYGYI-----APELAYTMVVTEK 117
+++ N +L+ VADFG+AR + D ++ + + A E T T K
Sbjct: 150 LAARNCMLDESFTVKVADFGLARDI-LDREYYSVQQHRHARLPVKWTALESLQTYRFTTK 208
Query: 118 SDVYSFGVVALEVLM-GKHP 136
SDV+SFGV+ E+L G P
Sbjct: 209 SDVWSFGVLLWELLTRGAPP 228
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 68.4 bits (168), Expect = 6e-15
Identities = 38/138 (27%), Positives = 67/138 (48%), Gaps = 20/138 (14%)
Query: 6 MFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYL-HHDCTPPIVHRDIS 64
++++ EYM GSL LR+ +V L + + A+ YL ++ VHRD++
Sbjct: 90 LYIVTEYMAKGSLVDYLRSRGRSV-LGGDCLLKFSLDVCEAMEYLEGNNF----VHRDLA 144
Query: 65 SNNILLNLELEAFVADFGVARLLNFDSSNRTLLAGTYGYI-----APELAYTMVVTEKSD 119
+ N+L++ + A V+DFG+ + + G + APE + KSD
Sbjct: 145 ARNVLVSEDNVAKVSDFGLTKEASSTQDT--------GKLPVKWTAPEALREKKFSTKSD 196
Query: 120 VYSFGVVALEVLM-GKHP 136
V+SFG++ E+ G+ P
Sbjct: 197 VWSFGILLWEIYSFGRVP 214
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 69.0 bits (169), Expect = 7e-15
Identities = 38/144 (26%), Positives = 61/144 (42%), Gaps = 23/144 (15%)
Query: 1 LHRKCMFLIYEYMEMGSLFCVLRT-----DEEAVGLDWAKRVNIVKGMAHALSYLHHDCT 55
L +L+ EY GS +L E + + G L+YLH
Sbjct: 124 LREHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAA-------VTHGALQGLAYLHSH-- 173
Query: 56 PPIVHRDISSNNILLNLELEAFVADFGVARLLNFDSSNRTLLAGTYGYIAPELAYTMVVT 115
++HRD+ + NILL+ + DFG A ++ + GT ++APE+ M
Sbjct: 174 -NMIHRDVKAGNILLSEPGLVKLGDFGSASIM----APANSFVGTPYWMAPEVILAMDEG 228
Query: 116 E---KSDVYSFGVVALEVLMGKHP 136
+ K DV+S G+ +E+ K P
Sbjct: 229 QYDGKVDVWSLGITCIELAERKPP 252
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 68.1 bits (167), Expect = 1e-14
Identities = 37/139 (26%), Positives = 58/139 (41%), Gaps = 16/139 (11%)
Query: 6 MFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYL--HHDCTPPIVHRDI 63
++ YM+ G L +R + + +A + YL VHRD+
Sbjct: 102 PLVVLPYMKHGDLRNFIRNETHN--PTVKDLIGFGLQVAKGMKYLASKK-----FVHRDL 154
Query: 64 SSNNILLNLELEAFVADFGVARLLNFDSSNRTLLAGTYGYI-----APELAYTMVVTEKS 118
++ N +L+ + VADFG+AR + T + A E T T KS
Sbjct: 155 AARNCMLDEKFTVKVADFGLARDMYDKEYYSV-HNKTGAKLPVKWMALESLQTQKFTTKS 213
Query: 119 DVYSFGVVALEVLM-GKHP 136
DV+SFGV+ E++ G P
Sbjct: 214 DVWSFGVLLWELMTRGAPP 232
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 67.4 bits (165), Expect = 2e-14
Identities = 36/142 (25%), Positives = 60/142 (42%), Gaps = 19/142 (13%)
Query: 6 MFLIYEYMEMGSLFCVLRT---DEEAVGLDWAKRVNIVKGMAHALSYL--HHDCTPPIVH 60
+I +M+ G L L E L V + +A + YL + +H
Sbjct: 106 PMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRN-----FIH 160
Query: 61 RDISSNNILLNLELEAFVADFGVARLLNFDSSNRTLLAGTYGYI-----APELAYTMVVT 115
RD+++ N +L ++ VADFG++R + R G + A E + T
Sbjct: 161 RDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYR---QGCASKLPVKWLALESLADNLYT 217
Query: 116 EKSDVYSFGVVALEVLM-GKHP 136
SDV++FGV E++ G+ P
Sbjct: 218 VHSDVWAFGVTMWEIMTRGQTP 239
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 67.3 bits (165), Expect = 2e-14
Identities = 40/146 (27%), Positives = 61/146 (41%), Gaps = 23/146 (15%)
Query: 6 MFLIYEYMEMGSLFCVLR----TDEEAVGLDWAKRVNIVKGMAHALSYL--HHDCTPPIV 59
F++ E M G L LR + L +++ + +A YL +H +
Sbjct: 108 RFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH-----FI 162
Query: 60 HRDISSNNILLNLELEAFV---ADFGVARLLNFDSSNRTLLAGTYGYI-----APELAYT 111
HRDI++ N LL V DFG+AR + S R G + PE
Sbjct: 163 HRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYR---KGGCAMLPVKWMPPEAFME 219
Query: 112 MVVTEKSDVYSFGVVALEVL-MGKHP 136
+ T K+D +SFGV+ E+ +G P
Sbjct: 220 GIFTSKTDTWSFGVLLWEIFSLGYMP 245
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 67.0 bits (164), Expect = 4e-14
Identities = 39/146 (26%), Positives = 60/146 (41%), Gaps = 23/146 (15%)
Query: 6 MFLIYEYMEMGSLFCVLR----TDEEAVGLDWAKRVNIVKGMAHALSYL--HHDCTPPIV 59
F++ E M G L LR + L +++ + +A YL +H +
Sbjct: 149 RFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH-----FI 203
Query: 60 HRDISSNNILLNLELEAFV---ADFGVARLLNFDSSNRTLLAGTYGYI-----APELAYT 111
HRDI++ N LL V DFG+AR + R G + PE
Sbjct: 204 HRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYR---KGGCAMLPVKWMPPEAFME 260
Query: 112 MVVTEKSDVYSFGVVALEVL-MGKHP 136
+ T K+D +SFGV+ E+ +G P
Sbjct: 261 GIFTSKTDTWSFGVLLWEIFSLGYMP 286
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 66.2 bits (162), Expect = 6e-14
Identities = 34/141 (24%), Positives = 59/141 (41%), Gaps = 19/141 (13%)
Query: 7 FLIYEYMEMGSLFCVLRT---DEEAVGLDWAKRVNIVKGMAHALSYL--HHDCTPPIVHR 61
+I +M+ G L L + + + + +A + YL + +HR
Sbjct: 117 MVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRN-----FLHR 171
Query: 62 DISSNNILLNLELEAFVADFGVARLLNFDSSNRTLLAGTYGYI-----APELAYTMVVTE 116
D+++ N +L ++ VADFG+++ + R G + A E V T
Sbjct: 172 DLAARNCMLRDDMTVCVADFGLSKKIYSGDYYR---QGRIAKMPVKWIAIESLADRVYTS 228
Query: 117 KSDVYSFGVVALEVLM-GKHP 136
KSDV++FGV E+ G P
Sbjct: 229 KSDVWAFGVTMWEIATRGMTP 249
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 65.8 bits (161), Expect = 8e-14
Identities = 38/154 (24%), Positives = 63/154 (40%), Gaps = 33/154 (21%)
Query: 6 MFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVN-----------------IVKGMAHALS 48
+ +I E+ + G+L LR+ + + KGM L+
Sbjct: 107 LMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEF-LA 165
Query: 49 YLHHDCTPPIVHRDISSNNILLNLELEAFVADFGVARLLNFDSSNRTLLAGTYGYI---- 104
+HRD+++ NILL+ + + DFG+AR + D +
Sbjct: 166 SRK------CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYV---RKGDARLPLKW 216
Query: 105 -APELAYTMVVTEKSDVYSFGVVALEVL-MGKHP 136
APE + V T +SDV+SFGV+ E+ +G P
Sbjct: 217 MAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 250
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 65.9 bits (161), Expect = 1e-13
Identities = 39/141 (27%), Positives = 63/141 (44%), Gaps = 19/141 (13%)
Query: 3 RKCMFLIYEYMEMGSLFCVLRT----DEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPI 58
++ +L+ E + G LF + +E I+K + ++YLH I
Sbjct: 108 KRNYYLVMECYKGGELFDEIIHRMKFNEVDAA-------VIIKQVLSGVTYLHKHN---I 157
Query: 59 VHRDISSNNILLNLELEAF---VADFGVARLLNFDSSNRTLLAGTYGYIAPELAYTMVVT 115
VHRD+ N+LL + + + DFG++ + + GT YIAPE+
Sbjct: 158 VHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKE-RLGTAYYIAPEV-LRKKYD 215
Query: 116 EKSDVYSFGVVALEVLMGKHP 136
EK DV+S GV+ +L G P
Sbjct: 216 EKCDVWSIGVILFILLAGYPP 236
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 65.4 bits (160), Expect = 1e-13
Identities = 40/152 (26%), Positives = 67/152 (44%), Gaps = 31/152 (20%)
Query: 6 MFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVN---------------IVKGMAHALSYL 50
+ +I EY G L LR + D A + + +GMA L+
Sbjct: 125 VLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAF-LASK 183
Query: 51 HHDCTPPIVHRDISSNNILLNLELEAFVADFGVARLLNFDSSNRTLLAGTYGYI-----A 105
+ +HRD+++ N+LL A + DFG+AR + DS+ + A
Sbjct: 184 N------CIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYI---VKGNARLPVKWMA 234
Query: 106 PELAYTMVVTEKSDVYSFGVVALEVL-MGKHP 136
PE + V T +SDV+S+G++ E+ +G +P
Sbjct: 235 PESIFDCVYTVQSDVWSYGILLWEIFSLGLNP 266
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 65.1 bits (159), Expect = 2e-13
Identities = 42/140 (30%), Positives = 64/140 (45%), Gaps = 17/140 (12%)
Query: 7 FLIYEYMEMGSLFCVLRTDEEAVGLDWAK--RVNIVKGMAHALSYLHHDCTPPIVHRDIS 64
+L+ EY G L +L E + + A+ IV A+ +H VHRDI
Sbjct: 137 YLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVM----AIDSVHRLG---YVHRDIK 189
Query: 65 SNNILLNLELEAFVADFGVARLLNFDSSNRTLLA-GTYGYIAPELAYTMVVTEKSDVY-- 121
+NILL+ +ADFG L D + R+L+A GT Y++PE+ + + Y
Sbjct: 190 PDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGP 249
Query: 122 -----SFGVVALEVLMGKHP 136
+ GV A E+ G+ P
Sbjct: 250 ECDWWALGVFAYEMFYGQTP 269
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 64.7 bits (158), Expect = 2e-13
Identities = 46/142 (32%), Positives = 64/142 (45%), Gaps = 21/142 (14%)
Query: 3 RKCMFLIYEYMEMGSLFCVLR-----TDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPP 57
+K +L+ E+ E G LF + + +A NI+K + + YLH
Sbjct: 118 KKYFYLVTEFYEGGELFEQIINRHKFDECDAA--------NIMKQILSGICYLHKHN--- 166
Query: 58 IVHRDISSNNILLNLELEAF---VADFGVARLLNFDSSNRTLLAGTYGYIAPELAYTMVV 114
IVHRDI NILL + + DFG++ + D R GT YIAPE
Sbjct: 167 IVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRD-RLGTAYYIAPE-VLKKKY 224
Query: 115 TEKSDVYSFGVVALEVLMGKHP 136
EK DV+S GV+ +L G P
Sbjct: 225 NEKCDVWSCGVIMYILLCGYPP 246
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 64.7 bits (158), Expect = 3e-13
Identities = 37/141 (26%), Positives = 61/141 (43%), Gaps = 19/141 (13%)
Query: 3 RKCMFLIYEYMEMGSLFCVLRT----DEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPI 58
+ +L+ E G LF + + E I++ + ++Y+H + I
Sbjct: 98 KGYFYLVGEVYTGGELFDEIISRKRFSEVDAA-------RIIRQVLSGITYMHKNK---I 147
Query: 59 VHRDISSNNILLNLELEAF---VADFGVARLLNFDSSNRTLLAGTYGYIAPELAYTMVVT 115
VHRD+ N+LL + + + DFG++ + GT YIAPE+
Sbjct: 148 VHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKD-KIGTAYYIAPEV-LHGTYD 205
Query: 116 EKSDVYSFGVVALEVLMGKHP 136
EK DV+S GV+ +L G P
Sbjct: 206 EKCDVWSTGVILYILLSGCPP 226
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 64.2 bits (157), Expect = 3e-13
Identities = 40/150 (26%), Positives = 60/150 (40%), Gaps = 31/150 (20%)
Query: 6 MFLIYEYMEMGSLFCVLRTDEEAVG-------------LDWAKRVNIVKGMAHALSYLHH 52
+I E M G L LR+ A+ + A I GMA+ L+
Sbjct: 103 TLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMA--GEIADGMAY-LNANK- 158
Query: 53 DCTPPIVHRDISSNNILLNLELEAFVADFGVARLLNFDSSNRTLLAGTYGYI-----APE 107
VHRD+++ N ++ + + DFG+ R + R G G + +PE
Sbjct: 159 -----FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYR---KGGKGLLPVRWMSPE 210
Query: 108 LAYTMVVTEKSDVYSFGVVALEVLM-GKHP 136
V T SDV+SFGVV E+ + P
Sbjct: 211 SLKDGVFTTYSDVWSFGVVLWEIATLAEQP 240
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 64.2 bits (157), Expect = 3e-13
Identities = 42/154 (27%), Positives = 63/154 (40%), Gaps = 34/154 (22%)
Query: 6 MFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVN----------------IVKGMAHALSY 49
+ +++EYM G L LR+ L + GM + L+
Sbjct: 118 LLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVY-LAG 176
Query: 50 LHHDCTPPIVHRDISSNNILLNLELEAFVADFGVARLLNFDSSNRTLLAGTYGYI----- 104
LH VHRD+++ N L+ L + DFG++R + R G +
Sbjct: 177 LH------FVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYR---VGGRTMLPIRWM 227
Query: 105 APE-LAYTMVVTEKSDVYSFGVVALEVL-MGKHP 136
PE + Y T +SDV+SFGVV E+ GK P
Sbjct: 228 PPESILYR-KFTTESDVWSFGVVLWEIFTYGKQP 260
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 64.2 bits (157), Expect = 3e-13
Identities = 39/156 (25%), Positives = 61/156 (39%), Gaps = 35/156 (22%)
Query: 6 MFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVN-------------------IVKGMAHA 46
+I EY G L LR ++ + KGMA
Sbjct: 102 TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAF- 160
Query: 47 LSYLHHDCTPPIVHRDISSNNILLNLELEAFVADFGVARLLNFDSSNRTLLAGTYGYI-- 104
L+ + +HRD+++ NILL + DFG+AR + DS+ +
Sbjct: 161 LASKN------CIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYV---VKGNARLPV 211
Query: 105 ---APELAYTMVVTEKSDVYSFGVVALEVL-MGKHP 136
APE + V T +SDV+S+G+ E+ +G P
Sbjct: 212 KWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSP 247
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 63.4 bits (155), Expect = 5e-13
Identities = 39/154 (25%), Positives = 62/154 (40%), Gaps = 33/154 (21%)
Query: 6 MFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVN-----------------IVKGMAHALS 48
+ +++EYM+ G L LR + + I GM + L+
Sbjct: 92 LIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVY-LA 150
Query: 49 YLHHDCTPPIVHRDISSNNILLNLELEAFVADFGVARLLNFDSSNRTLLAGTYGYI---- 104
H VHRD+++ N L+ L + DFG++R + R G + +
Sbjct: 151 SQH------FVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYR---VGGHTMLPIRW 201
Query: 105 -APELAYTMVVTEKSDVYSFGVVALEVL-MGKHP 136
PE T +SDV+SFGV+ E+ GK P
Sbjct: 202 MPPESIMYRKFTTESDVWSFGVILWEIFTYGKQP 235
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 63.5 bits (155), Expect = 6e-13
Identities = 39/154 (25%), Positives = 64/154 (41%), Gaps = 33/154 (21%)
Query: 6 MFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVN-----------------IVKGMAHALS 48
+++I EY G+L LR + +GM + L+
Sbjct: 116 LYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEY-LA 174
Query: 49 YLHHDCTPPIVHRDISSNNILLNLELEAFVADFGVARLLNFDSSNRTLLAGTYGYI---- 104
+HRD+++ N+L+ +ADFG+AR +N + T G +
Sbjct: 175 SQK------CIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYK---KTTNGRLPVKW 225
Query: 105 -APELAYTMVVTEKSDVYSFGVVALEVL-MGKHP 136
APE + V T +SDV+SFGV+ E+ +G P
Sbjct: 226 MAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP 259
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 63.6 bits (155), Expect = 6e-13
Identities = 40/143 (27%), Positives = 65/143 (45%), Gaps = 25/143 (17%)
Query: 7 FLIYEYMEMGSLFCVLRTDEEAVGLDWAK--RVNIVKGMAHALSYLH-HDCTPPIVHRDI 63
+L+ +Y G L +L E+ + + A+ +V A+ +H VHRDI
Sbjct: 150 YLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVI----AIDSVHQLH----YVHRDI 201
Query: 64 SSNNILLNLELEAFVADFGVARLLNFDSSNRTLLA-GTYGYIAPEL---------AYTMV 113
+NIL+++ +ADFG L D + ++ +A GT YI+PE+ Y
Sbjct: 202 KPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPE 261
Query: 114 VTEKSDVYSFGVVALEVLMGKHP 136
D +S GV E+L G+ P
Sbjct: 262 C----DWWSLGVCMYEMLYGETP 280
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 63.0 bits (154), Expect = 7e-13
Identities = 33/154 (21%), Positives = 56/154 (36%), Gaps = 33/154 (21%)
Query: 6 MFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVN-----------------IVKGMAHALS 48
+ +I+ Y G L L + I GM + LS
Sbjct: 87 LSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEY-LS 145
Query: 49 YLHHDCTPPIVHRDISSNNILLNLELEAFVADFGVARLLNFDSSNRTLLAGTYGYI---- 104
H +VH+D+++ N+L+ +L ++D G+ R + + +
Sbjct: 146 SHH------VVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYK---LLGNSLLPIRW 196
Query: 105 -APELAYTMVVTEKSDVYSFGVVALEVLM-GKHP 136
APE + SD++S+GVV EV G P
Sbjct: 197 MAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQP 230
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 63.5 bits (155), Expect = 7e-13
Identities = 39/154 (25%), Positives = 64/154 (41%), Gaps = 33/154 (21%)
Query: 6 MFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVN-----------------IVKGMAHALS 48
+++I EY G+L LR + +GM + L+
Sbjct: 162 LYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEY-LA 220
Query: 49 YLHHDCTPPIVHRDISSNNILLNLELEAFVADFGVARLLNFDSSNRTLLAGTYGYI---- 104
+HRD+++ N+L+ +ADFG+AR +N + T G +
Sbjct: 221 SQK------CIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYK---KTTNGRLPVKW 271
Query: 105 -APELAYTMVVTEKSDVYSFGVVALEVL-MGKHP 136
APE + V T +SDV+SFGV+ E+ +G P
Sbjct: 272 MAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP 305
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 63.2 bits (154), Expect = 8e-13
Identities = 36/154 (23%), Positives = 66/154 (42%), Gaps = 33/154 (21%)
Query: 6 MFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVN-----------------IVKGMAHALS 48
+++I EY G+L L+ + + +GM + L+
Sbjct: 150 LYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEY-LA 208
Query: 49 YLHHDCTPPIVHRDISSNNILLNLELEAFVADFGVARLLNFDSSNRTLLAGTYGYI---- 104
+HRD+++ N+L+ + +ADFG+AR ++ + T G +
Sbjct: 209 SKK------CIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYK---KTTNGRLPVKW 259
Query: 105 -APELAYTMVVTEKSDVYSFGVVALEVL-MGKHP 136
APE + + T +SDV+SFGV+ E+ +G P
Sbjct: 260 MAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSP 293
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 61.9 bits (151), Expect = 2e-12
Identities = 41/161 (25%), Positives = 67/161 (41%), Gaps = 40/161 (24%)
Query: 6 MFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVN------------------------IVK 41
++LI+EY G L LR+ E D + N + K
Sbjct: 124 IYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAK 183
Query: 42 GMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADFGVARLLNFDSSNRTLLAGTY 101
GM L + VHRD+++ N+L+ + DFG+AR + DS+
Sbjct: 184 GMEF-LEFKS------CVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYV---VRGN 233
Query: 102 GYI-----APELAYTMVVTEKSDVYSFGVVALEVL-MGKHP 136
+ APE + + T KSDV+S+G++ E+ +G +P
Sbjct: 234 ARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNP 274
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 61.9 bits (151), Expect = 2e-12
Identities = 41/155 (26%), Positives = 64/155 (41%), Gaps = 38/155 (24%)
Query: 6 MFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVN-----------------IVKGMAHALS 48
++L EY G+L LR N + +GM + LS
Sbjct: 101 LYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDY-LS 159
Query: 49 YLHHDCTPPIVHRDISSNNILLNLELEAFVADFGVARLLNFDSSNRTLLAGTYGYI---- 104
+HRD+++ NIL+ A +ADFG++R + T G +
Sbjct: 160 QKQ------FIHRDLAARNILVGENYVAKIADFGLSR------GQEVYVKKTMGRLPVRW 207
Query: 105 -APE-LAYTMVVTEKSDVYSFGVVALEVL-MGKHP 136
A E L Y+ V T SDV+S+GV+ E++ +G P
Sbjct: 208 MAIESLNYS-VYTTNSDVWSYGVLLWEIVSLGGTP 241
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 62.0 bits (151), Expect = 2e-12
Identities = 39/145 (26%), Positives = 64/145 (44%), Gaps = 27/145 (18%)
Query: 3 RKCMFLIYEYMEMGSLFCVLR-----TDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPP 57
+++ E G LF + ++ +A I+K + ++Y+H
Sbjct: 93 SSSFYIVGELYTGGELFDEIIKRKRFSEHDAA--------RIIKQVFSGITYMHKHN--- 141
Query: 58 IVHRDISSNNILLNLELEAF---VADFGVARLLNFDSSNRTLLAGTYGYIAPEL---AYT 111
IVHRD+ NILL + + + DFG++ ++ + GT YIAPE+ Y
Sbjct: 142 IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKD-RIGTAYYIAPEVLRGTY- 199
Query: 112 MVVTEKSDVYSFGVVALEVLMGKHP 136
EK DV+S GV+ +L G P
Sbjct: 200 ---DEKCDVWSAGVILYILLSGTPP 221
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 61.2 bits (149), Expect = 5e-12
Identities = 39/131 (29%), Positives = 57/131 (43%), Gaps = 23/131 (17%)
Query: 7 FLIYEYMEMGSLF--CVLR---TDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHR 61
+++ E ME G LF V + M A+ YLH + I+HR
Sbjct: 215 YIVLELMEGGELFDKVVGNKRLKEATCK--------LYFYQMLLAVQYLHENG---IIHR 263
Query: 62 DISSNNILLNLELEAF---VADFGVARLLNFDSSNRTLLAGTYGYIAPE-LAYTMVV--T 115
D+ N+LL+ + E + DFG +++L S RT L GT Y+APE L
Sbjct: 264 DLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRT-LCGTPTYLAPEVLVSVGTAGYN 322
Query: 116 EKSDVYSFGVV 126
D +S GV+
Sbjct: 323 RAVDCWSLGVI 333
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 60.3 bits (146), Expect = 9e-12
Identities = 32/104 (30%), Positives = 49/104 (47%), Gaps = 16/104 (15%)
Query: 39 IVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADFGVARLLNFDSSNRTLLA 98
+ KGM S +HRD+++ NILL+ + + DFG+AR + D
Sbjct: 202 VAKGMEFLAS-------RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYV---R 251
Query: 99 GTYGYI-----APELAYTMVVTEKSDVYSFGVVALEVL-MGKHP 136
+ APE + V T +SDV+SFGV+ E+ +G P
Sbjct: 252 KGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 295
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 59.8 bits (145), Expect = 1e-11
Identities = 36/136 (26%), Positives = 63/136 (46%), Gaps = 8/136 (5%)
Query: 3 RKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRD 62
M +IYE+M G LF + +E + + V ++ + L ++H + VH D
Sbjct: 226 DNEMVMIYEFMSGGELFE--KVADEHNKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLD 280
Query: 63 ISSNNILLNLELEAFV--ADFGVARLLNFDSSNRTLLAGTYGYIAPELAYTMVVTEKSDV 120
+ NI+ + + DFG+ L+ S + GT + APE+A V +D+
Sbjct: 281 LKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTT-GTAEFAAPEVAEGKPVGYYTDM 339
Query: 121 YSFGVVALEVLMGKHP 136
+S GV++ +L G P
Sbjct: 340 WSVGVLSYILLSGLSP 355
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 59.6 bits (145), Expect = 1e-11
Identities = 37/136 (27%), Positives = 63/136 (46%), Gaps = 24/136 (17%)
Query: 3 RKCMFLIYEYMEMGSLF--CVLRTDE-----EAVGLDWAKRVNIVKGMAHALSYLHHDCT 55
+ LI EY G +F C+ E + + ++K + + YLH +
Sbjct: 101 TSEIILILEYAAGGEIFSLCLPELAEMVSENDVI--------RLIKQILEGVYYLHQNN- 151
Query: 56 PPIVHRDISSNNILLNLELEAF---VADFGVARLLNFDSSNRTLLAGTYGYIAPE-LAYT 111
IVH D+ NILL+ + DFG++R + R ++ GT Y+APE L Y
Sbjct: 152 --IVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELREIM-GTPEYLAPEILNYD 208
Query: 112 MVVTEKSDVYSFGVVA 127
+T +D+++ G++A
Sbjct: 209 P-ITTATDMWNIGIIA 223
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 59.6 bits (145), Expect = 1e-11
Identities = 40/162 (24%), Positives = 70/162 (43%), Gaps = 41/162 (25%)
Query: 6 MFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVN-------------------------IV 40
+ LI EY + GSL LR + + I
Sbjct: 101 LLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQIS 160
Query: 41 KGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADFGVARLLNFDSSNRTLLAGT 100
+GM + L+ + +VHRD+++ NIL+ + ++DFG++R + + S +
Sbjct: 161 QGMQY-LAEMK------LVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSYV---KRS 210
Query: 101 YGYI-----APELAYTMVVTEKSDVYSFGVVALEVL-MGKHP 136
G I A E + + T +SDV+SFGV+ E++ +G +P
Sbjct: 211 QGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNP 252
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 59.3 bits (144), Expect = 2e-11
Identities = 32/134 (23%), Positives = 59/134 (44%), Gaps = 22/134 (16%)
Query: 3 RKCMFLIYEYMEMGSLF--CVLR----TDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTP 56
+ + L+ EY++ G LF + T+ + + +K + + ++H
Sbjct: 158 KNDIVLVMEYVDGGELFDRIIDESYNLTELDTI--------LFMKQICEGIRHMHQM--- 206
Query: 57 PIVHRDISSNNILLNLELEAFV--ADFGVARLLNFDSSNRTLLAGTYGYIAPE-LAYTMV 113
I+H D+ NIL + DFG+AR + GT ++APE + Y
Sbjct: 207 YILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKVNF-GTPEFLAPEVVNYD-F 264
Query: 114 VTEKSDVYSFGVVA 127
V+ +D++S GV+A
Sbjct: 265 VSFPTDMWSVGVIA 278
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 59.2 bits (144), Expect = 2e-11
Identities = 28/129 (21%), Positives = 58/129 (44%), Gaps = 9/129 (6%)
Query: 3 RKCMFLIYEYMEMGSLF-CVLRTDEEAVGLDWAKRVNIVKGMAHALSYLH-HDCTPPIVH 60
+++++E+M+ L +++ + A + ++ + AL Y H ++ I+H
Sbjct: 98 DGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNN----IIH 153
Query: 61 RDISSNNILLNLELEAF---VADFGVARLLNFDSSNRTLLAGTYGYIAPELAYTMVVTEK 117
RD+ + +LL + + + FGVA L GT ++APE+ +
Sbjct: 154 RDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPHFMAPEVVKREPYGKP 213
Query: 118 SDVYSFGVV 126
DV+ GV+
Sbjct: 214 VDVWGCGVI 222
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 59.0 bits (143), Expect = 2e-11
Identities = 38/144 (26%), Positives = 61/144 (42%), Gaps = 24/144 (16%)
Query: 3 RKCMFLIYEYMEMGSLF--CVLR----TDEEAVGLDWAKRVNIVKGMAHALSYLH-HDCT 55
+ M LI E++ G LF ++ E + N ++ L ++H H
Sbjct: 120 KYEMVLILEFLSGGELFDRIAAEDYKMSEAEVI--------NYMRQACEGLKHMHEHS-- 169
Query: 56 PPIVHRDISSNNILLNLELEAFV--ADFGVARLLNFDSSNRTLLAGTYGYIAPE-LAYTM 112
IVH DI NI+ + + V DFG+A LN D + T + APE +
Sbjct: 170 --IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKV-TTATAEFAAPEIVDREP 226
Query: 113 VVTEKSDVYSFGVVALEVLMGKHP 136
V +D+++ GV+ +L G P
Sbjct: 227 -VGFYTDMWAIGVLGYVLLSGLSP 249
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 58.9 bits (143), Expect = 3e-11
Identities = 39/142 (27%), Positives = 60/142 (42%), Gaps = 26/142 (18%)
Query: 7 FLIYEYMEMGSLFCVLRTDEEAVGLDWAK--RVNIVKGMAHALSYLH-HDCTPPIVHRDI 63
+++ EYM G L ++ V WA+ +V AL +H +HRD+
Sbjct: 145 YMVMEYMPGGDLVNLMS--NYDVPEKWARFYTAEVVL----ALDAIHSMG----FIHRDV 194
Query: 64 SSNNILLNLELEAFVADFGVARLLNFDSSNRT-LLAGTYGYIAPEL--------AYTMVV 114
+N+LL+ +ADFG +N + R GT YI+PE+ Y
Sbjct: 195 KPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGREC 254
Query: 115 TEKSDVYSFGVVALEVLMGKHP 136
D +S GV E+L+G P
Sbjct: 255 ----DWWSVGVFLYEMLVGDTP 272
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 58.7 bits (142), Expect = 3e-11
Identities = 34/107 (31%), Positives = 51/107 (47%), Gaps = 11/107 (10%)
Query: 38 NIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFV--ADFGVARLLNFDSSNR- 94
NI++ + AL YLH+ I HRDI N L + + DFG+++ ++
Sbjct: 172 NIMRQIFSALHYLHNQ---GICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEY 228
Query: 95 ---TLLAGTYGYIAPELAYTMV--VTEKSDVYSFGVVALEVLMGKHP 136
T AGT ++APE+ T K D +S GV+ +LMG P
Sbjct: 229 YGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLLLMGAVP 275
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 58.1 bits (141), Expect = 4e-11
Identities = 34/135 (25%), Positives = 62/135 (45%), Gaps = 23/135 (17%)
Query: 3 RKCMFLIYEYMEMGSLF--CVLR---TDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPP 57
R + LI E + G LF + ++EEA + +K + ++YLH
Sbjct: 87 RTDVVLILELVSGGELFDFLAQKESLSEEEAT--------SFIKQILDGVNYLHTKK--- 135
Query: 58 IVHRDISSNNILL-NLELEAF---VADFGVARLLNFDSSNRTLLAGTYGYIAPE-LAYTM 112
I H D+ NI+L + + + DFG+A + + + GT ++APE + Y
Sbjct: 136 IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKN-IFGTPEFVAPEIVNYEP 194
Query: 113 VVTEKSDVYSFGVVA 127
+ ++D++S GV+
Sbjct: 195 -LGLEADMWSIGVIT 208
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 58.1 bits (141), Expect = 5e-11
Identities = 33/137 (24%), Positives = 64/137 (46%), Gaps = 29/137 (21%)
Query: 3 RKCMFLIYEYMEMGSLF--CVLR---TDEEAVGLDWAKRVNIVKGMAHALSYLH-HDCTP 56
+LI++ + G LF V R ++ +A + ++ + A+ + H
Sbjct: 82 EGHHYLIFDLVTGGELFEDIVAREYYSEADAS--------HCIQQILEAVLHCHQMG--- 130
Query: 57 PIVHRDISSNNILLNLELEAF---VADFGVARLLNFDSSNRTLLAGTYGYIAPEL----A 109
+VHR++ N+LL +L+ +ADFG+A + + AGT GY++PE+
Sbjct: 131 -VVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSPEVLRKDP 189
Query: 110 YTMVVTEKSDVYSFGVV 126
Y + D+++ GV+
Sbjct: 190 Y----GKPVDLWACGVI 202
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 58.0 bits (141), Expect = 5e-11
Identities = 35/135 (25%), Positives = 61/135 (45%), Gaps = 23/135 (17%)
Query: 3 RKCMFLIYEYMEMGSLF--CVLR---TDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPP 57
FL+++ M+ G LF + +++E I++ + + LH
Sbjct: 96 NTFFFLVFDLMKKGELFDYLTEKVTLSEKETR--------KIMRALLEVICALHKLN--- 144
Query: 58 IVHRDISSNNILLNLELEAFVADFGVARLLNFDSSNRTLLAGTYGYIAPE-LAYTMVVTE 116
IVHRD+ NILL+ ++ + DFG + L+ R + GT Y+APE + +M
Sbjct: 145 IVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLRE-VCGTPSYLAPEIIECSMNDNH 203
Query: 117 KS-----DVYSFGVV 126
D++S GV+
Sbjct: 204 PGYGKEVDMWSTGVI 218
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 58.1 bits (141), Expect = 5e-11
Identities = 32/138 (23%), Positives = 58/138 (42%), Gaps = 30/138 (21%)
Query: 3 RKCMFLIYEYMEMGSLF--CVLR---TDEEAVGLDWAKRVNIVKGMAHALSYLH-HDCTP 56
K ++++ E M+ G L + + ++ EA ++ + + YLH
Sbjct: 88 GKYVYVVTELMKGGELLDKILRQKFFSEREAS--------AVLFTITKTVEYLHAQG--- 136
Query: 57 PIVHRDISSNNILLNLELEAF----VADFGVARLLNFDSSNRTLLAGTYGYIAPEL---- 108
+VHRD+ +NIL E + DFG A+ L ++ T ++APE+
Sbjct: 137 -VVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPCYTANFVAPEVLERQ 195
Query: 109 AYTMVVTEKSDVYSFGVV 126
Y D++S GV+
Sbjct: 196 GY----DAACDIWSLGVL 209
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 57.9 bits (140), Expect = 6e-11
Identities = 28/95 (29%), Positives = 46/95 (48%), Gaps = 12/95 (12%)
Query: 46 ALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADFGVARLLNFDSSNRTLLAGTYGYIA 105
L LH + IV+RD+ NILL+ ++D G+A + + + GT GY+A
Sbjct: 298 GLEDLHRER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGR-VGTVGYMA 353
Query: 106 PEL----AYTMVVTEKSDVYSFGVVALEVLMGKHP 136
PE+ YT D ++ G + E++ G+ P
Sbjct: 354 PEVVKNERYTFSP----DWWALGCLLYEMIAGQSP 384
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 57.7 bits (140), Expect = 6e-11
Identities = 40/163 (24%), Positives = 62/163 (38%), Gaps = 43/163 (26%)
Query: 6 MFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVN-------------------------IV 40
M L++EYM G L LR+ + +
Sbjct: 125 MCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVA 184
Query: 41 KGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADFGVARLLNFDSSNRTLLAGT 100
GMA+ LS VHRD+++ N L+ + +ADFG++R + + A
Sbjct: 185 AGMAY-LSERK------FVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYK---ADG 234
Query: 101 YGYI-----APE-LAYTMVVTEKSDVYSFGVVALEVL-MGKHP 136
I PE + Y T +SDV+++GVV E+ G P
Sbjct: 235 NDAIPIRWMPPESIFYN-RYTTESDVWAYGVVLWEIFSYGLQP 276
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 57.3 bits (139), Expect = 9e-11
Identities = 34/135 (25%), Positives = 61/135 (45%), Gaps = 23/135 (17%)
Query: 3 RKCMFLIYEYMEMGSLF--CVLR---TDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPP 57
R + LI E + G LF + ++EEA + +K + ++YLH
Sbjct: 87 RTDVVLILELVSGGELFDFLAQKESLSEEEAT--------SFIKQILDGVNYLHTKK--- 135
Query: 58 IVHRDISSNNILLNLELEAF----VADFGVARLLNFDSSNRTLLAGTYGYIAPE-LAYTM 112
I H D+ NI+L + + DFG+A + + + GT ++APE + Y
Sbjct: 136 IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKN-IFGTPEFVAPEIVNYEP 194
Query: 113 VVTEKSDVYSFGVVA 127
+ ++D++S GV+
Sbjct: 195 -LGLEADMWSIGVIT 208
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 56.8 bits (138), Expect = 1e-10
Identities = 33/133 (24%), Positives = 63/133 (47%), Gaps = 23/133 (17%)
Query: 3 RKCMFLIYEYMEMGSLF--CVLR---TDEEAVGLDWAKRVNIVKGMAHALSYLH-HDCTP 56
+L+ + + G LF + R T+++A +++ + A+ YLH +
Sbjct: 78 TTHYYLVMQLVSGGELFDRILERGVYTEKDAS--------LVIQQVLSAVKYLHENG--- 126
Query: 57 PIVHRDISSNNILL-NLELEAFV--ADFGVARLLNFDSSNRTLLAGTYGYIAPELAYTMV 113
IVHRD+ N+L E + + DFG++++ + + GT GY+APE+
Sbjct: 127 -IVHRDLKPENLLYLTPEENSKIMITDFGLSKM--EQNGIMSTACGTPGYVAPEVLAQKP 183
Query: 114 VTEKSDVYSFGVV 126
++ D +S GV+
Sbjct: 184 YSKAVDCWSIGVI 196
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 57.0 bits (138), Expect = 1e-10
Identities = 35/132 (26%), Positives = 63/132 (47%), Gaps = 20/132 (15%)
Query: 3 RKCMFLIYEYMEMGSLF--CVLR---TDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPP 57
+ L+ E + G LF V + ++ +A + VK + A++YLH +
Sbjct: 120 PTEISLVLELVTGGELFDRIVEKGYYSERDAA--------DAVKQILEAVAYLHENG--- 168
Query: 58 IVHRDISSNNILLNLELEAF---VADFGVARLLNFDSSNRTLLAGTYGYIAPELAYTMVV 114
IVHRD+ N+L +ADFG+++++ +T+ GT GY APE+
Sbjct: 169 IVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTV-CGTPGYCAPEILRGCAY 227
Query: 115 TEKSDVYSFGVV 126
+ D++S G++
Sbjct: 228 GPEVDMWSVGII 239
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 56.9 bits (138), Expect = 1e-10
Identities = 39/131 (29%), Positives = 57/131 (43%), Gaps = 23/131 (17%)
Query: 7 FLIYEYMEMGSLF--CVLR---TDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHR 61
+++ E ME G LF V + M A+ YLH + I+HR
Sbjct: 90 YIVLELMEGGELFDKVVGNKRLKEATCK--------LYFYQMLLAVQYLHENG---IIHR 138
Query: 62 DISSNNILLNLELEAF---VADFGVARLLNFDSSNRTLLAGTYGYIAPE-LAYTMVV--T 115
D+ N+LL+ + E + DFG +++L S RT L GT Y+APE L
Sbjct: 139 DLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRT-LCGTPTYLAPEVLVSVGTAGYN 197
Query: 116 EKSDVYSFGVV 126
D +S GV+
Sbjct: 198 RAVDCWSLGVI 208
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 56.5 bits (137), Expect = 1e-10
Identities = 34/140 (24%), Positives = 64/140 (45%), Gaps = 24/140 (17%)
Query: 7 FLIYEYMEMGSLFCVLR----TDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRD 62
++++E + G + V ++++A + + + YLH+ I+HRD
Sbjct: 114 YMVFELVNQGPVMEVPTLKPLSEDQAR--------FYFQDLIKGIEYLHYQK---IIHRD 162
Query: 63 ISSNNILLNLELEAFVADFGVARLLNFDSSNRTL--LAGTYGYIAPEL---AYTMVVTEK 117
I +N+L+ + +ADFGV+ F S+ L GT ++APE + +
Sbjct: 163 IKPSNLLVGEDGHIKIADFGVSNE--FKGSDALLSNTVGTPAFMAPESLSETRKIFSGKA 220
Query: 118 SDVYSFGVVALEVLM-GKHP 136
DV++ GV L + G+ P
Sbjct: 221 LDVWAMGVT-LYCFVFGQCP 239
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 56.7 bits (137), Expect = 1e-10
Identities = 28/95 (29%), Positives = 46/95 (48%), Gaps = 11/95 (11%)
Query: 46 ALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADFGVARLLNFDSSNRTLLAGTYGYIA 105
L +LH I++RD+ N+LL+ + ++D G+A L + AGT G++A
Sbjct: 301 GLEHLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMA 357
Query: 106 PEL----AYTMVVTEKSDVYSFGVVALEVLMGKHP 136
PEL Y V D ++ GV E++ + P
Sbjct: 358 PELLLGEEYDFSV----DYFALGVTLYEMIAARGP 388
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 56.5 bits (137), Expect = 2e-10
Identities = 37/132 (28%), Positives = 58/132 (43%), Gaps = 19/132 (14%)
Query: 3 RKCMFLIYEYMEMGSLF--CVLR---TDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPP 57
+ FL+ E + G LF + ++ EA I++ + A+S++H
Sbjct: 78 QLHTFLVMELLNGGELFERIKKKKHFSETEAS--------YIMRKLVSAVSHMHDVG--- 126
Query: 58 IVHRDISSNNILLNLELEAF---VADFGVARLLNFDSSNRTLLAGTYGYIAPELAYTMVV 114
+VHRD+ N+L E + + DFG ARL D+ T Y APEL
Sbjct: 127 VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAAPELLNQNGY 186
Query: 115 TEKSDVYSFGVV 126
E D++S GV+
Sbjct: 187 DESCDLWSLGVI 198
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 56.0 bits (136), Expect = 2e-10
Identities = 33/135 (24%), Positives = 61/135 (45%), Gaps = 23/135 (17%)
Query: 3 RKCMFLIYEYMEMGSLF--CVLR---TDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPP 57
+ + LI E + G LF + T++EA +K + + YLH
Sbjct: 80 KTDVVLILELVSGGELFDFLAEKESLTEDEAT--------QFLKQILDGVHYLHSKR--- 128
Query: 58 IVHRDISSNNILL-NLELEAF---VADFGVARLLNFDSSNRTLLAGTYGYIAPE-LAYTM 112
I H D+ NI+L + + + DFG+A + + + + GT ++APE + Y
Sbjct: 129 IAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKN-IFGTPEFVAPEIVNYEP 187
Query: 113 VVTEKSDVYSFGVVA 127
+ ++D++S GV+
Sbjct: 188 -LGLEADMWSIGVIT 201
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 56.2 bits (136), Expect = 2e-10
Identities = 33/137 (24%), Positives = 67/137 (48%), Gaps = 30/137 (21%)
Query: 3 RKCMFLIYEYMEMGSLF--CVLR---TDEEAVGLDWAKRVNIVKGMAHALSYLH-HDCTP 56
+L+++ + G LF V R ++ +A + ++ + +++Y H +
Sbjct: 100 ESFHYLVFDLVTGGELFEDIVAREFYSEADAS--------HCIQQILESIAYCHSNG--- 148
Query: 57 PIVHRDISSNNILLNLELEAF---VADFGVARLLNFDSSNRTLLAGTYGYIAPEL----A 109
IVHR++ N+LL + + +ADFG+A +N + AGT GY++PE+
Sbjct: 149 -IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGF-AGTPGYLSPEVLKKDP 206
Query: 110 YTMVVTEKSDVYSFGVV 126
Y ++ D+++ GV+
Sbjct: 207 Y----SKPVDIWACGVI 219
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 56.1 bits (136), Expect = 2e-10
Identities = 35/144 (24%), Positives = 61/144 (42%), Gaps = 24/144 (16%)
Query: 3 RKCMFLIYEYMEMGSLF--CVLR----TDEEAVGLDWAKRVNIVKGMAHALSYLH-HDCT 55
+ + +I+E++ +F + E V + V + AL +LH H+
Sbjct: 73 MEELVMIFEFISGLDIFERINTSAFELNEREIV--------SYVHQVCEALQFLHSHN-- 122
Query: 56 PPIVHRDISSNNILLNLELEAFV--ADFGVARLLNFDSSNRTLLAGTYGYIAPE-LAYTM 112
I H DI NI+ + + +FG AR L + R L Y APE + +
Sbjct: 123 --IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRL-LFTAPEYYAPEVHQHDV 179
Query: 113 VVTEKSDVYSFGVVALEVLMGKHP 136
V+ +D++S G + +L G +P
Sbjct: 180 -VSTATDMWSLGTLVYVLLSGINP 202
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 55.7 bits (135), Expect = 3e-10
Identities = 35/136 (25%), Positives = 64/136 (47%), Gaps = 25/136 (18%)
Query: 3 RKCMFLIYEYMEMGSLF--CVLR---TDEEAVGLDWAKRVNIVKGMAHALSYLH-HDCTP 56
+ + LI E + G LF + T+EEA +K + + + YLH
Sbjct: 86 KTDVILILELVAGGELFDFLAEKESLTEEEAT--------EFLKQILNGVYYLHSLQ--- 134
Query: 57 PIVHRDISSNNILL-NLELEAF---VADFGVARLLNFDSSNRTLLAGTYGYIAPE-LAYT 111
I H D+ NI+L + + + DFG+A ++F + + + GT ++APE + Y
Sbjct: 135 -IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN-IFGTPEFVAPEIVNYE 192
Query: 112 MVVTEKSDVYSFGVVA 127
+ ++D++S GV+
Sbjct: 193 P-LGLEADMWSIGVIT 207
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 55.5 bits (134), Expect = 4e-10
Identities = 41/135 (30%), Positives = 68/135 (50%), Gaps = 23/135 (17%)
Query: 3 RKCMFLIYEYMEMGSLF--CVLR---TDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPP 57
MFL+++ M G LF + +++E +I++ + A+S+LH +
Sbjct: 172 SSFMFLVFDLMRKGELFDYLTEKVALSEKETR--------SIMRSLLEAVSFLHANN--- 220
Query: 58 IVHRDISSNNILLNLELEAFVADFGVARLLNFDSSNRTLLAGTYGYIAPE-LAYTMVVTE 116
IVHRD+ NILL+ ++ ++DFG + L R L GT GY+APE L +M T
Sbjct: 221 IVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEKLRE-LCGTPGYLAPEILKCSMDETH 279
Query: 117 KS-----DVYSFGVV 126
D+++ GV+
Sbjct: 280 PGYGKEVDLWACGVI 294
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 55.7 bits (134), Expect = 4e-10
Identities = 34/139 (24%), Positives = 57/139 (41%), Gaps = 25/139 (17%)
Query: 7 FLIYEYMEMGSLFCVLRT----DEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRD 62
I + M G L L E + A+ + L ++H+ +V+RD
Sbjct: 268 SFILDLMNGGDLHYHLSQHGVFSEADMRFYAAE-------IILGLEHMHNRF---VVYRD 317
Query: 63 ISSNNILLNLELEAFVADFGVARLLNFDSSNRTLLAGTYGYIAPEL-----AYTMVVTEK 117
+ NILL+ ++D G+A + + GT+GY+APE+ AY
Sbjct: 318 LKPANILLDEHGHVRISDLGLACDFSKKKPHA--SVGTHGYMAPEVLQKGVAYDSSA--- 372
Query: 118 SDVYSFGVVALEVLMGKHP 136
D +S G + ++L G P
Sbjct: 373 -DWFSLGCMLFKLLRGHSP 390
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 55.5 bits (134), Expect = 4e-10
Identities = 29/95 (30%), Positives = 47/95 (49%), Gaps = 10/95 (10%)
Query: 46 ALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADFGVARLLNFDSSNRTLLAGTYGYIA 105
AL YLH + +V+RD+ N++L+ + + DFG+ + D + GT Y+A
Sbjct: 260 ALDYLHSEKN--VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLA 317
Query: 106 PEL----AYTMVVTEKSDVYSFGVVALEVLMGKHP 136
PE+ Y V D + GVV E++ G+ P
Sbjct: 318 PEVLEDNDYGRAV----DWWGLGVVMYEMMCGRLP 348
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 54.9 bits (133), Expect = 4e-10
Identities = 37/135 (27%), Positives = 61/135 (45%), Gaps = 27/135 (20%)
Query: 3 RKCMFLIYEYMEMGSLF--CVLR---TDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPP 57
+++ E G LF + R ++ +A I+K + ++Y+H
Sbjct: 93 SSSFYIVGELYTGGELFDEIIKRKRFSEHDAA--------RIIKQVFSGITYMHKHN--- 141
Query: 58 IVHRDISSNNILLNLELEAF---VADFGVARLLNFDSSNRTLLAGTYGYIAPEL---AYT 111
IVHRD+ NILL + + + DFG++ ++ + GT YIAPE+ Y
Sbjct: 142 IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKD-RIGTAYYIAPEVLRGTY- 199
Query: 112 MVVTEKSDVYSFGVV 126
EK DV+S GV+
Sbjct: 200 ---DEKCDVWSAGVI 211
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 55.3 bits (134), Expect = 5e-10
Identities = 36/138 (26%), Positives = 61/138 (44%), Gaps = 15/138 (10%)
Query: 2 HRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHR 61
+K +L++E+++ ++ L + GLD+ + + + + + H I+HR
Sbjct: 95 KKKRWYLVFEFVDH-TILDDL--ELFPNGLDYQVVQKYLFQIINGIGFCHSHN---IIHR 148
Query: 62 DISSNNILLNLELEAFVADFGVARLLNFDSSNRTLLAGTYGYIAPEL-----AYTMVVTE 116
DI NIL++ + DFG AR L T Y APEL Y V
Sbjct: 149 DIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVATRWYRAPELLVGDVKYGKAV-- 206
Query: 117 KSDVYSFGVVALEVLMGK 134
DV++ G + E+ MG+
Sbjct: 207 --DVWAIGCLVTEMFMGE 222
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 54.9 bits (133), Expect = 5e-10
Identities = 39/140 (27%), Positives = 65/140 (46%), Gaps = 18/140 (12%)
Query: 4 KCMFLIYEYMEMGSLFCVLRT----DEEAVGLDWAKRVNIVKGMAHALSYLH-HDCTPPI 58
+ ++ Y + G L +R DE A+ + AL YLH I
Sbjct: 103 EKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAE-------IVSALEYLHGKG----I 151
Query: 59 VHRDISSNNILLNLELEAFVADFGVARLLNFDSSN-RTL-LAGTYGYIAPELAYTMVVTE 116
+HRD+ NILLN ++ + DFG A++L+ +S R GT Y++PEL +
Sbjct: 152 IHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACK 211
Query: 117 KSDVYSFGVVALEVLMGKHP 136
SD+++ G + +++ G P
Sbjct: 212 SSDLWALGCIIYQLVAGLPP 231
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 54.8 bits (132), Expect = 6e-10
Identities = 16/130 (12%), Positives = 34/130 (26%), Gaps = 35/130 (26%)
Query: 7 FLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSN 66
++ E++ GSL V T + ++ +A A H + +
Sbjct: 107 LVVAEWIRGGSLQEVADT-----SPSPVGAIRAMQSLAAAADAAHRA---GVALSIDHPS 158
Query: 67 NILLNLELEAFVADFGVARLLNFDSSNRTLLAGTYGYIAPELAYTMVVTEKSDVYSFGVV 126
+ V+ G L + + D+ G
Sbjct: 159 RVR--------VSIDGDVVL------------AYPATMPD-------ANPQDDIRGIGAS 191
Query: 127 ALEVLMGKHP 136
+L+ + P
Sbjct: 192 LYALLVNRWP 201
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 54.7 bits (132), Expect = 6e-10
Identities = 38/139 (27%), Positives = 59/139 (42%), Gaps = 32/139 (23%)
Query: 3 RKCMFLIYEYMEMGSLF-------CVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCT 55
RKC+ ++ E ++ G LF T+ EA I+K + A+ YLH
Sbjct: 131 RKCLLIVMECLDGGELFSRIQDRGDQAFTEREAS--------EIMKSIGEAIQYLHSIN- 181
Query: 56 PPIVHRDISSNNILLNLELEAF---VADFGVARLLNFDSSNRTLLAGTYGYIAPELAYTM 112
I HRD+ N+L + + DFG A+ +S T T Y+APE
Sbjct: 182 --IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTT-PCYTPYYVAPE----- 233
Query: 113 VVTEKS-----DVYSFGVV 126
V+ + D++S GV+
Sbjct: 234 VLGPEKYDKSCDMWSLGVI 252
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 54.5 bits (132), Expect = 7e-10
Identities = 33/137 (24%), Positives = 67/137 (48%), Gaps = 30/137 (21%)
Query: 3 RKCMFLIYEYMEMGSLF--CVLR---TDEEAVGLDWAKRVNIVKGMAHALSYLH-HDCTP 56
+L+++ + G LF V R ++ +A + ++ + +++Y H +
Sbjct: 77 ESFHYLVFDLVTGGELFEDIVAREFYSEADAS--------HCIQQILESIAYCHSNG--- 125
Query: 57 PIVHRDISSNNILLNLELEAF---VADFGVARLLNFDSSNRTLLAGTYGYIAPEL----A 109
IVHR++ N+LL + + +ADFG+A +N + AGT GY++PE+
Sbjct: 126 -IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHG-FAGTPGYLSPEVLKKDP 183
Query: 110 YTMVVTEKSDVYSFGVV 126
Y ++ D+++ GV+
Sbjct: 184 Y----SKPVDIWACGVI 196
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 54.7 bits (132), Expect = 8e-10
Identities = 34/134 (25%), Positives = 57/134 (42%), Gaps = 23/134 (17%)
Query: 3 RKCMFLIYEYMEMGSLF-------CVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCT 55
++C+ +I E ME G LF T+ EA I++ + A+ +LH
Sbjct: 98 KRCLLIIMECMEGGELFSRIQERGDQAFTEREAA--------EIMRDIGTAIQFLHSHN- 148
Query: 56 PPIVHRDISSNNILLNLELEAF---VADFGVARLLNFDSSNRTLLAGTYGYIAPELAYTM 112
I HRD+ N+L + + + DFG A+ + T Y+APE+
Sbjct: 149 --IAHRDVKPENLLYTSKEKDAVLKLTDFGFAKE--TTQNALQTPCYTPYYVAPEVLGPE 204
Query: 113 VVTEKSDVYSFGVV 126
+ D++S GV+
Sbjct: 205 KYDKSCDMWSLGVI 218
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 54.4 bits (131), Expect = 1e-09
Identities = 37/151 (24%), Positives = 70/151 (46%), Gaps = 30/151 (19%)
Query: 4 KCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVN--IVKGMAH----ALSYLHHDCTPP 57
+ ++L+++Y E L+ +++ + ++ +VK + + + YLH +
Sbjct: 93 RKVWLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW--- 148
Query: 58 IVHRDISSNNILLNLELEAF----VADFGVARLLNFDSSNRTLLAG-----TYGYIAPEL 108
++HRD+ NIL+ E +AD G ARL F+S + L T+ Y APEL
Sbjct: 149 VLHRDLKPANILVMGEGPERGRVKIADMGFARL--FNSPLKPLADLDPVVVTFWYRAPEL 206
Query: 109 -----AYTMVVTEKSDVYSFGVVALEVLMGK 134
YT + D+++ G + E+L +
Sbjct: 207 LLGARHYTKAI----DIWAIGCIFAELLTSE 233
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 54.3 bits (131), Expect = 1e-09
Identities = 34/128 (26%), Positives = 62/128 (48%), Gaps = 10/128 (7%)
Query: 7 FLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSN 66
+++ E M+ +L V++ + LD + ++ M + +LH + I+HRD+ +
Sbjct: 106 YIVMELMDA-NLCQVIQME-----LDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPS 156
Query: 67 NILLNLELEAFVADFGVARLLNFDSSNRTLLAGTYGYIAPELAYTMVVTEKSDVYSFGVV 126
NI++ + + DFG+AR S T T Y APE+ M E D++S G +
Sbjct: 157 NIVVKSDCTLKILDFGLARTAG-TSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCI 215
Query: 127 ALEVLMGK 134
E++ G
Sbjct: 216 MGEMIKGG 223
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 53.4 bits (129), Expect = 2e-09
Identities = 38/132 (28%), Positives = 58/132 (43%), Gaps = 17/132 (12%)
Query: 3 RKCMFLIYEYMEMGSLFCVLRTDEEAVG-LDWAKRVNIVKGMAHALSYLH-HDCTPPIVH 60
M+++ E E G L + + + L ++K M +AL+Y H +VH
Sbjct: 92 YHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQH----VVH 147
Query: 61 RDISSNNILLNLELEAF---VADFGVARLLNFDSSNRTLLAGTYGYIAPEL---AYTMVV 114
+D+ NIL + DFG+A L D + AGT Y+APE+
Sbjct: 148 KDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTN-AAGTALYMAPEVFKRDV---- 202
Query: 115 TEKSDVYSFGVV 126
T K D++S GVV
Sbjct: 203 TFKCDIWSAGVV 214
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 53.5 bits (129), Expect = 2e-09
Identities = 42/143 (29%), Positives = 62/143 (43%), Gaps = 24/143 (16%)
Query: 3 RKCMFLIYEYMEMGSLFCVL----RTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPI 58
K ++LI EY G +F L R E+ A+ + + A+ Y H I
Sbjct: 86 EKTLYLIMEYASGGEVFDYLVAHGRMKEKE-----ARS--KFRQIVSAVQYCHQKR---I 135
Query: 59 VHRDISSNNILLNLELEAFVADFGVARLLNFDSSNRTLLAGTYGYIAPEL----AYTMVV 114
VHRD+ + N+LL+ ++ +ADFG + G Y APEL Y
Sbjct: 136 VHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDA-FCGAPPYAAPELFQGKKYD--- 191
Query: 115 TEKSDVYSFGVVALEVLM-GKHP 136
+ DV+S GV+ L L+ G P
Sbjct: 192 GPEVDVWSLGVI-LYTLVSGSLP 213
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 53.3 bits (129), Expect = 2e-09
Identities = 37/138 (26%), Positives = 58/138 (42%), Gaps = 15/138 (10%)
Query: 2 HRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHR 61
++ + L++EY + ++ L D G+ +I A+++ H +HR
Sbjct: 73 RKRRLHLVFEYCDH-TVLHEL--DRYQRGVPEHLVKSITWQTLQAVNFCHKHN---CIHR 126
Query: 62 DISSNNILLNLELEAFVADFGVARLLNFDSSNRTLLAGTYGYIAPEL-----AYTMVVTE 116
D+ NIL+ + DFG ARLL S T Y +PEL Y V
Sbjct: 127 DVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVATRWYRSPELLVGDTQYGPPV-- 184
Query: 117 KSDVYSFGVVALEVLMGK 134
DV++ G V E+L G
Sbjct: 185 --DVWAIGCVFAELLSGV 200
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 53.0 bits (128), Expect = 3e-09
Identities = 32/136 (23%), Positives = 55/136 (40%), Gaps = 29/136 (21%)
Query: 3 RKCMFLIYEYMEMGSLF--CVLR---TDEEAVGLDWAKRVNIVKGMAHALSYLH-HDCTP 56
++L+ E G LF V + + +A I+K + A++Y H +
Sbjct: 78 NTDIYLVMELCTGGELFERVVHKRVFRESDAA--------RIMKDVLSAVAYCHKLN--- 126
Query: 57 PIVHRDISSNNILLNLELEAF---VADFGVARLLNFDSSNRTLLAGTYGYIAPEL---AY 110
+ HRD+ N L + + DFG+A RT GT Y++P++ Y
Sbjct: 127 -VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRT-KVGTPYYVSPQVLEGLY 184
Query: 111 TMVVTEKSDVYSFGVV 126
+ D +S GV+
Sbjct: 185 ----GPECDEWSAGVM 196
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 53.1 bits (127), Expect = 3e-09
Identities = 30/96 (31%), Positives = 50/96 (52%), Gaps = 13/96 (13%)
Query: 46 ALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADFGVARL-LNFDSSNRTLLAGTYGYI 104
L +L I++RD+ +N++L+ E +ADFG+ + + + +T GT YI
Sbjct: 454 GLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKT-FCGTPDYI 509
Query: 105 APEL----AYTMVVTEKSDVYSFGVVALEVLMGKHP 136
APE+ Y V D ++FGV+ E+L G+ P
Sbjct: 510 APEIIAYQPYGKSV----DWWAFGVLLYEMLAGQAP 541
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 51.9 bits (125), Expect = 6e-09
Identities = 29/97 (29%), Positives = 49/97 (50%), Gaps = 15/97 (15%)
Query: 46 ALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADFGVARLLNFDSSNRTLLAG---TYG 102
L Y+H + ++HRD+ +N+LLN + + DFG+AR+ + D + L T
Sbjct: 140 GLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRW 196
Query: 103 YIAPEL-----AYTMVVTEKSDVYSFGVVALEVLMGK 134
Y APE+ YT + D++S G + E+L +
Sbjct: 197 YRAPEIMLNSKGYTKSI----DIWSVGCILAEMLSNR 229
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 51.7 bits (125), Expect = 7e-09
Identities = 35/138 (25%), Positives = 66/138 (47%), Gaps = 15/138 (10%)
Query: 2 HRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHR 61
+K + L++E+++ L +L D GL+ + + + + ++Y H ++HR
Sbjct: 71 TKKRLVLVFEHLDQ-DLKKLL--DVCEGGLESVTAKSFLLQLLNGIAYCHDRR---VLHR 124
Query: 62 DISSNNILLNLELEAFVADFGVARLLNFDSSNRTLLAGTYGYIAPEL-----AYTMVVTE 116
D+ N+L+N E E +ADFG+AR T T Y AP++ Y+ +
Sbjct: 125 DLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYSTTI-- 182
Query: 117 KSDVYSFGVVALEVLMGK 134
D++S G + E++ G
Sbjct: 183 --DIWSVGCIFAEMVNGT 198
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 51.8 bits (125), Expect = 7e-09
Identities = 39/138 (28%), Positives = 67/138 (48%), Gaps = 15/138 (10%)
Query: 2 HRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHR 61
+C+ L++E+ME L VL DE GL ++ + + +++ H I+HR
Sbjct: 90 SERCLTLVFEFMEK-DLKKVL--DENKTGLQDSQIKIYLYQLLRGVAHCHQHR---ILHR 143
Query: 62 DISSNNILLNLELEAFVADFGVARLLNFDSSNRTLLAGTYGYIAPEL-----AYTMVVTE 116
D+ N+L+N + +ADFG+AR + T T Y AP++ Y+ V
Sbjct: 144 DLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVVTLWYRAPDVLMGSKKYSTSV-- 201
Query: 117 KSDVYSFGVVALEVLMGK 134
D++S G + E++ GK
Sbjct: 202 --DIWSIGCIFAEMITGK 217
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 51.9 bits (125), Expect = 8e-09
Identities = 33/97 (34%), Positives = 48/97 (49%), Gaps = 15/97 (15%)
Query: 46 ALSYLH-HDCTPPIVHRDISSNNILLNLELEAFVADFGVARLLNFDSSNRTL-LAGTYGY 103
AL YLH + IV+RD+ NILL+ + + DFG+ + N + ++ T GT Y
Sbjct: 151 ALGYLHSLN----IVYRDLKPENILLDSQGHIVLTDFGLCK-ENIEHNSTTSTFCGTPEY 205
Query: 104 IAPEL----AYTMVVTEKSDVYSFGVVALEVLMGKHP 136
+APE+ Y V D + G V E+L G P
Sbjct: 206 LAPEVLHKQPYDRTV----DWWCLGAVLYEMLYGLPP 238
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 51.8 bits (125), Expect = 8e-09
Identities = 30/97 (30%), Positives = 45/97 (46%), Gaps = 15/97 (15%)
Query: 46 ALSYLH-HDCTPPIVHRDISSNNILLNLELEAFVADFGVARLLNFDSSNRTL-LAGTYGY 103
AL YLH D +V+RDI N++L+ + + DFG+ + GT Y
Sbjct: 117 ALEYLHSRD----VVYRDIKLENLMLDKDGHIKITDFGLCK-EGISDGATMKTFCGTPEY 171
Query: 104 IAPEL----AYTMVVTEKSDVYSFGVVALEVLMGKHP 136
+APE+ Y V D + GVV E++ G+ P
Sbjct: 172 LAPEVLEDNDYGRAV----DWWGLGVVMYEMMCGRLP 204
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 51.9 bits (125), Expect = 8e-09
Identities = 31/99 (31%), Positives = 47/99 (47%), Gaps = 16/99 (16%)
Query: 46 ALSYLH-HDCTPPIVHRDISSNNILLNLELEAFVADFGVARLLNFDSSNRTL-LAGTYGY 103
AL +LH I++RDI NILL+ + DFG+++ D + R GT Y
Sbjct: 171 ALEHLHKLG----IIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEY 226
Query: 104 IAPEL------AYTMVVTEKSDVYSFGVVALEVLMGKHP 136
+AP++ + V D +S GV+ E+L G P
Sbjct: 227 MAPDIVRGGDSGHDKAV----DWWSLGVLMYELLTGASP 261
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 51.9 bits (125), Expect = 8e-09
Identities = 30/144 (20%), Positives = 62/144 (43%), Gaps = 23/144 (15%)
Query: 2 HRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHR 61
+ ++L++++ E L +L V ++ +++ + + L Y+H + I+HR
Sbjct: 95 CKGSIYLVFDFCEH-DLAGLL--SNVLVKFTLSEIKRVMQMLLNGLYYIHRNK---ILHR 148
Query: 62 DISSNNILLNLELEAFVADFGVARLLNFDSSNRTLLAG------TYGYIAPEL-----AY 110
D+ + N+L+ + +ADFG+AR F + + T Y PEL Y
Sbjct: 149 DMKAANVLITRDGVLKLADFGLARA--FSLAKNSQPNRYTNRVVTLWYRPPELLLGERDY 206
Query: 111 TMVVTEKSDVYSFGVVALEVLMGK 134
+ D++ G + E+
Sbjct: 207 GPPI----DLWGAGCIMAEMWTRS 226
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 51.8 bits (124), Expect = 9e-09
Identities = 35/127 (27%), Positives = 61/127 (48%), Gaps = 10/127 (7%)
Query: 8 LIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNN 67
L+ E M+ +L V++ + LD + ++ M + +LH + I+HRD+ +N
Sbjct: 144 LVMELMDA-NLCQVIQME-----LDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSN 194
Query: 68 ILLNLELEAFVADFGVARLLNFDSSNRTLLAGTYGYIAPELAYTMVVTEKSDVYSFGVVA 127
I++ + + DFG+AR S T T Y APE+ M E D++S G +
Sbjct: 195 IVVKSDCTLKILDFGLARTAG-TSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIM 253
Query: 128 LEVLMGK 134
E++ K
Sbjct: 254 GEMVRHK 260
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 51.4 bits (124), Expect = 1e-08
Identities = 33/100 (33%), Positives = 51/100 (51%), Gaps = 15/100 (15%)
Query: 43 MAHALSYLH-HDCTPPIVHRDISSNNILLNLELEAFVADFGVARLLNFDSSNRTL-LAGT 100
+A AL +LH I++RD+ NILL+ E + DFG+++ + D + GT
Sbjct: 135 LALALDHLHSLG----IIYRDLKPENILLDEEGHIKLTDFGLSK-ESIDHEKKAYSFCGT 189
Query: 101 YGYIAPEL----AYTMVVTEKSDVYSFGVVALEVLMGKHP 136
Y+APE+ +T D +SFGV+ E+L G P
Sbjct: 190 VEYMAPEVVNRRGHTQSA----DWWSFGVLMFEMLTGTLP 225
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 51.1 bits (123), Expect = 1e-08
Identities = 32/140 (22%), Positives = 60/140 (42%), Gaps = 19/140 (13%)
Query: 2 HRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHR 61
K + L++EY++ L L D+ ++ + + L+Y H ++HR
Sbjct: 71 TEKSLTLVFEYLDK-DLKQYL--DDCGNIINMHNVKLFLFQLLRGLAYCHRQK---VLHR 124
Query: 62 DISSNNILLNLELEAFVADFGVARLLNFDSSNRTL--LAGTYGYIAPEL-----AYTMVV 114
D+ N+L+N E +ADFG+AR +T T Y P++ Y+ +
Sbjct: 125 DLKPQNLLINERGELKLADFGLARA--KSIPTKTYDNEVVTLWYRPPDILLGSTDYSTQI 182
Query: 115 TEKSDVYSFGVVALEVLMGK 134
D++ G + E+ G+
Sbjct: 183 ----DMWGVGCIFYEMATGR 198
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 51.2 bits (123), Expect = 1e-08
Identities = 35/104 (33%), Positives = 53/104 (50%), Gaps = 16/104 (15%)
Query: 43 MAHALSYLHHDCTPPIVHRDISSNNILLNLELEAF-VADFGVARLLNFDSSNRTLLAGTY 101
+ +L+Y+H + I HRDI N+LL+ + + DFG A+ L N + + Y
Sbjct: 165 LFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY 221
Query: 102 GYIAPEL-----AYTMVVTEKSDVYSFGVVALEVLMGKH--PGE 138
Y APEL YT + DV+S G V E+L+G+ PG+
Sbjct: 222 -YRAPELIFGATDYTSSI----DVWSAGCVLAELLLGQPIFPGD 260
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 51.0 bits (123), Expect = 1e-08
Identities = 30/140 (21%), Positives = 56/140 (40%), Gaps = 15/140 (10%)
Query: 2 HRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHR 61
K + L++E+ + L D LD + + + L + H ++HR
Sbjct: 72 SDKKLTLVFEFCDQ-DLKKYF--DSCNGDLDPEIVKSFLFQLLKGLGFCHSRN---VLHR 125
Query: 62 DISSNNILLNLELEAFVADFGVARLLNFDSSNRTLLAGTYGYIAPEL-----AYTMVVTE 116
D+ N+L+N E +A+FG+AR + T Y P++ Y+ +
Sbjct: 126 DLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSI-- 183
Query: 117 KSDVYSFGVVALEVLMGKHP 136
D++S G + E+ P
Sbjct: 184 --DMWSAGCIFAELANAGRP 201
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 51.1 bits (123), Expect = 1e-08
Identities = 29/98 (29%), Positives = 51/98 (52%), Gaps = 16/98 (16%)
Query: 46 ALSYLHHDCTPPIVHRDISSNNILLNLE-LEAFVADFGVARLLNFDSSNRTLLAG---TY 101
L Y+H + ++HRD+ N+ +N E L + DFG+AR+++ S++ L+ T
Sbjct: 132 GLKYIH---SANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTK 188
Query: 102 GYIAPEL-----AYTMVVTEKSDVYSFGVVALEVLMGK 134
Y +P L YT + D+++ G + E+L GK
Sbjct: 189 WYRSPRLLLSPNNYTKAI----DMWAAGCIFAEMLTGK 222
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 51.0 bits (123), Expect = 1e-08
Identities = 39/140 (27%), Positives = 66/140 (47%), Gaps = 19/140 (13%)
Query: 2 HRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHR 61
H+ + L++++ME L ++ + ++ L + + L YLH I+HR
Sbjct: 83 HKSNISLVFDFMET-DLEVII--KDNSLVLTPSHIKAYMLMTLQGLEYLHQHW---ILHR 136
Query: 62 DISSNNILLNLELEAFVADFGVARLLNFDSSNRTL--LAGTYGYIAPEL-----AYTMVV 114
D+ NN+LL+ +ADFG+A+ F S NR T Y APEL Y + V
Sbjct: 137 DLKPNNLLLDENGVLKLADFGLAKS--FGSPNRAYTHQVVTRWYRAPELLFGARMYGVGV 194
Query: 115 TEKSDVYSFGVVALEVLMGK 134
D+++ G + E+L+
Sbjct: 195 ----DMWAVGCILAELLLRV 210
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 50.7 bits (122), Expect = 2e-08
Identities = 36/142 (25%), Positives = 60/142 (42%), Gaps = 24/142 (16%)
Query: 2 HRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAH----ALSYLHHDCTPP 57
+ L++E+++ L L G+ +K M L +LH
Sbjct: 90 RETKLTLVFEHVDQ-DLTTYLD-KVPEPGVP----TETIKDMMFQLLRGLDFLHSHR--- 140
Query: 58 IVHRDISSNNILLNLELEAFVADFGVARLLNFDSSNR-TLLAGTYGYIAPEL----AYTM 112
+VHRD+ NIL+ + +ADFG+AR+ + T + T Y APE+ +Y
Sbjct: 141 VVHRDLKPQNILVTSSGQIKLADFGLARI--YSFQMALTSVVVTLWYRAPEVLLQSSYAT 198
Query: 113 VVTEKSDVYSFGVVALEVLMGK 134
V D++S G + E+ K
Sbjct: 199 PV----DLWSVGCIFAEMFRRK 216
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 50.7 bits (122), Expect = 2e-08
Identities = 38/141 (26%), Positives = 61/141 (43%), Gaps = 25/141 (17%)
Query: 4 KCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAK--RVNIVKGMAHALSYLH-HDCTPPIVH 60
++++ EY+ G +F LR A+ IV YLH D +++
Sbjct: 114 SNLYMVMEYVAGGEMFSHLR-RIGRFSEPHARFYAAQIVL----TFEYLHSLD----LIY 164
Query: 61 RDISSNNILLNLELEAFVADFGVARLLNFDSSNRTL-LAGTYGYIAPEL----AYTMVVT 115
RD+ N+L++ + V DFG A+ + RT L GT +APE+ Y V
Sbjct: 165 RDLKPENLLIDQQGYIQVTDFGFAKRVK----GRTWTLCGTPEALAPEIILSKGYNKAV- 219
Query: 116 EKSDVYSFGVVALEVLMGKHP 136
D ++ GV+ E+ G P
Sbjct: 220 ---DWWALGVLIYEMAAGYPP 237
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 50.6 bits (122), Expect = 2e-08
Identities = 28/97 (28%), Positives = 45/97 (46%), Gaps = 15/97 (15%)
Query: 46 ALSYLH-HDCTPPIVHRDISSNNILLNLELEAFVADFGVARLLNFDSSNRTL-LAGTYGY 103
AL +LH I++RD+ NI+LN + + DFG+ + + T GT Y
Sbjct: 133 ALGHLHQKG----IIYRDLKPENIMLNHQGHVKLTDFGLCK-ESIHDGTVTHTFCGTIEY 187
Query: 104 IAPEL----AYTMVVTEKSDVYSFGVVALEVLMGKHP 136
+APE+ + V D +S G + ++L G P
Sbjct: 188 MAPEILMRSGHNRAV----DWWSLGALMYDMLTGAPP 220
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 50.8 bits (122), Expect = 2e-08
Identities = 31/106 (29%), Positives = 52/106 (49%), Gaps = 18/106 (16%)
Query: 43 MAHALSYLHHDCTPPIVHRDISSNNILLNL---ELEAFVADFGVARLLNFDSSNRTLLAG 99
+ ++ LH + + HRDI +N+L+N L+ + DFG A+ L+ N +
Sbjct: 138 LIRSIGCLHLP-SVNVCHRDIKPHNVLVNEADGTLK--LCDFGSAKKLSPSEPNVAYICS 194
Query: 100 TYGYIAPEL-----AYTMVVTEKSDVYSFGVVALEVLMGKH--PGE 138
Y Y APEL YT V D++S G + E+++G+ G+
Sbjct: 195 RY-YRAPELIFGNQHYTTAV----DIWSVGCIFAEMMLGEPIFRGD 235
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 50.7 bits (122), Expect = 2e-08
Identities = 32/144 (22%), Positives = 54/144 (37%), Gaps = 31/144 (21%)
Query: 3 RKCMFLIYEYMEMGSLF--CVLR---TDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPP 57
+L++E M GS+ R + EA +V+ +A AL +LH
Sbjct: 83 EDRFYLVFEKMRGGSILSHIHKRRHFNELEAS--------VVVQDVASALDFLH---NKG 131
Query: 58 IVHRDISSNNILLNLELEAF---VADFGVARLLNFDSSNRTL-------LAGTYGYIAPE 107
I HRD+ NIL + + DF + + + + G+ Y+APE
Sbjct: 132 IAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPE 191
Query: 108 LAYTMVVTEKS-----DVYSFGVV 126
+ D++S GV+
Sbjct: 192 VVEAFSEEASIYDKRCDLWSLGVI 215
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 50.9 bits (122), Expect = 2e-08
Identities = 31/104 (29%), Positives = 50/104 (48%), Gaps = 16/104 (15%)
Query: 43 MAHALSYLHHDCTPPIVHRDISSNNILLNLELEAF-VADFGVARLLNFDSSNRTLLAGTY 101
+ A+ ++H + I HRDI N+L+N + + DFG A+ L + + +
Sbjct: 150 LFRAVGFIH---SLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPSVAYICSRF 206
Query: 102 GYIAPEL-----AYTMVVTEKSDVYSFGVVALEVLMGKH--PGE 138
Y APEL YT + D++S G V E+++GK GE
Sbjct: 207 -YRAPELMLGATEYTPSI----DLWSIGCVFGELILGKPLFSGE 245
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 50.7 bits (122), Expect = 2e-08
Identities = 32/97 (32%), Positives = 49/97 (50%), Gaps = 15/97 (15%)
Query: 46 ALSYLH-HDCTPPIVHRDISSNNILLNLELEAFVADFGVARL-LNFDSSNRTLLAGTYGY 103
AL +LH I++RD+ +N+LL+ E +ADFG+ + + + T GT Y
Sbjct: 136 ALMFLHDKG----IIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTTAT-FCGTPDY 190
Query: 104 IAPEL----AYTMVVTEKSDVYSFGVVALEVLMGKHP 136
IAPE+ Y V D ++ GV+ E+L G P
Sbjct: 191 IAPEILQEMLYGPAV----DWWAMGVLLYEMLCGHAP 223
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 50.7 bits (122), Expect = 2e-08
Identities = 29/96 (30%), Positives = 45/96 (46%), Gaps = 9/96 (9%)
Query: 46 ALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADFGVARLLNFDSSNRTL--LAGTYGY 103
L YLH IVH+DI N+LL ++ GVA L+ +++ T G+ +
Sbjct: 121 GLEYLHSQG---IVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAF 177
Query: 104 IAPELAYTMVVTE--KSDVYSFGVVALEVLM-GKHP 136
PE+A + K D++S GV L + G +P
Sbjct: 178 QPPEIANGLDTFSGFKVDIWSAGVT-LYNITTGLYP 212
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 50.7 bits (122), Expect = 2e-08
Identities = 31/97 (31%), Positives = 50/97 (51%), Gaps = 15/97 (15%)
Query: 46 ALSYLH-HDCTPPIVHRDISSNNILLNLELEAFVADFGVARL-LNFDSSNRTLLAGTYGY 103
AL+YLH I++RD+ +N+LL+ E + D+G+ + L + T GT Y
Sbjct: 122 ALNYLHERG----IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTST-FCGTPNY 176
Query: 104 IAPEL----AYTMVVTEKSDVYSFGVVALEVLMGKHP 136
IAPE+ Y V D ++ GV+ E++ G+ P
Sbjct: 177 IAPEILRGEDYGFSV----DWWALGVLMFEMMAGRSP 209
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 50.3 bits (121), Expect = 2e-08
Identities = 31/143 (21%), Positives = 58/143 (40%), Gaps = 21/143 (14%)
Query: 2 HRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHR 61
H + LI+EY E L + ++ + + + + + +++ H +HR
Sbjct: 104 HNHRLHLIFEYAEN-DLKKYM---DKNPDVSMRVIKSFLYQLINGVNFCHSRR---CLHR 156
Query: 62 DISSNNILLNLELEAF-----VADFGVARLLNFDSSNRTLLAGTYGYIAPEL-----AYT 111
D+ N+LL++ + + DFG+AR T T Y PE+ Y+
Sbjct: 157 DLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEIITLWYRPPEILLGSRHYS 216
Query: 112 MVVTEKSDVYSFGVVALEVLMGK 134
V D++S + E+LM
Sbjct: 217 TSV----DIWSIACIWAEMLMKT 235
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 50.3 bits (121), Expect = 2e-08
Identities = 37/134 (27%), Positives = 61/134 (45%), Gaps = 16/134 (11%)
Query: 6 MFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISS 65
+ L++E+++ L L GL ++++ L +LH +C IVHRD+
Sbjct: 94 VTLVFEHVDQ-DLRTYLD-KAPPPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKP 148
Query: 66 NNILLNLELEAFVADFGVARLLNFDSSNR-TLLAGTYGYIAPEL----AYTMVVTEKSDV 120
NIL+ +ADFG+AR+ + T + T Y APE+ Y V D+
Sbjct: 149 ENILVTSGGTVKLADFGLARI--YSYQMALTPVVVTLWYRAPEVLLQSTYATPV----DM 202
Query: 121 YSFGVVALEVLMGK 134
+S G + E+ K
Sbjct: 203 WSVGCIFAEMFRRK 216
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 50.4 bits (121), Expect = 2e-08
Identities = 31/97 (31%), Positives = 50/97 (51%), Gaps = 15/97 (15%)
Query: 46 ALSYLH-HDCTPPIVHRDISSNNILLNLELEAFVADFGVARL-LNFDSSNRTLLAGTYGY 103
AL+YLH I++RD+ +N+LL+ E + D+G+ + L + T GT Y
Sbjct: 165 ALNYLHERG----IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTST-FCGTPNY 219
Query: 104 IAPEL----AYTMVVTEKSDVYSFGVVALEVLMGKHP 136
IAPE+ Y V D ++ GV+ E++ G+ P
Sbjct: 220 IAPEILRGEDYGFSV----DWWALGVLMFEMMAGRSP 252
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 49.9 bits (120), Expect = 3e-08
Identities = 30/140 (21%), Positives = 58/140 (41%), Gaps = 14/140 (10%)
Query: 2 HRKCMFLIYEYMEM--GSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIV 59
+ L++E+M+ GL+ + L++ H + I+
Sbjct: 74 TENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENK---IL 130
Query: 60 HRDISSNNILLNLELEAFVADFGVARLLNFDSSNRTLLAGTYGYIAPEL-----AYTMVV 114
HRD+ N+L+N + + DFG+AR + + T Y AP++ Y+ +
Sbjct: 131 HRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEVVTLWYRAPDVLMGSRTYSTSI 190
Query: 115 TEKSDVYSFGVVALEVLMGK 134
D++S G + E++ GK
Sbjct: 191 ----DIWSCGCILAEMITGK 206
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 50.0 bits (120), Expect = 3e-08
Identities = 36/129 (27%), Positives = 61/129 (47%), Gaps = 12/129 (9%)
Query: 7 FLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSN 66
+L+ +M L +++ ++ L + +V M L Y+H I+HRD+
Sbjct: 106 YLVMPFMGT-DLGKLMKHEK----LGEDRIQFLVYQMLKGLRYIH---AAGIIHRDLKPG 157
Query: 67 NILLNLELEAFVADFGVARLLNFDSSNRTLLAGTYGYIAPELAYT-MVVTEKSDVYSFGV 125
N+ +N + E + DFG+AR S T T Y APE+ M T+ D++S G
Sbjct: 158 NLAVNEDCELKILDFGLARQA---DSEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGC 214
Query: 126 VALEVLMGK 134
+ E++ GK
Sbjct: 215 IMAEMITGK 223
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 49.9 bits (120), Expect = 4e-08
Identities = 31/96 (32%), Positives = 48/96 (50%), Gaps = 13/96 (13%)
Query: 46 ALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADFGVARLLNFDSSNRTL-LAGTYGYI 104
L +L I++RD+ +N++L+ E +ADFG+ + N T GT YI
Sbjct: 133 GLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCK-ENIWDGVTTKTFCGTPDYI 188
Query: 105 APEL----AYTMVVTEKSDVYSFGVVALEVLMGKHP 136
APE+ Y V D ++FGV+ E+L G+ P
Sbjct: 189 APEIIAYQPYGKSV----DWWAFGVLLYEMLAGQAP 220
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 49.6 bits (119), Expect = 4e-08
Identities = 26/104 (25%), Positives = 50/104 (48%), Gaps = 22/104 (21%)
Query: 46 ALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADFGVARLLNFDSSNRTLLAGTYG--- 102
A+ LH ++HRD+ +N+L+N + V DFG+AR+++ +++ + G
Sbjct: 124 AVKVLH---GSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMV 180
Query: 103 -------YIAPEL-----AYTMVVTEKSDVYSFGVVALEVLMGK 134
Y APE+ Y+ + DV+S G + E+ + +
Sbjct: 181 EFVATRWYRAPEVMLTSAKYSRAM----DVWSCGCILAELFLRR 220
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 49.5 bits (119), Expect = 4e-08
Identities = 35/97 (36%), Positives = 52/97 (53%), Gaps = 15/97 (15%)
Query: 46 ALSYLH-HDCTPPIVHRDISSNNILLNLELEAFVADFGVARL-LNFDSSNRTLLAGTYGY 103
L +LH IV+RD+ +NILL+ + +ADFG+ + + D+ T GT Y
Sbjct: 130 GLQFLHSKG----IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNT-FCGTPDY 184
Query: 104 IAPEL----AYTMVVTEKSDVYSFGVVALEVLMGKHP 136
IAPE+ Y V D +SFGV+ E+L+G+ P
Sbjct: 185 IAPEILLGQKYNHSV----DWWSFGVLLYEMLIGQSP 217
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 48.8 bits (117), Expect = 7e-08
Identities = 30/100 (30%), Positives = 44/100 (44%), Gaps = 15/100 (15%)
Query: 43 MAHALSYLHHDCTPPIVHRDISSNNILLNLE-LEAFVADFGVARLLNFDSSNRTLLAGTY 101
+ A+ + H +VHRDI NIL++L A + DFG LL+ D GT
Sbjct: 148 VVAAIQHCHSRG---VVHRDIKDENILIDLRRGCAKLIDFGSGALLH-DEPYTD-FDGTR 202
Query: 102 GYIAPEL----AYTMVVTEKSDVYSFGVVALEVLM-GKHP 136
Y PE Y + V+S G++ L ++ G P
Sbjct: 203 VYSPPEWISRHQYH---ALPATVWSLGIL-LYDMVCGDIP 238
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 48.9 bits (117), Expect = 8e-08
Identities = 28/90 (31%), Positives = 46/90 (51%), Gaps = 7/90 (7%)
Query: 46 ALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADFGVARLLNFDSSNRTLLAGTYGYIA 105
L Y+H + I+HRD+ +N+ +N + E + DFG+AR + T T Y A
Sbjct: 144 GLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHT---ADEMTGYVATRWYRA 197
Query: 106 PELAYT-MVVTEKSDVYSFGVVALEVLMGK 134
PE+ M + D++S G + E+L G+
Sbjct: 198 PEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 48.5 bits (116), Expect = 1e-07
Identities = 29/100 (29%), Positives = 45/100 (45%), Gaps = 15/100 (15%)
Query: 43 MAHALSYLHHDCTPPIVHRDISSNNILLNLE-LEAFVADFGVARLLNFDSSNRTLLAGTY 101
+ A+ + H+ ++HRDI NIL++L E + DFG LL D+ GT
Sbjct: 158 VLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFGSGALLK-DTVYTD-FDGTR 212
Query: 102 GYIAPEL----AYTMVVTEKSDVYSFGVVALEVLM-GKHP 136
Y PE Y + V+S G++ L ++ G P
Sbjct: 213 VYSPPEWIRYHRYH---GRSAAVWSLGIL-LYDMVCGDIP 248
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 48.5 bits (116), Expect = 1e-07
Identities = 30/94 (31%), Positives = 42/94 (44%), Gaps = 13/94 (13%)
Query: 46 ALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADFGVARLLNFDSSNRTLLAGTYGYIA 105
L LH +VHRD+ NILL + + DF +AR +N+T Y A
Sbjct: 146 GLHVLH---EAGVVHRDLHPGNILLADNNDITICDFNLAREDT-ADANKTHYVTHRWYRA 201
Query: 106 PEL-----AYTMVVTEKSDVYSFGVVALEVLMGK 134
PEL +T +V D++S G V E+ K
Sbjct: 202 PELVMQFKGFTKLV----DMWSAGCVMAEMFNRK 231
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 48.0 bits (115), Expect = 1e-07
Identities = 39/136 (28%), Positives = 66/136 (48%), Gaps = 25/136 (18%)
Query: 6 MFLIYEYMEMGSLFCVL----RTDE-EAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVH 60
F++ EY+ G LF + R +E EA + + + A+ Y H +VH
Sbjct: 86 FFMVMEYVSGGELFDYICKHGRVEEMEAR--------RLFQQILSAVDYCHRHM---VVH 134
Query: 61 RDISSNNILLNLELEAFVADFGVARLLNFDSSNRTLLAGTYGYIAPEL----AYTMVVTE 116
RD+ N+LL+ + A +ADFG++ +++ RT G+ Y APE+ Y
Sbjct: 135 RDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRT-SCGSPNYAAPEVISGRLYA---GP 190
Query: 117 KSDVYSFGVVALEVLM 132
+ D++S GV+ L L+
Sbjct: 191 EVDIWSCGVI-LYALL 205
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 48.1 bits (115), Expect = 1e-07
Identities = 29/90 (32%), Positives = 47/90 (52%), Gaps = 7/90 (7%)
Query: 46 ALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADFGVARLLNFDSSNRTLLAGTYGYIA 105
L Y+H + +VHRD+ N+ +N + E + DFG+AR + + T T Y A
Sbjct: 138 GLKYIH---SAGVVHRDLKPGNLAVNEDCELKILDFGLARHAD---AEMTGYVVTRWYRA 191
Query: 106 PELAYT-MVVTEKSDVYSFGVVALEVLMGK 134
PE+ + M + D++S G + E+L GK
Sbjct: 192 PEVILSWMHYNQTVDIWSVGCIMAEMLTGK 221
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 48.2 bits (115), Expect = 1e-07
Identities = 28/94 (29%), Positives = 41/94 (43%), Gaps = 12/94 (12%)
Query: 43 MAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADFGVARLLNFDSSNRTLLAGTYG 102
+ A+ YL I+HRDI NI++ + + DFG A L T GT
Sbjct: 139 LVSAVGYLRLKD---IIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYT-FCGTIE 194
Query: 103 YIAPEL----AYTMVVTEKSDVYSFGVVALEVLM 132
Y APE+ Y + +++S GV L L+
Sbjct: 195 YCAPEVLMGNPYR---GPELEMWSLGVT-LYTLV 224
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 47.5 bits (114), Expect = 2e-07
Identities = 35/97 (36%), Positives = 49/97 (50%), Gaps = 18/97 (18%)
Query: 46 ALSYLH-HDCTPPIVHRDISSNNILLNLELEAFVADFGVARLLNFDSSNRTL-LAGTYGY 103
AL YLH D I++RD+ NILL+ + DFG A+ + + T L GT Y
Sbjct: 118 ALEYLHSKD----IIYRDLKPENILLDKNGHIKITDFGFAKYVP----DVTYTLCGTPDY 169
Query: 104 IAPEL----AYTMVVTEKSDVYSFGVVALEVLMGKHP 136
IAPE+ Y + D +SFG++ E+L G P
Sbjct: 170 IAPEVVSTKPYNKSI----DWWSFGILIYEMLAGYTP 202
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 47.3 bits (113), Expect = 3e-07
Identities = 34/101 (33%), Positives = 51/101 (50%), Gaps = 16/101 (15%)
Query: 46 ALSYLHHDCTPPIVHRDISSNNILLNLELEAF-VADFGVARLLNFDSSNRTLLAGTYGYI 104
+L+Y+H + I HRDI N+LL+ + DFG A++L N + + Y Y
Sbjct: 153 SLAYIH---SIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSYICSRY-YR 208
Query: 105 APEL-----AYTMVVTEKSDVYSFGVVALEVLMGK--HPGE 138
APEL YT + D++S G V E++ G+ PGE
Sbjct: 209 APELIFGATNYTTNI----DIWSTGCVMAELMQGQPLFPGE 245
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 46.9 bits (112), Expect = 3e-07
Identities = 30/91 (32%), Positives = 48/91 (52%), Gaps = 12/91 (13%)
Query: 46 ALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADFGVARLLNFDSSNRTLLAGTYGYIA 105
A+ Y H IVHRD+ N+LL+ L +ADFG++ ++ + +T G+ Y A
Sbjct: 120 AIEYCHRHK---IVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKT-SCGSPNYAA 175
Query: 106 PEL----AYTMVVTEKSDVYSFGVVALEVLM 132
PE+ Y + DV+S G+V L V++
Sbjct: 176 PEVINGKLYA---GPEVDVWSCGIV-LYVML 202
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 46.4 bits (111), Expect = 4e-07
Identities = 31/93 (33%), Positives = 48/93 (51%), Gaps = 13/93 (13%)
Query: 46 ALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADFGVARLLNFDSSNRTL--LAGTYGY 103
+ YLH I HRDI N+LL+ ++DFG+A + +++ R L + GT Y
Sbjct: 117 GVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPY 173
Query: 104 IAPEL----AYTMVVTEKSDVYSFGVVALEVLM 132
+APEL + E DV+S G+V L ++
Sbjct: 174 VAPELLKRREFH---AEPVDVWSCGIV-LTAML 202
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 46.6 bits (111), Expect = 5e-07
Identities = 31/100 (31%), Positives = 47/100 (47%), Gaps = 19/100 (19%)
Query: 46 ALSYLHHDCTPPIVHRDISSNNILL--NLELEAFVADFGVARLLNFDSSNRTLLAGTYGY 103
+SY H I HRD+ N LL + + DFG ++ S ++ + GT Y
Sbjct: 128 GVSYCHSMQ---ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTV-GTPAY 183
Query: 104 IAPELAYTMVVTEK------SDVYSFGVVALEVLM-GKHP 136
IAPE V+ + +DV+S GV L V++ G +P
Sbjct: 184 IAPE-----VLLRQEYDGKIADVWSCGVT-LYVMLVGAYP 217
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 46.2 bits (110), Expect = 6e-07
Identities = 31/93 (33%), Positives = 48/93 (51%), Gaps = 13/93 (13%)
Query: 46 ALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADFGVARLLNFDSSNRTL--LAGTYGY 103
+ YLH I HRDI N+LL+ ++DFG+A + +++ R L + GT Y
Sbjct: 117 GVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPY 173
Query: 104 IAPEL----AYTMVVTEKSDVYSFGVVALEVLM 132
+APEL + E DV+S G+V L ++
Sbjct: 174 VAPELLKRREFH---AEPVDVWSCGIV-LTAML 202
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 46.2 bits (110), Expect = 7e-07
Identities = 29/141 (20%), Positives = 59/141 (41%), Gaps = 23/141 (16%)
Query: 6 MFLIYEYMEMGSLFCVL-RTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDIS 64
+ +++E + +L ++ + + + L + K+ I K + L Y+H C I+H DI
Sbjct: 105 VVMVFEVLGE-NLLALIKKYEHRGIPLIYVKQ--ISKQLLLGLDYMHRRCG--IIHTDIK 159
Query: 65 SNNILLNLELEAF------VADFGVARLLNFDSSNRTLLAGTYGYIAPE----LAYTMVV 114
N+L+ + +AD G A + + T T Y +PE +
Sbjct: 160 PENVLMEIVDSPENLIQIKIADLGNAC---WYDEHYTNSIQTREYRSPEVLLGAPWGC-- 214
Query: 115 TEKSDVYSFGVVALEVLMGKH 135
+D++S + E++ G
Sbjct: 215 --GADIWSTACLIFELITGDF 233
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 45.9 bits (109), Expect = 8e-07
Identities = 38/135 (28%), Positives = 65/135 (48%), Gaps = 25/135 (18%)
Query: 7 FLIYEYMEMGSLFCVL----RTDE-EAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHR 61
F++ EY+ G LF + R DE E+ + + + + Y H +VHR
Sbjct: 92 FMVMEYVSGGELFDYICKNGRLDEKESR--------RLFQQILSGVDYCHRHM---VVHR 140
Query: 62 DISSNNILLNLELEAFVADFGVARLLNFDSSNRTLLAGTYGYIAPEL----AYTMVVTEK 117
D+ N+LL+ + A +ADFG++ +++ RT G+ Y APE+ Y +
Sbjct: 141 DLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRT-SCGSPNYAAPEVISGRLYA---GPE 196
Query: 118 SDVYSFGVVALEVLM 132
D++S GV+ L L+
Sbjct: 197 VDIWSSGVI-LYALL 210
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 45.3 bits (106), Expect = 1e-06
Identities = 18/111 (16%), Positives = 35/111 (31%), Gaps = 6/111 (5%)
Query: 6 MFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISS 65
+F++ E+ G +RT A +I+ + +L+ HRD+
Sbjct: 137 LFIVLEFEFGGIDLEQMRTKL----SSLATAKSILHQLTASLAVAEASL--RFEHRDLHW 190
Query: 66 NNILLNLELEAFVADFGVARLLNFDSSNRTLLAGTYGYIAPELAYTMVVTE 116
N+LL + + S + Y E +V +
Sbjct: 191 GNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDGIVVFCD 241
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 43.8 bits (104), Expect = 4e-06
Identities = 22/97 (22%), Positives = 44/97 (45%), Gaps = 14/97 (14%)
Query: 46 ALSYLHHDCTPPIVHRDISSNNILLNLEL-EAFVADFGVARLLNFDSSNRTLLAGTYGYI 104
AL Y H + I+HRD+ +N++++ E + + D+G+A + + + +
Sbjct: 142 ALDYCH---SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH-PGQEYNVRVASRYFK 197
Query: 105 APEL-----AYTMVVTEKSDVYSFGVVALEVLMGKHP 136
PEL Y + D++S G + ++ K P
Sbjct: 198 GPELLVDYQMYDYSL----DMWSLGCMLASMIFRKEP 230
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 43.1 bits (102), Expect = 8e-06
Identities = 31/115 (26%), Positives = 47/115 (40%), Gaps = 33/115 (28%)
Query: 46 ALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADFGVARLLNFDSSNRTLLAGTYG--- 102
+ YLH + ++HRD+ +NILLN E VADFG++R + +
Sbjct: 121 VIKYLH---SGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENT 177
Query: 103 ------------------YIAPEL-----AYTMVVTEKSDVYSFGVVALEVLMGK 134
Y APE+ YT + D++S G + E+L GK
Sbjct: 178 ENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGI----DMWSLGCILGEILCGK 228
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 41.3 bits (97), Expect = 3e-05
Identities = 28/118 (23%), Positives = 43/118 (36%), Gaps = 34/118 (28%)
Query: 46 ALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADFGVARLLNFDSSNRTLLAGTYG--- 102
+++H I+HRD+ N LLN + V DFG+AR +N + +
Sbjct: 141 GENFIH---ESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEP 197
Query: 103 -------------------YIAPEL-----AYTMVVTEKSDVYSFGVVALEVLMGKHP 136
Y APEL YT + D++S G + E+L
Sbjct: 198 GPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSI----DIWSTGCIFAELLNMLQS 251
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 41.0 bits (96), Expect = 4e-05
Identities = 21/95 (22%), Positives = 40/95 (42%), Gaps = 8/95 (8%)
Query: 46 ALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADFGVARLLNFDSSNRTLLAGTYGYIA 105
+ Y+H + I+HRD+ N L+N + V DFG+AR +++ + + L +
Sbjct: 168 GVKYVH---SAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDD 224
Query: 106 PELAYTMVVTEKSDVYSFGVV-----ALEVLMGKH 135
L + VV A E+++ +
Sbjct: 225 MNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQE 259
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 41.0 bits (96), Expect = 4e-05
Identities = 28/147 (19%), Positives = 46/147 (31%), Gaps = 54/147 (36%)
Query: 39 IVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLE------------------------- 73
I++ + L YLH C I+H DI NILL++
Sbjct: 151 IIQQVLQGLDYLHTKCR--IIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGS 208
Query: 74 ------------------------LEAFVADFGVARLLNFDSSNRTLLAGTYGYIAPELA 109
L+ +AD G A + + T T Y + E+
Sbjct: 209 AVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNAC---WVHKHFTEDIQTRQYRSLEVL 265
Query: 110 YTMVVTEKSDVYSFGVVALEVLMGKHP 136
+D++S +A E+ G +
Sbjct: 266 IGSGYNTPADIWSTACMAFELATGDYL 292
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 39.7 bits (93), Expect = 1e-04
Identities = 30/142 (21%), Positives = 59/142 (41%), Gaps = 24/142 (16%)
Query: 2 HRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHR 61
R + + +E + M +L+ +++ ++ G + L LH I+H
Sbjct: 170 FRNHICMTFELLSM-NLYELIKKNKF-QGFSLPLVRKFAHSILQCLDALHK---NRIIHC 224
Query: 62 DISSNNILLNLELEAFVADFGVARLLNFDSS---NRTLLAGTYGYI------APELAYTM 112
D+ NILL + + + ++++F SS ++ + Y YI APE+
Sbjct: 225 DLKPENILLKQQGRSGI------KVIDFGSSCYEHQRV----YTYIQSRFYRAPEVILGA 274
Query: 113 VVTEKSDVYSFGVVALEVLMGK 134
D++S G + E+L G
Sbjct: 275 RYGMPIDMWSLGCILAELLTGY 296
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 39.2 bits (92), Expect = 2e-04
Identities = 31/135 (22%), Positives = 50/135 (37%), Gaps = 45/135 (33%)
Query: 3 RKCMFLIYEYMEMGSLF-------CVLRTDEEAVGLDWAKRVNIVKGMAHALSYLH-HDC 54
RKC+ ++ E ++ G LF T+ EA I+K + A+ YLH +
Sbjct: 87 RKCLLIVMECLDGGELFSRIQDRGDQAFTEREAS--------EIMKSIGEAIQYLHSIN- 137
Query: 55 TPPIVHRDISSNNILLNLELEAF---VADFGVARLLNFDSSNRTLLAGTYGYIAPELAYT 111
I HRD+ N+L + + DFG A + Y
Sbjct: 138 ---IAHRDVKPENLLYTSKRPNAILKLTDFGFA---------KETTGEKYD--------- 176
Query: 112 MVVTEKSDVYSFGVV 126
+ D++S GV+
Sbjct: 177 ----KSCDMWSLGVI 187
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 37.4 bits (87), Expect = 7e-04
Identities = 32/141 (22%), Positives = 62/141 (43%), Gaps = 20/141 (14%)
Query: 2 HRKCMFLIYEYMEMGSLFCVLR-TDEEAVGLDWAKRVNIVKGMAHALSYLH-HDCTPPIV 59
R + L++E + +L+ +LR T+ V L+ ++ + M AL +L + + I+
Sbjct: 127 FRNHLCLVFEMLSY-NLYDLLRNTNFRGVSLNLTRK--FAQQMCTALLFLATPELS--II 181
Query: 60 HRDISSNNILLNLELEAF--VADFGVARLLNFDSSNRTLLAGTYGYIAPE----LAYTMV 113
H D+ NILL + + DFG + + Y +PE + Y +
Sbjct: 182 HCDLKPENILLCNPKRSAIKIVDFGSSC---QLGQRIYQYIQSRFYRSPEVLLGMPYDL- 237
Query: 114 VTEKSDVYSFGVVALEVLMGK 134
D++S G + +E+ G+
Sbjct: 238 ---AIDMWSLGCILVEMHTGE 255
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 144 | |||
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 99.98 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 99.98 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 99.98 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 99.98 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 99.98 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 99.98 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 99.98 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 99.98 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 99.98 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 99.98 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 99.98 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 99.98 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 99.98 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 99.97 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 99.97 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 99.97 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 99.97 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 99.97 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 99.97 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 99.97 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 99.97 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 99.97 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 99.97 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 99.97 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 99.97 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 99.97 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 99.97 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 99.97 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 99.97 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 99.97 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 99.97 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 99.97 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 99.97 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 99.97 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 99.97 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 99.97 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 99.97 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 99.97 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 99.97 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 99.97 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 99.97 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 99.97 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 99.97 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 99.97 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 99.97 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 99.97 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 99.97 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 99.97 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 99.97 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 99.97 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 99.97 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 99.97 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 99.97 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 99.97 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 99.97 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 99.97 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 99.97 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 99.97 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 99.97 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 99.97 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 99.97 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 99.97 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 99.97 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 99.97 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 99.97 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 99.97 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 99.97 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 99.97 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 99.97 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 99.97 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 99.97 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 99.97 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 99.97 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 99.97 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 99.97 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 99.97 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 99.97 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 99.97 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 99.97 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 99.97 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 99.97 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 99.97 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 99.97 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 99.97 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 99.97 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 99.97 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 99.97 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 99.97 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 99.97 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 99.97 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 99.97 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 99.97 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 99.97 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 99.97 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 99.97 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 99.97 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 99.97 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 99.97 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 99.97 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 99.97 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 99.97 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 99.97 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 99.97 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 99.97 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 99.97 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 99.97 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 99.97 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 99.97 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 99.97 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 99.97 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 99.97 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 99.97 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 99.97 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 99.97 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 99.97 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 99.97 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 99.97 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 99.97 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 99.97 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 99.97 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 99.97 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 99.97 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 99.97 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 99.97 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 99.97 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 99.97 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 99.97 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 99.97 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 99.97 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 99.97 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 99.97 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 99.97 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 99.97 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 99.97 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 99.97 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 99.97 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 99.97 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 99.97 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 99.97 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 99.97 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 99.97 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 99.97 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 99.97 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 99.97 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 99.97 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 99.97 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 99.97 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 99.97 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 99.97 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 99.97 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 99.96 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 99.96 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 99.96 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 99.96 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 99.96 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 99.96 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 99.96 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 99.96 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 99.96 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 99.96 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 99.96 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 99.96 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 99.96 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 99.96 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 99.96 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 99.96 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 99.96 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 99.96 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 99.96 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 99.96 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 99.96 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 99.96 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 99.96 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 99.96 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 99.96 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.96 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 99.96 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 99.96 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 99.96 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 99.96 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 99.96 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 99.96 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 99.96 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 99.96 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 99.96 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 99.96 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 99.96 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 99.95 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 99.95 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 99.95 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 99.95 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 99.95 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 99.94 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 99.93 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.86 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.7 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.45 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.26 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 98.68 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 98.56 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 98.55 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.47 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.0 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 97.87 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 97.7 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 97.36 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 97.33 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 97.12 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 96.81 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 96.26 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 95.17 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 94.95 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 94.94 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 94.66 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 93.74 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 93.61 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 93.08 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 93.01 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 92.97 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 92.66 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 92.39 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 91.97 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 91.77 | |
| 4ano_A | 219 | ESSB; membrane protein, membrane secretion, ESS ty | 89.78 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 89.37 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 83.03 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 82.19 |
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-43 Score=238.59 Aligned_cols=133 Identities=29% Similarity=0.396 Sum_probs=118.6
Q ss_pred CceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeeec
Q 044494 3 RKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADFG 82 (144)
Q Consensus 3 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~~ 82 (144)
++++|+||||++||+|.+++++... +++..+..++.|++.||+||| ++|++||||||+||+++.++.+||+|||
T Consensus 98 ~~~~~ivmEy~~gg~L~~~l~~~~~---l~e~~~~~~~~qi~~aL~ylH---~~~IiHRDlKp~NILl~~~g~vKl~DFG 171 (304)
T 3ubd_A 98 EGKLYLILDFLRGGDLFTRLSKEVM---FTEEDVKFYLAELALALDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFG 171 (304)
T ss_dssp TTEEEEEECCCTTCEEHHHHHHHCC---CCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCCGGGEEECTTSCEEEESSE
T ss_pred CCEEEEEEEcCCCCCHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHH---HCCCcCCCCCHHHeEEcCCCCEEecccc
Confidence 5789999999999999999986443 999999999999999999999 8999999999999999999999999999
Q ss_pred ceeecccCCCCcccccccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCC
Q 044494 83 VARLLNFDSSNRTLLAGTYGYIAPELAYTMVVTEKSDVYSFGVVALEVLMGKHPGELLS 141 (144)
Q Consensus 83 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~d~~slg~~l~~~~~g~~p~~~~~ 141 (144)
+++.............||+.|+|||++.+..++.++|+||+||++|||++|..||.+.+
T Consensus 172 la~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~ 230 (304)
T 3ubd_A 172 LSKESIDHEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKD 230 (304)
T ss_dssp EEEC-----CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred cceeccCCCccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcC
Confidence 99865544444556789999999999999999999999999999999999999998754
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=238.13 Aligned_cols=134 Identities=27% Similarity=0.450 Sum_probs=120.5
Q ss_pred CCceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeee
Q 044494 2 HRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADF 81 (144)
Q Consensus 2 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~ 81 (144)
.++++|+||||++||+|.+++++.+. +++..+..++.|++.||+||| +++++||||||+||+++.++.+||+||
T Consensus 103 ~~~~~yivmEy~~gG~L~~~i~~~~~---l~e~~~~~~~~qi~~al~ylH---~~~IiHRDlKPeNILl~~~g~vKl~DF 176 (311)
T 4aw0_A 103 DDEKLYFGLSYAKNGELLKYIRKIGS---FDETCTRFYTAEIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDF 176 (311)
T ss_dssp CSSEEEEEECCCTTEEHHHHHHHHSS---CCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECCC
T ss_pred eCCEEEEEEecCCCCCHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHH---HCCCccCCCCHHHeEEcCCCCEEEEEc
Confidence 46789999999999999999986444 999999999999999999999 899999999999999999999999999
Q ss_pred cceeecccCC--CCcccccccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCC
Q 044494 82 GVARLLNFDS--SNRTLLAGTYGYIAPELAYTMVVTEKSDVYSFGVVALEVLMGKHPGELLS 141 (144)
Q Consensus 82 ~~~~~~~~~~--~~~~~~~~~~~~~~pe~~~~~~~~~~~d~~slg~~l~~~~~g~~p~~~~~ 141 (144)
|+++...... ....+.+||+.|+|||++.+..++.++|+||+||++|+|++|..||.+.+
T Consensus 177 Gla~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~ 238 (311)
T 4aw0_A 177 GTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGN 238 (311)
T ss_dssp TTCEECCTTTTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred CCceecCCCCCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 9998765322 23445789999999999999999999999999999999999999998654
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-42 Score=239.98 Aligned_cols=133 Identities=26% Similarity=0.423 Sum_probs=121.0
Q ss_pred CCceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeee
Q 044494 2 HRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADF 81 (144)
Q Consensus 2 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~ 81 (144)
.++++|+||||++||+|.+++.+. .+++..+..++.|++.||+||| ++||+||||||+||+++.++.+||+||
T Consensus 142 ~~~~~~ivmEy~~gg~L~~~l~~~----~l~e~~~~~~~~qi~~aL~ylH---~~~IiHRDlKp~NILl~~~g~vKl~DF 214 (346)
T 4fih_A 142 VGDELWVVMEFLEGGALTDIVTHT----RMNEEQIAAVCLAVLQALSVLH---AQGVIHRDIKSDSILLTHDGRVKLSDF 214 (346)
T ss_dssp ETTEEEEEECCCTTEEHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCC
T ss_pred ECCEEEEEEeCCCCCcHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHH---HCCcccccCCHHHEEECCCCCEEEecC
Confidence 357899999999999999998753 2899999999999999999999 899999999999999999999999999
Q ss_pred cceeecccCCCCcccccccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCC
Q 044494 82 GVARLLNFDSSNRTLLAGTYGYIAPELAYTMVVTEKSDVYSFGVVALEVLMGKHPGELLS 141 (144)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~d~~slg~~l~~~~~g~~p~~~~~ 141 (144)
|+++.............||+.|+|||++....|+.++|+||+||++|||++|..||.+.+
T Consensus 215 Gla~~~~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~ 274 (346)
T 4fih_A 215 GFCAQVSKEVPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEP 274 (346)
T ss_dssp TTCEECCSSSCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC
T ss_pred cCceecCCCCCcccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcC
Confidence 999877655455566789999999999999999999999999999999999999997654
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-42 Score=241.24 Aligned_cols=136 Identities=29% Similarity=0.422 Sum_probs=119.3
Q ss_pred CCceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeee
Q 044494 2 HRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADF 81 (144)
Q Consensus 2 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~ 81 (144)
+++++|+||||++||+|.+++.... ...+++..++.++.|++.||+||| ++||+||||||+||+++.++.+||+||
T Consensus 94 ~~~~~yiVmEy~~gg~L~~~i~~~~-~~~~~e~~~~~~~~qi~~aL~ylH---~~~IiHRDlKp~NILl~~~g~vKl~DF 169 (350)
T 4b9d_A 94 ENGSLYIVMDYCEGGDLFKRINAQK-GVLFQEDQILDWFVQICLALKHVH---DRKILHRDIKSQNIFLTKDGTVQLGDF 169 (350)
T ss_dssp ETTEEEEEEECCTTCBHHHHHHHTT-TCCCCHHHHHHHHHHHHHHHHHHH---HTTCEETTCCGGGEEECTTCCEEECST
T ss_pred ECCEEEEEEeCCCCCcHHHHHHHcC-CCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCCHHHEEECCCCCEEEccc
Confidence 3578999999999999999997533 233789999999999999999999 899999999999999999999999999
Q ss_pred cceeecccCCCCcccccccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCC
Q 044494 82 GVARLLNFDSSNRTLLAGTYGYIAPELAYTMVVTEKSDVYSFGVVALEVLMGKHPGELLS 141 (144)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~d~~slg~~l~~~~~g~~p~~~~~ 141 (144)
|+++.............||+.|+|||++.+..|+.++|+||+||++|||++|..||.+.+
T Consensus 170 Gla~~~~~~~~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~ 229 (350)
T 4b9d_A 170 GIARVLNSTVELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGS 229 (350)
T ss_dssp TEESCCCHHHHHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred ccceeecCCcccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcC
Confidence 999865432222344679999999999999999999999999999999999999998754
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-41 Score=235.76 Aligned_cols=134 Identities=28% Similarity=0.343 Sum_probs=116.5
Q ss_pred CceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCC-CeEEeee
Q 044494 3 RKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLEL-EAFVADF 81 (144)
Q Consensus 3 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~-~~~l~d~ 81 (144)
++.+|+||||++||+|.+++++.+. +++..+..++.|++.||.||| +++++||||||+||+++.++ .+||+||
T Consensus 122 ~~~~~ivmEy~~gg~L~~~l~~~~~---l~e~~~~~~~~qi~~aL~ylH---~~~IiHRDlKp~NILl~~~g~~vKl~DF 195 (336)
T 4g3f_A 122 GPWVNIFMELLEGGSLGQLIKQMGC---LPEDRALYYLGQALEGLEYLH---TRRILHGDVKADNVLLSSDGSRAALCDF 195 (336)
T ss_dssp TTEEEEEECCCTTCBHHHHHHHHSS---CCHHHHHHHHHHHHHHHHHHH---TTTEECSCCCGGGEEECTTSCCEEECCC
T ss_pred CCEEEEEEeccCCCcHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHH---HCCceecccCHHHEEEeCCCCEEEEeeC
Confidence 5678999999999999999986543 999999999999999999999 99999999999999999887 6999999
Q ss_pred cceeecccCCC-----CcccccccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCC
Q 044494 82 GVARLLNFDSS-----NRTLLAGTYGYIAPELAYTMVVTEKSDVYSFGVVALEVLMGKHPGELLSS 142 (144)
Q Consensus 82 ~~~~~~~~~~~-----~~~~~~~~~~~~~pe~~~~~~~~~~~d~~slg~~l~~~~~g~~p~~~~~~ 142 (144)
|+++....... ......||+.|+|||++.+..++.++|+||+||++|||++|..||...+.
T Consensus 196 Gla~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~ 261 (336)
T 4g3f_A 196 GHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFR 261 (336)
T ss_dssp TTCEEC------------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCC
T ss_pred CCCeEccCCCcccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCH
Confidence 99987643221 12235699999999999999999999999999999999999999987553
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=241.12 Aligned_cols=133 Identities=26% Similarity=0.423 Sum_probs=120.9
Q ss_pred CCceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeee
Q 044494 2 HRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADF 81 (144)
Q Consensus 2 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~ 81 (144)
.++++|+|||||+||+|.++++.. .+++..+..++.|++.||+||| ++||+||||||+||+++.++.+||+||
T Consensus 219 ~~~~~~iVmEy~~gG~L~~~i~~~----~l~e~~~~~~~~qil~aL~ylH---~~~IiHRDiKp~NILl~~~g~vKl~DF 291 (423)
T 4fie_A 219 VGDELWVVMEFLEGGALTDIVTHT----RMNEEQIAAVCLAVLQALSVLH---AQGVIHRDIKSDSILLTHDGRVKLSDF 291 (423)
T ss_dssp ETTEEEEEEECCTTEEHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSTTTEEECTTCCEEECCC
T ss_pred ECCEEEEEEeCCCCCcHHHHHhcc----CCCHHHHHHHHHHHHHHHHHHH---HCCeecccCCHHHEEEcCCCCEEEecC
Confidence 357899999999999999998753 2899999999999999999999 899999999999999999999999999
Q ss_pred cceeecccCCCCcccccccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCC
Q 044494 82 GVARLLNFDSSNRTLLAGTYGYIAPELAYTMVVTEKSDVYSFGVVALEVLMGKHPGELLS 141 (144)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~d~~slg~~l~~~~~g~~p~~~~~ 141 (144)
|+++.............||+.|+|||++.+..|+.++|+||+||++|||++|..||.+.+
T Consensus 292 Gla~~~~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~ 351 (423)
T 4fie_A 292 GFCAQVSKEVPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEP 351 (423)
T ss_dssp TTCEECCSSCCCBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC
T ss_pred ccceECCCCCccccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcC
Confidence 999877655455566789999999999999999999999999999999999999997654
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=226.70 Aligned_cols=130 Identities=28% Similarity=0.445 Sum_probs=113.6
Q ss_pred CceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCC--eEecCCCCCcEEEcC-CCCeEEe
Q 044494 3 RKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPP--IVHRDISSNNILLNL-ELEAFVA 79 (144)
Q Consensus 3 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~--~~h~~i~~~ni~~~~-~~~~~l~ 79 (144)
++.+|+||||++||+|.+++++... +++..+..++.|++.||+||| +++ ++||||||+||+++. ++.+||+
T Consensus 101 ~~~~~lvmEy~~gg~L~~~l~~~~~---l~~~~~~~~~~qi~~aL~ylH---~~~~~IiHRDlKp~NILl~~~~g~vKl~ 174 (290)
T 3fpq_A 101 KKCIVLVTELMTSGTLKTYLKRFKV---MKIKVLRSWCRQILKGLQFLH---TRTPPIIHRDLKCDNIFITGPTGSVKIG 174 (290)
T ss_dssp EEEEEEEEECCCSCBHHHHHHHHSS---CCHHHHHHHHHHHHHHHHHHH---TSSSCCCCCCCCGGGEEESSTTSCEEEC
T ss_pred CcEEEEEEeCCCCCCHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHH---HCCCCEEecccChhheeEECCCCCEEEE
Confidence 3568999999999999999986443 899999999999999999999 777 999999999999984 7899999
Q ss_pred eecceeecccCCCCcccccccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCC
Q 044494 80 DFGVARLLNFDSSNRTLLAGTYGYIAPELAYTMVVTEKSDVYSFGVVALEVLMGKHPGELLS 141 (144)
Q Consensus 80 d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~d~~slg~~l~~~~~g~~p~~~~~ 141 (144)
|||+++... ........||+.|+|||++.+ .++.++|+||+||++|||++|..||...+
T Consensus 175 DFGla~~~~--~~~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~ 233 (290)
T 3fpq_A 175 DLGLATLKR--ASFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQ 233 (290)
T ss_dssp CTTGGGGCC--TTSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCS
T ss_pred eCcCCEeCC--CCccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCC
Confidence 999997533 233445679999999999865 58999999999999999999999997643
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=227.91 Aligned_cols=135 Identities=29% Similarity=0.479 Sum_probs=112.9
Q ss_pred CceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeeec
Q 044494 3 RKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADFG 82 (144)
Q Consensus 3 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~~ 82 (144)
++.+|+||||+++|+|.+++..... .+++..+..++.|++.||.||| +++++||||||+||+++.++.+||+|||
T Consensus 103 ~~~~~iVmEy~~gGsL~~~l~~~~~--~l~~~~~~~i~~qia~gL~yLH---~~~IiHRDlKp~NILl~~~~~~Ki~DFG 177 (307)
T 3omv_A 103 KDNLAIVTQWCEGSSLYKHLHVQET--KFQMFQLIDIARQTAQGMDYLH---AKNIIHRDMKSNNIFLHEGLTVKIGDFG 177 (307)
T ss_dssp SSSCEEEEECCSSCBHHHHHHTSCC--CCCHHHHHHHHHHHHHHHHHHH---HTTCBCSCCCSSSEEEETTEEEEECCCS
T ss_pred CCeEEEEEEcCCCCCHHHHHhhcCC--CCCHHHHHHHHHHHHHHHHHHH---HCCccCCccCHHHEEECCCCcEEEeecc
Confidence 4568999999999999999975332 3999999999999999999999 8899999999999999999999999999
Q ss_pred ceeecccC--CCCcccccccccccCccccccC---CCCCcchhHHHHHHHHHHHhCCCCCCCCCC
Q 044494 83 VARLLNFD--SSNRTLLAGTYGYIAPELAYTM---VVTEKSDVYSFGVVALEVLMGKHPGELLSS 142 (144)
Q Consensus 83 ~~~~~~~~--~~~~~~~~~~~~~~~pe~~~~~---~~~~~~d~~slg~~l~~~~~g~~p~~~~~~ 142 (144)
+++..... ........||+.|+|||++... .++.++|+||+|+++|||++|..||...++
T Consensus 178 la~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~ 242 (307)
T 3omv_A 178 LATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINN 242 (307)
T ss_dssp SCBC------------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCC
T ss_pred CceecccCCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCCh
Confidence 99865422 2223446799999999998643 578899999999999999999999987553
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-40 Score=223.35 Aligned_cols=132 Identities=25% Similarity=0.402 Sum_probs=107.8
Q ss_pred CCceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeee
Q 044494 2 HRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADF 81 (144)
Q Consensus 2 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~ 81 (144)
.++++|+||||+ +|+|.+++.+.+. +++..+..++.|++.|++||| ++|++||||||+||+++.++.+||+||
T Consensus 84 ~~~~~~ivmEy~-~g~L~~~l~~~~~---l~e~~~~~~~~qi~~al~ylH---~~~IiHRDiKP~NILl~~~~~vkl~DF 156 (275)
T 3hyh_A 84 SKDEIIMVIEYA-GNELFDYIVQRDK---MSEQEARRFFQQIISAVEYCH---RHKIVHRDLKPENLLLDEHLNVKIADF 156 (275)
T ss_dssp CSSEEEEEEECC-CEEHHHHHHHSCS---CCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCTTTEEECTTCCEEECCS
T ss_pred ECCEEEEEEeCC-CCCHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHH---HCCcccccCChHHeEECCCCCEEEeec
Confidence 357899999999 6799999976544 999999999999999999999 899999999999999999999999999
Q ss_pred cceeecccCCCCcccccccccccCccccccCCC-CCcchhHHHHHHHHHHHhCCCCCCCCC
Q 044494 82 GVARLLNFDSSNRTLLAGTYGYIAPELAYTMVV-TEKSDVYSFGVVALEVLMGKHPGELLS 141 (144)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~-~~~~d~~slg~~l~~~~~g~~p~~~~~ 141 (144)
|+++.... .....+..||+.|+|||++.+..+ +.++|+||+||++|+|++|+.||...+
T Consensus 157 Gla~~~~~-~~~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~ 216 (275)
T 3hyh_A 157 GLSNIMTD-GNFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDES 216 (275)
T ss_dssp SCC----------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred CCCeecCC-CCccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCC
Confidence 99986543 223345679999999999998876 578999999999999999999997643
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-40 Score=224.03 Aligned_cols=137 Identities=28% Similarity=0.424 Sum_probs=119.3
Q ss_pred CCceEEEEEeeccCCCHHHHhhccc----------ccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEc
Q 044494 2 HRKCMFLIYEYMEMGSLFCVLRTDE----------EAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLN 71 (144)
Q Consensus 2 ~~~~~~lv~e~~~~~~L~~~l~~~~----------~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~ 71 (144)
+++.+|+||||+++|+|.+++++.. ....+++..+..++.|++.||.||| +++++||||||+||+++
T Consensus 86 ~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH---~~~iiHRDlKp~NILl~ 162 (299)
T 4asz_A 86 EGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLA---SQHFVHRDLATRNCLVG 162 (299)
T ss_dssp SSSSEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEC
T ss_pred eCCEEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCccCHhhEEEC
Confidence 4578999999999999999997532 2345999999999999999999999 89999999999999999
Q ss_pred CCCCeEEeeecceeecccCCC--CcccccccccccCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCC
Q 044494 72 LELEAFVADFGVARLLNFDSS--NRTLLAGTYGYIAPELAYTMVVTEKSDVYSFGVVALEVLM-GKHPGELLS 141 (144)
Q Consensus 72 ~~~~~~l~d~~~~~~~~~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~d~~slg~~l~~~~~-g~~p~~~~~ 141 (144)
.++.+||+|||+++....... ......||+.|+|||++....++.++|+||+|+++|||+| |+.||...+
T Consensus 163 ~~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~ 235 (299)
T 4asz_A 163 ENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLS 235 (299)
T ss_dssp GGGCEEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSC
T ss_pred CCCcEEECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCC
Confidence 999999999999986543222 1223468999999999999999999999999999999998 899998765
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-39 Score=237.16 Aligned_cols=132 Identities=23% Similarity=0.314 Sum_probs=118.2
Q ss_pred CCceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeee
Q 044494 2 HRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADF 81 (144)
Q Consensus 2 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~ 81 (144)
..+++|+||||++||+|.+++.+.+. +++..+..++.|++.||.||| ++||+||||||+||+++.+|.+||+||
T Consensus 263 ~~~~lylVmEy~~GGdL~~~l~~~~~---l~E~~a~~y~~qIl~aL~yLH---~~gIiHRDLKPeNILld~~G~vKL~DF 336 (689)
T 3v5w_A 263 TPDKLSFILDLMNGGDLHYHLSQHGV---FSEADMRFYAAEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDL 336 (689)
T ss_dssp CSSEEEEEECCCCSCBHHHHHHHHCC---CCHHHHHHHHHHHHHHHHHHH---TTTEECCCCSGGGEEECTTSCEEECCC
T ss_pred ECCEEEEEEecCCCCcHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHH---HCCccccCCchHHeEEeCCCCEEeccc
Confidence 35789999999999999999986544 999999999999999999999 999999999999999999999999999
Q ss_pred cceeecccCCCCcccccccccccCcccccc-CCCCCcchhHHHHHHHHHHHhCCCCCCCCC
Q 044494 82 GVARLLNFDSSNRTLLAGTYGYIAPELAYT-MVVTEKSDVYSFGVVALEVLMGKHPGELLS 141 (144)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~-~~~~~~~d~~slg~~l~~~~~g~~p~~~~~ 141 (144)
|+++.... ....+.+||+.|+|||++.. ..|+.++|+||+||++|||++|..||.+.+
T Consensus 337 GlA~~~~~--~~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~ 395 (689)
T 3v5w_A 337 GLACDFSK--KKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHK 395 (689)
T ss_dssp TTCEECSS--CCCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGG
T ss_pred ceeeecCC--CCCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 99987653 23345689999999999964 578999999999999999999999997643
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-39 Score=221.12 Aligned_cols=137 Identities=25% Similarity=0.339 Sum_probs=119.0
Q ss_pred CCceEEEEEeeccCCCHHHHhhcccc-------------cCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcE
Q 044494 2 HRKCMFLIYEYMEMGSLFCVLRTDEE-------------AVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNI 68 (144)
Q Consensus 2 ~~~~~~lv~e~~~~~~L~~~l~~~~~-------------~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni 68 (144)
.++.+++||||+++|+|.+++..... ...+++..+..++.|++.||.||| +++++||||||+||
T Consensus 100 ~~~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH---~~~iiHRDLK~~NI 176 (308)
T 4gt4_A 100 KDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLS---SHHVVHKDLATRNV 176 (308)
T ss_dssp SSSSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGE
T ss_pred ECCEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHH---hCCCCCCCccccce
Confidence 45678999999999999999965321 234899999999999999999999 89999999999999
Q ss_pred EEcCCCCeEEeeecceeecccC--CCCcccccccccccCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCC
Q 044494 69 LLNLELEAFVADFGVARLLNFD--SSNRTLLAGTYGYIAPELAYTMVVTEKSDVYSFGVVALEVLM-GKHPGELLS 141 (144)
Q Consensus 69 ~~~~~~~~~l~d~~~~~~~~~~--~~~~~~~~~~~~~~~pe~~~~~~~~~~~d~~slg~~l~~~~~-g~~p~~~~~ 141 (144)
+++.++.+||+|||+++..... ........||+.|+|||++....++.++|+||+|+++|||+| |..||.+.+
T Consensus 177 Ll~~~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~ 252 (308)
T 4gt4_A 177 LVYDKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYS 252 (308)
T ss_dssp EECGGGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCC
T ss_pred EECCCCCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCC
Confidence 9999999999999999865432 222344678999999999999999999999999999999998 899998765
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-39 Score=222.16 Aligned_cols=137 Identities=28% Similarity=0.422 Sum_probs=112.4
Q ss_pred CCceEEEEEeeccCCCHHHHhhcccc------------cCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEE
Q 044494 2 HRKCMFLIYEYMEMGSLFCVLRTDEE------------AVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNIL 69 (144)
Q Consensus 2 ~~~~~~lv~e~~~~~~L~~~l~~~~~------------~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~ 69 (144)
+++.+|+||||+++|+|.++++.... ...+++.+++.++.|++.||.||| +++++||||||+||+
T Consensus 114 ~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH---~~~iiHRDLKp~NIL 190 (329)
T 4aoj_A 114 EGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLA---GLHFVHRDLATRNCL 190 (329)
T ss_dssp SSSSEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEE
T ss_pred ECCEEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHh---cCCeecccccHhhEE
Confidence 45778999999999999999975321 234899999999999999999999 889999999999999
Q ss_pred EcCCCCeEEeeecceeecccCC--CCcccccccccccCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCC
Q 044494 70 LNLELEAFVADFGVARLLNFDS--SNRTLLAGTYGYIAPELAYTMVVTEKSDVYSFGVVALEVLM-GKHPGELLS 141 (144)
Q Consensus 70 ~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~~~~~pe~~~~~~~~~~~d~~slg~~l~~~~~-g~~p~~~~~ 141 (144)
++.++.+||+|||+++...... .......||+.|+|||++....++.++|+||||+++|||+| |+.||...+
T Consensus 191 l~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~ 265 (329)
T 4aoj_A 191 VGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLS 265 (329)
T ss_dssp EETTTEEEECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSC
T ss_pred ECCCCcEEEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCC
Confidence 9999999999999998654322 12234568999999999999999999999999999999999 899998765
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-39 Score=225.31 Aligned_cols=136 Identities=27% Similarity=0.398 Sum_probs=117.9
Q ss_pred CceEEEEEeeccCCCHHHHhhcccc-------------cCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEE
Q 044494 3 RKCMFLIYEYMEMGSLFCVLRTDEE-------------AVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNIL 69 (144)
Q Consensus 3 ~~~~~lv~e~~~~~~L~~~l~~~~~-------------~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~ 69 (144)
++.+|+|||||++|+|.++++.... ...+++..+..++.|++.||+||| +++++||||||+||+
T Consensus 141 ~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH---~~~iiHRDLK~~NIL 217 (353)
T 4ase_A 141 GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLA---SRKCIHRDLAARNIL 217 (353)
T ss_dssp TSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEE
T ss_pred CCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHh---hCCeecCccCcccee
Confidence 3568999999999999999975322 234889999999999999999999 899999999999999
Q ss_pred EcCCCCeEEeeecceeecccCCC--CcccccccccccCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCC
Q 044494 70 LNLELEAFVADFGVARLLNFDSS--NRTLLAGTYGYIAPELAYTMVVTEKSDVYSFGVVALEVLM-GKHPGELLS 141 (144)
Q Consensus 70 ~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~d~~slg~~l~~~~~-g~~p~~~~~ 141 (144)
++.++.+||+|||+++....... ......+|+.|+|||++....++.++|+||+||++|||+| |..||.+.+
T Consensus 218 l~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~ 292 (353)
T 4ase_A 218 LSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVK 292 (353)
T ss_dssp ECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCC
T ss_pred eCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCC
Confidence 99999999999999986543222 2234568999999999999999999999999999999998 999998765
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-38 Score=215.95 Aligned_cols=130 Identities=22% Similarity=0.362 Sum_probs=105.9
Q ss_pred ceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeeecc
Q 044494 4 KCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADFGV 83 (144)
Q Consensus 4 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~~~ 83 (144)
..+|+||||+++|+|.+++.........++..+..++.|++.||+||| +++++||||||+||+++.++.+||+|||+
T Consensus 88 ~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH---~~~IiHRDlKp~NILl~~~~~vKl~DFGl 164 (299)
T 4g31_A 88 VYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGL 164 (299)
T ss_dssp EEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECCCCC
T ss_pred cEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHH---HCcCccccCcHHHeEECCCCcEEEccCcc
Confidence 357999999999999999986554444677778899999999999999 89999999999999999999999999999
Q ss_pred eeecccCCCC------------cccccccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCC
Q 044494 84 ARLLNFDSSN------------RTLLAGTYGYIAPELAYTMVVTEKSDVYSFGVVALEVLMGKHPGEL 139 (144)
Q Consensus 84 ~~~~~~~~~~------------~~~~~~~~~~~~pe~~~~~~~~~~~d~~slg~~l~~~~~g~~p~~~ 139 (144)
++........ .....||+.|+|||++.+..++.++|+||+||++|||++ ||..
T Consensus 165 a~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~ 229 (299)
T 4g31_A 165 VTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFST 229 (299)
T ss_dssp C--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSS
T ss_pred ceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCC
Confidence 9866432111 123469999999999999999999999999999999996 7754
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-37 Score=215.88 Aligned_cols=128 Identities=28% Similarity=0.381 Sum_probs=109.9
Q ss_pred CceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCC-CCeEEeee
Q 044494 3 RKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLE-LEAFVADF 81 (144)
Q Consensus 3 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~-~~~~l~d~ 81 (144)
++++|+||||+++|+|.++++. +++.++..++.|++.||+||| ++|++||||||+||+++.+ +.+||+||
T Consensus 92 ~~~~~lvmE~~~g~~L~~~~~~------l~~~~~~~~~~qll~al~ylH---~~gIiHRDiKPeNiLl~~~~~~~kl~DF 162 (361)
T 4f9c_A 92 NDHVVIAMPYLEHESFLDILNS------LSFQEVREYMLNLFKALKRIH---QFGIVHRDVKPSNFLYNRRLKKYALVDF 162 (361)
T ss_dssp TTEEEEEEECCCCCCHHHHHTT------CCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEETTTTEEEECCC
T ss_pred CCEEEEEEeCCCcccHHHHHcC------CCHHHHHHHHHHHHHHHHHHH---HCCeEeCcCCHHHeEEeCCCCeEEECcC
Confidence 5789999999999999998852 899999999999999999999 8999999999999999877 78999999
Q ss_pred cceeecccCC----------------------------CCcccccccccccCccccccC-CCCCcchhHHHHHHHHHHHh
Q 044494 82 GVARLLNFDS----------------------------SNRTLLAGTYGYIAPELAYTM-VVTEKSDVYSFGVVALEVLM 132 (144)
Q Consensus 82 ~~~~~~~~~~----------------------------~~~~~~~~~~~~~~pe~~~~~-~~~~~~d~~slg~~l~~~~~ 132 (144)
|+++...... .......||+.|+|||++.+. .++.++|+||+||++|+|++
T Consensus 163 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~ 242 (361)
T 4f9c_A 163 GLAQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLS 242 (361)
T ss_dssp TTCEECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHH
T ss_pred CCCcccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHH
Confidence 9997543211 011234699999999998775 47889999999999999999
Q ss_pred CCCCCCC
Q 044494 133 GKHPGEL 139 (144)
Q Consensus 133 g~~p~~~ 139 (144)
|+.||..
T Consensus 243 G~~Pf~~ 249 (361)
T 4f9c_A 243 GRYPFYK 249 (361)
T ss_dssp TCSSSSC
T ss_pred CCCCCCC
Confidence 9999954
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-37 Score=212.98 Aligned_cols=130 Identities=28% Similarity=0.421 Sum_probs=106.6
Q ss_pred eEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcC-----CCCCeEecCCCCCcEEEcCCCCeEEe
Q 044494 5 CMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHD-----CTPPIVHRDISSNNILLNLELEAFVA 79 (144)
Q Consensus 5 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~-----~~~~~~h~~i~~~ni~~~~~~~~~l~ 79 (144)
.+|+||||+++|+|.++++.. .++++....++.|++.||.|||.. +..+++||||||+||+++.++.+||+
T Consensus 75 ~~~lV~Ey~~~gsL~~~l~~~----~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~ 150 (303)
T 3hmm_A 75 QLWLVSDYHEHGSLFDYLNRY----TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIA 150 (303)
T ss_dssp EEEEEEECCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEEC
T ss_pred EEEEEecCCCCCcHHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEE
Confidence 689999999999999999753 288999999999999999999931 12289999999999999999999999
Q ss_pred eecceeecccCCC----CcccccccccccCccccccC------CCCCcchhHHHHHHHHHHHhCCCCCC
Q 044494 80 DFGVARLLNFDSS----NRTLLAGTYGYIAPELAYTM------VVTEKSDVYSFGVVALEVLMGKHPGE 138 (144)
Q Consensus 80 d~~~~~~~~~~~~----~~~~~~~~~~~~~pe~~~~~------~~~~~~d~~slg~~l~~~~~g~~p~~ 138 (144)
|||+++....... ......||+.|+|||++.+. .++.++|+||+|+++|||++|..||.
T Consensus 151 DFGla~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~ 219 (303)
T 3hmm_A 151 DLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGG 219 (303)
T ss_dssp CCTTCEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTT
T ss_pred eCCCCccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCC
Confidence 9999987653221 12335799999999998754 35678999999999999999976654
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-37 Score=218.22 Aligned_cols=132 Identities=26% Similarity=0.385 Sum_probs=113.9
Q ss_pred CceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeeec
Q 044494 3 RKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADFG 82 (144)
Q Consensus 3 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~~ 82 (144)
.+++|+||||+. |+|.+++.+.+. +++..+..++.|++.||+||| ++|++||||||+||+++.++.+|++|||
T Consensus 131 ~~~~~ivmE~~~-g~L~~~i~~~~~---l~~~~~~~~~~qil~al~ylH---~~~iiHRDlKP~NIl~~~~~~~Ki~DFG 203 (398)
T 4b99_A 131 FKSVYVVLDLME-SDLHQIIHSSQP---LTLEHVRYFLYQLLRGLKYMH---SAQVIHRDLKPSNLLVNENCELKIGDFG 203 (398)
T ss_dssp CCCEEEEEECCS-EEHHHHHTSSSC---CCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTCCEEECCCT
T ss_pred CCEEEEEEeCCC-CCHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHH---HCcCcCCCcCccccccCCCCCEEEeecc
Confidence 467899999996 689999976443 999999999999999999999 8999999999999999999999999999
Q ss_pred ceeecccC----CCCcccccccccccCccccccC-CCCCcchhHHHHHHHHHHHhCCCCCCCCC
Q 044494 83 VARLLNFD----SSNRTLLAGTYGYIAPELAYTM-VVTEKSDVYSFGVVALEVLMGKHPGELLS 141 (144)
Q Consensus 83 ~~~~~~~~----~~~~~~~~~~~~~~~pe~~~~~-~~~~~~d~~slg~~l~~~~~g~~p~~~~~ 141 (144)
+++..... ........||+.|+|||++.+. .++.++|+||+||++|||++|..||.+.+
T Consensus 204 la~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~ 267 (398)
T 4b99_A 204 MARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKN 267 (398)
T ss_dssp TCBCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSS
T ss_pred eeeecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCC
Confidence 99865422 2223456899999999998875 46889999999999999999999998654
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-36 Score=221.69 Aligned_cols=134 Identities=26% Similarity=0.382 Sum_probs=117.9
Q ss_pred CCceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCC--CCeEEe
Q 044494 2 HRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLE--LEAFVA 79 (144)
Q Consensus 2 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~--~~~~l~ 79 (144)
.++.+|+||||++||+|.+++.... ..+++..+..++.|++.||+||| +++++||||||+||+++.+ +.+||+
T Consensus 225 ~~~~~~iv~E~~~gg~L~~~i~~~~--~~l~e~~~~~~~~qi~~al~ylH---~~~iiHRDlKp~Nill~~~~~~~vKl~ 299 (573)
T 3uto_A 225 DDNEMVMIYEFMSGGELFEKVADEH--NKMSEDEAVEYMRQVCKGLCHMH---ENNYVHLDLKPENIMFTTKRSNELKLI 299 (573)
T ss_dssp CSSEEEEEEECCCCCBHHHHHTCTT--SCEEHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSSSCCCEEEC
T ss_pred ECCEEEEEEeecCCCcHHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCChhhccccCCCCCCEEEe
Confidence 4678999999999999999986532 23899999999999999999999 8999999999999999854 789999
Q ss_pred eecceeecccCCCCcccccccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCC
Q 044494 80 DFGVARLLNFDSSNRTLLAGTYGYIAPELAYTMVVTEKSDVYSFGVVALEVLMGKHPGELLS 141 (144)
Q Consensus 80 d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~d~~slg~~l~~~~~g~~p~~~~~ 141 (144)
|||+++..... .......||+.|+|||++.+..++.++|+||+||++|+|++|..||.+.+
T Consensus 300 DFG~a~~~~~~-~~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~ 360 (573)
T 3uto_A 300 DFGLTAHLDPK-QSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGEN 360 (573)
T ss_dssp CCSSCEECCTT-SEEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSS
T ss_pred eccceeEccCC-CceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcC
Confidence 99999876532 22344679999999999999999999999999999999999999998654
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-35 Score=207.42 Aligned_cols=134 Identities=28% Similarity=0.435 Sum_probs=114.9
Q ss_pred CCceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeee
Q 044494 2 HRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADF 81 (144)
Q Consensus 2 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~ 81 (144)
..+.+|+||||+++|+|.+++.+... +++..+..++.|++.||.||| ++|++||||||+||+++.++.++|+||
T Consensus 95 ~~~~~~lv~E~~~gg~L~~~l~~~~~---~~~~~~~~~~~qi~~aL~~LH---~~givHrDlkp~NILl~~~g~ikL~DF 168 (353)
T 3txo_A 95 TPDRLFFVMEFVNGGDLMFHIQKSRR---FDEARARFYAAEIISALMFLH---DKGIIYRDLKLDNVLLDHEGHCKLADF 168 (353)
T ss_dssp CSSEEEEEEECCCSCBHHHHHHHHSS---CCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCC
T ss_pred eCCEEEEEEeCCCCCcHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHH---HCCCcccCCCHHHEEECCCCCEEEccc
Confidence 35678999999999999999976443 999999999999999999999 899999999999999999999999999
Q ss_pred cceeecccCCCCcccccccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCC
Q 044494 82 GVARLLNFDSSNRTLLAGTYGYIAPELAYTMVVTEKSDVYSFGVVALEVLMGKHPGELLS 141 (144)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~d~~slg~~l~~~~~g~~p~~~~~ 141 (144)
|++..............|++.|+|||++.+..++.++|+||+|+++|+|++|..||...+
T Consensus 169 G~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~ 228 (353)
T 3txo_A 169 GMCKEGICNGVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAEN 228 (353)
T ss_dssp TTCBCSCC---------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred cceeecccCCccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCC
Confidence 999864433344455679999999999999889999999999999999999999998654
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-35 Score=207.42 Aligned_cols=133 Identities=25% Similarity=0.409 Sum_probs=119.1
Q ss_pred CCceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeee
Q 044494 2 HRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADF 81 (144)
Q Consensus 2 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~ 81 (144)
.++.+|+||||+++|+|..++.+... +++..+..++.|++.||.+|| ++|++||||||+||+++.++.++|+||
T Consensus 124 ~~~~~~lV~E~~~gg~L~~~l~~~~~---l~~~~~~~~~~qi~~aL~~LH---~~givHrDLKp~NILl~~~g~ikL~DF 197 (396)
T 4dc2_A 124 TESRLFFVIEYVNGGDLMFHMQRQRK---LPEEHARFYSAEISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDY 197 (396)
T ss_dssp CSSEEEEEEECCTTCBHHHHHHHHSS---CCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCC
T ss_pred ECCEEEEEEEcCCCCcHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHH---HCCEEeccCCHHHEEECCCCCEEEeec
Confidence 35678999999999999999976443 999999999999999999999 899999999999999999999999999
Q ss_pred cceeecccCCCCcccccccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCC
Q 044494 82 GVARLLNFDSSNRTLLAGTYGYIAPELAYTMVVTEKSDVYSFGVVALEVLMGKHPGELL 140 (144)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~d~~slg~~l~~~~~g~~p~~~~ 140 (144)
|+++.............||+.|+|||++.+..++.++|+||+|+++|+|++|..||...
T Consensus 198 Gla~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~ 256 (396)
T 4dc2_A 198 GMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIV 256 (396)
T ss_dssp TTCBCCCCTTCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTT
T ss_pred ceeeecccCCCccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccc
Confidence 99986443344455677999999999999999999999999999999999999999653
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-35 Score=202.02 Aligned_cols=133 Identities=26% Similarity=0.366 Sum_probs=118.7
Q ss_pred CceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeeec
Q 044494 3 RKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADFG 82 (144)
Q Consensus 3 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~~ 82 (144)
++++|+||||+++|+|.+++.+... +++..+..++.|++.||.+|| ++|++||||||+||+++.++.++|+|||
T Consensus 77 ~~~~~lv~E~~~gg~L~~~l~~~~~---~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~vkL~DFG 150 (337)
T 1o6l_A 77 HDRLCFVMEYANGGELFFHLSRERV---FTEERARFYGAEIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFG 150 (337)
T ss_dssp SSEEEEEEECCTTCBHHHHHHHHSC---CCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCT
T ss_pred CCEEEEEEeCCCCCcHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHH---HCCeecCcCCHHHEEECCCCCEEEeecc
Confidence 5678999999999999999876443 899999999999999999999 8999999999999999999999999999
Q ss_pred ceeecccCCCCcccccccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCC
Q 044494 83 VARLLNFDSSNRTLLAGTYGYIAPELAYTMVVTEKSDVYSFGVVALEVLMGKHPGELLS 141 (144)
Q Consensus 83 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~d~~slg~~l~~~~~g~~p~~~~~ 141 (144)
++..............|++.|+|||++.+..++.++|+||+|+++|+|++|..||...+
T Consensus 151 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~ 209 (337)
T 1o6l_A 151 LCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD 209 (337)
T ss_dssp TCBCSCCTTCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred chhhcccCCCcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCC
Confidence 99864433344455679999999999999999999999999999999999999997643
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-35 Score=204.13 Aligned_cols=133 Identities=26% Similarity=0.409 Sum_probs=118.9
Q ss_pred CceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeeec
Q 044494 3 RKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADFG 82 (144)
Q Consensus 3 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~~ 82 (144)
.+.+|+||||++||+|.+++.+... +++..+..++.|++.||.+|| ++|++||||||+||+++.++.++|+|||
T Consensus 93 ~~~~~lv~E~~~gg~L~~~l~~~~~---~~~~~~~~~~~qi~~aL~~LH---~~givHrDlkp~NIll~~~g~vkL~DFG 166 (353)
T 2i0e_A 93 MDRLYFVMEYVNGGDLMYHIQQVGR---FKEPHAVFYAAEIAIGLFFLQ---SKGIIYRDLKLDNVMLDSEGHIKIADFG 166 (353)
T ss_dssp SSEEEEEEECCCSCBHHHHHHHHSS---CCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCT
T ss_pred CCEEEEEEeCCCCCcHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHH---HCCEEeccCCHHHEEEcCCCcEEEEeCC
Confidence 4678999999999999999976443 899999999999999999999 8999999999999999999999999999
Q ss_pred ceeecccCCCCcccccccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCC
Q 044494 83 VARLLNFDSSNRTLLAGTYGYIAPELAYTMVVTEKSDVYSFGVVALEVLMGKHPGELLS 141 (144)
Q Consensus 83 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~d~~slg~~l~~~~~g~~p~~~~~ 141 (144)
++..............|++.|+|||++.+..++.++|+||+|+++|+|++|..||...+
T Consensus 167 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~ 225 (353)
T 2i0e_A 167 MCKENIWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGED 225 (353)
T ss_dssp TCBCCCCTTCCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred cccccccCCcccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCC
Confidence 99864433334455679999999999999999999999999999999999999998654
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-35 Score=202.67 Aligned_cols=133 Identities=28% Similarity=0.482 Sum_probs=118.8
Q ss_pred CceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeeec
Q 044494 3 RKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADFG 82 (144)
Q Consensus 3 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~~ 82 (144)
.+.+|+||||+++|+|.+++.+... +++..+..++.|++.||.+|| ++|++||||||+||+++.++.++|+|||
T Consensus 90 ~~~~~lv~E~~~gg~L~~~l~~~~~---~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~vkL~DFG 163 (345)
T 1xjd_A 90 KENLFFVMEYLNGGDLMYHIQSCHK---FDLSRATFYAAEIILGLQFLH---SKGIVYRDLKLDNILLDKDGHIKIADFG 163 (345)
T ss_dssp SSEEEEEEECCTTCBHHHHHHHHSS---CCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCT
T ss_pred CCEEEEEEeCCCCCcHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCChhhEEECCCCCEEEeECh
Confidence 5678999999999999999976443 899999999999999999999 8999999999999999999999999999
Q ss_pred ceeecccCCCCcccccccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCC
Q 044494 83 VARLLNFDSSNRTLLAGTYGYIAPELAYTMVVTEKSDVYSFGVVALEVLMGKHPGELLS 141 (144)
Q Consensus 83 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~d~~slg~~l~~~~~g~~p~~~~~ 141 (144)
++..............|++.|+|||++.+..++.++|+||+|+++|+|++|..||...+
T Consensus 164 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~ 222 (345)
T 1xjd_A 164 MCKENMLGDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQD 222 (345)
T ss_dssp TCBCCCCTTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred hhhhcccCCCcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCC
Confidence 99864433334455679999999999999999999999999999999999999997654
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-34 Score=203.30 Aligned_cols=133 Identities=27% Similarity=0.399 Sum_probs=118.8
Q ss_pred CceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeeec
Q 044494 3 RKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADFG 82 (144)
Q Consensus 3 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~~ 82 (144)
.+++|+||||+++|+|.+++.+... +++..+..++.|++.||++|| ++|++||||||+||+++.++.++|+|||
T Consensus 111 ~~~~~lv~E~~~gg~L~~~l~~~~~---~~~~~~~~~~~qi~~aL~~LH---~~givHrDlkp~NIll~~~g~ikL~DFG 184 (373)
T 2r5t_A 111 ADKLYFVLDYINGGELFYHLQRERC---FLEPRARFYAAEIASALGYLH---SLNIVYRDLKPENILLDSQGHIVLTDFG 184 (373)
T ss_dssp SSEEEEEEECCCSCBHHHHHHHHSS---CCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCCC
T ss_pred CCEEEEEEeCCCCCcHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHH---HCCceecCCCHHHEEECCCCCEEEeeCc
Confidence 5688999999999999999976443 899999999999999999999 8999999999999999999999999999
Q ss_pred ceeecccCCCCcccccccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCC
Q 044494 83 VARLLNFDSSNRTLLAGTYGYIAPELAYTMVVTEKSDVYSFGVVALEVLMGKHPGELLS 141 (144)
Q Consensus 83 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~d~~slg~~l~~~~~g~~p~~~~~ 141 (144)
+++.............|++.|+|||++.+..++.++|+||+|+++|||++|..||...+
T Consensus 185 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~ 243 (373)
T 2r5t_A 185 LCKENIEHNSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRN 243 (373)
T ss_dssp BCGGGBCCCCCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSB
T ss_pred cccccccCCCccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCC
Confidence 99864433344455679999999999999999999999999999999999999997643
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-34 Score=214.87 Aligned_cols=133 Identities=26% Similarity=0.409 Sum_probs=120.1
Q ss_pred CceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeeec
Q 044494 3 RKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADFG 82 (144)
Q Consensus 3 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~~ 82 (144)
.+.+|+||||+++|+|.++++.... +++..+..++.|++.||.||| +++++||||||+||+++.++.++|+|||
T Consensus 414 ~~~~~lV~E~~~gg~L~~~l~~~~~---~~~~~~~~~~~qi~~aL~~LH---~~gIiHrDLKp~NILl~~~g~ikL~DFG 487 (674)
T 3pfq_A 414 MDRLYFVMEYVNGGDLMYHIQQVGR---FKEPHAVFYAAEIAIGLFFLQ---SKGIIYRDLKLDNVMLDSEGHIKIADFG 487 (674)
T ss_dssp SSEEEEEEECCCSCBHHHHHHHHSS---CCHHHHHHHHHHHHHHHHHHH---HTSEECCCCCSTTEEECSSSCEEECCCT
T ss_pred CCEEEEEEeCcCCCcHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHH---hCCeEeccCChhhEEEcCCCcEEEeecc
Confidence 4678999999999999999986443 999999999999999999999 8999999999999999999999999999
Q ss_pred ceeecccCCCCcccccccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCC
Q 044494 83 VARLLNFDSSNRTLLAGTYGYIAPELAYTMVVTEKSDVYSFGVVALEVLMGKHPGELLS 141 (144)
Q Consensus 83 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~d~~slg~~l~~~~~g~~p~~~~~ 141 (144)
+++.............||+.|+|||++....++.++|+||+|+++|||++|..||...+
T Consensus 488 la~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~ 546 (674)
T 3pfq_A 488 MCKENIWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGED 546 (674)
T ss_dssp TCEECCCTTCCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred eeeccccCCcccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCC
Confidence 99865434444556779999999999999999999999999999999999999998754
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-34 Score=200.59 Aligned_cols=132 Identities=25% Similarity=0.407 Sum_probs=117.9
Q ss_pred CCceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeee
Q 044494 2 HRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADF 81 (144)
Q Consensus 2 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~ 81 (144)
.++.+|+||||+++|+|.+++.+... +++..+..++.|++.||.+|| +++++||||||+||+++.++.++|+||
T Consensus 81 ~~~~~~lv~e~~~gg~L~~~l~~~~~---l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~~kL~DF 154 (345)
T 3a8x_A 81 TESRLFFVIEYVNGGDLMFHMQRQRK---LPEEHARFYSAEISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDY 154 (345)
T ss_dssp CSSEEEEEECCCCSCBHHHHHHHHSS---CCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCG
T ss_pred eCCEEEEEEeCCCCCcHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHH---HCCceecCCCHHHEEECCCCCEEEEec
Confidence 35678999999999999999976443 899999999999999999999 899999999999999999999999999
Q ss_pred cceeecccCCCCcccccccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCC
Q 044494 82 GVARLLNFDSSNRTLLAGTYGYIAPELAYTMVVTEKSDVYSFGVVALEVLMGKHPGEL 139 (144)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~d~~slg~~l~~~~~g~~p~~~ 139 (144)
|+++.............|++.|+|||++.+..++.++|+||+|+++|+|++|..||..
T Consensus 155 G~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~ 212 (345)
T 3a8x_A 155 GMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDI 212 (345)
T ss_dssp GGCBCSCCTTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred cccccccCCCCcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCC
Confidence 9998644333344556799999999999999999999999999999999999999975
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-34 Score=200.31 Aligned_cols=136 Identities=15% Similarity=0.149 Sum_probs=117.2
Q ss_pred CCceEEEEEeeccCCCHHHHhhccc--ccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcC-------
Q 044494 2 HRKCMFLIYEYMEMGSLFCVLRTDE--EAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNL------- 72 (144)
Q Consensus 2 ~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~------- 72 (144)
.++..|+||||+++|+|.+++.... ....+++..++.++.|++.||+||| +++++||||||+||+++.
T Consensus 138 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH---~~~ivHrDiKp~NIll~~~~~~~~~ 214 (365)
T 3e7e_A 138 FQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVH---DCEIIHGDIKPDNFILGNGFLEQDD 214 (365)
T ss_dssp CSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCSGGGEEECGGGTCC--
T ss_pred cCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHh---hCCeecCCCCHHHEEecccccCccc
Confidence 3567899999999999999997421 2345999999999999999999999 899999999999999998
Q ss_pred ----CCCeEEeeecceeecccC--CCCcccccccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCC
Q 044494 73 ----ELEAFVADFGVARLLNFD--SSNRTLLAGTYGYIAPELAYTMVVTEKSDVYSFGVVALEVLMGKHPGELL 140 (144)
Q Consensus 73 ----~~~~~l~d~~~~~~~~~~--~~~~~~~~~~~~~~~pe~~~~~~~~~~~d~~slg~~l~~~~~g~~p~~~~ 140 (144)
++.++|+|||++...... ........||+.|+|||++.+..++.++|+||+|+++|+|++|..||...
T Consensus 215 ~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~ 288 (365)
T 3e7e_A 215 EDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKN 288 (365)
T ss_dssp ----CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEE
T ss_pred cccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccC
Confidence 899999999999765422 22233456899999999999999999999999999999999999998643
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-34 Score=194.40 Aligned_cols=132 Identities=29% Similarity=0.495 Sum_probs=119.0
Q ss_pred CceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeeec
Q 044494 3 RKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADFG 82 (144)
Q Consensus 3 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~~ 82 (144)
++.+|+||||+++++|.+++... .+++..+..++.|++.|+.+|| ++|++||||||+||+++.++.++|+|||
T Consensus 89 ~~~~~lv~e~~~~~~L~~~~~~~----~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg 161 (297)
T 3fxz_A 89 GDELWVVMEYLAGGSLTDVVTET----CMDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFG 161 (297)
T ss_dssp TTEEEEEEECCTTCBHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCT
T ss_pred CCEEEEEEECCCCCCHHHHHhhc----CCCHHHHHHHHHHHHHHHHHHH---hCCceeCCCCHHHEEECCCCCEEEeeCC
Confidence 46789999999999999998753 3899999999999999999999 8999999999999999999999999999
Q ss_pred ceeecccCCCCcccccccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCC
Q 044494 83 VARLLNFDSSNRTLLAGTYGYIAPELAYTMVVTEKSDVYSFGVVALEVLMGKHPGELLS 141 (144)
Q Consensus 83 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~d~~slg~~l~~~~~g~~p~~~~~ 141 (144)
++..............+++.|+|||.+.+..++.++|+||+|+++|+|++|..||...+
T Consensus 162 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~ 220 (297)
T 3fxz_A 162 FCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNEN 220 (297)
T ss_dssp TCEECCSTTCCBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSC
T ss_pred CceecCCcccccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 99876654444555679999999999999999999999999999999999999997643
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-34 Score=195.44 Aligned_cols=130 Identities=32% Similarity=0.476 Sum_probs=116.8
Q ss_pred CceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeeec
Q 044494 3 RKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADFG 82 (144)
Q Consensus 3 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~~ 82 (144)
.+.+|+||||+++|+|.+++.+... +++..+..++.|++.||.+|| ++|++||||||+||+++.++.++|+|||
T Consensus 78 ~~~~~lv~e~~~gg~L~~~l~~~~~---~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~~kL~Dfg 151 (318)
T 1fot_A 78 AQQIFMIMDYIEGGELFSLLRKSQR---FPNPVAKFYAAEVCLALEYLH---SKDIIYRDLKPENILLDKNGHIKITDFG 151 (318)
T ss_dssp SSEEEEEECCCCSCBHHHHHHHTSS---CCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECTTSCEEECCCS
T ss_pred CCEEEEEEeCCCCCCHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHH---HCCccccCCChheEEEcCCCCEEEeecC
Confidence 5678999999999999999986443 899999999999999999999 9999999999999999999999999999
Q ss_pred ceeecccCCCCcccccccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCC
Q 044494 83 VARLLNFDSSNRTLLAGTYGYIAPELAYTMVVTEKSDVYSFGVVALEVLMGKHPGELLS 141 (144)
Q Consensus 83 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~d~~slg~~l~~~~~g~~p~~~~~ 141 (144)
++..... ......|++.|+|||++.+..++.++|+||+|+++|+|++|..||...+
T Consensus 152 ~a~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~ 207 (318)
T 1fot_A 152 FAKYVPD---VTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSN 207 (318)
T ss_dssp SCEECSS---CBCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSS
T ss_pred cceecCC---ccccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCC
Confidence 9986542 2334578999999999999999999999999999999999999997643
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-34 Score=204.45 Aligned_cols=135 Identities=29% Similarity=0.382 Sum_probs=116.6
Q ss_pred CCceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeee
Q 044494 2 HRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADF 81 (144)
Q Consensus 2 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~ 81 (144)
.++.+|+||||+++|+|.+++.+.. ..+++..+..++.|++.||.||| +++++||||||+||+++.++.++|+||
T Consensus 145 ~~~~~~lV~Ey~~gg~L~~~l~~~~--~~l~e~~~~~~~~qi~~aL~~LH---~~giiHrDLKp~NILl~~~g~vkL~DF 219 (437)
T 4aw2_A 145 DDNNLYLVMDYYVGGDLLTLLSKFE--DRLPEEMARFYLAEMVIAIDSVH---QLHYVHRDIKPDNILMDMNGHIRLADF 219 (437)
T ss_dssp CSSEEEEEECCCTTCBHHHHHHTTT--TCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCC
T ss_pred eCCEEEEEEecCCCCcHHHHHHHcc--CCCCHHHHHHHHHHHHHHHHHHH---hCCeEecccCHHHeeEcCCCCEEEcch
Confidence 3567899999999999999997632 23999999999999999999999 899999999999999999999999999
Q ss_pred cceeecccCCC-CcccccccccccCccccc-----cCCCCCcchhHHHHHHHHHHHhCCCCCCCCC
Q 044494 82 GVARLLNFDSS-NRTLLAGTYGYIAPELAY-----TMVVTEKSDVYSFGVVALEVLMGKHPGELLS 141 (144)
Q Consensus 82 ~~~~~~~~~~~-~~~~~~~~~~~~~pe~~~-----~~~~~~~~d~~slg~~l~~~~~g~~p~~~~~ 141 (144)
|++........ ......||+.|+|||++. ...++.++|+||+|+++|||++|..||...+
T Consensus 220 Gla~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~ 285 (437)
T 4aw2_A 220 GSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAES 285 (437)
T ss_dssp TTCEECCTTSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSS
T ss_pred hhhhhcccCCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCC
Confidence 99976543322 123357999999999987 4568899999999999999999999997654
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-34 Score=201.60 Aligned_cols=135 Identities=27% Similarity=0.362 Sum_probs=116.6
Q ss_pred CCceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeee
Q 044494 2 HRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADF 81 (144)
Q Consensus 2 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~ 81 (144)
.++++|+||||+++|+|.+++.+.. ..+++..+..++.|++.||.+|| +++++||||||+||+++.++.++|+||
T Consensus 132 ~~~~~~lVmE~~~gg~L~~~l~~~~--~~l~~~~~~~~~~qi~~aL~~LH---~~giiHrDLKp~NILld~~g~vkL~DF 206 (412)
T 2vd5_A 132 DENYLYLVMEYYVGGDLLTLLSKFG--ERIPAEMARFYLAEIVMAIDSVH---RLGYVHRDIKPDNILLDRCGHIRLADF 206 (412)
T ss_dssp CSSEEEEEECCCCSCBHHHHHHHHS--SCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCC
T ss_pred eCCEEEEEEcCCCCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHH---HCCeeecccCHHHeeecCCCCEEEeec
Confidence 3567899999999999999997532 23899999999999999999999 899999999999999999999999999
Q ss_pred cceeecccCCC-CcccccccccccCccccc-------cCCCCCcchhHHHHHHHHHHHhCCCCCCCCC
Q 044494 82 GVARLLNFDSS-NRTLLAGTYGYIAPELAY-------TMVVTEKSDVYSFGVVALEVLMGKHPGELLS 141 (144)
Q Consensus 82 ~~~~~~~~~~~-~~~~~~~~~~~~~pe~~~-------~~~~~~~~d~~slg~~l~~~~~g~~p~~~~~ 141 (144)
|++........ ......|++.|+|||++. ...++.++|+||+|+++|||++|..||...+
T Consensus 207 Gla~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~ 274 (412)
T 2vd5_A 207 GSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADS 274 (412)
T ss_dssp TTCEECCTTSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSS
T ss_pred hhheeccCCCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCC
Confidence 99987653322 123457999999999987 3567889999999999999999999997654
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-33 Score=196.97 Aligned_cols=131 Identities=23% Similarity=0.345 Sum_probs=117.4
Q ss_pred CCceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeee
Q 044494 2 HRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADF 81 (144)
Q Consensus 2 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~ 81 (144)
.++.+|+||||+++|+|.+++.+... +++..+..++.|++.||.+|| ++|++||||||+||+++.++.++|+||
T Consensus 112 ~~~~~~lv~e~~~gg~L~~~l~~~~~---~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~~kL~DF 185 (350)
T 1rdq_E 112 DNSNLYMVMEYVAGGEMFSHLRRIGR---FSEPHARFYAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDF 185 (350)
T ss_dssp CSSEEEEEEECCTTCBHHHHHHHHCC---CCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCC
T ss_pred cCCEEEEEEcCCCCCcHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHH---HCCcccccCccceEEECCCCCEEEccc
Confidence 35678999999999999999986443 899999999999999999999 899999999999999999999999999
Q ss_pred cceeecccCCCCcccccccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCC
Q 044494 82 GVARLLNFDSSNRTLLAGTYGYIAPELAYTMVVTEKSDVYSFGVVALEVLMGKHPGELLS 141 (144)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~d~~slg~~l~~~~~g~~p~~~~~ 141 (144)
|++..... ......|++.|+|||++.+..++.++|+||+|+++|+|++|..||...+
T Consensus 186 g~a~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~ 242 (350)
T 1rdq_E 186 GFAKRVKG---RTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQ 242 (350)
T ss_dssp TTCEECSS---CBCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred ccceeccC---CcccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCC
Confidence 99987542 2334578999999999999999999999999999999999999997643
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-34 Score=202.58 Aligned_cols=133 Identities=26% Similarity=0.361 Sum_probs=116.1
Q ss_pred CCceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeee
Q 044494 2 HRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADF 81 (144)
Q Consensus 2 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~ 81 (144)
.++.+|+||||++||+|.++++.. .+++..+..++.|++.||.||| ++|++||||||+||+++.++.++|+||
T Consensus 140 ~~~~~~lV~E~~~gg~L~~~l~~~----~~~e~~~~~~~~qi~~aL~~LH---~~givHrDLKp~NILl~~~g~ikL~DF 212 (410)
T 3v8s_A 140 DDRYLYMVMEYMPGGDLVNLMSNY----DVPEKWARFYTAEVVLALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADF 212 (410)
T ss_dssp CSSEEEEEECCCTTEEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCC
T ss_pred ECCEEEEEEeCCCCCcHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCCHHHeeECCCCCEEEecc
Confidence 356789999999999999998753 2899999999999999999999 899999999999999999999999999
Q ss_pred cceeecccCCC-CcccccccccccCccccccCC----CCCcchhHHHHHHHHHHHhCCCCCCCCC
Q 044494 82 GVARLLNFDSS-NRTLLAGTYGYIAPELAYTMV----VTEKSDVYSFGVVALEVLMGKHPGELLS 141 (144)
Q Consensus 82 ~~~~~~~~~~~-~~~~~~~~~~~~~pe~~~~~~----~~~~~d~~slg~~l~~~~~g~~p~~~~~ 141 (144)
|++........ ......|++.|+|||++.... ++.++|+||+|+++|+|++|..||...+
T Consensus 213 G~a~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~ 277 (410)
T 3v8s_A 213 GTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADS 277 (410)
T ss_dssp TTCEECCTTSEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSS
T ss_pred ceeEeeccCCcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCC
Confidence 99987553221 223567999999999998765 7789999999999999999999997654
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-33 Score=197.43 Aligned_cols=132 Identities=30% Similarity=0.443 Sum_probs=116.2
Q ss_pred CceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeeec
Q 044494 3 RKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADFG 82 (144)
Q Consensus 3 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~~ 82 (144)
.+.+|+||||+.+|+|.+++..... +++..+..++.|++.||.||| +.|++||||||+||+++.++.++|+|||
T Consensus 87 ~~~~~lv~e~~~gg~L~~~l~~~~~---l~~~~~~~~~~qi~~aL~~LH---~~givHrDlkp~NIll~~~g~vkL~DFG 160 (384)
T 4fr4_A 87 EEDMFMVVDLLLGGDLRYHLQQNVH---FKEETVKLFICELVMALDYLQ---NQRIIHRDMKPDNILLDEHGHVHITDFN 160 (384)
T ss_dssp SSEEEEEECCCTTEEHHHHHHTTCC---CCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCT
T ss_pred CCEEEEEEecCCCCcHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHH---HCCceeccCcHHHeEECCCCCEEEeccc
Confidence 5678999999999999999986443 999999999999999999999 8999999999999999999999999999
Q ss_pred ceeecccCCCCcccccccccccCcccccc---CCCCCcchhHHHHHHHHHHHhCCCCCCCCC
Q 044494 83 VARLLNFDSSNRTLLAGTYGYIAPELAYT---MVVTEKSDVYSFGVVALEVLMGKHPGELLS 141 (144)
Q Consensus 83 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~---~~~~~~~d~~slg~~l~~~~~g~~p~~~~~ 141 (144)
++..... ........|++.|+|||++.. ..++.++|+||+|+++|+|++|..||...+
T Consensus 161 ~a~~~~~-~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~ 221 (384)
T 4fr4_A 161 IAAMLPR-ETQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRS 221 (384)
T ss_dssp TCEECCT-TCCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCT
T ss_pred eeeeccC-CCceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCC
Confidence 9987543 233445679999999999874 357889999999999999999999997644
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-33 Score=204.67 Aligned_cols=136 Identities=22% Similarity=0.337 Sum_probs=120.1
Q ss_pred CceEEEEEeeccCCCHHHHhhccc-ccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeee
Q 044494 3 RKCMFLIYEYMEMGSLFCVLRTDE-EAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADF 81 (144)
Q Consensus 3 ~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~ 81 (144)
++.+|+||||++||+|.+++.... ....+++..+..++.|++.||.||| ++|++||||||+||+++.++.++|+||
T Consensus 257 ~~~l~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH---~~gIvHrDLKP~NILl~~~g~vkL~DF 333 (543)
T 3c4z_A 257 KTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLH---QRNIIYRDLKPENVLLDDDGNVRISDL 333 (543)
T ss_dssp SSEEEEEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTSCEEECCC
T ss_pred CCEEEEEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHH---HcCCcccCCChHHEEEeCCCCEEEeec
Confidence 567899999999999999987532 2345999999999999999999999 899999999999999999999999999
Q ss_pred cceeecccCCCCcccccccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCC
Q 044494 82 GVARLLNFDSSNRTLLAGTYGYIAPELAYTMVVTEKSDVYSFGVVALEVLMGKHPGELLS 141 (144)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~d~~slg~~l~~~~~g~~p~~~~~ 141 (144)
|++..............||+.|+|||++.+..++.++|+||+|+++|+|++|..||...+
T Consensus 334 Gla~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~ 393 (543)
T 3c4z_A 334 GLAVELKAGQTKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARG 393 (543)
T ss_dssp TTCEECCTTCCCBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTT
T ss_pred ceeeeccCCCcccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCc
Confidence 999876544333444579999999999999999999999999999999999999997653
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-33 Score=194.47 Aligned_cols=137 Identities=33% Similarity=0.495 Sum_probs=110.3
Q ss_pred CCceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCC--eEecCCCCCcEEEcCCCCeEEe
Q 044494 2 HRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPP--IVHRDISSNNILLNLELEAFVA 79 (144)
Q Consensus 2 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~--~~h~~i~~~ni~~~~~~~~~l~ 79 (144)
..+.+++||||+++++|.+++.+......+++..++.++.|++.|+.+|| +++ ++||||||+||+++.++.++|+
T Consensus 105 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~~~ivH~Dikp~NIll~~~~~~kL~ 181 (309)
T 3p86_A 105 QPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLH---NRNPPIVHRNLKSPNLLVDKKYTVKVC 181 (309)
T ss_dssp STTCCEEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHH---TSSSCCCCTTCCGGGEEECTTCCEEEC
T ss_pred ECCceEEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHH---cCCCCEECCCCChhhEEEeCCCcEEEC
Confidence 35678999999999999999986543344899999999999999999999 889 9999999999999999999999
Q ss_pred eecceeecccCCCCcccccccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCC
Q 044494 80 DFGVARLLNFDSSNRTLLAGTYGYIAPELAYTMVVTEKSDVYSFGVVALEVLMGKHPGELLS 141 (144)
Q Consensus 80 d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~d~~slg~~l~~~~~g~~p~~~~~ 141 (144)
|||++..............+++.|+|||.+.+..++.++|+||+|+++|++++|..||...+
T Consensus 182 Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~ 243 (309)
T 3p86_A 182 DFGLSRLKASTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLN 243 (309)
T ss_dssp CCC-----------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSC
T ss_pred CCCCCccccccccccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 99999765433333445678999999999999989999999999999999999999998754
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-33 Score=195.08 Aligned_cols=133 Identities=26% Similarity=0.380 Sum_probs=113.1
Q ss_pred CceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeeec
Q 044494 3 RKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADFG 82 (144)
Q Consensus 3 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~~ 82 (144)
++.+|+||||+++++|.+++..... +++..+..++.|++.||.+|| ++|++||||||+||+++.++.++|+|||
T Consensus 93 ~~~~~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~qi~~al~~lH---~~~ivH~Dlkp~Nill~~~~~~kl~Dfg 166 (327)
T 3a62_A 93 GGKLYLILEYLSGGELFMQLEREGI---FMEDTACFYLAEISMALGHLH---QKGIIYRDLKPENIMLNHQGHVKLTDFG 166 (327)
T ss_dssp SSCEEEEEECCTTEEHHHHHHHHSS---CCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCTTTEEECTTSCEEECCCS
T ss_pred CCEEEEEEeCCCCCcHHHHHHhCCC---CCHHHHHHHHHHHHHHHHHHH---hCCEEcccCCHHHeEECCCCcEEEEeCC
Confidence 5678999999999999999976433 899999999999999999999 8899999999999999999999999999
Q ss_pred ceeecccCCCCcccccccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCC
Q 044494 83 VARLLNFDSSNRTLLAGTYGYIAPELAYTMVVTEKSDVYSFGVVALEVLMGKHPGELLS 141 (144)
Q Consensus 83 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~d~~slg~~l~~~~~g~~p~~~~~ 141 (144)
++..............|++.|+|||.+....++.++|+||+|+++|+|++|..||...+
T Consensus 167 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~ 225 (327)
T 3a62_A 167 LCKESIHDGTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGEN 225 (327)
T ss_dssp CC----------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred cccccccCCccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCC
Confidence 98764433333444678999999999998889999999999999999999999997643
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-33 Score=195.67 Aligned_cols=133 Identities=27% Similarity=0.450 Sum_probs=117.0
Q ss_pred CCceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeee
Q 044494 2 HRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADF 81 (144)
Q Consensus 2 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~ 81 (144)
.++.+|+||||+++++|.+++..... +++..+..++.|++.|++||| +.+++||||||+||+++.++.++|+||
T Consensus 85 ~~~~~~lv~e~~~~~~L~~~l~~~~~---l~~~~~~~~~~qi~~al~~lH---~~~ivHrDlkp~NIll~~~~~~kl~DF 158 (328)
T 3fe3_A 85 TEKTLYLIMEYASGGEVFDYLVAHGR---MKEKEARSKFRQIVSAVQYCH---QKRIVHRDLKAENLLLDADMNIKIADF 158 (328)
T ss_dssp CSSEEEEEECCCTTCBHHHHHHHHCC---CCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECST
T ss_pred ECCEEEEEEECCCCCcHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHH---HCCEeccCCCHHHEEEcCCCCEEEeec
Confidence 35678999999999999999976443 899999999999999999999 899999999999999999999999999
Q ss_pred cceeecccCCCCcccccccccccCccccccCCCC-CcchhHHHHHHHHHHHhCCCCCCCCC
Q 044494 82 GVARLLNFDSSNRTLLAGTYGYIAPELAYTMVVT-EKSDVYSFGVVALEVLMGKHPGELLS 141 (144)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~-~~~d~~slg~~l~~~~~g~~p~~~~~ 141 (144)
|++...... .......+++.|+|||++.+..+. .++|+||+|+++++|++|..||++.+
T Consensus 159 G~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~ 218 (328)
T 3fe3_A 159 GFSNEFTVG-GKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQN 218 (328)
T ss_dssp TCCGGGSSS-CGGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred cCceecCCC-CccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCC
Confidence 999765432 233456799999999999888765 78999999999999999999998654
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-33 Score=202.97 Aligned_cols=133 Identities=25% Similarity=0.363 Sum_probs=116.0
Q ss_pred CceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCC-CCeEecCCCCCcEEEcCCCCeEEeee
Q 044494 3 RKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCT-PPIVHRDISSNNILLNLELEAFVADF 81 (144)
Q Consensus 3 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~-~~~~h~~i~~~ni~~~~~~~~~l~d~ 81 (144)
++.+|+||||+++|+|.+++..... +++..+..++.|++.||.||| + .|++||||||+||+++.++.++|+||
T Consensus 220 ~~~~~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~qi~~aL~~LH---~~~giiHrDlkp~NIll~~~~~~kl~DF 293 (446)
T 4ejn_A 220 HDRLCFVMEYANGGELFFHLSRERV---FSEDRARFYGAEIVSALDYLH---SEKNVVYRDLKLENLMLDKDGHIKITDF 293 (446)
T ss_dssp TTEEEEEECCCSSCBHHHHHHHHSC---CCHHHHHHHHHHHHHHHHHHH---HHTCCCCCCCCGGGEEECSSSCEEECCC
T ss_pred CCEEEEEEeeCCCCcHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHh---hcCCEEECCCCHHHEEECCCCCEEEccC
Confidence 4678999999999999999876443 899999999999999999999 7 89999999999999999999999999
Q ss_pred cceeecccCCCCcccccccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCC
Q 044494 82 GVARLLNFDSSNRTLLAGTYGYIAPELAYTMVVTEKSDVYSFGVVALEVLMGKHPGELLS 141 (144)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~d~~slg~~l~~~~~g~~p~~~~~ 141 (144)
|++..............|++.|+|||++.+..++.++|+||+|+++++|++|..||...+
T Consensus 294 G~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~ 353 (446)
T 4ejn_A 294 GLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD 353 (446)
T ss_dssp CCCCTTCC-----CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred CCceeccCCCcccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCC
Confidence 999764433333445679999999999999999999999999999999999999997654
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-33 Score=199.95 Aligned_cols=134 Identities=25% Similarity=0.329 Sum_probs=118.2
Q ss_pred CCceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEc---CCCCeEE
Q 044494 2 HRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLN---LELEAFV 78 (144)
Q Consensus 2 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~---~~~~~~l 78 (144)
.++..|+||||+++|+|.+.+..... +++..+..++.|++.|+.||| ++|++||||||+||+++ .++.++|
T Consensus 81 ~~~~~~lv~E~~~gg~L~~~i~~~~~---~~e~~~~~i~~qil~aL~~lH---~~givHrDlKp~NIll~~~~~~~~vkL 154 (444)
T 3soa_A 81 EEGHHYLIFDLVTGGELFEDIVAREY---YSEADASHCIQQILEAVLHCH---QMGVVHRNLKPENLLLASKLKGAAVKL 154 (444)
T ss_dssp CSSEEEEEECCCBCCBHHHHHHHCSC---CCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSSTTEEESBSSTTCCEEE
T ss_pred ECCEEEEEEEeCCCCCHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEEeccCCCCcEEE
Confidence 35678999999999999999876543 899999999999999999999 89999999999999998 4578999
Q ss_pred eeecceeecccCCCCcccccccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCC
Q 044494 79 ADFGVARLLNFDSSNRTLLAGTYGYIAPELAYTMVVTEKSDVYSFGVVALEVLMGKHPGELLS 141 (144)
Q Consensus 79 ~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~d~~slg~~l~~~~~g~~p~~~~~ 141 (144)
+|||++..............|++.|+|||++....++.++|+||+|+++|+|++|..||...+
T Consensus 155 ~DFG~a~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~ 217 (444)
T 3soa_A 155 ADFGLAIEVEGEQQAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDED 217 (444)
T ss_dssp CCCSSCBCCCTTCCBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred ccCceeEEecCCCceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCcc
Confidence 999999876544444445679999999999999889999999999999999999999996643
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-33 Score=194.70 Aligned_cols=132 Identities=28% Similarity=0.383 Sum_probs=116.7
Q ss_pred CceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCC----CeEE
Q 044494 3 RKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLEL----EAFV 78 (144)
Q Consensus 3 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~----~~~l 78 (144)
++.+|+||||+++|+|.+++..... +++..+..++.|++.|+.||| +.|++|+||||+||+++.++ .+++
T Consensus 87 ~~~~~lv~e~~~gg~L~~~l~~~~~---l~~~~~~~i~~qi~~aL~~LH---~~givHrDlkp~NIll~~~~~~~~~vkl 160 (361)
T 2yab_A 87 RTDVVLILELVSGGELFDFLAQKES---LSEEEATSFIKQILDGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKL 160 (361)
T ss_dssp SSEEEEEEECCCSCBHHHHHTTCSC---CBHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESCTTSSSCCEEE
T ss_pred CCEEEEEEEcCCCCcHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEeCCCCCccCEEE
Confidence 5678999999999999999976443 899999999999999999999 89999999999999998776 7999
Q ss_pred eeecceeecccCCCCcccccccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCC
Q 044494 79 ADFGVARLLNFDSSNRTLLAGTYGYIAPELAYTMVVTEKSDVYSFGVVALEVLMGKHPGELLS 141 (144)
Q Consensus 79 ~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~d~~slg~~l~~~~~g~~p~~~~~ 141 (144)
+|||++...... .......|++.|+|||++.+..++.++|+||+|+++|+|++|..||.+.+
T Consensus 161 ~DFG~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~ 222 (361)
T 2yab_A 161 IDFGLAHEIEDG-VEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDT 222 (361)
T ss_dssp CCCSSCEECCTT-CCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSS
T ss_pred EecCCceEcCCC-CccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCC
Confidence 999999876532 22344669999999999999889999999999999999999999997643
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-33 Score=197.56 Aligned_cols=134 Identities=27% Similarity=0.411 Sum_probs=110.6
Q ss_pred CceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcC---CCCeEEe
Q 044494 3 RKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNL---ELEAFVA 79 (144)
Q Consensus 3 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~---~~~~~l~ 79 (144)
++.+|+||||+++|+|.+++.... ...+++..+..++.|++.||.||| +.+++||||||+||+++. ++.++|+
T Consensus 131 ~~~~~lv~E~~~gg~L~~~l~~~~-~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~Nill~~~~~~~~~kl~ 206 (400)
T 1nxk_A 131 RKCLLIVMECLDGGELFSRIQDRG-DQAFTEREASEIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLT 206 (400)
T ss_dssp EEEEEEEEECCCSEEHHHHHHCC----CCBHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSSSTTCCEEEC
T ss_pred CcEEEEEEEeCCCCcHHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCcCcceEEEecCCCCccEEEE
Confidence 456899999999999999997633 234899999999999999999999 889999999999999997 7889999
Q ss_pred eecceeecccCCCCcccccccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCC
Q 044494 80 DFGVARLLNFDSSNRTLLAGTYGYIAPELAYTMVVTEKSDVYSFGVVALEVLMGKHPGELLS 141 (144)
Q Consensus 80 d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~d~~slg~~l~~~~~g~~p~~~~~ 141 (144)
|||++...... .......+++.|+|||++....++.++|+||+|+++|+|++|..||...+
T Consensus 207 DFG~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~ 267 (400)
T 1nxk_A 207 DFGFAKETTSH-NSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNH 267 (400)
T ss_dssp CCTTCEECC------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCT
T ss_pred ecccccccCCC-CccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCc
Confidence 99999865432 22334668999999999999999999999999999999999999997644
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-33 Score=193.65 Aligned_cols=134 Identities=29% Similarity=0.412 Sum_probs=98.4
Q ss_pred CCceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCC---CeEE
Q 044494 2 HRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLEL---EAFV 78 (144)
Q Consensus 2 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~---~~~l 78 (144)
+++..|+||||+++++|.+++..... +++..+..++.|++.++.+|| +++++||||||+||+++.++ .++|
T Consensus 77 ~~~~~~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~i~~qi~~~l~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~kl 150 (325)
T 3kn6_A 77 DQLHTFLVMELLNGGELFERIKKKKH---FSETEASYIMRKLVSAVSHMH---DVGVVHRDLKPENLLFTDENDNLEIKI 150 (325)
T ss_dssp CSSEEEEEECCCCSCBHHHHHHHCSC---CCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEEEC----CEEEE
T ss_pred cCCEEEEEEEccCCCcHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHH---HCCCeecCCCHHHEEEecCCCcccEEE
Confidence 35678999999999999999986443 999999999999999999999 89999999999999998765 7999
Q ss_pred eeecceeecccCCCCcccccccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCC
Q 044494 79 ADFGVARLLNFDSSNRTLLAGTYGYIAPELAYTMVVTEKSDVYSFGVVALEVLMGKHPGELLS 141 (144)
Q Consensus 79 ~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~d~~slg~~l~~~~~g~~p~~~~~ 141 (144)
+|||++..............+++.|+|||.+....++.++|+||+|+++++|++|..||...+
T Consensus 151 ~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~ 213 (325)
T 3kn6_A 151 IDFGFARLKPPDNQPLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHD 213 (325)
T ss_dssp CCCTTCEECCC----------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC---
T ss_pred eccccceecCCCCCcccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCc
Confidence 999999866544444455668999999999999999999999999999999999999998644
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-33 Score=191.03 Aligned_cols=134 Identities=30% Similarity=0.476 Sum_probs=112.8
Q ss_pred CCceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeee
Q 044494 2 HRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADF 81 (144)
Q Consensus 2 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~ 81 (144)
.++.+|+||||+++++|.+++..... +++..++.++.|++.++.+|| ++|++|+||||+||+++.++.++++||
T Consensus 82 ~~~~~~lv~e~~~g~~L~~~l~~~~~---~~~~~~~~~~~qi~~~l~~lH---~~~i~H~Dlkp~Nil~~~~~~~kl~Df 155 (294)
T 4eqm_A 82 EDDCYYLVMEYIEGPTLSEYIESHGP---LSVDTAINFTNQILDGIKHAH---DMRIVHRDIKPQNILIDSNKTLKIFDF 155 (294)
T ss_dssp CSSEEEEEEECCCSCBHHHHHHHHCS---CCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCC
T ss_pred eCCeEEEEEeCCCCCCHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEEeC
Confidence 35678999999999999999976443 899999999999999999999 899999999999999999999999999
Q ss_pred cceeecccCC-CCcccccccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCC
Q 044494 82 GVARLLNFDS-SNRTLLAGTYGYIAPELAYTMVVTEKSDVYSFGVVALEVLMGKHPGELLS 141 (144)
Q Consensus 82 ~~~~~~~~~~-~~~~~~~~~~~~~~pe~~~~~~~~~~~d~~slg~~l~~~~~g~~p~~~~~ 141 (144)
|++....... .......+++.|+|||.+.+..++.++|+||+|+++|+|++|..||...+
T Consensus 156 g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~ 216 (294)
T 4eqm_A 156 GIAKALSETSLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGET 216 (294)
T ss_dssp SSSTTC-------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSC
T ss_pred CCccccccccccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCC
Confidence 9997654222 12233568999999999999989999999999999999999999998754
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-32 Score=189.44 Aligned_cols=132 Identities=27% Similarity=0.479 Sum_probs=117.8
Q ss_pred CceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeeec
Q 044494 3 RKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADFG 82 (144)
Q Consensus 3 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~~ 82 (144)
.+..|+||||+++++|.+++... .+++..+..++.|++.|+.+|| +.+++|+||||+||+++.++.++++|||
T Consensus 114 ~~~~~lv~e~~~~~~L~~~l~~~----~l~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~kl~Dfg 186 (321)
T 2c30_A 114 GEELWVLMEFLQGGALTDIVSQV----RLNEEQIATVCEAVLQALAYLH---AQGVIHRDIKSDSILLTLDGRVKLSDFG 186 (321)
T ss_dssp TTEEEEEECCCCSCBHHHHHTTC----CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCT
T ss_pred CCEEEEEEecCCCCCHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCcEEEeeee
Confidence 46789999999999999988742 3899999999999999999999 8899999999999999999999999999
Q ss_pred ceeecccCCCCcccccccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCC
Q 044494 83 VARLLNFDSSNRTLLAGTYGYIAPELAYTMVVTEKSDVYSFGVVALEVLMGKHPGELLS 141 (144)
Q Consensus 83 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~d~~slg~~l~~~~~g~~p~~~~~ 141 (144)
++..............+++.|+|||.+....++.++|+||+|+++++|++|..||...+
T Consensus 187 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~ 245 (321)
T 2c30_A 187 FCAQISKDVPKRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDS 245 (321)
T ss_dssp TCEECCSSSCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC
T ss_pred eeeecccCccccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 99876544444455679999999999998889999999999999999999999997643
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-32 Score=192.52 Aligned_cols=135 Identities=23% Similarity=0.310 Sum_probs=116.7
Q ss_pred CceEEEEEeeccCCCHHHHhhccc-ccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCC---eEE
Q 044494 3 RKCMFLIYEYMEMGSLFCVLRTDE-EAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELE---AFV 78 (144)
Q Consensus 3 ~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~---~~l 78 (144)
++.+|+||||+++++|.+.+.... ....+++..+..++.|++.||.||| +++++||||||+||+++.++. +++
T Consensus 98 ~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH---~~~ivHrDlkp~NIl~~~~~~~~~vkl 174 (351)
T 3c0i_A 98 DGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCH---DNNIIHRDVKPHCVLLASKENSAPVKL 174 (351)
T ss_dssp TTEEEEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECSSSTTCCEEE
T ss_pred CCEEEEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCChHHeEEecCCCCCcEEE
Confidence 567899999999999998876432 2334899999999999999999999 899999999999999987654 999
Q ss_pred eeecceeecccCCCCcccccccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCC
Q 044494 79 ADFGVARLLNFDSSNRTLLAGTYGYIAPELAYTMVVTEKSDVYSFGVVALEVLMGKHPGELL 140 (144)
Q Consensus 79 ~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~d~~slg~~l~~~~~g~~p~~~~ 140 (144)
+|||++..............+++.|+|||++....++.++|+||+|+++|+|++|..||...
T Consensus 175 ~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~ 236 (351)
T 3c0i_A 175 GGFGVAIQLGESGLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGT 236 (351)
T ss_dssp CCCTTCEECCTTSCBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSS
T ss_pred ecCcceeEecCCCeeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCc
Confidence 99999987664443344567999999999999988999999999999999999999999763
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-33 Score=193.54 Aligned_cols=133 Identities=24% Similarity=0.344 Sum_probs=115.8
Q ss_pred CCceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCC----CCeE
Q 044494 2 HRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLE----LEAF 77 (144)
Q Consensus 2 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~----~~~~ 77 (144)
+++.+|+||||+++|+|.+++.+... +++..+..++.|++.|+.||| +.|++||||||+||++... +.++
T Consensus 87 ~~~~~~lv~E~~~gg~L~~~i~~~~~---~~~~~~~~~~~qi~~al~~lH---~~givHrDlkp~NIl~~~~~~~~~~~k 160 (342)
T 2qr7_A 87 DGKYVYVVTELMKGGELLDKILRQKF---FSEREASAVLFTITKTVEYLH---AQGVVHRDLKPSNILYVDESGNPESIR 160 (342)
T ss_dssp CSSEEEEEECCCCSCBHHHHHHTCTT---CCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEESSSSCSGGGEE
T ss_pred cCCEEEEEEeCCCCCcHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHH---HCCcEeccCCHHHEEEecCCCCcCeEE
Confidence 35678999999999999999876443 899999999999999999999 8999999999999998543 3499
Q ss_pred EeeecceeecccCCCCcccccccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCC
Q 044494 78 VADFGVARLLNFDSSNRTLLAGTYGYIAPELAYTMVVTEKSDVYSFGVVALEVLMGKHPGELL 140 (144)
Q Consensus 78 l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~d~~slg~~l~~~~~g~~p~~~~ 140 (144)
++|||++..............+++.|+|||++....++.++|+||+|+++|+|++|..||...
T Consensus 161 l~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~ 223 (342)
T 2qr7_A 161 ICDFGFAKQLRAENGLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANG 223 (342)
T ss_dssp ECCCTTCEECBCTTCCBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSS
T ss_pred EEECCCcccCcCCCCceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCC
Confidence 999999987654444445567899999999998888889999999999999999999999764
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-32 Score=190.19 Aligned_cols=134 Identities=18% Similarity=0.245 Sum_probs=116.6
Q ss_pred CceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCC-----eE
Q 044494 3 RKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELE-----AF 77 (144)
Q Consensus 3 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~-----~~ 77 (144)
++..++||||+ +++|.+++.... ..+++..++.++.|++.||++|| +.+++||||||+||+++.++. ++
T Consensus 77 ~~~~~lv~e~~-~~~L~~~~~~~~--~~~~~~~~~~i~~qi~~~l~~LH---~~~iiHrDlkp~Nill~~~~~~~~~~~k 150 (330)
T 2izr_A 77 GKYNAMVLELL-GPSLEDLFDLCD--RTFSLKTVLMIAIQLISRMEYVH---SKNLIYRDVKPENFLIGRPGNKTQQVIH 150 (330)
T ss_dssp TTEEEEEEECC-CCBHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECCGGGTCTTSEE
T ss_pred CCccEEEEEeC-CCCHHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHeeeccCCCCCCceEE
Confidence 46789999999 899999997532 24999999999999999999999 889999999999999998877 99
Q ss_pred EeeecceeecccCCCC-------cccccccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCC
Q 044494 78 VADFGVARLLNFDSSN-------RTLLAGTYGYIAPELAYTMVVTEKSDVYSFGVVALEVLMGKHPGELLSS 142 (144)
Q Consensus 78 l~d~~~~~~~~~~~~~-------~~~~~~~~~~~~pe~~~~~~~~~~~d~~slg~~l~~~~~g~~p~~~~~~ 142 (144)
|+|||++......... .....|++.|+|||.+.+..++.++|+||+|+++++|++|..||...+.
T Consensus 151 l~DFg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~ 222 (330)
T 2izr_A 151 IIDFALAKEYIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKA 222 (330)
T ss_dssp ECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCC
T ss_pred EEEcccceeeecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCcccccc
Confidence 9999999876432221 2346789999999999999899999999999999999999999987653
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-33 Score=194.25 Aligned_cols=131 Identities=19% Similarity=0.302 Sum_probs=114.0
Q ss_pred ceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEc--CCCCeEEeee
Q 044494 4 KCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLN--LELEAFVADF 81 (144)
Q Consensus 4 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~--~~~~~~l~d~ 81 (144)
...|+||||+ +++|.+++.... ..+++..++.++.|++.||.||| +++++||||||+||+++ .++.++|+||
T Consensus 125 ~~~~lv~e~~-g~~L~~~~~~~~--~~l~~~~~~~i~~qi~~~l~~lH---~~~iiHrDlkp~Nill~~~~~~~~kl~DF 198 (364)
T 3op5_A 125 SYRFMIMDRF-GSDLQKIYEANA--KRFSRKTVLQLSLRILDILEYIH---EHEYVHGDIKASNLLLNYKNPDQVYLVDY 198 (364)
T ss_dssp EEEEEEEECE-EEEHHHHHHHTT--SCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEEESSCTTCEEECCC
T ss_pred ceEEEEEeCC-CCCHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHH---HCCeEEecCCHHHEEEecCCCCeEEEEEC
Confidence 4589999999 999999997632 33999999999999999999999 88999999999999999 8899999999
Q ss_pred cceeecccCCCC-------cccccccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCC
Q 044494 82 GVARLLNFDSSN-------RTLLAGTYGYIAPELAYTMVVTEKSDVYSFGVVALEVLMGKHPGELL 140 (144)
Q Consensus 82 ~~~~~~~~~~~~-------~~~~~~~~~~~~pe~~~~~~~~~~~d~~slg~~l~~~~~g~~p~~~~ 140 (144)
|+++........ .....|++.|+|||.+.+..++.++|+||+|+++|+|++|..||...
T Consensus 199 G~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~ 264 (364)
T 3op5_A 199 GLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDN 264 (364)
T ss_dssp TTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGG
T ss_pred CcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCcccc
Confidence 999866432111 12345899999999999998999999999999999999999999864
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-32 Score=201.45 Aligned_cols=135 Identities=25% Similarity=0.326 Sum_probs=118.7
Q ss_pred CCceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeee
Q 044494 2 HRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADF 81 (144)
Q Consensus 2 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~ 81 (144)
.++.+|+||||++||+|.+++.... ...+++..+..++.|++.||.||| ++|++||||||+||+++.++.++|+||
T Consensus 255 ~~~~l~lVmEy~~gg~L~~~l~~~~-~~~l~e~~~~~i~~qIl~aL~yLH---~~gIvHrDLKPeNILld~~g~vKL~DF 330 (576)
T 2acx_A 255 TKDALCLVLTLMNGGDLKFHIYHMG-QAGFPEARAVFYAAEICCGLEDLH---RERIVYRDLKPENILLDDHGHIRISDL 330 (576)
T ss_dssp CSSEEEEEECCCCSCBHHHHHHSSS-SCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTSCEEECCC
T ss_pred eCCEEEEEEEcCCCCcHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHH---HCCEeccCCchheEEEeCCCCeEEEec
Confidence 3567899999999999999987533 234899999999999999999999 899999999999999999999999999
Q ss_pred cceeecccCCCCcccccccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCC
Q 044494 82 GVARLLNFDSSNRTLLAGTYGYIAPELAYTMVVTEKSDVYSFGVVALEVLMGKHPGELLS 141 (144)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~d~~slg~~l~~~~~g~~p~~~~~ 141 (144)
|++...... .......|++.|+|||++.+..++.++|+||+|+++|+|++|..||...+
T Consensus 331 Gla~~~~~~-~~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~ 389 (576)
T 2acx_A 331 GLAVHVPEG-QTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRK 389 (576)
T ss_dssp TTCEECCTT-CCEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSS
T ss_pred ccceecccC-ccccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccc
Confidence 999876432 22334579999999999999889999999999999999999999998754
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-32 Score=188.68 Aligned_cols=132 Identities=27% Similarity=0.404 Sum_probs=116.2
Q ss_pred CceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCC----CeEE
Q 044494 3 RKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLEL----EAFV 78 (144)
Q Consensus 3 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~----~~~l 78 (144)
.+.+|+||||+++++|.+++..... +++..+..++.|++.|+.+|| +.+++|+||||+||+++.++ .++|
T Consensus 86 ~~~~~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dlkp~NIll~~~~~~~~~~kl 159 (326)
T 2y0a_A 86 KTDVILILELVAGGELFDFLAEKES---LTEEEATEFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKI 159 (326)
T ss_dssp SSEEEEEEECCCSCBHHHHHTTSSC---CBHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESCSSSSSCCEEE
T ss_pred CCEEEEEEEcCCCCCHHHHHHhcCC---cCHHHHHHHHHHHHHHHHHHH---HCCeEcCCCCHHHEEEecCCCCCCCEEE
Confidence 5678999999999999999975433 899999999999999999999 89999999999999998877 7999
Q ss_pred eeecceeecccCCCCcccccccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCC
Q 044494 79 ADFGVARLLNFDSSNRTLLAGTYGYIAPELAYTMVVTEKSDVYSFGVVALEVLMGKHPGELLS 141 (144)
Q Consensus 79 ~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~d~~slg~~l~~~~~g~~p~~~~~ 141 (144)
+|||++....... ......+++.|+|||++....++.++|+||+|+++++|++|..||...+
T Consensus 160 ~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~ 221 (326)
T 2y0a_A 160 IDFGLAHKIDFGN-EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDT 221 (326)
T ss_dssp CCCTTCEECCTTS-CCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSS
T ss_pred EECCCCeECCCCC-ccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCC
Confidence 9999998765322 2334568999999999998889999999999999999999999997643
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-32 Score=191.58 Aligned_cols=133 Identities=26% Similarity=0.394 Sum_probs=115.5
Q ss_pred CCceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCC---CeEE
Q 044494 2 HRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLEL---EAFV 78 (144)
Q Consensus 2 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~---~~~l 78 (144)
+++..|+||||+++|+|.+++..... +++..+..++.|++.|+.||| +++++|+||||+||+++.++ .++|
T Consensus 99 ~~~~~~lv~e~~~gg~L~~~l~~~~~---~~~~~~~~~~~qi~~al~~lH---~~~ivH~Dlkp~NIll~~~~~~~~~kl 172 (362)
T 2bdw_A 99 EESFHYLVFDLVTGGELFEDIVAREF---YSEADASHCIQQILESIAYCH---SNGIVHRNLKPENLLLASKAKGAAVKL 172 (362)
T ss_dssp CSSEEEEEECCCCSCBHHHHHTTCSC---CCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSGGGEEESCSSTTCCEEE
T ss_pred eCCEEEEEEecCCCCCHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHH---HCCeEeccCchHHEEEecCCCCCCEEE
Confidence 35678999999999999998875443 899999999999999999999 88999999999999998654 5999
Q ss_pred eeecceeecccCCCCcccccccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCC
Q 044494 79 ADFGVARLLNFDSSNRTLLAGTYGYIAPELAYTMVVTEKSDVYSFGVVALEVLMGKHPGELLS 141 (144)
Q Consensus 79 ~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~d~~slg~~l~~~~~g~~p~~~~~ 141 (144)
+|||++...... .......|++.|+|||++....++.++|+||+|+++|+|++|..||...+
T Consensus 173 ~DfG~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~ 234 (362)
T 2bdw_A 173 ADFGLAIEVNDS-EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDED 234 (362)
T ss_dssp CCCTTCBCCTTC-CSCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred eecCcceEecCC-cccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCC
Confidence 999999865522 22334678999999999999889999999999999999999999997643
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-32 Score=189.88 Aligned_cols=133 Identities=28% Similarity=0.386 Sum_probs=116.4
Q ss_pred CceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcC--CCCeEEee
Q 044494 3 RKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNL--ELEAFVAD 80 (144)
Q Consensus 3 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~--~~~~~l~d 80 (144)
.+.+|+||||+++++|.+++.... ..+++..++.++.|++.|+.+|| +.|++|+||||+||+++. ++.++++|
T Consensus 73 ~~~~~lv~e~~~g~~L~~~l~~~~--~~~~~~~~~~i~~qi~~al~~lH---~~givH~Dlkp~NIl~~~~~~~~~kl~D 147 (321)
T 1tki_A 73 MEELVMIFEFISGLDIFERINTSA--FELNEREIVSYVHQVCEALQFLH---SHNIGHFDIRPENIIYQTRRSSTIKIIE 147 (321)
T ss_dssp TTEEEEEECCCCCCBHHHHHTSSS--CCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSSSCCCEEECC
T ss_pred CCEEEEEEEeCCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHH---HCCCCcCCCCHHHEEEccCCCCCEEEEE
Confidence 467899999999999999997532 23899999999999999999999 899999999999999987 78999999
Q ss_pred ecceeecccCCCCcccccccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCC
Q 044494 81 FGVARLLNFDSSNRTLLAGTYGYIAPELAYTMVVTEKSDVYSFGVVALEVLMGKHPGELLS 141 (144)
Q Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~d~~slg~~l~~~~~g~~p~~~~~ 141 (144)
||++..... ........+++.|+|||++.+..++.++|+||+|+++|+|++|..||...+
T Consensus 148 fg~a~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~ 207 (321)
T 1tki_A 148 FGQARQLKP-GDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAET 207 (321)
T ss_dssp CTTCEECCT-TCEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSS
T ss_pred CCCCeECCC-CCccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCC
Confidence 999987643 222344568999999999998888999999999999999999999997643
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-32 Score=184.70 Aligned_cols=134 Identities=21% Similarity=0.257 Sum_probs=116.1
Q ss_pred CceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCC-----eE
Q 044494 3 RKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELE-----AF 77 (144)
Q Consensus 3 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~-----~~ 77 (144)
++..++||||+ +++|.+++.... ..+++..+..++.|++.|+.+|| +++++|+||||+||+++.++. ++
T Consensus 78 ~~~~~lv~e~~-~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dlkp~NIl~~~~~~~~~~~~k 151 (298)
T 1csn_A 78 GLHNVLVIDLL-GPSLEDLLDLCG--RKFSVKTVAMAAKQMLARVQSIH---EKSLVYRDIKPDNFLIGRPNSKNANMIY 151 (298)
T ss_dssp TTEEEEEEECC-CCBHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECCSSSTTTTCEE
T ss_pred CceeEEEEEec-CCCHHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEeccCCCCCCCeEE
Confidence 46789999999 899999997533 23899999999999999999999 899999999999999987766 99
Q ss_pred EeeecceeecccCCC-------CcccccccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCC
Q 044494 78 VADFGVARLLNFDSS-------NRTLLAGTYGYIAPELAYTMVVTEKSDVYSFGVVALEVLMGKHPGELLSS 142 (144)
Q Consensus 78 l~d~~~~~~~~~~~~-------~~~~~~~~~~~~~pe~~~~~~~~~~~d~~slg~~l~~~~~g~~p~~~~~~ 142 (144)
++|||++........ ......+++.|+|||.+.+..++.++|+||+|+++++|++|..||...+.
T Consensus 152 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~ 223 (298)
T 1csn_A 152 VVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKA 223 (298)
T ss_dssp ECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCS
T ss_pred EEECccccccccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhc
Confidence 999999987653322 12345689999999999998899999999999999999999999987653
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-32 Score=188.55 Aligned_cols=134 Identities=28% Similarity=0.382 Sum_probs=115.5
Q ss_pred ceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEE----cCCCCeEEe
Q 044494 4 KCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILL----NLELEAFVA 79 (144)
Q Consensus 4 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~----~~~~~~~l~ 79 (144)
..+++||||+++++|.+++........+++..++.++.|++.||.+|| +++++|+||||+||++ +.++.++|+
T Consensus 82 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~~kL~ 158 (319)
T 4euu_A 82 RHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLR---ENGIVHRNIKPGNIMRVIGEDGQSVYKLT 158 (319)
T ss_dssp CCEEEEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEECTTSCEEEEEC
T ss_pred ceEEEEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHEEEeccCCCCceEEEc
Confidence 478999999999999999987555455999999999999999999999 8999999999999998 677789999
Q ss_pred eecceeecccCCCCcccccccccccCccccc--------cCCCCCcchhHHHHHHHHHHHhCCCCCCCCC
Q 044494 80 DFGVARLLNFDSSNRTLLAGTYGYIAPELAY--------TMVVTEKSDVYSFGVVALEVLMGKHPGELLS 141 (144)
Q Consensus 80 d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~--------~~~~~~~~d~~slg~~l~~~~~g~~p~~~~~ 141 (144)
|||++....... ......+++.|+|||++. ...++.++|+||+|+++|+|++|..||...+
T Consensus 159 Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~ 227 (319)
T 4euu_A 159 DFGAARELEDDE-QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFE 227 (319)
T ss_dssp CCTTCEECCTTC-CBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTT
T ss_pred cCCCceecCCCC-ceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 999998765332 233456899999999886 4667889999999999999999999997543
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=99.98 E-value=3.2e-32 Score=191.29 Aligned_cols=137 Identities=28% Similarity=0.420 Sum_probs=116.9
Q ss_pred CCceEEEEEeeccCCCHHHHhhcccc-------------cCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcE
Q 044494 2 HRKCMFLIYEYMEMGSLFCVLRTDEE-------------AVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNI 68 (144)
Q Consensus 2 ~~~~~~lv~e~~~~~~L~~~l~~~~~-------------~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni 68 (144)
.++.+|+||||+++|+|.+++..... ...+++..++.++.|++.||.||| +++++||||||+||
T Consensus 158 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NI 234 (370)
T 2psq_A 158 QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLA---SQKCIHRDLAARNV 234 (370)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGE
T ss_pred cCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHH---hCCeeccccchhhE
Confidence 35678999999999999999975331 234789999999999999999999 89999999999999
Q ss_pred EEcCCCCeEEeeecceeecccCCC--CcccccccccccCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCC
Q 044494 69 LLNLELEAFVADFGVARLLNFDSS--NRTLLAGTYGYIAPELAYTMVVTEKSDVYSFGVVALEVLM-GKHPGELLS 141 (144)
Q Consensus 69 ~~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~d~~slg~~l~~~~~-g~~p~~~~~ 141 (144)
+++.++.++|+|||++........ ......+++.|+|||++....++.++|+||+|+++|||++ |..||...+
T Consensus 235 ll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~ 310 (370)
T 2psq_A 235 LVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP 310 (370)
T ss_dssp EECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred EECCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCC
Confidence 999999999999999986543221 1223456788999999999889999999999999999999 999998754
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.98 E-value=5.4e-32 Score=185.74 Aligned_cols=133 Identities=32% Similarity=0.531 Sum_probs=114.8
Q ss_pred CceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeeec
Q 044494 3 RKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADFG 82 (144)
Q Consensus 3 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~~ 82 (144)
++..++||||+++++|.+++.... ..+++..++.++.|++.||.+|| +.+++|+||||+||+++.++.++|+|||
T Consensus 79 ~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg 153 (310)
T 3s95_A 79 DKRLNFITEYIKGGTLRGIIKSMD--SQYPWSQRVSFAKDIASGMAYLH---SMNIIHRDLNSHNCLVRENKNVVVADFG 153 (310)
T ss_dssp TTEEEEEEECCTTCBHHHHHHHCC--TTSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSTTSEEECTTSCEEECCCT
T ss_pred CCeeEEEEEecCCCcHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCCcCeEEECCCCCEEEeecc
Confidence 567899999999999999997632 23899999999999999999999 8999999999999999999999999999
Q ss_pred ceeecccCCCCc--------------ccccccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCC
Q 044494 83 VARLLNFDSSNR--------------TLLAGTYGYIAPELAYTMVVTEKSDVYSFGVVALEVLMGKHPGELL 140 (144)
Q Consensus 83 ~~~~~~~~~~~~--------------~~~~~~~~~~~pe~~~~~~~~~~~d~~slg~~l~~~~~g~~p~~~~ 140 (144)
++.......... ....|++.|+|||.+.+..++.++|+||+|++++++++|..||...
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~ 225 (310)
T 3s95_A 154 LARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDY 225 (310)
T ss_dssp TCEECC--------------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTT
T ss_pred cceecccccccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcch
Confidence 998654322111 1356899999999999999999999999999999999999998764
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=5.3e-32 Score=186.14 Aligned_cols=135 Identities=26% Similarity=0.390 Sum_probs=114.8
Q ss_pred CCceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeee
Q 044494 2 HRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADF 81 (144)
Q Consensus 2 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~ 81 (144)
.++.+++||||+++ +|.+.+.... ..+++..+..++.|++.|+.+|| ++|++||||||+||+++.++.++|+||
T Consensus 90 ~~~~~~lv~e~~~~-~l~~~~~~~~--~~~~~~~~~~~~~qi~~~l~~LH---~~~ivH~Dikp~NIl~~~~~~~kl~Df 163 (311)
T 3niz_A 90 SERCLTLVFEFMEK-DLKKVLDENK--TGLQDSQIKIYLYQLLRGVAHCH---QHRILHRDLKPQNLLINSDGALKLADF 163 (311)
T ss_dssp CSSCEEEEEECCSE-EHHHHHHTCT--TCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCC
T ss_pred cCCEEEEEEcCCCC-CHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCchHhEEECCCCCEEEccC
Confidence 35678999999985 8888776533 34899999999999999999999 899999999999999999999999999
Q ss_pred cceeecccCCCCcccccccccccCcccccc-CCCCCcchhHHHHHHHHHHHhCCCCCCCCCC
Q 044494 82 GVARLLNFDSSNRTLLAGTYGYIAPELAYT-MVVTEKSDVYSFGVVALEVLMGKHPGELLSS 142 (144)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~-~~~~~~~d~~slg~~l~~~~~g~~p~~~~~~ 142 (144)
|++..............+++.|+|||.+.+ ..++.++|+||+|+++++|++|..||...+.
T Consensus 164 g~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~ 225 (311)
T 3niz_A 164 GLARAFGIPVRSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTD 225 (311)
T ss_dssp TTCEETTSCCC---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSST
T ss_pred cCceecCCCcccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCCh
Confidence 999876544444445678999999999876 4578999999999999999999999987654
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=1.5e-32 Score=189.77 Aligned_cols=135 Identities=29% Similarity=0.452 Sum_probs=116.4
Q ss_pred CCceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeee
Q 044494 2 HRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADF 81 (144)
Q Consensus 2 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~ 81 (144)
+++..|+||||+++++|.+++..... +++..+..++.|++.|+++|| +.|++|+||||+||+++.++.++|+||
T Consensus 76 ~~~~~~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~i~~qi~~aL~~LH---~~givH~Dlkp~NIll~~~~~~kl~Df 149 (323)
T 3tki_A 76 EGNIQYLFLEYCSGGELFDRIEPDIG---MPEPDAQRFFHQLMAGVVYLH---GIGITHRDIKPENLLLDERDNLKISDF 149 (323)
T ss_dssp CSSEEEEEEECCTTEEGGGGSBTTTB---CCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCC
T ss_pred cCCeEEEEEEcCCCCcHHHHHhhcCC---CCHHHHHHHHHHHHHHHHHHH---HCCccccccchHHEEEeCCCCEEEEEe
Confidence 35678999999999999999875433 899999999999999999999 899999999999999999999999999
Q ss_pred cceeecccC--CCCcccccccccccCccccccCCC-CCcchhHHHHHHHHHHHhCCCCCCCCCC
Q 044494 82 GVARLLNFD--SSNRTLLAGTYGYIAPELAYTMVV-TEKSDVYSFGVVALEVLMGKHPGELLSS 142 (144)
Q Consensus 82 ~~~~~~~~~--~~~~~~~~~~~~~~~pe~~~~~~~-~~~~d~~slg~~l~~~~~g~~p~~~~~~ 142 (144)
|++...... ........|++.|+|||++....+ +.++|+||+|+++++|++|..||...+.
T Consensus 150 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~ 213 (323)
T 3tki_A 150 GLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSD 213 (323)
T ss_dssp TTCEECEETTEECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCT
T ss_pred eccceeccCCcccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCch
Confidence 999865422 122334578999999999987765 6789999999999999999999987554
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=2.2e-32 Score=188.82 Aligned_cols=131 Identities=33% Similarity=0.476 Sum_probs=112.7
Q ss_pred ceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCC----------CeEecCCCCCcEEEcCC
Q 044494 4 KCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTP----------PIVHRDISSNNILLNLE 73 (144)
Q Consensus 4 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~----------~~~h~~i~~~ni~~~~~ 73 (144)
..+++||||+++|+|.++++... +++..++.++.|++.|+.||| +. +++|+||||+||+++.+
T Consensus 95 ~~~~lv~e~~~~g~L~~~l~~~~----~~~~~~~~i~~qi~~al~~LH---~~~~~l~~~~~~~ivH~Dlkp~Nill~~~ 167 (322)
T 3soc_A 95 VDLWLITAFHEKGSLSDFLKANV----VSWNELCHIAETMARGLAYLH---EDIPGLKDGHKPAISHRDIKSKNVLLKNN 167 (322)
T ss_dssp EEEEEEEECCTTCBHHHHHHHCC----BCHHHHHHHHHHHHHHHHHHT---CCEEEETTEEECEEECSCCSGGGEEECTT
T ss_pred ceEEEEEecCCCCCHHHHHHhcC----CCHHHHHHHHHHHHHHHHHHH---hhccccccccCCCEEeCCCChHhEEECCC
Confidence 45799999999999999997532 899999999999999999999 77 99999999999999999
Q ss_pred CCeEEeeecceeecccCCC--CcccccccccccCccccccC-----CCCCcchhHHHHHHHHHHHhCCCCCCCCC
Q 044494 74 LEAFVADFGVARLLNFDSS--NRTLLAGTYGYIAPELAYTM-----VVTEKSDVYSFGVVALEVLMGKHPGELLS 141 (144)
Q Consensus 74 ~~~~l~d~~~~~~~~~~~~--~~~~~~~~~~~~~pe~~~~~-----~~~~~~d~~slg~~l~~~~~g~~p~~~~~ 141 (144)
+.++|+|||++........ ......+++.|+|||.+.+. .++.++|+||+|+++|+|++|..||.+..
T Consensus 168 ~~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~ 242 (322)
T 3soc_A 168 LTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPV 242 (322)
T ss_dssp CCEEECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCC
T ss_pred CeEEEccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCc
Confidence 9999999999987653322 22335689999999998863 45567899999999999999999997654
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=99.98 E-value=6.7e-32 Score=183.78 Aligned_cols=134 Identities=19% Similarity=0.302 Sum_probs=116.2
Q ss_pred CceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEE---cCCCCeEEe
Q 044494 3 RKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILL---NLELEAFVA 79 (144)
Q Consensus 3 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~---~~~~~~~l~ 79 (144)
++..++||||+ +++|.+++.... ..+++..++.++.|++.|+.+|| +++++|+||||+||++ +.++.++|+
T Consensus 77 ~~~~~lv~e~~-~~~L~~~~~~~~--~~~~~~~~~~i~~qi~~~l~~LH---~~~ivH~Dlkp~NIl~~~~~~~~~~kL~ 150 (296)
T 4hgt_A 77 GDYNVMVMELL-GPSLEDLFNFCS--RKFSLKTVLLLADQMISRIEYIH---SKNFIHRDVKPDNFLMGLGKKGNLVYII 150 (296)
T ss_dssp TTEEEEEEECC-CCBHHHHHHHTT--SCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECCGGGTTCEEEC
T ss_pred CCceEEEEEcc-CCCHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeeeeccCCCCeEEEe
Confidence 45679999999 899999987432 23899999999999999999999 8999999999999999 788999999
Q ss_pred eecceeecccCCC-------CcccccccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCC
Q 044494 80 DFGVARLLNFDSS-------NRTLLAGTYGYIAPELAYTMVVTEKSDVYSFGVVALEVLMGKHPGELLSS 142 (144)
Q Consensus 80 d~~~~~~~~~~~~-------~~~~~~~~~~~~~pe~~~~~~~~~~~d~~slg~~l~~~~~g~~p~~~~~~ 142 (144)
|||++........ ......+++.|+|||.+.+..++.++|+||+|++++++++|..||...+.
T Consensus 151 Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~ 220 (296)
T 4hgt_A 151 DFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKA 220 (296)
T ss_dssp CCTTCEECBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCC
T ss_pred cCccceeccCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccch
Confidence 9999987653322 12345689999999999998899999999999999999999999987654
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.98 E-value=5.2e-32 Score=184.91 Aligned_cols=131 Identities=23% Similarity=0.348 Sum_probs=113.0
Q ss_pred CceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeeec
Q 044494 3 RKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADFG 82 (144)
Q Consensus 3 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~~ 82 (144)
++.+|+||||+++++|.+++.. ..+++..+..++.|++.||.+|| +++++|+||||+||+++.++.++|+|||
T Consensus 110 ~~~~~lv~e~~~~~~l~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg 182 (298)
T 2zv2_A 110 EDHLYMVFELVNQGPVMEVPTL----KPLSEDQARFYFQDLIKGIEYLH---YQKIIHRDIKPSNLLVGEDGHIKIADFG 182 (298)
T ss_dssp SSEEEEEEECCTTCBSCCSSCS----SCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTSCEEECCCT
T ss_pred CCEEEEEEecCCCCcHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHEEECCCCCEEEecCC
Confidence 4678999999999999876543 23899999999999999999999 8899999999999999999999999999
Q ss_pred ceeecccCCCCcccccccccccCccccccCC---CCCcchhHHHHHHHHHHHhCCCCCCCC
Q 044494 83 VARLLNFDSSNRTLLAGTYGYIAPELAYTMV---VTEKSDVYSFGVVALEVLMGKHPGELL 140 (144)
Q Consensus 83 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~---~~~~~d~~slg~~l~~~~~g~~p~~~~ 140 (144)
++..............+++.|+|||.+.... .+.++|+||+|+++++|++|..||...
T Consensus 183 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~ 243 (298)
T 2zv2_A 183 VSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDE 243 (298)
T ss_dssp TCEECSSSSCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred CccccccccccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCc
Confidence 9987654333334467899999999998665 367899999999999999999999754
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=99.98 E-value=3.9e-32 Score=188.68 Aligned_cols=130 Identities=26% Similarity=0.423 Sum_probs=113.6
Q ss_pred CceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeeec
Q 044494 3 RKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADFG 82 (144)
Q Consensus 3 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~~ 82 (144)
.+.+++||||+ +|+|.+++..... +++..+..++.|++.|+.||| +.|++||||||+||+++.++.++++|||
T Consensus 81 ~~~~~lv~E~~-~g~l~~~l~~~~~---l~~~~~~~i~~qi~~aL~~LH---~~givH~Dlkp~NIll~~~~~~kl~DFG 153 (336)
T 3h4j_B 81 PTDIVMVIEYA-GGELFDYIVEKKR---MTEDEGRRFFQQIICAIEYCH---RHKIVHRDLKPENLLLDDNLNVKIADFG 153 (336)
T ss_dssp SSEEEEEECCC-CEEHHHHHHHHCS---CCHHHHHHHHHHHHHHHHHHH---HHTCCCCCCSTTTEEECTTCCEEECCSS
T ss_pred CCEEEEEEECC-CCcHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHH---HCCeEecCCchhhEEEcCCCCEEEEEec
Confidence 46789999999 6799998875443 899999999999999999999 8899999999999999999999999999
Q ss_pred ceeecccCCCCcccccccccccCccccccCCC-CCcchhHHHHHHHHHHHhCCCCCCCC
Q 044494 83 VARLLNFDSSNRTLLAGTYGYIAPELAYTMVV-TEKSDVYSFGVVALEVLMGKHPGELL 140 (144)
Q Consensus 83 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~-~~~~d~~slg~~l~~~~~g~~p~~~~ 140 (144)
++...... .......|++.|+|||.+.+..+ ++++|+||+|+++|+|++|..||+..
T Consensus 154 ~s~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~ 211 (336)
T 3h4j_B 154 LSNIMTDG-NFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDE 211 (336)
T ss_dssp CTBTTTTS-BTTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCS
T ss_pred cceeccCC-cccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCc
Confidence 99765432 22344568999999999988776 67899999999999999999999764
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.98 E-value=7.3e-32 Score=190.44 Aligned_cols=134 Identities=27% Similarity=0.374 Sum_probs=116.0
Q ss_pred CCceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcC--CCCeEEe
Q 044494 2 HRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNL--ELEAFVA 79 (144)
Q Consensus 2 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~--~~~~~l~ 79 (144)
+++.+++||||+.+++|.+++.... ..+++..++.++.|++.||.+|| +.|++||||||+||+++. .+.++|+
T Consensus 119 ~~~~~~lv~E~~~gg~L~~~l~~~~--~~l~~~~~~~i~~qi~~aL~~LH---~~givHrDlkp~NIll~~~~~~~vkL~ 193 (387)
T 1kob_A 119 DKYEMVLILEFLSGGELFDRIAAED--YKMSEAEVINYMRQACEGLKHMH---EHSIVHLDIKPENIMCETKKASSVKII 193 (387)
T ss_dssp CSSEEEEEEECCCCCBHHHHTTCTT--CCBCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSTTCCCEEEC
T ss_pred eCCEEEEEEEcCCCCcHHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccchHHeEEecCCCCceEEE
Confidence 3567899999999999999987532 23899999999999999999999 899999999999999974 4679999
Q ss_pred eecceeecccCCCCcccccccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCC
Q 044494 80 DFGVARLLNFDSSNRTLLAGTYGYIAPELAYTMVVTEKSDVYSFGVVALEVLMGKHPGELLS 141 (144)
Q Consensus 80 d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~d~~slg~~l~~~~~g~~p~~~~~ 141 (144)
|||++....... ......+++.|+|||++....++.++|+||+|+++|+|++|..||...+
T Consensus 194 DFG~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~ 254 (387)
T 1kob_A 194 DFGLATKLNPDE-IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGED 254 (387)
T ss_dssp CCTTCEECCTTS-CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSS
T ss_pred ecccceecCCCc-ceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCC
Confidence 999998765322 2334568999999999999889999999999999999999999998654
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=99.98 E-value=8.9e-32 Score=194.22 Aligned_cols=132 Identities=26% Similarity=0.439 Sum_probs=116.5
Q ss_pred CceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeeec
Q 044494 3 RKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADFG 82 (144)
Q Consensus 3 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~~ 82 (144)
.+.+|+||||+++|+|.+++.+... +++..+..++.|++.|+.||| +.+++||||||+||+++.++.++|+|||
T Consensus 88 ~~~~~lv~E~~~gg~L~~~l~~~~~---l~~~~~~~i~~qi~~aL~~LH---~~givHrDLkp~NIll~~~~~vkL~DFG 161 (476)
T 2y94_A 88 PSDIFMVMEYVSGGELFDYICKNGR---LDEKESRRLFQQILSGVDYCH---RHMVVHRDLKPENVLLDAHMNAKIADFG 161 (476)
T ss_dssp SSEEEEEEECCSSEEHHHHTTSSSS---CCHHHHHHHHHHHHHHHHHHH---TTTEECSCCSGGGEEECTTCCEEECCCS
T ss_pred CCEEEEEEeCCCCCcHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHH---HCCCCcccccHHHEEEecCCCeEEEecc
Confidence 4678999999999999999976443 899999999999999999999 9999999999999999999999999999
Q ss_pred ceeecccCCCCcccccccccccCccccccCCC-CCcchhHHHHHHHHHHHhCCCCCCCCC
Q 044494 83 VARLLNFDSSNRTLLAGTYGYIAPELAYTMVV-TEKSDVYSFGVVALEVLMGKHPGELLS 141 (144)
Q Consensus 83 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~-~~~~d~~slg~~l~~~~~g~~p~~~~~ 141 (144)
++...... .......|++.|+|||++.+..+ +.++|+||+|+++|+|++|..||...+
T Consensus 162 ~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~ 220 (476)
T 2y94_A 162 LSNMMSDG-EFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDH 220 (476)
T ss_dssp SCEECCTT-CCBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred chhhcccc-ccccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCC
Confidence 99876432 23344679999999999988765 678999999999999999999998643
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=1.6e-31 Score=184.07 Aligned_cols=136 Identities=22% Similarity=0.332 Sum_probs=115.9
Q ss_pred CCceEEEEEeeccCCCHHHHhhccc---ccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEE
Q 044494 2 HRKCMFLIYEYMEMGSLFCVLRTDE---EAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFV 78 (144)
Q Consensus 2 ~~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l 78 (144)
.++.+|+||||+. ++|.+++.... ....+++..+..++.|++.||.+|| +.|++|+||||+||+++.++.++|
T Consensus 74 ~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH---~~~ivH~Dlkp~NIl~~~~~~~kl 149 (317)
T 2pmi_A 74 TENKLTLVFEFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCH---ENKILHRDLKPQNLLINKRGQLKL 149 (317)
T ss_dssp CTTEEEEEEECCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEE
T ss_pred ECCeEEEEEEecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCChHHeEEcCCCCEEE
Confidence 3567899999998 59999886422 2234899999999999999999999 899999999999999999999999
Q ss_pred eeecceeecccCCCCcccccccccccCccccccC-CCCCcchhHHHHHHHHHHHhCCCCCCCCC
Q 044494 79 ADFGVARLLNFDSSNRTLLAGTYGYIAPELAYTM-VVTEKSDVYSFGVVALEVLMGKHPGELLS 141 (144)
Q Consensus 79 ~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~-~~~~~~d~~slg~~l~~~~~g~~p~~~~~ 141 (144)
+|||++..............+++.|+|||++.+. .++.++|+||+|+++++|++|..||...+
T Consensus 150 ~Dfg~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~ 213 (317)
T 2pmi_A 150 GDFGLARAFGIPVNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTN 213 (317)
T ss_dssp CCCSSCEETTSCCCCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred CcCccceecCCCcccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 9999998765443334456789999999998764 57899999999999999999999997643
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=1.8e-32 Score=188.27 Aligned_cols=131 Identities=30% Similarity=0.473 Sum_probs=108.5
Q ss_pred eEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeeecce
Q 044494 5 CMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADFGVA 84 (144)
Q Consensus 5 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~~~~ 84 (144)
..|+||||+++++|.++++.... +++..++.++.|++.++.+|| +++++|+||||+||+++.++.++|+|||++
T Consensus 90 ~~~lv~e~~~g~~L~~~l~~~~~---~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a 163 (311)
T 3ork_A 90 LPYIVMEYVDGVTLRDIVHTEGP---MTPKRAIEVIADACQALNFSH---QNGIIHRDVKPANIMISATNAVKVMDFGIA 163 (311)
T ss_dssp EEEEEEECCCEEEHHHHHHHHCS---CCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEEETTSCEEECCCSCC
T ss_pred ccEEEEecCCCCCHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHH---HCCCCcCCCCHHHEEEcCCCCEEEeeccCc
Confidence 45999999999999999976443 899999999999999999999 889999999999999999999999999999
Q ss_pred eecccCC---CCcccccccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCC
Q 044494 85 RLLNFDS---SNRTLLAGTYGYIAPELAYTMVVTEKSDVYSFGVVALEVLMGKHPGELLS 141 (144)
Q Consensus 85 ~~~~~~~---~~~~~~~~~~~~~~pe~~~~~~~~~~~d~~slg~~l~~~~~g~~p~~~~~ 141 (144)
....... .......|++.|+|||.+.+..++.++|+||+|+++|+|++|..||...+
T Consensus 164 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~ 223 (311)
T 3ork_A 164 RAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDS 223 (311)
T ss_dssp ------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred ccccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCC
Confidence 7654321 12233568999999999999889999999999999999999999998654
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=99.97 E-value=1.3e-31 Score=182.45 Aligned_cols=133 Identities=20% Similarity=0.302 Sum_probs=115.2
Q ss_pred CceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEE---cCCCCeEEe
Q 044494 3 RKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILL---NLELEAFVA 79 (144)
Q Consensus 3 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~---~~~~~~~l~ 79 (144)
++..++||||+ +++|.+++.... ..+++..++.++.|++.|+.+|| +++++|+||||+||++ +.++.++|+
T Consensus 77 ~~~~~lv~e~~-~~~L~~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dlkp~NIl~~~~~~~~~~kl~ 150 (296)
T 3uzp_A 77 GDYNVMVMELL-GPSLEDLFNFCS--RKFSLKTVLLLADQMISRIEYIH---SKNFIHRDVKPDNFLMGLGKKGNLVYII 150 (296)
T ss_dssp TTEEEEEEECC-CCBHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECCGGGTTCEEEC
T ss_pred CCceEEEEEec-CCCHHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHeEEecCCCCCeEEEe
Confidence 45679999999 899999997432 23899999999999999999999 8999999999999999 478899999
Q ss_pred eecceeecccCCC-------CcccccccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCC
Q 044494 80 DFGVARLLNFDSS-------NRTLLAGTYGYIAPELAYTMVVTEKSDVYSFGVVALEVLMGKHPGELLS 141 (144)
Q Consensus 80 d~~~~~~~~~~~~-------~~~~~~~~~~~~~pe~~~~~~~~~~~d~~slg~~l~~~~~g~~p~~~~~ 141 (144)
|||.+........ ......+++.|+|||.+.+..++.++|+||+|+++++|++|..||...+
T Consensus 151 Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~ 219 (296)
T 3uzp_A 151 DFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLK 219 (296)
T ss_dssp CCTTCEECBCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCC
T ss_pred eCCCcccccccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcC
Confidence 9999987653322 1234568999999999999889999999999999999999999998754
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.97 E-value=5.9e-32 Score=188.96 Aligned_cols=132 Identities=29% Similarity=0.401 Sum_probs=112.6
Q ss_pred CceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeeec
Q 044494 3 RKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADFG 82 (144)
Q Consensus 3 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~~ 82 (144)
++.+|+||||+++++|.+++..... +++..+..++.|++.||.||| +++++||||||+||+++.++.++|+|||
T Consensus 131 ~~~~~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kl~DfG 204 (355)
T 1vzo_A 131 ETKLHLILDYINGGELFTHLSQRER---FTEHEVQIYVGEIVLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFG 204 (355)
T ss_dssp TTEEEEEECCCCSCBHHHHHHHHSC---CCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEESCSS
T ss_pred CceEEEEeecCCCCCHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCcEEEeeCC
Confidence 4678999999999999999976443 899999999999999999999 8899999999999999999999999999
Q ss_pred ceeecccCC-CCcccccccccccCcccccc--CCCCCcchhHHHHHHHHHHHhCCCCCCCC
Q 044494 83 VARLLNFDS-SNRTLLAGTYGYIAPELAYT--MVVTEKSDVYSFGVVALEVLMGKHPGELL 140 (144)
Q Consensus 83 ~~~~~~~~~-~~~~~~~~~~~~~~pe~~~~--~~~~~~~d~~slg~~l~~~~~g~~p~~~~ 140 (144)
+++...... .......+++.|+|||++.+ ..++.++|+||+|+++|+|++|..||...
T Consensus 205 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~ 265 (355)
T 1vzo_A 205 LSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVD 265 (355)
T ss_dssp EEEECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCT
T ss_pred CCeecccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccC
Confidence 998654221 12233568999999999985 34678999999999999999999999754
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.97 E-value=9.6e-32 Score=185.47 Aligned_cols=132 Identities=21% Similarity=0.341 Sum_probs=113.6
Q ss_pred ceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeeecc
Q 044494 4 KCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADFGV 83 (144)
Q Consensus 4 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~~~ 83 (144)
..+++||||+++++|.+++..........+..++.++.|++.||.+|| +++++||||||+||+++.++.++|+|||+
T Consensus 134 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~DfG~ 210 (332)
T 3qd2_B 134 VYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGL 210 (332)
T ss_dssp CEEEEEEECCCSSCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTT
T ss_pred ceEEEEEEecCCCCHHHHHhcccCccchhhHHHHHHHHHHHHHHHHHH---hCCeeecCCCcccEEEeCCCCEEEeecCc
Confidence 358999999999999999987655555777788999999999999999 89999999999999999999999999999
Q ss_pred eeecccCC------------CCcccccccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCC
Q 044494 84 ARLLNFDS------------SNRTLLAGTYGYIAPELAYTMVVTEKSDVYSFGVVALEVLMGKHPGE 138 (144)
Q Consensus 84 ~~~~~~~~------------~~~~~~~~~~~~~~pe~~~~~~~~~~~d~~slg~~l~~~~~g~~p~~ 138 (144)
+....... .......+++.|+|||.+.+..++.++|+||+|+++++|++|..|+.
T Consensus 211 a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~ 277 (332)
T 3qd2_B 211 VTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQM 277 (332)
T ss_dssp CEECSCC--------------CCCSCC-CGGGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHH
T ss_pred ccccccchhhccccccccccccccccCCCcCccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChh
Confidence 98765332 12233568999999999999899999999999999999999887753
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=4.5e-32 Score=188.77 Aligned_cols=130 Identities=24% Similarity=0.337 Sum_probs=114.1
Q ss_pred CceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCC--CeEEee
Q 044494 3 RKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLEL--EAFVAD 80 (144)
Q Consensus 3 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~--~~~l~d 80 (144)
++.+|+||||+ +++|.+++.... .+++..++.++.|++.||++|| +++++|+||||+||+++.++ .++|+|
T Consensus 124 ~~~~~lv~e~~-~~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~~~kL~D 196 (345)
T 2v62_A 124 RSYRFMVMERL-GIDLQKISGQNG---TFKKSTVLQLGIRMLDVLEYIH---ENEYVHGDIKAANLLLGYKNPDQVYLAD 196 (345)
T ss_dssp CEEEEEEEECE-EEEHHHHCBGGG---BCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEESSSTTSEEECC
T ss_pred CcEEEEEEecc-CCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCcCHHHEEEccCCCCcEEEEe
Confidence 56789999999 899999997644 3999999999999999999999 88999999999999999887 999999
Q ss_pred ecceeecccCCC-------CcccccccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCC
Q 044494 81 FGVARLLNFDSS-------NRTLLAGTYGYIAPELAYTMVVTEKSDVYSFGVVALEVLMGKHPGEL 139 (144)
Q Consensus 81 ~~~~~~~~~~~~-------~~~~~~~~~~~~~pe~~~~~~~~~~~d~~slg~~l~~~~~g~~p~~~ 139 (144)
||+++....... ......+++.|+|||.+.+..++.++|+||+|+++|+|++|..||..
T Consensus 197 fg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~ 262 (345)
T 2v62_A 197 YGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQ 262 (345)
T ss_dssp CTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGG
T ss_pred CCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccc
Confidence 999986642211 11335689999999999988899999999999999999999999965
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.2e-31 Score=181.32 Aligned_cols=135 Identities=27% Similarity=0.448 Sum_probs=97.0
Q ss_pred CCceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeee
Q 044494 2 HRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADF 81 (144)
Q Consensus 2 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~ 81 (144)
+.+..|+||||+++++|.+++.... ..+++..++.++.|++.++.+|| +.+++|+||+|+||+++.++.++++||
T Consensus 82 ~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nili~~~~~~kl~df 156 (278)
T 3cok_A 82 DSNYVYLVLEMCHNGEMNRYLKNRV--KPFSENEARHFMHQIITGMLYLH---SHGILHRDLTLSNLLLTRNMNIKIADF 156 (278)
T ss_dssp CSSEEEEEEECCTTEEHHHHHHTCS--SCCCHHHHHHHHHHHHHHHHHHH---HTTEECSSCCGGGEEECTTCCEEECCC
T ss_pred cCCeEEEEEecCCCCcHHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCCEEEEee
Confidence 3567899999999999999987532 34899999999999999999999 889999999999999999999999999
Q ss_pred cceeecccCCCCcccccccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCC
Q 044494 82 GVARLLNFDSSNRTLLAGTYGYIAPELAYTMVVTEKSDVYSFGVVALEVLMGKHPGELLS 141 (144)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~d~~slg~~l~~~~~g~~p~~~~~ 141 (144)
|.+..............+++.|+|||.+....++.++|+||+|++++++++|..||...+
T Consensus 157 g~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 216 (278)
T 3cok_A 157 GLATQLKMPHEKHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDT 216 (278)
T ss_dssp TTCEECC----------------------------CTHHHHHHHHHHHHHHSSCSSCCCS
T ss_pred cceeeccCCCCcceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChh
Confidence 999876543333344668999999999998888999999999999999999999997643
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.5e-31 Score=185.55 Aligned_cols=133 Identities=29% Similarity=0.486 Sum_probs=118.4
Q ss_pred CCceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeee
Q 044494 2 HRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADF 81 (144)
Q Consensus 2 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~ 81 (144)
+++.+|+||||+.+++|.+++.... .+++..++.++.|++.++.+|| +++++|+||||+||+++.++.++|+||
T Consensus 112 ~~~~~~lv~e~~~~~~L~~~~~~~~---~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIl~~~~~~~kl~Df 185 (335)
T 2owb_A 112 DNDFVFVVLELCRRRSLLELHKRRK---ALTEPEARYYLRQIVLGCQYLH---RNRVIHRDLKLGNLFLNEDLEVKIGDF 185 (335)
T ss_dssp CSSEEEEEECCCTTCBHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECTTCCEEECCC
T ss_pred cCCeEEEEEecCCCCCHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHH---HCCCEecCCCchhEEEcCCCCEEEeec
Confidence 3567899999999999999887543 3899999999999999999999 889999999999999999999999999
Q ss_pred cceeecccCCCCcccccccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCC
Q 044494 82 GVARLLNFDSSNRTLLAGTYGYIAPELAYTMVVTEKSDVYSFGVVALEVLMGKHPGELL 140 (144)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~d~~slg~~l~~~~~g~~p~~~~ 140 (144)
|++..............+++.|+|||.+....++.++|+||+|+++++|++|..||...
T Consensus 186 g~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~ 244 (335)
T 2owb_A 186 GLATKVEYDGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETS 244 (335)
T ss_dssp TTCEECCSTTCCBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCS
T ss_pred cCceecccCcccccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCC
Confidence 99987654444445567899999999999888899999999999999999999999764
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2.1e-31 Score=181.50 Aligned_cols=134 Identities=28% Similarity=0.481 Sum_probs=118.6
Q ss_pred CCceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeee
Q 044494 2 HRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADF 81 (144)
Q Consensus 2 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~ 81 (144)
+++..++||||+++++|.+++..... +++..++.++.|++.++.+|| +.|++|+||+|+||+++.++.++++||
T Consensus 86 ~~~~~~lv~e~~~~~~L~~~~~~~~~---~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~df 159 (294)
T 2rku_A 86 DNDFVFVVLELCRRRSLLELHKRRKA---LTEPEARYYLRQIVLGCQYLH---RNRVIHRDLKLGNLFLNEDLEVKIGDF 159 (294)
T ss_dssp CSSEEEEEEECCTTCBHHHHHHHHCS---CCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCC
T ss_pred cCCEEEEEEecCCCCCHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHH---HCCccccCCChHhEEEcCCCCEEEEec
Confidence 35678999999999999998875433 899999999999999999999 889999999999999999999999999
Q ss_pred cceeecccCCCCcccccccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCC
Q 044494 82 GVARLLNFDSSNRTLLAGTYGYIAPELAYTMVVTEKSDVYSFGVVALEVLMGKHPGELLS 141 (144)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~d~~slg~~l~~~~~g~~p~~~~~ 141 (144)
|.+..............+++.|+|||.+....++.++|+||+|+++++|++|..||...+
T Consensus 160 g~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~ 219 (294)
T 2rku_A 160 GLATKVEYDGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSC 219 (294)
T ss_dssp TTCEECCSTTCCBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSS
T ss_pred cCceecccCccccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 999876544444455678999999999998888999999999999999999999997643
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=1e-31 Score=188.94 Aligned_cols=133 Identities=26% Similarity=0.352 Sum_probs=115.0
Q ss_pred CceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEE--cCCCCeEEee
Q 044494 3 RKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILL--NLELEAFVAD 80 (144)
Q Consensus 3 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~--~~~~~~~l~d 80 (144)
.+.+++||||+++++|.+++.... ..+++..+..++.|++.||.+|| +.+++|+||||+||++ +.++.++|+|
T Consensus 158 ~~~~~lv~E~~~~~~L~~~l~~~~--~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~~~kl~D 232 (373)
T 2x4f_A 158 KNDIVLVMEYVDGGELFDRIIDES--YNLTELDTILFMKQICEGIRHMH---QMYILHLDLKPENILCVNRDAKQIKIID 232 (373)
T ss_dssp SSEEEEEEECCTTCEEHHHHHHTG--GGCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEEEETTTTEEEECC
T ss_pred CCEEEEEEeCCCCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHH---HCCcccccCCHHHEEEecCCCCcEEEEe
Confidence 567899999999999999886532 23899999999999999999999 8999999999999999 4567899999
Q ss_pred ecceeecccCCCCcccccccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCC
Q 044494 81 FGVARLLNFDSSNRTLLAGTYGYIAPELAYTMVVTEKSDVYSFGVVALEVLMGKHPGELLS 141 (144)
Q Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~d~~slg~~l~~~~~g~~p~~~~~ 141 (144)
||++....... ......+++.|+|||++....++.++|+||+|+++++|++|..||...+
T Consensus 233 FG~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~ 292 (373)
T 2x4f_A 233 FGLARRYKPRE-KLKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDN 292 (373)
T ss_dssp CSSCEECCTTC-BCCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSS
T ss_pred CCCceecCCcc-ccccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCC
Confidence 99998765322 2334568999999999998888999999999999999999999997654
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=9.8e-32 Score=187.47 Aligned_cols=132 Identities=27% Similarity=0.396 Sum_probs=107.0
Q ss_pred CceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcC---CCCeEEe
Q 044494 3 RKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNL---ELEAFVA 79 (144)
Q Consensus 3 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~---~~~~~l~ 79 (144)
.+.+++||||+++++|.+++..... +++..++.++.|++.|+.+|| +.+++|+||||+||+++. ++.++|+
T Consensus 120 ~~~~~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dikp~NIll~~~~~~~~~kl~ 193 (349)
T 2w4o_A 120 PTEISLVLELVTGGELFDRIVEKGY---YSERDAADAVKQILEAVAYLH---ENGIVHRDLKPENLLYATPAPDAPLKIA 193 (349)
T ss_dssp SSEEEEEECCCCSCBHHHHHTTCSS---CCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEESSSSTTCCEEEC
T ss_pred CCeEEEEEEeCCCCCHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCcccEEEecCCCCCCEEEc
Confidence 4678999999999999999976443 899999999999999999999 889999999999999975 7889999
Q ss_pred eecceeecccCCCCcccccccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCC
Q 044494 80 DFGVARLLNFDSSNRTLLAGTYGYIAPELAYTMVVTEKSDVYSFGVVALEVLMGKHPGELLS 141 (144)
Q Consensus 80 d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~d~~slg~~l~~~~~g~~p~~~~~ 141 (144)
|||++...... .......+++.|+|||.+.+..++.++|+||+|+++|+|++|..||...+
T Consensus 194 Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~ 254 (349)
T 2w4o_A 194 DFGLSKIVEHQ-VLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDER 254 (349)
T ss_dssp CCC-----------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTT
T ss_pred cCccccccCcc-cccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCc
Confidence 99998865422 22334568999999999999889999999999999999999999997543
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=99.97 E-value=1e-31 Score=189.53 Aligned_cols=130 Identities=32% Similarity=0.447 Sum_probs=110.2
Q ss_pred ceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeeecc
Q 044494 4 KCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADFGV 83 (144)
Q Consensus 4 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~~~ 83 (144)
..+|+||||+. ++|.++++.. .+++..+..++.|++.||+||| +.|++||||||+||+++.++.++|+|||+
T Consensus 84 ~~~~lv~e~~~-~~L~~~~~~~----~~~~~~~~~i~~qi~~~L~~LH---~~~ivHrDlkp~NIll~~~~~~kl~DFG~ 155 (388)
T 3oz6_A 84 RDVYLVFDYME-TDLHAVIRAN----ILEPVHKQYVVYQLIKVIKYLH---SGGLLHRDMKPSNILLNAECHVKVADFGL 155 (388)
T ss_dssp SCEEEEEECCS-EEHHHHHHHT----CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTT
T ss_pred CEEEEEecccC-cCHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHH---hCCEEeCCCCHHHeEEcCCCCEEecCCcc
Confidence 46899999997 5899888753 3899999999999999999999 89999999999999999999999999999
Q ss_pred eeecccC---------------------CCCcccccccccccCcccccc-CCCCCcchhHHHHHHHHHHHhCCCCCCCCC
Q 044494 84 ARLLNFD---------------------SSNRTLLAGTYGYIAPELAYT-MVVTEKSDVYSFGVVALEVLMGKHPGELLS 141 (144)
Q Consensus 84 ~~~~~~~---------------------~~~~~~~~~~~~~~~pe~~~~-~~~~~~~d~~slg~~l~~~~~g~~p~~~~~ 141 (144)
++..... ........+|+.|+|||++.+ ..++.++|+||+||++++|++|..||.+.+
T Consensus 156 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~ 235 (388)
T 3oz6_A 156 SRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSS 235 (388)
T ss_dssp CEESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred cccccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 9865321 111223568999999999876 568899999999999999999999998754
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.3e-31 Score=188.94 Aligned_cols=136 Identities=21% Similarity=0.334 Sum_probs=115.3
Q ss_pred CceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeeec
Q 044494 3 RKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADFG 82 (144)
Q Consensus 3 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~~ 82 (144)
++.+|+||||+++++|.+++.... ...+++..+..++.|++.||+||| +++++||||||+||+++.++.++++|||
T Consensus 98 ~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivHrDlkp~NIll~~~~~~kl~dfg 173 (389)
T 3gni_B 98 DNELWVVTSFMAYGSAKDLICTHF-MDGMNELAIAYILQGVLKALDYIH---HMGYVHRSVKASHILISVDGKVYLSGLR 173 (389)
T ss_dssp TTEEEEEEECCTTCBHHHHHHHTC-TTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCGG
T ss_pred CCEEEEEEEccCCCCHHHHHhhhc-ccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEcccc
Confidence 567899999999999999987642 233899999999999999999999 8999999999999999999999999999
Q ss_pred ceeecccCC-------CCcccccccccccCcccccc--CCCCCcchhHHHHHHHHHHHhCCCCCCCCCC
Q 044494 83 VARLLNFDS-------SNRTLLAGTYGYIAPELAYT--MVVTEKSDVYSFGVVALEVLMGKHPGELLSS 142 (144)
Q Consensus 83 ~~~~~~~~~-------~~~~~~~~~~~~~~pe~~~~--~~~~~~~d~~slg~~l~~~~~g~~p~~~~~~ 142 (144)
.+....... .......+++.|+|||++.. ..++.++|+||+|+++++|++|..||...+.
T Consensus 174 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~ 242 (389)
T 3gni_B 174 SNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPA 242 (389)
T ss_dssp GCEECEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCS
T ss_pred cceeeccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCH
Confidence 876542211 11222468889999999987 5788999999999999999999999987554
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=8e-32 Score=186.14 Aligned_cols=134 Identities=30% Similarity=0.389 Sum_probs=114.1
Q ss_pred CceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeeec
Q 044494 3 RKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADFG 82 (144)
Q Consensus 3 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~~ 82 (144)
++..++||||+.+|+|.+++..... .+++..++.++.|++.||.+|| +.|++||||||+||+++.++.++|+|||
T Consensus 86 ~~~~~~v~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dikp~Nil~~~~~~~kl~Dfg 160 (325)
T 3kex_A 86 GSSLQLVTQYLPLGSLLDHVRQHRG--ALGPQLLLNWGVQIAKGMYYLE---EHGMVHRNLAARNVLLKSPSQVQVADFG 160 (325)
T ss_dssp BSSEEEEEECCTTCBSHHHHHSSGG--GSCTTHHHHHHHHHHHHHHHHH---HTTCCCSCCSSTTEEESSSSCEEECSCS
T ss_pred CCccEEEEEeCCCCCHHHHHHHccc--cCCHHHHHHHHHHHHHHHHHHH---hCCCCCCccchheEEECCCCeEEECCCC
Confidence 4678999999999999999976422 3888999999999999999999 8899999999999999999999999999
Q ss_pred ceeecccCCC--CcccccccccccCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCC
Q 044494 83 VARLLNFDSS--NRTLLAGTYGYIAPELAYTMVVTEKSDVYSFGVVALEVLM-GKHPGELLS 141 (144)
Q Consensus 83 ~~~~~~~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~d~~slg~~l~~~~~-g~~p~~~~~ 141 (144)
++........ ......+++.|+|||.+....++.++|+||+|+++|++++ |..||...+
T Consensus 161 ~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~ 222 (325)
T 3kex_A 161 VADLLPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLR 222 (325)
T ss_dssp GGGGSCCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSC
T ss_pred cccccCcccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccC
Confidence 9986643222 2233457778999999998889999999999999999999 999998754
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2.8e-31 Score=182.98 Aligned_cols=137 Identities=41% Similarity=0.610 Sum_probs=117.1
Q ss_pred CCceEEEEEeeccCCCHHHHhhccc-ccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEee
Q 044494 2 HRKCMFLIYEYMEMGSLFCVLRTDE-EAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVAD 80 (144)
Q Consensus 2 ~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d 80 (144)
+++..++||||+++++|.+++.... ....+++..++.++.|++.|+.+|| +++++|+||||+||+++.++.++++|
T Consensus 106 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~D 182 (321)
T 2qkw_B 106 ERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLH---TRAIIHRDVKSINILLDENFVPKITD 182 (321)
T ss_dssp CTTCCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCSTTEEECTTCCEEECC
T ss_pred CCCeEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhc---CCCeecCCCCHHHEEECCCCCEEEee
Confidence 3567899999999999999987532 2235899999999999999999999 89999999999999999999999999
Q ss_pred ecceeecccCCC--CcccccccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCC
Q 044494 81 FGVARLLNFDSS--NRTLLAGTYGYIAPELAYTMVVTEKSDVYSFGVVALEVLMGKHPGELLS 141 (144)
Q Consensus 81 ~~~~~~~~~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~d~~slg~~l~~~~~g~~p~~~~~ 141 (144)
||++........ ......+++.|+|||.+....++.++|+||+|+++++|++|..||....
T Consensus 183 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~ 245 (321)
T 2qkw_B 183 FGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSL 245 (321)
T ss_dssp CTTCEECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSS
T ss_pred cccccccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccC
Confidence 999986542211 2233558999999999988889999999999999999999999997643
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=99.97 E-value=2.8e-31 Score=185.47 Aligned_cols=131 Identities=26% Similarity=0.324 Sum_probs=114.3
Q ss_pred CceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcC----------
Q 044494 3 RKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNL---------- 72 (144)
Q Consensus 3 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~---------- 72 (144)
.+.+++||||+ +++|.+++..... ..+++..+..++.|++.||.||| ++|++||||||+||+++.
T Consensus 108 ~~~~~lv~e~~-~~~L~~~~~~~~~-~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~~~~~~~~~~ 182 (360)
T 3llt_A 108 YDHMCLIFEPL-GPSLYEIITRNNY-NGFHIEDIKLYCIEILKALNYLR---KMSLTHTDLKPENILLDDPYFEKSLITV 182 (360)
T ss_dssp TTEEEEEECCC-CCBHHHHHHHTTT-CCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESCTTCCEEEEEE
T ss_pred CCeeEEEEcCC-CCCHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCcccEEEccccccccccch
Confidence 46789999999 8899999976432 34899999999999999999999 899999999999999975
Q ss_pred ---------------CCCeEEeeecceeecccCCCCcccccccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCC
Q 044494 73 ---------------ELEAFVADFGVARLLNFDSSNRTLLAGTYGYIAPELAYTMVVTEKSDVYSFGVVALEVLMGKHPG 137 (144)
Q Consensus 73 ---------------~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~d~~slg~~l~~~~~g~~p~ 137 (144)
++.++|+|||++..... ......+++.|+|||++.+..++.++|+||+|+++++|++|..||
T Consensus 183 ~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf 259 (360)
T 3llt_A 183 RRVTDGKKIQIYRTKSTGIKLIDFGCATFKSD---YHGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGSLLF 259 (360)
T ss_dssp ECTTTCCEEEEEEESCCCEEECCCTTCEETTS---CCCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSC
T ss_pred hcccccccccccccCCCCEEEEeccCceecCC---CCcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHHHCCCCC
Confidence 78899999999986442 233456899999999999999999999999999999999999999
Q ss_pred CCCC
Q 044494 138 ELLS 141 (144)
Q Consensus 138 ~~~~ 141 (144)
...+
T Consensus 260 ~~~~ 263 (360)
T 3llt_A 260 RTHE 263 (360)
T ss_dssp CCSS
T ss_pred CCCc
Confidence 7643
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.2e-31 Score=184.99 Aligned_cols=134 Identities=41% Similarity=0.692 Sum_probs=116.2
Q ss_pred CCceEEEEEeeccCCCHHHHhhccc-ccCCCCHHHHHHHHHHHHHHHHHHhcCCCC---CeEecCCCCCcEEEcCCCCeE
Q 044494 2 HRKCMFLIYEYMEMGSLFCVLRTDE-EAVGLDWAKRVNIVKGMAHALSYLHHDCTP---PIVHRDISSNNILLNLELEAF 77 (144)
Q Consensus 2 ~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~---~~~h~~i~~~ni~~~~~~~~~ 77 (144)
..+..++||||+.+|+|.+++.... ....+++..+..++.|++.|+.+|| +. +++|+||||+||+++.++.++
T Consensus 98 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~~~~ivH~Dlkp~Nil~~~~~~~k 174 (326)
T 3uim_A 98 TPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLH---DHCDPKIIHRDVKAANILLDEEFEAV 174 (326)
T ss_dssp CSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHH---HSSSSCEECCCCSGGGEEECTTCCEE
T ss_pred cCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHH---hCCCCCeEeCCCchhhEEECCCCCEE
Confidence 3466799999999999999997643 3345899999999999999999999 66 999999999999999999999
Q ss_pred EeeecceeecccCCCC-cccccccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCC
Q 044494 78 VADFGVARLLNFDSSN-RTLLAGTYGYIAPELAYTMVVTEKSDVYSFGVVALEVLMGKHPGE 138 (144)
Q Consensus 78 l~d~~~~~~~~~~~~~-~~~~~~~~~~~~pe~~~~~~~~~~~d~~slg~~l~~~~~g~~p~~ 138 (144)
|+|||++......... .....+++.|+|||.+....++.++|+||+|+++++|++|..||+
T Consensus 175 l~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~ 236 (326)
T 3uim_A 175 VGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFD 236 (326)
T ss_dssp ECCCSSCEECCSSSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBC
T ss_pred eccCccccccCcccccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCccc
Confidence 9999999876533222 233458999999999988889999999999999999999999996
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2.7e-32 Score=191.50 Aligned_cols=129 Identities=12% Similarity=0.114 Sum_probs=108.6
Q ss_pred ceEEEEEeeccCCCHHHHhhcccccCCCCHHHH------HHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeE
Q 044494 4 KCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKR------VNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAF 77 (144)
Q Consensus 4 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~------~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~ 77 (144)
+++|+||||+. ++|.+++...... +.+... ..++.|++.||.||| +++++||||||+||+++.++.++
T Consensus 161 ~~~~lv~e~~~-~~L~~~l~~~~~~--~~~~~~~~~~vk~~i~~qi~~aL~~LH---~~~ivHrDikp~NIll~~~~~~k 234 (371)
T 3q60_A 161 ANYLLLMPAAS-VDLELLFSTLDFV--YVFRGDEGILALHILTAQLIRLAANLQ---SKGLVHGHFTPDNLFIMPDGRLM 234 (371)
T ss_dssp EEEEEEECCCS-EEHHHHHHHHHHS--CCCCHHHHHHHHHHHHHHHHHHHHHHH---HTTEEETTCSGGGEEECTTSCEE
T ss_pred eeEEEEecCCC-CCHHHHHHHhccc--cchhhhhhhhhHHHHHHHHHHHHHHHH---HCCCccCcCCHHHEEECCCCCEE
Confidence 45899999998 7999999864322 344444 567799999999999 89999999999999999999999
Q ss_pred EeeecceeecccCCCCcccccccccccCcccccc--CCCCCcchhHHHHHHHHHHHhCCCCCCCCC
Q 044494 78 VADFGVARLLNFDSSNRTLLAGTYGYIAPELAYT--MVVTEKSDVYSFGVVALEVLMGKHPGELLS 141 (144)
Q Consensus 78 l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~--~~~~~~~d~~slg~~l~~~~~g~~p~~~~~ 141 (144)
|+|||++..... ......+++.|+|||.+.. ..++.++|+||+|+++|+|++|..||...+
T Consensus 235 L~DFG~a~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~ 297 (371)
T 3q60_A 235 LGDVSALWKVGT---RGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVT 297 (371)
T ss_dssp ECCGGGEEETTC---EEEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCSTTBCC
T ss_pred EEecceeeecCC---CccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCCCCCcC
Confidence 999999986542 1213456699999999987 678999999999999999999999998763
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=99.97 E-value=2.2e-31 Score=183.60 Aligned_cols=132 Identities=28% Similarity=0.383 Sum_probs=116.1
Q ss_pred CceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCC----CeEE
Q 044494 3 RKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLEL----EAFV 78 (144)
Q Consensus 3 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~----~~~l 78 (144)
++.+++||||+++++|.+++..... +++..++.++.|++.|+.+|| +.|++|+||||+||+++.++ .+++
T Consensus 87 ~~~~~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~i~~qi~~aL~~lH---~~~ivH~dikp~NIl~~~~~~~~~~~kl 160 (321)
T 2a2a_A 87 RTDVVLILELVSGGELFDFLAQKES---LSEEEATSFIKQILDGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKL 160 (321)
T ss_dssp SSEEEEEECCCCSCBHHHHHHTCSC---EEHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESCTTSSSCCEEE
T ss_pred CCEEEEEEEcCCCCcHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHH---hCCeecCCCChHHEEEecCCCCcCCEEE
Confidence 5678999999999999999976433 899999999999999999999 88999999999999999887 7999
Q ss_pred eeecceeecccCCCCcccccccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCC
Q 044494 79 ADFGVARLLNFDSSNRTLLAGTYGYIAPELAYTMVVTEKSDVYSFGVVALEVLMGKHPGELLS 141 (144)
Q Consensus 79 ~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~d~~slg~~l~~~~~g~~p~~~~~ 141 (144)
+|||++....... ......+++.|+|||.+.+..++.++|+||+|+++++|++|..||...+
T Consensus 161 ~Dfg~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~ 222 (321)
T 2a2a_A 161 IDFGLAHEIEDGV-EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDT 222 (321)
T ss_dssp CCCTTCEECCTTC-CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSS
T ss_pred ccCccceecCccc-cccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCC
Confidence 9999998765322 2334568999999999998889999999999999999999999997643
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=8.5e-32 Score=186.14 Aligned_cols=134 Identities=34% Similarity=0.485 Sum_probs=112.9
Q ss_pred CceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeeec
Q 044494 3 RKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADFG 82 (144)
Q Consensus 3 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~~ 82 (144)
++..|+||||+++++|.++++... ..+++..++.++.|++.||.+|| +.+++|+||||+||+++.++.++|+|||
T Consensus 122 ~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~kl~Dfg 196 (325)
T 3kul_A 122 GRLAMIVTEYMENGSLDTFLRTHD--GQFTIMQLVGMLRGVGAGMRYLS---DLGYVHRDLAARNVLVDSNLVCKVSDFG 196 (325)
T ss_dssp GGCCEEEEECCTTCBHHHHHHTTT--TCSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCS
T ss_pred CCccEEEeeCCCCCcHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHH---HCCeeCCCCCcceEEECCCCCEEECCCC
Confidence 467899999999999999997532 23899999999999999999999 8999999999999999999999999999
Q ss_pred ceeecccCCCCc---ccccccccccCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCC
Q 044494 83 VARLLNFDSSNR---TLLAGTYGYIAPELAYTMVVTEKSDVYSFGVVALEVLM-GKHPGELLS 141 (144)
Q Consensus 83 ~~~~~~~~~~~~---~~~~~~~~~~~pe~~~~~~~~~~~d~~slg~~l~~~~~-g~~p~~~~~ 141 (144)
++.......... ....+++.|+|||.+....++.++|+||+|++++++++ |..||...+
T Consensus 197 ~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~ 259 (325)
T 3kul_A 197 LSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMT 259 (325)
T ss_dssp SCEECC----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSC
T ss_pred cccccccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCC
Confidence 998765332211 12335668999999998889999999999999999999 999997654
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=99.97 E-value=9.2e-32 Score=188.39 Aligned_cols=133 Identities=27% Similarity=0.357 Sum_probs=105.0
Q ss_pred CCceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCC--eEEe
Q 044494 2 HRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELE--AFVA 79 (144)
Q Consensus 2 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~--~~l~ 79 (144)
..+.+|+||||+++|+|.+++..... +++..+..++.|++.||+||| ++|++||||||+||+++.++. ++|+
T Consensus 87 ~~~~~~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~i~~ql~~~L~~LH---~~~ivH~Dlkp~Nill~~~~~~~~kl~ 160 (361)
T 3uc3_A 87 TPTHLAIIMEYASGGELYERICNAGR---FSEDEARFFFQQLLSGVSYCH---SMQICHRDLKLENTLLDGSPAPRLKIC 160 (361)
T ss_dssp CSSEEEEEEECCCSCBHHHHHHHHSS---CCHHHHHHHHHHHHHHHHHHH---HTTCCSCCCCGGGEEECSSSSCCEEEC
T ss_pred eCCEEEEEEEeCCCCCHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEcCCCCceEEEe
Confidence 35678999999999999999875443 899999999999999999999 899999999999999987765 9999
Q ss_pred eecceeecccCCCCcccccccccccCccccccCCCCCc-chhHHHHHHHHHHHhCCCCCCCCC
Q 044494 80 DFGVARLLNFDSSNRTLLAGTYGYIAPELAYTMVVTEK-SDVYSFGVVALEVLMGKHPGELLS 141 (144)
Q Consensus 80 d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~-~d~~slg~~l~~~~~g~~p~~~~~ 141 (144)
|||+++..... .......+++.|+|||++.+..+..+ +|+||+|+++|+|++|..||...+
T Consensus 161 Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~ 222 (361)
T 3uc3_A 161 DFGYSKSSVLH-SQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPE 222 (361)
T ss_dssp CCCCC----------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC---
T ss_pred ecCcccccccc-CCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCc
Confidence 99998743322 22334568999999999988877655 899999999999999999998654
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=2.6e-31 Score=184.43 Aligned_cols=133 Identities=26% Similarity=0.377 Sum_probs=115.6
Q ss_pred CCceEEEEEeeccCC-CHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEee
Q 044494 2 HRKCMFLIYEYMEMG-SLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVAD 80 (144)
Q Consensus 2 ~~~~~~lv~e~~~~~-~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d 80 (144)
.++.+++||||+.+| +|.+++..... +++..+..++.|++.|+.+|| +++++|+||||+||+++.++.++|+|
T Consensus 100 ~~~~~~lv~e~~~~g~~l~~~~~~~~~---l~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~D 173 (335)
T 3dls_A 100 NQGFFQLVMEKHGSGLDLFAFIDRHPR---LDEPLASYIFRQLVSAVGYLR---LKDIIHRDIKDENIVIAEDFTIKLID 173 (335)
T ss_dssp CSSEEEEEEECCTTSCBHHHHHHTCCC---CCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECC
T ss_pred eCCEEEEEEEeCCCCccHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHH---hCCeEEeccCHHHEEEcCCCcEEEee
Confidence 356789999999777 99998876443 899999999999999999999 88999999999999999999999999
Q ss_pred ecceeecccCCCCcccccccccccCccccccCCC-CCcchhHHHHHHHHHHHhCCCCCCCCC
Q 044494 81 FGVARLLNFDSSNRTLLAGTYGYIAPELAYTMVV-TEKSDVYSFGVVALEVLMGKHPGELLS 141 (144)
Q Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~-~~~~d~~slg~~l~~~~~g~~p~~~~~ 141 (144)
||++...... .......+++.|+|||++.+..+ +.++|+||+|+++|+|++|..||....
T Consensus 174 fg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~ 234 (335)
T 3dls_A 174 FGSAAYLERG-KLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELE 234 (335)
T ss_dssp CTTCEECCTT-CCBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGG
T ss_pred cccceECCCC-CceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHH
Confidence 9999876532 22334668999999999988876 778999999999999999999997643
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=99.97 E-value=1.1e-31 Score=182.56 Aligned_cols=133 Identities=26% Similarity=0.375 Sum_probs=110.2
Q ss_pred CceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeeec
Q 044494 3 RKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADFG 82 (144)
Q Consensus 3 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~~ 82 (144)
++.+++||||+.+ +|.+++.... ..+++..+..++.|++.|+.+|| ++|++|+||||+||+++.++.++++|||
T Consensus 72 ~~~~~lv~e~~~~-~l~~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg 145 (288)
T 1ob3_A 72 KKRLVLVFEHLDQ-DLKKLLDVCE--GGLESVTAKSFLLQLLNGIAYCH---DRRVLHRDLKPQNLLINREGELKIADFG 145 (288)
T ss_dssp SSCEEEEEECCSE-EHHHHHHTST--TCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECCTT
T ss_pred CCeEEEEEEecCC-CHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCCEEEeECc
Confidence 5678999999975 9998887532 23899999999999999999999 8999999999999999999999999999
Q ss_pred ceeecccCCCCcccccccccccCccccccC-CCCCcchhHHHHHHHHHHHhCCCCCCCCC
Q 044494 83 VARLLNFDSSNRTLLAGTYGYIAPELAYTM-VVTEKSDVYSFGVVALEVLMGKHPGELLS 141 (144)
Q Consensus 83 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~-~~~~~~d~~slg~~l~~~~~g~~p~~~~~ 141 (144)
++..............+++.|+|||.+.+. .++.++|+||+|+++++|++|..||...+
T Consensus 146 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~ 205 (288)
T 1ob3_A 146 LARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVS 205 (288)
T ss_dssp HHHHHCC---------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred cccccCccccccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 998665333333445689999999998764 57899999999999999999999997643
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=4.2e-31 Score=179.23 Aligned_cols=132 Identities=30% Similarity=0.499 Sum_probs=116.5
Q ss_pred CCceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeee
Q 044494 2 HRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADF 81 (144)
Q Consensus 2 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~ 81 (144)
+++..|+||||+++++|.+++..... +++..+..++.|++.|+.+|| +.|++|+||+|+||+++.++.++++||
T Consensus 85 ~~~~~~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~Df 158 (284)
T 2vgo_A 85 DRKRIYLMLEFAPRGELYKELQKHGR---FDEQRSATFMEELADALHYCH---ERKVIHRDIKPENLLMGYKGELKIADF 158 (284)
T ss_dssp CSSEEEEEECCCTTEEHHHHHHHHSS---CCHHHHHHHHHHHHHHHHHHH---TTTEECCCCSGGGEEECTTCCEEECCC
T ss_pred cCCEEEEEEEeCCCCcHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHH---HCCceecCCCHHHEEEcCCCCEEEecc
Confidence 35678999999999999999976443 899999999999999999999 899999999999999999999999999
Q ss_pred cceeecccCCCCcccccccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCC
Q 044494 82 GVARLLNFDSSNRTLLAGTYGYIAPELAYTMVVTEKSDVYSFGVVALEVLMGKHPGELLS 141 (144)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~d~~slg~~l~~~~~g~~p~~~~~ 141 (144)
|.+..... .......+++.|+|||.+.+..++.++|+||+|++++++++|..||...+
T Consensus 159 g~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~ 216 (284)
T 2vgo_A 159 GWSVHAPS--LRRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPS 216 (284)
T ss_dssp TTCEECSS--SCBCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSS
T ss_pred cccccCcc--cccccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCC
Confidence 99876542 22334568999999999999889999999999999999999999997643
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=2.4e-31 Score=183.75 Aligned_cols=133 Identities=22% Similarity=0.304 Sum_probs=108.7
Q ss_pred CceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeeec
Q 044494 3 RKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADFG 82 (144)
Q Consensus 3 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~~ 82 (144)
++.+++||||+. ++|.+++.... ..+++..+..++.|++.|+.+|| +.|++|+||||+||+++.++.++|+|||
T Consensus 72 ~~~~~lv~e~~~-~~l~~~~~~~~--~~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg 145 (324)
T 3mtl_A 72 EKSLTLVFEYLD-KDLKQYLDDCG--NIINMHNVKLFLFQLLRGLAYCH---RQKVLHRDLKPQNLLINERGELKLADFG 145 (324)
T ss_dssp SSCEEEEEECCS-EEHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHH---HTTEEESSCCGGGEEECTTCCEEECSSS
T ss_pred CCEEEEEecccc-cCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHH---HCCccCCCcCHHHEEECCCCCEEEccCc
Confidence 567899999997 58998887533 23899999999999999999999 8999999999999999999999999999
Q ss_pred ceeecccCCCCcccccccccccCcccccc-CCCCCcchhHHHHHHHHHHHhCCCCCCCCC
Q 044494 83 VARLLNFDSSNRTLLAGTYGYIAPELAYT-MVVTEKSDVYSFGVVALEVLMGKHPGELLS 141 (144)
Q Consensus 83 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~-~~~~~~~d~~slg~~l~~~~~g~~p~~~~~ 141 (144)
++..............+++.|+|||.+.+ ..++.++|+||+|+++++|++|..||.+.+
T Consensus 146 ~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~ 205 (324)
T 3mtl_A 146 LARAKSIPTKTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGST 205 (324)
T ss_dssp EEECC------------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred ccccccCCccccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 99865544434444568999999999876 567899999999999999999999997754
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=5.1e-31 Score=178.18 Aligned_cols=132 Identities=23% Similarity=0.333 Sum_probs=114.7
Q ss_pred CCceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEE---cCCCCeEE
Q 044494 2 HRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILL---NLELEAFV 78 (144)
Q Consensus 2 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~---~~~~~~~l 78 (144)
.++..++||||+++++|.+++..... +++..++.++.|++.++.+|| +++++|+||||+||++ +.++.+++
T Consensus 77 ~~~~~~lv~e~~~~~~L~~~~~~~~~---~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~~~~l 150 (277)
T 3f3z_A 77 DNTDIYLVMELCTGGELFERVVHKRV---FRESDAARIMKDVLSAVAYCH---KLNVAHRDLKPENFLFLTDSPDSPLKL 150 (277)
T ss_dssp CSSEEEEEEECCCSCBHHHHHHHHCS---CCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESSSSTTCCEEE
T ss_pred cCCeEEEEEeccCCCcHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHH---HCCccCCCCCHHHEEEecCCCCCcEEE
Confidence 35678999999999999998875433 899999999999999999999 8999999999999999 77889999
Q ss_pred eeecceeecccCCCCcccccccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCC
Q 044494 79 ADFGVARLLNFDSSNRTLLAGTYGYIAPELAYTMVVTEKSDVYSFGVVALEVLMGKHPGELLS 141 (144)
Q Consensus 79 ~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~d~~slg~~l~~~~~g~~p~~~~~ 141 (144)
+|||.+...... .......+++.|+|||.+.+. ++.++|+||+|+++++|++|..||...+
T Consensus 151 ~Dfg~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~ 211 (277)
T 3f3z_A 151 IDFGLAARFKPG-KMMRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPT 211 (277)
T ss_dssp CCCTTCEECCTT-SCBCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred EecccceeccCc-cchhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCC
Confidence 999999876532 233445689999999998765 7899999999999999999999998654
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2.3e-31 Score=184.03 Aligned_cols=135 Identities=26% Similarity=0.397 Sum_probs=113.4
Q ss_pred CCceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcC---CCCeEE
Q 044494 2 HRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNL---ELEAFV 78 (144)
Q Consensus 2 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~---~~~~~l 78 (144)
..+.+|+||||+++|+|.+++.... ...+++..++.++.|++.||.+|| ++|++|+||||+||+++. ++.++|
T Consensus 100 ~~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~i~~ql~~~L~~LH---~~givH~Dikp~NIl~~~~~~~~~~kL 175 (327)
T 3lm5_A 100 NTSEIILILEYAAGGEIFSLCLPEL-AEMVSENDVIRLIKQILEGVYYLH---QNNIVHLDLKPQNILLSSIYPLGDIKI 175 (327)
T ss_dssp CSSEEEEEEECCTTEEGGGGGSSCC--CCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEESCBTTBCCEEE
T ss_pred eCCeEEEEEEecCCCcHHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHH---HCCeecCcCChHHEEEecCCCCCcEEE
Confidence 3567899999999999999886532 234899999999999999999999 899999999999999987 789999
Q ss_pred eeecceeecccCCCCcccccccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCC
Q 044494 79 ADFGVARLLNFDSSNRTLLAGTYGYIAPELAYTMVVTEKSDVYSFGVVALEVLMGKHPGELLS 141 (144)
Q Consensus 79 ~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~d~~slg~~l~~~~~g~~p~~~~~ 141 (144)
+|||++....... ......+++.|+|||.+....++.++|+||+|+++++|++|..||...+
T Consensus 176 ~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~ 237 (327)
T 3lm5_A 176 VDFGMSRKIGHAC-ELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGED 237 (327)
T ss_dssp CCGGGCEEC----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred eeCccccccCCcc-ccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 9999998765322 2334568999999999999999999999999999999999999997643
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=2.2e-31 Score=187.58 Aligned_cols=137 Identities=27% Similarity=0.402 Sum_probs=117.2
Q ss_pred CCceEEEEEeeccCCCHHHHhhcccc-------------cCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcE
Q 044494 2 HRKCMFLIYEYMEMGSLFCVLRTDEE-------------AVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNI 68 (144)
Q Consensus 2 ~~~~~~lv~e~~~~~~L~~~l~~~~~-------------~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni 68 (144)
.++.+++||||+++|+|.+++..... ...+++..++.++.|++.||.+|| +.+++||||||+||
T Consensus 146 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NI 222 (382)
T 3tt0_A 146 QDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNV 222 (382)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGE
T ss_pred cCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCcceE
Confidence 35678999999999999999976431 234899999999999999999999 88999999999999
Q ss_pred EEcCCCCeEEeeecceeecccCC--CCcccccccccccCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCC
Q 044494 69 LLNLELEAFVADFGVARLLNFDS--SNRTLLAGTYGYIAPELAYTMVVTEKSDVYSFGVVALEVLM-GKHPGELLS 141 (144)
Q Consensus 69 ~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~~~~~pe~~~~~~~~~~~d~~slg~~l~~~~~-g~~p~~~~~ 141 (144)
+++.++.++|+|||++....... .......+++.|+|||.+.+..++.++|+||+|+++++|++ |..||...+
T Consensus 223 ll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~ 298 (382)
T 3tt0_A 223 LVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP 298 (382)
T ss_dssp EECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred EEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCC
Confidence 99999999999999998654322 12233456788999999999989999999999999999999 999998654
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.97 E-value=5.1e-31 Score=182.38 Aligned_cols=130 Identities=32% Similarity=0.468 Sum_probs=110.1
Q ss_pred ceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCC--------CeEecCCCCCcEEEcCCCC
Q 044494 4 KCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTP--------PIVHRDISSNNILLNLELE 75 (144)
Q Consensus 4 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~--------~~~h~~i~~~ni~~~~~~~ 75 (144)
+.+|+||||+++|+|.++++.. .+++..++.++.|++.|+.+|| +. +++||||||+||+++.++.
T Consensus 108 ~~~~lv~e~~~~g~L~~~l~~~----~~~~~~~~~i~~~i~~~l~~lH---~~~~~~~~~~~ivH~Dikp~Nill~~~~~ 180 (337)
T 3mdy_A 108 TQLYLITDYHENGSLYDYLKST----TLDAKSMLKLAYSSVSGLCHLH---TEIFSTQGKPAIAHRDLKSKNILVKKNGT 180 (337)
T ss_dssp CEEEEEECCCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHH---SCBCSTTCBCCEECSCCCGGGEEECTTSC
T ss_pred CceEEEEeccCCCcHHHHhhcc----CCCHHHHHHHHHHHHHHHHHHH---HhhhhhccCCCEEecccchHHEEECCCCC
Confidence 5789999999999999999753 3899999999999999999999 77 9999999999999999999
Q ss_pred eEEeeecceeecccCCCC----cccccccccccCccccccCCCCCc------chhHHHHHHHHHHHhC----------CC
Q 044494 76 AFVADFGVARLLNFDSSN----RTLLAGTYGYIAPELAYTMVVTEK------SDVYSFGVVALEVLMG----------KH 135 (144)
Q Consensus 76 ~~l~d~~~~~~~~~~~~~----~~~~~~~~~~~~pe~~~~~~~~~~------~d~~slg~~l~~~~~g----------~~ 135 (144)
++|+|||++......... .....+++.|+|||.+.......+ +|+||+|+++|+|++| ..
T Consensus 181 ~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~ 260 (337)
T 3mdy_A 181 CCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQL 260 (337)
T ss_dssp EEECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCC
T ss_pred EEEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccc
Confidence 999999999765432221 124568999999999987766554 8999999999999999 67
Q ss_pred CCCCC
Q 044494 136 PGELL 140 (144)
Q Consensus 136 p~~~~ 140 (144)
||...
T Consensus 261 p~~~~ 265 (337)
T 3mdy_A 261 PYHDL 265 (337)
T ss_dssp TTTTT
T ss_pred cHhhh
Confidence 77654
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=99.97 E-value=3.6e-31 Score=191.31 Aligned_cols=134 Identities=22% Similarity=0.331 Sum_probs=116.3
Q ss_pred CceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEE---cCCCCeEEe
Q 044494 3 RKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILL---NLELEAFVA 79 (144)
Q Consensus 3 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~---~~~~~~~l~ 79 (144)
.+..++||||+ +++|.+++.... ..+++..++.++.|++.||.||| +++++||||||+||++ +.++.++|+
T Consensus 75 ~~~~~lvme~~-g~sL~~ll~~~~--~~l~~~~~~~i~~qi~~aL~yLH---~~gIvHrDIKP~NILl~~~~~~~~vkL~ 148 (483)
T 3sv0_A 75 GDYNVLVMDLL-GPSLEDLFNFCS--RKLSLKTVLMLADQMINRVEFVH---SKSFLHRDIKPDNFLMGLGRRANQVYII 148 (483)
T ss_dssp TTEEEEEEECC-CCBHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECCGGGTTCEEEC
T ss_pred CCEEEEEEECC-CCCHHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccCcceEEEecCCCCCeEEEE
Confidence 46779999999 899999997532 23999999999999999999999 8999999999999999 578899999
Q ss_pred eecceeecccCCCC-------cccccccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCC
Q 044494 80 DFGVARLLNFDSSN-------RTLLAGTYGYIAPELAYTMVVTEKSDVYSFGVVALEVLMGKHPGELLSS 142 (144)
Q Consensus 80 d~~~~~~~~~~~~~-------~~~~~~~~~~~~pe~~~~~~~~~~~d~~slg~~l~~~~~g~~p~~~~~~ 142 (144)
|||++......... .....+++.|++||.+.+..++.++|+||||+++|+|++|..||...+.
T Consensus 149 DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~ 218 (483)
T 3sv0_A 149 DFGLAKKYRDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKA 218 (483)
T ss_dssp CCTTCEECBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCC
T ss_pred eCCcceeccCCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccc
Confidence 99999876533221 2246789999999999999999999999999999999999999987654
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.7e-31 Score=183.19 Aligned_cols=133 Identities=26% Similarity=0.286 Sum_probs=109.7
Q ss_pred CceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeeec
Q 044494 3 RKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADFG 82 (144)
Q Consensus 3 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~~ 82 (144)
++..++||||+.+++|.+++..... +++..+..++.|++.|+.+|| +.|++|+||||+||+++.++.++++|||
T Consensus 74 ~~~~~lv~e~~~~~~l~~~~~~~~~---~~~~~~~~i~~~l~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg 147 (311)
T 4agu_A 74 KRRLHLVFEYCDHTVLHELDRYQRG---VPEHLVKSITWQTLQAVNFCH---KHNCIHRDVKPENILITKHSVIKLCDFG 147 (311)
T ss_dssp TTEEEEEEECCSEEHHHHHHHTSSC---CCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCT
T ss_pred CCeEEEEEEeCCCchHHHHHhhhcC---CCHHHHHHHHHHHHHHHHHHH---HCCCcCCCCChhhEEEcCCCCEEEeeCC
Confidence 4678999999999999888765433 899999999999999999999 8999999999999999999999999999
Q ss_pred ceeecccCCCCcccccccccccCcccccc-CCCCCcchhHHHHHHHHHHHhCCCCCCCCC
Q 044494 83 VARLLNFDSSNRTLLAGTYGYIAPELAYT-MVVTEKSDVYSFGVVALEVLMGKHPGELLS 141 (144)
Q Consensus 83 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~-~~~~~~~d~~slg~~l~~~~~g~~p~~~~~ 141 (144)
.+..............+++.|+|||.+.+ ..++.++|+||+|++++++++|..||...+
T Consensus 148 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 207 (311)
T 4agu_A 148 FARLLTGPSDYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKS 207 (311)
T ss_dssp TCEECC------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred CchhccCcccccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCC
Confidence 99876543333445678999999999876 567899999999999999999999997754
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1e-31 Score=189.01 Aligned_cols=135 Identities=25% Similarity=0.384 Sum_probs=114.6
Q ss_pred CCceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeee
Q 044494 2 HRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADF 81 (144)
Q Consensus 2 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~ 81 (144)
.++.+|+||||+++|+|.++++... ..+++..+..++.|++.|++||| +++++||||||+||+++.++.++|+||
T Consensus 183 ~~~~~~lv~e~~~~g~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~LH---~~~ivHrDlkp~Nil~~~~~~~kl~Df 257 (377)
T 3cbl_A 183 QKQPIYIVMELVQGGDFLTFLRTEG--ARLRVKTLLQMVGDAAAGMEYLE---SKCCIHRDLAARNCLVTEKNVLKISDF 257 (377)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHHG--GGCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCG
T ss_pred cCCCcEEEEEcCCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHH---HCCcCCcccCHHHEEEcCCCcEEECcC
Confidence 3567899999999999999997533 23899999999999999999999 899999999999999999999999999
Q ss_pred cceeecccCC--CCcccccccccccCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCC
Q 044494 82 GVARLLNFDS--SNRTLLAGTYGYIAPELAYTMVVTEKSDVYSFGVVALEVLM-GKHPGELLS 141 (144)
Q Consensus 82 ~~~~~~~~~~--~~~~~~~~~~~~~~pe~~~~~~~~~~~d~~slg~~l~~~~~-g~~p~~~~~ 141 (144)
|+++...... .......+++.|+|||.+....++.++|+||+|+++||+++ |..||...+
T Consensus 258 G~s~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~ 320 (377)
T 3cbl_A 258 GMSREEADGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLS 320 (377)
T ss_dssp GGCEECTTSEEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSC
T ss_pred CCceecCCCceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC
Confidence 9997643211 11122335678999999998888999999999999999998 999998754
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=99.97 E-value=2.9e-31 Score=180.73 Aligned_cols=129 Identities=22% Similarity=0.319 Sum_probs=110.4
Q ss_pred CceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeeec
Q 044494 3 RKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADFG 82 (144)
Q Consensus 3 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~~ 82 (144)
++.+++||||+.+ ++.+.+.... ..+++..+..++.|++.|+.+|| ++|++|+||||+||+++.++.++++|||
T Consensus 73 ~~~~~lv~e~~~~-~l~~~~~~~~--~~l~~~~~~~~~~ql~~~l~~lH---~~~ivH~dikp~Nil~~~~~~~kl~Dfg 146 (292)
T 3o0g_A 73 DKKLTLVFEFCDQ-DLKKYFDSCN--GDLDPEIVKSFLFQLLKGLGFCH---SRNVLHRDLKPQNLLINRNGELKLANFG 146 (292)
T ss_dssp TTEEEEEEECCSE-EHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCT
T ss_pred CCEEEEEEecCCC-CHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEeecc
Confidence 5678999999976 6666665422 23999999999999999999999 8899999999999999999999999999
Q ss_pred ceeecccCCCCcccccccccccCccccccCC-CCCcchhHHHHHHHHHHHhCCCCC
Q 044494 83 VARLLNFDSSNRTLLAGTYGYIAPELAYTMV-VTEKSDVYSFGVVALEVLMGKHPG 137 (144)
Q Consensus 83 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~-~~~~~d~~slg~~l~~~~~g~~p~ 137 (144)
.+..............+++.|+|||.+.+.. ++.++|+||+|+++++|++|..||
T Consensus 147 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~ 202 (292)
T 3o0g_A 147 LARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPL 202 (292)
T ss_dssp TCEECCSCCSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCS
T ss_pred cceecCCccccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCC
Confidence 9987654444445567899999999998765 789999999999999999888775
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.1e-31 Score=185.77 Aligned_cols=128 Identities=28% Similarity=0.462 Sum_probs=107.5
Q ss_pred ceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCC---------CeEecCCCCCcEEEcCCC
Q 044494 4 KCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTP---------PIVHRDISSNNILLNLEL 74 (144)
Q Consensus 4 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~---------~~~h~~i~~~ni~~~~~~ 74 (144)
..+++||||+++|+|.+++.... .++..++.++.|++.||.||| +. +++||||||+||+++.++
T Consensus 85 ~~~~lv~e~~~~g~L~~~l~~~~----~~~~~~~~i~~qi~~~L~~LH---~~~~~~~~~~~~ivH~Dikp~Nill~~~~ 157 (336)
T 3g2f_A 85 MEYLLVMEYYPNGSLXKYLSLHT----SDWVSSCRLAHSVTRGLAYLH---TELPRGDHYKPAISHRDLNSRNVLVKNDG 157 (336)
T ss_dssp EEEEEEECCCTTCBHHHHHHHCC----BCHHHHHHHHHHHHHHHHHHH---CCBCCGGGCBCCEECSSCSGGGEEECTTS
T ss_pred ceEEEEEecCCCCcHHHHHhhcc----cchhHHHHHHHHHHHHHHHHH---hhhccccccccceeecccccceEEEcCCC
Confidence 46789999999999999997533 588889999999999999999 88 999999999999999999
Q ss_pred CeEEeeecceeecccCC--------CCcccccccccccCcccccc-------CCCCCcchhHHHHHHHHHHHhCCCCCC
Q 044494 75 EAFVADFGVARLLNFDS--------SNRTLLAGTYGYIAPELAYT-------MVVTEKSDVYSFGVVALEVLMGKHPGE 138 (144)
Q Consensus 75 ~~~l~d~~~~~~~~~~~--------~~~~~~~~~~~~~~pe~~~~-------~~~~~~~d~~slg~~l~~~~~g~~p~~ 138 (144)
.++|+|||++....... .......+++.|+|||++.+ ..++.++|+||+|+++|+|++|..||.
T Consensus 158 ~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~ 236 (336)
T 3g2f_A 158 TCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLF 236 (336)
T ss_dssp CEEECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGS
T ss_pred cEEEeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCC
Confidence 99999999998654221 11223468999999999986 345678999999999999999976653
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=3.7e-31 Score=179.12 Aligned_cols=131 Identities=35% Similarity=0.543 Sum_probs=112.7
Q ss_pred CceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeeec
Q 044494 3 RKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADFG 82 (144)
Q Consensus 3 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~~ 82 (144)
.+..++||||+++++|.+++..... +++..++.++.|++.++.+|| +.|++|+||+|+||+++.++.++++|||
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~---~~~~~~~~~~~qi~~~l~~LH---~~~i~H~dlkp~Nili~~~~~~~l~Dfg 154 (279)
T 3fdn_A 81 ATRVYLILEYAPLGTVYRELQKLSK---FDEQRTATYITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFG 154 (279)
T ss_dssp SSEEEEEECCCTTEEHHHHHHHHSS---CCHHHHHHHHHHHHHHHHHHH---TTTCEECCCCGGGEEECTTSCEEECSCC
T ss_pred CCEEEEEEecCCCCcHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHH---hCCEecccCChHhEEEcCCCCEEEEecc
Confidence 4678999999999999999876433 899999999999999999999 8999999999999999999999999999
Q ss_pred ceeecccCCCCcccccccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCC
Q 044494 83 VARLLNFDSSNRTLLAGTYGYIAPELAYTMVVTEKSDVYSFGVVALEVLMGKHPGELLS 141 (144)
Q Consensus 83 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~d~~slg~~l~~~~~g~~p~~~~~ 141 (144)
++..... .......+++.|+|||.+.+..++.++|+||+|+++++|++|..||...+
T Consensus 155 ~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 211 (279)
T 3fdn_A 155 WSVHAPS--SRRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANT 211 (279)
T ss_dssp EESCC----------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSS
T ss_pred ccccCCc--ccccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCc
Confidence 8865432 22234568999999999998888999999999999999999999998643
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.4e-31 Score=186.68 Aligned_cols=134 Identities=23% Similarity=0.271 Sum_probs=116.1
Q ss_pred CceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCC--CeEEee
Q 044494 3 RKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLEL--EAFVAD 80 (144)
Q Consensus 3 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~--~~~l~d 80 (144)
++..|+||||+ +++|.+++.... ...+++..++.++.|++.||.+|| +++++|+||||+||+++.++ .++|+|
T Consensus 130 ~~~~~lv~e~~-~~~L~~~l~~~~-~~~l~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dikp~NIl~~~~~~~~~kl~D 204 (352)
T 2jii_A 130 DKYRFLVLPSL-GRSLQSALDVSP-KHVLSERSVLQVACRLLDALEFLH---ENEYVHGNVTAENIFVDPEDQSQVTLAG 204 (352)
T ss_dssp TTEEEEEEECC-CEEHHHHHHHSG-GGCCCHHHHHHHHHHHHHHHHHHH---HTTCBCSCCCGGGEEEETTEEEEEEECC
T ss_pred CcEEEEEecCC-CcCHHHHHHhCC-cCCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCCHHHEEEcCCCCceEEEec
Confidence 57889999999 899999998642 234999999999999999999999 88999999999999999988 899999
Q ss_pred ecceeecccCCC-------CcccccccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCC
Q 044494 81 FGVARLLNFDSS-------NRTLLAGTYGYIAPELAYTMVVTEKSDVYSFGVVALEVLMGKHPGELLS 141 (144)
Q Consensus 81 ~~~~~~~~~~~~-------~~~~~~~~~~~~~pe~~~~~~~~~~~d~~slg~~l~~~~~g~~p~~~~~ 141 (144)
||++........ ......+++.|+|||.+.+..++.++|+||+|+++++|++|..||...+
T Consensus 205 fg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~ 272 (352)
T 2jii_A 205 YGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTNCL 272 (352)
T ss_dssp GGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGT
T ss_pred CcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcccCC
Confidence 999976543211 1123468999999999999889999999999999999999999998754
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.97 E-value=1.8e-31 Score=185.35 Aligned_cols=137 Identities=28% Similarity=0.437 Sum_probs=116.2
Q ss_pred CCceEEEEEeeccCCCHHHHhhccccc--------------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEec
Q 044494 2 HRKCMFLIYEYMEMGSLFCVLRTDEEA--------------------VGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHR 61 (144)
Q Consensus 2 ~~~~~~lv~e~~~~~~L~~~l~~~~~~--------------------~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~ 61 (144)
.++.+|+||||+++|+|.+++...... ..+++..++.++.|++.||.+|| +.|++|+
T Consensus 120 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~ 196 (344)
T 1rjb_A 120 LSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLE---FKSCVHR 196 (344)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHH---HTTEEET
T ss_pred eCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHH---hCCcccC
Confidence 356789999999999999999754321 23789999999999999999999 8999999
Q ss_pred CCCCCcEEEcCCCCeEEeeecceeecccCCCC--cccccccccccCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCC
Q 044494 62 DISSNNILLNLELEAFVADFGVARLLNFDSSN--RTLLAGTYGYIAPELAYTMVVTEKSDVYSFGVVALEVLM-GKHPGE 138 (144)
Q Consensus 62 ~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~--~~~~~~~~~~~~pe~~~~~~~~~~~d~~slg~~l~~~~~-g~~p~~ 138 (144)
||||+||+++.++.++|+|||++......... .....+++.|+|||.+....++.++|+||+|+++++|++ |..||.
T Consensus 197 Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~ 276 (344)
T 1rjb_A 197 DLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYP 276 (344)
T ss_dssp TCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSST
T ss_pred CCChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcc
Confidence 99999999999999999999999866433221 233456788999999998889999999999999999998 999998
Q ss_pred CCC
Q 044494 139 LLS 141 (144)
Q Consensus 139 ~~~ 141 (144)
..+
T Consensus 277 ~~~ 279 (344)
T 1rjb_A 277 GIP 279 (344)
T ss_dssp TCC
T ss_pred cCC
Confidence 764
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=4.7e-31 Score=180.46 Aligned_cols=132 Identities=33% Similarity=0.505 Sum_probs=117.5
Q ss_pred CceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeeec
Q 044494 3 RKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADFG 82 (144)
Q Consensus 3 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~~ 82 (144)
++.+|+||||+++++|.+++... .+++..+..++.|++.++.+|| +.|++|+||+|+||+++.++.++++|||
T Consensus 92 ~~~~~lv~e~~~~~~L~~~~~~~----~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~Dfg 164 (303)
T 3a7i_A 92 DTKLWIIMEYLGGGSALDLLEPG----PLDETQIATILREILKGLDYLH---SEKKIHRDIKAANVLLSEHGEVKLADFG 164 (303)
T ss_dssp TTEEEEEEECCTTEEHHHHHTTS----CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCT
T ss_pred CCeEEEEEEeCCCCcHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCChheEEECCCCCEEEeecc
Confidence 46789999999999999998742 3899999999999999999999 8899999999999999999999999999
Q ss_pred ceeecccCCCCcccccccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCC
Q 044494 83 VARLLNFDSSNRTLLAGTYGYIAPELAYTMVVTEKSDVYSFGVVALEVLMGKHPGELLS 141 (144)
Q Consensus 83 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~d~~slg~~l~~~~~g~~p~~~~~ 141 (144)
.+..............+++.|+|||.+....++.++|+||+|++++++++|..||...+
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 223 (303)
T 3a7i_A 165 VAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELH 223 (303)
T ss_dssp TCEECBTTBCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC
T ss_pred cceecCccccccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcC
Confidence 99876544434445678999999999998889999999999999999999999997643
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2.1e-31 Score=179.32 Aligned_cols=135 Identities=27% Similarity=0.468 Sum_probs=115.4
Q ss_pred CCceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeee
Q 044494 2 HRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADF 81 (144)
Q Consensus 2 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~ 81 (144)
+++..++||||+++++|.+++.... ..+++..++.++.|++.++.+|| +.+++|+||||+||+++.++.++++||
T Consensus 74 ~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~~l~Df 148 (268)
T 3sxs_A 74 KEYPIYIVTEYISNGCLLNYLRSHG--KGLEPSQLLEMCYDVCEGMAFLE---SHQFIHRDLAARNCLVDRDLCVKVSDF 148 (268)
T ss_dssp SSSSEEEEEECCTTCBHHHHHHHHG--GGCCHHHHHHHHHHHHHHHHHHH---HTTEEESSCSGGGEEECTTCCEEECCT
T ss_pred cCCceEEEEEccCCCcHHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCcCcceEEECCCCCEEEccC
Confidence 3567899999999999999997533 23899999999999999999999 899999999999999999999999999
Q ss_pred cceeecccCCC-CcccccccccccCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCC
Q 044494 82 GVARLLNFDSS-NRTLLAGTYGYIAPELAYTMVVTEKSDVYSFGVVALEVLM-GKHPGELLS 141 (144)
Q Consensus 82 ~~~~~~~~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~d~~slg~~l~~~~~-g~~p~~~~~ 141 (144)
|.+........ ......+++.|+|||.+.+..++.++|+||+|++++++++ |..||+..+
T Consensus 149 g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~ 210 (268)
T 3sxs_A 149 GMTRYVLDDQYVSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYT 210 (268)
T ss_dssp TCEEECCTTCEEECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSC
T ss_pred ccceecchhhhhcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccC
Confidence 99986543221 1222345677999999998888999999999999999999 999997654
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=3.1e-31 Score=181.96 Aligned_cols=135 Identities=28% Similarity=0.397 Sum_probs=109.5
Q ss_pred ceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCC-eEEeeec
Q 044494 4 KCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELE-AFVADFG 82 (144)
Q Consensus 4 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~-~~l~d~~ 82 (144)
+..++||||+++++|.+++........++...++.++.|++.|+.+||..+.++++|+||||+||+++.++. ++++|||
T Consensus 72 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg 151 (307)
T 2eva_A 72 NPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFG 151 (307)
T ss_dssp TTTEEEEECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCC
T ss_pred CCcEEEEEcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccc
Confidence 346899999999999999986554445889999999999999999999332289999999999999998887 7999999
Q ss_pred ceeecccCCCCcccccccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCC
Q 044494 83 VARLLNFDSSNRTLLAGTYGYIAPELAYTMVVTEKSDVYSFGVVALEVLMGKHPGELLS 141 (144)
Q Consensus 83 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~d~~slg~~l~~~~~g~~p~~~~~ 141 (144)
++...... .....+++.|+|||.+.+..++.++|+||+|+++++|++|..||....
T Consensus 152 ~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~ 207 (307)
T 2eva_A 152 TACDIQTH---MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIG 207 (307)
T ss_dssp C---------------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTC
T ss_pred cccccccc---cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhC
Confidence 98754422 223458999999999999889999999999999999999999997643
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=3.7e-31 Score=181.41 Aligned_cols=131 Identities=27% Similarity=0.338 Sum_probs=114.4
Q ss_pred eEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeeecce
Q 044494 5 CMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADFGVA 84 (144)
Q Consensus 5 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~~~~ 84 (144)
.+++||||+. ++|.+++..... ..+++..++.++.|++.|+.+|| +++++|+||||+||+++.++.++|+|||++
T Consensus 93 ~~~lv~e~~~-~~L~~~~~~~~~-~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a 167 (308)
T 3g33_A 93 KVTLVFEHVD-QDLRTYLDKAPP-PGLPAETIKDLMRQFLRGLDFLH---ANCIVHRDLKPENILVTSGGTVKLADFGLA 167 (308)
T ss_dssp EEEEEEECCC-CBHHHHHHTCCT-TCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCTTTEEECTTSCEEECSCSCT
T ss_pred eEEEEehhhh-cCHHHHHhhccC-CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEcCCCCEEEeeCccc
Confidence 5799999997 599999876432 34899999999999999999999 889999999999999999999999999999
Q ss_pred eecccCCCCcccccccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCC
Q 044494 85 RLLNFDSSNRTLLAGTYGYIAPELAYTMVVTEKSDVYSFGVVALEVLMGKHPGELLS 141 (144)
Q Consensus 85 ~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~d~~slg~~l~~~~~g~~p~~~~~ 141 (144)
..... ........+++.|+|||.+....++.++|+||+|+++++|++|..||...+
T Consensus 168 ~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~ 223 (308)
T 3g33_A 168 RIYSY-QMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNS 223 (308)
T ss_dssp TTSTT-CCCSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSS
T ss_pred cccCC-CcccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 76542 223344678999999999998889999999999999999999999997654
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2.1e-31 Score=191.93 Aligned_cols=128 Identities=27% Similarity=0.336 Sum_probs=106.8
Q ss_pred ceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeeecc
Q 044494 4 KCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADFGV 83 (144)
Q Consensus 4 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~~~ 83 (144)
+.+|+||||+.+ +|.+.+.. .+++..+..++.|++.||+||| +.|++||||||+||+++.++.++|+|||+
T Consensus 140 ~~~~lv~E~~~~-~l~~~~~~-----~l~~~~~~~~~~qil~aL~~lH---~~~iiHrDlkp~NIll~~~~~~kl~DFG~ 210 (464)
T 3ttj_A 140 QDVYLVMELMDA-NLCQVIQM-----ELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGL 210 (464)
T ss_dssp CEEEEEEECCSE-EHHHHHTS-----CCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCCCC
T ss_pred CeEEEEEeCCCC-CHHHHHhh-----cCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChHhEEEeCCCCEEEEEEEe
Confidence 467999999976 57666653 2889999999999999999999 88999999999999999999999999999
Q ss_pred eeecccCCCCcccccccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCC
Q 044494 84 ARLLNFDSSNRTLLAGTYGYIAPELAYTMVVTEKSDVYSFGVVALEVLMGKHPGELLS 141 (144)
Q Consensus 84 ~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~d~~slg~~l~~~~~g~~p~~~~~ 141 (144)
++..... .......+++.|+|||++.+..++.++|+||+|+++++|++|..||.+.+
T Consensus 211 a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~ 267 (464)
T 3ttj_A 211 ARTAGTS-FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRD 267 (464)
T ss_dssp C-----C-CCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred eeecCCC-cccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 9865532 22344678999999999999999999999999999999999999998754
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=99.97 E-value=3.5e-31 Score=190.10 Aligned_cols=132 Identities=27% Similarity=0.394 Sum_probs=113.5
Q ss_pred ceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeeecc
Q 044494 4 KCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADFGV 83 (144)
Q Consensus 4 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~~~ 83 (144)
+.+|+||||+++|+|.++++.... ..+++..++.++.|++.||.||| +++++||||||+||+++.++.++|+|||+
T Consensus 260 ~~~~iv~e~~~~g~L~~~l~~~~~-~~~~~~~~~~~~~qi~~~l~~LH---~~~ivHrDlkp~Nill~~~~~~kl~DfG~ 335 (450)
T 1k9a_A 260 GGLYIVTEYMAKGSLVDYLRSRGR-SVLGGDCLLKFSLDVCEAMEYLE---GNNFVHRDLAARNVLVSEDNVAKVSDFGL 335 (450)
T ss_dssp SCEEEEEECCTTCBHHHHHHHHCT-TTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECTTSCEEECCCTT
T ss_pred CceEEEEEecCCCcHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCCHhhEEECCCCCEEEeeCCC
Confidence 478999999999999999986332 23789999999999999999999 89999999999999999999999999999
Q ss_pred eeecccCCCCcccccccccccCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCC
Q 044494 84 ARLLNFDSSNRTLLAGTYGYIAPELAYTMVVTEKSDVYSFGVVALEVLM-GKHPGELLSS 142 (144)
Q Consensus 84 ~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~d~~slg~~l~~~~~-g~~p~~~~~~ 142 (144)
++..... .....+++.|+|||.+....++.++|+||+|+++||+++ |..||...+.
T Consensus 336 a~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~ 392 (450)
T 1k9a_A 336 TKEASST---QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL 392 (450)
T ss_dssp CEECC---------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCT
T ss_pred ccccccc---ccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCH
Confidence 9854321 122356788999999999999999999999999999998 9999987654
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=99.97 E-value=5.6e-32 Score=190.32 Aligned_cols=129 Identities=19% Similarity=0.191 Sum_probs=106.6
Q ss_pred eEEEEEeeccCCCHHHHhhcccc----cCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEee
Q 044494 5 CMFLIYEYMEMGSLFCVLRTDEE----AVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVAD 80 (144)
Q Consensus 5 ~~~lv~e~~~~~~L~~~l~~~~~----~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d 80 (144)
..|+||||+ +|+|.+++..... ...+++..++.++.|++.||+||| +++++||||||+||+++.++.++|+|
T Consensus 174 ~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivHrDikp~NIll~~~~~~kL~D 249 (377)
T 3byv_A 174 SRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLH---HYGLVHTYLRPVDIVLDQRGGVFLTG 249 (377)
T ss_dssp SEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECTTCCEEECC
T ss_pred EEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEEe
Confidence 378999999 5799999976332 111334788889999999999999 88999999999999999999999999
Q ss_pred ecceeecccCCCCcccccccccccCccccccC-----------CCCCcchhHHHHHHHHHHHhCCCCCCCCC
Q 044494 81 FGVARLLNFDSSNRTLLAGTYGYIAPELAYTM-----------VVTEKSDVYSFGVVALEVLMGKHPGELLS 141 (144)
Q Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~-----------~~~~~~d~~slg~~l~~~~~g~~p~~~~~ 141 (144)
||++..... ......| +.|+|||++... .++.++|+||+|+++|+|++|..||...+
T Consensus 250 FG~a~~~~~---~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il~elltg~~Pf~~~~ 317 (377)
T 3byv_A 250 FEHLVRDGA---RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLPITKDA 317 (377)
T ss_dssp GGGCEETTC---EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHHHHHHHSSCCC----
T ss_pred chhheecCC---cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHHHHHHHHCCCCCcccc
Confidence 999986432 2334456 999999999887 78999999999999999999999997654
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=99.97 E-value=1.4e-31 Score=183.92 Aligned_cols=133 Identities=24% Similarity=0.416 Sum_probs=109.2
Q ss_pred CceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCC---eEEe
Q 044494 3 RKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELE---AFVA 79 (144)
Q Consensus 3 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~---~~l~ 79 (144)
++.+|+||||+++++|.+++.... .+++..+..++.|++.||.+|| +++++|+||||+||+++.++. ++++
T Consensus 83 ~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~~~~kl~ 156 (316)
T 2ac3_A 83 EDRFYLVFEKMRGGSILSHIHKRR---HFNELEASVVVQDVASALDFLH---NKGIAHRDLKPENILCEHPNQVSPVKIC 156 (316)
T ss_dssp TTEEEEEEECCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEESCSSSSCSEEEC
T ss_pred CCEEEEEEEcCCCCcHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHH---hCCceeCCCCHHHEEEccCCCcCceEEE
Confidence 567899999999999999997643 3899999999999999999999 889999999999999998765 9999
Q ss_pred eecceeecccCC-------CCcccccccccccCcccccc-----CCCCCcchhHHHHHHHHHHHhCCCCCCCCC
Q 044494 80 DFGVARLLNFDS-------SNRTLLAGTYGYIAPELAYT-----MVVTEKSDVYSFGVVALEVLMGKHPGELLS 141 (144)
Q Consensus 80 d~~~~~~~~~~~-------~~~~~~~~~~~~~~pe~~~~-----~~~~~~~d~~slg~~l~~~~~g~~p~~~~~ 141 (144)
|||++....... .......+++.|+|||.+.. ..++.++|+||+|+++++|++|..||...+
T Consensus 157 Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~ 230 (316)
T 2ac3_A 157 DFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRC 230 (316)
T ss_dssp CTTCCC-------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCC
T ss_pred EccCccccccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccc
Confidence 999987543211 11123458999999999875 457889999999999999999999998754
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=99.97 E-value=6e-31 Score=184.47 Aligned_cols=131 Identities=31% Similarity=0.503 Sum_probs=114.1
Q ss_pred CceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeeec
Q 044494 3 RKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADFG 82 (144)
Q Consensus 3 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~~ 82 (144)
.+..|+||||+++++|.+++.... .+++..+..++.|++.||.+|| +.|++|+||||.||+++.++.++++|||
T Consensus 172 ~~~~~lv~e~~~g~~L~~~l~~~~---~l~~~~~~~i~~qi~~~L~~LH---~~gi~H~Dlkp~NIl~~~~~~ikl~DfG 245 (365)
T 2y7j_A 172 SSFMFLVFDLMRKGELFDYLTEKV---ALSEKETRSIMRSLLEAVSFLH---ANNIVHRDLKPENILLDDNMQIRLSDFG 245 (365)
T ss_dssp SSEEEEEECCCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCT
T ss_pred CCEEEEEEEeCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEEEecC
Confidence 467899999999999999997543 3899999999999999999999 8899999999999999999999999999
Q ss_pred ceeecccCCCCcccccccccccCccccccC------CCCCcchhHHHHHHHHHHHhCCCCCCCC
Q 044494 83 VARLLNFDSSNRTLLAGTYGYIAPELAYTM------VVTEKSDVYSFGVVALEVLMGKHPGELL 140 (144)
Q Consensus 83 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~------~~~~~~d~~slg~~l~~~~~g~~p~~~~ 140 (144)
++...... .......+++.|+|||++.+. .++.++|+||+|+++|+|++|..||...
T Consensus 246 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~ 308 (365)
T 2y7j_A 246 FSCHLEPG-EKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHR 308 (365)
T ss_dssp TCEECCTT-CCBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred cccccCCC-cccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCC
Confidence 98876532 223446789999999998633 5778999999999999999999999754
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=5.7e-31 Score=180.77 Aligned_cols=134 Identities=32% Similarity=0.452 Sum_probs=117.8
Q ss_pred CceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeeec
Q 044494 3 RKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADFG 82 (144)
Q Consensus 3 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~~ 82 (144)
++.+|+||||+.+++|.+++.... ..+++..++.++.|++.|+.+|| +.|++|+||+|+||+++.++.++++|||
T Consensus 96 ~~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~dfg 170 (314)
T 3com_A 96 NTDLWIVMEYCGAGSVSDIIRLRN--KTLTEDEIATILQSTLKGLEYLH---FMRKIHRDIKAGNILLNTEGHAKLADFG 170 (314)
T ss_dssp TTEEEEEEECCTTEEHHHHHHHHT--CCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCT
T ss_pred CCEEEEEeecCCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHH---hCCCcCCCcCHHHEEECCCCCEEEeecc
Confidence 467899999999999999987422 23899999999999999999999 8999999999999999999999999999
Q ss_pred ceeecccCCCCcccccccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCC
Q 044494 83 VARLLNFDSSNRTLLAGTYGYIAPELAYTMVVTEKSDVYSFGVVALEVLMGKHPGELLS 141 (144)
Q Consensus 83 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~d~~slg~~l~~~~~g~~p~~~~~ 141 (144)
.+..............+++.|+|||.+....++.++|+||+|+++++|++|..||...+
T Consensus 171 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 229 (314)
T 3com_A 171 VAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIH 229 (314)
T ss_dssp TCEECBTTBSCBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSC
T ss_pred cchhhhhhccccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCC
Confidence 99876544333445668999999999998889999999999999999999999997643
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=8e-32 Score=188.00 Aligned_cols=108 Identities=29% Similarity=0.423 Sum_probs=94.5
Q ss_pred CCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeeecceeecccCCC--CcccccccccccCccc
Q 044494 31 LDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADFGVARLLNFDSS--NRTLLAGTYGYIAPEL 108 (144)
Q Consensus 31 ~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~~~~~~~pe~ 108 (144)
+++..++.++.|++.||.||| +++++|+||||+||+++.++.++|+|||++........ ......+++.|+|||.
T Consensus 190 l~~~~~~~~~~ql~~aL~~LH---~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~ 266 (359)
T 3vhe_A 190 LTLEHLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPET 266 (359)
T ss_dssp BCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTCEEC--CEECGGGCCHHH
T ss_pred cCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChhhEEEcCCCcEEEEeccceeeecccccchhccccCCCceeEChhh
Confidence 889999999999999999999 89999999999999999999999999999986543221 2233567889999999
Q ss_pred cccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCC
Q 044494 109 AYTMVVTEKSDVYSFGVVALEVLM-GKHPGELLS 141 (144)
Q Consensus 109 ~~~~~~~~~~d~~slg~~l~~~~~-g~~p~~~~~ 141 (144)
+....++.++|+||+|+++++|++ |..||...+
T Consensus 267 ~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~ 300 (359)
T 3vhe_A 267 IFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVK 300 (359)
T ss_dssp HHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCC
T ss_pred hcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccc
Confidence 998889999999999999999998 999998754
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2.5e-31 Score=181.38 Aligned_cols=133 Identities=33% Similarity=0.477 Sum_probs=111.1
Q ss_pred ceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcC-----CCCCeEecCCCCCcEEEcCCCCeEE
Q 044494 4 KCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHD-----CTPPIVHRDISSNNILLNLELEAFV 78 (144)
Q Consensus 4 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~-----~~~~~~h~~i~~~ni~~~~~~~~~l 78 (144)
+.+++||||+++|+|.++++.. .+++..++.++.|++.|+.+||.. ++.+++||||||+||+++.++.++|
T Consensus 79 ~~~~lv~e~~~~g~L~~~l~~~----~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~~~kl 154 (301)
T 3q4u_A 79 TQLWLITHYHEMGSLYDYLQLT----TLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCI 154 (301)
T ss_dssp EEEEEEECCCTTCBHHHHHTTC----CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTSCEEE
T ss_pred ceeEEehhhccCCCHHHHHhhc----ccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCCCEEE
Confidence 4689999999999999999643 389999999999999999999931 1468999999999999999999999
Q ss_pred eeecceeecccCCCC----cccccccccccCccccccC------CCCCcchhHHHHHHHHHHHhC----------CCCCC
Q 044494 79 ADFGVARLLNFDSSN----RTLLAGTYGYIAPELAYTM------VVTEKSDVYSFGVVALEVLMG----------KHPGE 138 (144)
Q Consensus 79 ~d~~~~~~~~~~~~~----~~~~~~~~~~~~pe~~~~~------~~~~~~d~~slg~~l~~~~~g----------~~p~~ 138 (144)
+|||++......... .....+++.|+|||.+... .++.++|+||+|+++|+|++| ..||.
T Consensus 155 ~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~ 234 (301)
T 3q4u_A 155 ADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFY 234 (301)
T ss_dssp CCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTT
T ss_pred eeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCcccccccccccc
Confidence 999999765432221 2234689999999999876 344689999999999999999 88886
Q ss_pred CC
Q 044494 139 LL 140 (144)
Q Consensus 139 ~~ 140 (144)
..
T Consensus 235 ~~ 236 (301)
T 3q4u_A 235 DV 236 (301)
T ss_dssp TT
T ss_pred cc
Confidence 54
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=8.3e-31 Score=179.45 Aligned_cols=136 Identities=37% Similarity=0.564 Sum_probs=116.3
Q ss_pred CCceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeee
Q 044494 2 HRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADF 81 (144)
Q Consensus 2 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~ 81 (144)
+++..++||||+++++|.+++........+++..++.++.|++.|+.+|| +.+++|+||||+||+++.++.++++||
T Consensus 101 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~kl~Df 177 (307)
T 2nru_A 101 DGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLH---ENHHIHRDIKSANILLDEAFTAKISDF 177 (307)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECTTCCEEECCC
T ss_pred cCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHh---cCCeecCCCCHHHEEEcCCCcEEEeec
Confidence 35678999999999999999976444455999999999999999999999 899999999999999999999999999
Q ss_pred cceeecccCCCC--cccccccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCC
Q 044494 82 GVARLLNFDSSN--RTLLAGTYGYIAPELAYTMVVTEKSDVYSFGVVALEVLMGKHPGELLS 141 (144)
Q Consensus 82 ~~~~~~~~~~~~--~~~~~~~~~~~~pe~~~~~~~~~~~d~~slg~~l~~~~~g~~p~~~~~ 141 (144)
|.+......... .....+++.|+|||.+.+. ++.++|+||+|+++++|++|..||...+
T Consensus 178 g~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~Dv~slG~il~~l~~g~~p~~~~~ 238 (307)
T 2nru_A 178 GLARASEKFAQTVMTSRIVGTTAYMAPEALRGE-ITPKSDIYSFGVVLLEIITGLPAVDEHR 238 (307)
T ss_dssp TTCEECCSCSSCEECSSCCSCGGGCCHHHHTTE-ECTHHHHHHHHHHHHHHHHCCCSBCTTB
T ss_pred ccccccccccccccccccCCCcCcCChHHhcCC-CCccchhHHHHHHHHHHHHCCCCcccCc
Confidence 998865432221 2234689999999988754 7889999999999999999999998654
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=9.3e-31 Score=177.38 Aligned_cols=132 Identities=26% Similarity=0.399 Sum_probs=114.8
Q ss_pred CceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCC---eEEe
Q 044494 3 RKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELE---AFVA 79 (144)
Q Consensus 3 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~---~~l~ 79 (144)
++..++||||+++++|.+.+..... +++..+..++.|++.++.+|| +.+++|+||||+||+++.++. ++++
T Consensus 77 ~~~~~~v~e~~~~~~l~~~~~~~~~---~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~~~~kl~ 150 (284)
T 3kk8_A 77 ESFHYLVFDLVTGGELFEDIVAREF---YSEADASHCIQQILESIAYCH---SNGIVHRNLKPENLLLASKAKGAAVKLA 150 (284)
T ss_dssp SSEEEEEECCCCSCBHHHHHHHHSS---CCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEESSSSTTCCEEEC
T ss_pred CCEEEEEEecCCCCCHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHH---HCCcCcCCCCHHHEEEecCCCCCcEEEe
Confidence 4678999999999999998875433 899999999999999999999 889999999999999987655 9999
Q ss_pred eecceeecccCCCCcccccccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCC
Q 044494 80 DFGVARLLNFDSSNRTLLAGTYGYIAPELAYTMVVTEKSDVYSFGVVALEVLMGKHPGELLS 141 (144)
Q Consensus 80 d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~d~~slg~~l~~~~~g~~p~~~~~ 141 (144)
|||.+...... .......+++.|+|||.+.+..++.++|+||+|++++++++|..||...+
T Consensus 151 Dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~ 211 (284)
T 3kk8_A 151 DFGLAIEVNDS-EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDED 211 (284)
T ss_dssp CCTTCEECCSS-CBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred eceeeEEcccC-ccccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCc
Confidence 99999765532 22334568999999999999989999999999999999999999996643
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=99.97 E-value=1.2e-30 Score=177.42 Aligned_cols=130 Identities=28% Similarity=0.442 Sum_probs=112.2
Q ss_pred CceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCC--eEecCCCCCcEEEc-CCCCeEEe
Q 044494 3 RKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPP--IVHRDISSNNILLN-LELEAFVA 79 (144)
Q Consensus 3 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~--~~h~~i~~~ni~~~-~~~~~~l~ 79 (144)
++.+++||||+++++|.+++..... +++..++.++.|++.++.+|| +.+ ++|+||||+||+++ .++.++|+
T Consensus 101 ~~~~~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~qi~~~l~~lH---~~~~~i~H~dikp~Nil~~~~~~~~kl~ 174 (290)
T 1t4h_A 101 KKCIVLVTELMTSGTLKTYLKRFKV---MKIKVLRSWCRQILKGLQFLH---TRTPPIIHRDLKCDNIFITGPTGSVKIG 174 (290)
T ss_dssp CEEEEEEEECCCSCBHHHHHHHHSS---CCHHHHHHHHHHHHHHHHHHH---TSSSCCCCSCCCGGGEEESSTTSCEEEC
T ss_pred CceEEEEEEecCCCCHHHHHHHccC---CCHHHHHHHHHHHHHHHHHHH---cCCCCEEECCCCHHHEEEECCCCCEEEe
Confidence 4568999999999999999976433 899999999999999999999 888 99999999999998 78899999
Q ss_pred eecceeecccCCCCcccccccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCC
Q 044494 80 DFGVARLLNFDSSNRTLLAGTYGYIAPELAYTMVVTEKSDVYSFGVVALEVLMGKHPGELLS 141 (144)
Q Consensus 80 d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~d~~slg~~l~~~~~g~~p~~~~~ 141 (144)
|||++..... .......+++.|+|||.+.. .++.++|+||+|+++++|++|..||...+
T Consensus 175 Dfg~~~~~~~--~~~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~ 233 (290)
T 1t4h_A 175 DLGLATLKRA--SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQ 233 (290)
T ss_dssp CTTGGGGCCT--TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCS
T ss_pred eCCCcccccc--cccccccCCcCcCCHHHHhc-cCCCcchHHHHHHHHHHHHhCCCCCCCcC
Confidence 9999864332 22334568999999998864 47899999999999999999999997643
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=2.3e-31 Score=187.12 Aligned_cols=135 Identities=33% Similarity=0.486 Sum_probs=105.1
Q ss_pred CCceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeee
Q 044494 2 HRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADF 81 (144)
Q Consensus 2 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~ 81 (144)
+++.+|+||||+++++|.+++++.. ..+++..++.++.|++.||.+|| +.+++||||||+||+++.++.++|+||
T Consensus 117 ~~~~~~lv~e~~~~~sL~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kl~Df 191 (373)
T 2qol_A 117 KSKPVMIVTEYMENGSLDSFLRKHD--AQFTVIQLVGMLRGIASGMKYLS---DMGYVHRDLAARNILINSNLVCKVSDF 191 (373)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHTTT--TCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCC
T ss_pred eCCceEEEEeCCCCCcHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHH---HCCeeCCCCCcceEEEcCCCCEEECcC
Confidence 3567899999999999999997543 23899999999999999999999 889999999999999999999999999
Q ss_pred cceeecccCCCC---cccccccccccCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCC
Q 044494 82 GVARLLNFDSSN---RTLLAGTYGYIAPELAYTMVVTEKSDVYSFGVVALEVLM-GKHPGELLS 141 (144)
Q Consensus 82 ~~~~~~~~~~~~---~~~~~~~~~~~~pe~~~~~~~~~~~d~~slg~~l~~~~~-g~~p~~~~~ 141 (144)
|++......... .....+++.|+|||.+....++.++|+||+|+++||+++ |..||...+
T Consensus 192 g~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~ 255 (373)
T 2qol_A 192 GLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMS 255 (373)
T ss_dssp ----------------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCC
T ss_pred ccccccccCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCC
Confidence 999865432211 111234678999999998889999999999999999998 999997654
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=7.7e-32 Score=190.73 Aligned_cols=134 Identities=28% Similarity=0.382 Sum_probs=114.4
Q ss_pred ceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEE----cCCCCeEEe
Q 044494 4 KCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILL----NLELEAFVA 79 (144)
Q Consensus 4 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~----~~~~~~~l~ 79 (144)
...++||||+++|+|.+++........+++..++.++.|++.|++||| +.+++||||||+||++ +.++.++|+
T Consensus 82 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~~kL~ 158 (396)
T 4eut_A 82 RHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLR---ENGIVHRNIKPGNIMRVIGEDGQSVYKLT 158 (396)
T ss_dssp CCEEEEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEEEECTTSCEEEEEC
T ss_pred CeeEEEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHH---HCCEEECCcCHHHEEEeecCCCceeEEEe
Confidence 468999999999999999987555555999999999999999999999 8999999999999998 667779999
Q ss_pred eecceeecccCCCCcccccccccccCcccccc--------CCCCCcchhHHHHHHHHHHHhCCCCCCCCC
Q 044494 80 DFGVARLLNFDSSNRTLLAGTYGYIAPELAYT--------MVVTEKSDVYSFGVVALEVLMGKHPGELLS 141 (144)
Q Consensus 80 d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~--------~~~~~~~d~~slg~~l~~~~~g~~p~~~~~ 141 (144)
|||++....... ......+++.|+|||.+.. ..++.++|+||+|+++|+|++|..||...+
T Consensus 159 DFG~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~ 227 (396)
T 4eut_A 159 DFGAARELEDDE-QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFE 227 (396)
T ss_dssp CGGGCEECCCGG-GSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTT
T ss_pred cCCCceEccCCC-ccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCC
Confidence 999998754322 2233568999999999865 456778999999999999999999997543
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=99.97 E-value=3.3e-31 Score=188.79 Aligned_cols=132 Identities=30% Similarity=0.397 Sum_probs=106.4
Q ss_pred CceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCC---CeEEe
Q 044494 3 RKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLEL---EAFVA 79 (144)
Q Consensus 3 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~---~~~l~ 79 (144)
.+..|+||||+++++|.+++..... +++..+..++.|++.|+.||| +++++||||||+||+++.++ .++|+
T Consensus 211 ~~~~~lv~e~~~~g~L~~~l~~~~~---~~~~~~~~i~~qi~~~l~~LH---~~~ivHrDlkp~NIll~~~~~~~~~kl~ 284 (419)
T 3i6u_A 211 AEDYYIVLELMEGGELFDKVVGNKR---LKEATCKLYFYQMLLAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKIT 284 (419)
T ss_dssp SSEEEEEEECCTTCBGGGGTSSSCC---CCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESSSSSSCCEEEC
T ss_pred cCceEEEEEcCCCCcHHHHHhccCC---CCHHHHHHHHHHHHHHHHHHH---HCCccccCCChHhEEEecCCCcceEEEe
Confidence 4568999999999999998875443 899999999999999999999 88999999999999997654 49999
Q ss_pred eecceeecccCCCCcccccccccccCcccccc---CCCCCcchhHHHHHHHHHHHhCCCCCCCCC
Q 044494 80 DFGVARLLNFDSSNRTLLAGTYGYIAPELAYT---MVVTEKSDVYSFGVVALEVLMGKHPGELLS 141 (144)
Q Consensus 80 d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~---~~~~~~~d~~slg~~l~~~~~g~~p~~~~~ 141 (144)
|||++...... .......|++.|+|||++.. ..++.++|+||+|+++++|++|..||....
T Consensus 285 DFG~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~ 348 (419)
T 3i6u_A 285 DFGHSKILGET-SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHR 348 (419)
T ss_dssp CSSTTTSCC------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCS
T ss_pred ecccceecCCC-ccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCc
Confidence 99999865422 22334678999999999863 456789999999999999999999997643
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=8.4e-31 Score=180.09 Aligned_cols=128 Identities=26% Similarity=0.273 Sum_probs=107.9
Q ss_pred CceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeeec
Q 044494 3 RKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADFG 82 (144)
Q Consensus 3 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~~ 82 (144)
++.+|+||||+ +++|.+++.... ..+++..++.++.|++.||.||| +.+++|+||||+||+++.++.++|+|||
T Consensus 129 ~~~~~lv~e~~-~~~L~~~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIll~~~~~~kl~DFG 202 (311)
T 3p1a_A 129 GGILYLQTELC-GPSLQQHCEAWG--ASLPEAQVWGYLRDTLLALAHLH---SQGLVHLDVKPANIFLGPRGRCKLGDFG 202 (311)
T ss_dssp TTEEEEEEECC-CCBHHHHHHHHC--SCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECGGGCEEECCCT
T ss_pred CCEEEEEEecc-CCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHEEECCCCCEEEccce
Confidence 56789999999 679999887533 24999999999999999999999 8899999999999999999999999999
Q ss_pred ceeecccCCCCcccccccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCC
Q 044494 83 VARLLNFDSSNRTLLAGTYGYIAPELAYTMVVTEKSDVYSFGVVALEVLMGKHPGE 138 (144)
Q Consensus 83 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~d~~slg~~l~~~~~g~~p~~ 138 (144)
++...... .......|++.|+|||++.+ .++.++|+||+|+++++|++|..|+.
T Consensus 203 ~a~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~ 256 (311)
T 3p1a_A 203 LLVELGTA-GAGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPH 256 (311)
T ss_dssp TCEECC-------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCS
T ss_pred eeeecccC-CCCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCC
Confidence 98865432 22334568999999999876 68899999999999999999976554
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.4e-30 Score=180.08 Aligned_cols=131 Identities=20% Similarity=0.327 Sum_probs=113.9
Q ss_pred CceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcC----------
Q 044494 3 RKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNL---------- 72 (144)
Q Consensus 3 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~---------- 72 (144)
++.+++||||+ +++|.+++..... ..+++..+..++.|++.||.+|| +++++|+||||+||+++.
T Consensus 89 ~~~~~lv~e~~-~~~l~~~l~~~~~-~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~~~~ 163 (339)
T 1z57_A 89 HGHICIVFELL-GLSTYDFIKENGF-LPFRLDHIRKMAYQICKSVNFLH---SNKLTHTDLKPENILFVQSDYTEAYNPK 163 (339)
T ss_dssp TTEEEEEEECC-CCBHHHHHHHTTT-CCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESCCCEEEEEC--
T ss_pred CCcEEEEEcCC-CCCHHHHHHhcCC-CCCcHHHHHHHHHHHHHHHHHHH---HCCCcCCCCCHHHEEEeccccccccCCc
Confidence 46789999999 7899999876432 34889999999999999999999 889999999999999987
Q ss_pred ---------CCCeEEeeecceeecccCCCCcccccccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCC
Q 044494 73 ---------ELEAFVADFGVARLLNFDSSNRTLLAGTYGYIAPELAYTMVVTEKSDVYSFGVVALEVLMGKHPGELLS 141 (144)
Q Consensus 73 ---------~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~d~~slg~~l~~~~~g~~p~~~~~ 141 (144)
++.++++|||.+..... ......+++.|+|||.+.+..++.++|+||+|++++++++|..||...+
T Consensus 164 ~~~~~~~~~~~~~kl~Dfg~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~ 238 (339)
T 1z57_A 164 IKRDERTLINPDIKVVDFGSATYDDE---HHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHD 238 (339)
T ss_dssp --CEEEEESCCCEEECCCSSCEETTS---CCCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSC
T ss_pred cccccccccCCCceEeeCcccccCcc---ccccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCC
Confidence 66799999999986442 2234568999999999999889999999999999999999999997654
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=8.9e-31 Score=176.74 Aligned_cols=134 Identities=30% Similarity=0.475 Sum_probs=115.0
Q ss_pred CceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeeec
Q 044494 3 RKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADFG 82 (144)
Q Consensus 3 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~~ 82 (144)
++..|+||||+++++|.+++.... .+++..++.++.|++.++.+|| +.|++|+||+|+||+++.++.++++|||
T Consensus 77 ~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~dfg 150 (276)
T 2yex_A 77 GNIQYLFLEYCSGGELFDRIEPDI---GMPEPDAQRFFHQLMAGVVYLH---GIGITHRDIKPENLLLDERDNLKISDFG 150 (276)
T ss_dssp TTEEEEEEECCTTEEGGGGSBTTT---BCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCT
T ss_pred CCEEEEEEEecCCCcHHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCChHHEEEccCCCEEEeeCC
Confidence 467899999999999999887543 3899999999999999999999 8999999999999999999999999999
Q ss_pred ceeecccCC--CCcccccccccccCccccccCCC-CCcchhHHHHHHHHHHHhCCCCCCCCCC
Q 044494 83 VARLLNFDS--SNRTLLAGTYGYIAPELAYTMVV-TEKSDVYSFGVVALEVLMGKHPGELLSS 142 (144)
Q Consensus 83 ~~~~~~~~~--~~~~~~~~~~~~~~pe~~~~~~~-~~~~d~~slg~~l~~~~~g~~p~~~~~~ 142 (144)
.+....... .......+++.|+|||.+....+ +.++|+||+|++++++++|..||...+.
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~ 213 (276)
T 2yex_A 151 LATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSD 213 (276)
T ss_dssp TCEECEETTEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCT
T ss_pred CccccCCCcchhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCch
Confidence 987654221 12334568899999999987765 6789999999999999999999987554
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=3.9e-31 Score=183.02 Aligned_cols=133 Identities=26% Similarity=0.311 Sum_probs=109.6
Q ss_pred CceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeeec
Q 044494 3 RKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADFG 82 (144)
Q Consensus 3 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~~ 82 (144)
++..|+||||+.+++|.+++..... +++..+..++.|++.++.+|| +.|++|+||||+||+++.++.++|+|||
T Consensus 96 ~~~~~lv~e~~~~~~l~~~~~~~~~---~~~~~~~~~~~qi~~~l~~LH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg 169 (331)
T 4aaa_A 96 KKRWYLVFEFVDHTILDDLELFPNG---LDYQVVQKYLFQIINGIGFCH---SHNIIHRDIKPENILVSQSGVVKLCDFG 169 (331)
T ss_dssp TTEEEEEEECCSEEHHHHHHHSTTC---CCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCCT
T ss_pred CCEEEEEEecCCcchHHHHHhhccC---CCHHHHHHHHHHHHHHHHHHH---HCCEEccCcChheEEEcCCCcEEEEeCC
Confidence 4678999999999888887664333 899999999999999999999 8999999999999999999999999999
Q ss_pred ceeecccCCCCcccccccccccCccccccC-CCCCcchhHHHHHHHHHHHhCCCCCCCCC
Q 044494 83 VARLLNFDSSNRTLLAGTYGYIAPELAYTM-VVTEKSDVYSFGVVALEVLMGKHPGELLS 141 (144)
Q Consensus 83 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~-~~~~~~d~~slg~~l~~~~~g~~p~~~~~ 141 (144)
.+..............+++.|+|||.+.+. .++.++|+||+|+++++|++|..||...+
T Consensus 170 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~ 229 (331)
T 4aaa_A 170 FARTLAAPGEVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDS 229 (331)
T ss_dssp TC------------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred CceeecCCccccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 998665433344456689999999998875 67889999999999999999999997654
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.97 E-value=2.1e-31 Score=184.79 Aligned_cols=137 Identities=29% Similarity=0.430 Sum_probs=115.5
Q ss_pred CCceEEEEEeeccCCCHHHHhhcccc---------------------cCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEe
Q 044494 2 HRKCMFLIYEYMEMGSLFCVLRTDEE---------------------AVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVH 60 (144)
Q Consensus 2 ~~~~~~lv~e~~~~~~L~~~l~~~~~---------------------~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h 60 (144)
.++..|+||||+++++|.+++..... ...+++..++.++.|++.++.+|| +++++|
T Consensus 121 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH---~~~ivH 197 (343)
T 1luf_A 121 VGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLS---ERKFVH 197 (343)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHH---HTTCCC
T ss_pred cCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeec
Confidence 35678999999999999999975321 145899999999999999999999 899999
Q ss_pred cCCCCCcEEEcCCCCeEEeeecceeecccCC--CCcccccccccccCccccccCCCCCcchhHHHHHHHHHHHh-CCCCC
Q 044494 61 RDISSNNILLNLELEAFVADFGVARLLNFDS--SNRTLLAGTYGYIAPELAYTMVVTEKSDVYSFGVVALEVLM-GKHPG 137 (144)
Q Consensus 61 ~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~~~~~pe~~~~~~~~~~~d~~slg~~l~~~~~-g~~p~ 137 (144)
+||||+||+++.++.++|+|||++....... .......+++.|+|||.+....++.++|+||+|+++|+|++ |..||
T Consensus 198 ~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~ 277 (343)
T 1luf_A 198 RDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPY 277 (343)
T ss_dssp SCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTT
T ss_pred CCCCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcC
Confidence 9999999999999999999999987654221 22233557889999999998889999999999999999999 99999
Q ss_pred CCCC
Q 044494 138 ELLS 141 (144)
Q Consensus 138 ~~~~ 141 (144)
...+
T Consensus 278 ~~~~ 281 (343)
T 1luf_A 278 YGMA 281 (343)
T ss_dssp TTSC
T ss_pred CCCC
Confidence 7654
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=5.4e-31 Score=181.71 Aligned_cols=135 Identities=28% Similarity=0.417 Sum_probs=108.4
Q ss_pred CceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeeec
Q 044494 3 RKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADFG 82 (144)
Q Consensus 3 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~~ 82 (144)
++.+|+||||+++++|.+++.... ...+++..++.++.|++.+|.+|| +.|++|+||+|+||+++.++.++|+|||
T Consensus 99 ~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dlkp~NIl~~~~~~~kl~Dfg 174 (326)
T 2x7f_A 99 DDQLWLVMEFCGAGSVTDLIKNTK-GNTLKEEWIAYICREILRGLSHLH---QHKVIHRDIKGQNVLLTENAEVKLVDFG 174 (326)
T ss_dssp CCEEEEEEECCTTEEHHHHHHHSG-GGCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEECTTCCEEECCCT
T ss_pred cceEEEEEEcCCCCcHHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCcHHHEEEcCCCCEEEeeCc
Confidence 467899999999999999997632 234899999999999999999999 8899999999999999999999999999
Q ss_pred ceeecccCCCCcccccccccccCccccc-----cCCCCCcchhHHHHHHHHHHHhCCCCCCCCC
Q 044494 83 VARLLNFDSSNRTLLAGTYGYIAPELAY-----TMVVTEKSDVYSFGVVALEVLMGKHPGELLS 141 (144)
Q Consensus 83 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~-----~~~~~~~~d~~slg~~l~~~~~g~~p~~~~~ 141 (144)
++..............+++.|+|||.+. ...++.++|+||+|+++++|++|..||...+
T Consensus 175 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 238 (326)
T 2x7f_A 175 VSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMH 238 (326)
T ss_dssp TTC-------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSC
T ss_pred CceecCcCccccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCc
Confidence 9876543333334456899999999987 4567889999999999999999999997643
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.97 E-value=3.9e-31 Score=185.96 Aligned_cols=135 Identities=27% Similarity=0.378 Sum_probs=106.6
Q ss_pred CceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeeec
Q 044494 3 RKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADFG 82 (144)
Q Consensus 3 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~~ 82 (144)
++..++||||+++|+|.++++... ..+++..++.++.|++.|+.||| +++++||||||+||+++.++.++|+|||
T Consensus 163 ~~~~~lv~e~~~~g~L~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~~~~kL~DFG 237 (373)
T 3c1x_A 163 EGSPLVVLPYMKHGDLRNFIRNET--HNPTVKDLIGFGLQVAKGMKFLA---SKKFVHRDLAARNCMLDEKFTVKVADFG 237 (373)
T ss_dssp SSCCEEEEECCTTCBHHHHHHCTT--CCCBHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCC-
T ss_pred CCCeEEEEECCCCCCHHHHHhhcc--cCCCHHHHHHHHHHHHHHHHHHH---HCCEecCccchheEEECCCCCEEEeecc
Confidence 457799999999999999997533 23788999999999999999999 8999999999999999999999999999
Q ss_pred ceeecccCCC----CcccccccccccCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCC
Q 044494 83 VARLLNFDSS----NRTLLAGTYGYIAPELAYTMVVTEKSDVYSFGVVALEVLM-GKHPGELLSS 142 (144)
Q Consensus 83 ~~~~~~~~~~----~~~~~~~~~~~~~pe~~~~~~~~~~~d~~slg~~l~~~~~-g~~p~~~~~~ 142 (144)
+++....... ......+++.|+|||.+....++.++|+||+|+++|++++ |..||...+.
T Consensus 238 ~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~ 302 (373)
T 3c1x_A 238 LARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT 302 (373)
T ss_dssp --------------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCS
T ss_pred ccccccccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCH
Confidence 9976532211 1122446778999999998889999999999999999999 7888876543
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2.4e-31 Score=179.22 Aligned_cols=135 Identities=30% Similarity=0.407 Sum_probs=115.1
Q ss_pred CCceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeee
Q 044494 2 HRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADF 81 (144)
Q Consensus 2 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~ 81 (144)
+++..++||||+++++|.+++.... ..+++..++.++.|++.++.+|| +.+++|+||||+||+++.++.++++||
T Consensus 76 ~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~kl~Df 150 (269)
T 4hcu_A 76 EQAPICLVFEFMEHGCLSDYLRTQR--GLFAAETLLGMCLDVCEGMAYLE---EACVIHRDLAARNCLVGENQVIKVSDF 150 (269)
T ss_dssp SSSSEEEEEECCTTCBHHHHHHTTT--TCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECGGGCEEECCT
T ss_pred cCCceEEEEEeCCCCcHHHHHHhcC--cccCHHHHHHHHHHHHHHHHHHH---hCCeecCCcchheEEEcCCCCEEeccc
Confidence 3567899999999999999997533 23899999999999999999999 899999999999999999999999999
Q ss_pred cceeecccCC-CCcccccccccccCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCC
Q 044494 82 GVARLLNFDS-SNRTLLAGTYGYIAPELAYTMVVTEKSDVYSFGVVALEVLM-GKHPGELLS 141 (144)
Q Consensus 82 ~~~~~~~~~~-~~~~~~~~~~~~~~pe~~~~~~~~~~~d~~slg~~l~~~~~-g~~p~~~~~ 141 (144)
|++....... .......+++.|+|||.+....++.++|+||+|+++++|++ |..||...+
T Consensus 151 g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~ 212 (269)
T 4hcu_A 151 GMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRS 212 (269)
T ss_dssp TGGGGBCCHHHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC
T ss_pred cccccccccccccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCC
Confidence 9987543211 11223446778999999998889999999999999999999 999998654
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.6e-31 Score=181.10 Aligned_cols=134 Identities=28% Similarity=0.411 Sum_probs=105.5
Q ss_pred CceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeeec
Q 044494 3 RKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADFG 82 (144)
Q Consensus 3 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~~ 82 (144)
++..|+||||+++++|.+++.... ..+++..+..++.|++.++.+|| +.+++|+||||+||+++.++.++++|||
T Consensus 87 ~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg 161 (281)
T 1mp8_A 87 ENPVWIIMELCTLGELRSFLQVRK--YSLDLASLILYAYQLSTALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFG 161 (281)
T ss_dssp SSSCEEEEECCTTEEHHHHHHHTT--TTSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECC--
T ss_pred cCccEEEEecCCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHH---hCCeecccccHHHEEECCCCCEEECccc
Confidence 456899999999999999997533 23899999999999999999999 8899999999999999999999999999
Q ss_pred ceeecccCCC-CcccccccccccCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCC
Q 044494 83 VARLLNFDSS-NRTLLAGTYGYIAPELAYTMVVTEKSDVYSFGVVALEVLM-GKHPGELLS 141 (144)
Q Consensus 83 ~~~~~~~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~d~~slg~~l~~~~~-g~~p~~~~~ 141 (144)
++........ ......+++.|+|||.+....++.++|+||+|++++++++ |..||...+
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~ 222 (281)
T 1mp8_A 162 LSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVK 222 (281)
T ss_dssp -----------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCC
T ss_pred cccccCcccccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCC
Confidence 9986543221 1222346678999999998889999999999999999996 999998654
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=99.97 E-value=6.8e-31 Score=185.85 Aligned_cols=133 Identities=24% Similarity=0.257 Sum_probs=108.8
Q ss_pred eEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEc-CCCCeEEeeecc
Q 044494 5 CMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLN-LELEAFVADFGV 83 (144)
Q Consensus 5 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~-~~~~~~l~d~~~ 83 (144)
.+++||||+.++.+............+++..+..++.|++.||.||| ++|++||||||+||+++ .++.++|+|||+
T Consensus 112 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~Nill~~~~~~~kL~DFG~ 188 (394)
T 4e7w_A 112 FLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIH---SIGICHRDIKPQNLLLDPPSGVLKLIDFGS 188 (394)
T ss_dssp EEEEEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEETTTTEEEECCCTT
T ss_pred EEEEEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHH---HCCccCCCCCHHHEEEcCCCCcEEEeeCCC
Confidence 47899999987433333322222334899999999999999999999 89999999999999999 789999999999
Q ss_pred eeecccCCCCcccccccccccCccccccC-CCCCcchhHHHHHHHHHHHhCCCCCCCCC
Q 044494 84 ARLLNFDSSNRTLLAGTYGYIAPELAYTM-VVTEKSDVYSFGVVALEVLMGKHPGELLS 141 (144)
Q Consensus 84 ~~~~~~~~~~~~~~~~~~~~~~pe~~~~~-~~~~~~d~~slg~~l~~~~~g~~p~~~~~ 141 (144)
++...... ......+++.|+|||.+.+. .++.++|+||+|+++|+|++|..||.+.+
T Consensus 189 a~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~ 246 (394)
T 4e7w_A 189 AKILIAGE-PNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGES 246 (394)
T ss_dssp CEECCTTC-CCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred cccccCCC-CCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 98764322 23345689999999998765 58899999999999999999999998754
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.1e-30 Score=189.33 Aligned_cols=132 Identities=29% Similarity=0.430 Sum_probs=113.4
Q ss_pred CCceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCC---CCeEE
Q 044494 2 HRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLE---LEAFV 78 (144)
Q Consensus 2 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~---~~~~l 78 (144)
+.+.+|+||||+++|+|.+.+..... +++..+..++.|++.|+.||| ++|++||||||+||+++.. +.++|
T Consensus 107 ~~~~~~lv~e~~~~g~L~~~~~~~~~---~~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~kl 180 (494)
T 3lij_A 107 DKRNYYLVMECYKGGELFDEIIHRMK---FNEVDAAVIIKQVLSGVTYLH---KHNIVHRDLKPENLLLESKEKDALIKI 180 (494)
T ss_dssp CSSEEEEEEECCCSCBHHHHHHHHSS---CCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESCSSTTCCEEE
T ss_pred eCCEEEEEEecCCCCcHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHH---HCCceeccCChhhEEEeCCCCCCcEEE
Confidence 35678999999999999998875433 899999999999999999999 8999999999999999764 45999
Q ss_pred eeecceeecccCCCCcccccccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCC
Q 044494 79 ADFGVARLLNFDSSNRTLLAGTYGYIAPELAYTMVVTEKSDVYSFGVVALEVLMGKHPGELLS 141 (144)
Q Consensus 79 ~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~d~~slg~~l~~~~~g~~p~~~~~ 141 (144)
+|||++....... ......+++.|+|||++. ..++.++|+||+|+++|+|++|..||...+
T Consensus 181 ~DfG~a~~~~~~~-~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~ 241 (494)
T 3lij_A 181 VDFGLSAVFENQK-KMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQT 241 (494)
T ss_dssp CCCTTCEECBTTB-CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred EECCCCeECCCCc-cccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCC
Confidence 9999998765322 233456999999999986 458899999999999999999999997654
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=4.4e-31 Score=181.14 Aligned_cols=138 Identities=28% Similarity=0.426 Sum_probs=116.6
Q ss_pred CCceEEEEEeeccCCCHHHHhhcccc---------------------cCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEe
Q 044494 2 HRKCMFLIYEYMEMGSLFCVLRTDEE---------------------AVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVH 60 (144)
Q Consensus 2 ~~~~~~lv~e~~~~~~L~~~l~~~~~---------------------~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h 60 (144)
+++..++||||+++++|.+++..... ...+++..++.++.|++.|+.+|| +++++|
T Consensus 97 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH 173 (314)
T 2ivs_A 97 QDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLA---EMKLVH 173 (314)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHH---HTTEEC
T ss_pred cCCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHH---HCCCcc
Confidence 35678999999999999999975332 233889999999999999999999 889999
Q ss_pred cCCCCCcEEEcCCCCeEEeeecceeecccCCC--CcccccccccccCccccccCCCCCcchhHHHHHHHHHHHh-CCCCC
Q 044494 61 RDISSNNILLNLELEAFVADFGVARLLNFDSS--NRTLLAGTYGYIAPELAYTMVVTEKSDVYSFGVVALEVLM-GKHPG 137 (144)
Q Consensus 61 ~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~d~~slg~~l~~~~~-g~~p~ 137 (144)
+||||+||+++.++.++|+|||++........ ......+++.|+|||.+.+..++.++|+||+|+++++|++ |..||
T Consensus 174 ~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~ 253 (314)
T 2ivs_A 174 RDLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPY 253 (314)
T ss_dssp CCCSGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSS
T ss_pred cccchheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCC
Confidence 99999999999999999999999986643222 1223446778999999998888999999999999999999 99999
Q ss_pred CCCCC
Q 044494 138 ELLSS 142 (144)
Q Consensus 138 ~~~~~ 142 (144)
...+.
T Consensus 254 ~~~~~ 258 (314)
T 2ivs_A 254 PGIPP 258 (314)
T ss_dssp TTCCG
T ss_pred CCCCH
Confidence 87543
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=3e-31 Score=180.51 Aligned_cols=134 Identities=30% Similarity=0.481 Sum_probs=105.2
Q ss_pred CceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeeec
Q 044494 3 RKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADFG 82 (144)
Q Consensus 3 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~~ 82 (144)
++..++||||+.+++|.+++.... ..+++..++.++.|++.+|.+|| +.+++|+||||+||+++.++.++|+|||
T Consensus 91 ~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~L~~lH---~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg 165 (289)
T 3og7_A 91 APQLAIVTQWCEGSSLYHHLHASE--TKFEMKKLIDIARQTARGMDYLH---AKSIIHRDLKSNNIFLHEDNTVKIGDFG 165 (289)
T ss_dssp SSSCEEEEECCCEEEHHHHHTTC-----CCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEETTTEEEECCCC
T ss_pred CCccEEEEEecCCCcHHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHH---hCCcccccCccceEEECCCCCEEEccce
Confidence 456799999999999999996533 33899999999999999999999 8999999999999999999999999999
Q ss_pred ceeecccC--CCCcccccccccccCccccc---cCCCCCcchhHHHHHHHHHHHhCCCCCCCCC
Q 044494 83 VARLLNFD--SSNRTLLAGTYGYIAPELAY---TMVVTEKSDVYSFGVVALEVLMGKHPGELLS 141 (144)
Q Consensus 83 ~~~~~~~~--~~~~~~~~~~~~~~~pe~~~---~~~~~~~~d~~slg~~l~~~~~g~~p~~~~~ 141 (144)
++...... ........+++.|+|||.+. ...++.++|+||+|++++++++|..||...+
T Consensus 166 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~ 229 (289)
T 3og7_A 166 LATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNIN 229 (289)
T ss_dssp ------------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCC
T ss_pred eccccccccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccc
Confidence 98755421 12223356899999999987 5567789999999999999999999997654
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=2.7e-31 Score=183.68 Aligned_cols=134 Identities=25% Similarity=0.410 Sum_probs=114.2
Q ss_pred ceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeeecc
Q 044494 4 KCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADFGV 83 (144)
Q Consensus 4 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~~~ 83 (144)
+..++|+||+.+|+|.+++.... ..+++..++.++.|++.||.+|| +++++||||||+||+++.++.++|+|||+
T Consensus 89 ~~~~~v~e~~~~g~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~LH---~~~ivH~Dikp~NIll~~~~~~kl~Dfg~ 163 (327)
T 3poz_A 89 STVQLITQLMPFGCLLDYVREHK--DNIGSQYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGL 163 (327)
T ss_dssp SSEEEEEECCTTCBHHHHHHHST--TSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEEETTEEEECCTTH
T ss_pred CCeEEEEEecCCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHh---hCCeeCCCCChheEEECCCCCEEEccCcc
Confidence 45789999999999999997633 23899999999999999999999 88999999999999999999999999999
Q ss_pred eeecccCCCC--cccccccccccCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCC
Q 044494 84 ARLLNFDSSN--RTLLAGTYGYIAPELAYTMVVTEKSDVYSFGVVALEVLM-GKHPGELLSS 142 (144)
Q Consensus 84 ~~~~~~~~~~--~~~~~~~~~~~~pe~~~~~~~~~~~d~~slg~~l~~~~~-g~~p~~~~~~ 142 (144)
++........ .....+++.|+|||.+.+..++.++|+||+|++++++++ |..||...+.
T Consensus 164 a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~ 225 (327)
T 3poz_A 164 AKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA 225 (327)
T ss_dssp HHHHTTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCG
T ss_pred eeEccCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCH
Confidence 9866533222 222445778999999999999999999999999999999 9999987543
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.97 E-value=1e-30 Score=183.43 Aligned_cols=127 Identities=28% Similarity=0.386 Sum_probs=111.8
Q ss_pred ceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeeecc
Q 044494 4 KCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADFGV 83 (144)
Q Consensus 4 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~~~ 83 (144)
..+|+||||+ +++|.++++.. .+++..+..++.|++.|++||| +.|++||||||+||+++.++.++|+|||+
T Consensus 103 ~~~~lv~e~~-~~~L~~~~~~~----~l~~~~~~~~~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~ 174 (367)
T 1cm8_A 103 TDFYLVMPFM-GTDLGKLMKHE----KLGEDRIQFLVYQMLKGLRYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGL 174 (367)
T ss_dssp CCCEEEEECC-SEEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTT
T ss_pred ceEEEEEecC-CCCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHH---HCCccccCcCHHHEEEcCCCCEEEEeeec
Confidence 4569999999 78999988752 3899999999999999999999 89999999999999999999999999999
Q ss_pred eeecccCCCCcccccccccccCcccccc-CCCCCcchhHHHHHHHHHHHhCCCCCCCCC
Q 044494 84 ARLLNFDSSNRTLLAGTYGYIAPELAYT-MVVTEKSDVYSFGVVALEVLMGKHPGELLS 141 (144)
Q Consensus 84 ~~~~~~~~~~~~~~~~~~~~~~pe~~~~-~~~~~~~d~~slg~~l~~~~~g~~p~~~~~ 141 (144)
++..... .....+++.|+|||++.+ ..++.++|+||+|+++++|++|..||.+.+
T Consensus 175 a~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~ 230 (367)
T 1cm8_A 175 ARQADSE---MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSD 230 (367)
T ss_dssp CEECCSS---CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred ccccccc---cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 9875422 233568999999999877 678899999999999999999999998654
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=99.97 E-value=1.5e-30 Score=176.23 Aligned_cols=132 Identities=27% Similarity=0.385 Sum_probs=112.7
Q ss_pred CceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCC----CeEE
Q 044494 3 RKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLEL----EAFV 78 (144)
Q Consensus 3 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~----~~~l 78 (144)
.+..++||||+++++|.+++.... .+++..+..++.|++.++.+|| +.+++|+||+|+||+++.++ .+++
T Consensus 80 ~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~~~~kl 153 (283)
T 3bhy_A 80 KTDVVLILELVSGGELFDFLAEKE---SLTEDEATQFLKQILDGVHYLH---SKRIAHFDLKPENIMLLDKNVPNPRIKL 153 (283)
T ss_dssp SSEEEEEEECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESCSSSSSCCEEE
T ss_pred CCeEEEEEeecCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCChHHEEEecCCCCCCceEE
Confidence 467899999999999999997543 3899999999999999999999 89999999999999998876 7999
Q ss_pred eeecceeecccCCCCcccccccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCC
Q 044494 79 ADFGVARLLNFDSSNRTLLAGTYGYIAPELAYTMVVTEKSDVYSFGVVALEVLMGKHPGELLS 141 (144)
Q Consensus 79 ~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~d~~slg~~l~~~~~g~~p~~~~~ 141 (144)
+|||.+....... ......+++.|+|||.+....++.++|+||+|++++++++|..||...+
T Consensus 154 ~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 215 (283)
T 3bhy_A 154 IDFGIAHKIEAGN-EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGET 215 (283)
T ss_dssp CCCTTCEECC---------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSS
T ss_pred EecccceeccCCC-cccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcc
Confidence 9999998654322 2233568899999999998889999999999999999999999997643
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=99.97 E-value=5.8e-31 Score=182.78 Aligned_cols=137 Identities=29% Similarity=0.341 Sum_probs=110.4
Q ss_pred CCceEEEEEeeccCCCHHHHhhcccc-------------------------------------cCCCCHHHHHHHHHHHH
Q 044494 2 HRKCMFLIYEYMEMGSLFCVLRTDEE-------------------------------------AVGLDWAKRVNIVKGMA 44 (144)
Q Consensus 2 ~~~~~~lv~e~~~~~~L~~~l~~~~~-------------------------------------~~~~~~~~~~~~~~~l~ 44 (144)
+++..++||||+++|+|.+++..... ...+++..++.++.|++
T Consensus 99 ~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~ 178 (345)
T 3hko_A 99 DEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIF 178 (345)
T ss_dssp CSSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHH
T ss_pred cCCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHH
Confidence 35678999999999999998852100 11246777889999999
Q ss_pred HHHHHHhcCCCCCeEecCCCCCcEEEcCCC--CeEEeeecceeecccCCC----CcccccccccccCcccccc--CCCCC
Q 044494 45 HALSYLHHDCTPPIVHRDISSNNILLNLEL--EAFVADFGVARLLNFDSS----NRTLLAGTYGYIAPELAYT--MVVTE 116 (144)
Q Consensus 45 ~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~--~~~l~d~~~~~~~~~~~~----~~~~~~~~~~~~~pe~~~~--~~~~~ 116 (144)
.|+.+|| +++++|+||||+||+++.++ .++|+|||++........ ......+++.|+|||.+.. ..++.
T Consensus 179 ~~l~~LH---~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~ 255 (345)
T 3hko_A 179 SALHYLH---NQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGP 255 (345)
T ss_dssp HHHHHHH---HTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCT
T ss_pred HHHHHHH---HCCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCc
Confidence 9999999 88999999999999998776 899999999986543211 1234568999999999875 56788
Q ss_pred cchhHHHHHHHHHHHhCCCCCCCCC
Q 044494 117 KSDVYSFGVVALEVLMGKHPGELLS 141 (144)
Q Consensus 117 ~~d~~slg~~l~~~~~g~~p~~~~~ 141 (144)
++|+||+|+++++|++|..||...+
T Consensus 256 ~~DiwslG~il~el~~g~~pf~~~~ 280 (345)
T 3hko_A 256 KCDAWSAGVLLHLLLMGAVPFPGVN 280 (345)
T ss_dssp HHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred HHHHHHHHHHHHHHHHCCCCCCCCC
Confidence 9999999999999999999997654
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.5e-30 Score=189.11 Aligned_cols=131 Identities=34% Similarity=0.490 Sum_probs=114.3
Q ss_pred CceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCC---CeEEe
Q 044494 3 RKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLEL---EAFVA 79 (144)
Q Consensus 3 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~---~~~l~ 79 (144)
++.+|+||||+++|+|.+++..... +++..+..++.|++.||.||| +++++||||||+||+++.++ .++|+
T Consensus 118 ~~~~~lv~e~~~gg~L~~~l~~~~~---~~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~kl~ 191 (504)
T 3q5i_A 118 KKYFYLVTEFYEGGELFEQIINRHK---FDECDAANIMKQILSGICYLH---KHNIVHRDIKPENILLENKNSLLNIKIV 191 (504)
T ss_dssp SSEEEEEEECCTTCBHHHHHHHHSC---CCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESSTTCCSSEEEC
T ss_pred CCEEEEEEecCCCCcHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCcHHHEEEecCCCCccEEEE
Confidence 5678999999999999998875443 899999999999999999999 89999999999999998776 69999
Q ss_pred eecceeecccCCCCcccccccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCC
Q 044494 80 DFGVARLLNFDSSNRTLLAGTYGYIAPELAYTMVVTEKSDVYSFGVVALEVLMGKHPGELLS 141 (144)
Q Consensus 80 d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~d~~slg~~l~~~~~g~~p~~~~~ 141 (144)
|||++...... .......+++.|+|||++.. .++.++|+||+|+++|+|++|..||.+.+
T Consensus 192 Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~ 251 (504)
T 3q5i_A 192 DFGLSSFFSKD-YKLRDRLGTAYYIAPEVLKK-KYNEKCDVWSCGVIMYILLCGYPPFGGQN 251 (504)
T ss_dssp CCTTCEECCTT-SCBCCCCSCTTTCCHHHHTT-CBCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred ECCCCEEcCCC-CccccccCCcCCCCHHHhcc-CCCchHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 99999876532 23344669999999999874 58899999999999999999999998754
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=99.97 E-value=3.7e-31 Score=179.37 Aligned_cols=135 Identities=28% Similarity=0.448 Sum_probs=115.3
Q ss_pred CCceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeee
Q 044494 2 HRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADF 81 (144)
Q Consensus 2 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~ 81 (144)
.++.+++||||+++++|.+++.... ..+++..++.++.|++.++.+|| +++++|+||||+||+++.++.++++||
T Consensus 90 ~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dikp~Nili~~~~~~kl~Df 164 (283)
T 3gen_A 90 KQRPIFIITEYMANGCLLNYLREMR--HRFQTQQLLEMCKDVCEAMEYLE---SKQFLHRDLAARNCLVNDQGVVKVSDF 164 (283)
T ss_dssp SSSSEEEEECCCTTCBHHHHHHCGG--GCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCSGGGEEECTTSCEEECST
T ss_pred cCCCeEEEEeccCCCcHHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHH---HCCccCCCCccceEEEcCCCCEEEccc
Confidence 3567899999999999999997532 23899999999999999999999 899999999999999999999999999
Q ss_pred cceeecccCC-CCcccccccccccCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCC
Q 044494 82 GVARLLNFDS-SNRTLLAGTYGYIAPELAYTMVVTEKSDVYSFGVVALEVLM-GKHPGELLS 141 (144)
Q Consensus 82 ~~~~~~~~~~-~~~~~~~~~~~~~~pe~~~~~~~~~~~d~~slg~~l~~~~~-g~~p~~~~~ 141 (144)
|.+....... .......+++.|+|||.+....++.++|+||+|++++++++ |..||...+
T Consensus 165 g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~ 226 (283)
T 3gen_A 165 GLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFT 226 (283)
T ss_dssp TGGGGBCCHHHHSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSC
T ss_pred cccccccccccccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccC
Confidence 9987553211 11222346778999999998889999999999999999998 999998654
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=2.7e-31 Score=186.38 Aligned_cols=137 Identities=27% Similarity=0.369 Sum_probs=114.9
Q ss_pred CCceEEEEEeeccCCCHHHHhhccc----ccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCC---
Q 044494 2 HRKCMFLIYEYMEMGSLFCVLRTDE----EAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLEL--- 74 (144)
Q Consensus 2 ~~~~~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~--- 74 (144)
.++..|+||||+++|+|.+++.... ....+++..++.++.|++.||.+|| ++|++||||||+||+++.++
T Consensus 145 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~~~~~ 221 (367)
T 3l9p_A 145 QSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE---ENHFIHRDIAARNCLLTCPGPGR 221 (367)
T ss_dssp SSSSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESCSSTTC
T ss_pred cCCCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChhhEEEecCCCCc
Confidence 3566799999999999999997532 2234899999999999999999999 89999999999999999554
Q ss_pred CeEEeeecceeecccC--CCCcccccccccccCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCC
Q 044494 75 EAFVADFGVARLLNFD--SSNRTLLAGTYGYIAPELAYTMVVTEKSDVYSFGVVALEVLM-GKHPGELLS 141 (144)
Q Consensus 75 ~~~l~d~~~~~~~~~~--~~~~~~~~~~~~~~~pe~~~~~~~~~~~d~~slg~~l~~~~~-g~~p~~~~~ 141 (144)
.++|+|||+++..... ........+++.|+|||.+....++.++|+||+|+++++|++ |..||...+
T Consensus 222 ~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~ 291 (367)
T 3l9p_A 222 VAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKS 291 (367)
T ss_dssp CEEECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred eEEECCCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCC
Confidence 4999999999754321 122334567889999999998889999999999999999998 999997654
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1e-30 Score=184.29 Aligned_cols=132 Identities=25% Similarity=0.288 Sum_probs=112.3
Q ss_pred CceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCC-CeEecCCCCCcEEEcCCC-------
Q 044494 3 RKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTP-PIVHRDISSNNILLNLEL------- 74 (144)
Q Consensus 3 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~-~~~h~~i~~~ni~~~~~~------- 74 (144)
+..+|+||||+ ++++.+.+.... ...+++..+..++.|++.||.+|| ++ |++||||||+||+++.++
T Consensus 117 ~~~~~lv~e~~-~~~l~~~~~~~~-~~~~~~~~~~~i~~qi~~aL~~lH---~~~givHrDikp~NIll~~~~~~~~~~~ 191 (397)
T 1wak_A 117 GTHICMVFEVL-GHHLLKWIIKSN-YQGLPLPCVKKIIQQVLQGLDYLH---TKCRIIHTDIKPENILLSVNEQYIRRLA 191 (397)
T ss_dssp EEEEEEEECCC-CCBHHHHHHHTT-TSCCCHHHHHHHHHHHHHHHHHHH---HTTCEECCCCSGGGEEECCCHHHHHHHH
T ss_pred CceEEEEEecc-CccHHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHH---HhCCEecCCCCHHHeeEeccchhhhhhh
Confidence 45789999999 567777765432 234899999999999999999999 77 999999999999998775
Q ss_pred ------------------------------------------CeEEeeecceeecccCCCCcccccccccccCccccccC
Q 044494 75 ------------------------------------------EAFVADFGVARLLNFDSSNRTLLAGTYGYIAPELAYTM 112 (144)
Q Consensus 75 ------------------------------------------~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~ 112 (144)
.++|+|||.+...... .....+++.|+|||++.+.
T Consensus 192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~---~~~~~gt~~y~aPE~~~~~ 268 (397)
T 1wak_A 192 AEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH---FTEDIQTRQYRSLEVLIGS 268 (397)
T ss_dssp HHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC---SCSCCSCGGGCCHHHHHTS
T ss_pred hhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc---CccCCCCCcccCChhhcCC
Confidence 7999999999875432 2335689999999999999
Q ss_pred CCCCcchhHHHHHHHHHHHhCCCCCCCCCC
Q 044494 113 VVTEKSDVYSFGVVALEVLMGKHPGELLSS 142 (144)
Q Consensus 113 ~~~~~~d~~slg~~l~~~~~g~~p~~~~~~ 142 (144)
.++.++|+||+|+++|+|++|..||...+.
T Consensus 269 ~~~~~~DiwslG~il~elltg~~pf~~~~~ 298 (397)
T 1wak_A 269 GYNTPADIWSTACMAFELATGDYLFEPHSG 298 (397)
T ss_dssp CCCTHHHHHHHHHHHHHHHHSSCSCCCCCC
T ss_pred CCCcHHHHHHHHHHHHHHhhCCCCCCCCcc
Confidence 899999999999999999999999986543
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=5e-31 Score=179.46 Aligned_cols=135 Identities=28% Similarity=0.364 Sum_probs=114.0
Q ss_pred CceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcC-CCCeEEeee
Q 044494 3 RKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNL-ELEAFVADF 81 (144)
Q Consensus 3 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~-~~~~~l~d~ 81 (144)
++..++||||+++++|.+++........+++..+..++.|++.|+.+|| +.+++|+||+|+||+++. ++.++++||
T Consensus 91 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~kl~Df 167 (295)
T 2clq_A 91 NGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLH---DNQIVHRDIKGDNVLINTYSGVLKISDF 167 (295)
T ss_dssp TTEEEEEEECCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTTCCEEECCT
T ss_pred CCcEEEEEEeCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHH---hCCEEccCCChhhEEEECCCCCEEEeec
Confidence 4678999999999999999986544445788999999999999999999 889999999999999987 889999999
Q ss_pred cceeecccCCCCcccccccccccCccccccCC--CCCcchhHHHHHHHHHHHhCCCCCCCC
Q 044494 82 GVARLLNFDSSNRTLLAGTYGYIAPELAYTMV--VTEKSDVYSFGVVALEVLMGKHPGELL 140 (144)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~--~~~~~d~~slg~~l~~~~~g~~p~~~~ 140 (144)
|.+..............+++.|+|||.+.... ++.++|+||+|+++++|++|..||...
T Consensus 168 g~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~ 228 (295)
T 2clq_A 168 GTSKRLAGINPCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYEL 228 (295)
T ss_dssp TTCEESCC-----CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGG
T ss_pred ccccccCCCCCcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCC
Confidence 99987653333334456899999999987653 778999999999999999999999654
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=3.4e-31 Score=183.31 Aligned_cols=132 Identities=22% Similarity=0.289 Sum_probs=107.2
Q ss_pred CceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcC-----CCCeE
Q 044494 3 RKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNL-----ELEAF 77 (144)
Q Consensus 3 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~-----~~~~~ 77 (144)
++.+++||||+.+ +|.+++..... +++..+..++.|++.||.+|| +++++|+||||+||+++. .+.++
T Consensus 105 ~~~~~lv~e~~~~-~L~~~~~~~~~---~~~~~~~~i~~ql~~~l~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~~~k 177 (329)
T 3gbz_A 105 NHRLHLIFEYAEN-DLKKYMDKNPD---VSMRVIKSFLYQLINGVNFCH---SRRCLHRDLKPQNLLLSVSDASETPVLK 177 (329)
T ss_dssp TTEEEEEEECCSE-EHHHHHHHCTT---CCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEEC-----CCEEE
T ss_pred CCEEEEEEecCCC-CHHHHHhhcCC---CCHHHHHHHHHHHHHHHHHHH---hCCEECCCCCHHHEEEecCCCCccceEE
Confidence 5678999999975 99999876443 899999999999999999999 889999999999999954 44599
Q ss_pred EeeecceeecccCCCCcccccccccccCccccccC-CCCCcchhHHHHHHHHHHHhCCCCCCCCC
Q 044494 78 VADFGVARLLNFDSSNRTLLAGTYGYIAPELAYTM-VVTEKSDVYSFGVVALEVLMGKHPGELLS 141 (144)
Q Consensus 78 l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~-~~~~~~d~~slg~~l~~~~~g~~p~~~~~ 141 (144)
|+|||++..............+++.|+|||++.+. .++.++|+||+|+++++|++|..||...+
T Consensus 178 l~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~ 242 (329)
T 3gbz_A 178 IGDFGLARAFGIPIRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDS 242 (329)
T ss_dssp ECCTTHHHHHC-----------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred ECcCCCccccCCcccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCC
Confidence 99999998765443344445679999999999875 47899999999999999999999997643
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=3.8e-31 Score=180.30 Aligned_cols=131 Identities=29% Similarity=0.414 Sum_probs=109.7
Q ss_pred ceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeeecc
Q 044494 4 KCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADFGV 83 (144)
Q Consensus 4 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~~~ 83 (144)
+.+++||||+++++|.+++..... .+++..++.++.|++.|+.+|| +.+++|+||||+||+++.++.++|+|||+
T Consensus 86 ~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~ 160 (295)
T 3ugc_A 86 RNLKLIMEYLPYGSLRDYLQKHKE--RIDHIKLLQYTSQICKGMEYLG---TKRYIHRDLATRNILVENENRVKIGDFGL 160 (295)
T ss_dssp TSCEEEEECCTTCBHHHHHHHCGG--GCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECCCCS
T ss_pred CceEEEEEeCCCCCHHHHHHhccc--ccCHHHHHHHHHHHHHHHHHHh---cCCcccCCCCHhhEEEcCCCeEEEccCcc
Confidence 457999999999999999976432 3899999999999999999999 89999999999999999999999999999
Q ss_pred eeecccCCC---CcccccccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCC
Q 044494 84 ARLLNFDSS---NRTLLAGTYGYIAPELAYTMVVTEKSDVYSFGVVALEVLMGKHPGEL 139 (144)
Q Consensus 84 ~~~~~~~~~---~~~~~~~~~~~~~pe~~~~~~~~~~~d~~slg~~l~~~~~g~~p~~~ 139 (144)
+........ ......++..|+|||.+....++.++|+||+|++++++++|..||..
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~ 219 (295)
T 3ugc_A 161 TKVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKS 219 (295)
T ss_dssp CC-------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCS
T ss_pred cccccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCC
Confidence 986543221 12234466779999999999999999999999999999999998865
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=4.8e-31 Score=190.72 Aligned_cols=131 Identities=27% Similarity=0.422 Sum_probs=114.1
Q ss_pred CceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEE---cCCCCeEEe
Q 044494 3 RKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILL---NLELEAFVA 79 (144)
Q Consensus 3 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~---~~~~~~~l~ 79 (144)
++.+|+||||+.+++|.+++..... +++..++.++.|++.|+.||| +++++||||||+||++ +.++.++|+
T Consensus 98 ~~~~~lv~e~~~~~~L~~~~~~~~~---~~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~kl~ 171 (484)
T 3nyv_A 98 KGYFYLVGEVYTGGELFDEIISRKR---FSEVDAARIIRQVLSGITYMH---KNKIVHRDLKPENLLLESKSKDANIRII 171 (484)
T ss_dssp SSEEEEEECCCCSCBHHHHHHTCSC---CBHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESSSSTTCCEEEC
T ss_pred CCEEEEEEecCCCCCHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHHHEEEecCCCCCcEEEE
Confidence 5678999999999999998876443 899999999999999999999 8899999999999999 467889999
Q ss_pred eecceeecccCCCCcccccccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCC
Q 044494 80 DFGVARLLNFDSSNRTLLAGTYGYIAPELAYTMVVTEKSDVYSFGVVALEVLMGKHPGELLS 141 (144)
Q Consensus 80 d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~d~~slg~~l~~~~~g~~p~~~~~ 141 (144)
|||++...... .......+++.|+|||++.+ .++.++|+||+|+++|+|++|..||...+
T Consensus 172 Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~ 231 (484)
T 3nyv_A 172 DFGLSTHFEAS-KKMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGAN 231 (484)
T ss_dssp CTTHHHHBCCC-CSHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred eeeeeEEcccc-cccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCC
Confidence 99999765432 23344568999999999876 58899999999999999999999998654
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.3e-30 Score=186.23 Aligned_cols=131 Identities=21% Similarity=0.281 Sum_probs=114.2
Q ss_pred CceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCC--eEEee
Q 044494 3 RKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELE--AFVAD 80 (144)
Q Consensus 3 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~--~~l~d 80 (144)
++.+++||||+. ++|.+++.... ...+++..+..++.|++.||.||| +.+++||||||+||+++.++. ++|+|
T Consensus 171 ~~~~~lv~e~~~-~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlKp~NILl~~~~~~~vkL~D 245 (429)
T 3kvw_A 171 RNHICMTFELLS-MNLYELIKKNK-FQGFSLPLVRKFAHSILQCLDALH---KNRIIHCDLKPENILLKQQGRSGIKVID 245 (429)
T ss_dssp TTEEEEEECCCC-CBHHHHHHHTT-TCCCCHHHHHHHHHHHHHHHHHHH---HHTEECSCCSGGGEEESSTTSCCEEECC
T ss_pred CCeEEEEEeccC-CCHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEEccCCCcceEEee
Confidence 467899999996 69999887633 234899999999999999999999 889999999999999999887 99999
Q ss_pred ecceeecccCCCCcccccccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCC
Q 044494 81 FGVARLLNFDSSNRTLLAGTYGYIAPELAYTMVVTEKSDVYSFGVVALEVLMGKHPGELLS 141 (144)
Q Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~d~~slg~~l~~~~~g~~p~~~~~ 141 (144)
||++..... ......+++.|+|||++.+..++.++|+||+|+++++|++|..||.+.+
T Consensus 246 FG~a~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~ 303 (429)
T 3kvw_A 246 FGSSCYEHQ---RVYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGED 303 (429)
T ss_dssp CTTCEETTC---CCCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred cccceecCC---cccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCC
Confidence 999976432 2334568999999999999999999999999999999999999998754
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=99.97 E-value=8.6e-31 Score=179.86 Aligned_cols=132 Identities=27% Similarity=0.354 Sum_probs=105.6
Q ss_pred CceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeeec
Q 044494 3 RKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADFG 82 (144)
Q Consensus 3 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~~ 82 (144)
++.+|+||||+++++|.+++..... +++..++.++.|++.++.+|| +.+++|+||+|+||+++.++.++++|||
T Consensus 106 ~~~~~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dlkp~NIl~~~~~~~kl~Dfg 179 (309)
T 2h34_A 106 DGQLYVDMRLINGVDLAAMLRRQGP---LAPPRAVAIVRQIGSALDAAH---AAGATHRDVKPENILVSADDFAYLVDFG 179 (309)
T ss_dssp TTEEEEEEECCCCEEHHHHHHHHCS---CCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECSCC
T ss_pred CCeEEEEEEecCCCCHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHH---HCcCCcCCCChHHEEEcCCCCEEEecCc
Confidence 5678999999999999999976433 899999999999999999999 8899999999999999999999999999
Q ss_pred ceeecccCC-CCcccccccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCC
Q 044494 83 VARLLNFDS-SNRTLLAGTYGYIAPELAYTMVVTEKSDVYSFGVVALEVLMGKHPGELL 140 (144)
Q Consensus 83 ~~~~~~~~~-~~~~~~~~~~~~~~pe~~~~~~~~~~~d~~slg~~l~~~~~g~~p~~~~ 140 (144)
++....... .......+++.|+|||.+....++.++|+||+|++++++++|..||...
T Consensus 180 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~ 238 (309)
T 2h34_A 180 IASATTDEKLTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGD 238 (309)
T ss_dssp C----------------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSC
T ss_pred cCccccccccccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCc
Confidence 987654322 1223456889999999999888899999999999999999999999764
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=3.8e-30 Score=178.91 Aligned_cols=131 Identities=24% Similarity=0.334 Sum_probs=112.4
Q ss_pred CceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEE------------
Q 044494 3 RKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILL------------ 70 (144)
Q Consensus 3 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~------------ 70 (144)
++.+++||||+ ++++.+++.... ...+++..+..++.|++.||.+|| +++++|+||||+||++
T Consensus 94 ~~~~~lv~e~~-~~~l~~~l~~~~-~~~~~~~~~~~i~~qi~~~L~~lH---~~~ivH~Dlkp~NIll~~~~~~~~~~~~ 168 (355)
T 2eu9_A 94 HGHMCIAFELL-GKNTFEFLKENN-FQPYPLPHVRHMAYQLCHALRFLH---ENQLTHTDLKPENILFVNSEFETLYNEH 168 (355)
T ss_dssp TTEEEEEEECC-CCBHHHHHHHTT-TCCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEESCCCEEEEECCC
T ss_pred CCeEEEEEecc-CCChHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEeccccccccccc
Confidence 46789999999 567877776532 234899999999999999999999 8999999999999999
Q ss_pred -------cCCCCeEEeeecceeecccCCCCcccccccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCC
Q 044494 71 -------NLELEAFVADFGVARLLNFDSSNRTLLAGTYGYIAPELAYTMVVTEKSDVYSFGVVALEVLMGKHPGELLS 141 (144)
Q Consensus 71 -------~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~d~~slg~~l~~~~~g~~p~~~~~ 141 (144)
+.++.++|+|||++..... ......+++.|+|||++.+..++.++|+||+|+++++|++|..||...+
T Consensus 169 ~~~~~~~~~~~~~kl~Dfg~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~ 243 (355)
T 2eu9_A 169 KSCEEKSVKNTSIRVADFGSATFDHE---HHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHE 243 (355)
T ss_dssp -CCCEEEESCCCEEECCCTTCEETTS---CCCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred ccccccccCCCcEEEeecCccccccc---cccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCC
Confidence 5678899999999986432 2234568999999999998889999999999999999999999998654
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.2e-30 Score=188.88 Aligned_cols=131 Identities=28% Similarity=0.421 Sum_probs=111.4
Q ss_pred CceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEc---CCCCeEEe
Q 044494 3 RKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLN---LELEAFVA 79 (144)
Q Consensus 3 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~---~~~~~~l~ 79 (144)
.+.+|+||||+.+++|.+.+..... +++..+..++.|++.|+.||| ++|++||||||+||+++ .++.++|+
T Consensus 93 ~~~~~lv~e~~~~~~L~~~~~~~~~---~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~kl~ 166 (486)
T 3mwu_A 93 SSSFYIVGELYTGGELFDEIIKRKR---FSEHDAARIIKQVFSGITYMH---KHNIVHRDLKPENILLESKEKDCDIKII 166 (486)
T ss_dssp SSEEEEEECCCCSCBHHHHHHHHSS---CCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEESSSSTTCCEEEC
T ss_pred CCEEEEEEEcCCCCcHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHH---HCCeEeccCchHHEEEecCCCCCCEEEE
Confidence 5678999999999999998875433 899999999999999999999 89999999999999995 45679999
Q ss_pred eecceeecccCCCCcccccccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCC
Q 044494 80 DFGVARLLNFDSSNRTLLAGTYGYIAPELAYTMVVTEKSDVYSFGVVALEVLMGKHPGELLS 141 (144)
Q Consensus 80 d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~d~~slg~~l~~~~~g~~p~~~~~ 141 (144)
|||++...... .......+++.|+|||++.+ .++.++|+||+|+++|+|++|..||.+.+
T Consensus 167 Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~ 226 (486)
T 3mwu_A 167 DFGLSTCFQQN-TKMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKN 226 (486)
T ss_dssp SCSCTTTBCCC-----CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred ECCcCeECCCC-CccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 99998765432 22334568999999999876 48899999999999999999999997654
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=5.8e-31 Score=181.82 Aligned_cols=135 Identities=29% Similarity=0.426 Sum_probs=113.8
Q ss_pred CceEEEEEeeccCCCHHHHhhccc-------------ccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEE
Q 044494 3 RKCMFLIYEYMEMGSLFCVLRTDE-------------EAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNIL 69 (144)
Q Consensus 3 ~~~~~lv~e~~~~~~L~~~l~~~~-------------~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~ 69 (144)
++.+|+||||+++++|.+++.... ....+++..++.++.|++.||.+|| +++++|+||||+||+
T Consensus 98 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIl 174 (327)
T 1fvr_A 98 RGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNIL 174 (327)
T ss_dssp TTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEE
T ss_pred CCceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCccceEE
Confidence 567899999999999999997542 2235899999999999999999999 899999999999999
Q ss_pred EcCCCCeEEeeecceeecccCCCCcccccccccccCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCC
Q 044494 70 LNLELEAFVADFGVARLLNFDSSNRTLLAGTYGYIAPELAYTMVVTEKSDVYSFGVVALEVLM-GKHPGELLS 141 (144)
Q Consensus 70 ~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~d~~slg~~l~~~~~-g~~p~~~~~ 141 (144)
++.++.++|+|||++....... ......+++.|+|||.+....++.++|+||+|+++++|++ |..||...+
T Consensus 175 ~~~~~~~kL~Dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~ 246 (327)
T 1fvr_A 175 VGENYVAKIADFGLSRGQEVYV-KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT 246 (327)
T ss_dssp ECGGGCEEECCTTCEESSCEEC-CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCC
T ss_pred EcCCCeEEEcccCcCccccccc-cccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCc
Confidence 9999999999999987543211 2223446788999999988888999999999999999998 999997653
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=1.3e-30 Score=177.89 Aligned_cols=135 Identities=28% Similarity=0.392 Sum_probs=112.9
Q ss_pred CceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeeec
Q 044494 3 RKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADFG 82 (144)
Q Consensus 3 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~~ 82 (144)
++..++||||+++++|.+++.... ..+++..++.++.|++.|+.+|| +++++|+||||+||+++.++.++++|||
T Consensus 99 ~~~~~~v~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~ql~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg 173 (298)
T 3f66_A 99 EGSPLVVLPYMKHGDLRNFIRNET--HNPTVKDLIGFGLQVAKGMKYLA---SKKFVHRDLAARNCMLDEKFTVKVADFG 173 (298)
T ss_dssp SSCCEEEEECCTTCBHHHHHHCTT--CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTCCEEECSCG
T ss_pred CCceEEEEeCCCCCCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCchheEEECCCCCEEECccc
Confidence 457799999999999999997533 33889999999999999999999 8999999999999999999999999999
Q ss_pred ceeecccCC----CCcccccccccccCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCC
Q 044494 83 VARLLNFDS----SNRTLLAGTYGYIAPELAYTMVVTEKSDVYSFGVVALEVLM-GKHPGELLSS 142 (144)
Q Consensus 83 ~~~~~~~~~----~~~~~~~~~~~~~~pe~~~~~~~~~~~d~~slg~~l~~~~~-g~~p~~~~~~ 142 (144)
.+....... .......+++.|+|||.+.+..++.++|+||+|++++++++ |..||...+.
T Consensus 174 ~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~ 238 (298)
T 3f66_A 174 LARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT 238 (298)
T ss_dssp GGCCCSCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCT
T ss_pred ccccccccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCH
Confidence 997654221 11223456788999999998889999999999999999999 6777766543
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=99.97 E-value=2.1e-31 Score=191.47 Aligned_cols=135 Identities=30% Similarity=0.491 Sum_probs=114.7
Q ss_pred CceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeeec
Q 044494 3 RKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADFG 82 (144)
Q Consensus 3 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~~ 82 (144)
++.+|+||||+++|+|.++++... ...+++..+..++.|++.||.||| +++++||||||+||+++.++.++|+|||
T Consensus 254 ~~~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivHrDlkp~Nill~~~~~~kl~DFG 329 (454)
T 1qcf_A 254 KEPIYIITEFMAKGSLLDFLKSDE-GSKQPLPKLIDFSAQIAEGMAFIE---QRNYIHRDLRAANILVSASLVCKIADFG 329 (454)
T ss_dssp SSSCEEEECCCTTCBHHHHHHSHH-HHTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCSGGGEEECTTCCEEECSTT
T ss_pred CCccEEEEeecCCCcHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCCHHHEEECCCCcEEEeeCC
Confidence 456899999999999999997532 123888999999999999999999 8899999999999999999999999999
Q ss_pred ceeecccCC-CCcccccccccccCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCC
Q 044494 83 VARLLNFDS-SNRTLLAGTYGYIAPELAYTMVVTEKSDVYSFGVVALEVLM-GKHPGELLS 141 (144)
Q Consensus 83 ~~~~~~~~~-~~~~~~~~~~~~~~pe~~~~~~~~~~~d~~slg~~l~~~~~-g~~p~~~~~ 141 (144)
+++...... .......+++.|+|||.+....++.++|+||+|++++||++ |..||.+.+
T Consensus 330 ~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~ 390 (454)
T 1qcf_A 330 LARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMS 390 (454)
T ss_dssp GGGGBCCHHHHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred CceEcCCCceeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCC
Confidence 997653211 11222345678999999998889999999999999999999 999998754
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.97 E-value=5.7e-31 Score=181.44 Aligned_cols=133 Identities=25% Similarity=0.403 Sum_probs=107.0
Q ss_pred EEEEEeeccCCCHHHHhhccc---ccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeeec
Q 044494 6 MFLIYEYMEMGSLFCVLRTDE---EAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADFG 82 (144)
Q Consensus 6 ~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~~ 82 (144)
.++||||+.+++|.+++.... ....+++..++.++.|++.|+.+|| ++|++|+||||+||+++.++.++++|||
T Consensus 106 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH---~~~ivH~Dikp~NIli~~~~~~kl~Dfg 182 (323)
T 3qup_A 106 PMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLS---SRNFIHRDLAARNCMLAEDMTVCVADFG 182 (323)
T ss_dssp EEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTSCEEECCCC
T ss_pred cEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHH---cCCcccCCCCcceEEEcCCCCEEEeecc
Confidence 489999999999999986422 2224899999999999999999999 8999999999999999999999999999
Q ss_pred ceeecccCCC--CcccccccccccCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCC
Q 044494 83 VARLLNFDSS--NRTLLAGTYGYIAPELAYTMVVTEKSDVYSFGVVALEVLM-GKHPGELLS 141 (144)
Q Consensus 83 ~~~~~~~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~d~~slg~~l~~~~~-g~~p~~~~~ 141 (144)
++........ ......+++.|+|||.+....++.++|+||+|++++++++ |..||...+
T Consensus 183 ~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~ 244 (323)
T 3qup_A 183 LSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIE 244 (323)
T ss_dssp C-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC
T ss_pred ccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccC
Confidence 9976543221 1223446778999999999989999999999999999999 999998754
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=6.9e-31 Score=180.11 Aligned_cols=137 Identities=28% Similarity=0.427 Sum_probs=116.7
Q ss_pred CCceEEEEEeeccCCCHHHHhhcccc---------------cCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCC
Q 044494 2 HRKCMFLIYEYMEMGSLFCVLRTDEE---------------AVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSN 66 (144)
Q Consensus 2 ~~~~~~lv~e~~~~~~L~~~l~~~~~---------------~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ 66 (144)
.++..++||||+++|+|.+++..... ...+++..++.++.|++.|+.+|| +.+++|+||||+
T Consensus 98 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~ 174 (313)
T 1t46_A 98 IGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLA---SKNCIHRDLAAR 174 (313)
T ss_dssp SSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGG
T ss_pred cCCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCccc
Confidence 35678999999999999999975432 124899999999999999999999 889999999999
Q ss_pred cEEEcCCCCeEEeeecceeecccCCCC--cccccccccccCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCC
Q 044494 67 NILLNLELEAFVADFGVARLLNFDSSN--RTLLAGTYGYIAPELAYTMVVTEKSDVYSFGVVALEVLM-GKHPGELLS 141 (144)
Q Consensus 67 ni~~~~~~~~~l~d~~~~~~~~~~~~~--~~~~~~~~~~~~pe~~~~~~~~~~~d~~slg~~l~~~~~-g~~p~~~~~ 141 (144)
||+++.++.++++|||++......... .....+++.|+|||.+....++.++|+||+|+++++|++ |..||...+
T Consensus 175 Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~ 252 (313)
T 1t46_A 175 NILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMP 252 (313)
T ss_dssp GEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCC
T ss_pred eEEEcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCccc
Confidence 999999999999999999866533221 223456778999999998889999999999999999998 999998754
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.1e-30 Score=184.49 Aligned_cols=131 Identities=25% Similarity=0.384 Sum_probs=107.9
Q ss_pred CCceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeee
Q 044494 2 HRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADF 81 (144)
Q Consensus 2 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~ 81 (144)
.++.+|+||| +.+++|.+++.... .+++..+..++.|++.||.||| +.+++||||||+||+++ ++.++|+||
T Consensus 127 ~~~~~~lv~E-~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~lH---~~~ivHrDlkp~NIll~-~~~~kl~DF 198 (390)
T 2zmd_A 127 TDQYIYMVME-CGNIDLNSWLKKKK---SIDPWERKSYWKNMLEAVHTIH---QHGIVHSDLKPANFLIV-DGMLKLIDF 198 (390)
T ss_dssp CSSEEEEEEE-CCSEEHHHHHHHCS---SCCHHHHHHHHHHHHHHHHHHH---TTTCCCCCCCGGGEEES-SSCEEECCC
T ss_pred cCCEEEEEEe-cCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHEEEE-CCeEEEEec
Confidence 3567899999 56789999998644 3889999999999999999999 89999999999999995 578999999
Q ss_pred cceeecccCCC--CcccccccccccCcccccc-----------CCCCCcchhHHHHHHHHHHHhCCCCCCCC
Q 044494 82 GVARLLNFDSS--NRTLLAGTYGYIAPELAYT-----------MVVTEKSDVYSFGVVALEVLMGKHPGELL 140 (144)
Q Consensus 82 ~~~~~~~~~~~--~~~~~~~~~~~~~pe~~~~-----------~~~~~~~d~~slg~~l~~~~~g~~p~~~~ 140 (144)
|++........ ......|++.|+|||++.. ..++.++|+||+|+++|+|++|..||...
T Consensus 199 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~ 270 (390)
T 2zmd_A 199 GIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQI 270 (390)
T ss_dssp SSSCCC---------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTC
T ss_pred CccccccCCCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhh
Confidence 99986543221 2234569999999999875 35788999999999999999999999764
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=5.2e-31 Score=183.28 Aligned_cols=131 Identities=26% Similarity=0.388 Sum_probs=106.6
Q ss_pred CCceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeee
Q 044494 2 HRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADF 81 (144)
Q Consensus 2 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~ 81 (144)
.++.+|+||| +.+++|.+++..... +++..+..++.|++.||.||| +.+++||||||+||+++ ++.++|+||
T Consensus 80 ~~~~~~lv~e-~~~~~L~~~l~~~~~---~~~~~~~~i~~qi~~al~~lH---~~~iiHrDikp~NIll~-~~~~kl~DF 151 (343)
T 3dbq_A 80 TDQYIYMVME-CGNIDLNSWLKKKKS---IDPWERKSYWKNMLEAVHTIH---QHGIVHSDLKPANFLIV-DGMLKLIDF 151 (343)
T ss_dssp CSSEEEEEEC-CCSEEHHHHHHHSCC---CCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEEE-TTEEEECCC
T ss_pred eCCEEEEEEe-CCCCCHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCcceEEEE-CCcEEEeec
Confidence 3567899999 557899999986443 899999999999999999999 88999999999999997 577999999
Q ss_pred cceeecccCCC--CcccccccccccCcccccc-----------CCCCCcchhHHHHHHHHHHHhCCCCCCCC
Q 044494 82 GVARLLNFDSS--NRTLLAGTYGYIAPELAYT-----------MVVTEKSDVYSFGVVALEVLMGKHPGELL 140 (144)
Q Consensus 82 ~~~~~~~~~~~--~~~~~~~~~~~~~pe~~~~-----------~~~~~~~d~~slg~~l~~~~~g~~p~~~~ 140 (144)
|++........ ......|++.|+|||++.. ..++.++|+||+|+++++|++|..||...
T Consensus 152 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~ 223 (343)
T 3dbq_A 152 GIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQI 223 (343)
T ss_dssp SSSCCC------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTC
T ss_pred ccccccCcccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhh
Confidence 99986543222 2234568999999999865 56788999999999999999999999764
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=3e-31 Score=185.37 Aligned_cols=131 Identities=27% Similarity=0.355 Sum_probs=113.5
Q ss_pred CceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCC-CeEecCCCCCcEEEcCCCCeEEeee
Q 044494 3 RKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTP-PIVHRDISSNNILLNLELEAFVADF 81 (144)
Q Consensus 3 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~-~~~h~~i~~~ni~~~~~~~~~l~d~ 81 (144)
++.+|+||||+++++|.+++..... +++..+..++.|++.++.+|| ++ +++|+||||+||+++.++.++|+||
T Consensus 103 ~~~~~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~i~~~i~~~l~~lh---~~~~i~H~dlkp~Nil~~~~~~~kl~Df 176 (360)
T 3eqc_A 103 DGEISICMEHMDGGSLDQVLKKAGR---IPEQILGKVSIAVIKGLTYLR---EKHKIMHRDVKPSNILVNSRGEIKLCDF 176 (360)
T ss_dssp TTEEEEEECCCTTCBHHHHHHHHSS---CCHHHHHHHHHHHHHHHHHHH---HHHCCCCSCCSGGGEEECTTCCEEECCC
T ss_pred CCEEEEEEECCCCCCHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHH---HhCCEEcCCccHHHEEECCCCCEEEEEC
Confidence 5678999999999999999976443 899999999999999999999 75 8999999999999999999999999
Q ss_pred cceeecccCCCCcccccccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCC
Q 044494 82 GVARLLNFDSSNRTLLAGTYGYIAPELAYTMVVTEKSDVYSFGVVALEVLMGKHPGELLS 141 (144)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~d~~slg~~l~~~~~g~~p~~~~~ 141 (144)
|++...... ......+++.|+|||.+.+..++.++|+||+|+++++|++|..||...+
T Consensus 177 g~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~ 234 (360)
T 3eqc_A 177 GVSGQLIDS--MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPD 234 (360)
T ss_dssp CCCHHHHHH--C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCC
T ss_pred CCCcccccc--cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 998754321 1233568999999999999889999999999999999999999997643
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=99.97 E-value=1.4e-30 Score=180.49 Aligned_cols=137 Identities=28% Similarity=0.420 Sum_probs=115.6
Q ss_pred CCceEEEEEeeccCCCHHHHhhcccc-------------cCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcE
Q 044494 2 HRKCMFLIYEYMEMGSLFCVLRTDEE-------------AVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNI 68 (144)
Q Consensus 2 ~~~~~~lv~e~~~~~~L~~~l~~~~~-------------~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni 68 (144)
.++.+|+||||+++++|.+++..... ...+++..++.++.|++.||.+|| +.+++|+||||+||
T Consensus 112 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NI 188 (334)
T 2pvf_A 112 QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLA---SQKCIHRDLAARNV 188 (334)
T ss_dssp SSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGE
T ss_pred cCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCccceE
Confidence 35678999999999999999975331 224889999999999999999999 89999999999999
Q ss_pred EEcCCCCeEEeeecceeecccCCC--CcccccccccccCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCC
Q 044494 69 LLNLELEAFVADFGVARLLNFDSS--NRTLLAGTYGYIAPELAYTMVVTEKSDVYSFGVVALEVLM-GKHPGELLS 141 (144)
Q Consensus 69 ~~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~d~~slg~~l~~~~~-g~~p~~~~~ 141 (144)
+++.++.++|+|||++........ ......+++.|+|||.+....++.++|+||+|+++++|++ |..||...+
T Consensus 189 ll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~ 264 (334)
T 2pvf_A 189 LVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP 264 (334)
T ss_dssp EECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred EEcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCC
Confidence 999999999999999986553221 1222346778999999988888999999999999999999 999997653
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.2e-30 Score=187.56 Aligned_cols=122 Identities=28% Similarity=0.379 Sum_probs=102.1
Q ss_pred ceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeeecc
Q 044494 4 KCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADFGV 83 (144)
Q Consensus 4 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~~~ 83 (144)
+.+|+||||+ +++|.++++.... +++..+..++.|++.||+||| +.+++||||||+||+++.++.++|+|||+
T Consensus 130 ~~~~lv~e~~-~~~L~~~~~~~~~---l~~~~~~~~~~qi~~aL~~LH---~~~iiHrDlKp~NILl~~~~~~kl~DFGl 202 (458)
T 3rp9_A 130 DELYVVLEIA-DSDFKKLFRTPVY---LTELHIKTLLYNLLVGVKYVH---SAGILHRDLKPANCLVNQDCSVKVCDFGL 202 (458)
T ss_dssp CCEEEEECCC-SEEHHHHHHSSCC---CCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTCCEEECCCTT
T ss_pred ceEEEEEecc-ccchhhhcccCCC---CCHHHHHHHHHHHHHHHHHHH---hCCcCCCCCChhhEEECCCCCEeeccccc
Confidence 5689999998 4699998875433 999999999999999999999 88999999999999999999999999999
Q ss_pred eeecccCCC---------------------------CcccccccccccCcccc-ccCCCCCcchhHHHHHHHHHHHh
Q 044494 84 ARLLNFDSS---------------------------NRTLLAGTYGYIAPELA-YTMVVTEKSDVYSFGVVALEVLM 132 (144)
Q Consensus 84 ~~~~~~~~~---------------------------~~~~~~~~~~~~~pe~~-~~~~~~~~~d~~slg~~l~~~~~ 132 (144)
++....... ......+|+.|+|||++ ....++.++|+||+||++|||++
T Consensus 203 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~ellt 279 (458)
T 3rp9_A 203 ARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLN 279 (458)
T ss_dssp CBCTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHT
T ss_pred chhccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHH
Confidence 986542211 12234679999999976 45678999999999999999998
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.5e-31 Score=180.88 Aligned_cols=136 Identities=30% Similarity=0.454 Sum_probs=113.7
Q ss_pred CceEEEEEeeccCCCHHHHhhccc-ccCCCCHHHHHHHHHHHHHHHHHHhcCCCCC-----eEecCCCCCcEEEcCCCCe
Q 044494 3 RKCMFLIYEYMEMGSLFCVLRTDE-EAVGLDWAKRVNIVKGMAHALSYLHHDCTPP-----IVHRDISSNNILLNLELEA 76 (144)
Q Consensus 3 ~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~-----~~h~~i~~~ni~~~~~~~~ 76 (144)
++.+|+||||+++++|.+++.... ....+++..++.++.|++.++.+|| +.+ ++|+||+|+||+++.++.+
T Consensus 79 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~~~~~~ivH~dl~p~NIl~~~~~~~ 155 (279)
T 2w5a_A 79 NTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECH---RRSDGGHTVLHRDLKPANVFLDGKQNV 155 (279)
T ss_dssp GTEEEEEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---HHC------CCCCCSGGGEEECSSSCE
T ss_pred CceEEEEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHh---cccCCCCeeEEeccchhhEEEcCCCCE
Confidence 457899999999999999987532 2334899999999999999999999 777 9999999999999999999
Q ss_pred EEeeecceeecccCCCCcccccccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCC
Q 044494 77 FVADFGVARLLNFDSSNRTLLAGTYGYIAPELAYTMVVTEKSDVYSFGVVALEVLMGKHPGELLS 141 (144)
Q Consensus 77 ~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~d~~slg~~l~~~~~g~~p~~~~~ 141 (144)
+++|||.+..............+++.|+|||.+....++.++|+||+|++++++++|..||...+
T Consensus 156 kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 220 (279)
T 2w5a_A 156 KLGDFGLARILNHDTSFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFS 220 (279)
T ss_dssp EECCCCHHHHC---CHHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred EEecCchheeeccccccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccC
Confidence 99999998765432222233568899999999998888999999999999999999999998754
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=99.97 E-value=6.7e-31 Score=190.59 Aligned_cols=137 Identities=26% Similarity=0.373 Sum_probs=116.3
Q ss_pred CCceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeee
Q 044494 2 HRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADF 81 (144)
Q Consensus 2 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~ 81 (144)
.++.+|+||||+++|+|.++++.... ..+++..++.++.|++.||.||| +++++||||||+||+++.++.++|+||
T Consensus 287 ~~~~~~lv~E~~~~g~L~~~l~~~~~-~~~~~~~~~~i~~qi~~~L~~LH---~~~ivHrDlkp~NIll~~~~~~kl~DF 362 (495)
T 1opk_A 287 REPPFYIITEFMTYGNLLDYLRECNR-QEVSAVVLLYMATQISSAMEYLE---KKNFIHRNLAARNCLVGENHLVKVADF 362 (495)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHSCT-TTSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECGGGCEEECCT
T ss_pred cCCcEEEEEEccCCCCHHHHHHhcCc-CCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCChhhEEECCCCcEEEeec
Confidence 35678999999999999999975322 34899999999999999999999 899999999999999999999999999
Q ss_pred cceeecccCC-CCcccccccccccCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCC
Q 044494 82 GVARLLNFDS-SNRTLLAGTYGYIAPELAYTMVVTEKSDVYSFGVVALEVLM-GKHPGELLSS 142 (144)
Q Consensus 82 ~~~~~~~~~~-~~~~~~~~~~~~~~pe~~~~~~~~~~~d~~slg~~l~~~~~-g~~p~~~~~~ 142 (144)
|+++...... .......+++.|+|||.+....++.++|+||||+++|||++ |..||...+.
T Consensus 363 G~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~ 425 (495)
T 1opk_A 363 GLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL 425 (495)
T ss_dssp TCEECCTTCCEECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCG
T ss_pred ccceeccCCceeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCH
Confidence 9998654221 11222345678999999998889999999999999999999 9999987653
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=99.97 E-value=8.4e-31 Score=176.57 Aligned_cols=131 Identities=31% Similarity=0.484 Sum_probs=106.1
Q ss_pred CCceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCC---eEecCCCCCcEEEcC------
Q 044494 2 HRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPP---IVHRDISSNNILLNL------ 72 (144)
Q Consensus 2 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~---~~h~~i~~~ni~~~~------ 72 (144)
.++..++||||+++++|.+++... .+++..++.++.|++.++.+|| +++ ++|+||||+||+++.
T Consensus 77 ~~~~~~lv~e~~~~~~L~~~~~~~----~~~~~~~~~i~~~l~~~l~~lH---~~~~~~i~H~dikp~Nil~~~~~~~~~ 149 (271)
T 3dtc_A 77 KEPNLCLVMEFARGGPLNRVLSGK----RIPPDILVNWAVQIARGMNYLH---DEAIVPIIHRDLKSSNILILQKVENGD 149 (271)
T ss_dssp CC--CEEEEECCTTEEHHHHHTSS----CCCHHHHHHHHHHHHHHHHHHH---HSSSSCCCCSCCSGGGEEESSCCSSSC
T ss_pred cCCceEEEEEcCCCCCHHHHhhcC----CCCHHHHHHHHHHHHHHHHHHH---hCCCCceeecCCchHHEEEeccccccc
Confidence 356789999999999999988642 3899999999999999999999 777 899999999999986
Q ss_pred --CCCeEEeeecceeecccCCCCcccccccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCC
Q 044494 73 --ELEAFVADFGVARLLNFDSSNRTLLAGTYGYIAPELAYTMVVTEKSDVYSFGVVALEVLMGKHPGELLS 141 (144)
Q Consensus 73 --~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~d~~slg~~l~~~~~g~~p~~~~~ 141 (144)
++.++++|||.+....... .....+++.|+|||.+.+..++.++|+||+|++++++++|..||...+
T Consensus 150 ~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~ 218 (271)
T 3dtc_A 150 LSNKILKITDFGLAREWHRTT--KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGID 218 (271)
T ss_dssp CSSCCEEECCCCC---------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSC
T ss_pred ccCcceEEccCCccccccccc--ccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 6779999999997654322 224568999999999998889999999999999999999999998754
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2.6e-30 Score=180.13 Aligned_cols=133 Identities=22% Similarity=0.324 Sum_probs=111.5
Q ss_pred CceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeeec
Q 044494 3 RKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADFG 82 (144)
Q Consensus 3 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~~ 82 (144)
++.+|+||||+.+ +|.+.+.... ..+++..+..++.|++.||.+|| ++|++|+||||+||+++.++.++|+|||
T Consensus 96 ~~~~~lv~e~~~~-~l~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~LH---~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg 169 (351)
T 3mi9_A 96 KGSIYLVFDFCEH-DLAGLLSNVL--VKFTLSEIKRVMQMLLNGLYYIH---RNKILHRDMKAANVLITRDGVLKLADFG 169 (351)
T ss_dssp -CEEEEEEECCSE-EHHHHHHCTT--SCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCT
T ss_pred CceEEEEEeccCC-CHHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHH---HCCeeCCCCCHHHEEEcCCCCEEEccch
Confidence 4578999999975 7877776432 23899999999999999999999 8999999999999999999999999999
Q ss_pred ceeecccC----CCCcccccccccccCccccccC-CCCCcchhHHHHHHHHHHHhCCCCCCCCC
Q 044494 83 VARLLNFD----SSNRTLLAGTYGYIAPELAYTM-VVTEKSDVYSFGVVALEVLMGKHPGELLS 141 (144)
Q Consensus 83 ~~~~~~~~----~~~~~~~~~~~~~~~pe~~~~~-~~~~~~d~~slg~~l~~~~~g~~p~~~~~ 141 (144)
++...... ........+++.|+|||++.+. .++.++|+||+|+++++|++|..||.+.+
T Consensus 170 ~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~ 233 (351)
T 3mi9_A 170 LARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNT 233 (351)
T ss_dssp TCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred hcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCC
Confidence 99865422 1122335679999999998764 57899999999999999999999998654
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=99.97 E-value=1.3e-30 Score=178.34 Aligned_cols=131 Identities=24% Similarity=0.390 Sum_probs=114.2
Q ss_pred CCceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEE---cCCCCeEE
Q 044494 2 HRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILL---NLELEAFV 78 (144)
Q Consensus 2 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~---~~~~~~~l 78 (144)
.++..|+||||+++++|.+++..... +++..+..++.|++.|+.+|| +.|++|+||+|+||++ +.++.+++
T Consensus 77 ~~~~~~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dikp~NIl~~~~~~~~~~kl 150 (304)
T 2jam_A 77 STTHYYLVMQLVSGGELFDRILERGV---YTEKDASLVIQQVLSAVKYLH---ENGIVHRDLKPENLLYLTPEENSKIMI 150 (304)
T ss_dssp CSSEEEEEECCCCSCBHHHHHHHHSC---CCHHHHHHHHHHHHHHHHHHH---HTTCCCCSCCGGGCEESSSSTTCCEEB
T ss_pred cCCEEEEEEEcCCCccHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEEecCCCCCCEEE
Confidence 35678999999999999998875433 899999999999999999999 8899999999999999 67889999
Q ss_pred eeecceeecccCCCCcccccccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCC
Q 044494 79 ADFGVARLLNFDSSNRTLLAGTYGYIAPELAYTMVVTEKSDVYSFGVVALEVLMGKHPGELL 140 (144)
Q Consensus 79 ~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~d~~slg~~l~~~~~g~~p~~~~ 140 (144)
+|||.+..... .......+++.|+|||.+....++.++|+||+|+++++|++|..||...
T Consensus 151 ~Dfg~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~ 210 (304)
T 2jam_A 151 TDFGLSKMEQN--GIMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEE 210 (304)
T ss_dssp CSCSTTCCCCC--BTTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTS
T ss_pred ccCCcceecCC--CccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCC
Confidence 99999875432 1223356899999999999888999999999999999999999999764
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=5.8e-31 Score=182.69 Aligned_cols=133 Identities=26% Similarity=0.414 Sum_probs=95.9
Q ss_pred CceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCC---CCeEEe
Q 044494 3 RKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLE---LEAFVA 79 (144)
Q Consensus 3 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~---~~~~l~ 79 (144)
++.+++||||+++|+|.+++..... ..+++..++.++.|++.|+.+|| ++|++|+||||+||+++.+ +.++|+
T Consensus 98 ~~~~~lv~e~~~gg~L~~~l~~~~~-~~l~~~~~~~i~~ql~~~l~~LH---~~~ivH~dlkp~NIll~~~~~~~~~kl~ 173 (336)
T 3fhr_A 98 KRCLLIIMECMEGGELFSRIQERGD-QAFTEREAAEIMRDIGTAIQFLH---SHNIAHRDVKPENLLYTSKEKDAVLKLT 173 (336)
T ss_dssp EEEEEEEEECCTTEEHHHHHHTC-C-CCCBHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESCSSTTCCEEEC
T ss_pred CceEEEEEeccCCCCHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEEecCCCceEEEe
Confidence 3458999999999999999986432 34899999999999999999999 8899999999999999864 459999
Q ss_pred eecceeecccCCCCcccccccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCC
Q 044494 80 DFGVARLLNFDSSNRTLLAGTYGYIAPELAYTMVVTEKSDVYSFGVVALEVLMGKHPGELLS 141 (144)
Q Consensus 80 d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~d~~slg~~l~~~~~g~~p~~~~~ 141 (144)
|||++..... .......+++.|+|||.+....++.++|+||+|+++++|++|..||...+
T Consensus 174 Dfg~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~ 233 (336)
T 3fhr_A 174 DFGFAKETTQ--NALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNT 233 (336)
T ss_dssp CCTTCEEC------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC----
T ss_pred ccccceeccc--cccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCcc
Confidence 9999986542 22334567999999999988888899999999999999999999996543
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=5.8e-30 Score=180.30 Aligned_cols=133 Identities=23% Similarity=0.312 Sum_probs=113.3
Q ss_pred CceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEc--CCCCeEEee
Q 044494 3 RKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLN--LELEAFVAD 80 (144)
Q Consensus 3 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~--~~~~~~l~d 80 (144)
++.+|+||||+. ++|.+++.... ...+++..+..++.|++.|+.+||.. ..+++||||||+||+++ .++.++|+|
T Consensus 128 ~~~~~lv~e~~~-~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~al~~lH~~-~~~ivHrDlkp~NIll~~~~~~~~kL~D 204 (382)
T 2vx3_A 128 RNHLCLVFEMLS-YNLYDLLRNTN-FRGVSLNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVD 204 (382)
T ss_dssp TTEEEEEEECCC-CBHHHHHHHTT-TSCCCHHHHHHHHHHHHHHHHHHTST-TTCEECCCCSGGGEEESSTTSCCEEECC
T ss_pred CCceEEEEecCC-CCHHHHHhhcC-cCCCCHHHHHHHHHHHHHHHHHhccC-CCCEEcCCCCcccEEEecCCCCcEEEEe
Confidence 467899999996 59999987643 23489999999999999999999932 46899999999999995 467899999
Q ss_pred ecceeecccCCCCcccccccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCC
Q 044494 81 FGVARLLNFDSSNRTLLAGTYGYIAPELAYTMVVTEKSDVYSFGVVALEVLMGKHPGELLS 141 (144)
Q Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~d~~slg~~l~~~~~g~~p~~~~~ 141 (144)
||++..... ......+++.|+|||++.+..++.++|+||+|+++++|++|..||...+
T Consensus 205 FG~a~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~ 262 (382)
T 2vx3_A 205 FGSSCQLGQ---RIYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGAN 262 (382)
T ss_dssp CTTCEETTC---CCCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred ccCceeccc---ccccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 999987642 2234568999999999999999999999999999999999999998654
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.4e-30 Score=176.95 Aligned_cols=134 Identities=33% Similarity=0.429 Sum_probs=109.1
Q ss_pred CceEEEEEeeccCCCHHHHhhcc-cccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEE---cCCCCeEE
Q 044494 3 RKCMFLIYEYMEMGSLFCVLRTD-EEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILL---NLELEAFV 78 (144)
Q Consensus 3 ~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~---~~~~~~~l 78 (144)
.+..++||||+++++|.+++... .....+++..++.++.|++.|+.+|| +++++|+||||+||++ +.++.++|
T Consensus 92 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~dikp~NIl~~~~~~~~~~kl 168 (285)
T 3is5_A 92 YHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFH---SQHVVHKDLKPENILFQDTSPHSPIKI 168 (285)
T ss_dssp SSEEEEEECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEESSSSTTCCEEE
T ss_pred CCeEEEEEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHH---hCCEEECCCCHHHEEEecCCCCCCEEE
Confidence 56789999999999999988642 22344999999999999999999999 8999999999999999 45678999
Q ss_pred eeecceeecccCCCCcccccccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCC
Q 044494 79 ADFGVARLLNFDSSNRTLLAGTYGYIAPELAYTMVVTEKSDVYSFGVVALEVLMGKHPGELLS 141 (144)
Q Consensus 79 ~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~d~~slg~~l~~~~~g~~p~~~~~ 141 (144)
+|||++...... .......+++.|+|||.+. ..++.++|+||+|+++++|++|..||...+
T Consensus 169 ~Dfg~a~~~~~~-~~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~ 229 (285)
T 3is5_A 169 IDFGLAELFKSD-EHSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTS 229 (285)
T ss_dssp CCCCCCCC-----------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred EeeecceecCCc-ccCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCC
Confidence 999999765432 2233456899999999986 457889999999999999999999997653
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=4.5e-30 Score=175.07 Aligned_cols=132 Identities=28% Similarity=0.437 Sum_probs=114.3
Q ss_pred CceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeeec
Q 044494 3 RKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADFG 82 (144)
Q Consensus 3 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~~ 82 (144)
++..++||||+++++|.+++.... .+++..++.++.|++.++.+|| +.|++|+||+|+||+++.++.++++|||
T Consensus 96 ~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~dfg 169 (298)
T 1phk_A 96 NTFFFLVFDLMKKGELFDYLTEKV---TLSEKETRKIMRALLEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFG 169 (298)
T ss_dssp SSEEEEEEECCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCT
T ss_pred CCeEEEEEeccCCCcHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCcceEEEcCCCcEEEeccc
Confidence 567899999999999999997643 3899999999999999999999 8999999999999999999999999999
Q ss_pred ceeecccCCCCcccccccccccCccccc------cCCCCCcchhHHHHHHHHHHHhCCCCCCCCC
Q 044494 83 VARLLNFDSSNRTLLAGTYGYIAPELAY------TMVVTEKSDVYSFGVVALEVLMGKHPGELLS 141 (144)
Q Consensus 83 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~------~~~~~~~~d~~slg~~l~~~~~g~~p~~~~~ 141 (144)
.+...... .......+++.|+|||.+. ...++.++|+||+|+++++|++|..||...+
T Consensus 170 ~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~ 233 (298)
T 1phk_A 170 FSCQLDPG-EKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRK 233 (298)
T ss_dssp TCEECCTT-CCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred chhhcCCC-cccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCcc
Confidence 99875532 2233456889999999885 4457789999999999999999999997543
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.97 E-value=1.3e-30 Score=177.12 Aligned_cols=134 Identities=26% Similarity=0.402 Sum_probs=115.0
Q ss_pred CceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeeec
Q 044494 3 RKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADFG 82 (144)
Q Consensus 3 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~~ 82 (144)
.+..++||||+++++|.+++.... ..+++..++.++.|++.++.+|| +.+++|+||+|+||+++.++.++++|||
T Consensus 81 ~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~kl~Dfg 155 (287)
T 1u59_A 81 AEALMLVMEMAGGGPLHKFLVGKR--EEIPVSNVAELLHQVSMGMKYLE---EKNFVHRDLAARNVLLVNRHYAKISDFG 155 (287)
T ss_dssp SSSEEEEEECCTTEEHHHHHTTCT--TTSCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEEETTEEEECCCT
T ss_pred CCCcEEEEEeCCCCCHHHHHHhCC--ccCCHHHHHHHHHHHHHHHHHHH---HCCEeeCCCchheEEEcCCCCEEECccc
Confidence 456899999999999999987432 23899999999999999999999 8899999999999999999999999999
Q ss_pred ceeecccCCCC---cccccccccccCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCC
Q 044494 83 VARLLNFDSSN---RTLLAGTYGYIAPELAYTMVVTEKSDVYSFGVVALEVLM-GKHPGELLS 141 (144)
Q Consensus 83 ~~~~~~~~~~~---~~~~~~~~~~~~pe~~~~~~~~~~~d~~slg~~l~~~~~-g~~p~~~~~ 141 (144)
++......... .....+++.|+|||.+....++.++|+||+|+++++|++ |..||...+
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~ 218 (287)
T 1u59_A 156 LSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMK 218 (287)
T ss_dssp TCEECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCC
T ss_pred ceeeeccCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCC
Confidence 99876432211 122345788999999988888999999999999999998 999998754
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=6.9e-31 Score=194.62 Aligned_cols=135 Identities=25% Similarity=0.396 Sum_probs=112.4
Q ss_pred CceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeeec
Q 044494 3 RKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADFG 82 (144)
Q Consensus 3 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~~ 82 (144)
.+.+|+||||+.+|+|.+++.... ..+++..+..++.|++.||.||| +++++||||||+||+++.++.++|+|||
T Consensus 407 ~~~~~lv~E~~~~g~L~~~l~~~~--~~l~~~~~~~i~~qi~~~L~~LH---~~~iiHrDlkp~NILl~~~~~vkL~DFG 481 (613)
T 2ozo_A 407 AEALMLVMEMAGGGPLHKFLVGKR--EEIPVSNVAELLHQVSMGMKYLE---EKNFVHRNLAARNVLLVNRHYAKISDFG 481 (613)
T ss_dssp SSSEEEEEECCTTCBHHHHHTTCT--TTSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECCCS
T ss_pred cCCeEEEEEeCCCCcHHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHH---HCCEEcCcCCHHHEEEcCCCcEEEeecc
Confidence 356899999999999999997532 34899999999999999999999 8999999999999999999999999999
Q ss_pred ceeecccCCC---CcccccccccccCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCC
Q 044494 83 VARLLNFDSS---NRTLLAGTYGYIAPELAYTMVVTEKSDVYSFGVVALEVLM-GKHPGELLSS 142 (144)
Q Consensus 83 ~~~~~~~~~~---~~~~~~~~~~~~~pe~~~~~~~~~~~d~~slg~~l~~~~~-g~~p~~~~~~ 142 (144)
+++....... ......+++.|+|||++....++.++|+||+|+++|||++ |..||...+.
T Consensus 482 la~~~~~~~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~ 545 (613)
T 2ozo_A 482 LSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG 545 (613)
T ss_dssp TTTTCC--------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCS
T ss_pred CcccccCCCceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCH
Confidence 9976542211 1122335678999999998899999999999999999998 9999987653
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=7.4e-31 Score=180.75 Aligned_cols=137 Identities=26% Similarity=0.362 Sum_probs=115.3
Q ss_pred CCceEEEEEeeccCCCHHHHhhcccc-------cCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCC
Q 044494 2 HRKCMFLIYEYMEMGSLFCVLRTDEE-------AVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLEL 74 (144)
Q Consensus 2 ~~~~~~lv~e~~~~~~L~~~l~~~~~-------~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~ 74 (144)
+++..++||||+++++|.+++..... ...+++..++.++.|++.|+.+|| ++|++|+||||+||+++.++
T Consensus 99 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dikp~NIli~~~~ 175 (322)
T 1p4o_A 99 QGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDF 175 (322)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHH---HTTCBCSCCSGGGEEECTTC
T ss_pred cCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHH---HCCCccCCCccceEEEcCCC
Confidence 35678999999999999999875321 134789999999999999999999 88999999999999999999
Q ss_pred CeEEeeecceeecccCCC--CcccccccccccCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCC
Q 044494 75 EAFVADFGVARLLNFDSS--NRTLLAGTYGYIAPELAYTMVVTEKSDVYSFGVVALEVLM-GKHPGELLS 141 (144)
Q Consensus 75 ~~~l~d~~~~~~~~~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~d~~slg~~l~~~~~-g~~p~~~~~ 141 (144)
.++++|||++........ ......+++.|+|||.+.+..++.++|+||+|++++++++ |..||...+
T Consensus 176 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~ 245 (322)
T 1p4o_A 176 TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLS 245 (322)
T ss_dssp CEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSC
T ss_pred eEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCC
Confidence 999999999876543221 1223346788999999998889999999999999999999 899997654
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=3.4e-31 Score=196.83 Aligned_cols=133 Identities=28% Similarity=0.436 Sum_probs=112.3
Q ss_pred CceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeeec
Q 044494 3 RKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADFG 82 (144)
Q Consensus 3 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~~ 82 (144)
++..++||||+++|+|.++++.... +++..++.++.|++.||.||| +++++||||||+||+++.++.++|+|||
T Consensus 441 ~~~~~lv~E~~~~g~L~~~l~~~~~---l~~~~~~~i~~qi~~~L~yLH---~~~iiHrDLkp~NILl~~~~~~kL~DFG 514 (635)
T 4fl3_A 441 AESWMLVMEMAELGPLNKYLQQNRH---VKDKNIIELVHQVSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFG 514 (635)
T ss_dssp SSSEEEEEECCTTEEHHHHHHHCTT---CCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECCTT
T ss_pred cCCEEEEEEccCCCCHHHHHhhCCC---CCHHHHHHHHHHHHHHHHHHH---HCCEeCCCCChHhEEEeCCCCEEEEEcC
Confidence 4567899999999999999975433 899999999999999999999 8999999999999999999999999999
Q ss_pred ceeecccCCC---CcccccccccccCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCC
Q 044494 83 VARLLNFDSS---NRTLLAGTYGYIAPELAYTMVVTEKSDVYSFGVVALEVLM-GKHPGELLS 141 (144)
Q Consensus 83 ~~~~~~~~~~---~~~~~~~~~~~~~pe~~~~~~~~~~~d~~slg~~l~~~~~-g~~p~~~~~ 141 (144)
+++....... ......+++.|+|||++....++.++|+||+|++++||++ |..||.+.+
T Consensus 515 la~~~~~~~~~~~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~ 577 (635)
T 4fl3_A 515 LSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMK 577 (635)
T ss_dssp HHHHTTC-------------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCC
T ss_pred CccccccCccccccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCC
Confidence 9986543221 1222345678999999999899999999999999999998 999998764
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=8.1e-31 Score=181.38 Aligned_cols=134 Identities=25% Similarity=0.423 Sum_probs=109.3
Q ss_pred ceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeeecc
Q 044494 4 KCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADFGV 83 (144)
Q Consensus 4 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~~~ 83 (144)
+..++|+||+.+|+|.+++..... .+++..++.++.|++.||.+|| +++++|+||||+||+++.++.++|+|||+
T Consensus 89 ~~~~~v~~~~~~g~L~~~l~~~~~--~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIl~~~~~~~kL~DfG~ 163 (327)
T 3lzb_A 89 STVQLITQLMPFGCLLDYVREHKD--NIGSQYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGL 163 (327)
T ss_dssp SSEEEEECCCSSCBHHHHHHHTTT--CCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEEETTEEEECCTTC
T ss_pred CCceEEEEecCCCcHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHh---hCCCcCCCCCHHHEEEcCCCCEEEccCcc
Confidence 457899999999999999976332 3899999999999999999999 89999999999999999999999999999
Q ss_pred eeecccCCCC--cccccccccccCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCC
Q 044494 84 ARLLNFDSSN--RTLLAGTYGYIAPELAYTMVVTEKSDVYSFGVVALEVLM-GKHPGELLSS 142 (144)
Q Consensus 84 ~~~~~~~~~~--~~~~~~~~~~~~pe~~~~~~~~~~~d~~slg~~l~~~~~-g~~p~~~~~~ 142 (144)
+......... .....+++.|+|||.+.+..++.++|+||+|+++|++++ |..||...+.
T Consensus 164 a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~ 225 (327)
T 3lzb_A 164 AKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA 225 (327)
T ss_dssp ----------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCG
T ss_pred eeEccCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCH
Confidence 9865432221 222446778999999999999999999999999999999 9999987553
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=8e-31 Score=181.13 Aligned_cols=132 Identities=30% Similarity=0.435 Sum_probs=114.2
Q ss_pred CceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeeec
Q 044494 3 RKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADFG 82 (144)
Q Consensus 3 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~~ 82 (144)
++.+++||||+++++|.+++..... .+++..++.++.|++.++.+|| +.+++|+||||+||+++.++.++++|||
T Consensus 98 ~~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg 172 (327)
T 3lxl_A 98 RQSLRLVMEYLPSGCLRDFLQRHRA--RLDASRLLLYSSQICKGMEYLG---SRRCVHRDLAARNILVESEAHVKIADFG 172 (327)
T ss_dssp SCEEEEEEECCTTCBHHHHHHHHGG--GCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETTEEEECCGG
T ss_pred CceEEEEEeecCCCCHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCChhhEEECCCCCEEEcccc
Confidence 4668999999999999999975322 3899999999999999999999 8999999999999999999999999999
Q ss_pred ceeecccCCC---CcccccccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCC
Q 044494 83 VARLLNFDSS---NRTLLAGTYGYIAPELAYTMVVTEKSDVYSFGVVALEVLMGKHPGEL 139 (144)
Q Consensus 83 ~~~~~~~~~~---~~~~~~~~~~~~~pe~~~~~~~~~~~d~~slg~~l~~~~~g~~p~~~ 139 (144)
.+........ ......+++.|+|||.+.+..++.++|+||+|++++++++|..||..
T Consensus 173 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~ 232 (327)
T 3lxl_A 173 LAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCS 232 (327)
T ss_dssp GCEECCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGS
T ss_pred cceecccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCcc
Confidence 9987643221 12234577789999999988889999999999999999999999854
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=5.4e-30 Score=173.96 Aligned_cols=127 Identities=31% Similarity=0.514 Sum_probs=109.2
Q ss_pred EEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCC--eEecCCCCCcEEEcCCCC-----eEEe
Q 044494 7 FLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPP--IVHRDISSNNILLNLELE-----AFVA 79 (144)
Q Consensus 7 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~--~~h~~i~~~ni~~~~~~~-----~~l~ 79 (144)
++||||+++++|.+.+.... ..+++..++.++.|++.++.+|| +.+ ++|+||||+||+++.++. ++++
T Consensus 97 ~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~l~~~l~~lH---~~~~~ivH~dikp~Nil~~~~~~~~~~~~kl~ 171 (287)
T 4f0f_A 97 RMVMEFVPCGDLYHRLLDKA--HPIKWSVKLRLMLDIALGIEYMQ---NQNPPIVHRDLRSPNIFLQSLDENAPVCAKVA 171 (287)
T ss_dssp EEEEECCTTCBHHHHHHCTT--SCCCHHHHHHHHHHHHHHHHHHH---TSSSCCBCSCCSGGGEEESCCCTTCSCCEEEC
T ss_pred eEEEEecCCCCHHHHHhccc--CCccHHHHHHHHHHHHHHHHHHH---hCCCCeecCCCCcceEEEeccCCCCceeEEeC
Confidence 79999999999999886533 24899999999999999999999 888 999999999999988776 9999
Q ss_pred eecceeecccCCCCcccccccccccCccccc--cCCCCCcchhHHHHHHHHHHHhCCCCCCCCC
Q 044494 80 DFGVARLLNFDSSNRTLLAGTYGYIAPELAY--TMVVTEKSDVYSFGVVALEVLMGKHPGELLS 141 (144)
Q Consensus 80 d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~--~~~~~~~~d~~slg~~l~~~~~g~~p~~~~~ 141 (144)
|||++.... .......+++.|+|||.+. ...++.++|+||+|+++|+|++|..||...+
T Consensus 172 Dfg~~~~~~---~~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~ 232 (287)
T 4f0f_A 172 DFGLSQQSV---HSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYS 232 (287)
T ss_dssp CCTTCBCCS---SCEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCC
T ss_pred CCCcccccc---ccccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCcccc
Confidence 999987533 2233456899999999984 4456789999999999999999999998654
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=3.1e-30 Score=184.39 Aligned_cols=128 Identities=27% Similarity=0.336 Sum_probs=106.1
Q ss_pred ceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeeecc
Q 044494 4 KCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADFGV 83 (144)
Q Consensus 4 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~~~ 83 (144)
+.+|+||||+. ++|.++++.... +++..+..++.|++.||+||| +.|++||||||+||+++.++.++|+|||+
T Consensus 103 ~~~~lv~e~~~-~~L~~~~~~~~~---l~~~~~~~i~~qil~aL~~LH---~~givHrDlkp~NILl~~~~~~kL~DFGl 175 (432)
T 3n9x_A 103 DELYIVLEIAD-SDLKKLFKTPIF---LTEEHIKTILYNLLLGENFIH---ESGIIHRDLKPANCLLNQDCSVKVCDFGL 175 (432)
T ss_dssp CCEEEEEECCS-EEHHHHHHSSCC---CCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTT
T ss_pred CeEEEEEecCC-cCHHHHHhccCC---CCHHHHHHHHHHHHHHHHHHH---HCCCCCCCCCHHHeEECCCCCEEEccCCC
Confidence 57899999986 599999875433 899999999999999999999 88999999999999999999999999999
Q ss_pred eeecccCCC----------------------CcccccccccccCcccc-ccCCCCCcchhHHHHHHHHHHHhCCCCCC
Q 044494 84 ARLLNFDSS----------------------NRTLLAGTYGYIAPELA-YTMVVTEKSDVYSFGVVALEVLMGKHPGE 138 (144)
Q Consensus 84 ~~~~~~~~~----------------------~~~~~~~~~~~~~pe~~-~~~~~~~~~d~~slg~~l~~~~~g~~p~~ 138 (144)
++....... ......+++.|+|||++ ....++.++|+||+||+++||++|..||.
T Consensus 176 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~ 253 (432)
T 3n9x_A 176 ARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHI 253 (432)
T ss_dssp CEEC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTC
T ss_pred cccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccc
Confidence 987643211 12446789999999986 55668999999999999999998655554
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.6e-30 Score=176.07 Aligned_cols=130 Identities=25% Similarity=0.450 Sum_probs=113.5
Q ss_pred ceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeeecc
Q 044494 4 KCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADFGV 83 (144)
Q Consensus 4 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~~~ 83 (144)
+.+|+||||+++++|.+++.... ...+++..++.++.|++.|+.+|| +.+++|+||||+||+++.++.++++|||.
T Consensus 93 ~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~ 168 (284)
T 2a19_B 93 KCLFIQMEFCDKGTLEQWIEKRR-GEKLDKVLALELFEQITKGVDYIH---SKKLINRDLKPSNIFLVDTKQVKIGDFGL 168 (284)
T ss_dssp EEEEEEECCCCSCBHHHHHHHGG-GSCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETTEEEECCCTT
T ss_pred ceEEEEEeccCCCCHHHHHhhcc-CCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCCHHHEEEcCCCCEEECcchh
Confidence 45799999999999999997532 234899999999999999999999 88999999999999999999999999999
Q ss_pred eeecccCCCCcccccccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCC
Q 044494 84 ARLLNFDSSNRTLLAGTYGYIAPELAYTMVVTEKSDVYSFGVVALEVLMGKHPGE 138 (144)
Q Consensus 84 ~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~d~~slg~~l~~~~~g~~p~~ 138 (144)
+....... ......+++.|+|||.+....++.++|+||+|+++++|++|..|+.
T Consensus 169 ~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~ 222 (284)
T 2a19_B 169 VTSLKNDG-KRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAF 222 (284)
T ss_dssp CEESSCCS-CCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHH
T ss_pred heeccccc-cccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcch
Confidence 98765332 2233568999999999998889999999999999999999988764
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=7e-31 Score=177.92 Aligned_cols=134 Identities=27% Similarity=0.344 Sum_probs=112.2
Q ss_pred CceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeeec
Q 044494 3 RKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADFG 82 (144)
Q Consensus 3 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~~ 82 (144)
++..|+||||+++++|.+++.... ..+++..++.++.|++.++.+|| +.+++|+||||+||+++.++.++++|||
T Consensus 84 ~~~~~~v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg 158 (281)
T 3cc6_A 84 EEPTWIIMELYPYGELGHYLERNK--NSLKVLTLVLYSLQICKAMAYLE---SINCVHRDIAVRNILVASPECVKLGDFG 158 (281)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHHT--TTCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEEEETTEEEECCCC
T ss_pred CCCCEEEEecCCCCCHHHHHHhcc--ccCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCccceEEECCCCcEEeCccC
Confidence 456789999999999999997532 23899999999999999999999 8999999999999999999999999999
Q ss_pred ceeecccCCC-CcccccccccccCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCC
Q 044494 83 VARLLNFDSS-NRTLLAGTYGYIAPELAYTMVVTEKSDVYSFGVVALEVLM-GKHPGELLS 141 (144)
Q Consensus 83 ~~~~~~~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~d~~slg~~l~~~~~-g~~p~~~~~ 141 (144)
.+........ ......+++.|+|||.+....++.++|+||+|+++++|++ |..||...+
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~ 219 (281)
T 3cc6_A 159 LSRYIEDEDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLE 219 (281)
T ss_dssp GGGCC---------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSC
T ss_pred CCcccccccccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCC
Confidence 9876543221 1223446778999999988889999999999999999998 999997543
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.97 E-value=1.3e-30 Score=181.45 Aligned_cols=134 Identities=26% Similarity=0.335 Sum_probs=114.4
Q ss_pred CCceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeee
Q 044494 2 HRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADF 81 (144)
Q Consensus 2 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~ 81 (144)
+.+..++||||+.+ +|.+++.... ..+++..+..++.|++.|+.+|| +.+++|+||||+||+++.++.++|+||
T Consensus 83 ~~~~~~lv~e~~~~-~l~~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~kl~Df 156 (346)
T 1ua2_A 83 HKSNISLVFDFMET-DLEVIIKDNS--LVLTPSHIKAYMLMTLQGLEYLH---QHWILHRDLKPNNLLLDENGVLKLADF 156 (346)
T ss_dssp CTTCCEEEEECCSE-EHHHHHTTCC--SSCCSSHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECCC
T ss_pred eCCceEEEEEcCCC-CHHHHHHhcC--cCCCHHHHHHHHHHHHHHHHHHH---HCCEECCCCCHHHEEEcCCCCEEEEec
Confidence 35678999999986 8888887533 23888899999999999999999 889999999999999999999999999
Q ss_pred cceeecccCCCCcccccccccccCccccccC-CCCCcchhHHHHHHHHHHHhCCCCCCCCC
Q 044494 82 GVARLLNFDSSNRTLLAGTYGYIAPELAYTM-VVTEKSDVYSFGVVALEVLMGKHPGELLS 141 (144)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~-~~~~~~d~~slg~~l~~~~~g~~p~~~~~ 141 (144)
|++..............+++.|+|||.+.+. .++.++|+||+|+++++|++|..||.+.+
T Consensus 157 g~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~ 217 (346)
T 1ua2_A 157 GLAKSFGSPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDS 217 (346)
T ss_dssp GGGSTTTSCCCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred ccceeccCCcccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCC
Confidence 9998765444444456789999999998754 47889999999999999999999997643
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=2.7e-30 Score=184.11 Aligned_cols=132 Identities=27% Similarity=0.327 Sum_probs=108.8
Q ss_pred eEEEEEeeccCCCHHHHhhc-ccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCC-CCeEEeeec
Q 044494 5 CMFLIYEYMEMGSLFCVLRT-DEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLE-LEAFVADFG 82 (144)
Q Consensus 5 ~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~-~~~~l~d~~ 82 (144)
.+++||||+++ ++.+.+.. ......+++..+..++.|++.||.||| +.+++||||||+||+++.+ +.++|+|||
T Consensus 127 ~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NILl~~~~~~~kl~DFG 202 (420)
T 1j1b_A 127 YLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFG 202 (420)
T ss_dssp EEEEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---TTTEECSCCSGGGEEEETTTTEEEECCCT
T ss_pred eEEeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCChhhEEEeCCCCeEEeccch
Confidence 46799999986 66666543 122344899999999999999999999 8999999999999999965 567999999
Q ss_pred ceeecccCCCCcccccccccccCccccccC-CCCCcchhHHHHHHHHHHHhCCCCCCCCC
Q 044494 83 VARLLNFDSSNRTLLAGTYGYIAPELAYTM-VVTEKSDVYSFGVVALEVLMGKHPGELLS 141 (144)
Q Consensus 83 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~-~~~~~~d~~slg~~l~~~~~g~~p~~~~~ 141 (144)
+++...... ......+++.|+|||++.+. .++.++|+||+||++|||++|..||.+.+
T Consensus 203 ~a~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~ 261 (420)
T 1j1b_A 203 SAKQLVRGE-PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDS 261 (420)
T ss_dssp TCEECCTTC-CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred hhhhcccCC-CceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCC
Confidence 998654322 22335689999999998765 68899999999999999999999998754
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=99.97 E-value=3.8e-30 Score=181.31 Aligned_cols=133 Identities=26% Similarity=0.307 Sum_probs=111.2
Q ss_pred ceEEEEEeeccCCCHHHHhhc-ccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEc-CCCCeEEeee
Q 044494 4 KCMFLIYEYMEMGSLFCVLRT-DEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLN-LELEAFVADF 81 (144)
Q Consensus 4 ~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~-~~~~~~l~d~ 81 (144)
..+++||||+++ +|.+.+.. ......+++..+..++.|++.||.||| +.|++||||||+||+++ .++.++|+||
T Consensus 111 ~~~~lv~e~~~~-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~gi~H~Dikp~Nil~~~~~~~~kl~Df 186 (383)
T 3eb0_A 111 KYLNVIMEYVPD-TLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIH---SLGICHRDIKPQNLLVNSKDNTLKLCDF 186 (383)
T ss_dssp CEEEEEECCCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---TTTEECSCCCGGGEEEETTTTEEEECCC
T ss_pred eEEEEEEecCCc-cHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCcCccCccCHHHEEEcCCCCcEEEEEC
Confidence 458899999985 88777653 122334999999999999999999999 99999999999999998 6789999999
Q ss_pred cceeecccCCCCcccccccccccCccccccC-CCCCcchhHHHHHHHHHHHhCCCCCCCCC
Q 044494 82 GVARLLNFDSSNRTLLAGTYGYIAPELAYTM-VVTEKSDVYSFGVVALEVLMGKHPGELLS 141 (144)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~-~~~~~~d~~slg~~l~~~~~g~~p~~~~~ 141 (144)
|++....... ......+++.|+|||.+.+. .++.++|+||+|+++++|++|..||.+.+
T Consensus 187 g~a~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~ 246 (383)
T 3eb0_A 187 GSAKKLIPSE-PSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELILGKPLFSGET 246 (383)
T ss_dssp TTCEECCTTS-CCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred CCCcccCCCC-CCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHHHHHhCCCCCCCCC
Confidence 9998654322 23345678999999998765 48899999999999999999999998754
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.97 E-value=1.5e-30 Score=180.38 Aligned_cols=135 Identities=36% Similarity=0.491 Sum_probs=109.3
Q ss_pred CCceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeee
Q 044494 2 HRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADF 81 (144)
Q Consensus 2 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~ 81 (144)
..+..++||||+++++|.+++.... ..+++..++.++.|++.||.+|| +.|++|+||||+||+++.++.++|+||
T Consensus 117 ~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIl~~~~~~~kl~Df 191 (333)
T 1mqb_A 117 KYKPMMIITEYMENGALDKFLREKD--GEFSVLQLVGMLRGIAAGMKYLA---NMNYVHRDLAARNILVNSNLVCKVSDF 191 (333)
T ss_dssp SSSSEEEEEECCTTEEHHHHHHHTT--TCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCC
T ss_pred cCCCcEEEEeCCCCCcHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChheEEECCCCcEEECCC
Confidence 3567899999999999999997532 23899999999999999999999 889999999999999999999999999
Q ss_pred cceeecccCCCC---cccccccccccCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCC
Q 044494 82 GVARLLNFDSSN---RTLLAGTYGYIAPELAYTMVVTEKSDVYSFGVVALEVLM-GKHPGELLS 141 (144)
Q Consensus 82 ~~~~~~~~~~~~---~~~~~~~~~~~~pe~~~~~~~~~~~d~~slg~~l~~~~~-g~~p~~~~~ 141 (144)
|.+......... .....+++.|+|||.+....++.++|+||+|++++++++ |..||...+
T Consensus 192 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~ 255 (333)
T 1mqb_A 192 GLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELS 255 (333)
T ss_dssp CC-----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC
T ss_pred CcchhhccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCC
Confidence 999865432211 112335678999999998889999999999999999998 999997643
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.9e-30 Score=177.94 Aligned_cols=135 Identities=20% Similarity=0.256 Sum_probs=105.6
Q ss_pred CceEEEEEeeccCCCHHHHhhcc-cccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeee
Q 044494 3 RKCMFLIYEYMEMGSLFCVLRTD-EEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADF 81 (144)
Q Consensus 3 ~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~ 81 (144)
++..++||||+.+++|.+++... .....+++..++.++.|++.|+.+|| +.+++|+||+|+||+++.++.++++||
T Consensus 104 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dl~p~NIl~~~~~~~kl~Df 180 (310)
T 2wqm_A 104 DNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMH---SRRVMHRDIKPANVFITATGVVKLGDL 180 (310)
T ss_dssp TTEEEEEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCC
T ss_pred CCcEEEEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHh---hCCeeCCCCcHHHEEEcCCCCEEEEec
Confidence 56789999999999999998642 12334899999999999999999999 899999999999999999999999999
Q ss_pred cceeecccCCCCcccccccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCC
Q 044494 82 GVARLLNFDSSNRTLLAGTYGYIAPELAYTMVVTEKSDVYSFGVVALEVLMGKHPGELL 140 (144)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~d~~slg~~l~~~~~g~~p~~~~ 140 (144)
|++..............+++.|+|||.+....++.++|+||+|++++++++|..||...
T Consensus 181 g~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~ 239 (310)
T 2wqm_A 181 GLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGD 239 (310)
T ss_dssp ------------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC--
T ss_pred cceeeecCCCccccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCccc
Confidence 99876554333334456889999999999888999999999999999999999999653
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=2.4e-30 Score=181.67 Aligned_cols=128 Identities=26% Similarity=0.349 Sum_probs=103.4
Q ss_pred ceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeeecc
Q 044494 4 KCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADFGV 83 (144)
Q Consensus 4 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~~~ 83 (144)
..+|+||||+.+ +|.+.+.. .+++..+..++.|++.|+.+|| ++|++||||||+||+++.++.++|+|||+
T Consensus 103 ~~~~lv~e~~~~-~l~~~~~~-----~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~ 173 (371)
T 2xrw_A 103 QDVYIVMELMDA-NLCQVIQM-----ELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGL 173 (371)
T ss_dssp CEEEEEEECCSE-EHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECCCCC
T ss_pred cceEEEEEcCCC-CHHHHHhh-----ccCHHHHHHHHHHHHHHHHHHH---HCCeecccCCHHHEEEcCCCCEEEEEeec
Confidence 478999999975 78887752 2889999999999999999999 88999999999999999999999999999
Q ss_pred eeecccCCCCcccccccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCC
Q 044494 84 ARLLNFDSSNRTLLAGTYGYIAPELAYTMVVTEKSDVYSFGVVALEVLMGKHPGELLS 141 (144)
Q Consensus 84 ~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~d~~slg~~l~~~~~g~~p~~~~~ 141 (144)
+...... .......+++.|+|||++.+..++.++|+||+|+++++|++|..||.+.+
T Consensus 174 a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~ 230 (371)
T 2xrw_A 174 ARTAGTS-FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTD 230 (371)
T ss_dssp -----------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred ccccccc-cccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCC
Confidence 9865422 12234568999999999999889999999999999999999999998754
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=5.3e-31 Score=182.28 Aligned_cols=137 Identities=27% Similarity=0.410 Sum_probs=115.8
Q ss_pred CCceEEEEEeeccCCCHHHHhhcccc-----------cCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEE
Q 044494 2 HRKCMFLIYEYMEMGSLFCVLRTDEE-----------AVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILL 70 (144)
Q Consensus 2 ~~~~~~lv~e~~~~~~L~~~l~~~~~-----------~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~ 70 (144)
+++.+|+||||+++|+|.+++..... ...+++..++.++.|++.||.+|| +.+++|+||||+||++
T Consensus 121 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~NIl~ 197 (333)
T 2i1m_A 121 HGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLA---SKNCIHRDVAARNVLL 197 (333)
T ss_dssp SSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGCEE
T ss_pred cCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHh---cCCcccCCcccceEEE
Confidence 35678999999999999999875321 234799999999999999999999 8899999999999999
Q ss_pred cCCCCeEEeeecceeecccCCCC--cccccccccccCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCC
Q 044494 71 NLELEAFVADFGVARLLNFDSSN--RTLLAGTYGYIAPELAYTMVVTEKSDVYSFGVVALEVLM-GKHPGELLS 141 (144)
Q Consensus 71 ~~~~~~~l~d~~~~~~~~~~~~~--~~~~~~~~~~~~pe~~~~~~~~~~~d~~slg~~l~~~~~-g~~p~~~~~ 141 (144)
+.++.++|+|||++......... .....+++.|+|||.+....++.++|+||+|+++++|++ |..||...+
T Consensus 198 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~ 271 (333)
T 2i1m_A 198 TNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGIL 271 (333)
T ss_dssp EGGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCC
T ss_pred CCCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccc
Confidence 99999999999999865432221 223456778999999998889999999999999999998 999998754
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=8e-30 Score=176.09 Aligned_cols=127 Identities=20% Similarity=0.287 Sum_probs=110.9
Q ss_pred CceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCC-CeEEeee
Q 044494 3 RKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLEL-EAFVADF 81 (144)
Q Consensus 3 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~-~~~l~d~ 81 (144)
....++||||+.+++|.++++. +++..+..++.|++.|+.+|| ++|++|+||||+||+++.++ .++|+||
T Consensus 105 ~~~~~lv~e~~~~~~l~~~~~~------~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dikp~Nil~~~~~~~~kl~Df 175 (330)
T 3nsz_A 105 SRTPALVFEHVNNTDFKQLYQT------LTDYDIRFYMYEILKALDYCH---SMGIMHRDVKPHNVMIDHEHRKLRLIDW 175 (330)
T ss_dssp TCCEEEEEECCCCCCHHHHGGG------CCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTTTEEEECCC
T ss_pred CCceEEEEeccCchhHHHHHHh------CCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEEcCCCCEEEEEeC
Confidence 4678999999999999988853 889999999999999999999 89999999999999999776 7999999
Q ss_pred cceeecccCCCCcccccccccccCcccccc-CCCCCcchhHHHHHHHHHHHhCCCCCCC
Q 044494 82 GVARLLNFDSSNRTLLAGTYGYIAPELAYT-MVVTEKSDVYSFGVVALEVLMGKHPGEL 139 (144)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~-~~~~~~~d~~slg~~l~~~~~g~~p~~~ 139 (144)
|++...... .......+++.|+|||.+.. ..++.++|+||+|+++++|++|..||..
T Consensus 176 g~a~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~ 233 (330)
T 3nsz_A 176 GLAEFYHPG-QEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFH 233 (330)
T ss_dssp TTCEECCTT-CCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSC
T ss_pred CCceEcCCC-CccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCccc
Confidence 999865432 22344568899999999877 5688999999999999999999999943
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=8.4e-31 Score=178.98 Aligned_cols=130 Identities=25% Similarity=0.370 Sum_probs=112.7
Q ss_pred ceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeeecc
Q 044494 4 KCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADFGV 83 (144)
Q Consensus 4 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~~~ 83 (144)
+.+++||||+++++|.+++.... ..+++..++.++.|++.++.+|| +.+++|+||||+||+++.++.++++|||.
T Consensus 98 ~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg~ 172 (302)
T 4e5w_A 98 NGIKLIMEFLPSGSLKEYLPKNK--NKINLKQQLKYAVQICKGMDYLG---SRQYVHRDLAARNVLVESEHQVKIGDFGL 172 (302)
T ss_dssp CCEEEEEECCTTCBHHHHHHHHT--TTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETTEEEECCCTT
T ss_pred ceEEEEEEeCCCCcHHHHHHhcc--ccCCHHHHHHHHHHHHHHHHHhh---cCCcccCCCchheEEEcCCCCEEECcccc
Confidence 56899999999999999996432 23899999999999999999999 89999999999999999999999999999
Q ss_pred eeecccCCC---CcccccccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCC
Q 044494 84 ARLLNFDSS---NRTLLAGTYGYIAPELAYTMVVTEKSDVYSFGVVALEVLMGKHPGE 138 (144)
Q Consensus 84 ~~~~~~~~~---~~~~~~~~~~~~~pe~~~~~~~~~~~d~~slg~~l~~~~~g~~p~~ 138 (144)
+........ ......++..|+|||.+.+..++.++|+||+|+++++|++|..|+.
T Consensus 173 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~ 230 (302)
T 4e5w_A 173 TKAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDS 230 (302)
T ss_dssp CEECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGG
T ss_pred cccccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCc
Confidence 987653321 2233457778999999998888899999999999999999998764
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.2e-30 Score=177.67 Aligned_cols=133 Identities=28% Similarity=0.433 Sum_probs=113.8
Q ss_pred CceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeeec
Q 044494 3 RKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADFG 82 (144)
Q Consensus 3 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~~ 82 (144)
++..++||||+++++|.+++..... +++..++.++.|++.++.+|| +.+++|+||||+||+++.++.++++|||
T Consensus 89 ~~~~~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg 162 (291)
T 1xbb_A 89 AESWMLVMEMAELGPLNKYLQQNRH---VKDKNIIELVHQVSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFG 162 (291)
T ss_dssp SSSEEEEEECCTTEEHHHHHHHCTT---CCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETTEEEECCCT
T ss_pred CCCcEEEEEeCCCCCHHHHHHhCcC---CCHHHHHHHHHHHHHHHHHHH---hCCeEcCCCCcceEEEeCCCcEEEccCC
Confidence 4678999999999999999986443 899999999999999999999 8899999999999999999999999999
Q ss_pred ceeecccCCCC---cccccccccccCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCC
Q 044494 83 VARLLNFDSSN---RTLLAGTYGYIAPELAYTMVVTEKSDVYSFGVVALEVLM-GKHPGELLS 141 (144)
Q Consensus 83 ~~~~~~~~~~~---~~~~~~~~~~~~pe~~~~~~~~~~~d~~slg~~l~~~~~-g~~p~~~~~ 141 (144)
++......... .....+++.|+|||.+....++.++|+||+|++++++++ |..||...+
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~ 225 (291)
T 1xbb_A 163 LSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMK 225 (291)
T ss_dssp TCEECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCC
T ss_pred cceeeccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCC
Confidence 99866432211 112335678999999988888899999999999999999 999998754
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=3.5e-30 Score=176.83 Aligned_cols=134 Identities=25% Similarity=0.368 Sum_probs=108.9
Q ss_pred eEEEEEeeccCCCHHHHhhcc---cccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeee
Q 044494 5 CMFLIYEYMEMGSLFCVLRTD---EEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADF 81 (144)
Q Consensus 5 ~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~ 81 (144)
..++||||+++++|.+++... .....+++..++.++.|++.||.+|| +.+++|+||||+||+++.++.++++||
T Consensus 115 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dikp~NIli~~~~~~kl~Df 191 (313)
T 3brb_A 115 KPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLS---NRNFLHRDLAARNCMLRDDMTVCVADF 191 (313)
T ss_dssp CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHH---TTTCCCCCCSGGGEEECTTSCEEECSC
T ss_pred ccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCcceEEEcCCCcEEEeec
Confidence 469999999999999998532 22345999999999999999999999 899999999999999999999999999
Q ss_pred cceeecccCC--CCcccccccccccCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCC
Q 044494 82 GVARLLNFDS--SNRTLLAGTYGYIAPELAYTMVVTEKSDVYSFGVVALEVLM-GKHPGELLS 141 (144)
Q Consensus 82 ~~~~~~~~~~--~~~~~~~~~~~~~~pe~~~~~~~~~~~d~~slg~~l~~~~~-g~~p~~~~~ 141 (144)
|++....... .......+++.|+|||.+....++.++|+||+|+++++|++ |..||...+
T Consensus 192 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~ 254 (313)
T 3brb_A 192 GLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQ 254 (313)
T ss_dssp SCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred CcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCC
Confidence 9997654322 11223456778999999999889999999999999999999 999997654
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=1.1e-30 Score=179.38 Aligned_cols=136 Identities=27% Similarity=0.394 Sum_probs=115.3
Q ss_pred CceEEEEEeeccCCCHHHHhhcccc-------------cCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEE
Q 044494 3 RKCMFLIYEYMEMGSLFCVLRTDEE-------------AVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNIL 69 (144)
Q Consensus 3 ~~~~~lv~e~~~~~~L~~~l~~~~~-------------~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~ 69 (144)
++.+++||||+++++|.+++..... ...+++..++.++.|++.|+.+|| +.+++|+||||+||+
T Consensus 104 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~i~H~dikp~Nil 180 (316)
T 2xir_A 104 GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLA---SRKCIHRDLAARNIL 180 (316)
T ss_dssp TSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEE
T ss_pred CCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHH---hCCcccccCccceEE
Confidence 3458999999999999999976332 112788999999999999999999 889999999999999
Q ss_pred EcCCCCeEEeeecceeecccCCCC--cccccccccccCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCC
Q 044494 70 LNLELEAFVADFGVARLLNFDSSN--RTLLAGTYGYIAPELAYTMVVTEKSDVYSFGVVALEVLM-GKHPGELLS 141 (144)
Q Consensus 70 ~~~~~~~~l~d~~~~~~~~~~~~~--~~~~~~~~~~~~pe~~~~~~~~~~~d~~slg~~l~~~~~-g~~p~~~~~ 141 (144)
++.++.++++|||++......... .....+++.|+|||.+....++.++|+||+|+++++|++ |..||...+
T Consensus 181 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~ 255 (316)
T 2xir_A 181 LSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVK 255 (316)
T ss_dssp ECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred ECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcccc
Confidence 999999999999999865432221 223456788999999998889999999999999999998 999997654
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2.4e-30 Score=174.71 Aligned_cols=131 Identities=25% Similarity=0.437 Sum_probs=106.6
Q ss_pred CceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeeec
Q 044494 3 RKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADFG 82 (144)
Q Consensus 3 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~~ 82 (144)
.+..|+||||+++++|.+++..... +++..+..++.|++.++.+|| +.+++|+||+|+||+++.++.++++|||
T Consensus 83 ~~~~~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~l~dfg 156 (276)
T 2h6d_A 83 PTDFFMVMEYVSGGELFDYICKHGR---VEEMEARRLFQQILSAVDYCH---RHMVVHRDLKPENVLLDAHMNAKIADFG 156 (276)
T ss_dssp SSEEEEEEECCCSCBHHHHHHHHCS---CCHHHHHHHHHHHHHHHHHHH---HHCSSCCCCCGGGEEECTTSCEEECCCC
T ss_pred CCeEEEEEeccCCCcHHHHHhccCC---CCHHHHHHHHHHHHHHHHHHH---HCCCccCCCChhhEEECCCCCEEEeecc
Confidence 5678999999999999999976443 899999999999999999999 8899999999999999999999999999
Q ss_pred ceeecccCCCCcccccccccccCccccccCCC-CCcchhHHHHHHHHHHHhCCCCCCCC
Q 044494 83 VARLLNFDSSNRTLLAGTYGYIAPELAYTMVV-TEKSDVYSFGVVALEVLMGKHPGELL 140 (144)
Q Consensus 83 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~-~~~~d~~slg~~l~~~~~g~~p~~~~ 140 (144)
.+...... .......+++.|+|||.+....+ +.++|+||+|++++++++|..||...
T Consensus 157 ~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~ 214 (276)
T 2h6d_A 157 LSNMMSDG-EFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDE 214 (276)
T ss_dssp GGGCCCC--------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred cccccCCC-cceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCC
Confidence 98765432 22234568899999999987765 57899999999999999999999764
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=6.2e-31 Score=188.91 Aligned_cols=135 Identities=32% Similarity=0.462 Sum_probs=110.8
Q ss_pred CceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeeec
Q 044494 3 RKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADFG 82 (144)
Q Consensus 3 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~~ 82 (144)
++.+|+||||+++|+|.++++... ...+++..+..++.|++.||.||| +++++||||||+||+++.++.++|+|||
T Consensus 250 ~~~~~iv~e~~~~gsL~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~LH---~~~ivHrDlkp~Nill~~~~~~kl~DfG 325 (452)
T 1fmk_A 250 EEPIYIVTEYMSKGSLLDFLKGET-GKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFG 325 (452)
T ss_dssp SSSCEEEECCCTTCBHHHHHSHHH-HTTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCCC
T ss_pred CCceEEEehhhcCCCHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChhhEEECCCCCEEECCCc
Confidence 356899999999999999997522 234899999999999999999999 8999999999999999999999999999
Q ss_pred ceeecccCC-CCcccccccccccCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCC
Q 044494 83 VARLLNFDS-SNRTLLAGTYGYIAPELAYTMVVTEKSDVYSFGVVALEVLM-GKHPGELLS 141 (144)
Q Consensus 83 ~~~~~~~~~-~~~~~~~~~~~~~~pe~~~~~~~~~~~d~~slg~~l~~~~~-g~~p~~~~~ 141 (144)
+++...... .......+++.|+|||.+....++.++|+||+|++++++++ |..||.+.+
T Consensus 326 ~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~ 386 (452)
T 1fmk_A 326 LARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMV 386 (452)
T ss_dssp TTC--------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCC
T ss_pred cceecCCCceecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCC
Confidence 998654221 11223446778999999998889999999999999999999 999998754
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=2.1e-30 Score=175.33 Aligned_cols=135 Identities=31% Similarity=0.488 Sum_probs=114.9
Q ss_pred CceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeeec
Q 044494 3 RKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADFG 82 (144)
Q Consensus 3 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~~ 82 (144)
++..++||||+++++|.+++.... ...+++..+..++.|++.++.+|| ++|++|+||||+||+++.++.++++|||
T Consensus 79 ~~~~~~v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg 154 (279)
T 1qpc_A 79 QEPIYIITEYMENGSLVDFLKTPS-GIKLTINKLLDMAAQIAEGMAFIE---ERNYIHRDLRAANILVSDTLSCKIADFG 154 (279)
T ss_dssp SSSCEEEEECCTTCBHHHHTTSHH-HHTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECCCT
T ss_pred CCCcEEEEecCCCCCHHHHHhcCC-CCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHhhEEEcCCCCEEECCCc
Confidence 456899999999999999997532 124899999999999999999999 8999999999999999999999999999
Q ss_pred ceeecccCCC-CcccccccccccCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCC
Q 044494 83 VARLLNFDSS-NRTLLAGTYGYIAPELAYTMVVTEKSDVYSFGVVALEVLM-GKHPGELLS 141 (144)
Q Consensus 83 ~~~~~~~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~d~~slg~~l~~~~~-g~~p~~~~~ 141 (144)
.+........ ......+++.|+|||.+....++.++|+||+|+++++|++ |..||...+
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~ 215 (279)
T 1qpc_A 155 LARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMT 215 (279)
T ss_dssp TCEECSSSCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCC
T ss_pred ccccccCcccccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccC
Confidence 9987643221 1223446778999999988888999999999999999999 999997644
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.9e-30 Score=178.75 Aligned_cols=130 Identities=26% Similarity=0.378 Sum_probs=112.8
Q ss_pred CceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeeec
Q 044494 3 RKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADFG 82 (144)
Q Consensus 3 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~~ 82 (144)
.+.+++||||+++++|.+++.... +++..++.++.|++.++.+|| +.+++|+||||+||+++.++.++|+|||
T Consensus 107 ~~~~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~i~~~l~~~l~~LH---~~~ivH~Dikp~Nil~~~~~~~kl~Dfg 179 (318)
T 3lxp_A 107 AASLQLVMEYVPLGSLRDYLPRHS----IGLAQLLLFAQQICEGMAYLH---AQHYIHRDLAARNVLLDNDRLVKIGDFG 179 (318)
T ss_dssp TTEEEEEECCCTTCBHHHHGGGSC----CCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCGG
T ss_pred CceEEEEEecccCCcHHHHHhhCC----CCHHHHHHHHHHHHHHHHHHH---hCCccCCCCchheEEEcCCCCEEECCcc
Confidence 357899999999999999997532 899999999999999999999 8999999999999999999999999999
Q ss_pred ceeecccCCC---CcccccccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCC
Q 044494 83 VARLLNFDSS---NRTLLAGTYGYIAPELAYTMVVTEKSDVYSFGVVALEVLMGKHPGEL 139 (144)
Q Consensus 83 ~~~~~~~~~~---~~~~~~~~~~~~~pe~~~~~~~~~~~d~~slg~~l~~~~~g~~p~~~ 139 (144)
.+........ ......+++.|+|||.+....++.++|+||+|+++++|++|..||..
T Consensus 180 ~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~ 239 (318)
T 3lxp_A 180 LAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQS 239 (318)
T ss_dssp GCEECCTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGS
T ss_pred ccccccccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccc
Confidence 9987653221 12234577789999999988888999999999999999999999865
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=1.2e-30 Score=177.13 Aligned_cols=136 Identities=26% Similarity=0.379 Sum_probs=116.4
Q ss_pred CCceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeee
Q 044494 2 HRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADF 81 (144)
Q Consensus 2 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~ 81 (144)
.++.+++||||+++++|.+++..... ..+++..++.++.|++.++.+|| +.+++|+||||+||+++.++.++++||
T Consensus 80 ~~~~~~~v~e~~~~~~L~~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~~l~Df 155 (288)
T 3kfa_A 80 REPPFYIITEFMTYGNLLDYLRECNR-QEVSAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADF 155 (288)
T ss_dssp SSSSEEEEEECCTTEEHHHHHHHCCT-TTSCHHHHHHHHHHHHHHHHHHH---HHTCCCSCCSGGGEEECGGGCEEECCC
T ss_pred cCCCEEEEEEcCCCCcHHHHHHhccc-CCccHhHHHHHHHHHHHHHHHHH---HCCccCCCCCcceEEEcCCCCEEEccC
Confidence 35678999999999999999976332 34899999999999999999999 889999999999999999999999999
Q ss_pred cceeecccCCC-CcccccccccccCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCC
Q 044494 82 GVARLLNFDSS-NRTLLAGTYGYIAPELAYTMVVTEKSDVYSFGVVALEVLM-GKHPGELLS 141 (144)
Q Consensus 82 ~~~~~~~~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~d~~slg~~l~~~~~-g~~p~~~~~ 141 (144)
|.+........ ......+++.|+|||.+....++.++|+||+|+++++|++ |..||...+
T Consensus 156 g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~ 217 (288)
T 3kfa_A 156 GLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID 217 (288)
T ss_dssp CGGGTSCSSSSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred ccceeccCCccccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC
Confidence 99976543221 1223456778999999998889999999999999999999 999998754
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2.4e-30 Score=178.40 Aligned_cols=132 Identities=31% Similarity=0.412 Sum_probs=111.5
Q ss_pred CceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCC---eEEe
Q 044494 3 RKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELE---AFVA 79 (144)
Q Consensus 3 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~---~~l~ 79 (144)
.+..|+||||+++++|.+++.... .+++..+..++.|++.||.+|| +++++|+||||+||+++.++. ++|+
T Consensus 86 ~~~~~lv~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~NIl~~~~~~~~~~kl~ 159 (322)
T 2ycf_A 86 AEDYYIVLELMEGGELFDKVVGNK---RLKEATCKLYFYQMLLAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKIT 159 (322)
T ss_dssp SSSEEEEEECCTTEETHHHHSTTC---CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESSSSSSCCEEEC
T ss_pred CCceEEEEecCCCCcHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHEEEecCCCCCeEEEc
Confidence 345899999999999999887543 3899999999999999999999 899999999999999987664 9999
Q ss_pred eecceeecccCCCCcccccccccccCccccc---cCCCCCcchhHHHHHHHHHHHhCCCCCCCCC
Q 044494 80 DFGVARLLNFDSSNRTLLAGTYGYIAPELAY---TMVVTEKSDVYSFGVVALEVLMGKHPGELLS 141 (144)
Q Consensus 80 d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~---~~~~~~~~d~~slg~~l~~~~~g~~p~~~~~ 141 (144)
|||.+...... .......+++.|+|||.+. ...++.++|+||+|+++++|++|..||....
T Consensus 160 Dfg~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~ 223 (322)
T 2ycf_A 160 DFGHSKILGET-SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHR 223 (322)
T ss_dssp CCTTCEECCCC-HHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTT
T ss_pred cCccceecccc-cccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccc
Confidence 99999865421 1122356899999999974 4567889999999999999999999997654
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2.1e-30 Score=176.03 Aligned_cols=130 Identities=22% Similarity=0.383 Sum_probs=110.2
Q ss_pred CCceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCC------
Q 044494 2 HRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELE------ 75 (144)
Q Consensus 2 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~------ 75 (144)
.++..++||||+++++|.+++..... .+++..++.++.|++.||.+|| +++++|+||||+||+++.++.
T Consensus 83 ~~~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~~~ 157 (289)
T 4fvq_A 83 CGDENILVQEFVKFGSLDTYLKKNKN--CINILWKLEVAKQLAAAMHFLE---ENTLIHGNVCAKNILLIREEDRKTGNP 157 (289)
T ss_dssp CTTCCEEEEECCTTCBHHHHHHHTGG--GCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEEEECCBGGGTBC
T ss_pred eCCCCEEEEECCCCCCHHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHh---hCCeECCCcCcceEEEecCCccccccc
Confidence 35677999999999999999976432 3899999999999999999999 899999999999999998887
Q ss_pred --eEEeeecceeecccCCCCcccccccccccCcccccc-CCCCCcchhHHHHHHHHHHHh-CCCCCCCC
Q 044494 76 --AFVADFGVARLLNFDSSNRTLLAGTYGYIAPELAYT-MVVTEKSDVYSFGVVALEVLM-GKHPGELL 140 (144)
Q Consensus 76 --~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~-~~~~~~~d~~slg~~l~~~~~-g~~p~~~~ 140 (144)
++++|||.+.... ......+++.|+|||.+.. ..++.++|+||+|+++++|++ +..||...
T Consensus 158 ~~~kl~Dfg~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~ 222 (289)
T 4fvq_A 158 PFIKLSDPGISITVL----PKDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSAL 222 (289)
T ss_dssp CEEEECCCCSCTTTS----CHHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTS
T ss_pred ceeeeccCccccccc----CccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCcccc
Confidence 9999999886432 2233557889999999987 668899999999999999999 55666543
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=3.7e-30 Score=177.86 Aligned_cols=134 Identities=24% Similarity=0.329 Sum_probs=98.0
Q ss_pred CceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCC--eEecCCCCCcEEEcCCCCeEEee
Q 044494 3 RKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPP--IVHRDISSNNILLNLELEAFVAD 80 (144)
Q Consensus 3 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~--~~h~~i~~~ni~~~~~~~~~l~d 80 (144)
+..+++||||+. |+|.+++........+++..++.++.|++.+|.+|| +.+ ++|+||||+||+++.++.++|+|
T Consensus 106 ~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~~~ivH~Dikp~NIl~~~~~~~kl~D 181 (337)
T 3ll6_A 106 QAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMH---RQKPPIIHRDLKVENLLLSNQGTIKLCD 181 (337)
T ss_dssp SEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHH---TSSSCCBCCCCCGGGCEECTTSCEEBCC
T ss_pred CceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH---hCCCCEEEccCCcccEEECCCCCEEEec
Confidence 345799999996 699998875333345999999999999999999999 888 99999999999999999999999
Q ss_pred ecceeecccCCCC------------cccccccccccCcccc---ccCCCCCcchhHHHHHHHHHHHhCCCCCCCC
Q 044494 81 FGVARLLNFDSSN------------RTLLAGTYGYIAPELA---YTMVVTEKSDVYSFGVVALEVLMGKHPGELL 140 (144)
Q Consensus 81 ~~~~~~~~~~~~~------------~~~~~~~~~~~~pe~~---~~~~~~~~~d~~slg~~l~~~~~g~~p~~~~ 140 (144)
||++......... .....+++.|+|||.+ ....++.++|+||+|+++++|++|..||...
T Consensus 182 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~ 256 (337)
T 3ll6_A 182 FGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDG 256 (337)
T ss_dssp CTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC---
T ss_pred CccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcch
Confidence 9999865432111 1134588999999998 4566788999999999999999999999764
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=6.6e-30 Score=171.90 Aligned_cols=129 Identities=23% Similarity=0.307 Sum_probs=110.6
Q ss_pred ceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCC--eEecCCCCCcEEEcCCCCeEEeee
Q 044494 4 KCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPP--IVHRDISSNNILLNLELEAFVADF 81 (144)
Q Consensus 4 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~--~~h~~i~~~ni~~~~~~~~~l~d~ 81 (144)
+..++||||+++++|.+++.... ...+++..++.++.|++.|+.+|| +.+ ++|+||||+||+++.++.+++.|+
T Consensus 82 ~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH---~~~~~i~H~dikp~Nil~~~~~~~~l~~~ 157 (271)
T 3kmu_A 82 PHPTLITHWMPYGSLYNVLHEGT-NFVVDQSQAVKFALDMARGMAFLH---TLEPLIPRHALNSRSVMIDEDMTARISMA 157 (271)
T ss_dssp SSCEEEEECCTTCBHHHHHHSCS-SCCCCHHHHHHHHHHHHHHHHHHT---TSSSCCTTCCCSGGGEEECTTSCEEEEGG
T ss_pred CCeEeeecccCCCcHHHHHhhcc-cCCCCHHHHHHHHHHHHHHHHHHh---cCCCceecCCCccceEEEcCCcceeEEec
Confidence 67899999999999999998633 234899999999999999999999 888 999999999999999999999988
Q ss_pred cceeecccCCCCcccccccccccCccccccCCCCC---cchhHHHHHHHHHHHhCCCCCCCCC
Q 044494 82 GVARLLNFDSSNRTLLAGTYGYIAPELAYTMVVTE---KSDVYSFGVVALEVLMGKHPGELLS 141 (144)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~---~~d~~slg~~l~~~~~g~~p~~~~~ 141 (144)
++..... .....+++.|+|||.+.+..++. ++|+||+|++++++++|..||...+
T Consensus 158 ~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~ 215 (271)
T 3kmu_A 158 DVKFSFQ-----SPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLS 215 (271)
T ss_dssp GSCCTTS-----CTTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSC
T ss_pred cceeeec-----ccCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccC
Confidence 8765322 23356789999999998765544 7999999999999999999998654
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=5.3e-30 Score=178.72 Aligned_cols=129 Identities=28% Similarity=0.412 Sum_probs=110.8
Q ss_pred CceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeeec
Q 044494 3 RKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADFG 82 (144)
Q Consensus 3 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~~ 82 (144)
++..|+||||+. |+|.+++.... ..+++..+..++.|++.||.+|| +.+++|+||||+||+++.++.++|+|||
T Consensus 126 ~~~~~lv~e~~~-g~l~~~l~~~~--~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~DfG 199 (348)
T 1u5q_A 126 EHTAWLVMEYCL-GSASDLLEVHK--KPLQEVEIAAVTHGALQGLAYLH---SHNMIHRDVKAGNILLSEPGLVKLGDFG 199 (348)
T ss_dssp TTEEEEEEECCS-EEHHHHHHHHT--SCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSGGGEEEETTTEEEECCCT
T ss_pred CCeEEEEEecCC-CCHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEECCCCCEEEeecc
Confidence 467899999997 58888775422 23899999999999999999999 8899999999999999999999999999
Q ss_pred ceeecccCCCCcccccccccccCccccc---cCCCCCcchhHHHHHHHHHHHhCCCCCCCCC
Q 044494 83 VARLLNFDSSNRTLLAGTYGYIAPELAY---TMVVTEKSDVYSFGVVALEVLMGKHPGELLS 141 (144)
Q Consensus 83 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~---~~~~~~~~d~~slg~~l~~~~~g~~p~~~~~ 141 (144)
++..... .....+++.|+|||++. ...++.++|+||+|+++++|++|..||...+
T Consensus 200 ~a~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~ 257 (348)
T 1u5q_A 200 SASIMAP----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN 257 (348)
T ss_dssp TCBSSSS----BCCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC
T ss_pred CceecCC----CCcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 9976432 23456899999999984 4567889999999999999999999997643
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.8e-30 Score=174.53 Aligned_cols=135 Identities=30% Similarity=0.389 Sum_probs=114.4
Q ss_pred CCceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeee
Q 044494 2 HRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADF 81 (144)
Q Consensus 2 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~ 81 (144)
+++..++||||+++++|.+++.... ..+++..++.++.|++.++.+|| +.+++|+||+|+||+++.++.++++||
T Consensus 74 ~~~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~Nili~~~~~~kl~df 148 (267)
T 3t9t_A 74 EQAPICLVTEFMEHGCLSDYLRTQR--GLFAAETLLGMCLDVCEGMAYLE---EACVIHRDLAARNCLVGENQVIKVSDF 148 (267)
T ss_dssp SSSSCEEEECCCTTCBHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCCGGGEEECGGGCEEECCT
T ss_pred cCCCeEEEEeCCCCCcHHHHHhhCc--ccCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCchheEEECCCCCEEEccc
Confidence 3567899999999999999997532 23899999999999999999999 899999999999999999999999999
Q ss_pred cceeecccCC-CCcccccccccccCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCC
Q 044494 82 GVARLLNFDS-SNRTLLAGTYGYIAPELAYTMVVTEKSDVYSFGVVALEVLM-GKHPGELLS 141 (144)
Q Consensus 82 ~~~~~~~~~~-~~~~~~~~~~~~~~pe~~~~~~~~~~~d~~slg~~l~~~~~-g~~p~~~~~ 141 (144)
|.+....... .......+++.|+|||.+....++.++|+||+|+++++|++ |..||...+
T Consensus 149 g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~ 210 (267)
T 3t9t_A 149 GMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRS 210 (267)
T ss_dssp TGGGGBCCHHHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC
T ss_pred ccccccccccccccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCC
Confidence 9987543211 11122446778999999998888999999999999999999 899997643
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=2.4e-30 Score=183.45 Aligned_cols=135 Identities=24% Similarity=0.391 Sum_probs=105.5
Q ss_pred CceEEEEEeeccCCCHHHHhhccc------ccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEE----cC
Q 044494 3 RKCMFLIYEYMEMGSLFCVLRTDE------EAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILL----NL 72 (144)
Q Consensus 3 ~~~~~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~----~~ 72 (144)
++.+|+||||+.+ +|.+++.... ....+++..++.++.|++.||.||| +.+++||||||+||++ +.
T Consensus 92 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH---~~~ivH~Dlkp~NIll~~~~~~ 167 (405)
T 3rgf_A 92 DRKVWLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLH---ANWVLHRDLKPANILVMGEGPE 167 (405)
T ss_dssp TTEEEEEEECCSE-EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECCSSTT
T ss_pred CCeEEEEEeCCCC-CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHH---hCCEeCCCcCHHHeEEecCCCC
Confidence 5678999999974 8888775321 1224899999999999999999999 8999999999999999 67
Q ss_pred CCCeEEeeecceeecccCC---CCcccccccccccCccccccC-CCCCcchhHHHHHHHHHHHhCCCCCCCCC
Q 044494 73 ELEAFVADFGVARLLNFDS---SNRTLLAGTYGYIAPELAYTM-VVTEKSDVYSFGVVALEVLMGKHPGELLS 141 (144)
Q Consensus 73 ~~~~~l~d~~~~~~~~~~~---~~~~~~~~~~~~~~pe~~~~~-~~~~~~d~~slg~~l~~~~~g~~p~~~~~ 141 (144)
++.++|+|||++....... .......+++.|+|||++.+. .++.++|+||+|+++|+|++|..||...+
T Consensus 168 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~ 240 (405)
T 3rgf_A 168 RGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ 240 (405)
T ss_dssp TTCEEECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC
T ss_pred CCcEEEEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCcc
Confidence 7899999999998654321 223345789999999999874 48899999999999999999999997543
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=99.96 E-value=5.8e-30 Score=177.92 Aligned_cols=135 Identities=26% Similarity=0.407 Sum_probs=115.2
Q ss_pred CCceEEEEEeeccCCCHHHH------hhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCC-CCeEecCCCCCcEEEcCCC
Q 044494 2 HRKCMFLIYEYMEMGSLFCV------LRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCT-PPIVHRDISSNNILLNLEL 74 (144)
Q Consensus 2 ~~~~~~lv~e~~~~~~L~~~------l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~-~~~~h~~i~~~ni~~~~~~ 74 (144)
+++.+|+||||+++++|.++ +... ....+++..++.++.|++.|+.+|| + .|++|+||+|+||+++.++
T Consensus 114 ~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH---~~~~i~H~dl~p~Nil~~~~~ 189 (348)
T 2pml_X 114 NYDEVYIIYEYMENDSILKFDEYFFVLDKN-YTCFIPIQVIKCIIKSVLNSFSYIH---NEKNICHRDVKPSNILMDKNG 189 (348)
T ss_dssp SSSEEEEEEECCTTCBSSEESSSEESSCSS-SCCCCCHHHHHHHHHHHHHHHHHHH---HTSCEECCCCCGGGEEECTTS
T ss_pred eCCeEEEEEeccCCCcHHHHHHHhhhhhhc-cccCCCHHHHHHHHHHHHHHHHHHh---ccCCEeecCCChHhEEEcCCC
Confidence 35688999999999999998 5431 1345999999999999999999999 7 8999999999999999999
Q ss_pred CeEEeeecceeecccCCCCcccccccccccCccccccC-CCCC-cchhHHHHHHHHHHHhCCCCCCCCCC
Q 044494 75 EAFVADFGVARLLNFDSSNRTLLAGTYGYIAPELAYTM-VVTE-KSDVYSFGVVALEVLMGKHPGELLSS 142 (144)
Q Consensus 75 ~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~-~~~~-~~d~~slg~~l~~~~~g~~p~~~~~~ 142 (144)
.++++|||.+...... ......+++.|+|||.+... .++. ++|+||+|++++++++|..||...+.
T Consensus 190 ~~kl~dfg~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~ 257 (348)
T 2pml_X 190 RVKLSDFGESEYMVDK--KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKIS 257 (348)
T ss_dssp CEEECCCTTCEECBTT--EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSC
T ss_pred cEEEeccccccccccc--cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCc
Confidence 9999999999875432 23345688999999999877 5555 89999999999999999999987543
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=1.1e-30 Score=178.33 Aligned_cols=134 Identities=26% Similarity=0.415 Sum_probs=110.4
Q ss_pred CceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeeec
Q 044494 3 RKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADFG 82 (144)
Q Consensus 3 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~~ 82 (144)
++.+++||||+++++|.+++.... ..+++..+..++.|++.|+.+|| +.|++|+||+|+||+++.++.++++|||
T Consensus 88 ~~~~~lv~e~~~~~~l~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg 162 (302)
T 2j7t_A 88 DGKLWIMIEFCPGGAVDAIMLELD--RGLTEPQIQVVCRQMLEALNFLH---SKRIIHRDLKAGNVLMTLEGDIRLADFG 162 (302)
T ss_dssp C-CEEEEEECCTTEEHHHHHHHHT--SCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEECTTSCEEECCCH
T ss_pred CCeEEEEEEeCCCCcHHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHh---cCCcccCCCCHHHEEECCCCCEEEEECC
Confidence 567899999999999999886522 23899999999999999999999 8899999999999999999999999999
Q ss_pred ceeecccCCCCcccccccccccCccccc-----cCCCCCcchhHHHHHHHHHHHhCCCCCCCCC
Q 044494 83 VARLLNFDSSNRTLLAGTYGYIAPELAY-----TMVVTEKSDVYSFGVVALEVLMGKHPGELLS 141 (144)
Q Consensus 83 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~-----~~~~~~~~d~~slg~~l~~~~~g~~p~~~~~ 141 (144)
++..............+++.|+|||.+. ...++.++|+||+|+++++|++|..||...+
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 226 (302)
T 2j7t_A 163 VSAKNLKTLQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELN 226 (302)
T ss_dssp HHHHHHHHHHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSC
T ss_pred CCccccccccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCC
Confidence 8754322222223356889999999983 5667889999999999999999999998654
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=99.96 E-value=8e-30 Score=175.76 Aligned_cols=133 Identities=26% Similarity=0.341 Sum_probs=114.6
Q ss_pred CceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeeec
Q 044494 3 RKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADFG 82 (144)
Q Consensus 3 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~~ 82 (144)
...+++||||+. ++|.+++.... ...+++..+..++.|++.|+.+|| +.|++|+||||+||+++.++.++|+|||
T Consensus 91 ~~~~~lv~e~~~-~~L~~~l~~~~-~~~~~~~~~~~~~~qi~~~l~~lH---~~gi~H~dlkp~Nili~~~~~~kl~Dfg 165 (326)
T 1blx_A 91 ETKLTLVFEHVD-QDLTTYLDKVP-EPGVPTETIKDMMFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFG 165 (326)
T ss_dssp EEEEEEEEECCS-CBHHHHHHHSC-TTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECSCC
T ss_pred CceEEEEEecCC-CCHHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCCHHHeEEcCCCCEEEecCc
Confidence 456899999997 59999987532 234899999999999999999999 8899999999999999999999999999
Q ss_pred ceeecccCCCCcccccccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCC
Q 044494 83 VARLLNFDSSNRTLLAGTYGYIAPELAYTMVVTEKSDVYSFGVVALEVLMGKHPGELLS 141 (144)
Q Consensus 83 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~d~~slg~~l~~~~~g~~p~~~~~ 141 (144)
.+....... ......+++.|+|||.+....++.++|+||+|++++++++|..||...+
T Consensus 166 ~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~ 223 (326)
T 1blx_A 166 LARIYSFQM-ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSS 223 (326)
T ss_dssp SCCCCCGGG-GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred ccccccCCC-CccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCC
Confidence 987654221 2334568899999999998889999999999999999999999998643
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=99.96 E-value=2.9e-30 Score=181.18 Aligned_cols=127 Identities=25% Similarity=0.366 Sum_probs=98.6
Q ss_pred ceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeeecc
Q 044494 4 KCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADFGV 83 (144)
Q Consensus 4 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~~~ 83 (144)
+.+|+|+|++ +++|.+++... .+++..+..++.|++.||++|| +.|++||||||+||+++.++.++|+|||+
T Consensus 107 ~~~~lv~e~~-~~~L~~~~~~~----~l~~~~~~~i~~qi~~aL~~LH---~~givH~Dlkp~NIll~~~~~~kL~DFG~ 178 (367)
T 2fst_X 107 NDVYLVTHLM-GADLNNIVKCQ----KLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGL 178 (367)
T ss_dssp CCCEEEEECC-CEECC-----C----CCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECC---
T ss_pred CeEEEEeccc-CCCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHhhEEECCCCCEEEeeccc
Confidence 5679999999 67998888642 3899999999999999999999 89999999999999999999999999999
Q ss_pred eeecccCCCCcccccccccccCcccccc-CCCCCcchhHHHHHHHHHHHhCCCCCCCCC
Q 044494 84 ARLLNFDSSNRTLLAGTYGYIAPELAYT-MVVTEKSDVYSFGVVALEVLMGKHPGELLS 141 (144)
Q Consensus 84 ~~~~~~~~~~~~~~~~~~~~~~pe~~~~-~~~~~~~d~~slg~~l~~~~~g~~p~~~~~ 141 (144)
++.... ......+++.|+|||++.+ ..++.++|+||+|+++++|++|..||.+.+
T Consensus 179 a~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~ 234 (367)
T 2fst_X 179 ARHTAD---EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 234 (367)
T ss_dssp ---------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred cccccc---cCCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 976442 1233568999999999876 568899999999999999999999998754
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=4.2e-30 Score=175.38 Aligned_cols=136 Identities=28% Similarity=0.459 Sum_probs=111.2
Q ss_pred CceEEEEEeeccCCCHHHHhhcc-----cccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeE
Q 044494 3 RKCMFLIYEYMEMGSLFCVLRTD-----EEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAF 77 (144)
Q Consensus 3 ~~~~~lv~e~~~~~~L~~~l~~~-----~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~ 77 (144)
++..++||||+++++|.+++... .....+++..++.++.|++.|+.+|| +.|++|+||+|+||+++.++.++
T Consensus 85 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~k 161 (303)
T 2vwi_A 85 KDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLH---KNGQIHRDVKAGNILLGEDGSVQ 161 (303)
T ss_dssp SSCEEEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEECTTCCEE
T ss_pred cCCcEEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHH---hCCCCCCCCChhhEEEcCCCCEE
Confidence 46789999999999999998641 12334899999999999999999999 88999999999999999999999
Q ss_pred EeeecceeecccCC-----CCcccccccccccCcccccc-CCCCCcchhHHHHHHHHHHHhCCCCCCCCC
Q 044494 78 VADFGVARLLNFDS-----SNRTLLAGTYGYIAPELAYT-MVVTEKSDVYSFGVVALEVLMGKHPGELLS 141 (144)
Q Consensus 78 l~d~~~~~~~~~~~-----~~~~~~~~~~~~~~pe~~~~-~~~~~~~d~~slg~~l~~~~~g~~p~~~~~ 141 (144)
++|||.+....... .......+++.|+|||.+.. ..++.++|+||+|+++++|++|..||...+
T Consensus 162 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~ 231 (303)
T 2vwi_A 162 IADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYP 231 (303)
T ss_dssp ECCCHHHHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSC
T ss_pred EEeccchheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCc
Confidence 99999887543221 11233568899999999875 457889999999999999999999997643
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=99.96 E-value=1.1e-29 Score=177.88 Aligned_cols=130 Identities=27% Similarity=0.405 Sum_probs=111.4
Q ss_pred ceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeeecc
Q 044494 4 KCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADFGV 83 (144)
Q Consensus 4 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~~~ 83 (144)
...|+||||+. ++|.+++... .+++..++.++.|++.||.+|| ++|++|+||||+||+++.++.++|+|||.
T Consensus 103 ~~~~iv~e~~~-~~L~~~l~~~----~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~ 174 (364)
T 3qyz_A 103 KDVYIVQDLME-TDLYKLLKTQ----HLSNDHICYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGL 174 (364)
T ss_dssp CCEEEEEECCS-EEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTT
T ss_pred ceEEEEEcccC-cCHHHHHHhC----CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCChHhEEECCCCCEEEEeCcc
Confidence 46899999997 5999988753 2899999999999999999999 89999999999999999999999999999
Q ss_pred eeecccCCC---CcccccccccccCcccccc-CCCCCcchhHHHHHHHHHHHhCCCCCCCCC
Q 044494 84 ARLLNFDSS---NRTLLAGTYGYIAPELAYT-MVVTEKSDVYSFGVVALEVLMGKHPGELLS 141 (144)
Q Consensus 84 ~~~~~~~~~---~~~~~~~~~~~~~pe~~~~-~~~~~~~d~~slg~~l~~~~~g~~p~~~~~ 141 (144)
+........ ......+++.|+|||++.. ..++.++|+||+|+++++|++|..||.+.+
T Consensus 175 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~ 236 (364)
T 3qyz_A 175 ARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKH 236 (364)
T ss_dssp CEECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred eEecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCC
Confidence 986653221 1233578999999998654 457899999999999999999999997754
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.96 E-value=1e-29 Score=173.21 Aligned_cols=132 Identities=28% Similarity=0.367 Sum_probs=111.0
Q ss_pred eEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeeecce
Q 044494 5 CMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADFGVA 84 (144)
Q Consensus 5 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~~~~ 84 (144)
..++||||+.+++|.+++.... ..+++..++.++.|++.|+.+|| ++|++|+||||+||+++.++.++++|||.+
T Consensus 97 ~~~~v~e~~~~~~L~~~~~~~~--~~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dikp~Nili~~~~~~kl~Dfg~~ 171 (298)
T 3pls_A 97 LPHVLLPYMCHGDLLQFIRSPQ--RNPTVKDLISFGLQVARGMEYLA---EQKFVHRDLAARNCMLDESFTVKVADFGLA 171 (298)
T ss_dssp CCEEEECCCTTCBHHHHHHCTT--CCCBHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTCCEEECCTTSS
T ss_pred CcEEEEecccCCCHHHHHhccc--cCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCcceEEEcCCCcEEeCcCCCc
Confidence 3489999999999999997532 34889999999999999999999 889999999999999999999999999999
Q ss_pred eecccC----CCCcccccccccccCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCC
Q 044494 85 RLLNFD----SSNRTLLAGTYGYIAPELAYTMVVTEKSDVYSFGVVALEVLM-GKHPGELLS 141 (144)
Q Consensus 85 ~~~~~~----~~~~~~~~~~~~~~~pe~~~~~~~~~~~d~~slg~~l~~~~~-g~~p~~~~~ 141 (144)
...... ........+++.|+|||.+.+..++.++|+||+|+++++|++ +.+||...+
T Consensus 172 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~ 233 (298)
T 3pls_A 172 RDILDREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHID 233 (298)
T ss_dssp CTTTTGGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSC
T ss_pred ccccCCcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCC
Confidence 754321 122233557889999999999899999999999999999999 555555443
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=99.96 E-value=2.9e-30 Score=175.36 Aligned_cols=134 Identities=25% Similarity=0.361 Sum_probs=102.8
Q ss_pred CCceEEEEEeeccCCCHHHHhhc-ccccCCCCHHHHHHHHHHHHHHHHHHhcCCCC-CeEecCCCCCcEEEcCCCCeEEe
Q 044494 2 HRKCMFLIYEYMEMGSLFCVLRT-DEEAVGLDWAKRVNIVKGMAHALSYLHHDCTP-PIVHRDISSNNILLNLELEAFVA 79 (144)
Q Consensus 2 ~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~-~~~h~~i~~~ni~~~~~~~~~l~ 79 (144)
+++..++||||+++ +|.+++.. ......+++..++.++.|++.|+.+|| ++ |++|+||||+||+++.++.++|+
T Consensus 77 ~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~~i~H~dlkp~Nil~~~~~~~kl~ 152 (290)
T 3fme_A 77 REGDVWICMELMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLH---SKLSVIHRDVKPSNVLINALGQVKMC 152 (290)
T ss_dssp CSSSEEEEEECCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---HHSCCCCCCCSGGGCEECTTCCEEBC
T ss_pred ccCCEEEEEehhcc-chHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHh---hcCCeecCCCCHHHEEECCCCCEEEe
Confidence 35678999999975 88887754 122344999999999999999999999 77 99999999999999999999999
Q ss_pred eecceeecccCCCCcccccccccccCcccc----ccCCCCCcchhHHHHHHHHHHHhCCCCCCCC
Q 044494 80 DFGVARLLNFDSSNRTLLAGTYGYIAPELA----YTMVVTEKSDVYSFGVVALEVLMGKHPGELL 140 (144)
Q Consensus 80 d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~----~~~~~~~~~d~~slg~~l~~~~~g~~p~~~~ 140 (144)
|||.+...... .......+++.|+|||.+ ....++.++|+||+|++++++++|..||...
T Consensus 153 Dfg~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~ 216 (290)
T 3fme_A 153 DFGISGYLVDD-VAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSW 216 (290)
T ss_dssp CC----------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCC
T ss_pred ecCCccccccc-ccccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCcccc
Confidence 99999765432 223334689999999996 4556788999999999999999999999753
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=2e-30 Score=175.46 Aligned_cols=131 Identities=27% Similarity=0.402 Sum_probs=107.6
Q ss_pred ceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeeecc
Q 044494 4 KCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADFGV 83 (144)
Q Consensus 4 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~~~ 83 (144)
+.+|+||||+++++|.+++..... ..+++..++.++.|++.++.+|| +.+++|+||||+||+++.++.++++|||.
T Consensus 88 ~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~ 163 (278)
T 1byg_A 88 GGLYIVTEYMAKGSLVDYLRSRGR-SVLGGDCLLKFSLDVCEAMEYLE---GNNFVHRDLAARNVLVSEDNVAKVSDFGL 163 (278)
T ss_dssp -CCEEEECCCTTEEHHHHHHHHHH-HHCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTSCEEECCCCC
T ss_pred CceEEEEecCCCCCHHHHHHhccc-ccCCHHHHHHHHHHHHHHHHHHH---hCCccccCCCcceEEEeCCCcEEEeeccc
Confidence 468999999999999999975322 23788999999999999999999 89999999999999999999999999999
Q ss_pred eeecccCCCCcccccccccccCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCC
Q 044494 84 ARLLNFDSSNRTLLAGTYGYIAPELAYTMVVTEKSDVYSFGVVALEVLM-GKHPGELLS 141 (144)
Q Consensus 84 ~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~d~~slg~~l~~~~~-g~~p~~~~~ 141 (144)
+...... .....+++.|+|||.+....++.++|+||+|++++++++ |..||...+
T Consensus 164 ~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~ 219 (278)
T 1byg_A 164 TKEASST---QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP 219 (278)
T ss_dssp ---------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSC
T ss_pred ccccccc---ccCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCC
Confidence 8754422 223356788999999998888999999999999999998 999997654
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=99.96 E-value=6.3e-30 Score=179.13 Aligned_cols=129 Identities=22% Similarity=0.326 Sum_probs=108.6
Q ss_pred eEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCC-CeEecCCCCCcEEEcC------CCCeE
Q 044494 5 CMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTP-PIVHRDISSNNILLNL------ELEAF 77 (144)
Q Consensus 5 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~-~~~h~~i~~~ni~~~~------~~~~~ 77 (144)
.+++||||+ +++|.+++.... ...+++..+..++.|++.||.+|| ++ |++|+||||+||+++. .+.++
T Consensus 104 ~~~lv~e~~-~~~L~~~~~~~~-~~~~~~~~~~~i~~qi~~aL~~lH---~~~~ivH~Dikp~NIll~~~~~~~~~~~~k 178 (373)
T 1q8y_A 104 HVVMVFEVL-GENLLALIKKYE-HRGIPLIYVKQISKQLLLGLDYMH---RRCGIIHTDIKPENVLMEIVDSPENLIQIK 178 (373)
T ss_dssp EEEEEECCC-CEEHHHHHHHTT-TSCCCHHHHHHHHHHHHHHHHHHH---HTTCEECSCCSGGGEEEEEEETTTTEEEEE
T ss_pred eEEEEEecC-CCCHHHHHHHhh-ccCCcHHHHHHHHHHHHHHHHHHH---hcCCEEecCCChHHeEEeccCCCcCcceEE
Confidence 789999999 889999987532 233899999999999999999999 87 9999999999999953 34789
Q ss_pred EeeecceeecccCCCCcccccccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCC
Q 044494 78 VADFGVARLLNFDSSNRTLLAGTYGYIAPELAYTMVVTEKSDVYSFGVVALEVLMGKHPGELLS 141 (144)
Q Consensus 78 l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~d~~slg~~l~~~~~g~~p~~~~~ 141 (144)
|+|||++...... .....+++.|+|||.+.+..++.++|+||+|+++|+|++|..||...+
T Consensus 179 l~Dfg~a~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~ 239 (373)
T 1q8y_A 179 IADLGNACWYDEH---YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDE 239 (373)
T ss_dssp ECCCTTCEETTBC---CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC----
T ss_pred EcccccccccCCC---CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCc
Confidence 9999999865432 233468999999999999889999999999999999999999998654
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=1.2e-29 Score=177.25 Aligned_cols=131 Identities=27% Similarity=0.300 Sum_probs=104.8
Q ss_pred ceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeeecc
Q 044494 4 KCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADFGV 83 (144)
Q Consensus 4 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~~~ 83 (144)
..+|+||||+. |+|.+.+.... ..+++..+..++.|++.|+.+|| +.+++|+||||+||+++.++.++|+|||+
T Consensus 107 ~~~~lv~e~~~-~~l~~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~ 180 (362)
T 3pg1_A 107 HKLYLVTELMR-TDLAQVIHDQR--IVISPQHIQYFMYHILLGLHVLH---EAGVVHRDLHPGNILLADNNDITICDFNL 180 (362)
T ss_dssp CEEEEEEECCS-EEHHHHHHCTT--SCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECCTTC
T ss_pred ceEEEEEccCC-CCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHH---HCcCEecCCChHHEEEcCCCCEEEEecCc
Confidence 46899999997 58888887532 24899999999999999999999 88999999999999999999999999999
Q ss_pred eeecccCCCCcccccccccccCcccccc-CCCCCcchhHHHHHHHHHHHhCCCCCCCCC
Q 044494 84 ARLLNFDSSNRTLLAGTYGYIAPELAYT-MVVTEKSDVYSFGVVALEVLMGKHPGELLS 141 (144)
Q Consensus 84 ~~~~~~~~~~~~~~~~~~~~~~pe~~~~-~~~~~~~d~~slg~~l~~~~~g~~p~~~~~ 141 (144)
+...... .......+++.|+|||.+.+ ..++.++|+||+|++++++++|..||...+
T Consensus 181 ~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~ 238 (362)
T 3pg1_A 181 AREDTAD-ANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGST 238 (362)
T ss_dssp ----------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred ccccccc-cccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCC
Confidence 9754422 22334568899999999876 668899999999999999999999998653
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=99.96 E-value=5.2e-30 Score=174.16 Aligned_cols=133 Identities=26% Similarity=0.364 Sum_probs=111.9
Q ss_pred ceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeeecc
Q 044494 4 KCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADFGV 83 (144)
Q Consensus 4 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~~~ 83 (144)
+..++||||+++++|.+++.... ..+++..+..++.|++.++.+|| +.+++|+||||+||+++.++.++++|||.
T Consensus 93 ~~~~~v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dikp~Nili~~~~~~kl~Dfg~ 167 (291)
T 1u46_A 93 PPMKMVTELAPLGSLLDRLRKHQ--GHFLLGTLSRYAVQVAEGMGYLE---SKRFIHRDLAARNLLLATRDLVKIGDFGL 167 (291)
T ss_dssp SSCEEEEECCTTCBHHHHHHHHG--GGSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEEEETTEEEECCCTT
T ss_pred CCceeeEecccCCCHHHHHHhcc--CCcCHHHHHHHHHHHHHHHHHHH---hCCcccCCCchheEEEcCCCCEEEccccc
Confidence 45789999999999999997532 23899999999999999999999 88999999999999999999999999999
Q ss_pred eeecccCCC---CcccccccccccCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCC
Q 044494 84 ARLLNFDSS---NRTLLAGTYGYIAPELAYTMVVTEKSDVYSFGVVALEVLM-GKHPGELLS 141 (144)
Q Consensus 84 ~~~~~~~~~---~~~~~~~~~~~~~pe~~~~~~~~~~~d~~slg~~l~~~~~-g~~p~~~~~ 141 (144)
+........ ......+++.|+|||.+....++.++|+||+|++++++++ |..||...+
T Consensus 168 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~ 229 (291)
T 1u46_A 168 MRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLN 229 (291)
T ss_dssp CEECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCC
T ss_pred cccccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCC
Confidence 987643221 1223456778999999988888899999999999999999 999997654
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=9.8e-30 Score=172.24 Aligned_cols=130 Identities=18% Similarity=0.257 Sum_probs=108.5
Q ss_pred CceEEEEEeeccCCCHHHHhhcccc-cCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCC--------
Q 044494 3 RKCMFLIYEYMEMGSLFCVLRTDEE-AVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLE-------- 73 (144)
Q Consensus 3 ~~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~-------- 73 (144)
++..++||||+++++|.+++..... ...+++..++.++.|++.||.+|| +++++|+||||+||+++.+
T Consensus 83 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dikp~NIl~~~~~~~~~~~~ 159 (289)
T 1x8b_A 83 DDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIH---SMSLVHMDIKPSNIFISRTSIPNAASE 159 (289)
T ss_dssp TTEEEEEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEC----------
T ss_pred CCeEEEEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHH---hCCEeecCCCHHHEEEcCCCCCccccc
Confidence 5678999999999999999975321 234899999999999999999999 8999999999999999844
Q ss_pred -----------CCeEEeeecceeecccCCCCcccccccccccCccccccC-CCCCcchhHHHHHHHHHHHhCCCCCCC
Q 044494 74 -----------LEAFVADFGVARLLNFDSSNRTLLAGTYGYIAPELAYTM-VVTEKSDVYSFGVVALEVLMGKHPGEL 139 (144)
Q Consensus 74 -----------~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~-~~~~~~d~~slg~~l~~~~~g~~p~~~ 139 (144)
..++++|||.+...... ....+++.|+|||.+... .++.++|+||+|++++++++|..|+..
T Consensus 160 ~~~~~~~~~~~~~~kl~Dfg~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~ 233 (289)
T 1x8b_A 160 EGDEDDWASNKVMFKIGDLGHVTRISSP----QVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRN 233 (289)
T ss_dssp ----------CCCEEECCCTTCEETTCS----CCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSS
T ss_pred ccccccccCCceEEEEcccccccccCCc----cccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcc
Confidence 47899999999875532 224588999999999866 455789999999999999999876643
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=99.96 E-value=1e-29 Score=175.31 Aligned_cols=129 Identities=26% Similarity=0.303 Sum_probs=111.8
Q ss_pred CceEEEEEeeccC-CCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEc-CCCCeEEee
Q 044494 3 RKCMFLIYEYMEM-GSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLN-LELEAFVAD 80 (144)
Q Consensus 3 ~~~~~lv~e~~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~-~~~~~~l~d 80 (144)
.+..++|+|++.+ ++|.+++..... +++..++.++.|++.||++|| +.+++|+||||+||+++ .++.++|+|
T Consensus 120 ~~~~~lv~e~~~~~~~L~~~l~~~~~---l~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~~kL~D 193 (320)
T 3a99_A 120 PDSFVLILERPEPVQDLFDFITERGA---LQEELARSFFWQVLEAVRHCH---NCGVLHRDIKDENILIDLNRGELKLID 193 (320)
T ss_dssp SSEEEEEEECCSSEEEHHHHHHHHCS---CCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTTTEEEECC
T ss_pred CCcEEEEEEcCCCCccHHHHHhccCC---CCHHHHHHHHHHHHHHHHHHH---HCCcEeCCCCHHHEEEeCCCCCEEEee
Confidence 4678999999976 899999876433 899999999999999999999 89999999999999999 678999999
Q ss_pred ecceeecccCCCCcccccccccccCccccccCCC-CCcchhHHHHHHHHHHHhCCCCCCC
Q 044494 81 FGVARLLNFDSSNRTLLAGTYGYIAPELAYTMVV-TEKSDVYSFGVVALEVLMGKHPGEL 139 (144)
Q Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~-~~~~d~~slg~~l~~~~~g~~p~~~ 139 (144)
||++...... ......+++.|+|||.+....+ +.++|+||+|+++++|++|..||+.
T Consensus 194 fg~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~ 251 (320)
T 3a99_A 194 FGSGALLKDT--VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEH 251 (320)
T ss_dssp CTTCEECCSS--CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCS
T ss_pred Cccccccccc--cccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCC
Confidence 9999865532 2334568999999999887765 5788999999999999999999975
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=1.7e-29 Score=173.63 Aligned_cols=133 Identities=23% Similarity=0.382 Sum_probs=110.9
Q ss_pred ceEEEEEeeccCCCHHHHhhcc-cccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeeec
Q 044494 4 KCMFLIYEYMEMGSLFCVLRTD-EEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADFG 82 (144)
Q Consensus 4 ~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~~ 82 (144)
+..|+||||+.+++|.+++... .....+++..++.++.|++.|+.+|| +.+++|+||||+||+++.++.++++|||
T Consensus 103 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~dlkp~NIl~~~~~~~kl~dfg 179 (317)
T 2buj_A 103 HEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIH---AKGYAHRDLKPTNILLGDEGQPVLMDLG 179 (317)
T ss_dssp EEEEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTSCEEECCCS
T ss_pred ceeEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEEcCCCCEEEEecC
Confidence 4788999999999999998752 12334899999999999999999999 8899999999999999999999999999
Q ss_pred ceeecccCCCC---------cccccccccccCccccccCC---CCCcchhHHHHHHHHHHHhCCCCCCC
Q 044494 83 VARLLNFDSSN---------RTLLAGTYGYIAPELAYTMV---VTEKSDVYSFGVVALEVLMGKHPGEL 139 (144)
Q Consensus 83 ~~~~~~~~~~~---------~~~~~~~~~~~~pe~~~~~~---~~~~~d~~slg~~l~~~~~g~~p~~~ 139 (144)
.+......... .....+++.|+|||.+.... ++.++|+||+|++++++++|..||+.
T Consensus 180 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~ 248 (317)
T 2buj_A 180 SMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDM 248 (317)
T ss_dssp SCEESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHH
T ss_pred cchhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhh
Confidence 88754321111 01234688999999987554 67899999999999999999999954
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=99.96 E-value=1.4e-30 Score=190.50 Aligned_cols=135 Identities=32% Similarity=0.462 Sum_probs=114.3
Q ss_pred CceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeeec
Q 044494 3 RKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADFG 82 (144)
Q Consensus 3 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~~ 82 (144)
++.+|+||||+.+|+|.++++... ...+++..++.++.|++.||.||| +++++||||||+||+++.++.++|+|||
T Consensus 333 ~~~~~lv~e~~~~gsL~~~l~~~~-~~~l~~~~~~~i~~qi~~~L~~LH---~~~ivHrDlkp~NIll~~~~~~kl~DFG 408 (535)
T 2h8h_A 333 EEPIYIVTEYMSKGSLLDFLKGET-GKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFG 408 (535)
T ss_dssp SSSCEEEECCCTTEEHHHHHSHHH-HTTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCTT
T ss_pred eccceEeeehhcCCcHHHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCCHhhEEEcCCCcEEEcccc
Confidence 356899999999999999997522 234899999999999999999999 8999999999999999999999999999
Q ss_pred ceeecccCC-CCcccccccccccCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCC
Q 044494 83 VARLLNFDS-SNRTLLAGTYGYIAPELAYTMVVTEKSDVYSFGVVALEVLM-GKHPGELLS 141 (144)
Q Consensus 83 ~~~~~~~~~-~~~~~~~~~~~~~~pe~~~~~~~~~~~d~~slg~~l~~~~~-g~~p~~~~~ 141 (144)
+++...... .......++..|+|||.+....++.++|+||||+++|||++ |..||...+
T Consensus 409 ~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~ 469 (535)
T 2h8h_A 409 LARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMV 469 (535)
T ss_dssp STTTCCCHHHHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCC
T ss_pred cceecCCCceecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC
Confidence 997543211 11122345678999999998889999999999999999999 999998754
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=99.96 E-value=4.2e-29 Score=174.30 Aligned_cols=134 Identities=22% Similarity=0.265 Sum_probs=109.0
Q ss_pred eEEEEEeeccCCCHHHHhhc-ccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcC-CCCeEEeeec
Q 044494 5 CMFLIYEYMEMGSLFCVLRT-DEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNL-ELEAFVADFG 82 (144)
Q Consensus 5 ~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~-~~~~~l~d~~ 82 (144)
.+++||||+.+ +|.+.+.. ......+++..+..++.|++.++.+||. ++.|++|+||||+||+++. ++.++|+|||
T Consensus 100 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~-~~~~ivH~Dlkp~NIll~~~~~~~kl~Dfg 177 (360)
T 3e3p_A 100 YLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHL-PSVNVCHRDIKPHNVLVNEADGTLKLCDFG 177 (360)
T ss_dssp EEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTS-TTTCCBCSCCCGGGEEEETTTTEEEECCCT
T ss_pred eEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhC-CCCCeecCcCCHHHEEEeCCCCcEEEeeCC
Confidence 47899999986 55544432 2233448999999999999999999993 3679999999999999997 8999999999
Q ss_pred ceeecccCCCCcccccccccccCccccccCC-CCCcchhHHHHHHHHHHHhCCCCCCCCC
Q 044494 83 VARLLNFDSSNRTLLAGTYGYIAPELAYTMV-VTEKSDVYSFGVVALEVLMGKHPGELLS 141 (144)
Q Consensus 83 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~-~~~~~d~~slg~~l~~~~~g~~p~~~~~ 141 (144)
++....... ......+++.|+|||.+.+.. ++.++|+||+|+++++|++|..||...+
T Consensus 178 ~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~ 236 (360)
T 3e3p_A 178 SAKKLSPSE-PNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDN 236 (360)
T ss_dssp TCBCCCTTS-CCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred CceecCCCC-CcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCC
Confidence 998655322 233456899999999986654 7899999999999999999999998754
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=9.7e-30 Score=189.67 Aligned_cols=134 Identities=28% Similarity=0.414 Sum_probs=112.2
Q ss_pred CceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeeec
Q 044494 3 RKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADFG 82 (144)
Q Consensus 3 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~~ 82 (144)
++..|+||||+++|+|.++++... ..+++..+..++.|++.||.||| +++++||||||+||+++.++.++|+|||
T Consensus 462 ~~~~~lv~E~~~~g~L~~~l~~~~--~~l~~~~~~~i~~qi~~aL~~LH---~~givHrDikp~NILl~~~~~vkL~DFG 536 (656)
T 2j0j_A 462 ENPVWIIMELCTLGELRSFLQVRK--FSLDLASLILYAYQLSTALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFG 536 (656)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHTT--TTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECCCC
T ss_pred cCceEEEEEcCCCCcHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHH---hCCccccccchHhEEEeCCCCEEEEecC
Confidence 456899999999999999997533 23899999999999999999999 8899999999999999999999999999
Q ss_pred ceeecccCCC-CcccccccccccCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCC
Q 044494 83 VARLLNFDSS-NRTLLAGTYGYIAPELAYTMVVTEKSDVYSFGVVALEVLM-GKHPGELLS 141 (144)
Q Consensus 83 ~~~~~~~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~d~~slg~~l~~~~~-g~~p~~~~~ 141 (144)
++........ ......+++.|+|||.+....++.++|+||+|++++||++ |..||.+.+
T Consensus 537 ~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~ 597 (656)
T 2j0j_A 537 LSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVK 597 (656)
T ss_dssp CCCSCCC----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC
T ss_pred CCeecCCCcceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCC
Confidence 9986543221 1222346678999999998889999999999999999997 999998654
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=9.9e-30 Score=175.66 Aligned_cols=137 Identities=28% Similarity=0.379 Sum_probs=113.1
Q ss_pred CCceEEEEEeeccCCCHHHHhhcccc----cCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCC---C
Q 044494 2 HRKCMFLIYEYMEMGSLFCVLRTDEE----AVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLE---L 74 (144)
Q Consensus 2 ~~~~~~lv~e~~~~~~L~~~l~~~~~----~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~---~ 74 (144)
.++..|+||||+++++|.+++..... ...+++..++.++.|++.|+.+|| +.+++|+||||+||+++.+ .
T Consensus 104 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH---~~~i~H~dlkp~NIli~~~~~~~ 180 (327)
T 2yfx_A 104 QSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE---ENHFIHRDIAARNCLLTCPGPGR 180 (327)
T ss_dssp SSSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESCSSTTC
T ss_pred CCCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHh---hCCeecCcCCHhHEEEecCCCcc
Confidence 34567999999999999999976431 134899999999999999999999 8899999999999999844 4
Q ss_pred CeEEeeecceeecccCC--CCcccccccccccCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCC
Q 044494 75 EAFVADFGVARLLNFDS--SNRTLLAGTYGYIAPELAYTMVVTEKSDVYSFGVVALEVLM-GKHPGELLS 141 (144)
Q Consensus 75 ~~~l~d~~~~~~~~~~~--~~~~~~~~~~~~~~pe~~~~~~~~~~~d~~slg~~l~~~~~-g~~p~~~~~ 141 (144)
.++++|||++....... .......+++.|+|||.+....++.++|+||+|+++++|++ |..||...+
T Consensus 181 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~ 250 (327)
T 2yfx_A 181 VAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKS 250 (327)
T ss_dssp CEEECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred eEEECccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcC
Confidence 69999999987543222 12233457889999999988889999999999999999998 999997643
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=3e-29 Score=186.22 Aligned_cols=133 Identities=32% Similarity=0.426 Sum_probs=116.5
Q ss_pred CceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCC---eEEe
Q 044494 3 RKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELE---AFVA 79 (144)
Q Consensus 3 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~---~~l~ 79 (144)
++..|+||||+++|+|.+++........+++..++.++.|++.|+.+|| +.|++|+||+|+||+++.++. ++++
T Consensus 90 ~~~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLH---s~gIVHrDLKP~NILl~~~g~~~~vKL~ 166 (676)
T 3qa8_A 90 NDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLH---ENRIIHRDLKPENIVLQPGPQRLIHKII 166 (676)
T ss_dssp TSSCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHH---HTTBCCCCCCSTTEEEECCSSSCEEEEC
T ss_pred CCeEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCCHHHeEeecCCCceeEEEc
Confidence 5677999999999999999987554455899999999999999999999 899999999999999997765 8999
Q ss_pred eecceeecccCCCCcccccccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCC
Q 044494 80 DFGVARLLNFDSSNRTLLAGTYGYIAPELAYTMVVTEKSDVYSFGVVALEVLMGKHPGEL 139 (144)
Q Consensus 80 d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~d~~slg~~l~~~~~g~~p~~~ 139 (144)
|||.+....... ......+++.|+|||.+.+..++.++|+||+|++++++++|..||..
T Consensus 167 DFG~a~~~~~~~-~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~ 225 (676)
T 3qa8_A 167 DLGYAKELDQGE-LCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLP 225 (676)
T ss_dssp SCCCCCBTTSCC-CCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCS
T ss_pred cccccccccccc-ccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCc
Confidence 999998765322 23345789999999999999999999999999999999999999964
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=1.9e-29 Score=173.38 Aligned_cols=133 Identities=22% Similarity=0.391 Sum_probs=108.2
Q ss_pred CceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeeec
Q 044494 3 RKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADFG 82 (144)
Q Consensus 3 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~~ 82 (144)
.+.+++||||+++++|.+++.... ..+++..++.++.|++.|+.+|| +.+++|+||||+||+++ ++.++++|||
T Consensus 101 ~~~~~iv~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~al~~lH---~~~i~H~dlkp~NIl~~-~~~~~l~Dfg 174 (319)
T 2y4i_B 101 PPHLAIITSLCKGRTLYSVVRDAK--IVLDVNKTRQIAQEIVKGMGYLH---AKGILHKDLKSKNVFYD-NGKVVITDFG 174 (319)
T ss_dssp SSCEEEECBCCCSEEHHHHTTSSC--CCCCSHHHHHHHHHHHHHHHHHH---HTTCCCCCCCSTTEEEC---CCEECCCS
T ss_pred CCceEEEeecccCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHH---hCCccccCCChhhEEEe-CCCEEEeecC
Confidence 467899999999999999997633 24889999999999999999999 88999999999999998 6789999999
Q ss_pred ceeecccC-----CCCcccccccccccCcccccc---------CCCCCcchhHHHHHHHHHHHhCCCCCCCCC
Q 044494 83 VARLLNFD-----SSNRTLLAGTYGYIAPELAYT---------MVVTEKSDVYSFGVVALEVLMGKHPGELLS 141 (144)
Q Consensus 83 ~~~~~~~~-----~~~~~~~~~~~~~~~pe~~~~---------~~~~~~~d~~slg~~l~~~~~g~~p~~~~~ 141 (144)
++...... ........+++.|+|||.+.. ..++.++|+||+|++++++++|..||...+
T Consensus 175 ~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~ 247 (319)
T 2y4i_B 175 LFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQP 247 (319)
T ss_dssp CCC----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCC
T ss_pred CccccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 87654311 122233458899999999875 346789999999999999999999997643
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=3.8e-29 Score=174.11 Aligned_cols=130 Identities=25% Similarity=0.364 Sum_probs=109.7
Q ss_pred ceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeeecc
Q 044494 4 KCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADFGV 83 (144)
Q Consensus 4 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~~~ 83 (144)
+..|+||||+. ++|.+++... .+++..+..++.|++.||.+|| +.|++|+||||+||+++.++.++|+|||+
T Consensus 87 ~~~~lv~e~~~-~~L~~~~~~~----~~~~~~~~~~~~qi~~~L~~LH---~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~ 158 (353)
T 2b9h_A 87 NEVYIIQELMQ-TDLHRVISTQ----MLSDDHIQYFIYQTLRAVKVLH---GSNVIHRDLKPSNLLINSNCDLKVCDFGL 158 (353)
T ss_dssp CCEEEEECCCS-EEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECTTCCEEECCCTT
T ss_pred ceEEEEEeccC-ccHHHHHhhc----CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEEcCCCcEEEEeccc
Confidence 67899999997 5899888752 3899999999999999999999 88999999999999999999999999999
Q ss_pred eeecccCCCC----------cccccccccccCcccccc-CCCCCcchhHHHHHHHHHHHhCCCCCCCCC
Q 044494 84 ARLLNFDSSN----------RTLLAGTYGYIAPELAYT-MVVTEKSDVYSFGVVALEVLMGKHPGELLS 141 (144)
Q Consensus 84 ~~~~~~~~~~----------~~~~~~~~~~~~pe~~~~-~~~~~~~d~~slg~~l~~~~~g~~p~~~~~ 141 (144)
+......... .....+++.|+|||.+.. ..++.++|+||+|+++++|++|..||.+.+
T Consensus 159 a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~ 227 (353)
T 2b9h_A 159 ARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRD 227 (353)
T ss_dssp CEECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred ccccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 9865422111 122457899999998764 567889999999999999999999998654
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=1.1e-29 Score=175.34 Aligned_cols=131 Identities=28% Similarity=0.402 Sum_probs=112.1
Q ss_pred ceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeeecc
Q 044494 4 KCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADFGV 83 (144)
Q Consensus 4 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~~~ 83 (144)
+.+++||||+++++|.+++.... ..+++..++.++.|++.||.+|| +.+++|+||||+||+++.++.++|+|||+
T Consensus 117 ~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dikp~NIli~~~~~~kL~Dfg~ 191 (326)
T 2w1i_A 117 RNLKLIMEYLPYGSLRDYLQKHK--ERIDHIKLLQYTSQICKGMEYLG---TKRYIHRDLATRNILVENENRVKIGDFGL 191 (326)
T ss_dssp -CCEEEECCCTTCBHHHHHHHST--TSSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEEEETTEEEECCCTT
T ss_pred CceEEEEECCCCCCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHH---hCCEeccCCCcceEEEcCCCcEEEecCcc
Confidence 36799999999999999997643 23899999999999999999999 89999999999999999999999999999
Q ss_pred eeecccCCCC---cccccccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCC
Q 044494 84 ARLLNFDSSN---RTLLAGTYGYIAPELAYTMVVTEKSDVYSFGVVALEVLMGKHPGEL 139 (144)
Q Consensus 84 ~~~~~~~~~~---~~~~~~~~~~~~pe~~~~~~~~~~~d~~slg~~l~~~~~g~~p~~~ 139 (144)
+......... .....++..|+|||.+....++.++|+||+|+++++|++|..||..
T Consensus 192 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~ 250 (326)
T 2w1i_A 192 TKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKS 250 (326)
T ss_dssp CEECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGS
T ss_pred hhhccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCC
Confidence 9876532211 1223466779999999988888999999999999999999988764
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=4.3e-29 Score=173.11 Aligned_cols=132 Identities=29% Similarity=0.428 Sum_probs=110.6
Q ss_pred eEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcC-----CCCCeEecCCCCCcEEEcCCCCeEEe
Q 044494 5 CMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHD-----CTPPIVHRDISSNNILLNLELEAFVA 79 (144)
Q Consensus 5 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~-----~~~~~~h~~i~~~ni~~~~~~~~~l~ 79 (144)
.+|+||||+++|+|.+++.+. .+++..++.++.|++.++.+||.. ++.+++|+||||+||+++.++.++|+
T Consensus 114 ~~~lv~e~~~~g~L~~~l~~~----~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~~~kL~ 189 (342)
T 1b6c_B 114 QLWLVSDYHEHGSLFDYLNRY----TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIA 189 (342)
T ss_dssp CEEEEECCCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTTSCEEEC
T ss_pred eeEEEEeecCCCcHHHHHhcc----CccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCCCCEEEE
Confidence 789999999999999999753 389999999999999999999931 13689999999999999999999999
Q ss_pred eecceeecccCCC----CcccccccccccCccccccCC------CCCcchhHHHHHHHHHHHhC----------CCCCCC
Q 044494 80 DFGVARLLNFDSS----NRTLLAGTYGYIAPELAYTMV------VTEKSDVYSFGVVALEVLMG----------KHPGEL 139 (144)
Q Consensus 80 d~~~~~~~~~~~~----~~~~~~~~~~~~~pe~~~~~~------~~~~~d~~slg~~l~~~~~g----------~~p~~~ 139 (144)
|||++........ ......+++.|+|||.+.... ++.++|+||+|+++|+|++| ..||..
T Consensus 190 Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~~ 269 (342)
T 1b6c_B 190 DLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYD 269 (342)
T ss_dssp CCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTT
T ss_pred ECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCccc
Confidence 9999987653322 123356899999999987652 23679999999999999999 788866
Q ss_pred C
Q 044494 140 L 140 (144)
Q Consensus 140 ~ 140 (144)
.
T Consensus 270 ~ 270 (342)
T 1b6c_B 270 L 270 (342)
T ss_dssp T
T ss_pred c
Confidence 4
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=4.7e-31 Score=193.96 Aligned_cols=121 Identities=21% Similarity=0.174 Sum_probs=87.6
Q ss_pred CCceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeee
Q 044494 2 HRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADF 81 (144)
Q Consensus 2 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~ 81 (144)
+++.+||||||++|++|.+++++.+. ++.. .++.|++.||+|+| ++||+||||||+||+++.++.+||+||
T Consensus 313 d~~~~yLVMEyv~G~~L~d~i~~~~~---l~~~---~I~~QIl~AL~ylH---~~GIIHRDIKPeNILL~~dg~vKL~DF 383 (569)
T 4azs_A 313 NAQSGWLVMEKLPGRLLSDMLAAGEE---IDRE---KILGSLLRSLAALE---KQGFWHDDVRPWNVMVDARQHARLIDF 383 (569)
T ss_dssp CSSEEEEEEECCCSEEHHHHHHTTCC---CCHH---HHHHHHHHHHHHHH---HTTCEESCCCGGGEEECTTSCEEECCC
T ss_pred ECCEEEEEEecCCCCcHHHHHHhCCC---CCHH---HHHHHHHHHHHHHH---HCCceeccCchHhEEECCCCCEEEeec
Confidence 46789999999999999999987544 6654 47899999999999 999999999999999999999999999
Q ss_pred cceeecccCCCCcccccccccccCccccccCCCCCcchhHHHHHHHHHHHh
Q 044494 82 GVARLLNFDSSNRTLLAGTYGYIAPELAYTMVVTEKSDVYSFGVVALEVLM 132 (144)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~d~~slg~~l~~~~~ 132 (144)
|+++.............||+.|++||++.+. +..++|+|++|++.+++.+
T Consensus 384 GlAr~~~~~~~~~~t~vGTp~YmAPE~l~g~-~~~~~d~~s~g~~~~~l~~ 433 (569)
T 4azs_A 384 GSIVTTPQDCSWPTNLVQSFFVFVNELFAEN-KSWNGFWRSAPVHPFNLPQ 433 (569)
T ss_dssp TTEESCC---CCSHHHHHHHHHHHHHHC------------------CCCCT
T ss_pred ccCeeCCCCCccccCceechhhccHHHhCCC-CCCcccccccccchhhhcc
Confidence 9998765444445567899999999999765 4567899999998765543
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=4.1e-29 Score=171.54 Aligned_cols=131 Identities=25% Similarity=0.360 Sum_probs=108.7
Q ss_pred CceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEc-CCCCeEEeee
Q 044494 3 RKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLN-LELEAFVADF 81 (144)
Q Consensus 3 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~-~~~~~~l~d~ 81 (144)
.+..|+||||+. |+|.+++... .+++..+..++.|++.|+++|| ++|++|+||||+||+++ .++.++|+||
T Consensus 94 ~~~~~lv~e~~~-~~L~~~~~~~----~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~kl~Df 165 (320)
T 2i6l_A 94 LNSVYIVQEYME-TDLANVLEQG----PLLEEHARLFMYQLLRGLKYIH---SANVLHRDLKPANLFINTEDLVLKIGDF 165 (320)
T ss_dssp CSEEEEEEECCS-EEHHHHHTTC----CCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSGGGEEEETTTTEEEECCC
T ss_pred cCceeEEeeccC-CCHHHHhhcC----CccHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEcCCCCeEEEccC
Confidence 467899999997 5999988642 3899999999999999999999 88999999999999997 5678999999
Q ss_pred cceeecccC---CCCcccccccccccCcccccc-CCCCCcchhHHHHHHHHHHHhCCCCCCCCC
Q 044494 82 GVARLLNFD---SSNRTLLAGTYGYIAPELAYT-MVVTEKSDVYSFGVVALEVLMGKHPGELLS 141 (144)
Q Consensus 82 ~~~~~~~~~---~~~~~~~~~~~~~~~pe~~~~-~~~~~~~d~~slg~~l~~~~~g~~p~~~~~ 141 (144)
|.+...... ........+++.|+|||.+.. ..++.++|+||+|++++++++|..||...+
T Consensus 166 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~ 229 (320)
T 2i6l_A 166 GLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAH 229 (320)
T ss_dssp TTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred ccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCC
Confidence 999865422 112233456889999998865 567889999999999999999999998654
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=7.3e-29 Score=169.57 Aligned_cols=134 Identities=25% Similarity=0.325 Sum_probs=110.2
Q ss_pred CceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeeec
Q 044494 3 RKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADFG 82 (144)
Q Consensus 3 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~~ 82 (144)
++..|+||||+.++ |.+++.... ...+++..+..++.|++.|+.+|| +++++|+||||+||+++.++.++++|||
T Consensus 80 ~~~~~lv~e~~~~~-l~~~~~~~~-~~~~~~~~~~~~~~qi~~al~~LH---~~~i~H~dlkp~NIl~~~~~~~kl~dfg 154 (305)
T 2wtk_C 80 KQKMYMVMEYCVCG-MQEMLDSVP-EKRFPVCQAHGYFCQLIDGLEYLH---SQGIVHKDIKPGNLLLTTGGTLKISALG 154 (305)
T ss_dssp --CEEEEEECCSEE-HHHHHHHST-TCSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCT
T ss_pred CCeEEEEehhccCC-HHHHHHhCc-ccccCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCcccEEEcCCCcEEeeccc
Confidence 35789999999876 777766422 234899999999999999999999 8899999999999999999999999999
Q ss_pred ceeecccCC--CCcccccccccccCccccccCC--CCCcchhHHHHHHHHHHHhCCCCCCCCC
Q 044494 83 VARLLNFDS--SNRTLLAGTYGYIAPELAYTMV--VTEKSDVYSFGVVALEVLMGKHPGELLS 141 (144)
Q Consensus 83 ~~~~~~~~~--~~~~~~~~~~~~~~pe~~~~~~--~~~~~d~~slg~~l~~~~~g~~p~~~~~ 141 (144)
.+....... .......+++.|+|||.+.... .+.++|+||+|+++++|++|..||...+
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 217 (305)
T 2wtk_C 155 VAEALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDN 217 (305)
T ss_dssp TCEECCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred cccccCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCch
Confidence 998654221 1223456899999999987643 3678999999999999999999998643
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=5.3e-29 Score=169.21 Aligned_cols=131 Identities=28% Similarity=0.415 Sum_probs=111.4
Q ss_pred CceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCC---CCeEEe
Q 044494 3 RKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLE---LEAFVA 79 (144)
Q Consensus 3 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~---~~~~l~ 79 (144)
.+..|+||||+++++|.+++..... +++..++.++.|++.++.+|| +.|++|+||+|+||+++.+ +.++++
T Consensus 93 ~~~~~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dl~p~NIlv~~~~~~~~~kL~ 166 (287)
T 2wei_A 93 SSSFYIVGELYTGGELFDEIIKRKR---FSEHDAARIIKQVFSGITYMH---KHNIVHRDLKPENILLESKEKDCDIKII 166 (287)
T ss_dssp SSEEEEEECCCCSCBHHHHHHHHSS---CCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred CCeEEEEEEccCCCCHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHH---HCCeeccCCChhhEEEecCCCcccEEEe
Confidence 5678999999999999998875433 899999999999999999999 8899999999999999764 469999
Q ss_pred eecceeecccCCCCcccccccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCC
Q 044494 80 DFGVARLLNFDSSNRTLLAGTYGYIAPELAYTMVVTEKSDVYSFGVVALEVLMGKHPGELLS 141 (144)
Q Consensus 80 d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~d~~slg~~l~~~~~g~~p~~~~~ 141 (144)
|||++....... ......+++.|+|||.+.+. ++.++|+||+|++++++++|..||...+
T Consensus 167 Dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~ 226 (287)
T 2wei_A 167 DFGLSTCFQQNT-KMKDRIGTAYYIAPEVLRGT-YDEKCDVWSAGVILYILLSGTPPFYGKN 226 (287)
T ss_dssp STTGGGTBCCCS-SCSCHHHHHTTCCHHHHTTC-CCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred ccCcceeecCCC-ccccccCcccccChHHhcCC-CCCchhhHhHHHHHHHHHhCCCCCCCCC
Confidence 999987654322 22334588899999998764 7889999999999999999999997643
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=99.96 E-value=5.5e-29 Score=174.78 Aligned_cols=124 Identities=28% Similarity=0.411 Sum_probs=104.9
Q ss_pred EEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeeeccee
Q 044494 6 MFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADFGVAR 85 (144)
Q Consensus 6 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~~~~~ 85 (144)
+|+||||+. ++|.+.+.. .+++..+..++.|++.|+++|| +.|++|+||||+||+++.++.++|+|||++.
T Consensus 122 ~~lv~e~~~-~~l~~~~~~-----~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~ 192 (371)
T 4exu_A 122 FYLVMPFMQ-TDLQKIMGM-----EFSEEKIQYLVYQMLKGLKYIH---SAGVVHRDLKPGNLAVNEDCELKILDFGLAR 192 (371)
T ss_dssp CEEEEECCC-EEHHHHTTS-----CCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECSTTCC-
T ss_pred EEEEEcccc-ccHHHHhhc-----CCCHHHHHHHHHHHHHHHHHHH---HCCCcCCCcCHHHeEECCCCCEEEEecCccc
Confidence 499999997 588877642 2899999999999999999999 8899999999999999999999999999997
Q ss_pred ecccCCCCcccccccccccCcccccc-CCCCCcchhHHHHHHHHHHHhCCCCCCCCC
Q 044494 86 LLNFDSSNRTLLAGTYGYIAPELAYT-MVVTEKSDVYSFGVVALEVLMGKHPGELLS 141 (144)
Q Consensus 86 ~~~~~~~~~~~~~~~~~~~~pe~~~~-~~~~~~~d~~slg~~l~~~~~g~~p~~~~~ 141 (144)
.... ......+++.|+|||.+.. ..++.++|+||+|+++++|++|..||.+.+
T Consensus 193 ~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~ 246 (371)
T 4exu_A 193 HADA---EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKD 246 (371)
T ss_dssp ----------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred cccc---CcCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCC
Confidence 6542 2233567999999999887 678899999999999999999999998754
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=3.2e-29 Score=179.24 Aligned_cols=135 Identities=26% Similarity=0.407 Sum_probs=101.9
Q ss_pred CCceEEEEEeeccCCCHHHHhhcccccC----CCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCC----
Q 044494 2 HRKCMFLIYEYMEMGSLFCVLRTDEEAV----GLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLE---- 73 (144)
Q Consensus 2 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~----~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~---- 73 (144)
.++.+|+||||+. |+|.+++....... ...+..++.++.|++.||.||| +++++||||||+||+++.+
T Consensus 80 ~~~~~~lv~E~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDLkp~NILl~~~~~~~ 155 (434)
T 2rio_A 80 TDRFLYIALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLH---SLKIIHRDLKPQNILVSTSSRFT 155 (434)
T ss_dssp CSSEEEEEECCCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEECCHHHH
T ss_pred cCCeEEEEEecCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHH---HCCccccCCChHhEEEecCcccc
Confidence 3567899999996 59999997643211 1133345779999999999999 8999999999999999754
Q ss_pred ---------CCeEEeeecceeecccCCCC----cccccccccccCcccccc-------CCCCCcchhHHHHHHHHHHHh-
Q 044494 74 ---------LEAFVADFGVARLLNFDSSN----RTLLAGTYGYIAPELAYT-------MVVTEKSDVYSFGVVALEVLM- 132 (144)
Q Consensus 74 ---------~~~~l~d~~~~~~~~~~~~~----~~~~~~~~~~~~pe~~~~-------~~~~~~~d~~slg~~l~~~~~- 132 (144)
..++|+|||++......... .....|++.|+|||++.+ ..++.++|+||+|+++++|++
T Consensus 156 ~~~~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~ 235 (434)
T 2rio_A 156 ADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSK 235 (434)
T ss_dssp SCCTTCCCSCEEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTT
T ss_pred cccccCCCceEEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhC
Confidence 47999999999876532211 223568999999999875 567889999999999999998
Q ss_pred CCCCCCCC
Q 044494 133 GKHPGELL 140 (144)
Q Consensus 133 g~~p~~~~ 140 (144)
|..||...
T Consensus 236 g~~Pf~~~ 243 (434)
T 2rio_A 236 GKHPFGDK 243 (434)
T ss_dssp SCCTTCST
T ss_pred CCCCCCCc
Confidence 99999754
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=99.96 E-value=8.8e-29 Score=168.67 Aligned_cols=125 Identities=28% Similarity=0.508 Sum_probs=102.1
Q ss_pred CceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeeec
Q 044494 3 RKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADFG 82 (144)
Q Consensus 3 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~~ 82 (144)
.+.+|+||||+++++|.+++.... ..+++..++.++.|++.|+.+|| +.+++|+||+|+||+++.++.++++|||
T Consensus 87 ~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dlkp~Nil~~~~~~~kl~dfg 161 (303)
T 1zy4_A 87 KSTLFIQMEYCENGTLYDLIHSEN--LNQQRDEYWRLFRQILEALSYIH---SQGIIHRDLKPMNIFIDESRNVKIGDFG 161 (303)
T ss_dssp EEEEEEEEECCCSCBHHHHHHHSC--GGGCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECCCC
T ss_pred CCceEEEEecCCCCCHHHhhhccc--cccchHHHHHHHHHHHHHHHHHH---hCCeecccCCHHhEEEcCCCCEEEeeCc
Confidence 467899999999999999997533 23788899999999999999999 8899999999999999999999999999
Q ss_pred ceeecccCC--------------CCcccccccccccCccccccC-CCCCcchhHHHHHHHHHHHh
Q 044494 83 VARLLNFDS--------------SNRTLLAGTYGYIAPELAYTM-VVTEKSDVYSFGVVALEVLM 132 (144)
Q Consensus 83 ~~~~~~~~~--------------~~~~~~~~~~~~~~pe~~~~~-~~~~~~d~~slg~~l~~~~~ 132 (144)
.+....... .......+++.|+|||.+.+. .++.++|+||+|+++++|++
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~ 226 (303)
T 1zy4_A 162 LAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY 226 (303)
T ss_dssp CCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS
T ss_pred chhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh
Confidence 987653211 112335688999999999865 57889999999999999998
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=5.9e-29 Score=171.73 Aligned_cols=135 Identities=26% Similarity=0.275 Sum_probs=95.0
Q ss_pred CCceEEEEEeeccCCCHHHHhhc--ccccCCCCHHHHHHHHHHHHHHHHHHhcCCCC-CeEecCCCCCcEEEcCCCCeEE
Q 044494 2 HRKCMFLIYEYMEMGSLFCVLRT--DEEAVGLDWAKRVNIVKGMAHALSYLHHDCTP-PIVHRDISSNNILLNLELEAFV 78 (144)
Q Consensus 2 ~~~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~-~~~h~~i~~~ni~~~~~~~~~l 78 (144)
.++..++||||+.+ +|.+++.. ......+++..+..++.|++.++.+|| +. +++|+||||+||+++.++.++|
T Consensus 92 ~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~~ivH~dlkp~NIll~~~~~~kl 167 (327)
T 3aln_A 92 REGDCWICMELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLK---ENLKIIHRDIKPSNILLDRSGNIKL 167 (327)
T ss_dssp CSSEEEEEECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHH---HHHSCCCSCCCGGGEEEETTTEEEE
T ss_pred eCCceEEEEeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHh---ccCCEeECCCCHHHEEEcCCCCEEE
Confidence 35678999999985 88877753 112334899999999999999999999 77 9999999999999999999999
Q ss_pred eeecceeecccCCCCcccccccccccCcccc----ccCCCCCcchhHHHHHHHHHHHhCCCCCCCCC
Q 044494 79 ADFGVARLLNFDSSNRTLLAGTYGYIAPELA----YTMVVTEKSDVYSFGVVALEVLMGKHPGELLS 141 (144)
Q Consensus 79 ~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~----~~~~~~~~~d~~slg~~l~~~~~g~~p~~~~~ 141 (144)
+|||++....... ......+++.|+|||.+ ....++.++|+||+|+++++|++|..||...+
T Consensus 168 ~Dfg~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~ 233 (327)
T 3aln_A 168 CDFGISGQLVDSI-AKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWN 233 (327)
T ss_dssp CCCSSSCC-------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-
T ss_pred ccCCCceeccccc-ccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcc
Confidence 9999997654322 22334688999999998 45567889999999999999999999997643
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=7.9e-29 Score=170.16 Aligned_cols=131 Identities=26% Similarity=0.371 Sum_probs=105.4
Q ss_pred CCceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeee
Q 044494 2 HRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADF 81 (144)
Q Consensus 2 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~ 81 (144)
.++..|+||| +.+++|.+++.... .+++..+..++.|++.||.+|| +++++|+||||+||+++. +.++|+||
T Consensus 99 ~~~~~~lv~e-~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIl~~~-~~~kL~Df 170 (313)
T 3cek_A 99 TDQYIYMVME-CGNIDLNSWLKKKK---SIDPWERKSYWKNMLEAVHTIH---QHGIVHSDLKPANFLIVD-GMLKLIDF 170 (313)
T ss_dssp CSSEEEEEEC-CCSEEHHHHHHHCS---SCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEEET-TEEEECCC
T ss_pred cCCEEEEEEe-cCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCcccEEEEC-CeEEEeec
Confidence 3567899999 55789999998644 3899999999999999999999 889999999999999964 78999999
Q ss_pred cceeecccCCC--CcccccccccccCcccccc-----------CCCCCcchhHHHHHHHHHHHhCCCCCCCC
Q 044494 82 GVARLLNFDSS--NRTLLAGTYGYIAPELAYT-----------MVVTEKSDVYSFGVVALEVLMGKHPGELL 140 (144)
Q Consensus 82 ~~~~~~~~~~~--~~~~~~~~~~~~~pe~~~~-----------~~~~~~~d~~slg~~l~~~~~g~~p~~~~ 140 (144)
|++........ ......+++.|+|||.+.. ..++.++|+||+|+++++|++|..||...
T Consensus 171 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~ 242 (313)
T 3cek_A 171 GIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQI 242 (313)
T ss_dssp SSSCC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTC
T ss_pred cccccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhH
Confidence 99986543221 1234568999999999875 35778999999999999999999999764
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=99.96 E-value=2.9e-29 Score=178.51 Aligned_cols=129 Identities=18% Similarity=0.222 Sum_probs=106.7
Q ss_pred eEEEEEeeccCCCHHHHhhc----ccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEee
Q 044494 5 CMFLIYEYMEMGSLFCVLRT----DEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVAD 80 (144)
Q Consensus 5 ~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d 80 (144)
.++++|+.+ +++|.++++. ......+++..++.++.|++.||+||| +++++||||||+||+++.++.++|+|
T Consensus 179 ~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~iiHrDiKp~NILl~~~~~~kL~D 254 (413)
T 3dzo_A 179 SRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLH---HYGLVHTYLRPVDIVLDQRGGVFLTG 254 (413)
T ss_dssp SEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECTTCCEEECC
T ss_pred ceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCcccceEEEecCCeEEEEe
Confidence 467788866 5799998852 111233778888999999999999999 89999999999999999999999999
Q ss_pred ecceeecccCCCCcccccccccccCcccc----------ccCCCCCcchhHHHHHHHHHHHhCCCCCCCCC
Q 044494 81 FGVARLLNFDSSNRTLLAGTYGYIAPELA----------YTMVVTEKSDVYSFGVVALEVLMGKHPGELLS 141 (144)
Q Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~----------~~~~~~~~~d~~slg~~l~~~~~g~~p~~~~~ 141 (144)
||+++..... .....| +.|+|||++ ....++.++|+||+|+++|+|++|..||...+
T Consensus 255 FG~a~~~~~~---~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~ 321 (413)
T 3dzo_A 255 FEHLVRDGAS---AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNTDDA 321 (413)
T ss_dssp GGGCEETTEE---ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHHHHHSSCCCCTTG
T ss_pred ccceeecCCc---cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHHHHHCCCCCCCcc
Confidence 9998865432 333456 999999999 55567889999999999999999999998754
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=6.9e-29 Score=177.45 Aligned_cols=132 Identities=28% Similarity=0.438 Sum_probs=102.0
Q ss_pred CceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCC-----CCeE
Q 044494 3 RKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLE-----LEAF 77 (144)
Q Consensus 3 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~-----~~~~ 77 (144)
++.+|+||||+. |+|.+++..... ...+..++.++.|++.||.||| +.+++||||||+||+++.+ ..++
T Consensus 90 ~~~~~lv~E~~~-g~L~~~l~~~~~--~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlKp~NIll~~~~~~~~~~~k 163 (432)
T 3p23_A 90 RQFQYIAIELCA-ATLQEYVEQKDF--AHLGLEPITLLQQTTSGLAHLH---SLNIVHRDLKPHNILISMPNAHGKIKAM 163 (432)
T ss_dssp TTEEEEEEECCS-EEHHHHHHSSSC--CCCSSCHHHHHHHHHHHHHHHH---HTTCCCCCCSTTSEEECCCBTTTBCCEE
T ss_pred CCEEEEEEECCC-CCHHHHHHhcCC--CccchhHHHHHHHHHHHHHHHH---HCcCEeCCCCHHHEEEecCCCCCceeEE
Confidence 467899999996 599999875432 2444456789999999999999 8999999999999999532 3578
Q ss_pred EeeecceeecccCC---CCcccccccccccCccccc---cCCCCCcchhHHHHHHHHHHHh-CCCCCCCC
Q 044494 78 VADFGVARLLNFDS---SNRTLLAGTYGYIAPELAY---TMVVTEKSDVYSFGVVALEVLM-GKHPGELL 140 (144)
Q Consensus 78 l~d~~~~~~~~~~~---~~~~~~~~~~~~~~pe~~~---~~~~~~~~d~~slg~~l~~~~~-g~~p~~~~ 140 (144)
|+|||++....... .......|++.|+|||++. ...++.++|+||+|+++++|++ |..||...
T Consensus 164 L~DFG~a~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~ 233 (432)
T 3p23_A 164 ISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKS 233 (432)
T ss_dssp ECCTTEEECC------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBST
T ss_pred EecccceeeccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchh
Confidence 99999998654321 1223456899999999998 4556779999999999999999 99999653
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=6.1e-29 Score=170.58 Aligned_cols=129 Identities=26% Similarity=0.335 Sum_probs=110.0
Q ss_pred CceEEEEEee-ccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEc-CCCCeEEee
Q 044494 3 RKCMFLIYEY-MEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLN-LELEAFVAD 80 (144)
Q Consensus 3 ~~~~~lv~e~-~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~-~~~~~~l~d 80 (144)
++..++|+|+ +.+++|.+++..... +++..++.++.|++.++.+|| +.+++|+||||+||+++ .++.++++|
T Consensus 110 ~~~~~~v~e~~~~~~~L~~~l~~~~~---~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~kl~d 183 (312)
T 2iwi_A 110 QEGFMLVLERPLPAQDLFDYITEKGP---LGEGPSRCFFGQVVAAIQHCH---SRGVVHRDIKDENILIDLRRGCAKLID 183 (312)
T ss_dssp ---CEEEEECCSSEEEHHHHHHHHCS---CCHHHHHHHHHHHHHHHHHHH---HHTEECCCCSGGGEEEETTTTEEEECC
T ss_pred CCeEEEEEEecCCCCCHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHH---HCCeeecCCChhhEEEeCCCCeEEEEE
Confidence 4567899999 788999999976443 899999999999999999999 88999999999999999 788999999
Q ss_pred ecceeecccCCCCcccccccccccCccccccCCCC-CcchhHHHHHHHHHHHhCCCCCCC
Q 044494 81 FGVARLLNFDSSNRTLLAGTYGYIAPELAYTMVVT-EKSDVYSFGVVALEVLMGKHPGEL 139 (144)
Q Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~-~~~d~~slg~~l~~~~~g~~p~~~ 139 (144)
||++...... ......+++.|+|||.+....+. .++|+||+|++++++++|..||..
T Consensus 184 fg~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~ 241 (312)
T 2iwi_A 184 FGSGALLHDE--PYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFER 241 (312)
T ss_dssp CSSCEECCSS--CBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCS
T ss_pred cchhhhcccC--cccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCC
Confidence 9999865532 23345689999999998876654 489999999999999999999975
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=1.1e-28 Score=172.04 Aligned_cols=125 Identities=28% Similarity=0.397 Sum_probs=105.3
Q ss_pred eEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeeecce
Q 044494 5 CMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADFGVA 84 (144)
Q Consensus 5 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~~~~ 84 (144)
.+|+||||+. ++|.+++.. .+++..+..++.|++.|+.+|| +.|++|+||||+||+++.++.++|+|||++
T Consensus 103 ~~~lv~e~~~-~~l~~~~~~-----~~~~~~~~~i~~qi~~al~~LH---~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~ 173 (353)
T 3coi_A 103 DFYLVMPFMQ-TDLQKIMGL-----KFSEEKIQYLVYQMLKGLKYIH---SAGVVHRDLKPGNLAVNEDCELKILDFGLA 173 (353)
T ss_dssp CCEEEEECCS-EEGGGTTTS-----CCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCCGGGEEECTTCCEEECSTTCT
T ss_pred eEEEEecccc-CCHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEeECCCCcEEEeecccc
Confidence 4599999997 588777642 2899999999999999999999 889999999999999999999999999998
Q ss_pred eecccCCCCcccccccccccCcccccc-CCCCCcchhHHHHHHHHHHHhCCCCCCCCC
Q 044494 85 RLLNFDSSNRTLLAGTYGYIAPELAYT-MVVTEKSDVYSFGVVALEVLMGKHPGELLS 141 (144)
Q Consensus 85 ~~~~~~~~~~~~~~~~~~~~~pe~~~~-~~~~~~~d~~slg~~l~~~~~g~~p~~~~~ 141 (144)
..... ......+++.|+|||.+.. ..++.++|+||+|+++++|++|..||.+.+
T Consensus 174 ~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~ 228 (353)
T 3coi_A 174 RHADA---EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKD 228 (353)
T ss_dssp TC-----------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSC
T ss_pred cCCCC---CccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 76432 1233567899999999876 567889999999999999999999998654
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=3.1e-28 Score=167.26 Aligned_cols=132 Identities=24% Similarity=0.305 Sum_probs=100.6
Q ss_pred CCceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCC-CeEecCCCCCcEEEcCCCCeEEee
Q 044494 2 HRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTP-PIVHRDISSNNILLNLELEAFVAD 80 (144)
Q Consensus 2 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~-~~~h~~i~~~ni~~~~~~~~~l~d 80 (144)
.++.+|+||||+ ++.+..+.... ...+++..+..++.|++.++.+|| ++ +++|+||+|+||+++.++.++|+|
T Consensus 95 ~~~~~~lv~e~~-~~~~~~l~~~~--~~~~~~~~~~~~~~~i~~~l~~lH---~~~~i~H~dlkp~Nil~~~~~~~kl~d 168 (318)
T 2dyl_A 95 TNTDVFIAMELM-GTCAEKLKKRM--QGPIPERILGKMTVAIVKALYYLK---EKHGVIHRDVKPSNILLDERGQIKLCD 168 (318)
T ss_dssp CSSEEEEEECCC-SEEHHHHHHHH--TSCCCHHHHHHHHHHHHHHHHHHH---HHHCCCCCCCCGGGEEECTTSCEEECC
T ss_pred cCCcEEEEEecc-CCcHHHHHHHh--ccCCCHHHHHHHHHHHHHHHHHHH---hhCCEEeCCCCHHHEEECCCCCEEEEE
Confidence 356789999999 55565555432 223899999999999999999999 75 999999999999999999999999
Q ss_pred ecceeecccCCCCcccccccccccCccccc-----cCCCCCcchhHHHHHHHHHHHhCCCCCCCC
Q 044494 81 FGVARLLNFDSSNRTLLAGTYGYIAPELAY-----TMVVTEKSDVYSFGVVALEVLMGKHPGELL 140 (144)
Q Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~-----~~~~~~~~d~~slg~~l~~~~~g~~p~~~~ 140 (144)
||.+...... .......+++.|+|||.+. ...++.++|+||+|+++++|++|..||...
T Consensus 169 fg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~ 232 (318)
T 2dyl_A 169 FGISGRLVDD-KAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNC 232 (318)
T ss_dssp CTTC---------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTC
T ss_pred CCCchhccCC-ccccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCC
Confidence 9998765432 2223356889999999985 445788999999999999999999999763
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=99.95 E-value=3.6e-28 Score=181.97 Aligned_cols=120 Identities=28% Similarity=0.340 Sum_probs=103.5
Q ss_pred EEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeeeccee
Q 044494 6 MFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADFGVAR 85 (144)
Q Consensus 6 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~~~~~ 85 (144)
.|+||||+++++|.+++.. .+++..++.++.|++.+|.||| ++|++||||||+||+++.+ .++|+|||++.
T Consensus 159 ~~lv~E~~~g~~L~~~~~~-----~l~~~~~~~~~~qi~~aL~~lH---~~giiHrDlkp~NIll~~~-~~kl~DFG~a~ 229 (681)
T 2pzi_A 159 GYIVMEYVGGQSLKRSKGQ-----KLPVAEAIAYLLEILPALSYLH---SIGLVYNDLKPENIMLTEE-QLKLIDLGAVS 229 (681)
T ss_dssp EEEEEECCCCEECC----C-----CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECSS-CEEECCCTTCE
T ss_pred eEEEEEeCCCCcHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHH---HCCCeecccChHHeEEeCC-cEEEEecccch
Confidence 6999999999999887653 3899999999999999999999 8999999999999999985 89999999998
Q ss_pred ecccCCCCcccccccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCC
Q 044494 86 LLNFDSSNRTLLAGTYGYIAPELAYTMVVTEKSDVYSFGVVALEVLMGKHPGEL 139 (144)
Q Consensus 86 ~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~d~~slg~~l~~~~~g~~p~~~ 139 (144)
..... ....|++.|+|||++.... +.++|+||+|+++++|++|..||..
T Consensus 230 ~~~~~----~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~ 278 (681)
T 2pzi_A 230 RINSF----GYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNG 278 (681)
T ss_dssp ETTCC----SCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETT
T ss_pred hcccC----CccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCcc
Confidence 75432 3456899999999987654 7899999999999999999988865
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=99.95 E-value=1.9e-28 Score=169.86 Aligned_cols=125 Identities=18% Similarity=0.141 Sum_probs=106.3
Q ss_pred CceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCC--------
Q 044494 3 RKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLEL-------- 74 (144)
Q Consensus 3 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~-------- 74 (144)
++.+|+||||+++|++.+.+.+ ..+++..+..++.|++.||.|||+ +.+++||||||+||+++.++
T Consensus 134 ~~~~~lv~E~~~~g~ll~~~~~----~~~~~~~~~~i~~qi~~aL~~lH~--~~~ivHrDlKp~NILl~~~~~~~~~~~~ 207 (336)
T 2vuw_A 134 DDQLFIVLEFEFGGIDLEQMRT----KLSSLATAKSILHQLTASLAVAEA--SLRFEHRDLHWGNVLLKKTSLKKLHYTL 207 (336)
T ss_dssp TTCEEEEEEEECCCEETGGGTT----TCCCHHHHHHHHHHHHHHHHHHHH--HHCCBCSCCCGGGEEEEECSCSEEEEEE
T ss_pred cCeEEEEEEecCCCccHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHH--hCCEeECCCCHHHEEEeccCCcceeeec
Confidence 6789999999999987776653 238999999999999999999993 36899999999999999887
Q ss_pred ------------CeEEeeecceeecccCCCCcccccccccccCccccccCCCCCcchhHHHHHH-HHHHHhCCCCCCC
Q 044494 75 ------------EAFVADFGVARLLNFDSSNRTLLAGTYGYIAPELAYTMVVTEKSDVYSFGVV-ALEVLMGKHPGEL 139 (144)
Q Consensus 75 ------------~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~d~~slg~~-l~~~~~g~~p~~~ 139 (144)
.++|+|||+++.... ....|++.|+|||++.+.. +.++|+||++++ .+++++|..||..
T Consensus 208 ~~~~~~~~~~~~~vkL~DFG~a~~~~~-----~~~~gt~~y~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~ 279 (336)
T 2vuw_A 208 NGKSSTIPSCGLQVSIIDYTLSRLERD-----GIVVFCDVSMDEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSN 279 (336)
T ss_dssp TTEEEEEECTTEEEEECCCTTCBEEET-----TEEECCCCTTCSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHH
T ss_pred cCccccccCCCceEEEeeccccEecCC-----CcEEEeecccChhhhcCCC-ccceehhhhhCCCCcccccccCCCcc
Confidence 899999999986542 2357899999999998776 889999998777 6667789888853
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=4.9e-27 Score=160.45 Aligned_cols=113 Identities=27% Similarity=0.457 Sum_probs=97.1
Q ss_pred CceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcC---CCCeEEe
Q 044494 3 RKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNL---ELEAFVA 79 (144)
Q Consensus 3 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~---~~~~~l~ 79 (144)
++.+++||||+++++|.+++.... ...+++..++.++.|++.|+.+|| +++++|+||||+||+++. ++.++++
T Consensus 87 ~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~~~kl~ 162 (299)
T 3m2w_A 87 RKCLLIVMECLDGGELFSRIQDRG-DQAFTEREASEIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLT 162 (299)
T ss_dssp EEEEEEEECCCCSCBHHHHHHHCT-TCCCBHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESSSSTTCCEEEC
T ss_pred CceEEEEEeecCCCcHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEEecCCCCCcEEEe
Confidence 467899999999999999998643 234899999999999999999999 899999999999999998 7889999
Q ss_pred eecceeecccCCCCcccccccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCC
Q 044494 80 DFGVARLLNFDSSNRTLLAGTYGYIAPELAYTMVVTEKSDVYSFGVVALEVLMGKHPGELLS 141 (144)
Q Consensus 80 d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~d~~slg~~l~~~~~g~~p~~~~~ 141 (144)
|||++.... ...++.++|+||+|+++++|++|..||...+
T Consensus 163 Dfg~a~~~~----------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~ 202 (299)
T 3m2w_A 163 DFGFAKETT----------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNH 202 (299)
T ss_dssp CCTTCEECT----------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC--
T ss_pred ccccccccc----------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCc
Confidence 999886532 1335678999999999999999999996543
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=99.93 E-value=6.9e-26 Score=154.17 Aligned_cols=105 Identities=14% Similarity=0.154 Sum_probs=89.9
Q ss_pred CceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeeec
Q 044494 3 RKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADFG 82 (144)
Q Consensus 3 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~~ 82 (144)
++..|+||||++|++|.++++.. ....++..++.|++.||+||| ++|++|+||||+||+++.++.+++++.+
T Consensus 103 ~~~~~lv~e~~~g~~L~~~l~~~-----~~~~~~~~i~~ql~~aL~~lH---~~givH~Dikp~NIll~~~g~~kl~~~~ 174 (286)
T 3uqc_A 103 RAGGLVVAEWIRGGSLQEVADTS-----PSPVGAIRAMQSLAAAADAAH---RAGVALSIDHPSRVRVSIDGDVVLAYPA 174 (286)
T ss_dssp TTEEEEEEECCCEEEHHHHHTTC-----CCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEEETTSCEEECSCC
T ss_pred CCcEEEEEEecCCCCHHHHHhcC-----CChHHHHHHHHHHHHHHHHHH---HCCCccCCCCcccEEEcCCCCEEEEecc
Confidence 56789999999999999998642 355678889999999999999 8999999999999999999999987432
Q ss_pred ceeecccCCCCcccccccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCC
Q 044494 83 VARLLNFDSSNRTLLAGTYGYIAPELAYTMVVTEKSDVYSFGVVALEVLMGKHPGELLSS 142 (144)
Q Consensus 83 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~d~~slg~~l~~~~~g~~p~~~~~~ 142 (144)
|++ .++.++|+||+|+++|+|++|..||...+.
T Consensus 175 --------------------~~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~ 207 (286)
T 3uqc_A 175 --------------------TMP-------DANPQDDIRGIGASLYALLVNRWPLPEAGV 207 (286)
T ss_dssp --------------------CCT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSB
T ss_pred --------------------ccC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCc
Confidence 222 257889999999999999999999987553
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.86 E-value=5.3e-23 Score=150.58 Aligned_cols=120 Identities=13% Similarity=0.215 Sum_probs=100.7
Q ss_pred CceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeeec
Q 044494 3 RKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADFG 82 (144)
Q Consensus 3 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~~ 82 (144)
.+..|+||||+++++|.+++.. ...++.|++.+++||| +++++||||||+||+++. .++|+|||
T Consensus 411 ~~~~~lVmE~~~ggsL~~~l~~-----------~~~i~~qi~~aL~~LH---~~gIiHrDiKp~NILl~~--~~kL~DFG 474 (540)
T 3en9_A 411 LDNKRIMMSYINGKLAKDVIED-----------NLDIAYKIGEIVGKLH---KNDVIHNDLTTSNFIFDK--DLYIIDFG 474 (540)
T ss_dssp TTTTEEEEECCCSEEHHHHSTT-----------CTHHHHHHHHHHHHHH---HTTEECTTCCTTSEEESS--SEEECCCT
T ss_pred CCccEEEEECCCCCCHHHHHHH-----------HHHHHHHHHHHHHHHH---HCcCccCCCCHHHEEECC--eEEEEECc
Confidence 4566999999999999999875 3578999999999999 899999999999999999 99999999
Q ss_pred ceeecccCCCC-------cccccccccccCcccccc--CCCCCcchhHHHHHHHHHHHhCCCCCC
Q 044494 83 VARLLNFDSSN-------RTLLAGTYGYIAPELAYT--MVVTEKSDVYSFGVVALEVLMGKHPGE 138 (144)
Q Consensus 83 ~~~~~~~~~~~-------~~~~~~~~~~~~pe~~~~--~~~~~~~d~~slg~~l~~~~~g~~p~~ 138 (144)
+++........ .....||+.|+|||++.. ..|+...|.|+...-..+-+.++.+|.
T Consensus 475 la~~~~~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY~ 539 (540)
T 3en9_A 475 LGKISNLDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARYV 539 (540)
T ss_dssp TCEECCCHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred cCEECCCccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence 99876532111 134678999999999987 567777899999998888888777764
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.70 E-value=2.9e-18 Score=116.43 Aligned_cols=70 Identities=19% Similarity=0.312 Sum_probs=60.4
Q ss_pred ceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeeecc
Q 044494 4 KCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADFGV 83 (144)
Q Consensus 4 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~~~ 83 (144)
+..|+||||++|++|.+ +.. .....++.|++.++.+|| +.|++||||||.||+++ ++.++|+|||+
T Consensus 173 ~~~~lvmE~~~g~~L~~-l~~---------~~~~~i~~qi~~~l~~lH---~~giiHrDlkp~NILl~-~~~vkl~DFG~ 238 (282)
T 1zar_A 173 EGNAVLMELIDAKELYR-VRV---------ENPDEVLDMILEEVAKFY---HRGIVHGDLSQYNVLVS-EEGIWIIDFPQ 238 (282)
T ss_dssp ETTEEEEECCCCEEGGG-CCC---------SCHHHHHHHHHHHHHHHH---HTTEECSCCSTTSEEEE-TTEEEECCCTT
T ss_pred cceEEEEEecCCCcHHH-cch---------hhHHHHHHHHHHHHHHHH---HCCCEeCCCCHHHEEEE-CCcEEEEECCC
Confidence 45699999999999988 431 123468999999999999 89999999999999999 99999999999
Q ss_pred eeec
Q 044494 84 ARLL 87 (144)
Q Consensus 84 ~~~~ 87 (144)
+...
T Consensus 239 a~~~ 242 (282)
T 1zar_A 239 SVEV 242 (282)
T ss_dssp CEET
T ss_pred CeEC
Confidence 8743
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.45 E-value=1.3e-13 Score=92.44 Aligned_cols=74 Identities=23% Similarity=0.289 Sum_probs=58.2
Q ss_pred eEEEEEeeccC-C----CHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEe
Q 044494 5 CMFLIYEYMEM-G----SLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVA 79 (144)
Q Consensus 5 ~~~lv~e~~~~-~----~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~ 79 (144)
..++||||+.+ | +|.+.... .++..+..++.|++.++.+||. +.|++|+|+||.||+++. .++++
T Consensus 142 ~~~lVmE~~g~~g~~~~~L~~~~~~------~~~~~~~~i~~qi~~~l~~lH~--~~givHrDlkp~NILl~~--~~~li 211 (258)
T 1zth_A 142 KNVLLMEFIGEDELPAPTLVELGRE------LKELDVEGIFNDVVENVKRLYQ--EAELVHADLSEYNIMYID--KVYFI 211 (258)
T ss_dssp TTEEEEECCEETTEECCBHHHHGGG------GGGSCHHHHHHHHHHHHHHHHH--TSCEECSSCSTTSEEESS--SEEEC
T ss_pred CCEEEEEecCCCCCccccHHHHhhc------cChHHHHHHHHHHHHHHHHHHH--HCCEEeCCCCHHHEEEcC--cEEEE
Confidence 45799999942 3 66655432 2234567889999999999994 468999999999999998 89999
Q ss_pred eecceeecc
Q 044494 80 DFGVARLLN 88 (144)
Q Consensus 80 d~~~~~~~~ 88 (144)
|||++....
T Consensus 212 DFG~a~~~~ 220 (258)
T 1zth_A 212 DMGQAVTLR 220 (258)
T ss_dssp CCTTCEETT
T ss_pred ECcccccCC
Confidence 999997643
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.26 E-value=4.8e-12 Score=89.10 Aligned_cols=70 Identities=13% Similarity=0.191 Sum_probs=56.3
Q ss_pred EEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCC----------
Q 044494 6 MFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELE---------- 75 (144)
Q Consensus 6 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~---------- 75 (144)
.++||||+.|++|.++.. .+ ....+..|++.++.+|| +.|++|||+||.||+++.++.
T Consensus 186 ~~LVME~i~G~~L~~l~~-------~~--~~~~l~~qll~~l~~lH---~~gIVHrDLKp~NILl~~dgd~~d~~~~~~~ 253 (397)
T 4gyi_A 186 HTIVMSLVDALPMRQVSS-------VP--DPASLYADLIALILRLA---KHGLIHGDFNEFNILIREEKDAEDPSSITLT 253 (397)
T ss_dssp TEEEEECCSCEEGGGCCC-------CS--CHHHHHHHHHHHHHHHH---HTTEECSCCSTTSEEEEEEECSSCTTSEEEE
T ss_pred ceEEEEecCCccHhhhcc-------cH--HHHHHHHHHHHHHHHHH---HCCCcCCCCCHHHEEEeCCCCcccccccccc
Confidence 369999999888865432 11 23457889999999999 889999999999999988763
Q ss_pred eEEeeecceeec
Q 044494 76 AFVADFGVARLL 87 (144)
Q Consensus 76 ~~l~d~~~~~~~ 87 (144)
+.++||+-+...
T Consensus 254 ~~iID~~Q~V~~ 265 (397)
T 4gyi_A 254 PIIIXFPQMVSM 265 (397)
T ss_dssp EEECCCTTCEET
T ss_pred eEEEEeCCcccC
Confidence 789999977654
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=98.68 E-value=2.9e-08 Score=66.15 Aligned_cols=76 Identities=13% Similarity=0.018 Sum_probs=55.7
Q ss_pred CceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCC----------------------------
Q 044494 3 RKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDC---------------------------- 54 (144)
Q Consensus 3 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---------------------------- 54 (144)
.+..|+||||++|.+|.+.+.. ......++.++..++..||...
T Consensus 82 ~~~~~lv~e~i~G~~l~~~~~~--------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 153 (263)
T 3tm0_A 82 DGWSNLLMSEADGVLCSEEYED--------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADV 153 (263)
T ss_dssp TTEEEEEEECCSSEEHHHHCCT--------TTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCC
T ss_pred CCceEEEEEecCCeehhhccCC--------cccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhcccccc
Confidence 3567999999999998765321 1112356778888888998510
Q ss_pred ----------------------------CCCeEecCCCCCcEEEcCCCCeEEeeecceee
Q 044494 55 ----------------------------TPPIVHRDISSNNILLNLELEAFVADFGVARL 86 (144)
Q Consensus 55 ----------------------------~~~~~h~~i~~~ni~~~~~~~~~l~d~~~~~~ 86 (144)
...++|+|++|.||+++.+..+.++||+.+..
T Consensus 154 ~~~~~~~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T 3tm0_A 154 DCENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp SGGGGSTTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCEE
T ss_pred ccccccccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhccc
Confidence 14599999999999998765567999987754
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=98.56 E-value=1.2e-07 Score=62.88 Aligned_cols=29 Identities=21% Similarity=0.183 Sum_probs=25.3
Q ss_pred eEecCCCCCcEEEcCCCCeEEeeecceee
Q 044494 58 IVHRDISSNNILLNLELEAFVADFGVARL 86 (144)
Q Consensus 58 ~~h~~i~~~ni~~~~~~~~~l~d~~~~~~ 86 (144)
++|+|++|.||+++.+..+.++||+.+..
T Consensus 186 l~HgDl~~~Nil~~~~~~~~liD~~~a~~ 214 (264)
T 1nd4_A 186 VTHGDACLPNIMVENGRFSGFIDCGRLGV 214 (264)
T ss_dssp EECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred EECCCCCCCcEEEECCcEEEEEcchhccc
Confidence 99999999999998776667999998764
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=98.55 E-value=1.6e-07 Score=65.40 Aligned_cols=78 Identities=23% Similarity=0.297 Sum_probs=59.9
Q ss_pred ceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCC-----------------------------
Q 044494 4 KCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDC----------------------------- 54 (144)
Q Consensus 4 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~----------------------------- 54 (144)
+..|+||||++|..+.+.. ...++......+..++...+..||...
T Consensus 114 g~~~~vme~v~G~~l~~~~-----~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 188 (359)
T 3dxp_A 114 GRAFYIMEFVSGRVLWDQS-----LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKL 188 (359)
T ss_dssp SSCEEEEECCCCBCCCCTT-----CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHH
T ss_pred CCeEEEEEecCCeecCCCc-----cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHh
Confidence 3478999999987774311 122677777888899999999999521
Q ss_pred --------------------------CCCeEecCCCCCcEEEcCCCC--eEEeeecceee
Q 044494 55 --------------------------TPPIVHRDISSNNILLNLELE--AFVADFGVARL 86 (144)
Q Consensus 55 --------------------------~~~~~h~~i~~~ni~~~~~~~--~~l~d~~~~~~ 86 (144)
...++|+|+++.||+++.++. +.++||+.+..
T Consensus 189 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 189 SETESIPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp HCCSCCHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred cCCcCChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 257999999999999997753 58999998864
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.47 E-value=4.9e-08 Score=66.58 Aligned_cols=126 Identities=22% Similarity=0.178 Sum_probs=74.4
Q ss_pred EEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcC--------------------------------
Q 044494 6 MFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHD-------------------------------- 53 (144)
Q Consensus 6 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~-------------------------------- 53 (144)
.|+|||+++|.++.+... ..++.++...++.++...+..||..
T Consensus 91 ~~~vm~~i~G~~l~~~~~-----~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (304)
T 3sg8_A 91 SFAGFTKIKGVPLTPLLL-----NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSREL 165 (304)
T ss_dssp SCEEEECCCCEECCHHHH-----HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTS
T ss_pred ceEEEcccCCeECCcccc-----ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccC
Confidence 478999999987764322 1145555566666666666666631
Q ss_pred -----------------------CCCCeEecCCCCCcEEEcC--CCCeEEeeecceeecccCCCCcccccccccccCccc
Q 044494 54 -----------------------CTPPIVHRDISSNNILLNL--ELEAFVADFGVARLLNFDSSNRTLLAGTYGYIAPEL 108 (144)
Q Consensus 54 -----------------------~~~~~~h~~i~~~ni~~~~--~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~ 108 (144)
....++|+|++|.|++++. ...+.++||+.+....... ..........-..++.
T Consensus 166 ~~~~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~-Dl~~~~~~~~~~~~~~ 244 (304)
T 3sg8_A 166 KGPQMKKVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDN-DFISLMEDDEEYGMEF 244 (304)
T ss_dssp CHHHHHHHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTH-HHHTTCCTTTSCCHHH
T ss_pred CcccHHHHHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHH-HHHHHHhhccccCHHH
Confidence 0135899999999999998 4557899999876533110 0000000000011111
Q ss_pred ----cccCCC----------CCcchhHHHHHHHHHHHhCCCCC
Q 044494 109 ----AYTMVV----------TEKSDVYSFGVVALEVLMGKHPG 137 (144)
Q Consensus 109 ----~~~~~~----------~~~~d~~slg~~l~~~~~g~~p~ 137 (144)
+..... ....+.|+++.+++.+.+|..+|
T Consensus 245 ~~~~l~~Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 245 VSKILNHYKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp HHHHHHHHTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred HHHHHHHcCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHH
Confidence 111100 11257899999999999998765
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=97.87 E-value=2.6e-05 Score=52.01 Aligned_cols=30 Identities=20% Similarity=0.267 Sum_probs=25.9
Q ss_pred CeEecCCCCCcEEEcCCCCeEEeeecceee
Q 044494 57 PIVHRDISSNNILLNLELEAFVADFGVARL 86 (144)
Q Consensus 57 ~~~h~~i~~~ni~~~~~~~~~l~d~~~~~~ 86 (144)
.++|+|+.+.|++++.++.+.|+||+.+..
T Consensus 194 ~l~HGDl~~~Nil~~~~~~~~viDwe~a~~ 223 (272)
T 4gkh_A 194 VVTHGDFSLDNLIFDEGKLIGCIDVGRVGI 223 (272)
T ss_dssp EEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred EEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence 489999999999999877677999987764
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=97.70 E-value=0.00011 Score=50.06 Aligned_cols=33 Identities=36% Similarity=0.594 Sum_probs=26.7
Q ss_pred CCCeEecCCCCCcEEEcC---CCCe-EEeeecceeec
Q 044494 55 TPPIVHRDISSNNILLNL---ELEA-FVADFGVARLL 87 (144)
Q Consensus 55 ~~~~~h~~i~~~ni~~~~---~~~~-~l~d~~~~~~~ 87 (144)
...++|+|+++.|++++. ++.+ .|+||+.+...
T Consensus 189 ~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~g 225 (306)
T 3tdw_A 189 TPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAIS 225 (306)
T ss_dssp CCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEEE
T ss_pred CCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCCC
Confidence 457899999999999987 4554 79999877653
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=97.36 E-value=0.0017 Score=42.26 Aligned_cols=98 Identities=19% Similarity=0.125 Sum_probs=61.1
Q ss_pred CHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeeecceeecccCCCCccc
Q 044494 17 SLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADFGVARLLNFDSSNRTL 96 (144)
Q Consensus 17 ~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~ 96 (144)
+|.+.|+..+ .+++++++|.++.|.+..++-+-. +..-..+-+.|..+++..+|.|.+.+-. ..
T Consensus 34 SL~eIL~~~~--~PlsEEqaWALc~Qc~~~L~~~~~--~~~~~~~i~~~~~i~l~~dG~V~f~~~~-s~----------- 97 (229)
T 2yle_A 34 SLEEILRLYN--QPINEEQAWAVCYQCCGSLRAAAR--RRQPRHRVRSAAQIRVWRDGAVTLAPAA-DD----------- 97 (229)
T ss_dssp EHHHHHHHHT--SCCCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCCSGGGEEEETTSCEEECCC---------------
T ss_pred cHHHHHHHcC--CCcCHHHHHHHHHHHHHHHHhhhh--cccCCceecCCcceEEecCCceeccccc-cc-----------
Confidence 6888887533 239999999999999999887621 1111234445688888888887776411 10
Q ss_pred ccccccccCccccccCCCCCcchhHHHHHHHHHHHh
Q 044494 97 LAGTYGYIAPELAYTMVVTEKSDVYSFGVVALEVLM 132 (144)
Q Consensus 97 ~~~~~~~~~pe~~~~~~~~~~~d~~slg~~l~~~~~ 132 (144)
.....+.+||... ...+.+.-|||||+++|..+-
T Consensus 98 -~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALD 131 (229)
T 2yle_A 98 -AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALD 131 (229)
T ss_dssp ----------CCSS-SSSCHHHHHHHHHHHHHHHHT
T ss_pred -ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhh
Confidence 0112345777663 334567789999999998775
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=97.33 E-value=0.00044 Score=47.92 Aligned_cols=32 Identities=22% Similarity=0.266 Sum_probs=26.2
Q ss_pred CCCeEecCCCCCcEEEcCCCCeEEeeecceee
Q 044494 55 TPPIVHRDISSNNILLNLELEAFVADFGVARL 86 (144)
Q Consensus 55 ~~~~~h~~i~~~ni~~~~~~~~~l~d~~~~~~ 86 (144)
...++|+|+.+.||+++.+..+.|+||+.+..
T Consensus 221 ~~~l~HgDl~~~Nil~~~~~~~~vIDwe~a~~ 252 (357)
T 3ats_A 221 EPVLLWGDARVGNVLYRDFQPVAVLDWEMVAL 252 (357)
T ss_dssp CCEEECSSCSGGGEEEETTEEEEECCGGGCEE
T ss_pred CceEEeCCCCCCeEEEeCCcEEEEEccccccc
Confidence 45799999999999999544468999987764
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=96.81 E-value=0.0025 Score=43.60 Aligned_cols=32 Identities=25% Similarity=0.496 Sum_probs=28.4
Q ss_pred CCCeEecCCCCCcEEEcCCCCeEEeeecceee
Q 044494 55 TPPIVHRDISSNNILLNLELEAFVADFGVARL 86 (144)
Q Consensus 55 ~~~~~h~~i~~~ni~~~~~~~~~l~d~~~~~~ 86 (144)
..+++|+|+++.|++++.++.+.++||+.+..
T Consensus 221 ~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~~ 252 (346)
T 2q83_A 221 SPNLCHQDYGTGNTLLGENEQIWVIDLDTVSF 252 (346)
T ss_dssp SCCEECSSCSTTSEEECGGGCEEECCCTTCEE
T ss_pred cCceecCCCCcccEEEeCCCcEEEEehhhccc
Confidence 57899999999999998788899999997753
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=96.26 E-value=0.007 Score=42.96 Aligned_cols=31 Identities=13% Similarity=0.298 Sum_probs=27.7
Q ss_pred CCCeEecCCCCCcEEEcCCCCeEEeeecceee
Q 044494 55 TPPIVHRDISSNNILLNLELEAFVADFGVARL 86 (144)
Q Consensus 55 ~~~~~h~~i~~~ni~~~~~~~~~l~d~~~~~~ 86 (144)
...++|+|+++.||+++.++ +.++||+.+..
T Consensus 231 ~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~ 261 (420)
T 2pyw_A 231 AQALIHGDLHTGSVMVTQDS-TQVIDPEFSFY 261 (420)
T ss_dssp CCEEECSCCSGGGEEECSSC-EEECCCTTCEE
T ss_pred CCeEEecCCCCCcEEEeCCC-CEEEeCccccc
Confidence 67899999999999998776 99999987764
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=95.17 E-value=0.043 Score=37.49 Aligned_cols=33 Identities=36% Similarity=0.361 Sum_probs=28.0
Q ss_pred CCCeEecCCCCCcEEEcCC----CCeEEeeecceeec
Q 044494 55 TPPIVHRDISSNNILLNLE----LEAFVADFGVARLL 87 (144)
Q Consensus 55 ~~~~~h~~i~~~ni~~~~~----~~~~l~d~~~~~~~ 87 (144)
...++|+|+.+.|++++.+ +.+.++||+.+..-
T Consensus 182 ~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G 218 (333)
T 3csv_A 182 DMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG 218 (333)
T ss_dssp CCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred CCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence 5689999999999999874 67899999887653
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=94.95 E-value=0.009 Score=40.61 Aligned_cols=32 Identities=19% Similarity=0.210 Sum_probs=26.7
Q ss_pred CCCeEecCCCCCcEEEcCCCCeEEeeecceee
Q 044494 55 TPPIVHRDISSNNILLNLELEAFVADFGVARL 86 (144)
Q Consensus 55 ~~~~~h~~i~~~ni~~~~~~~~~l~d~~~~~~ 86 (144)
..+++|+|+.+.|++++.+..+.++||+.+..
T Consensus 186 ~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~~ 217 (322)
T 2ppq_A 186 PAGVIHADLFQDNVFFLGDELSGLIDFYFACN 217 (322)
T ss_dssp CEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred CcccCCCCCCccCEEEeCCceEEEecchhccC
Confidence 35799999999999998876567999987754
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=94.94 E-value=0.044 Score=37.30 Aligned_cols=30 Identities=30% Similarity=0.347 Sum_probs=25.6
Q ss_pred CCCeEecCCCCCcEEEcCCCCeEEeeecceee
Q 044494 55 TPPIVHRDISSNNILLNLELEAFVADFGVARL 86 (144)
Q Consensus 55 ~~~~~h~~i~~~ni~~~~~~~~~l~d~~~~~~ 86 (144)
...++|+|+++.||+++ + .+.++||+.+..
T Consensus 194 ~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~ 223 (328)
T 1zyl_A 194 TVLRLHGDCHAGNILWR-D-GPMFVDLDDARN 223 (328)
T ss_dssp CCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred CeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence 46789999999999998 4 789999987654
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=94.66 E-value=0.073 Score=35.86 Aligned_cols=31 Identities=16% Similarity=0.260 Sum_probs=26.1
Q ss_pred CCCeEecCCCCCcEEEcCCCCeEEeeecceee
Q 044494 55 TPPIVHRDISSNNILLNLELEAFVADFGVARL 86 (144)
Q Consensus 55 ~~~~~h~~i~~~ni~~~~~~~~~l~d~~~~~~ 86 (144)
...++|+|+.+.|++ ..++.+.++||..+..
T Consensus 172 ~~~l~HgDl~~~Nil-~~~~~~~lID~e~a~~ 202 (301)
T 3dxq_A 172 PLAACHCDPLCENFL-DTGERMWIVDWEYSGM 202 (301)
T ss_dssp CCEEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred CceeeccCCCcCCEE-ECCCCEEEEecccccC
Confidence 456999999999999 5667789999987764
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=93.74 E-value=0.086 Score=38.08 Aligned_cols=17 Identities=29% Similarity=0.372 Sum_probs=15.3
Q ss_pred CCCeEecCCCCCcEEEc
Q 044494 55 TPPIVHRDISSNNILLN 71 (144)
Q Consensus 55 ~~~~~h~~i~~~ni~~~ 71 (144)
...++|+|+.+.||+++
T Consensus 289 ~~v~cHnDl~~gNIL~~ 305 (458)
T 2qg7_A 289 PIVLCHCDLLSSNIINT 305 (458)
T ss_dssp CEEEECSCCCGGGEEEC
T ss_pred CeeEEecCCCCCcEEee
Confidence 34799999999999998
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=93.61 E-value=0.033 Score=38.70 Aligned_cols=31 Identities=26% Similarity=0.328 Sum_probs=25.1
Q ss_pred CCCeEecCCCCCcEEEcCCCCeEEeeecceee
Q 044494 55 TPPIVHRDISSNNILLNLELEAFVADFGVARL 86 (144)
Q Consensus 55 ~~~~~h~~i~~~ni~~~~~~~~~l~d~~~~~~ 86 (144)
...++|+|+.+.||+++.+. +.++||..+..
T Consensus 211 ~~~l~HgDl~~~Nil~~~~~-~~lID~e~a~~ 241 (369)
T 3c5i_A 211 TIVFCHNDLQENNIINTNKC-LRLIDFEYSGF 241 (369)
T ss_dssp CEEEECSCCCGGGEEECC-C-EEECCCTTCEE
T ss_pred CeEEEeCCCCcccEEecCCc-EEEEEecCCCC
Confidence 35799999999999997654 89999987753
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=93.08 E-value=0.044 Score=37.79 Aligned_cols=33 Identities=24% Similarity=0.399 Sum_probs=28.2
Q ss_pred CCCeEecCCCCCcEEEcCCCCeEEeeecceeec
Q 044494 55 TPPIVHRDISSNNILLNLELEAFVADFGVARLL 87 (144)
Q Consensus 55 ~~~~~h~~i~~~ni~~~~~~~~~l~d~~~~~~~ 87 (144)
...++|+|+.+.|++++.++.+.++||+.+...
T Consensus 205 ~~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~~ 237 (339)
T 3i1a_A 205 KYVLCHSDIHAGNVLVGNEESIYIIDWDEPMLA 237 (339)
T ss_dssp GCEEECSCCCGGGEEECGGGCEEECCCSSCEEE
T ss_pred CceeEeCCCCcCCEEEeCCCeEEEEECCCCeeC
Confidence 357999999999999998788999999877643
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=93.01 E-value=0.18 Score=35.32 Aligned_cols=31 Identities=23% Similarity=0.296 Sum_probs=26.2
Q ss_pred CCCeEecCCCCCcEEEcCCCCeEEeeecceee
Q 044494 55 TPPIVHRDISSNNILLNLELEAFVADFGVARL 86 (144)
Q Consensus 55 ~~~~~h~~i~~~ni~~~~~~~~~l~d~~~~~~ 86 (144)
...++|+|+.+.||+++.+ .+.++||..+..
T Consensus 226 ~~~L~HGDl~~~Nil~~~~-~~~lID~e~a~~ 256 (397)
T 2olc_A 226 AETLIHGDLHTGSIFASEH-ETKVIDPEFAFY 256 (397)
T ss_dssp CCEEECSCCSGGGEEECSS-CEEECCCTTCEE
T ss_pred CCceeeCCCCcCcEEEeCC-CeEEEeCccccc
Confidence 5689999999999999875 488999977654
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=92.97 E-value=0.048 Score=38.97 Aligned_cols=32 Identities=28% Similarity=0.384 Sum_probs=25.6
Q ss_pred CCCeEecCCCCCcEEEcCC----------------------------CCeEEeeecceee
Q 044494 55 TPPIVHRDISSNNILLNLE----------------------------LEAFVADFGVARL 86 (144)
Q Consensus 55 ~~~~~h~~i~~~ni~~~~~----------------------------~~~~l~d~~~~~~ 86 (144)
...++|+|+.+.||+++.+ +.+.++||..+..
T Consensus 248 ~~v~~H~Dl~~gNiL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lIDfEya~~ 307 (429)
T 1nw1_A 248 PVTFCHNDLQEGNILLPKASSGNIRMPSLSDETQALGNSLSAFNPADPRLVLIDFEYASY 307 (429)
T ss_dssp CEEEECSCCCGGGEEEEC------------------------------CCEECCCTTCEE
T ss_pred CeEEEeCCCCCCeEEeeCCccccccccccccccccccccccccccCCCeEEEEecccCCc
Confidence 3469999999999999875 6789999987764
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=92.66 E-value=0.079 Score=37.31 Aligned_cols=32 Identities=31% Similarity=0.385 Sum_probs=27.5
Q ss_pred CCCeEecCCCCCcEEEcCC----CCeEEeeecceee
Q 044494 55 TPPIVHRDISSNNILLNLE----LEAFVADFGVARL 86 (144)
Q Consensus 55 ~~~~~h~~i~~~ni~~~~~----~~~~l~d~~~~~~ 86 (144)
...++|+|+.+.||+++.+ +.+.++||..+..
T Consensus 219 ~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 219 PVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY 254 (379)
T ss_dssp CEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred CcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence 3479999999999999876 6889999987764
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=91.77 E-value=0.11 Score=36.59 Aligned_cols=31 Identities=26% Similarity=0.364 Sum_probs=25.5
Q ss_pred CeEecCCCCCcEEE------cCCCCeEEeeecceeec
Q 044494 57 PIVHRDISSNNILL------NLELEAFVADFGVARLL 87 (144)
Q Consensus 57 ~~~h~~i~~~ni~~------~~~~~~~l~d~~~~~~~ 87 (144)
.++|+|+.+.||++ +.+..+.++||..+..-
T Consensus 245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~n 281 (401)
T 3g15_A 245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSYN 281 (401)
T ss_dssp EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEEE
T ss_pred eeEEecCCCCeEEEecCcccCcCCeEEEechHhccCC
Confidence 47899999999999 34567899999888643
|
| >4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid} | Back alignment and structure |
|---|
Probab=89.78 E-value=1.1 Score=29.15 Aligned_cols=50 Identities=16% Similarity=0.240 Sum_probs=38.6
Q ss_pred CCHHHHHHHHHHHHHHHH-HHhcCCCCCeEecCCCCCcEEEcCCCCeEEeeeccee
Q 044494 31 LDWAKRVNIVKGMAHALS-YLHHDCTPPIVHRDISSNNILLNLELEAFVADFGVAR 85 (144)
Q Consensus 31 ~~~~~~~~~~~~l~~~l~-~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~~~~~ 85 (144)
.+....++++..++.... . ...-++.-+.|+|++++.++.+++.-.|+-.
T Consensus 82 ~~~~eKlrll~nl~~L~~~~-----~~~r~tf~l~P~NL~f~~~~~p~i~hRGi~~ 132 (219)
T 4ano_A 82 TTLLSRIRAAIHLVSKVKHH-----SARRLIFIVCPENLMFNRALEPFFLHVGVKE 132 (219)
T ss_dssp SCHHHHHHHHHHHHHHHSSC-----CSSSEECCCCGGGEEECTTCCEEESCCEETT
T ss_pred cCHHHHHHHHHHHHHHHHHh-----hhCceeEEEeCceEEEeCCCcEEEEEcCCcc
Confidence 677778877777766544 2 3356889999999999999999999777543
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=89.37 E-value=0.22 Score=35.65 Aligned_cols=32 Identities=19% Similarity=0.325 Sum_probs=27.0
Q ss_pred CCCeEecCCCCCcEEEcCCCCeEEeeecceeec
Q 044494 55 TPPIVHRDISSNNILLNLELEAFVADFGVARLL 87 (144)
Q Consensus 55 ~~~~~h~~i~~~ni~~~~~~~~~l~d~~~~~~~ 87 (144)
...++|+|+.+.|++ +.++.+.++||..+...
T Consensus 261 ~~~~~H~D~~~~N~l-~~~~~~~~IDwe~a~~~ 292 (424)
T 3mes_A 261 SLVFAHNDLQENNLL-QTQNNIRMIDYEYSAIN 292 (424)
T ss_dssp CEEEECSCCCGGGEE-ECSSCEEECCCTTCEEE
T ss_pred CceEECCCCCcccee-cCCCcEEEEecccCCcC
Confidence 347899999999999 77788999999887643
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=83.03 E-value=2.2 Score=27.61 Aligned_cols=49 Identities=2% Similarity=0.028 Sum_probs=39.4
Q ss_pred CCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeeecce
Q 044494 31 LDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADFGVA 84 (144)
Q Consensus 31 ~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~~~~ 84 (144)
.+....++++..++.....++ .-+|--+.|+|++++.++.+++.-.|+.
T Consensus 78 ~~~~eKlr~l~ni~~l~~~~~-----~r~tf~L~P~NL~f~~~~~p~i~~RGik 126 (215)
T 4ann_A 78 FTKNEKLRYLLNIKNLEEVNR-----TRYTFVLAPDELFFTRDGLPIAKTRGLQ 126 (215)
T ss_dssp SCHHHHHHHHHHGGGGGGGGG-----SSEECCCSGGGEEECTTSCEEESCCEET
T ss_pred cCHHHHHHHHHHHHHHHHHhc-----CceEEEEecceEEEcCCCCEEEEEccCc
Confidence 778888888888877664444 3588899999999999999999876643
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=82.19 E-value=0.58 Score=31.96 Aligned_cols=27 Identities=22% Similarity=0.335 Sum_probs=23.6
Q ss_pred CCCeEecCCCCCcEEEcCCCCeEEeeec
Q 044494 55 TPPIVHRDISSNNILLNLELEAFVADFG 82 (144)
Q Consensus 55 ~~~~~h~~i~~~ni~~~~~~~~~l~d~~ 82 (144)
...++|+|+.+.|++++.++ +.++|+.
T Consensus 206 ~~~l~HgD~~~~N~l~~~~~-~~~iD~~ 232 (312)
T 3jr1_A 206 KPSILHGNLWIENCIQVDDK-IFVCNPA 232 (312)
T ss_dssp CCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred CceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence 45799999999999999887 8899974
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 144 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 5e-37 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 4e-36 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 5e-36 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 1e-32 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 2e-32 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 5e-31 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 4e-30 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 1e-29 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 3e-29 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 2e-28 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 3e-28 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 3e-28 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 3e-28 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 3e-28 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 8e-28 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 1e-27 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 1e-27 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 4e-27 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 5e-27 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 6e-27 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 1e-26 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 2e-26 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 2e-26 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 2e-26 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 3e-26 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 6e-26 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 1e-25 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 3e-25 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 5e-25 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 2e-24 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 2e-24 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 2e-24 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 3e-24 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 4e-24 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 1e-23 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 2e-23 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 2e-23 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 3e-23 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 8e-23 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 8e-23 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 1e-22 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 1e-21 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 1e-21 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 3e-21 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 4e-21 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 5e-21 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 5e-21 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 1e-20 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 2e-20 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 3e-20 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 4e-20 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 4e-20 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 1e-18 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 2e-18 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 3e-18 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 4e-18 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 3e-17 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 1e-16 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 3e-15 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 3e-14 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 6e-14 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 7e-12 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 5e-06 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 125 bits (315), Expect = 5e-37
Identities = 41/138 (29%), Positives = 73/138 (52%), Gaps = 10/138 (7%)
Query: 4 KCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDI 63
+ ++ ++ E SL+ L E + K ++I + A + YLH I+HRD+
Sbjct: 76 PQLAIVTQWCEGSSLYHHLHIIETK--FEMIKLIDIARQTAQGMDYLHA---KSIIHRDL 130
Query: 64 SSNNILLNLELEAFVADFGVARLLNFDSSNRTL--LAGTYGYIAPELAYTM---VVTEKS 118
SNNI L+ +L + DFG+A + + S + L+G+ ++APE+ + +S
Sbjct: 131 KSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQS 190
Query: 119 DVYSFGVVALEVLMGKHP 136
DVY+FG+V E++ G+ P
Sbjct: 191 DVYAFGIVLYELMTGQLP 208
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 124 bits (312), Expect = 4e-36
Identities = 38/135 (28%), Positives = 66/135 (48%), Gaps = 7/135 (5%)
Query: 2 HRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHR 61
+ + E+M+ GSL VL+ +A + + + L+YL I+HR
Sbjct: 75 SDGEISICMEHMDGGSLDQVLK---KAGRIPEQILGKVSIAVIKGLTYLREKH--KIMHR 129
Query: 62 DISSNNILLNLELEAFVADFGVARLLNFDSSNRTLLAGTYGYIAPELAYTMVVTEKSDVY 121
D+ +NIL+N E + DFGV+ L S GT Y++PE + +SD++
Sbjct: 130 DVKPSNILVNSRGEIKLCDFGVSGQL--IDSMANSFVGTRSYMSPERLQGTHYSVQSDIW 187
Query: 122 SFGVVALEVLMGKHP 136
S G+ +E+ +G++P
Sbjct: 188 SMGLSLVEMAVGRYP 202
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 122 bits (308), Expect = 5e-36
Identities = 40/136 (29%), Positives = 66/136 (48%), Gaps = 3/136 (2%)
Query: 4 KCMFLIYEYMEMGSLFCVLRTDEEAVG-LDWAKRVNIVKGMAHALSYLH--HDCTPPIVH 60
++++ EY E G L V+ + LD + ++ + AL H D ++H
Sbjct: 78 TTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLH 137
Query: 61 RDISSNNILLNLELEAFVADFGVARLLNFDSSNRTLLAGTYGYIAPELAYTMVVTEKSDV 120
RD+ N+ L+ + + DFG+AR+LN D+S GT Y++PE M EKSD+
Sbjct: 138 RDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFVGTPYYMSPEQMNRMSYNEKSDI 197
Query: 121 YSFGVVALEVLMGKHP 136
+S G + E+ P
Sbjct: 198 WSLGCLLYELCALMPP 213
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 113 bits (285), Expect = 1e-32
Identities = 39/136 (28%), Positives = 66/136 (48%), Gaps = 8/136 (5%)
Query: 2 HRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHR 61
+KC+ L+ E M G+L L+ + + + + + L +LH PPI+HR
Sbjct: 83 GKKCIVLVTELMTSGTLKTYLKRFKV---MKIKVLRSWCRQILKGLQFLHTRT-PPIIHR 138
Query: 62 DISSNNILLNLEL-EAFVADFGVARLLNFDSSNRTLLAGTYGYIAPELAYTMVVTEKSDV 120
D+ +NI + + D G+A L +S + GT ++APE+ Y E DV
Sbjct: 139 DLKCDNIFITGPTGSVKIGDLGLATLK--RASFAKAVIGTPEFMAPEM-YEEKYDESVDV 195
Query: 121 YSFGVVALEVLMGKHP 136
Y+FG+ LE+ ++P
Sbjct: 196 YAFGMCMLEMATSEYP 211
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 113 bits (283), Expect = 2e-32
Identities = 46/135 (34%), Positives = 69/135 (51%), Gaps = 8/135 (5%)
Query: 2 HRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHR 61
++LI EY +G+++ L+ D + + +A+ALSY H ++HR
Sbjct: 77 DATRVYLILEYAPLGTVYRELQKLS---KFDEQRTATYITELANALSYCHS---KRVIHR 130
Query: 62 DISSNNILLNLELEAFVADFGVARLLNFDSSNRTLLAGTYGYIAPELAYTMVVTEKSDVY 121
DI N+LL E +ADFG + SS RT L GT Y+ PE+ + EK D++
Sbjct: 131 DIKPENLLLGSAGELKIADFGWSVHA--PSSRRTTLCGTLDYLPPEMIEGRMHDEKVDLW 188
Query: 122 SFGVVALEVLMGKHP 136
S GV+ E L+GK P
Sbjct: 189 SLGVLCYEFLVGKPP 203
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 109 bits (274), Expect = 5e-31
Identities = 39/136 (28%), Positives = 69/136 (50%), Gaps = 5/136 (3%)
Query: 2 HRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHR 61
++ +++I EYME GSL L+ + L K +++ +A ++++ +HR
Sbjct: 78 TQEPIYIITEYMENGSLVDFLK-TPSGIKLTINKLLDMAAQIAEGMAFIEERN---YIHR 133
Query: 62 DISSNNILLNLELEAFVADFGVARLLNFDSSN-RTLLAGTYGYIAPELAYTMVVTEKSDV 120
D+ + NIL++ L +ADFG+ARL+ + R + APE T KSDV
Sbjct: 134 DLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDV 193
Query: 121 YSFGVVALEVLMGKHP 136
+SFG++ E++
Sbjct: 194 WSFGILLTEIVTHGRI 209
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 108 bits (270), Expect = 4e-30
Identities = 37/140 (26%), Positives = 66/140 (47%), Gaps = 10/140 (7%)
Query: 2 HRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHR 61
+ ++++ E+ G++ V+ E L ++ + K AL+YLH I+HR
Sbjct: 80 YENNLWILIEFCAGGAVDAVMLELER--PLTESQIQVVCKQTLDALNYLHD---NKIIHR 134
Query: 62 DISSNNILLNLELEAFVADFGVARLLNFDSSNRTLLAGTYGYIAPELAYTMV-----VTE 116
D+ + NIL L+ + +ADFGV+ R GT ++APE+
Sbjct: 135 DLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDY 194
Query: 117 KSDVYSFGVVALEVLMGKHP 136
K+DV+S G+ +E+ + P
Sbjct: 195 KADVWSLGITLIEMAEIEPP 214
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 106 bits (267), Expect = 1e-29
Identities = 39/136 (28%), Positives = 72/136 (52%), Gaps = 7/136 (5%)
Query: 1 LHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVH 60
L ++++ EY+ GSL V+ +D + + + AL +LH + ++H
Sbjct: 87 LVGDELWVVMEYLAGGSLTDVVTET----CMDEGQIAAVCRECLQALEFLHSNQ---VIH 139
Query: 61 RDISSNNILLNLELEAFVADFGVARLLNFDSSNRTLLAGTYGYIAPELAYTMVVTEKSDV 120
RDI S+NILL ++ + DFG + + S R+ + GT ++APE+ K D+
Sbjct: 140 RDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDI 199
Query: 121 YSFGVVALEVLMGKHP 136
+S G++A+E++ G+ P
Sbjct: 200 WSLGIMAIEMIEGEPP 215
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 105 bits (262), Expect = 3e-29
Identities = 37/135 (27%), Positives = 64/135 (47%), Gaps = 7/135 (5%)
Query: 2 HRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHR 61
+ ++++ EYM GSL LR+ +V L + + A+ YL VHR
Sbjct: 72 EKGGLYIVTEYMAKGSLVDYLRSRGRSV-LGGDCLLKFSLDVCEAMEYLEG---NNFVHR 127
Query: 62 DISSNNILLNLELEAFVADFGVARLLNFDSSNRTLLAGTYGYIAPELAYTMVVTEKSDVY 121
D+++ N+L++ + A V+DFG+ + SS + + APE + KSDV+
Sbjct: 128 DLAARNVLVSEDNVAKVSDFGLTKEA---SSTQDTGKLPVKWTAPEALREKKFSTKSDVW 184
Query: 122 SFGVVALEVLMGKHP 136
SFG++ E+
Sbjct: 185 SFGILLWEIYSFGRV 199
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 103 bits (258), Expect = 2e-28
Identities = 38/158 (24%), Positives = 66/158 (41%), Gaps = 26/158 (16%)
Query: 2 HRKCMFLIYEYMEMGSLFCVLR---------------------TDEEAVGLDWAKRVNIV 40
K M L++EYM G L LR + L A+++ I
Sbjct: 87 VGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIA 146
Query: 41 KGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADFGVARLLNFDSSNR--TLLA 98
+ +A ++YL VHRD+++ N L+ + +ADFG++R + + A
Sbjct: 147 RQVAAGMAYLSE---RKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDA 203
Query: 99 GTYGYIAPELAYTMVVTEKSDVYSFGVVALEVLMGKHP 136
++ PE + T +SDV+++GVV E+
Sbjct: 204 IPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQ 241
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 103 bits (257), Expect = 3e-28
Identities = 42/136 (30%), Positives = 67/136 (49%), Gaps = 5/136 (3%)
Query: 2 HRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHR 61
+ ++++ EYM GSL L+ E L + V++ +A ++Y+ VHR
Sbjct: 82 SEEPIYIVTEYMSKGSLLDFLK-GETGKYLRLPQLVDMAAQIASGMAYVERMN---YVHR 137
Query: 62 DISSNNILLNLELEAFVADFGVARLLNFD-SSNRTLLAGTYGYIAPELAYTMVVTEKSDV 120
D+ + NIL+ L VADFG+ARL+ + + R + APE A T KSDV
Sbjct: 138 DLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 197
Query: 121 YSFGVVALEVLMGKHP 136
+SFG++ E+
Sbjct: 198 WSFGILLTELTTKGRV 213
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 102 bits (256), Expect = 3e-28
Identities = 36/139 (25%), Positives = 62/139 (44%), Gaps = 9/139 (6%)
Query: 2 HRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHR 61
+ + L+ E G L L E + + ++ ++ + YL VHR
Sbjct: 79 QAEALMLVMEMAGGGPLHKFLVGKRE--EIPVSNVAELLHQVSMGMKYLEE---KNFVHR 133
Query: 62 DISSNNILLNLELEAFVADFGVARLLNFDSSN---RTLLAGTYGYIAPELAYTMVVTEKS 118
D+++ N+LL A ++DFG+++ L D S R+ + APE + +S
Sbjct: 134 DLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRS 193
Query: 119 DVYSFGVVALEVL-MGKHP 136
DV+S+GV E L G+ P
Sbjct: 194 DVWSYGVTMWEALSYGQKP 212
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 102 bits (256), Expect = 3e-28
Identities = 41/138 (29%), Positives = 61/138 (44%), Gaps = 9/138 (6%)
Query: 2 HRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHR 61
+L EY G LF + D G+ + + YLH I HR
Sbjct: 74 EGNIQYLFLEYCSGGELFDRIEPDI---GMPEPDAQRFFHQLMAGVVYLHGIG---ITHR 127
Query: 62 DISSNNILLNLELEAFVADFGVARLLNFDSSNRTL--LAGTYGYIAPELAYTM-VVTEKS 118
DI N+LL+ ++DFG+A + +++ R L + GT Y+APEL E
Sbjct: 128 DIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPV 187
Query: 119 DVYSFGVVALEVLMGKHP 136
DV+S G+V +L G+ P
Sbjct: 188 DVWSCGIVLTAMLAGELP 205
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 103 bits (257), Expect = 3e-28
Identities = 37/152 (24%), Positives = 63/152 (41%), Gaps = 19/152 (12%)
Query: 2 HRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDC-----TP 56
++L+ +Y E GSLF L + + + A L++LH + P
Sbjct: 72 TWTQLWLVSDYHEHGSLFDYLNRY----TVTVEGMIKLALSTASGLAHLHMEIVGTQGKP 127
Query: 57 PIVHRDISSNNILLNLELEAFVADFGVARLLNFDSSN----RTLLAGTYGYIAPELAYTM 112
I HRD+ S NIL+ +AD G+A + + GT Y+APE+
Sbjct: 128 AIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDS 187
Query: 113 V------VTEKSDVYSFGVVALEVLMGKHPGE 138
+ +++D+Y+ G+V E+ G
Sbjct: 188 INMKHFESFKRADIYAMGLVFWEIARRCSIGG 219
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 102 bits (255), Expect = 8e-28
Identities = 36/139 (25%), Positives = 60/139 (43%), Gaps = 13/139 (9%)
Query: 1 LHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVH 60
L +L+ EY + + + L + + G L+YLH ++H
Sbjct: 85 LREHTAWLVMEYCLGSASDLLEVHKK---PLQEVEIAAVTHGALQGLAYLHS---HNMIH 138
Query: 61 RDISSNNILLNLELEAFVADFGVARLLNFDSSNRTLLAGTYGYIAPELAYTM---VVTEK 117
RD+ + NILL+ + DFG A ++ +S GT ++APE+ M K
Sbjct: 139 RDVKAGNILLSEPGLVKLGDFGSASIMAPANS----FVGTPYWMAPEVILAMDEGQYDGK 194
Query: 118 SDVYSFGVVALEVLMGKHP 136
DV+S G+ +E+ K P
Sbjct: 195 VDVWSLGITCIELAERKPP 213
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 101 bits (253), Expect = 1e-27
Identities = 36/137 (26%), Positives = 61/137 (44%), Gaps = 8/137 (5%)
Query: 2 HRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHR 61
+ ++ Y + G L +R D + AL YLH I+HR
Sbjct: 79 DDEKLYFGLSYAKNGELLKYIRKIG---SFDETCTRFYTAEIVSALEYLHG---KGIIHR 132
Query: 62 DISSNNILLNLELEAFVADFGVARLLNFDSSNRTL--LAGTYGYIAPELAYTMVVTEKSD 119
D+ NILLN ++ + DFG A++L+ +S GT Y++PEL + SD
Sbjct: 133 DLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSD 192
Query: 120 VYSFGVVALEVLMGKHP 136
+++ G + +++ G P
Sbjct: 193 LWALGCIIYQLVAGLPP 209
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 102 bits (256), Expect = 1e-27
Identities = 36/137 (26%), Positives = 63/137 (45%), Gaps = 8/137 (5%)
Query: 2 HRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHR 61
M +IYE+M G LF + +E + + V ++ + L ++H + VH
Sbjct: 94 DDNEMVMIYEFMSGGELFEKVA--DEHNKMSEDEAVEYMRQVCKGLCHMHENN---YVHL 148
Query: 62 DISSNNILLNLELEAFV--ADFGVARLLNFDSSNRTLLAGTYGYIAPELAYTMVVTEKSD 119
D+ NI+ + + DFG+ L+ S + GT + APE+A V +D
Sbjct: 149 DLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVT-TGTAEFAAPEVAEGKPVGYYTD 207
Query: 120 VYSFGVVALEVLMGKHP 136
++S GV++ +L G P
Sbjct: 208 MWSVGVLSYILLSGLSP 224
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 100 bits (250), Expect = 4e-27
Identities = 36/157 (22%), Positives = 65/157 (41%), Gaps = 25/157 (15%)
Query: 2 HRKCMFLIYEYMEMGSLFCVLRT--------------------DEEAVGLDWAKRVNIVK 41
++LI+EY G L LR+ +E+ L + +
Sbjct: 112 LSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAY 171
Query: 42 GMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADFGVARLLNFDSSNRTL--LAG 99
+A + +L VHRD+++ N+L+ + DFG+AR + DS+
Sbjct: 172 QVAKGMEFLEF---KSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARL 228
Query: 100 TYGYIAPELAYTMVVTEKSDVYSFGVVALEVLMGKHP 136
++APE + + T KSDV+S+G++ E+
Sbjct: 229 PVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVN 265
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 100 bits (251), Expect = 5e-27
Identities = 37/137 (27%), Positives = 61/137 (44%), Gaps = 8/137 (5%)
Query: 2 HRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHR 61
+ M LI E++ G LF + E + A+ +N ++ L ++H IVH
Sbjct: 97 DKYEMVLILEFLSGGELFDRIA--AEDYKMSEAEVINYMRQACEGLKHMHE---HSIVHL 151
Query: 62 DISSNNILLNLELEAFV--ADFGVARLLNFDSSNRTLLAGTYGYIAPELAYTMVVTEKSD 119
DI NI+ + + V DFG+A LN + T + APE+ V +D
Sbjct: 152 DIKPENIMCETKKASSVKIIDFGLATKLN-PDEIVKVTTATAEFAAPEIVDREPVGFYTD 210
Query: 120 VYSFGVVALEVLMGKHP 136
+++ GV+ +L G P
Sbjct: 211 MWAIGVLGYVLLSGLSP 227
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 100 bits (249), Expect = 6e-27
Identities = 36/137 (26%), Positives = 62/137 (45%), Gaps = 8/137 (5%)
Query: 2 HRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHR 61
+ + +I+E++ +F + A L+ + V+ V + AL +LH I H
Sbjct: 72 SMEELVMIFEFISGLDIFERIN--TSAFELNEREIVSYVHQVCEALQFLHS---HNIGHF 126
Query: 62 DISSNNILLNLELEAFV--ADFGVARLLNFDSSNRTLLAGTYGYIAPELAYTMVVTEKSD 119
DI NI+ + + +FG AR L + R L Y APE+ VV+ +D
Sbjct: 127 DIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLL-FTAPEYYAPEVHQHDVVSTATD 185
Query: 120 VYSFGVVALEVLMGKHP 136
++S G + +L G +P
Sbjct: 186 MWSLGTLVYVLLSGINP 202
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 98.6 bits (245), Expect = 1e-26
Identities = 35/138 (25%), Positives = 62/138 (44%), Gaps = 9/138 (6%)
Query: 2 HRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHR 61
+ L+ E E+G L L+ + + + +V ++ + YL VHR
Sbjct: 78 EAESWMLVMEMAELGPLNKYLQQNR---HVKDKNIIELVHQVSMGMKYLEE---SNFVHR 131
Query: 62 DISSNNILLNLELEAFVADFGVARLLNFDSSN---RTLLAGTYGYIAPELAYTMVVTEKS 118
D+++ N+LL + A ++DFG+++ L D + +T + APE + KS
Sbjct: 132 DLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKS 191
Query: 119 DVYSFGVVALEVLMGKHP 136
DV+SFGV+ E
Sbjct: 192 DVWSFGVLMWEAFSYGQK 209
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 98.7 bits (245), Expect = 2e-26
Identities = 38/148 (25%), Positives = 64/148 (43%), Gaps = 17/148 (11%)
Query: 2 HRKCMFLIYEYMEMGSLFCVLR-------------TDEEAVGLDWAKRVNIVKGMAHALS 48
HR ++L EY G+L LR + A L + ++ +A +
Sbjct: 82 HRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMD 141
Query: 49 YLHHDCTPPIVHRDISSNNILLNLELEAFVADFGVARLLNFDSSNRTLLAGTYGYIAPEL 108
YL +HRD+++ NIL+ A +ADFG++R +T+ ++A E
Sbjct: 142 YLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSR-GQEVYVKKTMGRLPVRWMAIES 197
Query: 109 AYTMVVTEKSDVYSFGVVALEVLMGKHP 136
V T SDV+S+GV+ E++
Sbjct: 198 LNYSVYTTNSDVWSYGVLLWEIVSLGGT 225
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 97.8 bits (243), Expect = 2e-26
Identities = 37/137 (27%), Positives = 67/137 (48%), Gaps = 7/137 (5%)
Query: 2 HRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHR 61
++ +F+I EYM G L LR + + + K + A+ YL +HR
Sbjct: 70 KQRPIFIITEYMANGCLLNYLREMRH--RFQTQQLLEMCKDVCEAMEYLES---KQFLHR 124
Query: 62 DISSNNILLNLELEAFVADFGVARLLNFDSSNRTL-LAGTYGYIAPELAYTMVVTEKSDV 120
D+++ N L+N + V+DFG++R + D ++ + PE+ + KSD+
Sbjct: 125 DLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDI 184
Query: 121 YSFGVVALEVL-MGKHP 136
++FGV+ E+ +GK P
Sbjct: 185 WAFGVLMWEIYSLGKMP 201
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 98.3 bits (244), Expect = 2e-26
Identities = 46/141 (32%), Positives = 73/141 (51%), Gaps = 11/141 (7%)
Query: 2 HRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHR 61
+ +I E+ME GSL LR ++ + V +++G+A + YL VHR
Sbjct: 98 KSTPVMIITEFMENGSLDSFLRQNDGQF--TVIQLVGMLRGIAAGMKYLADMN---YVHR 152
Query: 62 DISSNNILLNLELEAFVADFGVARLLNFDSSNRTLLA-----GTYGYIAPELAYTMVVTE 116
D+++ NIL+N L V+DFG++R L D+S+ T + + APE T
Sbjct: 153 DLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTS 212
Query: 117 KSDVYSFGVVALEVLM-GKHP 136
SDV+S+G+V EV+ G+ P
Sbjct: 213 ASDVWSYGIVMWEVMSYGERP 233
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 98.3 bits (244), Expect = 3e-26
Identities = 36/152 (23%), Positives = 64/152 (42%), Gaps = 20/152 (13%)
Query: 2 HRKCMFLIYEYMEMGSLFCVLR---------------TDEEAVGLDWAKRVNIVKGMAHA 46
+I EY G L LR +++ + LD ++ +A
Sbjct: 98 IGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKG 157
Query: 47 LSYLHHDCTPPIVHRDISSNNILLNLELEAFVADFGVARLLNFDSSN--RTLLAGTYGYI 104
+++L +HRD+++ NILL + DFG+AR + DS+ + ++
Sbjct: 158 MAFLAS---KNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWM 214
Query: 105 APELAYTMVVTEKSDVYSFGVVALEVLMGKHP 136
APE + V T +SDV+S+G+ E+
Sbjct: 215 APESIFNCVYTFESDVWSYGIFLWELFSLGSS 246
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 97.5 bits (242), Expect = 6e-26
Identities = 37/135 (27%), Positives = 63/135 (46%), Gaps = 6/135 (4%)
Query: 2 HRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHR 61
++ +F + EY+ G L ++ D ++ + L +LH IV+R
Sbjct: 74 TKENLFFVMEYLNGGDLMYHIQ---SCHKFDLSRATFYAAEIILGLQFLHSKG---IVYR 127
Query: 62 DISSNNILLNLELEAFVADFGVARLLNFDSSNRTLLAGTYGYIAPELAYTMVVTEKSDVY 121
D+ +NILL+ + +ADFG+ + + GT YIAPE+ D +
Sbjct: 128 DLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLGQKYNHSVDWW 187
Query: 122 SFGVVALEVLMGKHP 136
SFGV+ E+L+G+ P
Sbjct: 188 SFGVLLYEMLIGQSP 202
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 95.9 bits (238), Expect = 1e-25
Identities = 32/136 (23%), Positives = 58/136 (42%), Gaps = 6/136 (4%)
Query: 2 HRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHR 61
+ + L++E+ME G L LRT + + + + + ++HR
Sbjct: 71 EQAPICLVFEFMEHGCLSDYLRTQRGLF--AAETLLGMCLDVCEGM---AYLEEACVIHR 125
Query: 62 DISSNNILLNLELEAFVADFGVARLLNFDSSNRTL-LAGTYGYIAPELAYTMVVTEKSDV 120
D+++ N L+ V+DFG+ R + D + + +PE+ + KSDV
Sbjct: 126 DLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDV 185
Query: 121 YSFGVVALEVLMGKHP 136
+SFGV+ EV
Sbjct: 186 WSFGVLMWEVFSEGKI 201
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 95.6 bits (237), Expect = 3e-25
Identities = 34/139 (24%), Positives = 58/139 (41%), Gaps = 9/139 (6%)
Query: 2 HRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHR 61
++ YM+ G L +R + + + + + VHR
Sbjct: 100 SEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKG-----MKFLASKKFVHR 154
Query: 62 DISSNNILLNLELEAFVADFGVARLLNFDS----SNRTLLAGTYGYIAPELAYTMVVTEK 117
D+++ N +L+ + VADFG+AR + N+T ++A E T T K
Sbjct: 155 DLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTK 214
Query: 118 SDVYSFGVVALEVLMGKHP 136
SDV+SFGV+ E++ P
Sbjct: 215 SDVWSFGVLLWELMTRGAP 233
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 94.4 bits (234), Expect = 5e-25
Identities = 34/136 (25%), Positives = 60/136 (44%), Gaps = 5/136 (3%)
Query: 2 HRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHR 61
++I E+M G+L LR + + + + ++ A+ YL +HR
Sbjct: 84 REPPFYIITEFMTYGNLLDYLR-ECNRQEVSAVVLLYMATQISSAMEYLEK---KNFIHR 139
Query: 62 DISSNNILLNLELEAFVADFGVARLLNFDSSNR-TLLAGTYGYIAPELAYTMVVTEKSDV 120
D+++ N L+ VADFG++RL+ D+ + APE + KSDV
Sbjct: 140 DLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDV 199
Query: 121 YSFGVVALEVLMGKHP 136
++FGV+ E+
Sbjct: 200 WAFGVLLWEIATYGMS 215
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 92.8 bits (230), Expect = 2e-24
Identities = 39/141 (27%), Positives = 65/141 (46%), Gaps = 13/141 (9%)
Query: 2 HRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHR 61
FL+++ M+ G LF L E V L + I++ + + LH IVHR
Sbjct: 81 TNTFFFLVFDLMKKGELFDYLT---EKVTLSEKETRKIMRALLEVICALHK---LNIVHR 134
Query: 62 DISSNNILLNLELEAFVADFGVARLLNFDSSNRTLLAGTYGYIAPELAYTMVV------T 115
D+ NILL+ ++ + DFG + L+ + GT Y+APE+ +
Sbjct: 135 DLKPENILLDDDMNIKLTDFGFSCQLD-PGEKLREVCGTPSYLAPEIIECSMNDNHPGYG 193
Query: 116 EKSDVYSFGVVALEVLMGKHP 136
++ D++S GV+ +L G P
Sbjct: 194 KEVDMWSTGVIMYTLLAGSPP 214
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 93.6 bits (232), Expect = 2e-24
Identities = 38/138 (27%), Positives = 62/138 (44%), Gaps = 8/138 (5%)
Query: 2 HRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHR 61
RKC+ ++ E ++ G LF ++ D + I+K + A+ YLH I HR
Sbjct: 80 GRKCLLIVMECLDGGELFSRIQ-DRGDQAFTEREASEIMKSIGEAIQYLHSIN---IAHR 135
Query: 62 DISSNNILLNLELE---AFVADFGVARLLNFDSSNRTLLAGTYGYIAPELAYTMVVTEKS 118
D+ N+L + + DFG A+ +S T T Y+APE+ +
Sbjct: 136 DVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTP-CYTPYYVAPEVLGPEKYDKSC 194
Query: 119 DVYSFGVVALEVLMGKHP 136
D++S GV+ +L G P
Sbjct: 195 DMWSLGVIMYILLCGYPP 212
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 93.0 bits (230), Expect = 2e-24
Identities = 41/138 (29%), Positives = 64/138 (46%), Gaps = 8/138 (5%)
Query: 2 HRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHR 61
K M +I EYME G+ E+ + V +++G+A + + VHR
Sbjct: 80 KYKPMMIITEYMENGA--LDKFLREKDGEFSVLQLVGMLRGIAAGM---KYLANMNYVHR 134
Query: 62 DISSNNILLNLELEAFVADFGVARLLNFDSSNRTLLA---GTYGYIAPELAYTMVVTEKS 118
D+++ NIL+N L V+DFG++R+L D + + APE T S
Sbjct: 135 DLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSAS 194
Query: 119 DVYSFGVVALEVLMGKHP 136
DV+SFG+V EV+
Sbjct: 195 DVWSFGIVMWEVMTYGER 212
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 92.1 bits (228), Expect = 3e-24
Identities = 33/138 (23%), Positives = 54/138 (39%), Gaps = 8/138 (5%)
Query: 2 HRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHR 61
M ++ E +GSL LR + L R +A + YL +HR
Sbjct: 81 LTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSR--YAVQVAEGMGYLES---KRFIHR 135
Query: 62 DISSNNILLNLELEAFVADFGVARLLNFDSSN---RTLLAGTYGYIAPELAYTMVVTEKS 118
D+++ N+LL + DFG+ R L + + + + + APE T + S
Sbjct: 136 DLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHAS 195
Query: 119 DVYSFGVVALEVLMGKHP 136
D + FGV E+
Sbjct: 196 DTWMFGVTLWEMFTYGQE 213
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 92.4 bits (229), Expect = 4e-24
Identities = 38/138 (27%), Positives = 63/138 (45%), Gaps = 10/138 (7%)
Query: 2 HRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHR 61
++LI + + G LF + E ++ + A+ YLH IVHR
Sbjct: 78 SGGHLYLIMQLVSGGELFDRIV---EKGFYTERDASRLIFQVLDAVKYLHDLG---IVHR 131
Query: 62 DISSNNILLNLELEAF---VADFGVARLLNFDSSNRTLLAGTYGYIAPELAYTMVVTEKS 118
D+ N+L E ++DFG++++ + S T GT GY+APE+ ++
Sbjct: 132 DLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTA-CGTPGYVAPEVLAQKPYSKAV 190
Query: 119 DVYSFGVVALEVLMGKHP 136
D +S GV+A +L G P
Sbjct: 191 DCWSIGVIAYILLCGYPP 208
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 91.1 bits (225), Expect = 1e-23
Identities = 34/150 (22%), Positives = 63/150 (42%), Gaps = 18/150 (12%)
Query: 2 HRKCMFLIYEYMEMGSLFCVLR-------------TDEEAVGLDWAKRVNIVKGMAHALS 48
+++I EY G+L L+ + L V+ +A +
Sbjct: 90 QDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGME 149
Query: 49 YLHHDCTPPIVHRDISSNNILLNLELEAFVADFGVARLLNFDSSNRTLLA--GTYGYIAP 106
YL +HRD+++ N+L+ + +ADFG+AR ++ + ++AP
Sbjct: 150 YLAS---KKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAP 206
Query: 107 ELAYTMVVTEKSDVYSFGVVALEVLMGKHP 136
E + + T +SDV+SFGV+ E+
Sbjct: 207 EALFDRIYTHQSDVWSFGVLLWEIFTLGGS 236
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 91.7 bits (227), Expect = 2e-23
Identities = 33/136 (24%), Positives = 55/136 (40%), Gaps = 9/136 (6%)
Query: 2 HRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHR 61
+ I + M G L L A + L ++H+ +V+R
Sbjct: 78 TPDKLSFILDLMNGGDLHYHLSQHGVF---SEADMRFYAAEIILGLEHMHN---RFVVYR 131
Query: 62 DISSNNILLNLELEAFVADFGVARLLNFDSSNRTLLAGTYGYIAPE-LAYTMVVTEKSDV 120
D+ NILL+ ++D G+A +F GT+GY+APE L + +D
Sbjct: 132 DLKPANILLDEHGHVRISDLGLAC--DFSKKKPHASVGTHGYMAPEVLQKGVAYDSSADW 189
Query: 121 YSFGVVALEVLMGKHP 136
+S G + ++L G P
Sbjct: 190 FSLGCMLFKLLRGHSP 205
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 90.2 bits (223), Expect = 2e-23
Identities = 39/136 (28%), Positives = 69/136 (50%), Gaps = 9/136 (6%)
Query: 4 KCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDI 63
+++ EY++ +L ++ T+ + + + ++ AL++ H I+HRD+
Sbjct: 84 PLPYIVMEYVDGVTLRDIVHTEG---PMTPKRAIEVIADACQALNFSHQ---NGIIHRDV 137
Query: 64 SSNNILLNLELEAFVADFGVARLLNFDSSNRTL---LAGTYGYIAPELAYTMVVTEKSDV 120
NI+++ V DFG+AR + ++ T + GT Y++PE A V +SDV
Sbjct: 138 KPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDV 197
Query: 121 YSFGVVALEVLMGKHP 136
YS G V EVL G+ P
Sbjct: 198 YSLGCVLYEVLTGEPP 213
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 89.4 bits (221), Expect = 3e-23
Identities = 35/136 (25%), Positives = 59/136 (43%), Gaps = 6/136 (4%)
Query: 2 HRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHR 61
+++I E +G L LD A + ++ AL+YL VHR
Sbjct: 78 TENPVWIIMELCTLGELRSF--LQVRKYSLDLASLILYAYQLSTALAYLES---KRFVHR 132
Query: 62 DISSNNILLNLELEAFVADFGVARLLNFDSSNR-TLLAGTYGYIAPELAYTMVVTEKSDV 120
DI++ N+L++ + DFG++R + + + + ++APE T SDV
Sbjct: 133 DIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDV 192
Query: 121 YSFGVVALEVLMGKHP 136
+ FGV E+LM
Sbjct: 193 WMFGVCMWEILMHGVK 208
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 89.8 bits (222), Expect = 8e-23
Identities = 30/136 (22%), Positives = 51/136 (37%), Gaps = 4/136 (2%)
Query: 2 HRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHR 61
+ L+ +Y+ L + + +L+Y+H I HR
Sbjct: 90 DEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS---FGICHR 146
Query: 62 DISSNNILLNLELEAF-VADFGVARLLNFDSSNRTLLAGTYGYIAPELAYTMVVTEKSDV 120
DI N+LL+ + + DFG A+ L N + + Y + T DV
Sbjct: 147 DIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDV 206
Query: 121 YSFGVVALEVLMGKHP 136
+S G V E+L+G+
Sbjct: 207 WSAGCVLAELLLGQPI 222
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 89.1 bits (220), Expect = 8e-23
Identities = 32/137 (23%), Positives = 57/137 (41%), Gaps = 7/137 (5%)
Query: 2 HRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHR 61
+ LI + M G L E + +N +A ++YL +VHR
Sbjct: 81 LTSTVQLITQLMPFGCLLD--YVREHKDNIGSQYLLNWCVQIAKGMNYLED---RRLVHR 135
Query: 62 DISSNNILLNLELEAFVADFGVARLLNFDSSNRTL--LAGTYGYIAPELAYTMVVTEKSD 119
D+++ N+L+ + DFG+A+LL + ++A E + T +SD
Sbjct: 136 DLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSD 195
Query: 120 VYSFGVVALEVLMGKHP 136
V+S+GV E++
Sbjct: 196 VWSYGVTVWELMTFGSK 212
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 88.4 bits (218), Expect = 1e-22
Identities = 31/135 (22%), Positives = 61/135 (45%), Gaps = 6/135 (4%)
Query: 2 HRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHR 61
+ L++E+++ + + E G+ +++ + L +LH +VHR
Sbjct: 86 RETKLTLVFEHVDQDLTTYLDKVPEP--GVPTETIKDMMFQLLRGLDFLHSHR---VVHR 140
Query: 62 DISSNNILLNLELEAFVADFGVARLLNFDSSNRTLLAGTYGYIAPELAYTMVVTEKSDVY 121
D+ NIL+ + +ADFG+AR+ +F + ++ T Y APE+ D++
Sbjct: 141 DLKPQNILVTSSGQIKLADFGLARIYSFQMALTSV-VVTLWYRAPEVLLQSSYATPVDLW 199
Query: 122 SFGVVALEVLMGKHP 136
S G + E+ K
Sbjct: 200 SVGCIFAEMFRRKPL 214
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 86.1 bits (212), Expect = 1e-21
Identities = 32/136 (23%), Positives = 59/136 (43%), Gaps = 7/136 (5%)
Query: 2 HRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHR 61
H+ + L++++ME ++ + + K M L L + I+HR
Sbjct: 71 HKSNISLVFDFMETDLEVI-IKDNSLVLTPSHIKAY-----MLMTLQGLEYLHQHWILHR 124
Query: 62 DISSNNILLNLELEAFVADFGVARLLNFDSSNRTLLAGTYGYIAPELAYTM-VVTEKSDV 120
D+ NN+LL+ +ADFG+A+ + T T Y APEL + + D+
Sbjct: 125 DLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGARMYGVGVDM 184
Query: 121 YSFGVVALEVLMGKHP 136
++ G + E+L+
Sbjct: 185 WAVGCILAELLLRVPF 200
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 85.6 bits (211), Expect = 1e-21
Identities = 32/139 (23%), Positives = 65/139 (46%), Gaps = 11/139 (7%)
Query: 2 HRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHR 61
++ + LI E + G LF ++E++ + A + L+ +++ + I H
Sbjct: 84 NKTDVILILELVAGGELFDF-LAEKESLTEEEATEF-----LKQILNGVYYLHSLQIAHF 137
Query: 62 DISSNNILLNLE----LEAFVADFGVARLLNFDSSNRTLLAGTYGYIAPELAYTMVVTEK 117
D+ NI+L + DFG+A ++F + + GT ++APE+ + +
Sbjct: 138 DLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE-FKNIFGTPEFVAPEIVNYEPLGLE 196
Query: 118 SDVYSFGVVALEVLMGKHP 136
+D++S GV+ +L G P
Sbjct: 197 ADMWSIGVITYILLSGASP 215
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 84.4 bits (208), Expect = 3e-21
Identities = 34/137 (24%), Positives = 54/137 (39%), Gaps = 9/137 (6%)
Query: 2 HRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHR 61
LI E E T+ L + + A+ + H+ ++HR
Sbjct: 80 RPDSFVLILERPEPVQDLFDFITERG--ALQEELARSFFWQVLEAVRHCHN---CGVLHR 134
Query: 62 DISSNNILLNLE-LEAFVADFGVARLLNFDSSNRTLLAGTYGYIAPE-LAYTMVVTEKSD 119
DI NIL++L E + DFG LL + T GT Y PE + Y +
Sbjct: 135 DIKDENILIDLNRGELKLIDFGSGALL--KDTVYTDFDGTRVYSPPEWIRYHRYHGRSAA 192
Query: 120 VYSFGVVALEVLMGKHP 136
V+S G++ +++ G P
Sbjct: 193 VWSLGILLYDMVCGDIP 209
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 84.4 bits (208), Expect = 4e-21
Identities = 39/135 (28%), Positives = 61/135 (45%), Gaps = 9/135 (6%)
Query: 2 HRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHR 61
+ +F+I +Y+E G LF +LR + A L + + I++R
Sbjct: 75 DAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFY------AAEVCLALEYLHSKDIIYR 128
Query: 62 DISSNNILLNLELEAFVADFGVARLLNFDSSNRTLLAGTYGYIAPELAYTMVVTEKSDVY 121
D+ NILL+ + DFG A+ + L GT YIAPE+ T + D +
Sbjct: 129 DLKPENILLDKNGHIKITDFGFAKYVP---DVTYTLCGTPDYIAPEVVSTKPYNKSIDWW 185
Query: 122 SFGVVALEVLMGKHP 136
SFG++ E+L G P
Sbjct: 186 SFGILIYEMLAGYTP 200
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 84.4 bits (208), Expect = 5e-21
Identities = 32/135 (23%), Positives = 55/135 (40%), Gaps = 6/135 (4%)
Query: 2 HRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHR 61
+ + EY G LF L + + A +S L + + +V+R
Sbjct: 76 THDRLCFVMEYANGGELFFHLSRER---VFTEERARFY---GAEIVSALEYLHSRDVVYR 129
Query: 62 DISSNNILLNLELEAFVADFGVARLLNFDSSNRTLLAGTYGYIAPELAYTMVVTEKSDVY 121
DI N++L+ + + DFG+ + D + GT Y+APE+ D +
Sbjct: 130 DIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWW 189
Query: 122 SFGVVALEVLMGKHP 136
GVV E++ G+ P
Sbjct: 190 GLGVVMYEMMCGRLP 204
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 84.2 bits (207), Expect = 5e-21
Identities = 36/148 (24%), Positives = 63/148 (42%), Gaps = 18/148 (12%)
Query: 4 KCMFLIYEYMEMGSLFCVLRT-------------DEEAVGLDWAKRVNIVKGMAHALSYL 50
+ +I E+ + G+L LR+ D L + +A + +L
Sbjct: 91 GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFL 150
Query: 51 HHDCTPPIVHRDISSNNILLNLELEAFVADFGVARLLNFDSSN--RTLLAGTYGYIAPEL 108
+HRD+++ NILL+ + + DFG+AR + D + ++APE
Sbjct: 151 AS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPET 207
Query: 109 AYTMVVTEKSDVYSFGVVALEVLMGKHP 136
+ V T +SDV+SFGV+ E+
Sbjct: 208 IFDRVYTIQSDVWSFGVLLWEIFSLGAS 235
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 83.4 bits (205), Expect = 1e-20
Identities = 29/136 (21%), Positives = 57/136 (41%), Gaps = 6/136 (4%)
Query: 2 HRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHR 61
++L++E++ + + G+ + + + L++ H ++HR
Sbjct: 72 TENKLYLVFEFLHQDLKKFMDASALT--GIPLPLIKSYLFQLLQGLAFCHSHR---VLHR 126
Query: 62 DISSNNILLNLELEAFVADFGVARLLNFDSSNRTLLAGTYGYIAPE-LAYTMVVTEKSDV 120
D+ N+L+N E +ADFG+AR T T Y APE L + D+
Sbjct: 127 DLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDI 186
Query: 121 YSFGVVALEVLMGKHP 136
+S G + E++ +
Sbjct: 187 WSLGCIFAEMVTRRAL 202
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 82.6 bits (203), Expect = 2e-20
Identities = 35/144 (24%), Positives = 60/144 (41%), Gaps = 12/144 (8%)
Query: 2 HRKCMFLIYEYMEMGSLFCVLRTDEEAVG-------LDWAKRVNIVKGMAHALSYLHHDC 54
+ +I E M G L LR+ A+ +K + + +A ++YL+
Sbjct: 94 QGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNA-- 151
Query: 55 TPPIVHRDISSNNILLNLELEAFVADFGVARLLNFDSSNR--TLLAGTYGYIAPELAYTM 112
VHRD+++ N ++ + + DFG+ R + R +++PE
Sbjct: 152 -NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDG 210
Query: 113 VVTEKSDVYSFGVVALEVLMGKHP 136
V T SDV+SFGVV E+
Sbjct: 211 VFTTYSDVWSFGVVLWEIATLAEQ 234
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 82.2 bits (202), Expect = 3e-20
Identities = 24/145 (16%), Positives = 49/145 (33%), Gaps = 16/145 (11%)
Query: 2 HRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHR 61
++ E + + + + M + Y+H +HR
Sbjct: 74 EGDYNVMVMELLGPSLEDLFNFCSRK---FSLKTVLLLADQMISRIEYIHSKN---FIHR 127
Query: 62 DISSNNILLNLE---LEAFVADFGVARLLNFDSSN-------RTLLAGTYGYIAPELAYT 111
D+ +N L+ L ++ DFG+A+ ++ L GT Y +
Sbjct: 128 DVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLG 187
Query: 112 MVVTEKSDVYSFGVVALEVLMGKHP 136
+ + + D+ S G V + +G P
Sbjct: 188 IEQSRRDDLESLGYVLMYFNLGSLP 212
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 81.8 bits (201), Expect = 4e-20
Identities = 24/147 (16%), Positives = 48/147 (32%), Gaps = 18/147 (12%)
Query: 2 HRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHR 61
L+ + + + + K M + +H +V+R
Sbjct: 72 EGLHNVLVIDLLGPSLEDLLDLCGRK---FSVKTVAMAAKQMLARVQSIHE---KSLVYR 125
Query: 62 DISSNNILLNLELE-----AFVADFGVARLLNFDSSN-------RTLLAGTYGYIAPELA 109
DI +N L+ +V DFG+ + + + L+GT Y++
Sbjct: 126 DIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTH 185
Query: 110 YTMVVTEKSDVYSFGVVALEVLMGKHP 136
+ + D+ + G V + L G P
Sbjct: 186 LGREQSRRDDLEALGHVFMYFLRGSLP 212
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 81.9 bits (201), Expect = 4e-20
Identities = 30/140 (21%), Positives = 56/140 (40%), Gaps = 11/140 (7%)
Query: 2 HRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHR 61
+ ++L++++ E + + L KRV M L+ L++ I+HR
Sbjct: 88 CKGSIYLVFDFCEHDLAGLLSNVLVK-FTLSEIKRV-----MQMLLNGLYYIHRNKILHR 141
Query: 62 DISSNNILLNLELEAFVADFGVARLLNFDSS----NRTLLAGTYGYIAPE-LAYTMVVTE 116
D+ + N+L+ + +ADFG+AR + + T T Y PE L
Sbjct: 142 DMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGP 201
Query: 117 KSDVYSFGVVALEVLMGKHP 136
D++ G + E+
Sbjct: 202 PIDLWGAGCIMAEMWTRSPI 221
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 77.6 bits (190), Expect = 1e-18
Identities = 33/136 (24%), Positives = 56/136 (41%), Gaps = 6/136 (4%)
Query: 2 HRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHR 61
H K ++ L +L E + AK + L+ + + ++HR
Sbjct: 70 HTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSF-----LLQLLNGIAYCHDRRVLHR 124
Query: 62 DISSNNILLNLELEAFVADFGVARLLNFDSSNRTLLAGTYGYIAPE-LAYTMVVTEKSDV 120
D+ N+L+N E E +ADFG+AR T T Y AP+ L + + D+
Sbjct: 125 DLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDI 184
Query: 121 YSFGVVALEVLMGKHP 136
+S G + E++ G
Sbjct: 185 WSVGCIFAEMVNGTPL 200
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 77.9 bits (191), Expect = 2e-18
Identities = 30/135 (22%), Positives = 54/135 (40%), Gaps = 9/135 (6%)
Query: 2 HRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHR 61
++++ EY+ G +F LR + YLH +++R
Sbjct: 112 DNSNLYMVMEYVAGGEMFSHLR---RIGRFSEPHARFYAAQIVLTFEYLHSLD---LIYR 165
Query: 62 DISSNNILLNLELEAFVADFGVARLLNFDSSNRTLLAGTYGYIAPELAYTMVVTEKSDVY 121
D+ N+L++ + V DFG A+ L GT +APE+ + + D +
Sbjct: 166 DLKPENLLIDQQGYIQVTDFGFAK---RVKGRTWTLCGTPEALAPEIILSKGYNKAVDWW 222
Query: 122 SFGVVALEVLMGKHP 136
+ GV+ E+ G P
Sbjct: 223 ALGVLIYEMAAGYPP 237
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 76.5 bits (187), Expect = 3e-18
Identities = 25/136 (18%), Positives = 52/136 (38%), Gaps = 7/136 (5%)
Query: 2 HRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHR 61
K + L++E+ + + + + L L + ++HR
Sbjct: 72 SDKKLTLVFEFCDQDLKKYFDSCN------GDLDPEIVKSFLFQLLKGLGFCHSRNVLHR 125
Query: 62 DISSNNILLNLELEAFVADFGVARLLNFDSSNRTLLAGTYGYIAPELAY-TMVVTEKSDV 120
D+ N+L+N E +A+FG+AR + T Y P++ + + + D+
Sbjct: 126 DLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDM 185
Query: 121 YSFGVVALEVLMGKHP 136
+S G + E+ P
Sbjct: 186 WSAGCIFAELANAGRP 201
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 76.8 bits (188), Expect = 4e-18
Identities = 31/135 (22%), Positives = 58/135 (42%), Gaps = 11/135 (8%)
Query: 6 MFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISS 65
+ ++ L+ +L+T L + + L Y+H ++HRD+
Sbjct: 85 DVYLVTHLMGADLYKLLKTQ----HLSNDHICYFLYQILRGLKYIHS---ANVLHRDLKP 137
Query: 66 NNILLNLELEAFVADFGVARLLNFDSSNRTL---LAGTYGYIAPELAYT-MVVTEKSDVY 121
+N+LLN + + DFG+AR+ + D + T Y APE+ T+ D++
Sbjct: 138 SNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIW 197
Query: 122 SFGVVALEVLMGKHP 136
S G + E+L +
Sbjct: 198 SVGCILAEMLSNRPI 212
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 74.1 bits (181), Expect = 3e-17
Identities = 33/138 (23%), Positives = 56/138 (40%), Gaps = 9/138 (6%)
Query: 2 HRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHR 61
+ LI +Y+ G LF L + + + + L H I++R
Sbjct: 100 TETKLHLILDYINGGELFTHLSQR------ERFTEHEVQIYVGEIVLALEHLHKLGIIYR 153
Query: 62 DISSNNILLNLELEAFVADFGVA-RLLNFDSSNRTLLAGTYGYIAPELAYTMV--VTEKS 118
DI NILL+ + DFG++ + ++ GT Y+AP++ +
Sbjct: 154 DIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAV 213
Query: 119 DVYSFGVVALEVLMGKHP 136
D +S GV+ E+L G P
Sbjct: 214 DWWSLGVLMYELLTGASP 231
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 72.6 bits (177), Expect = 1e-16
Identities = 25/134 (18%), Positives = 53/134 (39%), Gaps = 10/134 (7%)
Query: 4 KCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDI 63
+ L++E++ + +T L + + AL Y H I+HRD+
Sbjct: 105 RTPALVFEHVNNTDFKQLYQT------LTDYDIRFYMYEILKALDYCHSMG---IMHRDV 155
Query: 64 SSNNILLNLE-LEAFVADFGVARLLNFDSSNRTLLAGTYGYIAPELAYTMVVTEKSDVYS 122
+N++++ E + + D+G+A + +A Y L + D++S
Sbjct: 156 KPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWS 215
Query: 123 FGVVALEVLMGKHP 136
G + ++ K P
Sbjct: 216 LGCMLASMIFRKEP 229
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 68.8 bits (167), Expect = 3e-15
Identities = 32/135 (23%), Positives = 57/135 (42%), Gaps = 10/135 (7%)
Query: 2 HRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHR 61
+ ++L+ E M+ + D + ++ M + +LH I+HR
Sbjct: 93 EFQDVYLVMELMDANLCQVIQMEL------DHERMSYLLYQMLCGIKHLHSAG---IIHR 143
Query: 62 DISSNNILLNLELEAFVADFGVARLLNFDSSNRTLLAGTYGYIAPELAYTMVVTEKSDVY 121
D+ +NI++ + + DFG+AR S T T Y APE+ M E D++
Sbjct: 144 DLKPSNIVVKSDCTLKILDFGLART-AGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIW 202
Query: 122 SFGVVALEVLMGKHP 136
S G + E++ K
Sbjct: 203 SVGCIMGEMVRHKIL 217
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 66.0 bits (160), Expect = 3e-14
Identities = 29/131 (22%), Positives = 51/131 (38%), Gaps = 10/131 (7%)
Query: 6 MFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISS 65
+L+ +M + L + +V M L Y+H HRD+
Sbjct: 98 FYLVMPFMGTDLGKLMKHE-----KLGEDRIQFLVYQMLKGLRYIHAAGII---HRDLKP 149
Query: 66 NNILLNLELEAFVADFGVARLLNFDSSNRTLLAGTYGYIAPELAYTMVVTEKSDVYSFGV 125
N+ +N + E + DFG+AR DS + + + M T+ D++S G
Sbjct: 150 GNLAVNEDCELKILDFGLAR--QADSEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGC 207
Query: 126 VALEVLMGKHP 136
+ E++ GK
Sbjct: 208 IMAEMITGKTL 218
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 65.1 bits (157), Expect = 6e-14
Identities = 28/138 (20%), Positives = 58/138 (42%), Gaps = 7/138 (5%)
Query: 2 HRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHR 61
+ + +++E + L + + + + L + K+ I K + L Y+H C I+H
Sbjct: 95 NGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQ--ISKQLLLGLDYMHRRC--GIIHT 150
Query: 62 DISSNNILLNLE-LEAFVADFGVARLLN--FDSSNRTLLAGTYGYIAPELAYTMVVTEKS 118
DI N+L+ + + +A L N + + T T Y +PE+ +
Sbjct: 151 DIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTREYRSPEVLLGAPWGCGA 210
Query: 119 DVYSFGVVALEVLMGKHP 136
D++S + E++ G
Sbjct: 211 DIWSTACLIFELITGDFL 228
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 59.1 bits (142), Expect = 7e-12
Identities = 26/136 (19%), Positives = 53/136 (38%), Gaps = 9/136 (6%)
Query: 1 LHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVH 60
L + ++ L +++ L ++ + L Y+H H
Sbjct: 92 LEEFNDVYLVTHLMGADLNNIVKCQ----KLTDDHVQFLIYQILRGLKYIHSADII---H 144
Query: 61 RDISSNNILLNLELEAFVADFGVARLLNFDSSNRTLLAGTYGYIAPELAYTMVVTEKSDV 120
RD+ +N+ +N + E + DFG+AR + D +A + + M + D+
Sbjct: 145 RDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDI 202
Query: 121 YSFGVVALEVLMGKHP 136
+S G + E+L G+
Sbjct: 203 WSVGCIMAELLTGRTL 218
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 41.7 bits (97), Expect = 5e-06
Identities = 16/96 (16%), Positives = 38/96 (39%), Gaps = 5/96 (5%)
Query: 1 LHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVH 60
L + +Y + ++ L +E + ++ + ++ +H IVH
Sbjct: 71 LQGLAVPKVYAWEG-NAVLMELIDAKELYRVRVENPDEVLDMILEEVAKFYHRG---IVH 126
Query: 61 RDISSNNILLNLELEAFVADFGVARLLNFDSSNRTL 96
D+S N+L++ E ++ DF + + + L
Sbjct: 127 GDLSQYNVLVS-EEGIWIIDFPQSVEVGEEGWREIL 161
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 144 | |||
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 99.98 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 99.98 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 99.97 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 99.97 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 99.97 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 99.97 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 99.97 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 99.97 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 99.94 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.57 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 97.68 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.09 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 96.07 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 93.17 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 92.51 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 89.5 |
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-40 Score=221.61 Aligned_cols=132 Identities=35% Similarity=0.547 Sum_probs=118.6
Q ss_pred CCceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeee
Q 044494 2 HRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADF 81 (144)
Q Consensus 2 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~ 81 (144)
+++++|+||||+++|+|.+++.+... +++..+..++.|++.||+||| ++|++||||||+||+++.++.+|++||
T Consensus 77 ~~~~~~ivmEy~~~g~L~~~l~~~~~---l~e~~~~~i~~qi~~al~~lH---~~~ivHrDiKp~Nill~~~~~~kl~DF 150 (263)
T d2j4za1 77 DATRVYLILEYAPLGTVYRELQKLSK---FDEQRTATYITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADF 150 (263)
T ss_dssp CSSEEEEEEECCTTCBHHHHHHHHSS---CCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCC
T ss_pred ECCEEEEEEeecCCCcHHHHHhhcCC---CCHHHHHHHHHHHHHHHHHHH---HCCeeeeeeccccceecCCCCEeeccc
Confidence 45789999999999999999986443 999999999999999999999 899999999999999999999999999
Q ss_pred cceeecccCCCCcccccccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCC
Q 044494 82 GVARLLNFDSSNRTLLAGTYGYIAPELAYTMVVTEKSDVYSFGVVALEVLMGKHPGELLS 141 (144)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~d~~slg~~l~~~~~g~~p~~~~~ 141 (144)
|++..... .......||+.|+|||++.+..++.++|+||+||++|+|++|+.||++.+
T Consensus 151 G~a~~~~~--~~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~ 208 (263)
T d2j4za1 151 GWSVHAPS--SRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANT 208 (263)
T ss_dssp CSCSCCCC--CCCEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSS
T ss_pred ceeeecCC--CcccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCC
Confidence 99976542 22344679999999999999999999999999999999999999998754
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-40 Score=223.32 Aligned_cols=132 Identities=29% Similarity=0.495 Sum_probs=119.4
Q ss_pred CceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeeec
Q 044494 3 RKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADFG 82 (144)
Q Consensus 3 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~~ 82 (144)
++++|+||||+++|+|.+++.+. .+++..+..++.|++.||+||| ++|++||||||+||+++.++.++++|||
T Consensus 89 ~~~~~ivmEy~~gg~L~~~~~~~----~l~~~~~~~i~~qi~~aL~yLH---~~~iiHrDiKp~NILl~~~~~vkl~DFG 161 (293)
T d1yhwa1 89 GDELWVVMEYLAGGSLTDVVTET----CMDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFG 161 (293)
T ss_dssp TTEEEEEEECCTTCBHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCT
T ss_pred CCEEEEEEEecCCCcHHHHhhcc----CCCHHHHHHHHHHHHHHHHHHH---HCCCcccCCcHHHeEECCCCcEeeccch
Confidence 56889999999999999987643 3899999999999999999999 8999999999999999999999999999
Q ss_pred ceeecccCCCCcccccccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCC
Q 044494 83 VARLLNFDSSNRTLLAGTYGYIAPELAYTMVVTEKSDVYSFGVVALEVLMGKHPGELLS 141 (144)
Q Consensus 83 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~d~~slg~~l~~~~~g~~p~~~~~ 141 (144)
+++.............||+.|+|||++.+..++.++|+||+|+++|+|++|..||.+.+
T Consensus 162 ~a~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~ 220 (293)
T d1yhwa1 162 FCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNEN 220 (293)
T ss_dssp TCEECCSTTCCBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSC
T ss_pred hheeeccccccccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCC
Confidence 99877644444556779999999999999999999999999999999999999997654
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.3e-40 Score=225.69 Aligned_cols=134 Identities=25% Similarity=0.362 Sum_probs=121.7
Q ss_pred CCceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeee
Q 044494 2 HRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADF 81 (144)
Q Consensus 2 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~ 81 (144)
+++++|+||||++||+|.+++.+... +++..+..++.|++.||+||| ++|++||||||+||+++.++.++|+||
T Consensus 76 ~~~~~~iv~ey~~gg~L~~~~~~~~~---~~e~~~~~~~~qil~al~ylH---~~~iiHRDlKP~NILl~~~g~vkl~DF 149 (337)
T d1o6la_ 76 THDRLCFVMEYANGGELFFHLSRERV---FTEERARFYGAEIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDF 149 (337)
T ss_dssp CSSEEEEEEECCTTCBHHHHHHHHSC---CCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCC
T ss_pred cccccccceeccCCCchhhhhhcccC---CcHHHHHHHHHHHhhhhhhhh---hcCccccccCHHHeEecCCCCEEEeec
Confidence 45789999999999999999886544 899999999999999999999 899999999999999999999999999
Q ss_pred cceeecccCCCCcccccccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCC
Q 044494 82 GVARLLNFDSSNRTLLAGTYGYIAPELAYTMVVTEKSDVYSFGVVALEVLMGKHPGELLS 141 (144)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~d~~slg~~l~~~~~g~~p~~~~~ 141 (144)
|+++.............||+.|+|||++.+..++.++|+||+||++|||++|..||.+.+
T Consensus 150 G~a~~~~~~~~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~ 209 (337)
T d1o6la_ 150 GLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD 209 (337)
T ss_dssp TTCBCSCCTTCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred ccccccccCCcccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcC
Confidence 999876544445556789999999999999999999999999999999999999998754
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.6e-40 Score=220.81 Aligned_cols=135 Identities=29% Similarity=0.454 Sum_probs=117.3
Q ss_pred CCceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeee
Q 044494 2 HRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADF 81 (144)
Q Consensus 2 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~ 81 (144)
+++.+|+||||+++|+|.+++.+... +++..+..++.|++.||+||| ++|++||||||+||+++.++.+||+||
T Consensus 74 ~~~~~~ivmEy~~gg~L~~~l~~~~~---l~e~~~~~i~~qi~~al~ylH---~~~IiHrDiKp~NILl~~~~~~KL~DF 147 (271)
T d1nvra_ 74 EGNIQYLFLEYCSGGELFDRIEPDIG---MPEPDAQRFFHQLMAGVVYLH---GIGITHRDIKPENLLLDERDNLKISDF 147 (271)
T ss_dssp ETTEEEEEEECCTTEEGGGGSBTTTB---CCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECTTCCEEECCC
T ss_pred cCceeEEEEeccCCCcHHHHHhcCCC---CCHHHHHHHHHHHHHHHHHHH---HcCCccCcccHHHEEECCCCCEEEccc
Confidence 35678999999999999999975443 999999999999999999999 899999999999999999999999999
Q ss_pred cceeecccCC--CCcccccccccccCccccccCCC-CCcchhHHHHHHHHHHHhCCCCCCCCCC
Q 044494 82 GVARLLNFDS--SNRTLLAGTYGYIAPELAYTMVV-TEKSDVYSFGVVALEVLMGKHPGELLSS 142 (144)
Q Consensus 82 ~~~~~~~~~~--~~~~~~~~~~~~~~pe~~~~~~~-~~~~d~~slg~~l~~~~~g~~p~~~~~~ 142 (144)
|+++...... .......||+.|+|||++.+..+ +.++|+||+|+++|+|++|..||...+.
T Consensus 148 G~a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~ 211 (271)
T d1nvra_ 148 GLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSD 211 (271)
T ss_dssp TTCEECEETTEECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSST
T ss_pred hhheeeccCCccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCCh
Confidence 9998654321 22344679999999999988876 5679999999999999999999977543
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-40 Score=221.87 Aligned_cols=136 Identities=30% Similarity=0.458 Sum_probs=107.3
Q ss_pred CceEEEEEeeccCCCHHHHhhcc-cccCCCCHHHHHHHHHHHHHHHHHHhcCCCCC-----eEecCCCCCcEEEcCCCCe
Q 044494 3 RKCMFLIYEYMEMGSLFCVLRTD-EEAVGLDWAKRVNIVKGMAHALSYLHHDCTPP-----IVHRDISSNNILLNLELEA 76 (144)
Q Consensus 3 ~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~-----~~h~~i~~~ni~~~~~~~~ 76 (144)
++.+|+||||+++|+|.+++.+. .....+++..++.++.|++.||+||| +++ ++||||||+||+++.++.+
T Consensus 77 ~~~~~ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH---~~~~~~~~IiHrDiKp~NIll~~~~~v 153 (269)
T d2java1 77 NTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECH---RRSDGGHTVLHRDLKPANVFLDGKQNV 153 (269)
T ss_dssp --CEEEEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHH---HHCC---------CCGGGEEECTTSCE
T ss_pred CCEEEEEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHH---HhcCCCCCEEeCcCchhhcCcCCCCcE
Confidence 45689999999999999998652 22345999999999999999999999 544 9999999999999999999
Q ss_pred EEeeecceeecccCCCCcccccccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCC
Q 044494 77 FVADFGVARLLNFDSSNRTLLAGTYGYIAPELAYTMVVTEKSDVYSFGVVALEVLMGKHPGELLS 141 (144)
Q Consensus 77 ~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~d~~slg~~l~~~~~g~~p~~~~~ 141 (144)
||+|||+++.............||+.|+|||++.+..++.++|+||+|+++|||++|..||...+
T Consensus 154 kl~DFG~a~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~ 218 (269)
T d2java1 154 KLGDFGLARILNHDTSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFS 218 (269)
T ss_dssp EECCHHHHHHC-----------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred EEeeccceeecccCCCccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCC
Confidence 99999999876544434445679999999999999999999999999999999999999998754
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-39 Score=219.70 Aligned_cols=134 Identities=27% Similarity=0.447 Sum_probs=116.6
Q ss_pred CCceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeee
Q 044494 2 HRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADF 81 (144)
Q Consensus 2 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~ 81 (144)
+++++|+||||+++|+|.+++...+. +++..+..++.|++.||+||| +++++||||||+||+++.++.++++||
T Consensus 79 ~~~~~~ivmEy~~gg~L~~~~~~~~~---l~e~~~~~~~~qi~~al~ylH---~~~iiHrDiKp~NIll~~~~~vkl~DF 152 (288)
T d1uu3a_ 79 DDEKLYFGLSYAKNGELLKYIRKIGS---FDETCTRFYTAEIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDF 152 (288)
T ss_dssp CSSEEEEEECCCTTEEHHHHHHHHSS---CCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECCC
T ss_pred ECCEEEEEEEccCCCCHHHhhhccCC---CCHHHHHHHHHHHHHHHHhhc---cccEEcCcCCccccccCCCceEEeccc
Confidence 45789999999999999998876544 999999999999999999999 899999999999999999999999999
Q ss_pred cceeecccCCC--CcccccccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCC
Q 044494 82 GVARLLNFDSS--NRTLLAGTYGYIAPELAYTMVVTEKSDVYSFGVVALEVLMGKHPGELLS 141 (144)
Q Consensus 82 ~~~~~~~~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~d~~slg~~l~~~~~g~~p~~~~~ 141 (144)
|+++....... ......||+.|+|||++.+..++.++|+||+||++|+|++|..||...+
T Consensus 153 G~a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~ 214 (288)
T d1uu3a_ 153 GTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGN 214 (288)
T ss_dssp TTCEECC----------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred ccceecccCCcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcC
Confidence 99987643222 2334579999999999999999999999999999999999999998654
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-39 Score=223.02 Aligned_cols=132 Identities=27% Similarity=0.352 Sum_probs=116.1
Q ss_pred CCceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCC-CeEecCCCCCcEEEcCCCCeEEee
Q 044494 2 HRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTP-PIVHRDISSNNILLNLELEAFVAD 80 (144)
Q Consensus 2 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~-~~~h~~i~~~ni~~~~~~~~~l~d 80 (144)
+++++|+||||+++|+|.+++.+... +++..+..++.|++.|+.||| ++ +++||||||+||+++.++.+||+|
T Consensus 75 ~~~~~~iVmEy~~gg~L~~~l~~~~~---l~~~~~~~~~~qil~aL~yLH---~~~~IiHRDiKP~NILl~~~~~vkl~D 148 (322)
T d1s9ja_ 75 SDGEISICMEHMDGGSLDQVLKKAGR---IPEQILGKVSIAVIKGLTYLR---EKHKIMHRDVKPSNILVNSRGEIKLCD 148 (322)
T ss_dssp CSSEEEEEEECCTTEEHHHHHHHHSS---CCHHHHHHHHHHHHHHHHHHH---HHHCCCCSCCSGGGEEECTTCCEEECC
T ss_pred ECCEEEEEEEcCCCCcHHHHHhhcCC---CCHHHHHHHHHHHHHHHHHHH---HhCCEEccccCHHHeeECCCCCEEEee
Confidence 45679999999999999999976443 999999999999999999999 64 899999999999999999999999
Q ss_pred ecceeecccCCCCcccccccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCC
Q 044494 81 FGVARLLNFDSSNRTLLAGTYGYIAPELAYTMVVTEKSDVYSFGVVALEVLMGKHPGELLS 141 (144)
Q Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~d~~slg~~l~~~~~g~~p~~~~~ 141 (144)
||+++..... ......||+.|+|||++.+..++.++|+||+||++|||++|+.||...+
T Consensus 149 FGla~~~~~~--~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~ 207 (322)
T d1s9ja_ 149 FGVSGQLIDS--MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPD 207 (322)
T ss_dssp CCCCHHHHHH--TC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCC
T ss_pred CCCccccCCC--ccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCC
Confidence 9999865422 2334679999999999999999999999999999999999999997644
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-39 Score=219.25 Aligned_cols=135 Identities=28% Similarity=0.403 Sum_probs=116.0
Q ss_pred CceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeeec
Q 044494 3 RKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADFG 82 (144)
Q Consensus 3 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~~ 82 (144)
++.+|+||||+++|+|.+++.+.. ..+++..+..++.|++.||.||| ++|++||||||+||+++.++.+||+|||
T Consensus 81 ~~~~~lvmEy~~~g~L~~~~~~~~--~~l~e~~~~~i~~qi~~gL~ylH---~~~ivHrDiKp~NIll~~~~~~Kl~DFG 155 (288)
T d2jfla1 81 ENNLWILIEFCAGGAVDAVMLELE--RPLTESQIQVVCKQTLDALNYLH---DNKIIHRDLKAGNILFTLDGDIKLADFG 155 (288)
T ss_dssp TTEEEEEEECCTTEEHHHHHHHHT--SCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCT
T ss_pred CCeEEEEEecCCCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHH---HCCEEEeecChhheeECCCCCEEEEech
Confidence 578899999999999999876432 23999999999999999999999 8999999999999999999999999999
Q ss_pred ceeecccCCCCcccccccccccCccccc-----cCCCCCcchhHHHHHHHHHHHhCCCCCCCCCC
Q 044494 83 VARLLNFDSSNRTLLAGTYGYIAPELAY-----TMVVTEKSDVYSFGVVALEVLMGKHPGELLSS 142 (144)
Q Consensus 83 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~-----~~~~~~~~d~~slg~~l~~~~~g~~p~~~~~~ 142 (144)
++..............||+.|+|||++. ...++.++|+||+||++|+|++|..||...++
T Consensus 156 ~a~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~ 220 (288)
T d2jfla1 156 VSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNP 220 (288)
T ss_dssp TCEECHHHHHHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCG
T ss_pred hhhccCCCcccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCH
Confidence 9976543222233467999999999984 44578899999999999999999999987653
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-38 Score=212.32 Aligned_cols=130 Identities=28% Similarity=0.450 Sum_probs=112.9
Q ss_pred CceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCC--eEecCCCCCcEEEc-CCCCeEEe
Q 044494 3 RKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPP--IVHRDISSNNILLN-LELEAFVA 79 (144)
Q Consensus 3 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~--~~h~~i~~~ni~~~-~~~~~~l~ 79 (144)
++.+|+||||+++|+|.+++.+... +++..+..++.|++.||+||| +++ ++||||||+||+++ .++.+||+
T Consensus 84 ~~~~~ivmE~~~~g~L~~~l~~~~~---~~~~~~~~~~~qi~~gl~yLH---~~~~~IiHrDiKp~NILl~~~~~~~Kl~ 157 (270)
T d1t4ha_ 84 KKCIVLVTELMTSGTLKTYLKRFKV---MKIKVLRSWCRQILKGLQFLH---TRTPPIIHRDLKCDNIFITGPTGSVKIG 157 (270)
T ss_dssp CEEEEEEEECCCSCBHHHHHHHHSS---CCHHHHHHHHHHHHHHHHHHH---TSSSCCCCSCCCGGGEEESSTTSCEEEC
T ss_pred CCEEEEEEeCCCCCcHHHHHhcccc---ccHHHHHHHHHHHHHHHHHHH---HCCCCEEeCCcChhhceeeCCCCCEEEe
Confidence 4568999999999999999976443 899999999999999999999 777 99999999999997 47899999
Q ss_pred eecceeecccCCCCcccccccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCC
Q 044494 80 DFGVARLLNFDSSNRTLLAGTYGYIAPELAYTMVVTEKSDVYSFGVVALEVLMGKHPGELLS 141 (144)
Q Consensus 80 d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~d~~slg~~l~~~~~g~~p~~~~~ 141 (144)
|||+++... ........||+.|+|||++.+ .++.++|+||+||++|+|++|..||...+
T Consensus 158 DFGla~~~~--~~~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~ 216 (270)
T d1t4ha_ 158 DLGLATLKR--ASFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQ 216 (270)
T ss_dssp CTTGGGGCC--TTSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCS
T ss_pred ecCcceecc--CCccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcc
Confidence 999997533 223345679999999999865 58999999999999999999999997643
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-38 Score=217.73 Aligned_cols=134 Identities=28% Similarity=0.477 Sum_probs=121.6
Q ss_pred CCceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeee
Q 044494 2 HRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADF 81 (144)
Q Consensus 2 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~ 81 (144)
+++.+|+||||+++|+|.+++..... +++..+..++.|++.||+||| +++++||||||+||+++.++.++++||
T Consensus 74 ~~~~~yivmEy~~~g~L~~~i~~~~~---~~e~~~~~~~~qi~~al~ylH---~~~iiHrDikp~NiL~~~~~~~kl~DF 147 (320)
T d1xjda_ 74 TKENLFFVMEYLNGGDLMYHIQSCHK---FDLSRATFYAAEIILGLQFLH---SKGIVYRDLKLDNILLDKDGHIKIADF 147 (320)
T ss_dssp CSSEEEEEEECCTTCBHHHHHHHHSS---CCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCC
T ss_pred cCCceeEEEeecCCCcHHHHhhccCC---CCHHHHHHHHHHHHHHHHHHH---hCCeeeccCcccceeecCCCceecccc
Confidence 46789999999999999999986444 899999999999999999999 899999999999999999999999999
Q ss_pred cceeecccCCCCcccccccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCC
Q 044494 82 GVARLLNFDSSNRTLLAGTYGYIAPELAYTMVVTEKSDVYSFGVVALEVLMGKHPGELLS 141 (144)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~d~~slg~~l~~~~~g~~p~~~~~ 141 (144)
|+++.............||+.|+|||++.+..++.++|+||+||++|+|++|..||.+.+
T Consensus 148 G~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~ 207 (320)
T d1xjda_ 148 GMCKENMLGDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQD 207 (320)
T ss_dssp TTCBCCCCTTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred chhhhcccccccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCC
Confidence 999876544445555779999999999999999999999999999999999999998754
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=3.3e-38 Score=215.87 Aligned_cols=131 Identities=32% Similarity=0.474 Sum_probs=118.0
Q ss_pred CCceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeee
Q 044494 2 HRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADF 81 (144)
Q Consensus 2 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~ 81 (144)
.++.+|+||||++||+|..++..... +++..+..++.|++.|+.||| ++|++||||||+||+++.++.+||+||
T Consensus 75 ~~~~~~ivmE~~~gg~l~~~~~~~~~---~~~~~~~~~~~qi~~al~~lH---~~~iiHrDiKp~NILl~~~g~vkL~DF 148 (316)
T d1fota_ 75 DAQQIFMIMDYIEGGELFSLLRKSQR---FPNPVAKFYAAEVCLALEYLH---SKDIIYRDLKPENILLDKNGHIKITDF 148 (316)
T ss_dssp CSSEEEEEECCCCSCBHHHHHHHTSS---CCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECTTSCEEECCC
T ss_pred eCCeeeeEeeecCCcccccccccccc---ccccHHHHHHHHHHHhhhhhc---cCcEEccccCchheeEcCCCCEEEecC
Confidence 45789999999999999998876554 889999999999999999999 999999999999999999999999999
Q ss_pred cceeecccCCCCcccccccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCC
Q 044494 82 GVARLLNFDSSNRTLLAGTYGYIAPELAYTMVVTEKSDVYSFGVVALEVLMGKHPGELLS 141 (144)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~d~~slg~~l~~~~~g~~p~~~~~ 141 (144)
|+++.... ......||+.|+|||++.+..++.++|+||+|+++|+|++|..||...+
T Consensus 149 G~a~~~~~---~~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~ 205 (316)
T d1fota_ 149 GFAKYVPD---VTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSN 205 (316)
T ss_dssp SSCEECSS---CBCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSS
T ss_pred ccceEecc---ccccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcC
Confidence 99987542 2334679999999999999999999999999999999999999998754
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.3e-38 Score=217.14 Aligned_cols=133 Identities=26% Similarity=0.391 Sum_probs=106.2
Q ss_pred CCceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEc---CCCCeEE
Q 044494 2 HRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLN---LELEAFV 78 (144)
Q Consensus 2 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~---~~~~~~l 78 (144)
+++++|+||||++||+|.+++.+.+. +++..+..++.|++.||+||| +++++||||||+||++. .++.+++
T Consensus 78 ~~~~~~lvmE~~~gg~L~~~l~~~~~---l~e~~~~~~~~qi~~al~ylH---~~~iiHrDiKp~Nil~~~~~~~~~vkl 151 (307)
T d1a06a_ 78 SGGHLYLIMQLVSGGELFDRIVEKGF---YTERDASRLIFQVLDAVKYLH---DLGIVHRDLKPENLLYYSLDEDSKIMI 151 (307)
T ss_dssp CSSEEEEEECCCCSCBHHHHHHTCSC---CCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESSSSTTCCEEE
T ss_pred ECCEEEEEEeccCCCcHHHhhhcccC---CCHHHHHHHHHHHHHHHHhhh---hceeeeEEecccceeecccCCCceEEE
Confidence 45789999999999999999976443 999999999999999999999 89999999999999995 4688999
Q ss_pred eeecceeecccCCCCcccccccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCC
Q 044494 79 ADFGVARLLNFDSSNRTLLAGTYGYIAPELAYTMVVTEKSDVYSFGVVALEVLMGKHPGELLS 141 (144)
Q Consensus 79 ~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~d~~slg~~l~~~~~g~~p~~~~~ 141 (144)
+|||+++..... .......||+.|+|||++.+..++.++|+||+||++|+|++|..||.+.+
T Consensus 152 ~DFG~a~~~~~~-~~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~ 213 (307)
T d1a06a_ 152 SDFGLSKMEDPG-SVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDEN 213 (307)
T ss_dssp CCC-------------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred eccceeEEccCC-CeeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCC
Confidence 999999865432 22344679999999999999999999999999999999999999997643
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=3.2e-38 Score=219.49 Aligned_cols=133 Identities=23% Similarity=0.316 Sum_probs=117.5
Q ss_pred CCceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeee
Q 044494 2 HRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADF 81 (144)
Q Consensus 2 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~ 81 (144)
.++.+|+||||++||+|.+++.+... +++..+..++.|++.||.||| +++++||||||+||+++.++.+||+||
T Consensus 78 ~~~~~~ivmE~~~gg~L~~~l~~~~~---~~e~~~~~~~~qi~~aL~ylH---~~~iiHrDlKP~NILl~~~g~iKl~DF 151 (364)
T d1omwa3 78 TPDKLSFILDLMNGGDLHYHLSQHGV---FSEADMRFYAAEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDL 151 (364)
T ss_dssp CSSEEEEEECCCCSCBHHHHHHHHCS---CCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECSSSCEEECCC
T ss_pred ECCEEEEEEEecCCCcHHHHHHhccc---ccHHHHHHHHHHHHHHHHHHH---HCCccceeeccceeEEcCCCcEEEeee
Confidence 35678999999999999999976443 899999999999999999999 899999999999999999999999999
Q ss_pred cceeecccCCCCcccccccccccCcccccc-CCCCCcchhHHHHHHHHHHHhCCCCCCCCCC
Q 044494 82 GVARLLNFDSSNRTLLAGTYGYIAPELAYT-MVVTEKSDVYSFGVVALEVLMGKHPGELLSS 142 (144)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~-~~~~~~~d~~slg~~l~~~~~g~~p~~~~~~ 142 (144)
|+++..... ......||+.|+|||++.. ..++.++|+||+||++|+|++|..||...+.
T Consensus 152 Gla~~~~~~--~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~ 211 (364)
T d1omwa3 152 GLACDFSKK--KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKT 211 (364)
T ss_dssp TTCEECSSS--CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCS
T ss_pred ceeeecCCC--cccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCH
Confidence 999876532 2344679999999999874 5689999999999999999999999987543
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.1e-39 Score=215.07 Aligned_cols=135 Identities=30% Similarity=0.493 Sum_probs=112.3
Q ss_pred CceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeeec
Q 044494 3 RKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADFG 82 (144)
Q Consensus 3 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~~ 82 (144)
++++++||||+++|+|.+++..... .+++..+..++.|++.||+||| +++++||||||+||+++.++.+||+|||
T Consensus 75 ~~~~~lv~Ey~~~g~L~~~l~~~~~--~~~~~~~~~i~~qi~~gl~yLH---~~~ivHrDlKp~NiLl~~~~~~Kl~DFG 149 (276)
T d1uwha_ 75 APQLAIVTQWCEGSSLYHHLHIIET--KFEMIKLIDIARQTAQGMDYLH---AKSIIHRDLKSNNIFLHEDLTVKIGDFG 149 (276)
T ss_dssp SSSCEEEEECCCEEEHHHHHHTSCC--CCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEETTSSEEECCCC
T ss_pred ccEEEEEEecCCCCCHHHHHhhccC--CCCHHHHHHHHHHHHHHHHHHh---cCCEeccccCHHHEEEcCCCCEEEcccc
Confidence 4568999999999999999975332 3899999999999999999999 8999999999999999999999999999
Q ss_pred ceeecccCC--CCcccccccccccCccccccC---CCCCcchhHHHHHHHHHHHhCCCCCCCCCC
Q 044494 83 VARLLNFDS--SNRTLLAGTYGYIAPELAYTM---VVTEKSDVYSFGVVALEVLMGKHPGELLSS 142 (144)
Q Consensus 83 ~~~~~~~~~--~~~~~~~~~~~~~~pe~~~~~---~~~~~~d~~slg~~l~~~~~g~~p~~~~~~ 142 (144)
+++...... .......||+.|+|||++... .++.++|+||+|+++|||++|..||.+.++
T Consensus 150 la~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~ 214 (276)
T d1uwha_ 150 LATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINN 214 (276)
T ss_dssp CSCC------------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCC
T ss_pred ceeeccccCCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCCh
Confidence 997654221 223445789999999998743 478899999999999999999999987653
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=8.4e-38 Score=216.42 Aligned_cols=131 Identities=23% Similarity=0.345 Sum_probs=118.4
Q ss_pred CCceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeee
Q 044494 2 HRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADF 81 (144)
Q Consensus 2 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~ 81 (144)
..+.+|+||||+.+|+|.+++.+.+. +++..+..++.|++.||.||| +++++||||||+||+++.++.++|+||
T Consensus 112 ~~~~~~~v~e~~~~g~l~~~l~~~~~---l~e~~~~~i~~qi~~aL~yLH---~~~iiHRDIKP~NILl~~~g~ikL~DF 185 (350)
T d1rdqe_ 112 DNSNLYMVMEYVAGGEMFSHLRRIGR---FSEPHARFYAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDF 185 (350)
T ss_dssp CSSEEEEEEECCTTCBHHHHHHHHCC---CCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCC
T ss_pred cccccccccccccccchhhhHhhcCC---CCHHHHHHHHHHHHHHHHHHH---hCCEecCcCCHHHcccCCCCCEEeeec
Confidence 35678999999999999999876443 999999999999999999999 899999999999999999999999999
Q ss_pred cceeecccCCCCcccccccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCC
Q 044494 82 GVARLLNFDSSNRTLLAGTYGYIAPELAYTMVVTEKSDVYSFGVVALEVLMGKHPGELLS 141 (144)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~d~~slg~~l~~~~~g~~p~~~~~ 141 (144)
|+++.... ......||+.|+|||++.+..++.++|+||+||++|+|++|..||.+.+
T Consensus 186 G~a~~~~~---~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~ 242 (350)
T d1rdqe_ 186 GFAKRVKG---RTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQ 242 (350)
T ss_dssp TTCEECSS---CBCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred eeeeeccc---ccccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcC
Confidence 99987652 2334679999999999999999999999999999999999999998754
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-38 Score=217.00 Aligned_cols=134 Identities=27% Similarity=0.411 Sum_probs=117.3
Q ss_pred CceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcC---CCCeEEe
Q 044494 3 RKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNL---ELEAFVA 79 (144)
Q Consensus 3 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~---~~~~~l~ 79 (144)
++.+|+|||||+||+|.+++.+.. ...+++..+..++.|++.|++||| ++|++||||||+||+++. .+.++++
T Consensus 81 ~~~~~ivmEy~~gg~L~~~i~~~~-~~~l~e~~~~~i~~qi~~al~ylH---~~~iiHRDiKp~NIll~~~~~~~~~Kl~ 156 (335)
T d2ozaa1 81 RKCLLIVMECLDGGELFSRIQDRG-DQAFTEREASEIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLT 156 (335)
T ss_dssp EEEEEEEEECCCSEEHHHHHHSCS-CCCEEHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESCSSTTCCEEEC
T ss_pred CCEEEEEEECCCCCcHHHHHHhcC-CCCcCHHHHHHHHHHHHHHHHHHH---HcCCcccccccccccccccccccccccc
Confidence 467899999999999999997532 234999999999999999999999 899999999999999985 4579999
Q ss_pred eecceeecccCCCCcccccccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCC
Q 044494 80 DFGVARLLNFDSSNRTLLAGTYGYIAPELAYTMVVTEKSDVYSFGVVALEVLMGKHPGELLS 141 (144)
Q Consensus 80 d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~d~~slg~~l~~~~~g~~p~~~~~ 141 (144)
|||+++...... ......|++.|+|||++.+..++.++|+||+||++|+|++|..||.+.+
T Consensus 157 DFG~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~ 217 (335)
T d2ozaa1 157 DFGFAKETTSHN-SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNH 217 (335)
T ss_dssp CCTTCEECCCCC-CCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETT
T ss_pred ccceeeeccCCC-ccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCC
Confidence 999998765332 3344679999999999999999999999999999999999999997654
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=1.1e-37 Score=215.95 Aligned_cols=134 Identities=27% Similarity=0.372 Sum_probs=117.9
Q ss_pred CCceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEc--CCCCeEEe
Q 044494 2 HRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLN--LELEAFVA 79 (144)
Q Consensus 2 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~--~~~~~~l~ 79 (144)
+++++|+||||++||+|.+++.... ..+++..+..++.|++.||+||| ++|++||||||+||+++ .++.++|+
T Consensus 97 ~~~~~~ivmE~~~gg~L~~~~~~~~--~~l~e~~~~~i~~qi~~aL~ylH---~~~iiHRDiKp~NILl~~~~~~~vkL~ 171 (352)
T d1koba_ 97 DKYEMVLILEFLSGGELFDRIAAED--YKMSEAEVINYMRQACEGLKHMH---EHSIVHLDIKPENIMCETKKASSVKII 171 (352)
T ss_dssp CSSEEEEEEECCCCCBHHHHTTCTT--CCBCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSTTCCCEEEC
T ss_pred ECCEEEEEEEcCCCChHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHH---HCCeeecccccccccccccCCCeEEEe
Confidence 4678899999999999998876533 23899999999999999999999 89999999999999998 56889999
Q ss_pred eecceeecccCCCCcccccccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCC
Q 044494 80 DFGVARLLNFDSSNRTLLAGTYGYIAPELAYTMVVTEKSDVYSFGVVALEVLMGKHPGELLS 141 (144)
Q Consensus 80 d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~d~~slg~~l~~~~~g~~p~~~~~ 141 (144)
|||++...... .......+++.|+|||++.+..++.++|+||+||++|+|++|..||.+.+
T Consensus 172 DFGla~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~ 232 (352)
T d1koba_ 172 DFGLATKLNPD-EIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGED 232 (352)
T ss_dssp CCTTCEECCTT-SCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSS
T ss_pred ecccceecCCC-CceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCC
Confidence 99999876532 23445678999999999999999999999999999999999999998754
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.6e-38 Score=214.90 Aligned_cols=138 Identities=28% Similarity=0.430 Sum_probs=118.0
Q ss_pred CCceEEEEEeeccCCCHHHHhhcccc--------------------cCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEec
Q 044494 2 HRKCMFLIYEYMEMGSLFCVLRTDEE--------------------AVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHR 61 (144)
Q Consensus 2 ~~~~~~lv~e~~~~~~L~~~l~~~~~--------------------~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~ 61 (144)
..+.+|+||||+++|+|.++++.... ...+++..++.++.|++.||+||| +++++||
T Consensus 112 ~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH---~~~IiHR 188 (325)
T d1rjba_ 112 LSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLE---FKSCVHR 188 (325)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHH---HTTEEET
T ss_pred eCCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHH---hCCeeec
Confidence 45678999999999999999975321 124889999999999999999999 8999999
Q ss_pred CCCCCcEEEcCCCCeEEeeecceeecccCCCC--cccccccccccCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCC
Q 044494 62 DISSNNILLNLELEAFVADFGVARLLNFDSSN--RTLLAGTYGYIAPELAYTMVVTEKSDVYSFGVVALEVLM-GKHPGE 138 (144)
Q Consensus 62 ~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~--~~~~~~~~~~~~pe~~~~~~~~~~~d~~slg~~l~~~~~-g~~p~~ 138 (144)
||||+||+++.++.+||+|||+++........ .....+|+.|+|||++....++.++|+||+|+++|||++ |..||.
T Consensus 189 DlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~ 268 (325)
T d1rjba_ 189 DLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYP 268 (325)
T ss_dssp TCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSST
T ss_pred cCchhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCC
Confidence 99999999999999999999999866533222 234567999999999999999999999999999999998 899998
Q ss_pred CCCC
Q 044494 139 LLSS 142 (144)
Q Consensus 139 ~~~~ 142 (144)
+.+.
T Consensus 269 ~~~~ 272 (325)
T d1rjba_ 269 GIPV 272 (325)
T ss_dssp TCCC
T ss_pred CCCH
Confidence 7653
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=1.3e-37 Score=215.48 Aligned_cols=134 Identities=26% Similarity=0.378 Sum_probs=117.2
Q ss_pred CCceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcC--CCCeEEe
Q 044494 2 HRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNL--ELEAFVA 79 (144)
Q Consensus 2 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~--~~~~~l~ 79 (144)
+++.+|+||||++||+|.+++.+.. ..+++..+..++.|++.||+||| ++|++||||||+||+++. ++.++|+
T Consensus 94 ~~~~~~ivmE~~~gg~L~~~l~~~~--~~l~e~~~~~i~~qi~~aL~ylH---~~~iiHrDiKp~NIll~~~~~~~vkL~ 168 (350)
T d1koaa2 94 DDNEMVMIYEFMSGGELFEKVADEH--NKMSEDEAVEYMRQVCKGLCHMH---ENNYVHLDLKPENIMFTTKRSNELKLI 168 (350)
T ss_dssp ETTEEEEEECCCCSCBHHHHHTCTT--SCBCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSTTSCCEEEC
T ss_pred ECCEEEEEEEcCCCCCHHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHH---hcCCeeeeechhHeeeccCCCCeEEEe
Confidence 3578999999999999999986432 23899999999999999999999 899999999999999964 5789999
Q ss_pred eecceeecccCCCCcccccccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCC
Q 044494 80 DFGVARLLNFDSSNRTLLAGTYGYIAPELAYTMVVTEKSDVYSFGVVALEVLMGKHPGELLS 141 (144)
Q Consensus 80 d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~d~~slg~~l~~~~~g~~p~~~~~ 141 (144)
|||+++.... ........||+.|+|||++.+..++.++|+||+||++|+|++|..||.+.+
T Consensus 169 DFG~a~~~~~-~~~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~ 229 (350)
T d1koaa2 169 DFGLTAHLDP-KQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGEN 229 (350)
T ss_dssp CCTTCEECCT-TSCEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred ecchheeccc-ccccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCC
Confidence 9999987653 233445679999999999999999999999999999999999999998654
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.2e-37 Score=208.08 Aligned_cols=133 Identities=27% Similarity=0.404 Sum_probs=117.5
Q ss_pred CCceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCC----CeE
Q 044494 2 HRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLEL----EAF 77 (144)
Q Consensus 2 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~----~~~ 77 (144)
+++++|+||||+++|+|.+++.+... +++..+..++.|++.||+||| +++++||||||+||+++.++ .++
T Consensus 84 ~~~~~~iv~E~~~gg~L~~~i~~~~~---l~~~~~~~~~~qi~~al~yLH---~~~ivHrDiKp~Nill~~~~~~~~~vk 157 (293)
T d1jksa_ 84 NKTDVILILELVAGGELFDFLAEKES---LTEEEATEFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIK 157 (293)
T ss_dssp CSSEEEEEEECCCSCBHHHHHHHHSS---CCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESCSSSSSCCEE
T ss_pred ECCEEEEEEEcCCCccccchhccccc---cchhHHHHHHHHHHHHHHhhh---hcceeecccccceEEEecCCCcccceE
Confidence 45788999999999999999976443 999999999999999999999 89999999999999998776 489
Q ss_pred EeeecceeecccCCCCcccccccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCC
Q 044494 78 VADFGVARLLNFDSSNRTLLAGTYGYIAPELAYTMVVTEKSDVYSFGVVALEVLMGKHPGELLS 141 (144)
Q Consensus 78 l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~d~~slg~~l~~~~~g~~p~~~~~ 141 (144)
++|||++...... .......+++.|+|||++.+..++.++|+||+|+++|+|++|..||.+.+
T Consensus 158 l~DfG~a~~~~~~-~~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~ 220 (293)
T d1jksa_ 158 IIDFGLAHKIDFG-NEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDT 220 (293)
T ss_dssp ECCCTTCEECTTS-CBCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred ecchhhhhhcCCC-ccccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCC
Confidence 9999999876532 23344678999999999999999999999999999999999999998754
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-37 Score=210.50 Aligned_cols=135 Identities=26% Similarity=0.403 Sum_probs=117.2
Q ss_pred CceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeeec
Q 044494 3 RKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADFG 82 (144)
Q Consensus 3 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~~ 82 (144)
.+.+|+||||+++|+|.+++.... ..+++..+..++.|++.||+||| +++++||||||+||+++.++.+||+|||
T Consensus 80 ~~~~~lvmE~~~~g~L~~~l~~~~--~~l~~~~~~~i~~qi~~gL~ylH---~~~iiHrDlKp~Nill~~~~~~Kl~DFG 154 (285)
T d1u59a_ 80 AEALMLVMEMAGGGPLHKFLVGKR--EEIPVSNVAELLHQVSMGMKYLE---EKNFVHRDLAARNVLLVNRHYAKISDFG 154 (285)
T ss_dssp SSSEEEEEECCTTEEHHHHHTTCT--TTSCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEEETTEEEECCCT
T ss_pred cCeEEEEEEeCCCCcHHHHhhccc--cCCCHHHHHHHHHHHHHHHHHHH---hCCeecCcCchhheeeccCCceeeccch
Confidence 457899999999999999886432 23899999999999999999999 8999999999999999999999999999
Q ss_pred ceeecccCCC---CcccccccccccCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCC
Q 044494 83 VARLLNFDSS---NRTLLAGTYGYIAPELAYTMVVTEKSDVYSFGVVALEVLM-GKHPGELLSS 142 (144)
Q Consensus 83 ~~~~~~~~~~---~~~~~~~~~~~~~pe~~~~~~~~~~~d~~slg~~l~~~~~-g~~p~~~~~~ 142 (144)
+++....... ......+++.|+|||++....++.++|+||+|+++|||++ |..||...+.
T Consensus 155 la~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~ 218 (285)
T d1u59a_ 155 LSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG 218 (285)
T ss_dssp TCEECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCT
T ss_pred hhhcccccccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCH
Confidence 9987653222 1223457889999999999999999999999999999998 9999987653
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-37 Score=210.09 Aligned_cols=133 Identities=28% Similarity=0.433 Sum_probs=115.5
Q ss_pred CceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeeec
Q 044494 3 RKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADFG 82 (144)
Q Consensus 3 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~~ 82 (144)
++..|+||||+++|+|.+++++... +++..+..++.|++.||+||| +++++||||||+||+++.++.++++|||
T Consensus 79 ~~~~~lvmE~~~~g~L~~~l~~~~~---l~~~~~~~i~~qi~~gl~ylH---~~~iiHrDlKp~Nill~~~~~~kl~DFG 152 (277)
T d1xbba_ 79 AESWMLVMEMAELGPLNKYLQQNRH---VKDKNIIELVHQVSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFG 152 (277)
T ss_dssp SSSEEEEEECCTTEEHHHHHHHCTT---CCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETTEEEECCCT
T ss_pred cCCEEEEEEcCCCCcHHHHHhhccC---CCHHHHHHHHHHHHHHHhhHH---hCCcccCCCcchhhcccccCcccccchh
Confidence 4567999999999999999986443 899999999999999999999 8899999999999999999999999999
Q ss_pred ceeecccCCCC---cccccccccccCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCC
Q 044494 83 VARLLNFDSSN---RTLLAGTYGYIAPELAYTMVVTEKSDVYSFGVVALEVLM-GKHPGELLS 141 (144)
Q Consensus 83 ~~~~~~~~~~~---~~~~~~~~~~~~pe~~~~~~~~~~~d~~slg~~l~~~~~-g~~p~~~~~ 141 (144)
+++........ .....+++.|+|||.+....++.++|+||+|+++|||++ |..||.+.+
T Consensus 153 la~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~ 215 (277)
T d1xbba_ 153 LSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMK 215 (277)
T ss_dssp TCEECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCC
T ss_pred hhhhccccccccccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCC
Confidence 99865432221 223468899999999999999999999999999999998 899998765
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=3.7e-37 Score=210.02 Aligned_cols=130 Identities=25% Similarity=0.362 Sum_probs=113.2
Q ss_pred CCceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeee
Q 044494 2 HRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADF 81 (144)
Q Consensus 2 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~ 81 (144)
.++++|+||||+.+|+|..++.... .+++..+..++.|++.||.||| ++|++||||||+||+++.++.+||+||
T Consensus 86 ~~~~~~iv~E~~~~g~l~~~~~~~~---~l~e~~~~~i~~qi~~aL~yLH---~~~iiHrDiKp~NILl~~~~~~Kl~DF 159 (309)
T d1u5ra_ 86 REHTAWLVMEYCLGSASDLLEVHKK---PLQEVEIAAVTHGALQGLAYLH---SHNMIHRDVKAGNILLSEPGLVKLGDF 159 (309)
T ss_dssp ETTEEEEEEECCSEEHHHHHHHHTS---CCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSGGGEEEETTTEEEECCC
T ss_pred ECCEEEEEEEecCCCchHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHH---hCCEeccCCCcceEEECCCCCEEEeec
Confidence 3568999999999998877665443 3999999999999999999999 899999999999999999999999999
Q ss_pred cceeecccCCCCcccccccccccCcccccc---CCCCCcchhHHHHHHHHHHHhCCCCCCCCC
Q 044494 82 GVARLLNFDSSNRTLLAGTYGYIAPELAYT---MVVTEKSDVYSFGVVALEVLMGKHPGELLS 141 (144)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~---~~~~~~~d~~slg~~l~~~~~g~~p~~~~~ 141 (144)
|++..... .....||+.|+|||++.+ ..++.++|+||+||++|+|++|..||.+.+
T Consensus 160 G~a~~~~~----~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~ 218 (309)
T d1u5ra_ 160 GSASIMAP----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN 218 (309)
T ss_dssp TTCBSSSS----BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC
T ss_pred ccccccCC----CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCC
Confidence 99976432 234579999999999864 357889999999999999999999997654
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=3.5e-37 Score=209.42 Aligned_cols=135 Identities=33% Similarity=0.485 Sum_probs=107.7
Q ss_pred CCceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeee
Q 044494 2 HRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADF 81 (144)
Q Consensus 2 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~ 81 (144)
+++.+|+||||+++|+|.+++..... .+++.++..++.|++.||+||| +++++||||||+||+++.++.+||+||
T Consensus 98 ~~~~~~iv~Ey~~~g~L~~~~~~~~~--~l~~~~~~~i~~qia~gl~yLH---~~~iiHrDlKp~NILl~~~~~~Kl~DF 172 (299)
T d1jpaa_ 98 KSTPVMIITEFMENGSLDSFLRQNDG--QFTVIQLVGMLRGIAAGMKYLA---DMNYVHRDLAARNILVNSNLVCKVSDF 172 (299)
T ss_dssp SSSSCEEEEECCTTEEHHHHHHTTTT--CSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCC
T ss_pred eCCEEEEEEEecCCCcceeeeccccC--CCCHHHHHHHHHHHHHHHHHHh---hCCCccCccccceEEECCCCcEEECCc
Confidence 45778999999999999998875332 3899999999999999999999 899999999999999999999999999
Q ss_pred cceeecccCCCC-----cccccccccccCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCC
Q 044494 82 GVARLLNFDSSN-----RTLLAGTYGYIAPELAYTMVVTEKSDVYSFGVVALEVLM-GKHPGELLS 141 (144)
Q Consensus 82 ~~~~~~~~~~~~-----~~~~~~~~~~~~pe~~~~~~~~~~~d~~slg~~l~~~~~-g~~p~~~~~ 141 (144)
|+++........ .....+++.|+|||.+....++.++|+||+|+++|||++ |..||...+
T Consensus 173 Gla~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~ 238 (299)
T d1jpaa_ 173 GLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMT 238 (299)
T ss_dssp -----------------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC
T ss_pred ccceEccCCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCC
Confidence 999865432111 112346889999999999999999999999999999998 899998754
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=2.2e-36 Score=203.42 Aligned_cols=133 Identities=28% Similarity=0.435 Sum_probs=116.8
Q ss_pred CCceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeee
Q 044494 2 HRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADF 81 (144)
Q Consensus 2 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~ 81 (144)
+++.+|+||||+++|+|.++++.... +++..+..++.|++.||+||| ++|++||||||+||+++.++.++|+||
T Consensus 81 ~~~~~~ivmE~~~~g~L~~~l~~~~~---l~e~~~~~~~~qi~~al~~lH---~~~ivHrDlkp~Nill~~~~~~kl~DF 154 (277)
T d1phka_ 81 TNTFFFLVFDLMKKGELFDYLTEKVT---LSEKETRKIMRALLEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDF 154 (277)
T ss_dssp CSSEEEEEEECCTTCBHHHHHHHHSS---CCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCC
T ss_pred cCcceEEEEEcCCCchHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHH---HcCCcccccccceEEEcCCCCeEEccc
Confidence 46788999999999999999976443 999999999999999999999 899999999999999999999999999
Q ss_pred cceeecccCCCCcccccccccccCcccccc------CCCCCcchhHHHHHHHHHHHhCCCCCCCCC
Q 044494 82 GVARLLNFDSSNRTLLAGTYGYIAPELAYT------MVVTEKSDVYSFGVVALEVLMGKHPGELLS 141 (144)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~------~~~~~~~d~~slg~~l~~~~~g~~p~~~~~ 141 (144)
|++....... ......||+.|++||.+.. ..++.++|+||+|+++|+|++|..||...+
T Consensus 155 G~a~~~~~~~-~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~ 219 (277)
T d1phka_ 155 GFSCQLDPGE-KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRK 219 (277)
T ss_dssp TTCEECCTTC-CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred hheeEccCCC-ceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCC
Confidence 9998765433 2344678999999998863 346778999999999999999999998754
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=1.2e-36 Score=204.88 Aligned_cols=132 Identities=30% Similarity=0.468 Sum_probs=109.6
Q ss_pred ceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeeecc
Q 044494 4 KCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADFGV 83 (144)
Q Consensus 4 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~~~ 83 (144)
..+|+||||++|++|.+++...+. +++.++..++.|++.|++||| ++|++||||||+||+++.++..+++|||.
T Consensus 84 ~~~~lvmE~~~g~~L~~~~~~~~~---l~~~~~~~i~~qi~~al~~lH---~~~iiHrDiKP~NIll~~~~~~~l~d~~~ 157 (277)
T d1o6ya_ 84 PLPYIVMEYVDGVTLRDIVHTEGP---MTPKRAIEVIADACQALNFSH---QNGIIHRDVKPANIMISATNAVKVMDFGI 157 (277)
T ss_dssp EEEEEEEECCCEEEHHHHHHHHCS---CCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTSCEEECCCTT
T ss_pred ceEEEEEECCCCCEehhhhcccCC---CCHHHHHHHHHHHHHHHHHHH---hCCccCccccCcccccCccccceeehhhh
Confidence 358999999999999998876544 899999999999999999999 89999999999999999999999999998
Q ss_pred eeecccCC---CCcccccccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCC
Q 044494 84 ARLLNFDS---SNRTLLAGTYGYIAPELAYTMVVTEKSDVYSFGVVALEVLMGKHPGELLS 141 (144)
Q Consensus 84 ~~~~~~~~---~~~~~~~~~~~~~~pe~~~~~~~~~~~d~~slg~~l~~~~~g~~p~~~~~ 141 (144)
+....... .......||+.|+|||++.+..+++++|+||+|+++|+|++|..||...+
T Consensus 158 ~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~ 218 (277)
T d1o6ya_ 158 ARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDS 218 (277)
T ss_dssp CEECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred hhhhccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcC
Confidence 87543221 22334578999999999999999999999999999999999999998654
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-36 Score=206.92 Aligned_cols=136 Identities=26% Similarity=0.371 Sum_probs=110.2
Q ss_pred CceEEEEEeeccCCCHHHHhhcccc-------------cCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEE
Q 044494 3 RKCMFLIYEYMEMGSLFCVLRTDEE-------------AVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNIL 69 (144)
Q Consensus 3 ~~~~~lv~e~~~~~~L~~~l~~~~~-------------~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~ 69 (144)
++.+++||||+++|+|.++++.... ...+++..+..++.|++.||+||| +++++||||||+||+
T Consensus 90 ~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH---~~~ivHrDlKp~NIL 166 (299)
T d1ywna1 90 GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLA---SRKCIHRDLAARNIL 166 (299)
T ss_dssp TSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEE
T ss_pred CCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHH---hCCCcCCcCCcccee
Confidence 4568999999999999999975321 224889999999999999999999 899999999999999
Q ss_pred EcCCCCeEEeeecceeecccCCC--CcccccccccccCccccccCCCCCcchhHHHHHHHHHHHhC-CCCCCCCC
Q 044494 70 LNLELEAFVADFGVARLLNFDSS--NRTLLAGTYGYIAPELAYTMVVTEKSDVYSFGVVALEVLMG-KHPGELLS 141 (144)
Q Consensus 70 ~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~d~~slg~~l~~~~~g-~~p~~~~~ 141 (144)
++.++.+||+|||+++....... ......||+.|+|||++.+..++.++|+||+|+++|||++| ..||...+
T Consensus 167 l~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~ 241 (299)
T d1ywna1 167 LSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVK 241 (299)
T ss_dssp ECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred ECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCC
Confidence 99999999999999986543222 23345789999999999999999999999999999999986 56887654
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-36 Score=203.16 Aligned_cols=135 Identities=30% Similarity=0.398 Sum_probs=106.9
Q ss_pred CCceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeee
Q 044494 2 HRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADF 81 (144)
Q Consensus 2 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~ 81 (144)
.++.+|+||||+++|+|.+++.... ..+++..+..++.|++.||+||| +++++||||||+||+++.++.+||+||
T Consensus 71 ~~~~~~lv~E~~~~g~L~~~l~~~~--~~~~~~~~~~i~~qia~gl~~lH---~~~iiHrDlKp~Nill~~~~~~Kl~DF 145 (263)
T d1sm2a_ 71 EQAPICLVFEFMEHGCLSDYLRTQR--GLFAAETLLGMCLDVCEGMAYLE---EACVIHRDLAARNCLVGENQVIKVSDF 145 (263)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHTTT--TCCCHHHHHHHHHHHHHHHHHHH---HTTCCCTTCSGGGEEECGGGCEEECSC
T ss_pred cCCceEEEEEecCCCcHHHHhhccc--cCCCHHHHHHHHHHHHHHHHhhh---ccceeecccchhheeecCCCCeEeccc
Confidence 4577899999999999999987533 23889999999999999999999 889999999999999999999999999
Q ss_pred cceeecccCCC-CcccccccccccCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCC
Q 044494 82 GVARLLNFDSS-NRTLLAGTYGYIAPELAYTMVVTEKSDVYSFGVVALEVLM-GKHPGELLS 141 (144)
Q Consensus 82 ~~~~~~~~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~d~~slg~~l~~~~~-g~~p~~~~~ 141 (144)
|+++....... ......|++.|+|||++....++.++|+||+|+++|||++ |..||...+
T Consensus 146 Gla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~ 207 (263)
T d1sm2a_ 146 GMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRS 207 (263)
T ss_dssp C------------------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCC
T ss_pred chheeccCCCceeecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCC
Confidence 99986543222 2233568899999999999999999999999999999999 566776543
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-36 Score=206.35 Aligned_cols=134 Identities=25% Similarity=0.285 Sum_probs=115.1
Q ss_pred CCceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeee
Q 044494 2 HRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADF 81 (144)
Q Consensus 2 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~ 81 (144)
+++++|+||||+.++++..+..... .+++..+..++.|++.||+||| ++|++||||||+||+++.++.+||+||
T Consensus 71 ~~~~~~ivmE~~~~~~~~~~~~~~~---~l~~~~~~~~~~qil~aL~~lH---~~~iiHrDiKp~NIli~~~~~~KL~DF 144 (299)
T d1ua2a_ 71 HKSNISLVFDFMETDLEVIIKDNSL---VLTPSHIKAYMLMTLQGLEYLH---QHWILHRDLKPNNLLLDENGVLKLADF 144 (299)
T ss_dssp CTTCCEEEEECCSEEHHHHHTTCCS---SCCSSHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECCC
T ss_pred cCCceeehhhhhcchHHhhhhhccc---CCCHHHHHHHHHHHHHHHHHhh---ccceecccCCcceEEecCCCccccccC
Confidence 4678899999999877766554332 3888999999999999999999 899999999999999999999999999
Q ss_pred cceeecccCCCCcccccccccccCccccccC-CCCCcchhHHHHHHHHHHHhCCCCCCCCC
Q 044494 82 GVARLLNFDSSNRTLLAGTYGYIAPELAYTM-VVTEKSDVYSFGVVALEVLMGKHPGELLS 141 (144)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~-~~~~~~d~~slg~~l~~~~~g~~p~~~~~ 141 (144)
|.+..............+|+.|+|||++... .++.++|+||+||++|||++|..||.+.+
T Consensus 145 G~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~ 205 (299)
T d1ua2a_ 145 GLAKSFGSPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDS 205 (299)
T ss_dssp GGGSTTTSCCCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred ccccccCCCcccccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCC
Confidence 9998766544445556799999999998754 57899999999999999999999997643
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.6e-36 Score=205.18 Aligned_cols=133 Identities=28% Similarity=0.387 Sum_probs=116.5
Q ss_pred CceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCC--CCeEEee
Q 044494 3 RKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLE--LEAFVAD 80 (144)
Q Consensus 3 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~--~~~~l~d 80 (144)
++++|+||||++||+|.+++.+.. ..+++.++..++.|++.|++||| ++|++||||||+||+++.+ ..++++|
T Consensus 73 ~~~~~lvmE~~~gg~L~~~i~~~~--~~l~e~~~~~i~~qi~~al~yLH---~~~iiHrDlKp~NIll~~~~~~~ikl~D 147 (321)
T d1tkia_ 73 MEELVMIFEFISGLDIFERINTSA--FELNEREIVSYVHQVCEALQFLH---SHNIGHFDIRPENIIYQTRRSSTIKIIE 147 (321)
T ss_dssp TTEEEEEECCCCCCBHHHHHTSSS--CCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSSSCCCEEECC
T ss_pred CCEEEEEEecCCCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHH---HcCCCcccccccceeecCCCceEEEEcc
Confidence 578999999999999999997543 23899999999999999999999 8999999999999999854 4789999
Q ss_pred ecceeecccCCCCcccccccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCC
Q 044494 81 FGVARLLNFDSSNRTLLAGTYGYIAPELAYTMVVTEKSDVYSFGVVALEVLMGKHPGELLS 141 (144)
Q Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~d~~slg~~l~~~~~g~~p~~~~~ 141 (144)
||++..... ........+++.|++||...+..++.++|+||+||++|+|++|..||...+
T Consensus 148 FG~~~~~~~-~~~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~ 207 (321)
T d1tkia_ 148 FGQARQLKP-GDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAET 207 (321)
T ss_dssp CTTCEECCT-TCEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSS
T ss_pred cchhhcccc-CCcccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCC
Confidence 999987542 223344678999999999999999999999999999999999999998754
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-36 Score=202.47 Aligned_cols=134 Identities=31% Similarity=0.473 Sum_probs=113.8
Q ss_pred CceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeeec
Q 044494 3 RKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADFG 82 (144)
Q Consensus 3 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~~ 82 (144)
++.+|+||||+++|+|.+++..... ..+++..+..++.|++.||+||| +++++||||||+||+++.++.+||+|||
T Consensus 79 ~~~~~iv~Ey~~~g~L~~~~~~~~~-~~l~~~~~~~i~~qi~~gl~~lH---~~~ivHrDiKp~NIll~~~~~~Kl~DFG 154 (272)
T d1qpca_ 79 QEPIYIITEYMENGSLVDFLKTPSG-IKLTINKLLDMAAQIAEGMAFIE---ERNYIHRDLRAANILVSDTLSCKIADFG 154 (272)
T ss_dssp SSSCEEEEECCTTCBHHHHTTSHHH-HTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECCCT
T ss_pred cCCeEEEEEeCCCCcHHHHHhhcCC-CCCCHHHHHHHHHHHHHHHHHHH---hCCcccCccchhheeeecccceeecccc
Confidence 4567999999999999998765332 34899999999999999999999 8999999999999999999999999999
Q ss_pred ceeecccCC-CCcccccccccccCccccccCCCCCcchhHHHHHHHHHHHhC-CCCCCCC
Q 044494 83 VARLLNFDS-SNRTLLAGTYGYIAPELAYTMVVTEKSDVYSFGVVALEVLMG-KHPGELL 140 (144)
Q Consensus 83 ~~~~~~~~~-~~~~~~~~~~~~~~pe~~~~~~~~~~~d~~slg~~l~~~~~g-~~p~~~~ 140 (144)
+++...... .......+++.|+|||++....++.++|+||+|+++|||++| .+||...
T Consensus 155 la~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~ 214 (272)
T d1qpca_ 155 LARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGM 214 (272)
T ss_dssp TCEECSSSCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTC
T ss_pred ceEEccCCccccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCC
Confidence 998765322 223345688899999999988899999999999999999995 5555543
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=4.5e-36 Score=202.85 Aligned_cols=135 Identities=25% Similarity=0.332 Sum_probs=114.3
Q ss_pred CCceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeee
Q 044494 2 HRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADF 81 (144)
Q Consensus 2 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~ 81 (144)
+++.+|+||||+++|+|.+++.+.. ...+++..+..++.|++.||+||| +++++||||||+||+++.++.+||+||
T Consensus 84 ~~~~~~iv~E~~~~g~l~~~l~~~~-~~~~~~~~~~~i~~qi~~gL~yLH---~~~iiHrDlKp~NILl~~~~~~Kl~DF 159 (287)
T d1opja_ 84 REPPFYIITEFMTYGNLLDYLRECN-RQEVSAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADF 159 (287)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHSC-TTTSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCC
T ss_pred eCCeeEEEeecccCcchHHHhhhcc-ccchHHHHHHHHHHHHHHHHHHHH---HCCcccCccccCeEEECCCCcEEEccc
Confidence 4578899999999999999987532 234899999999999999999999 889999999999999999999999999
Q ss_pred cceeecccCCC-CcccccccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCC-CCCC
Q 044494 82 GVARLLNFDSS-NRTLLAGTYGYIAPELAYTMVVTEKSDVYSFGVVALEVLMGKHP-GELL 140 (144)
Q Consensus 82 ~~~~~~~~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~d~~slg~~l~~~~~g~~p-~~~~ 140 (144)
|+++....... ......+++.|+|||++....++.++|+||+|+++|||++|..| |...
T Consensus 160 G~a~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~ 220 (287)
T d1opja_ 160 GLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGI 220 (287)
T ss_dssp CCTTTCCSSSSEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred cceeecCCCCceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcc
Confidence 99986543222 22334578899999999999999999999999999999996555 4443
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-35 Score=195.97 Aligned_cols=135 Identities=28% Similarity=0.445 Sum_probs=117.5
Q ss_pred CCceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeee
Q 044494 2 HRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADF 81 (144)
Q Consensus 2 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~ 81 (144)
.++.+++||||+++|+|.+++..... .+++..+..++.|++.|++||| +.|++||||||+||+++.++.+||+||
T Consensus 70 ~~~~~~iv~Ey~~~g~l~~~~~~~~~--~~~~~~~~~i~~qi~~gl~~LH---~~~iiH~dlk~~Nill~~~~~~kl~Df 144 (258)
T d1k2pa_ 70 KQRPIFIITEYMANGCLLNYLREMRH--RFQTQQLLEMCKDVCEAMEYLE---SKQFLHRDLAARNCLVNDQGVVKVSDF 144 (258)
T ss_dssp CSSSEEEEEECCTTEEHHHHHHSGGG--CCCHHHHHHHHHHHHHHHHHHH---HTTBCCSCCSGGGEEECTTCCEEECCC
T ss_pred eCCceEEEEEccCCCcHHHhhhcccc--CCcHHHHHHHHHHHHHHHHHHh---hcCcccccccceeEEEcCCCcEEECcc
Confidence 45789999999999999998765333 3889999999999999999999 889999999999999999999999999
Q ss_pred cceeecccCCC-CcccccccccccCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCC
Q 044494 82 GVARLLNFDSS-NRTLLAGTYGYIAPELAYTMVVTEKSDVYSFGVVALEVLM-GKHPGELLS 141 (144)
Q Consensus 82 ~~~~~~~~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~d~~slg~~l~~~~~-g~~p~~~~~ 141 (144)
|+++....... ......+++.|+|||.+....++.++|+||+|+++|||++ |..||+..+
T Consensus 145 G~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~ 206 (258)
T d1k2pa_ 145 GLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFT 206 (258)
T ss_dssp SSCCBCSSSSCCCCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSC
T ss_pred hhheeccCCCceeecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCC
Confidence 99976543322 2333568889999999999999999999999999999998 899998765
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.9e-36 Score=199.95 Aligned_cols=135 Identities=28% Similarity=0.410 Sum_probs=107.0
Q ss_pred CceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeeec
Q 044494 3 RKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADFG 82 (144)
Q Consensus 3 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~~ 82 (144)
++.+|+||||+++|+|.+++.... ..+++..++.++.|++.|++||| +++++||||||+||+++.++.+|++|||
T Consensus 79 ~~~~~iv~E~~~~g~l~~~~~~~~--~~l~~~~~~~~~~qi~~gl~ylH---~~~iiHrDlKp~NIll~~~~~~Kl~DfG 153 (273)
T d1mp8a_ 79 ENPVWIIMELCTLGELRSFLQVRK--YSLDLASLILYAYQLSTALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFG 153 (273)
T ss_dssp SSSCEEEEECCTTEEHHHHHHHTT--TTSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECC--
T ss_pred cCeEEEEEEeccCCcHHhhhhccC--CCCCHHHHHHHHHHHHHHhhhhc---ccCeeccccchhheeecCCCcEEEccch
Confidence 567899999999999999876432 23899999999999999999999 8999999999999999999999999999
Q ss_pred ceeecccCC-CCcccccccccccCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCC
Q 044494 83 VARLLNFDS-SNRTLLAGTYGYIAPELAYTMVVTEKSDVYSFGVVALEVLM-GKHPGELLSS 142 (144)
Q Consensus 83 ~~~~~~~~~-~~~~~~~~~~~~~~pe~~~~~~~~~~~d~~slg~~l~~~~~-g~~p~~~~~~ 142 (144)
+++...... .......+++.|+|||.+....++.++|+||+|+++|||++ |..||...+.
T Consensus 154 ~a~~~~~~~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~ 215 (273)
T d1mp8a_ 154 LSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKN 215 (273)
T ss_dssp -----------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCG
T ss_pred hheeccCCcceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCH
Confidence 998654322 22333567889999999999999999999999999999998 8999987654
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5e-35 Score=199.14 Aligned_cols=133 Identities=24% Similarity=0.322 Sum_probs=113.6
Q ss_pred CceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeeec
Q 044494 3 RKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADFG 82 (144)
Q Consensus 3 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~~ 82 (144)
+..++++|||+.++.+...... ....+++..+..++.|++.||+||| +++++||||||+||+++..+.++++|||
T Consensus 87 ~~~~~~~~e~~~~~~~~~~~~~--~~~~~~~~~~~~~~~qi~~aL~yLH---~~~ivHrDiKp~NILi~~~~~~kl~dfg 161 (305)
T d1blxa_ 87 ETKLTLVFEHVDQDLTTYLDKV--PEPGVPTETIKDMMFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFG 161 (305)
T ss_dssp EEEEEEEEECCSCBHHHHHHHS--CTTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECSCC
T ss_pred CceEEEEEEeccCCchhhhhhc--cCCCCCHHHHHHHHHHHHHHHHHHH---hCCEEecCCCccEEEEcCCCCeeecchh
Confidence 3568999999988766544433 2234899999999999999999999 8999999999999999999999999999
Q ss_pred ceeecccCCCCcccccccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCC
Q 044494 83 VARLLNFDSSNRTLLAGTYGYIAPELAYTMVVTEKSDVYSFGVVALEVLMGKHPGELLS 141 (144)
Q Consensus 83 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~d~~slg~~l~~~~~g~~p~~~~~ 141 (144)
.+..... ........||+.|+|||++.+..++.++|+||+||++|||++|..||.+.+
T Consensus 162 ~~~~~~~-~~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~ 219 (305)
T d1blxa_ 162 LARIYSF-QMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSS 219 (305)
T ss_dssp SCCCCCG-GGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred hhhhhcc-cccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCC
Confidence 9875432 223345679999999999999999999999999999999999999998654
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.5e-35 Score=196.74 Aligned_cols=131 Identities=27% Similarity=0.313 Sum_probs=111.4
Q ss_pred CCceEEEEEeeccC-CCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCC-CCeEEe
Q 044494 2 HRKCMFLIYEYMEM-GSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLE-LEAFVA 79 (144)
Q Consensus 2 ~~~~~~lv~e~~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~-~~~~l~ 79 (144)
.++.+|+||||+.+ +++.+++.+... +++..+..++.|++.||+||| +++++||||||+||+++.+ +.++++
T Consensus 80 ~~~~~~lv~e~~~~~~~l~~~~~~~~~---l~e~~~~~~~~qi~~al~~lH---~~~iiHrDiKp~NIll~~~~~~vkl~ 153 (273)
T d1xwsa_ 80 RPDSFVLILERPEPVQDLFDFITERGA---LQEELARSFFWQVLEAVRHCH---NCGVLHRDIKDENILIDLNRGELKLI 153 (273)
T ss_dssp CSSEEEEEEECCSSEEEHHHHHHHHCS---CCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEETTTTEEEEC
T ss_pred eCCeEEEEEEeccCcchHHHHHhccCC---CCHHHHHHHHHHHHHHHHHHH---HCCCccccCcccceEEecCCCeEEEC
Confidence 35678999999976 577777765443 999999999999999999999 8999999999999999855 789999
Q ss_pred eecceeecccCCCCcccccccccccCccccccCCC-CCcchhHHHHHHHHHHHhCCCCCCCC
Q 044494 80 DFGVARLLNFDSSNRTLLAGTYGYIAPELAYTMVV-TEKSDVYSFGVVALEVLMGKHPGELL 140 (144)
Q Consensus 80 d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~-~~~~d~~slg~~l~~~~~g~~p~~~~ 140 (144)
|||++..... .......||+.|+|||++.+..+ +.++|+||+||++|+|++|..||...
T Consensus 154 DFG~a~~~~~--~~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~ 213 (273)
T d1xwsa_ 154 DFGSGALLKD--TVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD 213 (273)
T ss_dssp CCTTCEECCS--SCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSH
T ss_pred ccccceeccc--ccccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCc
Confidence 9999986542 22344679999999999987765 56789999999999999999999763
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=5.6e-34 Score=193.06 Aligned_cols=134 Identities=21% Similarity=0.249 Sum_probs=114.7
Q ss_pred CceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcC-----CCCeE
Q 044494 3 RKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNL-----ELEAF 77 (144)
Q Consensus 3 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~-----~~~~~ 77 (144)
+...++||||+ +++|.++++... ..++..++..++.|++.++++|| ++|++||||||+||+++. .+.++
T Consensus 73 ~~~~~~vme~~-~~~l~~~~~~~~--~~~~~~~~~~i~~q~~~~l~~lH---~~giiHrDiKp~Nili~~~~~~~~~~vk 146 (293)
T d1csna_ 73 GLHNVLVIDLL-GPSLEDLLDLCG--RKFSVKTVAMAAKQMLARVQSIH---EKSLVYRDIKPDNFLIGRPNSKNANMIY 146 (293)
T ss_dssp TTEEEEEEECC-CCBHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECCSSSTTTTCEE
T ss_pred CCccEEEEEec-CCCHHHHHHhhc--cchhhHHHHHHHHHHHHHHHHHH---HCCceeccCCccceeecCcccccCCceE
Confidence 56789999999 689999887533 23899999999999999999999 999999999999999974 56799
Q ss_pred EeeecceeecccCC-------CCcccccccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCC
Q 044494 78 VADFGVARLLNFDS-------SNRTLLAGTYGYIAPELAYTMVVTEKSDVYSFGVVALEVLMGKHPGELLSS 142 (144)
Q Consensus 78 l~d~~~~~~~~~~~-------~~~~~~~~~~~~~~pe~~~~~~~~~~~d~~slg~~l~~~~~g~~p~~~~~~ 142 (144)
++|||+++...... .......||+.|+|||.+.+..++.++|+||+|+++|||++|..||++.+.
T Consensus 147 l~DFG~a~~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~ 218 (293)
T d1csna_ 147 VVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKA 218 (293)
T ss_dssp ECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCS
T ss_pred EcccceeEEcccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccc
Confidence 99999998764221 122345799999999999999999999999999999999999999987654
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-34 Score=196.12 Aligned_cols=137 Identities=27% Similarity=0.397 Sum_probs=118.5
Q ss_pred CCceEEEEEeeccCCCHHHHhhccc-------------ccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcE
Q 044494 2 HRKCMFLIYEYMEMGSLFCVLRTDE-------------EAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNI 68 (144)
Q Consensus 2 ~~~~~~lv~e~~~~~~L~~~l~~~~-------------~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni 68 (144)
+++.+|+||||+++|+|.+++.... ....+++.+++.++.|++.||+||| +.+++||||||+||
T Consensus 90 ~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH---~~~ivHrDiKp~Ni 166 (299)
T d1fgka_ 90 QDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNV 166 (299)
T ss_dssp SSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGE
T ss_pred cCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhh---hCCEEeeeecccce
Confidence 4677899999999999999997532 1234899999999999999999999 89999999999999
Q ss_pred EEcCCCCeEEeeecceeecccCCC--CcccccccccccCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCC
Q 044494 69 LLNLELEAFVADFGVARLLNFDSS--NRTLLAGTYGYIAPELAYTMVVTEKSDVYSFGVVALEVLM-GKHPGELLS 141 (144)
Q Consensus 69 ~~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~d~~slg~~l~~~~~-g~~p~~~~~ 141 (144)
+++.++.+||+|||++........ ......+++.|+|||.+....++.++|+||||+++|||++ |..||+..+
T Consensus 167 Ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~ 242 (299)
T d1fgka_ 167 LVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP 242 (299)
T ss_dssp EECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred eecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCC
Confidence 999999999999999987653322 2334568889999999999999999999999999999998 799997654
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.4e-35 Score=195.64 Aligned_cols=134 Identities=25% Similarity=0.375 Sum_probs=113.7
Q ss_pred CceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeeec
Q 044494 3 RKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADFG 82 (144)
Q Consensus 3 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~~ 82 (144)
++.+++||||+++|++.+++..... .+++..++.++.|++.||.||| +++++||||||+||+++.++.++++|||
T Consensus 82 ~~~~~lv~e~~~~~~l~~~~~~~~~--~l~~~~~~~~~~qi~~gl~ylH---~~~iiHrDikp~NIll~~~~~vkl~DfG 156 (273)
T d1u46a_ 82 TPPMKMVTELAPLGSLLDRLRKHQG--HFLLGTLSRYAVQVAEGMGYLE---SKRFIHRDLAARNLLLATRDLVKIGDFG 156 (273)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHHGG--GSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEEEETTEEEECCCT
T ss_pred ecchheeeeeecCcchhhhhhcccC--CCCHHHHHHHHHHHHHHHHHhh---hCCEeeeeecHHHhccccccceeeccch
Confidence 4567999999999999998775332 3899999999999999999999 8999999999999999999999999999
Q ss_pred ceeecccCCCC---cccccccccccCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCC
Q 044494 83 VARLLNFDSSN---RTLLAGTYGYIAPELAYTMVVTEKSDVYSFGVVALEVLM-GKHPGELLS 141 (144)
Q Consensus 83 ~~~~~~~~~~~---~~~~~~~~~~~~pe~~~~~~~~~~~d~~slg~~l~~~~~-g~~p~~~~~ 141 (144)
+++........ .....++..|+|||.+.+..++.++|+||||+++|||++ |..||.+.+
T Consensus 157 l~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~ 219 (273)
T d1u46a_ 157 LMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLN 219 (273)
T ss_dssp TCEECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCC
T ss_pred hhhhcccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcC
Confidence 99876432221 223456788999999999999999999999999999998 899998754
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-34 Score=196.02 Aligned_cols=134 Identities=22% Similarity=0.341 Sum_probs=113.5
Q ss_pred CceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeeec
Q 044494 3 RKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADFG 82 (144)
Q Consensus 3 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~~ 82 (144)
++++|+||||+.+ .+.+++... ....+++..+..++.|++.||+||| ++|++||||||+||+++.++.++++|||
T Consensus 73 ~~~~~iv~e~~~~-~~~~~~~~~-~~~~l~e~~~~~~~~qil~~L~yLH---~~~IiHrDiKpeNIl~~~~~~~kl~DFG 147 (298)
T d1gz8a_ 73 ENKLYLVFEFLHQ-DLKKFMDAS-ALTGIPLPLIKSYLFQLLQGLAFCH---SHRVLHRDLKPQNLLINTEGAIKLADFG 147 (298)
T ss_dssp TTEEEEEEECCSE-EHHHHHHHT-TTTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECSTT
T ss_pred ccceeEEEeecCC-chhhhhhhh-cccCCCHHHHHHHHHHHHHHHHHhh---cCCEEccccCchheeecccCcceeccCC
Confidence 5688999999975 555555432 2234999999999999999999999 8999999999999999999999999999
Q ss_pred ceeecccCCCCcccccccccccCccccccCC-CCCcchhHHHHHHHHHHHhCCCCCCCCC
Q 044494 83 VARLLNFDSSNRTLLAGTYGYIAPELAYTMV-VTEKSDVYSFGVVALEVLMGKHPGELLS 141 (144)
Q Consensus 83 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~-~~~~~d~~slg~~l~~~~~g~~p~~~~~ 141 (144)
.++.............+++.|+|||...... ++.++|+||+|+++|+|++|..||.+.+
T Consensus 148 ~a~~~~~~~~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~ 207 (298)
T d1gz8a_ 148 LARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDS 207 (298)
T ss_dssp HHHHHCCCSBCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred cceeccCCcccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCC
Confidence 9987665444455567999999999877665 4789999999999999999999997643
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-34 Score=194.08 Aligned_cols=133 Identities=35% Similarity=0.451 Sum_probs=106.8
Q ss_pred CCceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeee
Q 044494 2 HRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADF 81 (144)
Q Consensus 2 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~ 81 (144)
+.+..++||||+.++++.+.+.... ..+++..+..++.|++.|++||| +.+++||||||+||+++.++.+||+||
T Consensus 80 ~~~~~~~v~e~~~~~~l~~~~~~~~--~~~~~~~~~~i~~~i~~gl~~lH---~~~iiHrDlKp~NILl~~~~~~Kl~DF 154 (283)
T d1mqba_ 80 KYKPMMIITEYMENGALDKFLREKD--GEFSVLQLVGMLRGIAAGMKYLA---NMNYVHRDLAARNILVNSNLVCKVSDF 154 (283)
T ss_dssp SSSSEEEEEECCTTEEHHHHHHHTT--TCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCC
T ss_pred cCCceEEEEEecccCcchhhhhccc--ccccHHHHHHHHHHHHHhhhhcc---ccccccCccccceEEECCCCeEEEccc
Confidence 4577899999999999998876533 23899999999999999999999 889999999999999999999999999
Q ss_pred cceeecccCCCC---cccccccccccCccccccCCCCCcchhHHHHHHHHHHHhCC-CCCCC
Q 044494 82 GVARLLNFDSSN---RTLLAGTYGYIAPELAYTMVVTEKSDVYSFGVVALEVLMGK-HPGEL 139 (144)
Q Consensus 82 ~~~~~~~~~~~~---~~~~~~~~~~~~pe~~~~~~~~~~~d~~slg~~l~~~~~g~-~p~~~ 139 (144)
|+++........ .....+++.|+|||++....++.++|+||+|+++|||+++. .|+..
T Consensus 155 Gla~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~ 216 (283)
T d1mqba_ 155 GLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWE 216 (283)
T ss_dssp CC-----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTT
T ss_pred chhhcccCCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCcccc
Confidence 999865432221 22345788999999999999999999999999999999954 44544
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-34 Score=198.08 Aligned_cols=135 Identities=25% Similarity=0.406 Sum_probs=114.5
Q ss_pred CceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeeec
Q 044494 3 RKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADFG 82 (144)
Q Consensus 3 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~~ 82 (144)
++..++++||+.+++|.+.+.... ..+++..++.++.|++.||.||| +++++||||||+||+++.++.+||+|||
T Consensus 82 ~~~~~~v~e~~~~~~l~~~~~~~~--~~~~~~~~~~i~~qi~~gl~yLH---~~~iiHrDlKp~NIll~~~~~~kl~DFG 156 (317)
T d1xkka_ 82 TSTVQLITQLMPFGCLLDYVREHK--DNIGSQYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFG 156 (317)
T ss_dssp SSSEEEEEECCTTCBHHHHHHHTS--SSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEEETTEEEECCCS
T ss_pred cCCeeEEEEeccCCcccccccccc--cCCCHHHHHHHHHHHHHHHHHHH---HcCcccCcchhhcceeCCCCCeEeeccc
Confidence 456789999999999999887533 34899999999999999999999 8899999999999999999999999999
Q ss_pred ceeecccCCCC--cccccccccccCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCC
Q 044494 83 VARLLNFDSSN--RTLLAGTYGYIAPELAYTMVVTEKSDVYSFGVVALEVLM-GKHPGELLSS 142 (144)
Q Consensus 83 ~~~~~~~~~~~--~~~~~~~~~~~~pe~~~~~~~~~~~d~~slg~~l~~~~~-g~~p~~~~~~ 142 (144)
+++........ .....+|+.|+|||.+.+..++.++|+||+|+++|||++ |..||++.+.
T Consensus 157 la~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~ 219 (317)
T d1xkka_ 157 LAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA 219 (317)
T ss_dssp HHHHTTTTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCG
T ss_pred cceecccccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCH
Confidence 99866432222 223457899999999999999999999999999999998 8999987654
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.8e-35 Score=194.18 Aligned_cols=133 Identities=27% Similarity=0.399 Sum_probs=108.8
Q ss_pred CceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeeec
Q 044494 3 RKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADFG 82 (144)
Q Consensus 3 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~~ 82 (144)
++.+|+||||+++|+|.+++.+... ..+++..+..++.|++.|+.||| +.+++||||||+||+++.++.++++|||
T Consensus 73 ~~~~~lv~ey~~~g~L~~~l~~~~~-~~l~~~~~~~i~~~i~~al~ylH---~~~ivH~dlkp~Nil~~~~~~~kl~dfg 148 (262)
T d1byga_ 73 KGGLYIVTEYMAKGSLVDYLRSRGR-SVLGGDCLLKFSLDVCEAMEYLE---GNNFVHRDLAARNVLVSEDNVAKVSDFG 148 (262)
T ss_dssp --CCEEEECCCTTEEHHHHHHHHHH-HHCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTSCEEECCCC
T ss_pred CCcEEEEEeccCCCCHHHHHHhcCC-CCCCHHHHHHHHHHHHhhccccc---cCceeccccchHhheecCCCCEeecccc
Confidence 3568999999999999999975321 23899999999999999999999 8899999999999999999999999999
Q ss_pred ceeecccCCCCcccccccccccCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCC
Q 044494 83 VARLLNFDSSNRTLLAGTYGYIAPELAYTMVVTEKSDVYSFGVVALEVLM-GKHPGELLSS 142 (144)
Q Consensus 83 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~d~~slg~~l~~~~~-g~~p~~~~~~ 142 (144)
+++.... ......+++.|+|||.+.+..++.++|+||||+++|||++ |..||...+.
T Consensus 149 ~s~~~~~---~~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~ 206 (262)
T d1byga_ 149 LTKEASS---TQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL 206 (262)
T ss_dssp C---------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCG
T ss_pred cceecCC---CCccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCH
Confidence 9986542 2233457889999999999999999999999999999998 7889887654
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6e-34 Score=193.71 Aligned_cols=132 Identities=28% Similarity=0.434 Sum_probs=109.8
Q ss_pred ceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcC-----CCCCeEecCCCCCcEEEcCCCCeEE
Q 044494 4 KCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHD-----CTPPIVHRDISSNNILLNLELEAFV 78 (144)
Q Consensus 4 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~-----~~~~~~h~~i~~~ni~~~~~~~~~l 78 (144)
..+|+||||+++|+|.+++++. .+++.....++.|++.|+.++|.. ++++++||||||+||+++.++.+||
T Consensus 74 ~~~~lv~Ey~~~g~L~~~l~~~----~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl 149 (303)
T d1vjya_ 74 TQLWLVSDYHEHGSLFDYLNRY----TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCI 149 (303)
T ss_dssp EEEEEEEECCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEE
T ss_pred eEEEEEEecccCCCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEE
Confidence 3689999999999999999753 288999999999999999999942 1369999999999999999999999
Q ss_pred eeecceeecccCCC----CcccccccccccCccccccCC------CCCcchhHHHHHHHHHHHhCCCCCCC
Q 044494 79 ADFGVARLLNFDSS----NRTLLAGTYGYIAPELAYTMV------VTEKSDVYSFGVVALEVLMGKHPGEL 139 (144)
Q Consensus 79 ~d~~~~~~~~~~~~----~~~~~~~~~~~~~pe~~~~~~------~~~~~d~~slg~~l~~~~~g~~p~~~ 139 (144)
+|||++........ ......||+.|+|||++.... ++.++|+||||+++|||++|..||..
T Consensus 150 ~DFGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~ 220 (303)
T d1vjya_ 150 ADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGI 220 (303)
T ss_dssp CCCTTCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTB
T ss_pred EecCccccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCc
Confidence 99999987653322 223467899999999987543 45689999999999999999887754
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-34 Score=194.08 Aligned_cols=133 Identities=32% Similarity=0.437 Sum_probs=107.7
Q ss_pred CceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeeec
Q 044494 3 RKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADFG 82 (144)
Q Consensus 3 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~~ 82 (144)
++.+|+||||+++|+|..++.... ...+++..++.++.|++.|+++|| +.+++||||||+||+++.++.+||+|||
T Consensus 83 ~~~~~lv~Ey~~~g~l~~~~~~~~-~~~l~~~~~~~i~~~i~~gl~~LH---~~~ivH~DlKp~NIll~~~~~~kl~DfG 158 (285)
T d1fmka3 83 EEPIYIVTEYMSKGSLLDFLKGET-GKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFG 158 (285)
T ss_dssp SSSCEEEECCCTTCBHHHHHSHHH-HTTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCCC
T ss_pred cCCeEEEEEecCCCchhhhhhhcc-cccchHHHHHHHHHHHHHHHHHHh---hhheecccccceEEEECCCCcEEEcccc
Confidence 456799999999999999887532 234899999999999999999999 8899999999999999999999999999
Q ss_pred ceeecccC-CCCcccccccccccCccccccCCCCCcchhHHHHHHHHHHHhCCC-CCCC
Q 044494 83 VARLLNFD-SSNRTLLAGTYGYIAPELAYTMVVTEKSDVYSFGVVALEVLMGKH-PGEL 139 (144)
Q Consensus 83 ~~~~~~~~-~~~~~~~~~~~~~~~pe~~~~~~~~~~~d~~slg~~l~~~~~g~~-p~~~ 139 (144)
+++..... ........+++.|+|||.+....++.++|+||+|+++|||++|.. |+..
T Consensus 159 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~ 217 (285)
T d1fmka3 159 LARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPG 217 (285)
T ss_dssp TTC--------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTT
T ss_pred hhhhccCCCceeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCC
Confidence 99865422 222333568899999999999999999999999999999999554 4443
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-33 Score=194.64 Aligned_cols=134 Identities=25% Similarity=0.264 Sum_probs=109.4
Q ss_pred ceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCC-CeEEeeec
Q 044494 4 KCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLEL-EAFVADFG 82 (144)
Q Consensus 4 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~-~~~l~d~~ 82 (144)
.++|+||||+.++.+............+++..+..++.|++.||+||| ++|++||||||+||+++.++ .+||+|||
T Consensus 92 ~~~~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH---~~~IiHrDiKp~NILl~~~~~~~kl~DFG 168 (350)
T d1q5ka_ 92 VYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFG 168 (350)
T ss_dssp CEEEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECTTTCCEEECCCT
T ss_pred eEEEEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHH---hcCCcccCCCcceEEEecCCCceeEeccc
Confidence 457899999986543333332233345999999999999999999999 99999999999999999775 88999999
Q ss_pred ceeecccCCCCcccccccccccCcccccc-CCCCCcchhHHHHHHHHHHHhCCCCCCCCC
Q 044494 83 VARLLNFDSSNRTLLAGTYGYIAPELAYT-MVVTEKSDVYSFGVVALEVLMGKHPGELLS 141 (144)
Q Consensus 83 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~-~~~~~~~d~~slg~~l~~~~~g~~p~~~~~ 141 (144)
++...... .......|++.|+|||.+.. ..++.++|+||+||++|||++|..||...+
T Consensus 169 ~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~ 227 (350)
T d1q5ka_ 169 SAKQLVRG-EPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDS 227 (350)
T ss_dssp TCEECCTT-SCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSS
T ss_pred chhhccCC-cccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCC
Confidence 99876432 23344678999999998765 468999999999999999999999997654
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-33 Score=193.15 Aligned_cols=134 Identities=28% Similarity=0.394 Sum_probs=115.6
Q ss_pred CceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeeec
Q 044494 3 RKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADFG 82 (144)
Q Consensus 3 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~~ 82 (144)
++.++++|||+.+|+|.+++..... +++..+..++.|++.|++|+| +++++||||||+||+++.++.++|+|||
T Consensus 101 ~~~~~~v~e~~~~~~L~~~i~~~~~---~~e~~~~~~~~Qi~~al~~lH---~~~ivHrDiKp~Nill~~~~~vkL~DFG 174 (322)
T d1vzoa_ 101 ETKLHLILDYINGGELFTHLSQRER---FTEHEVQIYVGEIVLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFG 174 (322)
T ss_dssp TTEEEEEECCCCSCBHHHHHHHHSC---CCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEESCSS
T ss_pred CCceeeeeecccccHHHHHHHhccc---ccHHHHHHHHHHHHHHHHHhh---cCCEEeccCCccceeecCCCCEEEeecc
Confidence 5678999999999999999976544 789999999999999999999 8999999999999999999999999999
Q ss_pred ceeecccC-CCCcccccccccccCccccccC--CCCCcchhHHHHHHHHHHHhCCCCCCCCCC
Q 044494 83 VARLLNFD-SSNRTLLAGTYGYIAPELAYTM--VVTEKSDVYSFGVVALEVLMGKHPGELLSS 142 (144)
Q Consensus 83 ~~~~~~~~-~~~~~~~~~~~~~~~pe~~~~~--~~~~~~d~~slg~~l~~~~~g~~p~~~~~~ 142 (144)
+++..... ........+++.|++||.+... .++.++|+||+||++|+|++|..||...+.
T Consensus 175 ~a~~~~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~ 237 (322)
T d1vzoa_ 175 LSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGE 237 (322)
T ss_dssp EEEECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTS
T ss_pred chhhhcccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCH
Confidence 99876433 2234456789999999998754 467789999999999999999999987654
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-33 Score=193.02 Aligned_cols=136 Identities=29% Similarity=0.410 Sum_probs=114.6
Q ss_pred CCceEEEEEeeccCCCHHHHhhcc-------------cccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcE
Q 044494 2 HRKCMFLIYEYMEMGSLFCVLRTD-------------EEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNI 68 (144)
Q Consensus 2 ~~~~~~lv~e~~~~~~L~~~l~~~-------------~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni 68 (144)
.++.+|+||||+++|+|.+++++. .....+++..+..++.|++.|+.|+| +++++||||||+||
T Consensus 82 ~~~~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH---~~~iiHrDlkp~NI 158 (309)
T d1fvra_ 82 HRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNI 158 (309)
T ss_dssp ETTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGE
T ss_pred cCCeeEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhh---cCCccccccccceE
Confidence 356789999999999999999753 12345899999999999999999999 89999999999999
Q ss_pred EEcCCCCeEEeeecceeecccCCCCcccccccccccCccccccCCCCCcchhHHHHHHHHHHHhCC-CCCCCCC
Q 044494 69 LLNLELEAFVADFGVARLLNFDSSNRTLLAGTYGYIAPELAYTMVVTEKSDVYSFGVVALEVLMGK-HPGELLS 141 (144)
Q Consensus 69 ~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~d~~slg~~l~~~~~g~-~p~~~~~ 141 (144)
+++.++.+||+|||+++..... .......+++.|+|||.+....++.++|+||||+++|||++|. .||...+
T Consensus 159 L~~~~~~~kl~DfG~a~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~ 231 (309)
T d1fvra_ 159 LVGENYVAKIADFGLSRGQEVY-VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT 231 (309)
T ss_dssp EECGGGCEEECCTTCEESSCEE-CCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCC
T ss_pred EEcCCCceEEcccccccccccc-ccccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCC
Confidence 9999999999999999754422 2233456889999999999999999999999999999999965 6787654
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.7e-33 Score=190.11 Aligned_cols=134 Identities=20% Similarity=0.317 Sum_probs=111.5
Q ss_pred CceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcC---CCCeEEe
Q 044494 3 RKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNL---ELEAFVA 79 (144)
Q Consensus 3 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~---~~~~~l~ 79 (144)
++..++||||+ ++++.+.+.... ..+++..+..++.|++.||++|| ++|++||||||+||++.. +..++++
T Consensus 75 ~~~~~ivme~~-~~~l~~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH---~~~iiHrDiKp~NIl~~~~~~~~~vkl~ 148 (299)
T d1ckia_ 75 GDYNVMVMELL-GPSLEDLFNFCS--RKFSLKTVLLLADQMISRIEYIH---SKNFIHRDVKPDNFLMGLGKKGNLVYII 148 (299)
T ss_dssp TTEEEEEEECC-CCBHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECCGGGTTCEEEC
T ss_pred CCEEEEEEEEc-CCchhhhhhhcc--CCCcHHHHHHHHHHHHHHHHHHH---HCCeeeccCCHhhccccccCCCceeeee
Confidence 46788999999 457777665422 23999999999999999999999 899999999999999864 4579999
Q ss_pred eecceeecccCCC-------CcccccccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCC
Q 044494 80 DFGVARLLNFDSS-------NRTLLAGTYGYIAPELAYTMVVTEKSDVYSFGVVALEVLMGKHPGELLSS 142 (144)
Q Consensus 80 d~~~~~~~~~~~~-------~~~~~~~~~~~~~pe~~~~~~~~~~~d~~slg~~l~~~~~g~~p~~~~~~ 142 (144)
|||+++....... ......||+.|+|||.+.+..++.++|+||+|++++||++|..||...+.
T Consensus 149 DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~ 218 (299)
T d1ckia_ 149 DFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKA 218 (299)
T ss_dssp CCSSCEECBCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-
T ss_pred ccCcceeccccccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccch
Confidence 9999987653221 12345799999999999999999999999999999999999999987543
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=1.5e-33 Score=190.36 Aligned_cols=134 Identities=24% Similarity=0.340 Sum_probs=110.3
Q ss_pred CCceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeee
Q 044494 2 HRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADF 81 (144)
Q Consensus 2 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~ 81 (144)
+++..|++||++.++.+..+.+..+ .+++..+..++.|++.||+||| +.+++||||||+||+++.++.++++||
T Consensus 71 ~~~~~~i~~e~~~~~~~~~~~~~~~---~l~~~~~~~i~~qi~~~L~~LH---~~~IvHrDiKp~NIll~~~~~~kl~Df 144 (286)
T d1ob3a_ 71 TKKRLVLVFEHLDQDLKKLLDVCEG---GLESVTAKSFLLQLLNGIAYCH---DRRVLHRDLKPQNLLINREGELKIADF 144 (286)
T ss_dssp CSSCEEEEEECCSEEHHHHHHTSTT---CCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECCT
T ss_pred cCCceeEEEEeehhhhHHHHHhhcC---CcchhhhHHHHHHHHHHHHHhc---cCcEEecCCCCceeeEcCCCCEEeccc
Confidence 4678899999998766666655433 3999999999999999999999 889999999999999999999999999
Q ss_pred cceeecccCCCCcccccccccccCccccccC-CCCCcchhHHHHHHHHHHHhCCCCCCCCC
Q 044494 82 GVARLLNFDSSNRTLLAGTYGYIAPELAYTM-VVTEKSDVYSFGVVALEVLMGKHPGELLS 141 (144)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~-~~~~~~d~~slg~~l~~~~~g~~p~~~~~ 141 (144)
|.+..............+++.|++||.+... .++.++|+||+|++++||++|+.||...+
T Consensus 145 G~a~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~ 205 (286)
T d1ob3a_ 145 GLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVS 205 (286)
T ss_dssp THHHHHCC---------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred ccceecccCccccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCC
Confidence 9998766444445556789999999998755 46899999999999999999999997653
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.7e-33 Score=191.29 Aligned_cols=137 Identities=28% Similarity=0.406 Sum_probs=114.2
Q ss_pred CCceEEEEEeeccCCCHHHHhhccc---------------------ccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEe
Q 044494 2 HRKCMFLIYEYMEMGSLFCVLRTDE---------------------EAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVH 60 (144)
Q Consensus 2 ~~~~~~lv~e~~~~~~L~~~l~~~~---------------------~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h 60 (144)
..+..+++|||+++|+|.+++.... ....+++..+..++.|++.|++||| +++++|
T Consensus 87 ~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH---~~~ivH 163 (301)
T d1lufa_ 87 VGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLS---ERKFVH 163 (301)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHH---HTTCCC
T ss_pred cCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcc---cCCeEe
Confidence 3567899999999999999986421 1234888999999999999999999 899999
Q ss_pred cCCCCCcEEEcCCCCeEEeeecceeecccCC--CCcccccccccccCccccccCCCCCcchhHHHHHHHHHHHhCC-CCC
Q 044494 61 RDISSNNILLNLELEAFVADFGVARLLNFDS--SNRTLLAGTYGYIAPELAYTMVVTEKSDVYSFGVVALEVLMGK-HPG 137 (144)
Q Consensus 61 ~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~~~~~pe~~~~~~~~~~~d~~slg~~l~~~~~g~-~p~ 137 (144)
|||||+||+++.++.+||+|||+++...... .......+++.|+|||.+....++.++|+||||+++|||++|. .||
T Consensus 164 rDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~ 243 (301)
T d1lufa_ 164 RDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPY 243 (301)
T ss_dssp SCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTT
T ss_pred eEEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCC
Confidence 9999999999999999999999997654322 2233456888999999999999999999999999999999985 678
Q ss_pred CCCC
Q 044494 138 ELLS 141 (144)
Q Consensus 138 ~~~~ 141 (144)
...+
T Consensus 244 ~~~~ 247 (301)
T d1lufa_ 244 YGMA 247 (301)
T ss_dssp TTSC
T ss_pred CCCC
Confidence 7654
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.9e-33 Score=189.76 Aligned_cols=132 Identities=27% Similarity=0.363 Sum_probs=113.1
Q ss_pred CceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeeec
Q 044494 3 RKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADFG 82 (144)
Q Consensus 3 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~~ 82 (144)
++..++||||+++|+|.+++..... ..++..+..++.|++.|+.|+| +.+++||||||+||+++.++.++|+|||
T Consensus 101 ~~~~~lv~E~~~~g~l~~~~~~~~~--~~~~~~~~~i~~qia~gL~~lH---~~~iiHrDLK~~NILl~~~~~~kL~DFG 175 (311)
T d1r0pa_ 101 EGSPLVVLPYMKHGDLRNFIRNETH--NPTVKDLIGFGLQVAKGMKFLA---SKKFVHRDLAARNCMLDEKFTVKVADFG 175 (311)
T ss_dssp TTEEEEEEECCTTCBHHHHHHCTTC--CCBHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTCCEEECSSG
T ss_pred CCceEEEEEEeecCchhhhhccccc--cchHHHHHHHHHHHHHhhhhhc---ccCcccCCccHHhEeECCCCCEEEeccc
Confidence 4578999999999999998875432 3778889999999999999999 8899999999999999999999999999
Q ss_pred ceeecccCCCC----cccccccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCC
Q 044494 83 VARLLNFDSSN----RTLLAGTYGYIAPELAYTMVVTEKSDVYSFGVVALEVLMGKHPGEL 139 (144)
Q Consensus 83 ~~~~~~~~~~~----~~~~~~~~~~~~pe~~~~~~~~~~~d~~slg~~l~~~~~g~~p~~~ 139 (144)
+++........ .....+++.|+|||.+....++.++|+||||+++|||++|..||..
T Consensus 176 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~ 236 (311)
T d1r0pa_ 176 LARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYP 236 (311)
T ss_dssp GGCCTTTTTCCCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC
T ss_pred chhhccccccccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCC
Confidence 99866432221 2224678999999999999999999999999999999997777654
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-32 Score=190.13 Aligned_cols=129 Identities=26% Similarity=0.361 Sum_probs=108.7
Q ss_pred eEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeeecce
Q 044494 5 CMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADFGVA 84 (144)
Q Consensus 5 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~~~~ 84 (144)
.+|+ ++|+.+|+|.+++... .+++..+..++.|++.||+||| ++|++||||||+||+++.++.++|+|||++
T Consensus 85 ~~~l-~~~~~~g~L~~~l~~~----~l~~~~i~~i~~qil~al~yLH---~~~iiHRDIKp~NILl~~~~~~kl~DfG~a 156 (345)
T d1pmea_ 85 DVYL-VTHLMGADLYKLLKTQ----HLSNDHICYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLA 156 (345)
T ss_dssp CEEE-EEECCCEEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred eEEE-EEeecCCchhhhhhcC----CCCHHHHHHHHHHHHHHHHHHH---HCCCcCCCCCcceEEECCCCCEEEcccCce
Confidence 3444 5566789999999753 3899999999999999999999 899999999999999999999999999999
Q ss_pred eecccCCC---CcccccccccccCcccccc-CCCCCcchhHHHHHHHHHHHhCCCCCCCCC
Q 044494 85 RLLNFDSS---NRTLLAGTYGYIAPELAYT-MVVTEKSDVYSFGVVALEVLMGKHPGELLS 141 (144)
Q Consensus 85 ~~~~~~~~---~~~~~~~~~~~~~pe~~~~-~~~~~~~d~~slg~~l~~~~~g~~p~~~~~ 141 (144)
........ ......+++.|+|||++.. ..++.++|+||+|+++++|++|..||...+
T Consensus 157 ~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~ 217 (345)
T d1pmea_ 157 RVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKH 217 (345)
T ss_dssp EECCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred eeccCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCC
Confidence 86543221 2344568999999999854 456889999999999999999999997654
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.98 E-value=5.1e-33 Score=189.71 Aligned_cols=137 Identities=28% Similarity=0.428 Sum_probs=116.1
Q ss_pred CceEEEEEeeccCCCHHHHhhccc---------------ccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCc
Q 044494 3 RKCMFLIYEYMEMGSLFCVLRTDE---------------EAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNN 67 (144)
Q Consensus 3 ~~~~~lv~e~~~~~~L~~~l~~~~---------------~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~n 67 (144)
++.+|+||||+++|+|.+++++.. ....+++..+..++.|++.|++||| +++++||||||+|
T Consensus 99 ~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH---~~~ivHrDLKp~N 175 (311)
T d1t46a_ 99 GGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLA---SKNCIHRDLAARN 175 (311)
T ss_dssp SSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGG
T ss_pred CCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccccccc
Confidence 456899999999999999987532 1234889999999999999999999 8999999999999
Q ss_pred EEEcCCCCeEEeeecceeecccCCC--CcccccccccccCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCC
Q 044494 68 ILLNLELEAFVADFGVARLLNFDSS--NRTLLAGTYGYIAPELAYTMVVTEKSDVYSFGVVALEVLM-GKHPGELLSS 142 (144)
Q Consensus 68 i~~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~d~~slg~~l~~~~~-g~~p~~~~~~ 142 (144)
|+++.++.++++|||.++....... ......+++.|+|||.+....++.++|+||||+++|||++ |.+||+..+.
T Consensus 176 Il~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~ 253 (311)
T d1t46a_ 176 ILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPV 253 (311)
T ss_dssp EEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCS
T ss_pred ccccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCH
Confidence 9999999999999999986653222 2233578999999999999999999999999999999998 6777766543
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.98 E-value=9.1e-33 Score=188.88 Aligned_cols=133 Identities=20% Similarity=0.274 Sum_probs=109.5
Q ss_pred CceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeeec
Q 044494 3 RKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADFG 82 (144)
Q Consensus 3 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~~ 82 (144)
++.+|+||||+.++.+........ .+++..+..++.|++.|+.||| ++|++||||||+||+++.++.++++|||
T Consensus 89 ~~~~~iv~e~~~~~~~~~~~~~~~---~~~~~~~~~i~~qil~~l~~lH---~~~ivHrDlKp~NILl~~~~~~kl~dfg 162 (318)
T d3blha1 89 KGSIYLVFDFCEHDLAGLLSNVLV---KFTLSEIKRVMQMLLNGLYYIH---RNKILHRDMKAANVLITRDGVLKLADFG 162 (318)
T ss_dssp --CEEEEEECCCEEHHHHHTCTTC---CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTSCEEECCCT
T ss_pred CceEEEEEeccCCCccchhhhccc---ccccHHHHHHHHHHHHHHHHhc---cCCEEecCcCchheeecCCCcEEeeecc
Confidence 456899999998766554443322 3899999999999999999999 8999999999999999999999999999
Q ss_pred ceeecccCC----CCcccccccccccCccccccC-CCCCcchhHHHHHHHHHHHhCCCCCCCCC
Q 044494 83 VARLLNFDS----SNRTLLAGTYGYIAPELAYTM-VVTEKSDVYSFGVVALEVLMGKHPGELLS 141 (144)
Q Consensus 83 ~~~~~~~~~----~~~~~~~~~~~~~~pe~~~~~-~~~~~~d~~slg~~l~~~~~g~~p~~~~~ 141 (144)
++....... .......+|+.|+|||.+.+. .+++++|+||+|+++++|++|+.||.+.+
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~ 226 (318)
T d3blha1 163 LARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNT 226 (318)
T ss_dssp TCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred eeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCC
Confidence 997654221 122335689999999998765 57899999999999999999999997643
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=4.1e-32 Score=187.55 Aligned_cols=127 Identities=27% Similarity=0.368 Sum_probs=109.9
Q ss_pred ceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeeecc
Q 044494 4 KCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADFGV 83 (144)
Q Consensus 4 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~~~ 83 (144)
..+|+||||+ +.+|....+.. .+++..+..++.|++.||+||| ++|++||||||+||+++.++.++++|||.
T Consensus 96 ~~~~lv~e~~-~~~l~~~~~~~----~l~~~~~~~~~~qi~~aL~~LH---~~~IiHrDiKp~NIL~~~~~~~kl~Dfg~ 167 (346)
T d1cm8a_ 96 TDFYLVMPFM-GTDLGKLMKHE----KLGEDRIQFLVYQMLKGLRYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGL 167 (346)
T ss_dssp CCCEEEEECC-SEEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTT
T ss_pred ceEEEEEecc-cccHHHHHHhc----cccHHHHHHHHHHHHHHHHHHH---hCCCcccccCcchhhcccccccccccccc
Confidence 3579999999 56777766542 3999999999999999999999 89999999999999999999999999999
Q ss_pred eeecccCCCCcccccccccccCccccccC-CCCCcchhHHHHHHHHHHHhCCCCCCCCC
Q 044494 84 ARLLNFDSSNRTLLAGTYGYIAPELAYTM-VVTEKSDVYSFGVVALEVLMGKHPGELLS 141 (144)
Q Consensus 84 ~~~~~~~~~~~~~~~~~~~~~~pe~~~~~-~~~~~~d~~slg~~l~~~~~g~~p~~~~~ 141 (144)
+..... ......+++.|+|||.+.+. .++.++|+||+||++++|++|..||...+
T Consensus 168 a~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~ 223 (346)
T d1cm8a_ 168 ARQADS---EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSD 223 (346)
T ss_dssp CEECCS---SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred eeccCC---ccccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCC
Confidence 987543 23346689999999998764 46889999999999999999999997654
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=99.97 E-value=8.1e-32 Score=184.86 Aligned_cols=128 Identities=19% Similarity=0.266 Sum_probs=109.6
Q ss_pred CceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCC-CeEEeee
Q 044494 3 RKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLEL-EAFVADF 81 (144)
Q Consensus 3 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~-~~~l~d~ 81 (144)
.+.+++||||+.+++|..+.+ .+++..+..++.|++.||+||| ++|++||||||+||+++.++ .++++||
T Consensus 104 ~~~~~~v~e~~~~~~L~~~~~------~l~e~~i~~i~~qil~aL~~LH---~~gIvHrDiKp~NILi~~~~~~vkl~DF 174 (328)
T d3bqca1 104 SRTPALVFEHVNNTDFKQLYQ------TLTDYDIRFYMYEILKALDYCH---SMGIMHRDVKPHNVMIDHEHRKLRLIDW 174 (328)
T ss_dssp TCSEEEEEECCCSCBGGGTTT------SCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTTTEEEECCG
T ss_pred CCceeEEEeecCCCcHHHHhc------CCCHHHHHHHHHHHHHHHHHHh---hcccccccccccceEEcCCCCeeeeccc
Confidence 456899999999999876543 2899999999999999999999 89999999999999998765 5899999
Q ss_pred cceeecccCCCCcccccccccccCccccccC-CCCCcchhHHHHHHHHHHHhCCCCCCCC
Q 044494 82 GVARLLNFDSSNRTLLAGTYGYIAPELAYTM-VVTEKSDVYSFGVVALEVLMGKHPGELL 140 (144)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~-~~~~~~d~~slg~~l~~~~~g~~p~~~~ 140 (144)
|.+...... .......+|+.|+|||.+... .++.++|+||+|++++++++|..||...
T Consensus 175 G~a~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~ 233 (328)
T d3bqca1 175 GLAEFYHPG-QEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHG 233 (328)
T ss_dssp GGCEECCTT-CCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCC
T ss_pred ccceeccCC-CcccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCC
Confidence 999876532 223445689999999998765 4689999999999999999999999654
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=6.8e-32 Score=183.88 Aligned_cols=137 Identities=26% Similarity=0.345 Sum_probs=116.0
Q ss_pred CCceEEEEEeeccCCCHHHHhhcc-------cccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCC
Q 044494 2 HRKCMFLIYEYMEMGSLFCVLRTD-------EEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLEL 74 (144)
Q Consensus 2 ~~~~~~lv~e~~~~~~L~~~l~~~-------~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~ 74 (144)
.++..++||||+++|+|.+++... .....+++..+..++.|++.||.||| +++++||||||+||+++.++
T Consensus 94 ~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH---~~~ivHrDlk~~NiLld~~~ 170 (308)
T d1p4oa_ 94 QGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDF 170 (308)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHH---HTTCBCSCCSGGGEEECTTC
T ss_pred cCCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHh---hCCeeeceEcCCceeecCCc
Confidence 456789999999999999988642 12234788999999999999999999 88999999999999999999
Q ss_pred CeEEeeecceeecccCCC--CcccccccccccCccccccCCCCCcchhHHHHHHHHHHHhC-CCCCCCCC
Q 044494 75 EAFVADFGVARLLNFDSS--NRTLLAGTYGYIAPELAYTMVVTEKSDVYSFGVVALEVLMG-KHPGELLS 141 (144)
Q Consensus 75 ~~~l~d~~~~~~~~~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~d~~slg~~l~~~~~g-~~p~~~~~ 141 (144)
.+||+|||+++....... ......+++.|++||.+....++.++|+||+|+++|||++| ..||...+
T Consensus 171 ~~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~ 240 (308)
T d1p4oa_ 171 TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLS 240 (308)
T ss_dssp CEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSC
T ss_pred eEEEeecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCC
Confidence 999999999986543222 12334688999999999999999999999999999999997 57887654
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=4e-31 Score=178.60 Aligned_cols=132 Identities=20% Similarity=0.287 Sum_probs=114.0
Q ss_pred CCceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeee
Q 044494 2 HRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADF 81 (144)
Q Consensus 2 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~ 81 (144)
+....++|+|++.++++..++..... +++..+..++.|++.||+||| +++++||||||+||+++.++.++++||
T Consensus 72 ~~~~~~iv~~~~~~~~l~~~~~~~~~---~~~~~~~~~~~q~~~aL~~lH---~~~IvHrDiKP~NIli~~~~~~kl~DF 145 (292)
T d1unla_ 72 SDKKLTLVFEFCDQDLKKYFDSCNGD---LDPEIVKSFLFQLLKGLGFCH---SRNVLHRDLKPQNLLINRNGELKLANF 145 (292)
T ss_dssp CSSEEEEEEECCSEEHHHHHHHTTTC---CCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCC
T ss_pred cccceeEEeeeccccccccccccccc---cchhHHHHHHHHHHHHHHHhh---cCCEeeecccCcccccccCCceeeeec
Confidence 45678999999999888887765433 899999999999999999999 899999999999999999999999999
Q ss_pred cceeecccCCCCcccccccccccCccccccCC-CCCcchhHHHHHHHHHHHhCCCCCCC
Q 044494 82 GVARLLNFDSSNRTLLAGTYGYIAPELAYTMV-VTEKSDVYSFGVVALEVLMGKHPGEL 139 (144)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~-~~~~~d~~slg~~l~~~~~g~~p~~~ 139 (144)
|.+..............+++.|.|||.+.... ++.++|+||+||+++||++|..||..
T Consensus 146 G~a~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~ 204 (292)
T d1unla_ 146 GLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFP 204 (292)
T ss_dssp TTCEECCSCCSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCC
T ss_pred chhhcccCCCccceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCC
Confidence 99987765444445556778899999987665 58899999999999999999998743
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=2.7e-31 Score=184.05 Aligned_cols=129 Identities=26% Similarity=0.324 Sum_probs=103.0
Q ss_pred CceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeeec
Q 044494 3 RKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADFG 82 (144)
Q Consensus 3 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~~ 82 (144)
.+.+|+||||+.++ +.+.+.. .+++..+..++.|++.|+++|| ++|++||||||+||+++.++.++++||+
T Consensus 94 ~~~~~iv~Ey~~~~-l~~~~~~-----~~~~~~i~~~~~qil~gl~~LH---~~giiHrDlKP~Nil~~~~~~~kl~df~ 164 (355)
T d2b1pa1 94 FQDVYLVMELMDAN-LCQVIQM-----ELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFG 164 (355)
T ss_dssp CCEEEEEEECCSEE-HHHHHTS-----CCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCCC
T ss_pred CceeEEEEeccchH-HHHhhhc-----CCCHHHHHHHHHHHHHHHHHhh---hcccccccCCccccccccccceeeechh
Confidence 46789999999765 4444432 2899999999999999999999 8999999999999999999999999999
Q ss_pred ceeecccCCCCcccccccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCC
Q 044494 83 VARLLNFDSSNRTLLAGTYGYIAPELAYTMVVTEKSDVYSFGVVALEVLMGKHPGELLS 141 (144)
Q Consensus 83 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~d~~slg~~l~~~~~g~~p~~~~~ 141 (144)
+++..... .......+|+.|+|||.+.+..+++++|+||+||++++|++|..||.+.+
T Consensus 165 ~~~~~~~~-~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~ 222 (355)
T d2b1pa1 165 LARTAGTS-FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRD 222 (355)
T ss_dssp C----------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred hhhccccc-cccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCC
Confidence 88765432 23344568999999999999999999999999999999999999997654
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=1.8e-31 Score=184.33 Aligned_cols=128 Identities=23% Similarity=0.321 Sum_probs=106.6
Q ss_pred ceEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeeecc
Q 044494 4 KCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADFGV 83 (144)
Q Consensus 4 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~~~ 83 (144)
...+++++|+.+|+|.+++..+ .+++..+..++.|++.||+||| ++|++||||||+||+++.++.++++|||.
T Consensus 95 ~~~~~i~~~~~gg~L~~~~~~~----~l~e~~~~~i~~qil~aL~~LH---~~giiHrDiKp~NILi~~~~~~kl~dfg~ 167 (348)
T d2gfsa1 95 FNDVYLVTHLMGADLNNIVKCQ----KLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGL 167 (348)
T ss_dssp CCCCEEEEECCSEEHHHHHTTC----CCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECCC--
T ss_pred CceEEEEEeecCCchhhhcccc----cccHHHHHHHHHHHHHHHHHHH---hCCCcccccCCccccccccccccccccch
Confidence 3456677888899999998643 3999999999999999999999 89999999999999999999999999999
Q ss_pred eeecccCCCCcccccccccccCccccccCC-CCCcchhHHHHHHHHHHHhCCCCCCCCC
Q 044494 84 ARLLNFDSSNRTLLAGTYGYIAPELAYTMV-VTEKSDVYSFGVVALEVLMGKHPGELLS 141 (144)
Q Consensus 84 ~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~-~~~~~d~~slg~~l~~~~~g~~p~~~~~ 141 (144)
+.... .......+++.|+|||...+.. ++.++|+||+|+++|+|++|..||.+.+
T Consensus 168 a~~~~---~~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~ 223 (348)
T d2gfsa1 168 ARHTD---DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 223 (348)
T ss_dssp --CCT---GGGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred hcccC---cccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCC
Confidence 87543 2234456889999999876654 5789999999999999999999997654
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=99.94 E-value=2.3e-27 Score=164.29 Aligned_cols=132 Identities=22% Similarity=0.262 Sum_probs=103.0
Q ss_pred eEEEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCC------eEE
Q 044494 5 CMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELE------AFV 78 (144)
Q Consensus 5 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~------~~l 78 (144)
..+++++++..+..............+++..+..++.|++.|+.+||+ ..|++||||||+||+++.++. +++
T Consensus 96 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~--~~~IvHrDlKp~NIll~~~~~~~~~~~~kl 173 (362)
T d1q8ya_ 96 GVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHR--RCGIIHTDIKPENVLMEIVDSPENLIQIKI 173 (362)
T ss_dssp EEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHH--TTCEECSCCSGGGEEEEEEETTTTEEEEEE
T ss_pred ceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhh--hcCcccccCChhHeeeeccCcccccceeeE
Confidence 345666666554443333333344558999999999999999999993 379999999999999987653 899
Q ss_pred eeecceeecccCCCCcccccccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCC
Q 044494 79 ADFGVARLLNFDSSNRTLLAGTYGYIAPELAYTMVVTEKSDVYSFGVVALEVLMGKHPGELLS 141 (144)
Q Consensus 79 ~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~d~~slg~~l~~~~~g~~p~~~~~ 141 (144)
+|||.+..... ......+++.|+|||++....++.++|+||+|+++++|++|..||...+
T Consensus 174 ~dfg~s~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~ 233 (362)
T d1q8ya_ 174 ADLGNACWYDE---HYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDE 233 (362)
T ss_dssp CCCTTCEETTB---CCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC----
T ss_pred eeccccccccc---ccccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCc
Confidence 99999876442 2344568999999999999999999999999999999999999997644
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.57 E-value=1.2e-15 Score=96.42 Aligned_cols=103 Identities=16% Similarity=0.167 Sum_probs=69.5
Q ss_pred EEEEeeccCCCHHHHhhcccccCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEeeecceee
Q 044494 7 FLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHDCTPPIVHRDISSNNILLNLELEAFVADFGVARL 86 (144)
Q Consensus 7 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~~~~~~ 86 (144)
+++|||++++.+.+ ++...+..++.|++.++.+|| ++|++||||||+||+++.++ ++++|||.+..
T Consensus 86 ~lvme~~~~~~~~~----------l~~~~~~~i~~ql~~~l~~lH---~~giiHrDiKP~NILv~~~~-~~liDFG~a~~ 151 (191)
T d1zara2 86 AVLMELIDAKELYR----------VRVENPDEVLDMILEEVAKFY---HRGIVHGDLSQYNVLVSEEG-IWIIDFPQSVE 151 (191)
T ss_dssp EEEEECCCCEEGGG----------CCCSCHHHHHHHHHHHHHHHH---HTTEECSCCSTTSEEEETTE-EEECCCTTCEE
T ss_pred EEEEEeeccccccc----------hhhHHHHHHHHHHHHHHHHHh---hCCEEEccCChhheeeeCCC-EEEEECCCccc
Confidence 68999998755432 334445678999999999999 89999999999999999655 88999999876
Q ss_pred cccCCCCcccccccccccCccccccCCCCCcchhHHHHHH
Q 044494 87 LNFDSSNRTLLAGTYGYIAPELAYTMVVTEKSDVYSFGVV 126 (144)
Q Consensus 87 ~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~d~~slg~~ 126 (144)
...+.. .......... ..+.+ ...|+.++|+||+.--
T Consensus 152 ~~~~~~-~~~l~rd~~~-~~~~f-~r~y~~~~d~~s~~~~ 188 (191)
T d1zara2 152 VGEEGW-REILERDVRN-IITYF-SRTYRTEKDINSAIDR 188 (191)
T ss_dssp TTSTTH-HHHHHHHHHH-HHHHH-HHHHCCCCCHHHHHHH
T ss_pred CCCCCc-HHHHHHHHHH-HHHHH-cCCCCCcccHHHHHHH
Confidence 542211 1100000000 00111 3456778999998643
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=97.68 E-value=6.9e-05 Score=48.05 Aligned_cols=30 Identities=20% Similarity=0.230 Sum_probs=25.6
Q ss_pred CeEecCCCCCcEEEcCCCCeEEeeecceee
Q 044494 57 PIVHRDISSNNILLNLELEAFVADFGVARL 86 (144)
Q Consensus 57 ~~~h~~i~~~ni~~~~~~~~~l~d~~~~~~ 86 (144)
.++|+|+.|.|++++.++.+.++||+.+..
T Consensus 184 ~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T d1j7la_ 184 VFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp EEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred EEEEeeccCcceeecCCceEEEeechhccc
Confidence 489999999999999876667999987764
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.09 E-value=0.00023 Score=45.27 Aligned_cols=30 Identities=20% Similarity=0.158 Sum_probs=25.8
Q ss_pred CeEecCCCCCcEEEcCCCCeEEeeecceee
Q 044494 57 PIVHRDISSNNILLNLELEAFVADFGVARL 86 (144)
Q Consensus 57 ~~~h~~i~~~ni~~~~~~~~~l~d~~~~~~ 86 (144)
.++|+|+.|.|++++.+..+.|+||+.+..
T Consensus 176 ~liHgD~~~~Nvl~~~~~~~~iID~~~~~~ 205 (255)
T d1nd4a_ 176 VVTHGDACLPNIMVENGRFSGFIDCGRLGV 205 (255)
T ss_dssp EEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred eEEeCCCCCcceEEeCCceEEEEEchhccc
Confidence 489999999999999876677999987764
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=96.07 E-value=0.00088 Score=44.00 Aligned_cols=32 Identities=19% Similarity=0.210 Sum_probs=28.2
Q ss_pred CCCeEecCCCCCcEEEcCCCCeEEeeecceee
Q 044494 55 TPPIVHRDISSNNILLNLELEAFVADFGVARL 86 (144)
Q Consensus 55 ~~~~~h~~i~~~ni~~~~~~~~~l~d~~~~~~ 86 (144)
..|++|+|+.+.|++++.+....++||+.+..
T Consensus 182 ~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~~ 213 (316)
T d2ppqa1 182 PAGVIHADLFQDNVFFLGDELSGLIDFYFACN 213 (316)
T ss_dssp CEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred ccccccCCcchhhhhcccccceeEeccccccc
Confidence 56899999999999999887778999997764
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=93.17 E-value=0.024 Score=38.28 Aligned_cols=31 Identities=19% Similarity=0.228 Sum_probs=26.2
Q ss_pred CCCeEecCCCCCcEEEcCCCCeEEeeecceee
Q 044494 55 TPPIVHRDISSNNILLNLELEAFVADFGVARL 86 (144)
Q Consensus 55 ~~~~~h~~i~~~ni~~~~~~~~~l~d~~~~~~ 86 (144)
...++|+|+.+.||+++.+. ++++|+..+..
T Consensus 222 ~~~LiHGDl~~gNIlv~~~~-~~vID~E~a~~ 252 (392)
T d2pula1 222 AETLIHGDLHTGSIFASEHE-TKVIDPEFAFY 252 (392)
T ss_dssp CCEEECSCCCGGGEEECSSC-EEECCCTTCEE
T ss_pred CcceeccCCcCCceeEcCCc-eEEechhhccc
Confidence 45799999999999998765 89999987764
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=92.51 E-value=0.22 Score=32.35 Aligned_cols=47 Identities=23% Similarity=0.217 Sum_probs=30.6
Q ss_pred HHHHHHHHHHHHHh-cCCCCCeEecCCCCCcEEEcCCCCeEEeeecceee
Q 044494 38 NIVKGMAHALSYLH-HDCTPPIVHRDISSNNILLNLELEAFVADFGVARL 86 (144)
Q Consensus 38 ~~~~~l~~~l~~lh-~~~~~~~~h~~i~~~ni~~~~~~~~~l~d~~~~~~ 86 (144)
..+..+...+.-.- ..-..+++|+|+.+.|++++.+ ..++||+-+..
T Consensus 173 ~~~~~l~~~l~~~~~~~~p~~liHgDlh~~NvL~~~~--~~~IDFdd~~~ 220 (325)
T d1zyla1 173 KATDELIAAVTAHWREDFTVLRLHGDCHAGNILWRDG--PMFVDLDDARN 220 (325)
T ss_dssp HHHHHHHHHHHHHCCSCSCCEECCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred HHHHHHHHHHHHhccccCCceeecCCCCcccEEEeCC--ceEEechhccc
Confidence 33444444444332 1114579999999999999743 56899987764
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=89.50 E-value=0.084 Score=35.47 Aligned_cols=30 Identities=30% Similarity=0.459 Sum_probs=23.3
Q ss_pred CeEecCCCCCcEEEcC----------------------------CCCeEEeeecceee
Q 044494 57 PIVHRDISSNNILLNL----------------------------ELEAFVADFGVARL 86 (144)
Q Consensus 57 ~~~h~~i~~~ni~~~~----------------------------~~~~~l~d~~~~~~ 86 (144)
.++|+|+.+.||++.. ++.++++||..+..
T Consensus 219 v~CHnDL~~~NiL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~lID~EYa~~ 276 (395)
T d1nw1a_ 219 TFCHNDLQEGNILLPKASSGNIRMPSLSDETQALGNSLSAFNPADPRLVLIDFEYASY 276 (395)
T ss_dssp EEECSCCCGGGEEEEC------------------------------CCEECCCTTCEE
T ss_pred eEEecCCCcccEeeccccccccccccccccccccccccccccCCCCcEEEEeecccCC
Confidence 4789999999999843 45688999987764
|